PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jackson, GR; Salecker, I; Dong, XZ; Yao, X; Arnheim, N; Faber, PW; MacDonald, ME; Zipursky, SL				Jackson, GR; Salecker, I; Dong, XZ; Yao, X; Arnheim, N; Faber, PW; MacDonald, ME; Zipursky, SL			Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons	NEURON			English	Article							MACHADO-JOSEPH DISEASE; SPINOCEREBELLAR ATAXIA TYPE-2; PROGRAMMED CELL-DEATH; CAG REPEAT EXPANSION; INTRANUCLEAR INCLUSIONS; NEUROLOGICAL PHENOTYPE; PALLIDOLUYSIAN ATROPHY; TRINUCLEOTIDE REPEAT; EMBRYONIC LETHALITY; GENE HOMOLOG	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. Disease alleles contain a trinucleotide repeat expansion of variable length, which encodes polyglutamine tracts near the amino terminus of the HD protein, huntingtin. Polyglutamine-expanded huntingtin, but not normal huntingtin, forms nuclear inclusions. We describe a Drosophila model for HD. Amino-terminal fragments of human huntingtin containing tracts of 2, 75, and 120 glutamine residues were expressed in photoreceptor neurons in the compound eye. As in human neurons, polyglutamine-expanded huntingtin induced neuronal degeneration. The age of onset and severity of neuronal degeneration correlated with repeat length, and nuclear localization of huntingtin presaged neuronal degeneration. In contrast to other cell death paradigms in Drosophila, coexpression of the Viral antiapoptotic protein, P35, did not rescue the cell death phenotype induced by polyglutamine-expanded huntingtin.	Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ So Calif, Sch Med, Program Mol Biol, Los Angeles, CA 90089 USA; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; Harvard University; Massachusetts General Hospital	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.		; Salecker, Iris/V-1228-2018	Zipursky, Stephen/0000-0001-5630-7181; Salecker, Iris/0000-0003-3775-7763; Arnheim, Norman/0000-0003-1247-1347	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, R01NS032765, P01NS016367] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32765, NS16367] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGAPITE J, 1997, MOL CELLULAR APPROAC, P264; AKAI H, 1967, SCIENCE, V157, P810, DOI 10.1126/science.157.3790.810; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; [Anonymous], ADV NEUROL; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CANCEL G, 1995, AM J HUM GENET, V57, P809; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Davies SW, 1998, LANCET, V351, P131, DOI 10.1016/S0140-6736(97)08360-8; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Folstein S.E., 1989, HUNTINGTONS DIS DISO; Franceschini N., 1972, INFORMATION PROCESSI, P75; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; GARTNER LP, 1976, J GERONTOL, V31, P396, DOI 10.1093/geronj/31.4.396; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GUSELLA JF, 1995, CURR OPIN NEUROBIOL, V5, P656, DOI 10.1016/0959-4388(95)80072-7; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; HABERHAUSEN G, 1995, J NEUROL SCI, V132, P71, DOI 10.1016/0022-510X(95)90927-I; Hackam AS, 1998, CLIN GENET, V53, P233; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; HAY BA, 1994, DEVELOPMENT, V120, P2121; Higgins JJ, 1996, NEUROLOGY, V46, P208, DOI 10.1212/WNL.46.1.208; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; LINDSLEY D, 1992, GENOME DRISOPHILA ME; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; MIYAKE T, 1987, MOL GEN GENET, V207, P29, DOI 10.1007/BF00331487; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; ONODERA O, 1995, AM J HUM GENET, V57, P1050; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PEEL DJ, 1990, TISSUE CELL, V22, P749, DOI 10.1016/0040-8166(90)90069-L; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Riess O, 1997, HUM MOL GENET, V6, P1289, DOI 10.1093/hmg/6.8.1289; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STELLER H, 1994, PHILOS T ROY SOC B, V345, P247, DOI 10.1098/rstb.1994.0101; SUGIYAMA H, 1994, J FOOD HYG SOC JPN, V35, P13, DOI 10.3358/shokueishi.35.13; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YOUSSEF NN, 1975, TISSUE CELL, V7, P655, DOI 10.1016/0040-8166(75)90034-8; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	79	392	419	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					633	642		10.1016/S0896-6273(00)80573-5	http://dx.doi.org/10.1016/S0896-6273(00)80573-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768849	Bronze			2022-12-24	WOS:000076196400019
J	Stevens, CF; Wesseling, JF				Stevens, CF; Wesseling, JF			Activity-dependent modulation of the rate at which synaptic vesicles become available to undergo exocytosis	NEURON			English	Article							SHORT-TERM ENHANCEMENT; SQUID GIANT SYNAPSE; PRESYNAPTIC CALCIUM; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; TRANSMITTER RELEASE; SYMPATHETIC NEURONS; CHROMAFFIN CELLS; PAIRED-PULSE; DEPRESSION	The number of vesicles contained in the readily releasable pool at excitatory hippocampal synapses has recently been identified as a major determinant of the strength of these synapses. Here, we show that the rate at which this pool refills following depletion is variable from neuron to neuron and can be increased by the accumulation of intracellular calcium during action potential-mediated activation of the synapses. The refilling rate nearly doubles during the first second of a high frequency train of action potentials and does not increase further with additional stimulation. During periods of rest, the rate relaxes back to its original value, with a time constant of about 10 s. Since this refilling rate helps set the strength of synapses during high frequency bursts of action potentials and is modulated by physiological signaling, it is an attractive candidate point of control in the storage and manipulation of information by the central nervous system.	Salk Inst, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA.		Wesseling, John F/AAB-7941-2019	Wesseling, John F/0000-0002-7565-2594	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 12961] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADLER EM, 1991, J NEUROSCI, V11, P1496; ALTURI PP, 1996, J NEUROSCI, V16, P5661; Banker G., 1991, CULTURING NERVE CELL; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; Cummings DD, 1996, J NEUROSCI, V16, P5312; DELANEY KR, 1994, J NEUROSCI, V14, P5885; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HUBBARD JI, 1963, J PHYSIOL-LONDON, V169, P641, DOI 10.1113/jphysiol.1963.sp007286; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ PS, 1993, J NEUROSCI, V13, P3075; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; REGEHR WG, 1994, J NEUROSCI, V14, P523; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; TAKEUCHI AKIRA, 1958, JAPANESE JOUR PHYSIOL, V8, P102; Tank DW, 1995, J NEUROSCI, V15, P7940; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Varela JA, 1997, J NEUROSCI, V17, P7926; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WU LG, 1994, J NEUROSCI, V14, P645; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	42	243	247	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					415	424		10.1016/S0896-6273(00)80550-4	http://dx.doi.org/10.1016/S0896-6273(00)80550-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728922	Bronze			2022-12-24	WOS:000075598300018
J	Waggoner, LE; Zhou, GT; Schafer, RW; Schafer, WR				Waggoner, LE; Zhou, GT; Schafer, RW; Schafer, WR			Control of alternative behavioral states by serotonin in Caenorhabditis elegans	NEURON			English	Article							PROTEIN-KINASE-C; NERVOUS-SYSTEM; NEMATODE; MODULATION; VOLTAGE; NEURONS; MUTANTS; GENE; G(O)	Serotonin has been implicated in the regulation of a wide range of brain functions involving alternative behavioral states, including the control of mood, aggression, sex, and sleep. Here, we report that in the nematode Caenorhabditis elegans, serotonin controls a switch between two distinct, on/off states of egg-laying behavior. Through quantitative analysis of the temporal pattern of egg-laying events, we determined that egg laying can be modeled as a novel random process, in which animals fluctuate between discrete behavioral states: an active state, during which eggs are laid in clusters, and an inactive state, during which eggs are retained. Single-cell ablation experiments indicate that two pairs of motor neurons, HSNL/HSNR and VC4/VC5, can induce the active phase by releasing serotonin. These neurons also release acetylcholine, which appears to trigger individual egg-laying events within the active phase. Genetic experiments suggest that determination of the behavioral states observed for C. elegans egg laying may be mediated through protein kinase C-dependent (PKC-dependent) modulation of voltage-gated calcium channels.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30322 USA	University of California System; University of California San Diego; University System of Georgia; Georgia Institute of Technology	Schafer, WR (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.			Schafer, William/0000-0002-6676-8034				AVERY L, 1995, C ELEGANS, V2; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; BOLAND LM, 1991, J NEUROSCI, V11, P1140; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CROLL NA, 1975, CAN J ZOOL, V53, P894, DOI 10.1139/z75-103; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DRISCOLL M, 1997, C ELEGANS, V2; Extein Irl L., 1993, Journal of Addictive Diseases, V12, P29, DOI 10.1300/J069v12n03_04; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; HIRAKAWA Y, 1995, AM J PHYSIOL-HEART C, V268, pH544, DOI 10.1152/ajpheart.1995.268.2.H544; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; HUBER R, 1995, BRAIN BEHAV EVOLUT, V46, P72, DOI 10.1159/000113260; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KUPFERMANN I, 1991, PHYSIOL REV, V71, P683, DOI 10.1152/physrev.1991.71.3.683; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; Marder E, 1995, INVERTEBR NEUROSCI, V1, P105, DOI 10.1007/BF02331908; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; MESTON CM, 1992, J PSYCHOACTIVE DRUGS, V24, P1; NELSON ID, 1994, GEN PHARMACOL, V25, P539, DOI 10.1016/0306-3623(94)90212-7; OLIVIER B, 1992, BIOL PSYCHIAT, V16, P847; Portas CM, 1996, J NEUROSCI, V16, P2820; Priess JR, 1997, C ELEGANS; Rand J.B., 1997, C ELEGANS, VII; SANDOU F, 1994, SCIENCE, V265, P1875; SANO T, 1995, J MOL BIOL, V251, P477, DOI 10.1006/jmbi.1995.0449; Sawin E. R., 1996, THESIS MIT CAMBRIDGE; SCHINKMANN K, 1992, J COMP NEUROL, V316, P251, DOI 10.1002/cne.903160209; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SOUBRIE P, 1988, NEURONAL SEROTONIN; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TABUSE Y, 1989, SCIENCE, V243, P1713, DOI 10.1126/science.2538925; THOMAS JH, 1993, GENETICS, V134, P1105; TRENT C, 1983, GENETICS, V104, P619; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WORLEY JF, 1991, AM J PHYSIOL, V261, pH1951, DOI 10.1152/ajpheart.1991.261.6.H1951; YANG MM, 1995, BRIT J PHARMACOL, V111, P777; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366; ZHOU GT, 1995, IN PRESS IEEE T SIGN	43	165	166	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					203	214		10.1016/S0896-6273(00)80527-9	http://dx.doi.org/10.1016/S0896-6273(00)80527-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697864	Bronze			2022-12-24	WOS:000075061900019
J	Acharya, JK; Labarca, P; Delgado, R; Jalink, K; Zuker, CS				Acharya, JK; Labarca, P; Delgado, R; Jalink, K; Zuker, CS			Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants	NEURON			English	Article							PROTEIN-KINASE-C; DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTIONS; HETEROLOGOUS EXPRESSION; GENE; PHOSPHOINOSITIDES; EXCITABILITY; PHOSPHATES; HYDROLYSIS; PLASTICITY	Phosphoinositides function as important second messengers in a wide range of cellular processes. Inositol polyphosphate 1-phosphatase (IPP) is an enzyme essential for the hydrolysis of the 1-phosphate from either Ins(1,4)P-2 or Ins(1,3,4)P-3. This enzyme is Li+ sensitive, and is one of the proposed targets of Li+ therapy in manic-depressive illness. Drosophila ipp mutants accumulate IP2 in their system and are incapable of metabolizing exogenous Ins(1,4)P-2. Notably, ipp mutants demonstrate compensatory upregulation of an alternative branch in the inositol-phosphate metabolism tree, thus providing a means of ensuring continued availability of inositol. We demonstrate that ipp mutants have a defect in synaptic transmission resulting from a dramatic increase in the probability of vesicle release at larval neuromuscular junctions. We also show that Li+ phenocopies this effect in wild-type synapses. Together, these results support a role for phosphoinositides in synaptic vesicle function in vivo and mechanistically question the "lithium hypothesis".	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Chile, Fac Ciencias, Dept Biol, Ctr Estudios Cient Santiago, Santiago, Chile	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Universidad de Chile	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.			Jalink, Kees/0000-0001-7019-3440; Acharya, Jairaj/0000-0001-7366-4228				ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; BANSAL VS, 1987, J BIOL CHEM, V262, P9444; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CHOW SC, 1988, CELL IMMUNOL, V114, P96, DOI 10.1016/0008-8749(88)90257-2; CROSSLEY AC, 1978, GENETICS BIOL DROS B, V2, P449; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DELGADO R, 1994, EUR J NEUROSCI, V6, P1160, DOI 10.1111/j.1460-9568.1994.tb00614.x; DELGADO R, 1992, P ROY SOC B-BIOL SCI, V250, P181, DOI 10.1098/rspb.1992.0147; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; GEE NS, 1988, BIOCHEM J, V253, P777, DOI 10.1042/bj2530777; GEFFNER JR, 1988, CLIN EXP IMMUNOL, V74, P471; INHORN RC, 1988, J BIOL CHEM, V263, P14559; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Lin T, 1997, AM J HUM GENET, V60, P1384, DOI 10.1086/515471; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nussbaum RL, 1997, HUM GENET, V99, P145, DOI 10.1007/s004390050329; OKABE I, 1995, GENOMICS, V30, P358, DOI 10.1006/geno.1995.0030; Parissenti AM, 1996, ENDOCR RES, V22, P621, DOI 10.1080/07435809609043756; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SHAYMAN JA, 1987, ANAL BIOCHEM, V162, P562, DOI 10.1016/0003-2697(87)90434-9; Shears S B, 1996, Subcell Biochem, V26, P187; Shears Stephen B., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P63; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Timar J, 1996, ANTICANCER RES, V16, P3299; YORK JD, 1993, P NATL ACAD SCI USA, V90, P5833, DOI 10.1073/pnas.90.12.5833; YORK JD, 1990, P NATL ACAD SCI USA, V87, P9548, DOI 10.1073/pnas.87.24.9548; YORK JD, 1994, J MOL BIOL, V236, P584, DOI 10.1006/jmbi.1994.1167; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	53	54	55	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1219	1229		10.1016/S0896-6273(00)80502-4	http://dx.doi.org/10.1016/S0896-6273(00)80502-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655509	Bronze			2022-12-24	WOS:000074627300017
J	Fuller, RR; Moroz, LL; Gillette, R; Sweedler, JV				Fuller, RR; Moroz, LL; Gillette, R; Sweedler, JV			Single neuron analysis by capillary electrophoresis with fluorescence spectroscopy	NEURON			English	Article							WAVELENGTH-RESOLVED FLUORESCENCE; TUBULAR LIQUID-CHROMATOGRAPHY; INDIVIDUAL CHROMAFFIN CELLS; INDUCED NATIVE FLUORESCENCE; SEROTONIN-CONTAINING NEURON; RELEASE; EXOCYTOSIS; LOCALIZATION; VESICLES; APLYSIA	A technique to identify and quantitate simultaneously more than 30 compounds in individual neurons is described. The method uses nanoliter volume sampling, capillary electrophoresis separation, and wavelength-resolved native fluorescence detection. Limits of detection (LODs) range from the low attomole to the femtomole range, with 5-hydroxytryptamine (or serotonin [5-HT]) LODs being similar to 20 attomoles. Although the cellular sample matrix is chemically complex, the combination of electrophoretic migration time and fluorescence spectral information allows positive identification of aromatic monoamines, aromatic amino acids and peptides containing them, flavins, adenosine- and guanosine-nucleotide analogs, and other fluorescent compounds. Individual identified neurons from Aplysia californica and Pleurobranchaea californica are used to demonstrate the applicability and figures of merit of this technique.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sweedler, JV (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.		Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Moroz, Leonid/0000-0002-1333-3176	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR010294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609, R29NS031609] Funding Source: NIH RePORTER; NCRR NIH HHS [RR10294] Funding Source: Medline; NINDS NIH HHS [NS31609] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROWNSTEIN MJ, 1974, P NATL ACAD SCI USA, V71, P4662, DOI 10.1073/pnas.71.12.4662; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHANG HT, 1995, ANAL CHEM, V67, P1079, DOI 10.1021/ac00102a010; CHEN GY, 1995, J NEUROSCI, V15, P7747; Cooper J.R., 1996, BIOCH BASIS NEUROPHA, Vseventh; Cruz L, 1997, J NEUROCHEM, V69, P110; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Fuller RR, 1996, CYTOMETRY, V25, P144, DOI 10.1002/(SICI)1097-0320(19961001)25:2<144::AID-CYTO3>3.0.CO;2-H; GOLDMAN JE, 1974, J PHYSIOL-LONDON, V242, P61, DOI 10.1113/jphysiol.1974.sp010694; HANLEY MR, 1974, NATURE, V251, P631, DOI 10.1038/251631a0; JANKOWSKI JA, 1995, TRAC-TREND ANAL CHEM, V14, P170, DOI 10.1016/0165-9936(95)98315-Y; KENNEDY RT, 1989, SCIENCE, V246, P57, DOI 10.1126/science.2675314; KENNEDY RT, 1989, ANAL CHEM, V61, P436, DOI 10.1021/ac00180a012; KENNEDY RT, 1987, MIKROCHIM ACTA, V11, P37; LESZCZYSZYN DJ, 1990, J BIOL CHEM, V265, P14736; Lillard SJ, 1996, ANAL CHEM, V68, P2897, DOI 10.1021/ac960412j; LILLARD SJ, 1997, HDB CAPILLARY ELECTR, P523; Maiti S, 1997, SCIENCE, V275, P530, DOI 10.1126/science.275.5299.530; Moroz LL, 1996, J COMP NEUROL, V367, P607; Moroz LL, 1997, J COMP NEUROL, V382, P176, DOI 10.1002/(SICI)1096-9861(19970602)382:2<176::AID-CNE3>3.0.CO;2-0; OATES MD, 1990, ANAL CHEM, V62, P1573, DOI 10.1021/ac00214a006; ONO JK, 1984, NEUROSCIENCE, V11, P549, DOI 10.1016/0306-4522(84)90044-7; OSBORNE NN, 1972, INT J NEUROSCI, V3, P215, DOI 10.3109/00207457209147025; STEINBUSCH HW, 1984, HDB CHEM NEUROANAT 2, V3; Swanek FD, 1996, ANAL CHEM, V68, P3912, DOI 10.1021/ac960570a; SWANEK FD, 1997, HDB CAPILLARY ELECTR, P495; TIMPERMAN AT, 1995, ANAL CHEM, V67, P139, DOI 10.1021/ac00097a022; Tong W, 1997, J CHROMATOGR B, V689, P321, DOI 10.1016/S0378-4347(96)00317-9; Valaskovic GA, 1996, SCIENCE, V273, P1199, DOI 10.1126/science.273.5279.1199; WALKER RJ, 1986, MOLLUSCA 2, V9, P279; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754	31	90	94	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					173	181		10.1016/S0896-6273(00)80446-8	http://dx.doi.org/10.1016/S0896-6273(00)80446-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491979	Bronze			2022-12-24	WOS:000072154700003
J	Kanekar, S; Perron, M; Dorsky, R; Harris, WA; Jan, LY; Jan, YN; Vetter, ML				Kanekar, S; Perron, M; Dorsky, R; Harris, WA; Jan, LY; Jan, YN; Vetter, ML			Xath5 participates in a network of bHLH genes in the developing Xenopus retina	NEURON			English	Article							DEVELOPING NERVOUS-SYSTEM; LOOP-HELIX PROTEIN; PRONEURAL GENE; DROSOPHILA-MELANOGASTER; MULTIPOTENT PRECURSORS; ORGAN FORMATION; FROG RETINA; EXPRESSION; ACHAETE; SCUTE	We examined the function of basic-helix-loop-helix (bHLH) transcription factors during retinal neurogenesis. We identified Xath5, a Xenopus bHLH gene related to Drosophila atonal, which is expressed in the developing Xenopus retina. Targeted expression of Xath5 in retinal progenitor cells biased the differentiation of these cells toward a ganglion cell fate, suggesting that Xath5 can regulate the differentiation of retinal neurons. We examined the relationship between the three bHLH genes Xash3, NeuroD, and Xath5 during retinal neurogenesis and found that Xash3 is expressed in early retinoblasts, followed by coexpression of Xath5 and NeuroD in differentiating cells. We provide evidence that the expression of Xash3, NeuroD, and Xath5 is coupled and propose that these bHLH genes regulate successive stages of neuronal differentiation in the developing retina.	UNIV UTAH,DEPT NEUROBIOL & ANAT,SALT LAKE CITY,UT 84132; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Kanekar, Shami/M-3786-2016; Perron, Muriel/F-6795-2019	Perron, Muriel/0000-0002-1558-8236; Jan, Yuh Nung/0000-0003-1367-6299; Kanekar, Shami/0000-0002-7228-6840; Jan, Lily/0000-0003-3938-8498; Vetter, Monica/0000-0001-6262-8504	NEI NIH HHS [EY10422] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010422] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; ALONSO MC, 1988, EMBO J, V7, P2585, DOI 10.1002/j.1460-2075.1988.tb03108.x; ANDERSON DJ, 1995, CURR BIOL, V5, P1235, DOI 10.1016/S0960-9822(95)00246-6; BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; BRAND M, 1993, DEVELOPMENT, V119, P1; CAMPOSORTEGA JA, 1994, CELL, V77, P969, DOI 10.1016/0092-8674(94)90437-5; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; Cau E, 1997, DEVELOPMENT, V124, P1611; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Chitnis A, 1996, DEVELOPMENT, V122, P2295; DENT JA, 1989, DEVELOPMENT, V105, P61; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; EAGLESON G, 1995, J NEUROBIOL, V28, P146, DOI 10.1002/neu.480280203; EAGLESON GW, 1990, J NEUROBIOL, V21, P427, DOI 10.1002/neu.480210305; FEKETE DM, 1994, DEV BIOL, V166, P666, DOI 10.1006/dbio.1994.1346; FERREIRO B, 1994, DEVELOPMENT, V120, P3649; FERREIRO B, 1992, MECH DEVELOP, V40, P25; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GOMEZSKARMETA JL, 1995, GENE DEV, V9, P1869, DOI 10.1101/gad.9.15.1869; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; HALDER G, 1995, CURR OPIN GENET DEV, V5, P602, DOI 10.1016/0959-437X(95)80029-8; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HARMAN AM, 1989, NEUROSCIENCE, V28, P219, DOI 10.1016/0306-4522(89)90246-7; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HUANG S, 1993, J NEUROSCI, V13, P3193; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jasoni CL, 1996, J COMP NEUROL, V369, P319; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; KLEIN SL, 1983, J COMP NEUROL, V217, P17, DOI 10.1002/cne.902170103; LAVAIL MM, 1991, J COMP NEUROL, V309, P86, DOI 10.1002/cne.903090107; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; NIEUWKOOP PD, 1994, NORMAL XENOPUS LAEVI; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; PERRON M, UNPUB CILIARY MARGIN; Reddy GV, 1997, DEVELOPMENT, V124, P703; Reh Thomas A., 1992, P433; RICHTER K, 1988, P NATL ACAD SCI USA, V85, P8086, DOI 10.1073/pnas.85.21.8086; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; STRAZNICKY K, 1971, J EMBRYOL EXP MORPH, V26, P67; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221	60	214	217	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					981	994		10.1016/S0896-6273(00)80391-8	http://dx.doi.org/10.1016/S0896-6273(00)80391-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390513	Bronze			2022-12-24	WOS:A1997YH59400007
J	Davis, GW; Schuster, CM; Goodman, CS				Davis, GW; Schuster, CM; Goodman, CS			Genetic analysis of the mechanisms controlling target selection: Target-derived fasciclin II regulates the pattern of synapse formation	NEURON			English	Article							GROWTH CONE GUIDANCE; MOTOR AXON GUIDANCE; DENERVATED SKELETAL-MUSCLE; FUNCTIONAL COMPONENTS; NEUROMUSCULAR SPECIFICITY; RECOGNITION MOLECULE; N-CAM; DROSOPHILA; MOTONEURON; EXPRESSION	In Drosophila, motoneuron growth cones initially probe many potential muscle targets but later withdraw most of these contacts to form stereotypic synapses with only one or a few muscles. Prior to synapse formation, Fasciclin II (Fas II) is expressed at low levels on muscle. During synapse formation, Fas II concentrates at the synapse and disappears from the rest of the muscle. We previously showed that Fas II is required both pre- and postsynaptically for synaptic stabilization. Here, we show that the differential expression of target derived Pas II has a profound influence on the patterning of synapse formation. A transient increase in muscle Fas II stabilizes growth cone contacts and leads to novel synapses that are functional and stable; targets that normally receive two inputs can now receive up to six inputs. Changing the relative levels of Fas II on neighboring muscles leads to dramatic shifts in target selection.	UNIV CALIF BERKELEY,DEPT CELL & MOL BIOL,HOWARD HUGHES MED INST,BERKELEY,CA 94720	Howard Hughes Medical Institute; University of California System; University of California Berkeley					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BALL EE, 1985, J NEUROSCI, V5, P1808; BRAND AH, 1993, DEVELOPMENT, V118, P401; CASH S, 1992, J NEUROSCI, V12, P2051; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; CHIBA A, 1993, J NEUROSCI, V13, P714; COVAULT J, 1986, J CELL BIOL, V102, P731, DOI 10.1083/jcb.102.3.731; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; COVAULT J, 1987, J CELL BIOL, V105, P2479, DOI 10.1083/jcb.105.6.2479; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Jarecki J, 1995, J NEUROSCI, V15, P8177; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; Nose A, 1997, DEVELOPMENT, V124, P1433; Raghavan S, 1997, NEURON, V18, P873, DOI 10.1016/S0896-6273(00)80327-X; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SINK H, 1991, DEVELOPMENT, V114, P939; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5	34	144	145	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					561	573		10.1016/S0896-6273(00)80372-4	http://dx.doi.org/10.1016/S0896-6273(00)80372-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331349	Bronze			2022-12-24	WOS:A1997XZ01600012
J	Geiger, JRP; Lubke, J; Roth, A; Frotscher, M; Jonas, P				Geiger, JRP; Lubke, J; Roth, A; Frotscher, M; Jonas, P			Submillisecond AMPA receptor-mediated signaling at a principal neuron-interneuron synapse	NEURON			English	Article							RAT HIPPOCAMPAL SLICES; EXCITATORY POSTSYNAPTIC POTENTIALS; AVIAN NUCLEUS MAGNOCELLULARIS; CA3 PYRAMIDAL NEURONS; TIME-COURSE; NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; GLUTAMATE RECEPTORS; CA2+ PERMEABILITY; CLAMP ANALYSIS	Glutamatergic transmission at a principal neuron-interneuron synapse was investigated by dual whole-cell patch-clamp recording in rat hippocampal slices combined with morphological analysis. Evoked EPSPs with rapid time course (half duration approximate to 4 ms; 34 degrees C) were generated at multiple synaptic contacts established on the interneuron dendrites close to the soma. The underlying postsynaptic conductance change showed a submillisecond rise and decay, due to the precise timing of glutamate release and the rapid deactivation of the postsynaptic AMPA receptors. Simulations based an a compartmental model of the interneuron indicated that the rapid postsynaptic conductance change determines the shape and the somatodendritic integration of EPSPs, thus enabling interneurons to detect synchronous principal neuron activity.	UNIV FREIBURG,INST ANAT,D-79104 FREIBURG,GERMANY; MAX PLANCK INST MED RES,D-69120 HEIDELBERG,GERMANY	University of Freiburg; Max Planck Society	Geiger, JRP (corresponding author), UNIV FREIBURG,INST PHYSIOL,HERMANN HERDER STR 7,D-7800 FREIBURG,GERMANY.		; Lubke, Joachim/H-8762-2013	Roth, Arnd/0000-0003-0325-4287; Jonas, Peter/0000-0001-5001-4804; Lubke, Joachim/0000-0002-4086-3199				AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; ANDERSEN P, 1978, BRAIN RES, V144, P11, DOI 10.1016/0006-8993(78)90431-6; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; BURNASHEV N, 1993, CELL PHYSIOL BIOCHEM, V3, P318, DOI 10.1159/000154696; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; Hines M, 1993, NEURAL SYSTEMS ANAL, P127; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; JACK JJB, 1971, J PHYSIOL-LONDON, V215, P283, DOI 10.1113/jphysiol.1971.sp009472; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Katz B., 1969, RELEASE NEURAL TRANS; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; MAJOR G, 1994, J NEUROSCI, V14, P4613; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCBAIN C, 1992, J NEUROPHYSIOL, V68, P16, DOI 10.1152/jn.1992.68.1.16; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MENNERICK S, 1995, J NEUROSCI, V15, P3178; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; PATTON PE, 1995, HIPPOCAMPUS, V5, P245, DOI 10.1002/hipo.450050402; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Reyes AD, 1996, J NEUROSCI, V16, P993; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Traub RD, 1995, J COMPUT NEUROSCI, V2, P291, DOI 10.1007/BF00961441; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346	62	296	299	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					1009	1023		10.1016/S0896-6273(00)80339-6	http://dx.doi.org/10.1016/S0896-6273(00)80339-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208867	Bronze			2022-12-24	WOS:A1997XJ10200018
J	Linden, DJ				Linden, DJ			Long-term potentiation of glial synaptic currents in cerebellar culture	NEURON			English	Article							EXCITATORY AMINO-ACIDS; RAT-BRAIN; GLUTAMATE-RECEPTOR; PURKINJE-CELL; KAINATE RECEPTORS; TYPE-2 ASTROCYTES; NMDA RECEPTORS; CLIMBING FIBER; CALCIUM WAVES; SCHWANN-CELLS	Glial cells in the brain express neurotransmitter receptors and can respond appropriately to application of exogenous neurotransmitters such as glutamate. However, activation of receptors by endogenous, synaptically released transmitter has been difficult to demonstrate directly. Using cell-pair recording in cerebellar cultures from embryonic mouse, it is shown that activation of a cerebellar granule neuron can give rise to a rapid inward current in an adjacent glial cell. This current is mediated by activation of Ca2+-permeable AMPA/kainate receptors and is largely independent of glutamate reuptake or gap junctional coupling. Furthermore, prolonged stimulation of the granule neuron at 4 Hz can give rise to long-term potentiation (LTP) of the glial synaptic current that has similar properties to LTP of granule neuron-Purkinje neuron synaptic transmission - its induction is independent of postsynaptic depolarization, postsynaptic Ca2+ influx, or glutamate receptor activation but requires presynaptic Ca2+ influx. These findings suggest a model in which cerebellar LTP is both induced and expressed presynaptically and therefore may be detected by either neuronal or glial postsynaptic cells.			Linden, DJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051106, R37MH051106, R01MH051106] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; BAUDE A, 1994, J NEUROSCI, V14, P2830; BERNARDINI G, 1984, EUR J CELL BIOL, V34, P307; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BOWMAN CL, 1984, NATURE, V311, P656, DOI 10.1038/311656a0; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; CULLCANDY S, 1995, CURR BIOL, V5, P841, DOI 10.1016/S0960-9822(95)00168-0; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; FRANKLIN RJM, 1995, TRENDS NEUROSCI, V18, P151, DOI 10.1016/0166-2236(95)93893-3; GALLO V, 1991, GLIA, V4, P245, DOI 10.1002/glia.440040302; GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454; HAMPSON DR, 1992, NEUROSCIENCE, V50, P11, DOI 10.1016/0306-4522(92)90378-F; HASSINGER TD, 1995, J NEUROBIOL, V28, P159, DOI 10.1002/neu.480280204; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOSLI L, 1981, NEUROSCI LETT, V21, P83, DOI 10.1016/0304-3940(81)90062-8; HOSLI L, 1981, EXP BRAIN RES, V42, P43; HOUK JC, 1991, TUTORIALS MOTOR BEHA, V2; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; JENSEN AM, 1990, J NEUROSCI, V10, P1165; KETTENMANN H, 1984, NEUROSCI LETT, V52, P25, DOI 10.1016/0304-3940(84)90345-8; KMJEVIC K, 1967, EXP BRAIN RES, V3, P306; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LEVI G, 1992, J NEUROCHEM, V58, P1943, DOI 10.1111/j.1471-4159.1992.tb10073.x; LEVRAM V, 1995, J NEUROSCI, V15, P2628; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mennerick S, 1996, J NEUROSCI, V16, P55; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; MURPHY TH, 1993, J NEUROSCI, V13, P2672, DOI 10.1523/JNEUROSCI.13-06-02672.1993; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PARPURA V, 1995, J NEUROSCI, V15, P5831; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; Porter JT, 1996, J NEUROSCI, V16, P5073; PORTER JT, 1995, GLIA, V13, P101, DOI 10.1002/glia.440130204; RANSOM BR, 1974, BRAIN RES, V69, P83, DOI 10.1016/0006-8993(74)90373-4; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; SONTHEIMER H, 1988, GLIA, V1, P328, DOI 10.1002/glia.440010505; SPACEK J, 1985, ANAT EMBRYOL, V171, P245, DOI 10.1007/BF00341419; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; SZATKOWSKI M, 1991, BRAIN RES, V555, P343, DOI 10.1016/0006-8993(91)90363-Z; Tempia F, 1996, J NEUROSCI, V16, P456; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; Wang JH, 1996, J NEUROPHYSIOL, V76, P276, DOI 10.1152/jn.1996.76.1.276; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T	72	70	71	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					983	994		10.1016/S0896-6273(00)80337-2	http://dx.doi.org/10.1016/S0896-6273(00)80337-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208865	hybrid			2022-12-24	WOS:A1997XJ10200016
J	Leinekugel, X; Medina, I; Khalilov, I; BenAri, Y; Khazipov, R				Leinekugel, X; Medina, I; Khalilov, I; BenAri, Y; Khazipov, R			Ca2+ oscillations mediated by the synergistic excitatory actions of GABA(A) and NMDA receptors in the neonatal hippocampus	NEURON			English	Article							LONG-TERM POTENTIATION; DEPENDENT SYNAPTIC PLASTICITY; CA3 PYRAMIDAL NEURONS; EARLY POSTNATAL LIFE; VISUAL-CORTEX; NERVOUS-SYSTEM; DEVELOPING NEOCORTEX; ACTIVATED CHANNELS; RAT HIPPOCAMPUS; CRITICAL PERIOD	We asked whether GABA(A) and NMDA receptors may act in synergy in neonatal hippocampal slices, at a time when GABA exerts a depolarizing action. The GABA(A) receptor agonist isoguvacine reduced the voltage-dependent Mg2+ block of single NMDA channels recorded in cell-attached configuration from P-2-5 CA(3) pyramidal neurons and potentiated the Ca2+ influx through NMDA channels. The synaptic response evoked by electrical stimulation of stratum radiatum was mediated by a synergistic interaction between GABA(A) and NMDA receptors. Network-driven Giant Depolarizing Potentials, which are a typical feature of the neonatal hippocampal network, provided coactivation of GABA(A) and NMDA receptors and were associated with spontaneous and synchronous Ca2+ increases in CA(3) pyramidal neurons. Thus, at the early stages of development, GABA is a major excitatory transmitter that acts in synergy with NMDA receptors. This provides in neonatal neurons a hebbian stimulation that may be involved in neuronal plasticity and network formation in the developing hippocampus.			Leinekugel, X (corresponding author), HOP PORT ROYAL,INSERM U29,123 BD PORT ROYAL,F-75014 PARIS,FRANCE.		Leinekugel, Xavier/ABD-8347-2021; Khalilov, Ilgam/B-5267-2015; Medina, Igor/O-5532-2016; Leinekugel, Xavier/F-4034-2014; Khazipov, Roustem/M-1834-2016	Khalilov, Ilgam/0000-0002-9468-4778; Medina, Igor/0000-0001-6839-5414; Leinekugel, Xavier/0000-0003-2878-3791; Khazipov, Roustem/0000-0002-6763-2841; Ben-Ari, Yehezkel/0000-0001-6208-8480				AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F; Behar TN, 1996, J NEUROSCI, V16, P1808; BELHAGE B, 1988, INT J DEV NEUROSCI, V6, P125, DOI 10.1016/0736-5748(88)90036-6; BENARI Y, 1994, PROG BRAIN RES, V102, P261; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CONSTANTINE PATONM, 1992, ANN REV NEUROSCI, V13, P129; CORRADETTI R, 1988, EUR J PHARMACOL, V154, P221, DOI 10.1016/0014-2999(88)90103-3; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DESARMENIEN MG, 1991, NEURON, V7, P797, DOI 10.1016/0896-6273(91)90282-5; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FISZMAN ML, 1990, DEV BRAIN RES, P1; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; FOX K, 1989, J NEUROSCI, V9, P2443; FUKUDA A, 1993, J NEUROPHYSIOL, V70, P448, DOI 10.1152/jn.1993.70.1.448; GAIARSA JL, 1995, J NEUROBIOL, V26, P339, DOI 10.1002/neu.480260306; GAIARSA JL, 1990, EUR J NERUOSCI, V3, P301; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HALES TG, 1994, NEUROENDOCRINOLOGY, V59, P297, DOI 10.1159/000126671; HANSE E, 1996, SOC NERUOSCI, V26; HARA M, 1992, NEUROSCI LETT, V143, P135, DOI 10.1016/0304-3940(92)90250-B; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; KANTER ED, 1993, J NEUROSCI, V13, P2477, DOI 10.1523/JNEUROSCI.13-06-02477.1993; Kanter ED, 1996, J NEUROSCI, V16, P307; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Katz L C, 1993, Curr Opin Neurobiol, V3, P93, DOI 10.1016/0959-4388(93)90041-V; KHALILOV I, 1996, SOC NEUROSCI, V26; KHAZIPOV R, 1995, NEUROSCIENCE, V69, P1057, DOI 10.1016/0306-4522(95)00337-I; KHAZIPOV R, IN PRESS J PHYSL LON; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCBAIN C, 1992, J NEUROPHYSIOL, V68, P16, DOI 10.1152/jn.1992.68.1.16; MCLEAN HA, 1995, EUR J NEUROSCI, V7, P1442, DOI 10.1111/j.1460-9568.1995.tb01139.x; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; MEDINA I, 1994, J NEUROPHYSIOL, V72, P456, DOI 10.1152/jn.1994.72.1.456; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; ODONOVAN M, 1992, J EXP ZOOL, V261, P261, DOI 10.1002/jez.1402610306; POLLARD H, 1993, NEUROREPORT, V4, P411, DOI 10.1097/00001756-199304000-00018; RAKIC P, 1995, J NEUROBIOL, V26, P299, DOI 10.1002/neu.480260303; REDBURN D, 1987, NEUROL NEUROBIOL, V32, P1; REGHER WG, 1992, J NEUROSCI, V12, P4202; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; REPRESA A, 1989, NEUROSCI LETT, V99, P61, DOI 10.1016/0304-3940(89)90265-6; Rohrbough J, 1996, J NEUROSCI, V16, P82; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SCHERER WJ, 1989, J NEUROSCI, V9, P3837; SERAFINI R, 1995, J PHYSIOL-LONDON, V488, P371, DOI 10.1113/jphysiol.1995.sp020973; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SPOERRI PE, 1988, SYNAPSE, V2, P11, DOI 10.1002/syn.890020104; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STRECKER GJ, 1994, J NEUROPHYSIOL, V72, P1538, DOI 10.1152/jn.1994.72.4.1538; TREMBLAY E, 1988, BRAIN RES, V461, P393, DOI 10.1016/0006-8993(88)90275-2; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WU WI, 1992, J NEUROSCI, V12, P3935; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; ZHANG L, 1991, J PHYSIOL-LONDON, V444, P25, DOI 10.1113/jphysiol.1991.sp018864	80	330	341	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					243	255		10.1016/S0896-6273(00)80265-2	http://dx.doi.org/10.1016/S0896-6273(00)80265-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052795	Bronze			2022-12-24	WOS:A1997WK82200008
J	Hsu, SC; Ting, AE; Hazuka, CD; Davanger, S; Kenny, JW; Kee, Y; Scheller, RH				Hsu, SC; Ting, AE; Hazuka, CD; Davanger, S; Kenny, JW; Kee, Y; Scheller, RH			The mammalian brain rsec6/8 complex	NEURON			English	Article							PERMEABILIZED CHROMAFFIN CELLS; GTP-BINDING-PROTEIN; SYNAPTIC VESICLE MEMBRANE; ACTIN-FILAMENTS; YEAST; SECRETION; FUSION; DOCKING; EXOCYTOSIS; RELEASE	rsec6 and rsec8 are two components of a 17S complex in mammalian brain that is homologous to the yeast 834 kDa Sec6/8/15 complex which Ts essential for exocytosis. Purification and partial amino acid sequencing of the mammalian rsec6/8 complex reveals that it is composed of eight novel proteins with a combined molecular weight of 743 kDa. The complex is broadly expressed in brain and displays a plasma membrane localization in nerve terminals. Membrane associated rsec6/8 complex coimmunoprecipitates with syntaxin, a plasma membrane protein critical for neurotransmission. These data suggest a role for the mammalian rsec6/8 complex in neurotransmitter release via interactions with the core vesicle docking and fusion apparatus.	HEWLETT PACKARD CORP,PALO ALTO,CA 94034	Hewlett-Packard	Hsu, SC (corresponding author), STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT CELLULAR & MOL PHYSIOL,STANFORD,CA 94305, USA.		Davanger, Svend/AAN-8754-2020	Ting, Anthony/0000-0002-5058-9576				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1994, ANN NY ACAD SCI, V733, P256, DOI 10.1111/j.1749-6632.1994.tb17275.x; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOWSER R, 1992, J CELL BIOL, V118, P1041, DOI 10.1083/jcb.118.5.1041; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; BURGOYNE RD, 1989, CELL SIGNAL, V1, P323, DOI 10.1016/0898-6568(89)90051-X; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; HWANG BJ, 1996, IN PRESS J CHROMAT B; LANE RD, 1986, METHOD ENZYMOL, V121, P183; LELKES PI, 1986, FEBS LETT, V208, P357, DOI 10.1016/0014-5793(86)81049-3; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PERRIN D, 1987, NATURE, V326, P498, DOI 10.1038/326498a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; PFEFFER SR, 1994, P NATL ACAD SCI USA, V91, P1987, DOI 10.1073/pnas.91.6.1987; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; SCHELLER RH, 1995, NEURON, V14, P893; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; TING AE, 1995, P NATL ACAD SCI USA, V92, P9613, DOI 10.1073/pnas.92.21.9613; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988	37	226	235	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1209	1219		10.1016/S0896-6273(00)80251-2	http://dx.doi.org/10.1016/S0896-6273(00)80251-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982167	Bronze			2022-12-24	WOS:A1996WA24800017
J	Skoulakis, EMC; Davis, RL				Skoulakis, EMC; Davis, RL			Olfactory learning deficits in mutants for leonardo, a Drosophila gene encoding a 14-3-3 protein	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; CALCIUM-DEPENDENT EXOCYTOSIS; MEDIATED ENHANCER DETECTION; C INHIBITOR PROTEINS; KINASE-C; MUSHROOM BODIES; BRAIN 14-3-3; IN-VIVO; PREFERENTIAL EXPRESSION; TRYPTOPHAN-HYDROXYLASE	Studies of Drosophila and other insects have indicated an essential role for the mushroom bodies in learning and memory. The leonardo gene encodes a Drosophila protein highly homologous to the vertebrate 14-3-3 zeta isoform, a protein well studied for biochemical roles but without a well established biological function. The gene is expressed abundantly and preferentially in mushroom body neurons. Mutant alleles that reduce LEONARDO protein levels in the mushroom bodies significantly decrease the capacity for olfactory learning, but do not affect sensory modalities or brain neuroanatomy that are requisite for conditioning. These results establish a biological role for 14-3-3 proteins in mushroom body-mediated learning and memory processes, and suggest that proteins known to interact with them, such as RAF-1 or other protein kinases, may also have this biological function.	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA	Baylor College of Medicine	Skoulakis, EMC (corresponding author), BAYLOR COLL MED, DEPT CELL BIOL, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIGMS NIH HHS [GM15406] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015406] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; BOSTON PF, 1982, J NEUROCHEM, V38, P1466, DOI 10.1111/j.1471-4159.1982.tb07927.x; BOSTON PF, 1982, J NEUROCHEM, V38, P1475, DOI 10.1111/j.1471-4159.1982.tb07928.x; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; CHEN CN, 1986, P NATL ACAD SCI USA, V86, P3599; CHOI KW, 1991, J BIOL CHEM, V266, P15999; CONKLIN DS, 1995, P NATL ACAD SCI USA, V92, P7892, DOI 10.1073/pnas.92.17.7892; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DAVIS RL, 1984, MOL CELL BIOL, V4, P358, DOI 10.1128/MCB.4.2.358; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Davis RL, 1996, CURR BIOL, V6, P146, DOI 10.1016/S0960-9822(02)00447-5; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DUNBAR BS, 1987, 2 DIMENTIONAL ELECTR; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FEANY MB, 1995, SCIENCE, V268, P825; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; FOSTER JL, 1988, J BIOL CHEM, V263, P1676; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.0.CO;2-B; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; ICHIMURA T, 1991, J NEUROCHEM, V56, P1449, DOI 10.1111/j.1471-4159.1991.tb11446.x; ICHIMURA T, 1987, FEBS LETT, V219, P79, DOI 10.1016/0014-5793(87)81194-8; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; ISOBE T, 1992, FEBS LETT, V308, P121, DOI 10.1016/0014-5793(92)81257-M; ISOBE T, 1991, J MOL BIOL, V217, P125, DOI 10.1016/0022-2836(91)90616-E; JONES DH, 1995, FEBS LETT, V368, P55, DOI 10.1016/0014-5793(95)00598-4; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MAKITA Y, 1990, FEBS LETT, V268, P185, DOI 10.1016/0014-5793(90)81004-8; MARTIN H, 1993, FEBS LETT, V331, P296, DOI 10.1016/0014-5793(93)80356-Y; MENZEL R, 1991, NEUROBIOLOGY LEARNIN; MOORE BW, 1968, PHYSL BIOCH ASPECTS, P345; MORGAN A, 1992, BIOCHEM J, V286, P807, DOI 10.1042/bj2860807; MORGAN A, 1992, NATURE, V355, P833, DOI 10.1038/355833a0; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; PALLAS DC, 1994, SCIENCE, V265, P535, DOI 10.1126/science.8036498; PATEL Y, 1994, BBA-MOL CELL RES, V1222, P405, DOI 10.1016/0167-4889(94)90048-5; QUI Y, 1991, J MOL BIOL, V222, P553; REUTHER GW, 1994, SCIENCE, V266, P129, DOI 10.1126/science.7939633; ROSEBOOM PH, 1994, DNA CELL BIOL, V13, P629, DOI 10.1089/dna.1994.13.629; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; ROTH D, 1995, FEBS LETT, V374, P77, DOI 10.1016/0014-5793(95)01080-X; SCHWARTZ JH, 1993, P NATL ACAD SCI USA, V90, P8310, DOI 10.1073/pnas.90.18.8310; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; SKOULAKIS EMC, 1993, INT CONGR SER, V1036, P99; Sokal R. R., 1981, BIOMETRY; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; SWANSON KD, 1992, GENE, V113, P183, DOI 10.1016/0378-1119(92)90394-5; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TANJI M, 1994, J NEUROCHEM, V63, P1908; TOKER A, 1992, EUR J BIOCHEM, V206, P453, DOI 10.1111/j.1432-1033.1992.tb16946.x; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; WATANABE M, 1991, MOL BRAIN RES, V10, P151, DOI 10.1016/0169-328X(91)90105-7; WATANABE M, 1993, MOL BRAIN RES, V17, P135, DOI 10.1016/0169-328X(93)90082-Z; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; YAMAMORI B, 1995, J BIOL CHEM, V270, P11723, DOI 10.1074/jbc.270.20.11723; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	73	188	193	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV	1996	17	5					931	944		10.1016/S0896-6273(00)80224-X	http://dx.doi.org/10.1016/S0896-6273(00)80224-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938125	Bronze			2022-12-24	WOS:A1996VV15100015
J	Narasimhan, K; Linden, DJ				Narasimhan, K; Linden, DJ			Defining a minimal computational unit for cerebellar long-term depression	NEURON			English	Article							PROTEIN-KINASE-C; DENDRITIC SPINES; PURKINJE-CELLS; NITRIC-OXIDE; GLUTAMATE SENSITIVITY; SYNAPTIC PLASTICITY; CALCIUM CHANNELS; CA2+ TRANSIENTS; CLIMBING FIBER; NEURONS	In cerebellar long-term depression (LTD), conjunctive stimulation of parallel and climbing fiber inputs to a Purkinje neuron (PN) results in a selective depression of parallel fiber-PH synaptic strength. A similar phenomenon may be induced in the cultured PN when glutamate pulses and PH depolarization, which mimic the effects of parallel and climbing fibers, respectively, are coapplied. Here, we show that LTD can be induced in two very reduced preparations of the postsynaptic neuron; an acutely dissociated preparation and a perforated outside-out macropatch of dendritic membrane. LTD in these preparations retains properties of that seen in an intact cultured PH in that it is not induced by either glutamate pulses or depolarization alone and requires calcium influx, mGluR activation, and PKC activation for induction. As both of these preparations lack dendritic spine compartments, these findings suggest that the associative nature of LTD induction does not require this level of morphological organization.			Narasimhan, K (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, R37MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham W.C., 1991, KINDLING SYNAPTIC PL, P92; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; CHANG HT, 1952, COLD SPRING HARB SYM, V17, P189, DOI 10.1101/SQB.1952.017.01.019; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; COSS RG, 1985, BEHAV NEURAL BIOL, V44, P151, DOI 10.1016/S0163-1047(85)90170-0; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; DESCHUTTER E, 1995, TRENDS NEUROSCI, V18, P291, DOI 10.1016/0166-2236(95)93916-L; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; HOLMES WR, 1990, BRAIN RES, V519, P338, DOI 10.1016/0006-8993(90)90098-V; HOMER CH, 1993, PROG NEUROBIOL, V41, P281; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; JAFFE DB, 1994, J NEUROBIOL, V25, P220, DOI 10.1002/neu.480250303; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KOCH C, 1993, J NEUROSCI, V13, P413; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LEVITAN ES, 1990, NATURE, V348, P545, DOI 10.1038/348545a0; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Tanzi E., 1893, RIV SPER FRENIAT MED, V19, P419; TAUBE JS, 1987, BRAIN RES, V419, P32, DOI 10.1016/0006-8993(87)90565-8; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; WALLACE CS, 1991, LONG TERM POTENTIATI, P189; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; ZILBERTER YI, 1990, NEURON, V5, P597, DOI 10.1016/0896-6273(90)90214-Z	65	32	33	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					333	341		10.1016/S0896-6273(00)80164-6	http://dx.doi.org/10.1016/S0896-6273(00)80164-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780656	Bronze			2022-12-24	WOS:A1996VE84000015
J	Marty, S; Berninger, B; Carroll, P; Thoenen, H				Marty, S; Berninger, B; Carroll, P; Thoenen, H			GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor	NEURON			English	Article							FACTOR MESSENGER-RNA; NEURONS; CELLS	gamma-Aminobutyric acid (GABA) switches from enhancing to repressing brain-derived neurotrophic factor (BDNF) mRNA synthesis during the maturation of hippocampal neurons in vitro. Interneurons do not produce BDNF themselves, but BDNF enhances their differentiation. Therefore, the question arose whether hippocampal interneurons regulate their phenotype by regulating BDNF expression and release from adjacent cells. The GABA(A) receptor agonist muscimol and BDNF increased the size and neuropeptide Y (NPY) immunoreactivity of hippocampal interneurons. However, GABAergic stimulation failed to increase NPY immunoreactivity in cultures from BDNF knockout embryos. At later developmental stages, when GABA represses BDNF synthesis, treatment with muscimol induced a decrease in cell size and NPY immunoreactivity of interneurons. Interneurons might thus control their phenotype through the regulation of BDNF synthesis in, and release from, their target neurons.			Marty, S (corresponding author), MAX PLANCK INST PSYCHIAT, DEPT NEUROCHEM, KLOPFERSPITZ 18A, D-82152 MARTINSRIED, GERMANY.		Carroll, Patrick/AAL-7773-2021; Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782				ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; EINS S, 1983, CELL TISSUE RES, V229, P457; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GALL C, 1990, PROG BRAIN RES, V83, P371; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOSOKAWA Y, 1994, EUR J NEUROSCI, V6, P805, DOI 10.1111/j.1460-9568.1994.tb00991.x; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KATER SB, 1991, J NEUROSCI, V11, P891; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; MARTY S, 1996, IN PRESS J NEUROSCI; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; NAWA H, 1994, J NEUROSCI, V14, P3751; SCHOUSBOE A, 1995, J NEUROSCI RES, V41, P1, DOI 10.1002/jnr.490410102; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; ZAFRA F, 1992, J NEUROSCI, V12, P4793	18	226	233	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1996	16	3					565	570		10.1016/S0896-6273(00)80075-6	http://dx.doi.org/10.1016/S0896-6273(00)80075-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785053	Bronze			2022-12-24	WOS:A1996UC16800012
J	Airaksinen, MS; Koltzenburg, M; Lewin, GR; Masu, Y; Helbig, C; Wolf, E; Brem, G; Toyka, KV; Thoenen, H; Meyer, M				Airaksinen, MS; Koltzenburg, M; Lewin, GR; Masu, Y; Helbig, C; Wolf, E; Brem, G; Toyka, KV; Thoenen, H; Meyer, M			Specific subtypes of cutaneous mechanoreceptors require neurotrophin-3 following peripheral target innervation	NEURON			English	Article							NERVE GROWTH-FACTOR; SENSORY NEURONS; MYELINATED NOCICEPTORS; MESSENGER-RNA; TOUCH DOMES; RAT; FIBERS; INVIVO; RECEPTORS; SURVIVAL	Neurotrophin-3 (NT-3) is required for the development of most sensory neurons of the dorsal root ganglia. Using electrophysiological techniques in mice with null mutations of the NT-3 gene, we show that two functionally specific subsets of cutaneous afferents differentially require this factor: D-hair receptors and slowly adapting mechanoreceptors; other cutaneous receptors were unaffected. Merkel cells, which are the end organs of slowly adapting mechanoreceptors, are virtually absent in 14-day-old homozygous mutants and are severely reduced in adult NT-3 heterozygous animals. This loss of Merkel cells, together with their innervation, happens in the first postnatal weeks of life, in contrast to muscle spindles and afferents, which are never formed in the absence of NT-3. Thus, NT-3 is essential for the maintenance of specific cutaneous afferents known to subserve fine tactile discrimination in humans.	MAX PLANCK INST PSYCHIAT,DEPT NEUROBIOCHEM,D-82152 PLANEGG,GERMANY; UNIV WURZBURG,DEPT NEUROL,D-97080 WURZBURG,GERMANY; INST MOL ANIM BREEDING,D-81375 MUNICH,GERMANY	Max Planck Society; University of Wurzburg	Airaksinen, MS (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROCHEM,AM KLOPFERSPITZ 18A,D-82152 PLANEGG,GERMANY.		Lewin, Gary R/B-8028-2011	Wolf, Eckhard/0000-0002-0430-9510; Lewin, Gary/0000-0002-2890-6352; Airaksinen, Matti/0000-0002-7199-4984				BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Boyd I.A., 1968, COMPOSITION PERIPHER; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V92, P385, DOI 10.1007/BF00492495; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FORSTER C, 1990, J NEUROSCI METH, V31, P109, DOI 10.1016/0165-0270(90)90155-9; GAESE F, 1994, DEVELOPMENT, V120, P1613; HANDWERKER HO, 1991, J PHYSIOL-LONDON, V435, P229, DOI 10.1113/jphysiol.1991.sp018507; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; JOHNSON EM, 1986, TRENDS NEUROSCI, V9, P33, DOI 10.1016/0166-2236(86)90012-3; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; KUCERA J, 1995, J COMP NEUROL, V363, P307, DOI 10.1002/cne.903630211; LEWIN GR, 1992, J NEUROSCI, V12, P1896; LEWIN GR, 1991, J NEUROPHYSIOL, V66, P1205, DOI 10.1152/jn.1991.66.4.1205; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LEWIN GR, 1994, J NEUROPHYSIOL, V71, P941, DOI 10.1152/jn.1994.71.3.941; LISNEY SJW, 1989, Q J EXP PHYSIOL CMS, V74, P757, DOI 10.1113/expphysiol.1989.sp003348; LOPRESTI P, 1994, J NEUROBIOL, V25, P1613, DOI 10.1002/neu.480251212; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MILLS LR, 1989, DEV BIOL, V136, P61, DOI 10.1016/0012-1606(89)90130-9; NURSE CA, 1984, NEUROSCIENCE, V11, P521, DOI 10.1016/0306-4522(84)90042-3; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; PASCHE F, 1990, J INVEST DERMATOL, V95, P247, DOI 10.1111/1523-1747.ep12484847; PERL ER, 1973, HDB SENSORY PHYSL, V2, P29; Perl ER, 1992, SENSORY NEURONS DIVE, P3; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; TOJO H, 1995, BRAIN RES, V669, P163, DOI 10.1016/0006-8993(94)01219-8; VALLBO AB, 1979, PHYSIOL REV, V59, P919, DOI 10.1152/physrev.1979.59.4.919	41	189	193	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					287	295		10.1016/S0896-6273(00)80047-1	http://dx.doi.org/10.1016/S0896-6273(00)80047-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789944	Bronze			2022-12-24	WOS:A1996TW95700009
J	French, RJ; PrusakSochaczewski, E; Zamponi, GW; Becker, S; Kularatna, AS; Horn, R				French, RJ; PrusakSochaczewski, E; Zamponi, GW; Becker, S; Kularatna, AS; Horn, R			Interactions between a pore-blocking peptide and the voltage sensor of the sodium channel: An electrostatic approach to channel geometry	NEURON			English	Article							MU-CONOTOXIN-GIIIA; SKELETAL-MUSCLE; NA+ CHANNELS; RAT-BRAIN; BATRACHOTOXIN; INSENSITIVITY; CHARYBDOTOXIN; TETRODOTOXIN; SAXITOXIN; CALCIUM	Few experimental data illuminate the relationship between the molecular structures that mediate ion conduction through voltage-dependent ion channels and the structures responsible for sensing transmembrane voltage and controlling gating. To fill this void, we have used a strongly cationic, mutated mu-conotoxin peptide, which only partially blocks current through voltage-dependent sodium channels, to study voltage-dependent activation gating in both bound and unbound channels. When the peptide binds to the ion-conducting pore, it inhibits channel opening, necessitating stronger depolarization for channel activation. We show that this activation shift could result entirely from electrostatic inhibition of the movement of the voltage-sensing S4 charges and estimate the approximate physical distance through which the S4 charges move.	MAX PLANCK INST BIOPHYS, W-6000 FRANKFURT, GERMANY; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT PHYSIOL, PHILADELPHIA, PA 19107 USA	Max Planck Society; Jefferson University	French, RJ (corresponding author), UNIV CALGARY, FAC MED, DEPT MED PHYSIOL, NEUROSCI RES GRP, CALGARY, AB T2N 4N1, CANADA.			Zamponi, Gerald W./0000-0002-0644-9066	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041691] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41691] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CORREA AM, 1991, J GEN PHYSIOL, V97, P605, DOI 10.1085/jgp.97.3.605; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; CUKIERMAN S, 1988, J GEN PHYSIOL, V92, P431, DOI 10.1085/jgp.92.4.431; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; DURELL SR, 1992, BIOPHYS J, V62, P243; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUO XT, 1987, BIOCHEMISTRY-US, V26, P7546, DOI 10.1021/bi00398a003; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; HUANG LYM, 1982, P NATL ACAD SCI-BIOL, V79, P2082, DOI 10.1073/pnas.79.6.2082; KHODOROV BI, 1985, PROG BIOPHYS MOL BIO, V45, P57, DOI 10.1016/0079-6107(85)90005-7; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MATHIAS RT, 1992, NATO ADV SCI I C-MAT, V335, P473; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MINTZ IM, 1994, J NEUROSCI, V14, P2844; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; QUANDT FN, 1982, P NATL ACAD SCI-BIOL, V79, P6732, DOI 10.1073/pnas.79.21.6732; SATO K, 1991, J BIOL CHEM, V266, P16989; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1993, Q REV BIOPHYS, V27, P1; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STEPHAN MM, 1994, J MEMBRANE BIOL, V137, P1; STILLINGER F, 1961, J CHEM PHYS, V35, P1584, DOI 10.1063/1.1732113; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; ZAMPONI GW, 1993, BIOPHYS J, V65, P2335, DOI 10.1016/S0006-3495(93)81292-X	40	83	84	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB	1996	16	2					407	413		10.1016/S0896-6273(00)80058-6	http://dx.doi.org/10.1016/S0896-6273(00)80058-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789955	Bronze			2022-12-24	WOS:A1996TW95700020
J	Raman, IM; Tong, G; Jahr, CE				Raman, IM; Tong, G; Jahr, CE			beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; NORADRENALINE; ENHANCEMENT; ACTIVATION; CHANNELS; CALCIUM; DESENSITIZATION; PHOSPHORYLATION	To identify the protein kinases regulating synaptic NMDA receptors, as well as the conditions favoring enhancement of NMDA receptor-mediated excitatory postsynaptic currents (EPSCs) by phosphorylation, we studied the effects of kinase activation and inhibition in hippocampal neurons. Inhibition of cAMP-dependent protein kinase (PKA) prevented recovery of NMDA receptors from calcineurin-mediated dephosphorylation induced by synaptic activity, suggesting that tonically active PKA phosphorylates receptors during quiescent periods. Conversely, elevation of PKA activity by forskolin, cAMP analogs, or the beta-adrenergic receptor agonists norepinephrine and isoproterenol overcame the ability of calcineurin to depress the amplitude of NMDA EPSCs. Thus, stimulation of beta-adrenergic receptors during excitatory synaptic transmission can increase charge transfer and Ca2+ influx through NMDA receptors.			Raman, IM (corresponding author), OREGON HLTH SCI UNIV,PORTLAND,OR 97201, USA.		Tong, Gary/AAC-9426-2022		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021419] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21419] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE R, 1993, NEURON, V10, P83, DOI 10.1016/0896-6273(93)90244-L; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; DOZE VA, 1991, NEURON, V6, P889, DOI 10.1016/0896-6273(91)90229-S; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; DUNWIDDIE TV, 1992, J NEUROSCI, V12, P506; GEREAU RW, 1994, J NEUROSCI, V14, P3310; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; LIMAN ER, 1989, BRAIN RES, V481, P399, DOI 10.1016/0006-8993(89)90822-6; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OLPE HR, 1986, NEUROSCI LETT, V65, P11, DOI 10.1016/0304-3940(86)90112-6; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SCANZIANI M, 1993, J NEUROSCI, V13, P5393, DOI 10.1523/JNEUROSCI.13-12-05393.1993; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; SHARMA RK, 1986, J BIOL CHEM, V261, P1322; SHARMA RK, 1985, P NATL ACAD SCI USA, V82, P2603, DOI 10.1073/pnas.82.9.2603; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0	45	247	252	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					415	421		10.1016/S0896-6273(00)80059-8	http://dx.doi.org/10.1016/S0896-6273(00)80059-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789956	Bronze			2022-12-24	WOS:A1996TW95700021
J	Campagna, JA; Ruegg, MA; Bixby, JL				Campagna, JA; Ruegg, MA; Bixby, JL			Agrin is a differentiation-inducing ''stop signal'' for motoneurons in vitro	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; NEUROMUSCULAR-JUNCTIONS INVITRO; BASAL LAMINA; CULTURED MYOTUBES; CHICK-EMBRYO; MUSCLE; PROTEINS; EXPRESSION; OUTGROWTH; NEURONS	Proteins of the synaptic basal lamina are important in directing the differentiation of motor nerve terminals. One synaptic basal lamina protein, agrin, which influences postsynaptic muscle differentiation, has been suggested to influence nerve terminals as well. To test this hypothesis, we cocultured chick ciliary ganglion neurons with agrin-expressing CHO cells. Ciliary ganglion neurons, but not sensory neurons, adhered five times as well to agrin-expressing cells as to untransfected cells. Further, ciliary ganglion neurites were growth inhibited upon contact with agrin-expressing cells. Finally, the synaptic vesicle protein synaptotagmin became concentrated at contacts between ciliary ganglion neurites and agrin-expressing cells. These activities were shared by neuronal and muscle-derived agrin isoforms, consistent with the hypothesis that muscle agrin may influence the presynaptic axon. Our results suggest that agrin influences the growth and differentiation of motoneurons in vivo.	UNIV BASEL,BIOZENTRUM,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND	University of Basel	Campagna, JA (corresponding author), UNIV MIAMI,SCH MED,DEPT MOLEC & CELLULAR PHARMACOL,R-189,1600 NW 10 AVE,MIAMI,FL 33136, USA.		Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Bixby, John/0000-0003-1633-5318	NICHD NIH HHS [HD25154] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025154] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BETZ W, 1976, J PHYSIOL-LONDON, V254, P75, DOI 10.1113/jphysiol.1976.sp011222; BIXBY JL, 1985, J NEUROSCI, V5, P3070; BIXBY JL, 1995, J NEUROBIOL, V26, P262, DOI 10.1002/neu.480260210; BIXBY JL, 1987, DEV BIOL, V119, P363, DOI 10.1016/0012-1606(87)90041-8; BIXBY JL, 1989, NEURON, V3, P287, DOI 10.1016/0896-6273(89)90253-5; BURG MA, 1995, J NEUROSCI RES, V41, P49, DOI 10.1002/jnr.490410107; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CHIU AY, 1984, DEV BIOL, V103, P456, DOI 10.1016/0012-1606(84)90333-6; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; HUNTER DD, 1991, J NEUROSCI, V11, P3960; JAMES DW, 1969, Z ZELLFORSCH MIK ANA, V100, P126, DOI 10.1007/BF00343826; LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F; LIETH E, 1993, J NEUROSCI, V13, P2509, DOI 10.1523/JNEUROSCI.13-06-02509.1993; LOU XJ, 1995, MOL CELL NEUROSCI, V6, P252, DOI 10.1006/mcne.1995.1020; LUPA MT, 1990, DEV BIOL, V142, P31, DOI 10.1016/0012-1606(90)90148-C; LUPA MT, 1989, J NEUROSCI, V9, P3937; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; NAKAJIMA Y, 1980, DEV BIOL, V77, P52, DOI 10.1016/0012-1606(80)90456-X; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; SMITH MA, 1994, NEURON, V12, P795, DOI 10.1016/0896-6273(94)90332-8; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094	43	109	111	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1365	1374		10.1016/0896-6273(95)90014-4	http://dx.doi.org/10.1016/0896-6273(95)90014-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845159	Bronze			2022-12-24	WOS:A1995TL67800014
J	Wang, LC; Dani, J; Godement, P; Marcus, RC; Mason, CA				Wang, LC; Dani, J; Godement, P; Marcus, RC; Mason, CA			Crossed and uncrossed retinal axons respond differently to cells of the optic chiasm midline in vitro	NEURON			English	Article							GROWTH CONE GUIDANCE; SPINAL-CORD; RADIAL GLIA; GANGLION-CELLS; NERVOUS-SYSTEM; CHICK-EMBRYO; FLOOR PLATE; INVITRO; MOUSE; PROJECTIONS	In mouse, retinal axon divergence takes place within a cellular specialization localized at the midline of the optic chiasm. To test whether the cells in this locus present cues for differential retinal axon growth, retinal explants were cocultured with cells dissociated from the chiasmatic midline, both taken from day 14-15 embryos, during the principal period of retinal axon divergence. Compared with crossed axons from other retinal regions, arena from ventrotemporal retina, the sole source of uncrossed axons, were shorter, more fasciculated, and fewer in number when growing on chiasm cells. Furthermore, uncrossed axons avoided clusters of chiasm neurons and glia having the composition and arrangement of the midline specialization, but crossed axons readily grew over them. In contrast to the clusters of chiasm cells, however, individual neurons and glia. did not elicit differential retinal axon growth. These data demonstrate that cues for divergence derive from cells resident to the chiasm and suggest that cellular interactions among resident midline cells are required to produce these cues.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, DEPT ANAT & CELL BIOL, NEW YORK, NY 10032 USA; INST ALFRED FESSARD, CNRS, UPR 2212, F-91198 GIF SUR YVETTE, FRANCE	Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Wang, LC (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, 630 W 168TH ST, NEW YORK, NY 10032 USA.				NEI NIH HHS [EY06510] Funding Source: Medline; NINDS NIH HHS [NS/EY 27615, NS30522] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027615] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BAIRD DH, 1992, J NEUROSCI, V12, P619; BAIRD DH, 1994, NEUROPROTOCOLS, V4, P106; BAKER GE, 1993, J COMP NEUROL, V330, P95, DOI 10.1002/cne.903300108; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BURDENGULLEY SM, 1995, J NEUROSCI, V15, P4370; BURMEISTER DW, 1988, J NEUROSCI, V8, P3151; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHANG WS, 1993, DEVELOPMENT, V118, P651; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; COLELLO RJ, 1992, J COMP NEUROL, V317, P357, DOI 10.1002/cne.903170404; CULICAN SM, 1990, J NEUROSCI, V10, P684; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; Gierer Alfred, 1995, Current Opinion in Neurobiology, V5, P91, DOI 10.1016/0959-4388(95)80092-1; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GODEMENT P, 1989, DEVELOPMENT, V106, P313; GODEMENT P, 1994, J NEUROSCI, V14, P7024; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; GUILLERY RW, 1991, P RET RES F, V3, P153; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; GUILLERY RW, 1987, J COMP NEUROL, V265, P203, DOI 10.1002/cne.902650205; HAMRE KM, 1995, J COMP NEUROL, V352, P421, DOI 10.1002/cne.903520308; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1984, J CELL BIOL, V98, P193, DOI 10.1083/jcb.98.1.193; HO RK, 1982, NATURE, V297, P44; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; JEFFERY G, 1992, J COMP NEUROL, V325, P57, DOI 10.1002/cne.903250106; Jhaveri S, 1993, Perspect Dev Neurobiol, V1, P237; JOHNSTON AR, 1991, DEVELOPMENT, V113, P409; KAPRIELIAN Z, 1994, BIOESSAYS, V16, P1, DOI 10.1002/bies.950160102; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KESHISHIAN H, 1983, DEV BIOL, V96, P89, DOI 10.1016/0012-1606(83)90314-7; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; KNOWLES BB, 1982, DEV BIOL, V93, P54, DOI 10.1016/0012-1606(82)90238-X; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KUHN TB, 1995, NEURON, V14, P275, DOI 10.1016/0896-6273(95)90285-6; LEMMON V, 1992, J NEUROSCI, V12, P818; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; MARCUS RC, 1995, J NEUROSCI, V15, P3716; MARCUS RC, 1995, J NEUROSCI, V15, P6389; MCCABE CF, 1992, DEV BRAIN RES, V66, P11, DOI 10.1016/0165-3806(92)90135-J; MCKANNA JA, 1992, DEV DYNAM, V195, P75, DOI 10.1002/aja.1001950202; MCLOON SC, 1991, J NEUROSCI, V11, P1470; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; NORRIS CR, 1991, J NEUROSCI, V11, P3481; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Polyak S., 1957, VERTEBRATE VISUAL SY; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RABACCHI SA, 1990, DEVELOPMENT, V109, P521; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; REESE BE, 1994, J COMP NEUROL, V349, P303, DOI 10.1002/cne.903490211; RUTISHAUSER U, 1980, J CELL BIOL, V87, P370, DOI 10.1083/jcb.87.2.370; SAVITT JW, 1995, NEURON, V14, P253, DOI 10.1016/0896-6273(95)90283-X; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHEFFIELD JB, 1970, DEV BIOL, V23, P36, DOI 10.1016/S0012-1606(70)80006-9; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; SRETAVAN DW, 1995, SCIENCE, V269, P98, DOI 10.1126/science.7541558; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; TAYLOR JSH, 1994, J COMP NEUROL, V350, P109, DOI 10.1002/cne.903500108; THEITER K, 1972, HOUSE MOUSE; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; VANSELOW J, 1989, DEV BRAIN RES, V45, P15, DOI 10.1016/0165-3806(89)90003-5; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WANG LC, 1994, J NEUROSCI, V14, P3195; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107	81	77	78	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC	1995	15	6					1349	1364		10.1016/0896-6273(95)90013-6	http://dx.doi.org/10.1016/0896-6273(95)90013-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845158	Bronze			2022-12-24	WOS:A1995TL67800013
J	Tamura, K; Shan, WS; Hendrickson, WA; Colman, DR; Shapiro, L				Tamura, K; Shan, WS; Hendrickson, WA; Colman, DR; Shapiro, L			Structure-function analysis of cell adhesion by neural (N-) cadherin	NEURON			English	Article							EPITHELIAL CADHERIN; EXTRACELLULAR DOMAIN; MORPHOGENESIS; MOLECULES; BINDING; IDENTIFICATION; DIMERIZATION; EXPRESSION; OUTGROWTH; TISSUE	To investigate the possible biological function of the lateral "strand dimer" observed in crystal structures of a D1 domain extracellular fragment from N-cadherin, we have undertaken site-directed mutagenesis studies of this molecule. Mutation of most residues important in the strand dimer interface abolish the ability of N-cadherin to mediate cell adhesion. Mutation of an analogous central residue (Trp-2) in E-cadherin also abrogates the adhesive capacity of that molecule. We also determined the crystal structure of a Ca2+-complexed two-domain fragment from N-cadherin. This structure, like its E-cadherin counterpart, does not adopt the strand dimer conformation. This suggests the possibility that classical cadherins might stably exist in both dimeric and monomeric forms. Data from several laboratories imply that:lateral dimerization or clustering of cadherins may increase their adhesivity. We suggest the possibility that the strand dimer may play a role in this activation.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; CUNY Mt Sinai Sch Med, Brookdale Ctr Dev & Mol Biol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Fishberg Ctr Neurosci, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University; Howard Hughes Medical Institute; Columbia University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Shapiro, L (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, Box 1218, New York, NY 10029 USA.		Shapiro, Lawrence/AAE-7172-2019		NINDS NIH HHS [NS33165] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS033165] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FRANKE WW, 1981, EXP CELL RES, V131, P299, DOI 10.1016/0014-4827(81)90234-2; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; JONES TA, 1985, METHOD ENZYMOL, V115, P157; Kemler R, 1992, Semin Cell Biol, V3, P149; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; MIYATANI S, 1989, NEURAL CADHERIN ROLE; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Overduin M, 1996, J BIOMOL NMR, V7, P173; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Serafini T, 1997, TRENDS NEUROSCI, V20, P322; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1990, COLD SH Q B, V55, P319; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; TONG KI, 1994, FEBS LETT, V352, P318; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	34	272	273	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1153	1163		10.1016/S0896-6273(00)80496-1	http://dx.doi.org/10.1016/S0896-6273(00)80496-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655503	hybrid			2022-12-24	WOS:000074627300011
J	Wilson, GG; Karlin, A				Wilson, GG; Karlin, A			The location of the gate in the acetylcholine receptor channel	NEURON			English	Article							SHAKER-K+ CHANNEL; AMINO-ACIDS; LINING RESIDUES; ALPHA-SUBUNIT; CYSTEINE-SUBSTITUTION; NICOTINIC RECEPTORS; ACTIVATED CHANNELS; GAMMA-SUBUNIT; BINDING-SITES; ION-TRANSPORT	The cation-conducting channel of the nicotinic acetylcholine (ACh) receptor is lined by the first (M1) and second (M2) membrane-spanning segments of each of its five subunits. Six consecutive residues, alpha S239 to alpha T244, in the alpha subunit M1-M2 loop and at the intracellular end of M2 were mutated to cysteine. The accessibility of the substituted cysteines were probed with small, cationic, sulfhydryl-specific reagents added extracellularly and intracellularly. In the closed state of the channel, there is a barrier to these reagents added from either side between alpha G240 and alpha T244. ACh induces the removal of this barrier, which acts as an activation gate. The residues alpha G240, alpha E241, alpha K242, and alpha T244 line a narrow part of the channel, in which this gate is located.	Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA	Columbia University	Karlin, A (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA.			KARLIN, ARTHUR/0000-0002-4813-752X	NINDS NIH HHS [NS 07065] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1995, BIOCHEMISTRY-US, V34, P12496, DOI 10.1021/bi00039a002; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRONG CM, 1975, QUART REV BIOPH, V7, P179; Auerbach A, 1996, J PHYSIOL-LONDON, V494, P155, DOI 10.1113/jphysiol.1996.sp021482; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; COHEN BN, 1992, J GEN PHYSIOL, V99, P545, DOI 10.1085/jgp.99.4.545; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; DANI JA, 1989, J NEUROSCI, V9, P884; DANI JA, 1987, J GEN PHYSIOL, V89, P959, DOI 10.1085/jgp.89.6.959; DANI JA, 1990, J THEOR BIOL, V146, P289, DOI 10.1016/S0022-5193(05)80740-4; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P5452, DOI 10.1021/bi00292a029; HESS GP, 1993, BIOCHEMISTRY-US, V32, P989, DOI 10.1021/bi00055a001; Hilgemann Donald W., 1995, P307; Hille B., 1992, IONIC CHANNELS EXCIT, P607; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HUANG LYM, 1978, J GEN PHYSIOL, V71, P397, DOI 10.1085/jgp.71.4.397; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kellenberger S, 1997, J GEN PHYSIOL, V109, P589, DOI 10.1085/jgp.109.5.589; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LEMOINE NR, 1990, ANIMAL CELL CULTURE, P565; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; NEUBIG RR, 1982, BIOCHEMISTRY-US, V21, P3460, DOI 10.1021/bi00257a032; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; PEDERSEN SE, 1992, J BIOL CHEM, V267, P10489; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; REVAH F, 1990, P NATL ACAD SCI USA, V87, P4675, DOI 10.1073/pnas.87.12.4675; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VILLARROEL A, 1992, P ROY SOC B-BIOL SCI, V249, P317, DOI 10.1098/rspb.1992.0121; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; XU M, 1993, J BIOL CHEM, V268, P21505; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m	57	165	168	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1269	1281		10.1016/S0896-6273(00)80506-1	http://dx.doi.org/10.1016/S0896-6273(00)80506-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655513	hybrid			2022-12-24	WOS:000074627300021
J	Fujita, Y; Shirataki, H; Sakisaka, T; Asakura, T; Ohya, T; Kotani, H; Yokoyama, S; Nishioka, H; Matsuura, Y; Mizoguchi, A; Scheller, RH; Takai, Y				Fujita, Y; Shirataki, H; Sakisaka, T; Asakura, T; Ohya, T; Kotani, H; Yokoyama, S; Nishioka, H; Matsuura, Y; Mizoguchi, A; Scheller, RH; Takai, Y			Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process	NEURON			English	Article							SYNAPTIC VESICLE DOCKING; TUMOR-SUPPRESSOR PROTEIN; II HEAVY-CHAIN; PC12 CELLS; MYOSIN-II; CA2+-DEPENDENT EXOCYTOSIS; BINDING PROTEIN; SYNTAXIN; DROSOPHILA; FUSION	Syntaxin-1 is a component of the synaptic vesicle docking and/or membrane fusion soluble N-etyhlmaleimide-sensitive factor attachment receptor (SNARE) complex (75 and 20S complexes) in nerve terminals, Syntaxin-1 also forms a heterodimer with Munc18/n-Sec1/rbSec1 in a complex that is distinct from the 75 and 20S complexes. In this report, we identify a novel syntaxin-1-binding protein, tomosyn, that is capable of dissociating Munc18 from syntaxin-1 and forming a novel 10S complex with syntaxin-1, soluble N-etyhlmaleimide-sensitive factor attachment (SNAP) 25, and synaptotagmin. The 130 kDa isoform of tomosyn is specifically expressed in brain, where its distribution partly overlaps with that of syntaxin-1 in nerve terminals. High level expression of either syntaxin-1 or tomosyn results in a specific reduction in Ca2+-dependent exocytosis from PC12 cells. These results suggest that tomosyn is an important component in the neurotransmitter release process where it may stimulate SNARE complex formation.	Osaka Univ, Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 565, Japan; JCR Pharmaceut Co Ltd, Japan Sci & Technol Corp, ERATO, Takai Biotimer Project,Nishi Ku, Kobe, Hyogo 65122, Japan; NIH, Dept Virol 2, Tokyo 162, Japan; Kyoto Univ, Grad Sch, Dept Anat & Neurobiol, Kyoto 60601, Japan; Stanford Univ, Med Ctr, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Osaka University; Japan Science & Technology Agency (JST); National Institute of Health Sciences - Japan; Kyoto University; Howard Hughes Medical Institute; Stanford University	Takai, Y (corresponding author), Osaka Univ, Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 565, Japan.		Fujita, Yasuyuki/A-4324-2012					BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BEACH RL, 1981, BRAIN RES, V225, P75, DOI 10.1016/0006-8993(81)90319-X; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Edwardson JM, 1997, CELL, V90, P325, DOI 10.1016/S0092-8674(00)80340-2; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GATEFF E, 1969, NATL CANCER I MONOGR, P365; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; IMAZUMI K, 1994, BIOCHEM BIOPH RES CO, V205, P1409, DOI 10.1006/bbrc.1994.2822; Kee Y, 1996, J NEUROSCI, V16, P1975; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Komuro R, 1996, BIOCHEM BIOPH RES CO, V219, P435, DOI 10.1006/bbrc.1996.0251; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SCHWEITZER ES, 1985, J CELL BIOL, V101, P667, DOI 10.1083/jcb.101.2.667; SHIRATAKI H, 1994, J BIOL CHEM, V269, P32717; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAND D, 1994, J CELL BIOL, V127, P1345, DOI 10.1083/jcb.127.5.1345; STRAND D, 1995, ONCOGENE, V11, P291; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; TOMOTSUNE D, 1993, NATURE, V365, P69, DOI 10.1038/365069a0; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; WICK PF, 1993, J BIOL CHEM, V268, P10983	50	228	235	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1998	20	5					905	915		10.1016/S0896-6273(00)80472-9	http://dx.doi.org/10.1016/S0896-6273(00)80472-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620695	Bronze			2022-12-24	WOS:000073864700010
J	Bradke, F; Dotti, CG				Bradke, F; Dotti, CG			Neuronal polarity: Vectorial cytoplasmic flow precedes axon formation	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; GROWTH CONES; PLASMALEMMAL EXPANSION; MICROTUBULE BEHAVIOR; GLUTAMATE RECEPTORS; DENDRITIC GROWTH; GOLGI-APPARATUS; GROWING AXONS; MEMBRANE; TRANSPORT	Axon formation in multipolar neurons is believed to depend on the existence of precise sorting mechanisms for axonal membrane and membrane-associated proteins. Conclusive evidence in living neurons, however, is lacking. In the present study, we use light and video microscopy to address this issue directly. We show that axon formation is preceded by the appearance in one of the multiple neurites of (1) a larger growth cone, (2) a higher amount and greater transport of membrane organelles, (3) polarized delivery of TGN-derived vesicles, (4) a higher concentration of mitochondria and peroxisomes, (5) a higher concentration of a cytosolic protein, and (6) a higher concentration of ribosomes. These results provide evidence for the involvement of bulk cytoplasmic flow as an early determinant of neuronal morphological polarization. Molecular sorting events would later trigger the establishment of functional polarity.	European Mol Biol Lab, Cell Biol Program, D-69012 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Dotti, CG (corresponding author), European Mol Biol Lab, Cell Biol Program, Meyerhofstr 1, D-69012 Heidelberg, Germany.		Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719; Bradke, Frank/0000-0002-0345-3772				ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; BERGMANN JE, 1983, P NATL ACAD SCI-BIOL, V80, P1367, DOI 10.1073/pnas.80.5.1367; BRADKE F, 1997, IN PRESS MICROINJECT; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; CHENG TPO, 1987, J NEUROSCI, V7, P1752; CHU JL, 1991, J EXP MED, V174, P507, DOI 10.1084/jem.174.3.507; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; DAI JW, 1995, CELL, V83, P693; DEHOOP M, 1995, J CELL BIOL, V130, P1447, DOI 10.1083/jcb.130.6.1447; DEHOOP MJ, 1993, J CELL SCI, P85; DEHOOP MJ, 1997, IN PRESS CELL BIOL L; DEITCH JS, 1993, J NEUROSCI, V13, P4301; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; DOTTI CG, 1991, J CELL SCI, P75; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; ELKON KB, 1985, J EXP MED, V162, P459, DOI 10.1084/jem.162.2.459; FERREIRA A, 1989, DEV BRAIN RES, V49, P205, DOI 10.1016/0165-3806(89)90022-9; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; GOLDBERG DJ, 1987, DEV BIOL, V124, P35, DOI 10.1016/0012-1606(87)90456-8; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; GOSLIN K, 1990, J CELL BIOL, V110, P1319, DOI 10.1083/jcb.110.4.1319; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Goslin K., 1991, CULTURING NERVE CELL, P251; GOTLIEB AI, 1981, J CELL BIOL, V91, P589, DOI 10.1083/jcb.91.2.589; GRIFFIN JW, 1981, J CELL BIOL, V88, P205, DOI 10.1083/jcb.88.1.205; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; HEIKOOP JC, 1992, EUR J CELL BIOL, V57, P165; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HUBER LA, 1995, MOL CELL BIOL, V15, P918; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; KLEIMAN R, 1994, J NEUROSCI, V14, P1130, DOI 10.1523/JNEUROSCI.14-03-01130.1994; KOENIG E, 1985, J NEUROSCI, V5, P715; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; LEFCORT F, 1989, J CELL BIOL, V108, P1737, DOI 10.1083/jcb.108.5.1737; LIM SS, 1989, J CELL BIOL, V109, P253, DOI 10.1083/jcb.109.1.253; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; LOCKERBIE RO, 1991, J CELL BIOL, V112, P1215, DOI 10.1083/jcb.112.6.1215; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MORRIS RL, 1993, J CELL SCI, V104, P917; OKABE S, 1992, J CELL BIOL, V117, P105, DOI 10.1083/jcb.117.1.105; OKABE S, 1990, NATURE, V343, P479, DOI 10.1038/343479a0; Overly CC, 1996, J CELL SCI, V109, P971; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PAGANO RE, 1994, CELL BIOL LAB HDB, P387; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; PFENNINGER KH, 1981, J CELL BIOL, V89, P547, DOI 10.1083/jcb.89.3.547; PROCHIANTZ A, 1995, NEURON, V15, P743, DOI 10.1016/0896-6273(95)90164-7; REINSCH SS, 1991, J CELL BIOL, V115, P365, DOI 10.1083/jcb.115.2.365; SABRY J, 1995, NEURON, V14, P1247, DOI 10.1016/0896-6273(95)90271-6; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; SPIEGELMAN BM, 1979, CELL, V16, P253, DOI 10.1016/0092-8674(79)90003-5; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Vogt L, 1996, CURR BIOL, V6, P1153, DOI 10.1016/S0960-9822(02)70682-9	64	192	196	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1997	19	6					1175	1186		10.1016/S0896-6273(00)80410-9	http://dx.doi.org/10.1016/S0896-6273(00)80410-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427242	Bronze			2022-12-24	WOS:000071236500006
J	Ming, GL; Song, HJ; Berninger, B; Holt, CE; Tessier-Lavigne, M; Poo, MM				Ming, GL; Song, HJ; Berninger, B; Holt, CE; Tessier-Lavigne, M; Poo, MM			CAMP-dependent growth cone guidance by netrin-1	NEURON			English	Article							C-ELEGANS; COLORECTAL-CANCER; AXON GUIDANCE; CYCLIC-AMP; COMMISSURAL AXONS; NEURITE OUTGROWTH; ADENYLYL-CYCLASE; SPINAL NEURONS; PROTEIN-KINASE; NERVOUS-SYSTEM	Netrin-1 is known to function as a chemoattractant for several classes of developing axons and as a chemorepellent for other classes of axons, apparently dependent on the receptor type expressed by responsive cells. In culture, growth cones of embryonic Xenopus spinal neurons exhibited chemoattractive turning toward the source of netrin-1 but showed chemorepulsive responses in the presence of a competitive analog of cAMP or an inhibitor of protein kinase A. Both attractive and repulsive responses were abolished by depleting extracellular calcium and by adding a blocking antibody against the netrin-1 receptor Deleted in Colorectal Cancer. Thus, nerve growth cones may respond to the same guidance cue with opposite turning behavior, dependent on other coincident signals that set the level of cytosolic cAMP.	Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.		Berninger, Benedikt/H-4098-2019; Ming, Guo-li/J-7880-2013	Berninger, Benedikt/0000-0003-2652-2782; Ming, Guo-li/0000-0002-2517-6075; Holt, Christine Elizabeth/0000-0003-2829-121X				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; BIXBY JL, 1984, J PHYSIOL-LONDON, V353, P143, DOI 10.1113/jphysiol.1984.sp015328; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Cooper J.R., 1996, BIOCH BASIS NEUROPHA, Vseventh; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; EVERS J, 1989, J NEUROSCI, V9, P1523; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hempel CM, 1996, NATURE, V384, P166, DOI 10.1038/384166a0; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KATER SB, 1988, TRENDS NEUROSCI, V11, P317; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; LANKFORD KL, 1989, J CELL BIOL, V109, P1229, DOI 10.1083/jcb.109.3.1229; LAUDANNA G, 1997, J BIOL CHEM, V272, P24141; LAUFER R, 1987, EMBO J, V6, P901, DOI 10.1002/j.1460-2075.1987.tb04836.x; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; MARK MD, 1995, J CELL BIOL, V130, P701, DOI 10.1083/jcb.130.3.701; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; PIERCEALL WE, 1994, DEV BIOL, V166, P654, DOI 10.1006/dbio.1994.1345; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tabti N., 1991, CULTURING NERVE CELL, P137; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YAO H, 1995, J BIOL CHEM, V270, P20748, DOI 10.1074/jbc.270.35.20748; YOVELL Y, 1992, J NEUROCHEM, V59, P1736, DOI 10.1111/j.1471-4159.1992.tb11005.x; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	49	462	471	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1225	1235		10.1016/S0896-6273(00)80414-6	http://dx.doi.org/10.1016/S0896-6273(00)80414-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427246	Bronze			2022-12-24	WOS:000071236500010
J	Gordon, SE; Varnum, MD; Zagotta, WN				Gordon, SE; Varnum, MD; Zagotta, WN			Direct interaction between amino- and carboxyl-terminal domains of cyclic nucleotide-gated channels	NEURON			English	Article							MOLECULAR MECHANISM; ACTIVATED CHANNELS; COMPLEMENTARY-DNA; POTASSIUM CHANNEL; CATION CHANNEL; ION CHANNELS; CGMP; SULFHYDRYL; MODULATION; RECEPTOR	We have examined domain interactions in the rod cyclic nucleotide-gated ion channel using both physiological and biochemical interaction assays. We have found an interaction between two regions of the channel distant in primary structure, the amino-terminal region and the carboxyl-terminal region containing the cyclic nucleotide-binding (CNB) domain. The interaction in functional channels was detected by the formation of a disulfide bond between cysteine residues at position 35 in the amino-terminal region and 481 in the carboxyl-terminal region. The disulfide bond resulted in channel potentiation, which was due, in part, to an increase in availability of C481 to modification when the channels were open. This state dependence is likely to underlie previously reported potentiation of cyclic nucleotide-gated channels by sulfhydryl-reactive compounds. Polypeptides derived from the aminoterminal and carboxyl-terminal regions were shown to interact, even under conditions which precluded disulfide bond formation. These data argue for a previously unknown, direct interaction between disparate regions of channel sequence.			Gordon, SE (corresponding author), UNIV WASHINGTON,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,BOX 357370,SEATTLE,WA 98195, USA.				NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [EY 10329, R01 EY010329] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; BALAKRISHNAN K, 1990, BIOPHYS J, V57, pA371; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; COSSART P, 1982, NUCLEIC ACIDS RES, V10, P1363, DOI 10.1093/nar/10.4.1363; DONNER K, 1990, EXP EYE RES, V51, P97, DOI 10.1016/0014-4835(90)90176-U; FESENKO EE, 1986, BIOCHIM BIOPHYS ACTA, V856, P661, DOI 10.1016/0005-2736(86)90162-8; Finn J. T., 1995, Biophysical Journal, V68, pA253; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; HURWITZ R, 1991, J BIOL CHEM, V266, P7975; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; MOLDAY RS, 1991, J BIOL CHEM, V266, P21917; NAKAMURA T, 1987, NATURE, V325, P42; Oae S., 1991, ORGANIC SULFUR CHEM; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; VARNUM MD, 1997, IN PRESS SCIENCE	30	66	68	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					431	441		10.1016/S0896-6273(00)80951-4	http://dx.doi.org/10.1016/S0896-6273(00)80951-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292731	Bronze			2022-12-24	WOS:A1997XU14600020
J	Ono, K; Yasui, Y; Rutishauser, U; Miller, RH				Ono, K; Yasui, Y; Rutishauser, U; Miller, RH			Focal ventricular origin and migration of oligodendrocyte precursors into the chick optic nerve	NEURON			English	Article							MULTIPLE ADHESION MOLECULES; GRANULE CELL-MIGRATION; O-2A PROGENITOR CELLS; RAT SPINAL-CORD; POLYSIALIC ACID; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; NEURAL-TUBE; N-CADHERIN; EXPRESSION	During central nervous system (CNS) development, oligodendrocyte precursors originate in specific locations and subsequently migrate to all regions of the CNS. Here, we demonstrate that the chick optic nerve is populated by oligodendrocyte precursors, which initially appeared in a focal region at the ventral midline of the third ventricle at stage 26-27. Oligodendrocyte precursors migrated into the chiasmal end of the nerve by stage 29 and became uniformly distributed by stage 35. Migrating precursors were restricted to the anterior region of the nerve, closely apposed to axons, and had a bipolar morphology. In contrast to the polysialic acid (PSA)-dependent cooperative streaming migration of olfactory neuronal precursors, the migration of oligodendrocyte precursors along the optic nerve appeared axophilic and unaffected by removal of neural cell adhesion molecule (N-CAM)-associated PSA. These data indicate that during development, defined domains of the ventricular zone give rise to distinct cell types that utilize discrete mechanisms to navigate specific migrational pathways.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT GENET, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, SCH MED, DEPT NEUROSCI, CLEVELAND, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Ono, K (corresponding author), SHIMANE MED UNIV, DEPT ANAT, DIV 2, IZUMO, SHIMANE 693, JAPAN.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030800] Funding Source: NIH RePORTER; NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD18369] Funding Source: Medline; NINDS NIH HHS [NS30800] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASOU H, 1992, NEUROREPORT, V3, P481, DOI 10.1097/00001756-199206000-00006; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; CHUONG CM, 1990, EXPERIENTIA, V46, P892, DOI 10.1007/BF01939381; FFRENCHCONSTANT C, 1988, J NEUROCYTOL, V17, P13, DOI 10.1007/BF01735374; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Kiernan BW, 1996, MOL CELL NEUROSCI, V7, P322, DOI 10.1006/mcne.1996.0024; KIERNAN BW, 1993, DEVELOPMENT, P219; LACHAPELLE F, 1984, DEV NEUORSCI, V10, P325; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MILNER R, 1994, DEVELOPMENT, V120, P3497; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOLL E, 1993, DEVELOPMENT, V118, P563; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; ONO K, 1995, DEVELOPMENT, V121, P1743; ONO K, 1989, EXP BRAIN RES, V79, P190; Orentas DM, 1996, DEV BIOL, V177, P43, DOI 10.1006/dbio.1996.0143; PAYNE HR, 1993, DEV BIOL, V159, P595, DOI 10.1006/dbio.1993.1267; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; REDIES C, 1993, GLIA, V8, P161, DOI 10.1002/glia.440080304; Robinson S, 1996, MOL CELL NEUROSCI, V8, P38, DOI 10.1006/mcne.1996.0042; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; TIMSIT S, 1995, J NEUROSCI, V15, P1012; WANG C, 1994, J NEUROSCI, V14, P4446; Wang C, 1996, J CELL BIOL, V135, P1565, DOI 10.1083/jcb.135.6.1565; WARF BC, 1991, J NEUROSCI, V11, P2477; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102	45	139	144	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					283	292		10.1016/S0896-6273(00)80939-3	http://dx.doi.org/10.1016/S0896-6273(00)80939-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292719	Bronze			2022-12-24	WOS:A1997XU14600008
J	Jonas, EA; Knox, RJ; Kaczmarek, LK				Jonas, EA; Knox, RJ; Kaczmarek, LK			Giga-ohm seals on intracellular membranes: A technique for studying intracellular ion channels in intact cells	NEURON			English	Article							PATCH-CLAMP TECHNIQUES; INOSITOL TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; CALCIUM-RELEASE; RECEPTOR; CEREBELLUM; VESICLES; NEURONS	A method is outlined for obtaining giga-ohm seals on intracellular membranes in intact cells. The technique employs a variant of the patch-clamp technique: a concentric electrode arrangement protects an inner patch pipette during penetration of the plasma membrane, after which a seal can be formed on an internal organelle membrane. Using this technique, successful recordings can be obtained with the same frequency as with conventional patch clamping. To localize the position of the pipette within cells, lipophilic fluorescent dyes are included in the pipette solution. These dyes stain the membrane of internal organelles during seal formation and can then be visualized by video-enhanced or confocal imaging. The method can detect channels activated by inositol trisphosphate, as well as other types of intracellular membrane ion channel activity, and should facilitate studies of internal membranes in intact neurons and other cell types.	MARINE BIOL LABS,WOODS HOLE,MA	Marine Biological Laboratory - Woods Hole	Jonas, EA (corresponding author), YALE UNIV,SCH MED,DEPT PHARMACOL,333 CEDAR ST,NEW HAVEN,CT 06520, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018492] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-18492] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberts B., 1994, MOL BIOL CELL; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BEZPROZVANNY IB, 1993, MOL BIOL CELL, V4, P347, DOI 10.1091/mbc.4.3.347; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4; FEVRE F, 1994, BIOPHYS J, V66, P1887, DOI 10.1016/S0006-3495(94)80982-8; FINK LA, 1988, J NEUROSCI, V8, P2544; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; Hahn SJ, 1996, NEUROPHARMACOLOGY, V35, P895, DOI 10.1016/0028-3908(96)00094-9; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; Jonas EA, 1996, J NEUROSCI, V16, P1645; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kaczmarek L. K., 1986, NEUROMODULATION BIOC; KELLER BU, 1992, METHOD ENZYMOL, V207, P673; KINNALLY KW, 1994, MOL BIOL MITOCHONDRI, P169; KNOX RJ, 1992, NEURON, V8, P883, DOI 10.1016/0896-6273(92)90202-O; LOHRET TA, 1995, BIOPHYS J, V68, P2299, DOI 10.1016/S0006-3495(95)80412-1; MAK DOD, 1994, J BIOL CHEM, V269, P29375; MAZZANTI M, 1990, NATURE, V343, P764, DOI 10.1038/343764a0; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; PUTNEY JW, 1993, SCIENCE, V262, P676, DOI 10.1126/science.8235587; SCHMID A, 1990, NATURE, V346, P374, DOI 10.1038/346374a0; STEHNOBITTEL L, 1995, NEURON, V14, P163, DOI 10.1016/0896-6273(95)90250-3; WATRAS J, 1991, J NEUROSCI, V11, P3239; YAKIR N, 1995, J PHYSIOL-LONDON, V485, P683, DOI 10.1113/jphysiol.1995.sp020762; ZIZI M, 1995, J MEMBRANE BIOL, V144, P121	29	41	42	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					7	13		10.1016/S0896-6273(00)80343-8	http://dx.doi.org/10.1016/S0896-6273(00)80343-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247259	hybrid			2022-12-24	WOS:A1997XN39400002
J	Liu, Y; Holmgren, M; Jurman, ME; Yellen, G				Liu, Y; Holmgren, M; Jurman, ME; Yellen, G			Gated access to the pore of a voltage-dependent K+ channel	NEURON			English	Article							SHAKER POTASSIUM CHANNELS; BINDING-SITE; TETRAETHYLAMMONIUM ION; TEA BLOCKADE; RECEPTOR; MUTATIONS; INACTIVATION; REGION; CONDUCTANCE; ACTIVATION	Voltage-activated K+ channels are integral membrane proteins that open or close a K+-selective pore in response to changes in transmembrane voltage. Although the S4 region of these channels has been implicated as the voltage sensor, little is known about how opening and closing of the pore is accomplished. We explored the gating process by introducing cysteines at various positions thought to lie in or near the pore of the Shaker K+ channel, and by testing their ability to be chemically modified. We found a series of positions in the S6 transmembrane region that react rapidly with water-soluble thiol reagents in the open state but not the closed state. An open-channel blocker can protect several of these cysteines, showing that they lie in the ion-conducting pore. At two of these sites, Cd2+ ions bind to the cysteines without affecting the energetics of gating; at a third site, Cd2+ binding holds the channel open. The results suggest that these channels open and close by the movement of an intracellular gate, distinct from the selectivity filter, that regulates access to the pore.	MASSACHUSETTS GEN HOSP,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital	Liu, Y (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02114, USA.			Yellen, Gary/0000-0003-4228-7866	NINDS NIH HHS [NS 29693, R01 NS029693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRONG CM, 1982, J GEN PHYSIOL, V80, P663, DOI 10.1085/jgp.80.5.663; ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; ARMSTRONG CM, 1975, QUART REV BIOPH, V7, P179; Baukrowitz T, 1996, P NATL ACAD SCI USA, V93, P13357, DOI 10.1073/pnas.93.23.13357; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; CHERVITZ SA, 1995, J BIOL CHEM, V270, P24043, DOI 10.1074/jbc.270.41.24043; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; Fitzgerald MM, 1996, NAT STRUCT BIOL, V3, P626, DOI 10.1038/nsb0796-626; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; GRISSMER S, 1989, J GEN PHYSIOL, V93, P609, DOI 10.1085/jgp.93.4.609; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LORING RH, 1992, MOL BRAIN RES, V15, P113, DOI 10.1016/0169-328X(92)90158-8; LUKIN SH, 1997, IN PRESS EMBO J; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHIEH CC, 1994, BIOPHYS J, V67, P2316, DOI 10.1016/S0006-3495(94)80718-0; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; TAGLIALATELA M, 1994, J BIOL CHEM, V269, P13867; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TOTH MS, 1993, PROTEIN SCI, V2, P1024; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	47	426	434	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					175	184		10.1016/S0896-6273(00)80357-8	http://dx.doi.org/10.1016/S0896-6273(00)80357-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247273	Bronze			2022-12-24	WOS:A1997XN39400016
J	Ebens, A; Brose, K; Leonardo, ED; Hanson, MG; Bladt, F; Birchmeier, C; Barres, BA; TessierLavigne, M				Ebens, A; Brose, K; Leonardo, ED; Hanson, MG; Bladt, F; Birchmeier, C; Barres, BA; TessierLavigne, M			Hepatocyte growth factor scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons	NEURON			English	Article							MACROPHAGE-STIMULATING PROTEIN; JAPANESE MEDAKA FISH; C-MET RECEPTOR; CHICK-EMBRYO; TYROSINE KINASE; NERVE GROWTH; MONOCLONAL-ANTIBODY; PATHWAY SELECTION; MAMMALIAN BRAIN; SCHWANN-CELLS	In the embryonic nervous system, developing axons can be guided to their targets by diffusible factors secreted by their intermediate and final cellular targets. To date only one family of chemoattractants for developing axons has been identified. Grafting and ablation experiments in fish, amphibians, and birds have suggested that spinal motor axons are guided to their targets in the limb in part by a succession of chemoattractants made by the sclerotome and by the limb mesenchyme, two intermediate targets that these axons encounter en route to their target muscles. Here we identify the limb mesenchyme-derived chemoattractant as hepatocyte growth factor/scatter factor (HGF/SF), a diffusible ligand for the c-Met receptor tyrosine kinase, and we also implicate HGF/SF at later stages as a muscle-derived survival factor for motoneurons. These results indicate that, in addition to functioning as a mitogen, a motogen, and a morphogen in nonneural systems, HGF/SF can function as a guidance and survival factor in the developing nervous system.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA; STANFORD UNIV, SCH MED, DEPT NEUROBIOL, STANFORD, CA 94305 USA; MAX DELBRUCK CTR MOL MED, D-13122 BERLIN, GERMANY	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Stanford University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ebens, A (corresponding author), UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM CELL & DEV BIOL, SAN FRANCISCO, CA 94143 USA.		Leonardo, Eduardo/AAH-1525-2020	Leonardo, Eduardo/0000-0001-7426-0217				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; CAMU W, 1992, J NEUROSCI METH, V44, P59, DOI 10.1016/0165-0270(92)90114-S; CHARLWOOD KA, 1972, NERVE GROWTH FACTOR, P102; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Detwiler SR, 1934, J EXP ZOOL, V67, P395, DOI 10.1002/jez.1400670303; EISEN JS, 1994, ANNU REV NEUROSCI, V17, P1; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gilliland G., 1990, PCR PROTOCOLS GUIDE, P60; GORHAM JD, 1990, DEV BRAIN RES, V57, P235, DOI 10.1016/0165-3806(90)90049-5; Hamburger V, 1934, J EXP ZOOL, V68, P449, DOI 10.1002/jez.1400680305; Hamburger V, 1939, J EXP ZOOL, V80, P347, DOI 10.1002/jez.1400800302; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; Hotary KB, 1996, DEV BIOL, V176, P22, DOI 10.1006/dbio.1996.9997; Huff JL, 1996, ONCOGENE, V12, P299; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; Kochhar KS, 1996, CANCER LETT, V104, P163, DOI 10.1016/0304-3835(96)04244-9; KRASNOSELSKY A, 1994, J NEUROSCI, V14, P7284; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; LANSER ME, 1984, J NEUROSCI, V4, P2043; LEWIS J, 1981, J EMBRYOL EXP MORPH, V64, P211; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUMSDEN AGS, 1988, MAKING NERVOUS SYSTE, P168; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P39, DOI 10.1113/jphysiol.1986.sp016104; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; OKAMOTO H, 1991, DEV BIOL, V146, P62, DOI 10.1016/0012-1606(91)90446-A; OKAMOTO H, 1991, DEV BIOL, V146, P49, DOI 10.1016/0012-1606(91)90445-9; OPPENHEIM RW, 1978, J COMP NEUROL, V177, P87, DOI 10.1002/cne.901770107; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; PHELAN KA, 1990, J NEUROSCI, V10, P2699; PIATT J, 1956, J EXP ZOOL, V131, P173, DOI 10.1002/jez.1401310109; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PLACZEK M, 1990, DEVELOPMENT, V110, P19; POLLACK ED, 1977, SCIENCE, V197, P899, DOI 10.1126/science.302031; Pourquie O, 1996, CELL, V84, P461, DOI 10.1016/S0092-8674(00)81291-X; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RONSIN C, 1993, ONCOGENE, V8, P1195; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; STERN CD, 1990, DEVELOPMENT, V110, P1271; STERN CD, 1986, J EMBRYOL EXP MORPH, V91, P209; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; STREIT A, 1995, DEVELOPMENT, V121, P813; Takayama H, 1996, P NATL ACAD SCI USA, V93, P5866, DOI 10.1073/pnas.93.12.5866; Tessier-Lavigne M, 1992, Curr Opin Neurobiol, V2, P60, DOI 10.1016/0959-4388(92)90163-F; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THERY C, 1995, DEV GENET, V17, P90, DOI 10.1002/dvg.1020170110; TOSNEY KW, 1987, DEV BIOL, V122, P540, DOI 10.1016/0012-1606(87)90318-6; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TOSNEY KW, 1991, BIOESSAYS, V13, P17; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; WANG MH, 1995, P NATL ACAD SCI USA, V92, P3933, DOI 10.1073/pnas.92.9.3933; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; YAMAGATA T, 1995, BIOCHEM BIOPH RES CO, V210, P231, DOI 10.1006/bbrc.1995.1651; YAN Q, 1988, J NEUROSCI, V8, P3481; YANG XM, 1993, DEV BIOL, V157, P308, DOI 10.1006/dbio.1993.1137	74	361	372	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1157	1172		10.1016/S0896-6273(00)80247-0	http://dx.doi.org/10.1016/S0896-6273(00)80247-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982163	Bronze			2022-12-24	WOS:A1996WA24800013
J	Jia, ZP; Agopyan, N; Miu, P; Xiong, ZG; Henderson, J; Gerlai, R; Taverna, FA; Velumian, A; MacDonald, J; Carlen, P; AbramowNewerly, W; Roder, J				Jia, ZP; Agopyan, N; Miu, P; Xiong, ZG; Henderson, J; Gerlai, R; Taverna, FA; Velumian, A; MacDonald, J; Carlen, P; AbramowNewerly, W; Roder, J			Enhanced LTP in mice deficient in the AMPA receptor GluR2	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; CALCIUM-PERMEABLE AMPA; GLUTAMATE RECEPTORS; STRUCTURAL DETERMINANTS; METABOTROPIC RECEPTORS; HIPPOCAMPAL-NEURONS; KAINATE RECEPTORS; RAT HIPPOCAMPUS; MURINE NEURONS	AMPA receptors (AMPARs) are not thought to be involved in the induction of long-term potentiation (LTP), but may be involved in its expression via second messenger pathways. However, one subunit of the AMPARs, GluR2, is also known to control Ca2+ influx. To test whether GluR2 plays any role in the induction of LTP, we generated mice that lacked this subunit. In GluR2 mutants, LTP in the CA1 region of hippocampal slices was markedly enhanced (2-fold) and nonsaturating, whereas neuronal excitability and paired-pulse facilitation were normal. The 9-fold increase in Ca2+ permeability, in response to kainate application, suggests one possible mechanism for enhanced LTP. Mutant mice exhibited increased mortality, and those surviving showed reduced exploration and impaired motor coordination. These results suggest an important role for GluR2 in regulating synaptic plasticity and behavior.	TORONTO HOSP,PLAYFAIR NEUROSCI UNIT,TORONTO,ON M5T 2S8,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Jia, ZP (corresponding author), MT SINAI HOSP,SAMUEL LUNENFELD RES INST,600 UNIV AVE,TORONTO,ON M5G 1X5,CANADA.		Jia, zhengping/AAZ-4190-2021; Roder, John/G-6468-2013	Carlen, Peter/0000-0002-3339-8102				ANDERSEN P, 1978, BRAIN RES, V144, P11, DOI 10.1016/0006-8993(78)90431-6; ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; BARRETT EF, 1976, BIOL CHOLINERGIC FUN, P29; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BLANTON M, 1990, J NEUROSCI METH, V30, P203; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; CHIAIA NL, 1992, NEUROSCIENCE, V49, P141, DOI 10.1016/0306-4522(92)90082-D; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; EHLERS MD, 1996, CELL, V84, P746; GELGER JRP, 1995, NEURON, V15, P193; GERBER G, 1989, J NEUROSCI, V9, P3606; GERLAI R, 1993, BEHAV BRAIN RES, V55, P51, DOI 10.1016/0166-4328(93)90006-C; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; GROVER LM, 1990, BRAIN RES, V506, P53, DOI 10.1016/0006-8993(90)91198-P; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1991, SCIENCE, V52, P81; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MACDONALD JF, 1982, CAN J PHYSIOL PHARM, V60, P282, DOI 10.1139/y82-039; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; PURPURA D P, 1968, Brain Research, V7, P310, DOI 10.1016/0006-8993(68)90109-1; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; TURNER RW, 1982, NEUROSCIENCE, V7, P1411, DOI 10.1016/0306-4522(82)90254-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I	58	417	423	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					945	956		10.1016/S0896-6273(00)80225-1	http://dx.doi.org/10.1016/S0896-6273(00)80225-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938126	Bronze			2022-12-24	WOS:A1996VV15100016
J	Li, XJ; Greenwald, I				Li, XJ; Greenwald, I			Membrane topology of the C-elegans SEL-12 presenilin	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; MISSENSE MUTATIONS; GENE; PROTEINS; CHROMOSOME-1; SEQUENCE; RESOLUTION; MODEL	Mutant presenilins cause Alzheimer's disease. Presenilins have multiple hydrophobic regions that could theoretically span a membrane, and a knowledge of the membrane topology is crucial for deducing,the mechanism of presenilin function. By analyzing the activity of beta-galactosidase hybrid proteins expressed in C. elegans, we show that the C. elegans SEL-12 presenilin has eight transmembrane domains and that there is a cleavage site after the sixth transmembrane domain. We examine the presenilin sequence in view of the predicted topology and discuss possible mechanisms for presenilin function.	COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOL BIOPHYS,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Howard Hughes Medical Institute	Li, XJ (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,INTEGRATED PROGRAM CELLULAR MOL & BIOPHYS STUDIES,NEW YORK,NY 10032, USA.							BRENNER S, 1974, GENETICS, V77, P71; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; FIRE A, 1992, GENET ANAL-BIOMOL E, V9, P151, DOI 10.1016/1050-3862(92)90042-4; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVITAN D, 1996, IN PRESS P NATL ACAD; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li JH, 1995, P NATL ACAD SCI USA, V92, P12180, DOI 10.1073/pnas.92.26.12180; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; PerezTur J, 1995, NEUROREPORT, V7, P297; PERRY MD, 1993, GENE DEV, V7, P216, DOI 10.1101/gad.7.2.216; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; REITHMEIER RAF, 1995, CURR OPIN STRUC BIOL, V5, P491, DOI 10.1016/0959-440X(95)80034-4; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SILHAVY TJ, 1985, MICROBIOL REV, V49, P398, DOI 10.1128/MMBR.49.4.398-418.1985; SONG L, 1996, IN PRESS SCIENCE; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; TRAXLER B, 1993, J MEMBRANE BIOL, V132, P1; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	35	185	192	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					1015	1021		10.1016/S0896-6273(00)80231-7	http://dx.doi.org/10.1016/S0896-6273(00)80231-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938132	hybrid			2022-12-24	WOS:A1996VV15100022
J	Brunet, LJ; Gold, GH; Ngai, J				Brunet, LJ; Gold, GH; Ngai, J			General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel	NEURON			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; 2ND MESSENGER PATHWAYS; EMBRYONIC STEM-CELLS; FUNCTIONAL EXPRESSION; ODORANT RECEPTORS; ACTIVATED CHANNEL; ROD PHOTORECEPTOR; ADENYLATE-CYCLASE; INDUCED CURRENTS; MARKER PROTEIN	Olfactory neurons transduce the binding of odorants into membrane depolarization. Two intracellular messengers, cyclic AMP (cAMP) and inositol trisphosphate (IP3), are thought to mediate this process, with cAMP generating responses to some odorants and IP3 mediating responses to others. cAMP causes membrane depolarization by activating a cation-selective cyclic nucleotide-gated (CNG) channel. We created a mutant ''knockout'' mouse lacking functional olfactory CNG channels to assess the roles of different second messenger pathways in olfactory transduction. Using an electrophysiological assay, we find that excitatory responses to both cAMP- and IP3-producing odorants are undetectable in knockout mice. Our results provide direct evidence that the CNG channel subserves excitatory olfactory signal transduction, and further suggest that cAMP is the sole second messenger mediating this process.	MONELL CHEM SENSES CTR,PHILADELPHIA,PA 19104	Monell Chemical Senses Center	Brunet, LJ (corresponding author), UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.				NIDCD NIH HHS [R01 DC-00505, R01 DC-02253] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002253, R01DC000505] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANHOLT RRH, 1990, BIOCHEMISTRY-US, V29, P4049, DOI 10.1021/bi00469a004; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BORISY FF, 1992, J NEUROSCI, V12, P915; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; BREER H, 1991, CHEM SENSES, V16, P19, DOI 10.1093/chemse/16.1.19; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; CUNNINGHAM AM, 1993, NEUROSCIENCE, V57, P339, DOI 10.1016/0306-4522(93)90067-P; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; DAVIS DE, 1956, MANUAL ANAL RODENT P; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; EZEH PI, 1995, J NEUROPHYSIOL, V73, P2207, DOI 10.1152/jn.1995.73.6.2207; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; FRINGS S, 1991, J GEN PHYSIOL, V97, P1, DOI 10.1085/jgp.97.1.1; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; FRINGS S, 1990, BIOPHYS J, V57, P1091, DOI 10.1016/S0006-3495(90)82627-8; FRINGS S, 1993, J GEN PHYSIOL, V101, P1; GORDON SE, 1995, BIOPHYS J, V69, P409, DOI 10.1016/S0006-3495(95)79913-1; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUDSON R, 1986, PHYSIOL BEHAV, V37, P123, DOI 10.1016/0031-9384(86)90394-X; HUQUE T, 1986, BIOCHEM BIOPH RES CO, V137, P36, DOI 10.1016/0006-291X(86)91172-1; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KALINOSKI DL, 1992, BIOCHEM J, V281, P449, DOI 10.1042/bj2810449; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1994, J EXP BIOL, V195, P307; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; KRAMER RH, 1992, NEURON, V9, P897, DOI 10.1016/0896-6273(92)90242-6; KURAHASHI T, 1993, J PHYSIOL-LONDON, V466, P287; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; LYNCH JW, 1989, BIOPHYS J, V55, P755, DOI 10.1016/S0006-3495(89)82874-7; MARGOLIS FL, 1985, TRENDS NEUROSCI, V8, P542, DOI 10.1016/0166-2236(85)90192-4; MIYAMOTO T, 1992, J MEMBRANE BIOL, V127, P173; Nakamura T, 1996, BIOPHYS J, V70, P813, DOI 10.1016/S0006-3495(96)79625-X; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; OKADA Y, 1994, J NEUROPHYSIOL, V71, P595, DOI 10.1152/jn.1994.71.2.595; OKANO M, 1974, J PHYSIOL-LONDON, V242, P353, DOI 10.1113/jphysiol.1974.sp010711; OTTOSON D, 1956, ACTA PHYSIOL SC S122, V35, P1; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; RESTREPO D, 1993, AM J PHYSIOL, V264, P906; RISSER JM, 1987, PHYSIOL BEHAV, V40, P545, DOI 10.1016/0031-9384(87)90042-4; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHILD D, 1995, J NEUROPHYSIOL, V73, P862, DOI 10.1152/jn.1995.73.2.862; SIDAR PB, 1986, J BIOL CHEM, V261, P15538; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; SZABO P, 1994, DEVELOPMENT, V120, P1651; TEICHER MH, 1977, SCIENCE, V198, P635, DOI 10.1126/science.918660; THOMMESEN G, 1977, ACTA PHYSIOL SCAND, V99, P270, DOI 10.1111/j.1748-1716.1977.tb10380.x; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; ZHAINAZAROV AB, 1995, J NEUROPHYSIOL, V74, P479, DOI 10.1152/jn.1995.74.1.479	74	384	399	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					681	693		10.1016/S0896-6273(00)80200-7	http://dx.doi.org/10.1016/S0896-6273(00)80200-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893025	Bronze			2022-12-24	WOS:A1996VP74300013
J	Shapiro, L; Doyle, JP; Hensley, P; Colman, DR; Hendrickson, WA				Shapiro, L; Doyle, JP; Hensley, P; Colman, DR; Hendrickson, WA			Crystal structure of the extracellular domain from P-0, the major structural protein of peripheral nerve myelin	NEURON			English	Article							TOOTH NEUROPATHY TYPE-1; CELL-ADHESION MOLECULE; FREEZE-FRACTURE; MEMBRANE INTERACTIONS; SURFACE-CHARGE; SOLUBLE FORM; HUMAN CD4; PO GENE; RESOLUTION; FRAGMENT	P-0, the major protein of peripheral nerve myelin, mediates membrane adhesion in the spiral wraps of the myelin sheath. We have determined the crystal structure of the extracellular domain from P-0 (P(0)ex) at 1.9 Angstrom resolution. P(0)ex is folded like a typical immunoglobulin variable-like domain; five residues at the C-terminus are disordered, suggesting a flexible linkage to the membrane. The requirements for crystallization of P(0)ex are similar to those for maintaining the native extracellular spacing of adjacent myelin lamellae; thus, given the self-adhesive character of P(0)ex, the crystal itself may reveal some of the natural interactions that occur between P-0 molecules in myelin. The structure leads to the suggestion that P-0 extracellular domains may emanate from the membrane surface as tetramers that link to tetramers on the opposing membrane surface, to result in the formation of networks of molecules. We report analytical ultracentrifugation data for P(0)ex that support this idea.	COLUMBIA UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA; CUNY MT SINAI SCH MED, BROOKDALE CTR MOL BIOL, NEW YORK, NY 10029 USA; SMITHKLINE BEECHAM PHARMACEUT, DEPT MACROMOL SCI, KING OF PRUSSIA, PA 19406 USA	Columbia University; Howard Hughes Medical Institute; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; GlaxoSmithKline	Shapiro, L (corresponding author), COLUMBIA UNIV, DEPT BIOCHEM & MOL BIOPHYS, 630 W 168TH ST, NEW YORK, NY 10032 USA.		Shapiro, Lawrence/AAE-7172-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, R37GM034102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34102] Funding Source: Medline; NINDS NIH HHS [NS20147] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOLLENSEN E, 1987, NEUROSCI LETT, V82, P77, DOI 10.1016/0304-3940(87)90174-1; BROOKS I, 1994, METHOD ENZYMOL, V240, P459; BROOKS I, 1994, MODERN ANAL ULTRACEN, P15; DEISENHOFER J, 1991, ANNU REV BIOPHYS BIO, V20, P247; DING YG, 1994, J BIOL CHEM, V269, P10764; Doyle JP, 1993, CURR OPIN CELL BIOL, V5, P779, DOI 10.1016/0955-0674(93)90025-L; DOYLE JP, 1995, J CELL BIOL, V131, P465, DOI 10.1083/jcb.131.2.465; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FILBIN MT, 1991, NEURON, V7, P845, DOI 10.1016/0896-6273(91)90286-9; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GABRIEL G, 1986, J ANAT, V146, P153; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GRIFFITH LS, 1992, J NEUROSCI RES, V33, P639, DOI 10.1002/jnr.490330417; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; HENDRICKSON WA, 1979, ACTA CRYSTALLOGR A, V35, P158, DOI 10.1107/S0567739479000279; HIMORO M, 1993, BIOCHEM MOL BIOL INT, V31, P169; INOUYE H, 1988, BIOPHYS J, V53, P247, DOI 10.1016/S0006-3495(88)83086-8; INOUYE H, 1988, BIOPHYS J, V53, P235, DOI 10.1016/S0006-3495(88)83085-6; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KILBY PM, 1995, BIOCHEM J, V305, P935, DOI 10.1042/bj3050935; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; Kirschner Daniel A., 1992, P3; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; MINTON AP, 1981, BIOPHYS CHEM, V14, P317, DOI 10.1016/0301-4622(81)85033-8; NELIS E, 1994, HUM GENET, V94, P653, DOI 10.1007/BF00206959; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OWENS GC, 1991, DEVELOPMENT, V112, P639; PANAGOPOULOS G, 1989, J COMP NEUROL, V286, P337, DOI 10.1002/cne.902860304; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PINTODASILVA P, 1975, P NATL ACAD SCI USA, V72, P4046; Raine C., 1984, MYELIN, P1, DOI 10.1007/978-1-4757-1830-0_1; RANVIER ML, 1878, LECONS HISTOLOGIE SY; RITCHIE JM, 1982, PROC R SOC SER B-BIO, V217, P29, DOI 10.1098/rspb.1982.0092; ROSSMANN MG, 1975, J BIOL CHEM, V250, P3910; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SAAVEDRA RA, 1989, J MOL EVOL, V29, P149, DOI 10.1007/BF02100113; SAUL FA, 1992, PROTEINS, V14, P363, DOI 10.1002/prot.340140305; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; STOLINSKI C, 1982, J NEUROL SCI, V57, P1, DOI 10.1016/0022-510X(82)90107-1; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; WELLS CA, 1993, J NEUROCHEM, V61, P1987, DOI 10.1111/j.1471-4159.1993.tb07434.x; WIMLEY WC, 1993, BIOCHEMISTRY-US, V32, P6307, DOI 10.1021/bi00076a001	58	318	319	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					435	449		10.1016/S0896-6273(00)80176-2	http://dx.doi.org/10.1016/S0896-6273(00)80176-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816707	hybrid			2022-12-24	WOS:A1996VJ44000010
J	Rothstein, JD; DykesHoberg, M; Pardo, CA; Bristol, LA; Jin, L; Kuncl, RW; Kanai, Y; Hediger, MA; Wang, YF; Schielke, JP; Welty, DF				Rothstein, JD; DykesHoberg, M; Pardo, CA; Bristol, LA; Jin, L; Kuncl, RW; Kanai, Y; Hediger, MA; Wang, YF; Schielke, JP; Welty, DF			Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate	NEURON			English	Article							RAT-BRAIN; AMINO-ACIDS; LOCALIZATION; ASTROCYTES; SYNTHETASE; EXPRESSION; INHIBITION; RELEASE; DAMAGE	Three glutamate transporters have been identified in rat, including astroglial transporters GLAST and GLT-1 and a neuronal transporter EAAC1. Here we demonstrate that inhibition of the synthesis of each glutamate transporter subtype using chronic antisense oligonucleotide administration, in vitro and in vivo, selectively and specifically reduced the protein expression and function of glutamate transporters. The loss of glial glutamate transporters GLAST or GLT-1 produced elevated extracellular glutamate levels, neurodegeneration characteristic of excitotoxicity, and a progressive paralysis. The loss of the neuronal glutamate transporter EAAC1 did not elevate extracellular glutamate in the striatum but did produce mild neurotoxicity and resulted in epilepsy. These studies suggest that glial glutamate transporters provide the majority of functional glutamate transport and are essential for maintaining low extracellular glutamate and for preventing chronic glutamate neurotoxicity.	JOHNS HOPKINS UNIV HOSP,DEPT NEUROPATHOL,BALTIMORE,MD 21287; KYORIN UNIV,SCH MED,DEPT PHARMACOL,MITAKA,TOKYO 181,JAPAN; HARVARD UNIV,SCH MED,BRIGHAM & WOMENS HOSP,DEPT MED,RENAL DIV,BOSTON,MA 02115; WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,DEPT PHARMACOKINET & DRUG METAB,ANN ARBOR,MI 48105; WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,DEPT NEUROSCI PHARMACOL,ANN ARBOR,MI 48105	Johns Hopkins University; Johns Hopkins Medicine; Kyorin University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pfizer; Pfizer	Rothstein, JD (corresponding author), JOHNS HOPKINS UNIV HOSP,DEPT NEUROL,BALTIMORE,MD 21287, USA.		Pardo, Carlos A./A-5192-2008; rothstein, jeffrey d/C-9470-2013	Pardo, Carlos A./0000-0002-4128-5335; Hediger, Matthias/0000-0003-1946-027X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012992] Funding Source: NIH RePORTER; NIA NIH HHS [AG12992] Funding Source: Medline; NINDS NIH HHS [NS33958] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BARKS JDE, 1994, MOL CHEM NEUROPATHOL, V23, P201, DOI 10.1007/BF02815412; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; HAJOS F, 1986, NEUROSCIENCE, V18, P417, DOI 10.1016/0306-4522(86)90163-6; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; Kanai Y, 1995, NEUROREPORT, V6, P2357, DOI 10.1097/00001756-199511270-00020; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANAI Y, 1995, EXCITATORY AMINO ACI; LEHRE KP, 1995, J NEUROSCI, V15, P1835; MAKI R, 1994, J NEUROSCI, V14, P6754; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Merlis JK, 1940, AM J PHYSIOL, V131, P0067, DOI 10.1152/ajplegacy.1940.131.1.67; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; OLNEY JW, 1969, J NEUROPATH EXP NEUR, V28, P455, DOI 10.1097/00005072-196907000-00007; OLNEY JW, 1983, BRAIN RES BULL, V10, P699, DOI 10.1016/0361-9230(83)90038-2; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; POW DV, 1994, NEUROSCIENCE, V60, P355, DOI 10.1016/0306-4522(94)90249-6; RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0; ROBINSON MB, 1993, J NEUROCHEM, V61, P2099, DOI 10.1111/j.1471-4159.1993.tb07447.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SHAW PJ, 1994, BRAIN RES, V655, P195, DOI 10.1016/0006-8993(94)91614-4; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WHITESELL L, 1993, P NATL ACAD SCI USA, V90, P4665, DOI 10.1073/pnas.90.10.4665	35	2010	2061	1	86	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					675	686		10.1016/S0896-6273(00)80086-0	http://dx.doi.org/10.1016/S0896-6273(00)80086-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785064	hybrid			2022-12-24	WOS:A1996UC16800023
J	Zou, DJ; Cline, HT				Zou, DJ; Cline, HT			Expression of constitutively active CaMKII in target tissue modifies presynaptic axon arbor growth	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; EYE-SPECIFIC STRIPES; SQUID GIANT SYNAPSE; II MUTANT MICE; VISUAL-CORTEX; RETINOTECTAL SYSTEM; STRIATE CORTEX; MAP FORMATION; CALMODULIN	Calcium/calmodulin-dependent protein kinase II (CaMKII) can be regulated by synaptic activity and could therefore be involved in activity-dependent control of neuronal growth. We tested whether increased CaMKII activity in postsynaptic optic tectal neurons can modify the development of retinotectal axons in Xenopus. The elaboration of individual presynaptic retinal axons was observed in vivo before and up to 3 days after infecting the tectal cells with vaccinia virus carrying the gene for constitutively active truncated CaMKII (tCaMKII). Elevated postsynaptic CaMKII activity prevented the axons from developing the complexity of normal arbors by increasing the normal rate of branch retractions. Some effects of tCaMKII on arbor morphology were seen 1 day after infection, but they became more dramatic by the third day. The results suggest that postsynaptic CaMKII plays a role in the development of presynaptic arbor structure.			Zou, DJ (corresponding author), COLD SPRING HARBOR LAB,POB 100,COLD SPRING HARBOR,NY 11724, USA.							ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BENTLEY D, 1991, J NEUROSCI, V11, P1300; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CABELL L, 1993, INT J DEV NEUROSCI, V11, P357, DOI 10.1016/0736-5748(93)90007-Z; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1990, J NEUROSCI, V10, P1197; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; CLINE HT, 1990, NEURON, V4, P899, DOI 10.1016/0896-6273(90)90143-4; CYPHER C, 1992, Current Opinion in Cell Biology, V4, P4, DOI 10.1016/0955-0674(92)90051-D; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; DAVIS GW, 1994, J NEUROBIOL, V25, P740, DOI 10.1002/neu.480250612; DIAMOND J, 1962, J PHYSIOL-LONDON, V162, P393, DOI 10.1113/jphysiol.1962.sp006941; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOSHIMA Y, 1993, J NEUROSCI, V13, P559; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10041; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HENDRY SHC, 1986, P NATL ACAD SCI USA, V83, P1536, DOI 10.1073/pnas.83.5.1536; JEFFERSON AB, 1991, J BIOL CHEM, V266, P346; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P4050, DOI 10.1073/pnas.88.9.4050; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; JIA WG, 1992, DEV NEUROSCI-BASEL, V14, P238, DOI 10.1159/000111668; JIAN X, 1994, J NEUROBIOL, V25, P1310, DOI 10.1002/neu.480251011; KATER SB, 1994, PROG BRAIN RES, V102, P49; KATZ LC, 1992, ANNU REV NEUROSCI, V15, P31; KENNEDY MB, 1983, J NEUROSCI, V3, P818; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MCGLADEMCULLOCH E, 1992, NATURE, V362, P640; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NAKANE M, 1991, BIOCHEM BIOPH RES CO, V180, P1696; NEVE RL, 1989, P NATL ACAD SCI USA, V86, P4781, DOI 10.1073/pnas.86.12.4781; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SCHERER WJ, 1989, J NEUROSCI, V9, P3837; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; Scott J D, 1992, Curr Opin Neurobiol, V2, P289, DOI 10.1016/0959-4388(92)90117-4; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; Uylings H. B., 1989, COMPUTER TECHNIQUES, P215, DOI 10.1007/978-1-4684-5691-2_11; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; YEN LH, 1993, J NEUROSCI, V13, P4949; YEN LS, 1995, J NEUROSCI, V15, P4712; ZHONG Y, 1992, J NEUROSCI, V12, P644	60	68	70	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					529	539		10.1016/S0896-6273(00)80072-0	http://dx.doi.org/10.1016/S0896-6273(00)80072-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785050	Bronze			2022-12-24	WOS:A1996UC16800009
J	Patel, M; Day, BJ; Crapo, JD; Fridovich, I; McNamara, JO				Patel, M; Day, BJ; Crapo, JD; Fridovich, I; McNamara, JO			Requirement for superoxide in excitotoxic cell death	NEURON			English	Article							GLUTAMATE NEUROTOXICITY; NITRIC-OXIDE; MEDIATED NEUROTOXICITY; ESCHERICHIA-COLI; CULTURES; INACTIVATION; DISMUTASE; ACONITASE; INJURY; NMDA	We tested the pathogenic role of O-2(-) radicals in excitotoxic injury. Inactivation of the TCA cycle enzyme, aconitase, was used as a marker of intracellular O-2(-) levels, and a porphyrin SOD mimetic was used to scavenge O-2(-). The selective, reversible, and SOD-sensitive inactivation of aconitase by known O-2(-) generators was used to validate aconitase activity as a marker of O-2(-) generation. Treatment of rat cortical cultures with NMDA, KA, or the intracellular O-2(-) generator PQ(2+) produced a selective and reversible inactivation of aconitase, which closely correlated with subsequent cell death produced by these agents. The SOD mimetic, but not its less active congener, attenuated both aconitase inactivation and cell death produced by NMDA, KA, and pQ(2+). These results provide direct evidence implicating O-2(-) generation in the pathway to excitotoxic injury.	DUKE UNIV,DEPT BIOCHEM,DURHAM 27710,ENGLAND; DUKE UNIV,DEPT NEUROBIOL,DURHAM 27710,ENGLAND; DUKE UNIV,DEPT PHARMACOL,DURHAM 27710,ENGLAND; VET ADM MED CTR,DURHAM,NC 27710	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Patel, M (corresponding author), DUKE UNIV,DEPT MED,DURHAM 27710,ENGLAND.				NHLBI NIH HHS [HL 31992] Funding Source: Medline; NINDS NIH HHS [NS 32334] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; CHAN PH, 1990, STROKE, V21, P80; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; DUMIUS A, 1988, NATURE, V336, P68; DYKENS JA, 1987, J NEUROCHEM, V49, P1222, DOI 10.1111/j.1471-4159.1987.tb10014.x; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARTHWAITE G, 1986, NEUROSCI LETT, V66, P193, DOI 10.1016/0304-3940(86)90189-8; GHADE GDJ, 1995, MOL PHARMACOL, V47, P1095; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Halliwell B, 1989, FREE RADICAL BIO MED, P22; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; KOH JY, 1990, J NEUROSCI, V10, P693; KREBS HA, 1952, BIOCHEM J, V52, P527, DOI 10.1042/bj0520527; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; LIOCHEV SI, 1995, ARCH BIOCHEM BIOPHYS, V321, P271, DOI 10.1006/abbi.1995.1395; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; OLNEY JW, 1989, BIOL PSYCHIAT, V26, P505, DOI 10.1016/0006-3223(89)90072-3; OLNEY JW, 1986, ADV EXPT MED BIOL, V203, P632; PATEL MN, 1992, TOXICOL APPL PHARM, V115, P124, DOI 10.1016/0041-008X(92)90375-3; PATEL MN, 1993, NEUROTOXICOLOGY, V14, P35; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RACKER E, 1950, BIOCHIM BIOPHYS ACTA, V4, P211, DOI 10.1016/0006-3002(50)90026-6; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1994, P NATL ACAD SCI USA, V91, P4155, DOI 10.1073/pnas.91.10.4155; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; Vassault A, 1984, METHODS ENZYM ANAL, V3, P118	47	390	399	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					345	355		10.1016/S0896-6273(00)80052-5	http://dx.doi.org/10.1016/S0896-6273(00)80052-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789949	Bronze			2022-12-24	WOS:A1996TW95700014
J	Cochilla, AJ; Alford, S				Cochilla, AJ; Alford, S			Metabotropic glutamate receptor-mediated control of neurotransmitter release	NEURON			English	Article							PRESYNAPTIC NERVE-TERMINALS; SYNAPTIC TRANSMISSION; CALCIUM CHANNELS; NEURONS; LAMPREY; CELLS; HIPPOCAMPUS; ACTIVATION; INHIBITION; COMPONENT	Presynaptic metabotropic glutamate receptors (mGluRs) modulate the release of transmitter from most central synapses. However, difficulties in recording from presynaptic structures has lead to an incomplete understanding of the mechanisms underlying these fundamental processes. By recording directly from presynaptic reticulospinal axons and postsynaptic motoneurons of the lamprey spinal cord, we have obtained electrophysiological and optical evidence that vertebrate presynaptic metabotropic glutamate receptors modulate neurotransmitter release at this synapse through two distinct mechanisms: (1) mGluR activation in the presynaptic terminal depresses transmitter release by activating a presynaptic K+ current, and (2) mGluR activation enhances transmitter release by amplifying the action potential-evoked presynaptic Ca2+ signal by rapidly releasing Ca2+ from intracellular stores in a Ca2+-dependent manner. Furthermore, this effect is mediated by physiological release of glutamate from the presynaptic terminals. These autoreceptor-mediated processes are likely to generate complex effects on transmitter release evoked by repetitive stimulation.	Northwestern Univ, Sch Med, Dept Physiol, Inst Neurosci, Chicago, IL 60611 USA	Northwestern University	Alford, S (corresponding author), Northwestern Univ, Sch Med, Dept Physiol, Inst Neurosci, Chicago, IL 60611 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Alford, Simon/0000-0002-0454-4246				ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; Annoura H, 1996, BIOORG MED CHEM LETT, V6, P763, DOI 10.1016/0960-894X(96)00104-7; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BRODIN L, 1988, ARCH ITAL BIOL, V126, P317; CHAVIS P, 1995, J NEUROSCI, V15, P135; Cochilla AJ, 1997, J PHYSIOL-LONDON, V499, P443, DOI 10.1113/jphysiol.1997.sp021940; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; FURUYA S, 1989, J PHYSIOL-LONDON, V414, P539, DOI 10.1113/jphysiol.1989.sp017702; HERRERO I, 1992, NATURE, V360, P163, DOI 10.1038/360163a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Krieger P, 1996, J NEUROPHYSIOL, V76, P3834, DOI 10.1152/jn.1996.76.6.3834; Langer SZ, 1997, TRENDS PHARMACOL SCI, V18, P95, DOI 10.1016/S0165-6147(96)01034-6; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; Liou HC, 1996, NEUROSCIENCE, V75, P325, DOI 10.1016/0306-4522(96)00280-1; LOVINGER DM, 1991, NEUROSCI LETT, V129, P17, DOI 10.1016/0304-3940(91)90710-B; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Morishige K, 1996, BIOCHEM BIOPH RES CO, V220, P300, DOI 10.1006/bbrc.1996.0400; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Peng YY, 1996, J NEUROSCI, V16, P6703; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; RINGHAM GL, 1975, J PHYSIOL-LONDON, V251, P395, DOI 10.1113/jphysiol.1975.sp011100; Saugstad JA, 1996, J NEUROSCI, V16, P5979; SAYER RJ, 1992, J NEUROPHYSIOL, V68, P833, DOI 10.1152/jn.1992.68.3.833; SCANZIANI M, 1995, NEUROPHARMACOLOGY, V34, P1549, DOI 10.1016/0028-3908(95)00119-Q; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; WICKELGREN WO, 1977, J PHYSIOL-LONDON, V270, P89, DOI 10.1113/jphysiol.1977.sp011940; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6	35	134	138	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1998	20	5					1007	1016		10.1016/S0896-6273(00)80481-X	http://dx.doi.org/10.1016/S0896-6273(00)80481-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620704	Bronze			2022-12-24	WOS:000073864700019
J	Maina, F; Hilton, MC; Andres, R; Wyatt, S; Klein, R; Davies, AM				Maina, F; Hilton, MC; Andres, R; Wyatt, S; Klein, R; Davies, AM			Multiple roles for hepatocyte growth factor in sympathetic neuron development	NEURON			English	Article							FACTOR-SCATTER FACTOR; CENTRAL-NERVOUS-SYSTEM; C-MET; PRECURSOR CELLS; SENSORY NEURONS; RECEPTOR GENE; IN-VIVO; SURVIVAL; DIFFERENTIATION; NEUROTROPHIN-3	We have studied the role of hepatocyte growth factor (HGF)/Met signaling in the development of sympathetic neuroblasts and neurons. Anti-HGF antibodies reduced the number of sympathetic neuroblasts that differentiated into neurons, but neither anti-HGF antibodies nor HGF affected neuroblast proliferation. Anti-HGF antibodies also reduced the survival of neuroblasts but not sympathetic neurons. HGF greatly enhanced the neurite outgrowth of NGF-dependent sympathetic neurons throughout development. These in vitro effects of anti-HGF antibodies and HGF were abolished by a disabling mutation of Met, the HGF receptor tyrosine kinase. The Met mutation also increased sympathetic neuroblast apoptosis in vivo. Because Met and HGF are expressed in sympathetic ganglia throughout development, it is possible that the multiple effects of HGF/Met signaling on sympathetic neuroblasts and neurons occur in part by an autocrine mechanism.	Univ St Andrews, Sch Biol & Med Sci, St Andrews KY16 9TS, Fife, Scotland; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of St Andrews; European Molecular Biology Laboratory (EMBL)	Davies, AM (corresponding author), Univ St Andrews, Sch Biol & Med Sci, St Andrews KY16 9TS, Fife, Scotland.		Davies, Alun M/A-4334-2010; Andres, Rosa/A-7236-2012; Maina, Flavio/J-9962-2019; Klein, Ruediger/C-6147-2008; Wyatt, Sean/A-5266-2010	Davies, Alun M/0000-0001-5841-8176; Maina, Flavio/0000-0001-6100-4695; Klein, Ruediger/0000-0002-3109-0163; Wyatt, Sean/0000-0002-0572-234X; Andres, Rosa/0000-0002-6818-5203	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Andermarcher E, 1996, DEV GENET, V18, P254, DOI 10.1002/(SICI)1520-6408(1996)18:3<254::AID-DVG6>3.0.CO;2-8; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BRINKMANN V, 1995, J CELL BIOL, V131, P1573, DOI 10.1083/jcb.131.6.1573; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN AM, 1974, WENN CTR INT S SER D; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; Davies AM, 1997, CURR OPIN NEUROBIOL, V7, P110, DOI 10.1016/S0959-4388(97)80128-6; DAVIES AM, 1989, NATURE, V337, P553, DOI 10.1038/337553a0; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; Fagan AM, 1996, J NEUROSCI, V16, P6208; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; GHERARDI E, 1991, CANCER CELL-MON REV, V3, P227; Hamanoue M, 1996, J NEUROSCI RES, V43, P554, DOI 10.1002/(SICI)1097-4547(19960301)43:5<554::AID-JNR5>3.0.CO;2-H; Hilton M, 1997, CURR BIOL, V7, P798, DOI 10.1016/S0960-9822(06)00339-3; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; Pinon LGP, 1996, DEVELOPMENT, V122, P3255; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; ROHRER H, 1987, J NEUROSCI, V7, P3739; ROTHMAN TP, 1980, P NATL ACAD SCI-BIOL, V77, P6221, DOI 10.1073/pnas.77.10.6221; ROTHMAN TP, 1978, DEV BIOL, V65, P322, DOI 10.1016/0012-1606(78)90030-1; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wong VV, 1997, J BIOL CHEM, V272, P5187, DOI 10.1074/jbc.272.8.5187; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; Yamamoto Y, 1997, DEVELOPMENT, V124, P2903; ZHOU XF, 1995, J NEUROSCI, V15, P6521	44	134	139	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					835	846		10.1016/S0896-6273(00)80466-3	http://dx.doi.org/10.1016/S0896-6273(00)80466-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620689	Bronze			2022-12-24	WOS:000073864700004
J	Miller, JC; Silverman, SK; England, PM; Dougherty, DA; Lester, HA				Miller, JC; Silverman, SK; England, PM; Dougherty, DA; Lester, HA			Flash decaging of tyrosine sidechains in an ion channel	NEURON			English	Article							NEURONAL NICOTINIC RECEPTORS; PROTECTING GROUP; CAGED COMPOUNDS; KINETICS; PROTEIN; BINDING	A nonsense codon suppression technique was employed to incorporate ortho-nitrobenzyl tyrosine, "caged tyrosine," in place of tyrosine at any of three positions (93, 127, or 198) in the alpha subunit of the muscle nicotinic ACh receptor (nAChR) expressed in Xenopus oocytes. The ortho-nitrobenzyl group was then removed by 1 ms flashes at 300-350 nm to yield tyrosine itself while macroscopic currents were recorded during steady ACh exposure. Responses to multiple flashes showed (1) that each flash decages up to 17% of the tyrosines and (2) that two tyrosines must be decaged per receptor for a response. The conductance relaxations showed multiple kinetic components; rate constants (<0.1 s(-1) to 10(3) s(-1)) depended on pH and the site of incorporation, and relative amplitudes depended on the number of prior flashes. This method, which is potentially quite general, (1) provides a time-resolved assay for the behavior of a protein when a mutant sidechain is abruptly changed to the wild-type residue and (2) will also allow for selective decaging of sidechains that are candidates for covalent modification (such as phosphorylation) in specific proteins in intact cells.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Lester, HA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.			Silverman, Scott/0000-0001-8166-3460	NINDS NIH HHS [NS-34407, NS-11756] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756, R01NS034407, R37NS034407] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1981, J MEMBRANE BIOL, V58, P161, DOI 10.1007/BF01870902; COOK SN, 1995, ANGEW CHEM INT EDIT, V34, P1629, DOI 10.1002/anie.199516291; England PM, 1997, P NATL ACAD SCI USA, V94, P11025, DOI 10.1073/pnas.94.20.11025; Figl A, 1996, J GEN PHYSIOL, V107, P369, DOI 10.1085/jgp.107.3.369; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; GURNEY AM, 1987, PHYSIOL REV, V67, P583, DOI 10.1152/physrev.1987.67.2.583; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; LESTER HA, 1982, ANNU REV BIOPHYS BIO, V11, P151, DOI 10.1146/annurev.bb.11.060182.001055; MADSEN R, 1995, J ORG CHEM, V60, P7920, DOI 10.1021/jo00129a036; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; MENDEL D, 1991, J AM CHEM SOC, V113, P2758, DOI 10.1021/ja00007a063; NARGEOT J, 1982, J GEN PHYSIOL, V79, P657, DOI 10.1085/jgp.79.4.657; Nerbonne JM, 1996, CURR OPIN NEUROBIOL, V6, P379, DOI 10.1016/S0959-4388(96)80123-1; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; NOWAK MW, 1998, IN PRESS METHODS ENZ; Saks ME, 1996, J BIOL CHEM, V271, P23169, DOI 10.1074/jbc.271.38.23169; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; SILVERMAN SK, 1997, THESIS CALIFORNIA I; Tatsu Y, 1996, BIOCHEM BIOPH RES CO, V227, P688, DOI 10.1006/bbrc.1996.1570; WIEBOLDT R, 1994, BIOCHEMISTRY-US, V33, P1526, DOI 10.1021/bi00172a032	20	66	101	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1998	20	4					619	624		10.1016/S0896-6273(00)81001-6	http://dx.doi.org/10.1016/S0896-6273(00)81001-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581754	Bronze			2022-12-24	WOS:000073346500001
J	Reuss, H; Mojet, MH; Chyb, S; Hardie, RC				Reuss, H; Mojet, MH; Chyb, S; Hardie, RC			In vivo analysis of the Drosophila light-sensitive channels, TRP and TRPL	NEURON			English	Article							CAPACITATIVE CA2+ ENTRY; PHOTORECEPTORS; CALCIUM; PROTEIN; PHOTOTRANSDUCTION; EXPRESSION; MUTANT; STORE; GENE; TRANSDUCTION	We have tested the proposal that the right-sensitive conductance in Drosophila is composed of two independent components by comparing the wild-type conductance with that in mutants lacking one or the other of the putative light-sensitive channel subunits, TRP and TRPL. For a wide range of cations, ionic permeability ratios in wild type were always intermediate between those of trp and trpl mutants. Effective channel conductances derived by noise analysis in wild type were again intermediate (17 pS; c.f. 35 pS in trp and 4 pS in trpl) and also showed a complex voltage dependence, which was quantitatively explained by the summation of TRPL and TRP channels after taking their different reversal potentials into account. Although La3+ partially blocked the light response in wild-type photoreceptors, it increased the effective single channel conductance. The results indicate that the wild-type light-activated conductance is composed of two separate channels, with the properties of TRP-and TRPL-dependent channels as determined in the respective mutants.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Hardie, RC (corresponding author), Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England.		Chyb, Sylwester/B-5783-2009	Hardie, Roger/0000-0001-5531-3264	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Clapham DE, 1996, NEURON, V16, P1069, DOI 10.1016/S0896-6273(00)80132-4; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Gillo B, 1996, P NATL ACAD SCI USA, V93, P14146, DOI 10.1073/pnas.93.24.14146; Gomez MD, 1996, J GEN PHYSIOL, V107, P715, DOI 10.1085/jgp.107.6.715; Hardie RC, 1995, J NEUROPHYSIOL, V74, P2590, DOI 10.1152/jn.1995.74.6.2590; Hardie RC, 1997, CELL CALCIUM, V21, P431, DOI 10.1016/S0143-4160(97)90054-3; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HARDIE RC, 1995, J NEUROSCI, V15, P889; Hardie RC, 1996, CURR BIOL, V6, P1371, DOI 10.1016/S0960-9822(96)00733-6; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARTENECK C, 1995, FEBS LETT, V358, P297, DOI 10.1016/0014-5793(94)01455-A; Hille B., 1992, IONIC CHANNELS EXCIT; HOCHSTRATE P, 1989, J COMP PHYSIOL A, V166, P179, DOI 10.1007/BF00193462; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Lan L, 1996, BIOCHEM J, V316, P793, DOI 10.1042/bj3160793; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; Minke B, 1996, CURR OPIN NEUROBIOL, V6, P459, DOI 10.1016/S0959-4388(96)80050-X; MINKE B, 1983, J COMP PHYSIOL, V151, P483, DOI 10.1007/BF00605465; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; PAK WL, 1974, J GEN PHYSIOL, V63, P740, DOI 10.1085/jgp.63.6.740; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; SUSSTOBY E, 1991, J GEN PHYSIOL, V98, P849, DOI 10.1085/jgp.98.4.849; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	37	155	158	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1249	1259		10.1016/S0896-6273(00)80416-X	http://dx.doi.org/10.1016/S0896-6273(00)80416-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427248	Bronze			2022-12-24	WOS:000071236500012
J	Rosenblatt, KP; Sun, ZP; Heller, S; Hudspeth, AJ				Rosenblatt, KP; Sun, ZP; Heller, S; Hudspeth, AJ			Distribution of Ca2+-activated K+ channel isoforms along the tonotopic gradient of the chicken's cochlea	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; ION-DEPENDENT CONDUCTANCES; CALCIUM-BINDING PROTEIN; VERTEBRATE HAIR-CELLS; BASILAR PAPILLA; INNER-EAR; FREQUENCY-SELECTIVITY; SYNAPTIC TRANSMISSION; COMPLEMENTARY DNAS; RANA-CATESBEIANA	In some cochleae, the number and kinetic properties of Ca2+-activated K+ (K-Ca) channels partly determine the characteristic frequency of each hair cell and thus help establish a tonotopic map. In the chicken's basilar papilla, we found numerous isoforms of K-Ca channels generated by alternative mRNA splicing at seven sites in a single gene, cSlo. In situ polymerase chain reactions demonstrated cSlo expression in hair cells and revealed differential distributions of K-Ca channel isoforms along the basilar papilla. Analysis of single hair cells by the reverse transcription polymerase chain reaction confirmed the differential expression of channel variants. Heterologously expressed cSlo variants differed in their sensitivities to Ca2+ and voltage, suggesting that the distinct spatial distributions of cSlo variants help determine the tonotopic map.	ROCKEFELLER UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10021 USA; ROCKEFELLER UNIV, LAB SENSORY NEUROSCI, NEW YORK, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University					NIDCD NIH HHS [DC00317] Funding Source: Medline; NIGMS NIH HHS [GM08014] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; ASHMORE JF, 1983, NATURE, V304, P536, DOI 10.1038/304536a0; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BABILA T, 1994, NEURON, V12, P615, DOI 10.1016/0896-6273(94)90217-8; BAGASRA O, 1997, INSITU PCR TECHNIQUE, P37; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHEN L, 1994, HEARING RES, V81, P130, DOI 10.1016/0378-5955(94)90160-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cox DH, 1997, J GEN PHYSIOL, V109, P633, DOI 10.1085/jgp.109.5.633; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; FREEMAN DM, 1990, HEARING RES, V48, P1, DOI 10.1016/0378-5955(90)90195-U; FRISHKOPF LS, 1983, HEARING RES, V12, P393, DOI 10.1016/0378-5955(83)90008-4; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; FUCHS PA, 1990, P ROY SOC B-BIOL SCI, V241, P122, DOI 10.1098/rspb.1990.0075; FUCHS PA, 1992, PROG NEUROBIOL, V39, P493, DOI 10.1016/0301-0082(92)90003-W; Fuchs PA, 1996, CURR OPIN NEUROBIOL, V6, P514, DOI 10.1016/S0959-4388(96)80058-4; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; FUCHS PA, 1988, J NEUROSCI, V8, P2460; FUCHS PA, 1988, J COMP PHYSIOL A, V164, P151, DOI 10.1007/BF00603947; GRAY L, 1985, J ACOUST SOC AM, V77, P1162, DOI 10.1121/1.392180; GUMMER AW, 1987, HEARING RES, V29, P63, DOI 10.1016/0378-5955(87)90206-1; HINRICHSEN RD, 1993, CALCIUM DEPENDENT PO, P16; HIROKAWA N, 1978, J COMP NEUROL, V181, P361, DOI 10.1002/cne.901810208; HOLTON T, 1983, SCIENCE, V222, P508, DOI 10.1126/science.6623089; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; Jiang GJ, 1997, P ROY SOC B-BIOL SCI, V264, P731, DOI 10.1098/rspb.1997.0104; JONES SM, 1995, HEARING RES, V82, P149, DOI 10.1016/0378-5955(94)00173-N; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; Lewis RS., 1983, HEARING PHYSIOLOGICA, P17, DOI [10.1007/978-3-642-69257-4_3, DOI 10.1007/978-3-642-69257-4_3]; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MANLEY GA, 1989, J COMP PHYSIOL A, V164, P289, DOI 10.1007/BF00612989; MANLEY GA, 1987, SCIENCE, V237, P655, DOI 10.1126/science.3603046; Manley GA, 1996, AUDIT NEUROSCI, V3, P199; MANLEY GA, 1990, PERIPHERAL HEARING M, P206; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; MURROW BW, 1994, J PHYSIOL-LONDON, V480, P247, DOI 10.1113/jphysiol.1994.sp020357; MURROW BW, 1990, P ROY SOC B-BIOL SCI, V242, P189, DOI 10.1098/rspb.1990.0123; NAVARATNAM DS, 1995, J BIOL CHEM, V270, P19238, DOI 10.1074/jbc.270.33.19238; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; NUOVO GJ, 1996, PCR INSITU HYBRIDIZA; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBERTS WM, 1986, AUDITORY FREQUENCY S, P89; RUBEL EW, 1984, ANNU REV PHYSIOL, V46, P213; RUBEL EW, 1984, ANN OTO RHINOL LARYN, V93, P609, DOI 10.1177/000348948409300614; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHEN NV, 1993, NEURON, V11, P67; SHUSTER MJ, 1991, J PHYSIOL-LONDON, V440, P601, DOI 10.1113/jphysiol.1991.sp018727; STRAHLE U, 1994, TRENDS GENET, V10, P75, DOI 10.1016/0168-9525(94)90221-6; Subramony P, 1996, NEURON, V17, P115, DOI 10.1016/S0896-6273(00)80285-8; TAKEUCHI S, 1992, HEARING RES, V61, P86, DOI 10.1016/0378-5955(92)90039-P; TANAKA K, 1978, AM J ANAT, V153, P251, DOI 10.1002/aja.1001530206; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; TILNEY LG, 1986, DEV BIOL, V116, P110; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; von Bekesy G, 1960, EXPT HEARING; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang ZW, 1997, J GEN PHYSIOL, V110, P35, DOI 10.1085/jgp.110.1.35; WILSON PW, 1985, NUCLEIC ACIDS RES, V13, P8867, DOI 10.1093/nar/13.24.8867; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5; Wu YC, 1996, BIOPHYS J, V70, P2557, DOI 10.1016/S0006-3495(96)79827-2; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	79	140	145	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1997	19	5					1061	1075		10.1016/S0896-6273(00)80397-9	http://dx.doi.org/10.1016/S0896-6273(00)80397-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390519	Bronze			2022-12-24	WOS:A1997YH59400013
J	Thomas, U; Kim, E; Kuhlendahl, S; Koh, YH; Gundelfinger, ED; Sheng, M; Garner, CC; Budnik, V				Thomas, U; Kim, E; Kuhlendahl, S; Koh, YH; Gundelfinger, ED; Sheng, M; Garner, CC; Budnik, V			Synaptic clustering of the cell adhesion molecule fasciclin II by discs-large and its role in the regulation of presynaptic structure	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; DENSITY PROTEIN PSD-95; NMDA RECEPTOR SUBUNITS; FUNCTIONAL COMPONENTS; NEUROMUSCULAR-JUNCTIONS; DROSOPHILA-MELANOGASTER; GUANYLATE KINASES; CHANNEL PROTEINS; EMBRYONIC NEURON; MOTOR AXONS	The cell adhesion molecule Fasciclin II (FASII) is involved in synapse development and plasticity. Here we provide genetic and biochemical evidence that proper localization of FASII at type I glutamatergic synapses of the Drosophila neuromuscular junction is mediated by binding between the intracellular tSXV bearing C-terminal tail of FASII and the PDZ1-2 domains of Discs-Large (DLG). Moreover, mutations in fasII and/or dig have similar effects on presynaptic ultrastructure, suggesting their functional involvement in a common developmental pathway. DLG can directly mediate a biochemical complex and a macroscopic cluster of FASII and Shaker Kf channels in heterologous cells. These results indicate a central role for DLG in the structural organization and downstream signaling mechanisms of cell adhesion molecules and ion channels at synapses.	UNIV MASSACHUSETTS,DEPT BIOL,AMHERST,MA 01003; FED INST NEUROBIOL,DEPT NEUROCHEM & MOL BIOL,D-39118 MAGDEBURG,GERMANY; HARVARD UNIV,SCH MED,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT NEUROBIOL,BOSTON,MA 02114; UNIV ALABAMA,DEPT NEUROBIOL,BIRMINGHAM,AL 35294	University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; University of Alabama System; University of Alabama Birmingham			Kim, Eunjoon/C-1566-2011	Sheng, Morgan/0000-0002-8703-5366; Garner, Craig/0000-0003-1970-5417	NIA NIH HHS [AG12978-02] Funding Source: Medline; NICHD NIH HHS [P50 HD32901] Funding Source: Medline; NINDS NIH HHS [R01 NS30072, R01 NS030072] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD032901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012978] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BAILEY CH, 1989, J NEUROBIOL, V20, P356, DOI 10.1002/neu.480200508; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bartel P. L., 1993, CELLULAR INTERACTION, P153; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FIELDS DR, 1995, TRENDS NEUROSCI, V19, P473; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; GAMER C, 1996, TRENDS CELL BIOL, V6, P429; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOODMAN CS, 1993, NEURON S, V10, P77; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Niethammer M, 1996, J NEUROSCI, V16, P2157; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 1997, NATURE, V386, P221, DOI 10.1038/386221a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stewart BA, 1996, J NEUROSCI, V16, P3877; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; WU CF, 1985, J NEUROSCI, V5, P2626; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; ZHONG Y, 1992, J NEUROSCI, V12, P644	66	173	175	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					787	799		10.1016/S0896-6273(00)80961-7	http://dx.doi.org/10.1016/S0896-6273(00)80961-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354326	Bronze, Green Accepted			2022-12-24	WOS:A1997YD18900007
J	Nicolelis, MAL; Ghazanfar, AA; Faggin, BM; Votaw, S; Oliveira, LMO				Nicolelis, MAL; Ghazanfar, AA; Faggin, BM; Votaw, S; Oliveira, LMO			Reconstructing the engram: Simultaneous, multisite, many single neuron recordings	NEURON			English	Article							MOVEMENT; THALAMUS; CORTEX; SYSTEM; ARRAY; RATS	Little is known about the physiological principles that govern large-scale neuronal interactions in the mammalian brain. Here, we describe an electrophysiological paradigm capable of simultaneously recording the extracellular activity of large populations of single neurons, distributed across multiple cortical and subcortical structures in behaving and anesthetized animals. Up to 100 neurons were simultaneously recorded after 48 microwires were implanted in the brain stem, thalamus, and somatosensory cortex of rats. Overall, 86% of the implanted microwires yielded single neurons, and an average of 2.3 neurons were discriminated per microwire. Our population recordings remained stable for weeks, demonstrating that this method can be employed to investigate the dynamic and distributed neuronal ensemble interactions that underlie processes such as sensory perception, motor control, and sensorimotor learning in freely behaving animals.			Nicolelis, MAL (corresponding author), DUKE UNIV,SCH MED,DEPT NEUROBIOL,DURHAM,NC 27710, USA.				NIDCR NIH HHS [DE-1112101] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; Barlow Horace, 1995, P415; Deadwyler SA, 1996, J NEUROSCI, V16, P354; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; ERICKSON RP, 1968, PSYCHOL REV, V75, P447, DOI 10.1037/h0026752; FREEMAN WJ, 1983, BIOL PSYCHIAT, V18, P1107; Freeman WJ, 1975, MASS ACTION NERVOUS; Fuster JM, 1995, MEMORY CEREBRAL CORT; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; GERSTEIN GL, 1964, SCIENCE, V143, P1325, DOI 10.1126/science.143.3612.1325; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; HEBB DO, 1949, ORG BEHAVIOR; HOOGERWERF AC, 1994, IEEE T BIO-MED ENG, V41, P1136, DOI 10.1109/10.335862; KRUGER J, 1983, REV PHYSIOL BIOCH P, V98, P177, DOI 10.1007/BFb0033868; KUBIE JL, 1984, PHYSIOL BEHAV, V32, P115, DOI 10.1016/0031-9384(84)90080-5; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; Lilly JC, 1958, BIOL BIOCH BASES BEH, P83; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; NICOLELLIS MAL, 1996, SOC NEUROSCI SUMM, V3, P2023; NORDHAUSEN CT, 1994, BRAIN RES, V637, P27, DOI 10.1016/0006-8993(94)91213-0; PEREPELKIN PD, 1996, SOC NEUROSCI SUMM, V3, P2022; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; SHIN HC, 1990, NEUROSCI LETT, V108, P116, DOI 10.1016/0304-3940(90)90716-M; Somjen G., 1972, SENSORY CODING MAMMA; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	30	290	309	0	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					529	537		10.1016/S0896-6273(00)80295-0	http://dx.doi.org/10.1016/S0896-6273(00)80295-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136763	Bronze			2022-12-24	WOS:A1997WW62600003
J	OCraven, KM; Rosen, BR; Kwong, KK; Treisman, A; Savoy, RL				OCraven, KM; Rosen, BR; Kwong, KK; Treisman, A; Savoy, RL			Voluntary attention modulates fMRI activity in human MT-MST	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; PURSUIT EYE-MOVEMENTS; SELECTIVE ATTENTION; VISUAL-ATTENTION; PERCEPTUAL LOAD; CORTEX; AREAS; SHAPE; COLOR; V1	How does voluntary attention to one attribute of a visual stimulus affect the neural processing of that stimulus? We used functional magnetic resonance imaging to examine the attentional modulation of neural activity in the human homolog of the MT-MST complex, which is known to be involved in the processing of visual motion. Using a visual stimulus containing both moving and stationary dots, we found significantly more MT-MST activation when subjects attended to the moving dots than when they attended to the stationary dots, even though the visual stimulus was identical during the two conditions.	NMR CTR,MGH,CHARLESTOWN,MA 02129; PRINCETON UNIV,DEPT PSYCHOL,PRINCETON,NJ 08544	Princeton University	OCraven, KM (corresponding author), ROWLAND INST SCI INC,100 EDWIN LAND BLVD,CAMBRIDGE,MA 02142, USA.				NCI NIH HHS [P01 CA48729] Funding Source: Medline; NHLBI NIH HHS [R01 HL39810] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA048729] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039810] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aisenberg Sol, 1996, Investigative Ophthalmology and Visual Science, V37, pS274; BAYLIS GC, 1993, J EXP PSYCHOL HUMAN, V19, P451, DOI 10.1037/0096-1523.19.3.451; BEAUCHAMP M, 1996, NEUROIMAGE, V3, P245; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CORBETTA M, 1991, J NEUROSCI, V11, P2383; DEUTSCH JA, 1963, PSYCHOL REV, V70, P80, DOI 10.1037/h0039515; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fiez JA, 1996, CEREB CORTEX, V6, P1, DOI 10.1093/cercor/6.1.1; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Jiang AP, 1995, HUM BRAIN MAPP, V3, P224, DOI 10.1002/hbm.460030306; Kanwisher N., 1992, CURR DIR PSYCHOL SCI, V1, P26; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MAUNSELL JHR, 1993, COGNITIVE NEUROSCIEN; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; PINKER S, 1994, J COGNITIVE NEUROSCI, V6, P92, DOI 10.1162/jocn.1994.6.1.92; PRESS WH, 1992, NUMERICAL RECIPES C, P623; REPPAS JB, 1995, INVEST OPHTH VIS SCI, V36, pS205; SCHMIT PW, 1995, INVEST OPHTH VIS SCI, V36, pS374; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SIMPSON GV, 1995, 2 ANN M COGN NEUR SO; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; TREISMAN A, 1983, PERCEPT PSYCHOPHYS, V33, P527, DOI 10.3758/BF03202934; TREISMAN AM, 1964, BRIT MED BULL, V20, P12, DOI 10.1093/oxfordjournals.bmb.a070274; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Woodruff PWR, 1996, NEUROREPORT, V7, P1909, DOI 10.1097/00001756-199608120-00007; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; WORDEN M, 1996, 3 ANN M COGN NEUR SO; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S., 1993, VISION BRAIN	39	372	377	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					591	598		10.1016/S0896-6273(00)80300-1	http://dx.doi.org/10.1016/S0896-6273(00)80300-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136768	Bronze			2022-12-24	WOS:A1997WW62600008
J	Paas, Y; Eisenstein, M; Medevielle, F; Teichberg, VI; DevillersThiery, A				Paas, Y; Eisenstein, M; Medevielle, F; Teichberg, VI; DevillersThiery, A			Identification of the amino acid subsets accounting for the ligand binding specificity of a glutamate receptor	NEURON			English	Article							TRIPHOSPHATE CONFORMATION; TRANSPORT-SYSTEMS; CRYSTAL-STRUCTURE; N-GLYCOSYLATION; PROTEIN; SITE; MECHANISM; MUTATIONS; TOPOLOGY; DOMAINS	In a situation so far unique among neurotransmitter receptors, glutamate receptors share amino acid sequence similarities with the bacterial periplasmic binding proteins (PBPs). On the basis of the primary structure similarity of two bacterial periplasmic proteins (lysine/arginine/ornithine- and phosphate-binding proteins) with the chick cerebellar kainate-binding protein (KBP), a member of the ionotropic glutamate receptor family, we have generated a three-dimensional model structure of the KBP extracellular domain. By an interplay between homology modeling and site-directed mutagenesis, we have investigated the kainate binding properties of 55 different mutants (corresponding to 43 positions) and studied the interactions of some of these mutants with various glutamatergic ligands. As a result, we present here the subsets of amino acids accounting for the binding free energies and specificities of KBP for kainate, glutamate, and CNQX and propose a three-dimensional model, at the microarchitectural level, of the glutamatergic binding domain.	WEIZMANN INST SCI,DEPT CHEM SCI,IL-76100 REHOVOT,ISRAEL; INST PASTEUR,CNRS,URA D1284,F-75015 PARIS,FRANCE	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Paas, Y (corresponding author), WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BEALL JA, 1986, J IMMUNOL METHODS, V86, P217, DOI 10.1016/0022-1759(86)90456-4; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BERLAND CR, 1995, BIOCHEMISTRY-US, V34, P10153, DOI 10.1021/bi00032a008; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; COCKCROFT VB, 1993, NEUROCHEM INT, V23, P583, DOI 10.1016/0197-0186(93)90107-G; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GORODINSKY A, 1993, NEUROCHEM INT, V23, P285, DOI 10.1016/0197-0186(93)90119-P; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GREGOR P, 1988, EMBO J, V7, P2673, DOI 10.1002/j.1460-2075.1988.tb03120.x; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; KANG CH, 1991, J BIOL CHEM, V266, P23893; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Levitzki A., 1978, QUANTITATIVE ASPECTS; LI F, 1995, MOL PHARMACOL, V47, P148; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OH BH, 1993, J BIOL CHEM, V268, P11348; OH BH, 1994, J BIOL CHEM, V269, P4135; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Paas Y, 1996, EMBO J, V15, P1548, DOI 10.1002/j.1460-2075.1996.tb00499.x; PAAS Y, 1994, J NEUROCHEM S1, V63, pSD1; PAAS Y, 1992, INT J DEV NEUROSCI S, V10, P47; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sutcliffe MJ, 1996, BIOPHYS J, V70, P1575, DOI 10.1016/S0006-3495(96)79724-2; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WANG ZM, 1994, J BIOL CHEM, V269, P25091; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WO ZGL, 1995, J BIOL CHEM, V270, P2000, DOI 10.1074/jbc.270.5.2000; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4	52	67	68	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					979	990		10.1016/S0896-6273(00)80228-7	http://dx.doi.org/10.1016/S0896-6273(00)80228-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938129	Bronze			2022-12-24	WOS:A1996VV15100019
J	Alder, J; Cho, NK; Hatten, ME				Alder, J; Cho, NK; Hatten, ME			Embryonic precursor cells from the rhombic lip are specified to a cerebellar granule neuron identity	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT CEREBELLUM; PURKINJE-CELLS; IN-VITRO; DIFFERENTIATION; INVITRO; EXPRESSION; ECTODERM; IDENTIFICATION; ANTIBODIES	The specification of diverse classes of neurons is critical to the development of the cerebellar cortex. Here, we describe the purification of early embryonic precursors of cerebellar granule neurons from the rhombic lip, the dorsal aspect of the midbrain/hindbrain region. Isolation of rhombic lip cells reveals a homogenous population of precursor cells that express general neuronal markers and the granule cell marker RU49, but fail to extend neurites or express differentiation markers. Differentiation is induced by coculture with external germinal layer (EGL) cells, or their membranes, suggesting that a local inducing factor acts after formation of the EGL. Thus, proliferating precursors within the rhombic lip are specified to be granule cells very early, with the availability of an inducing factor increasing over the course of development.			Alder, J (corresponding author), ROCKEFELLER UNIV,DEV NEUROBIOL LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.			Alder, Janet/0000-0002-5694-4946	NINDS NIH HHS [NS30532-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030532] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1985, J COMP NEUROL, V231, P42, DOI 10.1002/cne.902310105; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BRUNETTE DM, 1971, J MEMBRANE BIOL, V5, P215, DOI 10.1007/BF01870550; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CAJAL SR, 1889, REV TRIM HISTOL NORM, V3, P4; CELIO MR, 1990, CELL CALCIUM, V11, P599, DOI 10.1016/0143-4160(90)90014-L; DEHAY C, 1993, NATURE, V366, P464, DOI 10.1038/366464a0; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FISHELL G, 1995, DEVELOPMENT, V121, P803; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1994, DEVELOPMENT, V120, P1059; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1981, J CELL BIOL, V90, P622, DOI 10.1083/jcb.90.3.622; HATTEN ME, 1978, EXP CELL RES, V113, P111, DOI 10.1016/0014-4827(78)90092-7; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; KUHAR SG, 1993, DEVELOPMENT, V117, P97; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Lumsden A, 1995, CURR BIOL, V5, P1347, DOI 10.1016/S0960-9822(95)00266-1; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MIALE IL, 1961, EXP NEUROL, V47, P26; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; OTERO RA, 1993, J COMP NEUROL, V333, P579; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SMITH JC, 1993, CURR BIOL, V3, P582, DOI 10.1016/0960-9822(93)90003-7; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; STEMPLE DL, 1993, DEV BIOL, V159, P12, DOI 10.1006/dbio.1993.1218; STITT TN, 1990, NEURON, V5, P639, DOI 10.1016/0896-6273(90)90218-5; THIERY JP, 1977, J BIOL CHEM, V252, P6841; VOGEL KS, 1993, DEVELOPMENT, V119, P263; Yang XW, 1996, DEVELOPMENT, V122, P555; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417; ZHENG L, 1996, NEURON, V16, P47	48	185	188	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					389	399		10.1016/S0896-6273(00)80172-5	http://dx.doi.org/10.1016/S0896-6273(00)80172-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816703	hybrid			2022-12-24	WOS:A1996VJ44000006
J	Lee, KH; McCormick, DA				Lee, KH; McCormick, DA			Abolition of spindle oscillations by serotonin and norepinephrine in the ferret lateral geniculate and perigeniculate nuclei in vitro	NEURON			English	Article							ACTIVATED CATION CURRENT; THALAMIC RELAY NEURONS; GUINEA-PIG; IN-VITRO; SYNCHRONIZED OSCILLATIONS; RETICULARIS THALAMI; NORADRENERGIC MODULATION; THALAMOCORTICAL NEURONS; CELLULAR MECHANISMS; UNIT-ACTIVITY	The transition from sleep to waking is associated with the abolition of spindle waves in thalamecortical neurons and the GABAergic cells of the thalamic reticular/perigeniculate nuclei. We tested the possibility that norepinephrine (NE) and serotonin (5-HT) may abolish spindle wave generation through an enhancement of the hyperpolarization-activated cation current lh in thalamocortical neurons. Local application of agents known to enhance I-h, including 5-HT, NE, the adenylyl cyclase activator, forskolin, and the beta-adrenergic agonist, isoproterenol, to lamina A1 of the dorsal lateral geniculate nucleus resulted in an abolition of local spindle wave generation in thalamocortical neurons. The abolition of spindle waves was reversed by the local application of the I-h channel blocker, cesium. These results suggest that NE and 5-HT may abolish the generation of spindle waves through the modulation of I-h in thalamocortical neurons.			Lee, KH (corresponding author), YALE UNIV,SCH MED,NEUROBIOL SECT,NEW HAVEN,CT 06510, USA.		McCormick, David A/J-2649-2015; Kobelt, Liza/F-5926-2011	McCormick, David A/0000-0002-9803-8335; 				AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; [Anonymous], [No title captured]; ASTONJONES G, 1981, J NEUROSCI, V1, P878; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; BAL T, 1996, NEURON, V17; COX CL, 1995, J NEUROPHYSIOL, V74, P990, DOI 10.1152/jn.1995.74.3.990; DELIMA AD, 1987, J COMP NEUROL, V259, P92, DOI 10.1002/cne.902590107; DELIMA AD, 1987, J COMP NEUROL, V258, P339, DOI 10.1002/cne.902580303; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; JOUVET M, 1972, ERG PHYSIOL BIOL CH, V64, P166; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCCORMICK DA, 1992, J NEUROSCI, V12, P278; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1991, J PHYSIOL-LONDON, V442, P235, DOI 10.1113/jphysiol.1991.sp018791; MCCORMICK DA, 1988, J NEUROPHYSIOL, V59, P978, DOI 10.1152/jn.1988.59.3.978; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; PAPE HC, 1992, NEURON, V9, P441, DOI 10.1016/0896-6273(92)90182-D; POLLARD H, 1987, TRENDS NEUROSCI, V10, P86, DOI 10.1016/0166-2236(87)90031-2; SCHWARTZ ML, 1992, CEREB CORTEX, V2, P16, DOI 10.1093/cercor/2.1.16; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1991, J NEUROSCI, V11, P3200; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; Steriade M., 1990, BRAINSTEM CONTROL WA; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; ULRICH D, 1995, NEURON, V15, P909, DOI 10.1016/0896-6273(95)90181-7; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750	41	52	54	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					309	321		10.1016/S0896-6273(00)80162-2	http://dx.doi.org/10.1016/S0896-6273(00)80162-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780654	Bronze			2022-12-24	WOS:A1996VE84000013
J	Itasaki, N; Sharpe, J; Morrison, A; Krumlauf, R				Itasaki, N; Sharpe, J; Morrison, A; Krumlauf, R			Reprogramming Hox expression in the vertebrate hindbrain: Influence of paraxial mesoderm and rhombomere transposition	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYO SPINAL-CORD; ANTEROPOSTERIOR PATTERN; HOMEOBOX GENE; INDUCTION; PROTEIN; PLANAR; SEGMENTATION; CELLS; CODE	The developing vertebrate hindbrain consists of segments known as rhombomeres, which express combinations of Hox genes implicated in specifying segmental identity. Using chick-chick and chick-transgenic mouse graftings, we show that anterior to posterior rhombomere transpositions result in a progressive posterior transformation and coordinate induction of new Hox expression. This shows that hindbrain plasticity is evolutionarily conserved and implies rhombomeres may be undergoing continual assessment of their identities. The nature of the changes is dependent on both the anteroposterior position of the graft and its origin. Transposed somites from specific axial levels and developmental stages have a graded ability to induce changes in Hox expression, indicating that paraxial mesoderm is a source of the environmental signal responsible for the plasticity.			Itasaki, N (corresponding author), NATL INST MED RES,MRC,DIV DEV NEUROBIOL,THE RIDGEWAY,LONDON NW7 1AA,ENGLAND.		Sharpe, James/AAB-7948-2019; Krumlauf, Robb/AAH-5012-2019; Sharpe, James/L-1150-2014	Krumlauf, Robb/0000-0001-9102-7927; Sharpe, James/0000-0002-1434-9743; Itasaki, Nobue/0000-0003-0587-9141				ALTABA ARI, 1992, DEVELOPMENT, V116, P67; ALTABA ARI, 1994, TRENDS NEUROSCI, V17, P233, DOI 10.1016/0166-2236(94)90006-X; ANG SL, 1994, DEVELOPMENT, V120, P2979; APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; BALLYCUIF L, 1992, DEVELOPMENT, V115, P999; CHEVALLIER A, 1975, J EMBRYOL EXP MORPH, V33, P291; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; DONIACH T, 1992, DEVELOPMENT, P183; DONIACH T, 1992, SCIENCE, V257, P542, DOI 10.1126/science.1636091; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; GAPINBOTTON A, 1995, DEVELOPMENT, V121, P2707; GARDNER CA, 1991, DEVELOPMENT, V113, P1037; GUTHRIE S, 1993, DEVELOPMENT, V118, P527; GUTHRIE S, 1992, NATURE, V356, P157, DOI 10.1038/356157a0; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; KINTNER C, 1992, ANNU REV NEUROSCI, V15, P251, DOI 10.1146/annurev.neuro.15.1.251; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KURATANI SC, 1993, DEVELOPMENT, V117, P105; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; LIM TM, 1991, DEVELOPMENT, V113, P227; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MADEN M, 1991, DEVELOPMENT, V111, P35; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T; MARTINEZ S, 1995, MECH DEVELOP, V51, P289, DOI 10.1016/0925-4773(95)00376-2; MORRISON A, 1995, MECH DEVELOP, V53, P47, DOI 10.1016/0925-4773(95)00423-8; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; PRINCE V, 1994, DEVELOPMENT, V120, P911; SASAKI H, 1990, NUCLEIC ACIDS RES, V18, P184, DOI 10.1093/nar/18.1.184; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SIMON H, 1995, CURR BIOL, V5, P205, DOI 10.1016/S0960-9822(95)00041-8; SLACK JMW, 1992, DEVELOPMENT, V114, P285; STERN CD, 1991, DEVELOPMENT, V113, P239; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	42	156	159	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					487	500		10.1016/S0896-6273(00)80069-0	http://dx.doi.org/10.1016/S0896-6273(00)80069-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785047	Bronze			2022-12-24	WOS:A1996UC16800006
J	Moriyoshi, K; Richards, LJ; Akazawa, C; OLeary, DDM; Nakanishi, S				Moriyoshi, K; Richards, LJ; Akazawa, C; OLeary, DDM; Nakanishi, S			Labeling neural cells using adenoviral gene transfer of membrane-targeted GFP	NEURON			English	Article							NEURONS; VECTOR	We describe an experimental system to visualize the soma and processes of mammalian neurons and glia in living and fixed preparations by using a recombinant adenovirus vector to transfer the jellyfish green fluorescent protein (GFP) into postmitotic neural cells both in vitro and in vivo. We have introduced several modifications of GFP that enhance its fluorescence intensity in mammalian axons and dendrites. This method should be useful for studying the dynamic processes of cell migration and the development of neuronal connections, as well as for analyzing the function of exogenous genes introduced into cells using the adenovirus vector.	SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037	Salk Institute	Moriyoshi, K (corresponding author), KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.		Richards AO, Linda/P-6372-2014	Richards AO, Linda/0000-0002-7590-7390	NINDS NIH HHS [NS 31558] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558, R01NS031558] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Bayer S.A., 1991, NEOCORTICAL DEV; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHROBOCZEK J, 1992, VIROLOGY, V186, P280, DOI 10.1016/0042-6822(92)90082-Z; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LIU YC, 1994, J NEUROSCI, V14, P5807; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; PENNYPACKER K, 1991, EXP NEUROL, V111, P25, DOI 10.1016/0014-4886(91)90047-G; Precious B., 1985, VIROLOGY PRACTICAL A, P193; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2	21	239	248	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					255	260		10.1016/S0896-6273(00)80044-6	http://dx.doi.org/10.1016/S0896-6273(00)80044-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789941	Bronze			2022-12-24	WOS:A1996TW95700006
J	Quinlan, EM; Halpain, S				Quinlan, EM; Halpain, S			Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; LONG-TERM POTENTIATION; RAT HIPPOCAMPAL-NEURONS; KINASE-C; DENDRITIC SPINES; ACTIN-FILAMENTS; OKADAIC ACID; TUBULIN POLYMERIZATION; SYNAPTIC ACTIVATION; NMDA RECEPTORS	Many activity-dependent changes in synaptic efficacy occur through elevations in postsynaptic calcium triggered by glutamate receptor activation. Here, the postsynaptic, neuron-specific microtubule-associated protein MAPS is identified as a target of bidirectional calcium-dependent signaling pathways activated by glutamate. Glutamate produced a biphasic change in MAPS: a rapid, transient increase in phosphorylation mediated by metabotropic receptors and attenuated by inhibitors of calcium/calmodulin-dependent protein kinases and protein kinase C, followed by a persistent dephosphorylation of MAP2 mediated by NMDA receptors and activation of the calcium/calmodulin-dependent protein phosphatase 2B (calcineurin). Thus, a single transmembrane signal, glutamate, and the increased intracellular calcium it evokes can have opposing actions on a postsynaptic target phosphoprotein. The phosphorylation state of MAPS determines its interaction with microtubules and actin filaments, suggesting that glutamatergic regulation of MAPS phosphorylation may transduce neural activity into modifications in dendritic structure.			Quinlan, EM (corresponding author), UNIV VIRGINIA, DEPT NEUROSCI, CTR CELL SIGNALING, HLTH SCI CTR, CHARLOTTESVILLE, VA 22908 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050861, R29MH050861] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50861, R01 MH050861] Funding Source: Medline; NINDS NIH HHS [NS07199] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKIYAMA T, 1986, J BIOL CHEM, V261, P5648; ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; AOKI C, 1985, J NEUROSCI, V5, P2465; ARIAS C, 1993, J NEUROCHEM, V61, P673; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BERLING B, 1994, EUR J CELL BIOL, V64, P120; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BURGOYNE RD, 1982, FEBS LETT, V146, P273, DOI 10.1016/0014-5793(82)80933-2; CHINESTRA P, 1993, J NEUROPHYSIOL, V70, P2684, DOI 10.1152/jn.1993.70.6.2684; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DESMOND NL, 1983, BRAIN RES, V265, P21, DOI 10.1016/0006-8993(83)91329-X; DIAZNIDO J, 1993, EUR J NEUROSCI, V5, P818, DOI 10.1111/j.1460-9568.1993.tb00933.x; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; EATON SA, 1993, EUR J PHARM-MOLEC PH, V244, P195, DOI 10.1016/0922-4106(93)90028-8; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; ENAN E, 1993, BIOCHEM PHARMACOL, V45, P703, DOI 10.1016/0006-2952(93)90146-N; ETOH S, 1991, NEUROSCI LETT, V126, P119, DOI 10.1016/0304-3940(91)90533-Y; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GOLDENRING JR, 1985, J NEUROCHEM, V45, P900, DOI 10.1111/j.1471-4159.1985.tb04078.x; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; Greenough W. T., 1988, CEREB CORTEX, P391, DOI DOI 10.1007/978-1-4615-6619-9_11; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HARTLEY DM, 1989, J PHARMACOL EXP THER, V250, P752; HERZOG W, 1978, EUR J BIOCHEM, V92, P1, DOI 10.1111/j.1432-1033.1978.tb12716.x; HOSHI M, 1988, EUR J BIOCHEM, V174, P225, DOI 10.1111/j.1432-1033.1988.tb14086.x; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JAMESON L, 1981, P NATL ACAD SCI-BIOL, V78, P3413, DOI 10.1073/pnas.78.6.3413; JEFFERSON AB, 1991, J BIOL CHEM, V266, P346; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; KLANN E, 1991, J BIOL CHEM, V266, P24253; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; KUNZ J, 1993, TRENDS BIOCHEM SCI, V18, P334, DOI 10.1016/0968-0004(93)90069-Y; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; LIPINSKI HG, 1987, BRAIN RES, V437, P26, DOI 10.1016/0006-8993(87)91523-X; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MONTORO RJ, 1993, NEUROSCIENCE, V54, P859, DOI 10.1016/0306-4522(93)90580-9; MORALES M, 1989, CELL TISSUE RES, V256, P447; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; NICHOLSON C, 1983, FED PROC, V42, P2865; NISHIDA E, 1981, J BIOCHEM-TOKYO, V90, P575, DOI 10.1093/oxfordjournals.jbchem.a133510; OTANI S, 1993, INT REV NEUROBIOL, V35, P1, DOI 10.1016/S0074-7742(08)60567-X; PENN AA, 1994, J NEUROSCI, V14, P3805; RANDALL RD, 1992, J NEUROSCI, V12, P1882; RECASENS M, 1995, ANN NY ACAD SCI, V757, P418, DOI 10.1111/j.1749-6632.1995.tb17501.x; SANDOVAL IV, 1978, EUR J BIOCHEM, V92, P463, DOI 10.1111/j.1432-1033.1978.tb12768.x; SATTILARO RF, 1986, BIOCHEMISTRY-US, V25, P2003, DOI 10.1021/bi00356a025; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SELDEN SC, 1983, J BIOL CHEM, V258, P7064; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; SLOBODA RD, 1976, BIOCHEMISTRY-US, V15, P4497, DOI 10.1021/bi00665a026; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; TEYLER TJ, 1994, HIPPOCAMPUS, V4, P623, DOI 10.1002/hipo.450040602; TSUYAMA S, 1986, J BIOL CHEM, V261, P4110; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VALLEE R, 1980, P NATL ACAD SCI-BIOL, V77, P3206, DOI 10.1073/pnas.77.6.3206; WALAAS SI, 1989, J MOL NEUROSCI, V1, P117, DOI 10.1007/BF02918897; WATKINS JC, 1981, ANN REV PHARM TOXICO, V21, P265; WOLFF DJ, 1985, J BIOL CHEM, V260, P4195; YAMAMOTO H, 1988, J NEUROCHEM, V50, P1614, DOI 10.1111/j.1471-4159.1988.tb03051.x; YAMAMOTO H, 1985, J NEUROCHEM, V44, P759, DOI 10.1111/j.1471-4159.1985.tb12880.x; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	87	114	114	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					357	368		10.1016/S0896-6273(00)80053-7	http://dx.doi.org/10.1016/S0896-6273(00)80053-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789950	Bronze			2022-12-24	WOS:A1996TW95700015
J	Tucker, T; Fettiplace, R				Tucker, T; Fettiplace, R			Confocal imaging of calcium microdomains and calcium extrusion in turtle hair cells	NEURON			English	Article							K+ CHANNELS; DEPENDENT CONDUCTANCES; FREQUENCY-SELECTIVITY; TRANSMITTER RELEASE; COCHLEA; CHICK; ION; CURRENTS; TRANSDUCTION; ADAPTATION	We have studied spatial Ca2+ distribution in hair cells filled with the low affinity fluorescent indicator Calcium Green 5N using real-time confocal microscopy and whole-cell recording. During depolarizations lasting several hundred milliseconds, Ca2+ fluorescence increased at a number of hotspots around the base of the cell but changed little near the hair bundle. The hotspots required influx of Ca2+ through voltage-dependent channels, and they expanded during the pulse from an initial diameter of <1 mu m. Strong Ca2+ buffers like BAPTA slowed their growth rate. On repolarization, the fluorescence decayed with two time constants: similar to 0.1 s, which may represent Ca2+ diffusion away from the entry sites, and 10 s, probably reflecting Ca2+ extrusion. Extrusion occurs mainly via a CaAT-Pase that can be blocked by vanadate. We suggest the hotspots are microdomains of Ca2+ attaining a concentration of at least 85 mu M near assemblies of synaptic release sites.			Tucker, T (corresponding author), UNIV WISCONSIN,SCH MED,DEPT NEUROPHYSIOL,NEUROSCI TRAINING PROGRAM,MADISON,WI 53706, USA.				NIDCD NIH HHS [5 R01 DC 01362] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ART JJ, 1993, J PHYSIOL-LONDON, V470, P109, DOI 10.1113/jphysiol.1993.sp019850; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; ASHMORE JF, 1990, J PHYSIOL-LONDON, V428, P109, DOI 10.1113/jphysiol.1990.sp018203; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLAUSTEI.MP, 1969, J PHYSIOL-LONDON, V200, P497, DOI 10.1113/jphysiol.1969.sp008704; BLAUSTEIN MP, 1991, ANN NY ACAD SCI, V639, P254, DOI 10.1111/j.1749-6632.1991.tb17315.x; CHABBERT C, 1994, PFLUGERS ARCH, V420, P493; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; EATOCK RA, 1987, J NEUROSCI, V7, P2821; ESCOBAR AL, 1994, NATURE, V367, P739, DOI 10.1038/367739a0; FETTIPLACE R, 1992, SOC GEN PHY, V47, P343; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FUCHS PA, 1988, J NEUROSCI, V8, P2460; FUCHS PA, 1992, J NEUROSCI, V12, P800; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; IKEDA K, 1992, PFLUG ARCH EUR J PHY, V420, P493, DOI 10.1007/BF00374624; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; KASS GEN, 1989, J BIOL CHEM, V264, P15192; LANG DG, 1990, J PHYSIOL-LONDON, V425, P117, DOI 10.1113/jphysiol.1990.sp018095; Lenzi David, 1994, Current Opinion in Neurobiology, V4, P496, DOI 10.1016/0959-4388(94)90049-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Mountcastle V., 1984, HDB PHYSL NERVOUS SY, VIII, P639; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; OHMORI H, 1984, J PHYSIOL-LONDON, V350, P561, DOI 10.1113/jphysiol.1984.sp015218; OLIVA C, 1988, BIOPHYS J, V54, P791, DOI 10.1016/S0006-3495(88)83017-0; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Pawley James, 1995, P19; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SAITO K, 1983, CELL TISSUE RES, V229, P467; SCHATZMANN HJ, 1989, ANNU REV PHYSIOL, V51, P473, DOI 10.1146/annurev.ph.51.030189.002353; SCHULTE BA, 1993, HEARING RES, V65, P262, DOI 10.1016/0378-5955(93)90219-Q; SHIGEMOTO T, 1991, J PHYSIOL-LONDON, V442, P669, DOI 10.1113/jphysiol.1991.sp018814; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SNEARY MG, 1988, J COMP NEUROL, V276, P588, DOI 10.1002/cne.902760411; TSIEN RY, 1980, BIOCHIM BIOPHYS ACTA, V599, P623, DOI 10.1016/0005-2736(80)90205-9; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; YAO Y, 1994, J PHYSIOL-LONDON, V476, P17	46	136	137	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1323	1335		10.1016/0896-6273(95)90011-X	http://dx.doi.org/10.1016/0896-6273(95)90011-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845156	Bronze			2022-12-24	WOS:A1995TL67800011
J	Diamond, JS; Bergles, DE; Jahr, CE				Diamond, JS; Bergles, DE; Jahr, CE			Glutamate release monitored with astrocyte transporter currents during LTP	NEURON			English	Article							LONG-TERM POTENTIATION; ARACHIDONIC-ACID; 3-DIMENSIONAL STRUCTURE; SYNAPTIC CURRENTS; DENDRITIC SPINES; SILENT SYNAPSES; NITRIC-OXIDE; GLIAL-CELLS; CA1 REGION; HIPPOCAMPUS	Long-term potentiation (LTP) of synaptic transmission in the CA1 region of the hippocampus is thought to result from either increased transmitter release, heightened postsynaptic sensitivity, or a combination of the two. We have measured evoked glutamate release from Schaffer collateral/commissural fiber terminals in CA1 by recording synaptically activated glutamate transporter currents in hippocampal astrocytes located in stratum radiatum. Although several manipulations of release probability caused parallel changes in extracellular field potentials and synaptically activated transporter current amplitudes, induction of LTP failed to alter transporter-mediated responses, suggesting that LTP does not alter the amount of glutamate released upon synaptic stimulation.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.		Bergles, Dwight/U-8343-2019; Diamond, Jeffrey/C-1835-2015	Bergles, Dwight/0000-0002-7133-7378; Diamond, Jeffrey/0000-0002-1770-2629	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010041, R01NS021419] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21419, NS10041] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brown T., 1990, SYNAPTIC ORG BRAIN, P346; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FORSTERMANN U, 1988, BRIT J PHARMACOL, V93, P569; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; HARRIS KM, 1992, J NEUROSCI, V12, P2685; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; LLINAS R, 1974, HDB ELECTROENCEPHA B, V2, P61; LYNCH MA, 1989, NEUROSCIENCE, V30, P693, DOI 10.1016/0306-4522(89)90162-0; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mennerick S, 1996, J NEUROSCI, V16, P55; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; PEROUANSKY M, 1993, J PHYSIOL-LONDON, V465, P223, DOI 10.1113/jphysiol.1993.sp019674; POGUN S, 1994, SYNAPSE, V18, P21, DOI 10.1002/syn.890180104; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SPACEK J, 1985, ANAT EMBRYOL, V171, P245, DOI 10.1007/BF00341419; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TROTTI D, 1995, J BIOL CHEM, V270, P9890, DOI 10.1074/jbc.270.17.9890; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WILLIAMS JH, 1989, NEUROSCI LETT, V107, P301, DOI 10.1016/0304-3940(89)90835-5; ZERANGUE N, 1995, J BIOL CHEM, V270, P6433, DOI 10.1074/jbc.270.12.6433; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	46	124	126	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1998	21	2					425	433		10.1016/S0896-6273(00)80551-6	http://dx.doi.org/10.1016/S0896-6273(00)80551-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728923	Bronze			2022-12-24	WOS:000075598300019
J	Grill-Spector, K; Kushnir, T; Edelman, S; Itzchak, Y; Malach, R				Grill-Spector, K; Kushnir, T; Edelman, S; Itzchak, Y; Malach, R			Cue-invariant activation in object-related areas of the human occipital lobe	NEURON			English	Article							HUMAN VISUAL-CORTEX; HUMAN BRAIN; MOTION; RECOGNITION; PERCEPTION; ANATOMY; SHAPE; COLOR; FORM; MT	The extent to which primary visual cues such as motion or luminance are segregated in different cortical areas is a subject of controversy. To address this issue, we examined cortical activation in the human occipital lobe using functional magnetic resonance imaging (fMRI) while subjects performed a fixed visual task, object recognition, using three different primary visual cues: motion, texture, or luminance contrast. in the first experiment, a region located on the lateral aspect of the occipital lobe (LO complex) was preferentially activated in all 11 subjects both by luminance and motion-defined object silhouettes compared to full-field moving and stationary noise (ratios, 2.00 +/- 0.19 and 1.86 +/- 0.65, respectively). In the second experiment, all subjects showed enhanced activation in the LO complex to objects defined both by luminance and texture contrast compared to full-field texture patterns (ratios, 1.43 +/- 0.08 and 1.32 +/- 0.08, respectively). An additional smaller dorsal focus that exhibited convergence of object-related cues appeared to correspond to area V3a or a region slightly anterior to it. These results show convergence of visual cues in LO and provide strong evidence for its role in object processing.	Weizmann Inst Sci, IL-76100 Rehovot, Israel; Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel; Univ Sussex, Sch Cognit & Comp Sci, Brighton BN1 9QH, E Sussex, England	Weizmann Institute of Science; Chaim Sheba Medical Center; University of Sussex	Malach, R (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.			Grill-Spector, Kalanit/0000-0002-5404-9606				Courtney SM, 1997, CURR OPIN NEUROBIOL, V7, P554, DOI 10.1016/S0959-4388(97)80036-0; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Efron B., 1994, INTRO BOOTSTRAP; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FFYTCHE DH, 1995, P ROY SOC B-BIOL SCI, V260, P353, DOI 10.1098/rspb.1995.0104; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GRILLSPECTOR K, 1998, IN PRESS HUM BRAIN M, V6; GULYAS B, 1994, P NATL ACAD SCI USA, V91, P9965, DOI 10.1073/pnas.91.21.9965; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; HIRSCH J, 1995, P NATL ACAD SCI USA, V92, P6469, DOI 10.1073/pnas.92.14.6469; Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Puce A, 1996, J NEUROSCI, V16, P5205; Reppas JB, 1997, NATURE, V388, P175, DOI 10.1038/40633; Reyment R. A., 1993, APPL FACTOR ANAL NAT; SALIN PA, 1989, J COMP NEUROL, V283, P486, DOI 10.1002/cne.902830405; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VanEssen DC, 1997, J NEUROSCI, V17, P7079; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0	37	309	309	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					191	202		10.1016/S0896-6273(00)80526-7	http://dx.doi.org/10.1016/S0896-6273(00)80526-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697863	Bronze			2022-12-24	WOS:000075061900018
J	Garcia-Anoveros, J; Garcia, JA; Liu, JD; Corey, DP				Garcia-Anoveros, J; Garcia, JA; Liu, JD; Corey, DP			The nematode degenerin UNC-105 forms ion channels that are activated by degeneration- or hypercontraction-causing mutations	NEURON			English	Article							SENSITIVE NA+ CHANNEL; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; K+ CHANNELS; C-ELEGANS; NEURONAL DEGENERATION; MOLECULAR-CLONING; SODIUM-CHANNEL; CATION CHANNEL; HAIR-CELLS	Nematode degenerins have been implicated in touch sensitivity and other forms of mechanosensation. Certain mutations in several degenerin genes cause the swelling, vacuolation, and death of neurons, and other mutations in the muscle degenerin gene unc-105 cause hypercontraction. Here, we confirm that unc-105 encodes an ion channel and show that it is constitutively active when mutated. These mutations disrupt different regions of the channel and have different effects on its gating. The UNC-105 channels are permeable to small monovalent cations but show voltage-dependent block by Ca2+ and Mg2+. Amiloride also produces voltage-dependent block, consistent with a single binding site 65% into the electric field. Mammalian cells expressing the mutant channels accumulate membranous whorls and multicompartment vacuoles, hallmarks of degenerin-induced cell death across species.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst,Dept Neurobiol, Boston, MA 02114 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Washington University (WUSTL)	Corey, DP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst,Dept Neurobiol, Boston, MA 02114 USA.			Corey, David/0000-0003-4497-6016; Garcia-Anoveros, Jaime/0000-0001-6561-9048				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; ASSAD JA, 1992, J NEUROSCI, V12, P3291; AWAYDA MS, 1995, AM J PHYSIOL-CELL PH, V268, pC1450, DOI 10.1152/ajpcell.1995.268.6.C1450; AWAYDA MS, 1998, IN PRESS J GEN PHYSL; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Corey DP, 1996, SCIENCE, V273, P323, DOI 10.1126/science.273.5273.323; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GarciaAnoveros J, 1996, CURR BIOL, V6, P541, DOI 10.1016/S0960-9822(02)00537-7; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; GARCIAANOVEROS J, 1997, CURR BIOL, V20, P567; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GUSTIN MC, 1988, SCIENCE, V242, P762, DOI 10.1126/science.2460920; HACKNEY CM, 1995, AM J PHYSIOL, V268, pC1; Hall DH, 1997, J NEUROSCI, V17, P1033; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Ismailov II, 1997, BIOPHYS J, V72, P1182, DOI 10.1016/S0006-3495(97)78766-6; Ismailov II, 1997, J BIOL CHEM, V272, P21075, DOI 10.1074/jbc.272.34.21075; Ismailov II, 1995, BIOPHYS J, V69, P1789, DOI 10.1016/S0006-3495(95)80049-4; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Kizer N, 1997, P NATL ACAD SCI USA, V94, P1013, DOI 10.1073/pnas.94.3.1013; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; LANE JW, 1991, J PHYSIOL-LONDON, V441, P347, DOI 10.1113/jphysiol.1991.sp018755; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMBRICK DD, 1995, BRAIN RES, V690, P145, DOI 10.1016/0006-8993(95)00552-2; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; PALMER LG, 1985, J MEMBRANE BIOL, V87, P191, DOI 10.1007/BF01871218; PARK EC, 1986, GENETICS, V113, P821; PARK EC, 1986, GENETICS, V113, P853; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; RUSCH A, 1994, J PHYSIOL-LONDON, V474, P75; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; SHREFFLER W, 1995, GENETICS, V139, P1261; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; VOILLEY N, 1994, P NATL ACAD SCI USA, V91, P247, DOI 10.1073/pnas.91.1.247; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALDMANN R, 1995, J BIOL CHEM, V270, P11735, DOI 10.1074/jbc.270.20.11735; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687	66	76	82	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1231	1241		10.1016/S0896-6273(00)80503-6	http://dx.doi.org/10.1016/S0896-6273(00)80503-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655510	Bronze			2022-12-24	WOS:000074627300018
J	De Zeeuw, CI; Hansel, C; Bian, F; Koekkoek, SKE; van Alphen, AM; Linden, DJ; Oberdick, J				De Zeeuw, CI; Hansel, C; Bian, F; Koekkoek, SKE; van Alphen, AM; Linden, DJ; Oberdick, J			Expression of a protein kinase C inhibitor in Purkinje cells blocks cerebellar LTD and adaptation of the vestibulo-ocular reflex	NEURON			English	Article							LONG-TERM DEPRESSION; CENTRAL-NERVOUS-SYSTEM; GAMMA MUTANT MICE; CLIMBING FIBERS; MESSENGER-RNA; EYE-MOVEMENTS; MULTIPLE INNERVATION; SYNAPTIC DEPRESSION; MOTOR COORDINATION; RAT CEREBELLUM	Cerebellar long-term depression (LTD) is a model system for neuronal information storage that has an absolute requirement for activation of protein kinase C (PKC). It has been claimed to underlie several forms of cerebellar motor learning. Previous studies using various knockout mice (mGluR1, GluR delta 2, glial fibrillary acidic protein) have supported this claim; however, this work has suffered from the limitations that the knockout technique lacks anatomical specificity and that functional compensation can occur via similar gene family members. To overcome these limitations, a transgenic mouse (called L7-PKCI) has been produced in which the pseudosubstrate PKC inhibitor, PKC[19-31], was selectively expressed. in Purkinje cells under the control of the pcp-2(L7) gene promoter. Cultured Purkinje cells prepared from heterozygous or homozygous L7-PKCI embryos showed a complete blockade of LTD induction. In addition, the compensatory eye movements of L7-PKCI mice were recorded during vestibular and visual stimulation. Whereas the absolute gain, phase, and latency values of the vestibule-ocular reflex and optokinetic reflex of the L7-PKCI mice were normal, their ability to adapt their vestibuloocular reflex gain during visuo-vestibular training was absent. These data strongly support the hypothesis that activation of PKC in the Purkinje cell is necessary for cerebellar LTD induction, and that cerebellar LTD is required for a particular form of motor learning, adaptation of the vestibule-ocular reflex.	Ohio State Univ, Dept Anat Cell Biol & Neurobiol, Div Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Neurobiotechnol Ctr, Columbus, OH 43210 USA; Erasmus Univ, Dept Anat, NL-3000 DR Rotterdam, Netherlands; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Erasmus University Rotterdam; Johns Hopkins University	Oberdick, J (corresponding author), Ohio State Univ, Dept Anat Cell Biol & Neurobiol, Div Neurosci, Columbus, OH 43210 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R01MH051106, R29MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033114] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106] Funding Source: Medline; NINDS NIH HHS [1RO1NS33114] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Baader SL, 1998, J NEUROSCI, V18, P1763; Bian F, 1996, MOL CELL NEUROSCI, V7, P116, DOI 10.1006/mcne.1996.0009; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BUIJS RM, 1987, NEUROSCIENCE, V20, P347, DOI 10.1016/0306-4522(87)90025-X; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; CHEN S, 1993, NEUROSCIENCE, V56, P177, DOI 10.1016/0306-4522(93)90572-W; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1980, NATURE, V283, P483, DOI 10.1038/283483a0; CREPEL F, 1976, J NEUROBIOL, V7, P579, DOI 10.1002/neu.480070610; DESCHUTTER E, 1995, TRENDS NEUROSCI, V18, P291, DOI 10.1016/0166-2236(95)93916-L; DeSchutter E, 1997, PROG BRAIN RES, V114, P529; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DeZeeuw CI, 1997, J NEUROPHYSIOL, V77, P1747, DOI 10.1152/jn.1997.77.4.1747; DEZEEUW CI, 1994, J COMP NEUROL, V349, P428, DOI 10.1002/cne.903490308; DEZEEUW CI, 1995, J NEUROPHYSIOL, V74, P2051, DOI 10.1152/jn.1995.74.5.2051; DOERNER D, 1988, J NEUROSCI, V8, P4069; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; FARLEY J, 1986, NATURE, V319, P220, DOI 10.1038/319220a0; Funabiki K, 1995, NEUROREPORT, V7, P189, DOI 10.1097/00001756-199512000-00045; Garcia MM, 1997, J COMP NEUROL, V385, P26; GREGA DS, 1987, SCIENCE, V235, P345, DOI 10.1126/science.2432663; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Highstein SM, 1997, PROG BRAIN RES, V114, P383; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG FL, 1989, J CELL BIOCHEM, V39, P401, DOI 10.1002/jcb.240390406; HUANG FL, 1990, DEV BRAIN RES, V52, P121, DOI 10.1016/0165-3806(90)90227-P; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; ITO M, 1982, EXP BRAIN RES, V45, P233; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; JANDE SS, 1981, NATURE, V294, P765, DOI 10.1038/294765a0; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KHATER TT, 1993, EXP BRAIN RES, V94, P16; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LECLERC N, 1992, P NATL ACAD SCI USA, V89, P5006, DOI 10.1073/pnas.89.11.5006; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; Linden DJ, 1996, BEHAV BRAIN SCI, V19, P339, DOI 10.1017/S0140525X00081437; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LINDEN DJ, 1992, J NEUROSCI, V12, P3601; Linden DJ, 1996, BEHAV BRAIN SCI, V19, P482, DOI 10.1017/S0140525X00081942; LISBERGER SG, 1983, J NEUROSCI, V3, P1234; LISBERGER SG, 1988, SCIENCE, V242, P728, DOI 10.1126/science.3055293; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P974, DOI 10.1152/jn.1994.72.2.974; Llinas R, 1997, LEARN MEMORY, V3, P445, DOI 10.1101/lm.3.6.445; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MERCHENTHALER I, 1993, J COMP NEUROL, V336, P378, DOI 10.1002/cne.903360306; NAGAO S, 1983, EXP BRAIN RES, V53, P36; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; OBERDICK J, 1993, NEURON, V10, P1007, DOI 10.1016/0896-6273(93)90050-2; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; PASTOR AM, 1994, J NEUROPHYSIOL, V72, P1383, DOI 10.1152/jn.1994.72.3.1383; POWELL KD, 1991, BRAIN RES, V550, P137, DOI 10.1016/0006-8993(91)90417-T; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHILLING K, 1994, NEUROSCIENCE, V59, P893, DOI 10.1016/0306-4522(94)90293-3; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SHIBUKI K, 1996, NEURON, V16, P586; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; SHIMOHAMA S, 1990, J CHEM NEUROANAT, V3, P367; SIMPSON JI, 1996, BEHAV BRAIN SCI, V19, P380; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Stevens CF, 1996, CELL, V87, P1147, DOI 10.1016/S0092-8674(00)81808-5; THOMPSON RF, 1994, ANNU REV NEUROSCI, V108, P44; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Voogd J., 1980, INFERIOR OLIVARY NUC, P207; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022; YOSHIDA Y, 1988, J BIOL CHEM, V263, P9868; Young W S 3rd, 1988, J Chem Neuroanat, V1, P177; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878	87	312	317	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR	1998	20	3					495	508		10.1016/S0896-6273(00)80990-3	http://dx.doi.org/10.1016/S0896-6273(00)80990-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539124	hybrid			2022-12-24	WOS:000072755600015
J	Gafni, J; Munsch, JA; Lam, TH; Catlin, MC; Costa, LG; Molinski, TF; Pessah, IN				Gafni, J; Munsch, JA; Lam, TH; Catlin, MC; Costa, LG; Molinski, TF; Pessah, IN			Xestospongins: Potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor	NEURON			English	Article							INTRACELLULAR CA2+ POOLS; VASCULAR SMOOTH-MUSCLE; PROTEIN-KINASE-C; CALCIUM-RELEASE; RYANODINE RECEPTOR; PHOSPHOINOSITIDE METABOLISM; SKELETAL-MUSCLE; MARINE SPONGE; PC12 CELLS; LOCALIZATION	Xestospongins (Xe's) A, C, D, araguspongine B, and demethylxestospongin B, a group of macrocyclic bis-1-oxaquinolizidines isolated from the Australian sponge, Xestospongia species, are shown to be potent blockers of IP3-mediated Ca2+ release from endoplasmic reticulum vesicles of rabbit cerebellum. XeC blocks IP3-induced Ca2+ release (IC50 = 358 nM) without interacting with the IP3-binding site, suggesting a mechanism that is independent of the IP3 effector site. Analysis of Pheochormocytoma cells and primary astrocytes loaded with Ca2+-sensitive dye reveals that XeC selectively blocks bradykinin-and carbamylcholine-induced Ca2+ efflux from endoplasmic reticulum stores. Xe's represent a new class of potent, membrane permeable IP3 receptor blockers exhibiting a high selectivity over ryanodine receptors. Xe's are a valuable tool for investigating the structure and function of IP3 receptors and Ca2+ signaling in neuronal and nonneuronal cells.	UNIV CALIF DAVIS,SCH VET MED,DEPT MOL BIOSCI,DAVIS,CA 95616; UNIV CALIF DAVIS,GRAD PROGRAM NEUROSCI,DAVIS,CA 95616; UNIV CALIF DAVIS,DEPT CHEM,DAVIS,CA 95616; UNIV WASHINGTON,DEPT ENVIRONM HLTH,SEATTLE,WA 98195	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle			Molinski, Tadeusz F/P-2125-2018		NIAID NIH HHS [R01 AI39987] Funding Source: Medline; NIEHS NIH HHS [R01 ES05002, ES07059] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007059, R01ES005002] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARRANG JM, 1994, CELL MOL BIOL, V40, P275; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY IB, 1993, MOL BIOL CELL, V4, P347, DOI 10.1091/mbc.4.3.347; BRANN MR, 1993, LIFE SCI, V52, P405, DOI 10.1016/0024-3205(93)90295-E; BRETSCHNEIDER E, 1995, AGENT ACTION SUPPL, V45, P309; BRETSCHNEIDER E, 1995, BIOCHEM PHARMACOL, V49, P33, DOI 10.1016/0006-2952(94)00404-A; BRINER VA, 1993, AM J PHYSIOL, V264, pF322, DOI 10.1152/ajprenal.1993.264.2.F322; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CREWS P, 1994, DEV ONCOL, V74, P364; DAUPHIN F, 1994, J NEUROCHEM, V63, P544; ENDO M, 1986, PURE APPL CHEM, V58, P387, DOI 10.1351/pac198658030387; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Grohovaz F, 1992, Agents Actions Suppl, V38 ( Pt 2), P9; Guizzetti M, 1996, EUR J PHARMACOL, V297, P265, DOI 10.1016/0014-2999(95)00746-6; HARNICK DJ, 1995, J BIOL CHEM, V270, P2833, DOI 10.1074/jbc.270.6.2833; HOYE TR, 1994, J ORG CHEM, V59, P6904, DOI 10.1021/jo00102a012; HOYE TR, 1995, J ORG CHEM, V60, P4958, DOI 10.1021/jo00120a055; KITAGAWA I, 1989, CHEM PHARM BULL, V37, P1676; KOBAYASHI S, 1988, BIOCHEM BIOPH RES CO, V153, P625, DOI 10.1016/S0006-291X(88)81141-0; KOVACS KA, 1995, NEUROCHEM RES, V20, P939, DOI 10.1007/BF00970740; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MOHR FC, 1993, BIOCHIM BIOPHYS ACTA, V1147, P105, DOI 10.1016/0005-2736(93)90320-Y; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; NAKAGAWA M, 1984, TETRAHEDRON LETT, V25, P3227, DOI 10.1016/S0040-4039(01)91016-0; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Pessah IN, 1997, AM J PHYSIOL-CELL PH, V272, pC601, DOI 10.1152/ajpcell.1997.272.2.C601; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; Pettit GR, 1996, BIOORG MED CHEM LETT, V6, P1313, DOI 10.1016/0960-894X(96)00225-9; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; QUIRION JC, 1992, J NAT PROD, V55, P1505, DOI 10.1021/np50088a017; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; SULLIVAN KMC, 1995, P NATL ACAD SCI USA, V92, P8611, DOI 10.1073/pnas.92.19.8611; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TINKER A, 1995, BIOPHYS J, V68, P111, DOI 10.1016/S0006-3495(95)80165-7; VERMA A, 1990, CELL REGUL, V1, P781, DOI 10.1091/mbc.1.10.781; YAMADA N, 1994, BIOCHEM J, V302, P781, DOI 10.1042/bj3020781; ZACCHETTI D, 1991, J BIOL CHEM, V266, P20152	46	505	509	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					723	733		10.1016/S0896-6273(00)80384-0	http://dx.doi.org/10.1016/S0896-6273(00)80384-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331361	Bronze			2022-12-24	WOS:A1997XZ01600024
J	Saiardi, A; Bozzi, Y; Baik, JH; Borrelli, E				Saiardi, A; Bozzi, Y; Baik, JH; Borrelli, E			Antiproliferative role of dopamine: Loss of D-2 receptors causes hormonal dysfunction and pituitary hyperplasia	NEURON			English	Article							MESSENGER-RNA LEVELS; ANTERIOR-PITUITARY; GROWTH-HORMONE; PROLACTIN RECEPTOR; DWARF MICE; RAT ANTERIOR; CELL-TYPES; G-PROTEINS; EXPRESSION; GENE	The function of dopamine (DA) in the nervous system is paralleled by its neuroendocrine control of pituitary gland functions. Here, we document the neuroendocrine function of dopamine by studying the pituitary gland of mice lacking DA D-2 receptors (D2R). These mice present a striking, progressive increase in lactotroph number, which ultimately leads to tumors in aged animals. Females develop tumors much earlier than males. An estrogen-mediated lactotroph proliferation cannot account for this sexual dimorphism, since D2R-null females are hypoestrogenic and, thus, have estrogen levels similar to males. In contrast, prolactin levels are six times higher in females than in males. We show that active prolactin receptors are present in the pituitary and their expression increases in concomitance with tumor expansion. These results point to prolactin as an autocrine proliferative factor in the pituitary gland. Additionally, they demonstrate an antiproliferative function for DA regulated through D-2 receptor activation.			Saiardi, A (corresponding author), ULP,CNRS,INSERM,INST GENET & BIOL MOL & CELLULAIRE,BP 163,CAMPUS UNIV STRASBOURG,F-67404 ILLKIRCH GRAFFENS,FRANCE.		Borrelli, Emiliana/M-8994-2018					ABE H, 1985, ENDOCRINOLOGY, V116, P1383, DOI 10.1210/endo-116-4-1383; AKERBLOM IE, 1990, MOL ENDOCRINOL, V4, P589, DOI 10.1210/mend-4-4-589; ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; AUTELITANO DJ, 1989, MOL CELL ENDOCRINOL, V67, P101, DOI 10.1016/0303-7207(89)90235-9; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BANSAL S, 1981, AM J MED, V71, P961, DOI 10.1016/0002-9343(81)90314-4; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BENJONATHAN N, 1994, PITUITARY GLAND, P261; BOOCKFOR FR, 1986, AM J PHYSIOL, V250, pE103, DOI 10.1152/ajpendo.1986.250.1.E103; BORRELLI E, 1994, TRENDS GENET, V10, P222, DOI 10.1016/0168-9525(94)90154-6; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; BORRELLI E, 1992, P NATL ACAD SCI USA, V89, P2764, DOI 10.1073/pnas.89.7.2764; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; CARBAJOPEREZ E, 1990, CELL TISSUE RES, V261, P333, DOI 10.1007/BF00318674; CHEN CLC, 1983, P NATL ACAD SCI-BIOL, V80, P2211, DOI 10.1073/pnas.80.8.2211; COTE TE, 1986, J BIOL CHEM, V261, P4555; DAY RN, 1990, MOL ENDOCRINOL, V4, P1964, DOI 10.1210/mend-4-12-1964; DORRINGTON J, 1981, NATURE, V290, P600, DOI 10.1038/290600a0; ELIAS KA, 1987, ENDOCRINOLOGY, V120, P617, DOI 10.1210/endo-120-2-617; ELSHOLTZ HP, 1991, J BIOL CHEM, V266, P22919; FRAWLEY LS, 1989, ENDOCRINOLOGY, V124, P3, DOI 10.1210/endo-124-1-3; FROHMAN LA, 1987, ENDOCRINOL METAB, P247; Gage PJ, 1996, DEVELOPMENT, V122, P151; Gao J, 1996, MOL ENDOCRINOL, V10, P847, DOI 10.1210/me.10.7.847; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; GUIRAMAND J, 1995, J BIOL CHEM, V270, P7354, DOI 10.1074/jbc.270.13.7354; HERROELEN L, 1994, BRAIN RES, V648, P222, DOI 10.1016/0006-8993(94)91121-5; JACOBS LS, 1971, J CLIN ENDOCR METAB, V33, P996, DOI 10.1210/jcem-33-6-996; JAHN GA, 1991, ENDOCRINOLOGY, V128, P2976, DOI 10.1210/endo-128-6-2976; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; LEBRUN JJ, 1995, P NATL ACAD SCI USA, V92, P4031, DOI 10.1073/pnas.92.9.4031; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LI SY, 1992, ENDOCRINOLOGY, V131, P395, DOI 10.1210/en.131.1.395; LIEBERMAN ME, 1983, J STEROID BIOCHEM, V19, P275, DOI 10.1016/S0022-4731(83)80037-5; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MERSHON J, 1995, ENDOCRINOLOGY, V136, P3619, DOI 10.1210/en.136.8.3619; Missale C, 1996, P NATL ACAD SCI USA, V93, P4240, DOI 10.1073/pnas.93.9.4240; Missale C, 1996, MOL ENDOCRINOL, V10, P272, DOI 10.1210/me.10.3.272; MONTMAYEUR JP, 1993, MOL ENDOCRINOL, V7, P161, DOI 10.1210/me.7.2.161; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; RHODES SJ, 1994, CURR OPIN GENET DEV, V4, P709, DOI 10.1016/0959-437X(94)90138-S; RUI H, 1994, J BIOL CHEM, V269, P5364; Sambrook J., 2002, MOL CLONING LAB MANU; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SLABAUGH MB, 1981, ENDOCRINOLOGY, V109, P1040, DOI 10.1210/endo-109-4-1040; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; VALERIO A, 1994, NEUROBIOL AGING, V15, P713, DOI 10.1016/0197-4580(94)90053-1; VOSS JW, 1992, CELL, V70, P527, DOI 10.1016/0092-8674(92)90422-9; WANG C, 1980, MOL CELL ENDOCRINOL, V20, P135, DOI 10.1016/0303-7207(80)90077-5; Weiner R.I., 1988, P1235; WOOD DF, 1991, CLIN ENDOCRINOL, V35, P455, DOI 10.1111/j.1365-2265.1991.tb00928.x	59	157	157	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					115	126		10.1016/S0896-6273(00)80352-9	http://dx.doi.org/10.1016/S0896-6273(00)80352-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247268	Bronze			2022-12-24	WOS:A1997XN39400011
J	Acharya, JK; Jalink, K; Hardy, RW; Hartenstein, V; Zuker, CS				Acharya, JK; Jalink, K; Hardy, RW; Hartenstein, V; Zuker, CS			InsP(3) receptor is essential for growth and differentiation but not for vision in Drosophila	NEURON			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; RYANODINE RECEPTOR; CA2+ INFLUX; CALCIUM; MELANOGASTER; PHOTORECEPTORS; EXPRESSION; CHANNELS; STORES; 1,4,5-TRIPHOSPHATE	Phospholipase C (PLC) is the focal point for two major signal transduction pathways: one initiated by G protein-coupled receptors and the other by tyrosine kinase receptors. Active PLC hydrolyzes phosphatidylinositol bisphosphate (PIP2) into the two second messengers inositol 1,4,5-trisphosphate (InsP(3)) and diacyl glycerol (DAG). DAG activates protein kinase C, and InsP(3) mobilizes calcium from intracellular stores via the InsP(3) receptor. Changes in [Ca2+](i) regulate the function of a wide range of target proteins, including ion channels, kinases, phosphatases, proteases, and transcription factors (Berridge, 1993). In the mouse, there are three InsP(3)R genes, and type 1 InsP(3)R mutants display ataxia and epileptic seizures (Matsumoto et al., 1996). In Drosophila, only one InsP(3) receptor (InsP(3)R) gene is known, and it is expressed ubiquitously throughout development (Hasan and Rosbash, 1992; Yoshikawa et al., 1992; Raghu and Hasan, 1995). Here, we characterize Drosophila InsP(3)R mutants and demonstrate that the InsP(3)R is essential for embryonic and larval development. Interestingly, maternal InsP(3)R mRNA is sufficient for progression through the embryonic stages, but larval organs show asynchronous and defective cell divisions, and imaginal discs arrest early and fail to differentiate. We also generated adult mosaic animals and demonstrate that phototransduction, a model PLC pathway thought to require InsP(3)R, does not require InsP(3)R for signaling.	UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA; UNIV CALIF LOS ANGELES, DEPT BIOL, LOS ANGELES, CA 90024 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Acharya, JK (corresponding author), UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA.			Jalink, Kees/0000-0001-7019-3440; Acharya, Jairaj/0000-0001-7366-4228				ASHBURNER M, 1989, DROSOPHILA LABORATOR, P1017; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CHOU TB, 1993, DEVELOPMENT, V119, P1359; DECAMILLI P, 1990, NATURE, V344, P495, DOI 10.1038/344495a0; FAIN JN, 1990, BIOCHIM BIOPHYS ACTA, V1053, P81, DOI 10.1016/0167-4889(90)90029-D; FISCHER GA, 1994, J BIOL CHEM, V269, P19216; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Goo Rhee Sue, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P35; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HASAN G, 1992, DEVELOPMENT, V116, P967; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; Mikoshiba Katsuhiko, 1994, Seminars in Cell Biology, V5, P273, DOI 10.1006/scel.1994.1033; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PAK WL, 1991, PROG CLIN BIOL RES, V362, P1; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RAGHU P, 1995, DEV BIOL, V171, P564, DOI 10.1006/dbio.1995.1305; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; RANGANATHAN R, 1994, NEURON, V13, P837, DOI 10.1016/0896-6273(94)90250-X; ROBERTSON HM, 1988, GENETICS, V118, P461; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; TAMHUN JW, 1992, CELL, V68, P561; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; ULTSCH A, 1993, FEBS LETT, V324, P171, DOI 10.1016/0014-5793(93)81387-F; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Wieschaus E., 1986, P199; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P16613; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	41	191	193	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1997	18	6					881	887		10.1016/S0896-6273(00)80328-1	http://dx.doi.org/10.1016/S0896-6273(00)80328-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208856	Bronze			2022-12-24	WOS:A1997XJ10200007
J	LevRam, V; Jiang, T; Wood, J; Lawrence, DS; Tsien, RY				LevRam, V; Jiang, T; Wood, J; Lawrence, DS; Tsien, RY			Synergies and coincidence requirements between NO, cGMP, and Ca2+ in the induction of cerebellar long-term depression	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; PURKINJE-CELLS; GUANYLATE-CYCLASE; CLIMBING FIBER; INSITU HYBRIDIZATION; GLUTAMATE RECEPTORS; SYNAPTIC DEPRESSION; PROTEIN-KINASES; MESSENGER-RNA	Parallel fiber synapses onto Purkinje neurons in acute cerebellar slices undergo long-term depression (LTD) when presynaptic activity coincides with postsynaptic depolarization. These electrical inputs can be respectively replaced by nitric oxide (NO) and Ca2+ photolytically released inside the Purkinje neuron,: showing that these two messengers are sufficient for LTD induction. NO acts via cGMP production because inhibitors of guanylate cyclase prevent LTD but can be circumvented by photoreleased cGMP combined with Ca2+ elevation. Three inhibitors of cGMP-dependent protein kinase, Rp-8Br-PET-cGMPS, KT5823, and a novel pseudosubstrate peptide, all block LTD. LTD induction permits <10 ms gap between NO release and Ca2+ elevation, whereas 200-300 ms is allowed between uncaged cGMP and Ca2+ increase. This surprising difference in timing precision can be explained either by tighter localization and faster decay of cGMP when generated by NO rather than uncaging, or by two independent coincidence detectors in series.	UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA; ALBERT EINSTEIN COLL MED, DEPT BIOCHEM, BRONX, NY 10461 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine	LevRam, V (corresponding author), UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA.				NIGMS NIH HHS [GM-45989] Funding Source: Medline; NINDS NIH HHS [NS-27177] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; Butt E, 1995, BRIT J PHARMACOL, V116, P3110, DOI 10.1111/j.1476-5381.1995.tb15112.x; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1989, NEUROSCI RES, V6, P264, DOI 10.1016/0168-0102(89)90065-5; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; GRIDER JR, 1993, AM J PHYSIOL, V264, pG334, DOI 10.1152/ajpgi.1993.264.2.G334; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; Hartell NA, 1996, J NEUROSCI, V16, P2881; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HEMART N, 1994, NEUROSCI RES, V19, P213, DOI 10.1016/0168-0102(94)90145-7; Hempel CM, 1996, NATURE, V384, P166, DOI 10.1038/384166a0; HESS DT, 1994, NEUROPHARMACOLOGY, V33, P1283, DOI 10.1016/0028-3908(94)90028-0; ITO M, 1992, NEUROSCI RES, V14, P27, DOI 10.1016/S0168-0102(05)80004-5; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 1990, Neuroreport, V1, P129; Ito M, 1991, Curr Opin Neurobiol, V1, P616, DOI 10.1016/S0959-4388(05)80038-8; JAFFREY SR, 1994, P NATL ACAD SCI USA, V91, P12994, DOI 10.1073/pnas.91.26.12994; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KASONO K, 1994, NEUROREPORT, V6, P17, DOI 10.1097/00001756-199412300-00006; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; Lipton SA, 1996, TRENDS PHARMACOL SCI, V17, P186, DOI 10.1016/0165-6147(96)20028-8; MAKINGS LR, 1994, J BIOL CHEM, V269, P6282; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; MAYER B, 1992, J NEUROCHEM, V59, P2024; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; NAKANE M, 1983, BRAIN RES, V273, P9, DOI 10.1016/0006-8993(83)91088-0; NERBONNE JM, 1984, NATURE, V310, P74, DOI 10.1038/310074a0; OLSON DR, 1976, LIFE SCI, V18, P935, DOI 10.1016/0024-3205(76)90411-2; PEUNOVA N, 1993, NATURE, V364, P450, DOI 10.1038/364450a0; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SCHMIDT MJ, 1985, J PHARMACOL EXP THER, V232, P764; SCHREURS BG, 1993, BRAIN RES, V631, P235, DOI 10.1016/0006-8993(93)91540-9; SCHUMAN EM, 1994, P NATL ACAD SCI USA, V91, P11958, DOI 10.1073/pnas.91.25.11958; SHESKIN DJ, 1997, HDB PARAMETRIC NONPA, P259; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; SOUTHAM E, 1992, NEUROSCI LETT, V137, P241, DOI 10.1016/0304-3940(92)90413-2; STONE JR, 1996, BIOCHEMISTRY-US, V35, P1094; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; WOOD PL, 1994, LIFE SCI, V54, P615, DOI 10.1016/0024-3205(94)00867-1; WOOTTON JF, 1989, NATO ADV SCI I C-MAT, V272, P277; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	64	187	193	2	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN	1997	18	6					1025	1038		10.1016/S0896-6273(00)80340-2	http://dx.doi.org/10.1016/S0896-6273(00)80340-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208868	Bronze, Green Published			2022-12-24	WOS:A1997XJ10200019
J	Muller, D; Wang, C; Skibo, G; Toni, N; Cremer, H; Calaora, V; Rougon, G; Kiss, JZ				Muller, D; Wang, C; Skibo, G; Toni, N; Cremer, H; Calaora, V; Rougon, G; Kiss, JZ			PSA-NCAM is required for activity-induced synaptic plasticity	NEURON			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; HIPPOCAMPAL ORGANOTYPIC CULTURES; N-CAM; POLYSIALIC ACID; NEURITE OUTGROWTH; AREA CA1; ADULT; GROWTH; L1	Hippocampal organotypic slice cultures maintained 10-20 days in vitro express a high level of the polysialylated embryonic form of neural cell adhesion molecule (NCAM) (PSA-NCAM). Treatment of the cultures with endoneuraminidase-N selectively removed polysialic acid (PSA) from NCAM and completely prevented induction of long-term potentiation (LTP) and long-term depression (LTD) without affecting cellular or synaptic parameters. Similarly, slices prepared from transgenic mice lacking the NCAM gene exhibited a decaying LTP. No inhibition of N-methyl-D-aspartic acid receptor-dependent synaptic responses was detected. Washout of the enzyme resulted in reexpression of PSA immunoreactivity which correlated with a complete recovery of LTP and LTD. This reexpression was blocked by TTX and low calcium and enhanced by bicuculline. Taken together, these results indicate that neuronal activity regulates the expression of PSA-NCAM at the synapse and that this expression is required for the induction of synaptic plasticity.	AA BOGOMOLETS PHYSIOL INST,UA-252601 KIEV,UKRAINE; UNIV LUMINY,LAB GENET & PHYSIOL DEV,F-13288 MARSEILLE,FRANCE	National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Muller, D (corresponding author), UNIV GENEVA,CTR MED,DEPT MORPHOL,CH-1211 GENEVA 4,SWITZERLAND.		ROUGON, Genevieve/G-2578-2013; Toni, Nicolas/M-2057-2014	Toni, Nicolas/0000-0001-5585-268X; ROUGON, Genevieve/0000-0003-1316-8200; Skibo, Galyna/0000-0003-2187-6178; Cremer, Harold/0000-0002-8673-5176				BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P417, DOI 10.1002/hipo.450030404; Goridis C, 1992, Semin Cell Biol, V3, P189; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; KISS JZ, 1993, NEUROSCIENCE, V53, P213, DOI 10.1016/0306-4522(93)90299-U; KLINZ SG, 1995, J NEUROCHEM, V65, P84; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER D, 1994, NEUROSCIENCE, V61, P441, DOI 10.1016/0306-4522(94)90424-3; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; ROUGON G, 1993, EUR J CELL BIOL, V61, P197; ROUGON G, 1986, J CELL BIOL, V103, P2429, DOI 10.1083/jcb.103.6.2429; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SADOUL R, 1983, NATURE, V304, P347, DOI 10.1038/304347a0; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STOPPINI L, 1993, NEUROSCIENCE, V57, P985, DOI 10.1016/0306-4522(93)90043-F; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; WANG C, 1994, J NEUROSCI, V14, P4446; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; WILLIAMS EJ, 1995, MOL CELL NEUROSCI, V6, P69, DOI 10.1006/mcne.1995.1007; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992; ZUBER C, 1992, J BIOL CHEM, V267, P9965	41	505	519	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					413	422		10.1016/S0896-6273(00)80174-9	http://dx.doi.org/10.1016/S0896-6273(00)80174-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816705	Bronze			2022-12-24	WOS:A1996VJ44000008
J	McFarlane, S; Cornel, E; Amaya, E; Holt, CE				McFarlane, S; Cornel, E; Amaya, E; Holt, CE			Inhibition of FGF receptor activity in retinal ganglion cell axons causes errors in target recognition	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; NEURITE OUTGROWTH; XENOPUS-LAEVIS; VISUAL-SYSTEM; DEVELOPMENTAL EXPRESSION; CONE GUIDANCE; IN-VIVO; NEURONS; DIFFERENTIATION; IDENTIFICATION	Native fibroblast growth factor receptor (FGFR) function was inhibited in developing Xenopus retinal ganglion cells (RGCs) by in vivo transfection of a dominant negative FGFR. Axons expressing the dominant negative protein advanced at 60% of the normal speed, but nevertheless navigated appropriately in the embryonic optic pathway. When they neared the optic tectum, however, many axons made erroneous turns, causing them to bypass rather than enter their target. By contrast, RGC axons expressing nonfunctional FGFR mutants entered the tectum correctly. These findings demonstrate a role for FGFR signaling in the extension and targeting of RGC axons and suggest that receptor tyrosine kinase/growth factor interactions play a critical function in establishing initial connectivity in the vertebrate visual system.	UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	McFarlane, S (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.			Holt, Christine Elizabeth/0000-0003-2829-121X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023780] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23780] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMAYA E, 1993, DEVELOPMENT, V118, P477; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BYERS S, 1992, DEV BIOL, V152, P411, DOI 10.1016/0012-1606(92)90149-B; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Elshamy WM, 1996, DEVELOPMENT, V122, P491; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FRIESEL R, 1991, MOL CELL BIOL, V11, P2481, DOI 10.1128/MCB.11.5.2481; FRIESEL R, 1992, DEVELOPMENT, V116, P1051; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; ISAACS HV, 1995, INT J DEV BIOL, V39, P575; KINOSHITA N, 1995, CELL, V83, P621, DOI 10.1016/0092-8674(95)90102-7; Launay C, 1996, DEVELOPMENT, V122, P869; LILIENBAUM A, 1995, MOL CELL NEUROSCI, V6, P139, DOI 10.1006/mcne.1995.1013; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIPTON SA, 1988, P NATL ACAD SCI USA, V85, P2388, DOI 10.1073/pnas.85.7.2388; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; MUSOI TJ, 1990, P NATL ACAD SCI USA, V87, P8365; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ROU JF, 1996, BIOCHEM BIOPH RES CO, V218, P198; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SHIOZAKI C, 1995, GENE, V152, P215, DOI 10.1016/0378-1119(94)00694-N; TANNAHILL D, 1992, DEVELOPMENT, V115, P695; TCHENG M, 1994, EXP EYE RES, V58, P351, DOI 10.1006/exer.1994.1025; UENO H, 1992, J BIOL CHEM, V267, P1470; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WALLICKE PC, 1986, P NATL ACAD SCI USA, V83, P3012; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1995, J CELL SCI, V108, P3523; Worley T, 1996, J NEUROSCI, V16, P2294; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; ZHANG L, 1994, J NEUROSCI, V14, P5187	51	132	133	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					245	254		10.1016/S0896-6273(00)80156-7	http://dx.doi.org/10.1016/S0896-6273(00)80156-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780648	Bronze			2022-12-24	WOS:A1996VE84000007
J	Bonci, A; Williams, JT				Bonci, A; Williams, JT			A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine	NEURON			English	Article							RAT NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; BEHAVIORAL SENSITIZATION; CYCLIC-AMP; EXTRACELLULAR DOPAMINE; RECEPTOR FUNCTION; CEREBRAL-CORTEX; TIME COURSE; RELEASE; ADENOSINE	The mesolimbic system is known to play a role in self-administration of opioids and psychostimulants. Although morphine and cocaine act by separate cellular mechanisms initially, the present study describes a common change in synaptic regulation of dopamine cells in the ventral tegmental area 1 week after termination of chronic treatment with either drug. Normally, D1 receptor activation augmented the amplitude of a gamma-aminobutyric acid type a (GABA(B)) inhibitory postsynaptic potential (IPSP), but in drug-experienced animals, D1 receptor activation caused an inhibition of the GABA(B) IPSP. The inhibition was blocked by adenosine A1 receptor antagonists and by agents that disrupted the metabolism of cAMP. This long-lasting dopamine-adenosine interaction may be one mechanism involved in dopamine-mediated craving and relapse to drug-seeking behaviors.			Bonci, A (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.				NIDA NIH HHS [DA08163, DA04523] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008163, R01DA004523] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ACKERMAN JM, 1992, EUR J PHARMACOL, V218, P171, DOI 10.1016/0014-2999(92)90161-V; BARBER R, 1981, MOL PHARMACOL, V19, P38; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; CAMERON DL, 1993, NATURE, V366, P344, DOI 10.1038/366344a0; CAMERON DL, 1994, J NEUROSCI, V14, P6763; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; CUNHA RA, 1992, J NEUROCHEM, V59, P657, DOI 10.1111/j.1471-4159.1992.tb09420.x; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; DUNWIDDIE TV, 1985, INT REV NEUROBIOL, V27, P63, DOI 10.1016/S0074-7742(08)60556-5; EGAWA M, 1988, BRAIN RES, V458, P303, DOI 10.1016/0006-8993(88)90472-6; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; GEREAU RW, 1994, NEURON, V12, P1121, DOI 10.1016/0896-6273(94)90319-0; HAAS HL, 1988, N-S ARCH PHARMACOL, V337, P561; HENRY DJ, 1995, J NEUROSCI, V15, P6287; HENRY DJ, 1989, J PHARMACOL EXP THER, V251, P833; HENRY DJ, 1991, J PHARMACOL EXP THER, V258, P882; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KALIVAS PW, 1993, J NEUROSCI, V13, P276; KORF J, 1976, NATURE, V260, P257, DOI 10.1038/260257a0; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LAZARENO S, 1985, BRAIN RES, V361, P91, DOI 10.1016/0006-8993(85)91278-8; LINDEN J, 1989, TRENDS PHARMACOL SCI, V10, P260, DOI 10.1016/0165-6147(89)90021-7; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MAYFIELD RD, 1992, BRAIN RES, V573, P331, DOI 10.1016/0006-8993(92)90783-6; MERCURI NB, 1989, BRIT J PHARMACOL, V98, P127, DOI 10.1111/j.1476-5381.1989.tb16872.x; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; NESTLER EJ, 1994, CELL, V79, P923, DOI 10.1016/0092-8674(94)90022-1; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; PADEN C, 1976, LIFE SCI, V19, P1499, DOI 10.1016/0024-3205(76)90094-1; PERIS J, 1990, J PHARMACOL EXP THER, V253, P38; RAGAZZI E, 1991, CIRC RES, V68, P1036; ROBERTSON GS, 1991, J NEUROSCI, V11, P2209; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; ROSEBOOM PH, 1990, J PHARMACOL EXP THER, V255, P197; ROSENBERG PA, 1989, J NEUROSCI, V9, P2654; ROSENBERG PA, 1994, J NEUROSCI, V14, P2953; SCHOEN SW, 1995, NEUROSCIENCE, V65, P37, DOI 10.1016/0306-4522(94)00469-L; SCHWABE U, 1980, N-S ARCH PHARMACOL, V313, P179, DOI 10.1007/BF00505731; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; TIMMERMAN W, 1995, IN PRESS SYNAPSE; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WOOLVERTON WL, 1992, TRENDS PHARMACOL SCI, V13, P193, DOI 10.1016/0165-6147(92)90063-C; WU YN, 1995, J PHARMACOL EXP THER, V273, P576; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; ZIMMERMANN H, 1993, NEUROSCIENCE, V55, P105, DOI 10.1016/0306-4522(93)90458-R	50	186	187	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					631	639		10.1016/S0896-6273(00)80082-3	http://dx.doi.org/10.1016/S0896-6273(00)80082-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785060	Bronze			2022-12-24	WOS:A1996UC16800019
J	Neveu, D; Zucker, RS				Neveu, D; Zucker, RS			Postsynaptic levels of [Ca2+](i) needed to trigger LTD and LTP	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC TRANSMISSION; RAT VISUAL-CORTEX; PROTEIN-KINASE; AREA CA1; BLOCKS INDUCTION; DM-NITROPHEN; DEPRESSION; CALCIUM; HIPPOCAMPUS	Long-term potentiation (LTP) and long-term depression (LTD) in CA1 pyramidal neurons are both triggered by a postsynaptic rise in intracellular Ca2+ concentration ([Ca2+](i)). We used photolysis of postsynaptic caged Ca2+ compounds to search for differential thresholds for activation of these processes. Longlasting potentiation (LLP) resembling LTP, and longlasting depression (LLD) resembling LTD, were evoked by [Ca2+](i) elevations of comparable magnitude and duration in different cells. No distinctions in threshold for these processes were detectable. LLP was occluded by tetanically induced LTP and blocked by calmodulin inhibition, and LLD was occluded by electrically induced LTD and blocked by phosphatase inhibition.			Neveu, D (corresponding author), UNIV CALIF BERKELEY,DIV NEUROBIOL,BERKELEY,CA 94720, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15114] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; HIRSCH JC, 1991, EXP BRAIN RES, V85, P621; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; KAPLAN JH, 1989, TRENDS NEUROSCI, V2, P54; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; Kimura F, 1990, Neuroreport, V1, P65, DOI 10.1097/00001756-199009000-00018; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; LANDO L, 1989, J GEN PHYSIOL, V93, P1017, DOI 10.1085/jgp.93.6.1017; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LIN JH, 1993, BRAIN RES, V603, P117, DOI 10.1016/0006-8993(93)91306-D; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MERAT DL, 1985, J BIOL CHEM, V260, P1053; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEVEU D, 1996, IN PRESS J NEUROPHYS; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; REGEHR WG, 1992, J NEUROSCI, V12, P4202; SCHULMAN H, 1994, CURR OPIN NEUROBIOL, V5, P374; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; YOSHIMURA Y, 1991, NEUROREPORT, V2, P393, DOI 10.1097/00001756-199107000-00010; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER R, 1994, METHOD CELL BIOL, V40, P31; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	57	158	161	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					619	629		10.1016/S0896-6273(00)80081-1	http://dx.doi.org/10.1016/S0896-6273(00)80081-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785059	Bronze			2022-12-24	WOS:A1996UC16800018
J	Cheng, LL; Mudge, AW				Cheng, LL; Mudge, AW			Cultured schwann cells constitutively express the myelin protein P-0	NEURON			English	Article							MAJOR MYELIN; NGF-RECEPTOR; CYCLIC-AMP; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; NERVOUS-SYSTEM; GROWTH-FACTORS; SCIATIC-NERVE; GALACTOCEREBROSIDE; PROLIFERATION	It is widely thought that mammalian Schwann cells do not express P-0, the major glycoprotein in peripheral myelin, unless they are induced to do so by axonal signals that can be mimicked by agents that trigger cAMP signaling pathways. In contrast, we find that cultured Schwann cells make large amounts of P-0 without the addition of any axonal-like signal, provided they have not been exposed to serum during the culture process. We also report that glial growth factor/neuregulin inhibits this constitutive P-0 expression. Myelin basic protein is regulated in a similar way. We suggest that expression of P-0 by Schwann cells before the onset of myelination may be prevented by inhibitory signals within the nerve, rather than by the absence of a positive signal from axons.			Cheng, LL (corresponding author), UNIV LONDON UNIV COLL, DEPT BIOL,MRC,DEV NEUROBIOL PROGRAMME, LAB MOL CELL BIOL, GOWER ST, LONDON WC1E 6BT, ENGLAND.							BARON P, 1994, J NEUROCYTOL, V23, P249, DOI 10.1007/BF01275529; BOLIN LM, 1993, J CELL BIOL, V123, P237, DOI 10.1083/jcb.123.1.237; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BROCKES JP, 1980, J NEUROCYTOL, V9, P67, DOI 10.1007/BF01205227; BRUNDEN KR, 1987, J CELL BIOL, V104, P661, DOI 10.1083/jcb.104.3.661; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; CHENG L, 1995, J CELL BIOL, V129, P789, DOI 10.1083/jcb.129.3.789; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; CLEMENCE A, 1989, J NEUROCYTOL, V18, P185, DOI 10.1007/BF01206661; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; FERNANDEZVALLE C, 1993, DEVELOPMENT, V119, P867; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GOODEARL ADJ, 1993, J BIOL CHEM, V268, P18095; Jessen K R, 1992, Curr Opin Neurobiol, V2, P575, DOI 10.1016/0959-4388(92)90021-C; JESSEN KR, 1985, J CELL BIOL, V101, P1135, DOI 10.1083/jcb.101.3.1135; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; LEBLANC AC, 1990, J NEUROSCI RES, V26, P317, DOI 10.1002/jnr.490260308; LEMKE G, 1988, DEVELOPMENT, V102, P499; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MEWS M, 1993, GLIA, V8, P208, DOI 10.1002/glia.440080308; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MORGAN L, 1994, DEVELOPMENT, V120, P1399; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; MORRISON S, 1991, J NEUROCYTOL, V20, P769, DOI 10.1007/BF01187850; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUDGE AW, 1993, CURR BIOL, V3, P361, DOI 10.1016/0960-9822(93)90201-X; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; PODUSLO JF, 1985, J NEUROSCI RES, V14, P177, DOI 10.1002/jnr.490140203; PODUSLO JF, 1985, J NEUROCHEM, V44, P1194, DOI 10.1111/j.1471-4159.1985.tb08743.x; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; SCHERER SS, 1994, J NEUROSCI, V14, P1930; SOBUE G, 1984, SCIENCE, V224, P72, DOI 10.1126/science.6322307; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; TANIUCHI M, 1985, J CELL BIOL, V101, P1100, DOI 10.1083/jcb.101.3.1100; TRAPP BD, 1981, J CELL BIOL, V90, P1, DOI 10.1083/jcb.90.1.1; TRAPP BD, 1988, J NEUROSCI, V8, P3515; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x	42	85	85	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB	1996	16	2					309	319		10.1016/S0896-6273(00)80049-5	http://dx.doi.org/10.1016/S0896-6273(00)80049-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789946	Bronze			2022-12-24	WOS:A1996TW95700011
J	Larsson, HP; Baker, OS; Dhillon, DS; Isacoff, EY				Larsson, HP; Baker, OS; Dhillon, DS; Isacoff, EY			Transmembrane movement of the Shaker K+ channel S4	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; INACTIVATION; RECEPTOR; SEQUENCE	We have probed internal and external accessibility of S4 residues to the membrane-impermeant thiol reagent methanethiosulfonate-ethyltrimethylammonium (MTSET) in both open and closed, cysteine-substituted Shaker K+ channels. Our results indicate that S4 traverses the membrane with no more than 5 amino acids in the closed state, and that the distribution of buried residues changes when channels open. This change argues for a displacement of S4 through the plane of the membrane in which an initially intracellular residue moves to within 3 amino acids of the extracellular solution. These results demonstrate that the putative voltage-sensing charges of S4 actually reside in the membrane and that they move outward when channels open. We consider constraints placed on channel structure by these results.	UNIV CALIF BERKELEY,GRAD GRP BIOPHYS,BERKELEY,CA 94720	University of California System; University of California Berkeley	Larsson, HP (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,229 STANLEY HALL,BERKELEY,CA 94720, USA.		isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOFFER AM, 1995, FASEB J, V9, P788; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STRYER L, 1988, NATURE, V339, P597; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	34	448	458	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					387	397		10.1016/S0896-6273(00)80056-2	http://dx.doi.org/10.1016/S0896-6273(00)80056-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789953	Bronze			2022-12-24	WOS:A1996TW95700018
J	Enomoto, H; Araki, T; Jackman, A; Heuckeroth, RO; Snider, WD; Johnson, EM; Milbrandt, J				Enomoto, H; Araki, T; Jackman, A; Heuckeroth, RO; Snider, WD; Johnson, EM; Milbrandt, J			GFR alpha 1-deficient mice have deficits in the enteric nervous system and kidneys	NEURON			English	Article							FACTOR-RECEPTOR-BETA; NEUROTROPHIC FACTOR; TYROSINE KINASE; LACKING GDNF; SURVIVAL FACTOR; NEURONS; RET; ALPHA; EXPRESSION; NEURTURIN	Glial cell line-derived neurotrophic factor (GDNF) signals through a receptor complex composed of the Pet tyrosine kinase and a glycosylphosphatidylinositol(GPl-) anchored cell surface coreceptor, either GDNF family receptor alpha 1 (GFR alpha 1) or GFR alpha 2. To investigate the usage of these coreceptors for GDNF signaling in vivo, gene targeting was used to produce mice lacking the GFR alpha 1 coreceptor. GFR alpha 1-deficient mice demonstrate absence of enteric neurons and agenesis of the kidney, characteristics that are reminiscent of both GDNF- and Ret-deficient mice. Midbrain dopaminergic and motor neurons in GFR alpha 1 null mice were normal. Minimal or no neuronal losses were observed in a number of peripheral ganglia examined, including the superior cervical and nodose, which are severely affected in both Ret- and GDNF-deficient mice. These results suggest that while stringent physiologic pairing exists between GFR alpha 1 and GDNF in renal and enteric nervous system development, significant cross-talk between GDNF and other GFR alpha coreceptors must occur in other neuronal populations.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.		Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Heuckeroth, Robert/0000-0002-3282-1765; Milbrandt, Jeffrey/0000-0002-5477-7689	NIA NIH HHS [R01 AG13729, R01 AG13730] Funding Source: Medline; NICHD NIH HHS [KO8 HD01166] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013729, R01AG013730] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217; GOLDEN J, IN PRESS J COMP NEUR; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HEUCKEROTH RO, 1998, IN PRESS DEV BIOL; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; PAYETTE RF, 1987, J COMP NEUROL, V257, P237, DOI 10.1002/cne.902570209; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Suvanto P, 1997, HUM MOL GENET, V6, P1267, DOI 10.1093/hmg/6.8.1267; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1997, J NEUROSCI, V17, P3554; Vainio S, 1997, CELL, V90, P975, DOI 10.1016/S0092-8674(00)80363-3; Vega QC, 1996, P NATL ACAD SCI USA, V93, P10657, DOI 10.1073/pnas.93.20.10657; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502; Yu T, 1998, J NEUROSCI, V18, P4684	34	373	376	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					317	324		10.1016/S0896-6273(00)80541-3	http://dx.doi.org/10.1016/S0896-6273(00)80541-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728913	Bronze			2022-12-24	WOS:000075598300009
J	Suri, VP; Qian, ZW; Hall, JC; Rosbash, M				Suri, VP; Qian, ZW; Hall, JC; Rosbash, M			Evidence that the TIM light response is relevant to light-induced phase shifts in Drosophila melanogaster	NEURON			English	Article							CIRCADIAN BEHAVIORAL RHYTHMS; PERIOD GENE-PRODUCT; VISUAL-SYSTEM; CLOCK MUTANTS; PROTEIN; TIMELESS; EXPRESSION; PHOTOSENSITIVITY; AUTOREGULATION; ENTRAINMENT	Light is a major environmental signal for the entrainment of circadian rhythms. In Drosophila melanogaster, recent experiments suggest that photic information is transduced to the clock through the timeless gene product, TIM. We provide genetic and spectral evidence supporting the relevance of TIM light responses to clock resetting. A missense mutant TIM, TIM-SL, exhibits greater sensitivity to light in both TIM protein disappearance and locomotor activity phase shifting assays. We show that the wavelength dependence of light-induced decreases in TIM levels and that of light-mediated phase shifting are virtually identical. Analysis of dose response of TIM disappearance in a variety of mutant genotypes suggests cell-autonomous light responses that are largely independent of the canonical visual transduction pathway.	Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02254 USA; Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02254 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Howard Hughes Medical Institute	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02254 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023549] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23549] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad M, 1996, PLANT MOL BIOL, V30, P851, DOI 10.1007/BF00020798; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; ASCHOFF J, 1965, CIRCADIAN CLOCKS, P94; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DUSHAY MS, 1989, J BIOL RHYTHM, V4, P1, DOI 10.1177/074873048900400101; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; Edmunds LN, 1988, CELLULAR MOL BASES B; EWER J, 1992, J NEUROSCI, V12, P3321; FRANK KD, 1969, SCIENCE, V163, P688, DOI 10.1126/science.163.3868.688; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Giebultowicz JM, 1997, NATURE, V386, P664, DOI 10.1038/386664a0; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, EMBO J, V11, P1; HASTINGS JW, 1960, J GEN PHYSIOL, V43, P697, DOI 10.1085/jgp.43.4.697; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KLEMM E, 1976, PHOTOCHEM PHOTOBIOL, V24, P369, DOI 10.1111/j.1751-1097.1976.tb06838.x; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; LIU X, 1988, GENE DEV, V2, P228, DOI 10.1101/gad.2.2.228; MONTELL C, 1989, BIOESSAYS, V11, P43, DOI 10.1002/bies.950110202; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Rosbash M, 1996, COLD SPRING HARB SYM, V61, P265; ROSBASH M, 1995, CURR OPIN GENET DEV, V5, P662, DOI 10.1016/0959-437X(95)80037-9; Rutila JE, 1996, NEURON, V17, P921, DOI 10.1016/S0896-6273(00)80223-8; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SARGENT ML, 1966, PLANT PHYSIOL, V41, P1343, DOI 10.1104/pp.41.8.1343; SAUNDERS DS, 1994, J INSECT PHYSIOL, V40, P957, DOI 10.1016/0022-1910(94)90134-1; Saunders DS, 1982, INSECT CLOCKS; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; STARK WS, 1976, NATURWISSENSCHAFTEN, V63, P513, DOI 10.1007/BF00596847; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZERR DM, 1990, J NEUROSCI, V10, P2749; ZIMMERMAN WF, 1971, SCIENCE, V171, P1167, DOI 10.1126/science.171.3976.1167	51	119	126	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					225	234		10.1016/S0896-6273(00)80529-2	http://dx.doi.org/10.1016/S0896-6273(00)80529-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697866	Bronze			2022-12-24	WOS:000075061900021
J	Storm, DR; Hansel, C; Hacker, B; Parent, A; Linden, DJ				Storm, DR; Hansel, C; Hacker, B; Parent, A; Linden, DJ			Impaired cerebellar long-term potentiation in type I adenylyl cyclase mutant mice	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; PURKINJE-CELL; RAT-BRAIN; HIPPOCAMPAL-NEURONS; GRANULE CELL; CA1 REGION; LATE-PHASE; FIBER LTP; DEPRESSION; CALCIUM	Activation of adenylyl cyclase and the consequent production of cAMP is a process that has been shown to be central to invertebrate model systems of information storage. In the vertebrate brain, it has been suggested that a presynaptic cascade involving Ca influx, cAMP production, and subsequent activation of cAMP-dependent protein kinase is necessary for induction of long-term potentiation (LTP) at the cerebellar parallel fiber-Purkinje cell synapse. We have used mutant mice in which the major Ca-sensitive adenylyl cyclase isoform of cerebellar cortex (type 1) is deleted to show that this results in an similar to 65% reduction in cerebellar Ca-sensitive cyclase activity and a nearly complete blockade of cerebellar LTP assessed using granule cell-Purkinje cell pairs in culture. This blockade is not accompanied by alterations in a number of basal electrophysiological parameters and may be bypassed by application of an exogenous cAMP analog, suggesting that it results specifically from deletion of the type 1 adenylyl cyclase.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Washington; University of Washington Seattle; Johns Hopkins University	Linden, DJ (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.			Parent, Angele/0000-0001-8686-1175	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R29MH051106, R01MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106] Funding Source: Medline; NINDS NIH HHS [NS20498] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bradley J, 1997, J NEUROSCI, V17, P1993; Byrne JH, 1996, J NEUROSCI, V16, P425; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; CHOI EJ, 1992, J BIOL CHEM, V267, P12440; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DIXON D, 1989, J NEUROSCI, V9, P4246; ELHUSSEINI AED, 1995, NEUROREPORT, V6, P1459, DOI 10.1097/00001756-199507100-00024; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GERIAL R, 1996, TRENDS NEUROSCI, V19, P177; Goodwin SF, 1997, J NEUROSCI, V17, P8817; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; HOPKINS WF, 1984, SCIENCE, V226, P350, DOI 10.1126/science.6091272; HOSHI T, 1988, SCIENCE, V240, P1652, DOI 10.1126/science.2454506; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Ito M, 1984, CEREBELLUM NEURAL CO; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kingston PA, 1996, P NATL ACAD SCI USA, V93, P10440, DOI 10.1073/pnas.93.19.10440; Kramer RH, 1996, J NEUROSCI, V16, P1285; LALONDE R, 1992, PHYSIOL BEHAV, V51, P523, DOI 10.1016/0031-9384(92)90174-Z; Linden DJ, 1996, BEHAV BRAIN SCI, V19, P339, DOI 10.1017/S0140525X00081437; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Linden DJ, 1998, J NEUROPHYSIOL, V79, P3151, DOI 10.1152/jn.1998.79.6.3151; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; Linden DJ, 1996, BEHAV BRAIN SCI, V19, P482, DOI 10.1017/S0140525X00081942; Llinas R, 1997, LEARN MEMORY, V3, P445, DOI 10.1101/lm.3.6.445; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Parent A, 1998, J NEUROPHYSIOL, V79, P3295, DOI 10.1152/jn.1998.79.6.3295; Pekhletski R, 1996, J NEUROSCI, V16, P6364; PERRETT SP, 1995, J NEUROSCI, V15, P2074, DOI 10.1523/JNEUROSCI.15-03-02074.1995; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; TANG WJ, 1991, J BIOL CHEM, V266, P8595; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Villacres EC, 1998, J NEUROSCI, V18, P3186; VILLACRES EC, 1995, J BIOL CHEM, V270, P14352, DOI 10.1074/jbc.270.24.14352; Wang JH, 1997, J NEUROPHYSIOL, V78, P2707, DOI 10.1152/jn.1997.78.5.2707; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; Wei JY, 1997, NEUROSCI LETT, V233, P37, DOI 10.1016/S0304-3940(97)00622-8; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WU Z, 1995, J BIOL CHEM, V268, P23766; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Zerr P, 1996, EUR J PHARMACOL, V303, P101, DOI 10.1016/0014-2999(96)00048-9; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	68	124	128	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1199	1210		10.1016/S0896-6273(00)80500-0	http://dx.doi.org/10.1016/S0896-6273(00)80500-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655507	Bronze			2022-12-24	WOS:000074627300015
J	Wolf, FW; Hung, MS; Wightman, B; Way, J; Garriga, G				Wolf, FW; Hung, MS; Wightman, B; Way, J; Garriga, G			vab-8 is a key regulator of posteriorly directed migrations in C-elegans and encodes a novel protein with kinesin motor similarity	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PIONEER AXON MIGRATIONS; COLORECTAL-CANCER; COMMISSURAL AXONS; CRYSTAL-STRUCTURE; MOSAIC ANALYSIS; CELL LINEAGE; NETRIN CUES; GUIDES CELL; GENE	Nervous system assembly requires the directed migrations of cells and axon growth cones along the dorsoventral and anteroposterior axes. Although guidance mechanisms for dorsoventral migrations are conserved from nematodes to mammals, mechanisms for anteroposterior migrations are unknown. In C. elegans, the gene vab-8, which specifically functions in posteriorly directed migrations, encodes two isoforms of a novel intracellular protein that act cell-autonomously in different migrations. VAB-8L, which contains a domain similar to kinesin-like motors, functions in all vab-8-dependent axon growth cone migrations. VAB-8S, which lacks this N-terminal domain, functions in a subset of vab-8-dependent cell migrations. Continuous expression of VAB-8L in the ALM mechanosensory neuron, which normally requires vab-8 early in its development for posteriorly directed cell migration, redirects its anteriorly projecting axon posteriorly. We propose that regulation of vab-8 activity is a mechanism for controlling the direction of cell and axon growth cone migrations.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Rutgers State Univ, Dept Biol, Piscataway, NJ 08855 USA	University of California System; University of California Berkeley; Rutgers State University New Brunswick	Wolf, FW (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		Hung, Ming-Shiu/ABY-8059-2022; Hung, Ming-Shiu/C-1375-2010	Wightman, Bruce/0000-0001-7811-8760	NINDS NIH HHS [NS32057] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032057] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTEBI A, 1997, C ELEGANS, V2, P543; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; BLOOM GS, 1994, PROTEIN PROFILE, V1, P1059; BRENNER S, 1974, GENETICS, V77, P71; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; COSTA M, 1988, CELL, V55, P747, DOI 10.1016/0092-8674(88)90131-6; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Forrester WC, 1997, DEVELOPMENT, V124, P1831; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Harlow E., 1988, ANTIBODIES LAB MANUA; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1995, GENETICS, V141, P989; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HEKIMI S, 1993, J NEUROSCI, V13, P4254; Herman RK, 1995, METHOD CELL BIOL, V48, P123; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KENYON C, 1986, CELL, V46, P477, DOI 10.1016/0092-8674(86)90668-9; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; LI C, 1990, NEURON, V4, P681, DOI 10.1016/0896-6273(90)90195-L; LILLIE SH, 1992, NATURE, V356, P358, DOI 10.1038/356358a0; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller LM, 1996, GENETICS, V143, P1181; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moulder GL, 1996, MOL BIOL CELL, V7, P1181, DOI 10.1091/mbc.7.8.1181; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VARELA EA, 1997, NEURON, V18, P193; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Wightman B, 1996, DEVELOPMENT, V122, P671; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; WILLIAMS BD, 1992, GENETICS, V131, P609; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3	61	55	62	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1998	20	4					655	666		10.1016/S0896-6273(00)81006-5	http://dx.doi.org/10.1016/S0896-6273(00)81006-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581759	Bronze			2022-12-24	WOS:000073346500006
J	Davis, JA; Naruse, S; Chen, H; Eckman, C; Younkin, S; Price, DL; Borchelt, DR; Sisodia, SS; Wong, PC				Davis, JA; Naruse, S; Chen, H; Eckman, C; Younkin, S; Price, DL; Borchelt, DR; Sisodia, SS; Wong, PC			An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos	NEURON			English	Article							PRECURSOR PROTEIN GENE; IN-VIVO; CAENORHABDITIS-ELEGANS; MISSENSE MUTATIONS; PRESENILIN-1; CHROMOSOME-14; NOTCH1; LOCUS; MICE	Mutations in presenilin 1 (PS1) cosegregate with similar to 25% of early onset familial Alzheimer's disease (FAD) pedigrees. A variety of in vitro and in vivo paradigms have established that one mechanism by which PS1 variants cause AD is by elevating the production of highly amyloidogenic A beta 1-42/43 peptides. PS1 is homologous to sel-12, a C. elegans protein that facilitates signaling mediated by the Notch/lin-12 family of receptors. Wild-type human PS1 complements an egg-laying defect in C. elegans lacking sel-12, while FAD-linked PS1 variants exhibit reduced rescue activity. These data suggested that mutant PS1 may cause disease as a result of reduction in PS1 function. To test the function of FAD-linked PS1 in mammals, we examined the ability of the A246E PS1 variant to complement the embryonic lethality and axial skeletal defects in mice lacking PS1. Finally, to examine the influence of reduced PS1 levels on A beta production, we quantified A beta 1-42/43 peptide levels in PS1 heterozygous null mice (PS1(+/-) mice). We now report that both human wild-type and A246E PS1 efficiently rescue the phenotypes observed in PS1(-/-) embryos, findings consistent with the view that FAD-linked PSI mutants retain sufficient normal function during mammalian embryonic development. Moreover, the levels of A beta 1-42/43 and A beta 1-40 peptides between PS1(+/-) and control mice are indistinguishable. Collectively, these data lead us to conclude that mutant PS1 causes AD not by loss of normal PS1 function but by influencing amyloid precursor protein (APP) processing in a manner that elevates A beta 1-42/43 production.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020471, P01NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014248] Funding Source: NIH RePORTER; NIA NIH HHS [1PO1 AG14248, AG05146] Funding Source: Medline; NINDS NIH HHS [NS 20471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Baumeister R, 1997, Genes Funct, V1, P149; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; CHAPMAN J, 1995, LANCET, V346, P1040, DOI 10.1016/S0140-6736(95)91723-3; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cruts M, 1996, HUM MOL GENET, V5, P1449, DOI 10.1093/hmg/5.Supplement_1.1449; Davis JA, 1996, J NEUROSCI, V16, P5082; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hogan B, 1994, MANIPULATING MOUSE E; Lah JJ, 1997, J NEUROSCI, V17, P1971; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; SUNDIN O, 1992, DEVELOPMENT, V114, P841; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; WASCO W, 1995, NAT MED, V1, P848, DOI 10.1038/nm0995-848a; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0	40	125	127	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1998	20	3					603	609		10.1016/S0896-6273(00)80998-8	http://dx.doi.org/10.1016/S0896-6273(00)80998-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539132	Bronze			2022-12-24	WOS:000072755600023
J	Livingstone, MS				Livingstone, MS			Mechanisms of direction selectivity in macaque V1	NEURON			English	Article							CAT STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; VISUAL-CORTEX; SIMPLE CELLS; AREA 17; RESPONSE PROPERTIES; LINEAR MECHANISMS; COMPLEX CELLS; RHESUS-MONKEY	Mechanisms underlying direction selectivity were studied in V1 of alert fixating macaque monkeys. Some direction-selective cells showed delayed asymmetric inhibition, some showed a shifting excitatory time course across the receptive field, and some showed both. Both the direction of the spatial offset of the inhibition and the direction of the shift in excitatory response time course correlated with the cells' preferred directionality. The delayed asymmetric inhibition may contribute to the shifting response time course. The data suggest that asymmetric inhibition is the major determinant for directionality in these cells, though both mechanisms could contribute. Based on this physiology, a simple, single-cell model is proposed, consistent with the known anatomy of some direction-selective cells.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Livingstone, MS (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Livingstone, Margaret/0000-0002-1950-0123	NEI NIH HHS [R01 EY10203] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010203] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; BISHOP PO, 1973, J PHYSL, V238, P25; Clark WELG, 1942, J ANAT, V76, P369; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; FERSTER D, 1988, J NEUROSCI, V8, P1172; FREUND TF, 1983, J COMP NEUROL, V221, P263, DOI 10.1002/cne.902210303; GANZ L, 1984, J NEUROPHYSIOL, V51, P294, DOI 10.1152/jn.1984.51.2.294; GANZ L, 1984, VISION RES, P243; GASKA JP, 1994, VISUAL NEUROSCI, V11, P805, DOI 10.1017/S0952523800003102; GLEZER VD, 1982, BIOL CYBERN, V43, P35, DOI 10.1007/BF00337286; GOODWIN AW, 1975, J NEUROPHYSIOL, V38, P1500, DOI 10.1152/jn.1975.38.6.1500; HAMILTON DB, 1989, VISION RES, V29, P1285, DOI 10.1016/0042-6989(89)90186-7; HAMMOND P, 1994, P ROY SOC B-BIOL SCI, V257, P179, DOI 10.1098/rspb.1994.0113; HEGGELUND P, 1986, J PHYSIOL-LONDON, V373, P293, DOI 10.1113/jphysiol.1986.sp016048; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; HUMPHREY AL, 1988, J COMP NEUROL, V268, P429, DOI 10.1002/cne.902680311; INNOCENTI GM, 1974, BRAIN RES, V80, P122, DOI 10.1016/0006-8993(74)90728-8; IRVIN GE, 1986, BRAIN RES, V362, P254, DOI 10.1016/0006-8993(86)90450-6; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LANDAU LD, 1976, MECHANICS, P99; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; LUND JS, 1973, J COMP NEUROL, V147, P455, DOI 10.1002/cne.901470404; MARTIN KAC, 1984, J PHYSIOL-LONDON, V356, P291, DOI 10.1113/jphysiol.1984.sp015465; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P357, DOI 10.1152/jn.1987.57.2.357; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; MCLEAN J, 1994, VISUAL NEUROSCI, V11, P271, DOI 10.1017/S0952523800001632; Meynert T., 1872, HDB LEHRE GEWEBEN ME, V2, P694; MOTTER BC, 1984, EXP BRAIN RES, V54, P304; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Movshon JA, 1996, J NEUROSCI, V16, P7733; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; PALMER LA, 1981, J NEUROPHYSIOL, V46, P277, DOI 10.1152/jn.1981.46.2.277; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1369, DOI 10.1152/jn.1977.40.6.1369; Rail W., 1964, NEURAL THEORY MODELI, P122; Ramon y Cajal S., 1899, CORTEZA VISUAL REV T, V4, P1; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; SATO H, 1995, J NEUROPHYSIOL, V74, P1382, DOI 10.1152/jn.1995.74.4.1382; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SHAPLEY R, 1991, COMPUTATIONAL MODELS, P109; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SNODDERLY DM, 1985, VISION RES, V25, P83, DOI 10.1016/0042-6989(85)90083-5; SNODDERLY DM, 1987, VISION RES, V27, P401, DOI 10.1016/0042-6989(87)90089-7; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; SPATZ WB, 1975, BRAIN RES, V92, P450, DOI 10.1016/0006-8993(75)90329-7; SPEAR PD, 1994, J NEUROPHYSIOL, V72, P402, DOI 10.1152/jn.1994.72.1.402; STEVENS JK, 1976, J NEUROPHYSIOL, V39, P213, DOI 10.1152/jn.1976.39.2.213; TIGGES J, 1981, J COMP NEUROL, V202, P539, DOI 10.1002/cne.902020407; TOLHURST DJ, 1991, VISUAL NEUROSCI, V6, P421, DOI 10.1017/S0952523800001280; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; WINFIELD DA, 1983, PROC R SOC SER B-BIO, V217, P129, DOI 10.1098/rspb.1983.0002	71	144	145	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1998	20	3					509	526		10.1016/S0896-6273(00)80991-5	http://dx.doi.org/10.1016/S0896-6273(00)80991-5			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539125	Bronze			2022-12-24	WOS:000072755600016
J	Ma, QF; Chen, ZF; Barrantes, ID; de la Pompa, JL; Anderson, DJ				Ma, QF; Chen, ZF; Barrantes, ID; de la Pompa, JL; Anderson, DJ			neurogenin1 is essential for the determination of neuronal precursors for proximal cranial sensory ganglia	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; LOOP-HELIX PROTEIN; ACHAETE-SCUTE HOMOLOG-1; PRONEURAL GENE; XENOPUS-EMBRYOS; RESTRICTED EXPRESSION; ECTODERMAL PLACODES; DROSOPHILA HOMOLOG; NEURAL DEVELOPMENT; ORGAN FORMATION	The NEUROGENINS (NGNs) are neural-specific basic helix-loop-helix (bHLH) transcription factors. Mouse embryos lacking ngn1 fail to generate the proximal subset of cranial sensory neurons. ngn1 is required for the activation of a cascade of downstream bHLH factors, including NeuroD, MATH3, and NSCL1. ngn1 is expressed by placodal ectodermal cells and acts prior to neuroblast delamination. Moreover, NGN1 positively regulates the Delta homolog DLL1 and can be negatively regulated by Notch signaling. Thus, ngn1 functions similarly to the proneural genes in Drosophila. However, the initial pattern of ngn1 expression appears to be Notch independent. Taken together with the fact that ectopic ngn1 expression can convert ectodermal cells to neurons in Xenopus (Ma et al., 1996), these data and those of Fode et al. (1998 [this issue of Neuron]) identify ngns as vertebrate neuronal determination genes, analogous to myoD and myf5 in myogenesis.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; Univ Toronto, Amgen Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada	California Institute of Technology; Howard Hughes Medical Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA.		De La Pompa, José Luis/F-9719-2014	De La Pompa, José Luis/0000-0001-6761-7265				AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; ANDERSON DJ, 1995, CURR BIOL, V5, P1235, DOI 10.1016/S0960-9822(95)00246-6; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Blader P, 1997, DEVELOPMENT, V124, P4557; BRAND M, 1993, DEVELOPMENT, V119, P1; Cau E, 1997, DEVELOPMENT, V124, P1611; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Chitnis A, 1996, DEVELOPMENT, V122, P2295; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; delaPompa J, 1997, DEVELOPMENT, V124, P1139; DOMINGUEZ M, 1993, EMBO J, V12, P2049, DOI 10.1002/j.1460-2075.1993.tb05854.x; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; GARRELL J, 1991, BIOESSAYS, V13, P493, DOI 10.1002/bies.950131002; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; Gilbert S., 1997, DEV BIOL; GOMEZSKARMETA JL, 1995, GENE DEV, V9, P1869, DOI 10.1101/gad.9.15.1869; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guillemot F, 1995, BIOL CELL, V84, P3, DOI 10.1016/0248-4900(96)81312-8; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Henrique D, 1997, GENE DEV, V11, P603, DOI 10.1101/gad.11.5.603; HOGAN B, 1986, MANIPULATING MOUSE E; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Jan Yuh Nung, 1994, Current Opinion in Neurobiology, V4, P8, DOI 10.1016/0959-4388(94)90025-6; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kim P, 1997, DEV BIOL, V187, P1, DOI 10.1006/dbio.1997.8572; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN NM, 1986, TRENDS NEUROSCI, V9, P175, DOI 10.1016/0166-2236(86)90055-X; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; MARTINEZ C, 1991, SCIENCE, V251, P1485, DOI 10.1126/science.1900954; Matsuno K, 1997, DEVELOPMENT, V124, P4265; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; OKA C, 1995, DEVELOPMENT, V121, P3291; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; RAMIREZSOLIS R, 1992, IN PRESS METHODS ENZ; RODRIGUEZ I, 1990, EMBO J, V9, P3583, DOI 10.1002/j.1460-2075.1990.tb07569.x; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Seugnet L, 1997, DEVELOPMENT, V124, P2015; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shawber C, 1996, DEVELOPMENT, V122, P3765; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VALARCHE I, 1993, DEVELOPMENT, V119, P881; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; Vogel Kristine S., 1992, P171; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WEBB JF, 1993, AM ZOOL, V33, P434; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; ZHANG SM, 1995, J NEUROSCI RES, V40, P241, DOI 10.1002/jnr.490400213; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221	89	594	604	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1998	20	3					469	482		10.1016/S0896-6273(00)80988-5	http://dx.doi.org/10.1016/S0896-6273(00)80988-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539122	Bronze			2022-12-24	WOS:000072755600013
J	Davis, GW; DiAntonio, A; Petersen, SA; Goodman, CS				Davis, GW; DiAntonio, A; Petersen, SA; Goodman, CS			Postsynaptic PKA controls quantal size and reveals a retrograde signal that regulates presynaptic transmitter release in Drosophila	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; DEVELOPING NEUROMUSCULAR SYNAPSES; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; CATALYTIC SUBUNIT; FUNCTIONAL COMPONENTS; GLUTAMATE RECEPTORS; GENETIC DISSECTION; HIPPOCAMPAL LTP; CYCLIC-AMP	Two distinct mechanisms regulate synaptic efficacy at the Drosophila neuromuscular junction (NMJ): a PKA-dependent modulation of quantal size and a retrograde regulation of presynaptic release. Postsynaptic expression of a constitutively active PKA catalytic subunit decreases quantal size, whereas overexpression of a mutant PKA regulatory subunit (inhibiting PKA activity) increases quantal size. Increased PKA activity also decreases the response to direct iontophoresis of glutamate onto postsynaptic receptors. The PKA-dependent modulation of quantal size requires the presence of the muscle-specific glutamate receptor DGluRIIA, since PKA-dependent modulation of quantal size is lost in homozygous viable DGluRIIA(-) mutants. Furthermore, elevated postsynaptic PKA reduces the quantal amplitude and the time constant of miniature excitatory junctional potential (mEJP) decay to values that are nearly identical to those observed in DGluRIIA(-) mutants. The PKA-dependent reduction in quantal size is accompanied developmentally by an increase in presynaptic quantal content, indicating the presence of a retrograde signal that regulates presynaptic release.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.			DiAntonio, Aaron/0000-0002-7262-0968				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; Coffino P, 1976, Recent Prog Horm Res, V32, P669; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DAVIS GW, 1997, NEURON, V19, P1; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FRANK E, 1973, J PHYSIOL-LONDON, V233, P635, DOI 10.1113/jphysiol.1973.sp010327; GOVIND CK, 1981, SCIENCE, V212, P1522, DOI 10.1126/science.7233240; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HARISH OE, 1992, NEURON, V9, P1201, DOI 10.1016/0896-6273(92)90077-Q; HAWKINS RD, 1994, J NEUROBIOL, V25, P625; HOFFMAN PW, 1994, J NEUROSCI, V14, P4185; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MELENDEZ A, 1995, GENETICS, V141, P1507; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	44	172	172	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					305	315		10.1016/S0896-6273(00)80458-4	http://dx.doi.org/10.1016/S0896-6273(00)80458-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491991	Bronze			2022-12-24	WOS:000072154700015
J	Schiffer, HH; Swanson, GT; Heinemann, SF				Schiffer, HH; Swanson, GT; Heinemann, SF			Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate	NEURON			English	Article							HIGH-AFFINITY KAINATE; CULTURED HIPPOCAMPAL-NEURONS; CHANNELS; AMPA; DESENSITIZATION; CLONING; RELEASE; DOMOATE	Glutamate receptors of the kainate-preferring subtype have recently been shown to mediate synaptic transmission in the hippocampus. The low-affinity kainate receptor subunit GluR7 was found to be nonfunctional in previous studies. We report here that the GluR7 subunit and a novel carboxy-terminal splice variant, GluR7b, are functional glutamate receptors with unique pharmacological properties. In particular, glutamate exhibits a 10-fold lower potency for (non-desensitized) GluR7-mediated currents as compared to other non-NMDA receptor channels. These data will facilitate understanding of the distinct role played by GluR7 receptors in synaptic transmission.			Schiffer, HH (corresponding author), SALK INST BIOL STUDIES, MOL NEUROBIOL LAB, LA JOLLA, CA 92037 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709] Funding Source: NIH RePORTER; NIGMS NIH HHS [1 F32 GM 18717-01] Funding Source: Medline; NINDS NIH HHS [2 RO1 NS 28709-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Diamond JS, 1997, J NEUROSCI, V17, P4672; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; LOMELI H, 1992, FEBS LETT, V307, P139, DOI 10.1016/0014-5793(92)80753-4; NUTT SL, 1994, RECEPTOR CHANNEL, V2, P315; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Sahara Y, 1997, J NEUROSCI, V17, P6611; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; SPRENGEL R, 1995, LIGAND VOLTAGE GATED, P213; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wilding TJ, 1997, J NEUROSCI, V17, P2713; Yue KT, 1995, EUR J PHARM-MOLEC PH, V291, P229, DOI 10.1016/0922-4106(95)90062-4	24	143	147	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1997	19	5					1141	1146		10.1016/S0896-6273(00)80404-3	http://dx.doi.org/10.1016/S0896-6273(00)80404-3			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390526	Bronze			2022-12-24	WOS:A1997YH59400020
J	Khalilov, I; Esclapez, M; Medina, I; Aggoun, D; Lamsa, K; Leinekugle, X; Khazipov, R; BenAri, Y				Khalilov, I; Esclapez, M; Medina, I; Aggoun, D; Lamsa, K; Leinekugle, X; Khazipov, R; BenAri, Y			A novel in vitro preparation: the intact hippocampal formation	NEURON			English	Article							SPINAL-CORD; 2 FORMS; GLUTAMATE-DECARBOXYLASE; SYNAPTIC DRIVE; BRAIN-SLICES; IN-VITRO; RAT; NEURONS; INTERNEURONS; MOTONEURONS	The intact hippocampal formation (IHF) of neonatal or young rats can be kept alive for an extended period in a fully submerged chamber with excellent morphological preservation. Field or patch-clamp recordings, intracellular Ca2+ measurements, and 3-D reconstruction of biocytin-filled neurons can be performed routinely. The generation and propagation of network-driven activities can be studied within the IHF or between connected intact structures such as the septum and the hippocampus or two hippocampi, and the use of a dual chamber enables the application of drugs separately to each structure. This preparation will be useful to study intact neuronal networks in the developing hippocampus in vitro.	HOP PORT ROYAL,INSERM U29,F-75014 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Khazipov, Roustem/M-1834-2016; Medina, Igor/O-5532-2016; Leinekugel, Xavier/F-4034-2014; Lamsa, Karri/T-2025-2019; Esclapez, Monique/O-6509-2016; Khalilov, Ilgam/B-5267-2015; Leinekugel, Xavier/ABD-8347-2021	Khazipov, Roustem/0000-0002-6763-2841; Medina, Igor/0000-0001-6839-5414; Leinekugel, Xavier/0000-0003-2878-3791; Esclapez, Monique/0000-0002-8558-1363; Khalilov, Ilgam/0000-0002-9468-4778; Lamsa, Karri/0000-0002-4609-1337; Ben-Ari, Yehezkel/0000-0001-6208-8480				AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BOURQUE CW, 1984, J PHYSIOL-LONDON, V349, P631, DOI 10.1113/jphysiol.1984.sp015178; Cazalets JR, 1996, J NEUROSCI, V16, P298; de Curtis M, 1991, Hippocampus, V1, P341, DOI 10.1002/hipo.450010402; Dupuy ST, 1996, J NEUROSCI, V16, P6919; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Frank E, 1993, Curr Opin Neurobiol, V3, P82, DOI 10.1016/0959-4388(93)90039-2; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; FULTON BP, 1986, J PHYSIOL-LONDON, V370, P651, DOI 10.1113/jphysiol.1986.sp015956; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hirsch JC, 1996, J NEUROPHYSIOL, V76, P4185, DOI 10.1152/jn.1996.76.6.4185; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Khazipov R, 1997, J PHYSIOL-LONDON, V498, P763, DOI 10.1113/jphysiol.1997.sp021900; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; MUHLETHALER M, 1993, EUR J NEUROSCI, V5, P915, DOI 10.1111/j.1460-9568.1993.tb00942.x; NICHOLSON C, 1993, J NEUROSCI METH, V48, P199, DOI 10.1016/0165-0270(93)90092-6; ODONOVAN MJ, 1989, J NEUROSCI, V9, P943; OTSUKA M, 1974, NATURE, V252, P733, DOI 10.1038/252733a0; PARE D, 1995, HIPPOCAMPUS, V5, P115, DOI 10.1002/hipo.450050205; Peters A, 1991, NEURONS THEIR SUPPOR; ROZENBERG F, 1989, DEV BRAIN RES, V50, P177, DOI 10.1016/0165-3806(89)90193-4; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Toth K, 1997, J PHYSIOL-LONDON, V500, P463, DOI 10.1113/jphysiol.1997.sp022033; TREMBLAY E, 1984, NEUROSCIENCE, V13, P1051, DOI 10.1016/0306-4522(84)90288-4; VOIPIO J, 1995, J NEUROPHYSIOL, V74, P633, DOI 10.1152/jn.1995.74.2.633	31	125	130	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					743	749		10.1016/S0896-6273(00)80956-3	http://dx.doi.org/10.1016/S0896-6273(00)80956-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354321	Bronze			2022-12-24	WOS:A1997YD18900002
J	Kombian, SB; Mouginot, D; Pittman, QJ				Kombian, SB; Mouginot, D; Pittman, QJ			Dendritically released peptides act as retrograde modulators of afferent excitation in the supraoptic nucleus in vitro	NEURON			English	Article							HYPOTHALAMIC MAGNOCELLULAR NEURONS; LONG-TERM POTENTIATION; MILK-EJECTION REFLEX; SYNAPTIC TRANSMISSION; RAT-BRAIN; BINDING-SITES; IN-VITRO; ENDOGENOUS DYNORPHINS; NEUROSECRETORY-CELLS; ARGININE-VASOPRESSIN	Oxytocin (OXT) and vasopressin (VP) are known to be released from dendrites of magnocellular neurons. Here, we show that these peptides reduced evoked EPSCs by a presynaptic mechanism, an effect blocked by peptide antagonists and mimicked by inhibition of endogenous peptidases. Dendritic release of peptides, elicited with depolarization achieved by high frequency stimulation of afferents or with current injection into an individual neuron, induced short-term synaptic depression similar to that seen following exogenous peptide application and was prevented by peptide antagonists. Thus, dendritically released peptides depress evoked EPSCs in magnocellular neurons by activating presynaptic OXT and/or VP receptors. Such a retrograde modulatory action on afferent excitation may serve as a feedback mechanism to permit peptidergic neurosecretory neurons to autoregulate their own activity.			Kombian, SB (corresponding author), UNIV CALGARY, NEUROSCI RES GRP, CALGARY, AB T2N 4N1, CANADA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Pittman, Quentin/0000-0003-0984-7665				Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; BARKER JL, 1971, BRAIN RES, V33, P353, DOI 10.1016/0006-8993(71)90108-9; BICKNELL RJ, 1988, J EXP BIOL, V139, P51; BRINTON RE, 1984, P NATL ACAD SCI-BIOL, V81, P7248, DOI 10.1073/pnas.81.22.7248; BRINTON RE, 1984, EUR J PHARMACOL, V102, P365, DOI 10.1016/0014-2999(84)90270-X; Brussaard AB, 1996, J PHYSIOL-LONDON, V497, P495, DOI 10.1113/jphysiol.1996.sp021783; BURBACH JPH, 1983, J BIOL CHEM, V258, P1487; CASTEL M, 1988, NEUROSCIENCE, V24, P937, DOI 10.1016/0306-4522(88)90078-4; CHOWDREY HS, 1993, ANN NY ACAD SCI, V689, P183, DOI 10.1111/j.1749-6632.1993.tb55547.x; CLAYBAUGH JR, 1993, ANN NY ACAD SCI, V689, P250, DOI 10.1111/j.1749-6632.1993.tb55552.x; CONDE H, 1992, EXP BRAIN RES, V88, P233, DOI 10.1007/BF02259099; CONRAD LCA, 1976, J COMP NEUROL, V169, P221, DOI 10.1002/cne.901690206; Dayanithi G, 1996, J PHYSIOL-LONDON, V490, P713, DOI 10.1113/jphysiol.1996.sp021180; DISCALAGUENOT D, 1987, NEUROSCI LETT, V76, P209, DOI 10.1016/0304-3940(87)90717-8; DISCALAGUENOT D, 1994, GLIA, V11, P269, DOI 10.1002/glia.440110308; DRAKE CT, 1994, J NEUROSCI, V14, P3736; DREIFUSS JJ, 1971, J PHYSIOL-LONDON, V215, P805, DOI 10.1113/jphysiol.1971.sp009499; Elands J, 1988, J Chem Neuroanat, V1, P293; Fisher TE, 1996, TRENDS NEUROSCI, V19, P440; FREUNDMERCIER MJ, 1988, NEUROSCIENCE, V26, P273, DOI 10.1016/0306-4522(88)90144-3; FREUNDMERCIER MJ, 1981, NEUROSCI LETT, V23, P193, DOI 10.1016/0304-3940(81)90039-2; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; GRIBKOFF VK, 1990, J NEUROPHYSIOL, V63, P60, DOI 10.1152/jn.1990.63.1.60; HATTON GI, 1990, PROG NEUROBIOL, V34, P437, DOI 10.1016/0301-0082(90)90017-B; Kombian SB, 1996, J NEUROPHYSIOL, V76, P1166, DOI 10.1152/jn.1996.76.2.1166; KRUSZYNSKI M, 1980, J MED CHEM, V23, P364, DOI 10.1021/jm00178a003; LAMBERT RC, 1994, J PHYSIOL-LONDON, V478, P275, DOI 10.1113/jphysiol.1994.sp020249; LAMBERT RC, 1993, NEUROSCIENCE, V57, P1027, DOI 10.1016/0306-4522(93)90046-I; LOWBRIDGE J, 1977, J MED CHEM, V20, P120, DOI 10.1021/jm00211a025; LUDWIG M, 1992, BRAIN RES, V576, P231, DOI 10.1016/0006-8993(92)90685-3; LUPICA CR, 1992, J NEUROSCI, V12, P3753; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MANNING M, 1989, J LAB CLIN MED, V114, P617; MASON WT, 1984, NEUROSCIENCE, V11, P169, DOI 10.1016/0306-4522(84)90221-5; MILLS LR, 1994, J NEUROSCI, V14, P6815; MOOS F, 1989, J PHYSIOL-LONDON, V408, P1, DOI 10.1113/jphysiol.1989.sp017442; MORRIS JF, 1993, ANN NY ACAD SCI, V689, P16, DOI 10.1111/j.1749-6632.1993.tb55534.x; MUHLETHALER M, 1983, PROG BRAIN RES, V60, P147; NEUMANN I, 1993, NEUROSCIENCE, V53, P65, DOI 10.1016/0306-4522(93)90285-N; NICOLL RA, 1971, BRAIN RES, V35, P501, DOI 10.1016/0006-8993(71)90491-4; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; POW DV, 1988, NEUROSECRETION CELLU, P113; PUCAK ML, 1995, CRIT REV NEUROBIOL, V9, P67; RANDLE JCR, 1986, J NEUROPHYSIOL, V56, P1703, DOI 10.1152/jn.1986.56.6.1703; RENAUD LP, 1991, PROG NEUROBIOL, V36, P131, DOI 10.1016/0301-0082(91)90020-2; Saleh TM, 1996, J NEUROSCI, V16, P6046; SAPHIER D, 1987, EXP BRAIN RES, V69, P60; SIMMONS ML, 1995, NEURON, V14, P1265, DOI 10.1016/0896-6273(95)90273-2; STARK H, 1989, PEPTIDES, V10, P717, DOI 10.1016/0196-9781(89)90102-2; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; VANLEEUWEN FW, 1985, BRAIN RES, V359, P320, DOI 10.1016/0006-8993(85)91443-X; WAGNER JJ, 1991, J NEUROCHEM, V57, P333, DOI 10.1111/j.1471-4159.1991.tb02132.x; WAGNER JJ, 1993, NATURE, V363, P451, DOI 10.1038/363451a0; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; YAMASHITA H, 1987, BRAIN RES, V416, P364, DOI 10.1016/0006-8993(87)90920-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	57	158	158	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1997	19	4					903	912		10.1016/S0896-6273(00)80971-X	http://dx.doi.org/10.1016/S0896-6273(00)80971-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354336	Bronze			2022-12-24	WOS:A1997YD18900017
J	Molliver, DC; Wright, DE; Leitner, ML; Parsadanian, AS; Doster, K; Wen, D; Yan, Q; Snider, WD				Molliver, DC; Wright, DE; Leitner, ML; Parsadanian, AS; Doster, K; Wen, D; Yan, Q; Snider, WD			IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life	NEURON			English	Article							NERVE GROWTH-FACTOR; DORSAL-ROOT GANGLION; PRIMARY SENSORY NEURONS; C-RET PROTOONCOGENE; MICE LACKING GDNF; NEUROTROPHIC FACTOR; PRIMARY AFFERENTS; TYROSINE KINASE; ADULT-RATS; RECEPTOR	We have tested the role of glial cell line-derived neurotrophic factor (GDNF) in regulating a group of putatively nociceptive dorsal root ganglion (DRG) neurons that do not express calcitonin gene-related peptide (CGRP) and that downregulate the nerve growth factor (NGF) receptor tyrosine kinase, TrkA, after birth. We show that mRNA and protein for the GDNF receptor tyrosine kinase, Ret, are expressed in the DRG in patterns that differ markedly from those of any of the neurotrophin receptors. Most strikingly, a population of small neurons initiates expression of Ret between embryonic day 15.5 and postnatal day 7.5 and maintains Ret expression into adulthood. These Ret-expressing small neurons are selectively labeled by the lectin IB4 and project to lamina Iii of the dorsal horn. Ret-expressing neurons also express the glycosyl-phosphatidyl inositol-linked (GPI-linked) GDNF binding component CDNFR-alpha and retrogradely transport I-125-GDNF, indicating the presence of a biologically active GDNF receptor complex. In vitro, GDNF supports the survival of small neurons that express Ret and bind IB4 while failing to support the survival of neurons expressing TrkA and CGRP. Together, our findings suggest that IB4-binding neurons switch from dependence on NGF in embryonic life to dependence on GDNF in postnatal life and are likely regulated by GDNF in maturity.	WASHINGTON UNIV,SCH MED,DEPT NEUROL,CTR STUDY NERVOUS SYST INJURY,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOL BIOL & PHARMACOL,ST LOUIS,MO 63110; UNIV KANSAS,MED CTR,DEPT ANAT & CELL BIOL,KANSAS CITY,KS 66160; AMGEN INC,DEPT NEUROSCI,THOUSAND OAKS,CA 91320	Washington University (WUSTL); Washington University (WUSTL); University of Kansas; University of Kansas Medical Center; Amgen				Molliver, Derek/0000-0002-4406-7384	NIA NIH HHS [AG 13729] Funding Source: Medline; NINDS NIH HHS [NS 17763, NS 31768] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017763, R01NS031768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013729] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Bennett DLH, 1996, EUR J NEUROSCI, V8, P2204; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COPRAY JCVM, 1994, DEV BRAIN RES, V81, P57, DOI 10.1016/0165-3806(94)90068-X; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Ernfors P, 1995, INT J DEV BIOL, V39, P799; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Farinas I, 1996, SEMIN NEUROSCI, V8, P133, DOI 10.1006/smns.1996.0018; FLEISCHER E, 1983, BRAIN RES, V267, P81, DOI 10.1016/0006-8993(83)91041-7; HIRATA T, 1995, DEV BRAIN RES, V85, P201, DOI 10.1016/0165-3806(94)00205-E; HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028; JANSCO G, 1988, REGUL PEPTIDES, V22, P97; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Lapchak PA, 1996, CELL TISSUE RES, V286, P179, DOI 10.1007/s004410050687; LAWSON SN, 1987, ACTA PHYSIOL HUNG, V69, P315; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LEWIN GR, 1993, J NEUROSCI, V13, P2136; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LIGHT AR, 1992, INITIAL PROCESSING P; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; LYNN B, 1982, BRAIN RES, V238, P29, DOI 10.1016/0006-8993(82)90768-5; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; Matheson CR, 1997, J NEUROBIOL, V32, P22, DOI 10.1002/(SICI)1097-4695(199701)32:1<22::AID-NEU3>3.3.CO;2-B; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; MCMAHON SB, 1995, NAT MED, V1, P740; MOLLIVER DC, 1995, J COMP NEUROL, V361, P404, DOI 10.1002/cne.903610305; Molliver DC, 1997, J COMP NEUROL, V381, P428, DOI 10.1002/(SICI)1096-9861(19970519)381:4<428::AID-CNE3>3.0.CO;2-4; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P1, DOI 10.1111/j.1365-2818.1988.tb04582.x; PETTY BG, 1994, ANN NEUROL, V36, P244, DOI 10.1002/ana.410360221; PINI A, 1990, EUR J NEUROSCI, V2, P89, DOI 10.1111/j.1460-9568.1990.tb00384.x; REINHARDT RR, 1994, J NEUROSCI, V14, P4674; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SILOSSANTIAGO I, 1997, IN PRESS EUR J NEURO; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P259, DOI 10.3109/07367228809144630; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; SUNICKER K, 1996, CELL TISSUE RES, V286, P175; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; WHITE FA, 1990, J COMP NEUROL, V300, P249, DOI 10.1002/cne.903000208; Woolf CJ, 1996, J NEUROSCI, V16, P2716; Woolf CJ, 1996, PHILOS T ROY SOC B, V351, P441, DOI 10.1098/rstb.1996.0040; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; YIP HK, 1984, J NEUROSCI, V4, P2986	62	588	601	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					849	861		10.1016/S0896-6273(00)80966-6	http://dx.doi.org/10.1016/S0896-6273(00)80966-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354331	Bronze			2022-12-24	WOS:A1997YD18900012
J	Siegel, MS; Isacoff, EY				Siegel, MS; Isacoff, EY			A genetically encoded optical probe of membrane voltage	NEURON			English	Article							GREEN-FLUORESCENT PROTEIN; SHAKER POTASSIUM CHANNELS; XENOPUS-OOCYTES; HETEROMULTIMERIC CHANNELS; MOLECULAR-BASIS; FUSION PROTEIN; K+ CHANNELS; INACTIVATION; DROSOPHILA; EXPRESSION	Measuring electrical activity in large numbers of cells with high spatial and temporal resolution is a fundamental problem for the study of neural development and information processing. To address this problem, we have constructed a novel, genetically encoded probe that can be used to measure transmembrane voltage in single cells. We fused a modified green fluorescent protein (GFP) into a voltage-sensitive K+ channel so that voltage-dependent rearrangements in the K+ channel would induce changes in the fluorescence of GFP. The probe has a maximal fractional fluorescence change of 5.1%, making it comparable to some of the best organic voltage-sensitive dyes. Moreover, the fluorescent signal is expanded in time in a way that makes the signal 30-fold easier to detect. A voltage sensor encoded into DNA has the advantage that it may be introduced into an organism noninvasively and targeted to specific developmental stages, brain regions, cell types, and subcellular compartments.	UNIV CALIF BERKELEY, DEPT MOL & CELL BIOL, BERKELEY, CA 94720 USA; CALTECH, PASADENA, CA 91125 USA	University of California System; University of California Berkeley; California Institute of Technology			isacoff, ehud/AAP-1459-2020; Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Isacoff, Ehud Y./0000-0003-4775-9359				AMSTERDAM A, 1995, DEV BIOL, V171, P123, DOI 10.1006/dbio.1995.1265; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Cohen L B, 1986, Soc Gen Physiol Ser, V40, P71; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Dopf J, 1996, GENE, V173, P39, DOI 10.1016/0378-1119(95)00692-3; DREWE JA, 1992, J NEUROSCI, V12, P538; Gonzalez JE, 1997, CHEM BIOL, V4, P269, DOI 10.1016/S1074-5521(97)90070-3; GROSS D, 1989, METHOD CELL BIOL, V30, P193; Haykin S., 1994, COMMUNICATION SYSTEM; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Levy DI, 1996, BIOPHYS J, V71, P3157, DOI 10.1016/S0006-3495(96)79509-7; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; Nobile M, 1997, EXP BRAIN RES, V114, P138, DOI 10.1007/PL00005613; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SHEN NV, 1993, NEURON, V11, P67; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	38	328	350	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1997	19	4					735	741		10.1016/S0896-6273(00)80955-1	http://dx.doi.org/10.1016/S0896-6273(00)80955-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354320	Bronze			2022-12-24	WOS:A1997YD18900001
J	Feiner, L; Koppel, AM; Kobayashi, H; Raper, JA				Feiner, L; Koppel, AM; Kobayashi, H; Raper, JA			Secreted chick semaphorins bind recombinant neuropilin with similar affinities but bind different subsets of neurons in situ	NEURON			English	Article							MEMBRANE-PROTEIN; NERVOUS-SYSTEM; GROWTH CONES; RECEPTOR; NGF; EXPRESSION; MOLECULES; COLLAPSIN; FAMILY	Collapsin-1, a member of the semaphorin family, activates receptors on specific growth cones, thereby inhibiting their motility. Neuropilin, a previously cloned transmembrane protein, has recently been identified as a candidate receptor for collapsin-1. We have completed the cloning of chick collapsin-3 and -5 and show that collapsin-1, -2, -3, and -5 bind to overlapping but distinct axon tracts. We infer that in situ, there are distinct receptors with different affinities for collapsin-1, -2, -3, and -5. In contrast, these four collapsins all bind recombinant neuropilin with similar affinities. Strong binding to neuropilin is mediated by the carboxy third of the collapsins, while the semaphorin domain confers their unique binding patterns in situ. We propose that neuropilin is a common component of a semaphorin receptor complex, and that additional differentially expressed receptor components interact with the semaphorin domains to confer binding specificity.	UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104	University of Pennsylvania								BECKMANN G, 1993, TRENDS BIOCHEM SCI, V18, P40, DOI 10.1016/0968-0004(93)90049-S; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Fujisawa H, 1995, DEV NEUROSCI-BASEL, V17, P343, DOI 10.1159/000111304; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HIRATA T, 1993, NEUROSCI RES, V17, P159, DOI 10.1016/0168-0102(93)90092-5; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; KOBAYASHI H, 1997, IN PRESS J NEUROSCI; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; LAVAIL JH, 1971, BRAIN RES, V28, P421; LUO Y, 1995, NEURON, V15, P1218; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208	22	176	179	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					539	545		10.1016/S0896-6273(00)80370-0	http://dx.doi.org/10.1016/S0896-6273(00)80370-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331347	hybrid			2022-12-24	WOS:A1997XZ01600010
J	Wright, DE; Zhou, L; Kucera, J; Snider, WD				Wright, DE; Zhou, L; Kucera, J; Snider, WD			Introduction of a neurotrophin-3 transgene into muscle selectively rescues proprioceptive neurons in mice lacking endogenous neurotrophin-3	NEURON			English	Article							DORSAL-ROOT GANGLIA; SENSORY NEURONS; MESSENGER-RNA; NERVOUS-SYSTEM; SPINAL-CORD; REQUIRE NEUROTROPHIN-3; RAT; EXPRESSION; SURVIVAL; SPINDLES	To clarify the role of muscle-derived neurotrophin-3 (NT-3) in the development of sensory neurons, we generated transgenic mice selectively overexpressing NT-3 in skeletal muscles under the control of a myogenin promoter (myo-NT-3 mice). The myo-NT-3 transgene was then bred into an NT-3 null mutant (-/-) line to generate myo-NT-3, NT-3(-/-) mice in which NT-3 was expressed in muscles, but not elsewhere. Transient overexpression of NT-3 in developing muscles increased the number of proprioceptive neurons as well as the density of both their central and peripheral projections, resulting in more la afferents in spinal cord and more spindles (end organs of la afferents) in muscles. NT-3 expression restricted to muscles was sufficient to secure the development of proprioceptive neurons and their central and peripheral projections in myo-NT-3, NT-3(-/-) mice. The loss of nonproprioceptive neurons observed in NT-3(-/-) mice was not reversed by the transgene, suggesting that these neurons are regulated by NT-3 from sources other than muscle. We conclude that target-derived rather than intraganglionic NT-3 is preeminent in supporting the development of proprioceptive neurons. The level of NT-3 in developing muscles may be the principal factor determining the number of proprioceptive neurons in dorsal root ganglions and spindles in skeletal muscles of adults.	WASHINGTON UNIV,SCH MED,DEPT NEUROL,CTR STUDY NERVOUS SYST INJURY,ST LOUIS,MO 63110; BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118	Washington University (WUSTL); Boston University					NINDS NIH HHS [R01 NS31768, R01 NS25796, P01 NS34448] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025796, P01NS034448, R01NS031768] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; [Anonymous], [No title captured]; ARAKSINEN MS, 1996, NEUROSCIENCE, V73, P907; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BOYD IA, 1962, PHILOS T ROY SOC B, V245, P81, DOI 10.1098/rstb.1962.0007; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; Buckingham M, 1996, BIOCHEM SOC T, V24, P506, DOI 10.1042/bst0240506; CARR PA, 1989, NEUROSCIENCE, V33, P363, DOI 10.1016/0306-4522(89)90216-9; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHENG TC, 1992, J CELL BIOL, V119, P1649, DOI 10.1083/jcb.119.6.1649; COGGESHALL RE, 1984, J NEUROSCI METH, V12, P125, DOI 10.1016/0165-0270(84)90011-6; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; COPRAY JCVM, 1994, DEV BRAIN RES, V81, P57, DOI 10.1016/0165-3806(94)90068-X; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; Davies AM, 1996, PHILOS T ROY SOC B, V351, P389, DOI 10.1098/rstb.1996.0033; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; Donovan MJ, 1996, NAT GENET, V14, P210, DOI 10.1038/ng1096-210; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLLACKEY HP, 1990, DEV SENSORY SYSTEMS, P403; KUCERA J, 1989, AM J ANAT, V186, P144, DOI 10.1002/aja.1001860205; KUCERA J, 1995, J COMP NEUROL, V363, P307, DOI 10.1002/cne.903630211; KUCERA J, 1995, ANAT EMBRYOL, V192, P149; KUCERA J, 1992, ANAT EMBRYOL, V186, P301; MU XJ, 1993, J NEUROSCI, V13, P4029; MYIATA Y, 1986, J NEUROSCI, V6, P2012; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; Oakley RA, 1997, J NEUROSCI, V17, P4262; Ockel M, 1996, DEVELOPMENT, V122, P301; Ozaki S, 1997, J COMP NEUROL, V380, P215; PEDROSA F, 1990, HISTOCHEMISTRY, V94, P231; RINGSTEDT T, 1997, IN PRESS DEVELOPMENT; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; White FA, 1996, J NEUROSCI, V16, P4662; Woolsey T.A., 1990, P461; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; ZELENA J, 1957, J EMBRYOL EXP MORPH, V5, P283; Zelena J, 1994, NERVES MECHANORECEPT; ZHANG L, 1994, J NEUROSCI, V14, P5187	49	90	93	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					503	517		10.1016/S0896-6273(00)80367-0	http://dx.doi.org/10.1016/S0896-6273(00)80367-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331344	hybrid			2022-12-24	WOS:A1997XZ01600007
J	Ma, JY; Catterall, WA; Scheuer, T				Ma, JY; Catterall, WA; Scheuer, T			Persistent sodium currents through brain sodium channels induced by G protein beta gamma subunits	NEURON			English	Article							SOMATIC-CELL LINE; KINASE-C; NA+-CHANNEL; XENOPUS-OOCYTES; ALPHA-SUBUNITS; K+ CHANNEL; FUNCTIONAL MODULATION; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; TRANSFECTED CELLS	Persistent Na+ currents are thought to be important for integration of neuronal responses. Here, we show that beta gamma subunits of G proteins can induce persistent Na+ currents. Coexpression of G beta(2) gamma(3), G beta(1) gamma(3), or G beta(5) gamma(3), but not G beta(1) gamma(1) subunits with rat brain type IIA Na+ channel alpha subunits in tsA-201 cells greatly enhances a component of Na+ current with a normal voltage dependence of activation but with dramatically slowed and incomplete inactivation and with steady-state inactivation shifted +37 mV. Synthetic peptides containing the proposed G beta gamma-binding motif, Gln-X-X-Glu-Arg, from either adenylyl cyclase 2 or the Na+ channel alpha subunit C-terminal domain reversed the effect of G beta(2) gamma(3), subunits. These results are consistent with direct binding of G beta gamma subunits to the C-terminal domain of the Na+ channel, stabilizing a gating mode responsible for slowed and persistent Na+ current. Modulation of Na+ channel gating by G beta gamma subunits is expected to have profound effects on neuronal excitability.			Ma, JY (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,BOX 357280,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15751, NS09797] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALZHEIMER C, 1993, J NEUROSCI, V13, P660; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; DASCAL N, 1991, NEURON, V6, P165, DOI 10.1016/0896-6273(91)90131-I; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; JI S, 1994, J GEN PHYSIOL, V104, P625, DOI 10.1085/jgp.104.4.625; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; MA JY, 1994, P NATL ACAD SCI USA, V91, P12351, DOI 10.1073/pnas.91.25.12351; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; NILIUS B, 1988, BIOPHYS J, V53, P857, DOI 10.1016/S0006-3495(88)83166-7; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PATTON DE, 1994, J BIOL CHEM, V269, P17649; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; Smith RD, 1996, J NEUROSCI, V16, P1965; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; TAYLOR CP, 1993, TRENDS NEUROSCI, V16, P455, DOI 10.1016/0166-2236(93)90077-Y; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; UEDA N, 1994, J BIOL CHEM, V269, P4388; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	56	95	95	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					443	452		10.1016/S0896-6273(00)80952-6	http://dx.doi.org/10.1016/S0896-6273(00)80952-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292732	Bronze			2022-12-24	WOS:A1997XU14600021
J	Williams, BP; Park, JK; Alberta, JA; Muhlebach, SG; Hwang, GY; Roberts, TM; Stiles, CD				Williams, BP; Park, JK; Alberta, JA; Muhlebach, SG; Hwang, GY; Roberts, TM; Stiles, CD			A PDGF-regulated immediate early gene response initiates neuronal differentiation in ventricular zone progenitor cells	NEURON			English	Article							RAT CEREBRAL-CORTEX; C-FOS GENE; GROWTH-FACTOR RECEPTOR; CENTRAL-NERVOUS-SYSTEM; ACHAETE-SCUTE HOMOLOG; PRECURSOR CELL; OPTIC-NERVE; STEM-CELLS; EXPRESSION; LINEAGE	When exposed to platelet-derived growth factor (PDGF), uncommitted neuroepithelial cells from the developing cortex of embryonic day 14 (E14) rats develop into neurons. Outward signs of the neuronal phenotype are not observed for 4 days following exposure to PDGF. However, only a brief (23 hr) period of PDGF receptor activation is required to initiate neuronal development. During the window of receptor activation, RNA synthesis is essential, but protein synthesis is not. These observations indicate that specification of neuronal fate is mediated by an immediate early gene response.	HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOL GENET,CAMBRIDGE,MA 02138; HARVARD UNIV,SCH MED,DEPT PATHOL,CAMBRIDGE,MA 02138; DANA FARBER CANC INST,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT NEUROSURG,BOSTON,MA 02115; CHILDRENS HOSP,BOSTON,MA 02115	Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital				Williams, Brenda Patricia/0000-0003-4690-5932				AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BANGALORE L, 1992, P NATL ACAD SCI USA, V89, P11637, DOI 10.1073/pnas.89.23.11637; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOSTROM H, 1996, CELL, V85, P1; BOWENPOPE DF, 1991, TRENDS GENET, V7, P413, DOI 10.1016/0168-9525(91)90222-C; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; EPSTEIN RJ, 1992, P NATL ACAD SCI USA, V89, P10435, DOI 10.1073/pnas.89.21.10435; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GROVE EA, 1993, DEVELOPMENT, V117, P553; HELDIN CH, 1993, GROWTH FACTORS, V8, P245, DOI 10.3109/08977199308991570; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; JAKOBOVITS EB, 1984, CELL, V38, P757, DOI 10.1016/0092-8674(84)90271-X; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mountcastle V., 1978, MINDFUL BRAIN; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; OGAWA M, 1993, BLOOD, V81, P2844; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAEDLER E, 1980, ANAT EMBRYOL, V158, P253, DOI 10.1007/BF00301816; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; REDDY UR, 1992, J NEUROSCI RES, V31, P670, DOI 10.1002/jnr.490310411; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SASAHARA A, 1992, DEV BRAIN RES, V68, P41, DOI 10.1016/0165-3806(92)90246-S; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; SMART I, 1978, NEOSTRIATUM; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; SONYANG Z, 1993, CELL, V72, P767; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; WOOD PM, 1984, ADV NEUROCHEM, P1; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221	62	137	144	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					553	562		10.1016/S0896-6273(00)80297-4	http://dx.doi.org/10.1016/S0896-6273(00)80297-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136765	Bronze			2022-12-24	WOS:A1997WW62600005
J	Saffell, JL; Williams, EJ; Mason, IJ; Walsh, FS; Doherty, P				Saffell, JL; Williams, EJ; Mason, IJ; Walsh, FS; Doherty, P			Expression of a dominant negative FGF receptor inhibits axonal growth and FGF receptor phosphorylation stimulated by CAMs	NEURON			English	Article							DEPENDENT NEURITE OUTGROWTH; NEURON-SPECIFIC ENOLASE; CELL-ADHESION MOLECULES; SIGNAL-TRANSDUCTION; N-CADHERIN; TYROSINE KINASES; TRANSGENIC MICE; CALCIUM INFLUX; SPINAL-CORD; L1	The cell adhesion molecules (CAMs) NCAM, N-cadherin, and L1 are homophilic binding molecules that stimulate axonal growth. We have postulated that the above CAMs can stimulate this response by activating the fibroblast growth factor receptor (FGFR) in neurons. In the present study, we demonstrate that activation of NCAM and L1 can lead to phosphorylation of the FGFR. Both this and the neurite outgrowth response stimulated by all three of the above CAMs are lost when a kinase-deleted, dominant negative form of FGFR1 is expressed in PC12 cells. In addition, we have generated transgenic mice that express the dominant negative FGFR under control of the neuron-specific enolase (NSE) promoter. We show that cerebellar neurons isolated from these mice have also lost their ability to respond to NCAM, N-cadherin, and L1. A peptide inhibitor of phospholipase C gamma (PLC gamma) that inhibits neurite outgrowth stimulated by FGF also inhibited neurite outgrowth stimulated by the CAMs. Thus, we conclude that activation of the FGFR is both necessary and sufficient to account for the ability of the above CAMs to stimulate axonal growth, and that PLC gamma is a key downstream effector of this response.	UNITED MED & DENT SCH, GUYS HOSP, DEPT DEV NEUROBIOL, LONDON SE1 9RT, ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Saffell, JL (corresponding author), UNITED MED & DENT SCH, GUYS HOSP, DEPT EXPT PATHOL, LONDON BRIDGE, LONDON SE1 9RT, ENGLAND.		Doherty, Patrick/A-8752-2008; Mason, Ivor/B-1859-2008	Mason, Ivor/0000-0001-8390-3050	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Brambilla R, 1995, MOL CELL NEUROSCI, V6, P487, DOI 10.1006/mcne.1995.0001; Brittis PA, 1996, MOL CELL NEUROSCI, V8, P120, DOI 10.1006/mcne.1996.0051; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GOWER HJ, 1988, CELL, V55, P955, DOI 10.1016/0092-8674(88)90241-3; Green PJ, 1996, BIOESSAYS, V18, P639, DOI 10.1002/bies.950180807; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P424; Hall H, 1996, CURR BIOL, V6, P580, DOI 10.1016/S0960-9822(02)00544-4; HARPER SJ, 1994, CELL ADHES COMMUN, V2, P441, DOI 10.3109/15419069409004454; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KIOUSSI C, 1994, J CELL BIOL, V125, P417, DOI 10.1083/jcb.125.2.417; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; MACARTHUR H, 1984, J VIROL, V52, P483, DOI 10.1128/JVI.52.2.483-491.1984; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; SAFFELL JL, 1994, J CELL BIOL, V125, P427, DOI 10.1083/jcb.125.2.427; SAFFELL JL, 1992, J CELL BIOL, V118, P663, DOI 10.1083/jcb.118.3.663; SAFRAN A, 1990, ONCOGENE, V5, P635; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHMECHEL DE, 1980, BRAIN RES, V190, P195, DOI 10.1016/0006-8993(80)91169-5; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; TOGARI A, 1985, J NEUROSCI, V5, P307; UENO H, 1992, J BIOL CHEM, V267, P1470; VAINIKKA S, 1994, J BIOL CHEM, V269, P18320; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WHITEHEAD MC, 1982, DEV NEUROSCI-BASEL, V5, P298, DOI 10.1159/000112689; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1994, DEVELOPMENT, V120, P1685; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P1231; WILLIAMS EJ, 1994, J CELL BIOL, V124, P1029, DOI 10.1083/jcb.124.6.1029; WILLIAMS EJ, 1995, MOL CELL NEUROSCI, V6, P69, DOI 10.1006/mcne.1995.1007; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WILLIAMS EJ, 1995, J CELL SCI, V108, P3523; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6; Wu DY, 1996, J NEUROSCI, V16, P1470	53	283	292	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					231	242		10.1016/S0896-6273(00)80264-0	http://dx.doi.org/10.1016/S0896-6273(00)80264-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052794	Bronze			2022-12-24	WOS:A1997WK82200007
J	Masai, I; Heisenberg, CP; Barth, KA; Macdonald, R; Adamek, S; Wilson, SW				Masai, I; Heisenberg, CP; Barth, KA; Macdonald, R; Adamek, S; Wilson, SW			floating head and masterblind regulate neuronal patterning in the roof of the forebrain	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC ZEBRAFISH; XENOPUS-EMBRYOS; SONIC HEDGEHOG; HOMEOBOX GENE; PROTEIN ISL-1; NEURAL FATE; PINEAL EYE; EXPRESSION; DIFFERENTIATION	The epiphysial region of the dorsal diencephalon is the first site at which neurogenesis occurs in the roof of the zebrafish forebrain. We show that the homeobox containing gene floating head (flh) is required for neurogenesis to proceed in the epiphysis. In flh(-) embryos, the first few epiphysial neurons are generated, but beyond the 18 somite stage, neuronal production ceases. In contrast, in masterblind(-) (mbl(-)) embryos, epiphysial neurons are generated throughout the dorsal forebrain. We show that mbl is required to prevent the expression of flh in dorsal forebrain cells rostral to the epiphysis. Furthermore, epiphysial neurons are not ectopically induced in mbl(-)/flh(-) embryos, demonstrating that the epiphysial phenotype of mbl(-) embryos is mediated by ectopic Flh activity. We propose a role for Flh in linking the signaling pathways that regulate regional patterning to the signaling pathways that regulate neurogenesis.	UNIV LONDON KINGS COLL,RANDALL INST,DEV BIOL RES CTR,LONDON WC2B 5RL,ENGLAND; MAX PLANCK INST ENTWICKLUNGSBIOL,TUBINGEN,GERMANY	University of London; King's College London; Max Planck Society			Masai, Ichiro/N-3085-2019; Wilson, Stephen W/B-9404-2008; Masai, Ichiro/N-1130-2014	Masai, Ichiro/0000-0002-6626-6595; Wilson, Stephen W/0000-0002-8557-5940; Masai, Ichiro/0000-0002-6626-6595; Heisenberg, Carl-Philipp/0000-0002-0912-4566	NEI NIH HHS [EY-00168] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALLENDE ML, 1994, DEV BIOL, V166, P509, DOI 10.1006/dbio.1994.1334; Appel B, 1995, DEVELOPMENT, V121, P4117; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BARTH KA, 1995, DEVELOPMENT, V121, P1755; CHALEPAKIS G, 1993, J NEUROBIOL, V24, P1367, DOI 10.1002/neu.480241009; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; DONLACH T, 1995, CELL, V83, P1067; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; FERREIRO B, 1994, DEVELOPMENT, V120, P3649; FOSTER RG, 1982, J COMP PHYSIOL, V145, P413, DOI 10.1007/BF00619346; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Halpern ME, 1995, DEVELOPMENT, V121, P4257; HEISENBERG CP, 1996, IN PRESS DEVELOPMENT; Jan Yuh Nung, 1994, Current Opinion in Neurobiology, V4, P8, DOI 10.1016/0959-4388(94)90025-6; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KNEZEVIC V, 1995, DEV BIOL, V171, P458, DOI 10.1006/dbio.1995.1296; KORF HW, 1986, VERTEBRATE ENDOCRINO, V1, P105; KORZH V, 1993, DEVELOPMENT, V118, P417; LACALLI TC, 1994, PHILOS T R SOC B, V344, P165, DOI 10.1098/rstb.1994.0059; LARISON KD, 1990, DEVELOPMENT, V109, P567; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; MOLVEN A, 1991, EMBO J, V10, P799, DOI 10.1002/j.1460-2075.1991.tb08012.x; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Placzek M, 1996, CURR BIOL, V6, P526, DOI 10.1016/S0960-9822(02)00533-X; ROBERTS A, 1978, NATURE, V273, P774, DOI 10.1038/273774a0; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; SHAH MN, 1996, CELL, V85, P331; SIMPSON P, 1995, NEURON, V15, P739, DOI 10.1016/0896-6273(95)90163-9; SKEATH JB, 1995, NATURE, V376, P427, DOI 10.1038/376427a0; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; STEIN S, 1995, MECH DEVELOP, V49, P37, DOI 10.1016/0925-4773(94)00300-C; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; TOKUMOTO M, 1995, DEV BIOL, V171, P578, DOI 10.1006/dbio.1995.1306; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VANDASSOW G, 1993, GENE DEV, V7, P355; WILSON SW, 1991, DEVELOPMENT, V112, P723; WILSON SW, 1990, DEVELOPMENT, V108, P121; WILSON SW, 1991, P NATL ACAD SCI USA, V88, P2293, DOI 10.1073/pnas.88.6.2293; XU QL, 1994, DEVELOPMENT, V120, P287	46	118	118	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					43	57		10.1016/S0896-6273(01)80045-3	http://dx.doi.org/10.1016/S0896-6273(01)80045-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010204	Bronze			2022-12-24	WOS:A1997WE71800007
J	Farinas, I; Yoshida, CK; Backus, C; Reichardt, LF				Farinas, I; Yoshida, CK; Backus, C; Reichardt, LF			Lack of neurotrophin-3 results in death of spinal sensory neurons and premature differentiation of their precursors	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; DORSAL-ROOT GANGLION; NEURAL CREST CELLS; MESSENGER-RNA; REQUIRE NEUROTROPHIN-3; TROPHIC FACTORS; TRK RECEPTORS; IN-VITRO; RAT TRKC; EXPRESSION	To understand mechanisms resulting in the absence of two-thirds of spinal sensory neurons in mice lacking NT-3, we have compared dorsal root ganglia development in normal and mutant embryos. The reduction in neurons, achieved by E13, results from several deficits: first, elevated neuronal apoptosis significantly reduces neuronal numbers; second, elevated neurogenesis between E11 and E12, without changes in rates of precursor proliferation or apoptosis, depletes the precursor pool; consequently, the reduced precursor pool prevents increases in neuronal numbers between E12 and E13, when most neurons are born in normal animals. Although deficits occur before final target innervation, we show that NT-3 is expressed at all stages in regions accessible to these neurons or their axons and is only restricted to final targets after innervation.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Farinas, I (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.		Farinas, Isabel/L-7118-2014	Farinas, Isabel/0000-0003-2903-4960	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 48200] Funding Source: Medline; NINDS NIH HHS [P01 NS016033-20, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; CHALAZONITIS A, 1994, J NEUROSCI, V14, P6571; COCHARD P, 1984, J NEUROSCI, V4, P2080; COGGESHALL RE, 1994, DEV BRAIN RES, V82, P193, DOI 10.1016/0165-3806(94)90163-5; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; EASTER SS, 1993, J NEUROSCI, V13, P285; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; Farinas I, 1996, SEMIN NEUROSCI, V8, P133, DOI 10.1006/smns.1996.0018; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; GAESE F, 1994, DEVELOPMENT, V120, P1613; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Henion PD, 1995, DEV BIOL, V172, P602, DOI 10.1006/dbio.1995.8054; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KARAVANOV A, 1995, P NATL ACAD SCI USA, V92, P11279, DOI 10.1073/pnas.92.24.11279; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KUCERA J, 1995, J COMP NEUROL, V363, P307, DOI 10.1002/cne.903630211; LAMBALLE F, 1994, J NEUROSCI, V14, P14; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Lefcort F, 1996, J NEUROSCI, V16, P3704; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MEMBERG SP, 1995, MOL CELL NEUROSCI, V6, P323, DOI 10.1006/mcne.1995.1025; Minichiello L, 1995, DEVELOPMENT, V121, P4067; MU XJ, 1993, J NEUROSCI, V13, P4029; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; Ockel M, 1996, DEVELOPMENT, V122, P301; PINCO O, 1993, J NEUROBIOL, V24, P1626, DOI 10.1002/neu.480241207; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; Scott SA, 1992, SENSORY NEURONS DIVE; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; TOJO H, 1995, BRAIN RES, V669, P163, DOI 10.1016/0006-8993(94)01219-8; Tojo H, 1996, NEUROSCIENCE, V71, P221, DOI 10.1016/0306-4522(95)00445-9; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; White FA, 1996, J NEUROSCI, V16, P4662; Wilkinson GA, 1996, J NEUROSCI, V16, P7661; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; YOSHIDA Y, 1987, BIOMED RES-TOKYO, V8, P431	54	196	197	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1065	1078		10.1016/S0896-6273(00)80240-8	http://dx.doi.org/10.1016/S0896-6273(00)80240-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982156	Green Accepted, Bronze			2022-12-24	WOS:A1996WA24800006
J	Zhang, ZW; Coggan, JS; Berg, DK				Zhang, ZW; Coggan, JS; Berg, DK			Synaptic currents generated by neuronal acetylcholine receptors sensitive to alpha-bungarotoxin	NEURON			English	Article							CILIARY GANGLION NEURONS; BLOCKS NICOTINIC TRANSMISSION; RAT HIPPOCAMPAL-NEURONS; BINDING-SITES; CHICK; NEUROTOXIN; CALCIUM; LOCALIZATION; SUBTYPES; CULTURE	Nicotinic acetylcholine receptors are widely distributed throughout the nervous system, but their functions remain largely unknown. One of the most abundant is a class of receptors that contains the alpha 7 gene product, has a high relative permeability to calcium, and binds alpha-bungarotoxin. Here, we report that receptors sensitive to alpha-bungarotoxin, though concentrated in perisynaptic clusters on neurons, can generate a large amount of the synaptic current. Residual currents through other nicotinic receptors are sufficient to elicit action potentials, but with slower rise times. This demonstrates a postsynaptic response for alpha-bungarotoxin-sensitive receptors on neurons and suggests that the functional domain of the postsynaptic membrane is broader than previously recognized.	UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego				Coggan, Jay S/0000-0002-2270-1989; Zhang, Zhong-wei/0000-0001-7165-6216	NINDS NIH HHS [R01 NS12601] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; ATKINS PW, 1986, PHYSICAL CHEM; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; CHIAPPINELLI VA, 1978, P NATL ACAD SCI USA, V75, P2999, DOI 10.1073/pnas.75.6.2999; CHIAPPINELLI VA, 1981, BRAIN RES, V211, P107, DOI 10.1016/0006-8993(81)90070-6; CHIAPPINELLI VA, 1978, NEUROCHEM RES, V3, P465, DOI 10.1007/BF00966328; CHIAPPINELLI VA, 1985, PHARMACOL THERAPEUT, V31, P1, DOI 10.1016/0163-7258(85)90035-X; CLARKE P, 1995, ADV PHARM SCI, V2; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CORRIVEAU RA, 1994, J NEUROBIOL, V25, P1579, DOI 10.1002/neu.480251210; COURAUD JY, 1980, J NEUROCHEM, V34, P1209, DOI 10.1111/j.1471-4159.1980.tb09961.x; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DRYER SE, 1985, J NEUROSCI, V5, P2654; FUJII JT, 1987, DEV BIOL, V123, P346, DOI 10.1016/0012-1606(87)90393-9; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; Horch HLW, 1995, J NEUROSCI, V15, P7778; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; JACOB MH, 1983, J NEUROSCI, V3, P260; KATO AC, 1980, DEV BIOL, V76, P222, DOI 10.1016/0012-1606(80)90374-7; LORING RH, 1987, J NEUROSCI, V7, P2153; LORING RH, 1985, NEUROSCIENCE, V14, P645, DOI 10.1016/0306-4522(85)90316-1; LORING RH, 1984, NEUROSCIENCE, V11, P989, DOI 10.1016/0306-4522(84)90209-4; MARGIOTTA JF, 1982, NATURE, V296, P152, DOI 10.1038/296152a0; MARTIN AR, 1964, J PHYSIOL-LONDON, V171, P454, DOI 10.1113/jphysiol.1964.sp007390; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; OLIVIERISANGIACOMO C, 1983, DEV BRAIN RES, V7, P61, DOI 10.1016/0165-3806(83)90081-0; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; PUGH PC, 1995, MOL PHARMACOL, V47, P717; PUGH PC, 1994, J NEUROSCI, V14, P889; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; RATHOUZ MM, 1995, J BIOL CHEM, V270, P14366, DOI 10.1074/jbc.270.24.14366; RAVDIN PM, 1981, J NEUROSCI, V1, P849; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCARSELLA G, 1978, DEV NEUROSCI-BASEL, V1, P133, DOI 10.1159/000112565; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SEGUELA P, 1993, J NEUROSCI, V13, P596; SMITH MA, 1985, J NEUROSCI, V5, P2726; ULLIAN EM, 1995, J NEUROSCI, V15, P7012; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; YAWO H, 1994, J PHYSIOL-LONDON, V477, P437, DOI 10.1113/jphysiol.1994.sp020205; ZHANG ZW, 1995, J PHYSIOL-LONDON, V487, P395, DOI 10.1113/jphysiol.1995.sp020888; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9; ZORUMSKI CF, 1992, MOL PHARMACOL, V41, P931	47	158	158	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1231	1240		10.1016/S0896-6273(00)80253-6	http://dx.doi.org/10.1016/S0896-6273(00)80253-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982169	Bronze			2022-12-24	WOS:A1996WA24800019
J	Wang, LC; Rachel, RA; Marcus, RC; Mason, CA				Wang, LC; Rachel, RA; Marcus, RC; Mason, CA			Chemosuppression of retinal axon growth by the mouse optic chiasm	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; FLOOR PLATE; SPINAL-CORD; UNCROSSED AXONS; NEURITE OUTGROWTH; COMMISSURAL AXONS; CROSSED AXONS; MOTOR AXONS; TIME-LAPSE; GUIDANCE	To determine whether diffusible guidance cues direct retinal axon growth and divergence at the optic chiasm, we cocultured mouse retinal and chiasm explants in collagen gels. The chiasm reduced retinal neurite lengths and numbers, but did not affect commissural or pontine neurite growth. This reduction in growth was equal for all retinal quadrants and occurred without reorienting the direction of neurite extension. The floor plate, another midline guidance locus, also suppressed retinal neurite outgrowth, whereas cortex or cerebellum explants did not. Growth suppression was not mediated by netrin-1, which instead enhanced retinal neurite extension. We propose that chemosuppression may be a general guidance mechanism that acts in intermediate targets to prime growth cones to perceive other, more specific cues.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT ANAT & CELL BIOL,NEW YORK,NY 10032	Columbia University	Wang, LC (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT PATHOL,722 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL EYE INSTITUTE [F32EY006510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027615] Funding Source: NIH RePORTER; NEI NIH HHS [NRSA EY06510] Funding Source: Medline; NINDS NIH HHS [P0 NS30522, NS/EY 27615] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIRD DH, 1992, J NEUROSCI, V12, P619; Baird DH, 1996, J NEUROSCI, V16, P2642; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bolz Juergen, 1994, Current Opinion in Neurobiology, V4, P545, DOI 10.1016/0959-4388(94)90055-8; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; ERZURUMLU RS, 1993, P NATL ACAD SCI USA, V90, P7235, DOI 10.1073/pnas.90.15.7235; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; Halfter W, 1996, DEV BIOL, V177, P160, DOI 10.1006/dbio.1996.0153; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HU H, 1996, NEURON, V16, P923; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KUANG RZ, 1994, DEVELOPMENT, V120, P1937; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MARCUS RC, 1995, J NEUROSCI, V15, P3716; MARCUS RC, 1995, J NEUROSCI, V15, P6389; Marcus RC, 1996, DEVELOPMENT, V122, P859; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RICE DS, 1995, J COMP NEUROL, V354, P459, DOI 10.1002/cne.903540312; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; TAMADA A, 1995, NEURON, V14, P1083, DOI 10.1016/0896-6273(95)90347-X; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Theiler K., 1972, HOUSE MOUSE; Tucker A, 1996, EUR J NEUROSCI, V8, P906, DOI 10.1111/j.1460-9568.1996.tb01577.x; VONBOXBERG Y, 1993, NEURON, V10, P345; WANG LC, 1994, J NEUROSCI, V14, P3195; Wang LC, 1995, NEURON, V15, P1349, DOI 10.1016/0896-6273(95)90013-6; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; YAMAGATA M, 1995, DEVELOPMENT, V121, P189	54	61	61	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					849	862		10.1016/S0896-6273(00)80217-2	http://dx.doi.org/10.1016/S0896-6273(00)80217-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938118	Bronze			2022-12-24	WOS:A1996VV15100008
J	Jacquin, TD; Borday, V; SchneiderMaunoury, S; Topilko, P; Ghilini, G; Kato, F; Charnay, P; Champagnat, J				Jacquin, TD; Borday, V; SchneiderMaunoury, S; Topilko, P; Ghilini, G; Kato, F; Charnay, P; Champagnat, J			Reorganization of pontine rhythmogenic neuronal networks in Krox-20 knockout mice	NEURON			English	Article							CHICK-EMBRYO HINDBRAIN; ZINC-FINGER GENE; INFANT-DEATH-SYNDROME; NEURAL CREST CELLS; BRAIN-STEM; RESPIRATORY RHYTHM; TRANSCRIPTION FACTOR; RETICULAR-FORMATION; 2 RHOMBOMERES; GUINEA-PIG	We have shown previously that the inactivation of the zinc finger gene Krox-20 affects hindbrain segmentation, resulting in the elimination of rhombomeres 3 and 5. We demonstrate here that Krox-20 homozygous mutant mice exhibit abnormally slow respiratory and jaw opening rhythms, indicating that a modification of hindbrain segmentation influences the function of neuronal networks after birth. Central neuronal networks that control respiratory frequency are made predominantly depressant by the elimination of a previously undescribed rhythm-promoting system. Recordings of rhythmic activity from the isolated hindbrain following progressive tissue transections indicate that the reorganization takes place in the caudal pontine reticular formation. The newborn (P0) Krox-20(-/-) mice, in which apneas are ten times longer than in wild-type animals, may be a valuable model for the study of life-threatening apneas during early infancy.	ECOLE NORMALE SUPER, INSERM, U368, F-75230 PARIS 05, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Jacquin, TD (corresponding author), CNRS, INST ALFRED FESSARD, F-91198 GIF SUR YVETTE, FRANCE.		Schneider-Maunoury, Sylvie/K-6795-2017	Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Charnay, Patrick/0000-0002-3847-6042				ANCH A M, 1981, Electromyography and Clinical Neurophysiology, V21, P317; ARVIDSSON U, 1995, J NEUROSCI, V15, P1215; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; BIRGBAUER E, 1995, DEVELOPMENT, V121, P935; BIRGBAUER E, 1994, DEVELOPMENT, V120, P1347; BRANCHEREAU P, 1992, J PHARMACOL EXP THER, V260, P1433; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; CHAMPAGNAT J, 1994, J PHYSIOL-LONDON, V479, P127, DOI 10.1113/jphysiol.1994.sp020282; CHAMPAGNAT J, 1993, NEUROREPORT, V4, P861, DOI 10.1097/00001756-199307000-00005; CHAMPAGNAT J, 1994, NUCLEUS SOLITARY TRA, P215; CHANDLER SH, 1986, J NEUROSCI, V6, P1831; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Cortez SC, 1996, J NEUROPATH EXP NEUR, V55, P841, DOI 10.1097/00005072-199607000-00009; DAWES GS, 1983, J PHYSIOL-LONDON, V335, P535, DOI 10.1113/jphysiol.1983.sp014549; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; DOLLE P, 1993, P NATL ACAD SCI USA, V90, P7666, DOI 10.1073/pnas.90.16.7666; DONGA R, 1991, J NEUROPHYSIOL, V66, P1564, DOI 10.1152/jn.1991.66.5.1564; ERRCHIDI S, 1991, J PHYSIOL-LONDON, V443, P477, DOI 10.1113/jphysiol.1991.sp018846; FORTIN G, 1995, J PHYSIOL-LONDON, V486, P735, DOI 10.1113/jphysiol.1995.sp020849; FORTIN G, 1994, NEUROREPORT, V5, P1149, DOI 10.1097/00001756-199405000-00032; FORTIN G, 1994, NEUROREPORT, V5, P1137, DOI 10.1097/00001756-199405000-00029; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; HANSON MA, 1988, J PHYSIOL-LONDON, V400, P415, DOI 10.1113/jphysiol.1988.sp017129; HAXHIU MA, 1993, BRAIN RES, V618, P115, DOI 10.1016/0006-8993(93)90435-P; JACQUIN T, 1988, P NATL ACAD SCI USA, V85, P948, DOI 10.1073/pnas.85.3.948; JACQUIN T, 1989, BRAIN RES, V502, P214, DOI 10.1016/0006-8993(89)90616-1; JAEGER CB, 1986, NEUROSCIENCE, V18, P121, DOI 10.1016/0306-4522(86)90183-1; JANSEN AH, 1983, PHYSIOL REV, V63, P437, DOI 10.1152/physrev.1983.63.2.437; JODKOWSKI JS, 1994, NEUROSCI LETT, V172, P67, DOI 10.1016/0304-3940(94)90664-5; KINNEY HC, 1995, SCIENCE, V269, P1446, DOI 10.1126/science.7660131; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LIJOWSKA A, 1995, RESP CRIT CARE MED, V151, pA151; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1994, DEVELOPMENT, V120, P1581; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; LUTKIN T, 1991, CELL, V66, P1105; MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x; MARK M, 1993, DEVELOPMENT, V119, P319; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; MORTOLA JP, 1987, PHYSIOL REV, V67, P187, DOI 10.1152/physrev.1987.67.1.187; Nonchev S, 1996, DEVELOPMENT, V122, P543; NOZAKI S, 1993, J NEUROPHYSIOL, V69, P595, DOI 10.1152/jn.1993.69.2.595; NUNEZABADES PA, 1993, J AUTONOM NERV SYST, V42, P99, DOI 10.1016/0165-1838(93)90042-S; ONIMARU H, 1995, NEUROSCI RES, V21, P183, DOI 10.1016/0168-0102(94)00863-B; PIERREFICHE O, 1995, NEUROSCI LETT, V184, P101, DOI 10.1016/0304-3940(94)11179-M; PINE DS, 1994, AM J PSYCHIAT, V151, P864; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Rekling JC, 1996, J NEUROPHYSIOL, V75, P795, DOI 10.1152/jn.1996.75.2.795; RICHTER DW, 1993, J PHYSIOL-LONDON, V470, P23, DOI 10.1113/jphysiol.1993.sp019844; ROMAGNANO MA, 1991, J NEUROSCI, V11, P3539; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH JC, 1990, J NEUROPHYSIOL, V64, P1149, DOI 10.1152/jn.1990.64.4.1149; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; VERT P, 1994, BIOL NEONATE, V65, P133; Wilkinson D G, 1993, Perspect Dev Neurobiol, V1, P117; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0	67	164	168	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					747	758		10.1016/S0896-6273(00)80206-8	http://dx.doi.org/10.1016/S0896-6273(00)80206-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893031	Bronze			2022-12-24	WOS:A1996VP74300019
J	Linden, DJ				Linden, DJ			A protein synthesis-dependent late phase of cerebellar long-term depression	NEURON			English	Article							APLYSIA SENSORY NEURONS; CAMP-RESPONSIVE ELEMENT; PURKINJE-CELLS; CRITICAL PERIOD; DENTATE GYRUS; NITRIC-OXIDE; HETEROSYNAPTIC INHIBITION; MACROMOLECULAR-SYNTHESIS; SYNAPTIC DEPRESSION; DENDRITIC SPINES	Synthesis of new protein has been shown to be required for establishment of a late phase in hippocampal long-term potentiation. Whether a similar requirement is needed to produce the late phase of long-term depression (LTD) remains to be determined. Application of transcription inhibitors or of the translation inhibitor anisomycin, immediately, but not 30 min after glutamate/depolarization conjunction, attenuated a late phase of cerebellar LTD in culture. LTD, produced in a perforated outside-out amcropatch of Purkinje neuron dendrite, which lacks nuclear material, returned to baseline values with a time course paralleling that observed with protein synthesis inhibitors in intact cultured Purkinje neurons. These findings suggest that there is a distinct late phase of cerebellar LTD that is dependent upon postsynaptic protein synthesis.			Linden, DJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R37MH051106, R29MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham W.C., 1991, KINDLING SYNAPTIC PL, P92; ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1994, MOL CELL MECH NEUROT, P529; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1987, PSYCHOL BULL, V3, P518; DEADWYLER SA, 1987, SYNAPSE, V1, P90, DOI 10.1002/syn.890010112; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DESCHUTTER E, 1995, TRENDS NEUROSCI, V18, P291, DOI 10.1016/0166-2236(95)93916-L; DRAGUNOW M, 1989, NEUROSCI LETT, V101, P274, DOI 10.1016/0304-3940(89)90545-4; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1995, NEUROSCIENCE, V67, P799, DOI 10.1016/0306-4522(95)00117-2; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEBB DO, 1949, ORG BEHAVIOR; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; LAUB O, 1980, P NATL ACAD SCI-BIOL, V77, P3297, DOI 10.1073/pnas.77.6.3297; LEVITAN ES, 1990, NATURE, V348, P545, DOI 10.1038/348545a0; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; Linden DJ, 1995, NEURON, V15, P1393, DOI 10.1016/0896-6273(95)90017-9; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6; MATTHIES H, 1989, ANNU REV PSYCHOL, V40, P381, DOI 10.1146/annurev.ps.40.020189.002121; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTAROLO PG, 1988, NATURE, V333, P171, DOI 10.1038/333171a0; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NGUYEN PV, 1990, J NEUROSCI, V10, P1099; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Osten P, 1996, J NEUROSCI, V16, P2444; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHACHER S, 1993, NEURON, V10, P1079, DOI 10.1016/0896-6273(93)90056-W; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Slack JR, 1995, NEUROSCI LETT, V201, P25, DOI 10.1016/0304-3940(94)12121-6; Sossin WS, 1996, TRENDS NEUROSCI, V19, P215; Squire L.R, 1987, MEMORY BRAIN, P134; STANTON PK, 1984, J NEUROSCI, V4, P3080; STEWARD O, 1988, J NEUROSCI, V8, P176; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; STEWARD O, 1982, J NEUROSCI, V2, P284; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WORLEY PF, 1993, J NEUROSCI, V13, P4776; WU F, 1994, NEURON, V12, P407, DOI 10.1016/0896-6273(94)90281-X; Yamagata K, 1994, Learn Mem, V1, P140; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	75	130	130	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					483	490		10.1016/S0896-6273(00)80180-4	http://dx.doi.org/10.1016/S0896-6273(00)80180-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816711	Bronze			2022-12-24	WOS:A1996VJ44000014
J	Araki, T; Milbrandt, J				Araki, T; Milbrandt, J			Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth	NEURON			English	Article							NEURONAL PROCESS OUTGROWTH; CELL-SURFACE PROTEINS; SCHWANN-CELLS; PERIPHERAL-NERVES; MESSENGER-RNA; N-CAM; SYSTEM; EXPRESSION; REGENERATION; RECEPTORS	Peripheral nerve injury results in axonal degeneration and in phenotypic changes of the surrounding Schwann cells, whose presence is critical for nerve regeneration. Using differential screening strategies, we identified a novel protein, termed ninjurin (for nerve injury-induced protein), that is up-regulated after axotomy in neurons and in Schwann cells surrounding the distal nerve segment. Ninjurin is located on the cell surface, is capable of mediating homophilic adhesion, and promotes neurite extension of dorsal root ganglion neurons in vitro. Ninjurin is also expressed in a number of other tissues, predominantly in epithelial cells. These results suggest that ninjurin plays a role in nerve regeneration and in the formation and function of other tissues.	UNIV WASHINGTON, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	Araki, T (corresponding author), UNIV WASHINGTON, SCH MED, DEPT PATHOL, DIV LAB MED, ST LOUIS, MO 63110 USA.		Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689				Aguayo A.J., 1985, SYNAPTIC PLASTICITY, P457; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BRODKEY JA, 1993, EXP NEUROL, V123, P251, DOI 10.1006/exnr.1993.1158; BUNGE RP, 1992, DIS NERV SYST, P87; CHONCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156; DANILOFF JK, 1986, J CELL BIOL, V103, P929, DOI 10.1083/jcb.103.3.929; DOHERTY P, 1989, J CELL BIOL, V109, P789, DOI 10.1083/jcb.109.2.789; EICHLER ME, 1989, BRAIN RES, V482, P340, DOI 10.1016/0006-8993(89)91197-9; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; FALLON JR, 1985, J NEUROSCI, V5, P3169; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P401, DOI 10.1111/j.1365-2990.1986.tb00151.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MANIATIS T, 1982, MOL CLONING LABORATO, P280; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MARTINI R, 1988, J CELL BIOL, V106, P1746; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; RIEGER F, 1988, J CELL BIOL, V107, P707, DOI 10.1083/jcb.107.2.707; ROST B, 1995, PROTEIN SCI, V4, P521; RUBENSTEIN JLR, 1990, NUCLEIC ACIDS RES, V18, P4833, DOI 10.1093/nar/18.16.4833; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TANIUCHI M, 1988, J NEUROSCI, V8, P664; THOMPSON JA, 1987, BIOCHEMISTRY-US, V26, P743, DOI 10.1021/bi00377a014; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TRAPP BD, 1988, J NEUROSCI, V8, P3515; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WHITE FV, 1989, J NEUROCHEM, V52, P1085, DOI 10.1111/j.1471-4159.1989.tb01851.x	41	158	172	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					353	361		10.1016/S0896-6273(00)80166-X	http://dx.doi.org/10.1016/S0896-6273(00)80166-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780658	Bronze			2022-12-24	WOS:A1996VE84000017
J	Zhang, L; Marcu, MG; NauStaudt, K; Trifaro, JM				Zhang, L; Marcu, MG; NauStaudt, K; Trifaro, JM			Recombinant scinderin enhances exocytosis, an effect blocked by two scinderin-derived actin-binding peptides and PIP2	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; FILAMENT-SEVERING PROTEIN; CATECHOLAMINE SECRETION; KINASE-C; CALCIUM; REORGANIZATION; STIMULATION; GELSOLIN; RELEASE; EXPRESSION	The cortical F-actin cytoskeleton represents a negative control for secretion, and it must be locally disassembled to allow chromaffin vesicle exocytosis. Recombinant scinderin (a Ca2+-dependent F-actin-severing protein) potentiated Ca2+-evoked F-actin disassembly and exocytosis in permeabilized chromaffin cells, an effect blocked by peptides Sc-ABP(1) and Sc-ABP(2) (with sequences corresponding to two actin-binding sites of scinderin), exogenous gamma-actin, or phosphatidylinositol 4,5-bisphosphate (PIP2) PIP2 effect was blocked by peptide Sc-PIP2BP (with sequence corresponding to a PIP2-binding site of scinderin). Truncated scinderin(254-715) (lacking actin-severing domains) did not potentiate exocytosis. Sc-ABP(1), Sc-ABP(2), and gamma-actin also inhibited exocytosis in the absence of recombinant scinderin, suggesting an inhibition of endogenous scinderin. Results suggest that scinderin-evoked cortical F-actin disassembly is required for secretion and that scinderin is an important component of the exocytotic machinery.			Zhang, L (corresponding author), UNIV OTTAWA, FAC MED, DEPT PHARMACOL, SECRETORY PROC RES PROGRAM, OTTAWA, ON K1H 8M5, CANADA.							BADER MF, 1986, J CELL BIOL, V102, P636, DOI 10.1083/jcb.102.2.636; BERNSTEIN BW, 1985, J NEUROSCI, V5, P2565; BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449; BURGOYNE RD, 1989, CELL SIGNAL, V1, P323, DOI 10.1016/0898-6568(89)90051-X; CALDWELL P C, 1970, P10; CHEEK TR, 1987, J BIOL CHEM, V262, P11663; CHEEK TR, 1986, FEBS LETT, V207, P110, DOI 10.1016/0014-5793(86)80022-9; DELCASTILLO AR, 1992, J CELL BIOL, V119, P797, DOI 10.1083/jcb.119.4.797; DELCASTILLO AR, 1990, EMBO J, V9, P43, DOI 10.1002/j.1460-2075.1990.tb08078.x; DOUCET JP, 1988, ANAL BIOCHEM, V168, P265, DOI 10.1016/0003-2697(88)90317-X; DUNN LA, 1983, J BIOL CHEM, V258, P4989; EDMONDS CG, 1990, METHOD ENZYMOL, V193, P412, DOI 10.1016/0076-6879(90)93430-S; HENVICK RM, 1981, J BIOL CHEM, V256, P7990; KENIGSBERG RL, 1980, NEUROSCIENCE, V5, P1547, DOI 10.1016/0306-4522(80)90019-6; LEE RWH, 1981, NEUROSCIENCE, V6, P2087, DOI 10.1016/0306-4522(81)90048-8; MAEKAWA S, 1990, J BIOL CHEM, V265, P10940; MARCU MG, 1994, MOL CELL BIOCHEM, V141, P153, DOI 10.1007/BF00926179; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PERRIN D, 1985, NATURE, V315, P589, DOI 10.1038/315589a0; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; TCHAKAROV L, 1990, FEBS LETT, V268, P209, DOI 10.1016/0014-5793(90)81010-L; TRIFARO JM, 1989, INT CONGR SER, V839, P15; TRIFARO JM, 1985, CAN J BIOCHEM CELL B, V63, P661, DOI 10.1139/o85-084; TRIFARO JM, 1984, CAN J PHYSIOL PHARM, V62, P493, DOI 10.1139/y84-079; TRIFARO JM, 1980, NEUROSCIENCE, V5, P1533, DOI 10.1016/0306-4522(80)90018-4; TRIFARO JM, 1982, ADV BIOSCI, V5, P151; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; VITALE ML, 1992, J NEUROCHEM, V59, P1717, DOI 10.1111/j.1471-4159.1992.tb11003.x; WILSON SP, 1983, J BIOL CHEM, V258, P4994; YIN H, 1981, J CELL BIOL, V19, P901; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0	34	65	68	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG	1996	17	2					287	296		10.1016/S0896-6273(00)80160-9	http://dx.doi.org/10.1016/S0896-6273(00)80160-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780652	Bronze			2022-12-24	WOS:A1996VE84000011
J	Hartell, NA				Hartell, NA			Strong activation of parallel fibers produces localized calcium transients and a form of LTD that spreads to distant synapses	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; NITRIC-OXIDE; SYNAPTIC DEPRESSION; CLIMBING FIBER; PROTEIN-KINASE; CURRENTS; INVITRO; SENSITIVITY	The temporal and spatial changes in intracellular calcium levels during separate activation of parallel fiber (PF) and climbing fiber (CF) inputs to cerebellar Purkinje cells were studied. PF stimulation (1 Hz), at relatively high stimulus strengths, led to accumulations of calcium that were similar in peak levels to those following CF stimulation but that remained spatially localized. Such stimuli consistently induced a durable depression of PF synaptic transmission that partially occluded further depression by conventional conjunctive stimuli and that was independent of nitric oxide. This depression was accompanied by a reduction of synaptic efficacy in spatially isolated PF inputs to the same cell that was independent of postsynaptic calcium but that was mediated by nitric oxide. These data indicate that LTD comprises at least two separate processes and that parameters of PF stimulation that are capable of raising calcium levels in Purkinje cell dendrites are also able to induce long-term changes in synaptic efficacy.	RIKEN, FRONTIER RES PROGRAM, LAB SYNAPT FUNCT, WAKO, SAITAMA 35101, JAPAN	RIKEN								AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; AJIMA A, 1991, NEUROSCI RES, V12, P281, DOI 10.1016/0168-0102(91)90117-H; Albus JS, 1971, MATH BIOSCI, V28, P167; BATCHELOR AM, 1993, NEUROPHARMACOLOGY, V32, P11, DOI 10.1016/0028-3908(93)90124-L; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; DANIEL H, 1992, EXP BRAIN RES, V90, P327; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; DESCHUTTER E, 1995, TRENDS NEUROSCI, V18, P291, DOI 10.1016/0166-2236(95)93916-L; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HIRANO T, 1990, NEUROSCI LETT, V119, P145, DOI 10.1016/0304-3940(90)90819-U; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; ITO M, 1992, NEUROSCI RES, V14, P27, DOI 10.1016/S0168-0102(05)80004-5; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KASONO K, 1994, NEUROREPORT, V6, P17, DOI 10.1097/00001756-199412300-00006; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LOHMANN SM, 1981, P NATL ACAD SCI-BIOL, V78, P653, DOI 10.1073/pnas.78.1.653; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MONTGOMERY JC, 1994, NEUROSCI LETT, V174, P145, DOI 10.1016/0304-3940(94)90007-8; OJAKANGAS CL, 1994, J NEUROPHYSIOL, V72, P2617, DOI 10.1152/jn.1994.72.6.2617; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHREURS BG, 1993, BRAIN RES, V631, P223; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SUGIMORI M, 1990, P NATL ACAD SCI USA, V87, P5084, DOI 10.1073/pnas.87.13.5084	48	131	132	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR	1996	16	3					601	610		10.1016/S0896-6273(00)80079-3	http://dx.doi.org/10.1016/S0896-6273(00)80079-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785057	Bronze			2022-12-24	WOS:A1996UC16800016
J	Sewing, S; Roeper, J; Pongs, O				Sewing, S; Roeper, J; Pongs, O			Kv beta 1 subunit binding specific for Shaker-related potassium channel alpha subunits	NEURON			English	Article							CALCIUM-CHANNEL; FUNCTIONAL EXPRESSION; K+-CHANNEL; RAT-BRAIN; XENOPUS-OOCYTES; BETA-SUBUNIT; INACTIVATION; PURIFICATION; FAMILY; CDNA	Voltage-activated potassium (Kv) channels from mammalian brain are hetero-oligomers containing alpha and beta subunits. Coexpression of Kv1 alpha and Kv beta 1 subunits confers rapid A-type inactivation on noninactivating potassium channels (delayed rectifiers) in expression systems in vitro. We have delineated a Kv1.5 amino-terminal region of up to 90 amino acids (residues 112-201) that is sufficient for interactions of Kv1.5 alpha and Kv beta 1 subunits. Within this region of the Kv1.5 amino terminus (residues 193-201), a Kv beta 1 interaction site necessary for Kv beta 1-mediated rapid inactivation of Kv1.5 currents was detected. This interaction site motif (FYE/QLGE/DEAM/L) is found exclusively in the Shaker-related subfamily (Kv1). The results show that hetero-oligomerization between alpha and Kv beta 1 subunits is restricted to Shaker-related potassium channel alpha subunits.			Sewing, S (corresponding author), INST NEURALE SIGNALVERARBEITUNG,ZENTRUM MOL NEUROBIOL,MARTINISTR 52,D-20246 HAMBURG,GERMANY.			Roeper, Jochen/0000-0003-2145-8742				BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHANDY G, 1994, HDB RECEPTORS CHANNE, P1; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN S, 1994, J PHYSIOL-PARIS, V88, P173, DOI 10.1016/0928-4257(94)90003-5; Hille B., 1992, IONIC CHANNELS EXCIT; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; IKEDA SR, 1992, PFLUG ARCH EUR J PHY, V422, P201, DOI 10.1007/BF00370422; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MCCORMACK T, 1994, CELL, V79, P1133, DOI 10.1016/0092-8674(94)90004-3; MORALES MJ, 1995, J BIOL CHEM, V270, P6270; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; PARCEJ DN, 1989, BIOCHEM J, V257, P899, DOI 10.1042/bj2570899; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; PONGS O, 1995, SEMIN NEUROSCI, V7, P137, DOI 10.1006/smns.1995.0015; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHEN NV, 1993, NEURON, V11, P67; SHEN V, 1995, NEURON, V14, P625; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	47	165	167	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					455	463		10.1016/S0896-6273(00)80063-X	http://dx.doi.org/10.1016/S0896-6273(00)80063-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789960	Bronze			2022-12-24	WOS:A1996TW95700025
J	Brustle, O; Maskos, U; McKay, RDG				Brustle, O; Maskos, U; McKay, RDG			Host-guided migration allows targeted introduction of neurons into the embryonic brain	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CORTICAL-NEURONS; INFERIOR COLLICULUS; ASTROCYTE MIGRATION; CORPUS-CALLOSUM; VISUAL-CORTEX; RAT; INDUCTION; ORIGIN; TIME	The stereotyped positions occupied by individual classes of neurons are a fundamental characteristic of CNS cytoarchitecture. To study the regulation of neuronal positioning, we injected genetically labeled neural precursors derived from dorsal and ventral mouse forebrain into the telencephalic vesicles of embryonic rats. Cells from both areas were found to participate in the generation of telencephalic, diencephalic, and mesencephalic brain regions. Donor-derived neurons populated the host brain in distinct patterns and acquired phenotypic features appropriate for their final location. These observations indicate that neuronal migration and differentiation are predominantly regulated by non-cell-autonomous signals. Exploiting this phenomenon, intrauterine transplantation allows generation of controlled chimerism in the mammalian brain.			Brustle, O (corresponding author), NINCDS,MOLEC BIOL LAB,BETHESDA,MD 20892, USA.							ALTABA AR, 1993, J NEUROBIOL, V24, P1276, DOI 10.1002/neu.480241004; ALTMAN J, 1981, EXP BRAIN RES, V42, P411; ALTMAN J, 1981, EXP BRAIN RES, V42, P424; ALTMAN J, 1979, J COMP NEUROL, V188, P455, DOI 10.1002/cne.901880308; ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; Altman J, 1986, DEV RAT HYPOTHALAMUS; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; ALVARADOMALLART RM, 1990, DEV BIOL, V139, P75, DOI 10.1016/0012-1606(90)90280-V; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BARBE MF, 1991, J NEUROSCI, V11, P519; Bayer S.A., 1991, NEOCORTICAL DEV; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; FISHELL G, 1995, DEVELOPMENT, V121, P803; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; HYNES RO, 1994, CURR OPIN GENET DEV, V4, P569, DOI 10.1016/0959-437X(94)90074-D; LAGENAUR C, 1981, J SUPRAMOL STR CELL, V15, P335, DOI 10.1002/jsscb.1981.380150404; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LUND RD, 1993, INT J DEV NEUROSCI, V11, P595, DOI 10.1016/0736-5748(93)90048-I; LUND RD, 1985, NEUROSCI LETT, V61, P221, DOI 10.1016/0304-3940(85)90428-8; MALENKA RC, 1994, NATURE, V372, P218, DOI 10.1038/372218a0; MALMIERCA MS, 1993, J COMP NEUROL, V333, P1, DOI 10.1002/cne.903330102; MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; ROUTTENBERG A, 1995, NATURE, V374, P314, DOI 10.1038/374314b0; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SORIANO P, 1995, ANNU REV NEUROSCI, V18, P1; STANFIELD BB, 1985, NATURE, V313, P135, DOI 10.1038/313135a0; VICARIOABEJON C, 1995, J NEUROSCI, V15, P6351; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; ZHOU HF, 1990, J COMP NEUROL, V292, P320, DOI 10.1002/cne.902920213; ZHOU HF, 1992, J COMP NEUROL, V317, P145, DOI 10.1002/cne.903170204; ZHOU HF, 1993, EXP NEUROL, V122, P155, DOI 10.1006/exnr.1993.1116; ZIMMER A, 1992, ANNU REV NEUROSCI, V15, P115, DOI 10.1146/annurev.neuro.15.1.115	48	177	181	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1275	1285		10.1016/0896-6273(95)90007-1	http://dx.doi.org/10.1016/0896-6273(95)90007-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845152	Bronze			2022-12-24	WOS:A1995TL67800007
J	Wang, SL; Sdrulla, AD; diSibio, G; Bush, G; Nofziger, D; Hicks, C; Weinmaster, G; Barres, BA				Wang, SL; Sdrulla, AD; diSibio, G; Bush, G; Nofziger, D; Hicks, C; Weinmaster, G; Barres, BA			Notch receptor activation inhibits oligodendrocyte differentiation	NEURON			English	Article							RAT OPTIC-NERVE; GLIAL PROGENITOR-CELL; RETINAL GANGLION-CELLS; DROSOPHILA-MELANOGASTER; MONOCLONAL-ANTIBODY; NEUROGENESIS; PROTEIN; ASTROCYTE; GENE; EXPRESSION	In this study, we show that oligodendrocyte differentiation is powerfully inhibited by activation of the Notch pathway. Oligodendrocytes and their precursors in the developing rat optic nerve express Notch1 receptors and, at the same time, retinal ganglion cells express Jagged1, a ligand of the Notch1 receptor, along their axons. Jagged1 expression is developmentally regulated, decreasing with a time course that parallels myelination in the optic nerve. These results suggest that the timing of oligodendrocyte differentiation and myelination is controlled by the Notch pathway and raise the; question of whether localization of myelination is controlled by this pathway.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.				NEI NIH HHS [R29 EY10257] Funding Source: Medline; NINDS NIH HHS [NS31885] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY010257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031885, R01NS031885] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahlgren SC, 1997, MOL CELL NEUROSCI, V9, P420, DOI 10.1006/mcne.1997.0631; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Bao ZZ, 1997, J NEUROSCI, V17, P1425; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BARTLETT PF, 1981, BRAIN RES, V204, P339, DOI 10.1016/0006-8993(81)90593-X; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; Fitzgerald K, 1995, DEVELOPMENT, V121, P4275; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; FORTINI ME, 1993, CELL, V75, P1245, DOI 10.1016/0092-8674(93)90611-S; FRIEDE RL, 1973, ACTA NEUROPATHOL, V23, P48, DOI 10.1007/BF00689004; FULTON BP, 1991, ANN NY ACAD SCI, V633, P27; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; KONIETZKO U, 1994, HIPPOCAMPUS, V4, P297, DOI 10.1002/hipo.450040313; KOPAN R, 1994, DEVELOPMENT, V120, P2385; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; MATHESON D F, 1970, Brain Research, V24, P257, DOI 10.1016/0006-8993(70)90105-8; MATHESON D F, 1970, Brain Research, V24, P271, DOI 10.1016/0006-8993(70)90106-X; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; Millot C., 1984, GEO-MARINE LETT, V4, P13, DOI DOI 10.1007/BF02237968; Muskavitch M.A.T., 1990, Current Topics in Developmental Biology, V24, P289, DOI 10.1016/S0070-2153(08)60091-5; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; NYE JS, 1994, DEVELOPMENT, V120, P2421; Ono K, 1997, NEURON, V19, P283, DOI 10.1016/S0896-6273(00)80939-3; Peters A., 1991, FINE STRUCTURE NERVO; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAFF MC, 1983, COLD SPRING HARB SYM, V48, P569, DOI 10.1101/SQB.1983.048.01.061; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; Richardson WD, 1990, SEMIN NEUROSCI, V2, P445; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Sanchez I, 1996, J NEUROSCI, V16, P5095; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shi JY, 1998, J NEUROSCI, V18, P4627; SKOFF RP, 1980, J COMP NEUROL, V191, P237, DOI 10.1002/cne.901910207; SKOFF RP, 1990, ANN NY ACAD SCI, V605, P122; SKOFF RP, 1978, NEUROSCI LETT, V7, P191, DOI 10.1016/0304-3940(78)90166-0; SKOFF RP, 1976, J COMP NEUROL, V169, P313, DOI 10.1002/cne.901690304; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387	68	540	560	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					63	75		10.1016/S0896-6273(00)80515-2	http://dx.doi.org/10.1016/S0896-6273(00)80515-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697852	Bronze			2022-12-24	WOS:000075061900007
J	Hsu, SC; Hazuka, CD; Roth, R; Foletti, DL; Heuser, J; Scheller, RH				Hsu, SC; Hazuka, CD; Roth, R; Foletti, DL; Heuser, J; Scheller, RH			Subunit composition, protein interactions, and structures of the mammalian brain sec6/8 complex and septin filaments	NEURON			English	Article							CEREVISIAE CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; MEMBRANE TRAFFICKING; HIPPOCAMPAL-NEURONS; VESICLE DOCKING; GENE-PRODUCT; BUDDING SITE; MOUSE-BRAIN; YEAST; EXPRESSION	Both the sec6/8 complex and septin filaments have been implicated in directing vesicles and proteins to sites of active membrane addition in yeast. The rat brain sec6/8 complex coimmunoprecipitates with a filament composed of four mammalian septins, suggesting an interaction between these complexes. One of the septins, CDC10, displays broad subcellular and tissue distributions and is found in postmitotic neurons as well as dividing cells. Electron microscopic studies showed that the purified rat brain septins form filaments of 8.25 nm in diameter; the lengths of the filaments are multiples of 25 nm. Glutaraldehyde-fixed rat brain sec6/8 complex adopts a conformation resembling the letter "T" or "Y". The sec6/8 and septin complexes likely play an important role in trafficking vesicles and organizing proteins at the plasma membrane of neurons.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Stanford University; Washington University (WUSTL)	Scheller, RH (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.							AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; CATSICAS S, 1992, J NEUROSCI RES, V33, P1, DOI 10.1002/jnr.490330102; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Fares H, 1996, J CELL BIOL, V132, P399, DOI 10.1083/jcb.132.3.399; FARES H, 1995, MOL BIOL CELL, V6, P1843, DOI 10.1091/mbc.6.12.1843; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Finger FP, 1997, MOL BIOL CELL, V8, P647, DOI 10.1091/mbc.8.4.647; FLESCHER EG, 1993, J CELL BIOL, V122, P373, DOI 10.1083/jcb.122.2.373; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Guo W, 1997, FEBS LETT, V404, P135, DOI 10.1016/S0014-5793(97)00109-9; HAARER BK, 1987, MOL CELL BIOL, V7, P378; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hazuka CD, 1997, GENE, V187, P67, DOI 10.1016/S0378-1119(96)00720-2; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; HEUSER JE, 1983, J MOL BIOL, V169, P155, DOI 10.1016/S0022-2836(83)80179-X; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; KATO K, 1990, EUR J NEUROSCI, V2, P704, DOI 10.1111/j.1460-9568.1990.tb00460.x; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; KOH S, 1993, J NEUROCYTOL, V22, P995, DOI 10.1007/BF01218356; KONOPKA JB, 1995, MOL CELL BIOL, V15, P723; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; LANE RD, 1986, METHOD ENZYMOL, V121, P183; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Mondesert G, 1997, GENETICS, V147, P421; Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167; NAKATSURU S, 1994, BIOCHEM BIOPH RES CO, V202, P82, DOI 10.1006/bbrc.1994.1896; NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X; NOTTENBURG C, 1990, GENE, V95, P279, DOI 10.1016/0378-1119(90)90372-X; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OYLER GA, 1992, DEV BRAIN RES, V65, P133, DOI 10.1016/0165-3806(92)90172-S; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SANDERS SL, 1994, CURR BIOL, V4, P907, DOI 10.1016/S0960-9822(00)00201-3; SCHELLER RH, 1995, NEURON, V14, P893; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; TING AE, 1995, P NATL ACAD SCI USA, V92, P9613, DOI 10.1073/pnas.92.21.9613; Zieger B, 1997, J CLIN INVEST, V99, P520, DOI 10.1172/JCI119188	56	285	292	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1111	1122		10.1016/S0896-6273(00)80493-6	http://dx.doi.org/10.1016/S0896-6273(00)80493-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655500	Bronze			2022-12-24	WOS:000074627300008
J	Gray, PC; Johnson, BD; Westenbroek, RE; Hays, LG; Yates, JR; Scheuer, T; Catterall, WA; Murphy, BJ				Gray, PC; Johnson, BD; Westenbroek, RE; Hays, LG; Yates, JR; Scheuer, T; Catterall, WA; Murphy, BJ			Primary structure and function of an A kinase anchoring protein associated with calcium channels	NEURON			English	Article							VOLTAGE-DEPENDENT POTENTIATION; SKELETAL-MUSCLE; TRANSVERSE TUBULES; VERTEBRATE CELLS; CA2+ CHANNELS; CONTRACTION; PHOSPHORYLATION; NITRENDIPINE; RECEPTORS; LOCALIZATION	Rapid, voltage-dependent potentiation of skeletal muscle L-type calcium channels requires phosphorylation by cAMP-dependent protein kinase (PKA) anchored via an A kinase anchoring protein (AKAP). Here we report the isolation, primary sequence determination, and functional characterization of AKAP15 a lipid-anchored protein of 81 amino acid residues with a single amphipathic helix that binds PKA, AKAP15 co-localizes with L-type calcium channels in transverse tubules and is associated with L-type calcium channels in transfected cells. A peptide fragment of AKAP15 encompassing the RII-binding domain blocks voltage-dependent potentiation. These results indicate that AKAP15 targets PKA to the calcium channel and plays a critical role in voltage-dependent potentiation and regulation of skeletal muscle contraction. The expression of AKAP15 in the brain and heart suggests that it may mediate rapid PKA regulation of L-type calcium channels in neurons and cardiac myocytes.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.				NHLBI NIH HHS [P01 HL44948] Funding Source: Medline; NIGMS NIH HHS [T32 GM07750] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARREOLA J, 1987, J PHYSIOL-LONDON, V393, P307, DOI 10.1113/jphysiol.1987.sp016825; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BOURINET E, 1994, EMBO J, V13, P5032, DOI 10.1002/j.1460-2075.1994.tb06832.x; Burton KA, 1997, P NATL ACAD SCI USA, V94, P11067, DOI 10.1073/pnas.94.20.11067; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1991, J BIOL CHEM, V266, P14188; CATTERALL WA, 1991, CELL, V64, P871, DOI 10.1016/0092-8674(91)90309-M; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; DULHUNTY AF, 1988, J PHYSIOL-LONDON, V399, P63; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; FLEIG A, 1995, J PHYSIOL-LONDON, V489, P41, DOI 10.1113/jphysiol.1995.sp021028; FOSSET M, 1983, J BIOL CHEM, V258, P6086; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; Johnson BD, 1997, J NEUROSCI, V17, P1243; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; KERNELL D, 1983, EXP BRAIN RES, V50, P220; KOTSIAS BA, 1986, AM J PHYSIOL, V250, pC40, DOI 10.1152/ajpcell.1986.250.1.C40; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Link AJ, 1997, ELECTROPHORESIS, V18, P1314, DOI 10.1002/elps.1150180808; LU XY, 1994, J BIOL CHEM, V269, P6511; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Murphy BJ, 1998, TRENDS CARDIOVAS MED, V8, P89, DOI 10.1016/S1050-1738(97)00131-X; OZ M, 1991, J PHARMACOL EXP THER, V257, P575; PINCONRAYMOND M, 1991, DEV BIOL, V148, P517, DOI 10.1016/0012-1606(91)90270-D; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RIOS E, 1991, J MUSCLE RES CELL M, V12, P127, DOI 10.1007/BF01774031; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SANCHEZ JA, 1978, J PHYSIOL-LONDON, V283, P197, DOI 10.1113/jphysiol.1978.sp012496; SCHMID A, 1985, J BIOL CHEM, V260, P3041; SCHWARTZ LM, 1985, NATURE, V314, P747, DOI 10.1038/314747a0; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SCULPTOREANU A, 1993, P NATL ACAD SCI USA, V90, P10135, DOI 10.1073/pnas.90.21.10135; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; TSIEN RW, 1983, ANNU REV PHYSIOL, V45, P341, DOI 10.1146/annurev.ph.45.030183.002013; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016	44	157	162	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1998	20	5					1017	1026		10.1016/S0896-6273(00)80482-1	http://dx.doi.org/10.1016/S0896-6273(00)80482-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620705	Bronze			2022-12-24	WOS:000073864700020
J	Iwasato, T; Erzurumlu, RS; Huerta, PT; Chen, DF; Sasaoka, T; Ulupinar, E; Tonegawa, S				Iwasato, T; Erzurumlu, RS; Huerta, PT; Chen, DF; Sasaoka, T; Ulupinar, E; Tonegawa, S			NMDA receptor-dependent refinement of somatotopic maps	NEURON			English	Article							TRIGEMINAL PATTERN-FORMATION; RAT SOMATOSENSORY CORTEX; CRITICAL PERIOD; MESSENGER-RNAS; NEONATAL RAT; GLUTAMATE-RECEPTOR; SPLICE VARIANTS; BRAIN; BLOCKADE; EXPRESSION	We have examined the role of NMDA receptor-mediated neural activity in the formation of periphery-related somatosensory patterns, using genetically engineered mice. We demonstrate that ectopic expression of a transgene of an NMDAR1 splice variant rescues neonatally fatal NMDAR1 knockout (KO) mice, although the average life span varies depending on the level of the transgene expression. In NMDAR1 KO mice with "high" levels of the transgene expression, sensory periphery-related patterns were normal along both the trigeminal and dorsal column pathways. In the KO mice with "low" levels of the transgene expression, the patterns were absent in the trigeminal pathway. Our results indicate that NMDA receptor-mediated neural activity plays a critical role in pattern formation; along the ascending somatosensory pathways.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; Louisiana State Univ, Med Ctr, Dept Anat & Cell Biol, New Orleans, LA 70112 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Louisiana State University System	Iwasato, T (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.		, 笹岡俊邦/N-9152-2015; ulupinar, emel/AAA-2762-2020	, 笹岡俊邦/0000-0002-7797-4394; Huerta, Patricio/0000-0003-0270-2308	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032195, R01NS032925] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32925, NS32195] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; BELFORD GR, 1978, BRAIN RES, V158, P450, DOI 10.1016/0006-8993(78)90688-1; BELFORD GR, 1979, J COMP NEUROL, V183, P305, DOI 10.1002/cne.901830207; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; DAWSON DR, 1987, J COMP NEUROL, V256, P246, DOI 10.1002/cne.902560205; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; HOFER M, 1994, J NEUROCHEM, V62, P2300; HOGAN B, 1986, MANIPULATING MOUSE E; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KATSUWADA T, 1996, NEURON, V16, P333; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Killackey H.P., 1990, P403; KILLACKEY HP, 1985, DEV BRAIN RES, V22, P141, DOI 10.1016/0165-3806(85)90077-X; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LAURIE DJ, 1995, MOL BRAIN RES, V32, P94, DOI 10.1016/0169-328X(95)00067-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MA PM, 1984, BRAIN RES, V306, P374, DOI 10.1016/0006-8993(84)90390-1; Mitrovic N, 1996, EUR J NEUROSCI, V8, P1793, DOI 10.1111/j.1460-9568.1996.tb01323.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; Sakmann Bert, 1995, P199; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; VANDERLOOS H, 1976, NEUROSCI LETT, V2, P1, DOI 10.1016/0304-3940(76)90036-7; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZHONG J, 1995, J NEUROCHEM, V64, P531	44	154	157	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1201	1210		10.1016/S0896-6273(00)80412-2	http://dx.doi.org/10.1016/S0896-6273(00)80412-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427244	Bronze			2022-12-24	WOS:000071236500008
J	Raman, IM; Sprunger, LK; Meisler, MH; Bean, BP				Raman, IM; Sprunger, LK; Meisler, MH; Bean, BP			Altered subthreshold sodium currents and disrupted firing patterns in Purkinje neurons of Scn8a mutant mice	NEURON			English	Article							END-PLATE DISEASE; CHANNEL MESSENGER-RNAS; MOTOR ENDPLATE DISEASE; CENTRAL NERVOUS-SYSTEM; INACTIVATION GATE; RAT CEREBELLUM; MOUSE; MUTATION; EXPRESSION; SUBTYPES	Sodium currents and action potentials were characterized in Purkinje neurons from ataxic mice lacking expression of the sodium channel Scn8a. Peak transient sodium current was similar to 60% of that in normal mice, but subthreshold sodium current was affected much more. Steady-state current elicited by voltage ramps was reduced to similar to 30%, and resurgent sodium current, an unusual transient current elicited on repolarization following strong depolarizations, was reduced to 8%-18%. In jolting mice, with a missense mutation in Scn8a, steady-state and resurgent current were also reduced, with altered voltage dependence and kinetics. Both spontaneous firing and evoked bursts of spikes were diminished in cells from null and jolting mice. Evidently Scn8a channels carry most subthreshold sodium current and are crucial for repetitive firing.	UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	Raman, IM (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.		Sprunger, Leslie K/A-7840-2010; Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010396, R01NS036855] Funding Source: NIH RePORTER; NINDS NIH HHS [F32-NS10396, R01-NS34059, R01-NS36855] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALZHEIMER C, 1993, J NEUROSCI, V13, P660; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; BECKH S, 1990, FEBS LETT, V262, P317, DOI 10.1016/0014-5793(90)80218-8; BLACK JA, 1994, MOL BRAIN RES, V22, P275, DOI 10.1016/0169-328X(94)90056-6; BROWN AM, 1994, J NEUROPHYSIOL, V71, P2562, DOI 10.1152/jn.1994.71.6.2562; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; DEMIERA EVS, 1997, P NATL ACAD SCI USA, V94, P7059; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; DICK DJ, 1986, J NEUROL SCI, V76, P255, DOI 10.1016/0022-510X(86)90173-5; DICK DJ, 1985, NEUROPATH APPL NEURO, V11, P141; Dickie M.M., 1965, MOUSE NEWS LETT, V32, P44; DUCHEN LW, 1970, J NEUROL NEUROSUR PS, V33, P238, DOI 10.1136/jnnp.33.2.238; DUCHEN LW, 1971, J PHYSIOL-LONDON, V212, P535, DOI 10.1113/jphysiol.1971.sp009340; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; FURUYAMA T, 1993, MOL BRAIN RES, V17, P169, DOI 10.1016/0169-328X(93)90087-6; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GOLDIN AL, 1995, HDB RECEPTORS CHANNE, P73; GRUOL DL, 1987, J NEUROSCI, V7, P1271; HARRIS JB, 1986, J NEUROL SCI, V76, P239, DOI 10.1016/0022-510X(86)90172-3; HARRIS JB, 1992, J NEUROL SCI, V110, P186, DOI 10.1016/0022-510X(92)90027-I; Hille B., 1992, IONIC CHANNELS EXCIT; HOUNSGAARD J, 1979, ACTA PHYSIOL SCAND, V106, P91, DOI 10.1111/j.1748-1716.1979.tb06375.x; KISKIN NI, 1993, NEUROSCIENCE, V54, P575, DOI 10.1016/0306-4522(93)90229-9; Kohrman DC, 1996, J NEUROSCI, V16, P5993; KOHRMAN DC, 1995, GENOMICS, V26, P171, DOI 10.1016/0888-7543(95)80198-U; Kohrman DC, 1996, J BIOL CHEM, V271, P17576, DOI 10.1074/jbc.271.29.17576; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MEISLER MH, 1997, IN PRESS ANN MED HEL; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PATTON DE, 1994, J BIOL CHEM, V269, P17649; Plummer NW, 1997, J BIOL CHEM, V272, P24008, DOI 10.1074/jbc.272.38.24008; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; REGAN LJ, 1991, J NEUROSCI, V11, P2259; SCHALLER KL, 1995, J NEUROSCI, V15, P3231; Song JH, 1996, J PHARMACOL EXP THER, V277, P445; TAYLOR CP, 1993, TRENDS NEUROSCI, V16, P455, DOI 10.1016/0166-2236(93)90077-Y; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9	44	311	315	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					881	891		10.1016/S0896-6273(00)80969-1	http://dx.doi.org/10.1016/S0896-6273(00)80969-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354334	Bronze			2022-12-24	WOS:A1997YD18900015
J	Dou, CL; Ye, X; Stewart, C; Lai, E; Li, SC				Dou, CL; Ye, X; Stewart, C; Lai, E; Li, SC			TWH regulates the development of subsets of spinal cord neurons	NEURON			English	Article							NERVOUS-SYSTEM; TRANSCRIPTION FACTORS; MOUSE EMBRYO; GENE FAMILY; CELL-DEATH; HEAD; ORGANIZATION; EXPRESSION; PROTEINS; IDENTIFICATION	Thymocyte winged helix (TWH) is a putative transcription factor expressed in the developing neural tube. At midgestation, TWH expression identifies subsets of spinal cord motor neurons and interneurons. TWH-expressing motor neurons were restricted to specific spinal cord levels, distinguishing motor neurons at lumbar from those at cervical levels. To understand the developmental role of TWH, we replaced the TWH gene with the lacZ reporter gene and generated mice with a homozygous disruption of the TWH gene. TWH(-/-) mutant mice had increased perinatal mortality, retarded postnatal growth, and motor weakness. The TWH(-/-) mutation resulted in alterations in the sizes and position of different neuronal populations. Our results demonstrate that TWH plays a critical role in neuronal development and suggest that TWH regulates the early differentiation of neural progenitors.	MEM SLOAN KETTERING CANC CTR,CELL BIOL PROGRAM,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DIV ENDOCRINOL,NEW YORK,NY 10021; ADV BIOSCI LABS INC,BASIC RES PROGRAM,FREDERICK,MD 21702	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Dou, CL (corresponding author), COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10032, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007313] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD29584] Funding Source: Medline; NIDDK NIH HHS [T32 DK07313] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Appel B, 1995, DEVELOPMENT, V121, P4117; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; EISEN JS, 1994, ANNU REV NEUROSCI, V17, P1; FLANAGAN AE, 1969, J MORPHOL, V129, P281, DOI 10.1002/jmor.1051290303; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hogan B, 1994, MANIPULATING MOUSE E; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; KAESTNER KH, 1993, P NATL ACAD SCI USA, V90, P7628, DOI 10.1073/pnas.90.16.7628; Kaestner KH, 1996, MECH DEVELOP, V55, P221, DOI 10.1016/0925-4773(96)00507-2; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KONTGEN F, 1993, GUIDE TECHNIQUES MOU, P878; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; LO AC, 1995, ARCH HISTOL CYTOL, V58, P139, DOI 10.1679/aohc.58.139; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; MILLER LM, 1993, GENE DEV, V7, P933, DOI 10.1101/gad.7.6.933; Moynahan ME, 1996, HUM MOL GENET, V5, P875, DOI 10.1093/hmg/5.7.875; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; SASAKI H, 1993, DEVELOPMENT, V118, P47; SMITH CL, 1983, J COMP NEUROL, V220, P16, DOI 10.1002/cne.902200104; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; TOSNEY KW, 1995, BIOESSAYS, V17, P379, DOI 10.1002/bies.950170503; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7	43	34	34	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					539	551		10.1016/S0896-6273(00)80296-2	http://dx.doi.org/10.1016/S0896-6273(00)80296-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136764	hybrid			2022-12-24	WOS:A1997WW62600004
J	Cohen, NA; Brenman, JE; Snyder, SH; Bredt, DS				Cohen, NA; Brenman, JE; Snyder, SH; Bredt, DS			Binding of the inward rectifier K+ channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation	NEURON			English	Article							RECTIFYING POTASSIUM CHANNEL; TUMOR-SUPPRESSOR PROTEIN; NITRIC-OXIDE SYNTHASE; FUNCTIONAL EXPRESSION; SEPTATE JUNCTIONS; MESSENGER-RNA; CLONING; RECEPTOR; BRAIN; RECTIFICATION	Dynamic regulation of ion channel interactions with the cytoskeleton mediates aspects of synaptic plasticity, yet mechanisms for this process are largely unknown. Here, we report that two inwardly rectifying K+ channels, Kir 2.1 and 2.3, bind to PSD-95, a cytoskeletal protein of postsynaptic densities that clusters NMDA receptors and voltage-dependent K+ channels. Kir 2.3 colocalizes with PSD-95 in neuronal populations in forebrain, and a PSD-95/Kir 2.3 complex occurs in hippocampus. Within the C-terminal tail of Kir 2.3, a serine residue critical for interaction with PSD-95, is also a substrate for phosphorylation by protein kinase A (PKA). Stimulation of PKA in intact cells causes rapid dissociation of the channel from PSD-95. This work identifies a physiological mechanism for regulating ion channel interactions with the postsynaptic density.	JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & MOL SCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,PROGRAM BIOMED SCI,SAN FRANCISCO,CA 94143	Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cohen, NA (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.			Cohen, Noam/0000-0002-9462-3932	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266] Funding Source: Medline; NIMH NIH HHS [MH-18501] Funding Source: Medline; NINDS NIH HHS [R01NS34822] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AOKI C, 1993, BRAIN RES, V620, P97, DOI 10.1016/0006-8993(93)90275-R; BREDT DS, 1995, P NATL ACAD SCI USA, V92, P6753, DOI 10.1073/pnas.92.15.6753; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BRENMAN JE, 1996, IN PRESS J NEUROSCI; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FALK T, 1995, FEBS LETT, V367, P127, DOI 10.1016/0014-5793(95)00527-G; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONAS AA, 1996, CURR OPIN NEUROBIOL, V6, P318; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KOUMI S, 1995, J PHYSIOL-LONDON, V486, P661, DOI 10.1113/jphysiol.1995.sp020842; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; LAU LF, 1996, J BIOL CHEM, V35, P21622; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1991, ANNU REV PHYSIOL, V53, P289, DOI 10.1146/annurev.ph.53.030191.001445; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MORISHIGE K, 1993, FEBS LETT, V336, P375, DOI 10.1016/0014-5793(93)80840-Q; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; PESSIA M, 1995, NEURON, V14, P1039, DOI 10.1016/0896-6273(95)90342-9; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; Roche WK, 1996, NEURON, V16, P1179; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SASSOON D, 1993, METHOD ENZYMOL, V225, P384; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; WALLACE BG, 1992, J NEUROBIOL, V23, P592, DOI 10.1002/neu.480230512; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; Wischmeyer E, 1996, P NATL ACAD SCI USA, V93, P5819, DOI 10.1073/pnas.93.12.5819; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	62	225	228	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					759	767		10.1016/S0896-6273(00)80207-X	http://dx.doi.org/10.1016/S0896-6273(00)80207-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893032	hybrid			2022-12-24	WOS:A1996VP74300020
J	Citron, M; Diehl, TS; Capell, A; Haass, C; Teplow, DB; Selkoe, DJ				Citron, M; Diehl, TS; Capell, A; Haass, C; Teplow, DB; Selkoe, DJ			Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF	NEURON			English	Article							PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PEPTIDE; IDENTIFICATION; SECRETION; MUTATION; CLEAVAGE; FRAGMENT; TERMINUS; MONKEY	Cerebral deposition of amyloid beta protein (A beta) is an early and critical feature of Alzheimer's disease. A beta production requires the proteolytic release of A beta from the beta-amyloid precursor protein (beta APP). Thus, inhibition of A beta release is a prime therapeutic goal. Here, we show that the broad spectrum, irreversible serine protease inhibitor, AEBSF, inhibits the constitutive production of A beta in five different human cell lines, both neural and nonneural. AEBSF also stabilizes full-length beta APP and enhances alpha-secretion, as shown by an increase in the proteolytic derivative, alpha-APP(s). Further, we demonstrate that the inhibitory effect of AEBSF is specific for A beta proteins starting at Aspartate 1, suggesting that AEBSF directly inhibits beta-secretase, the Methionine-Aspartate (Met-Asp)-cleaving enzyme. These results indicate that specific inhibition of this A beta-generating protease is possible in living human neural cells and provide information about the characteristics of this as yet unidentified enzyme.	UNIV HEIDELBERG,ZENT INST SEEL GESUNDHEIT,D-68159 MANNHEIM,GERMANY; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,BIOPOLYMER LAB,BOSTON,MA 02115	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital					NIA NIH HHS [AG12749, AG05134] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012749] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; EVIN G, 1994, AMYLOID, V1, P263, DOI 10.3109/13506129409146118; FEISENSTEIN KM, 1994, NAT GENET, V6, P251; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1994, J BIOL CHEM, V269, P17741; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4; HUNG AY, 1993, J BIOL CHEM, V268, P22959; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAZMIROWSKI HG, 1971, PHARMAZIE, V26, P390; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; PRASS D, 1992, GES BIOL CHEM, V373, P812; RAZZABONI BL, 1992, BRAIN RES, V589, P207, DOI 10.1016/0006-8993(92)91279-N; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; WAISMANN P, 1972, ACTA BIOL MED GER, V28, P577; WAITER J, 1996, IN PRESS J BIOL CHEM; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	39	81	85	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					171	179		10.1016/S0896-6273(00)80290-1	http://dx.doi.org/10.1016/S0896-6273(00)80290-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755488	Bronze			2022-12-24	WOS:A1996UY98100017
J	Mainen, ZF; Joerges, J; Huguenard, JR; Sejnowski, TJ				Mainen, ZF; Joerges, J; Huguenard, JR; Sejnowski, TJ			A model of spike initiation in neocortical pyramidal neurons	NEURON			English	Article							DEPENDENT SODIUM-CHANNELS; CEREBELLAR PURKINJE-CELLS; RAT VISUAL-CORTEX; ACTION-POTENTIALS; BRAIN; DENDRITES; AXON; MORPHOLOGY; SLICES; ELECTROPHYSIOLOGY	Neocortical pyramidal cells possess voltage-dependent dendritic sodium channels that promote propagation of action potentials into the dendritic tree but paradoxically may fail to originate dendritic spikes. A biophysical model was constructed to reconcile these observations with known anatomical and physiological properties. When dendritic and somatic sodium channel densities compatible with electrophysiological measurements were combined with much higher densities in the axon initial segment then, regardless of the site of stimulation, spikes initiated at the initial segment and subsequently invaded the dendrites. The lower initial segment threshold arose from high current density and electrical isolation from the soma. Failure of dendritic channels to initiate spikes was due to inactivation and source-load considerations, which were more favorable for conduction of back-propagated spikes.	SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,COMPUTAT NEUROBIOL LAB,LA JOLLA,CA 92037; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,GRAD PROGRAM NEUROSCI,LA JOLLA,CA 92093; STANFORD UNIV,DEPT NEUROL,STANFORD,CA 94305	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University			Huguenard, John/I-5016-2012; Sejnowski, Terrence/AAV-5558-2021; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Mainen, Zachary/0000-0001-7913-9109	NINDS NIH HHS [NS12151, NS06477] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS012151, P50NS012151] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALZHEIMER C, 1993, J NEUROSCI, V13, P660; AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; BEDLACK RS, 1994, NEURON, V13, P1187, DOI 10.1016/0896-6273(94)90056-6; BELLUZZI O, 1986, J PHYSIOL-LONDON, V380, P275, DOI 10.1113/jphysiol.1986.sp016285; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; CHIU SY, 1987, J PHYSIOL-LONDON, V391, P631, DOI 10.1113/jphysiol.1987.sp016760; COOLEY JW, 1966, BIOPHYS J, V6, P583, DOI 10.1016/S0006-3495(66)86679-1; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; CUMMINS TR, 1994, J NEUROPHYSIOL, V71, P1052, DOI 10.1152/jn.1994.71.3.1052; DESCHENES M, 1980, BRAIN RES, V191, P538, DOI 10.1016/0006-8993(80)91302-5; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FARINAS I, 1991, J COMP NEUROL, V304, P70, DOI 10.1002/cne.903040106; FRANK K, 1957, FED PROC, V16, P39; GOGAN P, 1983, J PHYSIOL-LONDON, V335, P205, DOI 10.1113/jphysiol.1983.sp014529; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Haug H, 1968, Brain Res, V11, P65, DOI 10.1016/0006-8993(68)90074-7; HINAS M, 1993, NEURAL SYSTEMS ANAL, P127; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUGUENARD JR, 1989, P NATL ACAD SCI USA, V86, P2473, DOI 10.1073/pnas.86.7.2473; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; KAARS C, 1981, SCIENCE, V212, P1063, DOI 10.1126/science.7233201; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; LARKMAN A, 1990, J NEUROSCI, V10, P1407; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MAJOR G, 1994, J NEUROSCI, V14, P4613; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MASON A, 1990, J NEUROSCI, V10, P1415; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P285, DOI 10.1113/jphysiol.1983.sp014581; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; PALAY SL, 1968, J CELL BIOL, V37, P193; PETERS A, 1968, J CELL BIOL, V39, P604, DOI 10.1083/jcb.39.3.604; PITLER TA, 1994, NEURON, V13, P1447; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; RHODES PA, 1994, NEURAL COMPUT, V6, P1086, DOI 10.1162/neco.1994.6.6.1086; SAH P, 1988, J GEN PHYSIOL, V91, P373, DOI 10.1085/jgp.91.3.373; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SKAUGEN E, 1980, ACTA PHYSIOL SCAND, V109, P377, DOI 10.1111/j.1748-1716.1980.tb06610.x; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Stratford K., 1989, COMPUTING NEURON; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WESTRUM LE, 1970, J COMP NEUROL, V139, P337, DOI 10.1002/cne.901390306; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	65	329	340	2	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1427	1439		10.1016/0896-6273(95)90020-9	http://dx.doi.org/10.1016/0896-6273(95)90020-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845165	Bronze			2022-12-24	WOS:A1995TL67800020
J	Song, I; Kamboj, S; Xia, J; Dong, HL; Liao, DZ; Huganir, RL				Song, I; Kamboj, S; Xia, J; Dong, HL; Liao, DZ; Huganir, RL			Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors	NEURON			English	Article							GLUTAMATE RECEPTORS; RAT-BRAIN; SILENT SYNAPSES; PROTEIN; NEURONS; FUSION; LOCALIZATION; ACTIVATION; TRANSPORT; SUBTYPES	Glutamate receptors mediate the majority of rapid excitatory synaptic transmission in the central nervous system (CNS) and play important roles in synaptic plasticity and neuronal development. Recently, protein-protein interactions with the C-terminal domain of glutamate receptor subunits have been shown to be involved in the modulation of receptor function and clustering at excitatory synapses. In this paper, we have found that the N-ethylmaleimide-sensitive factor (NSF), a protein involved in membrane fusion events, specifically interacts with the C terminus of the GluR2 and GluR4c subunits of AMPA receptors in vitro and in vivo. Moreover, intracellular perfusion of neurons with a synthetic peptide that competes with the interaction of NSF and AMPA receptor subunits rapidly decreases the amplitude of miniature excitatory postsynaptic currents (mEPSCs), suggesting that NSF regulates AMPA receptor function.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.		Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188; Kamboj, Sunjeev/0000-0003-2197-0826	NINDS NIH HHS [NS36715, R01 NS036715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banker G., 1991, CULTURING NERVE CELL; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLACKSTONE CD, 1992, ANN NEUROL, V31, P680, DOI 10.1002/ana.410310620; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Feng HP, 1998, CURR BIOL, V8, pR464, DOI 10.1016/S0960-9822(98)70294-5; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hu BR, 1998, J NEUROSCI, V18, P625; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONES KA, 1991, NEURON, V7, P593, DOI 10.1016/0896-6273(91)90372-7; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Mammen AL, 1997, J NEUROSCI, V17, P7351; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 1996, CURR OPIN NEUROBIOL, V6, P602, DOI 10.1016/S0959-4388(96)80091-2; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0	35	338	346	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					393	400		10.1016/S0896-6273(00)80548-6	http://dx.doi.org/10.1016/S0896-6273(00)80548-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728920	hybrid			2022-12-24	WOS:000075598300016
J	Betz, A; Ashery, U; Rickmann, M; Augustin, I; Neher, E; Sudhof, TC; Rettig, J; Brose, N				Betz, A; Ashery, U; Rickmann, M; Augustin, I; Neher, E; Sudhof, TC; Rettig, J; Brose, N			Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release	NEURON			English	Article							PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; UNC-13 GENE; NEUROMUSCULAR SYNAPSES; ACETYLCHOLINE LEVELS; C-2-DOMAIN PROTEINS; BINDING-PROTEIN; DIACYLGLYCEROL; DOMAIN; CELLS	Munc13-1, a mammalian homolog of C. elegans unc-13p, is thought to be involved in the regulation of synaptic transmission. We now demonstrate that Munc13-1 is a presynaptic high-affinity phorbol ester and diacylglycerol receptor with ligand affinities similar to those of protein kinase C. Munc13-1 associates with the plasma membrane in response to phorbol ester binding and acts as a phorbol ester-dependent enhancer of transmitter release when overexpressed presynaptically in the Xenopus neuromuscular junction. These observations establish Munc13-1 as a novel presynaptic target of the diacylglycerol second messenger pathway that acts in parallel with protein kinase C to regulate neurotransmitter secretion.	Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Univ Gottingen, Zentrum Anat, Abt Neuroanat, D-37075 Gottingen, Germany; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA	Max Planck Society; Max Planck Society; University of Gottingen; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brose, N (corresponding author), Max Planck Inst Expt Med, Abt Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@mail.mpiem.gwdg.de	Neher, Erwin/A-2109-2013; Rettig, Jens/K-5103-2013	Rettig, Jens/0000-0001-6160-3954; Ashery, Uri/0000-0001-6338-7888				AHMED S, 1992, BIOCHEM J, V287, P995, DOI 10.1042/bj2870995; ALDER J, 1995, J NEUROSCI, V15, P511; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1996, BIOCHEM SOC T, V24, P661, DOI 10.1042/bst0240661; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BROSE N, 1993, J BIOL CHEM, V268, P22663; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Byrne JH, 1996, J NEUROSCI, V16, P425; CHAZAL G, 1986, J NEUROCYTOL, V15, P777, DOI 10.1007/BF01625194; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DEKKER LV, 1991, PROG BRAIN RES, V89, P209; FABBRI M, 1994, J BIOL CHEM, V269, P26848; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GORDGE PC, 1994, CELL SIGNAL, V6, P871, DOI 10.1016/0898-6568(94)90020-5; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; HOSONO R, 1987, J NEUROCHEM, V49, P1820, DOI 10.1111/j.1471-4159.1987.tb02442.x; HOSONO R, 1991, NEUROSCI LETT, V128, P243, DOI 10.1016/0304-3940(91)90270-4; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P10777, DOI 10.1074/jbc.270.18.10777; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; PIOTTE M, 1985, J COMP NEUROL, V239, P44, DOI 10.1002/cne.902390104; PUCAK ML, 1995, CRIT REV NEUROBIOL, V9, P67; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; QUEST AFG, 1994, J BIOL CHEM, V269, P20000; Redman RS, 1997, J PHYSIOL-LONDON, V501, P41, DOI 10.1111/j.1469-7793.1997.041bo.x; Rettig J, 1997, J NEUROSCI, V17, P6647; RICKMANN M, 1995, NEUROSCIENCE, V67, P977, DOI 10.1016/0306-4522(94)00615-C; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; SCHAEFFER E, 1994, P NATL ACAD SCI USA, V91, P3882, DOI 10.1073/pnas.91.9.3882; SCHNITTLER HJ, 1993, AM J PHYSIOL, V265, pC289, DOI 10.1152/ajpcell.1993.265.1.C289; SCHOLFIELD CN, 1989, BRIT J PHARMACOL, V98, P1344, DOI 10.1111/j.1476-5381.1989.tb12683.x; SHARKEY NA, 1985, CANCER RES, V45, P19; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607; Sollner TH, 1996, EXPERIENTIA, V52, P1021; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Tabti N., 1991, CULTURING NERVE CELL, P137; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	49	334	342	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					123	136		10.1016/S0896-6273(00)80520-6	http://dx.doi.org/10.1016/S0896-6273(00)80520-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697857	Bronze, Green Published			2022-12-24	WOS:000075061900012
J	Gould, A; Itasaki, N; Krumlauf, R				Gould, A; Itasaki, N; Krumlauf, R			Initiation of rhombomeric HoxbL4 expression requires induction by somites and a retinoid pathway	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL CREST; ACID CAUSES; TRANSPOSED RHOMBOMERES; SEGMENTAL EXPRESSION; ECTOPIC EXPRESSION; XENOPUS EMBRYOS; GENE-EXPRESSION; MOUSE HINDBRAIN; PATTERN	Anteroposterior (AP) patterning in the vertebrate hindbrain is dependent upon the establishment of segmental domains of Hox expression. We investigated the mechanism that governs the early expression of Hoxb4 and found that transient signaling from the paraxial mesoderm induces expression in the hindbrain. Induction involves a retinoid pathway requiring retinoic acid receptor (RAR) function within the neural plate. Characterization of a prerhombomeric enhancer from Hoxb4 reveals that a retinoic acid (RA) response element is an essential component of the early neural response to somite (s) signaling and can interpret positional information for setting the anterior boundary of expression. These data suggest a mechanism whereby, during normal hindbrain development, Hoxb4 expression is initiated by extrinsic signals and is subsequently maintained by Hox feedback circuits. This mechanism also accounts for the ectopic response of Hoxb4 in rhombomere (r) transpositions and after exposure to retinoids.	Natl Inst Med Res, MRC, Dev Neurobiol Lab, London NW7 1AA, England	MRC National Institute for Medical Research	Krumlauf, R (corresponding author), Natl Inst Med Res, MRC, Dev Neurobiol Lab, London NW7 1AA, England.		Krumlauf, Robb/AAH-5012-2019; Gould, Alex/M-5353-2019; Gould, Alex/A-7479-2010	Krumlauf, Robb/0000-0001-9102-7927; Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Itasaki, Nobue/0000-0003-0587-9141				Alexandre D, 1996, DEVELOPMENT, V122, P735; ALTABA ARI, 1991, DEVELOPMENT, V112, P945; ALTABA ARI, 1994, TRENDS NEUROSCI, V17, P233, DOI 10.1016/0166-2236(94)90006-X; APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; BEDDINGTON R, 1998, IN PRESS TRENDS GENE, V14; Blumberg B, 1997, DEVELOPMENT, V124, P373; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; Cockroft DL, 1990, POSTIMPLANTATION MAM, P15; CONLON RA, 1995, TRENDS GENET, V11, P314, DOI 10.1016/S0168-9525(00)89089-7; CONLON RA, 1992, DEVELOPMENT, V116, P357; Cox WG, 1995, DEVELOPMENT, V121, P4349; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; Dupe V, 1997, DEVELOPMENT, V124, P399; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; Ensini M, 1998, DEVELOPMENT, V125, P969; Foley AC, 1997, DEVELOPMENT, V124, P2983; FRASCH M, 1995, DEVELOPMENT, V121, P957; Gale E, 1996, DEVELOPMENT, V122, P783; Gavalas A, 1997, DEVELOPMENT, V124, P3693; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Goddard JM, 1996, DEVELOPMENT, V122, P3217; GOULD A, 1995, GENE DEV, V11, P900; GRAPINBOTTON A, 1995, DEVELOPMENT, V121, P2707; GrapinBotton A, 1997, DEVELOPMENT, V124, P849; GUTHRIE S, 1992, NATURE, V356, P157, DOI 10.1038/356157a0; HILL J, 1995, MECH DEVELOP, V50, P3, DOI 10.1016/0925-4773(94)00321-D; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; KESSEL M, 1993, NEURON, V10, P379, DOI 10.1016/0896-6273(93)90328-O; KEYNES R, 1994, ANNU REV NEUROSCI, V17, P109, DOI 10.1146/annurev.ne.17.030194.000545; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; KURATANI SC, 1993, DEVELOPMENT, V117, P105; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARK M, 1993, DEVELOPMENT, V119, P319; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MARTINEZ S, 1995, MECH DEVELOP, V51, P289, DOI 10.1016/0925-4773(95)00376-2; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morrison A, 1996, DEVELOPMENT, V122, P1895; Morrison A, 1997, DEVELOPMENT, V124, P3135; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; NIEUWKOOP PD, 1985, J EMBRYOL EXP MORPH, V89, P333; PAPALOPULU N, 1991, DEVELOPMENT, V113, P1145; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; PLACZEK M, 1993, DEVELOPMENT, V117, P205; POPPERL H, 1993, MOL CELL BIOL, V13, P257; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Pownall ME, 1996, DEVELOPMENT, V122, P3881; PRINCE V, 1994, DEVELOPMENT, V120, P911; SLACK JMW, 1992, DEVELOPMENT, V114, P285; Stratford T, 1996, CURR BIOL, V6, P1124, DOI 10.1016/S0960-9822(02)70679-9; Streit A, 1997, DEVELOPMENT, V124, P1191; Studer M, 1998, DEVELOPMENT, V125, P1025; SUEMORI H, 1990, CELL DIFFER DEV, V29, P181, DOI 10.1016/0922-3371(90)90120-L; TOIVONEN S, 1968, SCIENCE, V159, P539, DOI 10.1126/science.159.3814.539; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; ZHANG MB, 1994, DEVELOPMENT, V120, P2431	66	231	235	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					39	51		10.1016/S0896-6273(00)80513-9	http://dx.doi.org/10.1016/S0896-6273(00)80513-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697850	Bronze			2022-12-24	WOS:000075061900005
J	Nishimune, A; Isaac, JTR; Molnar, E; Noel, J; Nash, SR; Tagaya, M; Collingridge, GL; Nakanishi, S; Henley, JM				Nishimune, A; Isaac, JTR; Molnar, E; Noel, J; Nash, SR; Tagaya, M; Collingridge, GL; Nakanishi, S; Henley, JM			NSF binding to GluR2 regulates synaptic transmission	NEURON			English	Article							SENSITIVE FUSION PROTEIN; LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; NMDA RECEPTOR SUBUNITS; MEMBRANE-FUSION; POSTSYNAPTIC DENSITY; GUANYLATE KINASES; SILENT SYNAPSES; AMPA; EXPRESSION	Here, we show that N-ethylmaleimide-sensitive fusion protein (NSF) interacts directly and selectively with the intracellular C-terminal domain of the GluR2 subunit of AMPA receptors. The interaction requires all three domains of, NSF but occurs between residues Lys-844 and Gln-853 of rat GluR2, with Asn-851 playing a critical role. Loading of decapeptides corresponding to the NSF-binding domain of GluR2 into rat hippocampal CA1 pyramidal neurons results in a marked, progressive decrement of AMPA receptor-mediated synaptic transmission. This reduction in synaptic transmission was also observed when an anti-NSF monoclonal antibody (mAb) was loaded into CA1 neurons. These results demonstrate a previously unsuspected direct interaction in the postsynaptic neuron between two major proteins involved in synaptic transmission and suggest a rapid NSF-dependent modulation of AMPA receptor function.	Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 606, Japan; Univ Bristol, Sch Med, Dept Anat, Bristol BS8 1TD, Avon, England; Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan	Kyoto University; University of Bristol; Tokyo University of Pharmacy & Life Sciences	Henley, JM (corresponding author), Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 606, Japan.		collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Molnár, Elek/D-1427-2019; Henley, Jeremy M/A-2776-2009	Collingridge, Graham L/0000-0002-9572-5359; Molnár, Elek/0000-0002-3525-4671; Henley, Jeremy/0000-0003-3589-8335	MRC [G9629038] Funding Source: UKRI; Medical Research Council [G9629038] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONG RM, 1994, FEBS LETT, V350, P253, DOI 10.1016/0014-5793(94)00778-0; Hu BR, 1998, J NEUROSCI, V18, P625; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Mammen AL, 1997, J NEUROSCI, V17, P7351; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Miller J.H., 1972, EXPT MOL GENETICS; Niethammer M, 1996, J NEUROSCI, V16, P2157; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PUSCHEL AW, 1994, FEBS LETT, V347, P55, DOI 10.1016/0014-5793(94)00505-2; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RAMAN IM, 1994, J NEUROSCI, V14, P4998; Richmond SA, 1996, NEUROSCIENCE, V75, P69, DOI 10.1016/0306-4522(96)00217-5; ROTHMAN JE, 1994, ADV SEC MESS PHOSPH, V29, P81; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WALSH MJ, 1992, J NEUROCHEM, V59, P667, DOI 10.1111/j.1471-4159.1992.tb09421.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945	46	441	457	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					87	97		10.1016/S0896-6273(00)80517-6	http://dx.doi.org/10.1016/S0896-6273(00)80517-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697854	Green Submitted, Bronze			2022-12-24	WOS:000075061900009
J	Krapivinsky, G; Medina, I; Eng, L; Krapivinsky, L; Yang, YH; Clapham, DE				Krapivinsky, G; Medina, I; Eng, L; Krapivinsky, L; Yang, YH; Clapham, DE			A novel inward rectifier K+ channel with unique pore properties	NEURON			English	Article							POTASSIUM CHANNEL; ANOMALOUS RECTIFICATION; FUNCTIONAL EXPRESSION; CLONING; MEMBRANE; CONDUCTANCE; PROTEINS; RECEPTOR; SUBUNITS; CELLS	We have cloned a novel K+-selective, inward rectifier channel that is widely expressed in brain but is especially abundant in the Purkinje cell layer of the cerebellum and pyramidal cells of the hippocampus. It is also present in a wide array of tissues, including kidney and intestine. The channel is only 38% identical to its closest relative, Kir1.3 (Kir1-ATP-regulated inward rectifier K+ [ROMK] family) and displays none of the functional properties unique to the ROMK class. Kir7.1 has several unique features, including a very low estimated single channel conductance (similar to 50 fS), low sensitivity to block by external Ba2+ and Cs+, and no dependence of its inward rectification properties on the internal blocking particle Mg2+. The unusual pore properties of Kir7.1 seem to be explained by amino acids in the pore sequence that differ from corresponding conserved residues in all other Kir channel proteins. Replacement of one of these amino acids (Met-125) with the Arg absolutely conserved in all other Kir channels dramatically increases its single channel conductance and Ba2+ sensitivity. This channel would provide a steady background K+ current to help set the membrane potential in cells in which it is expressed. We propose that the novel channel be assigned to a new Kir subfamily, Kir7.1.	Childrens Hosp, Howard Hughes Med Inst, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Div Cardiovasc, Boston, MA 02115 USA.		Medina, Igor/O-5532-2016; Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Medina, Igor/0000-0001-6839-5414; Clapham, David/0000-0002-4459-9428; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009432] Funding Source: NIH RePORTER; NHLBI NIH HHS [NHLBI 54873] Funding Source: Medline; NIDDK NIH HHS [NIDDK 09432] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov A, 1996, BIOPHYS J, V70, P2680, DOI 10.1016/S0006-3495(96)79837-5; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; BREDT DS, 1995, P NATL ACAD SCI USA, V92, P6753, DOI 10.1073/pnas.92.15.6753; CIANI S, 1978, J MEMBRANE BIOL, V44, P103, DOI 10.1007/BF01976035; DEFELICE LJ, 1981, INTRO MEMBRANE NOISE, P115; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; MAKHINA EN, 1994, J BIOL CHEM, V269, P20468; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Medina I, 1996, J PHYSIOL-LONDON, V495, P411, DOI 10.1113/jphysiol.1996.sp021603; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Sabirov RZ, 1997, J GEN PHYSIOL, V110, P665, DOI 10.1085/jgp.110.6.665; SAMBROOK J, 1989, MOL CLONING LAB MANU, V3; Shuck ME, 1997, J BIOL CHEM, V272, P586; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; TAKUMI T, 1995, J BIOL CHEM, V270, P16339, DOI 10.1074/jbc.270.27.16339; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	30	144	147	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					995	1005		10.1016/S0896-6273(00)80480-8	http://dx.doi.org/10.1016/S0896-6273(00)80480-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620703	Bronze			2022-12-24	WOS:000073864700018
J	Burke, NV; Han, WP; Li, DQ; Takimoto, K; Watkins, SC; Levitan, ES				Burke, NV; Han, WP; Li, DQ; Takimoto, K; Watkins, SC; Levitan, ES			Neuronal peptide release is limited by secretory granule mobility	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; ATRIAL-NATRIURETIC-FACTOR; ADRENAL CHROMAFFIN CELLS; PC12 CELLS; SENSITIVITY; EXOCYTOSIS; EXPRESSION; ATP	Neuropeptides are slowly released from a limited pool of secretory granules. To visualize this process, GFP-tagged preproatrial natriuretic factor (ANF) was expressed in nerve growth factor-treated PC12 cells. Biochemical and microfluorimetric experiments demonstrate that proANF-EGFP is packaged in granules that accumulate at neurite endings and is released in a Ca2+-dependent manner by secretagogs. Confocal microscopy shows that secretion is associated with depletion of granules distributed throughout the terminal. Fluorescence recovery after photobleaching and time-lapse particle tracking reveal that only a subpopulation of cytoplasmic secretory granules, similar in size to the releasable pool, can move quickly enough (D = 6 x 10(-11) cm(2)/s) to support release. Therefore, sustained secretory responses are limited by the number of mobile granules and their slow rate of diffusion.	UNIV PITTSBURGH,DEPT PHARMACOL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT CELL BIOL & PHYSIOL,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Oka, Yoshitaka/C-9670-2010; Watkins, Simon/ABG-2590-2021	Oka, Yoshitaka/0000-0002-3482-3051; Watkins, Simon/0000-0003-4092-1552	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032385] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32385] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANERJEE A, 1993, NEUROSCI LETT, V164, P93, DOI 10.1016/0304-3940(93)90865-I; BEAN AJ, 1994, FASEB J, V8, P630, DOI 10.1096/fasebj.8.9.8005390; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; FELDMAN EL, 1981, J NEUROBIOL, V12, P591, DOI 10.1002/neu.480120607; Gutierrez LM, 1997, J BIOL CHEM, V272, P2634, DOI 10.1074/jbc.272.5.2634; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; HUANG WQ, 1991, ENDOCRINOLOGY, V128, P2591, DOI 10.1210/endo-128-5-2591; LAETHER C, 1995, FEBS LETT, V369, P267; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; MAJID MA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P283, DOI 10.1016/0167-4889(92)90118-U; Patterson G. H., 1996, Biophysical Journal, V70, pA426; PEPPERS SC, 1986, J BIOL CHEM, V261, P4665; RIVAS RJ, 1989, J CELL BIOL, V109, P51, DOI 10.1083/jcb.109.1.51; SEI CA, 1992, MOL ENDOCRINOL, V6, P309, DOI 10.1210/me.6.3.309; SEIDMAN CE, 1984, SCIENCE, V225, P324, DOI 10.1126/science.6234658; SHIELDS PP, 1990, J BIOL CHEM, V265, P10905; SHIONO S, 1991, BIOCHEM BIOPH RES CO, V176, P1232, DOI 10.1016/0006-291X(91)90417-6; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; TERRY BR, 1995, BIOCHEM BIOPH RES CO, V217, P21, DOI 10.1006/bbrc.1995.2740; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573	24	137	139	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1095	1102		10.1016/S0896-6273(00)80400-6	http://dx.doi.org/10.1016/S0896-6273(00)80400-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390522	Bronze			2022-12-24	WOS:A1997YH59400016
J	Borchelt, DR; Ratovitski, T; vanLare, J; Lee, MK; Gonzales, V; Jenkins, NA; Copeland, NG; Price, DL; Sisodia, SS				Borchelt, DR; Ratovitski, T; vanLare, J; Lee, MK; Gonzales, V; Jenkins, NA; Copeland, NG; Price, DL; Sisodia, SS			Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; BETA-PROTEIN; A-BETA; SENILE PLAQUES; IN-VIVO; MISSENSE MUTATIONS; DOWN-SYNDROME; GENE; A-BETA-42(43); LOCUS	Missense mutations in two related genes, termed presenilin 1 (PS1) and presenilin 2 (PS2), cause dementia in a subset of early-onset familiar Alzheimer's disease (FAD) pedigrees. In a variety of experimental in vitro and in vivo settings, PAD-linked presenilin variants influence the processing of the amyloid precursor protein (APP), leading to elevated levels of the highly fibrillogenic A beta 1-42 peptides that are preferentially deposited in the brains of Alzheimer Disease (AD) patients. In this report, we demonstrate that transgenic animals that coexpress an PAD-linked human PS1 variant (A246E) and a chimeric mouse/human APP harboring mutations linked to Swedish PAD kindreds (APP swe) develop numerous amyloid deposits much earlier than age-matched mice expressing APP swe and wild-type Hu PS1 or APP swe alone. These results provide evidence for the view that one pathogenic mechanism by which PAD-linked mutant PS1 causes AD is to accelerate the rate of beta-amyloid deposition in brain.	JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA; NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MAMMALIAN GENET LAB, FREDERICK, MD 21702 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Lee, Michael K/D-9491-2013	Lee, Michael K/0000-0001-5865-9682	NIA NIH HHS [AG14248, AG05146] Funding Source: Medline; NINDS NIH HHS [NS 20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014248] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; BORCHELT DR, 1994, J BIOL CHEM, V269, P14711; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Boteva K, 1996, LANCET, V347, P130, DOI 10.1016/S0140-6736(96)90261-5; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Campion D, 1996, NEUROREPORT, V7, P1582, DOI 10.1097/00001756-199607080-00009; CHAPMAN J, 1995, LANCET, V346, P1040, DOI 10.1016/S0140-6736(95)91723-3; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Mann DMA, 1996, AM J PATHOL, V148, P1257; MARTIN LJ, 1994, AM J PATHOL, V145, P1358; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NAKANO I, 1987, J NEUROPATH EXP NEUR, V46, P40, DOI 10.1097/00005072-198701000-00004; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PerezTur J, 1995, NEUROREPORT, V7, P297; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sherrington R, 1996, HUM MOL GENET, V5, P985, DOI 10.1093/hmg/5.7.985; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1993, J NEUROSCI, V13, P3136; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TERRY RD, 1983, NEUROLOGY AGING, P51; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; WASCO W, 1995, NAT MED, V1, P848, DOI 10.1038/nm0995-848a; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I	51	835	901	3	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT	1997	19	4					939	945		10.1016/S0896-6273(00)80974-5	http://dx.doi.org/10.1016/S0896-6273(00)80974-5			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354339	hybrid			2022-12-24	WOS:A1997YD18900020
J	RodriguezMoreno, A; Herreras, O; Lerma, J				RodriguezMoreno, A; Herreras, O; Lerma, J			Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus	NEURON			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; KAINIC ACID; SYNAPTIC TRANSMISSION; EPILEPTIFORM ACTIVITY; PREFERRING RECEPTORS; PYRAMIDAL NEURONS; AMPA RECEPTORS; MOSSY FIBERS; SUBUNITS	Using microcultured neurons and hippocampal slices, we found that under conditions that completely block AMPA receptors, kainate induces a reduction in the effectiveness of GABAergic synaptic inhibition. Evoked inhibitory postsynaptic currents (IPSCs) were decreased by kainate by up to 90%, showing a bell-shaped dose-response curve similar to that of native kainate-selective receptors. The down-regulation of GABAergic inhibition was not affected by antagonism of metabotropic receptors, while it was attenuated by CNQX. Kainate increased synaptic failures and reduced the frequency of miniature IPSCs, indicating a presynaptic locus of action. In vivo experiments using brain dialysis demonstrated that kainate reversibly abolished recurrent inhibition and induced an epileptic-like electroencephalogram (EEG) activity. These results indicate that kainate receptor activation downregulates GABAergic inhibition by modulating the reliability of GABA synapses.	CSIC,INST CAJAL,DEPT NEURAL PLAST,E-28002 MADRID,SPAIN; HOSP RAMON Y CAJAL,DEPT INVEST,E-28034 MADRID,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Hospital Universitario Ramon y Cajal			Lerma, Juan/G-7907-2015; herreras, oscar/D-5256-2016; Herreras, Oscar/O-1711-2019; Rodriguez-Moreno, Antonio/I-5225-2015	Lerma, Juan/0000-0001-7838-5199; herreras, oscar/0000-0002-8210-3710; Herreras, Oscar/0000-0002-8210-3710; Rodriguez-Moreno, Antonio/0000-0002-8078-6175				BAHN S, 1994, J NEUROSCI, V14, P5525; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHERUBINI E, 1990, EPILEPSY RES, V5, P18, DOI 10.1016/0920-1211(90)90062-Z; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; CLEMENTS J, 1991, NATURE, V353, P396, DOI 10.1038/353396a0; CLEMENTS JD, 1990, J NEUROSCI METH, V31, P75, DOI 10.1016/0165-0270(90)90012-5; COOPER JR, 1986, BIOCH BASIS NEUROPHA; COYLE JT, 1983, J NEUROCHEM, V41, P1; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; FISHER RS, 1984, J NEUROSCI, V4, P1312; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GAIARSA JL, 1994, J NEUROPHYSIOL, V71, P204, DOI 10.1152/jn.1994.71.1.204; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENDRY SHC, 1983, J NEUROCYTOL, V12, P639, DOI 10.1007/BF01181528; HERRERAS O, 1994, J NEUROSCI, V14, P7087; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Houser C.R., 1984, CEREB CORTEX, V2, P63, DOI [10.1007/978-1-4615-6610-6_3, DOI 10.1007/978-1-4615-6610-6_3]; HUNTLEY GW, 1993, J NEUROSCI, V13, P2965; KEHL SJ, 1985, EXP BRAIN RES, V60, P309; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Largo C, 1996, J NEUROSCI, V16, P1219; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; Lerma J, 1997, TRENDS NEUROSCI, V20, P9, DOI 10.1016/S0166-2236(96)20055-4; LERMA J, 1997, IN PRESS DEV BIOL; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; McGehee DS, 1996, CURR OPIN NEUROBIOL, V6, P342, DOI 10.1016/S0959-4388(96)80118-8; Paternain AV, 1996, EUR J NEUROSCI, V8, P2129, DOI 10.1111/j.1460-9568.1996.tb00734.x; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; POCOCK JM, 1988, J NEUROCHEM, V50, P745, DOI 10.1111/j.1471-4159.1988.tb02977.x; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; RIBAK CE, 1978, J NEUROCYTOL, V7, P461, DOI 10.1007/BF01173991; ROVIRA C, 1990, PFLUG ARCH EUR J PHY, V415, P471, DOI 10.1007/BF00373625; RUANO D, 1995, NEURON, V14, P1009, DOI 10.1016/0896-6273(95)90339-9; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; SIEGEL SJ, 1995, J NEUROSCI, V15, P2702; Siegelbaum S A, 1991, Curr Opin Neurobiol, V1, P113, DOI 10.1016/0959-4388(91)90018-3; SLOVITER RS, 1981, NEUROPHARMACOLOGY, V20, P1001; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; THOMSON AM, 1995, EXCITATORY AMINO ACI, P145; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; VIZI ES, 1996, CNS DRUG REV, V2, P91; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; Wilding TJ, 1996, MOL PHARMACOL, V49, P540; Wilding TJ, 1997, J NEUROSCI, V17, P2713; WILDING TJ, 1995, MOL PHARMACOL, V47, P582; ZIEGRA CJ, 1992, P NATL ACAD SCI USA, V89, P4134, DOI 10.1073/pnas.89.9.4134	56	268	273	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					893	901		10.1016/S0896-6273(00)80970-8	http://dx.doi.org/10.1016/S0896-6273(00)80970-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354335	Bronze			2022-12-24	WOS:A1997YD18900016
J	Quirk, GJ; Armony, JL; LeDoux, JE				Quirk, GJ; Armony, JL; LeDoux, JE			Fear conditioning enhances different temporal components of tone-evoked spike trains in auditory cortex and lateral amygdala	NEURON			English	Article							MEDIAL GENICULATE-BODY; RECEPTIVE-FIELD PLASTICITY; POTENTIATED STARTLE; SINGLE NEURONS; PHYSIOLOGICAL PLASTICITY; UNCONDITIONED STIMULUS; RESPONSE PROPERTIES; PERIRHINAL CORTEX; HEART-RATE; NUCLEUS	Single neurons were recorded in freely behaving rats during fear conditioning from areas of auditory cortex that project to the lateral nucleus of the amygdala (LA). The latency and rate of conditioning and extinction were analyzed, and the results were compared to previous recordings from LA itself. Auditory cortex neurons took more trials to learn, and they responded more slowly than LA neurons within trials. Short-latency plasticity in LA, therefore, reflects inputs from the auditory thalamus rather than the auditory cortex. Unlike LA cells, some auditory cortex cells showed late conditioned responses that seemed to anticipate the unconditioned stimulus, while others showed extinction-resistant memory storage. Thus, rapid conditioning of fear responses to potentially dangerous stimuli depends on plasticity in the amygdala, while cortical areas may be particularly involved in higher cognitive (mnemonic and attentional) processing of fear experiences.	NYU,CTR NEURAL SCI,NEW YORK,NY 10003	New York University					NIMH NIH HHS [MH46516, MH00956, MH38774] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, K02MH000956, R01MH038774, R37MH038774] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adey W R, 1967, Prog Brain Res, V27, P228; Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Armony JL, 1997, TRENDS COGN SCI, V1, P28, DOI 10.1016/S1364-6613(97)01007-3; BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; BIRT D, 1979, BRAIN RES, V167, P129, DOI 10.1016/0006-8993(79)90268-3; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BORDI F, 1992, J NEUROSCI, V12, P2493; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; BOUTON ME, 1994, CURR DIR PSYCHOL SCI, V3, P49, DOI 10.1111/1467-8721.ep10769943; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; CHAMEY DS, 1996, CRIT REV NEUROBIOL, V10, P419; CLUGNET MC, 1990, J NEUROSCI, V10, P2818; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; CRUIKSHANK SJ, 1992, BEHAV NEUROSCI, V106, P471, DOI 10.1037/0735-7044.106.3.471; DAVIS M, 1989, J EXP PSYCHOL-ANIM B, V15, P295, DOI 10.1037/0097-7403.15.4.295; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; DIAMOND DM, 1984, BEHAV NEUROSCI, V98, P189, DOI 10.1037/0735-7044.98.2.189; DIAMOND DM, 1986, BRAIN RES, V372, P357, DOI 10.1016/0006-8993(86)91144-3; DISTERHOFT JF, 1976, J NEUROPHYSIOL, V39, P266, DOI 10.1152/jn.1976.39.2.266; EDELINE JM, 1990, PSYCHOBIOLOGY, V18, P382; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P539, DOI 10.1037/0735-7044.107.4.539; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; FALLS WA, 1992, J NEUROSCI, V12, P854; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P275; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P124; GALLISTEL CR, 1990, ORG LEARNING, P287; GONZALEZLIMA F, 1986, BEHAV BRAIN RES, V20, P281, DOI 10.1016/0166-4328(86)90228-7; JARELL TW, 1987, BRAIN RES, V412, P285; KAPP B S, 1992, P229; KRAUS N, 1982, BRAIN RES, V246, P205, DOI 10.1016/0006-8993(82)91168-4; KUBIE JL, 1984, PHYSIOL BEHAV, V32, P115, DOI 10.1016/0031-9384(84)90080-5; Ledoux J E, 1989, J Cogn Neurosci, V1, P238, DOI 10.1162/jocn.1989.1.3.238; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEDOUX JE, 1984, J NEUROSCI, V4, P683; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; LEDOUX JE, 1983, SCIENCE, V221, P576, DOI 10.1126/science.6867731; LI XF, 1995, EXP BRAIN RES, V105, P87; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; MASCAGNI F, 1993, NEUROSCIENCE, V57, P697, DOI 10.1016/0306-4522(93)90016-9; MCECHRON MD, 1995, BRAIN RES, V682, P157, DOI 10.1016/0006-8993(95)00331-J; MISERENDINO MJD, 1990, NATURE, V163, P109; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Ohman A., 1992, HDB EMOTIONS, P511; OLESON TD, 1975, J NEUROPHYSIOL, V38, P1114, DOI 10.1152/jn.1975.38.5.1114; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Quirk GJ, 1996, COLD SPRING HARB SYM, V61, P247; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; ROSEN JB, 1992, J NEUROSCI, V12, P4624; RYUGO DK, 1978, BEHAV BIOL, V22, P275, DOI 10.1016/S0091-6773(78)92351-9; SEGAL M, 1973, J NEUROPHYSIOL, V36, P840, DOI 10.1152/jn.1973.36.5.840; SHALEV AY, 1992, BIOL PSYCHIAT, V31, P863, DOI 10.1016/0006-3223(92)90113-E; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; TEICH AH, 1989, BRAIN RES, V480, P210, DOI 10.1016/0006-8993(89)91584-9; TIAN B, 1994, J NEUROPHYSIOL, V71, P1959, DOI 10.1152/jn.1994.71.5.1959; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; WEINBERGER NM, 1984, BEHAV NEUROSCI, V98, P171, DOI 10.1037/0735-7044.98.2.171; Weinberger Norman M., 1995, P1071; WOLPE J, 1988, BEHAV RES THER, V26, P441, DOI 10.1016/0005-7967(88)90138-6; WOOLF NJ, 1994, NEUROREPORT, V5, P1045, DOI 10.1097/00001756-199405000-00007; Zilles K., 1985, RAT NERVOUS SYSTEM F, V1, P375	74	434	442	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					613	624		10.1016/S0896-6273(00)80375-X	http://dx.doi.org/10.1016/S0896-6273(00)80375-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XZ016	9331352	hybrid			2022-12-24	WOS:A1997XZ01600015
J	Cseresnyes, Z; Bustamante, AI; Klein, MG; Schneider, MF				Cseresnyes, Z; Bustamante, AI; Klein, MG; Schneider, MF			Release-activated Ca2+ transport in neurons of frog sympathetic ganglia	NEURON			English	Article							INTRACELLULAR CALCIUM POOLS; SMOOTH-MUSCLE CELLS; SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR; CA-2+ RELEASE; ACTION-POTENTIALS; CAFFEINE; STORES; CHANNELS	Frog sympathetic ganglion neurons exhibit a novel Ca2+ uptake mechanism, release-activated calcium transport or RACT, which is manifest in both cytosolic and store [Ca2+] signals as greatly accelerated Ca2+ uptake after Ca2+ release from internal stores. RACT is activated by Ca2+ release but not by Ca2+ entry and serves to selectively refill Ca2+ stores after release. RACT lowers cytosolic [Ca2+] with a rate constant about 1.6 times that of the SERCA pump with empty ER. RACT is thapsigargin-insensitive, was eliminated by ryanodine, but was not affected by blocking mitochondrial or plasma membrane Ca2+ transport. A Ca2+ flux model with RACT in the ER membrane reproduced the cytosolic and store [Ca2+] responses to all stimuli.			Cseresnyes, Z (corresponding author), UNIV MARYLAND,SCH MED,DEPT BIOCHEM & MOL BIOL,BALTIMORE,MD 21201, USA.		Cseresnyes, Zoltan/AAG-4266-2020	Cseresnyes, Zoltan/0000-0002-6574-2588	NINDS NIH HHS [NIHER01-NS33578] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033578] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRY VA, 1994, BIOCHEM J, V300, P589, DOI 10.1042/bj3000589; BECKER PL, 1989, SCIENCE, V244, P211, DOI 10.1126/science.2704996; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BIAN JH, 1991, J BIOL CHEM, V266, P8801; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FRIEL DD, 1992, NEURON, V8, P1109, DOI 10.1016/0896-6273(92)90132-W; FRIEL DD, 1995, BIOPHYS J, V68, P1752, DOI 10.1016/S0006-3495(95)80352-8; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GINTY DD, 1997, NEURON, V18, P186; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hehl S, 1996, CELL CALCIUM, V20, P515, DOI 10.1016/S0143-4160(96)90094-9; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HerrmannFrank A, 1996, BBA-GEN SUBJECTS, V1289, P31, DOI 10.1016/0304-4165(95)00131-X; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; HUA SY, 1994, NEURON, V12, P1073, DOI 10.1016/0896-6273(94)90315-8; HUA SY, 1993, J PHYSIOL-LONDON, V464, P245, DOI 10.1113/jphysiol.1993.sp019633; Huang WC, 1996, BRAIN RES, V718, P151, DOI 10.1016/0006-8993(96)00108-4; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KASS RS, 1978, J PHYSIOL-LONDON, V281, P187, DOI 10.1113/jphysiol.1978.sp012416; KUBA K, 1992, CAN J PHYSIOL PHARM, V70, pS64, DOI 10.1139/y92-245; KUBA K, 1994, JPN J PHYSIOL, V44, P613, DOI 10.2170/jjphysiol.44.613; LeGuennec JY, 1996, EXP PHYSIOL, V81, P577, DOI 10.1113/expphysiol.1996.sp003960; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MCBURNEY RN, 1985, J NEUROSCI METH, V13, P65, DOI 10.1016/0165-0270(85)90044-5; MCPHERSON PS, 1993, J BIOL CHEM, V268, P19785; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; MULLER CE, 1993, BIOCHEM PHARMACOL, V46, P1825, DOI 10.1016/0006-2952(93)90589-O; NOHMI M, 1992, J PHYSIOL-LONDON, V450, P513, DOI 10.1113/jphysiol.1992.sp019140; NOHMI M, 1992, J PHYSIOL-LONDON, V458, P171, DOI 10.1113/jphysiol.1992.sp019412; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; PALADE P, 1987, J BIOL CHEM, V262, P6142; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; SHORT AD, 1993, J BIOL CHEM, V268, P25887; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH PA, 1994, PROG NEUROBIOL, V43, P439, DOI 10.1016/0301-0082(94)90062-0; TANAKA Y, 1993, BIOCHEMISTRY-US, V32, P12062, DOI 10.1021/bi00096a017; TERASAKI M, 1991, J CELL BIOL, V115, P1031, DOI 10.1083/jcb.115.4.1031; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; TRIBE RM, 1994, P NATL ACAD SCI USA, V91, P5908, DOI 10.1073/pnas.91.13.5908; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; ZIDICHOUSKI JA, 1989, BRIT J PHARMACOL, V96, P779, DOI 10.1111/j.1476-5381.1989.tb11883.x; ZORZATO F, 1993, MOL PHARMACOL, V44, P1192	56	18	18	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					403	419		10.1016/S0896-6273(00)80949-6	http://dx.doi.org/10.1016/S0896-6273(00)80949-6			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292729	Bronze			2022-12-24	WOS:A1997XU14600018
J	Gensert, JM; Goldman, JE				Gensert, JM; Goldman, JE			Endogenous progenitors remyelinate demyelinated axons in the adult CNS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; SPINAL-CORD; LYSOPHOSPHATIDYL CHOLINE; MATURE OLIGODENDROCYTES; CELL LINEAGE; IN-VIVO; PROLIFERATION; LESIONS; MOUSE	Remyelination occurs in demyelinated CNS regions in diseases such as multiple sclerosis. Identification of the cell type(s) responsible for this remyelination, however, has been elusive. Here, we examine one potential source of remyelinating oligodendrocytes-immature, cycling cells endogenous to adult white matter-and demonstrate that this population responds to demyelination by differentiating into myelinating oligodendrocytes. Dividing cells in subcortical white matter of adult rats were labeled by stereotactic injection of a replication-deficient lacZ-encoding retrovirus (BAG). Following a focal demyelination induced with lysolecithin, many of the BAG-labeled cells differentiated into myelinating oligodendrocytes engaging in repair of the lesion. Identification of endogenous cells capable of remyelination provides a target for the study of CNS repair processes in demyelinating diseases.	COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Columbia University; Columbia University	Gensert, JM (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PHYSIOL & CELLULAR BIOPHYS, NEW YORK, NY 10032 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017125] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-17125] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen I.V., 1992, GREENFIELDS NEUROPAT, P447; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; ANDERSSON C, 1993, INT J DEV NEUROSCI, V11, P555, DOI 10.1016/0736-5748(93)90045-F; ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BLAKEMORE WF, 1996, GLIAL CELL DEV BASIC, P209; COMPSTON A, 1994, ANN NEUROL, V36, pS146, DOI 10.1002/ana.410360736; DALTON MM, 1968, J COMP NEUROL, V134, P397, DOI 10.1002/cne.901340403; DASTON MM, 1994, J NEUROCYTOL, V23, P323, DOI 10.1007/BF01188500; DEIBLER GE, 1972, PREP BIOCHEM, V2, P139, DOI 10.1080/00327487208061467; DUNCAN ID, 1992, DEV NEUROSCI-BASEL, V14, P114, DOI 10.1159/000111655; DUNCAN ID, 1994, NATO ADV SCI INST SE, V258, P195; EMMETT CJ, 1991, J COMP NEUROL, V310, P330; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; Gensert JM, 1996, GLIA, V17, P39; HALL SM, 1972, J CELL SCI, V10, P535; HALL SM, 1971, J CELL SCI, V9, P769; HOMMES OR, 1967, J COMP NEUROL, V29, P269; Honmou O, 1996, J NEUROSCI, V16, P3199; LUDWIN SK, 1993, GLIA, V8, P219, DOI 10.1002/glia.440080402; LUDWIN SK, 1994, ANN NEUROL, V36, pS143, DOI 10.1002/ana.410360735; LUDWIN SK, 1988, J NEUROSCI, V8, P1239; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; LUDWIN SK, 1987, CRIT REV NEUROBIOL, V3, P1; LUDWIN SK, 1979, AM J PATHOL, V95, P683; Noble M, 1992, Semin Cell Biol, V3, P413, DOI 10.1016/1043-4682(92)90012-K; PRICE J, 1987, DEVELOPMENT, V101, P409; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PRINEAS JW, 1993, ANN NEUROL, V33, P137, DOI 10.1002/ana.410330203; PRINEAS JW, 1989, LAB INVEST, V61, P489; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; RAINE CS, 1981, LAB INVEST, V45, P534; RAINE CS, 1991, TXB NEUROPATHOLOGY, P535; RMO S, 1995, HISTOLOGY NERVOUS SY, V2, P589; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Szuchet Sara, 1995, P23; VIGNAIS L, 1993, INT J DEV NEUROSCI, V11, P603, DOI 10.1016/0736-5748(93)90049-J; WOLSWIJK G, 1989, DEVELOPMENT, V105, P3387; WOOD PM, 1991, GLIA, V4, P225, DOI 10.1002/glia.440040214; WU E, 1992, LAB INVEST, V67, P88	42	455	467	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL	1997	19	1					197	203		10.1016/S0896-6273(00)80359-1	http://dx.doi.org/10.1016/S0896-6273(00)80359-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247275	Bronze			2022-12-24	WOS:A1997XN39400018
J	McAllister, AK; Katz, LC; Lo, DC				McAllister, AK; Katz, LC; Lo, DC			Neurotrophin regulation of cortical dendritic growth requires activity	NEURON			English	Review							RAT VISUAL-CORTEX; MESSENGER-RNA; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; NEURONAL PLASTICITY; MOLECULAR-CLONING; NERVOUS-SYSTEM; TRK FAMILY; NGF; SURVIVAL	Neurotrophins have been proposed to mediate several forms of activity-dependent competition in the central nervous system. A key element of such hypotheses is that neurotrophins act preferentially on active neurons; however, little direct evidence supports this postulate. We therefore examined, in ferret cortical brain slices, the interactions between activity and neurotrophins in regulating dendritic growth of layer 4 pyramidal neurons. Inhibition of spontaneous electrical activity, synaptic transmission, or L-type calcium channels each prevented the otherwise dramatic increase in dendritic arborizations elicited by brain-derived neurotrophic factor. In developing cortex, this requirement for conjoint neurotrophin signaling and activity provides a mechanism for selectively enhancing the growth and connectivity of active neurons.	DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA	Duke University	McAllister, AK (corresponding author), DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DURHAM, NC 27710 USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NEI NIH HHS [EY11553, EY07690] Funding Source: Medline; NINDS NIH HHS [NS32742] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032742, R29NS032742] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BERARDI N, 1994, P NATL ACAD SCI USA, V91, P684, DOI 10.1073/pnas.91.2.684; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; COHENCORY S, 1991, J NEUROSCI, V11, P462; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; FRANKLIN JL, 1994, PHILOS T ROY SOC B, V345, P251, DOI 10.1098/rstb.1994.0102; GALUSKE RAW, 1996, IN PRESS EUR J NEURO; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; GU Q, 1994, P NATL ACAD SCI USA, V91, P8408, DOI 10.1073/pnas.91.18.8408; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; KATZ LC, 1989, J NEUROSCI, V9, P1389; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; PURVES D, 1988, BODY BRAIN; REH TA, 1985, J NEUROSCI, V5, P1132; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SCHOUPS AA, 1995, DEV BRAIN RES, V86, P326, DOI 10.1016/0165-3806(95)00043-D; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; VALVERDE F, 1968, EXP BRAIN RES, V5, P274; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6	51	416	421	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1057	1064		10.1016/S0896-6273(00)80239-1	http://dx.doi.org/10.1016/S0896-6273(00)80239-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982155				2022-12-24	WOS:A1996WA24800005
J	Breiter, HC; Etcoff, NL; Whalen, PJ; Kennedy, WA; Rauch, SL; Buckner, RL; Strauss, MM; Hyman, SE; Rosen, BR				Breiter, HC; Etcoff, NL; Whalen, PJ; Kennedy, WA; Rauch, SL; Buckner, RL; Strauss, MM; Hyman, SE; Rosen, BR			Response and habituation of the human amygdala during visual processing of facial expression	NEURON			English	Article							STIMULUS-REWARD ASSOCIATIONS; HUMAN BRAIN; IMPAIRED RECOGNITION; UNIPOLAR DEPRESSION; SENSORY STIMULATION; OVERLYING AREAS; TEMPORAL CORTEX; MONKEY; NEURONS; FACES	We measured amygdala activity in human volunteers during rapid visual presentations of fearful, happy, and neutral faces using functional magnetic resonance imaging (fMRI). The first experiment involved a fixed order of conditions both within and across runs, while the second one used a fully counterbalanced order in addition to a low level baseline of simple visual stimuli. In both experiments, the amygdala was preferentially activated in response to fearful versus neutral faces. In the counterbalanced experiment, the amygdala also responded preferentially to happy versus neutral faces, suggesting a possible generalized response to emotionally valenced stimuli. Rapid habituation effects were prominent in both experiments. Thus, the human amygdala responds preferentially to emotionally valenced faces and rapidly habituates to them.	MASSACHUSETTS GEN HOSP,DEPT RADIOL,NUCL MAGNET RESONANCE CTR,CHARLESTOWN,MA 02129; HARVARD UNIV,SCH MED,CHARLESTOWN,MA 02129	Harvard University; Massachusetts General Hospital; Harvard University	Breiter, HC (corresponding author), MASSACHUSETTS GEN HOSP,DEPT PSYCHIAT,CHARLESTOWN,MA 02129, USA.		anand, amit/A-7222-2009; Tudusciuc, Oana/C-1339-2011		NHLBI NIH HHS [HL39810] Funding Source: Medline; NIDA NIH HHS [DA00265, DA09467] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039810] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Andreasen NC, 1996, J NEUROPSYCH CLIN N, V8, P139; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BENKELFAT C, 1995, AM J PSYCHIAT, V152, P1180; BORDI F, 1993, BEHAV NEUROSCI, V107, P757, DOI 10.1037/0735-7044.107.5.757; BORDI F, 1992, J NEUROSCI, V12, P2493; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; BREITER HC, 1996, IN PRESS NEUROIMAGE; BUCKNER RL, 1995, J NEUROSCI, V15, P12; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DAVIS M, 1992, P255; DREVETS WC, 1992, J NEUROSCI, V12, P3628; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Ekman P., 1976, PICTURES FACIAL AFFE; EKMAN P, 1988, HDB SOCIAL PSYCHOPHY, P143; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; FEINBERG TE, 1986, ARCH GEN PSYCHIAT, V43, P276; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; FROMM D, 1984, BIOL PSYCHIAT, V19, P55; GAFFAN D, 1987, J NEUROSCI, V7, P2285; GAFFAN EA, 1988, J NEUROSCI, V8, P3144; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; GEORGE MS, 1993, J NEUROPSYCHIAT, V5, P284; GREDEN JF, 1986, ARCH GEN PSYCHIAT, V43, P269; GUR RC, 1992, PSYCHIAT RES, V42, P241, DOI 10.1016/0165-1781(92)90116-K; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Hamann SB, 1996, NATURE, V379, P497, DOI 10.1038/379497a0; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hatfield T, 1996, J NEUROSCI, V16, P5256; HAXBY JV, 1994, J NEUROSCI, V14, P6336; IRWIN W, 1996, IN PRESS HUMAN AMYGD; JAEGER J, 1986, J AFFECT DISORDERS, V11, P43, DOI 10.1016/0165-0327(86)90058-3; JIANG A, 1995, HUM BRAIN MAPP, V3, P1; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KANWISHER N, 1996, IN PRESS COGN BRAIN; KAPP B S, 1992, P229; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LABAR KS, 1995, J NEUROSCI, V15, P6846; LEDOUX J E, 1992, P339; LEDOUX JE, 1993, ANN NY ACAD SCI, V702, P149, DOI 10.1111/j.1749-6632.1993.tb17246.x; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Mikhailova ES, 1996, BIOL PSYCHIAT, V40, P697, DOI 10.1016/0006-3223(96)00032-7; NAKAMURA K, 1992, J NEUROPHYSIOL, V67, P1447, DOI 10.1152/jn.1992.67.6.1447; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; PERRETT DI, 1982, ADV VERTEBRATE NEURO; Puce A, 1996, J NEUROSCI, V16, P5205; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Reese TG, 1995, JMRI-J MAGN RESON IM, V5, P739, DOI 10.1002/jmri.1880050621; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; ROLLS ET, 1985, SCI BASIS CLIN NEURO, P201; ROLLS ET, 1991, PROCESSING IMAGES FA; ROLLS ET, 1981, AMYGDALOID COMPLEX, P383; RUBINOW DR, 1992, BIOL PSYCHIAT, V31, P947, DOI 10.1016/0006-3223(92)90120-O; SCHNEIDER F, 1992, NERVENARZT, V63, P545; Schneider F, 1996, AM J PSYCHIAT, V153, P206; Sergent J., 1994, VIS COGN, V1, P349, DOI [10.1080/13506289408402305, DOI 10.1080/13506289408402305]; SPIEGLER BJ, 1981, BEHAV BRAIN RES, V3, P303, DOI 10.1016/0166-4328(81)90002-4; Talairach J., 1988, COPLANAR STEREOTAXIC; Tomkins, 1963, AFFECT IMAGERY CONSC, V2; Tomkins SS, 1962, AFFECT IMAGERY CONSC, V1; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	71	1291	1309	2	117	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					875	887		10.1016/S0896-6273(00)80219-6	http://dx.doi.org/10.1016/S0896-6273(00)80219-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	VV151	8938120	Bronze			2022-12-24	WOS:A1996VV15100010
J	Kuner, T; Wollmuth, LP; Karlin, A; Seeburg, PH; Sakmann, B				Kuner, T; Wollmuth, LP; Karlin, A; Seeburg, PH; Sakmann, B			Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines	NEURON			English	Article							VOLTAGE-DEPENDENT BLOCK; LONG-TERM POTENTIATION; GLUTAMATE-RECEPTOR; ACTIVATED CHANNELS; N-GLYCOSYLATION; TOPOLOGY; NEURONS; HIPPOCAMPUS; RESIDUES; SUBUNIT	The structure of the NMDA receptor channel M2 segment was investigated by probing the extracellular and cytoplasmic faces of cysteine-substituted NR1-NRPC channels with charged sulfhydryl-specific reagents. The pattern of accessible positions suggests that the M2 segment forms a channel-lining loop originating and ending on the cytoplasmic side of the channel, with the ascending limb in an alpha-helical structure and the descending limb in an extended structure. A functionally critical asparagine (N-site) is positioned at the tip of the loop, and a cluster of hydrophilic residues of the descending limb, adjacent to the tip, forms the narrow constriction of the channel. An apparent asymmetric positioning of the NR1- and NRP-subunit N-site asparagines may account for their unequal role in Ca2+ permeability and Mg2+ block.	MAX PLANCK INST MED RES,ABT MOL NEUROBIOL,D-69120 HEIDELBERG,GERMANY; MAX PLANCK INST MED RES,ZELLPHYSIOL ABT,D-69120 HEIDELBERG,GERMANY; COLUMBIA UNIV COLL PHYS & SURG,CTR MOL RECOGNIT,DEPT BIOCHEM,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR MOL RECOGNIT,DEPT PHYSIOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR MOL RECOGNIT,DEPT NEUROL,NEW YORK,NY 10032	Max Planck Society; Max Planck Society; Columbia University; Columbia University; Columbia University	Kuner, T (corresponding author), UNIV HEIDELBERG,ZENTRUM MOL BIOL,NEUENHEIMER FELD 282,D-69120 HEIDELBERG,GERMANY.			KARLIN, ARTHUR/0000-0002-4813-752X; Wollmuth, Lonnie/0000-0002-8179-1259				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARELLANO RO, 1995, J PHYSIOL-LONDON, V484, P593, DOI 10.1113/jphysiol.1995.sp020689; AUSUBEL FM, 1995, CURRENT PROTOCOLS MO, pCH8; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hilgemann Donald W., 1995, P307; Hille B., 1992, IONIC CHANNELS EXCIT; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; ISHII T, 1993, J BIOL CHEM, V268, P2833; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; Kuner T, 1996, J NEUROSCI, V16, P3549; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; MACDERMOTT AB, 1956, NATURE, V321, P261; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERKEL DJ, 1993, NEURON, V11, P811; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882	33	190	194	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					343	352		10.1016/S0896-6273(00)80165-8	http://dx.doi.org/10.1016/S0896-6273(00)80165-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780657	hybrid			2022-12-24	WOS:A1996VE84000016
J	Huang, YY; Kandel, ER				Huang, YY; Kandel, ER			Modulation of both the early and the late phase of mossy fiber LTP by the activation of beta-adrenergic receptors	NEURON			English	Article							LONG-TERM POTENTIATION; ADULT-RAT; HIPPOCAMPUS; NOREPINEPHRINE; INNERVATION; RESPONSES; INCREASES; NEURONS; MEMORY; BRAIN	cAMP and the cAMP-dependent protein kinase (PKA) are required in the messy fiber pathway for both the early and the late phase of long-term potentiation (LTP). Since the CA3 region, which is the target of the messy fibers, receives extensive noradrenergic innervation, we examined the role of beta-adrenergic receptors in messy fiber LTP. We found that we could induce an early phase of LTP by pairing isoproterenol, a beta-adrenergic receptor agonist, with a weak train, subthreshold for LTP. This LTP was specific to the messy fiber pathway, was blocked by inhibitors of PKA, and occluded paired-pulse facilitation, suggesting that isoproterenol was acting presynaptically. When isoproterenol was paired with a train that induced only the early phase of LTP, it gave rise to a protein synthesis-dependent late phase. Consistent with these findings, beta-adrenergic antagonists blocked both the late and the early phase of LTP induced by messy fiber stimulation. Thus, beta-adrenegic receptor modulation is important for both phases of messy fiber LTP.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Columbia University	Huang, YY (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32099] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CASTELLANO C, 1991, BEHAV NEURAL BIOL, V56, P283, DOI 10.1016/0163-1047(91)90439-W; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CROW TJ, 1976, NATURE, V259, P42, DOI 10.1038/259042b0; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GEREAU RW, 1994, J NEUROPHYSIOL, V72, P1438, DOI 10.1152/jn.1994.72.3.1438; GEREAU RW, 1994, J NEUROSCI, V14, P3310; GOLD PE, 1978, BEHAV BIOL, V23, P509, DOI 10.1016/S0091-6773(78)91614-0; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2448; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; MONTAGUE PR, 1995, P NATL ACAD SCI USA, V92, P2425; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; MUELLER AL, 1981, BRAIN RES, V214, P113, DOI 10.1016/0006-8993(81)90442-X; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; OLESKEVICH S, 1989, J NEUROSCI, V9, P3803; PARFITT KD, 1992, HIPPOCAMPUS, V2, P59, DOI 10.1002/hipo.450020108; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STANTON PK, 1985, BRAIN RES, V358, P343, DOI 10.1016/0006-8993(85)90981-3; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WINDER DG, 1993, J NEUROSCI, V13, P38; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167	27	162	167	3	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					611	617		10.1016/S0896-6273(00)80080-X	http://dx.doi.org/10.1016/S0896-6273(00)80080-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785058	hybrid			2022-12-24	WOS:A1996UC16800017
J	Wang, KW; Tai, KK; Goldstein, SAN				Wang, KW; Tai, KK; Goldstein, SAN			MinK residues line a potassium channel pore	NEURON			English	Article							DEPENDENT K+ CHANNEL; PROTEIN-KINASE-C; XENOPUS OOCYTES; CYSTEINE-SUBSTITUTION; MEMBRANE-PROTEIN; TEA BLOCKADE; MUTATIONS; CLONING; ISK; EXPRESSION	MinK has neither the P region nor signature sequence that characterizes pore-forming subunits of all known K+ channels. A specific minK region has now been identified that affects external blockade by 2 common probes of K+ channel pores. When mutated to cysteine, residues in this region render minK susceptible to covalent blockade by methanethiosulfonate ethylsulfonate and alter reversible inhibition by tetraethylammonium. The 2 blockers are found to share overlapping binding site determinants and to interact. Since inhibition by external tetraethylammonium is sensitive to voltage and to the internal concentration of permeant ions, we argue that tetraethylammonium blocks by occluding the external end of a water-filled transmembrane pore. These findings support the view that minK is directly involved in forming a K+-selective ion conduction pathway.	YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOYER CTR MOLEC MED,NEW HAVEN,CT 06536	Yale University	Wang, KW (corresponding author), YALE UNIV,SCH MED,DEPT PEDIAT,BOYER CTR MOLEC MED,333 CEDAR ST,NEW HAVEN,CT 06536, USA.		Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ATTALI B, 1993, NATURE, V365, P850, DOI 10.1038/365850a0; BLUMENTHAL EM, 1992, J NEUROSCI, V12, P290; BLUMENTHAL EM, 1994, J NEUROSCI, V14, P3097; BUSCH AE, 1992, J PHYSIOL-LONDON, V450, P491, DOI 10.1113/jphysiol.1992.sp019138; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; BUSCH AE, 1995, J BIOL CHEM, V270, P3638, DOI 10.1074/jbc.270.8.3638; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FREEMAN LC, 1993, CIRC RES, V73, P968, DOI 10.1161/01.RES.73.5.968; FREEMAN LC, 1994, BIOPHYS J, V66, pA143; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; HAUSDORFF SF, 1991, BIOCHEMISTRY-US, V30, P3341, DOI 10.1021/bi00227a025; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hille B., 1992, IONIC CHANNELS EXCIT; HONORE E, 1991, EMBO J, V10, P2805, DOI 10.1002/j.1460-2075.1991.tb07829.x; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LAU YT, 1988, SCIENCE, V240, P1321, DOI 10.1126/science.3375816; LESAGE F, 1993, RECEPTOR CHANNEL, V1, P143; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MARCUS DC, 1994, AM J PHYSIOL, V267, pC857, DOI 10.1152/ajpcell.1994.267.3.C857; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; MURAI T, 1989, BIOCHEM BIOPH RES CO, V161, P176, DOI 10.1016/0006-291X(89)91577-5; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; SAKAGAMI M, 1991, HEARING RES, V56, P168, DOI 10.1016/0378-5955(91)90166-7; Shimbo K, 1995, BIOPHYS J, V69, P1819, DOI 10.1016/S0006-3495(95)80052-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; SWANSON R, 1993, SEMIN NEUROSCI, V5, P117; Tai Kwok-Keung, 1996, Biophysical Journal, V70, pA151; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TZOUNOPOULOS T, 1995, P NATL ACAD SCI USA, V92, P9593, DOI 10.1073/pnas.92.21.9593; TZOUNOPOULOS T, 1995, BIOPHYS J, V69, P904, DOI 10.1016/S0006-3495(95)79964-7; VARNUM MD, 1993, P NATL ACAD SCI USA, V90, P11528, DOI 10.1073/pnas.90.24.11528; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; XU M, 1993, J BIOL CHEM, V268, P21505; YANG UY, 1995, BIOPHYS J, V68, pA22; YEH TS, 1994, BIOPHYS J, V66, pA143; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	42	79	84	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					571	577		10.1016/S0896-6273(00)80076-8	http://dx.doi.org/10.1016/S0896-6273(00)80076-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785054	hybrid, Green Published			2022-12-24	WOS:A1996UC16800013
J	Adelman, JP; Bond, CT; Pessia, M; Maylie, J				Adelman, JP; Bond, CT; Pessia, M; Maylie, J			Episodic ataxia results from voltage-dependent potassium channels with altered functions	NEURON			English	Article							K+ CHANNEL; ACETAZOLAMIDE; RECEPTOR	Episodic ataxia (EA) is an autosomal dominant human disorder that produces persistent myokymia and attacks of generalized ataxia. Recently, familial EA has been linked to the voltage-dependent delayed rectifier, Kv1.1, on chromosome 12. Six EA families have been identified that carry distinct Kv1.1 missense mutations; all individuals are heterozygous. Expression in Xenopus oocytes demonstrates that two of the EA subunits form homomeric channels with altered gating properties. V408A channels have voltage dependence similar to that bf wild-type channels, but with faster kinetics and increased C-type inactivation, while the voltage dependence of F184C channels is shifted 20 mV positive. The other four EA subunits do not produce functional homomeric channels but reduce the potassium current when coassembled with wild-type subunits. The results suggest a cellular mechanism underlying EA in which the affected nerve cells cannot efficiently repolarize following an action potential because of altered delayed rectifier function.	OREGON HLTH SCI UNIV,DEPT OBSTET & GYNECOL,PORTLAND,OR 97201	Oregon Health & Science University	Adelman, JP (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.			Pessia, Mauro/0000-0002-2857-6795				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ASHIZAWA T, 1983, ANN NEUROL, V13, P285, DOI 10.1002/ana.410130310; BOUCHARD JP, 1984, CAN J NEUROL SCI, V11, P550, DOI 10.1017/S0317167100035022; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BROWNE DL, 1995, MOL GENET, V4, P1671; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; IRANI PF, 1977, ACTA NEUROL SCAND, V55, P273, DOI 10.1111/j.1600-0404.1977.tb05647.x; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; SHEN NV, 1993, NEURON, V11, P67; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; TU LW, 1995, BIOPHYS J, V68, P147, DOI 10.1016/S0006-3495(95)80169-4; ZASORIN NL, 1983, NEUROLOGY, V33, P1212, DOI 10.1212/WNL.33.9.1212	15	185	190	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1449	1454		10.1016/0896-6273(95)90022-5	http://dx.doi.org/10.1016/0896-6273(95)90022-5			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845167	Bronze			2022-12-24	WOS:A1995TL67800022
J	Gad, H; Low, P; Zotova, E; Brodin, L; Shupliakov, O				Gad, H; Low, P; Zotova, E; Brodin, L; Shupliakov, O			Dissociation between Ca2+-triggered synaptic vesicle exocytosis and clathrin-mediated endocytosis at a central synapse	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; ADRENAL CHROMAFFIN CELLS; TRANSMITTER RELEASE; NERVE-TERMINALS; GLUTAMATERGIC TRANSMISSION; RETICULOSPINAL AXONS; PRESYNAPTIC BOUTONS; MEMBRANE RETRIEVAL; COATED VESICLES; DYNAMIN-I	We have tested whether action potential-evoked Ca2+ influx is required to initiate clathrin-mediated synaptic vesicle endocytosis in the lamprey reticulospinal synapse. Exo- and endocytosis were temporally separated by a procedure involving tonic action potential stimulation and subsequent removal of extracellular Ca2+ (Ca-e(2+)). A low concentration of Ca2+ ([Ca2+](e) of 11 mu M) was found to be required for the induction of early stages of endocytosis. However, the entire endocytic process, from the formation of clathrin-coated membrane invaginations to the generation of synaptic vesicles, proceeded in the absence of action potential-mediated Ca2+ entry. Our results indicate that the membrane of synaptic vesicles newly incorporated in the plasma membrane is a sufficient trigger of clathrin-mediated synaptic Vesicle endocytosis.	Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Brodin, L (corresponding author), Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden.		Gad, Helge/J-2238-2014; Shupliakov, Oleg/R-9148-2016	Shupliakov, Oleg/0000-0001-5352-6848; Gad, Helge/0000-0001-6530-1443				ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; ARTALEJO CR, 1996, NEURON, V16, P1; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Brodin L, 1997, EUR J NEUROSCI, V9, P2503, DOI 10.1111/j.1460-9568.1997.tb01679.x; BRODIN L, 1994, ADV SEC MESS PHOSPH, V29, P205; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CECCARELLI B, 1980, PHYSIOL REV, V60, P396, DOI 10.1152/physrev.1980.60.2.396; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HENKEL AW, 1995, NEUROPHARMACOLOGY, V34, P1397, DOI 10.1016/0028-3908(95)00126-Q; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HURLBUT WP, 1994, J MEMBRANE BIOL, V138, P91, DOI 10.1007/BF00211072; Huttner WB, 1995, COLD SPRING HARB SYM, V60, P315, DOI 10.1101/SQB.1995.060.01.036; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KASICKI S, 1989, BRAIN RES, V484, P203, DOI 10.1016/0006-8993(89)90363-6; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOENIG JH, 1989, J NEUROSCI, V9, P3844; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; MALLABIABARRENA A, 1995, CELL, V83, P667, DOI 10.1016/0092-8674(95)90177-9; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Nucifora PGP, 1998, J PHYSIOL-LONDON, V508, P483, DOI 10.1111/j.1469-7793.1998.483bq.x; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; ROBINSON PJ, 1994, TRENDS NEUROSCI, V17, P348, DOI 10.1016/0166-2236(94)90179-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P1035, DOI 10.1016/S0896-6273(00)80236-6; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; SHUPLIAKOV O, 1995, EUR J NEUROSCI, V7, P1111, DOI 10.1111/j.1460-9568.1995.tb01099.x; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TORRITARELLI F, 1990, J CELL BIOL, V110, P449, DOI 10.1083/jcb.110.2.449; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; WHITNEY JA, 1995, CELL, V83, P703; WICKELGREN WO, 1985, J NEUROSCI, V5, P1188; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	56	131	135	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					607	616		10.1016/S0896-6273(00)80570-X	http://dx.doi.org/10.1016/S0896-6273(00)80570-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768846	Bronze			2022-12-24	WOS:000076196400016
J	Farinas, I; Wilkinson, GA; Backus, C; Reichardt, LF; Patapoutian, A				Farinas, I; Wilkinson, GA; Backus, C; Reichardt, LF; Patapoutian, A			Characterization of neurotrophin and Trk receptor functions in developing sensory ganglia: Direct NT-3 activation of TrkB neurons in vivo	NEURON			English	Article							NERVE GROWTH-FACTOR; NEURAL CREST CELLS; DORSAL-ROOT GANGLIA; TARGETED DISRUPTION; EXPRESSION; MICE; GENE; SYSTEM; DEATH; INNERVATION	Spinal sensory ganglia have been shown to contain neuronal subpopulations with different functions and neurotrophin dependencies. Neurotrophins act, in targe part, through Trk receptor tyrosine kinases: nerve growth factor (NGF) via TrkA, brain-derived neurotrophic factor (BDNF) and neurotrophin-4/5 (NT-4/5) via TrkB, and neurotrophin-3 (NT-3) via TrkC. In the present paper, we use antibodies to TrkA, TrkB, and TrkC to characterize their expression patterns and to determine which subpopulations of cells are lost in mice lacking individual neurotrophins or Trk receptors. Despite previous reports of Trk receptor mRNAs in neural crest cells, we detect Trk receptor proteins only in neurons and not in neural crest cells or neuronal precursors. Comparisons of neonatal mice deficient in NT-3 or its cognate receptor TrkC have shown that there is a much greater deficiency in spinal sensory neurons in the former, suggesting that NT-3 may activate receptors in addition to TrkC. Using the same antibodies, we show that, during the major period of neurogenesis, NT-3 is required to maintain neurons that express TrkB in addition to those that express TrkC but is not essential for neurons expressing TrkA. Results also indicate that survival of cells expressing both receptors can be maintained by activation of either one alone. NT-3 can thus activate more than one Trk receptor in vivo, which when coexpressed are functionally redundant.	Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Dept Physiol, Program Neurosci, Box 0444, San Francisco, CA 94143 USA.		Farinas, Isabel/L-7118-2014	Farinas, Isabel/0000-0003-2903-4960	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48200, P50 MH048200-070005] Funding Source: Medline; NINDS NIH HHS [P01 NS016033, P01 NS016033-180014] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; GAESE F, 1994, DEVELOPMENT, V120, P1613; Haddon C, 1998, DEVELOPMENT, V125, P359; Henion PD, 1995, DEV BIOL, V172, P602, DOI 10.1006/dbio.1995.8054; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, DEVELOPMENT, V109, P845; LAMBALLE F, 1994, J NEUROSCI, V14, P14; Lefcort F, 1996, J NEUROSCI, V16, P3704; Liebl DJ, 1997, J NEUROSCI, V17, P9113; Martin SC, 1998, DEV BIOL, V195, P114, DOI 10.1006/dbio.1997.8839; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MEMBERG SP, 1995, MOL CELL NEUROSCI, V6, P323, DOI 10.1006/mcne.1995.1025; Minichiello L, 1995, DEVELOPMENT, V121, P4067; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; Scott SA, 1992, SENSORY NEURONS DIVE; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; TOJO H, 1995, BRAIN RES, V669, P163, DOI 10.1016/0006-8993(94)01219-8; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; White FA, 1996, J NEUROSCI, V16, P4662; WILKINSON GA, 1997, THESIS U CALIF, P1	42	154	160	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					325	334		10.1016/S0896-6273(00)80542-5	http://dx.doi.org/10.1016/S0896-6273(00)80542-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728914	Green Accepted, Bronze			2022-12-24	WOS:000075598300010
J	Belluscio, L; Gold, GH; Nemes, A; Axel, R				Belluscio, L; Gold, GH; Nemes, A; Axel, R			Mice deficient in G(olf) are anosmic	NEURON			English	Article							OLFACTORY RECEPTOR-CELLS; GTP-BINDING PROTEINS; NUCLEOTIDE-GATED CONDUCTANCE; SENSITIVE ADENYLATE-CYCLASE; 2ND MESSENGER PATHWAYS; MITRAL TUFTED CELLS; MOVEMENT-DISORDERS; GENE-EXPRESSION; ODOR MOLECULES; 2-DEOXYGLUCOSE METHOD	We have used gene targeting to examine the role of the G alpha subunit, G(olf) in olfactory signal transduction. Mice homozygous for a null mutation in G(olf) show a striking reduction in the electrophysiological response of primary olfactory sensory neurons to a wide variety of odors. Despite this profound diminution in response to odors, the topographic map of primary sensory projections to the olfactory bulb remains unaltered in G(olf) mutants. Greater than 75% of the G(olf) mutant mice are unable to nurse and die within 2 days after birth. Rare surviving homozygotes mate and are fertile, but mutant females exhibit inadequate maternal behaviors. Surviving homozygous mutant mice also exhibit hyperactive behaviors. These behavioral phenotypes, taken together with the patterns of G(olf) expression, suggest that G(olf) is required for olfactory signal transduction and may also function as an essential signaling molecule more centrally in the brain.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Monell Chemical Senses Center	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.			Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NCI NIH HHS [5PO1 CA23767] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHE BW, 1995, CURR OPIN NEUROBIOL, V5, P461, DOI 10.1016/0959-4388(95)80006-9; ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; ALTAR CA, 1988, ANN NY ACAD SCI, V515, P343, DOI 10.1111/j.1749-6632.1988.tb33006.x; ANHOLT RRH, 1990, BIOCHEMISTRY-US, V29, P4049, DOI 10.1021/bi00469a004; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BREER H, 1993, CIBA F SYMP, V179, P97; BREER H, 1991, CHEM SENSES, V16, P19, DOI 10.1093/chemse/16.1.19; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BRESSLER SL, 1988, BEHAV NEUROSCI, V102, P740, DOI 10.1037/0735-7044.102.5.740; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1992, CURR OPIN GENET DEV, V2, P467, DOI 10.1016/S0959-437X(05)80159-5; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; CALAMANDREI G, 1992, PHYSIOL BEHAV, V52, P901, DOI 10.1016/0031-9384(92)90369-D; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Conklin BR, 1996, MOL PHARMACOL, V50, P885; COPPOLA DM, 1994, PHYSIOL BEHAV, V56, P729, DOI 10.1016/0031-9384(94)90234-8; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DI PG, 1985, BEHAV NEUROSCI, V99, P964; DRINNAN S L, 1991, Molecular and Cellular Neuroscience, V2, P66, DOI 10.1016/1044-7431(91)90040-U; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; FRINGS S, 1991, J GEN PHYSIOL, V97, P1, DOI 10.1085/jgp.97.1.1; Gerfen CR, 1995, J NEUROSCI, V15, P8167; Griffith MK, 1996, BIOL REPROD, V54, P761, DOI 10.1095/biolreprod54.4.761; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hauber W, 1996, NEUROSCIENCE, V73, P121, DOI 10.1016/0306-4522(96)00036-X; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; HERVE D, 1995, MOL BRAIN RES, V32, P125, DOI 10.1016/0169-328X(95)00070-9; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JONES DT, 1988, COLD SPRING HARB SYM, V53, P349, DOI 10.1101/SQB.1988.053.01.042; JONES DT, 1990, J BIOL CHEM, V265, P2671; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES DT, 1990, CHEM SENSES, V15, P333, DOI 10.1093/chemse/15.3.333; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; KEEFE KA, 1995, NEUROSCIENCE, V66, P903, DOI 10.1016/0306-4522(95)00024-D; KLEENE SJ, 1994, J EXP BIOL, V195, P307; Koob GF, 1996, MOL PSYCHIATR, V1, P186; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; KURAHASHI T, 1989, IN PRESS J PHYSL LON, V424, P561; LANCET D, 1982, P NATL ACAD SCI-BIOL, V79, P670, DOI 10.1073/pnas.79.2.670; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; MARSHALL JF, 1979, SCIENCE, V206, P477, DOI 10.1126/science.504992; MARSHALL JF, 1988, ANN NY ACAD SCI, V515, P215, DOI 10.1111/j.1749-6632.1988.tb32988.x; MASTERS SB, 1986, PROTEIN ENG, V1, P47, DOI 10.1093/protein/1.1.47; MASTERS SB, 1990, ADV ENZYME REGUL, V30, P75; MAYER AD, 1993, J COMP PSYCHOL, V107, P12; MEEK LR, 1994, BIOL REPROD, V51, P400, DOI 10.1095/biolreprod51.3.400; MENCO BPM, 1994, J NEUROCYTOL, V23, P708, DOI 10.1007/BF01181645; MEREDITH M, 1994, PSYCHONEUROENDOCRINO, V19, P657, DOI 10.1016/0306-4530(94)90048-5; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MONSMA FJ, 1990, P NATL ACAD SCI USA, V87, P6723, DOI 10.1073/pnas.87.17.6723; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; Nakamura T, 1996, BIOPHYS J, V70, P813, DOI 10.1016/S0006-3495(96)79625-X; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; OKANO M, 1974, J PHYSIOL-LONDON, V242, P353, DOI 10.1113/jphysiol.1974.sp010711; OTTOSON D, 1956, ACTA PHYSIOL SCAND, V35, P7; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; RAJENDREN G, 1990, NEUROENDOCRINOLOGY, V52, P368, DOI 10.1159/000125619; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Restrepo D, 1996, J NEUROBIOL, V30, P37; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROMEYER A, 1994, PHYSIOL BEHAV, V56, P693, DOI 10.1016/0031-9384(94)90229-1; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shiosaki K, 1996, EUR J PHARMACOL, V317, P183, DOI 10.1016/S0014-2999(96)00718-2; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; SULLIVAN KA, 1986, P NATL ACAD SCI USA, V83, P6687, DOI 10.1073/pnas.83.18.6687; TAKAGI SF, 1968, J GEN PHYSIOL, V51, P552, DOI 10.1085/jgp.51.4.552; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; VANDERWOLF CH, 1992, BRAIN RES, V593, P197, DOI 10.1016/0006-8993(92)91308-2; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; ZEBROWSKALUPINA I, 1977, N-S ARCH PHARMACOL, V297, P227, DOI 10.1007/BF00509265; ZIGMAN JM, 1993, ENDOCRINOLOGY, V133, P2508, DOI 10.1210/en.133.6.2508	99	426	443	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1998	20	1					69	81		10.1016/S0896-6273(00)80435-3	http://dx.doi.org/10.1016/S0896-6273(00)80435-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459443	hybrid			2022-12-24	WOS:000071719700010
J	Liu, C; Weaver, DR; Jin, XW; Shearman, LP; Pieschl, RL; Gribkoff, VK; Reppert, SM				Liu, C; Weaver, DR; Jin, XW; Shearman, LP; Pieschl, RL; Gribkoff, VK; Reppert, SM			Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock	NEURON			English	Article							2-<I-125>IODOMELATONIN BINDING-SITES; BIOLOGICAL CLOCK; NUCLEUS NEURONS; SYRIAN-HAMSTERS; PHASE ADVANCES; K+ CHANNEL; G-PROTEINS; JET-LAG; RAT; INVITRO	The pineal hormone melatonin elicits two effects on the suprachiasmatic nuclei (SCN): acute neuronal inhibition and phase-shifting. Melatonin evokes its biological effects through G protein-coupled receptors. Since the Mel(1a) melatonin receptor may transduce the major neurobiological actions of melatonin in mammals, we examined whether it mediates both melatonin effects on SCN function by using mice with targeted disruption of the Mel(1a) receptor. The Mel(1a) receptor accounts for all detectable, high affinity melatonin binding in mouse brain. Functionally, this receptor is necessary for the acute inhibitory action of melatonin on the SCN. Melatonin-induced phase shifts, however, are only modestly altered in the receptor-deficient mice; pertussis toxin still blocks melatonin-induced phase shifts in Mel(1a) receptor-deficient mice. The other melatonin receptor subtype, the Mel(1b) receptor, is expressed in mouse SCN, implicating it in the phase-shifting response. The results provide a molecular basis for two distinct, mechanistically separable effects of melatonin on SCN physiology.	MASSACHUSETTS GEN HOSP,SERV PEDIAT,LAB DEV CHRONOBIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114; BRISTOL MYERS SQUIBB CO,PHARMACEUT RES INST,CNS ELECTROPHYSIOL,WALLINGFORD,CT 06492	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Bristol-Myers Squibb			Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Weaver, David/0000-0001-7941-6719	NICHD NIH HHS [R37 HD14427] Funding Source: Medline; NIDDK NIH HHS [DK42125] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042125] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARENDT J, 1987, ERGONOMICS, V30, P1379, DOI 10.1080/00140138708966031; Benloucif S, 1996, J BIOL RHYTHM, V11, P113, DOI 10.1177/074873049601100204; BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; BOUSKILA Y, 1995, J PHYSIOL-LONDON, V488, P339, DOI 10.1113/jphysiol.1995.sp020970; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; CARLSON LL, 1989, ENDOCRINOLOGY, V125, P2670, DOI 10.1210/endo-125-5-2670; CASSONE VM, 1990, TRENDS NEUROSCI, V13, P457, DOI 10.1016/0166-2236(90)90099-V; DAVIS FC, 1988, AM J PHYSIOL, V255, pR439, DOI 10.1152/ajpregu.1988.255.3.R439; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dubocovich ML, 1996, BEHAV BRAIN RES, V73, P141; DUNCAN MJ, 1993, DEV BRAIN RES, V73, P205, DOI 10.1016/0165-3806(93)90140-6; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Grosse J, 1996, AM J PHYSIOL-REG I, V270, pR533, DOI 10.1152/ajpregu.1996.270.3.R533; HAAS HL, 1979, J NEUROSCI METH, V1, P323, DOI 10.1016/0165-0270(79)90021-9; HASTINGS MH, 1992, BRAIN RES, V591, P20, DOI 10.1016/0006-8993(92)90973-D; JIANG ZG, 1995, BRAIN RES, V687, P125, DOI 10.1016/0006-8993(95)00478-9; KARSCHIN C, 1994, FEBS LETT, V348, P139, DOI 10.1016/0014-5793(94)00590-7; KELLEY MR, 1993, ALCOHOL, V10, P185, DOI 10.1016/0741-8329(93)90033-K; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KLEIN DC, 1993, LIGHT BIOL RHYTHMS M, P55; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu C, 1996, J NEUROSCI, V16, P744; MASON R, 1988, NEUROSCI LETT, V95, P296, DOI 10.1016/0304-3940(88)90674-X; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MORGAN PJ, 1990, J NEUROENDOCRINOL, V2, P773, DOI 10.1111/j.1365-2826.1990.tb00639.x; Nelson CS, 1996, NEUROREPORT, V7, P717, DOI 10.1097/00001756-199602290-00009; PALM L, 1991, ANN NEUROL, V29, P336, DOI 10.1002/ana.410290318; PETRIE K, 1989, BRIT MED J, V298, P705, DOI 10.1136/bmj.298.6675.705; PROSSER RA, 1994, BRAIN RES, V644, P67, DOI 10.1016/0006-8993(94)90348-4; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Reppert SM, 1995, CELL, V83, P1059, DOI 10.1016/0092-8674(95)90131-0; REPPERT SM, 1988, SCIENCE, V242, P78, DOI 10.1126/science.2845576; Roca AL, 1996, ENDOCRINOLOGY, V137, P3469, DOI 10.1210/en.137.8.3469; ROCA AL, 1996, THESIS HARVARD U CAM; SACK RL, 1991, J BIOL RHYTHM, V6, P249, DOI 10.1177/074873049100600305; SHIBATA S, 1989, NEUROSCI LETT, V97, P140, DOI 10.1016/0304-3940(89)90153-5; SIUCIAK JA, 1990, EUR J PHARMACOL, V180, P387, DOI 10.1016/0014-2999(90)90328-4; STARKEY SJ, 1995, NEUROREPORT, V6, P1947, DOI 10.1097/00001756-199510020-00029; Starkey SJ, 1996, NEUROSCI LETT, V211, P199, DOI 10.1016/0304-3940(96)12756-7; STEHLE J, 1989, J NEURAL TRANSM-GEN, V78, P173, DOI 10.1007/BF01252503; VANECEK J, 1992, ENDOCRINOLOGY, V130, P701, DOI 10.1210/en.130.2.701; VANREETH O, 1989, NATURE, V339, P49, DOI 10.1038/339049a0; Weaver DR, 1996, NEUROREPORT, V8, P109, DOI 10.1097/00001756-199612200-00022; Weaver DR, 1996, MOL ENDOCRINOL, V10, P1478, DOI 10.1210/me.10.11.1478; WEAVER DR, 1991, SUPRACHIASMATIC NUCL, P289; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865	51	555	575	2	34	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					91	102		10.1016/S0896-6273(00)80350-5	http://dx.doi.org/10.1016/S0896-6273(00)80350-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247266	Bronze			2022-12-24	WOS:A1997XN39400009
J	Rio, C; Rieff, HI; Qi, PM; Corfas, G				Rio, C; Rieff, HI; Qi, PM; Corfas, G			Neuregulin and erbB receptors play a critical role in neuronal migration	NEURON			English	Article							NEU DIFFERENTIATION FACTOR; CEREBELLAR CORTEX; CARDIAC DEVELOPMENT; ADHESION MOLECULE; SCHWANN-CELLS; MUTANT MICE; PROTEIN; BINDING; BRAIN; GLIA	The migration of neuronal precursors along radial glial fibers is a critical step in the formation of the nervous system. In this report, we show that neuregulin-erbB receptor signaling plays a crucial role in the migration of cerebellar granule cells along radial glial fibers. Granule cells express neuregulin (NRG), and radial glia cells express erbB4 in the developing cerebellum and in vitro. When the glial erbB receptors are blocked, neurons fail to induce radial glia formation, and their migration along radial glial fibers is impaired. Moreover, soluble NRG is as effective as neuron-glia contact in the induction of radial glia formation. These results suggest that the activation of glial erbB4 by NRG is an early critical step in the neuronal migration program.	CHILDRENS HOSP,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Rio, C (corresponding author), CHILDRENS HOSP,DIV NEUROSCI,300 LONGWOOD AVE,BOSTON,MA 02115, USA.		Río, Carlos/GQA-4045-2022; Corfas, Gabriel/AAH-2378-2020	Río, Carlos/0000-0003-2666-7746; Corfas, Gabriel/0000-0001-5412-9473	NEI NIH HHS [T32EY07110-05] Funding Source: Medline; NICHD NIH HHS [P30-HD 18655] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007110] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AICARDI J, 1994, CAN J NEUROL SCI, V21, P185, DOI 10.1017/S0317167100041159; ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELCERRO M, 1976, J NEUROCYTOL, V5, P669, DOI 10.1007/BF01181580; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FENG L, 1995, DEVELOPMENT, V121, P1719; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; FISHELL G, 1991, DEVELOPMENT, V113, P755; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GRAVEL C, 1987, J NEUROSCI METH, V21, P145, DOI 10.1016/0165-0270(87)90112-9; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1982, J NEUROSCI, V2, P1195; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; INCE C, 1983, J IMMUNOL METHODS, V60, P269, DOI 10.1016/0022-1759(83)90354-X; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Loeb JA, 1997, J NEUROSCI, V17, P1416; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MASON PW, 1990, J NEUROSCI RES, V26, P296, DOI 10.1002/jnr.490260305; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; OCHIAI A, 1994, BIOCHEM BIOPH RES CO, V205, P73, DOI 10.1006/bbrc.1994.2631; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; SANDROCK AW, 1995, J NEUROSCI, V15, P6124; STAEBLER A, 1994, BREAST CANC RES TREA, V31, P174; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; STITT TN, 1990, NEURON, V5, P639, DOI 10.1016/0896-6273(90)90218-5; Syroid DE, 1996, P NATL ACAD SCI USA, V93, P9229, DOI 10.1073/pnas.93.17.9229; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; Wadsworth WG, 1996, BIOESSAYS, V18, P355, DOI 10.1002/bies.950180505; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; ZHENG T, 1996, SCIENCE, V272, P417; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	63	317	324	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					39	50		10.1016/S0896-6273(00)80346-3	http://dx.doi.org/10.1016/S0896-6273(00)80346-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247262	Bronze			2022-12-24	WOS:A1997XN39400005
J	Friedrich, RW; Korsching, SI				Friedrich, RW; Korsching, SI			Combinatorial and chemotopic odorant coding in the zebrafish olfactory bulb visualized by optical imaging	NEURON			English	Article							MITRAL TUFTED CELLS; FUNCTIONAL-ORGANIZATION; NEURONAL-ACTIVITY; CHANNEL CATFISH; RECEPTOR-CELLS; RAINBOW-TROUT; DISCRIMINATION; MOLECULES; SYSTEM; SENSITIVITY	Odors are thought to be represented by a distributed code across the glomerular modules in the olfactory bulb (OB). Here, we optically imaged presynaptic activity in glomerular modules of the zebrafish OB induced by a class of natural odorants (amino acids [AAs]) after labeling of primary afferents with a calcium-sensitive dye. AAs induce complex combinatorial patterns of active glomerular modules that are unique for different stimuli and concentrations. Quantitative analysis shows that defined molecular features of stimuli are correlated with activity in spatially confined groups of glomerular modules. These results provide direct evidence that identity and concentration of odorants are encoded by glomerular activity patterns and reveal a coarse chemotopic organization of the array of glomerular modules.			Friedrich, RW (corresponding author), MAX PLANCK INST ENTWICKLUNGSBIOL,ABT PHYS BIOL,D-72076 TUBINGEN,GERMANY.			Friedrich, Rainer/0000-0001-9107-0482				ADAMEK GD, 1984, BRAIN RES, V310, P87, DOI 10.1016/0006-8993(84)90012-X; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Andres K.H., 1970, CIBA FDN S TASTE SME, P177; AXEL R, 1995, SCI AM, V273, P130; BALER H, 1994, J NEUROSCI, V14, P219; Barth AL, 1996, NEURON, V16, P23, DOI 10.1016/S0896-6273(00)80020-3; BIEBER SL, 1986, CHEM SENSES, V11, P19, DOI 10.1093/chemse/11.1.19; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; BYRD CA, 1995, J COMP NEUROL, V358, P247, DOI 10.1002/cne.903580207; CANCALON P, 1983, TISSUE CELL, V15, P245, DOI 10.1016/0040-8166(83)90020-4; CAPRIO J, 1984, J GEN PHYSIOL, V84, P403, DOI 10.1085/jgp.84.3.403; Caprio J., 1988, P313; Carr W.E.S., 1988, P3; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; DOVING KB, 1980, ACTA PHYSIOL SCAND, V108, P123, DOI 10.1111/j.1748-1716.1980.tb06509.x; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; GETCHELL TV, 1986, PHYSIOL REV, V66, P772, DOI 10.1152/physrev.1986.66.3.772; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; IVANOVA TT, 1993, J GEN PHYSIOL, V102, P1085, DOI 10.1085/jgp.102.6.1085; KANG JS, 1995, J NEUROPHYSIOL, V73, P172, DOI 10.1152/jn.1995.73.1.172; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; KORSCHING S, 1997, IN PRESS SEMIN CELL; LANCET D, 1982, P NATL ACAD SCI-BIOL, V79, P670, DOI 10.1073/pnas.79.2.670; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; MEREDITH M, 1981, CHEM SENSES, V6, P277, DOI 10.1093/chemse/6.4.277; MICHEL WC, 1995, J COMP PHYSIOL A, V177, P191; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; MOULTON DG, 1967, OLFACTION TASTE, V2, P109; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Oka Y, 1982, CHEMORECEPTION FISHE, P61; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; REVIAL MF, 1982, CHEM SENSES, V7, P175, DOI 10.1093/chemse/7.2.175; RHEIN LD, 1983, J NEUROCHEM, V41, P569, DOI 10.1111/j.1471-4159.1983.tb04777.x; RIDDLE DR, 1992, J COMP NEUROL, V324, P575, DOI 10.1002/cne.903240410; RUMMEL RJ, 1970, APPLIED FACTOR ANAL; Satou M., 1992, FISH CHEMORECEPTION, P40; SCOTT JW, 1993, MICROSC RES TECHNIQ, V24, P142, DOI 10.1002/jemt.1070240206; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Shipley MT, 1996, J NEUROBIOL, V30, P123; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Treloar H, 1996, J COMP NEUROL, V367, P550; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Weth F, 1996, P NATL ACAD SCI USA, V93, P13321, DOI 10.1073/pnas.93.23.13321; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; ZIPPEL HP, 1993, J COMP PHYSIOL A, V172, P81, DOI 10.1007/BF00214717	54	452	457	1	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					737	752		10.1016/S0896-6273(00)80314-1	http://dx.doi.org/10.1016/S0896-6273(00)80314-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182799	Bronze			2022-12-24	WOS:A1997XB72200008
J	McAllister, AK; Katz, LC; Lo, DC				McAllister, AK; Katz, LC; Lo, DC			Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; PROJECTION NEURONS; MOLECULAR-CLONING; MESSENGER-RNAS; VISUAL-CORTEX; BRAIN-SLICES; TRK FAMILY; RECEPTOR; EXPRESSION	Neurons within each layer of cerebral cortex express multiple members of the neurotrophin family and their corresponding receptors. This multiplicity could provide functional redundancy; alternatively, different neurotrophins may direct distinct aspects of cortical neuronal growth and differentiation. By neutralizing endogenous neurotrophins in organotypic slices of developing cortex with Trk receptor bodies (Trk-lgGs), we found that BDNF and NT-3 oppose one another in regulating the dendritic growth of pyramidal neurons. In layer 4, both endogenous and exogenous NT-3 inhibited the dendritic growth stimulated by BDNF. In contrast, in layer 6 both endogenous and exogenous BDNF inhibited dendritic growth stimulated by NT-3. These antagonistic actions of endogenous BDNF and NT-3 provide a mechanism by which dendritic growth and retraction can be dynamically regulated during cortical development, and suggest that the multiple neurotrophins expressed in developing cortex represent distinct components of an extracellular signaling system for regulating dendritic growth.	DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710	Duke University	McAllister, AK (corresponding author), DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710, USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NEI NIH HHS [EY11553, EY07690] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x; CAJAL SRR, 1929, STUDIES VERTEBRATE N; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; DECHANT G, 1993, DEVELOPMENT, V119, P545; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GIFFIN K, 1991, NEURON, V6, P321, DOI 10.1016/0896-6273(91)90242-R; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; Kalcheim C, 1996, PHILOS T ROY SOC B, V351, P375, DOI 10.1098/rstb.1996.0031; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KATZ LC, 1987, J NEUROSCI, V7, P1223; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOESTER SE, 1992, J NEUROSCI, V12, P1382; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCALLISTER AK, 1996, NEURON, V17, P1; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MILLER MW, 1988, CEREB CORTEX, P140; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123	36	465	469	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					767	778		10.1016/S0896-6273(00)80316-5	http://dx.doi.org/10.1016/S0896-6273(00)80316-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182801	Bronze			2022-12-24	WOS:A1997XB72200010
J	Iwasaki, K; Staunton, J; Saifee, O; Nonet, M; Thomas, JH				Iwasaki, K; Staunton, J; Saifee, O; Nonet, M; Thomas, JH			aex-3 encodes a novel regulator of presynaptic activity in C-elegans	NEURON			English	Article							GTP-BINDING PROTEIN; NEMATODE CAENORHABDITIS-ELEGANS; SYNAPTIC VESICLES; NEUROENDOCRINE CELLS; AXONAL-TRANSPORT; GENETIC-ANALYSIS; RAB3A; EXOCYTOSIS; MOTOR; SECRETION	C. elegans aex-3 mutations cause pleiotropic behavioral defects that are suggestive of reduced synaptic transmission. aex-3 mutations also show strong genetic interactions with mutations in unc-31 and unc-64, two other genes implicated in synaptic transmission. Physiological and pharmacological studies indicate that aex-3 defects are presynaptic. In aex-3 mutants, the synaptic vesicle-associated RAB-3 protein aberrantly accumulates in neuronal cell bodies and is reduced in synapse-rich axons. This localization defect is specific to RAB-3, since other synaptic proteins are localized normally in aex-3 mutants. aex-3 encodes a 1409 amino acid protein with strong homology to DENN, a human protein of unknown function. In C. elegans, aex-3 is expressed in all or nearly all neurons. These results suggest that AEX-3 is a novel regulator of presynaptic activity that interacts with RAB-3 to regulate synaptic vesicle release.	WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110	Washington University (WUSTL)	Iwasaki, K (corresponding author), UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032057, R01NS030187] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS32057, R01NS30187, NS09937] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFONSO A, 1994, J NEUROSCI, V14, P2290; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Avery L, 1995, METHOD CELL BIOL, V48, P251; AVERY L, 1993, GENETICS, V133, P897; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; BRENNER S, 1974, GENETICS, V77, P71; BRONDYK WH, 1995, MOL CELL BIOL, V15, P1137; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BURTON JL, 1994, EMBO J, V13, P5547, DOI 10.1002/j.1460-2075.1994.tb06892.x; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; FLEMING JT, 1993, COMP MOL NEUROBIOL, V63, P65; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HODGKIN J, 1983, GENETICS, V103, P43; HORVITZ HR, 1979, MOL GEN GENET, V175, P129, DOI 10.1007/BF00425528; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEWIS JA, 1980, GENETICS, V95, P905; LICHY JH, 1992, CELL GROWTH DIFFER, V3, P541; LIU DWC, 1994, J NEUROSCI, V14, P1953; LIVINGSTONE D, 1991, THESIS U CAMBRIDGE; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OBERHAUSER AF, 1992, NATURE, V360, P270, DOI 10.1038/360270a0; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OLSZEWSKI S, 1994, J BIOL CHEM, V269, P27987; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Sambrook J., 2002, MOL CLONING LAB MANU; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; STAHL B, 1994, J BIOL CHEM, V269, P24770; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SULSTON J, 1988, METHODS APPENDIX NEM; THOMAS JH, 1993, BIOESSAYS, V15, P791, DOI 10.1002/bies.950151204; THOMAS JH, 1990, GENETICS, V124, P855; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; VOWELS JJ, 1992, GENETICS, V130, P105; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	59	118	128	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					613	622		10.1016/S0896-6273(00)80302-5	http://dx.doi.org/10.1016/S0896-6273(00)80302-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136770	Bronze			2022-12-24	WOS:A1997WW62600010
J	Klugmann, M; Schwab, MH; Puhlhofer, A; Schneider, A; Zimmermann, F; Griffiths, IR; Nave, KA				Klugmann, M; Schwab, MH; Puhlhofer, A; Schneider, A; Zimmermann, F; Griffiths, IR; Nave, KA			Assembly of CNS myelin in the absence of proteolipid protein	NEURON			English	Article							PELIZAEUS-MERZBACHER-DISEASE; CENTRAL-NERVOUS-SYSTEM; JIMPY MUTANT MOUSE; BASIC-PROTEIN; MESSENGER-RNA; CELL-DEATH; GOLGI-APPARATUS; GENE DOSAGE; MICE; EXPRESSION	Two proteolipid proteins, PLP and DM20, are the major membrane components of central nervous system (CNS) myelin. Mutations of the X-linked PLP/DM20 gene cause dysmyelination in mouse and man and result in significant mortality. Here we show that mutant mice that lack expression of a targeted PLP gene fail to exhibit the known dysmyelinated phenotype. Unable to encode PLP/DM20 or PLP-related polypeptides, oligodendrocytes are still competent to myelinate CNS axons of all calibers and to assemble compacted myelin sheaths. Ultrastructurally, however, the electron-dense 'intraperiod' lines in myelin remain condensed, correlating with its reduced physical stability. This suggests that after myelin compaction, PLP forms a stabilizing membrane junction, similar to a ''zipper.'' Dysmyelination and oligodendrocyte death emerge as an epiphenomenon of other PLP mutations and have been uncoupled in the PLP null allele from the risk of premature myelin breakdown.	UNIV HEIDELBERG,ZENTRUM MOL BIOL,D-6900 HEIDELBERG,GERMANY; UNIV GLASGOW,DEPT VET CLIN STUDIES,GLASGOW,LANARK,SCOTLAND	Ruprecht Karls University Heidelberg; University of Glasgow			Nave, Klaus-Armin/C-8883-2011	Schneider, Armin/0000-0003-0296-0059				BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; BENJAMINS JA, 1994, NEUROCHEM RES, V19, P1013, DOI 10.1007/BF00968711; BOISON D, 1995, J NEUROSCI, V15, P5502; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; BRAUN PE, 1984, MYELIN, P97; Bunge Richard P., 1995, P44; Campagnoni Anthony T., 1995, P555; CARANGO P, 1995, ANN NEUROL, V38, P610, DOI 10.1002/ana.410380409; Dickinson PJ, 1996, NEUROPATH APPL NEURO, V22, P188; DUNCAN ID, 1987, P NATL ACAD SCI USA, V84, P6287, DOI 10.1073/pnas.84.17.6287; DUNCAN ID, 1989, GLIA, V2, P148, DOI 10.1002/glia.440020303; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; FANNON AM, 1994, NEUROCHEM RES, V19, P1005, DOI 10.1007/BF00968710; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GOMEZ CM, 1990, P NATL ACAD SCI USA, V87, P4481, DOI 10.1073/pnas.87.12.4481; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; GRIFFITHS IR, 1981, J NEUROCYTOL, V10, P847, DOI 10.1007/BF01262657; GUTIERREZ R, 1995, NEUROSCI LETT, V195, P93, DOI 10.1016/0304-3940(94)11789-L; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; HUDSON LD, 1987, P NATL ACAD SCI USA, V84, P1454, DOI 10.1073/pnas.84.5.1454; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; IKENAKA K, 1988, J MOL BIOL, V199, P587, DOI 10.1016/0022-2836(88)90303-8; Inoue K, 1996, AM J HUM GENET, V59, P32; Jung M, 1996, J NEUROSCI, V16, P7920; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; Kirschner D., 1984, MYELIN, P51; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KNAPP PE, 1986, J NEUROSCI, V6, P2813; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; Lees M., 1984, MYELIN, P197; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MARTINI R, 1995, J NEUROSCI, V15, P4488; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; NADON NL, 1994, J NEUROCHEM, V63, P822; Nave KA, 1996, NEUROSCIENTIST, V2, P33, DOI 10.1177/107385849600200111; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NAVE KA, 1986, P NATL ACAD SCI USA, V83, P9264, DOI 10.1073/pnas.83.23.9264; Nave Klaus-Armin, 1995, P571; NORTON WT, 1974, METHODS ENZYMOLOGY, V31; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; Raine C., 1984, MYELIN, P1, DOI 10.1007/978-1-4757-1830-0_1; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; Rosenbluth J, 1996, J COMP NEUROL, V371, P336, DOI 10.1002/(SICI)1096-9861(19960722)371:2<336::AID-CNE12>3.0.CO;2-Q; ROUSSEL G, 1987, J NEUROCYTOL, V16, P195, DOI 10.1007/BF01795303; SCHNEIDER A, 1995, P NATL ACAD SCI USA, V92, P4447, DOI 10.1073/pnas.92.10.4447; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; SEITELBERGER F, 1996, IN PRESS HDB CLIN NE; SKOFF RP, 1995, BRAIN PATHOL, V5, P283, DOI 10.1111/j.1750-3639.1995.tb00605.x; Snipes G J, 1993, Curr Opin Neurobiol, V3, P694; SNIPES GJ, 1995, BRAIN PATHOL, V5, P233, DOI 10.1111/j.1750-3639.1995.tb00600.x; TAN SS, 1995, DEVELOPMENT, V121, P1029; TIMSIT S, 1995, J NEUROSCI, V15, P1012; TOSIC M, 1994, J NEUROCHEM, V63, P2210; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; YANAGISAWA K, 1986, J NEUROCHEM, V47, P322; Yoshida M, 1996, NEURON, V16, P1115, DOI 10.1016/S0896-6273(00)80138-5	66	343	344	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					59	70		10.1016/S0896-6273(01)80046-5	http://dx.doi.org/10.1016/S0896-6273(01)80046-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010205	Bronze			2022-12-24	WOS:A1997WE71800008
J	OMalley, DM; Kao, YH; Fetcho, JR				OMalley, DM; Kao, YH; Fetcho, JR			Imaging the functional organization of zebrafish hindbrain segments during escape behaviors	NEURON			English	Article							CHICK-EMBRYO HINDBRAIN; MAUTHNER CELL; SPINAL-CORD; RETICULOSPINAL NEURONS; CALCIUM TRANSIENTS; GOLDFISH; VISUALIZATION; ACTIVATION; RESPONSES; PATHWAYS	Although vertebrate hindbrains are segmented structures, the functional significance of the segmentation is unknown. In zebrafish, the hindbrain segments contain serially repeated classes of individually identifiable neurons. We took advantage of the transparency of larval zebrafish and used confocal calcium imaging in the intact fish to study the activity of one set of individually identified, serially homologous reticulospinal cells (the Mauthner cell, MiD2cm, and MiD3cm) during behavior. Behavioral studies predicted that differential activity in this set of serially homologous neurons might serve to control the directionality of the escape behavior that fish use to avoid predators. We found that the serially homologous cells are indeed activated during escapes and that the combination of cells activated depends upon the location of the sensory stimulus used to elicit the escape. The patterns of activation we observed were exactly those predicted by behavioral studies. The data suggest that duplication of ancestral hindbrain segments, and subsequent functional diversification, resulted in sets of related neurons whose activity patterns create behavioral variability.	SUNY STONY BROOK,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026539, U24NS109113, F32NS009113, R29NS026539, R01NS026539] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS026539-25, NS26539, R01 NS026539, NS09113] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; CRUCE WLR, 1984, AM ZOOL, V24, P733; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; EATON RC, 1991, J EXP BIOL, V161, P469; EATON RC, 1991, BRAIN BEHAV EVOLUT, V37, P272, DOI 10.1159/000114365; EATON RC, 1975, J NEUROPHYSIOL, V38, P502, DOI 10.1152/jn.1975.38.3.502; EATON RC, 1982, J COMP PHYSIOL, V145, P485, DOI 10.1007/BF00612814; EATON RC, 1984, J COMP PHYSIOL, V155, P813, DOI 10.1007/BF00611598; FABER DS, 1991, BRAIN BEHAV EVOLUT, V37, P286, DOI 10.1159/000114366; FABER DS, 1989, ANN NY ACAD SCI, V563, P11, DOI 10.1111/j.1749-6632.1989.tb42187.x; FEATHERSTONE D, 1991, J EXP BIOL, V158, P583; FETCHO JR, 1988, J NEUROSCI, V8, P4192; FETCHO JR, 1995, J NEUROPHYSIOL, V73, P399, DOI 10.1152/jn.1995.73.1.399; FOREMAN MB, 1993, J NEUROSCI, V13, P4101; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GUTHRIE S, 1995, TRENDS NEUROSCI, V18, P74, DOI 10.1016/0166-2236(95)80027-Y; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; LEE RKK, 1991, J COMP NEUROL, V304, P34; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MCCLELLAN AD, 1994, BRAIN RES, V663, P61, DOI 10.1016/0006-8993(94)90462-6; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; MORTON DW, 1994, TRENDS NEUROSCI, V17, P413, DOI 10.1016/0166-2236(94)90015-9; MULLINS MC, 1993, CURR OPIN GENET DEV, V3, P648, DOI 10.1016/0959-437X(93)90102-U; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; ODONOVAN MJ, 1993, J NEUROSCI METH, V46, P91, DOI 10.1016/0165-0270(93)90145-H; OMALLEY DM, 1994, J NEUROSCI, V14, P5741; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; SOBIERAJSKI LM, 1995, IEEE COMPUT GRAPH, V15, P55, DOI 10.1109/38.391491; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WINE JJ, 1972, J EXP BIOL, V56, P1; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; ZOTTOLI SJ, 1977, J EXP BIOL, V66, P243	38	229	233	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1145	1155		10.1016/S0896-6273(00)80246-9	http://dx.doi.org/10.1016/S0896-6273(00)80246-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982162	Bronze			2022-12-24	WOS:A1996WA24800012
J	Prokop, A; Landgraf, M; Rushton, E; Broadie, K; Bate, M				Prokop, A; Landgraf, M; Rushton, E; Broadie, K; Bate, M			Presynaptic development at the Drosophila neuromuscular junction: Assembly and localization of presynaptic active zones	NEURON			English	Article							CELL-ADHESION MOLECULE; TRANSCRIPTION FACTOR; SYNAPTIC CONNECTIONS; MUSCLE DEVELOPMENT; GROWTH CONES; GENE; RECEPTOR; LARVAL; DIFFERENTIATION; EMBRYOGENESIS	We describe the extent to which presynaptic structures at the embryonic neuromuscular junction of Drosophila can form in mutants where development of postsynaptic somatic muscles is affected. Although twist mutant embryos lack mesoderm, motor axons still grow out of the CNS and form morphologically normal presynaptic active zones, independent of their target cells. In myoblast city mutant embryos, myoblasts do not fuse but form fully differentiated mononucleate muscles, which make functional neuromuscular synapses with correctly localized presynaptic active tones. Myoblasts also fail to fuse but still attract appropriate innervation in mef2 mutant embryos. However, these myoblasts fail to differentiate into muscles and presynaptic active zones fail to localize at neuromuscular contacts. Thus, the process of synapse formation can be genetically separated from the process of target recognition, revealing that localization of presynaptic active zones requires mef2-dependent muscle differentiation.			Prokop, A (corresponding author), UNIV CAMBRIDGE,DEPT ZOOL,DOWNING ST,CAMBRIDGE CB2 3EJ,ENGLAND.			Landgraf, Matthias/0000-0001-5142-1997; Prokop, Andreas/0000-0001-8482-3298	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BALLEY CH, 1993, ANN REV PHYSL, V55, P397; BATE M, 1993, DEVELOPMENT, P149; BATE M, 1995, NEURON, V15, P513, DOI 10.1016/0896-6273(95)90141-8; BATE M, 1990, DEVELOPMENT, V110, P791; Bate Michael, 1993, P1013; BAYLIES MK, 1995, DEVELOPMENT, V121, P3829; BINNINGTON KC, 1982, TISSUE CELL, V14, P463, DOI 10.1016/0040-8166(82)90040-4; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROADIE KS, 1994, J PHYSIOLOGY-PARIS, V88, P123, DOI 10.1016/0928-4257(94)90023-X; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; BURROWS M, 1989, EUR J NEUROSCI, V1, P111, DOI 10.1111/j.1460-9568.1989.tb00778.x; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CASH S, 1992, J NEUROSCI, V12, P2051; CHIBA A, 1993, J NEUROSCI, V13, P714; CURRIE DA, 1995, DEV DYNAM, V203, P311, DOI 10.1002/aja.1002030303; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; GALEY FR, 1966, J ULTRA MOL STRUCT R, V14, P405, DOI 10.1016/S0022-5320(66)80057-6; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Goodman Corey S., 1993, P1131; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HALPERN ME, 1991, J NEUROSCI, V11, P3227; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; KIDOKORO Y, 1994, NEUROSCI RES, V19, P143, DOI 10.1016/0168-0102(94)90137-6; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; MEADOWS LA, 1994, J CELL SCI, V107, P321; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V192, P267; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Prokop Andreas, 1993, P33; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; Schulz RA, 1996, ONCOGENE, V12, P1827; SEECOF RL, 1972, P NATL ACAD SCI USA, V69, P566, DOI 10.1073/pnas.69.3.566; SHAW SR, 1986, P NATL ACAD SCI USA, V83, P7961, DOI 10.1073/pnas.83.20.7961; SIMPSON P, 1983, GENETICS, V105, P615; Stewart BA, 1996, J NEUROSCI, V16, P3877; TAYLOR MV, 1995, CURR BIOL, V5, P740, DOI 10.1016/S0960-9822(95)00149-7; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	57	109	109	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					617	626		10.1016/S0896-6273(00)80195-6	http://dx.doi.org/10.1016/S0896-6273(00)80195-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893020	Bronze			2022-12-24	WOS:A1996VP74300008
J	Renstrom, E; Ding, WG; Bokvist, K; Rorsman, P				Renstrom, E; Ding, WG; Bokvist, K; Rorsman, P			Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin	NEURON			English	Article							PANCREATIC B-CELLS; ADRENAL CHROMAFFIN CELLS; FREE CA-2+ CONCENTRATION; G-PROTEIN; ACTION-POTENTIALS; CALCIUM CURRENTS; CA2+ CHANNELS; OKADAIC ACID; RELEASE; MEMBRANE	Neurotransmitters and hormones such as somatostatin, galanin, and adrenalin reduce insulin secretion. Their inhibitory action involves direct interference with the exocytotic machinery. We have examined the molecular processes underlying this effect using high resolution measurements of cell capacitance. Suppression of exocytosis was maximal at concentrations that did not cause complete inhibition of glucose-stimulated electrical activity. This action was dependent on activation of G proteins but was not associated with inhibition of the voltage-dependent Ca2+ currents or adenylate cyclase activity. The molecular processes initiated by the agonists culminate in the activation of the Ca2+-dependent protein phosphatase calcineurin, and suppression of the activity of this enzyme abolishes their action on exocytosis. We propose that mechanisms similar to those we report here may contribute to adrenergic and peptidergic inhibition of secretion in other neuroendocrine cells and in nerve terminals.			Renstrom, E (corresponding author), NOVO NORDISK AS,DEPT ISLET CELL PHYSIOL,SYMB SCI PK,FRUEBJERGVEJ 3,DK-2100 COPENHAGEN,DENMARK.		Rorsman, Patrik/A-4331-2016; Tuluc, Petronel/C-2527-2011	Rorsman, Patrik/0000-0001-7578-0767; 				AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BOKVIST K, 1991, BIOSCIENCE REP, V11, P147, DOI 10.1007/BF01182483; CHEN C, 1992, GROWTH REGULAT, V2, P167; CHEN C, 1994, TRENDS ENDOCRIN MET, V5, P227, DOI 10.1016/1043-2760(94)P3080-Q; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COOK DL, 1982, DIABETES, V31, P985, DOI 10.2337/diabetes.31.11.985; DEBUYSER A, 1991, PFLUG ARCH EUR J PHY, V419, P131, DOI 10.1007/BF00372998; DREWS G, 1990, ENDOCRINOLOGY, V126, P1646, DOI 10.1210/endo-126-3-1646; DREWS G, 1994, MOL CELL ENDOCRINOL, V105, P97, DOI 10.1016/0303-7207(94)90040-X; ENAN E, 1992, PESTIC SCI, V37, P21; GALINDO E, 1992, P NATL ACAD SCI USA, V89, P7398, DOI 10.1073/pnas.89.16.7398; GILLISON SL, 1994, INSULIN SECRETION PA, P287; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HENQUIN JC, 1984, EXPERIENTIA, V40, P1043, DOI 10.1007/BF01971450; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HOMAIDAN FR, 1991, P NATL ACAD SCI USA, V88, P8744, DOI 10.1073/pnas.88.19.8744; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOWELL SL, 1991, TXB DIABETES, P72; HSU WH, 1991, J BIOL CHEM, V266, P837; ISHIBASHI H, 1995, J NEUROPHYSIOL, V74, P1028, DOI 10.1152/jn.1995.74.3.1028; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KEAHEY HH, 1990, AM J PHYSIOL, V357, pC1171; NEER EJ, 1988, NATURE, V333, P129, DOI 10.1038/333129a0; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; NILSSON T, 1989, J BIOL CHEM, V264, P973; NILSSON T, 1988, J BIOL CHEM, V263, P1855; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RASMUSSEN H, 1990, DIABETES CARE, V13, P655, DOI 10.2337/diacare.13.6.655; RORSMAN P, 1988, J GEN PHYSIOL, V91, P223, DOI 10.1085/jgp.91.2.223; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; RORSMAN P, 1986, J PHYSIOL-LONDON, V374, P531, DOI 10.1113/jphysiol.1986.sp016096; SAKURA H, 1995, DIABETOLOGIA, V38, pA111; SEAQUIST ER, 1992, DIABETES, V41, P1390, DOI 10.2337/diabetes.41.11.1390; SHARP GWG, 1989, J BIOL CHEM, V264, P7302; SWAIN JE, 1991, J NEUROBIOL, V22, P855, DOI 10.1002/neu.480220806; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; ULLRICH S, 1989, FEBS LETT, V247, P401, DOI 10.1016/0014-5793(89)81379-1; ULLRICH S, 1988, J BIOL CHEM, V263, P8615; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WAHLANDER K, 1991, WENNER GREN INT S SE, V8, P237	48	148	149	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					513	522		10.1016/S0896-6273(00)80183-X	http://dx.doi.org/10.1016/S0896-6273(00)80183-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816714	Bronze			2022-12-24	WOS:A1996VJ44000017
J	Muller, BM; Kistner, U; Kindler, S; Chung, WJ; Kuhlendahl, S; Fenster, SD; Lau, LF; Veh, RW; Huganir, RL; Gundelfinger, ED; Garner, CC				Muller, BM; Kistner, U; Kindler, S; Chung, WJ; Kuhlendahl, S; Fenster, SD; Lau, LF; Veh, RW; Huganir, RL; Gundelfinger, ED; Garner, CC			SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; RAT-BRAIN; SYNAPTIC LOCALIZATION; DENSITY FRACTION; K+ CHANNELS; DROSOPHILA; MEMBRANE; HOMOLOG; DOMAINS; SAP90	Synapse-associated proteins (SAPs) are constituents of the pre- and postsynaptic submembraneous cytomatrix. Here, we present SAP102, a novel 102 kDa SAP detected in dendritic shafts and spines of asymmetric type 1 synapses. SAP102 is enriched in preparations of synaptic junctions, where it biochemically behaves as a component of the cortical cytoskeleton. Antibodies directed against NMDA receptors coimmunoprecipitate SAP102 from rat brain synaptosomes. Recombinant proteins containing the carboxy-terminal tail of NMDA receptor subunit NR2B interact with SAP102 from rat brain homogenates. All three PDZ domains in SAP102 bind the cytoplasmic tail of NR2B in vitro. These data represent direct evidence that in vivo SAP102 is involved in linking NMDA receptors to the submembraneous cytomatrix associated with postsynaptic densities at excitatory synapses.	UNIV ALABAMA,NEUROBIOL RES CTR,BIRMINGHAM,AL 35213; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205; UNIV HAMBURG,INST CELLULAR BIOCHEM & CLIN NEUROBIOL,D-22529 HAMBURG,GERMANY; INST NEUROBIOL,D-39008 MAGDEBURG,GERMANY; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510	University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; Johns Hopkins University; University of Hamburg; Leibniz Institut fur Neurobiologie (LIN); Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Muller, BM (corresponding author), UNIV HAMBURG,CTR MOL NEUROBIOL,D-20246 HAMBURG,GERMANY.			Garner, Craig/0000-0003-1970-5417; Fenster, Steven/0000-0002-4470-8145	NICHD NIH HHS [P50 HD32901] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD032901] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CARBONETTO S, 1995, CURR OPIN NEUROBIOL, V5, P596, DOI 10.1016/0959-4388(95)80064-6; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Hunt CA, 1996, J NEUROSCI, V16, P1380; HUNTLEY CW, 1994, TRENDS NEUROSCI, V17, P536; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1995, FEBS LETT, V359, P159, DOI 10.1016/0014-5793(95)00030-D; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1995, SCIENCE, V269, P1737; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LANDIS DMD, 1988, INTRINSIC DETERMINAN, P201; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MCPHERSON PS, 1994, P NATL ACAD SCI USA, V91, P6486, DOI 10.1073/pnas.91.14.6486; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1996, J NEUROSCI, V16, P2157; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; SAHYOUN N, 1985, BIOCHEM BIOPH RES CO, V132, P878, DOI 10.1016/0006-291X(85)91889-3; Sambrook J., 2002, MOL CLONING LAB MANU; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	34	356	359	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					255	265		10.1016/S0896-6273(00)80157-9	http://dx.doi.org/10.1016/S0896-6273(00)80157-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780649	Bronze			2022-12-24	WOS:A1996VE84000008
J	Broillet, MC; Firestein, S				Broillet, MC; Firestein, S			Direct activation of the olfactory cyclic nucleotide-gated channel through modification of sulfhydryl groups by NO compounds	NEURON			English	Article							NITRIC-OXIDE; RECEPTOR NEURONS; FUNCTIONAL EXPRESSION; NITROGEN-DIOXIDE; CELLS	The activation of a cyclic nucleotide-gated channel is the final step in sensory transduction in olfaction. Normally, this channel is opened by the intracellular cyclic nucleotide second messenger cAMP or cGMP. However, in single channel recordings we found that donors of nitric oxide, a putative intercellular messenger, could directly activate the native olfactory neuron channel. Its action was independent of the presence of the normal ligand and did not involve the cyclic nucleotide binding site, suggesting an alternate site on the molecule that is critical in channel gating. The biochemical pathway appears to utilize nitric oxide in one of its alternate redox states, the nitrosonium ion, transnitrosylating a free sulfhydryl group belonging to a cysteine residue tentatively identified as being in the region linking the S6 transmembrane domain to the ligand binding domain.			Broillet, MC (corresponding author), COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027, USA.			Broillet, Marie-Christine/0000-0002-0487-6638				BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; BUTLER AR, 1995, TRENDS PHARMACOL SCI, V16, P18, DOI 10.1016/S0165-6147(00)88968-3; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DONNER K, 1990, EXP EYE RES, V51, P97, DOI 10.1016/0014-4835(90)90176-U; DRYER SE, 1991, NATURE, V353, P756, DOI 10.1038/353756a0; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; Firestein Stuart, 1994, Seminars in Cell Biology, V5, P39, DOI 10.1006/scel.1994.1006; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; JOCELYN PC, 1987, SULFUR SULFUR AMINO, P246; JOCELYN PC, 1987, SULFUR SULFUR AMINO, P44; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KENYON GL, 1977, ENZYME STRUCTURE, P407; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LEINDERSZUFALL T, 1995, NEUROREPORT, V6, P45; LIPTON SA, 1994, NEUROPHARMACOLOGY, V33, P1229, DOI 10.1016/0028-3908(94)90021-3; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LISCHKA FW, 1993, NEUROREPORT, V4, P582, DOI 10.1097/00001756-199305000-00031; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MONCADA S, 1991, PHARMACOL REV, V43, P109; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; PRYOR WA, 1981, SCIENCE, V214, P435, DOI 10.1126/science.214.4519.435; PRYOR WA, 1982, J ORG CHEM, V47, P156, DOI 10.1021/jo00340a038; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; ROSKAMS AJ, 1994, NEURON, V13, P289; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SNYDER SH, 1992, SCIENCE, V257, P494, DOI 10.1126/science.1353273; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHITE FHJ, 1972, ENZYME STRUCTURE, P481; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481; ZHAO HQ, 1994, NEUROREPORT, V6, P149, DOI 10.1097/00001756-199412300-00038; ZUFALL F, 1991, J NEUROSCI, V11, P3573; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	42	133	137	3	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					377	385		10.1016/S0896-6273(00)80055-0	http://dx.doi.org/10.1016/S0896-6273(00)80055-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789952	hybrid			2022-12-24	WOS:A1996TW95700017
J	Yu, WF; Xu, J; Li, M				Yu, WF; Xu, J; Li, M			NAB domain is essential for the subunit assembly of both alpha-alpha and alpha-beta and complexes of Shaker-like potassium channels	NEURON			English	Article							HETEROMULTIMERIC K+ CHANNELS; XENOPUS-OOCYTES; ION CHANNELS; BOVINE BRAIN; RAT-BRAIN; A-CURRENT; INACTIVATION; DROSOPHILA; CELLS; PROTEIN	There are at least five subfamilies of Shaker-like K+ channels. The diverse functions of K+ channels are thought to be further modulated by hydrophilic beta subunits. Here we report that Kv beta 1 inactivates RCK4 and Shaker B K+ channels of the Kv1 subfamily, but not Shal2 of the Kv4 subfamily. This correlates the subfamily-specific binding of Kv beta 1 to the cytoplasmic N-terminal domains of Kv1 alpha subunits. We map the Kv beta 1-binding site to a region overlapping NAB(Kv1), a domain that specifies different Kv1 or subunits to form heterotetramers. Using chimeric or subunits, we demonstrate that NAB(Kv1) is essential for the Kv beta 1-mediated inactivation. These results suggest that Kv beta 1 modulates a subset of K+ channels through the specific assembly of alpha-beta complexes and reveal the dual function of the NAB domain in mediating the assembly of both alpha-alpha and alpha-beta complexes.	JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA	Johns Hopkins University	Yu, WF (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PHYSIOL, BALTIMORE, MD 21205 USA.							BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BEIRAO PSL, 1994, J PHYSIOL-LONDON, V474, P269, DOI 10.1113/jphysiol.1994.sp020019; BUTLER A, 1990, NUCLEIC ACIDS RES, V18, P2173, DOI 10.1093/nar/18.8.2173; BYRNE JH, 1980, J NEUROPHYSIOL, V43, P651, DOI 10.1152/jn.1980.43.3.651; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; DREWE JA, 1992, J NEUROSCI, V12, P538; DUBOIS JM, 1993, PROG BIOPHYS MOL BIO, V59, P1, DOI 10.1016/0079-6107(93)90005-5; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FOSTER CD, 1992, NEURON, V9, P229, DOI 10.1016/0896-6273(92)90162-7; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1991, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MILKMAN R, 1994, P NATL ACAD SCI USA, V91, P3510, DOI 10.1073/pnas.91.9.3510; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MORALES MJ, 1995, J BIOL CHEM, V270, P6272, DOI 10.1074/jbc.270.11.6272; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; ROGAWSKI MA, 1985, TRENDS NEUROSCI, V8, P214, DOI 10.1016/0166-2236(85)90082-7; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; STEPHENS GJ, 1995, J PHYSIOL-LONDON, V484, P1; SUMMERS MD, 1987, TEX AGR EXP ST B, V1555; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TORO L, 1992, NEURON, V9, P237, DOI 10.1016/0896-6273(92)90163-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WU J, 1995, J BIOL CHEM, V270, P24761; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZHAO B, 1994, NEURON, V13, P1205, DOI 10.1016/0896-6273(94)90058-2	56	128	132	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					441	453		10.1016/S0896-6273(00)80062-8	http://dx.doi.org/10.1016/S0896-6273(00)80062-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789959	hybrid			2022-12-24	WOS:A1996TW95700024
J	Mori, H; Manabe, T; Watanabe, M; Satoh, Y; Suzuki, N; Toki, S; Nakamura, K; Yagi, T; Kushiya, E; Takahashi, T; Inoue, Y; Sakimura, K; Mishina, M				Mori, H; Manabe, T; Watanabe, M; Satoh, Y; Suzuki, N; Toki, S; Nakamura, K; Yagi, T; Kushiya, E; Takahashi, T; Inoue, Y; Sakimura, K; Mishina, M			Role of the carboxy-terminal region of the GluR epsilon 2 subunit in synaptic localization of the NMDA receptor channel	NEURON			English	Article							D-ASPARTATE RECEPTOR; MESSENGER-RNAS; RAT-BRAIN; IN-VIVO; TARGETED DISRUPTION; EPSILON-2 SUBUNIT; SINGLE-CHANNEL; PSD-95 FAMILY; PROTEIN; GENE	The synaptic localization of the N-methyl-D-aspartate (NMDA) type glutamate receptor (GluR) channel is a prerequisite for synaptic plasticity in the brain. We generated mutant mice carrying the carboxy-terminal truncated GluR epsilon 2 subunit of the NMDA receptor channel. The mutant mice died neonatally and failed to form barrelette structures in the brainstem. The mutation greatly decreased the NMDA receptor-mediated component of hippocampal excitatory postsynaptic potentials and punctate immunofluorescent labelings of GluR epsilon 2 protein in the neuropil regions, while GluR epsilon 2 protein expression was comparable. Immunostaining of cultured cerebral neurons showed the reduced punctate staining of the truncated GluR epsilon 2 protein at synapses. These results suggest that the carboxy-terminal region of the GluR epsilon 2 subunit is important for efficient clustering and synaptic localization of the NMDA receptor channel.	Univ Tokyo, Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo 1130033, Japan; Univ Tokyo, Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; Natl Inst Physiol Sci, Lab Neurobiol & Behav Genet, Okazaki, Aichi 4440867, Japan; Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan	University of Tokyo; University of Tokyo; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Niigata University	Mishina, M (corresponding author), Univ Tokyo, Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo 1130033, Japan.		Takahashi, Tomoyuki/G-5951-2015; Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012	Takahashi, Tomoyuki/0000-0002-8771-7666; Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138				AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; AOKI C, 1994, J NEUROSCI, V14, P5202; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUCKLEY KM, 1987, J CELL BIOL, V105, P2447, DOI 10.1083/jcb.105.6.2447; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Colquhoun David, 1995, P483; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; IKEDA K, 1934, FEBS LETT, P313; Ito I, 1997, J PHYSIOL-LONDON, V500, P401, DOI 10.1113/jphysiol.1997.sp022030; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIYAMA Y, IN PRESS J NEUROSCI; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; MORI H, 1993, NEUROREPORT, V4, P519, DOI 10.1097/00001756-199305000-00014; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Nagasawa M, 1996, MOL BRAIN RES, V36, P1, DOI 10.1016/0169-328X(95)00225-H; Niethammer M, 1996, J NEUROSCI, V16, P2157; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SCHMECHEL D, 1978, SCIENCE, V199, P313, DOI 10.1126/science.339349; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; STERNBERG N, 1986, J MOL BIOL, V187, P197, DOI 10.1016/0022-2836(86)90228-7; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; Takahashi T, 1996, J NEUROSCI, V16, P4376; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; YAMAKURA T, 1993, BIOCHEM BIOPH RES CO, V196, P1537, DOI 10.1006/bbrc.1993.2426; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I; ZHONG J, 1995, J NEUROCHEM, V64, P531	58	121	125	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1998	21	3					571	580		10.1016/S0896-6273(00)80567-X	http://dx.doi.org/10.1016/S0896-6273(00)80567-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768843	Bronze			2022-12-24	WOS:000076196400013
J	de la Torre, JR; Hopker, VH; Ming, GL; Poo, MM; Tessier-Lavigne, M; Hemmati-Brivanlou, A; Holt, CE				de la Torre, JR; Hopker, VH; Ming, GL; Poo, MM; Tessier-Lavigne, M; Hemmati-Brivanlou, A; Holt, CE			Turning of retinal growth cones in a netrin-1 gradient mediated by the netrin receptor DCC	NEURON			English	Article							PIONEER AXON MIGRATIONS; C-ELEGANS; COLORECTAL-CANCER; COMMISSURAL AXONS; NERVOUS-SYSTEM; EMBRYONIC CHICK; XENOPUS EMBRYOS; MOTOR AXONS; GUIDES CELL; SPINAL-CORD	Netrin-1 promotes outgrowth of axons in vitro through the receptor Deleted in Colorectal Cancer (DCC) and elicits turning of axons within embryonic explants when presented as a point source. It is not known whether netrin-1 alone can elicit turning nor whether DCC mediates the turning response. We show that Xenopus retinal ganglion cell growth cones orient rapidly toward a pipette ejecting netrin-1, an effect blocked by antibodies to DCC. In vitro, netrin-1 induces a complex growth cone morphology reminiscent of that at the optic nerve head, a site of netrin-1 expression in vivo. These results demonstrate that netrin-1 can function alone to induce turning, implicate DCC in this response, and support the idea that netrin-1 contributes to steering axons out of the retina.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Diego, Dept Biol, San Diego, CA 92039 USA; Rockefeller Univ, New York, NY 10021 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; Rockefeller University	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.		Ming, Guo-li/J-7880-2013; de la Torre, Jose R/H-2081-2012	de la Torre, Jose R/0000-0002-9553-6048; Holt, Christine Elizabeth/0000-0003-2829-121X; Ming, Guo-li/0000-0002-2517-6075	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD032105, R01HD032105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764, R01NS033713] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32105] Funding Source: Medline; NINDS NIH HHS [NS33713, NS22764] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKERMAN SL, 1997, DEVELOPMENT, V109, P435; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P413, DOI 10.1006/mcne.1995.1031; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Cajal SR., 1893, CELLULE, V9, P119; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FROHMAN MA, 1989, TECHNIQUE, V1, P165; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; GUNDERSEN RW, 1985, J NEUROSCI RES, V13, P199, DOI 10.1002/jnr.490130114; HALFTER W, 1984, DEV BIOL, V102, P344, DOI 10.1016/0012-1606(84)90199-4; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; HOLT CE, 1989, J NEUROSCI, V9, P3123; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; KRAYANEK S, 1981, DEV BIOL, V84, P41, DOI 10.1016/0012-1606(81)90368-7; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Macdonald R, 1997, DEVELOPMENT, V124, P2397; MacLennan AJ, 1997, J NEUROSCI, V17, P5466; Mason CA, 1997, J NEUROSCI, V17, P1086; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Metin C, 1997, DEVELOPMENT, V124, P5063; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PIERCEALL WE, 1994, DEV BIOL, V166, P654, DOI 10.1006/dbio.1994.1345; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PLACZEK M, 1990, COLD SPRING HARB SYM, V55, P279; Richards LJ, 1997, J NEUROSCI, V17, P2445; RIVAS RJ, 1992, NEURON, V8, P107, DOI 10.1016/0896-6273(92)90112-Q; ROBERTS A, 1988, DEVELOPMENT, V103, P447; SAMBROOK J, 1990, MOL CLONING LAB GUID, V2; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; SILVER J, 1980, J COMP NEUROL, V189, P101, DOI 10.1002/cne.901890106; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SILVER J, 1981, J COMP NEUROL, V202, P521, DOI 10.1002/cne.902020406; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Strahle U, 1997, MECH DEVELOP, V62, P147, DOI 10.1016/S0925-4773(97)00657-6; TAYLOR JSH, 1991, DEVELOPMENT, P95; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VanRaay TJ, 1997, GENOMICS, V41, P279, DOI 10.1006/geno.1997.4659; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wang LC, 1996, NEURON, V17, P849, DOI 10.1016/S0896-6273(00)80217-2; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	66	226	229	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1997	19	6					1211	1224		10.1016/S0896-6273(00)80413-4	http://dx.doi.org/10.1016/S0896-6273(00)80413-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427245	Bronze			2022-12-24	WOS:000071236500009
J	Bolshakov, VY; Golan, H; Kandel, ER; Siegelbaum, SA				Bolshakov, VY; Golan, H; Kandel, ER; Siegelbaum, SA			Recruitment of new sites of synaptic transmission during the cAMP-dependent late phase of LTP at CA3-CA1 synapses in the hippocampus	NEURON			English	Article							LONG-TERM POTENTIATION; CA1 REGION; PYRAMIDAL CELLS; PROTEIN-KINASE; QUANTAL SIZE; TRANSMITTER RELEASE; SILENT SYNAPSES; RAT HIPPOCAMPUS; MICE LACKING; NEURONS	Long-term potentiation at CA3-CA1 hippocampal synapses exhibits an early phase and a late phase, which can be distinguished by their underlying molecular mechanisms. Unlike the early phase, the late phase is dependent on both cAMP and protein synthesis. Quantal analysis of unitary synaptic transmission between a single presynaptic CA3 neuron and a single postsynaptic CA1 neuron suggests that, under certain conditions, the early phase of LTP involves an increase in the probability of release of a single quantum of transmitter from a single presynaptic release site, with no change in the number of quanta that are released or in postsynaptic sensitivity to transmitter. Here, we show that the cAMP-induced late phase of LTP involves an increase in the number of quanta released in response to a single presynaptic action potential, possibly due to an increase in the number of sites of synaptic transmission between a single CA3 and a single CA1 neuron.	COLUMBIA UNIV,COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT PHARMACOL,HOWARD HUGHES MED INST,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT PHYSIOL,HOWARD HUGHES MED INST,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT BIOCHEM & BIOPHYS,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University			GOLAN, HAVA/F-2121-2012	GOLAN, HAVA/0000-0001-8661-3665	NIMH NIH HHS [MH50733] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BARNES CA, 1995, NEURON, V15, P751, DOI 10.1016/0896-6273(95)90166-3; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DITYATEV AE, 1994, PFLUG ARCH EUR J PHY, V429, P22, DOI 10.1007/BF02584026; EDWARDS F, 1991, NATURE, V350, P271, DOI 10.1038/350271a0; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JACK JJB, 1994, ADV SEC MESS PHOSPH, V29, P275; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KORN H, 1993, J NEUROPHYSIOL, V70, P1249, DOI 10.1152/jn.1993.70.3.1249; KORN H, 1994, ADV SEC MESS PHOSPH, V29, P301; KRASZEWSKI K, 1992, NEUROSCIENCE, V47, P555, DOI 10.1016/0306-4522(92)90165-X; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LILEY AW, 1957, J PHYSIOL-LONDON, V136, P595, DOI 10.1113/jphysiol.1957.sp005784; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MAYFORD M, 1995, CURR OPIN NEUROBIOL, V5, P141, DOI 10.1016/0959-4388(95)80019-0; MELAMED N, 1993, J NEUROSCI, V13, P632; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; POCKETT S, 1993, NEUROSCIENCE, V52, P229, DOI 10.1016/0306-4522(93)90151-5; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STRICKER C, 1994, BIOPHYS J, V67, P656, DOI 10.1016/S0006-3495(94)80514-4; STRICKER C, 1994, BIOPHYS J, V67, P532, DOI 10.1016/S0006-3495(94)80513-2; Stricker C, 1996, J PHYSIOL-LONDON, V490, P443, DOI 10.1113/jphysiol.1996.sp021156; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; ULRICH D, 1993, J NEUROPHYSIOL, V69, P1769, DOI 10.1152/jn.1993.69.5.1769; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P20; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	66	169	171	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					635	651		10.1016/S0896-6273(00)80377-3	http://dx.doi.org/10.1016/S0896-6273(00)80377-3			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331354	hybrid			2022-12-24	WOS:A1997XZ01600017
J	Johnstone, DB; Wei, AG; Butler, A; Salkoff, L; Thomas, JH				Johnstone, DB; Wei, AG; Butler, A; Salkoff, L; Thomas, JH			Behavioral defects in C-elegans egl-36 mutants result from potassium channels shifted in voltage-dependence of activation	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; HETEROMULTIMERIC K+ CHANNELS; RAT-BRAIN; FUNCTIONAL EXPRESSION; DROSOPHILA NEURONS; GENETIC-ANALYSIS; XENOPUS-OOCYTES; WILD-TYPE; MUTATIONS; PROTEINS	Mutations in the C. elegans egl-36 gene result in defective excitation of egg-laying and enteric muscles. Dominant gain-of-function alleles inhibit enteric and egg-laying muscle contraction, whereas a putative null mutation has no observed phenotype. egl-36 encodes a Shaw-type (Kv3) voltage-dependent potassium channel subunit. In Xenopus oocytes, wild-type egl-36 expresses noninactivating channels with slow activation kinetics. One gain-of-function mutation causes a single amino acid substitution in S6, and the other causes a substitution in the cytoplasmic amino terminal domain. Both mutant alleles produce channels dramatically shifted in their midpoints of activation toward hyperpolarized voltages. An egl-36::gfp fusion is expressed in egg-laying muscles and in a pair of enteric muscle motor neurons. The mutant egl-36 phenotypes can thus be explained by expression in these cells of potassium channels that are inappropriately opened at hyperpolarized potentials, causing decreased excitability due to increased potassium conductance.	UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110	University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL)	Johnstone, DB (corresponding author), UNIV WASHINGTON,MOL & CELLULAR BIOL PROGRAM,SEATTLE,WA 98195, USA.				NINDS NIH HHS [R01NS24785, R01NS30187] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030187, R01NS024785] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; BRENNER S, 1974, GENETICS, V77, P71; BRUGGEMAN A, 1993, NATURE, V265, P445; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; GANETZKY B, 1995, SOC GEN PHY, V50, P29; GHANSHANI S, 1992, GENOMICS, V12, P190, DOI 10.1016/0888-7543(92)90365-Y; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; GREENWALD IS, 1980, GENETICS, V96, P147; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; Ho CS, 1997, P NATL ACAD SCI USA, V94, P1533, DOI 10.1073/pnas.94.4.1533; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; KAPLAN WD, 1969, GENETICS, V61, P399; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LIU DWC, 1994, J NEUROSCI, V14, P1953; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PARK EC, 1986, GENETICS, V113, P821; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; REINER DJ, 1995, GENETICS, V141, P961; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RUDY B, 1991, J NEUROSCI RES, V29, P401, DOI 10.1002/jnr.490290316; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; SIGWORTH FJ, 1993, Q REV BIOPHYS, V27, P1; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; THOMAS JH, 1990, GENETICS, V124, P855; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Titus SA, 1997, J NEUROSCI, V17, P875; TRENT C, 1983, GENETICS, V104, P619; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang XJ, 1997, J NEUROSCI, V17, P882; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; WOOD WB, 1988, NEMATODE CAENORHABDI, P81; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	81	43	45	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					151	164		10.1016/S0896-6273(00)80355-4	http://dx.doi.org/10.1016/S0896-6273(00)80355-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247271	Bronze			2022-12-24	WOS:A1997XN39400014
J	Pedraza, L; Fidler, L; Staugaitis, SM; Colman, DR				Pedraza, L; Fidler, L; Staugaitis, SM; Colman, DR			The active transport of myelin basic protein into the nucleus suggests a regulatory role in myelination	NEURON			English	Article							GREEN-FLUORESCENT PROTEIN; TRANSGENIC SHIVERER MICE; MOUSE-BRAIN; INSITU HYBRIDIZATION; LOCALIZATION SIGNAL; GENE-EXPRESSION; MESSENGER-RNAS; MUTANT MOUSE; KINASE-C; CELLS	The myelin basic proteins (MBPs) are a set of membrane proteins that function to adhere the cytoplasmic leaflets of the myelin bilayer. During oligodendrocyte maturation prior to compact myelin formation, however, certain MBPs have been observed within the cell body and nucleus. We explored the parameters of the translocation of the exon II-containing MBPs (MBPexII) from the site of synthesis in the cell cytoplasm into the nucleus and in some experiments used GFP as a molecular reporter to monitor the intracellular distribution of MBP-GFP fusion proteins in living cells. We show here that the transport of MBPexII into cell nuclei is an active process, which is temperature and energy dependent, and may be regulated by phosphorylation state. Further, MBPexII can direct the entry of macromolecular complexes into cell nuclei, revealing that the exon II peptide segment may provide a nuclear localization signal (NLS), perhaps a novel one, or may induce a conformational change in the full-length protein that exposes a cryptic NLS. The MBPexII are thus very unusual in that they are plasma membrane proteins that are also targeted to the nucleus. In oligodendrocytes and Schwann cells, where the MBPs are naturally expressed, it is likely that karyophilic MBPs subserve a regulatory function in implementing the myelination program.	COLUMBIA PRESBYTERIAN MED CTR, DEPT PATHOL, NEW YORK, NY 10029 USA	Columbia University; NewYork-Presbyterian Hospital	Pedraza, L (corresponding author), MT SINAI SCH MED, BROOKDALE CTR MOL BIOL, NEW YORK, NY 10029 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147, R01NS031032] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 31032, NS 20147] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLINQUANT B, 1991, J CELL BIOL, V113, P393, DOI 10.1083/jcb.113.2.393; AMURUMARJEE SG, 1990, DEV NEUROSCI-BASEL, V12, P263, DOI 10.1159/000111855; BARBARESE E, 1978, J NEUROCHEM, V31, P779, DOI 10.1111/j.1471-4159.1978.tb00110.x; BREEUWER M, 1990, CELL, V60, P999, DOI 10.1016/0092-8674(90)90348-I; BROPHY PJ, 1993, TRENDS NEUROSCI, V16, P515, DOI 10.1016/0166-2236(93)90196-S; BUSTOS JG, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83; CAMPAGNONI AT, 1980, J NEUROCHEM, V34, P677, DOI 10.1111/j.1471-4159.1980.tb11197.x; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; DEFERRA F, 1985, CELL, V43, P721, DOI 10.1016/0092-8674(85)90245-4; FARSETTI A, 1991, J BIOL CHEM, V266, P23226; FELDHERR CM, 1991, J CELL BIOL, V115, P933, DOI 10.1083/jcb.115.4.933; FELDHERR CM, 1993, EXP CELL RES, V205, P179, DOI 10.1006/excr.1993.1073; FELDHERR CM, 1990, J CELL BIOL, V111, P1, DOI 10.1083/jcb.111.1.1; GANSER AL, 1980, NEUROLOGICAL MUTATIO, P171; GOLDFARB DS, 1995, CURR BIOL, V5, P570, DOI 10.1016/S0960-9822(95)00111-4; GORMAN CM, 1983, NUCLEIC ACIDS RES, V11, P7631, DOI 10.1093/nar/11.21.7631; Hardy RJ, 1996, J NEUROSCI RES, V46, P246, DOI 10.1002/(SICI)1097-4547(19961015)46:2<246::AID-JNR13>3.0.CO;2-0; HARTMAN BK, 1979, J COMP NEUROL, V188, P273, DOI 10.1002/cne.901880206; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; INOUE T, 1990, J BIOL CHEM, V265, P19065; JORDAN C, 1989, J NEUROSCI, V9, P248; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; KIMURA M, 1989, P NATL ACAD SCI USA, V86, P5661, DOI 10.1073/pnas.86.14.5661; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; Landry CF, 1996, J NEUROSCI, V16, P2452; MARTENSON RE, 1986, J NEUROCHEM, V46, P1612, DOI 10.1111/j.1471-4159.1986.tb01784.x; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; MILLER M, 1991, DEVELOPMENT, V113, P569; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; NEWMAN S, 1987, P NATL ACAD SCI USA, V84, P886, DOI 10.1073/pnas.84.3.886; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; PAINE PL, 1992, NUCLEAR TRAFFICKING, P3; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; PRUSCHY M, 1994, J CELL BIOL, V127, P1527, DOI 10.1083/jcb.127.6.1527; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; ROUSSEL G, 1981, HISTOCHEM J, V13, P1029, DOI 10.1007/BF01002642; SAAVEDRA RA, 1989, J MOL EVOL, V29, P149, DOI 10.1007/BF02100113; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; SMITH MR, 1992, VIROLOGY, V187, P316, DOI 10.1016/0042-6822(92)90320-O; SMITH R, 1980, BIOCHEMISTRY-US, V19, P1826, DOI 10.1021/bi00550a015; STAUGAITIS SM, 1990, J CELL BIOL, V110, P1719, DOI 10.1083/jcb.110.5.1719; STERNBERGER NH, 1978, J NEUROCYTOL, V7, P251, DOI 10.1007/BF01217922; TAGAWA T, 1995, J CELL BIOL, V130, P255, DOI 10.1083/jcb.130.2.255; TAKAHASHI N, 1985, CELL, V42, P139, DOI 10.1016/S0092-8674(85)80109-4; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; VERITY AN, 1988, J NEUROSCI RES, V21, P238, DOI 10.1002/jnr.490210216; WAEHNELDT TV, 1990, ANN NY ACAD SCI, V605, P15, DOI 10.1111/j.1749-6632.1990.tb42377.x; YU JS, 1994, J NEUROCHEM, V62, P1596	61	111	111	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR	1997	18	4					579	589		10.1016/S0896-6273(00)80299-8	http://dx.doi.org/10.1016/S0896-6273(00)80299-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136767	Bronze			2022-12-24	WOS:A1997WW62600007
J	Chevesich, J; Kreuz, AJ; Montell, C				Chevesich, J; Kreuz, AJ; Montell, C			Requirement for the PDZ domain protein, INAD, for localization of the TRP store-operated channel to a signaling complex	NEURON			English	Article							POSTSYNAPTIC DENSITY PROTEIN; CAPACITATIVE CALCIUM-ENTRY; DROSOPHILA-NINAC KINASE; PHOTORECEPTOR CELL; VISUAL TRANSDUCTION; CALMODULIN-BINDING; PHOSPHOLIPASE-C; HUMAN HOMOLOG; ION-CHANNEL; I-CRAC	In Drosophila, the store-operated Ca2+ channel, TRP, is required in photoreceptor cells for a sustained response to light. Here, we show that TRP forms a complex with phospholipase C-beta (NORPA), rhodopsin (RH1), calmodulin, and the PDZ domain containing protein INAD. Proteins with PDZ domains have previously been shown to cluster ion channels in vitro. We show that in InaD mutant flies, TRP is no longer spatially restricted to its normal subcellular compartment, the rhabdomere. These results provide evidence that a PDZ domain protein is required, in vivo, for anchoring of an ion channel to a signaling complex. Furthermore, disruption of this interaction results in retinal degeneration. We propose that the TRP channel is linked to NORPA and RH1 to facilitate feedback regulation of these upstream signaling molecules.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University	Chevesich, J (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.		Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482	NEI NIH HHS [EY10852] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENNETT DL, 1995, CURR BIOL, V5, P1225, DOI 10.1016/S0960-9822(95)00243-0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Blest A., 1988, ADV INSECT PHYSL, P1, DOI 10.1016/s0065-2806(08)60021-1; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; COSENS D, 1972, J INSECT PHYSIOL, V18, P1773, DOI 10.1016/0022-1910(72)90109-6; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; INOUE H, 1988, J BIOCHEM-TOKYO, V103, P91, DOI 10.1093/oxfordjournals.jbchem.a122246; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; SAIMI Y, 1994, FEBS LETT, V350, P155, DOI 10.1016/0014-5793(94)00782-9; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STARK WS, 1989, INHERITED ENV INDUCE, P467; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Warr CG, 1996, BIOCHEM J, V314, P497, DOI 10.1042/bj3140497; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; WONG F, 1989, NEURON, V3, P81, DOI 10.1016/0896-6273(89)90117-7; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	57	245	254	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					95	105		10.1016/S0896-6273(01)80049-0	http://dx.doi.org/10.1016/S0896-6273(01)80049-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010208	hybrid			2022-12-24	WOS:A1997WE71800011
J	Riehl, R; Johnson, K; Bradley, R; Grunwald, GB; Cornel, E; Lilienbaum, A; Holt, CE				Riehl, R; Johnson, K; Bradley, R; Grunwald, GB; Cornel, E; Lilienbaum, A; Holt, CE			Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo	NEURON			English	Article							PURIFIED N-CADHERIN; ADHESION MOLECULES; R-CADHERIN; NEURITE OUTGROWTH; XENOPUS-EMBRYOS; OPTIC-NERVE; CYTOPLASMIC DOMAIN; EXPRESSION; GROWTH; INTEGRINS	The cell-cell adhesion molecule N-cadherin strongly promotes neurite outgrowth in cultured retinal neurons. To test whether cadherins regulate process outgrowth in retinal neurons in vivo, we have blocked cadherin function in single cells by expression of a dominant negative N-cadherin mutant. We report that when cadherin function is inhibited, axon and dendrite outgrowth are severely impaired, particularly in retinal ganglion cells. Laminar migration and cell type specification, by contrast, appear unaffected. Further, expression of the catenin-binding domain of N-cadherin, which blocks cadherin-mediated adhesion in early embryos, does not affect axon outgrowth, suggesting that outgrowth and adhesion are mediated by distinct regions of the cytoplasmic domain. These findings indicate that cadherins play an essential role in the initiation and extension of axons from retinal ganglion cells in vivo.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92037; SALK INST BIOL STUDIES,MOL NEUROBIOL LAB,SAN DIEGO,CA 92138; THOMAS JEFFERSON UNIV,DEPT PATHOL ANAT & CELL BIOL,PHILADELPHIA,PA 19107	University of California System; University of California San Diego; Salk Institute; Jefferson University				Holt, Christine Elizabeth/0000-0003-2829-121X; Johnson, Karl/0000-0003-3931-5985	NCI NIH HHS [1F32CA66313-01] Funding Source: Medline; NEI NIH HHS [EY06658] Funding Source: Medline; NINDS NIH HHS [R01 NS23780] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA066313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023780] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERLE H, 1994, J CELL SCI, V107, P3655; AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; BARAMI K, 1994, NEURON, V13, P567, DOI 10.1016/0896-6273(94)90026-4; BIXBY JL, 1994, J CELL BIOL, V127, P1461, DOI 10.1083/jcb.127.5.1461; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BOLLER K, 1985, J CELL BIOL, V100, P357; CHNG SK, 1992, ANAT EMBRYOL, V186, P175; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; DUFOUR S, 1994, J CELL BIOL, V127, P521, DOI 10.1083/jcb.127.2.521; DUNLOP SA, 1984, VISION RES, V24, P417, DOI 10.1016/0042-6989(84)90040-3; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; GRANT P, 1980, J COMP NEUROL, V189, P671, DOI 10.1002/cne.901890405; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HOLT CE, 1994, P NATL ACAD SCI USA, V91, P10844, DOI 10.1073/pnas.91.23.10844; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; KLJAVIN IJ, 1994, J NEUROSCI, V14, P5035; LEMMON V, 1992, J NEUROSCI, V12, P818; LEVINE E, 1994, DEVELOPMENT, V120, P901; LILIENBAUM A, 1995, MOL CELL NEUROSCI, V6, P139, DOI 10.1006/mcne.1995.1013; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; MULLER HAJ, 1994, MECH DEVELOP, V47, P213, DOI 10.1016/0925-4773(94)90040-X; MURPHYERDOSH C, 1994, DEV BIOL, V161, P107, DOI 10.1006/dbio.1994.1013; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PARADIES NE, 1993, J NEUROSCI RES, V36, P33, DOI 10.1002/jnr.490360105; PAYNE HR, 1992, CELL MOTIL CYTOSKEL, V21, P65, DOI 10.1002/cm.970210108; REDIES C, 1993, GLIA, V8, P161, DOI 10.1002/glia.440080304; REDIES C, 1992, J NEUROSCI, V12, P3525; REDIES C, 1993, J COMP NEUROL, V333, P398, DOI 10.1002/cne.903330307; REICHARDT LF, 1989, DEV NEUROSCI-BASEL, V11, P332, DOI 10.1159/000111910; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; SIMONNEAU L, 1992, DEV DYNAM, V194, P247, DOI 10.1002/aja.1001940402; STIER H, 1995, DEVELOPMENT, V121, P1443; SUZUKI S, 1991, CELL REGUL, V2, P261, DOI 10.1091/mbc.2.4.261	49	238	238	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					837	848		10.1016/S0896-6273(00)80216-0	http://dx.doi.org/10.1016/S0896-6273(00)80216-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938117	Bronze			2022-12-24	WOS:A1996VV15100007
J	Sauman, I; Reppert, SM				Sauman, I; Reppert, SM			Circadian clock neurons in the silkmoth Antheraea pernyi: Novel mechanisms of period protein regulation	NEURON			English	Article							DROSOPHILA-MELANOGASTER; NERVOUS-SYSTEM; GENE-PRODUCT; TIMELESS; EXPRESSION; CLONING; AUTOREGULATION; FEEDBACK; SEQUENCE; REVEALS	We examined Period (PER) protein regulation in the brain of the silkmoth Antheraea pernyi. PER expression is restricted to the cytoplasm and axons of eight neurons, with no evidence of temporal movement into the nucleus. These neurons appear to be circadian clock cells, because PER and per mRNA are colocalized and their levels oscillate in these cells, Timeless protein immunoreactivity is coexpressed in each PER-positive neuron, and clock protein and mRNA oscillations are all suppressed in these neurons by constant light. A per antisense RNA oscillation was detected that is spatially restricted to PER-expressing cells, suggesting a novel mechanism of PER regulation. PER-positive neurons and their projections are strategically positioned for regulating prothoracicotropic hormone and eclosion hormone, two neurohormones under circadian control. Differences in the molecular details of PER expression and regulation between the brains of silkmoths and fruitflies provide insights into the mechanisms of clock gene regulation.	MASSACHUSETTS GEN HOSP,SERV PEDIAT,LAB DEV CHRONOBIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School			Sauman, Ivo/H-2071-2014		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; COLOT HV, 1988, EMBO J, V7, P3929, DOI 10.1002/j.1460-2075.1988.tb03279.x; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DUNLAP JC, 1995, CIBA F SYMP, V183, P1; EWER J, 1992, J NEUROSCI, V12, P3321; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; HALL JC, 1995, TRENDS NEUROSCI, V18, P230, DOI 10.1016/0166-2236(95)93908-G; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; INOUYE M, 1988, GENE, V72, P25, DOI 10.1016/0378-1119(88)90124-2; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; KAY SA, 1995, CELL, V83, P361, DOI 10.1016/0092-8674(95)90113-2; Kimelman D., 1992, Gene regulation: biology of antisense RNA and DNA., P1; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1995, NEURON, V15, P147, DOI 10.1016/0896-6273(95)90072-1; Murashov AK, 1996, MOL BRAIN RES, V37, P85, DOI 10.1016/0169-328X(95)00288-4; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; NIELSEN J, 1994, MOL BIOL EVOL, V11, P839; RAO KR, 1992, PIGM CELL RES, P266, DOI 10.1111/j.1600-0749.1990.tb00383.x; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; Sauman I, 1996, DEV BIOL, V178, P418, DOI 10.1006/dbio.1996.0228; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; TRUMAN JW, 1992, PROG BRAIN RES, V92, P361, DOI 10.1016/S0079-6123(08)61189-9; TRUMAN JW, 1974, J COMP PHYSIOL, V95, P281, DOI 10.1007/BF00609702; TRUMAN JW, 1972, J COMP PHYSIOL, V81, P99, DOI 10.1007/BF00693553; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; TRUMAN JW, 1971, P NATL ACAD SCI USA, V68, P595, DOI 10.1073/pnas.68.3.595; Williams C M, 1969, Symp Soc Exp Biol, V23, P285; WILLIAMS CM, 1964, BIOL BULL, V127, P511, DOI 10.2307/1539252; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	38	186	189	3	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					889	900		10.1016/S0896-6273(00)80220-2	http://dx.doi.org/10.1016/S0896-6273(00)80220-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938121	Bronze			2022-12-24	WOS:A1996VV15100011
J	Raastad, M; Johnson, BR; Kiehn, O				Raastad, M; Johnson, BR; Kiehn, O			The number of postsynaptic currents necessary to produce locomotor-related cyclic information in neurons in the neonatal rat spinal cord	NEURON			English	Article							METHYL-D-ASPARTATE; IN-VITRO; HIPPOCAMPAL SLICES; PYRAMIDAL CELLS; PATCH-CLAMP; INVITRO; MECHANISMS	To understand better how synaptic signaling contributes to network activity, we analyzed the potential contribution of putative unitary postsynaptic currents (PSCs) to locomotor-related information received by spinal interneurons in neonatal rats. The average cyclic modulation of the whole-cell current in 13 neurons was quantified as the difference between the current integral (charge) during the first and second halves of the cyclic locomotor network output. Between 7.6 and 303 average unitary PSCs per second were needed to produce the cyclic modulation. This number is so low that very few (1-5) of the synapses contributing to the cyclic information need to be active simultaneously. This suggests that individual presynaptic cells in a central locomotor network can have a powerful influence on other neurons.			Raastad, M (corresponding author), UNIV COPENHAGEN, DIV NEUROPHYSIOL, DEPT MED PHYSIOL, BLEGDAMSVEJ 3, DK-2200 COPENHAGEN, DENMARK.		Kiehn, Ole/C-4679-2008; kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019	Kiehn, Ole/0000-0002-5954-469X				ANDERSEN P, 1990, PROG BRAIN RES, V83, P215; ARSHAVSKY YI, 1993, TRENDS NEUROSCI, V16, P227, DOI 10.1016/0166-2236(93)90161-E; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; CARR PA, 1995, BRAIN RES BULL, V37, P213, DOI 10.1016/0361-9230(94)00271-2; CAZALETS JR, 1994, J PHYSIOL-LONDON, V474, P173, DOI 10.1113/jphysiol.1994.sp020011; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; COWLEY KC, 1994, NEUROSCI LETT, V171, P147, DOI 10.1016/0304-3940(94)90626-2; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; Feldman J L, 1991, Curr Opin Neurobiol, V1, P590, DOI 10.1016/S0959-4388(05)80033-9; GRILLNER S, 1991, NEURON, V7, P1, DOI 10.1016/0896-6273(91)90069-C; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P565, DOI 10.1152/jn.1994.72.2.565; Kiehn O, 1996, NEUROSCIENCE, V75, P263, DOI 10.1016/0306-4522(96)00250-3; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; KIRKWOOD PA, 1977, J PHYSL, V275, P103; KJAERULFF O, 1994, J PHYSIOL-LONDON, V478, P265, DOI 10.1113/jphysiol.1994.sp020248; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Neher Erwin, 1995, P147; Raastad M, 1996, EUR J NEUROSCI, V8, P1265, DOI 10.1111/j.1460-9568.1996.tb01295.x; Rossignol S, 1996, HDB PHYSL SECTION 12, P173; SMITH JC, 1992, NEUROSCI LETT, V134, P153, DOI 10.1016/0304-3940(92)90504-Z; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; SQALLIHOUSSAINI Y, 1993, J NEUROPHYSIOL, V70, P803, DOI 10.1152/jn.1993.70.2.803; THURBON D, 1994, J NEUROPHYSIOL, V71, P1948, DOI 10.1152/jn.1994.71.5.1948; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208	29	23	24	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					729	738		10.1016/S0896-6273(00)80204-4	http://dx.doi.org/10.1016/S0896-6273(00)80204-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893029	Bronze			2022-12-24	WOS:A1996VP74300017
J	Hsu, SF; Augustine, GJ; Jackson, MB				Hsu, SF; Augustine, GJ; Jackson, MB			Adaptation of Ca2+-triggered exocytosis in presynaptic terminals	NEURON			English	Article							SQUID GIANT SYNAPSE; BOVINE CHROMAFFIN CELLS; TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; CA2+ RELEASE; NEUROTRANSMITTER RELEASE; INTRACELLULAR CALCIUM; FLUORESCENT INDICATOR; PHOTOLABILE CHELATOR; FLASH-PHOTOLYSIS	Rapid increases in Ca2+ concentration, produced by photolysis of caged Ca2+, triggered exocytosis in squid nerve terminals. This exocytosis was transient in nature, decaying with a time constant of approximately 30 ms. The decay could not be explained by a decline in presynaptic Ca2+ concentration, depletion of synaptic vesicles, or desensitization of postsynaptic receptors. Experiments in which Ca2+ was increased either in a series of steps or continuously at different rates suggested that the decay is caused by adaptation of the exocytotic Ca2+ receptor to higher levels of Ca2+. This adjustable sensitivity to Ca2+ represents a novel property of the triggering mechanism that can be used to evaluate molecular models of exocytosis. Adaptation can limit the amount of transmitter released by a nerve terminal and permit the speed of a presynaptic Ca2+ rise to serve as a critical determinant of synaptic efficacy.	DUKE UNIV, SCH MED, DEPT NEUROBIOL, DURHAM, NC 27710 USA; MARINE BIOL LAB, WOODS HOLE, MA 02543 USA	Duke University; Marine Biological Laboratory - Woods Hole	Hsu, SF (corresponding author), UNIV WISCONSIN, SCH MED, DEPT PHYSIOL, MADISON, WI 53706 USA.		Augustine, George James/J-9228-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030016, R01NS021624, R37NS030016] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30016, NS21624] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P143, DOI 10.1113/jphysiol.1985.sp015818; AUGUSTINE GJ, 1984, J PHYSIOL-LONDON, V346, P257, DOI 10.1113/jphysiol.1984.sp015020; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BOWNDS MD, 1995, BEHAV BRAIN SCI, V18, P415, DOI 10.1017/S0140525X00039170; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CHENG HP, 1995, SCIENCE, V267, P2009, DOI 10.1126/science.7701326; CORRIE JET, 1993, J PHYSIOL-LONDON, V465, P1; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; EATOCK RA, 1987, J NEUROSCI, V7, P2821; EllisDavies GCR, 1996, BIOPHYS J, V70, P1006, DOI 10.1016/S0006-3495(96)79644-3; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GYORKE S, 1993, SCIENCE, V260, P807, DOI 10.1126/science.8387229; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HERRINGTON J, 1994, PULSE CONTROL VERSIO; Hodgkin AL., 1964, CONDUCTION NERVOUS I; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Katz B., 1969, RELEASE NEURAL TRANS; KELLY JS, 1969, J NEUROBIOL, V2, P209; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KNOX BE, 1986, P NATL ACAD SCI USA, V83, P2345, DOI 10.1073/pnas.83.8.2345; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; LLINAS R, 1975, P NATL ACAD SCI USA, V72, P187, DOI 10.1073/pnas.72.1.187; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MOORE WJ, 1972, PHYSICAL CHEM; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; PARNAS H, 1989, BIOPHYS J, V55, P859, DOI 10.1016/S0006-3495(89)82885-1; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; SCHELLER RH, 1995, NEURON, V14, P893; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; STUENKEL EL, 1993, J PHYSIOL-LONDON, V468, P335, DOI 10.1113/jphysiol.1993.sp019775; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	57	132	132	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					501	512		10.1016/S0896-6273(00)80182-8	http://dx.doi.org/10.1016/S0896-6273(00)80182-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816713	Bronze			2022-12-24	WOS:A1996VJ44000016
J	Freitag, J; Krieger, J; Strotmann, J; Breer, H				Freitag, J; Krieger, J; Strotmann, J; Breer, H			Two grasses of olfactory receptors in Xenopus laevis	NEURON			English	Article							ENCODING ODORANT RECEPTORS; MULTIGENE FAMILY; EXPRESSION; EPITHELIUM; CATFISH; INFORMATION; GENES	Xenopus laevis possess a gene repertoire encoding two distinct classes of olfactory receptors: one class related to receptors of fish and one class similar to receptors of mammals. Sequence comparison indicates that the fish-like receptors represent closely related members of only two subfamilies, whereas mammalian-like receptors are more distantly related, most of them representing a different subfamily. The fishlike receptor genes are exclusively expressed in the lateral diverticulum of the frog's nose, specialized for detecting water-soluble odorants, whereas mammalian-like receptors are expressed in sensory neurons of the main diverticulum, responsible for the reception of volatile odors.			Freitag, J (corresponding author), UNIV STUTTGART HOHENHEIM,INST ZOOPHYSIOL,D-70593 STUTTGART,GERMANY.							ALTNER H, 1962, Z VERGL PHYSIOL, V45, P272, DOI 10.1007/BF00302326; Angerer L.M., 1992, IN SITU HYBRIDIZATIO, P15; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUCK L, 1993, CHEM SENSES, V18, P203, DOI 10.1093/chemse/18.2.203; ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189; Foske H., 1934, Zeitschrift fuer Anatomie Entw Mech, V103, P519, DOI 10.1007/BF02118933; HARA TJ, 1994, ACTA PHYSIOL SCAND, V152, P207, DOI 10.1111/j.1748-1716.1994.tb09800.x; HOFMANN MH, 1991, BRAIN RES, V564, P344, DOI 10.1016/0006-8993(91)91475-G; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; Mayr E., 1942, SYSTEMATICS ORIGIN S; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CHEM SENSES, V18, P209, DOI 10.1093/chemse/18.2.209; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARTZ RM, 1979, ATLAS PROTEIN SEQUEU; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; STROTMANN J, 1994, CELL TISSUE RES, V276, P429; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M	28	202	207	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1383	1392		10.1016/0896-6273(95)90016-0	http://dx.doi.org/10.1016/0896-6273(95)90016-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845161	Bronze			2022-12-24	WOS:A1995TL67800016
J	Corriveau, RA; Huh, GS; Shatz, CJ				Corriveau, RA; Huh, GS; Shatz, CJ			Regulation of class I MHC gene expression in the developing and mature CNS by neural activity	NEURON			English	Review							LONG-TERM POTENTIATION; COMPLEX CLASS-I; GLUTAMATE RECEPTOR SUBUNIT; LATERAL GENICULATE-NUCLEUS; CENTRAL-NERVOUS-SYSTEM; NICOTINIC ACETYLCHOLINE-RECEPTOR; ACTIVITY-DEPENDENT REGULATION; MESSENGER-RNA EXPRESSION; OCULAR DOMINANCE COLUMNS; CELL-ADHESION MOLECULES	To elucidate molecular mechanisms underlying activity-dependent synaptic remodeling in the developing mammalian visual system, we screened for genes whose expression in the lateral geniculate nucleus (LGN) is regulated by spontaneously generated action potentials present prior to vision. Activity blockade did not alter expression in the LGN of 32 known genes. Differential mRNA display, however, revealed a decrease in mRNAs encoding class I major histocompatibility complex antigens (class I MHC). Postnatally, visually driven activity can regulate class I MHC in the LGN during the final remodeling of retinal ganglion cell axon terminals. Moreover, in the mature hippocampus, class I MHC mRNA levels are increased by kainic acid-induced seizures. Normal expression of class I MHC mRNA is correlated with times and regions of synaptic plasticity, and immunohistochemistry confirms that class I MHC is present in specific subsets of CNS neurons. Finally, beta 2-microglobulin, a cosubunit of class I MHC, and CD3 zeta, a component of a receptor complex for class I MHC, are also expressed by CNS neurons. These observations indicate that class I MHC molecules, classically thought to mediate cell-cell interactions exclusively in immune function, may play a novel role in neuronal signaling and activity-dependent changes in synaptic connectivity.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Shatz, CJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; ARCEGOMEZ B, 1978, TISSUE ANTIGENS, V11, P96, DOI 10.1111/j.1399-0039.1978.tb01233.x; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; Bittigau P, 1997, J CHILD NEUROL, V12, P471, DOI 10.1177/088307389701200802; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; BOTTINO C, 1994, EUR J IMMUNOL, V24, P2527, DOI 10.1002/eji.1830241040; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; Campbell G, 1997, VISUAL NEUROSCI, V14, P779, DOI 10.1017/S0952523800012724; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CLINE HT, 1990, J NEUROSCI, V10, P1197; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DALVA MB, 1994, J NEUROSCI, V14, P3588; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DUBIN MW, 1986, J NEUROSCI, V6, P1021; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FUKUMOTO T, 1982, EUR J IMMUNOL, V12, P237, DOI 10.1002/eji.1830120313; GALL C, 1990, P NATL ACAD SCI USA, V87, P7643, DOI 10.1073/pnas.87.19.7643; GERVAIS AG, 1970, NATURE, V225, P647, DOI 10.1038/225647a0; GERVAIS AG, 1968, TRANSPLANTATION, V6, P261; GOLDEN GT, 1991, NEUROREPORT, V2, P141, DOI 10.1097/00001756-199103000-00008; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; GUILLERY RW, 1973, J COMP NEUROL, V148, P417, DOI 10.1002/cne.901480402; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HART DNJ, 1981, TRANSPLANTATION, V31, P318, DOI 10.1097/00007890-198105010-00003; HOLLMANN M, 1990, COLD SH Q B, V55, P41; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; JOLY E, 1992, NEURON, V8, P1185, DOI 10.1016/0896-6273(92)90138-4; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; KANDEL ER, 1992, SCIENCE, V258, P243, DOI 10.1126/science.1411522; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LAMPSON LA, 1987, TRENDS NEUROSCI, V10, P211, DOI 10.1016/0166-2236(87)90153-6; LAMPSON LA, 1995, MICROSC RES TECHNIQ, V32, P267, DOI 10.1002/jemt.1070320402; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PLOEGH HL, 1979, P NATL ACAD SCI USA, V76, P2273, DOI 10.1073/pnas.76.5.2273; POTTER TA, 1984, J EXP MED, V160, P317, DOI 10.1084/jem.160.1.317; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; RAO K, 1993, J COMP NEUROL, V336, P613, DOI 10.1002/cne.903360413; SCHMIDT JT, 1983, BRAIN RES, V269, P29, DOI 10.1016/0006-8993(83)90959-9; SCHMIDT JT, 1983, BRAIN RES, V269, P15, DOI 10.1016/0006-8993(83)90958-7; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SEGUELA P, 1993, J NEUROSCI, V13, P596; SHATZ CJ, 1986, ANNU REV NEUROSCI, V9, P171, DOI 10.1146/annurev.ne.09.030186.001131; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SPENCER SC, 1987, IMMUNOGENETICS, V25, P91, DOI 10.1007/BF00364273; SPENCER SC, 1987, J EXP MED, V165, P1595, DOI 10.1084/jem.165.6.1595; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STREIT WJ, 1989, J NEUROIMMUNOL, V21, P117, DOI 10.1016/0165-5728(89)90167-7; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SUR M, 1984, NATURE, V310, P246, DOI 10.1038/310246a0; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tully T, 1997, P NATL ACAD SCI USA, V94, P4239, DOI 10.1073/pnas.94.9.4239; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WASTERLAIN CG, 1994, BRAIN DEV-JPN, V16, P279, DOI 10.1016/0387-7604(94)90025-6; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; WORLEY PF, 1990, COLD SH Q B, V55, P213, DOI 10.1101/SQB.1990.055.01.023; XU J, 1994, NEUROSCIENCE, V60, P959, DOI 10.1016/0306-4522(94)90275-5; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yamagata K, 1994, Learn Mem, V1, P140; YEE KT, 1990, BRAIN RES, V530, P121, DOI 10.1016/0006-8993(90)90667-Z; YUHKI N, 1994, J MOL EVOL, V39, P22, DOI 10.1007/BF00178246; YUHKI N, 1988, IMMUNOGENETICS, V27, P414, DOI 10.1007/BF00364427; YUHKI N, 1990, J EXP MED, V172, P621, DOI 10.1084/jem.172.2.621; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	125	414	422	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1998	21	3					505	520		10.1016/S0896-6273(00)80562-0	http://dx.doi.org/10.1016/S0896-6273(00)80562-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768838	Bronze			2022-12-24	WOS:000076196400008
J	Holmgren, M; Shin, KS; Yellen, G				Holmgren, M; Shin, KS; Yellen, G			The activation gate of a voltage-gated K+ channel can be trapped in the open state by an intersubunit metal bridge	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; TETRAETHYLAMMONIUM ION; GATING CHARGE; INACTIVATION; MUTATIONS; REGION; CELLS; SITE; PORE	Voltage-activated K+ channels are integral membrane proteins containing a potassium-selective transmembrane pore gated by changes in the membrane potential. This activation gating (opening) occurs in milliseconds and involves a gate at the cytoplasmic side of the pore. We found that substituting cysteine at a particular position in the last transmembrane region (S6) of the homotetrameric Shaker K+ channel creates metal binding sites at which Cd2+ ions can bind with high affinity. The bound Cd2+ ions form a bridge between the introduced cysteine in one channel subunit and a native histidine in another subunit, and the bridge traps the gate in the open state. These results suggest that gating involves a rearrangement of the intersubunit contacts at the intracellular end of S6. The recently solved structure of a bacterial KC channel shows that the S6 homologs cross in a bundle, leaving an aperture at the bundle crossing. In the context of this structure, the metal ions form a bridge between a cysteine above the bundle crossing and a histidine below the bundle crossing in a neighboring subunit. Our results suggest that gating occurs at the bundle crossing, possibly through a change in the conformation of the bundle itself.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yellen, G (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.		Shin, Ki Soon/AAK-1939-2020	Shin, Ki Soon/0000-0002-5701-3596; Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29693, R01 NS029693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; BOLAND LM, 1994, BIOPHYS J, V66, P694, DOI 10.1016/S0006-3495(94)80843-4; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KRIZEK BA, 1993, INORG CHEM, V32, P937, DOI 10.1021/ic00058a030; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Means G.E., 1971, CHEM MODIFICATION PR; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; YEH JZ, 1978, NATURE, V273, P387, DOI 10.1038/273387a0	22	181	182	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					617	621		10.1016/S0896-6273(00)80571-1	http://dx.doi.org/10.1016/S0896-6273(00)80571-1			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768847	Bronze			2022-12-24	WOS:000076196400017
J	Tan, SS; Kalloniatis, M; Sturm, K; Tam, PPL; Reese, BE; Faulkner-Jones, B				Tan, SS; Kalloniatis, M; Sturm, K; Tam, PPL; Reese, BE; Faulkner-Jones, B			Separate progenitors for radial and tangential cell dispersion during development of the cerebral neocortex	NEURON			English	Article							CLONALLY RELATED CELLS; AMINO-ACID SIGNATURES; EMBRYONIC STEM-CELLS; NEURONAL CLONES; VISUAL-CORTEX; SOMATOSENSORY CORTEX; CORTICAL AREAS; MOUSE EMBRYO; SPECIFICATION; LINEAGE	Cell lineage analyses suggest that cortical neuroblasts are capable of undertaking both radial and tangential modes of cell movement. However, it is unclear whether distinct progenitors are committed to generating neuroblasts that disperse exclusively in either radial or tangential directions. Using highly unbalanced mouse stem cell chimeras, we have identified certain progenitors that are committed to one mode of cell dispersion only. Radially dispersed neurons expressed glutamate, the neurochemical signature of excitatory pyramidal cells. In contrast, tangential progenitors gave rise to widely scattered neurons that are predominantly GABAergic. These results suggest lineage-based mechanisms for early specification of certain progenitors to distinct dispersion pathways and neuronal phenotypes.	Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; Childrens Med Res Inst, Westmead, NSW 2145, Australia; Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Children's Medical Research Institute - Australia; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Tan, SS (corresponding author), Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3052, Australia.			Kalloniatis, Michael/0000-0002-5264-4639				Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; BARBE MF, 1991, J NEUROSCI, V11, P519; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; BERRY M, 1965, J ANAT, V99, P691; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Cai L, 1997, J NEUROSCI, V17, P2079; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DEHAY C, 1993, NATURE, V366, P464, DOI 10.1038/366464a0; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; FISHELL G, 1990, DEV BIOL, V141, P70, DOI 10.1016/0012-1606(90)90102-O; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; GOTZ M, 1995, EUR J NEUROSCI, V7, P889, DOI 10.1111/j.1460-9568.1995.tb01076.x; GROVE EA, 1993, DEVELOPMENT, V117, P553; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; HERRUP K, 1986, DEV BIOL, V117, P417, DOI 10.1016/0012-1606(86)90310-6; HUANG S, 1995, J COMP NEUROL, V360, P442, DOI 10.1002/cne.903600306; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; KRUSHEL LA, 1993, NEUROSCIENCE, V53, P1035, DOI 10.1016/0306-4522(93)90487-Z; Lavdas AA, 1996, CEREB CORTEX, V6, P490, DOI 10.1093/cercor/6.3.490; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; LUMSDEN A, 1994, DEVELOPMENT, V120, P1581; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MARC RE, 1995, J NEUROSCI, V15, P5106; Mione MC, 1997, J NEUROSCI, V17, P2018; MIONE MC, 1994, J NEUROSCI, V14, P107; NAGY A, 1990, DEVELOPMENT, V110, P815; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; Polleux F, 1997, J NEUROSCI, V17, P7763; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Sturm KS, 1997, DEV GENES EVOL, V206, P377, DOI 10.1007/s004270050067; Takahashi T, 1996, J NEUROSCI, V16, P6183; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TAN SS, 1995, DEVELOPMENT, V121, P1029; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520	59	194	196	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					295	304		10.1016/S0896-6273(00)80539-5	http://dx.doi.org/10.1016/S0896-6273(00)80539-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728911	Bronze			2022-12-24	WOS:000075598300007
J	Carabelli, V; Carra, I; Carbone, E				Carabelli, V; Carra, I; Carbone, E			Localized secretion of ATP and opioids revealed through single Ca2+ channel modulation in bovine chromaffin cells	NEURON			English	Article							BULLFROG SYMPATHETIC NEURONS; VOLTAGE-DEPENDENT MODULATION; BETA-GAMMA-SUBUNITS; CALCIUM CHANNELS; OMEGA-CONOTOXIN; EXOCYTOTIC RELEASE; SENSORY NEURONS; ADRENAL-MEDULLA; CA-2+ CHANNELS; RAT INSULINOMA	In bovine chromaffin cells, the Ca2+ channels involved in exocytosis are effectively inhibited by ATP and opioids that are coreleased with catecholamines during cell activity. This autocrine loop causes a delay in Ca2+ channel activation that is quickly removed by preceding depolarizations. Changes in Ca2+ channel gating by secreted products thus make it possible to correlate Ca2+ channel activity to secretory events. Here, using cell-attached patch recordings, we found a remarkable correlation between delayed Ca2+ channel openings and neurotransmitter secretion induced by either local or whole-cell Ba2+ stimulation. The action is specific for N- and P/Q-type channels and largely prevented by PTX and mixtures of purinergic and opioid receptor antagonists. Overall, our data provide evidence that exocytosis, viewed through the autocrine inhibition of non-L-type channels, is detectable in membrane patches of similar to 1 mu m(2) distributed over 30%-40% of the total cell surface, while Ca2+ channels and autoreceptors are uniformly distributed over most of the cell membrane.	INFM, Res Unit, Dept Neurosci, I-10125 Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Carbone, E (corresponding author), INFM, Res Unit, Dept Neurosci, I-10125 Turin, Italy.		Carbone, Emilio/W-5763-2019; carabelli, valentina/AAN-1998-2020	Carbone, Emilio/0000-0003-2239-6280; carabelli, valentina/0000-0002-8718-1208				ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Albillos A, 1996, EUR J NEUROSCI, V8, P1561, DOI 10.1111/j.1460-9568.1996.tb01301.x; ALBILLOS A, 1994, J PHYSIOL-LONDON, V477, P197, DOI 10.1113/jphysiol.1994.sp020184; Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Albillos A, 1996, J PHYSIOL-LONDON, V494, P687, DOI 10.1113/jphysiol.1996.sp021524; ARTALEJO CR, 1990, NATURE, V348, P239, DOI 10.1038/348239a0; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ARTALEJO CR, 1991, J PHYSIOL-LONDON, V444, P213, DOI 10.1113/jphysiol.1991.sp018874; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOLAND LM, 1994, J NEUROSCI, V14, P5011; BOSSU JL, 1991, J PHYSIOL-LONDON, V437, P621, DOI 10.1113/jphysiol.1991.sp018615; CAMPBELL V, 1993, J PHYSIOL-LONDON, V470, P1; Carabelli V, 1996, BIOPHYS J, V70, P2144, DOI 10.1016/S0006-3495(96)79780-1; CASTANAS E, 1984, MOL PHARMACOL, V25, P38; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DOUPNIK CA, 1994, J MEMBRANE BIOL, V140, P47; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Engisch KL, 1996, J NEUROSCI, V16, P1359; GANDIA L, 1993, J PHYSIOL-LONDON, V470, P55, DOI 10.1113/jphysiol.1993.sp019847; GANDIA L, 1995, PFLUG ARCH EUR J PHY, V430, P55, DOI 10.1007/BF00373839; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; HAMILL OP, 1981, PFLUGERS ARCH, V380, P258; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Hollins B, 1996, J NEUROPHYSIOL, V76, P1195, DOI 10.1152/jn.1996.76.2.1195; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Kumakura K, 1980, Adv Biochem Psychopharmacol, V22, P571; KUO CC, 1993, NATURE, V365, P258, DOI 10.1038/365258a0; MAGNELLI V, 1995, PFLUG ARCH EUR J PHY, V429, P762, DOI 10.1007/BF00374799; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; MINTZ IM, 1993, NEUROPHARMACOLOGY, V32, P1161, DOI 10.1016/0028-3908(93)90010-Z; MORO MA, 1990, ANAL BIOCHEM, V185, P243, DOI 10.1016/0003-2697(90)90287-J; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; PINTOR J, 1991, BRIT J PHARMACOL, V103, P1980, DOI 10.1111/j.1476-5381.1991.tb12363.x; POLLO A, 1992, PFLUG ARCH EUR J PHY, V422, P75; POLLO A, 1993, PFLUG ARCH EUR J PHY, V423, P462, DOI 10.1007/BF00374942; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; SCHROEDER TJ, 1994, J BIOL CHEM, V269, P17215; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; TWITCHELL WA, 1993, NEURON, V10, P701, DOI 10.1016/0896-6273(93)90171-M; VIVEROS OH, 1979, MOL PHARMACOL, V16, P1101; VONRUDEN L, 1993, FEBS LETT, V336, P48, DOI 10.1016/0014-5793(93)81606-Z; Williams S, 1997, J NEUROSCI, V17, P1625; WINKLER H, 1980, NEUROSCIENCE, V5, P1083; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0	54	68	68	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1255	1268		10.1016/S0896-6273(00)80505-X	http://dx.doi.org/10.1016/S0896-6273(00)80505-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655512	Bronze			2022-12-24	WOS:000074627300020
J	Gitler, D; Spira, ME				Gitler, D; Spira, ME			Real time imaging of calcium-induced localized proteolytic activity after axotomy and its relation to growth cone formation	NEURON			English	Article							CULTURED HIPPOCAMPAL SLICES; LONG-TERM POTENTIATION; APLYSIA NEURONS; CALPAIN-I; TRANSECTED AXONS; HUMAN PLATELETS; BRAIN SPECTRIN; MEMBRANE; CELLS; ORGANIZATION	The emergence of a neuronal growth cone from a transected axon is a necessary step in the sequence of events that leads to successful regeneration. Yet, the molecular mechanisms underlying its formation after axotomy are unknown. In this study, we show by real time imaging of the free intracellular Ca2+ concentration, of proteolytic activity, and of growth cone formation that the activation of localized and transient Ca2+-dependent proteolysis is a necessary step in the cascade of events that leads to growth cone formation. Inhibition of this proteolytic activity by calpeptin, a calpain inhibitor, abolishes growth cone formation. We suggest that calpain plays a central role in the reorganization of the axon's cytoskeleton during its transition from a stable differentiated structure into a dynamically extending growth cone.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; Interuniv Inst Marine Sci, IL-88103 Elat, Israel	Hebrew University of Jerusalem	Spira, ME (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.		Gitler, Daniel/F-1304-2012; Spira, Micha/B-6470-2012	Gitler, Daniel/0000-0001-9544-3610; 				AMBON RT, 1996, J NEUROSCI, V16, P7469; ARIYOSHI H, 1992, BIOCHEM INT, V27, P335; Ashery U, 1996, NEURON, V16, P641, DOI 10.1016/S0896-6273(00)80083-5; AUNIS D, 1988, J EXP BIOL, V139, P253; Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BANNO Y, 1995, J BIOL CHEM, V270, P4318, DOI 10.1074/jbc.270.9.4318; BEDNARSKI E, 1995, BRAIN RES, V694, P147, DOI 10.1016/0006-8993(95)00851-G; BENBASSAT D, 1994, EUR J NEUROSCI, V6, P1605, DOI 10.1111/j.1460-9568.1994.tb00551.x; BENBASSAT D, 1993, EXP NEUROL, V122, P295, DOI 10.1006/exnr.1993.1129; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; BRORSON JR, 1994, J NEUROSCI, V14, P187; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; COVAULT J, 1991, MOL BRAIN RES, V11, P11, DOI 10.1016/0169-328X(91)90015-P; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; DELCERRO S, 1994, NEUROSCI LETT, V167, P149, DOI 10.1016/0304-3940(94)91049-9; DELCERRO S, 1990, BRAIN RES, V530, P91; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; Faddis BT, 1997, J NEUROSCI, V17, P951; FAWCETT JW, 1993, TRENDS NEUROSCI, V16, P165, DOI 10.1016/0166-2236(93)90141-8; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Goldberg DJ, 1996, PERSPECT DEV NEUROBI, V4, P183; GOLL DE, 1992, BIOESSAYS, V14, P549, DOI 10.1002/bies.950140810; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HAYDON PG, 1995, TRENDS NEUROSCI, V18, P196, DOI 10.1016/0166-2236(95)93901-9; HAYDON PG, 1994, J NEUROBIOL, V25, P694, DOI 10.1002/neu.480250609; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; Kawasaki H, 1996, MOL MEMBR BIOL, V13, P217, DOI 10.3109/09687689609160599; KUMAMOTO T, 1992, ANAT REC, V232, P60, DOI 10.1002/ar.1092320108; LETOURNEAU PC, 1992, NERVE GROWTH CONE; LEYTUS SP, 1983, BIOCHEM J, V215, P253, DOI 10.1042/bj2150253; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LYNCH G, 1990, PROG BRAIN RES, V83, P233; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MANESS PF, 1992, DEV NEUROSCI-BASEL, V14, P257, DOI 10.1159/000111670; MARTENSON C, 1993, NATURE, V366, P66, DOI 10.1038/366066a0; Melloni E, 1996, BIOCHEM BIOPH RES CO, V229, P193, DOI 10.1006/bbrc.1996.1779; NISHIMURA T, 1991, J BIOL CHEM, V266, P11842; PERRIN D, 1992, J CELL BIOL, V116, P127, DOI 10.1083/jcb.116.1.127; PFENNINGER KH, 1993, DEV BRAIN RES, V71, P181, DOI 10.1016/0165-3806(93)90170-F; RASER KJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P211, DOI 10.1006/abbi.1995.1284; Rehder V, 1996, PERSPECT DEV NEUROBI, V4, P215; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SATO K, 1995, EUR J BIOCHEM, V230, P25, DOI 10.1111/j.1432-1033.1995.0025i.x; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SEUBERT P, 1988, BRAIN RES, V460, P189, DOI 10.1016/0006-8993(88)91222-X; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; Spira ME, 1996, J NEUROSCI METH, V69, P91, DOI 10.1016/S0165-0270(96)00024-6; SPIRA ME, 1998, IN PRESS NEURON TISS; STEFFENSEN I, 1995, J EXP BIOL, V198, P2067; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; VANDERKLISH P, 1995, MOL BRAIN RES, V32, P25, DOI 10.1016/0169-328X(95)00057-Y; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; WU F, 1995, J NEUROSCI, V15, P7517; YU WQ, 1994, J NEUROSCI, V14, P5872; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x; Ziv NE, 1997, J NEUROSCI, V17, P3568; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625, DOI 10.1152/jn.1995.74.6.2625; Ziv NE, 1998, J CELL BIOL, V140, P223, DOI 10.1083/jcb.140.1.223	69	125	131	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1998	20	6					1123	1135		10.1016/S0896-6273(00)80494-8	http://dx.doi.org/10.1016/S0896-6273(00)80494-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655501	Bronze			2022-12-24	WOS:000074627300009
J	Bergles, DE; Jahr, CE				Bergles, DE; Jahr, CE			Synaptic activation of glutamate transporters in hippocampal astrocytes	NEURON			English	Article							HIGH-AFFINITY UPTAKE; CEREBELLAR PURKINJE-CELLS; MULTIPLE RELEASE SITES; RAT-BRAIN SLICES; GLIAL-CELLS; TIME-COURSE; 3-DIMENSIONAL STRUCTURE; POSTNATAL-DEVELOPMENT; PYRAMIDAL CELLS; EXPRESSION	Glutamate transporters in the CNS are expressed in neurons and glia and mediate high affinity, electrogenic uptake of extracellular glutamate. Although glia have the highest capacity for glutamate uptake, the amount of glutamate that reaches glial membranes following release and the rate that glial transporters bind and sequester transmitter is not known. We find that stimulation of Schaffer collateral/commissural fibers in hippocampal slices evokes glutamate transporter currents in CA1 astrocytes that activate rapidly, indicating that a significant amount of transmitter escapes the synaptic cleft shortly after release. Transporter currents in outside-out patches from astrocytes have faster kinetics than synaptically elicited currents, suggesting that the glutamate concentration attained at astrocytic membranes is lower but remains elevated for longer than in the synaptic cleft.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Bergles, DE (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378				AITKEN PG, 1986, BRAIN RES, V369, P163, DOI 10.1016/0006-8993(86)90524-X; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BALCAR VJ, 1977, J NEUROCHEM, V28, P1145, DOI 10.1111/j.1471-4159.1977.tb10682.x; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DEBARRY J, 1982, NEUROSCIENCE, V7, P1289, DOI 10.1016/0306-4522(82)91134-4; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; ISAACSON JS, 1995, NEURON, V15, P1; JOHNSTON GAR, 1979, J NEUROCHEM, V32, P121, DOI 10.1111/j.1471-4159.1979.tb04518.x; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KARPEN JW, 1992, J PHYSIOL-LONDON, V448, P257, DOI 10.1113/jphysiol.1992.sp019040; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KLOCKNER U, 1994, J NEUROSCI, V14, P5759; KONEINTZKO U, 1994, HIPPOCAMPUS, V4, P297; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; MCLENNAN H, 1976, BRAIN RES, V115, P139, DOI 10.1016/0006-8993(76)90828-3; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mennerick S, 1996, J NEUROSCI, V16, P55; NEWMAN EA, 1986, SCIENCE, V233, P453, DOI 10.1126/science.3726539; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Palay S. L., 1974, CEREBELLAR CORTEX CY; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROTHSTEIN D, 1996, NEURON, V16, P675; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Sakmann Bert, 1995, P199; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SCHMIDT W, 1988, EXP BRAIN RES, V70, P50; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SCHWARTZKROIN PA, 1979, BRAIN RES, V161, P533, DOI 10.1016/0006-8993(79)90683-8; Shibata T, 1996, NEUROREPORT, V7, P705, DOI 10.1097/00001756-199602290-00006; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SORRA KE, 1993, J NEUROSCI, V13, P3736; SPACEK J, 1985, ANAT EMBRYOL, V171, P245, DOI 10.1007/BF00341419; SPACEK J, 1971, Z ZELLFORSCH MIK ANA, V112, P430; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; STEINHAUSER C, 1994, HIPPOCAMPUS, V4, P19, DOI 10.1002/hipo.450040105; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Takahashi M, 1996, J PHYSIOL-LONDON, V497, P523, DOI 10.1113/jphysiol.1996.sp021785; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WILKIN GP, 1982, BRAIN RES, V244, P69, DOI 10.1016/0006-8993(82)90905-2; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; YAMAMOTO T, 1992, DEV BRAIN RES, V66, P165, DOI 10.1016/0165-3806(92)90077-A; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705	65	409	415	1	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1297	1308		10.1016/S0896-6273(00)80420-1	http://dx.doi.org/10.1016/S0896-6273(00)80420-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427252	Bronze			2022-12-24	WOS:000071236500016
J	DeArmond, SJ; Sanchez, H; Yehiely, F; Qiu, Y; Ninchak-Casey, A; Daggett, V; Camerino, AP; Cayetano, J; Rogers, M; Groth, D; Torchia, M; Tremblay, P; Scott, MR; Cohen, FE; Prusiner, SB				DeArmond, SJ; Sanchez, H; Yehiely, F; Qiu, Y; Ninchak-Casey, A; Daggett, V; Camerino, AP; Cayetano, J; Rogers, M; Groth, D; Torchia, M; Tremblay, P; Scott, MR; Cohen, FE; Prusiner, SB			Selective neuronal targeting in prion disease	NEURON			English	Article							ASPARAGINE-LINKED GLYCOSYLATION; CREUTZFELDT-JAKOB-DISEASE; RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; FATAL FAMILIAL INSOMNIA; TRANSGENIC MICE; CULTURED-CELLS; STRAIN VARIATION; SCRAPIE PRIONS; NEUROBLASTOMA-CELLS; INDEPENDENT GENOME	The pattern of scrapie prion protein (PrPSc) accumulation in the brain is different for each prion strain. We tested whether the PrPSc deposition pattern is influenced by the Asn-linked oligosaccharides of PrPC in transgenic mice. Deletion of the first oligosaccharide altered PrPC trafficking and prevented infection with two prion strains. Deletion of the second did not alter PrPC trafficking, permitted infection with one prion strain, and had a profound effect on the PrPSc deposition pattern. Our data raise the possibility that glycosylation can modify the conformation of PrPC. Glycosylation could affect the affinity of PrPC for a particular conformer of PrPSc, thereby determining the rate of nascent PrPSc formation and the specific patterns of PrPSc deposition.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	DeArmond, SJ (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.		Rogers, Mark/M-4524-2013	Rogers, Mark/0000-0002-5288-0295	NIA NIH HHS [AG08967, AG02132] Funding Source: Medline; NINDS NIH HHS [NS14069] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS014069, P50NS014069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R35AG008967, P01AG002132] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; BARRY RA, 1986, J INFECT DIS, V154, P518, DOI 10.1093/infdis/154.3.518; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BOLTON DC, 1985, J VIROL, V53, P596, DOI 10.1128/JVI.53.2.596-606.1985; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BRUCE ME, 1976, NEUROPATH APPL NEURO, V2, P471, DOI 10.1111/j.1365-2990.1976.tb00521.x; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Carp RI, 1997, J GEN VIROL, V78, P283, DOI 10.1099/0022-1317-78-1-283; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DAVIS SJ, 1995, J BIOL CHEM, V270, P369, DOI 10.1074/jbc.270.1.369; DEARMOND SJ, 1993, P NATL ACAD SCI USA, V90, P6449, DOI 10.1073/pnas.90.14.6449; DEARMOND SJ, 1987, NEUROLOGY, V37, P1271, DOI 10.1212/WNL.37.8.1271; DEARMOND SJ, 1993, J NEUROCHEM, V61, P1589, DOI 10.1111/j.1471-4159.1993.tb09792.x; DEARMOND SJ, 1997, GREENFIELDS NEUROPAT, P235; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; DICKINSON AG, 1988, CIBA F SYMP, V135, P63; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; HUANG ZW, 1994, P NATL ACAD SCI USA, V91, P7139, DOI 10.1073/pnas.91.15.7139; Huang ZW, 1996, FOLD DES, V1, P13, DOI 10.1016/S1359-0278(96)00007-7; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; JENDROSKA K, 1991, NEUROLOGY, V41, P1482, DOI 10.1212/WNL.41.9.1482; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KELLINGS K, 1994, PHILOS T R SOC B, V343, P425, DOI 10.1098/rstb.1994.0039; KENWARD N, 1994, J NEUROCHEM, V62, P1870; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; MCKINLEY MP, 1991, LAB INVEST, V65, P622; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; OConnor SE, 1996, CHEM BIOL, V3, P803, DOI 10.1016/S1074-5521(96)90064-2; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OTVOS L, 1991, INT J PEPT PROT RES, V38, P476; PARCHI P, 1995, ANN NEUROL, V38, P21, DOI 10.1002/ana.410380107; PATTISON IH, 1961, J COMP PATHOL THERAP, V71, P101, DOI 10.1016/S0368-1742(61)80013-1; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; PRUSINER SB, 1997, IN PRESS ANN REV GEN; RICKERT KW, 1995, CHEM BIOL, V2, P751, DOI 10.1016/1074-5521(95)90103-5; Ridley RM, 1996, NEURODEGENERATION, V5, P219, DOI 10.1006/neur.1996.0030; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROGERS M, 1990, Glycobiology, V1, P101, DOI 10.1093/glycob/1.1.101; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wong K, 1996, NEUROLOGY, V47, P741, DOI 10.1212/WNL.47.3.741; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x	83	168	171	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1997	19	6					1337	1348		10.1016/S0896-6273(00)80424-9	http://dx.doi.org/10.1016/S0896-6273(00)80424-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427256	Bronze			2022-12-24	WOS:000071236500020
J	Brussaard, AB; Kits, KS; Baker, RE; Willems, WPA; LeytingVermeulen, JW; Voorn, P; Smit, AB; Bicknell, RJ; Herbison, AE				Brussaard, AB; Kits, KS; Baker, RE; Willems, WPA; LeytingVermeulen, JW; Voorn, P; Smit, AB; Bicknell, RJ; Herbison, AE			Plasticity in fast synaptic inhibition of adult oxytocin neurons caused by switch in GABA(A) receptor subunit expression	NEURON			English	Article							HYPOTHALAMIC MAGNOCELLULAR NEURONS; A RECEPTOR; MESSENGER-RNAS; RAT-BRAIN; ANTISENSE OLIGONUCLEOTIDES; POSTNATAL-DEVELOPMENT; ALPHA-SUBUNITS; GABA(A)-RECEPTOR SUBTYPES; POSTSYNAPTIC CURRENTS; FUNCTIONAL-PROPERTIES	We found that magnocellular oxytocin neurons in adult female rats exhibit an endogenous GABA(A) receptor subunit switch around parturition: a decrease in alpha 1:alpha 2 subunit mRNA ratio correlated with a decrease in allopregnanolone potentiation and increase in decay time constant of the GABA(A) receptor-mediated IPSCs in these cells. The causal relationship between changes in alpha 1:alpha 2 mRNA ratio and the ion channel kinetics was confirmed using in vitro antisense deletion. Further, GABA(A) receptors exhibited a tonic inhibitory influence upon oxytocin release in vivo, and allopregnanolone helped to restrain oxytocin neuron in vitro firing only before parturition, when the alpha 1:alpha 2 subunit mRNA ratio was still high. Such observations provide evidence for the physiological significance of GABA(A) receptor subunit heterogeneity and plasticity in the adult brain.	VRIJE UNIV AMSTERDAM,NEUROSCI RES INST,MOL NEUROBIOL SECT,NL-1081 HV AMSTERDAM,NETHERLANDS; VRIJE UNIV AMSTERDAM,NEUROSCI RES INST,DEPT ANAT,NL-1081 HV AMSTERDAM,NETHERLANDS; BABRAHAM INST,NEUROENDOCRINOL LAB,CAMBRIDGE CB2 4AT,ENGLAND	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Brussaard, AB (corresponding author), VRIJE UNIV AMSTERDAM,NEUROSCI RES INST,MEMBRANE PHYSIOL SECT,DE BOELELAAN 1087,NL-1081 HV AMSTERDAM,NETHERLANDS.		Smit, August B/E-8410-2011	Herbison, Allan/0000-0002-9615-3022				Akhtar S, 1992, Trends Cell Biol, V2, P139, DOI 10.1016/0962-8924(92)90100-2; ARMSTRONG WE, 1994, J PHYSIOL-LONDON, V475, P115, DOI 10.1113/jphysiol.1994.sp020053; Belelli D, 1996, NEUROPHARMACOLOGY, V35, P1223, DOI 10.1016/S0028-3908(96)00066-4; BICKNELL RJ, 1984, J PHYSIOL-LONDON, V348, P601, DOI 10.1113/jphysiol.1984.sp015128; BORST JGG, 1994, J NEUROPHYSIOL, V71, P639, DOI 10.1152/jn.1994.71.2.639; BRUSSAARD AB, 1995, NEUROSCI LETT, V191, P111, DOI 10.1016/0304-3940(95)11539-6; Brussaard AB, 1996, J PHYSIOL-LONDON, V497, P495, DOI 10.1113/jphysiol.1996.sp021783; Brussaard AB, 1997, J NEUROSCI METH, V71, P55, DOI 10.1016/S0165-0270(96)00126-4; BRUSSAARD AB, 1994, PFLUG ARCH EUR J PHY, V429, P27, DOI 10.1007/BF02584027; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUMASHEV N, 1996, CURR OPIN NEUROBIOL, V6, P311; BUREAU MH, 1993, J NEUROCHEM, V61, P1479, DOI 10.1111/j.1471-4159.1993.tb13643.x; CORPECHOT C, 1993, ENDOCRINOLOGY, V133, P1003, DOI 10.1210/en.133.3.1003; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; De Koninck Y, 1996, NEUROPHARMACOLOGY, V35, P1365, DOI 10.1016/S0028-3908(96)00063-9; DUGGAN MJ, 1991, J BIOL CHEM, V266, P24778; EBIHARA S, 1995, J PHYSL, V484, P7; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FENELON VS, 1995, NEUROSCIENCE, V64, P1129, DOI 10.1016/0306-4522(94)00402-Q; FENELON VS, 1995, MOL BRAIN RES, V34, P45, DOI 10.1016/0169-328X(95)00130-K; Fenelon VS, 1996, J NEUROSCI, V16, P4872; FISCHBACH GD, 1980, J PHYSIOL-LONDON, V303, P125, DOI 10.1113/jphysiol.1980.sp013275; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GIES U, 1994, J NEUROSCI, V14, P2861; Hatton GI, 1997, ANNU REV NEUROSCI, V20, P375, DOI 10.1146/annurev.neuro.20.1.375; Herbison AE, 1997, ENDOCRINOLOGY, V138, P33, DOI 10.1210/en.138.1.33; HIGUCHI T, 1985, J ENDOCRINOL, V105, P339, DOI 10.1677/joe.0.1050339; HU ZY, 1987, P NATL ACAD SCI USA, V84, P8215, DOI 10.1073/pnas.84.23.8215; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONES MV, 1993, J NEUROPHYSIOL, V70, P1339, DOI 10.1152/jn.1993.70.4.1339; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; KIMURA F, 1993, NEUROENDOCRINOLOGY, V57, P605, DOI 10.1159/000126414; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Lavoie AM, 1996, NEUROPHARMACOLOGY, V35, P1383, DOI 10.1016/S0028-3908(96)00077-9; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; MACLENNAN AJ, 1991, NEUROSCIENCE, V43, P369, DOI 10.1016/0306-4522(91)90301-4; MARSHALL LM, 1985, NATURE, V317, P621, DOI 10.1038/317621a0; MATHEWS GC, 1994, NEURON, V13, P149, DOI 10.1016/0896-6273(94)90465-0; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOSS BL, 1989, NEURON, V3, P597, DOI 10.1016/0896-6273(89)90270-5; Murray J. A. H., 1992, Antisense RNA and DNA., P1; NAYEEM N, 1994, J NEUROCHEM, V62, P815; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; POULTER MO, 1993, NEUROSCIENCE, V53, P1019, DOI 10.1016/0306-4522(93)90486-Y; PUIA G, 1994, NEURON, V12, P117, DOI 10.1016/0896-6273(94)90157-0; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; SAKMANN B, 1978, NATURE, V276, P401, DOI 10.1038/276401a0; SHINGAI R, 1991, EUR J PHARM-MOLEC PH, V206, P77, DOI 10.1016/0922-4106(91)90149-C; SIEGHART W, 1995, PHARMACOL REV, V47, P181; STERN JE, 1995, J PHYSIOL-LONDON, V488, P701, DOI 10.1113/jphysiol.1995.sp021001; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; TWYMAN RE, 1992, J PHYSIOL-LONDON, V456, P215, DOI 10.1113/jphysiol.1992.sp019334; VERDOORN TA, 1994, MOL PHARMACOL, V45, P475; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; WISDEN W, 1992, J NEUROSCI, V12, P1040; WOOLF TM, 1992, P NATL ACAD SCI USA, V89, P7305, DOI 10.1073/pnas.89.16.7305; YU C, 1993, DEV GENET, V14, P296, DOI 10.1002/dvg.1020140407; ZHANG SJ, 1994, J NEUROENDOCRINOL, V6, P533, DOI 10.1111/j.1365-2826.1994.tb00616.x	68	192	195	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1103	1114		10.1016/S0896-6273(00)80401-8	http://dx.doi.org/10.1016/S0896-6273(00)80401-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390523	Bronze			2022-12-24	WOS:A1997YH59400017
J	Yan, Z; Surmeier, DJ				Yan, Z; Surmeier, DJ			D-5 dopamine receptors enhance Zn2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade	NEURON			English	Article							PROTEIN-KINASE-C; AMINOBUTYRIC ACIDA RECEPTOR; RAT NEOSTRIATAL NEURONS; GATED CHLORIDE FLUX; A RECEPTOR; BASAL GANGLIA; BRAIN SYNAPTONEUROSOMES; PHOSPHORYLATION SITES; OKADAIC ACID; 2 FORMS	Cholinergic interneurons have been implicated in striatally mediated associative learning. In classical conditioning paradigms, conditioned stimuli trigger a transient suppression of neuronal activity that is dependent upon an intact dopaminergic innervation. Our hypothesis was that this suppression reflected dopaminergic enhancement of sensory-linked GABAergic input. As a test, the impact of dopamine on interneuronal GABA(A) receptor function was studied by combined patch-clamp recording and single-cell reverse transcription PCR. Activation of D-5 dopamine receptors reversibly enhanced a Zn2+-sensitive component of GABA(A) currents. Although dependent upon protein kinase A (PKA) activation, the modulation was blocked by protein phosphatase 1 (PP1) inhibition, suggesting it was dependent upon dephosphorylation. These results establish a novel mechanism by which intrastriatally released dopamine mediates changes in GABAergic signaling that could underlie the initial stages of associative learning.	UNIV TENNESSEE,COLL MED,DEPT ANAT & NEUROBIOL,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center					NINDS NIH HHS [NS 28647, NS 34696] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; ASSAF SY, 1984, NATURE, V308, P764; BARGAS J, 1994, J NEUROSCI, V14, P6667; Bartholini G, 1981, Adv Biochem Psychopharmacol, V30, P119; Bergson C, 1995, J NEUROSCI, V15, P7821; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BOLAM JP, 1986, BRAIN RES, V397, P279, DOI 10.1016/0006-8993(86)90629-3; BROWNING MD, 1993, NEUROCHEM RES, V18, P95, DOI 10.1007/BF00966927; BROWNING MD, 1990, P NATL ACAD SCI USA, V87, P1315, DOI 10.1073/pnas.87.4.1315; CHEUN JE, 1992, NEUROSCIENCE, V51, P951, DOI 10.1016/0306-4522(92)90532-7; Chu YF, 1996, J BIOL CHEM, V271, P2574, DOI 10.1074/jbc.271.5.2574; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; FEIGENSPAN A, 1994, P NATL ACAD SCI USA, V91, P10893, DOI 10.1073/pnas.91.23.10893; GRANDY DK, 1991, P NATL ACAD SCI USA, V88, P9175, DOI 10.1073/pnas.88.20.9175; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; GRIGORENKO EV, 1994, VISUAL NEUROSCI, V11, P379, DOI 10.1017/S0952523800001723; GUSTAFSON EL, 1991, J COMP NEUROL, V310, P170, DOI 10.1002/cne.903100204; HEUSCHNEIDER G, 1989, P NATL ACAD SCI USA, V86, P2938, DOI 10.1073/pnas.86.8.2938; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; KANO M, 1992, NEUROREPORT, V3, P563, DOI 10.1097/00001756-199207000-00004; Kapur J, 1996, J NEUROPHYSIOL, V76, P2626, DOI 10.1152/jn.1996.76.4.2626; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; KITA H, 1993, CHEM SIGNALLING BASA, P51; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KOFUJI P, 1991, J NEUROCHEM, V56, P713, DOI 10.1111/j.1471-4159.1991.tb08209.x; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; LEHMANN J, 1983, NEUROSCIENCE, V10, P1105, DOI 10.1016/0306-4522(83)90102-1; LEIDENHEIMER NJ, 1992, MOL PHARMACOL, V41, P1116; Leidenheimer NJ, 1996, MOL BRAIN RES, V42, P131, DOI 10.1016/S0169-328X(96)00153-2; LEIDENHEIMER NJ, 1990, MOL PHARMACOL, V38, P823; LEMOINE C, 1990, NEUROSCI LETT, V117, P248, DOI 10.1016/0304-3940(90)90671-U; Lin YF, 1996, MOL PHARMACOL, V50, P185; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MARTONE ME, 1992, BRAIN RES, V594, P253, DOI 10.1016/0006-8993(92)91132-X; McGeer P L, 1977, Adv Biochem Psychopharmacol, V16, P397; MCGEER PL, 1974, BRAIN RES, V81, P373, DOI 10.1016/0006-8993(74)90955-X; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; MENGUAL E, 1995, NEUROSCIENCE, V66, P523, DOI 10.1016/0306-4522(94)00592-S; MOSS SJ, 1992, J BIOL CHEM, V267, P14470; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; PORTER NM, 1990, NEURON, V5, P789, DOI 10.1016/0896-6273(90)90338-G; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SAXENA NC, 1994, J NEUROSCI, V14, P7077; SCHONROCK B, 1993, EUR J NEUROSCI, V5, P1042, DOI 10.1111/j.1460-9568.1993.tb00957.x; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHWARTZ RD, 1991, MOL PHARMACOL, V39, P370; SIBLEY DR, 1995, MOL CELLULAR MECH NE, P255; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; SWEETNAM PM, 1988, J NEUROCHEM, V51, P1274, DOI 10.1111/j.1471-4159.1988.tb03097.x; TEHRANI MHJ, 1995, EPILEPSY RES, V22, P13, DOI 10.1016/0920-1211(95)00033-7; Tukey JW, 1977, EXPLORATORY DATA ANA; VINCENT S R, 1989, Developmental Brain Research, V45, P155, DOI 10.1016/0165-3806(89)90017-5; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WHITE G, 1995, NEUROREPORT, V6, P461, DOI 10.1097/00001756-199502000-00014; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; WILSON CJ, 1990, J NEUROSCI, V10, P508; WISDEN W, 1992, J NEUROSCI, V12, P1040; YAN Z, 1997, J NEUROPHYSIOL, V78, P1003	67	165	170	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1115	1126		10.1016/S0896-6273(00)80402-X	http://dx.doi.org/10.1016/S0896-6273(00)80402-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390524	Bronze			2022-12-24	WOS:A1997YH59400018
J	Luscher, C; Jan, LY; Stoffel, M; Malenka, RC; Nicoll, RA				Luscher, C; Jan, LY; Stoffel, M; Malenka, RC; Nicoll, RA			G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons	NEURON			English	Article							GUINEA-PIG HIPPOCAMPUS; RAT HIPPOCAMPUS; POTASSIUM CURRENT; GABAB RECEPTORS; CA3 NEURONS; IN-VITRO; INHIBITION; BACLOFEN; SEROTONIN; INVITRO	To study the role of G protein-coupled, inwardly rectifying K+ (GIRK) channels in mediating neurotransmitter actions in hippocampal neurons, we have examined slices from transgenic mice lacking the GIRK2 gene. The outward currents evoked by agonists for GABA(B) receptors, 5HT1A receptors, and adenosine A1 receptors were essentially absent in mutant mice, while the inward current evoked by muscarinic receptor activation was unaltered. In contrast, the presynaptic inhibitory action of a number of presynaptic receptors on excitatory and inhibitory terminals was unaltered in mutant mice. These included GABA(B), adenosine, muscarinic, metabotropic gIutamate, and NPY receptors on excitatory synapses and GABA(B) and opioid receptors on inhibitory synapses. These findings suggest that a number of G protein-coupled receptors activate the same class of postsynaptic K+ channel, which contains GIRK2. In addition, the GIRK2 channels play no role in the inhibition mediated by presynaptic G protein-coupled receptors, suggesting that the same receptor can couple to different effector systems according to its subcellular location in the neuron.	UNIV CALIF SAN FRANCISCO,DEPT MOL & CELLULAR PHARMACOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; ROCKEFELLER UNIV,LAB METAB DIS & MOL CELL BIOL,NEW YORK,NY 10021	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Rockefeller University			Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Jan, Lily/0000-0003-3938-8498; Stoffel, Markus/0000-0003-1304-5817				ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; ANDRADE R, 1991, J PHARMACOL EXP THER, V257, P930; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; BENSON DM, 1988, J PHYSIOL-LONDON, V404, P479, DOI 10.1113/jphysiol.1988.sp017301; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; COLINO A, 1987, NATURE, V328, P73, DOI 10.1038/328073a0; COLMERS WF, 1994, TRENDS NEUROSCI, V17, P373, DOI 10.1016/0166-2236(94)90046-9; Dittman JS, 1996, J NEUROSCI, V16, P1623; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; DUTAR P, 1988, J NEUROSCI, V8, P4214; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; JAROLIMEK W, 1994, SYNAPSE, V18, P169, DOI 10.1002/syn.890180302; Karschin C, 1996, J NEUROSCI, V16, P3559; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LAMBERT NA, 1991, BRAIN RES, V547, P349, DOI 10.1016/0006-8993(91)90985-5; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Liao YJ, 1996, J NEUROSCI, V16, P7137; MADISON DV, 1987, J NEUROSCI, V7, P733; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; MISGELD U, 1989, PFLUG ARCH EUR J PHY, V414, P139, DOI 10.1007/BF00580955; MULLER W, 1989, NEUROSCI LETT, V102, P229, DOI 10.1016/0304-3940(89)90083-9; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; OGATA N, 1987, SYNAPSE, V1, P62, DOI 10.1002/syn.890010109; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; Ponce A, 1996, J NEUROSCI, V16, P1990; PREMKUMAR LS, 1994, J NEUROPHYSIOL, V71, P2570, DOI 10.1152/jn.1994.71.6.2570; PROCTOR WR, 1987, BRAIN RES, V426, P187, DOI 10.1016/0006-8993(87)90441-0; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Spauschus A, 1996, J NEUROSCI, V16, P930; Storm JF, 1990, PROG BRAIN RES, P161; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; TRUSSELL LO, 1987, J NEUROSCI, V7, P3306; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6	49	556	572	1	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					687	695		10.1016/S0896-6273(00)80381-5	http://dx.doi.org/10.1016/S0896-6273(00)80381-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331358	Bronze			2022-12-24	WOS:A1997XZ01600021
J	Anderson, SA; Qiu, MS; Bulfone, A; Eisenstat, DD; Meneses, J; Pedersen, R; Rubenstein, JLR				Anderson, SA; Qiu, MS; Bulfone, A; Eisenstat, DD; Meneses, J; Pedersen, R; Rubenstein, JLR			Mutations of the homeobox genes Dlx-1 and Dlx-2 disrupt the striatal subventricular zone and differentiation of late born striatal neurons	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; SPATIALLY RESTRICTED EXPRESSION; DEVELOPING FOREBRAIN; MAMMALIAN FOREBRAIN; GENERATED NEURONS; OPIATE RECEPTORS; CEREBRAL-CORTEX; RAT STRIATUM; MOUSE; MIGRATION	The striatum has a central role in many neurobiological processes, yet little is known about the molecular control of its development. Inroads to this subject have been made, due to the discovery of transcription factors, such as the Dlx genes, whose expression patterns suggest that they have a role in striatal development. We report that mice lacking both Dlx-1 and Dlx-2 have a time-dependent block in striatal differentiation. In these mutants, early born neurons migrate into a striatum-like region, which is enriched for markers of the striosome (patch) compartment. However, later born neurons accumulate within the proliferative zone. Several lines of evidence suggest that mutations in Dlx-1 and Dlx-2 produce abnormalities in the development of the striatal subventricular zone and in the differentiation of striatal matrix neurons.	UNIV CALIF SAN FRANCISCO, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, PROGRAM DEV BIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Anderson, SA (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PSYCHIAT, CTR NEUROBIOL & PSYCHIAT, NINA IRELAND LAB DEV NEUROBIOL, SAN FRANCISCO, CA 94143 USA.		Eisenstat, David/AAA-4653-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD026732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046, R01MH049428] Funding Source: NIH RePORTER; NICHD NIH HHS [NICDPO-1 HD26732] Funding Source: Medline; NIMH NIH HHS [K02 MH01046-01, R01 MH49428-01] Funding Source: Medline; Telethon [TGM97000, TGM06S01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon)		ACKLIN SE, 1993, DEVELOPMENT, V118, P175; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bhide PG, 1996, J COMP NEUROL, V374, P506; BRAND S, 1979, NEUROSCIENCE, V4, P767, DOI 10.1016/0306-4522(79)90005-8; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; BULFONE A, 1993, J NEUROSCI, V13, P3155; CARMEN CW, 1992, HISTOCHEM J, V24, P121; CHUN JJM, 1989, J NEUROSCI, V9, P1648; CRANDALL JE, 1986, DEV BRAIN RES, V28, P127, DOI 10.1016/0165-3806(86)90072-6; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; Ding M, 1997, J MOL NEUROSCI, V8, P93, DOI 10.1007/BF02736776; Fan CM, 1996, MOL CELL NEUROSCI, V7, P1, DOI 10.1006/mcne.1996.0001; FOSTER GA, 1987, J NEUROSCI, V7, P1994; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; GOLDMANRAKIC PS, 1982, J COMP NEUROL, V205, P398, DOI 10.1002/cne.902050408; GRAYBIEL AM, 1982, P NATL ACAD SCI-BIOL, V79, P198, DOI 10.1073/pnas.79.1.198; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; IMAM SA, 1995, ANTICANCER RES, V15, P1153; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; KRUSHEL LA, 1993, NEUROSCIENCE, V53, P1035, DOI 10.1016/0306-4522(93)90487-Z; KRUSHEL LA, 1995, EUR J NEUROSCI, V7, P1210, DOI 10.1111/j.1460-9568.1995.tb01111.x; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; MATHIS JM, 1992, EMBO J, V11, P2551, DOI 10.1002/j.1460-2075.1992.tb05320.x; McGuinness T, 1996, GENOMICS, V35, P473, DOI 10.1006/geno.1996.0387; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MURRIN LC, 1984, NEUROSCI LETT, V47, P155, DOI 10.1016/0304-3940(84)90422-1; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; RAKIC P, 1995, J NEUROBIOL, V26, P299, DOI 10.1002/neu.480260303; ROBINSON GW, 1991, NEW BIOL, V3, P1183; Rubenstein JLR, 1997, MOL CELLULAR APPROAC, P356; Sauer FC, 1936, J MORPHOL, V37, P1; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; Sheth AN, 1997, J COMP NEUROL, V383, P220; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; SNYDERKELLER AM, 1991, J NEUROSCI, V11, P810; SONG DD, 1994, DEV BRAIN RES, V83, P233, DOI 10.1016/0165-3806(94)00144-8; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; TOBET SA, 1994, HORM BEHAV, V28, P320, DOI 10.1006/hbeh.1994.1028; VACCARINO FM, 1995, CEREB CORTEX, V5, P64, DOI 10.1093/cercor/5.1.64; VANDERKOOY D, 1984, DEV BRAIN RES, V14, P300, DOI 10.1016/0165-3806(84)90318-3; VANDERKOOY D, 1987, BRAIN RES, V401, P155, DOI 10.1016/0006-8993(87)91176-0; Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I	54	357	363	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1997	19	1					27	37		10.1016/S0896-6273(00)80345-1	http://dx.doi.org/10.1016/S0896-6273(00)80345-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247261	Bronze			2022-12-24	WOS:A1997XN39400004
J	Rubio, ME; Wenthold, RJ				Rubio, ME; Wenthold, RJ			Glutamate receptors are selectively targeted to postsynaptic sites in neurons	NEURON			English	Article							DORSAL COCHLEAR NUCLEUS; DIFFERENTIAL EXPRESSION PATTERNS; CEREBELLAR PURKINJE NEURONS; RAT-BRAIN; HIPPOCAMPAL-NEURONS; MESSENGER-RNAS; ENDOPLASMIC-RETICULUM; CA2+ PERMEABILITY; AMPA RECEPTORS; GUINEA-PIG	The objective of the present study was to determine if a neuron that expresses multiple glutamate receptors targets the same receptors to all glutamatergic postsynaptic populations, or if the receptors are differentially targeted to specific postsynaptic populations. As a model for this study, we chose the fusiform cell of the dorsal cochlear nucleus. This neuron expresses multiple glutamate receptors and receives two distinct glutamatergic inputs: parallel fibers synapse on apical dendrites, and auditory nerve fibers synapse on basal dendrites. Pre- and postembedding immunocytochemistry were combined with retrograde tracing to identify the receptors expressed on postsynaptic membranes of parallel fiber and auditory nerve synapses. Most receptors were found at both populations of synapses, but the AMPA receptor subunit, GluR4, and the metabotropic receptor, mGluR1 alpha, were found only at the auditory nerve synapse. These results demonstrate that glutamate receptors are targeted to specific postsynaptic populations of glutamatergic synapses.			Rubio, ME (corresponding author), NATL INST DEAFNESS & OTHER COMMUN DISORDERS, NEUROCHEM LAB, NIH, BETHESDA, MD 20892 USA.							AJIMA A, 1991, NEUROSCI RES, V12, P281, DOI 10.1016/0168-0102(91)90117-H; BAHN S, 1997, IONOTROPIC GLUTAMATE, P149; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Bernard V, 1997, J NEUROSCI, V17, P819; Bilak MM, 1996, NEUROSCIENCE, V75, P1075, DOI 10.1016/0306-4522(96)00197-2; CAMPAGNE MV, 1991, J HISTOCHEM CYTOCHEM, V39, P1267, DOI 10.1177/39.9.1833448; CANT NB, 1984, HEARING SCI RECENT A, P371; CANT NB, 1992, SPRINGER HDB AUDITOR, P67; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CIDARREGUI A, 1995, J NEUROSCI, V15, P4259; deNo R Lorente, 1981, PRIMARY ACOUSTIC NUC; DERRICK BE, 1991, BRAIN RES BULL, V27, P219, DOI 10.1016/0361-9230(91)90071-Q; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; ESHHAR N, 1993, NEUROSCIENCE, V57, P943, DOI 10.1016/0306-4522(93)90040-M; GALLO V, 1992, J NEUROSCI, V12, P1010; Gazzaley AH, 1997, J NEUROSCI, V17, P2006; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; HACKNEY CM, 1990, ANAT EMBRYOL, V182, P123; Hackney CM, 1996, EUR J NEUROSCI, V8, P79, DOI 10.1111/j.1460-9568.1996.tb01169.x; HJELLE OP, 1994, EUR J NEUROSCI, V6, P794; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOOP MJ, 1993, J CELL SCI, V17, P85; HUBER LA, 1993, J CELL BIOL, V123, P47, DOI 10.1083/jcb.123.1.47; Hunt CA, 1996, J NEUROSCI, V16, P1380; HUNTER C, 1993, J NEUROSCI, V13, P1932; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONES KA, 1991, NEURON, V7, P593, DOI 10.1016/0896-6273(91)90372-7; JUIZ JM, 1993, NATO ADV SCI INST SE, V239, P167; KANE EC, 1974, J COMP NEUROL, V155, P301, DOI 10.1002/cne.901550303; Katayama E, 1996, EMBO J, V15, P4844, DOI 10.1002/j.1460-2075.1996.tb00865.x; KELLY RB, 1993, ANNU REV NEUROSCI, V16, P95, DOI 10.1146/annurev.ne.16.030193.000523; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Kunimoto M, 1995, J CELL BIOL, V131, P1821, DOI 10.1083/jcb.131.6.1821; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LERMA J, 1994, EUR J NEUROSCI, V6, P1080, DOI 10.1111/j.1460-9568.1994.tb00605.x; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MANIS PB, 1994, J COMP NEUROL, V348, P261, DOI 10.1002/cne.903480208; MANIS PB, 1990, J NEUROSCI, V10, P2338; Martone ME, 1996, J NEUROSCI, V16, P7437; Matsubara A, 1996, J NEUROSCI, V16, P4457; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MAYAT E, 1995, J NEUROSCI, V15, P2533, DOI 10.1523/JNEUROSCI.15-03-02533.1995; Merighi A., 1993, IMMUNOHISTOCHEMISTRY, P229; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MOLITOR SC, 1997, IN PRESS J NEUROPHYS; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; MUGNAINI E, 1980, J NEUROCYTOL, V9, P537, DOI 10.1007/BF01204841; MULLER BM, 1995, J NEUROSCI, V15, P31; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Odorizzi G, 1996, J CELL BIOL, V135, P139, DOI 10.1083/jcb.135.1.139; OERTEL D, 1989, J COMP NEUROL, V283, P228, DOI 10.1002/cne.902830206; OSEN KK, 1995, J COMP NEUROL, V357, P482, DOI 10.1002/cne.903570311; OTTIGER HP, 1995, J NEUROCHEM, V64, P2413; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Petralia RS, 1996, J COMP NEUROL, V372, P356; PETRALIA RS, 1994, J NEUROSCI, V14, P667; PETRALIA RS, 1996, EXCITATORY AMINO ACI, P22; PETRALIA RS, 1997, IONOTROPIC GLUTAMATE, P219; Racca C, 1997, J NEUROSCI, V17, P1691; RAMAN IM, 1994, J NEUROSCI, V14, P4998; RYUGO DK, 1993, J COMP NEUROL, V329, P20, DOI 10.1002/cne.903290103; RYUGO DK, 1992, SPRINGER HDB AUDITOR, P23; SATO K, 1993, NEUROSCIENCE, V52, P515, DOI 10.1016/0306-4522(93)90403-3; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SMITH PH, 1985, J COMP NEUROL, V237, P127, DOI 10.1002/cne.902370110; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; SUCHER NJ, 1993, J BIOL CHEM, V268, P22299; Terada S, 1996, SCIENCE, V273, P784, DOI 10.1126/science.273.5276.784; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Tiedge H, 1996, J NEUROSCI, V16, P7171; Torre ER, 1996, J NEUROSCI, V16, P5967; TRUSSELL LO, 1994, SEMIN NEUROSCI, V6, P71; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VILLA A, 1992, NEUROSCIENCE, V49, P467, DOI 10.1016/0306-4522(92)90111-E; VOLPE P, 1993, COMP BIOCHEM PHYS A, V105, P205, DOI 10.1016/0300-9629(93)90196-B; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WICKESBURG RE, 1989, BRAIN RES, V486, P423; Wozniak M, 1996, J BIOL CHEM, V271, P5017; YOSHIMORY T, 1996, J CELL BIOL, V111, P987; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhao HM, 1997, J NEUROCHEM, V68, P1041	98	195	197	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN	1997	18	6					939	950		10.1016/S0896-6273(00)80333-5	http://dx.doi.org/10.1016/S0896-6273(00)80333-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208861	Bronze			2022-12-24	WOS:A1997XJ10200012
J	Gustincich, S; Feigenspan, A; Wu, DK; Koopman, LJ; Raviola, E				Gustincich, S; Feigenspan, A; Wu, DK; Koopman, LJ; Raviola, E			Control of dopamine release in the retina: A transgenic approach to neural networks	NEURON			English	Article							PLACENTAL ALKALINE-PHOSPHATASE; RHESUS-MONKEY RETINA; BIPOLAR CELLS; ENDOGENOUS DOPAMINE; HORIZONTAL CELLS; AMACRINE CELLS; RABBIT RETINA; TURTLE RETINA; CAT RETINA; AMPHIBIAN RETINA	Dopaminergic, interplexiform amacrines (DA cells) were labeled in transgenic mice with human placental alkaline phosphatase, an enzyme that resides on the outer surface of the cell membrane. It was therefore possible to investigate their activity in vitro after dissociation of the retina with whole-cell current and voltage clamp, as well as their connections in the intact retina with the electron microscope. DA cells generate action potentials even in the absence of synaptic inputs. This activity is abolished by the amacrine cell transmitters GABA and glycine, which induce an inward current carried by chloride ions, and is stimulated by kainate, an agonist at the receptor for the bipolar cell transmitter glutamate, which opens nonselective cation channels. Since DA cells are postsynaptic to amacrine and bipolar cells, we suggest that the spontaneous discharge of DA cells is inhibited in the dark by GABAergic amacrines that receive their input from off-bipolars. Upon illumination, the GABA-inhibition is removed, DA cells generate action potentials, and their firing is modulated by the excitation received from on-bipolars.			Gustincich, S (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.			Gustincich, Stefano/0000-0002-2749-2514	NATIONAL EYE INSTITUTE [R01EY001344] Funding Source: NIH RePORTER; NEI NIH HHS [EY 01344] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BANERJEE SA, 1992, J NEUROSCI, V12, P4460; BAUER B, 1980, A GRAEF ARCH KLIN EX, V215, P71, DOI 10.1007/BF00414464; BERGER J, 1987, P NATL ACAD SCI USA, V84, P4885, DOI 10.1073/pnas.84.14.4885; BOATRIGHT JH, 1994, VISUAL NEUROSCI, V11, P1003, DOI 10.1017/S095252380000393X; BOATRIGHT JH, 1989, BRAIN RES, V482, P164, DOI 10.1016/0006-8993(89)90555-6; BOATRIGHT JH, 1994, BRAIN RES, V649, P339, DOI 10.1016/0006-8993(94)91084-7; BORMANN J, 1992, ELECT METHODS IN VIT, P136; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; CRITZ SD, 1992, VISUAL NEUROSCI, V9, P271, DOI 10.1017/S0952523800010683; DACEY DM, 1990, J COMP NEUROL, V301, P461, DOI 10.1002/cne.903010310; DAW NW, 1990, TRENDS NEUROSCI, V13, P110, DOI 10.1016/0166-2236(90)90187-F; DEARRY A, 1986, J NEUROCHEM, V46, P1006, DOI 10.1111/j.1471-4159.1986.tb00612.x; DEARRY A, 1989, J NEUROCHEM, V53, P870, DOI 10.1111/j.1471-4159.1989.tb11785.x; DEGROOTE G, 1983, CLIN CHEM, V29, P115; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; DEWAELE P, 1982, ARCH INT PHYSIOL BIO, V90, pB21; DJAMGOZ MBA, 1992, NEUROCHEM INT, V20, P139, DOI 10.1016/0197-0186(92)90166-O; DOWLING JE, 1978, J COMP NEUROL, V180, P203, DOI 10.1002/cne.901800202; FEIGENSPAN A, 1994, EUR J PHARM-MOLEC PH, V288, P97, DOI 10.1016/0922-4106(94)90014-0; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Gallego A, 1971, Vision Res, VSuppl 3, P33; GILLETTE MA, 1995, J NEUROPHYSIOL, V74, P856, DOI 10.1152/jn.1995.74.2.856; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1992, IONIC CHANNELS EXCIT, P351; HOKOC JN, 1988, BRAIN RES, V461, P17, DOI 10.1016/0006-8993(88)90721-4; HOKOC JN, 1987, J NEUROSCI, V7, P2785; KAM W, 1985, P NATL ACAD SCI USA, V82, P8715, DOI 10.1073/pnas.82.24.8715; KAMP CW, 1981, EUR J PHARMACOL, V69, P273, DOI 10.1016/0014-2999(81)90473-8; KIRSCH M, 1989, VISION RES, V29, P147, DOI 10.1016/0042-6989(89)90120-X; KNAPP AG, 1987, NATURE, V325, P437, DOI 10.1038/325437a0; KOLB H, 1990, J NEUROCYTOL, V19, P343, DOI 10.1007/BF01188404; KOLB H, 1991, J COMP NEUROL, V310, P267, DOI 10.1002/cne.903100210; KOLBINGER W, 1993, VISUAL NEUROSCI, V10, P1035, DOI 10.1017/S0952523800010142; KRAMER SG, 1971, INVEST OPHTH VISUAL, V10, P438; LASATER EM, 1985, P NATL ACAD SCI USA, V82, P3025, DOI 10.1073/pnas.82.9.3025; MAGUIRE G, 1994, J NEUROSCI, V14, P6094; MARIANI AP, 1988, J COMP NEUROL, V276, P81, DOI 10.1002/cne.902760106; MAYAHARA H, 1967, HISTOCHEMISTRY, V11, P88, DOI 10.1007/BF00326615; MCCOMB RB, 1972, CLIN CHEM, V18, P97; Nguyen-Legros J., 1988, Progress in Retinal Research, V7, P113, DOI 10.1016/0278-4327(88)90007-7; OCONNOR PM, 1987, J NEUROCHEM, V49, P916, DOI 10.1111/j.1471-4159.1987.tb00980.x; PASANTESMORALES H, 1988, BRAIN RES, V459, P120, DOI 10.1016/0006-8993(88)90291-0; PICCOLINO M, 1987, J NEUROSCI, V7, P2273; PICCOLINO M, 1984, J NEUROSCI, V4, P2477; POSEN S, 1969, ANN NY ACAD SCI, V166, P733, DOI 10.1111/j.1749-6632.1969.tb46431.x; POURCHO RG, 1982, BRAIN RES, V252, P101, DOI 10.1016/0006-8993(82)90982-9; POURCHO RG, 1985, J COMP NEUROL, V233, P473, DOI 10.1002/cne.902330406; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; SARTHY PV, 1981, J COMP NEUROL, V195, P595, DOI 10.1002/cne.901950405; SLAUGHTER MM, 1983, NATURE, V303, P537, DOI 10.1038/303537a0; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; TAUCHI M, 1990, J COMP NEUROL, V293, P178, DOI 10.1002/cne.902930203; TAYLOR IH, 1982, ACTA OPHTHALMOL    S, V152, P4; VERSAUXBOTTERI C, 1984, BRAIN RES, V301, P192, DOI 10.1016/0006-8993(84)90423-2; VOIGT T, 1987, J NEUROSCI, V7, P4115; WITKOVSKY P, 1991, PROG RETIN RES, V11, P247, DOI 10.1016/0278-4327(91)90031-V	59	189	189	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					723	736		10.1016/S0896-6273(00)80313-X	http://dx.doi.org/10.1016/S0896-6273(00)80313-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182798	Bronze			2022-12-24	WOS:A1997XB72200007
J	Causing, CG; Gloster, A; Aloyz, R; Bamji, SX; Chang, E; Fawcett, J; Kuchel, G; Miller, FD				Causing, CG; Gloster, A; Aloyz, R; Bamji, SX; Chang, E; Fawcett, J; Kuchel, G; Miller, FD			Synaptic innervation density is regulated by neuron-derived BDNF	NEURON			English	Article							NERVE GROWTH-FACTOR; SUPERIOR CERVICAL-GANGLION; TRANSGENIC MICE; SYMPATHETIC NEURONS; NEUROTROPHIC FACTOR; MESSENGER-RNAS; EXPRESSION; SYSTEM; RAT; BRAIN	In this report, we have examined the role of neuron-derived BDNF at an accessible synapse, that of preganglionic neurons onto their sympathetic neuron targets. Developing and mature sympathetic neurons synthesize BDNF, and preganglionic neurons express the full-length BDNF/TrkB receptor. When sympathetic neuron-derived BDNF is increased 2- to 4-fold in transgenic mice, preganglionic cell bodies and axons hypertrophy, and the synaptic innervation to sympathetic neurons is increased. Conversely, when BDNF synthesis is eliminated in BDNF -/- mice, preganglionic synaptic innervation to sympathetic neurons is decreased. Together these results indicate that variations in neuronal neurotrophin synthesis directly regulate neuronal circuitry by selectively modulating synaptic innervation density.			Causing, CG (corresponding author), MCGILL UNIV,MONTREAL GEN HOSP,RES INST,MONTREAL NEUROL INST,CTR NEURONAL SURVIVAL,MONTREAL,PQ H3A 2B4,CANADA.			Fawcett, Jim/0000-0003-0043-2164; Gloster, Andrew/0000-0002-3751-0878; Kuchel, George/0000-0001-8387-7040; Aloyz, Raquel/0000-0002-6812-497X				ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; AGUAYO AJ, 1973, BRAIN RES, V54, P360, DOI 10.1016/0006-8993(73)90061-9; ALBERS KM, 1994, J NEUROSCI, V14, P1422, DOI 10.1523/JNEUROSCI.14-03-01422.1994; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Apfel SC, 1996, MOL CELL NEUROSCI, V7, P134, DOI 10.1006/mcne.1996.0010; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BELLIVEAU DJ, 1997, J CELL BIOL, V136, P1; CHIBBAR R, 1993, J CLIN INVEST, V91, P185, DOI 10.1172/JCI116169; COGGESHALL RE, 1984, J NEUROSCI METH, V12, P125, DOI 10.1016/0165-0270(84)90011-6; COGGESHALL RE, 1990, J NEUROSCI METH, V35, P187, DOI 10.1016/0165-0270(90)90123-W; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; EDWARDS RH, 1989, CELL, V58, P161, DOI 10.1016/0092-8674(89)90412-1; EMFORS P, 1994, NATURE, V368, P147; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Florini JR, 1996, J BIOL CHEM, V271, P12699, DOI 10.1074/jbc.271.22.12699; HOYLE GW, 1994, J NEUROSCI, V14, P2455; KAPUR RP, 1991, NEURON, V7, P717, DOI 10.1016/0896-6273(91)90275-5; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; MILLER FD, 1994, DEV BIOL, V161, P206, DOI 10.1006/dbio.1994.1021; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; NJA A, 1977, J PHYSIOL-LONDON, V272, P633, DOI 10.1113/jphysiol.1977.sp012064; NJA A, 1978, J PHYSIOL-LONDON, V277, P53; OPPENHEIM RW, 1982, J COMP NEUROL, V210, P174, DOI 10.1002/cne.902100208; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; PURVES D, 1986, J NEUROSCI, V6, P1049; SCHAFER T, 1983, J NEUROSCI, V3, P1501; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHWAB M, 1977, BRAIN RES, V122, P459, DOI 10.1016/0006-8993(77)90457-7; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; VOYVODIC JT, 1989, J NEUROSCI, V9, P1997; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	41	233	236	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					257	267		10.1016/S0896-6273(00)80266-4	http://dx.doi.org/10.1016/S0896-6273(00)80266-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052796	Bronze			2022-12-24	WOS:A1997WK82200009
J	Mooney, R; Penn, AA; Gallego, R; Shatz, CJ				Mooney, R; Penn, AA; Gallego, R; Shatz, CJ			Thalamic relay of spontaneous retinal activity prior to vision	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; VISUAL-CORTEX; RETINOGENICULATE SYNAPSE; POSTNATAL-DEVELOPMENT; ACTION-POTENTIALS; MAMMALIAN RETINA; OCULAR DOMINANCE; NMDA RECEPTORS; GANGLION-CELLS; SEGREGATION	Before vision, retinal ganglion cells produce spontaneous waves of action potentials. A crucial question is whether this spontaneous activity is transmitted to lateral geniculate nucleus (LGN) neurons. Using a novel in vitro preparation, we report that LGN neurons receive periodic barrages of postsynaptic currents from the retina that drive them to fire bursts of action potentials. Groups of LGN neurons are highly correlated in their firing. Experiments in wild-type and NMDAR1 knockout mice show that NMDA receptor activation is not necessary for firing. The transmission of the highly correlated retinal activity to the LGN supports the hypothesis that retinal waves drive retinogeniculate synaptic remodeling. Because LGN neurons are driven to fire action potentials, this spontaneous activity could also act more centrally to influence synaptic modification within the developing visual cortex.	UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,BERKELEY,CA 94720	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley				Mooney, Richard/0000-0002-3308-1367	NIGMS NIH HHS [GM 07365] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CRUNELLI V, 1987, J PHYSIOL-LONDON, V384, P603, DOI 10.1113/jphysiol.1987.sp016472; ESGUERRA M, 1992, VISUAL NEUROSCI, V8, P545, DOI 10.1017/S0952523800005642; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109; Horton JC, 1996, J NEUROSCI, V16, P1791; KALIL RE, 1986, NATURE, V323, P156, DOI 10.1038/323156a0; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8390, DOI 10.1073/pnas.83.21.8390; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MASON CA, 1982, NEUROSCIENCE, V7, P561, DOI 10.1016/0306-4522(82)90064-1; MCCORMICK DA, 1995, J NEUROSCI, V15, P5739; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1992, SEMIN NEUROSCI, V4, P61; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; RAMOA AS, 1994, J NEUROSCI, V14, P2098; SCHARFMAN HE, 1990, P NATL ACAD SCI USA, V87, P4548, DOI 10.1073/pnas.87.12.4548; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SMETTERS DK, 1994, BRAIN RES, V658, P168, DOI 10.1016/S0006-8993(09)90023-3; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STRYKER MP, 1986, J NEUROSCI, V6, P2117; WIESEL TN, 1974, J COMP NEUROL, V158, P301; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0	38	173	175	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					863	874		10.1016/S0896-6273(00)80218-4	http://dx.doi.org/10.1016/S0896-6273(00)80218-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938119	Bronze			2022-12-24	WOS:A1996VV15100009
J	Budnik, V; Koh, YH; Guan, B; Hartmann, B; Hough, C; Woods, D; Gorczyca, M				Budnik, V; Koh, YH; Guan, B; Hartmann, B; Hough, C; Woods, D; Gorczyca, M			Regulation of synapse structure and function by the Drosophila tumor suppressor gene dlg	NEURON			English	Article							NEUROMUSCULAR-JUNCTIONS; MUSCLE; MUTANTS; PROTEIN; INNERVATION; CRAYFISH; RECEPTOR; LARVAE; ULTRASTRUCTURE; EXCITABILITY	Mutations of the tumor suppressor gene discs-large (dlg) lead to postsynaptic structural defects. Here, we report that mutations in dig also result in larger synaptic currents at fly neuromuscular junctions. By selectively targeting DLG protein to either muscles or motorneurons using Gal-4 enhancer trap lines, we were able to rescue substantially the reduced postsynaptic structure in mutants. Rescue of the physiological defect was accomplished by presynaptic, but not postsynaptic targeting, consistent with our finding that miniature excitatory junctional currents were not changed in dig mutants. These results suggest that DLG functions in the regulation of neurotransmitter release and postsynaptic structure. We propose that DLG is an integral part of a mechanism by which changes in both neurotransmitter release and synapse structure are accomplished during development and plasticity.	UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92717	University of California System; University of California Irvine	Budnik, V (corresponding author), UNIV MASSACHUSETTS,DEPT BIOL,AMHERST,MA 01003, USA.				NINDS NIH HHS [R01 NS030072, R01 NS70032, R21 NS070032, K04 NS01786] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030072, K04NS001786, R21NS070032] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MS, 1988, J NEUROSCI, V8, P242; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; ATWOOD HL, 1976, J NEUROBIOL, V7, P289, DOI 10.1002/neu.480070403; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; ATWOOD HL, 1995, AM ZOOL, V35, P28; BELOTE JM, 1980, NATURE, V285, P573, DOI 10.1038/285573a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1993, DEVELOPMENT, V119, P533; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BUDNIK V, 1996, IN PRESS CURR OPIN N, V6; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; GARNER C, 1996, IN PRESS TRENDS CELL; GENISMAN Y, 1993, HIPPOCAMPUS, V3, P435; GOODMAN CS, 1993, NEURON S, V10, P77; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; HALL ZW, 1993, NEURON S, V10, P99; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KESHISHIAN H, 1993, TRENDS NEUROSCI, V16, P278, DOI 10.1016/0166-2236(93)90182-L; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KIM E, 1996, IN PRESS NEUROPHARMA; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KURDYAK P, 1995, J COMP NEUROL, V348, P1; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LNENICKA GA, 1985, J NEUROSCI, V5, P459; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; WOODS DF, 1996, IN PRESS J CELL BIOL; WU CF, 1985, J NEUROSCI, V5, P2626; ZHONG Y, 1995, J NEUROSCI, V15, P6679	49	313	316	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					627	640		10.1016/S0896-6273(00)80196-8	http://dx.doi.org/10.1016/S0896-6273(00)80196-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893021	Bronze, Green Accepted			2022-12-24	WOS:A1996VP74300009
J	Deckwerth, TL; Elliott, JL; Knudson, CM; Johnson, EM; Snider, WD; Korsmeyer, SJ				Deckwerth, TL; Elliott, JL; Knudson, CM; Johnson, EM; Snider, WD; Korsmeyer, SJ			BAX is required for neuronal death after trophic factor deprivation and during development	NEURON			English	Article							PROGRAMMED CELL-DEATH; NERVE GROWTH-FACTOR; BCL-2 HOMOLOG BAK; SYMPATHETIC NEURONS; IN-VIVO; GENE-EXPRESSION; MOTOR-NEURONS; POLYCYSTIC KIDNEY; TRANSGENIC MICE; DEFICIENT MICE	Members of the BCL2-related family of proteins either promote or repress programmed cell death. BAX, a death-promoting member, heterodimerizes with multiple death-repressing molecules, suggesting that it could prove critical to cell death. We tested whether Bax is required for neuronal death by trophic factor deprivation and during development. Neonatal sympathetic neurons and facial motor neurons from Bax-deficient mice survived nerve growth factor deprivation and disconnection from their targets by axotomy, respectively. These salvaged neurons displayed remarkable soma atrophy and reduced elaboration of neurites; yet they responded to readdition of trophic factor with soma hypertrophy and enhanced neurite outgrowth. Bax-deficient superior cervical ganglia and facial nuclei possessed increased numbers of neurons. Our observations demonstrate that trophic factor deprivation-induced death of sympathetic and motor neurons depends on Bax.	WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT MOL BIOL & PHARMACOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT NEUROL, ST LOUIS, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Deckwerth, TL (corresponding author), WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT PATHOL & MED, ST LOUIS, MO 63110 USA.			Knudson, Charles Michael/0000-0003-3964-5466	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, R37AG012947] Funding Source: NIH RePORTER; NIA NIH HHS [AG 05681, AG 12947] Funding Source: Medline; NINDS NIH HHS [NS 24679] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberi S, 1996, P NATL ACAD SCI USA, V93, P3978, DOI 10.1073/pnas.93.9.3978; BAKHSHI A, 1985, CELL, V41, P889; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BORNER C, 1994, J CELL BIOL, V126, P1059, DOI 10.1083/jcb.126.4.1059; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; COUGHLIN MD, 1985, DEV BIOL, V110, P392, DOI 10.1016/0012-1606(85)90098-3; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4297; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; FRANKOWSKI H, 1995, NEUROREPORT, V6, P1917, DOI 10.1097/00001756-199510020-00023; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; GORIN PD, 1979, P NATL ACAD SCI USA, V76, P5382, DOI 10.1073/pnas.76.10.5382; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HOUENOU LJ, 1994, PROG BRAIN RES, V102, P217; KAMADA S, 1995, CANCER RES, V55, P354; KIEFER MC, 1995, NATURE, V374, P736, DOI 10.1038/374736a0; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; MARTINOU I, 1995, J CELL BIOL, V128, P201, DOI 10.1083/jcb.128.1.201; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MERRY DE, 1994, DEVELOPMENT, V120, P301; Middleton G, 1996, DEVELOPMENT, V122, P695; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; SAGOT Y, 1995, J NEUROSCI, V15, P7727; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	64	636	645	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					401	411		10.1016/S0896-6273(00)80173-7	http://dx.doi.org/10.1016/S0896-6273(00)80173-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816704	Bronze			2022-12-24	WOS:A1996VJ44000007
J	Beck, KD; Irwin, I; Valverde, J; Brennan, TJ; Langston, JW; Hefti, F				Beck, KD; Irwin, I; Valverde, J; Brennan, TJ; Langston, JW; Hefti, F			GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis	NEURON			English	Article							IMMUNO-CYTOCHEMICAL LOCALIZATION; VENTRAL TEGMENTAL AREA; DORSAL RAPHE NUCLEUS; SUBSTANTIA NIGRA; TYROSINE-HYDROXYLASE; POSTNATAL-DEVELOPMENT; NEUROTROPHIC FACTOR; FINE-STRUCTURE; NEURONS; BRAIN	To test whether glial cell line-derived neurotrophic factor (GDNF) regulates the development of nigral dopaminergic neurons in vivo, neonatal rats received bilateral injections of GDNF into the striatum. Injections at postnatal day 2 induced a unique transient behavioral pattern characterized by forelimb hyperflexure, clawed toes of all limbs, and a kinked tail. Parallel to the behavioral changes, the levels of striatal and ventral mesencephalic dopamine and serotonin were increased from 60% to 100% with a proportional increase of principal metabolite levels. GDNF increased tyrosine hydroxylase activity in the ventral mesencephalon, but did not affect striatal activity of choline acetyltransferase and GABA uptake. GDNF failed to induce sprouting of dopaminergic neurites. Our findings suggest that during development striatal GDNF regulates the capacity of dopaminergic and of serotonergic neurons for neurotransmitter production and release.	GENENTECH INC,DEPT NEUROSCI,S SAN FRANCISCO,CA 94080; PARKINSONS INST,SUNNYVALE,CA 94086	Roche Holding; Genentech					NATIONAL INSTITUTE ON AGING [P01AG010480] Funding Source: NIH RePORTER; NIA NIH HHS [AG10480] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams R. D., 1993, PRINCIPLES NEUROLOGY; ARBOGAST LA, 1991, DEV BRAIN RES, V63, P151, DOI 10.1016/0165-3806(91)90075-T; AZMITIA E, 1978, J COMP NEUROL, V79, P641; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BECK KD, 1994, PROG NEUROBIOL, V44, P497, DOI 10.1016/0301-0082(94)90009-4; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; BENLOUCIF S, 1991, EUR J PHARMACOL, V200, P1, DOI 10.1016/0014-2999(91)90658-D; BERGMAN J, 1989, J PHARMACOL EXP THER, V251, P150; BROADDUS WC, 1990, DEV BRAIN RES, V52, P265, DOI 10.1016/0165-3806(90)90244-S; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; CHOILUNDBERG DL, 1995, DEV BRAIN RES, V85, P80, DOI 10.1016/0165-3806(94)00197-8; DEWEY SL, 1995, J NEUROSCI, V15, P821; DRAY A, 1976, BRAIN RES, V113, P45, DOI 10.1016/0006-8993(76)90005-6; DRAY A, 1978, BRAIN RES, V151, P431, DOI 10.1016/0006-8993(78)91077-6; EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217; FERRE S, 1994, J NEUROSCI, V14, P4839; GREENBERG D, 1974, SCIENCE, V184, P1243; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HERVE D, 1987, BRAIN RES, V435, P71, DOI 10.1016/0006-8993(87)91588-5; HO A, 1995, NEUROREPORT, V6, P1326; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; HUANG XM, 1993, EUR J PHARMACOL, V238, P291, DOI 10.1016/0014-2999(93)90859-G; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; IRWIN I, 1990, BRAIN RES, V531, P242, DOI 10.1016/0006-8993(90)90780-F; JAVITCH JA, 1984, MOL PHARMACOL, V26, P35; KALEN P, 1988, EXP BRAIN RES, V73, P69, DOI 10.1007/BF00279662; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; KILPATRICK IC, 1986, J NEUROCHEM, V46, P1865; KRIEGLSTEIN K, 1994, NEUROSCIENCE, V63, P1189, DOI 10.1016/0306-4522(94)90583-5; LAPCHAK PA, 1993, NEUROSCIENCE, V53, P639, DOI 10.1016/0306-4522(93)90612-J; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; NEDERGAARD S, 1988, NATURE, V333, P174, DOI 10.1038/333174a0; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PASQUIER DA, 1977, BRAIN RES BULL, V2, P323, DOI 10.1016/0361-9230(77)90066-1; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; SAUER H, 1995, IN PRESS P NATL ACAD; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; SCHMIDTKASTNER R, 1994, MOL BRAIN RES, V26, P325, DOI 10.1016/0169-328X(94)90106-6; SPECHT LA, 1981, BRAIN RES, V218, P49, DOI 10.1016/0006-8993(81)90988-4; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; SPRINGER JE, 1994, EXP NEUROL, V127, P167, DOI 10.1006/exnr.1994.1091; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; SUTERCRAZZOLARA C, 1994, NEUROREPORT, V5, P2486, DOI 10.1097/00001756-199412000-00020; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; TOMAC A, 1995, NATURE, V373, P339; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; VANBOCKSTAELE EJ, 1993, BRAIN RES, V624, P188, DOI 10.1016/0006-8993(93)90077-Z; VANERO JL, 1994, NEUROSCIENCE, V61, P257; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; YADID G, 1994, J PHARMACOL EXP THER, V270, P1158; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZURN AD, 1994, NEUROREPORT, V6, P113, DOI 10.1097/00001756-199412300-00030	53	69	69	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					665	673		10.1016/S0896-6273(00)80085-9	http://dx.doi.org/10.1016/S0896-6273(00)80085-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785063	Bronze			2022-12-24	WOS:A1996UC16800022
J	DiversePierluissi, M; Inglese, J; Stoffel, RH; Lefkowitz, RJ; Dunlap, K				DiversePierluissi, M; Inglese, J; Stoffel, RH; Lefkowitz, RJ; Dunlap, K			G protein-coupled receptor kinase mediates desensitization of norepinephrine-induced Ca2+ channel inhibition	NEURON			English	Article							BETA-GAMMA-SUBUNITS; CALCIUM CURRENTS; N-TYPE; MODULATION; NEURONS; PHOSPHORYLATION; SIGNAL	G protein-coupled receptors are essential signaling molecules at sites of synaptic transmission. Here, we explore the mechanisms responsible for the use-dependent termination of metabotropic receptor signaling in embryonic sensory neurons. We report that the inhibition of voltage-dependent Ca2+ channels mediated by alpha(2)-adrenergic receptors desensitizes slowly with prolonged exposure to the transmitter and that the desensitization is mediated by a G protein-coupled receptor kinase (GRK). Intracellular introduction of recombinant, purified kinases or synthetic blocking peptides into individual neurons demonstrates the specific involvement of a GRK3-like protein. These results suggest that GRK-mediated termination of receptor-G protein coupling is likely to regulate synaptic strength and, as such, may provide one effective mechanism for depression of synaptic transmission.	TUFTS UNIV,SCH MED,DEPT NEUROSCI,BOSTON,MA 02111; PHARMACOPEIA INC,PRINCETON,NJ 08540; DUKE UNIV,SCH MED,DEPT MED,HOWARD HUGHES MED INST,DURHAM,NC 27710; DUKE UNIV,SCH MED,DEPT BIOCHEM,HOWARD HUGHES MED INST,DURHAM,NC 27710	Tufts University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	DiversePierluissi, M (corresponding author), TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111, USA.		Lefkowitz, Robert/AAW-2649-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016483] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16037] Funding Source: Medline; NINDS NIH HHS [NS16483] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIZA JL, 1992, J NEUROSCI, V12, P4045; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; CANFIELD DR, 1984, BRIT J PHARMACOL, V82, P557, DOI 10.1111/j.1476-5381.1984.tb10794.x; CLEMENTS JD, 1992, SCIENCE, V258, P12498; COX DH, 1992, J NEUROSCI, V12, P906; DIVERSEPIERLUIS.M, 1995, NEUROSCIENCE, V65, P47; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; EASON MG, 1992, J BIOL CHEM, V267, P25473; ELMSLIE KS, 1993, PFLUG ARCH EUR J PHY, V423, P472, DOI 10.1007/BF00374943; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; HAGA T, 1994, J NEUROCHEM, V63, P400; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HEADLEY PM, 1978, BRAIN RES, V145, P185, DOI 10.1016/0006-8993(78)90809-0; HOMCY CJ, 1991, ANNU REV PHYSIOL, V53, P137, DOI 10.1146/annurev.physiol.53.1.137; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; INGLESE J, 1993, J BIOL CHEM, V268, P23735; ISHII K, 1994, J BIOL CHEM, V269, P1125; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; KLEIN WL, 1989, FASEB J, V3, P2132, DOI 10.1096/fasebj.3.10.2546848; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KUROSE H, 1994, J BIOL CHEM, V269, P10093; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; MULLER S, 1993, P NATL ACAD SCI USA, V90, P10439, DOI 10.1073/pnas.90.22.10439; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206	40	48	49	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					579	585		10.1016/S0896-6273(00)80077-X	http://dx.doi.org/10.1016/S0896-6273(00)80077-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785055	Bronze			2022-12-24	WOS:A1996UC16800014
J	Ribeiro, S; Cecchi, GA; Magnasco, MO; Mello, CV				Ribeiro, S; Cecchi, GA; Magnasco, MO; Mello, CV			Toward a song code: Evidence for a syllabic representation in the canary brain	NEURON			English	Article							AUDITORY-CORTEX ANALOG; FUNCTIONAL-ORGANIZATION; TRANSCRIPTION FACTORS; FEMALE CANARIES; GENE-EXPRESSION; TOPOGRAPHIC REPRESENTATION; TONOTOPIC ORGANIZATION; GROWTH-FACTORS; VISUAL-CORTEX; FOREBRAIN	We show that presentation of individual canary song syllables results in distinct expression patterns of the immediate-early gene ZENK in the caudomedial neostriatum (NCM) of adult canaries. Information on the spatial distribution and labeling of stained cells provides for a classification of ZENK patterns that (1) accords to the organization of stimuli into families, (2) preserves the stimuli intrafamily relationships, and (3) confers salience to natural over artificial stimuli, resulting in a nonclassical tonotopic map. Moreover, complex syllable maps cannot be reduced to any linear combinations of simple syllable maps. These properties arise from the collective response of NCM neurons to auditory stimuli, rather than from the behavior of single neurons. The syllabic representation described here may constitute an important step toward deciphering the rules of birdsong auditory representation.	Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Mello, CV (corresponding author), Rockefeller Univ, Lab Anim Behav, 1230 York Ave, New York, NY 10021 USA.		Ribeiro, Sidarta/C-5794-2016	Ribeiro, Sidarta/0000-0001-9325-9545; Mello, Claudio/0000-0002-9826-8421	PHS HHS [2853] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ball GF, 1997, NEUROREPORT, V8, P2965, DOI 10.1097/00001756-199709080-00032; BRILLOUIN L, 1989, MAXWELLS DEMON ENTRO, P101; BROWN JL, 1975, EVOLUTION BEHAV, P329; Capsius B, 1996, HEARING RES, V96, P59, DOI 10.1016/0378-5955(96)00038-X; CECCHI GA, 1998, IN PRESS J NEUROSCI; Chapman B, 1996, J NEUROSCI, V16, P6443; Chaudhuri A, 1997, NEUROREPORT, V8, pR3, DOI 10.1097/00001756-199709080-00002; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Chew SJ, 1996, SCIENCE, V274, P1909, DOI 10.1126/science.274.5294.1909; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Deadwyler SA, 1997, ANNU REV NEUROSCI, V20, P217, DOI 10.1146/annurev.neuro.20.1.217; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; GODARD R, 1991, NATURE, V350, P228, DOI 10.1038/350228a0; GOLDSMITH AR, 1984, J ENDOCRINOL, V103, P251, DOI 10.1677/joe.0.1030251; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; GUTTINGER HR, 1985, BEHAVIOUR, V94, P254, DOI 10.1163/156853985X00226; HARTLEY RS, 1990, RESP PHYSIOL, V81, P177, DOI 10.1016/0034-5687(90)90044-Y; HEIL P, 1991, BRAIN RES, V539, P110, DOI 10.1016/0006-8993(91)90692-O; HOSE B, 1987, BRAIN RES, V422, P367, DOI 10.1016/0006-8993(87)90946-2; Immelmann K., 1969, P61; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kroodsma D.E., 1996, ECOLOGY EVOLUTION AC; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LEPPELSACK HJ, 1976, J COMP PHYSIOL, V107, P263, DOI 10.1007/BF00656737; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MULLER CM, 1985, EXP BRAIN RES, V59, P587; MULLER CM, 1988, CELL TISSUE RES, V252, P99; MULLER SC, 1985, J COMP PHYSIOL A, V156, P1, DOI 10.1007/BF00610661; Mundinger PC, 1995, ANIM BEHAV, V50, P1491, DOI 10.1016/0003-3472(95)80006-9; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NOTTEBOHM F, 1978, Z TIERPSYCHOL, V46, P298; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; Okabe A, 1992, SPATIAL TESSELLATION; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147, DOI 10.1152/jn.1987.57.1.147; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Scheich H, 1991, Curr Opin Neurobiol, V1, P236, DOI 10.1016/0959-4388(91)90084-K; Shannon C. E., 1948, BELL SYS TECH J, V27; Solis MM, 1997, J NEUROSCI, V17, P6447; Stripling R, 1997, J NEUROSCI, V17, P3883; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; THEURICH M, 1984, BRAIN RES, V322, P157, DOI 10.1016/0006-8993(84)91197-1; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; VALLET EM, 1992, BEHAVIOUR, V121, P155, DOI 10.1163/156853992X00354; VANSTEVENINCK D, 1997, SCIENCE, V275, P1805; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; WALLACE CS, 1995, MOL BRAIN RES, V32, P211, DOI 10.1016/0169-328X(95)00076-5; WINGFIELD JC, 1990, HORM BEHAV, V24, P89, DOI 10.1016/0018-506X(90)90029-W; Woolsey CN, 1942, B JOHNS HOPKINS HOSP, V71, P315	62	116	119	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					359	371		10.1016/S0896-6273(00)80545-0	http://dx.doi.org/10.1016/S0896-6273(00)80545-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728917	Bronze			2022-12-24	WOS:000075598300013
J	Sauman, I; Reppert, SM				Sauman, I; Reppert, SM			Brain control of embryonic circadian rhythms in the silkmoth Antheraea pernyi	NEURON			English	Article							ECLOSION HORMONE; PERIOD PROTEIN; CLOCK; TIMELESS; MECHANISM; INSECTS; LIGHT	The clock protein PER is necessary for circadian control of egg-hatching behavior in the silkmoth Antheraea pernyi. Since the brain and midgut of the silkmoth embryo contain PER-positive cells, we examined the circadian clock potential of these embryonic tissues. Transplantation experiments indicate that the circadian clock controlling egg-hatching behavior resides in brain, and that a humoral factor mediates this circadian regulation. We also used ligation experiments on first instar larvae to show that the circadian control of PER movement into the nuclei of midgut epithelial cells is dependent on an intact (connected) brain. These results implicate a novel brain factor in the circadian regulation of egg-hatching behavior and provide further evidence for differing mechanisms of PER control among species.	Acad Sci Czech Republ, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Lab Dev Chronobiol, Serv Pediat, Boston, MA 02114 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Sauman, I (corresponding author), Acad Sci Czech Republ, Inst Entomol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.		Sauman, Ivo/H-2071-2014					Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; Hall JC, 1996, NEURON, V17, P799, DOI 10.1016/S0896-6273(00)80211-1; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; MIZOGUCHI A, 1982, P NATL ACAD SCI-BIOL, V79, P2726, DOI 10.1073/pnas.79.8.2726; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; RIDDIFORD LM, 1971, P 13 INT C ENT MOSC, V1, P431; SAKAMOTO K, 1994, J BIOL RHYTHM, V9, P61, DOI 10.1177/074873049400900106; Sauman I, 1996, NEURON, V17, P901, DOI 10.1016/S0896-6273(00)80221-4; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Sauman I, 1996, DEV BIOL, V178, P418, DOI 10.1006/dbio.1996.0228; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; SUZUKI K, 1990, J INSECT PHYSIOL, V36, P855, DOI 10.1016/0022-1910(90)90172-C; TRUMAN JW, 1992, PROG BRAIN RES, V92, P361, DOI 10.1016/S0079-6123(08)61189-9; TRUMAN JW, 1981, NATURE, V291, P70, DOI 10.1038/291070a0; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; Williams C M, 1969, Symp Soc Exp Biol, V23, P285; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	23	27	28	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					741	748		10.1016/S0896-6273(00)81012-0	http://dx.doi.org/10.1016/S0896-6273(00)81012-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581765	Bronze			2022-12-24	WOS:000073346500012
J	Lin, CLG; Bristol, LA; Jin, L; Dykes-Hoberg, M; Crawford, T; Clawson, L; Rothstein, JD				Lin, CLG; Bristol, LA; Jin, L; Dykes-Hoberg, M; Crawford, T; Clawson, L; Rothstein, JD			Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2 a glutamate transporter, in amyotrophic lateral sclerosis	NEURON			English	Article							MOTOR-NEURON DISEASE; SUPEROXIDE-DISMUTASE; CONTROLLED TRIAL; HIGH-AFFINITY; SPINAL-CORD; RAT-BRAIN; RILUZOLE; GENE; ACID; EXCITOTOXICITY	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is characterized by selective upper and lower motor neuron degeneration, the pathogenesis of which is unknown. About 60%-70% of sporadic ALS patients have a 30%-95% loss of the astroglial glutamate transporter EAAT2 (excitatory amino acid transporter 2) protein in motor cortex and spinal cord. Loss of EAAT2 leads to increased extracellular glutamate and excitotoxic neuronal degeneration. Multiple abnormal EAAT2 mRNAs, including intron-retention and exon-skipping, have now been identified from the affected areas of ALS patients. The aberrant mRNAs were highly abundant and were found only in neuropathologically affected areas of ALS patients but not in other brain regions. They were found in 65% of sporadic ALS patients but were not found in nonneurologic disease or other disease controls. They were also detectable in the cerebrospinal fluid (CSF) of living ALS patients, early in the disease. In vitro expression studies suggest that proteins translated from these aberrant mRNAs may undergo rapid degradation and/or produce a dominant negative effect on normal EAAT2 resulting in loss of protein and activity. These findings suggest that the loss of EAAT2 in ALS is due to aberrant mRNA and that these aberrant mRNAs could result from RNA processing errors. Aberrant RNA processing could be important in the pathophysiology of neurodegenerative disease and in excitotoxicity. The presence of these mRNA species in ALS CSF may have diagnostic utility.	Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA.		rothstein, jeffrey d/C-9470-2013; Lin, Chien-liang G/E-3513-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036465, R01NS033958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012992] Funding Source: NIH RePORTER; NIA NIH HHS [AG12992] Funding Source: Medline; NINDS NIH HHS [NS 33958, NS 36465] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AOKI M, 1998, IN PRESS ANN NEUROL, V43; APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brown RH, 1996, ANN NEUROL, V39, P145, DOI 10.1002/ana.410390202; Bruijn LI, 1996, NEUROPATH APPL NEURO, V22, P373, DOI 10.1111/j.1365-2990.1996.tb00907.x; CAMPAGNE MV, 1995, EUR J NEUROSCI, V7, P1627; CARRIEDO SG, 1995, NEUROREPORT, V6, P945, DOI 10.1097/00001756-199504190-00030; COURATIER P, 1993, LANCET, V341, P265, DOI 10.1016/0140-6736(93)92615-Z; COURATIER P, 1994, NEUROREPORT, V5, P1012, DOI 10.1097/00001756-199404000-00040; Didier M, 1996, J NEUROSCI, V16, P2238; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hagiwara T, 1996, GENOMICS, V33, P508, DOI 10.1006/geno.1996.0226; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Ikonomidou C, 1996, J NEUROPATH EXP NEUR, V55, P211, DOI 10.1097/00005072-199602000-00010; INCE P, 1993, NEUROPATH APPL NEURO, V19, P291, DOI 10.1111/j.1365-2990.1993.tb00443.x; Kuivenhoven JA, 1996, J CLIN INVEST, V98, P358, DOI 10.1172/JCI118800; KUNCL RW, 1992, DIS NERV SYST, P1179; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Meyer T, 1997, NEUROREPORT, V8, P775, DOI 10.1097/00001756-199702100-00039; Miller RG, 1996, NEUROLOGY, V47, P1383, DOI 10.1212/WNL.47.6.1383; Morrison M, 1997, P NATL ACAD SCI USA, V94, P9782, DOI 10.1073/pnas.94.18.9782; Rothstein JD, 1996, NEUROLOGY, V47, pS19, DOI 10.1212/WNL.47.4_Suppl_2.19S; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sakai N, 1996, J LIPID RES, V37, P2065; SHAW PJ, 1994, BRAIN RES, V655, P195, DOI 10.1016/0006-8993(94)91614-4; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; SHAW PJ, 1994, J NEUROL SCI, V124, P6, DOI 10.1016/0022-510X(94)90170-8; Siddique T, 1996, HUM MOL GENET, V5, P1465, DOI 10.1093/hmg/5.Supplement_1.1465; SMITH RG, 1992, NEW ENGL J MED, V327, P1721, DOI 10.1056/NEJM199212103272405; Stoffel W, 1996, FEBS LETT, V386, P189, DOI 10.1016/0014-5793(96)00424-3; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Trotti D, 1996, J BIOL CHEM, V271, P5976, DOI 10.1074/jbc.271.11.5976; VOLTERRA A, 1994, MOL PHARMACOL, V46, P986; Wang Q, 1996, J BIOL CHEM, V271, P28617, DOI 10.1074/jbc.271.45.28617; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	55	537	546	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1998	20	3					589	602		10.1016/S0896-6273(00)80997-6	http://dx.doi.org/10.1016/S0896-6273(00)80997-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539131	hybrid			2022-12-24	WOS:000072755600022
J	Jaffrey, SR; Snowman, AM; Eliasson, MJL; Cohen, NA; Snyder, SH				Jaffrey, SR; Snowman, AM; Eliasson, MJL; Cohen, NA; Snyder, SH			CAPON: A protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95	NEURON			English	Article							NMDA RECEPTOR; RAT-BRAIN; BINDING DOMAIN; LOCALIZATION; PSD-95; PHOSPHORYLATION; RECOGNITION; HOMOLOG; KINASE; GENE	Nitric oxide (NO) produced by neuronal nitric oxide synthase (nNOS) is important for N-methyl-D-aspartate (NMDA) receptor-dependent neurotransmitter release, neurotoxicity, and cyclic GMP elevations. The coupling of NMDA receptor-mediated calcium influx and nNOS activation is postulated to be due to a physical coupling of the receptor and the enzyme by an intermediary adaptor protein, PSD95, through a unique PDZ-PDZ domain interaction between PSD95 and nNOS. Here, we report the identification of a novel nNOS-associated protein, CAPON, which is highly enriched in brain and has numerous colocalizations with nNOS. CAPON interacts with the nNOS PDZ domain through its C terminus. CAPON competes with PSD95 for interaction with nNOS, and overexpression of CAPON results in a loss of PSD95/nNOS complexes in transfected cells. CAPON may influence nNOS by regulating its ability to associate with PSD95/NMDA receptor complexes.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.			Jaffrey, Samie/0000-0003-3615-6958; Cohen, Noam/0000-0002-9462-3932	NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH010341] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00074] Funding Source: Medline; NIGMS NIH HHS [GM-07309] Funding Source: Medline; NIMH NIH HHS [MH-10341] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bredt DS, 1996, P SOC EXP BIOL MED, V211, P41; BREDT DS, 1992, J BIOL CHEM, V267, P10976; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Dawson VL, 1996, P SOC EXP BIOL MED, V211, P33; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; HECKER M, 1994, J NEUROCHEM, V62, P1524; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; HUANG PL, 1997, CURR BIOL, V7, pR141; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; JAFFREY SR, 1994, P NATL ACAD SCI USA, V91, P12994, DOI 10.1073/pnas.91.26.12994; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LIPTON SA, 1994, NEUROPHARMACOLOGY, V33, P1229, DOI 10.1016/0028-3908(94)90021-3; MONCADA S, 1994, J HYPERTENS        S, V12, pS35; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; RODRIGO J, 1994, PHILOS T R SOC B, V345, P175, DOI 10.1098/rstb.1994.0096; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Yun HY, 1996, CRIT REV NEUROBIOL, V10, P291, DOI 10.1615/CritRevNeurobiol.v10.i3-4.20; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	41	291	315	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1998	20	1					115	124		10.1016/S0896-6273(00)80439-0	http://dx.doi.org/10.1016/S0896-6273(00)80439-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459447	hybrid			2022-12-24	WOS:000071719700014
J	Starace, DM; Stefani, E; Bezanilla, F				Starace, DM; Stefani, E; Bezanilla, F			Voltage-dependent proton transport by the voltage sensor of the shaker K+ channel	NEURON			English	Article							POTASSIUM-CHANNEL; GATING CURRENTS; SUBUNIT STOICHIOMETRY; S4 SEGMENT; MOVEMENT; SITE; COMPONENTS; ACTIVATION; CHARGE	In voltage-dependent ion channels, pore opening is initiated by electrically driven movements of charged residues, and this movement generates a gating current. To examine structural rearrangements in the Shaker K+ channel, basic residues R365 and R368 in the S4 segment were replaced with histidine, and gating currents were recorded. Changes in gating charge displacement with solvent pH reveal voltage-dependent changes in exposure of the histidine to solvent protons. This technique directly monitors accessibility changes during gating, probes the environment even in confined locations, and introduces minimal interference of gating charge motion. The results indicate that charges 365 and 368 traverse the entire electric field during gating. The remarkable implication of the successive exposure of histidine to each side of the membrane is that in a pH gradient, the voltage sensor transports protons.	Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; CONICET, RA-1033 Buenos Aires, DF, Argentina	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bezanilla, F (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.				NIGMS NIH HHS [GM30376] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030376, R37GM030376] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Boorer KJ, 1996, J BIOL CHEM, V271, P2213, DOI 10.1074/jbc.271.4.2213; COHEN JS, 1970, BIOCHEM BIOPH RES CO, V40, P144, DOI 10.1016/0006-291X(70)91058-2; EIGEN M, 1960, J AM CHEM SOC, V82, P3482; HILLE B, 1992, IONIC CHANNELS EXCIT, P458; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KASIANOWICZ J, 1987, J MEMBRANE BIOL, V95, P73, DOI 10.1007/BF01869632; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LU Z, 1995, BIOCHEMISTRY-US, V34, P13133, DOI 10.1021/bi00040a026; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Rodriguez B. M., 1995, Biophysical Journal, V68, pA137; RUTERJAN.H, 1971, EUR J BIOCHEM, V18, P313, DOI 10.1111/j.1432-1033.1971.tb01246.x; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shih TM, 1997, J CELL BIOL, V136, P1037, DOI 10.1083/jcb.136.5.1037; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	29	192	197	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1319	1327		10.1016/S0896-6273(00)80422-5	http://dx.doi.org/10.1016/S0896-6273(00)80422-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427254	Bronze			2022-12-24	WOS:000071236500018
J	Wang, YM; Gainetdinov, RR; Fumagalli, F; Xu, F; Jones, SR; Bock, CB; Miller, GW; Wightman, RM; Caron, MG				Wang, YM; Gainetdinov, RR; Fumagalli, F; Xu, F; Jones, SR; Bock, CB; Miller, GW; Wightman, RM; Caron, MG			Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine	NEURON			English	Article							MOUSE FETAL DEVELOPMENT; AMINE TRANSPORTER; CHROMAFFIN GRANULES; MOLECULAR-CLONING; NERVOUS-SYSTEM; RAT-BRAIN; EXPRESSION; DOPAMINE; MICE; CATECHOLAMINES	Vesicular monoamine transporters are known to transport monoamines from the cytoplasm into secretory vesicles. We have used homologous recombination to generate mutant mice lacking the vesicular monoamine transporter 2 (VMAT2), the predominant form expressed in the brain. Newborn homozygotes die within a few days after birth, manifesting severely impaired monoamine storage and vesicular release. In heterozygous adult mice, extracellular striatal dopamine levels, as well as K(+)- and amphetamine-evoked dopamine release, are diminished. The observed changes in presynaptic homeostasis are accompanied by a pronounced supersensitivity of the mice to the locomotor effects of the dopamine agonist apomorphine, the psychostimulants cocaine and amphetamine, and ethanol. Importantly, VMAT2 heterozygous mice do not develop further sensitization to repeated cocaine administration. These observations stress the importance of VMAT2 in the maintenance of presynaptic function and suggest that these mice may provide an animal model for delineating the mechanisms of vesicular release, monoamine function, and postsynaptic sensitization associated with drug abuse.	Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst Labs, Durham, NC 27710 USA	Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst Labs, Durham, NC 27710 USA.		Gainetdinov, Raul R/G-5875-2011; Jones, Sara R/K-4816-2014; Fumagalli, Fabio/E-8992-2012	Gainetdinov, Raul R/0000-0003-2951-6038; Jones, Sara R/0000-0002-3424-7576; Fumagalli, Fabio/0000-0002-8814-7706	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010900] Funding Source: NIH RePORTER; NIDA NIH HHS [NIDA 10900] Funding Source: Medline; NINDS NIH HHS [NS19576, NS 09930] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARA SG, 1995, NEUROSCIENTIST, V1, P259; BOAKES RJ, 1971, BRIT J PHARMACOL, V43, pP443; BRODIE BB, 1955, SCIENCE, V122, P968, DOI 10.1126/science.122.3177.968; CALLAWAY CW, 1989, BRAIN RES, V505, P83, DOI 10.1016/0006-8993(89)90118-2; CARLSSON A, 1972, N-S ARCH PHARMACOL, V275, P153, DOI 10.1007/BF00508904; Carlsson A., 1987, PSYCHOPHARMACOLOGY 3, P39; COOPER JR, 1996, BIOCH BASIS NEUROPHA, P226; DAUGHERTY DF, 1991, TXB GASTROENTEROLOGY, P233; Dimaline R, 1996, J PHYSIOL-LONDON, V490, P249, DOI 10.1113/jphysiol.1996.sp021140; ERICKSON JD, 1993, J NEUROCHEM, V61, P2314, DOI 10.1111/j.1471-4159.1993.tb07476.x; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GEOGE FR, 1991, ALCOHOL ALCOHOLISM S, V1, P427; GERMAN DC, 1981, BRAIN RES BULL, V6, P131, DOI 10.1016/S0361-9230(81)80037-8; GONZALEZ AM, 1994, MOL BRAIN RES, V22, P219, DOI 10.1016/0169-328X(94)90050-7; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOWELL M, 1994, FEBS LETT, V338, P16, DOI 10.1016/0014-5793(94)80108-8; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KREJCI E, 1993, FEBS LETT, V335, P27, DOI 10.1016/0014-5793(93)80432-T; LAHOSTE GJ, 1994, NEUROSCI LETT, V179, P153, DOI 10.1016/0304-3940(94)90957-1; LAHOSTE GJ, 1992, SYNAPSE, V12, P14, DOI 10.1002/syn.890120103; LIN PYT, 1984, J LIQ CHROMATOGR, V7, P509, DOI 10.1080/01483918408073983; LIU L, 1994, MOL BRAIN RES, V25, P90, DOI 10.1016/0169-328X(94)90282-8; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; LONG TD, 1993, ANN CLIN PSYCHIAT, V5, P269; MACON JB, 1971, J NEUROCHEM, V18, P323, DOI 10.1111/j.1471-4159.1971.tb11961.x; MAES M, 1994, PSYCHOPHARMACOLOGY 4, P813; MAHATA SK, 1993, NEUROSCI LETT, V156, P70, DOI 10.1016/0304-3940(93)90442-N; MCNEILL JH, 1972, RES COMMUN CHEM PATH, V3, P339; MELTZER HY, 1987, SCHIZOPHRENIA BULL, V13, P77, DOI 10.1093/schbul/13.1.77; MERICKEL A, 1995, NEUROPHARMACOLOGY, V34, P1543, DOI 10.1016/0028-3908(95)00148-Y; MESHGINAZARIAN S, 1988, J NEUROCHEM, V50, P824, DOI 10.1111/j.1471-4159.1988.tb02987.x; MULLER EE, 1995, ENDOCRINOLOGY, P178; NEAR JA, 1986, MOL PHARMACOL, V30, P252; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Nirenberg MJ, 1997, SYNAPSE, V26, P194; PETER D, 1993, GENOMICS, V18, P720, DOI 10.1016/S0888-7543(05)80383-0; PETER D, 1995, J NEUROSCI, V15, P6179; RENYI L, 1986, ACTA PHARMACOL TOX, V59, P298; Roberts MI, 1997, BIOCHEM PHARMACOL, V53, P347, DOI 10.1016/S0006-2952(96)00717-4; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SAMSON HH, 1992, TRENDS PHARMACOL SCI, V13, P206, DOI 10.1016/0165-6147(92)90065-E; SCHERMAN D, 1986, J NEUROCHEM, V47, P331; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; SEEMAN P, 1988, J CLIN PSYCHOPHARM, V8, pS3, DOI 10.1097/00004714-198808001-00002; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SINGER HS, 1994, BRAIN DEV-JPN, V16, P353, DOI 10.1016/0387-7604(94)90122-8; SINGER HS, 1994, CURR OPIN NEUROL, V7, P153, DOI 10.1097/00019052-199404000-00012; SMITH AD, 1992, J NEUROSCI METH, V44, P33, DOI 10.1016/0165-0270(92)90111-P; SPECTOR S, 1967, MOL PHARMACOL, V3, P549; SURRATT CK, 1993, FEBS LETT, V318, P325, DOI 10.1016/0014-5793(93)80539-7; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WEIHE E, 1995, J MOL NERUOSCI, V94, P149; WILCOX RE, 1980, PHARMACOL BIOCHEM BE, V12, P29, DOI 10.1016/0091-3057(80)90411-6; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; WOOLVERTON WL, 1992, TRENDS PHARMACOL SCI, V13, P193, DOI 10.1016/0165-6147(92)90063-C; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	66	277	283	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1285	1296		10.1016/S0896-6273(00)80419-5	http://dx.doi.org/10.1016/S0896-6273(00)80419-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427251	Bronze			2022-12-24	WOS:000071236500015
J	Kitsukawa, T; Shimizu, M; Sanbo, M; Hirata, T; Taniguchi, M; Bekku, Y; Yagi, T; Fujisawa, H				Kitsukawa, T; Shimizu, M; Sanbo, M; Hirata, T; Taniguchi, M; Bekku, Y; Yagi, T; Fujisawa, H			Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice	NEURON			English	Article							GROWTH CONE GUIDANCE; NEURONAL RECOGNITION MOLECULE; COLLAPSIN-1 MESSENGER-RNA; SPINAL-CORD; CELL-ADHESION; DIFFERENTIAL EXPRESSION; SENSORY INNERVATION; NEURITE OUTGROWTH; MEMBRANE-PROTEIN; CHICK-EMBRYO	Neuropilin is a neuronal cell surface protein and has been shown to function as a receptor for a secreted protein, semaphorin III/D, that can induce neuronal growth cone collapse and repulsion of neurites in vitro. The roles of neuropilin in vivo, however, are unknown. Here, we report that neuropilin-deficient mutant mice produced by targeted disruption of the neuropilin gene show severe abnormalities in the trajectory of efferent fibers of the PNS. We also describe that neuropilin-deprived dorsal root ganglion neurons are perfectly protected from growth cone collapse elicited by semaphorin III/D. Our results indicate that neuropilin-semaphorin III/D-mediated chemorepulsive signals play a major role in guidance of PNS efferents.	NAGOYA UNIV,GRAD SCH SCI,GRP DEV NEUROBIOL,DIV BIOL SCI,CHIKUSA KU,NAGOYA,AICHI 46401,JAPAN; AICHI HUMAN SERV CTR,INST DEV RES,DEPT MORPHOL,KASUGAI,AICHI 48003,JAPAN; NATL INST PHYSIOL SCI,LAB NEUROBIOL & BEHAV GENET,OKAZAKI,AICHI 444,JAPAN	Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)			Bekku, Yoko/AHB-9813-2022; Kitsukawa, Takashi/X-3176-2018	Bekku, Yoko/0000-0003-3206-1396; 				Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fujisawa H, 1995, DEV NEUROSCI-BASEL, V17, P343, DOI 10.1159/000111304; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HIRATA T, 1993, NEUROSCI RES, V17, P159, DOI 10.1016/0168-0102(93)90092-5; Jin Z, 1997, J NEUROSCI, V17, P6256; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANCEJONES C, 1991, DEV BIOL, V143, P93, DOI 10.1016/0012-1606(91)90057-A; LANDMESSER L, 1984, TRENDS NEUROSCI, V7, P336, DOI 10.1016/S0166-2236(84)80083-1; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RAFUSE VF, 1996, J NEUROSCI, V16, P6846; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; SATODA M, 1995, J NEUROSCI, V15, P942; SCOTT SA, 1986, J NEUROBIOL, V17, P649, DOI 10.1002/neu.480170609; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TESSIERLAVIGNE M, 1996, SCIENCE, V274, P1133; TOSNEY KW, 1988, DEV BIOL, V127, P266, DOI 10.1016/0012-1606(88)90314-4; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; WATANABE S, 1995, BIOCHEM BIOPH RES CO, V213, P130, DOI 10.1006/bbrc.1995.2107; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	51	533	546	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					995	1005		10.1016/S0896-6273(00)80392-X	http://dx.doi.org/10.1016/S0896-6273(00)80392-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390514	Bronze			2022-12-24	WOS:A1997YH59400008
J	Chen, H; Chedotal, A; He, ZG; Goodman, CS; TessierLavigne, M				Chen, H; Chedotal, A; He, ZG; Goodman, CS; TessierLavigne, M			Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III	NEURON			English	Article							GROWTH CONE GUIDANCE; NERVOUS-SYSTEM; CELL-SURFACE; SPINAL-CORD; LUNG-CANCER; RECOGNITION MOLECULE; ALPHA-DYSTROGLYCAN; EXPRESSION; AGRIN; IDENTIFICATION	Semaphorins are a targe family of secreted and transmembrane proteins, several of which are implicated in repulsive axon guidance. Neuropilin (neuropilin-1) was recently identified as a receptor for Collapsin-1/Semaphorin III/D (Sema III). We report the identification of a related protein, neuropilin-2, whose mRNA is expressed by developing neurons in a pattern largely, though not comptetely, nonoverlapping with that of neuropilin-1. Unlike neuropilin-1, which binds with high affinity to the th ree structurally related semaphorins Sema III, Sema E, and Sema IV, neuropilin-2 shows high affinity binding only to Sema E and Sema IV, not Sema III. These results identify neuropilins as a family of receptors (or components of receptors) for at least one semaphorin subfamily. They also suggest that the specificity of action of different members of this subfamily may be determined by the complement of neuropilins expressed by responsive cells.	UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT CELL & MOL BIOL,BERKELEY,CA 94720	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Chen, H (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA.		Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794				Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Campanelli JT, 1996, DEVELOPMENT, V122, P1663; Chedotal A, 1996, J NEUROSCI, V16, P3296; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; OToole JJ, 1996, P NATL ACAD SCI USA, V93, P7369, DOI 10.1073/pnas.93.14.7369; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Roche J, 1996, ONCOGENE, V12, P1289; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VarelaEchavarria A, 1997, GENE DEV, V11, P545, DOI 10.1101/gad.11.5.545; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Xiang RH, 1996, GENOMICS, V32, P39, DOI 10.1006/geno.1996.0074; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	38	534	563	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					547	559		10.1016/S0896-6273(00)80371-2	http://dx.doi.org/10.1016/S0896-6273(00)80371-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331348	Bronze			2022-12-24	WOS:A1997XZ01600011
J	Muhr, J; Jessell, TM; Edlund, T				Muhr, J; Jessell, TM; Edlund, T			Assignment of early caudal identity to neural plate cells by a signal from caudal paraxial mesoderm	NEURON			English	Article							DEVELOPING NERVOUS-SYSTEM; ZINC-FINGER GENE; SONIC HEDGEHOG; FLOOR PLATE; CHICK-EMBRYO; INDUCTIVE INTERACTIONS; RETINOIC ACID; SPINAL-CORD; DIFFERENTIATION; EXPRESSION	The early patterning of the vertebrate central nervous system involves the generation of progenitor cells with distinct fates at rostral and caudal levels of the neuraxis. We provide evidence that the assignment of early rostrocaudal differences in progenitor cell properties is established by spatial restrictions in the signaling properties of the paraxial mesoderm and epidermal ectoderm. Caudal level paraxial mesoderm secretes a factor, distinct from retinoic acid or fibroblast growth factors (FGFs), that can impose caudal fates on prospective anterior proencephalic progenitors. The caudalizing activity of the paraxial mesoderm can, however, be induced by FGF signaling. The distinct properties of cells at rostral and caudal levels of the neural plate appear to depend, in addition, on the early exclusion of bone morphogenetic proteins (BMPs) from rostral lever epidermal ectoderm. Thus, differences in the signaling properties of cell groups that flank the neural plate appear to contribute to the early rostrocaudal identity of neural cells, distinguishing progenitor cells at prospective anterior proencephalic regions from those at more caudal levels of the neuraxis.	COLUMBIA UNIV,HOWARD HUGHES MED INST,DEPT MOL BIOPHYS & BIOCHEM,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute	Muhr, J (corresponding author), UMEA UNIV,DEPT MICROBIOL,S-90187 UMEA,SWEDEN.							ANG SL, 1994, DEVELOPMENT, V120, P2979; Arkell R, 1997, DEVELOPMENT, V124, P1; Bang AG, 1997, DEVELOPMENT, V124, P2075; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CONLON RA, 1995, TRENDS GENET, V11, P314, DOI 10.1016/S0168-9525(00)89089-7; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; Cox WG, 1995, DEVELOPMENT, V121, P4349; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; DONLACH T, 1995, CELL, V83, P1067; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Foley AC, 1997, DEVELOPMENT, V124, P2983; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Furuta Y, 1997, DEVELOPMENT, V124, P2203; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; GrapinBotton A, 1997, DEVELOPMENT, V124, P849; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; HARLAND RM, 1997, IN PRESS NEURONAL DE; Henrique D, 1997, GENE DEV, V11, P603, DOI 10.1101/gad.11.5.603; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; KENGAKU M, 1995, DEVELOPMENT, V121, P3121; KINTNER CR, 1991, DEVELOPMENT, V113, P1495; LAMB TM, 1995, DEVELOPMENT, V121, P3627; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Lumsden A, 1995, CURR BIOL, V5, P1347, DOI 10.1016/S0960-9822(95)00266-1; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; MAHMOOD R, 1995, DEVELOPMENT, V121, P1399; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; MONSOROBURQ AH, 1995, MECH DEVELOP, V53, P157, DOI 10.1016/0925-4773(95)00426-2; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P83, DOI 10.1002/jez.1401200104; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; PLACZEK M, 1995, CURR OPIN GENET DEV, V5, P499, DOI 10.1016/0959-437X(95)90055-L; Pourquie O, 1996, CELL, V84, P461, DOI 10.1016/S0092-8674(00)81291-X; Pownall ME, 1996, DEVELOPMENT, V122, P3881; ROBERTS C, 1991, DEVELOPMENT, V112, P959; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Sechrist J, 1995, DEVELOPMENT, V121, P4103; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Shimamura K, 1995, DEVELOPMENT, V121, P3923; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 1997, DEVELOPMENT, V124, P1191; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; Waddington CI, 1936, P K AKAD WET-AMSTERD, V39, P887; WAGNER M, 1992, DEVELOPMENT, V116, P55; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V	65	90	96	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					487	502		10.1016/S0896-6273(00)80366-9	http://dx.doi.org/10.1016/S0896-6273(00)80366-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331343	hybrid			2022-12-24	WOS:A1997XZ01600006
J	Auger, C; Marty, A				Auger, C; Marty, A			Heterogeneity of functional synaptic parameters among single release sites	NEURON			English	Article							WIDOW SPIDER VENOM; FROG NEUROMUSCULAR-JUNCTION; RAT HIPPOCAMPAL SLICES; CEREBELLAR SLICES; ALPHA-LATROTOXIN; CENTRAL SYNAPSES; FREEZE-FRACTURE; PATCH-CLAMP; CELLS; TRANSMITTER	Following alpha-latrotoxin application to cerebellar slices, bursts of miniature IPSCs (mIPSCs) were observed in interneurons of the molecular layer. Within bursts, mIPSCs had homogeneous amplitudes with a narrow Gaussian distribution. Analysis of successive event amplitudes revealed an interaction between consecutive IPSCs, indicating that bursts originate at single release sites. A mean receptor occupancy of 76% was calculated. IPSCs within a burst were analyzed using nonstationary noise analysis. The results indicate that individual release sites differ in the number, unitary conductance, and peak opening probability of their postsynaptic channels. In addition, the IPSC decay kinetics were very different among release sites. Finally, a significant correlation was found between several pairs of single site synaptic parameters.			Auger, C (corresponding author), MAX PLANCK INST BIOPHYS CHEM,ARBEITSGRP ZELLULARE NEUROBIOL,D-37077 GOTTINGEN,GERMANY.							ARANCIO O, 1994, J PHYSIOL-LONDON, V481, P395, DOI 10.1113/jphysiol.1994.sp020448; BARBOUR B, 1997, IN PRESS TRENDS NEUR; Barnett DW, 1996, PFLUG ARCH EUR J PHY, V432, P1039, DOI 10.1007/s004240050232; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Capogna M, 1996, J NEUROPHYSIOL, V76, P3149, DOI 10.1152/jn.1996.76.5.3149; CECCARELLI B, 1979, J CELL BIOL, V81, P163, DOI 10.1083/jcb.81.1.163; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; DELCASTILLO J, 1975, J PHYSIOL-LONDON, V252, P491; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FESCE R, 1986, J GEN PHYSIOL, V88, P59, DOI 10.1085/jgp.88.1.59; FINKELSTEIN A, 1976, SCIENCE, V193, P1009, DOI 10.1126/science.948756; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HURLBUT WP, 1994, J MEMBRANE BIOL, V138, P91, DOI 10.1007/BF00211072; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KOUULEN P, 1996, J NEUROSCI, V16, P2127; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LONGENEC.HE, 1970, NATURE, V225, P701, DOI 10.1038/225701a0; Poncer JC, 1996, NEUROPHARMACOLOGY, V35, P1169, DOI 10.1016/S0028-3908(96)00055-X; PUMPLIN DW, 1977, J PHYSIOL-LONDON, V273, P443, DOI 10.1113/jphysiol.1977.sp012103; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; SCHNEGGENBURGER R, 1992, PFLUG ARCH EUR J PHY, V421, P364, DOI 10.1007/BF00374225; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; Tia S, 1996, J NEUROSCI, V16, P3630	36	93	96	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					139	150		10.1016/S0896-6273(00)80354-2	http://dx.doi.org/10.1016/S0896-6273(00)80354-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247270	Green Published, Bronze, Green Submitted			2022-12-24	WOS:A1997XN39400013
J	Clement, JP; Kunjilwar, K; Gonzalez, G; Schwanstecher, M; Panten, U; AguilarBryan, L; Bryan, J				Clement, JP; Kunjilwar, K; Gonzalez, G; Schwanstecher, M; Panten, U; AguilarBryan, L; Bryan, J			Association and stoichiometry of K-ATP channel subunits	NEURON			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; GREEN FLUORESCENT PROTEIN; INSULIN-SECRETING CELLS; SULFONYLUREA RECEPTOR; POTASSIUM CHANNELS; GLYBURIDE ANALOG; AFFINITY; GENE; RECTIFICATION; EXPRESSION	ATP-sensitive potassium channels (K-ATP channels) are heteromultimers of sulfonylurea receptors (SUR) and inwardly rectifying potassium channel subunits (K(IR)6.x) with a (SUR-K(IR)6.x)(4) stoichiometry. Association is specific for K(IR)6.x and affects receptor glycosylation and cophotolabeling of K(IR)6.x by I-125-azidoglibenclamide. Association produces digitonin stable complexes with an estimated mass of 950 kDa. These complexes can be purified by lectin chromatography or by using Ni2+-agarose and a his-tagged SUR1. Expression of SUR1 similar to(K(IR)6.2), fusion constructs shows that a 1:1 SUR1:K(IR)6.2 stoichiometry is both necessary and sufficient for assembly of active K-ATP channels. Coexpression of a mixture of strongly and weakly rectifying triple fusion proteins, rescued by SUR1, produced the three channel types expected of a tetrameric pore.	BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; INST PHARMAKOL & TOXIKOL,BRAUNSCHWEIG,GERMANY	Baylor College of Medicine	Clement, JP (corresponding author), BAYLOR COLL MED,DEPT CELL BIOL,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.							Aguilar-Bryan L, 1996, DIABETES REV, V4, P336; AGUILARBRYAN L, 1990, J BIOL CHEM, V265, P8218; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ALAWQATI Q, 1995, SCIENCE, V269, P805, DOI 10.1126/science.7543697; Ammala C, 1996, NATURE, V379, P545, DOI 10.1038/379545a0; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Dunne MJ, 1997, NEW ENGL J MED, V336, P703, DOI 10.1056/NEJM199703063361005; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; GLASER B, 1994, NAT GENET, V7, P185, DOI 10.1038/ng0694-185; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V261, P251, DOI 10.1098/rspb.1995.0145; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Kane C, 1996, NAT MED, V2, P1344, DOI 10.1038/nm1296-1344; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; Nelson DA, 1996, BIOCHEMISTRY-US, V35, P14793, DOI 10.1021/bi960777y; NELSON DA, 1992, J BIOL CHEM, V267, P14928; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; NESTOROWICZ A, 1996, P 10 INT C END SAN F, P748; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OZANNE SE, 1995, DIABETOLOGIA, V38, P277; RAJAN AS, 1993, J BIOL CHEM, V268, P15221; SCHWANSTECHER M, 1994, J BIOL CHEM, V269, P17768; SCHWANSTECHER M, 1994, J NEUROCHEM, V63, P698; Shyng S.-L., 1997, Biophysical Journal, V72, pA251; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; THOMAS PM, 1995, AM J HUM GENET, V56, P416; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	37	592	596	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					827	838		10.1016/S0896-6273(00)80321-9	http://dx.doi.org/10.1016/S0896-6273(00)80321-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182806	Bronze			2022-12-24	WOS:A1997XB72200015
J	Swartz, KJ; MacKinnon, R				Swartz, KJ; MacKinnon, R			Hanatoxin modifies the gating of a voltage-dependent K+ channel through multiple binding sites	NEURON			English	Article							POTASSIUM CHANNEL; CHARYBDOTOXIN BLOCK; INHIBITOR; PORE; RECEPTOR; VENOM	We studied the mechanism by which Hanatoxin (HaTx) inhibits the drk1 voltage-gated KC channel. HaTx inhibits the K+ channel by shifting channel opening to more depolarized voltages. Channels opened by strong depolarization in the presence of HaTx deactivate much faster upon repolarization, indicating that toxin bound channels can open. Thus, HaTx inhibits the drk1 KC channel, not by physically occluding the ion conduction pore, but by modifying channel gating. Occupancy of the channel by HaTx was studied using various strength depolarizations. The concentration dependence for equilibrium occupancy as well as the kinetics of onset and recovery from inhibition indicate that multiple HaTx molecules can simultaneously bind to a single K+ channel. These results are consistent with a simple model in which HaTx binds to the surface of the drk1 KC channel at four equivalent sites and alters the energetics of channel gating.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; ROCKEFELLER UNIV,LAB MOL NEUROBIOL & BIOPHYS,NEW YORK,NY 10021	Harvard University; Harvard Medical School; Rockefeller University					NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGGARWAL SK, 1996, THESIS HARVARD U CAM; AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; HILDAGO P, 1995, SCIENCE, V268, P307; HURST RS, 1991, MOL PHARMACOL, V40, P572; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MATTESON DR, 1986, J GEN PHYSIOL, V87, P795, DOI 10.1085/jgp.87.5.795; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0	21	216	221	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					665	673		10.1016/S0896-6273(00)80306-2	http://dx.doi.org/10.1016/S0896-6273(00)80306-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136774	Bronze			2022-12-24	WOS:A1997WW62600014
J	Brunstrom, JE; GraySwain, MR; Osborne, PA; Pearlman, AL				Brunstrom, JE; GraySwain, MR; Osborne, PA; Pearlman, AL			Neuronal heterotopias in the developing cerebral cortex produced by neurotrophin-4	NEURON			English	Article							TYROSINE PROTEIN-KINASE; NERVOUS-SYSTEM; CELL-DEATH; RECEPTOR EXPRESSION; VISUAL-CORTEX; BRAIN; TRKB; NEOCORTEX; RAT; NEUROGENESIS	The marginal zone (MZ) of embryonic neocortex is crucial to its normal development. We report that neurotrophin-4 (but not NT3 or NGF), applied to embryonic rodent cortex in vitro or in vivo, produces heterotopic accumulations of neurons in the MZ. Although heterotopia production is TrkB mediated, BDNF is >10-fold less effective than NT4. Heterotopic neurons have the same birth date and phenotype as normal MZ neurons; they are not the result of NT4-induced proliferation or rescue from apoptosis. We suggest that NT4 causes excess neurons to migrate into the MZ and thus may play a role in normal MZ formation as well as in the pathogenesis of certain human cortical dysplasias.	WASHINGTON UNIV,SCH MED,DEPT MOL BIOL & PHARMACOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT CELL BIOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	Brunstrom, JE (corresponding author), WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110, USA.							ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; ANNIS CM, 1990, J NEUROSCI METH, V32, P63, DOI 10.1016/0165-0270(90)90072-N; ARDELT AA, 1994, BRAIN RES, V647, P340, DOI 10.1016/0006-8993(94)91333-1; Bayer S.A., 1991, NEOCORTICAL DEV; BAYER SA, 1991, J COMP NEUROL, V307, P499, DOI 10.1002/cne.903070312; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; BRITTIS PA, 1995, EXP NEUROL, V133, P1; Cabelli RJ, 1996, J NEUROSCI, V16, P7965; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CAJAL SR, 1980, GRAC MED CATALANA, V3, P737; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; CHUN JJM, 1988, J CELL BIOL, V106, P857, DOI 10.1083/jcb.106.3.857; COHN SM, 1984, J BIOL CHEM, V259, P2456; CRANDALL JE, 1986, DEV BRAIN RES, V28, P127, DOI 10.1016/0165-3806(86)90072-6; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DEDIEGO I, 1994, EUR J NEUROSCI, V6, P983, DOI 10.1111/j.1460-9568.1994.tb00593.x; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; ELLWART J, 1985, CYTOMETRY, V6, P513, DOI 10.1002/cyto.990060605; ESCANDON E, 1994, J NEUROSCI, V14, P2054; FERRER I, 1992, PROG NEUROBIOL, V39, P1, DOI 10.1016/0301-0082(92)90029-E; FINLAY BL, 1983, SCIENCE, V219, P1349, DOI 10.1126/science.6828866; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; GADISSEUX JF, 1992, J COMP NEUROL, V324, P94, DOI 10.1002/cne.903240108; Garner AS, 1996, J NEUROSCI, V16, P1740; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; GONCHOROFF NJ, 1985, CYTOMETRY, V6, P506, DOI 10.1002/cyto.990060604; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; HENDERSON TA, 1994, J NEUROSCI, V14, P3389; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; KULDA K, 1996, NATURE, V384, P368; LAMBALLE F, 1994, J NEUROSCI, V14, P14; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Levi-Montalcini R, 1976, Prog Brain Res, V45, P235, DOI 10.1016/S0079-6123(08)60993-0; LINDHOLM D, 1993, J CELL BIOL, V122, P443, DOI 10.1083/jcb.122.2.443; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MEENCKE HJ, 1992, MOL NEUROBIOL EPILSP, V9, P31; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; MEUTH M, 1974, CELL, V2, P109, DOI 10.1016/0092-8674(74)90099-3; MEYER G, 1993, J COMP NEUROL, V338, P317, DOI 10.1002/cne.903380302; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Miyata T, 1996, J COMP NEUROL, V372, P215; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; OLEARY DDM, 1990, COLD SH Q B, V55, P453; PEARLMAN AL, 1996, NEURAL DEV PLASTICIT, P119; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; RAKIC P, 1975, BRAIN MECHANISMS MEN, P3; ROSEN GD, 1992, DEV BRAIN RES, V67, P285, DOI 10.1016/0165-3806(92)90229-P; RYDEN M, 1995, EMBO J, V14, P1979, DOI 10.1002/j.1460-2075.1995.tb07190.x; SCHIFFMANN SN, 1997, IN PRESS EUR J NEURO; SHEPPARD AM, 1991, J NEUROSCI, V11, P3928; Sheppard AM, 1995, DEV BIOL, V172, P504, DOI 10.1006/dbio.1995.8034; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SPREAFICO R, 1995, J COMP NEUROL, V363, P281, DOI 10.1002/cne.903630209; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Strohmaier C, 1996, EMBO J, V15, P3332, DOI 10.1002/j.1460-2075.1996.tb00698.x; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; Takahashi T, 1996, J NEUROSCI, V16, P6183; VALVERDE F, 1994, DEV BRAIN RES, V80, P96, DOI 10.1016/0165-3806(94)90093-0; VALVERDE F, 1995, CEREB CORTEX, V5, P483, DOI 10.1093/cercor/5.6.483; Yamaguchi K, 1996, PEDIATR NEUROL, V14, P75, DOI 10.1016/0887-8994(95)00259-6; YAN Q, 1994, EXP NEUROL, V127, P23, DOI 10.1006/exnr.1994.1076; Zigova T, 1996, DEV BIOL, V173, P459, DOI 10.1006/dbio.1996.0040	80	99	101	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					505	517		10.1016/S0896-6273(00)81250-7	http://dx.doi.org/10.1016/S0896-6273(00)81250-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115743	Bronze			2022-12-24	WOS:A1997WQ07400017
J	Chae, T; Kwon, YT; Bronson, R; Dikkes, P; Li, E; Tsai, LH				Chae, T; Kwon, YT; Bronson, R; Dikkes, P; Li, E; Tsai, LH			Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; CENTRAL NERVOUS-SYSTEM; CDC2-LIKE KINASE; PROTEIN-KINASE; REELER MICE; MOUSE; EXPRESSION; BRAIN; ORGANIZATION; DISRUPTION	The adult mammalian cortex is characterized by a distinct laminar structure generated through a well-defined pattern of neuronal migration. Successively generated neurons are layered in an ''inside-out'' manner to produce six cortical laminae. We demonstrate here that p35, the neuronal-specific activator of cyclin-dependent kinase 5, plays a key role in proper neuronal migration. Mice lacking p35, and thus p35/cdk5 kinase activity, display severe cortical lamination defects and suffer from sporadic adult lethality and seizures. Histological examination reveals that the mutant mice lack the characteristic laminated structure of the cortex. Neuronal birth-dating experiments indicate a reversed packing order of cortical neurons such that earlier born neurons reside in superficial layers and later generated neurons occupy deep layers. The phenotype of p35 mutant mice thus demonstrates that the formation of cortical laminar structure depends on the action of the p35/cdk5 kinase.	TUFTS UNIV,USDA,HUMAN NUTR RES CTR AGING,SCH VET MED,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,DEPT PATHOL,BOSTON,MA 02111; CHILDRENS HOSP,DEPT NEUROL,DIV NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,MASSACHUSETTS GEN HOSP,CARDIOVASC RES CTR,CHARLESTOWN,MA 02129	Tufts University; United States Department of Agriculture (USDA); Tufts University; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital	Chae, T (corresponding author), HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115, USA.				NICHD NIH HHS [P30-HD18655] Funding Source: Medline; NIGMS NIH HHS [GM52106, GM53049] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052106, R01GM053049] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BANCROFT JD, 1977, THEORY PRACTICE HIST, P355; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CAVINESS VS, 1976, J COMP NEUROL, V170, P435, DOI 10.1002/cne.901700404; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELLALE I, 1997, IN PRESS J NEUROCYTO; DOBYNS WB, 1992, NEUROLOGY, V42, P1375, DOI 10.1212/WNL.42.7.1375; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; FINK ROBERT P., 1967, BRAIN RES, V4, P369, DOI 10.1016/0006-8993(67)90166-7; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HOFFARTH RM, 1995, J NEUROSCI, V15, P4838; LEW J, 1992, J BIOL CHEM, V267, P13383; LEW J, 1995, TRENDS BIOCHEM SCI, V20, P33, DOI 10.1016/S0968-0004(00)88948-3; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; PINTOLORD MC, 1979, J COMP NEUROL, V187, P49, DOI 10.1002/cne.901870104; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; STENSAAS LJ, 1968, J COMP NEUROL, V132, P93, DOI 10.1002/cne.901320105; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M	39	637	659	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					29	42		10.1016/S0896-6273(01)80044-1	http://dx.doi.org/10.1016/S0896-6273(01)80044-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010203	Bronze			2022-12-24	WOS:A1997WE71800006
J	Wu, LG; Betz, WJ				Wu, LG; Betz, WJ			Nerve activity but not intracellular calcium determines the time course of endocytosis at the frog neuromuscular junction	NEURON			English	Article							TRANSMITTER RELEASE; POSTTETANIC POTENTIATION; PRESYNAPTIC BOUTONS; SYNAPTIC VESICLES; EXOCYTOSIS; TERMINALS; MEMBRANE; CELLS; CA2+; DEPRESSION	We used FM1-43 imaging and intracellular recordings of synaptic potentials to measure the time course of endocytosis in frog motor nerve terminals following tetanic nerve stimulation, and we used fura-2 imaging of intraterminal Ca2+ concentration to compare endocytic rate and [Ca2+](i). Following a 30 Hz tetanus, endocytosis declined exponentially with a time constant that depended on the duration of stimulation. The level of [Ca2+](i) rose from a resting value of about 100 nM to more than 500 nM during 30 Hz stimulation, and rapidly declined to 200-250 nM after stimulation. [Ca2+](i) returned to resting level with a time course that, like endocytosis, depended on the duration of tetanic stimulation. However, the rate of [Ca2+](i) recovery was much slower than the rate of endocytosis, leading to the conclusion that endocytic rate is not determined solely by the instantaneous level of [Ca2+](i).	UNIV COLORADO,SCH MED,DEPT PHYSIOL,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023466] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23466] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; BURGOYNE RD, 1995, PFLUG ARCH EUR J PHY, V430, P213, DOI 10.1007/BF00374652; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; DELANEY KR, 1989, J NEUROSCI, V9, P3558; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1995, J NEUROSCI, V15, P8246; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; MELDOLESI J, 1981, PHILOS T ROY SOC B, V296, P55, DOI 10.1098/rstb.1981.0171; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; REGEHR WG, 1994, J NEUROSCI, V14, P523; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Tank DW, 1995, J NEUROSCI, V15, P7940; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; ZENGEL JE, 1994, J PHYSIOL-LONDON, V477, P267, DOI 10.1113/jphysiol.1994.sp020189; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	34	143	148	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					769	779		10.1016/S0896-6273(00)80208-1	http://dx.doi.org/10.1016/S0896-6273(00)80208-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893033	Bronze			2022-12-24	WOS:A1996VP74300021
J	Kullmann, DM; Erdemli, G; Asztely, F				Kullmann, DM; Erdemli, G; Asztely, F			LTP of AMPA and NMDA receptor-mediated signals: Evidence for presynaptic expression and extrasynaptic glutamate spill-over	NEURON			English	Article							LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; EXCITATORY SYNAPTIC CURRENTS; TRANSMITTER RELEASE; HIPPOCAMPAL SLICES; CA1 REGION; LASTING POTENTIATION; PYRAMIDAL CELLS; TIME COURSE; COMPONENT	We have addressed the expression of long-term potentiation (LTP) in hippocampal CA1 by comparing AMPA and NMDA receptor-(AMPAR- and NMDAR-) mediated postsynaptic signals. We find that potentiation of NMDAR-mediated signals accompanies LTP of AMPAR-mediated signals, and is associated with a change in variability implying an increase in quantal content. Further, tetanic LTP of NMDAR-mediated signals can be elicited when LTP of AMPAR-mediated signals is prevented. We propose that LTP is mainly expressed presynaptically, and that, while AMPARs respond only to glutamate from immediately apposed terminals, NMDARs also sense glutamate released from terminals presynaptic to neighboring cells. We also find that tetanic LTP increases the rate of depression of NMDAR-mediated signals by the use-dependent blocker MK-801, implying an increase in the glutamate release probability. These findings argue for a presynaptic contribution to LTP and for extrasynaptic spill-over of glutamate onto NMDARs.			Kullmann, DM (corresponding author), UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND.		Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; ASZTELY F, 1992, EUR J NEUROSCI, V4, P681, DOI 10.1111/j.1460-9568.1992.tb00177.x; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERETTA N, 1991, EUR J NEUROSCI, V3, P850; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CORMIER RJ, 1993, NEURON, V10, P907, DOI 10.1016/0896-6273(93)90206-7; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; HESSLER NA, 1993, NATURE, V366, P568; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; KAMIYA H, 1993, SYNAPSE, V13, P186, DOI 10.1002/syn.890130210; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Neveu D, 1996, J NEUROPHYSIOL, V75, P2157, DOI 10.1152/jn.1996.75.5.2157; OCONNOR JJ, 1995, NEUROSCIENCE, V69, P363, DOI 10.1016/0306-4522(95)00295-T; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Stricker C, 1996, J PHYSIOL-LONDON, V490, P443, DOI 10.1113/jphysiol.1996.sp021156; TSIEN RW, 1990, COLD SPRING HARB SYM, V45, P147; VORONIN LL, 1993, NEUROSCIENCE, V56, P275, DOI 10.1016/0306-4522(93)90332-A; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	53	228	231	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					461	474		10.1016/S0896-6273(00)80178-6	http://dx.doi.org/10.1016/S0896-6273(00)80178-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816709	Bronze			2022-12-24	WOS:A1996VJ44000012
J	Gotz, M; Wizenmann, A; Reinhardt, S; Lumsden, A; Price, J				Gotz, M; Wizenmann, A; Reinhardt, S; Lumsden, A; Price, J			Selective adhesion of cells from different telencephalic regions	NEURON			English	Article							RAT-BRAIN DEVELOPMENT; CEREBRAL-CORTEX; HOMEOBOX GENES; NERVOUS-SYSTEM; REAGGREGATE CULTURES; MAMMALIAN FOREBRAIN; CHICK-EMBRYO; MOUSE-BRAIN; EXPRESSION; MOLECULES	We asked whether specification of different regions of the rodent and avian telencephalon during development involved the acquisition of differential adhesive properties. Cells from different regions were aggregated in a short-term aggregation assay, and their segregation was analyzed. Both neurons and precursor cells from cortex segregate from striatal cells at early, but not later, stages, whereas cells from rodent neocortex and hippocampus segregated only during later stages. Segregation was abolished when Ca2+-dependent but not Ca2+-independent adhesion molecules were selectively removed. Thus, selective adhesion appears to be a conserved mechanism that restricts cellular mixing and might serve to maintain positional information during forebrain development. A candidate for mediating the Ca2+-dependent segregation is the CD15 (Lewis(x)) carbohydrate epitope, which is selectively expressed by mammalian cortex but not striatum.	UNITED MED & DENT SCH,GUYS & ST THOMAS HOSP,SCH MED,MRC,BRAIN DEV PROGRAM,LONDON SE1 9RT,ENGLAND; UNIV MAINZ,INST PHYSIOL CHEM & PATHOBIOCHEM,D-55099 MAINZ,GERMANY	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Johannes Gutenberg University of Mainz	Gotz, M (corresponding author), SMITHKLINE BEECHAM PHARMACEUT,NEW FRONTIERS SCI PK N,3RD AVE,HARLOW CM19 5AD,ESSEX,ENGLAND.		Lumsden, Andrew/C-5146-2009; Price, Jack/G-9510-2011	Gotz, Magdalena/0000-0003-1551-9203	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKAGAWA K, 1987, BRAIN RES, V437, P298, DOI 10.1016/0006-8993(87)91644-1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bayer S.A., 1991, NEOCORTICAL DEV; BAYER SA, 1991, J COMP NEUROL, V307, P499, DOI 10.1002/cne.903070312; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BINDER LI, 1986, ANN NY ACAD SCI, V466, P154; BLASSKAMPMANN S, 1994, J NEUROSCI RES, V37, P359, DOI 10.1002/jnr.490370308; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRACKENBURY R, 1977, J BIOL CHEM, V252, P6835; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; CHALEPAKIS G, 1994, DNA CELL BIOL, V13, P891, DOI 10.1089/dna.1994.13.891; CHUONG CM, 1984, J NEUROSCI, V4, P2354; DEDIEGO I, 1994, EUR J NEUROSCI, V6, P983, DOI 10.1111/j.1460-9568.1994.tb00593.x; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; FISHELL G, 1995, DEVELOPMENT, V121, P803; GANSMULLER A, 1991, GLIA, V4, P580, DOI 10.1002/glia.440040605; GANZLER SII, 1995, J NEUROSCI, V15, P4157; GARBER BB, 1972, DEV BIOL, V27, P217, DOI 10.1016/0012-1606(72)90099-1; GODFRAIND IR, 1991, DEV BRAIN RES, V42, P99; GOTZ M, 1992, DEVELOPMENT, V116, P507; GOTZ M, 1995, IN PRESS EXPERIENTIA; GRAHAM A, 1992, SEMIN NEUROSCI, V4, P307; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; GUTHRIE S, 1993, DEVELOPMENT, V118, P527; HINCK L, 1994, TRENDS BIOCHEM SCI, V19, P538, DOI 10.1016/0968-0004(94)90057-4; Huelsken Joerg, 1994, Current Opinion in Cell Biology, V6, P711; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; Karten H J, 1989, J Cogn Neurosci, V1, P291, DOI 10.1162/jocn.1989.1.4.291; KOJIMA N, 1994, GLYCOCONJUGATE J, V11, P238, DOI 10.1007/BF00731224; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; KRUSHEL LA, 1993, DEV BIOL, V158, P145, DOI 10.1006/dbio.1993.1175; LAMANTIA AS, 1993, NEURON, V10, P1035, DOI 10.1016/0896-6273(93)90052-S; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; LIEPELT U, 1990, DEV BRAIN RES, V51, P267, DOI 10.1016/0165-3806(90)90285-7; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MAURO VP, 1994, P NATL ACAD SCI USA, V91, P2868, DOI 10.1073/pnas.91.7.2868; NAGAFUCHI A, 1994, DEV GROWTH DIFFER, V36, P59; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; PROBSTMEIER R, 1994, J NEUROSCI RES, V37, P324, DOI 10.1002/jnr.490370305; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; RANSCHT B, 1994, CURR OPIN CELL BIOL, V6, P740, DOI 10.1016/0955-0674(94)90102-3; REDIES C, 1993, J COMP NEUROL, V333, P398, DOI 10.1002/cne.903330307; REINHARDTMAELIC.S, 1994, J BRAIN RES, V35, P121; REINHARDTMAELIC.S, 1988, TGHESIS; REINHARDTMAELICKE S, 1990, DEV BRAIN RES, V51, P279, DOI 10.1016/0165-3806(90)90286-8; REYES AA, 1993, MOL BRAIN RES, V17, P201, DOI 10.1016/0169-328X(93)90003-8; SEEDS NW, 1973, TISSUE CULTURE NERVO, P35; SHIMAMURA K, 1992, DEVELOPMENT, V116, P1011; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SMART IHM, 1982, J ANAT, V134, P273; SMART IHM, 1979, ONTOGENY NEOSTRIATUM, P127; SONG DD, 1994, DEV BRAIN RES, V83, P233, DOI 10.1016/0165-3806(94)00144-8; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; TOLE S, 1995, J NEUROSCI, V15, P957; TRAPP BD, 1979, BRAIN RES, V160, P117, DOI 10.1016/0006-8993(79)90605-X; TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207; TUTTLE R, 1995, J NEUROSCI, V15, P3039; URUSHIHARA H, 1979, DEV BIOL, V70, P206, DOI 10.1016/0012-1606(79)90017-4; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WHITESIDES JG, 1995, DEV BIOL, V169, P229, DOI 10.1006/dbio.1995.1140; [No title captured]	79	75	75	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					551	564		10.1016/S0896-6273(00)80074-4	http://dx.doi.org/10.1016/S0896-6273(00)80074-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785052	Bronze			2022-12-24	WOS:A1996UC16800011
J	Verdi, JM; Groves, AK; Farinas, I; Jones, K; Marchionni, MA; Reichardt, LF; Anderson, DJ				Verdi, JM; Groves, AK; Farinas, I; Jones, K; Marchionni, MA; Reichardt, LF; Anderson, DJ			A reciprocal cell-cell interaction mediated by NT-3 and neuregulins controls the early survival and development of sympathetic neuroblasts	NEURON			English	Article							NERVE GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; NEURAL CREST CELLS; SENSORY NEURONS; REGIONAL DISTRIBUTION; FACTOR RECEPTORS; GRANULE NEURONS; CNTF RECEPTOR; MESSENGER-RNA; EXPRESSION	Neurotrophin 3 (NT-3) can support the survival of some embryonic sympathetic neuroblasts before they become nerve growth factor dependent. We show that NT-3 is produced in vivo by nonneuronal cells neighboring embryonic sympathetic ganglia. NT-3 mRNA is produced by these nonneuronal cells in vitro and is up-regulated by platelet-derived growth factor, ciliary neurotrophic factor, and glial growth factor 2 (a neuregulin). Nonneuronal cell-conditioned medium promotes survival and induces TrkA expression in isolated sympathetic neuroblasts, and this activity is blocked by anti-NT-3 antibody. Neuroblasts also enhance NT-3 production by nonneuronal cells. Neuroblasts synthesize several forms of neuregulin, and antibodies to neuregulin attenuate the effect of the neuroblasts on the nonneuronal cells. These data suggest a reciprocal cell-cell interaction, in which neuroblast-derived neuregulins promote NT-3 production by neighboring nonneuronal cells, which in turn promotes neuroblast survival and further differentiation.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; CAMBRIDGE NEUROSCI INC,CAMBRIDGE,MA 02139; AMGEN INST,TORONTO,ON,CANADA; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Verdi, JM (corresponding author), CALTECH,DIV BIOL 21676,PASADENA,CA 91125, USA.		Farinas, Isabel/L-7118-2014	Farinas, Isabel/0000-0003-2903-4960; Groves, Andrew/0000-0002-0784-7998; JONES, KEVIN/0000-0002-3802-7562	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-180014, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; BUJBELLO A, 1994, DEVELOPMENT, V120, P1573; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DAVIES AM, 1994, CURR BIOL, V4, P273, DOI 10.1016/S0960-9822(00)00064-6; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DECHANT G, 1993, J NEUROSCI, V13, P2610, DOI 10.1523/JNEUROSCI.13-06-02610.1993; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; IP NY, 1994, NEURON, V13, P443, DOI 10.1016/0896-6273(94)90359-X; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; LEE KF, 1994, DEVELOPMENT, V120, P1027; LEUNG DW, 1992, NEURON, V8, P1045, DOI 10.1016/0896-6273(92)90126-X; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAO MS, 1993, NEURON, V11, P1175, DOI 10.1016/0896-6273(93)90229-K; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; WESKAMP G, 1991, NEURON, V6, P49; WRIGHT EM, 1992, NEURON, V9, P1; WYATT S, 1993, DEVELOPMENT, V119, P635; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; ZACKENFELS K, 1995, NEURON, V14, P731, DOI 10.1016/0896-6273(95)90217-1	52	125	128	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					515	527		10.1016/S0896-6273(00)80071-9	http://dx.doi.org/10.1016/S0896-6273(00)80071-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785049	Bronze, Green Accepted			2022-12-24	WOS:A1996UC16800008
J	Arenas, E; Trupp, M; Akerud, P; Ibanez, CF				Arenas, E; Trupp, M; Akerud, P; Ibanez, CF			GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo	NEURON			English	Article							PARKINSONS-DISEASE; LOCUS-CERULEUS; ALZHEIMERS-DISEASE; SENILE DEMENTIA; CELL LOSS; DOPAMINERGIC-NEURONS; STRIATAL DOPAMINE; BASAL FOREBRAIN; COERULEUS; NEUROPATHOLOGY	The locus coeruleus (LC), the main noradrenergic center in the brain, participates in many neural functions, as diverse as memory and motor output, and is severely affected in several neurodegenerative disorders of the CNS. GDNF, a neurotrophic factor intitially identified as dopaminotrophic, was found to be expressed in several targets of central noradrenergic neurons in the adult rat brain. Grafting of genetically engineered fibroblasts expressing high levels of GDNF prevented >8O% of the 6-hydroxydopamine-induced degeneration of noradrenergic neurons in the LC in vivo. Moreover, GDNF induced a fasciculated sprouting and increased by 2.5-fold both tyrosine hydroxylase levels and the soma size of lesioned LC neurons. These findings reveal a novel and potent neurotrophic activity of GDNF that may have therapeutic applications in neurodegenerative disorders affecting central noradrenergic neurons, such as Alzheimer's, Parkinson's, and Huntington's diseases.			Arenas, E (corresponding author), KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,MOLEC NEUROBIOL LAB,S-17177 STOCKHOLM,SWEDEN.		Arenas, Ernest/AAO-5231-2020	Arenas, Ernest/0000-0003-0197-6577				ARENAS E, 1994, NATURE, V367, P368, DOI 10.1038/367368a0; ARIMA K, 1990, ACTA NEUROPATHOL, V79, P629, DOI 10.1007/BF00294240; BARNES CD, 1991, PROG BRAIN RES, V88, P365; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; CASH R, 1987, NEUROLOGY, V37, P42, DOI 10.1212/WNL.37.1.42; CHANPALAY V, 1989, J COMP NEUROL, V287, P373, DOI 10.1002/cne.902870308; CHANPALAY V, 1991, PROG BRAIN RES, V88, P625; CHUI HC, 1986, ARCH NEUROL-CHICAGO, V43, P991, DOI 10.1001/archneur.1986.00520100013007; DAVIES P, 1976, LANCET, V2, P1403; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FIBIGER HC, 1991, TRENDS NEUROSCI, V14, P220, DOI 10.1016/0166-2236(91)90117-D; FORNO LS, 1966, J NEUROSURG, V24, P266; FRIEDMAN WJ, 1993, EXP NEUROL, V119, P72, DOI 10.1006/exnr.1993.1007; GASPAR P, 1984, ACTA NEUROPATHOL, V64, P43, DOI 10.1007/BF00695605; GASPAR P, 1991, ANN NEUROL, V30, P385; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; HALLIDAY GM, 1990, ANN NEUROL, V27, P373, DOI 10.1002/ana.410270405; HARDY J, 1985, NEUROCHEM INT, V7, P545, DOI 10.1016/0197-0186(85)90050-6; HARLEY C, 1991, PROG BRAIN RES, V88, P307; Hassler R, 1938, J PSYCHOL NEUROL, V48, P387; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hornykiewicz O, 1986, ADV NEUROL, V45, P19; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LOUGHLIN SE, 1985, LOCUS COERULEUS; MANN DMA, 1983, CLIN NEUROPATHOL, V2, P1; MANN DMA, 1983, NEUROPATH APPL NEURO, V9, P3, DOI 10.1111/j.1365-2990.1983.tb00320.x; MARCYNIUK B, 1986, J NEUROL SCI, V76, P335, DOI 10.1016/0022-510X(86)90179-6; MARIEN M, 1993, EUR J PHARMACOL, V236, P487, DOI 10.1016/0014-2999(93)90489-5; MAVRIDIS M, 1991, NEUROSCIENCE, V41, P507, DOI 10.1016/0306-4522(91)90345-O; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PAKKENBERG H., 1965, ACTA NEUROPATHOL, V5, P320; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; SCHNEIDER JS, 1987, NEUROLOGY, V37, P951, DOI 10.1212/WNL.37.6.951; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TOMLINSON BE, 1981, J NEUROL SCI, V49, P419, DOI 10.1016/0022-510X(81)90031-9; TOMONAGA M, 1983, J NEUROL, V230, P231, DOI 10.1007/BF00313699; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZWEIG RM, 1988, ANN NEUROL, V24, P233, DOI 10.1002/ana.410240210; ZWEIG RM, 1993, NEUROLOGY, V43, P986, DOI 10.1212/WNL.43.5.986	51	306	322	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1465	1473		10.1016/0896-6273(95)90024-1	http://dx.doi.org/10.1016/0896-6273(95)90024-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845169	Bronze			2022-12-24	WOS:A1995TL67800024
J	Min, MY; Rusakov, DA; Kullmann, DM				Min, MY; Rusakov, DA; Kullmann, DM			Activation of AMPA, kainate, and metabotropic receptors at hippocampal mossy fiber synapses: Role of glutamate diffusion	NEURON			English	Article							RAT HIPPOCAMPUS; PYRAMIDAL CELLS; DENDRITIC SPINES; NEURONS; MODULATION; RELEASE	Glutamatergic transmission at mossy fiber (MF) synapses on CA3 pyramidal neurons in the hippocampus is mediated by AMPA, kainate, and NMDA receptors and undergoes presynaptic modulation by metabo-tropic glutamate receptors. The recruitment of different receptors has thus far been studied by altering presynaptic stimulation to modulate glutamate release and interfering pharmacologically with receptors and transporters. Here, we introduce two novel experimental manipulations that alter the fate of glutamate molecules following release. First, an enzymatic glutamate scavenger reduces the postsynaptic response as well as presynaptic modulation by metabotropic receptors. At physiological temperature, however, the scavenger is effective only when glutamate uptake is blocked, revealing a role of active transport in both synaptic and extrasynaptic communication. Second, AMPA and kainate receptor-mediated postsynaptic signals are enhanced when extracellular diffusion is retarded by adding dextran to the perfusion solution, as is feedback modulation by metabotropic receptors, suggesting that the receptors are not saturated under baseline conditions. These results show that manipulating the spatiotemporal profile of glutamate following exocytosis can alter the involvement of different receptors in synaptic transmission.	Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England; Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England	University of London; University College London; MRC National Institute for Medical Research	Kullmann, DM (corresponding author), Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.		Rusakov, Dmitri/AAH-4529-2021; Kullmann, Dimitri M/A-3162-2009; Rusakov, Dmitri A/E-1987-2011	Rusakov, Dmitri/0000-0001-9539-9947; Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri A/0000-0001-9539-9947; MIN, MING-YUAN/0000-0003-4211-6725				Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Diamond JS, 1997, J NEUROSCI, V17, P4672; GRIFFITH WH, 1990, J NEUROPHYSIOL, V63, P491, DOI 10.1152/jn.1990.63.3.491; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; MANZONI OJ, 1995, NEUROPHARMACOLOGY, V34, P965, DOI 10.1016/0028-3908(95)00060-J; Mayer M, 1997, NATURE, V389, P542, DOI 10.1038/39177; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; NICHOLSON C, 1993, BIOPHYS J, V65, P2277, DOI 10.1016/S0006-3495(93)81324-9; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OBRIEN RJ, 1986, J NEUROSCI, V6, P3290; Overstreet LS, 1997, NEUROPHARMACOLOGY, V36, P831, DOI 10.1016/S0028-3908(97)00031-2; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; REGEHR WG, 1994, J NEUROSCI, V14, P523; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; Rusakov DA, 1998, NEUROPHARMACOLOGY, V37, P513, DOI 10.1016/S0028-3908(98)00023-9; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SORRA KE, 1993, J NEUROSCI, V13, P3736; Tao L, 1996, NEUROSCIENCE, V75, P839, DOI 10.1016/0306-4522(96)00303-X; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645	38	166	167	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					561	570		10.1016/S0896-6273(00)80566-8	http://dx.doi.org/10.1016/S0896-6273(00)80566-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768842	Bronze			2022-12-24	WOS:000076196400012
J	Luthi, A; McCormick, DA				Luthi, A; McCormick, DA			Periodicity of thalamic synchronized oscillations: The role of Ca2+-mediated upregulation of I-h	NEURON			English	Article							FERRET LATERAL GENICULATE; CAT THALAMOCORTICAL CELLS; ACTIVATED INWARD CURRENT; RELAY NEURONS; INTRACELLULAR CALCIUM; ADENYLYL CYCLASES; NODE CELLS; VITRO; MODULATION; MECHANISMS	Thalamocortical networks can generate both normal and abnormal patterns of synchronized network activity, such as spindle waves and spike-and-wave seizures. These periods of synchronized discharge are often separated by a silent, refractory phase of between 5 and 20 s. In vitro investigations have demonstrated that this refractory period is due in large part to the persistent activation of the hyperpolarization-activated cation current I-h in thalamocortical cells. Here, we show that increases in [Ca2+](i) due to rebound Ca2+ bursts result in persistent activation of I-h resulting from a positive shift in the activation curve of this current. The dynamical upregulation and persistent activation of I-h is the critical determinant of the time course of the refractory period. These findings demonstrate that periodicity in neural network oscillations may be generated through an interaction between the electrophysiological properties and intracellular signaling pathways of the constituent neurons.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA.		Kobelt, Liza/F-5926-2011; Luthi, Anita/ABE-1411-2021; McCormick, David A/J-2649-2015	McCormick, David A/0000-0002-9803-8335; Luthi, Anita/0000-0002-4954-4143				[Anonymous], [No title captured]; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Budde T, 1997, J PHYSIOL-LONDON, V503, P79, DOI 10.1111/j.1469-7793.1997.079bi.x; Contreras D, 1997, J NEUROSCI, V17, P1179; COOPER DMF, 1994, CELL SIGNAL, V6, P823, DOI 10.1016/0898-6568(94)90016-7; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; HAGIWARA N, 1989, J PHYSIOL-LONDON, V409, P121, DOI 10.1113/jphysiol.1989.sp017488; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; JANDO G, 1995, NEUROSCIENCE, V64, P301, DOI 10.1016/0306-4522(94)00329-4; Jones EG, 1985, THALAMUS; KAPLAN JH, 1990, ANNU REV PHYSIOL, V52, P897; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; LANCASTER B, 1994, J PHYSIOL-LONDON, V475, P229, DOI 10.1113/jphysiol.1994.sp020064; Lee KH, 1996, NEURON, V17, P309, DOI 10.1016/S0896-6273(00)80162-2; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Matsuoka I, 1997, J NEUROCHEM, V68, P498; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001; NIEDERMEYER E, 1990, EPILEPSIES DIAGNOSIS; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1992, NEURON, V9, P441, DOI 10.1016/0896-6273(92)90182-D; SCHWINDT PC, 1992, NEUROSCIENCE, V47, P571, DOI 10.1016/0306-4522(92)90166-Y; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS, VI; TERZANO MG, 1985, SLEEP, V8, P137, DOI 10.1093/sleep/8.2.137; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Williams SR, 1997, J PHYSIOL-LONDON, V505, P727, DOI 10.1111/j.1469-7793.1997.727ba.x; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZAZA A, 1991, PFLUG ARCH EUR J PHY, V419, P662, DOI 10.1007/BF00370312; Zhou Q, 1997, J NEUROPHYSIOL, V77, P2816, DOI 10.1152/jn.1997.77.5.2816; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L; ZUFALL F, 1993, P NATL ACAD SCI USA, V90, P9335, DOI 10.1073/pnas.90.20.9335	47	143	146	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1998	20	3					553	563		10.1016/S0896-6273(00)80994-0	http://dx.doi.org/10.1016/S0896-6273(00)80994-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539128	hybrid			2022-12-24	WOS:000072755600019
J	Krupp, JJ; Vissel, B; Heinemann, SF; Westbrook, GL				Krupp, JJ; Vissel, B; Heinemann, SF; Westbrook, GL			N-terminal domains in the NR2 subunit control desensitization of NMDA receptors	NEURON			English	Article							METHYL-D-ASPARTATE; GLYCINE-INSENSITIVE DESENSITIZATION; ACID-BINDING PROTEINS; GLUTAMATE RECEPTORS; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; MUTATIONAL ANALYSIS; AMPA RECEPTOR; CHANNELS; LIGAND	Recent molecular studies of glutamate channels have provided increasingly detailed models of the agonist-binding site and of the channel pore. However, little information is available on the domains involved in channel gating. We examined the molecular determinants for the NR2-subunit specificity of glycine-independent desensitization of NMDA channels using NR2C/NR2A chimeric subunits expressed in HEK 293 cells. We show that glycine-independent desensitization is controlled by N-terminal domains of the NR2 subunit that frank the putative agonist-binding domain: a four amino acid (aa) segment immediately preceding the first transmembrane domain (M1) and a region containing the leucine/isoleucine/valine-binding protein-like (LIVBP-like) domain. Our results provide evidence for a functional role of the region containing the LIVBP-like domain in glutamate receptor channels. We suggest that the pre-M1 segment, presumably situated near the entrance to the pore, serves as a dynamic link between ligand binding and channel gating.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Oregon Health & Science University; Salk Institute	Westbrook, GL (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.			Vissel, Bryce/0000-0001-8860-8050	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046613, R37MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46613] Funding Source: Medline; NINDS NIH HHS [NS28709] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; CHEN J, 1995, BIOPHYS J, V69, P849, DOI 10.1016/S0006-3495(95)79959-3; COLQUHOUN D, 1995, P NATL ACAD SCI USA, V92, P10327, DOI 10.1073/pnas.92.22.10327; Corringer PJ, 1998, J NEUROSCI, V18, P648; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; ISHII T, 1993, J BIOL CHEM, V268, P2836; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MEDINA I, 1995, J PHYSIOL-LONDON, V482, P567, DOI 10.1113/jphysiol.1995.sp020540; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; OH BH, 1993, J BIOL CHEM, V268, P11348; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; OLAH GA, 1993, J BIOL CHEM, V268, P16241; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Paas Y, 1996, NEURON, V17, P979, DOI 10.1016/S0896-6273(00)80228-7; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sutcliffe MJ, 1996, BIOPHYS J, V70, P1575, DOI 10.1016/S0006-3495(96)79724-2; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VAMUM MD, 1997, SCIENCE, V278, P110; WAFFORD KA, 1993, NEUROREPORT, V4, P1347, DOI 10.1097/00001756-199309150-00015; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882	50	139	141	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					317	327		10.1016/S0896-6273(00)80459-6	http://dx.doi.org/10.1016/S0896-6273(00)80459-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491992	Bronze			2022-12-24	WOS:000072154700016
J	Brenowitz, S; David, J; Trussell, L				Brenowitz, S; David, J; Trussell, L			Enhancement of synaptic efficacy by presynaptic GABA(B) receptors	NEURON			English	Article							AVIAN NUCLEUS MAGNOCELLULARIS; COCHLEAR NUCLEUS; NERVE-FIBERS; RELEASE; NEUROTRANSMITTER; TRANSMISSION; POTENTIALS; LAMINARIS; NEURONS; CATS	Activation of presynaptic inhibitory receptors or high-frequency synaptic stimulation normally inhibits excitatory synaptic transmission by reducing transmitter release. We have explored the interactions between these two pathways for reducing synaptic strength and found that for synapses stimulated at high rates, agonists of the GABA, receptor become excitatory and strengthen transmission. At an auditory glutamatergic synapse featuring strong synaptic depression, the GABA(B) agonist baclofen reduced by 90% postsynaptic currents elicited at low frequency. By contrast, synaptic currents elicited at high frequencies were 5-fold larger in baclofen and had a markedly increased likelihood of firing well-timed postsynaptic action potentials. Presynaptic GABA(B) receptors may thus regulate transmitter release to enable sustained transmission at higher stimulus frequencies, thereby extending the dynamic range of neural circuits.	Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Trussell, L (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028901, R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002004] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02004] Funding Source: Medline; NINDS NIH HHS [NS28901] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P193, DOI 10.1113/jphysiol.1978.sp012228; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; JACKSON H, 1985, NEUROSCIENCE, V16, P171, DOI 10.1016/0306-4522(85)90054-5; Konishi M., 1988, AUDITORY FUNCTION NE, P721; LACHICA EA, 1994, J COMP NEUROL, V348, P403, DOI 10.1002/cne.903480307; LEVTOV A, 1992, J PHYSIOL-LONDON, V447, P149, DOI 10.1113/jphysiol.1992.sp018996; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; MANLEY GA, 1985, J COMP PHYSIOL A, V157, P161, DOI 10.1007/BF01350025; Manley GA, 1997, J ACOUST SOC AM, V101, P1560, DOI 10.1121/1.418273; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; ODonovan MJ, 1997, TRENDS NEUROSCI, V20, P431, DOI 10.1016/S0166-2236(97)01124-7; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1996, J NEUROPHYSIOL, V76, P3584, DOI 10.1152/jn.1996.76.5.3584; OTIS TS, 1996, J NEUROSCI, V16, P1633; Pena JL, 1996, J NEUROSCI, V16, P7046; SACHS MB, 1974, J ACOUST SOC AM, V56, P1835, DOI 10.1121/1.1903521; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; STEVENS CF, 1993, NEURON S, V10, P55; TAKEUCHI AKIRA, 1958, JAPANESE JOUR PHYSIOL, V8, P102; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Varela JA, 1997, J NEUROSCI, V17, P7926; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	30	163	163	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1998	20	1					135	141		10.1016/S0896-6273(00)80441-9	http://dx.doi.org/10.1016/S0896-6273(00)80441-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459449	Bronze			2022-12-24	WOS:000071719700016
J	Chen, SM; Wang, QL; Nie, ZQ; Sun, H; Lennon, G; Copeland, NG; Gilbert, DJ; Jenkins, NA; Zack, DJ				Chen, SM; Wang, QL; Nie, ZQ; Sun, H; Lennon, G; Copeland, NG; Gilbert, DJ; Jenkins, NA; Zack, DJ			Crx, a novel Otx-like paired-homeodomain protein, binds to and transactivates photoreceptor cell-specific genes	NEURON			English	Article							ROD RETINAL DYSTROPHY; CIS-ACTING ELEMENT; TISSUE-SPECIFIC EXPRESSION; TRANSCRIPTION FACTOR NRL; HOMEO DOMAIN PROTEIN; RAT OPSIN PROMOTER; TRANSGENIC MICE; UPSTREAM REGION; CHROMOSOME 19Q; MOUSE RETINA	The otd/Otx gene family encodes paired-like homeodomain proteins that are involved in the regulation of anterior head structure and sensory organ development. Using the yeast one-hybrid screen with a bait containing the Ret 4 site from the bovine rhodopsin promoter, we have cloned a new member of the family, Crx (Cone rod homeobox). Crx encodes a 299 amino acid residue protein with a paired-like homeodomain near its N terminus. In the adult, it is expressed predominantly in photoreceptors and pinealocytes. In the developing mouse retina, it is expressed by embryonic day 12.5 (E12.5). Recombinant Crx binds in vitro not only to the Ret 4 site but also to the Ret 1 and BAT-1 sites. In transient transfection studies, Crx transactivates rhodopsin promoter-reporter constructs. Its activity is synergistic with that of Nr1. Crx also binds to and transactivates the genes for several other photoreceptor cell-specific proteins (interphotoreceptor retinoid-binding protein, beta-phosphodiesterase, and arrestin). Human Crx maps to chromosome 19q13.3, the site of a cone rod dystrophy (CORDII). These studies implicate Crx as a potentially important regulator of photoreceptor cell development and gene expression and also identify it as a candidate gene for CORDII and other retinal diseases.	JOHNS HOPKINS UNIV,SCH MED,WILMER INST,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21287; LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,LIVERMORE,CA 94550; NCI,FREDERICK CANC RES & DEV CTR,MAMMALIAN GENET LAB,ABL BASIC RES PROGRAM,FREDERICK,MD 21702	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Lennon, Greg/T-4717-2019	Zack, Don/0000-0002-7966-1973	NEI NIH HHS [F32 EY006614, EY01765, EY09769] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001765, F32EY006614, R01EY009769] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; ADLER R, 1993, INVEST OPHTH VIS SCI, V34, P1677; Ahmad I, 1995, Brain Res Dev Brain Res, V90, P184; AlMaghtheh M, 1996, AM J HUM GENET, V59, P864; Ang SL, 1996, DEVELOPMENT, V122, P243; ARAKI M, 1988, J NEUROCYTOL, V17, P179, DOI 10.1007/BF01674205; BallyCuif L, 1997, BIOESSAYS, V19, P127, DOI 10.1002/bies.950190207; Boatright JH, 1997, EXP EYE RES, V64, P269, DOI 10.1006/exer.1996.0222; BOBOLA N, 1995, J BIOL CHEM, V270, P1289, DOI 10.1074/jbc.270.3.1289; BONCINELLI E, 1995, CURR OPIN GENET DEV, V5, P619, DOI 10.1016/0959-437X(95)80031-X; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; Bosserhoff AK, 1997, DEV DYNAM, V208, P516, DOI 10.1002/(SICI)1097-0177(199704)208:4<516::AID-AJA7>3.0.CO;2-L; Bovolenta P, 1997, J NEUROSCI, V17, P4243; BRMEISTER M, 1996, NAT GENET, V12, P376; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chang JHT, 1997, J NEUROSCI, V17, P5881; CHEN J, 1994, P NATL ACAD SCI USA, V91, P2611, DOI 10.1073/pnas.91.7.2611; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; CHIU MI, 1994, GENOMICS, V21, P440, DOI 10.1006/geno.1994.1292; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DesJardin LE, 1996, INVEST OPHTH VIS SCI, V37, P154; DiPolo A, 1996, INVEST OPHTH VIS SCI, V37, P551; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; EVANS K, 1995, ARCH OPHTHALMOL-CHIC, V113, P195, DOI 10.1001/archopht.1995.01100020079033; FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516; FINKELSTEIN R, 1994, TRENDS GENET, V10, P310, DOI 10.1016/0168-9525(94)90033-7; Freund C, 1996, HUM MOL GENET, V5, P1471, DOI 10.1093/hmg/5.Supplement_1.1471; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; GARCIA E, 1995, GENOMICS, V27, P52, DOI 10.1006/geno.1995.1007; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GREGORY CY, 1994, AM J HUM GENET, V55, P1061; HANES SD, 1991, SCIENCE, V251, P426, DOI 10.1126/science.1671176; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; Kablar B, 1996, MECH DEVELOP, V55, P145, DOI 10.1016/0925-4773(96)00497-2; KIKUCHI T, 1993, MOL CELL BIOL, V13, P4400, DOI 10.1128/MCB.13.7.4400; Kockel L, 1997, GENE DEV, V11, P1140, DOI 10.1101/gad.11.9.1140; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; KUMAR R, 1995, MOL GENETICS OCULAR, P139; Latchman DS, 1996, NEW ENGL J MED, V334, P28, DOI 10.1056/NEJM199601043340108; Lee CHJ, 1996, J NEUROSCI, V16, P6784; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; LIOU GI, 1991, BIOCHEM BIOPH RES CO, V181, P159, DOI 10.1016/S0006-291X(05)81395-6; LIOU GI, 1990, J BIOL CHEM, V265, P8373; LIOU GI, 1994, BIOCHEM BIOPH RES CO, V203, P1875, DOI 10.1006/bbrc.1994.2406; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; LU XP, 1994, MOL ENDOCRINOL, V8, P1774, DOI 10.1210/me.8.12.1774; Mao CA, 1996, DEVELOPMENT, V122, P1489; MAO CA, 1994, DEV BIOL, V165, P229, DOI 10.1006/dbio.1994.1249; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MERCIER P, 1995, INT J DEV BIOL, V39, P559; MORABITO MA, 1991, J BIOL CHEM, V266, P9667; MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3; Nie ZQ, 1996, J BIOL CHEM, V271, P2667, DOI 10.1074/jbc.271.5.2667; OLIVER G, 1977, TTRENDS NEUROSCI, V20, P415; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; ROYET J, 1995, DEVELOPMENT, V121, P3561; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; TREISMAN JE, 1988, MOL CELL BIOL, V8, P1570, DOI 10.1128/MCB.8.4.1570; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; YU X, 1994, J MOL NEUROSCI, V5, P259, DOI 10.1007/BF02736726; Yu X, 1996, J NEUROCHEM, V67, P2494; YU X, 1993, BIOCHEM BIOPH RES CO, V191, P76, DOI 10.1006/bbrc.1993.1186; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4	77	558	567	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1017	1030		10.1016/S0896-6273(00)80394-3	http://dx.doi.org/10.1016/S0896-6273(00)80394-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390516	hybrid			2022-12-24	WOS:A1997YH59400010
J	Finkbeiner, S; Tavazoie, SF; Maloratsky, A; Jacobs, KM; Harris, KM; Greenberg, ME				Finkbeiner, S; Tavazoie, SF; Maloratsky, A; Jacobs, KM; Harris, KM; Greenberg, ME			CREB: A major mediator of neuronal neurotrophin responses	NEURON			English	Article							NERVE-GROWTH-FACTOR; TYROSINE KINASE RECEPTORS; LONG-TERM FACILITATION; TRANSCRIPTION FACTOR-I; C-FOS TRANSCRIPTION; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; PC12 CELLS; HIPPOCAMPAL-NEURONS; MEMBRANE DEPOLARIZATION	Neurotrophins regulate neuronal survival, differentiation, and synaptic function. To understand how neurotrophins elicit such diverse responses, we elucidated signaling pathways by which brain-derived neurotrophic factor (BDNF) activates gene expression in cultured neurons and hippocampal slices. We found, unexpectedly, that the transcription factor cyclic AMP response element-binding protein (CREB) is an important regulator of BDNF-induced gene expression. Exposure of neurons to BDNF stimulates CREB phosphorylation and activation via at least two signaling pathways: by a calcium/calmodulin-dependent kinase IV (CaMKIV)-regulated pathway that is activated by the release of intracellular calcium and by a Ras-dependent pathway. These findings reveal a previously unrecognized, CaMK-dependent mechanism by which neurotrophins activate CREB and suggest that CREB plays a central role in mediating neurotrophin responses in neurons.	CHILDRENS HOSP, DEPT NEUROL, DIV NEUROSCI, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, GRAD PROGRAM NEUROSCI, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School				Harris, Kristen/0000-0002-1943-4744	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033574, K08NS001817, R37NS021184, R01NS021184, R23NS021184] Funding Source: NIH RePORTER; NINDS NIH HHS [K08 NS01817, NS33574, NS21184] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ARENAS E, 1994, NATURE, V367, P368, DOI 10.1038/367368a0; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BAXTER RM, 1995, EUR J BIOCHEM, V234, P84, DOI 10.1111/j.1432-1033.1995.084_c.x; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Blanquet PR, 1997, J BIOL CHEM, V272, P24133, DOI 10.1074/jbc.272.39.24133; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; CHERRINGTON JM, 1989, J VIROL, V63, P1435, DOI 10.1128/JVI.63.3.1435-1440.1989; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DArcangelo G, 1996, MOL CELL BIOL, V16, P4621; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; DIAMOND J, 1992, J NEUROSCI, V12, P1467; DIAMOND J, 1992, J NEUROSCI, V12, P1454; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; DOMENICO B, 1989, NEURON, V2, P1087; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELLIS MJC, 1995, MOL ENDOCRINOL, V9, P255, DOI 10.1210/me.9.2.255; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FANGER GR, 1995, J NEUROSCI, V15, P202; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Gaiddon C, 1996, J NEUROCHEM, V66, P2279; GARBER SS, 1989, J NEUROSCI, V9, P3976; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IP NY, 1993, J NEUROSCI, V13, P3394; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Iwata E, 1996, BBA-MOL CELL RES, V1311, P85, DOI 10.1016/0167-4889(95)00199-9; JENSEN FE, 1989, J NEUROSCI METH, V29, P217, DOI 10.1016/0165-0270(89)90146-5; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, DEVELOPMENT, V109, P845; KOBAYASHI M, 1995, NUCLEIC ACIDS RES, V23, P2848, DOI 10.1093/nar/23.15.2848; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LIU F, 1993, J BIOL CHEM, V268, P6714; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MARSH HN, 1993, J NEUROSCI, V13, P4281; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; NG NFL, 1993, J BIOL CHEM, V268, P25329; NISWENDER KD, 1995, J MICROSC-OXFORD, V180, P109, DOI 10.1111/j.1365-2818.1995.tb03665.x; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; PENDE M, 1994, P NATL ACAD SCI USA, V91, P3215, DOI 10.1073/pnas.91.8.3215; Prakash N, 1996, NATURE, V381, P702, DOI 10.1038/381702a0; RIVERA VM, 1990, GENE DEV, V4, P255, DOI 10.1101/gad.4.2.255; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SNIDER WD, 1988, J NEUROSCI, V8, P2628; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TOLEDOARAL JJ, 1995, NEURON, V14, P607, DOI 10.1016/0896-6273(95)90317-8; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; VAILLANCOURT RR, 1995, MOL CELL BIOL, V15, P3644; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; WIDMER HR, 1993, J NEUROCHEM, V60, P2111, DOI 10.1111/j.1471-4159.1993.tb03496.x; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; ZIRRGIEBEL U, 1995, J NEUROCHEM, V65, P2241	92	727	753	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1997	19	5					1031	1047		10.1016/S0896-6273(00)80395-5	http://dx.doi.org/10.1016/S0896-6273(00)80395-5			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390517	Bronze			2022-12-24	WOS:A1997YH59400011
J	Xu, M; Koeltzow, TE; Santiago, GT; Moratalla, R; Cooper, DC; Hu, XT; White, NM; Graybiel, AM; White, FJ; Tonegawa, S				Xu, M; Koeltzow, TE; Santiago, GT; Moratalla, R; Cooper, DC; Hu, XT; White, NM; Graybiel, AM; White, FJ; Tonegawa, S			Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors	NEURON			English	Article							CONDITIONED PLACE PREFERENCE; RAT NUCLEUS-ACCUMBENS; D-3 RECEPTOR; LOCOMOTOR STIMULATION; MESSENGER-RNA; PLUS-MAZE; AMPHETAMINE; COCAINE; BRAIN; EXPRESSION	The dopamine D3 receptor is expressed primarily in regions of the brain that are thought to influence motivation and motor functions. To specify in vivo D3 receptor function, we generated mutant mice lacking this receptor. Our analysis indicates that in a novel environment, D3 mutant mice are transiently more active than wild-type mice, an effect not associated with anxiety state. Moreover, D3 mutant mice exhibit enhanced behavioral sensitivity to combined injections of D1 and D2 class receptor agonists, cocaine and amphetamine. However, the combined electrophysiological effects of the same D1 and D2 agonists on single neurons within the nucleus accumbens were not altered by the D3 receptor mutation. We conclude that one function of the D3 receptor is to modulate behaviors by inhibiting the cooperative effects of postsynaptic D1 and other D2 class receptors at systems level.	MIT,HOWARD HUGHES MED INST,CTR LEARNING & MEMORY,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; FINCH UNIV HLTH SCI CHICAGO MED SCH,DEPT NEUROSCI,N CHICAGO,IL 60064; MCGILL UNIV,DEPT PSYCHOL,MONTREAL,PQ H3A 1B1,CANADA; MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Chicago Medical School; McGill University; Massachusetts Institute of Technology (MIT)			Moratalla, Rosario V/H-9280-2015	Moratalla, Rosario V/0000-0002-7623-8010; Graybiel, Ann/0000-0002-4326-7720; White, Norman/0000-0002-4616-5252	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004093, R01DA008037, F31DA005794, R37DA004093] Funding Source: NIH RePORTER; NIDA NIH HHS [F31 DA005794, DA08037, DA04093, DA00207] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Accili D, 1996, P NATL ACAD SCI USA, V93, P1945, DOI 10.1073/pnas.93.5.1945; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BECHARA A, 1989, J NEUROSCI, V9, P3400; BENINGER RJ, 1992, J PSYCHOPHARMACOL, V6, P34, DOI 10.1177/026988119200600109; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BURRIS KD, 1995, NEUROPSYCHOPHARMACOL, V12, P335, DOI 10.1016/0893-133X(94)00099-L; CABIB S, 1991, PSYCHOPHARMACOLOGY, V105, P335, DOI 10.1007/BF02244427; CAINE SB, 1993, SCIENCE, V260, P1814, DOI 10.1126/science.8099761; Calabresi P, 1997, J NEUROSCI, V17, P4536; Carr G.D., 1989, NEUROPHARMACOLOGICAL, P264; CARR GD, 1988, PSYCHOPHARMACOLOGY, V94, P221; CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281; CLARK D, 1985, J NEURAL TRANSM, V62, P1, DOI 10.1007/BF01260414; CLARK D, 1987, SYNAPSE, V1, P347, DOI 10.1002/syn.890010408; DALY SA, 1993, NEUROPHARMACOLOGY, V32, P509, DOI 10.1016/0028-3908(93)90177-5; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; DIAZ J, 1995, NEUROSCIENCE, V65, P731, DOI 10.1016/0306-4522(94)00527-C; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; GONZALEZ AM, 1995, EUR J PHARMACOL, V272, pR1, DOI 10.1016/0014-2999(94)00738-S; GRAYBIEL AM, 1989, P NATL ACAD SCI USA, V86, P9020, DOI 10.1073/pnas.86.22.9020; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HIROI N, 1991, J NEUROSCI, V11, P2107; HIROI N, 1991, BRAIN RES, V552, P141, DOI 10.1016/0006-8993(91)90672-I; HOEBEL BG, 1983, PSYCHOPHARMACOLOGY, V81, P158, DOI 10.1007/BF00429012; HU XT, 1988, J NEUROSCI, V8, P4340; HU XT, 1994, SYNAPSE, V17, P43, DOI 10.1002/syn.890170106; Hyman SE, 1996, NEURON, V16, P901, DOI 10.1016/S0896-6273(00)80111-7; JACKSON DM, 1988, PSYCHOPHARMACOLOGY, V95, P433; JACKSON DM, 1986, PSYCHOPHARMACOLOGY, V90, P147; KELSEY JE, 1989, BEHAV NEUROSCI, V103, P1327, DOI 10.1037/0735-7044.103.6.1327; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; LANDWEHRMEYER B, 1993, MOL BRAIN RES, V18, P187, DOI 10.1016/0169-328X(93)90188-U; LARGE CH, 1994, TRENDS PHARMACOL SCI, V15, P46, DOI 10.1016/0165-6147(94)90108-2; LAVIOLA G, 1994, BEHAV NEUROSCI, V108, P514; LEMOAL M, 1991, PHYSIOL REV, V71, P155, DOI 10.1152/physrev.1991.71.1.155; LeMoine C, 1996, NEUROSCIENCE, V73, P131, DOI 10.1016/0306-4522(96)00029-2; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; MACKEY WB, 1985, PHARMACOL BIOCHEM BE, V22, P101, DOI 10.1016/0091-3057(85)90492-7; MARKOU A, 1993, PSYCHOPHARMACOLOGY, V112, P163, DOI 10.1007/BF02244907; MURRAY AM, 1994, P NATL ACAD SCI USA, V91, P11271, DOI 10.1073/pnas.91.23.11271; OLDS ME, 1982, BRAIN RES, V237, P429, DOI 10.1016/0006-8993(82)90454-1; OLDS ME, 1979, BRAIN RES, V168, P351, DOI 10.1016/0006-8993(79)90175-6; Parsons LH, 1996, J NEUROCHEM, V67, P1078; Pickens R, 1971, STIMULUS PROPERTIES, P172; REICHER MA, 1977, ANIM LEARN BEHAV, V5, P343, DOI 10.3758/BF03209576; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P93; Sautel F, 1995, J PHARMACOL EXP THER, V275, P1239; SCHECHTER MD, 1993, NEUROSCI BIOBEHAV R, V17, P21, DOI 10.1016/S0149-7634(05)80228-3; Schotte A, 1996, HISTOCHEM J, V28, P791, DOI 10.1007/BF02272152; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SVENSSON K, 1994, J NEURAL TRANSM-GEN, V95, P71, DOI 10.1007/BF01283032; SVENSSON K, 1994, EUR J PHARMACOL, V263, P235, DOI 10.1016/0014-2999(94)90718-8; TELLA SR, 1994, PHARMACOL BIOCHEM BE, V48, P151, DOI 10.1016/0091-3057(94)90511-8; WADDINGTON JL, 1993, D1 D2 DOPAMINE RECEP, P51; WALTERS JR, 1987, SCIENCE, V236, P719; WATERS N, 1994, J NEURAL TRANSM-GEN, V98, P39, DOI 10.1007/BF01277593; WATERS N, 1993, J NEURAL TRANSM-GEN, V94, P11, DOI 10.1007/BF01244979; WHITE FJ, 1986, J NEUROSCI, V6, P274; WHITE FJ, 1988, PHARMACOL BIOCHEM BE, V30, P189, DOI 10.1016/0091-3057(88)90442-X; WHITE FJ, 1993, J PHARMACOL EXP THER, V266, P1075; WHITE FJ, 1993, D1 D2 DOPAMINE RECEP, P79; White N. M., 1987, METHODS MEASURING RE, P591; WHITE NM, 1989, LIFE SCI, V45, P1943, DOI 10.1016/0024-3205(89)90569-9; WHITE NM, 1991, PSYCHOPHARMACOLOGY, V103, P271, DOI 10.1007/BF02244216; WHITE NM, 1985, PHARMACOL BIOCHEM BE, V23, P37, DOI 10.1016/0091-3057(85)90127-3; WHITE NM, 1992, ANNU REV PSYCHOL, V43, P443; WHITE NM, 1993, SEMIN NEUROSCI, V5, P329; Xu M, 1996, ANN NY ACAD SCI, V801, P51, DOI 10.1111/j.1749-6632.1996.tb17431.x; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; ZAHM DS, 1992, NEUROSCIENCE, V50, P751, DOI 10.1016/0306-4522(92)90202-D	76	275	286	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					837	848		10.1016/S0896-6273(00)80965-4	http://dx.doi.org/10.1016/S0896-6273(00)80965-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354330	Bronze			2022-12-24	WOS:A1997YD18900011
J	Cabelli, RJ; Shelton, DL; Segal, RA; Shatz, CJ				Cabelli, RJ; Shelton, DL; Segal, RA; Shatz, CJ			Blockade of endogenous ligands of trkB inhibits formation of ocular dominance columns	NEURON			English	Article							DEVELOPING NEUROMUSCULAR SYNAPSES; DEVELOPING VISUAL-CORTEX; NERVE GROWTH-FACTOR; MONOCULAR DEPRIVATION; NEUROTROPHIC FACTOR; CORTICAL-NEURONS; STRIATE CORTEX; BDNF; NGF; PLASTICITY	We have examined the hypothesis that the segregation of LGN axon terminals into ocular dominance (OD) patches in layer 4 of the visual cortex requires neurotrophins, acting as signals to modulate the pattern of synaptic connectivity. Neurotrophin receptor antagonists, composed of the extracellular domain of each member of the trk family of neurotrophin receptors fused to a human Fc domain, were infused directly into visual cortex during the peak phase of OD column formation. Infusion of trkB-IgG, which binds BDNF and NT-4/5, inhibited the formation of OD patches within layer 4, while trkA-IgG and trkC-IgG, which preferentially bind NGF and NT-3, respectively, had no effect. The autoradiographic labeling of LGN terminals in cortical layer 4 was reduced by trkB-IgG, in contrast with the increased labeling observed following NT-4/5 infusion. These data suggest that an endogenous ligand of trkB, normally present in limiting amounts within visual cortex, is necessary for the selective growth and remodeling of LGN axons into eye-specific patches.	UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT CELL & MOL BIOL,BERKELEY,CA 94720	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Cabelli, RJ (corresponding author), UNIV SO CALIF,SCH MED,DEPT CELL & NEUROBIOL,DOHENY EYE INST,MARY D ALLEN LAB VIS RES,LOS ANGELES,CA 90033, USA.				NATIONAL EYE INSTITUTE [R01EY002858, R37EY002858] Funding Source: NIH RePORTER; NEI NIH HHS [EY02858] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ANTONINI A, 1993, J NEUROSCI, V13, P3549; Antonini A, 1996, J COMP NEUROL, V369, P64; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; ARMANINI MP, 1995, EUR J NEUROSCI, V7, P1403, DOI 10.1111/j.1460-9568.1995.tb01132.x; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Cabelli RJ, 1996, J NEUROSCI, V16, P7965; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cellerino A, 1996, EUR J NEUROSCI, V8, P1190, DOI 10.1111/j.1460-9568.1996.tb01287.x; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; COHENCORY S, 1991, J NEUROSCI, V11, P462; DIAMOND J, 1992, J NEUROSCI, V12, P1454; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; FERRER I, 1992, PROG NEUROBIOL, V39, P1, DOI 10.1016/0301-0082(92)90029-E; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; GAESE F, 1994, DEVELOPMENT, V120, P1613; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JOHNSON J, 1994, CURR BIOL, V4, P662, DOI 10.1016/S0960-9822(00)00149-4; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVINE ES, 1995, J NEUROSCI, V15, P3084; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCDONALD NQ, 1995, J BIOL CHEM, V270, P19669, DOI 10.1074/jbc.270.34.19669; MCMAHON SB, 1995, NAT MED, V1, P774, DOI 10.1038/nm0895-774; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Strohmaier C, 1996, EMBO J, V15, P3332, DOI 10.1002/j.1460-2075.1996.tb00698.x; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; VANSLUYTERS RC, 1980, J NEUROPHYSIOL, V43, P686, DOI 10.1152/jn.1980.43.3.686; WANG T, 1995, J NEUROSCI, V15, P4796; WILLIAMS RW, 1988, J COMP NEUROL, V272, P424, DOI 10.1002/cne.902720310	52	256	260	2	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					63	76		10.1016/S0896-6273(00)80348-7	http://dx.doi.org/10.1016/S0896-6273(00)80348-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247264	Bronze			2022-12-24	WOS:A1997XN39400007
J	Tang, YG; Zucker, RS				Tang, YG; Zucker, RS			Mitochondrial involvement in post-tetanic potentiation of synaptic transmission	NEURON			English	Article							INTRACELLULAR CALCIUM STORES; BULLFROG SYMPATHETIC NEURONS; MOTOR-NERVE TERMINALS; ROOT GANGLION NEURONS; SENSITIVE CA2+ STORE; TRANSMITTER RELEASE; POSTTETANIC POTENTIATION; CELLS; ACCUMULATION; HOMEOSTASIS	Posttetanic potentiation (PTP) is an essential aspect of synaptic transmission that arises from a persistent presynaptic [Ca2+](i) following tetanic stimulation. At crayfish neuromuscular junctions, several inhibitors of mitochondrial Ca2+ uptake and release (tetraphenylphosphonium or TPP+, carbonyl cyanide m-chlorophenylhydrazone or CCCP, and ruthenium red) blocked PTP and the persistence of presynaptic residual [Ca2+](i), while endoplasmic reticulum (ER) Ca2+ pump inhibitors and release channel activators (thapsigargin, 2,5-di-(tert-butyl)-1,4-benzohydroquinone or BHQ, and caffeine) had no effects. PTP apparently results from the slow efflux of tetanically accumulated mitochondrial Ca2+.			Tang, YG (corresponding author), UNIV CALIF BERKELEY,DIV NEUROBIOL,BERKELEY,CA 94720, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343	NINDS NIH HHS [NS 15114] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIUCHI T, 1985, BIOCHIM BIOPHYS ACTA, V843, P20, DOI 10.1016/0304-4165(85)90044-3; ALBALDAWI NF, 1993, J PHYSIOL-LONDON, V461, P633, DOI 10.1113/jphysiol.1993.sp019533; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; ALNAES E, 1975, J PHYSIOL-LONDON, V248, P285, DOI 10.1113/jphysiol.1975.sp010974; Atluri PP, 1996, J NEUROSCI, V16, P5661; BLAUSTEIN MP, 1978, J GEN PHYSIOL, V72, P43, DOI 10.1085/jgp.72.1.43; Brain KL, 1995, J PHYSIOL-LONDON, V489, P637, DOI 10.1113/jphysiol.1995.sp021079; BRINLEY FJ, 1978, ANNU REV BIOPHYS BIO, V7, P363, DOI 10.1146/annurev.bb.07.060178.002051; BRORSON JR, 1991, J NEUROSCI, V11, P4024; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELANEY KR, 1994, J NEUROSCI, V14, P5885; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; FISHER SA, 1997, IN PRESS TRENDS NEUR; FOSSIER P, 1994, NEUROSCIENCE, V63, P405, DOI 10.1016/0306-4522(94)90538-X; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; FRIEL DD, 1994, J NEUROSCI, V14, P4007; Grohovaz F, 1996, P NATL ACAD SCI USA, V93, P4799, DOI 10.1073/pnas.93.10.4799; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HEYTLER PG, 1962, BIOCHEM BIOPH RES CO, V7, P272, DOI 10.1016/0006-291X(62)90189-4; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; HUA SY, 1993, J PHYSIOL-LONDON, V464, P245, DOI 10.1113/jphysiol.1993.sp019633; IRVING AJ, 1992, J PHYSIOL-LONDON, V456, P667, DOI 10.1113/jphysiol.1992.sp019360; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KANO M, 1995, J PHYSIOL-LONDON, V487, P1; KARADJOV JS, 1986, CELL CALCIUM, V7, P115, DOI 10.1016/0143-4160(86)90014-X; KOBAYASHI K, 1995, J PHYSIOL-LONDON, V482, P7, DOI 10.1113/jphysiol.1995.sp020495; LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P5656, DOI 10.1073/pnas.86.14.5656; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MCBURNEY RN, 1987, TRENDS NEUROSCI, V10, P164, DOI 10.1016/0166-2236(87)90042-7; MCGRAW CF, 1980, J CELL BIOL, V85, P228, DOI 10.1083/jcb.85.2.228; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; MOLGO J, 1988, NEUROSCIENCE, V24, P695, DOI 10.1016/0306-4522(88)90362-4; MULKEY RM, 1992, J NEUROSCI, V12, P4327; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; RASGADOFLORES H, 1987, AM J PHYSIOL, V252, pC588, DOI 10.1152/ajpcell.1987.252.6.C588; REBER BFX, 1991, J PHYSIOL-LONDON, V435, P145, DOI 10.1113/jphysiol.1991.sp018502; REBER BFX, 1993, J PHYSIOL-LONDON, V468, P711, DOI 10.1113/jphysiol.1993.sp019796; REGEHR WG, 1994, J NEUROSCI, V14, P523; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; SMITH SJ, 1980, J PHYSIOL-LONDON, V300, P167, DOI 10.1113/jphysiol.1980.sp013157; STUENKEL EL, 1994, J PHYSIOL-LONDON, V481, P251, DOI 10.1113/jphysiol.1994.sp020436; Tank DW, 1995, J NEUROSCI, V15, P7940; TARASKEVICH PS, 1971, BIOCHIM BIOPHYS ACTA, V241, P700, DOI 10.1016/0005-2736(71)90071-X; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; Trudeau LE, 1996, J NEUROSCI, V16, P46; TSE A, 1994, J PHYSIOL-LONDON, V477, P511, DOI 10.1113/jphysiol.1994.sp020212; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WANG GJ, 1994, J NEUROPHYSIOL, V72, P2563, DOI 10.1152/jn.1994.72.6.2563; WEBER A, 1968, J GEN PHYSIOL, V52, P750, DOI 10.1085/jgp.52.5.750; WERTH JL, 1994, J NEUROSCI, V14, P348; WHITE RJ, 1995, J NEUROSCI, V15, P1318; WINGROVE DE, 1986, J BIOL CHEM, V261, P5166; ZUCKER RS, 1986, J PHYSIOL-PARIS, V81, P237; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; ZUCKER RS, 1974, J PHYSIOL-LONDON, V241, P91, DOI 10.1113/jphysiol.1974.sp010642; ZUCKER RS, 1986, SCIENCE, V231, P574, DOI 10.1126/science.2868525	63	336	340	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					483	491		10.1016/S0896-6273(00)81248-9	http://dx.doi.org/10.1016/S0896-6273(00)81248-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115741	Bronze			2022-12-24	WOS:A1997WQ07400015
J	Qian, XM; Davis, AA; Goderie, SK; Temple, S				Qian, XM; Davis, AA; Goderie, SK; Temple, S			FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; NEURAL PRECURSOR CELLS; CENTRAL-NERVOUS-SYSTEM; RAT CEREBRAL-CORTEX; FACTOR RECEPTORS; FATE; DIFFERENTIATION; NEUROGENESIS; LOCALIZATION; EXPRESSION	The embryonic cerebral cortex contains a population of stem-like founder cells capable of generating large, mixed clones of neurons and glia in vitro. We report that the default state of early cortical stem cells is neuronal, and that stem cells are heterogeneous in the number of neurons that they generate. In low fibroblast growth factor (FGF2) concentrations, most maintain this specification, generating solely neuronal progeny. Oligodendroglial production within these clones is stimulated by a higher, threshold level of FGF2, and astrocyte production requires additional environmental factors. Because most cortical neurons are born before glia in vivo, these data support a model in which the scheduled production of cortical cells involves an intrinsic neuronal program in the early stem cells and exposure to environmental, glia-inducing signals.			Qian, XM (corresponding author), ALBANY MED COLL, DEPT PHARMACOL & NEUROSCI, A-136, ALBANY, NY 12208 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033529] Funding Source: NIH RePORTER; NINDS NIH HHS [NIH RO1 NS 33529] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1960, NATURE, V192, P129; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; Bayer S.A., 1991, NEOCORTICAL DEV; BRICKMAN YG, 1995, J BIOL CHEM, V270, P24941, DOI 10.1074/jbc.270.42.24941; Calof Anne L., 1995, Current Opinion in Neurobiology, V5, P19, DOI 10.1016/0959-4388(95)80082-4; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; Florkiewicz RZ, 1991, GROWTH FACTORS, V4, P265, DOI 10.3109/08977199109043912; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; GHOSH A, 1995, NEURON, V15, P1; GIORDANO S, 1992, DEV BIOL, V152, P293, DOI 10.1016/0012-1606(92)90136-5; Gritti A, 1996, J NEUROSCI, V16, P1091; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HOLZTER H, 1978, STEM CELLS HEMOSTASI, P2; HOSOYA T, 1995, CELL, V82, P17025; Jacobson M., 1991, DEV NEUROBIOLOGY; JAN YN, 1995, NEURON, V14, P1; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; KILPATRICK TJ, 1995, MOL CELL NEUROSCI, V6, P2, DOI 10.1006/mcne.1995.1002; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; POWELL PP, 1991, MOL BRAIN RES, V11, P71, DOI 10.1016/0169-328X(91)90023-Q; REH TA, 1994, PERSPECT DEV NEUROBI, V2, P183; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; RENKO M, 1990, J CELL PHYSIOL, V144, P108, DOI 10.1002/jcp.1041440114; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SHAOUL E, 1995, ONCOGENE, V10, P1553; Slack J, 1983, EGG EMBRYO; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; TEMPLE S, 1994, DEVELOPMENT, V120, P999; TEMPLE S, 1995, NEURON, V15, P249, DOI 10.1016/0896-6273(95)90030-6; Temple S, 1996, CURR OPIN NEUROBIOL, V6, P11, DOI 10.1016/S0959-4388(96)80003-1; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; WEISE B, 1993, J NEUROSCI RES, V34, P442, DOI 10.1002/jnr.490340409; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; YAMAGUCHI TP, 1992, DEV BIOL, V152, P75, DOI 10.1016/0012-1606(92)90157-C	50	369	416	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					81	93		10.1016/S0896-6273(01)80048-9	http://dx.doi.org/10.1016/S0896-6273(01)80048-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010207	Bronze			2022-12-24	WOS:A1997WE71800010
J	Emerling, DE; Lander, AD				Emerling, DE; Lander, AD			Inhibitors and promoters of thalamic neuron adhesion and outgrowth in embryonic neocortex: Functional association with chondroitin sulfate	NEURON			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; CELL-ADHESION; GROWTH-FACTORS; CHICK-EMBRYO; PROTEOGLYCAN; GLYCOSAMINOGLYCANS; AXONS; BRAIN	When embryonic thalamic neurons are plated onto living slices of mouse forebrain, cell attachment and neurite outgrowth on different layers of the developing cerebral cortex vary dramatically, in ways that correlate with the timing and pattern of thalamocortical innervation. These layer-specific differences can be eliminated from embryonic day 16 slices by enzymatic removal of chondroitin sulfate (CS). The cortical plate (a zone avoided by thalamic axons in vivo) possesses inhibitory activity (anti-adhesive, neurite repelling) and the intermediate zone and subplate (in which thalamic axons normally grow) possess stimulatory activity (adhesive, neurite promoting), both of which are chondroitinase sensitive. These opposing activities appear not to reflect the presence of different CS proteoglycans (CSPGs) in different zones, but rather the presence of differentially localized CS-binding molecules, which can be competed away by soluble CS. This model reconciles conflicting reports on the actions of CSPGs in neural development, and suggests a role for CSPGs in the organization of matrix-bound cues in the brain.	UNIV CALIF IRVINE,DEPT DEV & CELL BIOL,IRVINE,CA 92697; UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92697	University of California System; University of California Irvine; University of California System; University of California Irvine	Emerling, DE (corresponding author), MIT,DEPT BRAIN & COGNIT SCI,E25-618,CAMBRIDGE,MA 02139, USA.		Lander, Arthur/L-2827-2019; Lander, Arthur D/C-9008-2011	Lander, Arthur/0000-0002-4380-5525; Lander, Arthur D/0000-0002-4380-5525	NINDS NIH HHS [NS26862] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026862] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; BARNEA G, 1994, J BIOL CHEM, V269, P14349; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; BRITTIS PA, 1994, P NATL ACAD SCI USA, V91, P7539, DOI 10.1073/pnas.91.16.7539; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; CARBONETTO S, 1983, J NEUROSCI, V3, P2324; CATALANO SM, 1996, J COMP NEUROL, V366, P36; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CRANDALL JE, 1984, DEV BRAIN RES, V14, P185, DOI 10.1016/0165-3806(84)90305-5; DOU CL, 1994, J NEUROSCI, V14, P7616; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; EMERLING DE, 1994, DEVELOPMENT, V120, P2811; Engel M, 1996, J COMP NEUROL, V366, P34; FAISSNER A, 1995, GLIA, V13, P233, DOI 10.1002/glia.440130402; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FERNAUDESPINOSA I, 1994, J CELL SCI, V107, P1437; FICHARD A, 1991, DEV BIOL, V148, P1, DOI 10.1016/0012-1606(91)90312-Q; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; GREEN SJ, 1988, J CELL SCI, V90, P145; GRUMET M, 1994, J BIOL CHEM, V269, P12142; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; HERNDON ME, 1996, THESIS MIT CAMBRIDGE; IIJIMA N, 1991, J NEUROCHEM, V56, P706, DOI 10.1111/j.1471-4159.1991.tb08207.x; IWATA M, 1993, J BIOL CHEM, V268, P15061; KITAMURA K, 1987, DEVELOPMENT, V100, P501; Klagsbrun M, 1992, Semin Cancer Biol, V3, P81; LAFONT F, 1992, DEVELOPMENT, V114, P17; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; Lander Arthur D., 1993, P341; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; LITWACK ED, 1994, J NEUROSCI, V14, P3713; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; Maeda N, 1996, DEVELOPMENT, V122, P647; MARGOLIS RK, 1975, BIOCHEMISTRY-US, V14, P4797, DOI 10.1021/bi00693a004; MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014; MCADAMS BD, 1995, J COMP NEUROL, V352, P594, DOI 10.1002/cne.903520408; MeyerPuttlitz B, 1996, J COMP NEUROL, V366, P44, DOI 10.1002/(SICI)1096-9861(19960226)366:1<44::AID-CNE4>3.0.CO;2-K; MILLER B, 1995, J COMP NEUROL, V355, P615, DOI 10.1002/cne.903550410; MOSCATELLI D, 1992, J BIOL CHEM, V267, P25803; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PERRIS R, 1991, DEVELOPMENT, V111, P583; PERRIS R, 1987, J CELL BIOL, V105, P2511, DOI 10.1083/jcb.105.6.2511; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; RAUCH U, 1992, J BIOL CHEM, V267, P19536; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; SHEPPARD AM, 1991, J NEUROSCI, V11, P3928; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; SNOW DM, 1991, DEVELOPMENT, V113, P1473; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; Toole BP, 1976, NEURONAL RECOGNITION, P275; TUTTLE R, 1995, J NEUROSCI, V15, P3039; VERNA JM, 1989, INT J DEV NEUROSCI, V7, P389, DOI 10.1016/0736-5748(89)90060-9; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; YAGINUMA H, 1991, J NEUROSCI, V11, P2598; YAMADA H, 1994, J BIOL CHEM, V269, P10119; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	65	111	116	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1089	1100		10.1016/S0896-6273(00)80242-1	http://dx.doi.org/10.1016/S0896-6273(00)80242-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982158	Green Published, Bronze			2022-12-24	WOS:A1996WA24800008
J	Saez, L; Young, MW				Saez, L; Young, MW			Regulation of nuclear entry of the Drosophila clock proteins period and timeless	NEURON			English	Article							CIRCADIAN CLOCK; GENE-PRODUCT; BIOLOGICAL CLOCK; VISUAL-SYSTEM; MUTANTS; EXPRESSION; MELANOGASTER; MUTATION; CLONING; RHYTHMS	Two genes, period (per) and timeless (tim), are essential for circadian rhythmicity in drosophila. The encoded proteins (PER and TIM) physically interact. Here, it is shown that TIM and PER accumulate in the cytoplasm when independently expressed in cultured (S2) Drosophila cells. However, the proteins move to the nuclei of these cells if coexpressed. Domains of PER and TIM have been identified that block nuclear localization of the monomeric proteins. In vitro protein interaction studies indicate that the sequence inhibiting the nuclear accumulation of PER forms a binding site for TIM. The results indicate a mechanism for controlled nuclear localization in which suppression of cytoplasmic localization is accomplished by direct interaction of PER and TIM. No other clock functions are required for nuclear localization. The findings suggest that a checkpoint in the circadian cycle is established by requiring cytoplasmic assembly of a PEW TIM complex as a condition for nuclear transport of either protein.	ROCKEFELLER UNIV,GENET LAB,NEW YORK,NY 10021	Rockefeller University	Saez, L (corresponding author), ROCKEFELLER UNIV,NATL SCI FDN,SCI & TECHNOL CTR BIOL TIMING,HOWARD HUGHES MED INST,1230 YORK AVE,NEW YORK,NY 10021, USA.		, 机智的马小跳和机智的羊不愁/ABC-5169-2020					BARGIELLO TA, 1984, P NATL ACAD SCI-BIOL, V81, P2142, DOI 10.1073/pnas.81.7.2142; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BAYLIES MK, 1993, MOL GENETICS BIOL RH, P123; BRUCE VG, 1972, GENETICS, V70, P537; CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; Edmunds LN, 1988, CELLULAR MOL BASES B; FELDMAN J F, 1973, Genetics, V75, P605; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; ISODA K, 1992, GENE DEV, V6, P619, DOI 10.1101/gad.6.4.619; KAY SA, 1995, CELL, V83, P361, DOI 10.1016/0092-8674(95)90113-2; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LI XX, 1994, J CELL BIOL, V124, P7, DOI 10.1083/jcb.124.1.7; LIU X, 1992, J NEUROSCI, V12, P2735; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; PINES J, 1994, EMBO J, V13, P3777; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; REDDY P, 1984, CELL, V38, P701, DOI 10.1016/0092-8674(84)90265-4; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; RIO DC, 1986, CELL, V44, P21, DOI 10.1016/0092-8674(86)90481-2; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Thummel CS, 1992, DROS INF SERV, V71, P150; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; VOSSHALL LB, 1993, THESIS ROCKEFELLER U; YOUNG MW, 1996, IN PRESS COLD SPRING, V61; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZERR DM, 1990, J NEUROSCI, V10, P2749	44	255	261	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					911	920		10.1016/S0896-6273(00)80222-6	http://dx.doi.org/10.1016/S0896-6273(00)80222-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938123	Bronze			2022-12-24	WOS:A1996VV15100013
J	Schuster, CM; Davis, GW; Fetter, RD; Goodman, CS				Schuster, CM; Davis, GW; Fetter, RD; Goodman, CS			Genetic dissection of structural and functional components of synaptic plasticity .1. Fasciclin II controls synaptic stabilization and growth	NEURON			English	Article							CELL-ADHESION MOLECULE; CONE GUIDANCE; IMMUNOGLOBULIN SUPERFAMILY; NEURONAL RECOGNITION; DROSOPHILA MUTANTS; LIVING MICE; APLYSIA; EXPRESSION; SYNAPSES; PROTEIN	The glutamatergic neuromuscular synapse in Drosophila forms and differentiates into distinct boutons in the embryo and grows by sprouting new boutons throughout larval life. We demonstrate that two axons form similar to 18 boutons on muscles 7 and 6 by hatching and grow to similar to 180 boutons by third instar. We further show that, after synapse formation, the homophilic cell adhesion molecule Fasciclin II (Fas II) is localized both pre- and postsynaptically where it controls synapse stabilization. In FasII null mutants, synapse formation is normal, but boutons then retract during larval development. Synapse elimination and resulting lethality are rescued by transgenes that drive Fas II expression both pre- and postsynaptically; driving Fas II expression on either side alone is insufficient. Fas II can also control synaptic growth; various FasII alleles lead to either an increase or decrease in sprouting, depending upon the level of Fas II.			Schuster, CM (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOL & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1989, J NEUROBIOL, V20, P356, DOI 10.1002/neu.480200508; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BEYER WH, 1987, CRC HDB MATH SCI, P162; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P144; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Dan Yang, 1994, Current Opinion in Neurobiology, V4, P95, DOI 10.1016/0959-4388(94)90037-X; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; FIELDS DR, 1996, IN PRESS TRENDS NEUR; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; GUAN B, 1996, CURR OPIN NEUROBIOL, V6, P697; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; LICHTMAN JW, 1990, J NEUROBIOL, V21, P99, DOI 10.1002/neu.480210107; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUTHL A, 1994, NATURE, V327, P777; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1986, J NEUROSCI, V6, P1051; Stewart BA, 1996, J NEUROSCI, V16, P3877; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; ZHONG Y, 1995, J NEUROSCI, V15, P6679; ZHONG Y, 1992, J NEUROSCI, V12, P644; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	39	365	370	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					641	654		10.1016/S0896-6273(00)80197-X	http://dx.doi.org/10.1016/S0896-6273(00)80197-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893022	Bronze			2022-12-24	WOS:A1996VP74300010
J	Chen, ML; Hoshi, T; Wu, CF				Chen, ML; Hoshi, T; Wu, CF			Heteromultimeric interactions among K+ channel subunits from Shaker and eag families in Xenopus oocytes	NEURON			English	Article							VOLTAGE-CLAMP ANALYSIS; POTASSIUM-CHANNEL; MOLECULAR MECHANISMS; DROSOPHILA-EAG; INACTIVATION; CURRENTS; LOCUS; MUTATIONS; MUTANTS; MUSCLE	Heteromultimeric interactions of K+ channel subunits across different families have been thought to contribute to the functional diversity of ionic currents, as suggested by previous genetic evidence. We present here direct demonstration in Xenopus oocytes that subunits from distinct eag and Shaker families functionally interact, most likely as heteromultimeric channels. Coexpression with eag accelerates the inactivation and slows the recovery from inactivation of the transient Shaker current. Site-directed mutagenesis indicates that the eag carboxyl terminus is crucial for this interaction, exerting effects preferentially on N-type inactivation. Many members of the eag and Shaker families have now been identified and their human homologs implicated in cardiac and neurological disorders. Studies on channel subunit interactions may prove important in understanding the disease pattern and the complex functions of the brain.	UNIV IOWA, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA	University of Iowa	Chen, ML (corresponding author), UNIV IOWA, DEPT BIOL SCI, IOWA CITY, IA 52242 USA.			Wu, Chun-Fang/0000-0002-4973-2021				ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HAUGLAND FN, 1990, J NEUROSCI, V10, P1357; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SINGH S, 1989, NEURON, V2, P1325, DOI 10.1016/0896-6273(89)90070-6; Tsui L C, 1991, Adv Hum Genet, V20, P153; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wu C F, 1995, Chin J Physiol, V38, P131; Wu C F, 1992, Ion Channels, V3, P261; WU CF, 1985, J NEUROSCI, V5, P2626; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; WU CF, 1986, ION CHANNELS NEURAL, P407; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZHONG Y, 1993, J NEUROSCI, V13, P4669; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864	42	42	43	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					535	542		10.1016/S0896-6273(00)80185-3	http://dx.doi.org/10.1016/S0896-6273(00)80185-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816716	Bronze			2022-12-24	WOS:A1996VJ44000019
J	Campbell, K; Olsson, M; Bjorklund, A				Campbell, K; Olsson, M; Bjorklund, A			Regional incorporation and site-specific differentiation of striatal precursors transplanted to the embryonic forebrain ventricle	NEURON			English	Article							CHOLINE-ACETYLTRANSFERASE; RESTRICTED EXPRESSION; CORTICAL-NEURONS; RAT NEOSTRIATUM; BASAL GANGLIA; GLIAL-CELLS; MIGRATION; GENE; PARVALBUMIN; ASTROCYTES	The developmental potential of neural progenitors derived from the E13.5-E14 lateral or medial ganglionic eminences (LGE and MGE, respectively) or the E12 ventral mesencephalon (VM) was examined in a cross-species transplantation model. After injection into the E15 rat forebrain ventricle, mouse LGE progenitors (unlike those of the MGE or VM) were consistently integrated into the host striatum, expressing neurochemical phenotypes and axonal projections characteristic of striatal projection neurons. Additionally, both LGE and MGE precursors displayed widespread incorporation into distinct forebrain and midbrain structures, whereas the more caudally derived VM cells were largely confined to midbrain structures. These results suggest that many LGE precursors are positionally specified for striatal incorporation, while a portion also possess greater potential reflected in more widespread integration following intraventricular injection.	LUND UNIV,DEPT MED CELL RES,S-22362 LUND,SWEDEN	Lund University			Björklund, Anders/ABA-1326-2020; Campbell, Kenneth/ABC-3570-2021	Bjorklund, Anders/0000-0002-5676-6203	NINDS NIH HHS [NS 06701] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKLIN SE, 1993, DEVELOPMENT, V118, P175; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ANDERSON KD, 1991, BRAIN RES, V568, P235, DOI 10.1016/0006-8993(91)91403-N; BARBE MF, 1991, J NEUROSCI, V11, P519; BATCHELOR PE, 1989, J COMP NEUROL, V284, P187, DOI 10.1002/cne.902840204; BAYER SA, 1984, INT J DEV NEUROSCI, V2, P163, DOI 10.1016/0736-5748(84)90008-X; BULFONE A, 1993, J NEUROSCI, V13, P3155; CAMPBELL K, 1995, NEUROSCIENCE, V64, P17, DOI 10.1016/0306-4522(94)00412-X; CATTANEO E, 1994, DEV BRAIN RES, V83, P197, DOI 10.1016/0165-3806(94)00137-5; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; COWAN RL, 1990, J COMP NEUROL, V302, P197, DOI 10.1002/cne.903020202; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; DEACON TW, 1994, EXP NEUROL, V130, P151, DOI 10.1006/exnr.1994.1194; EHRLICH ME, 1990, DEV BRAIN RES, V54, P257, DOI 10.1016/0165-3806(90)90148-R; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; FISHELL G, 1995, DEVELOPMENT, V121, P803; GERFEN CR, 1985, P NATL ACAD SCI USA, V82, P8780, DOI 10.1073/pnas.82.24.8780; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; GOTZ M, 1996, IN PRESS NEURON; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; KISS J, 1990, NEUROSCIENCE, V36, P61, DOI 10.1016/0306-4522(90)90351-4; LAGENAUR C, 1981, J SUPRAMOL STR CELL, V15, P335, DOI 10.1002/jsscb.1981.380150404; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LAMMERS GJ, 1980, ANAT EMBRYOL, V158, P193, DOI 10.1007/BF00315906; LUND RD, 1989, TRANSPLANT P, V21, P3174; LUND RD, 1985, NEUROSCI LETT, V61, P221, DOI 10.1016/0304-3940(85)90428-8; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1985, SCIENCE, V229, P1268, DOI 10.1126/science.4035355; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; NAKAO N, 1994, NEUROREPORT, V5, P1081, DOI 10.1097/00001756-199405000-00015; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; PAKZABAN P, 1993, EXP BRAIN RES, V97, P13; Paxinos G., 2004, J CHEM INF MODEL, V5th; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SMART IHM, 1976, J ANAT, V121, P71; SMART IHM, 1979, NEOSTRIATUM, P127; SOTELO C, 1986, P NATL ACAD SCI USA, V83, P1135, DOI 10.1073/pnas.83.4.1135; VANDERKOOY D, 1987, BRAIN RES, V401, P155, DOI 10.1016/0006-8993(87)91176-0; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WICTORIN K, 1992, PROG NEUROBIOL, V38, P611, DOI 10.1016/0301-0082(92)90044-F; WICTORIN K, 1991, EUR J NEUROSCI, V3, P86, DOI 10.1111/j.1460-9568.1991.tb00814.x; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; ZHOU HF, 1990, J COMP NEUROL, V292, P320, DOI 10.1002/cne.902920213; ZHOU HF, 1992, J COMP NEUROL, V317, P145, DOI 10.1002/cne.903170204	50	160	165	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1259	1273		10.1016/0896-6273(95)90006-3	http://dx.doi.org/10.1016/0896-6273(95)90006-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845151	Bronze			2022-12-24	WOS:A1995TL67800006
J	LoTurco, JJ; Owens, DF; Heath, MJS; Davis, MBE; Kriegstein, AR				LoTurco, JJ; Owens, DF; Heath, MJS; Davis, MBE; Kriegstein, AR			GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis	NEURON			English	Article							RAT CEREBRAL-CORTEX; SUBUNIT MESSENGER-RNAS; CEREBELLAR GRANULE CELLS; GAMMA-AMINOBUTYRIC-ACID; HIPPOCAMPAL-NEURONS; A RECEPTOR; POSTNATAL-DEVELOPMENT; TRANSIENT EXPRESSION; PRENATAL DEVELOPMENT; DEVELOPING NEOCORTEX	We have found that, during the early stages of cortical neurogenesis, both GABA and glutamate depolarize cells in the ventricular zone of rat embryonic neocortex. In the ventricular zone, glutamate acts on AMPA/kainate receptors, while GABA acts on GABA(A) receptors. GABA induces an inward current at resting membrane potentials, presumably owing to a high intracellular Cl- concentration maintained by furosemide-sensitive Cl- transport. GABA and glutamate also produce increases in intracellular Ca2+ in ventricular zone cells, in part through activation of voltage-gated Ca2+ channels. Furthermore, GABA and glutamate decrease the number of embryonic cortical cells synthesizing DNA. Depolarization with K+ similarly decreases DNA synthesis, suggesting that the neurotransmitters act via membrane depolarization. Applied alone, GABAA and AMPAA/kainate receptor antagonists increase DNA synthesis, indicating that endogenously released amino acids influence neocortical progenitors in the cell cycle. These results demonstrate a novel role for amino acid neurotransmitters in regulating neocortical neurogenesis.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT ANESTHESIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA	Columbia University; Columbia University; Columbia University	LoTurco, JJ (corresponding author), UNIV CONNECTICUT, DEPT PHYSIOL & NEUROBIOL, STORRS, CT 06269 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 07280, NS 21223] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE Y, 1994, J NEUROPHYSIOL, V72, P1530, DOI 10.1152/jn.1994.72.4.1530; ALTMAN J, 1990, EXP NEUROL, V107, P23, DOI 10.1016/0014-4886(90)90060-6; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; ARAKI T, 1992, NEUROSCIENCE, V51, P583, DOI 10.1016/0306-4522(92)90298-G; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; BEHAR TN, 1994, J NEUROSCI, V14, P29; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERRY M, 1965, J ANAT, V99, P691; BISCONTE JC, 1975, EXP BRAIN RES, V22, P37; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLANTON MG, 1991, J COMP NEUROL, V310, P550, DOI 10.1002/cne.903100405; BREWER GJ, 1989, NEUROSCI LETT, V99, P268, DOI 10.1016/0304-3940(89)90458-8; BRUCKNER G, 1976, J COMP NEUROL, V166, P245, DOI 10.1002/cne.901660208; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHUN JJM, 1987, NATURE, V325, P617, DOI 10.1038/325617a0; COBAS A, 1991, NEUROSCIENCE, V40, P375, DOI 10.1016/0306-4522(91)90127-A; DICICCOBLOOM E, 1989, BRAIN RES, V491, P403, DOI 10.1016/0006-8993(89)90080-2; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; GHOSH A, 1992, J NEUROSCI, V12, P39; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANSEN GH, 1984, INT J DEV NEUROSCI, V2, P247, DOI 10.1016/0736-5748(84)90019-4; HANSEN GH, 1987, NEUROTROPHIC ACTIVIT, P109; HAZELTON B, 1979, J CELL BIOL, V83, P487, DOI 10.1083/jcb.83.2.487; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; HLADKY SB, 1972, BIOCHIM BIOPHYS ACTA, V274, P294, DOI 10.1016/0005-2736(72)90178-2; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IZANT JG, 1983, CHROMOSOMA, V88, P1, DOI 10.1007/BF00329497; JANIGRO D, 1988, DEV BRAIN RES, V41, P171, DOI 10.1016/0165-3806(88)90180-0; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; KOSTOVIC I, 1980, J NEUROCYTOL, V9, P219, DOI 10.1007/BF01205159; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LAUDER JM, 1986, NEUROSCIENCE, V19, P465, DOI 10.1016/0306-4522(86)90275-7; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; MATTSON MP, 1988, J NEUROSCI, V8, P1704; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MEIER E, 1991, NEUROCHEM INT, V19, P1, DOI 10.1016/0197-0186(91)90113-R; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; MILLER MW, 1988, CEREB CORTEX, V7, P133; MIONE MC, 1994, J NEUROSCI, V14, P107; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOUNT HTJ, 1993, J NEUROSCI, V13, P3173; MUELLER AL, 1984, J NEUROSCI, V4, P860; MUELLER AL, 1983, NEUROSCI LETT, V39, P193, DOI 10.1016/0304-3940(83)90076-9; MURRAY AW, 1991, SCI AM, V264, P56, DOI 10.1038/scientificamerican0391-56; MYERS VB, 1972, BIOCHIM BIOPHYS ACTA, V274, P313, DOI 10.1016/0005-2736(72)90179-4; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; PARNAVELAS JG, 1988, TRENDS NEUROSCI, V11, P92; POULTER MO, 1992, J NEUROSCI, V12, P2888, DOI 10.1523/JNEUROSCI.12-08-02888.1992; RAEDLER A, 1976, ANAT EMBRYOL, V149, P173, DOI 10.1007/BF00317896; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; RAEDLER E, 1980, ANAT EMBRYOL, V158, P253, DOI 10.1007/BF00301816; RAMSDELL JS, 1991, J CELL PHYSIOL, V146, P197, DOI 10.1002/jcp.1041460203; REDBURN D, 1987, NEUROL NEUROBIOL, V32, P1; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; RICKMANN M, 1977, ANAT EMBRYOL, V151, P285, DOI 10.1007/BF00318931; SCHLUMPF M, 1980, J COMP NEUROL, V192, P361, DOI 10.1002/cne.901920210; SCHWARTZ ML, 1992, CEREB CORTEX, V2, P16, DOI 10.1093/cercor/2.1.16; SWANN JW, 1989, NEUROSCIENCE, V28, P551, DOI 10.1016/0306-4522(89)90004-3; TAYLOR J, 1990, J NEUROCHEM, V54, P1689, DOI 10.1111/j.1471-4159.1990.tb01223.x; VALVERDE F, 1989, J COMP NEUROL, V290, P118, DOI 10.1002/cne.902900108; VANEDEN CG, 1989, J COMP NEUROL, V289, P213, DOI 10.1002/cne.902890204; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0	79	890	909	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1287	1298		10.1016/0896-6273(95)90008-X	http://dx.doi.org/10.1016/0896-6273(95)90008-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845153	hybrid			2022-12-24	WOS:A1995TL67800008
J	Rusanescu, G; Qi, HQ; Thomas, SM; Brugge, JS; Halegoua, S				Rusanescu, G; Qi, HQ; Thomas, SM; Brugge, JS; Halegoua, S			Calcium influx induces neurite growth through a Src-Ras signaling cassette	NEURON			English	Article							LONG-TERM POTENTIATION; PC12 CELLS; TYROSINE KINASES; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; MONOCLONAL-ANTIBODIES; ACTIVATED PP60C-SRC; V-SRC; TRANSDUCTION; DEATH	We find that calcium influx through voltage-dependent calcium channels causes extensive neu rite outgrowth in PC12 cells. The calcium signal transduction pathway promoting neurite outgrowth causes the rapid activation of protein tyrosine kinases, which include Src. Protein tyrosine phosphorylation results in the formation of an Shc/Grb2 complex, reading to Ras activation, MAP kinase activation, and the subsequent induction of the immediate early gene NGFI-A. Protein tyrosine phosphorylation, gene induction, and neurite outgrowth are inhibited by the expression of dominant negative forms of both Src and Ras, indicating a requirement for both proto-oncoproteins in calcium signaling. Our results suggest that a signaling cassette which includes Src and Ras is likely to underlie it broad range of calcium actions in the nervous system.	SUNY STONY BROOK, INST CELL & DEV BIOL, STONY BROOK, NY 11794 USA; ARIAD PHARMACEUT INC, CAMBRIDGE, MA 02138 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Takeda Pharmaceutical Company Ltd; Takeda Oncology	Rusanescu, G (corresponding author), SUNY STONY BROOK, DEPT NEUROBIOL & BEHAV, STONY BROOK, NY 11794 USA.				NCI NIH HHS [CA 47572] Funding Source: Medline; NINDS NIH HHS [NS 18218] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018218] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1994, ADV SEC MESS PHOSPH, V29, P139; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BONIECE IR, 1993, J NEUROSCI, V13, P4220; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; CURRAN T, 1987, ONCOGENE, V2, P79; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; Davies Alun M., 1994, Progress in Growth Factor Research, V5, P263, DOI 10.1016/0955-2235(94)90010-8; DEFRANCO C, 1993, MOL ENDOCRINOL, V7, P365, DOI 10.1210/me.7.3.365; FLY CM, 1994, J NEUROCHEM, V62, P923; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HORVATH AR, 1992, EMBO J, V11, P855, DOI 10.1002/j.1460-2075.1992.tb05123.x; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Keegan K, 1993, Curr Opin Neurobiol, V3, P14, DOI 10.1016/0959-4388(93)90029-X; KOIZUMI S, 1988, J NEUROSCI, V8, P715; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; MCTIGUE M, 1985, J BIOL CHEM, V260, P9047; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; SCHLAEPFER DD, 1994, NATURE, V372, P786; SCHRAMM M, 1983, NATURE, V303, P535, DOI 10.1038/303535a0; SEELEY PJ, 1984, J CELL BIOL, V98, P417, DOI 10.1083/jcb.98.2.417; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIEGELBAUM SA, 1994, CURR BIOL, V4, P242, DOI 10.1016/S0960-9822(00)00054-3; Spitzer Nicholas C., 1994, Current Opinion in Neurobiology, V4, P70, DOI 10.1016/0959-4388(94)90034-5; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TENG KK, 1993, J NEUROSCI, V13, P3124; THOMAS SM, 1991, MOL CELL BIOL, V11, P4739, DOI 10.1128/MCB.11.9.4739; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; ZACCHETTI D, 1991, J BIOL CHEM, V266, P20152; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298	60	243	248	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1415	1425		10.1016/0896-6273(95)90019-5	http://dx.doi.org/10.1016/0896-6273(95)90019-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845164	Bronze			2022-12-24	WOS:A1995TL67800019
J	Soucy, E; Wang, YS; Nirenberg, S; Nathans, J; Meister, M				Soucy, E; Wang, YS; Nirenberg, S; Nathans, J; Meister, M			A novel signaling pathway from rod photoreceptors to ganglion cells in mammalian retina	NEURON			English	Article							GLUTAMIC-ACID DECARBOXYLASE; INNER PLEXIFORM LAYER; CONE BIPOLAR CELLS; MOUSE RETINA; RAT RETINA; CAT RETINA; VERTEBRATE RETINA; RABBIT RETINA; 2-AMINO-4-PHOSPHONOBUTYRIC ACID; DEPOLARIZING BIPOLAR	Current understanding suggests that mammalian rod photoreceptors connect only to an ON-type bipolar cell. This rod-specific bipolar cell excites the AII amacrine eel, which makes connections to cone-specific bipolar cells of both ON and OFF type; these, in turn, synapse with ganglion cells. Recent work on rabbit retina has shown that rod signals can also reach ganglion cells without passing through the rod bipolar cell. This route was thought to be provided by electrical gap junctions, through which rods signal directly to cones and thence to cone bipolar cells. Here, we show that the mouse retina also provides a rod pathway bypassing the rod bipolar eel, suggesting that this is a common feature in mammals. However, this alternative pathway does not require cone photoreceptors; it is perfectly intact in a transgenic mouse whose retina lacks cones. Instead, the results can be explained if rods connect directly to OFF bipolar cells.	Harvard Univ, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Harvard University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Meister, M (corresponding author), Harvard Univ, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA.			Nathans, Jeremy/0000-0001-8106-5460; Meister, Markus/0000-0003-2136-6506				ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P77; BLANKS JC, 1983, J COMP NEUROL, V221, P31, DOI 10.1002/cne.902210103; BOYCOTT BB, 1969, PHILOS T ROY SOC B, V255, P109, DOI 10.1098/rstb.1969.0004; BOYCOTT BB, 1973, J COMP NEUROL, V148, P91, DOI 10.1002/cne.901480106; BREITMAN ML, 1990, MOL CELL BIOL, V10, P474, DOI 10.1128/MCB.10.2.474; Cajal SR., 1893, CELLULE, V9, P119; CALDERONE JB, 1995, VISUAL NEUROSCI, V12, P463, DOI 10.1017/S0952523800008361; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CHIU MI, 1994, VISUAL NEUROSCI, V11, P773, DOI 10.1017/S0952523800003072; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Dowling J. E., 1987, RETINA APPROACHABLE; Euler T, 1996, J NEUROSCI, V16, P2934; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; GRUNERT U, 1991, J NEUROSCI, V11, P2742; HAMANO K, 1990, J COMP NEUROL, V302, P417, DOI 10.1002/cne.903020217; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Hughes TE, 1997, VISUAL NEUROSCI, V14, P103, DOI 10.1017/S0952523800008804; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; KOLB H, 1983, VISION RES, V23, P301, DOI 10.1016/0042-6989(83)90078-0; KOLB H, 1970, PHILOS T R SOC B, V258, P261, DOI 10.1098/rstb.1970.0036; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; LINBERG KA, 1988, J COMP NEUROL, V268, P281, DOI 10.1002/cne.902680211; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; MULLER F, 1988, J NEUROPHYSIOL, V59, P1657, DOI 10.1152/jn.1988.59.6.1657; MULLER JF, 1993, INVEST OPHTH VIS SCI, V34, P984; NAKATANI K, 1991, J GEN PHYSIOL, V97, P413, DOI 10.1085/jgp.97.3.413; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; NELSON R, 1977, J COMP NEUROL, V172, P109, DOI 10.1002/cne.901720106; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; OWEN WG, 1989, NEUROSCI RES       S, V10, P77; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; POURCHO RG, 1985, J COMP NEUROL, V233, P473, DOI 10.1002/cne.902330406; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; SARTHY PV, 1989, J COMP NEUROL, V288, P593, DOI 10.1002/cne.902880406; SCHILLER PH, 1992, TRENDS NEUROSCI, V15, P86, DOI 10.1016/0166-2236(92)90017-3; SCHNAPF JL, 1982, NATURE, V296, P862, DOI 10.1038/296862a0; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; SCHREINER DS, 1985, ACTA ANAT, V121, P153; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SMITH RG, 1986, J NEUROSCI, V6, P3505; Sterling P., 1990, SYNAPTIC ORG BRAIN, P170; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; STRETTOI E, 1995, J NEUROSCI, V15, P875; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; To KW, 1998, ARCH OPHTHALMOL-CHIC, V116, P100, DOI 10.1001/archopht.116.1.100; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; VARDI N, 1994, VISUAL NEUROSCI, V11, P135, DOI 10.1017/S0952523800011172; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WEST RW, 1978, VISION RES, V18, P129, DOI 10.1016/0042-6989(78)90177-3; YAMASHITA M, 1991, J NEUROSCI, V11, P2372; YANG XL, 1991, P NATL ACAD SCI USA, V88, P3310, DOI 10.1073/pnas.88.8.3310; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	71	231	237	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					481	493		10.1016/S0896-6273(00)80560-7	http://dx.doi.org/10.1016/S0896-6273(00)80560-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768836	hybrid			2022-12-24	WOS:000076196400006
J	Kantheti, P; Qiao, XX; Diaz, ME; Peden, AA; Meyer, GE; Carskadon, SL; Kapfhamer, D; Sufalko, D; Robinson, MS; Noebels, JL; Burmeister, M				Kantheti, P; Qiao, XX; Diaz, ME; Peden, AA; Meyer, GE; Carskadon, SL; Kapfhamer, D; Sufalko, D; Robinson, MS; Noebels, JL; Burmeister, M			Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles	NEURON			English	Article							CONFERS RESISTANCE; POOL DEFICIENCY; RECEPTOR GENE; ZINC; PROTEIN; NEURONS; RAT; LOCALIZATION; MAP; CHROMOSOME-10	The mouse mutant mocha, a model for the Hermansky-Pudlak storage pool deficiency syndrome, is characterized by defective platelets, coat and eye color dilution, lysosomal abnormalities, inner ear degeneration, and neurological deficits. Here, we show that mocha is a null allele of the delta subunit of the adaptor-like protein complex AP-3, which is associated with coated vesicles budding from the trans-Golgi network, and that AP-3 is missing in mocha tissues. In mocha brain, the ZnT-3 transporter is reduced, resulting in a lack of zinc-associated Timm historeactivity in hippocampal mossy fibers. Our results demonstrate that the AP-3 complex is responsible for cargo selection to lysosome-related organelles such as melanosomes and platelet dense granules as well as to neurotransmitter vesicles.	Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Cambridge	Burmeister, M (corresponding author), Univ Michigan, Mental Hlth Res Inst, 205 Washtenaw Pl, Ann Arbor, MI 48109 USA.		Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434; Peden, Andrew/0000-0003-0144-7712; Noebels, Jeffrey/0000-0002-2887-0839	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029709, R55NS032130, R01NS032130] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS29709, NS32130] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAN J, 1994, ARCH VIROL, V138, P379, DOI 10.1007/BF01379141; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Budde T, 1997, NEUROSCIENCE, V79, P347, DOI 10.1016/S0306-4522(96)00695-1; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; FREDERICKSON CJ, 1992, J CHEM NEUROANAT, V5, P521, DOI 10.1016/0891-0618(92)90007-D; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; JACKSON IJ, 1992, EMBO J, V11, P527, DOI 10.1002/j.1460-2075.1992.tb05083.x; KAPFHAMER D, 1994, GENOMICS, V23, P635, DOI 10.1006/geno.1994.1552; LANE PW, 1974, J HERED, V65, P362, DOI 10.1093/oxfordjournals.jhered.a108551; LLOYD V, 1995, THESIS U BRIT COLUMB; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; MATSUMURA K, 1993, NEUROMUSCULAR DISORD, V3, P109, DOI 10.1016/0960-8966(93)90002-2; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEWMAN LS, 1995, CELL, V82, P773, DOI 10.1016/0092-8674(95)90474-3; NOEBELS JL, 1989, J NEUROGENET, V6, P53, DOI 10.3109/01677068909107100; NOVAK EK, 1984, BLOOD, V63, P536; NOVAK EK, 1979, GENETICS, V92, P189; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; Ooi CE, 1997, EMBO J, V16, P4508; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Pevsner J, 1996, GENE, V183, P7, DOI 10.1016/S0378-1119(96)00367-8; REDDINGTON M, 1987, BLOOD, V69, P1300; ROBINSON MS, 1986, J CELL BIOL, V102, P48, DOI 10.1083/jcb.102.1.48; ROLFSEN RM, 1984, J HERED, V75, P158, DOI 10.1093/oxfordjournals.jhered.a109903; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Seaman MNJ, 1996, J BIOL CHEM, V271, P25446, DOI 10.1074/jbc.271.41.25446; Seymour A. B., 1997, Molecular Biology of the Cell, V8, p227A; SHOTELERSUK V, 1998, IN PRESS MOL GENET M; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; Suzuki T, 1996, MAMM GENOME, V7, P708, DOI 10.1007/s003359900215; SWANK RT, 1991, BLOOD, V78, P2036, DOI 10.1182/blood.V78.8.2036.bloodjournal7882036; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; WATSON JB, 1994, J NEUROSCI RES, V39, P108, DOI 10.1002/jnr.490390113; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; XIE XM, 1991, NATURE, V349, P521, DOI 10.1038/349521a0	55	326	330	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					111	122		10.1016/S0896-6273(00)80519-X	http://dx.doi.org/10.1016/S0896-6273(00)80519-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697856	Bronze			2022-12-24	WOS:000075061900011
J	Dynes, JL; Ngai, J				Dynes, JL; Ngai, J			Pathfinding of olfactory neuron axons to stereotyped glomerular targets revealed by dynamic imaging in living zebrafish embryos	NEURON			English	Article							ODORANT RECEPTOR EXPRESSION; GREEN FLUORESCENT PROTEIN; BRACHYDANIO-RERIO; GENE-EXPRESSION; XENOPUS-EMBRYOS; GROWTH CONES; C-ELEGANS; IN-VIVO; EPITHELIUM; CELLS	In the vertebrate olfactory system, sensory neurons with common odorant specificities project to specific glomeruli in the olfactory bulb. How do olfactory sensory neurons find their glomerular targets? To address this question, we have visualized the genesis of the peripheral olfactory system in living zebrafish embryos. Dye labelings reveal that a primordial yet stereotyped map of glomeruli is apparent during embryogenesis. By labeling a small number of cells with an ectopically expressed green fluorescent protein reporter, we can observe the dynamic growth behaviors of individual olfactory neuron growth cones as they project to their glomeruli. We find that olfactory axons extend directly to their partner glomeruli, suggesting that these cells' growth cones rely upon pathfinding cues to reach their targets.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ngai, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.							BAIER H, 1994, J NEUROSCI, V14, P219; Barth AL, 1997, NEURON, V19, P359, DOI 10.1016/S0896-6273(00)80945-9; Barth AL, 1996, NEURON, V16, P23, DOI 10.1016/S0896-6273(00)80020-3; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHITNIS AB, 1991, NEURON, V7, P277, DOI 10.1016/0896-6273(91)90266-3; Cooper MS, 1996, DEV BIOL, V180, P184, DOI 10.1006/dbio.1996.0294; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HANSEN A, 1993, J COMP NEUROL, V333, P289, DOI 10.1002/cne.903330213; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HOLCOMB JD, 1995, DEV BIOL, V172, P307, DOI 10.1006/dbio.1995.0025; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; JOHNSON AD, 1994, GENE, V147, P223, DOI 10.1016/0378-1119(94)90070-1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; LILIENBAUM A, 1995, MOL CELL NEUROSCI, V6, P139, DOI 10.1006/mcne.1995.1013; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MEISAMI E, 1993, DEV BRAIN RES, V71, P253, DOI 10.1016/0165-3806(93)90177-C; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1987, PROG NEUROBIOL, V29, P275, DOI 10.1016/0301-0082(87)90024-4; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; POMEROY SL, 1990, J NEUROSCI, V10, P1952; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; SHEPHERD GM, 1991, OLFACTION, P3; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; STROTMANN J, 1995, EUR J NEUROSCI, V7, P492, DOI 10.1111/j.1460-9568.1995.tb00345.x; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; SULLIVAN SL, 1995, NEURON, V15, P779, DOI 10.1016/0896-6273(95)90170-1; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Westerfield M, 1993, ZEBRAFISH BOOK; WHITLOCK K, 1997, TRANSIENT CLASS NEUR; WILSON SW, 1990, DEVELOPMENT, V108, P121	54	96	97	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1081	1091		10.1016/S0896-6273(00)80490-0	http://dx.doi.org/10.1016/S0896-6273(00)80490-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655497	Bronze			2022-12-24	WOS:000074627300005
J	Chavis, P; Mollard, P; Bockaert, J; Manzoni, O				Chavis, P; Mollard, P; Bockaert, J; Manzoni, O			Visualization of cyclic AMP-regulated presynaptic activity at cerebellar granule cells	NEURON			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM POTENTIATION; GUINEA-PIG HIPPOCAMPUS; SYNAPTIC TRANSMISSION; CALCIUM INFLUX; RAT; SYNAPSES; NEURONS; DEPRESSION; MODULATION	Adenylyl cyclase (AC) modulation of vesicular cycling was visualized at cultured cerebellar granule cell synapses using the sequential uptake of antibodies directed against the intraluminal domain of synaptotagmin I. Vesicle recycling due to spontaneous transmitter release in the absence of action potentials was increased by the AC/protein kinase A (PKA) activators forskolin and CPT-cAMP. These effects were blocked by the PKA inhibitor Rp-cAMPs. Cyclic AMP elevation also induced new cycling at previously silent sites. Activation of L-AP4-sensitive mGluR reduced the cAMP/PKA enhancement at preexisting synapses downstream of both AC and calcium channels. Modulation of the turnover and the number of vesicular release sites provide one mechanism that may underlie CAMP-dependent cerebellar long-term potentiation.	CNRS, F-34094 Montpellier 05, France; INSERM, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Manzoni, O (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L-474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Manzoni, Olivier/M-7899-2016; Chavis, Pascale/M-8312-2016	Manzoni, Olivier/0000-0002-5579-6208; Chavis, Pascale/0000-0002-3038-1014				BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; Chen CF, 1997, J NEUROSCI, V17, P8687; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; COTMAN CW, 1986, J PHYSIOL-LONDON, V378, P403, DOI 10.1113/jphysiol.1986.sp016227; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DULAC S, 1995, ANN REV NEUROSCI, V18, P109; Elferink LA, 1995, PROG BRAIN RES, V105, P79; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kinoshita A, 1996, NEUROSCI LETT, V207, P199, DOI 10.1016/0304-3940(96)12519-2; KOERNER JF, 1981, BRAIN RES, V216, P192, DOI 10.1016/0006-8993(81)91288-9; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; OHISHI H, 1995, J COMP NEUROL, V360, P555, DOI 10.1002/cne.903600402; Pekhletski R, 1996, J NEUROSCI, V16, P6364; PREZEAU L, 1994, MOL PHARMACOL, V45, P570; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SAUGSTAD JA, 1994, MOL PHARMACOL, V45, P367; SCANZIANI M, 1995, NEUROPHARMACOLOGY, V34, P1549, DOI 10.1016/0028-3908(95)00119-Q; Schulz PE, 1997, P NATL ACAD SCI USA, V94, P5888, DOI 10.1073/pnas.94.11.5888; SEAMON KB, 1986, ADV CYCLIC NUCLEOTID, V420, P1; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; TANABE Y, 1993, J NEUROSCI, V13, P1372; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; TYLER EC, 1995, NEUROPHARMACOLOGY, V34, P939, DOI 10.1016/0028-3908(95)00066-F; VANVLIET BJ, 1989, J NEUROCHEM, V52, P1229; WEISSKOPF MG, 1994, SCIENCE, V265, P1876; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	43	102	104	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					773	781		10.1016/S0896-6273(00)81015-6	http://dx.doi.org/10.1016/S0896-6273(00)81015-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581768	Bronze			2022-12-24	WOS:000073346500015
J	He, XP; Patel, M; Whitney, KD; Janumpalli, S; Tenner, A; McNamara, JO				He, XP; Patel, M; Whitney, KD; Janumpalli, S; Tenner, A; McNamara, JO			Glutamate receptor GluR3 antibodies and death of cortical cells	NEURON			English	Article							BLOOD-BRAIN-BARRIER; MYASTHENIA-GRAVIS; RASMUSSENS ENCEPHALITIS; NERVOUS-SYSTEM; NEURONS; COMPLEMENT	Rasmussen's encephalitis (RE), a childhood disease characterized by epileptic seizures associated with progressive destruction of a single cerebral hemisphere, is an autoimmune disease in which one of the autoantigens is a glutamate receptor, GluR3. The improvement of some affected children following plasma exchange that removed circulating GluR3 antibodies (anti-GluR3) suggested that anti-GluR3 gained access to the central nervous system where it exerted deleterious effects. Here, we demonstrate that a subset of rabbits immunized with a GluR3 fusion protein develops a neurological disorder mimicking RE. Anti-GluR3 IgG isolated from serum of both ill and healthy GluR3-immunized animals promoted death of cultured cortical cells by a complement-dependent mechanism. IgG immunoreactivity decorated neurons and their processes in neocortex and hippocampus in ill but not in healthy rabbits. Moreover, both IgG and complement membrane attack complex (MAC) immunoreactivity was evident on neurons and their processes in the cortex of a subset of patients with RE. We suggest that access of IgG to epitopes in the central nervous system triggers complement-mediated neuronal damage and contributes to the pathogenesis of both this animal model and RE.	Duke Univ, Med Ctr, Dept Med, Div Neurol,Epilepsy Res Lab, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; Vet Affairs Med Ctr, Durham, NC 27705 USA; Univ Calif Irvine, Dept Biochem & Mol Biol, Irvine, CA 92697 USA	Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Irvine	McNamara, JO (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Neurol,Epilepsy Res Lab, Durham, NC 27710 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032334, P01NS017771] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS17771, R01 NS32334] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBAS AK, 1991, CELLULAR MOL IMMUNOL, P260; Andrews PI, 1996, NEUROLOGY, V46, P242, DOI 10.1212/WNL.46.1.242; BRIGHTMA.MW, 1970, J NEUROL SCI, V10, P215, DOI 10.1016/0022-510X(70)90151-6; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHRISTADOSS P, 1985, J NEUROIMMUNOL, V8, P29, DOI 10.1016/S0165-5728(85)80045-X; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Engel A., 1979, CURRENT TOPICS NERVE, P111; ENGEL AG, 1987, ANN NY ACAD SCI, V505, P326, DOI 10.1111/j.1749-6632.1987.tb51301.x; ESHHAR N, 1993, NEUROSCIENCE, V57, P943, DOI 10.1016/0306-4522(93)90040-M; FABIAN RH, 1986, J NEUROL SCI, V73, P257, DOI 10.1016/0022-510X(86)90150-4; FARRELL MA, 1995, ACTA NEUROPATHOL, V89, P313; HARLOW E, 1988, ANTIBODIES LAB MANUA, P632; Kabat EA, 1961, EXPT IMMUNOHISTOCHEM, P133; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; MCGEER PL, 1989, CAN J NEUROL SCI, V16, P516, DOI 10.1017/S0317167100029863; MORGAN BP, 1993, COMPLEMENT HLTH DISE, P353; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; RASMUSSEN T, 1958, NEUROLOGY, V8, P435, DOI 10.1212/WNL.8.6.435; RASMUSSEN T, 1989, CLEVE CLIN J MED S1, V56, P81; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; SCHMIDTKASTNER R, 1993, J NEUROSCI METH, V46, P121, DOI 10.1016/0165-0270(93)90147-J; TWYMAN RE, 1995, NEURON, V14, P755, DOI 10.1016/0896-6273(95)90219-8; VASSAULT A, 1983, METHOD ENZYMAT AN, P188; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	26	99	104	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1998	20	1					153	163		10.1016/S0896-6273(00)80443-2	http://dx.doi.org/10.1016/S0896-6273(00)80443-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459451	Bronze			2022-12-24	WOS:000071719700018
J	Petersen, SA; Fetter, RD; Noordermeer, JN; Goodman, CS; DiAntonio, A				Petersen, SA; Fetter, RD; Noordermeer, JN; Goodman, CS; DiAntonio, A			Genetic analysis of glutamate receptors in Drosophila reveals a retrograde signal regulating presynaptic transmitter release	NEURON			English	Article							SYNAPTIC PLASTICITY; FUNCTIONAL COMPONENTS; FASCICLIN-II; NEUROMUSCULAR-JUNCTION; SILENT SYNAPSES; MUTANTS; EXPRESSION; MUSCLE; DISSECTION; MEMORY	Postsynaptic sensitivity to glutamate was genetically manipulated at the Drosophila neuromuscularjunction (NMJ) to test whether postsynaptic activity can regulate presynaptic function during development. We cloned the gene encoding a second muscle-specific glutamate receptor, DGluRIIB, which is closely related to the previously identified DGluRIIA and located adjacent to it in the genome. Mutations that eliminate DGluRIIA (but not DGluRIIB) or transgenic constructs that increase DGluRIIA expression were generated. When DGluRIIA is missing, the response of the muscle to a single vesicle of transmitter is substantially decreased.;However, the response of the muscle to nerve stimulation is normal because quantal content is significantly increased. Thus, a decrease in postsynaptic receptors leads to an increase in presynaptic transmitter release, indicating that postsynaptic activity controls a retrograde signal that regulates presynaptic function.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.			DiAntonio, Aaron/0000-0002-7262-0968				ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BASLER K, 1991, CELL, V64, P1069, DOI 10.1016/0092-8674(91)90262-W; BETZ H, 1993, TRENDS PHARMACOL SCI, V14, P428, DOI 10.1016/0165-6147(93)90177-L; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CULLCANDY SG, 1980, J PHYSIOL-LONDON, V299, P621, DOI 10.1113/jphysiol.1980.sp013145; CURRIE DA, 1995, DEV DYNAM, V203, P311, DOI 10.1002/aja.1002030303; Dan Yang, 1994, Current Opinion in Neurobiology, V4, P95, DOI 10.1016/0959-4388(94)90037-X; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; TOWER J, 1993, GENETICS, V133, P347; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; WASSENBERG DR, 1987, J BIOL CHEM, V262, P10741; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; XU T, 1993, DEVELOPMENT, V117, P1223; ZHONG Y, 1995, J NEUROSCI, V15, P6679; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	50	354	357	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1237	1248		10.1016/S0896-6273(00)80415-8	http://dx.doi.org/10.1016/S0896-6273(00)80415-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427247	Bronze, Green Published			2022-12-24	WOS:000071236500011
J	Patton, DE; Silva, T; Bezanilla, F				Patton, DE; Silva, T; Bezanilla, F			RNA editing generates a diverse array of transcripts encoding squid Kv2 K+ channels with altered functional properties	NEURON			English	Article							DELAYED-RECTIFIER PROPERTIES; POTASSIUM-CHANNEL; MESSENGER-RNA; SHAKER LOCUS; IN-VITRO; ADENOSINE-DEAMINASE; RECEPTOR CHANNELS; XENOPUS-OOCYTES; SODIUM-CHANNEL; DNA-POLYMERASE	We have cloned a Kv2 potassium channel from squid optic lobe termed sqKv2. Multiple overlapping sqKv2 cDNA clones differed from one another at specific positions by purine transitions. To test whether the purine transitions were generated by RNA editing, we compared a 360 nucleotide genomic sequence with corresponding cDNA sequences (encoding S4-S6) isolated from individual animals and lying on a single gene and exon. cDMA sequences differed from genomic sequence at 17 positions, resulting in 28 unique sequences. There was invariantly an adenosine in the genomic sequence and a guanosine in the edited cDNA sequences. Two of the edits altered the rates of channel closure and stow inactivation. These results extend selective RNA editing to invertebrate taxa and represents a novel mechanism for the posttranscriptional modulation of voltage-gated ion channels.	UNIV CALIF LOS ANGELES,SCH MED,DEPT ANESTHESIOL,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Patton, DE (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90095, USA.				NIGMS NIH HHS [GM30376] Funding Source: Medline; NINDS NIH HHS [NS07101] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AUSUBEL FM, 1991, CURRENT PROTOCOL S15, V1; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; BARO DJ, 1994, RECEPTOR CHANNEL, V2, P193; Bass BL, 1997, RNA, V3, P947; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Burger C, 1996, J NEUROSCI, V16, P1412; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAQUILA RT, 1991, NUCLEIC ACIDS RES, V19, P3749, DOI 10.1093/nar/19.13.3749; DEBIASI M, 1993, PFLUG ARCH EUR J PHY, V422, P354, DOI 10.1007/BF00374291; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; EHRENSTEIN G, 1966, BIOPHYS J, V6, P553, DOI 10.1016/S0006-3495(66)86677-8; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; FREEMAN GJ, 1983, P NATL ACAD SCI-BIOL, V80, P4094, DOI 10.1073/pnas.80.13.4094; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LLANO I, 1988, J GEN PHYSIOL, V92, P179, DOI 10.1085/jgp.92.2.179; LLANO I, 1986, J GEN PHYSIOL, V88, P543, DOI 10.1085/jgp.88.4.543; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAK MD, 1991, J NEUROSCI, V11, P869; Polson AG, 1996, NATURE, V380, P454; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; QUATTROCKI EA, 1994, NEURON, V126, P73; ROBERDS SL, 1991, FEBS LETT, V284, P152, DOI 10.1016/0014-5793(91)80673-Q; Rosenthal JC, 1996, J GEN PHYSIOL, V108, P207, DOI 10.1085/jgp.108.3.207; RUETER SM, 1995, SCIENCE, V267, P1491, DOI 10.1126/science.7878468; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Shih TM, 1997, J CELL BIOL, V136, P1037, DOI 10.1083/jcb.136.5.1037; Simpson L, 1996, ANNU REV NEUROSCI, V19, P27, DOI 10.1146/annurev.ne.19.030196.000331; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; TAGLIALATELA M, 1994, BIOPHYS J, V66, P179, DOI 10.1016/S0006-3495(94)80755-6; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; WHITE MM, 1985, J GEN PHYSIOL, V85, P539, DOI 10.1085/jgp.85.4.539; YANG JH, 1995, NATURE, V374, P77, DOI 10.1038/374077a0; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	60	111	114	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					711	722		10.1016/S0896-6273(00)80383-9	http://dx.doi.org/10.1016/S0896-6273(00)80383-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331360	Bronze			2022-12-24	WOS:A1997XZ01600023
J	Hobert, O; Mori, I; Yamashita, Y; Honda, H; Ohshima, Y; Liu, YX; Ruvkun, G				Hobert, O; Mori, I; Yamashita, Y; Honda, H; Ohshima, Y; Liu, YX; Ruvkun, G			Regulation of interneuron function in the C-elegans thermoregulatory pathway by the ttx-3 LIM homeobox gene	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; TEMPERATURE RECEPTORS; CHEMOSENSORY NEURONS; HOMEODOMAIN PROTEIN; LARVAL DEVELOPMENT; NERVOUS-SYSTEM; MOTOR-NEURONS; CELL LINEAGE; DROSOPHILA	Neural pathways, which couple temperature-sensing neurons to motor and autonomic outputs, allow animals to navigate away from and adjust metabolism rates in response to the temperature extremes often encountered. ttx-3 is required for the specification of the AIY interneuron in the C. elegans neural pathway that mediates thermoregulation. ttx-3 null mutant animals exhibit the same thermotactic behavioral defect as that seen with laser ablation of AIY in wild type, suggesting that AIY does not signal in this mutant. ttx-3 encodes a LIM homeodomain protein. A ttx-3-GFP fusion gene is expressed specifically in the adult AIY interneuron pair, which connects to thermosensory neurons. In ttx-3 mutant animals, the AIY interneuron is generated but exhibits patterns of abnormal axonal outgrowth. Thus, the TTX-3 LIM homeodomain protein is likely to regulate the expression of target genes required late in AIY differentiation for the function of this interneuron in the thermoregulatory pathway. The ttx-3-dependent thermosensory pathway also couples to the temperature-modulated dauer neuroendocrine signaling pathway, showing that ttx-3 specifies AIY thermosensory information processing of both motor and autonomic outputs.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02114; KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 81281,JAPAN	Harvard University; Harvard Medical School; Kyushu University	Hobert, O (corresponding author), MASSACHUSETTS GEN HOSP,DEPT MOL BIOL,BOSTON,MA 02114, USA.			Hobert, Oliver/0000-0002-7634-2854				BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Basson M, 1996, GENE DEV, V10, P1953, DOI 10.1101/gad.10.15.1953; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLUMENTHAL T, 1997, C ELEGANS, V2, P117; BOULANT JA, 1986, ANNU REV PHYSIOL, V48, P639, DOI 10.1146/annurev.ph.48.030186.003231; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; BURGLIN TR, 1995, BIODIVERSITY EVOLUTI, P291; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Daston MM, 1996, NEURON, V17, P5, DOI 10.1016/S0896-6273(00)80275-5; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; FEANY MB, 1993, NATURE, V364, P537, DOI 10.1038/364537a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HELLER HC, 1979, ANNU REV PHYSIOL, V41, P305, DOI 10.1146/annurev.ph.41.030179.001513; HENDERSON CE, 1983, NATURE, V302, P609, DOI 10.1038/302609a0; HENSEL H, 1973, PHYSIOL REV, V53, P948, DOI 10.1152/physrev.1973.53.4.948; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PORTER FD, 1997, IN PRESS DEVELOPMENT, V124; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, C ELEGANS, P739; Sambrook J., 2002, MOL CLONING LAB MANU; SATINOFF E, 1978, SCIENCE, V201, P16, DOI 10.1126/science.351802; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SPRAY DC, 1986, ANNU REV PHYSIOL, V48, P625; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227	45	204	213	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					345	357		10.1016/S0896-6273(00)80944-7	http://dx.doi.org/10.1016/S0896-6273(00)80944-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292724	Bronze			2022-12-24	WOS:A1997XU14600013
J	Martin, KC; Michael, D; Rose, JC; Barad, M; Casadio, A; Zhu, HX; Kandel, ER				Martin, KC; Michael, D; Rose, JC; Barad, M; Casadio, A; Zhu, HX; Kandel, ER			MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL GROWTH-FACTOR; CYCLIC-AMP; PC12 CELLS; MACROMOLECULAR-SYNTHESIS; SUBSTRATE RECOGNITION; SYNAPTIC PLASTICITY; SENSORY NEURONS; CRITICAL PERIOD; LATE-PHASE	Long-term facilitation of the sensory to motor synapse in Aplysia requires gene expression. While some transcription factors involved in long-term facilitation are phosphorylated by PKA, others lack PKA sites but contain MAP Kinase (MAPK) phosphorylation sites. We now show that MAPK translocates into the nucleus of the presynaptic but not the postsynaptic cell during 5-HT-induced long-term facilitation. The presynaptic nuclear translocation of MAPK is also triggered by elevations in intracellular cAMP. Injection of anti-MAPK antibodies or of MAPK Kinase inhibitors into the presynaptic cell blocks long-term facilitation, without affecting basal synaptic transmission or short-term facilitation. Thus, MAPK appears to be specifically recruited and necessary for the long-term form of facilitation. This mechanism for long-term plasticity may be quite general: cAMP also activated MAPK in mouse hippocampal neurons, suggesting that MAPK may play a role in hippocampal long-term potentiation.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Columbia University	Martin, KC (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.			Michael, Dan/0000-0003-2942-4301				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BACKSAI BJ, 1993, SCIENCE, V260, P222; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1989, J NEUROSCI, V9, P1774; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Carew TJ, 1996, NEURON, V16, P5, DOI 10.1016/S0896-6273(00)80016-1; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FAURE M, 1995, MOL BIOL CELL, V6, P1025, DOI 10.1091/mbc.6.8.1025; FAURE M, 1994, J BIOL CHEM, V269, P7851; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GAUSE KC, 1993, J BIOL CHEM, V268, P16124; Geinisman Y, 1996, J COMP NEUROL, V368, P413; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Graves JD, 1995, ANN NY ACAD SCI, V766, P320, DOI 10.1111/j.1749-6632.1995.tb26684.x; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; HARRIS KE, 1993, TRENDS NEUROSCI, V16, P141; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Lisman J, 1995, J NIH RES, V7, P43; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Qian Z, 1994, Learn Mem, V1, P180; RAYPORT SG, 1986, J NEUROSCI, V6, P759; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; Sossin WS, 1996, TRENDS NEUROSCI, V19, P215; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; VOSSLER MR, 1997, CELL, V88, P73; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAO H, 1995, J BIOL CHEM, V270, P20748, DOI 10.1074/jbc.270.35.20748; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318	67	466	476	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					899	912		10.1016/S0896-6273(00)80330-X	http://dx.doi.org/10.1016/S0896-6273(00)80330-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208858	Bronze			2022-12-24	WOS:A1997XJ10200009
J	Murthy, VN; Sejnowski, TJ; Stevens, CF				Murthy, VN; Sejnowski, TJ; Stevens, CF			Heterogeneous release properties of visualized individual hippocampal synapses	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; PAIRED-PULSE; CURRENTS; FACILITATION; PROBABILITY; PLASTICITY; DEPRESSION; TERMINALS; MEMBRANE	We have used endocytotic uptake of the styryl dye FM1-43 at synaptic terminals (Betz and Bewick, 1992) to study properties of individual synapses formed by axons of single hippocampal neurons in tissue culture. The distribution of values for probability of evoked transmitter release p estimated by dye uptake is continuous, with a preponderance of low p synapses and a broad spread of probabilities. We have validated this method by demonstrating that the optically estimated distribution of p at autapses in single-neuron microislands predicts, with no free parameters, the rate of blocking of NMDA responses by the noncompetitive antagonist MK-801 at the same synapses. Different synapses made by a single axon exhibited varying amounts of paired-pulse modulation; synapses with low p tended to be facilitated more than those with high p. The increment in release probability produced by increasing external calcium ion concentration also depended on a synapse's initial p value. The size of the recycling pool of vesicles was strongly correlated with p as well, suggesting that synapses with higher release probabilities had more vesicles. Finally, p values of neighboring synapses were correlated, indicating local interactions in the dendrite or axon, or both.	SALK INST BIOL STUDIES,MOL NEUROBIOL LAB,LA JOLLA,CA 92037	Salk Institute	Murthy, VN (corresponding author), SALK INST BIOL STUDIES,COMPUTAT NEUROBIOL LAB,10010 N TORREY PINES RD,LA JOLLA,CA 92037, USA.		Sejnowski, Terrence/AAV-5558-2021	Murthy, Venkatesh/0000-0003-2443-4252	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER; NIMH NIH HHS [R1MH46482A] Funding Source: Medline; NINDS NIH HHS [NS 12961] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Frenguelli BG, 1996, LEARN MEMORY, V3, P150, DOI 10.1101/lm.3.2-3.150; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Katz B., 1969, SHERRINGTON LECT; MacKenzie PJ, 1996, NEURON, V16, P783, DOI 10.1016/S0896-6273(00)80098-7; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MALLART A, 1968, J PHYSIOL-LONDON, V196, P593, DOI 10.1113/jphysiol.1968.sp008525; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	29	457	458	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					599	612		10.1016/S0896-6273(00)80301-3	http://dx.doi.org/10.1016/S0896-6273(00)80301-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136769	Bronze			2022-12-24	WOS:A1997WW62600009
J	Coburn, CM; Bargmann, CI				Coburn, CM; Bargmann, CI			A putative cyclic nucleotide-gated channel is required for sensory development and function in C-elegans	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; OLFACTORY RECEPTOR-CELLS; CHEMOSENSORY NEURONS; MOLECULAR MECHANISM; ROD PHOTORECEPTOR; EXPRESSION; MUTANTS; SUBUNIT; CAMP; CONDUCTANCE	In vertebrate visual and olfactory systems, a cyclic nucleotide-gated channel couples receptor activation to electrical activity of the sensory neurons. The Caenorhabditis elegans tax-2 gene is required for some farms of olfaction, for chemosensation of salts, and for thermosensation. We show here that tax-2 encodes a predicted subunit of a cyclic nucleotide-gated channel that is expressed in olfactory, gustatory, and thermosensory neurons, implicating this channel in multiple sensory modalities. Some sensory neurons display axon outgrowth defects in tax-2 mutants. Thus, the channel has an unexpected role in sensory neuron development in addition to its role in sensation. Consistent with this proposed dual function, a Tax-2::GFP fusion protein is present both in sensory cilia and in sensory axons.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,GENET PROGRAM,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Coburn, CM (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,PROGRAM DEV BIOL,SAN FRANCISCO,CA 94143, USA.			Bargmann, Cornelia/0000-0002-8484-0618	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001393] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC01393] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AHMAD I, 1994, NEURON, V12, P155, DOI 10.1016/0896-6273(94)90160-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AVENET P, 1988, J MEMBRANE BIOL, V105, P245, DOI 10.1007/BF01871001; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; BRENNER S, 1974, GENETICS, V77, P71; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DUBIN AE, 1994, J GEN PHYSIOL, V103, P181, DOI 10.1085/jgp.103.2.181; DUSENBERY DB, 1975, GENETICS, V80, P297; ELHUSSEINI AED, 1995, NEUROREPORT, V6, P1459, DOI 10.1097/00001756-199507100-00024; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; HERMAN RK, 1990, NATURE, V348, P169, DOI 10.1038/348169a0; HIRAOKA Y, 1990, BIOPHYS J, V57, P325, DOI 10.1016/S0006-3495(90)82534-0; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEIN RD, 1993, CELL, V72, P349, DOI 10.1016/0092-8674(93)90113-5; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHACHER S, 1993, NEURON, V10, P1079, DOI 10.1016/0896-6273(93)90056-W; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; STRYER L, 1991, J BIOL CHEM, V266, P10711; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; VOWELS JJ, 1994, GENETICS, V138, P303; WANG BB, 1993, CELL, V74, P29, DOI 10.1016/0092-8674(93)90292-X; WANG T, 1995, NATURE, V374, P262, DOI 10.1038/374262a0; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; YAO XQ, 1995, P NATL ACAD SCI USA, V92, P11711, DOI 10.1073/pnas.92.25.11711; ZHONG Y, 1992, J NEUROSCI, V12, P644	62	327	336	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					695	706		10.1016/S0896-6273(00)80201-9	http://dx.doi.org/10.1016/S0896-6273(00)80201-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893026	Bronze			2022-12-24	WOS:A1996VP74300014
J	Mochida, S; Sheng, ZH; Baker, C; Kobayashi, H; Catterall, WA				Mochida, S; Sheng, ZH; Baker, C; Kobayashi, H; Catterall, WA			Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels	NEURON			English	Article							RAT SYMPATHETIC NEURONS; SENSITIVE CALCIUM-CHANNEL; TRANSMITTER RELEASE; ACETYLCHOLINE-RELEASE; SYNTAXIN; SYNAPTOTAGMIN; EXOCYTOSIS; SYNAPSES; IDENTIFICATION; COMPLEX	N-type Ca2+ channels bind directly to the synaptic core complex of VAMP/synaptobrevin, syntaxin, and SNAP-25. Peptides containing the synaptic protein interaction (''synprint'') site caused dissociation of N-type Ca2+ channels from the synaptic core complex. Introduction of synprint peptides into presynaptic superior cervical ganglion neurons reversibly inhibited synaptic transmission. Fast EPSPs due to synchronous transmitter release were inhibited, while late EPSPs arising from asynchronous release following a train of action potentials were increased and paired-pulse facilitation was increased. The corresponding peptides from L-type Ca2+ channels had no effect, and the N-type peptides had no effect on Ca2+ currents through N-type Ca2+ channels. These results are consistent with the hypothesis that binding of the synaptic core complex to presynaptic N-type Ca2+ channels is required for Ca2+ influx to elicit rapid, synchronous neurotransmitter release.	UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	Mochida, S (corresponding author), TOKYO MED COLL,DEPT PHYSIOL,TOKYO 160,JAPAN.				NINDS NIH HHS [NS22625] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; INOUE A, 1992, J BIOL CHEM, V267, P10613; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MALLART A, 1968, J PHYSIOL-LONDON, V196, P593, DOI 10.1113/jphysiol.1968.sp008525; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MOCHIDA S, 1995, NEUROSCIENCE, V65, P905, DOI 10.1016/0306-4522(94)00508-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; MOCHIDA S, 1996, IN PRESS NEUROSCIENC; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; OLAGUE PH, 1974, P NATL ACAD SCI USA, V71, P3602, DOI 10.1073/pnas.71.9.3602; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SAISU H, 1991, BIOCHEM BIOPH RES CO, V181, P59, DOI 10.1016/S0006-291X(05)81381-6; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WAKSHULL E, 1979, J NEUROPHYSIOL, V42, P1410, DOI 10.1152/jn.1979.42.5.1410; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WU LG, 1994, J NEUROSCI, V14, P5613; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	40	229	238	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					781	788		10.1016/S0896-6273(00)80209-3	http://dx.doi.org/10.1016/S0896-6273(00)80209-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893034	Bronze			2022-12-24	WOS:A1996VP74300022
J	Tear, G; Harris, R; Sutaria, S; Kilomanski, K; Goodman, CS; Seeger, MA				Tear, G; Harris, R; Sutaria, S; Kilomanski, K; Goodman, CS; Seeger, MA			commissureless controls growth cone guidance across the CNS midline in Drosophila and encodes a novel membrane protein	NEURON			English	Article							PIONEER AXON MIGRATIONS; CENTRAL-NERVOUS-SYSTEM; C-ELEGANS; FLOOR PLATE; ESCHERICHIA-COLI; SPINAL-CORD; GUIDES CELL; GENES; EXPRESSION; PURIFICATION	The commissureless (comm) gene was identified previously in a large-scale screen for mutations that disrupt CNS axon pathways in Drosophila. The comm gene has a unique mutant phenotype: the complete absence of most axon commissures, while midline cells and other aspects of CNS fate and patterning are left unchanged. Here, we report on the molecular cloning, characterization, and expression of the comm gene. comm encodes a novel protein of 370 amino acids that lacks a signal sequence, has a transmembrane domain, and biochemically copurifies with membranes. COMM mRNA and COMM protein are dynamically expressed during embryogenesis, including by CNS midline glia during the formation of the axon commissures. Anti-COMM antibodies reveal strong staining of organelles likely to include the Golgi complex and endosomes and weaker staining of the cell surface. As commissural growth cones contact and traverse the CNS midline, COMM protein is apparently transferred from midline glia to commissural axons.	OKLAHOMA MED RES FDN, CELL & MOLEC BIOL PROGRAM, OKLAHOMA CITY, OK 73104 USA	Oklahoma Medical Research Foundation	Tear, G (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOLEC & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA.		Tear, Guy/C-5444-2009		NINDS NIH HHS [NS 32839, NS 18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366, R29NS032839, R01NS032839] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; CAMPBELL RM, 1993, DEVELOPMENT, V119, P1217; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Harlow E., 1988, ANTIBODIES LAB MANUA; HARRISONLAVOIE KJ, 1993, EMBO J, V12, P2847, DOI 10.1002/j.1460-2075.1993.tb05946.x; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HORTSCH M, 1994, METHOD CELL BIOL, V44, P289, DOI 10.1016/S0091-679X(08)60920-6; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; JACOBS JR, 1989, J NEUROSCI, V9, P2412; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MARSHALL BA, 1993, J BIOL CHEM, V268, P26193; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MCKANNA JA, 1989, SCIENCE, V243, P1477, DOI 10.1126/science.2928781; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PARKS AL, 1995, MECH DEVELOP, V50, P201, DOI 10.1016/0925-4773(94)00336-L; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PERIN MS, 1991, J BIOL CHEM, V266, P623; RESTIFO LL, 1986, J MOL BIOL, V188, P517, DOI 10.1016/S0022-2836(86)80002-X; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; RIPOCHE J, 1994, P NATL ACAD SCI USA, V91, P1878, DOI 10.1073/pnas.91.5.1878; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOH S, 1993, J BIOL CHEM, V268, P17820; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMOLLER DA, 1991, CHROMOSOMA, V100, P487, DOI 10.1007/BF00352199; SPINDLER KR, 1984, J VIROL, V49, P132, DOI 10.1128/JVI.49.1.132-141.1984; SWANSON J, 1989, METHOD CELL BIOL, V29, P137; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	56	213	216	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1996	16	3					501	514		10.1016/S0896-6273(00)80070-7	http://dx.doi.org/10.1016/S0896-6273(00)80070-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785048	Bronze			2022-12-24	WOS:A1996UC16800007
J	Gurnett, CA; DeWaard, M; Campbell, KP				Gurnett, CA; DeWaard, M; Campbell, KP			Dual function of the voltage-dependent Ca2+ channel alpha(2)delta subunit in current stimulation and subunit interaction	NEURON			English	Article							SENSITIVE CALCIUM-CHANNEL; MUSCLE DIHYDROPYRIDINE RECEPTOR; SKELETAL-MUSCLE; 1,4-DIHYDROPYRIDINE RECEPTOR; STRUCTURAL CHARACTERIZATION; BETA-SUBUNIT; EXPRESSION; BRAIN; PURIFICATION; DELTA	Voltage-dependent Ca2+ channels are modulated by complex interactions with the alpha(2) delta subunit. In vitro translation was used to demonstrate a single transmembrane topology of the alpha(2) delta subunit in which all but the transmembrane sequence and 5 carboxy-terminal amino acids are extracellular. The glycosylated extracellular domain is required for current stimulation, as shown by coexpression of truncated alpha(2) delta subunits with alpha(1A) and beta(4) subunits in Xenopus oocytes and deglycosylation with peptide-N-glycosidase F. However, coexpression of the transmembrane domain-containing delta subunit reduced the stimulatory effects of full-length alpha(2) delta subunits and substitution of a different transmembrane domain resulted in a loss of current stimulation. These results support a model whereby the alpha(2) delta transmembrane domain mediates subunit interactions and the glycosylated extracellular domain enhances current amplitude.			Gurnett, CA (corresponding author), UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,HOWARD HUGHES MED INST,IOWA CITY,IA 52242, USA.		De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Gurnett, Christina/0000-0001-9129-315X; Campbell, Kevin/0000-0003-2066-5889				BAMBERG K, 1994, J BIOL CHEM, V269, P16909; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BRICKLEY K, 1995, FEBS LETT, V364, P129, DOI 10.1016/0014-5793(95)00371-F; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; CHEN C, 1996, IN PRESS PFLUGERS AR; COOPER CL, 1987, J BIOL CHEM, V262, P509; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; GURNETT CA, 1995, J BIOL CHEM, V270, P9035, DOI 10.1074/jbc.270.16.9035; HAMRICK M, 1993, J BIOL CHEM, V268, P24367; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAY SD, 1991, J BIOL CHEM, V266, P3287; KIM HL, 1992, P NATL ACAD SCI USA, V89, P3251, DOI 10.1073/pnas.89.8.3251; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SCHWALBE RA, 1995, J BIOL CHEM, V270, P15336, DOI 10.1074/jbc.270.25.15336; SHARP AH, 1987, J BIOL CHEM, V262, P12309; SKACH WR, 1993, J BIOL CHEM, V268, P6903; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TAM LY, 1994, J BIOL CHEM, V269, P32542; TANABE T, 1990, NATURE, V346, P467; TOKUMARU H, 1992, EUR J PHARM-MOLEC PH, V227, P363, DOI 10.1016/0922-4106(92)90152-L; WIERZBICKI AS, 1993, ANN NY ACAD SCI, V681, P422, DOI 10.1111/j.1749-6632.1993.tb22926.x; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754	45	234	245	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					431	440		10.1016/S0896-6273(00)80061-6	http://dx.doi.org/10.1016/S0896-6273(00)80061-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789958	Bronze			2022-12-24	WOS:A1996TW95700023
J	Nakao, K; CamposOrtega, JA				Nakao, K; CamposOrtega, JA			Persistent expression of genes of the Enhancer of split complex suppresses neural development in Drosophila	NEURON			English	Article							EARLY NEUROGENESIS; NERVOUS-SYSTEM; NEUROBLAST SEGREGATION; ADJACENT GENES; PRONEURAL GENE; MOTHER CELLS; SCUTE GENES; WING DISK; MELANOGASTER; ACHAETE	The segregation of neural and epidermal progenitors in Drosophila requires the activity of transcription factors encoded by the proneural genes and the genes of the E(SPL)-C. Persistent expression of two genes of the E(SPL)-C suppresses neural development. Embryos exhibit conspicuous central neural hypoplasia and lack sensory organs; imaginal sensory organs are also affected. Suppression of neural development is associated with suppression of the activity of proneural genes. DNA binding is not essential for this effect. Large cells with characteristics of neuroblasts segregate normally in embryos, but these cells fail to express various markers, and the segregated cells and/or their progeny eventually die. These findings indicate that proneural and E(spl) proteins exert antagonistic functions.			Nakao, K (corresponding author), UNIV COLOGNE, INST ENTWICKLUNGSBIOL, D-50923 COLOGNE, GERMANY.							ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ALBERGA A, 1991, DEVELOPMENT, V111, P983; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; BRAND M, 1988, ROUX ARCH DEV BIOL, V197, P457, DOI 10.1007/BF00385679; CABRERA CV, 1987, CELL, V50, P425, DOI 10.1016/0092-8674(87)90496-X; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1992, ROUX ARCH DEV BIOL, V201, P1, DOI 10.1007/BF00188770; CAMPOSORTEGA JA, 1993, DEV DROSOPHILA; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CRONMILLER C, 1993, MECH DEVELOP, V42, P159, DOI 10.1016/0925-4773(93)90005-I; DEDIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731; DELACONCHA A, 1988, GENETICS, V118, P499; DOE CQ, 1992, DEVELOPMENT, V116, P855; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; HARTENSTEIN V, 1994, DEV BIOL, V165, P480, DOI 10.1006/dbio.1994.1269; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; HUANG F, 1991, DEVELOPMENT, V111, P1087; IP YT, 1994, DEVELOPMENT, V120, P199; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; JIMENEZ F, 1990, NEURON, V5, P81, DOI 10.1016/0896-6273(90)90036-F; JIMENEZ F, 1979, NATURE, V282, P310, DOI 10.1038/282310a0; JIMENEZ F, 1987, J NEUROGENET, V4, P179, DOI 10.3109/01677068709102340; JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1987, EMBO J, V6, P4113, DOI 10.1002/j.1460-2075.1987.tb02757.x; KNUST E, 1992, GENETICS, V132, P505; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; LEHMANN R, 1981, ROUX ARCH DEV BIOL, V190, P226, DOI 10.1007/BF00848307; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; OHSAKO S, 1994, GENE DEV, V8, P2743, DOI 10.1101/gad.8.22.2743; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; RUIZGOMEZ M, 1993, EMBO J, V12, P1121, DOI 10.1002/j.1460-2075.1993.tb05753.x; SCHRONS H, 1992, GENETICS, V132, P481; SHEPARD SB, 1989, GENETICS, V122, P429; SIMPSON P, 1990, TRENDS GENET, V6, P343, DOI 10.1016/0168-9525(90)90260-D; SINGSON A, 1994, GENE DEV, V8, P2058, DOI 10.1101/gad.8.17.2058; SKEATH JB, 1994, DEVELOPMENT, V120, P1517; SKEATH JB, 1992, DEVELOPMENT, V114, P939; SKEATH JB, 1992, GENE DEV, V6, P2606, DOI 10.1101/gad.6.12b.2606; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TIETZE K, 1992, P NATL ACAD SCI USA, V89, P6152, DOI 10.1073/pnas.89.13.6152; TREACY MN, 1992, CELL, V68, P491, DOI 10.1016/0092-8674(92)90186-G; USUI K, 1992, DEVELOPMENT, V116, P601; VAESSIN H, 1994, DEVELOPMENT, V120, P935; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; VANDOREN M, 1994, GENE DEV, V8, P2729, DOI 10.1101/gad.8.22.2729; WHITE K, 1980, DEV BIOL, V80, P332, DOI 10.1016/0012-1606(80)90409-1; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	59	115	116	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					275	286		10.1016/S0896-6273(00)80046-X	http://dx.doi.org/10.1016/S0896-6273(00)80046-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789943	Bronze			2022-12-24	WOS:A1996TW95700008
J	Blitzer, RD; Wong, T; Nouranifar, R; Iyengar, R; Landau, EM				Blitzer, RD; Wong, T; Nouranifar, R; Iyengar, R; Landau, EM			Postsynaptic cAMP pathway gates early LTP in hippocampal CA1 region	NEURON			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CALMODULIN-BINDING; ADENYLYL-CYCLASE; MICROCYSTIN-LR; NMDA RECEPTORS; AREA CA1; INHIBITION; CALCIUM; PHOSPHORYLATION	The role of the cAMP pathway in LTP was studied in the CAI region of hippocampus. Widely spaced trains of high frequency stimulation generated cAMP postsynaptically via NMDA receptors and calmodulin, consistent with the Ca2+/calmodulin-mediated stimulation of postsynaptic adenylyl cyclase. The early phase of LTP produced by the same pattern of high frequency stimulation was dependent an postsynaptic cAMP, However, synaptic transmission was not increased by postsynaptic application of cAMP. Early LTP became cAMP-independent when protein phosphatase inhibitors were injected postsynaptically. These observations indicate that in early LTP the cAMP signaling pathway, instead of transmitting signals for the generation of LTP, gates LTP through postsynaptic protein phosphatases.	CUNY MT SINAI SCH MED,DEPT PHARMACOL,NEW YORK,NY 10029; VET ADM MED CTR,PSYCHIAT SERV,BRONX,NY 10468	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Blitzer, RD (corresponding author), CUNY MT SINAI SCH MED,DEPT PSYCHIAT,NEW YORK,NY 10029, USA.				NATIONAL CANCER INSTITUTE [R01CA044998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038761] Funding Source: NIH RePORTER; NCI NIH HHS [CA44998] Funding Source: Medline; NIDDK NIH HHS [DK38761] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; BLAIR SS, 1995, NATURE, V373, P656, DOI 10.1038/373656a0; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLITZER RD, 1994, BRAIN RES, V646, P312, DOI 10.1016/0006-8993(94)90096-5; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CARR DW, 1992, J BIOL CHEM, V267, P16816; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; DOSEMECI A, 1993, J NEUROCHEM, V61, P550; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HAVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761; HOFMANN F, 1985, EUR J BIOCHEM, V150, P85, DOI 10.1111/j.1432-1033.1985.tb08991.x; HONKANEN RE, 1990, J BIOL CHEM, V265, P19401; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; INGLEBRITTSEN TS, 1982, SCIENCE, V221, P331; IYENGAR R, 1993, FASEB J, V7, P768, DOI 10.1096/fasebj.7.9.8330684; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; KELLY PT, 1988, P NATL ACAD SCI USA, V85, P4991, DOI 10.1073/pnas.85.14.4991; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; KENNEDY MB, 1983, P NATL ACAD SCI USA, V80, P945; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MONS N, 1995, IN PRESS P NATL ACAD; MULKEY RM, 1994, NATURE, V369, P488; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NISHIWAKI S, 1990, CARCINOGENESIS, V11, P1837, DOI 10.1093/carcin/11.10.1837; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; PITTALUGA A, 1990, EUR J PHARMACOL, V191, P231, DOI 10.1016/0014-2999(90)94153-O; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SHINOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STONE EA, 1990, BRAIN RES, V530, P295, DOI 10.1016/0006-8993(90)91298-U; THIEMANN W, 1986, BRAIN RES BULL, V17, P1, DOI 10.1016/0361-9230(86)90154-1; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P20; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	70	258	263	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1403	1414		10.1016/0896-6273(95)90018-7	http://dx.doi.org/10.1016/0896-6273(95)90018-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845163	Bronze			2022-12-24	WOS:A1995TL67800018
J	Minichiello, L; Casagranda, F; Tatche, RS; Stucky, CL; Postigo, A; Lewin, GR; Davies, AM; Klein, R				Minichiello, L; Casagranda, F; Tatche, RS; Stucky, CL; Postigo, A; Lewin, GR; Davies, AM; Klein, R			Point mutation in trkB causes loss of NT4-dependent neurons without major effects on diverse BDNF responses	NEURON			English	Article							NERVE-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; NEUROTROPHIC FACTOR; SENSORY NEURONS; SIGNAL-TRANSDUCTION; TARGETED DISRUPTION; ADAPTER PROTEIN; BINDING-SITES; PC12 CELLS; IN-VIVO	Neurotrophins are a family of soluble ligands that promote the survival and differentiation of peripheral and central neurons and regulate synaptic function. The two neurotrophins, brain-derived neurotrophic factor(BDNF) and neurotrophin-4 (NT4), bind and activate a single high-affinity receptor, TrkB. Experiments in cell culture have revealed that an intact Shc adaptor binding site on TrkB and subsequent activation of the Ras/MAPK pathway are important for neuronal survival and neurite outgrowth. To elucidate the intracellular signaling pathways that mediate the diverse effects of BDNF and NT4 in vivo, we have mutated in the mouse germline the Shc binding site in the trkB gene. This trkB(shc) mutation revealed distinctive responses to BDNF and NT4. While nearly all NT4-dependent sensory neurons were lost in trkB(shc/shc) mutant mice, BDNF-dependent neurons were only modestly affected. Activation of MAP kinases and in vitro survival of cultured trkB(shc/shc) neurons were reduced in response to both neurotrophins, with NT4 being less potent than BDNF, suggesting differential activation of TrkB by the two ligands. Moreover, while the Ras/MAPK pathway is required for in vitro differentiation of neuronal cells, trkB(shc/shc) mutant mice do not show any defects in BDNF-dependent differentiation of CNS neurons or in the function of sensory neurons that mediate innocuous touch.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ St Andrews, St Andrews KY16 9TS, Fife, Scotland; Max Delbruck Inst Mol Med, Growth Factor & Regenerat Grp, Dept Neurosci, D-13122 Berlin, Germany	European Molecular Biology Laboratory (EMBL); University of St Andrews; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Klein, R (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Lewin, Gary R/B-8028-2011; Soler, Rosa M/A-7361-2010; Davies, Alun M/A-4334-2010; Minichiello, Liliana/AAA-7190-2022; Klein, Ruediger/C-6147-2008; Tatche, Rosa M Soler/AAJ-6721-2021	Soler, Rosa M/0000-0003-0528-3102; Davies, Alun M/0000-0001-5841-8176; Klein, Ruediger/0000-0002-3109-0163; Tatche, Rosa M Soler/0000-0003-0528-3102; Lewin, Gary/0000-0002-2890-6352				ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Alcantara S, 1997, J NEUROSCI, V17, P3623; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; BAXTER RM, 1995, EUR J BIOCHEM, V234, P84, DOI 10.1111/j.1432-1033.1995.084_c.x; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Carter BD, 1997, NEURON, V18, P187, DOI 10.1016/S0896-6273(00)80259-7; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; Davies AM, 1997, CURR BIOL, V7, pR38, DOI 10.1016/S0960-9822(06)00016-9; DAVIES AM, 1993, J NEUROSCI, V13, P4961; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; Davies AM, 1997, CURR OPIN NEUROBIOL, V7, P110, DOI 10.1016/S0959-4388(97)80128-6; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; de Hoop MJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P154; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; DYMECKI SM, 1998, IN PRESS DEV BIOL; ElShamy WM, 1997, J NEUROSCI, V17, P8667; Erickson JT, 1996, J NEUROSCI, V16, P5361; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FISCHER W, 1994, P NATL ACAD SCI USA, V91, P8607, DOI 10.1073/pnas.91.18.8607; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fritzsch B, 1997, TRENDS NEUROSCI, V20, P159, DOI 10.1016/S0166-2236(96)01007-7; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; GUITON M, 1994, J BIOL CHEM, V269, P30370; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; HYMAN C, 1994, J NEUROSCI, V14, P335; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Minichiello L, 1995, DEVELOPMENT, V121, P4067; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Nakamura T, 1996, ONCOGENE, V13, P1111; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; OBryan JP, 1996, P NATL ACAD SCI USA, V93, P2729, DOI 10.1073/pnas.93.7.2729; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shieh PB, 1997, CURR BIOL, V7, pR627, DOI 10.1016/S0960-9822(06)00319-8; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; STUCKY CL, 1998, IN PRESS J NEUROSCI; Teng KK, 1996, MOL CELL NEUROSCI, V8, P157, DOI 10.1006/mcne.1996.0054; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; VAILLANCOURT RR, 1995, MOL CELL BIOL, V15, P3644; VANDERGEER P, 1995, CURR BIOL, V5, P404, DOI 10.1016/S0960-9822(95)00081-9; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	64	152	157	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					335	345		10.1016/S0896-6273(00)80543-7	http://dx.doi.org/10.1016/S0896-6273(00)80543-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728915	Bronze			2022-12-24	WOS:000075598300011
J	Buchel, C; Morris, J; Dolan, RJ; Friston, KJ				Buchel, C; Morris, J; Dolan, RJ; Friston, KJ			Brain systems mediating aversive conditioning: an event-related fMRI study	NEURON			English	Article							POSITRON-EMISSION TOMOGRAPHY; LATERAL AMYGDALOID NUCLEUS; FEAR-POTENTIATED STARTLE; SINGLE-UNIT ACTIVITY; FUNCTIONAL-ANATOMY; OVERLYING AREAS; NEURAL NETWORKS; MAMMALIAN BRAIN; RED NUCLEUS; MEMORY	We have used event-related functional magnetic resonance imaging (fMRI) to characterize neural responses associated with emotional learning. Employing a classical conditioning paradigm in which faces were conditioned by pairing with an aversive tone (US), we compared responses evoked by conditioned (CS+) and nonconditioned (CS-) stimuli. Pairing 50% of the CS+ with the US enabled us to constrain our analysis to responses evoked by a CS+ not followed by a US. Differential evoked responses, related to conditioning, were found in the anterior cingulate and the anterior insula, regions with known involvement in emotional processing. Differential responses of the amygdalae were best characterized by a time by stimulus interaction indicating a rapid adaptation of CS+-specific responses in this region.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Royal Free Hosp, Sch Med, London NW3 2PF, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Buchel, C (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.		; Friston, Karl/D-9230-2011	Dolan, Ray/0000-0001-9356-761X; Friston, Karl/0000-0001-7984-8909	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BORDI F, 1993, BEHAV NEUROSCI, V107, P757, DOI 10.1037/0735-7044.107.5.757; BORDI F, 1992, J NEUROSCI, V12, P2493; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; CACACE AT, 1992, J ACOUST SOC AM, V91, P203, DOI 10.1121/1.402756; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; CASEY KL, 1995, ADV PAIN RES THER, V22, P201; CLARK RE, 1993, BEHAV NEUROSCI, V107, P264, DOI 10.1037/0735-7044.107.2.264; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; DESMOND JE, 1991, NEUROSCI RES, V10, P260, DOI 10.1016/0168-0102(91)90083-B; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Ekman P., 1982, EMOTION HUMAN FACE; ESTEVES F, 1994, PSYCHOPHYSIOLOGY, V31, P375, DOI 10.1111/j.1469-8986.1994.tb02446.x; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; FANSELOW MS, 1984, TRENDS NEUROSCI, V7, P460; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; Fink GR, 1996, J NEUROSCI, V16, P4275; Fredrikson M, 1995, NEUROREPORT, V7, P97, DOI 10.1097/00001756-199512000-00023; Freeman JH, 1996, BEHAV BRAIN RES, V80, P123, DOI 10.1016/0166-4328(96)00027-7; Friston K, 1995, HUM BRAIN MAPP, V2, P1; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LaBar KS, 1996, BEHAV NEUROSCI, V110, P991, DOI 10.1037/0735-7044.110.5.991; LeDoux J., 1996, EMOTIONAL BRAIN, P138; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; LOGAN CG, 1995, P NATL ACAD SCI USA, V92, P7500, DOI 10.1073/pnas.92.16.7500; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Morris JS, 1997, P ROY SOC B-BIOL SCI, V264, P769, DOI 10.1098/rspb.1997.0109; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Poremba A, 1997, J NEUROSCI, V17, P8645; Poremba A, 1997, J NEUROSCI, V17, P5237; Powell DA, 1996, J NEUROSCI, V16, P6296; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ramnani N, 1996, J PHYSIOL-LONDON, V495, P159, DOI 10.1113/jphysiol.1996.sp021581; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; ROLLS ET, 1994, COGNITIVE NEUROSCIEN, P1091; Schreurs BG, 1997, J NEUROPHYSIOL, V77, P2153, DOI 10.1152/jn.1997.77.4.2153; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Talairach P., 1988, STEREOTACTIC COPLANA; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Whalen PJ, 1998, J NEUROSCI, V18, P411; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	58	729	733	0	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					947	957		10.1016/S0896-6273(00)80476-6	http://dx.doi.org/10.1016/S0896-6273(00)80476-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620699	Bronze, Green Published			2022-12-24	WOS:000073864700014
J	Cabeza, R; Mangels, J; Nyberg, L; Habib, R; Houle, S; McIntosh, AR; Tulving, E				Cabeza, R; Mangels, J; Nyberg, L; Habib, R; Houle, S; McIntosh, AR; Tulving, E			Brain regions differentially involved in remembering what and when: a PET study	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; FRONTAL-LOBE LESIONS; TEMPORAL-ORDER; PREFRONTAL CORTEX; MEMORY RETRIEVAL; EPISODIC MEMORY; AMNESIA; INFORMATION; HUMANS; ACTIVATION	Recollecting a past episode involves remembering not only what happened but also when it happened. We used positron emission tomography (PET) to directly contrast the neural correlates of item and temporal-order memory. Subjects studied a list of words and were then scanned while retrieving information about what words were in the list or when they occurred within the list. Item retrieval was related to increased neural activity in medial temporal and basal forebrain regions, whereas temporal-order retrieval was associated with activations in dorsal prefrontal, cuneus/precuneus, and right posterior parietal regions. The dissociation between temporal and frontal robe regions confirms and extends previous lesion data. The results show that temporal-order retrieval involves a network of frontal and posterior brain regions.	UNIV TORONTO,ROTMAN RES INST,BAYCREST CTR,TORONTO,ON M6A 2E1,CANADA; UMEA UNIV,DEPT PSYCHOL,S-90187 UMEA,SWEDEN; UNIV TORONTO,CLARKE INST PSYCHIAT,PET CTR,TORONTO,ON M5T 1R8,CANADA	University of Toronto; University Toronto Affiliates; Baycrest; Umea University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada			McIntosh, Anthony R/G-4955-2011; Nyberg, Lars/C-2514-2009; Nyberg, Lars/M-5986-2019	Nyberg, Lars/0000-0002-3367-1746; Nyberg, Lars/0000-0002-3367-1746; Houle, Sylvain/0000-0002-4231-6316; McIntosh, Anthony/0000-0002-1784-5662				ALEXANDER MP, 1984, NEUROLOGY, V34, P752, DOI 10.1212/WNL.34.6.752; Awh E, 1995, ANN NY ACAD SCI, V769, P97, DOI 10.1111/j.1749-6632.1995.tb38134.x; BOWERS D, 1988, BRAIN COGNITION, V8, P47, DOI 10.1016/0278-2626(88)90038-3; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1996, J NEUROSCI, V16, P6219; Butters M.A., 1994, NEUROPSYCHOLOGY, V8, P343, DOI DOI 10.1037/0894-4105.8.3.343; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P254, DOI 10.1162/jocn.1997.9.2.254; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; DUDAR JD, 1975, BRAIN RES, V83, P123, DOI 10.1016/0006-8993(75)90863-X; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; FUSTER JM, 1997, PREFRONTAL CORTEX; FUSTER JM, 1985, BRAIN RES, V330, P290; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V13, P1305; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; GOLDMANRAKIC PS, 1993, BRAIN MECHANISMS OF PERCEPTION AND MEMORY: FROM NEURON TO BEHAVIOR, P445; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; KESNER RP, 1994, NEUROPSYCHOLOGIA, V32, P881, DOI 10.1016/0028-3932(94)90040-X; Mangels JA, 1997, NEUROPSYCHOLOGY, V11, P207, DOI 10.1037/0894-4105.11.2.207; Markowitsch Hans J., 1995, P765; MAYES AR, 1995, BEHAV BRAIN RES, V66, P29, DOI 10.1016/0166-4328(94)00120-5; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; MOSCOVITCH M, 1995, P NATL ACAD SCI USA, V92, P3721, DOI 10.1073/pnas.92.9.3721; NAVEHBENJAMIN M, 1990, J EXP PSYCHOL LEARN, V16, P117, DOI 10.1037/0278-7393.16.1.117; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; Nyberg L, 1996, P NATL ACAD SCI USA, V93, P11280, DOI 10.1073/pnas.93.20.11280; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Owen AM, 1996, J COGNITIVE NEUROSCI, V8, P588, DOI 10.1162/jocn.1996.8.6.588; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; PETRIDES M, 1995, ANN NY ACAD SCI; PRIBRAM KH, 1967, SCIENCE, V156, P1765, DOI 10.1126/science.156.3783.1765; Quinlan P. T., 1992, OXFORD PSYCHOLINGUIS; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; RUGG MD, 1997, IN PRESS NEUROREPORT; SAGAR HJ, 1990, BRAIN, V113, P581, DOI 10.1093/brain/113.3.581; SCHACTER DL, 1987, PSYCHOBIOLOGY, V15, P21; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHACTER DL, 1995, NATURE, V376, P537; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Shimamura Arthur P., 1995, P803; Squire L. R., 1987, MEMORY BRAIN; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1982, J EXP PSYCHOL LEARN, V8, P560, DOI 10.1037/0278-7393.8.6.560; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355, https://doi.org/10.1037/0894-4105.8.3.355]; STUSS DT, 1994, HDB NEUROPSYCHOLOGY, V9, P149; TALAIRACH J, 1988, COPLANAR STEROTACTIC; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WEINSTOCK M, 1995, NEURODEGENERATION, V4, P249; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; YAJEYA J, 1988, BRAIN RES, V474, P222, DOI 10.1016/0006-8993(88)90437-4; ZACKS RT, 1984, MEM COGNITION, V12, P387, DOI 10.3758/BF03198299	65	163	164	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					863	870		10.1016/S0896-6273(00)80967-8	http://dx.doi.org/10.1016/S0896-6273(00)80967-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354332	Bronze			2022-12-24	WOS:A1997YD18900013
J	Wang, XH; Poo, MM				Wang, XH; Poo, MM			Potentiation of developing synapses by postsynaptic release of neurotrophin-4	NEURON			English	Article							NERVE GROWTH-FACTOR; DEVELOPING NEUROMUSCULAR SYNAPSES; NICOTINIC ACETYLCHOLINE-RECEPTOR; CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; KITTEN VISUAL-CORTEX; GENE-RELATED PEPTIDE; SYNAPTIC TRANSMISSION; CORTICAL-NEURONS; CELLS	The hypothesis that synaptic functions can be regulated by neurotrophins secreted from the postsynaptic cell was examined in Xenopus nerve-muscle cultures. Neuromuscular synapses formed on myocytes overexpressing neurotrophin-4 (M+ synapses) exhibited a higher level of spontaneous synaptic activity and enhanced evoked synaptic transmission as compared to those formed on normal control myocytes (M- synapses). The NT-4 effects involve a potentiation of presynaptic transmitter secretion as well as a lengthening of the mean burst duration of postsynaptic low conductance acetylcholine channels. Repetitive stimulation of either the presynaptic neuron or the postsynaptic myocyte led to a potentiation of synaptic transmission at M+ synapses. All potentiation effects of NT-4 overexpression were abolished by the extracellular presence of TrkB-IgG but not by the presence of TrkA-IgG, indicating that postsynaptic secretion of NT-4 was responsible for the synaptic modification.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093	University of California System; University of California San Diego								ALDER J, 1995, J NEUROSCI, V15, P511; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; BREHM P, 1984, J PHYSIOL-LONDON, V357, P203, DOI 10.1113/jphysiol.1984.sp015497; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CARMIGNOTO G, 1993, J PHYSIOL-LONDON, V464, P343, DOI 10.1113/jphysiol.1993.sp019638; Cash S, 1996, NEURON, V16, P745, DOI 10.1016/S0896-6273(00)80095-1; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; DAN Y, 1992, NATURE, V359, P733, DOI 10.1038/359733a0; DECKER ER, 1990, J NEUROSCI, V10, P3413; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; EUSEBI F, 1985, J CELL BIOL, V100, P1339, DOI 10.1083/jcb.100.4.1339; EVERS J, 1989, J NEUROSCI, V9, P1523; FERRERMONTIEL AV, 1991, P NATL ACAD SCI USA, V88, P10213, DOI 10.1073/pnas.88.22.10213; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FU WM, 1994, J PHYSIOL-LONDON, V477, P449, DOI 10.1113/jphysiol.1994.sp020206; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HENDERSON LP, 1994, J NEUROSCI, V14, P1153, DOI 10.1523/JNEUROSCI.14-03-01153.1994; Holm NR, 1997, P NATL ACAD SCI USA, V94, P1002, DOI 10.1073/pnas.94.3.1002; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; Ibanez CF, 1996, NEUROCHEM RES, V21, P787, DOI 10.1007/BF02532301; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; KNIPPER M, 1994, NEUROREPORT, V5, P2433, DOI 10.1097/00001756-199412000-00007; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LESSER SS, 1995, J NEUROSCI, V15, P253; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liou JC, 1997, J NEUROSCI, V17, P2459; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; LO YJ, 1994, J NEUROSCI, V14, P4694; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; LOHOF AM, 1994, THESIS COLUMBIA U NE; LU B, 1991, P NATL ACAD SCI USA, V88, P6289, DOI 10.1073/pnas.88.14.6289; LU B, 1993, NATURE, V363, P76, DOI 10.1038/363076a0; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Nawa H, 1997, CRIT REV NEUROBIOL, V11, P91, DOI 10.1615/CritRevNeurobiol.v11.i1.50; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PURVES D, 1985, PRINCIPLES NEURAL DE; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; ROA M, 1991, NEUROSCIENCE, V41, P563, DOI 10.1016/0306-4522(91)90349-S; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; Stoop R, 1996, J NEUROSCI, V16, P3256; Tabti N., 1991, CULTURING NERVE CELL, P137; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; WANG T, 1995, J NEUROSCI, V15, P4796; Xie KW, 1997, J NEUROSCI, V17, P2947; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	77	150	153	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					825	835		10.1016/S0896-6273(00)80964-2	http://dx.doi.org/10.1016/S0896-6273(00)80964-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354329	Bronze			2022-12-24	WOS:A1997YD18900010
J	Taniguchi, M; Yuasa, S; Fujisawa, H; Naruse, I; Saga, S; Mishina, M; Yagi, T				Taniguchi, M; Yuasa, S; Fujisawa, H; Naruse, I; Saga, S; Mishina, M; Yagi, T			Disruption of Semaphorin III/D gene causes severe abnormality in peripheral nerve projection	NEURON			English	Article							GROWTH CONE GUIDANCE; POSTERIOR TECTAL MEMBRANES; COLLAPSIN-1 MESSENGER-RNA; SPINAL-CORD; LUNG-CANCER; AXONAL GUIDANCE; EXPRESSION; SYSTEM; FAMILY; CHEMOREPELLENT	The molecules of the collapsin/semaphorin gene family have been thought to play an essential role in axon guidance during development. Semaphorin III/D is a member of this family, has been shown to repel dorsal root ganglion (DRG) axons in vitro, and has been implicated in the patterning of sensory afferents in the spinal cord. Although semaphorin III/D mRNA is expressed in a wide variety of neural and nonneural tissues in vivo, the role played by semaphorin III/D in regions other than the spinal cord is not known. Here, we show that mice homozygous for a targeted mutation in semaphorin III/D show severe abnormality in peripheral nerve projection. This abnormality is seen in the trigeminal, facial, vagus, accessory, and glossopharyngeal nerves but not in the oculomotor nerve. These results suggest that semaphorin III/D functions as a selective repellent in vivo.	INST DEV RES, AICHI HUMAN SERV CTR, DEPT MORPHOL, KASUGAI, AICHI 48003, JAPAN; CHIBA UNIV, SCH MED, DEPT ANAT, CHUO KU, CHIBA 260, JAPAN; NAGOYA UNIV, GRAD SCH SCI,DIV BIOL SCI,GRP DEV NEUROBIOL, CHIKUSA KU, NAGOYA, AICHI 46401, JAPAN; KYOTO UNIV, SCH MED, CONGENITAL ANOMALY RES CTR, SAKYO KU, KYOTO 60601, JAPAN; UNIV TOKYO, SCH MED, DEPT MOL NEUROBIOL & PHARMACOL, BUNKYO KU, TOKYO 113, JAPAN	Chiba University; Nagoya University; Kyoto University; University of Tokyo	Taniguchi, M (corresponding author), NATL INST PHYSIOL SCI, LAB NEUROBIOL & BEHAV GENET, OKAZAKI, AICHI 444, JAPAN.		Taniguchi, Masaru/N-7932-2015	Taniguchi, Masaru/0000-0001-7821-7179				Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Ozaki S, 1997, J COMP NEUROL, V380, P215; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Roche J, 1996, ONCOGENE, V12, P1289; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; WALTER J, 1987, DEVELOPMENT, V101, P909; WATANABE S, 1995, BIOCHEM BIOPH RES CO, V213, P130, DOI 10.1006/bbrc.1995.2107; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Xiang RH, 1996, GENOMICS, V32, P39, DOI 10.1006/geno.1996.0074; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	43	464	470	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1997	19	3					519	530		10.1016/S0896-6273(00)80368-2	http://dx.doi.org/10.1016/S0896-6273(00)80368-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331345	Bronze			2022-12-24	WOS:A1997XZ01600008
J	Chou, WH; Hall, KJ; Wilson, DB; Wideman, CL; Townson, SM; Chadwell, LV; Britt, SG				Chou, WH; Hall, KJ; Wilson, DB; Wideman, CL; Townson, SM; Chadwell, LV; Britt, SG			Identification of a novel Drosophila opsin reveals specific patterning of the R7 and R8 photoreceptor cells	NEURON			English	Article							ELECTRO-PHYSIOLOGICAL ANALYSIS; TYROSINE KINASE DOMAIN; SCHIFF-BASE COUNTERION; HUMAN COLOR-VISION; MOLECULAR-GENETICS; VISUAL PIGMENT; SEVENLESS PROTEIN; BOVINE RHODOPSIN; COMPOUND EYE; EXTRACELLULAR DOMAIN	The function of the compound eye is dependent upon a developmental program that specifies different cell fates and directs the expression of spectrally distinct opsins in different photoreceptor cells. Rh5 is a novel Drosophila opsin gene that encodes a biologically active visual pigment that is expressed in a subset of R8 photoreceptor cells. Rh5 expression in the R8 cell of an individual ommatidium is strictly coordinated with the expression of Rh3, in the overlying R7 cell. In sevenless mutant flies, which lack R7 photoreceptor cells, the expression of the Rh5 protein in R8 cells is disrupted, providing evidence for a specific developmental signal between the R7 and R8 cells that is responsible for the paired expression of opsin genes.	UNIV TEXAS, HLTH SCI CTR, DEPT MOL MED, SAN ANTONIO, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Chou, WH (corresponding author), UNIV TEXAS, HLTH SCI CTR, INST BIOTECHNOL, SAN ANTONIO, TX 78245 USA.		Chou, Wen-Hai/H-1970-2016; Britt, Steven/GVT-1340-2022	Chou, Wen-Hai/0000-0002-7899-1129; Britt, Steven/0000-0001-7656-7984				ALTSCHUL SF, 1990, BASIC LOCAL ALIGNMEN, V216, P403; Ashburner M, 1989, DROSOPHILA LABORATOR, P44; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BASLER K, 1988, CELL, V54, P299; BASLER K, 1989, SCIENCE, V243, P931, DOI 10.1126/science.2493159; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRITT SG, 1993, NEURON, V11, P29, DOI 10.1016/0896-6273(93)90268-V; BURKHARDT D., 1962, SYMPOSIA SOC EXPTL BIOL, V16, P86; CARULLI JP, 1992, GENETICS, V132, P193; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COWMAN AF, 1986, CELL, V44, P705, DOI 10.1016/0092-8674(86)90836-6; Dickson Barry, 1993, P1327; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Gelbart WM, 1996, NUCLEIC ACIDS RES, V24, P53, DOI 10.1093/nar/24.1.53; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1979, J COMP PHYSIOL, V129, P19, DOI 10.1007/BF00679908; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; HARDIE RC, 1979, J COMP PHYSIOL, V133, P23, DOI 10.1007/BF00663107; HARDIE RC, 1983, CELL TISSUE RES, V233, P1, DOI 10.1007/BF00222228; HARDIE RC, 1983, BIOPHYS STRUCT MECH, V9, P171, DOI 10.1007/BF00537814; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HART AC, 1993, NATURE, V361, P732, DOI 10.1038/361732a0; HEISENBERG M, 1971, J EXP BIOL, V55, P85; HEISENBERG M, 1984, VISION DROSOPHILA; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HU KG, 1978, J COMP PHYSIOL, V126, P15, DOI 10.1007/BF01342646; HUBER A, 1990, J BIOL CHEM, V265, P17906; ISONO K, 1988, J GEN PHYSIOL, V92, P587, DOI 10.1085/jgp.92.5.587; Jacobs GH, 1981, COMP COLOR VISION; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V162, P421, DOI 10.1007/BF00612508; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V163, P421, DOI 10.1007/BF00604896; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MEFFERT P, 1976, NATURE, V260, P342, DOI 10.1038/260342a0; MINKE B, 1979, J GEN PHYSIOL, V73, P517, DOI 10.1085/jgp.73.5.517; MONTELL C, 1987, J NEUROSCI, V7, P1558; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NATHANS J, 1992, ANNU REV GENET, V26, P403, DOI 10.1146/annurev.ge.26.120192.002155; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; Ohguro H, 1996, J BIOL CHEM, V271, P5215; OPRIAN DD, 1992, J BIOENERG BIOMEMBR, V24, P211, DOI 10.1007/BF00762679; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; RANGANATHAN R, 1991, TRENDS NEUROSCI, V14, P486, DOI 10.1016/0166-2236(91)90060-8; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; ROBERTSON HM, 1989, GENETICS, V123, P815; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SMOLA U, 1979, J COMP PHYSIOL, V133, P41, DOI 10.1007/BF00663108; STARK WS, 1977, J COMP PHYSIOL, V115, P47, DOI 10.1007/BF00667784; STARK WS, 1977, J COMP PHYSIOL, V121, P289, DOI 10.1007/BF00613010; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Sved J, 1986, DROSOPH INF SERV, V63, P169; SWIMMER C, 1985, NUCLEIC ACIDS RES, V13, P8053, DOI 10.1093/nar/13.22.8053; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VOGT K, 1984, NATURWISSENSCHAFTEN, V71, P211, DOI 10.1007/BF00490436; VOGT K, 1984, Z NATURFORSCH C, V39, P196; Wolff Tanya, 1993, P1277; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373; ZUKER CS, 1987, J NEUROSCI, V7, P1550; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	97	142	146	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1101	1115		10.1016/S0896-6273(00)80243-3	http://dx.doi.org/10.1016/S0896-6273(00)80243-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982159	Bronze			2022-12-24	WOS:A1996WA24800009
J	Liu, FC; Graybiel, AM				Liu, FC; Graybiel, AM			Spatiotemporal dynamics of CREB phosphorylation: Transient versus sustained phosphorylation in the developing striatum	NEURON			English	Article							LONG-TERM-MEMORY; DEPENDENT PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY GENES; MAMMALIAN BRAIN; NERVOUS-SYSTEM; DOPAMINERGIC REGULATION; MOLECULAR MECHANISMS; ORGANOTYPIC CULTURES; PHOSPHATASE CASCADE	The cAMP response element-binding protein (CREB) is a plasticity-associated transcription factor that can potentially integrate cAMP and calcium signals at the gene activation level. We tested for convergent Ser-133 phosphorylation of CREB via dopamine D1/D5 receptors and L-type calcium channels in organotypic cultures of neonatal striatum. We found such convergence only transiently. Sustained CREB phosphorylation by D1/D5 receptor and L-type channel agonists was targeted to opposite (striosome and matrix) cellular phenotypes. Subsequent expression of the CRE-containing gene, c-fos, matched the divergent patterns of sustained CREB phosphorylation, and both divergent patterns could be switched by inhibition of phosphatases, including calcineurin. Control of the duration of CREB phosphorylation may be a critical regulator of CRE-mediated gene expression by dopamine and calcium.	MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139; NATL YANG MING UNIV,INST NEUROSCI,TAIPEI 11221,TAIWAN	Massachusetts Institute of Technology (MIT); National Yang Ming Chiao Tung University				Graybiel, Ann/0000-0002-4326-7720	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028341] Funding Source: NIH RePORTER; NICHD NIH HHS [1-R01-HD28341] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BITO H, 1996, IN PRESS CELL, V87; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; COMB M, 1987, TRENDS NEUROSCI, V10, P473, DOI 10.1016/0166-2236(87)90103-2; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FOSTER GA, 1987, J NEUROSCI, V7, P1994; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOTO S, 1989, EXP BRAIN RES, V77, P442, DOI 10.1007/BF00275004; GOTO S, 1987, NEUROSCIENCE, V22, P189, DOI 10.1016/0306-4522(87)90209-0; GRAYBIEL AM, 1984, NEUROSCIENCE, V13, P1157, DOI 10.1016/0306-4522(84)90293-8; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HEMMINGS HC, 1987, TRENDS NEUROSCI, V10, P377, DOI 10.1016/0166-2236(87)90075-0; HEMMINGS HC, 1984, NATURE, V310, P502; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HUGHES P, 1995, PHARMACOL REV, V47, P133; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; KING MM, 1984, J BIOL CHEM, V259, P8080; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; KRUSHEL LA, 1995, EUR J NEUROSCI, V7, P1210, DOI 10.1111/j.1460-9568.1995.tb01111.x; LIU FC, 1995, J NEUROSCI, V15, P2367, DOI 10.1523/JNEUROSCI.15-03-02367.1995; LIU FC, 1992, J COMP NEUROL, V320, P304, DOI 10.1002/cne.903200304; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MIN BH, 1994, P NATL ACAD SCI USA, V91, P9081, DOI 10.1073/pnas.91.19.9081; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; OUIMET CC, 1984, J NEUROSCI, V4, P111; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; SCHULMAN H, 1995, CURR OPIN NEUROBIOL, V5, P375, DOI 10.1016/0959-4388(95)80051-4; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	52	162	164	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1133	1144		10.1016/S0896-6273(00)80245-7	http://dx.doi.org/10.1016/S0896-6273(00)80245-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982161	Bronze			2022-12-24	WOS:A1996WA24800011
J	Davis, GW; Schuster, CM; Goodman, CS				Davis, GW; Schuster, CM; Goodman, CS			Genetic dissection of structural and functional components of synaptic plasticity .3. CREB is necessary for presynaptic functional plasticity	NEURON			English	Article							CAMP-RESPONSIVE ELEMENT; LONG-TERM FACILITATION; APLYSIA SENSORY NEURONS; CYCLIC-AMP; BEHAVIORAL SENSITIZATION; MACROMOLECULAR-SYNTHESIS; MOTOR AXONS; DROSOPHILA; PROTEIN; MEMORY	Increased cAMP (in dunce mutants) leads to an increase in the structure and function of the Drosophila neuromuscular junction. Synaptic Fasciclin II (Fas II) controls this structural plasticity, but does not alter synaptic function. Here, we show that CREB, the cAMP response element-binding protein, acts in parallel with Fas II to cause an increase in synaptic strength. Expression of the cREB repressor (dCREB2-b) in the dunce mutant blocks functional but not structural plasticity. Expression of the CREB activator (dCREB2-a) increases synaptic strength only in FasII mutants that increase bouton number. This CREB-mediated increase in synaptic strength is due to increased presynaptic transmitter release. Expression of dCREB2-a in a FasII mutant background genetically reconstitutes this cAMP-dependent plasticity. Thus, cAMP initiates parallel changes in CREB and Fas II to achieve long-term synaptic enhancement.			Davis, GW (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOL & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYD IA, 1956, J PHYSIOL-LONDON, V132, P74, DOI 10.1113/jphysiol.1956.sp005503; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; EVENS M, 1993, STAT DISTRIBUTIONS; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Nishikawa K, 1995, J NEUROSCI, V15, P7905; OLSON NJ, 1995, P NATL ACAD SCI USA, V92, P1659, DOI 10.1073/pnas.92.5.1659; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864; ZHONG Y, 1992, J NEUROSCI, V12, P644	32	213	217	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					669	679		10.1016/S0896-6273(00)80199-3	http://dx.doi.org/10.1016/S0896-6273(00)80199-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893024	Bronze			2022-12-24	WOS:A1996VP74300012
J	Littleton, JT; Chapman, ER; Kreber, R; Garment, MB; Carlson, SD; Ganetzky, B				Littleton, JT; Chapman, ER; Kreber, R; Garment, MB; Carlson, SD; Ganetzky, B			Temperature-sensitive paralytic mutations demonstrate that synaptic exocytosis requires SNARE complex assembly and disassembly	NEURON			English	Article							PROTEIN-PROTEIN INTERACTIONS; CYSTEINE-STRING PROTEIN; NEUROTRANSMITTER RELEASE; VESICLE FUSION; YEAST VACUOLES; T-SNARE; DROSOPHILA; SYNAPTOTAGMIN; DOCKING; SYNAPTOBREVIN	The neuronal SNARE complex is formed via the interaction of synaptobrevin with syntaxin and SNAP-25. Purified SNARE proteins assemble spontaneously, while disassembly requires the ATPase NSF. cycles of assembly and disassembly have been proposed to drive lipid bilayer fusion. However, this hypothesis remains to be tested in vivo. We have isolated a Drosophila temperature-sensitive paralytic mutation in syntaxin that rapidly blocks synaptic transmission at nonpermissive temperatures. This paralytic mutation specifically and selectively decreases binding to synaptobrevin and abolishes assembly of the 7S SNARE complex. Temperature-sensitive paralytic mutations in NSF (comatose) also block synaptic transmission, but over a much slower time course and with the accumulation of syntaxin and SNARE complexes on synaptic vesicles. These results provide in vivo evidence that cycles of assembly and disassembly of SNARE complexes drive membrane trafficking at synapses.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Littleton, JT (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.			Littleton, J. Troy/0000-0001-5576-2887; Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827, R01GM043100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015390] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43100, R01 GM56827] Funding Source: Medline; NINDS NIH HHS [NS15390] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; LITTLETON JT, 1995, TRENDS NEUROSCI, V18, P177; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Marsal J, 1997, P NATL ACAD SCI USA, V94, P14871, DOI 10.1073/pnas.94.26.14871; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MORGAN A, 1994, J BIOL CHEM, V269, P29347; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; PALLANCK L, 1995, NATURE, V376, P25, DOI 10.1038/376025a0; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; SAINTMARIE RL, 1982, J NEUROCYTOL, V11, P747, DOI 10.1007/BF01153517; SCHELLER RH, 1995, NEURON, V14, P893; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SIDDIQI O, 1976, P NATL ACAD SCI USA, V73, P3253, DOI 10.1073/pnas.73.9.3253; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	62	171	178	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1998	21	2					401	413		10.1016/S0896-6273(00)80549-8	http://dx.doi.org/10.1016/S0896-6273(00)80549-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728921	Bronze			2022-12-24	WOS:000075598300017
J	Mansuy, IM; Winder, DG; Moallem, TM; Osman, M; Mayford, M; Hawkins, RD; Kandel, ER				Mansuy, IM; Winder, DG; Moallem, TM; Osman, M; Mayford, M; Hawkins, RD; Kandel, ER			Inducible and reversible gene expression with the rtTA system for the study of memory	NEURON			English	Article							TRANSGENIC MICE; MAMMALIAN-CELLS; RETRIEVAL; RATS; ACTIVATION; PROMOTER	To obtain rapidly inducible and reversible expression of transgenes in the forebrain of the mouse, we have combined the reverse tetracycline-controlled trans-activator (rtTA) system with the CaMKll alpha promoter. We show that doxycycline induces maximal gene expression in neurons of the forebrain within 6 days and that this expression can be reversed by removal of doxycycline. Using calcineurin as a test transgene, we show that doxycycline-induced expression impairs both an intermediate form of LTP (l-LTP) in the hippocampus and the storage of spatial memory. The reversibility of the rtTA system in turn allowed us to examine the effects of the transgene on memory retrieval after normal storage had occurred. This examination suggests that retrieval requires some of the same molecular components required for storage.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York State Psychiat Inst, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Howard Hughes Medical Institute	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York State Psychiat Inst, 722 W 168th St, New York, NY 10032 USA.		Mansuy, Isabelle M/N-3042-2015; Winder, Danny G./H-4857-2013	Mansuy, Isabelle M/0000-0001-7785-5371; Mayford, Mark/0000-0002-9001-5024				BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CAI ZJ, 1990, NEUROSCI BIOBEHAV R, V14, P295, DOI 10.1016/S0149-7634(05)80039-9; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GILLUND G, 1984, PSYCHOL REV, V91, P1, DOI 10.1037/0033-295X.91.1.1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OVERTON DA, 1966, PSYCHOPHARMACOLOGIA, V10, P6, DOI 10.1007/BF00401896; OVERTON DA, 1964, J COMP PHYSIOL PSYCH, V57, P3, DOI 10.1037/h0048023; SPEAR NE, 1973, PSYCHOL REV, V80, P163, DOI 10.1037/h0034326; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X	22	194	201	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					257	265		10.1016/S0896-6273(00)80533-4	http://dx.doi.org/10.1016/S0896-6273(00)80533-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728905	hybrid			2022-12-24	WOS:000075598300001
J	Huang, YY; Kandel, ER				Huang, YY; Kandel, ER			Postsynaptic induction and PKA-dependent expression of LTP in the lateral amygdala	NEURON			English	Article							LONG-TERM POTENTIATION; PAIRED-PULSE FACILITATION; HIPPOCAMPAL CA1 REGION; SYNAPTIC TRANSMISSION; BASOLATERAL AMYGDALA; QUANTAL ANALYSIS; LATE-PHASE; FIBER LTP; AREA CA1; 2 FORMS	Whereas much is now known about the behavioral importance of the lateral nucleus of the amygdala for the storage of implicit memories of fear, little is known in molecular terms about the signal transduction pathways required for long-term potentiation (LTP) in this nucleus. Using brain slices containing the amygdala, we have studied LTP in the pathway from external capsule to the lateral nucleus, a pathway that mediates information from the auditory cortex important for fear conditioning. We found the induction of LTP is postsynaptic; it is dependent on postsynaptic depolarization, on the influx of Ca2+ into the postsynaptic cell and, at least in part, on the activation of N-methyl-D-aspartate (NMDA) receptors. The LTP is associated with a decrease of paired-pulse facilitation (PPF) and is blocked by bath application but not blocked by postsynaptic injection of inhibitors of the cyclic adenosine monophosphate-dependent (cAMP-dependent) protein kinase (PKA). Consistent with the possibility that the expression might involve PKA presynaptically, the adenylyl cyclase activator forskolin induced synaptic potentiation of this pathway that also was associated with a decrease of PPF, and this potentiation occluded the tetanus-induced LTP.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; New York State Psychiat Inst, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.							Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Arai A, 1996, BRAIN RES, V716, P202, DOI 10.1016/0006-8993(96)00030-3; Asztely F, 1996, NEUROREPORT, V7, P1609, DOI 10.1097/00001756-199607080-00016; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Byrne JH, 1996, J NEUROSCI, V16, P425; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; CHAPMAN PF, 1992, SYNAPSE, V11, P310, DOI 10.1002/syn.890110406; CHAPMAN PF, 1990, SYNAPSE, V6, P271, DOI 10.1002/syn.890060306; CHRISTIE BR, 1994, NEUROREPORT, V5, P385, DOI 10.1097/00001756-199401120-00003; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; DIXON D, 1989, J NEUROSCI, V9, P4246; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GEAN PW, 1993, BRAIN RES BULL, V31, P7; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; GUSTAFSSON B, 1988, NEUROSCI LETT, V85, P77, DOI 10.1016/0304-3940(88)90432-6; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; HUANG YY, 1993, J NEUROSCI, V13, P568; JAHR CE, 1985, J NEUROSCI, V5, P2281; KUHNT U, 1994, NEUROSCIENCE, V62, P391, DOI 10.1016/0306-4522(94)90374-3; Lamprecht R, 1997, J NEUROSCI, V17, P8443; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; LIANG KC, 1986, BRAIN RES, V368, P125, DOI 10.1016/0006-8993(86)91049-8; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MULLER D, 1989, BRAIN RES, V479, P290, DOI 10.1016/0006-8993(89)91631-4; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; RAINNIE DG, 1991, J NEUROPHYSIOL, V66, P986, DOI 10.1152/jn.1991.66.3.986; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; SALIN PA, 1996, NEURON, V16, P747; Schulz PE, 1997, P NATL ACAD SCI USA, V94, P5888, DOI 10.1073/pnas.94.11.5888; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; Wang JH, 1996, J NEUROPHYSIOL, V76, P276, DOI 10.1152/jn.1996.76.1.276; WATANABE Y, 1995, NEUROSCI RES, V21, P317, DOI 10.1016/0168-0102(94)00867-F; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167	47	271	278	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					169	178		10.1016/S0896-6273(00)80524-3	http://dx.doi.org/10.1016/S0896-6273(00)80524-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697861	hybrid			2022-12-24	WOS:000075061900016
J	Gibbs, SM; Truman, JW				Gibbs, SM; Truman, JW			Nitric oxide and cyclic GMP regulate retinal patterning in the optic lobe of Drosophila	NEURON			English	Article							LONG-TERM POTENTIATION; NADPH-DIAPHORASE; VISUAL-SYSTEM; INTERCELLULAR MESSENGER; GUANYLATE-CYCLASE; METHYLENE-BLUE; GROWTH CONES; SYNTHASE; INHIBITION; NEURONS	The photoreceptors of Drosophila express a nitric oxide-sensitive guanylate cyclase during the first half of metamorphosis, when postsynaptic elements in the optic robe are being selected. Throughout this period, the optic robes show NADPH-diaphorase activity and stain with an antibody to nitric oxide synthase (NOS). The NOS inhibitor L-NAME, the NO scavenger PTIO, the sGC inhibitor ODQ, and methylene blue, which inhibits NOS and guanylate cyclase, each caused the disorganization of retinal projections and extension of photoreceptor axons beyond their normal synaptic layers in vitro. The disruptive effects of L-NAME were prevented with the addition of 8-bromo-cGMP. These results suggest NO and cGMP act to stabilize retinal growth cones at the start of synaptic assembly.	Univ Washington, Dept Zool, Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gibbs, SM (corresponding author), Univ Washington, Dept Zool, Program Neurobiol & Behav, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013079] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 13079] Funding Source: Medline; PHS HHS [5T32H007138] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3202; ASHLEY JA, 1994, DEVELOPMENT, V120, P1537; AWAD TA, 1995, THESIS U WASHINGTON; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; BRUNE B, 1987, MOL PHARMACOL, V32, P497; CAMPOS AR, 1992, DEVELOPMENT, V114, P355; Cramer KS, 1996, J NEUROSCI, V16, P7995; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; Elphick MR, 1996, J EXP BIOL, V199, P2395; FARBER DB, 1979, BIOCHEMISTRY-US, V18, P370, DOI 10.1021/bi00569a022; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GELPERIN A, 1994, NATURE, V369, P61, DOI 10.1038/369061a0; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HARTZELL HC, 1986, NATURE, V323, P273, DOI 10.1038/323273a0; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Ientile R, 1996, FEBS LETT, V379, P82, DOI 10.1016/0014-5793(95)01490-X; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KALB RG, 1993, NEUROSCIENCE, V57, P1, DOI 10.1016/0306-4522(93)90107-Q; KUNES S, 1993, J NEUROSCI, V13, P752; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LI CL, 1995, J NEUROBIOL, V28, P363, DOI 10.1002/neu.480280309; LUO D, 1995, EUR J PHARM-MOLEC PH, V290, P247, DOI 10.1016/0922-4106(95)00084-4; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Meinertzhagen Ian A., 1993, P1363; MEULEMANS A, 1994, NEUROSCI LETT, V171, P89, DOI 10.1016/0304-3940(94)90612-2; MIKI N, 1977, BIOCHEM BIOPH RES CO, V75, P851, DOI 10.1016/0006-291X(77)91460-7; MORTON DB, 1992, J NEUROCHEM, V59, P1522, DOI 10.1111/j.1471-4159.1992.tb08469.x; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; MULLER U, 1993, NATURWISSENSCHAFTEN, V80, P524, DOI 10.1007/BF01140811; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; PAUPARDINTRITSCH D, 1986, J NEUROSCI, V6, P2715; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Renteria RC, 1996, J NEUROBIOL, V29, P415; Riddiford Lynn M., 1993, P899; ROSKAMS AJ, 1994, NEURON, V13, P289; SCHOLZ NL, 1998, IN PRESS J NEUROBIOL; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; Truman JW, 1996, DEVELOPMENT, V122, P3949; WANG T, 1995, NATURE, V374, P262, DOI 10.1038/374262a0; Wolff Tanya, 1993, P1277; WU HH, 1994, SCIENCE, V265, P1593, DOI 10.1126/science.7521541; XIONG WC, 1995, NEURON, V14, P581, DOI 10.1016/0896-6273(95)90314-3; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZHOU M, 1993, SCIENCE, V260, P1946; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	55	183	184	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1998	20	1					83	93		10.1016/S0896-6273(00)80436-5	http://dx.doi.org/10.1016/S0896-6273(00)80436-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459444	Bronze			2022-12-24	WOS:000071719700011
J	Navaratnam, DS; Bell, TJ; Tu, TD; Cohen, EL; Oberholtzer, JC				Navaratnam, DS; Bell, TJ; Tu, TD; Cohen, EL; Oberholtzer, JC			Differential distribution of Ca2+-activated K+ channel splice variants among hair cells along the tonotopic axis of the chick cochlea	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; ION-DEPENDENT CONDUCTANCES; CALCIUM-BINDING PROTEIN; BETA-SUBUNIT; ELECTRICAL RESONANCE; INNER-EAR; RANA-CATESBEIANA; BIRD COCHLEA; HUMAN BRAIN; BULL-FROG	We have cloned from the receptor epithelium of the chick cochlea a family of alternatively spliced cDNAs derived from cslo, which encodes a Ca2+-activated K+ channel like those shown to help determine the resonant frequency of electrically tuned hair cells. Our results from PCRs using template RNAs from both tonotopically subdivided receptor epithelia and single hair cells demonstrate differential exon usage along the frequency axis of the epithelium at multiple splice sites in cslo. We also show that single hair cells express more than one splice variant at a given splice site. Since channel isoforms encoded by differentially spliced slo transcripts in other species are functionally heterogeneous, these data suggest that differential processing of slo transcripts may account, at least in part, for the systematic variation in hair-cell membrane properties along the frequency axis of electrically tuned auditory receptor epithelia.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,DIV NEUROPATHOL,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002755] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02755] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; EATOCK RA, 1993, J NEUROSCI, V13, P1767; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; FETTIPLACE R, 1980, HEARING RES, V2, P447, DOI 10.1016/0378-5955(80)90081-7; FETTIPLACE R, 1987, TRENDS NEUROSCI, V10, P421, DOI 10.1016/0166-2236(87)90013-0; FUCHS PA, 1992, PROG NEUROBIOL, V39, P493, DOI 10.1016/0301-0082(92)90003-W; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; FUCHS PA, 1988, J NEUROSCI, V8, P2460; FUCHS PA, 1988, J COMP PHYSIOL A, V164, P151, DOI 10.1007/BF00603947; Goodman MB, 1996, J PHYSIOL-LONDON, V497, P395, DOI 10.1113/jphysiol.1996.sp021776; Goodman MB, 1996, BIOPHYS J, V71, P430, DOI 10.1016/S0006-3495(96)79245-7; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; HUNZIKER W, 1986, P NATL ACAD SCI USA, V83, P7578, DOI 10.1073/pnas.83.20.7578; Jiang GJ, 1997, P ROY SOC B-BIOL SCI, V264, P731, DOI 10.1098/rspb.1997.0104; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; NAVARATNAM DS, 1995, J BIOL CHEM, V270, P19238, DOI 10.1074/jbc.270.33.19238; OBERHOLTZER JC, 1994, DNA CELL BIOL, V13, P857, DOI 10.1089/dna.1994.13.857; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; PITCHFORD S, 1987, HEARING RES, V27, P75, DOI 10.1016/0378-5955(87)90027-X; REINHART PH, 1995, J NEUROSCI, V15, P4572; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Sambrok J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; SIEBERT PD, 1993, BIOTECHNIQUES, V14, P244; SUGIHARA I, 1989, J NEUROPHYSIOL, V62, P1330, DOI 10.1152/jn.1989.62.6.1330; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; TILNEY LG, 1988, J CELL BIOL, V107, P2563, DOI 10.1083/jcb.107.6.2563; TILNEY LG, 1986, DEV BIOL, V116, P100, DOI 10.1016/0012-1606(86)90047-3; TsengCrank J, 1996, P NATL ACAD SCI USA, V93, P9200, DOI 10.1073/pnas.93.17.9200; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5; Wu YC, 1996, BIOPHYS J, V70, P2557, DOI 10.1016/S0006-3495(96)79827-2; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7	59	144	147	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1077	1085		10.1016/S0896-6273(00)80398-0	http://dx.doi.org/10.1016/S0896-6273(00)80398-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390520	Bronze			2022-12-24	WOS:A1997YH59400014
J	Gil, Z; Connors, BW; Amitai, Y				Gil, Z; Connors, BW; Amitai, Y			Differential regulation of neocortical synapses by neuromodulators and activity	NEURON			English	Article							BUNGAROTOXIN BINDING-SITES; TERM SYNAPTIC PLASTICITY; RAT PREFRONTAL CORTEX; CROSS-CORRELATION; NUCLEUS BASALIS; PERFORANT PATH; BARREL CORTEX; MESSENGER-RNA; VISUAL-CORTEX; RECEPTORS	Synapses are continually regulated by chemical modulators and by their own activity. We tested the specificity of regulation in two excitatory pathways of the neocortex: thalamocortical (TC) synapses, which mediate specific inputs, and intracortical (IC) synapses, which mediate the recombination of cortical information. Frequency-sensitive depression was much stronger in TC synapses than in IC synapses. The two synapse types were differentially sensitive to presynaptic neuromodulators: only IC synapses were suppressed by activation of GABA, receptors, only TC synapses were enhanced by nicotinic acetylcholine receptors, and muscarinic acetylcholine receptors suppressed both synapse types. Modulators also differentially altered the frequency sensitivity of the synapses. Our results suggest a mechanism by which the relative strength and dynamics of input and associational pathways of neocortex are regulated during changes in behavioral state.	BEN GURION UNIV NEGEV,ZLOTOWSKI CTR NEUROSCI,DEPT PHYSIOL,IL-84105 BEER SHEVA,ISRAEL; BROWN UNIV,DEPT NEUROSCI,PROVIDENCE,RI 02912	Ben Gurion University; Brown University			Connors, Barry/AAX-1975-2020; Amitai, Yael/G-2791-2013	Connors, Barry/0000-0002-3739-3157; Amitai, Yael/0000-0001-6664-8705				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADAMS RW, 1988, ELECTROEN CLIN NEURO, V69, P45, DOI 10.1016/0013-4694(88)90034-X; AGMON A, 1992, J NEUROSCI, V12, P319; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; ALBUQUERQUE EX, 1995, SEMIN NEUROSCI, V7, P91, DOI 10.1006/smns.1995.0011; BINA KG, 1995, J COMP NEUROL, V363, P321, DOI 10.1002/cne.903630212; BROIDE RS, 1995, NEUROSCIENCE, V67, P83, DOI 10.1016/0306-4522(94)00623-D; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; CastroAlamancos MA, 1996, J NEUROSCI, V16, P2767; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; ECKENSTEIN F, 1987, CEREB CORTEX, V6, P129; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Gil Z, 1996, J NEUROSCI, V16, P6567; GRANON S, 1995, PSYCHOPHARMACOLOGY, V119, P139, DOI 10.1007/BF02246154; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Johnson MJ, 1996, J NEUROPHYSIOL, V75, P1444, DOI 10.1152/jn.1996.75.4.1444; KAHLE JS, 1989, BRAIN RES, V482, P159, DOI 10.1016/0006-8993(89)90554-4; Kang Y, 1995, J NEUROSCI, V15, P8268; Katz PS, 1996, TRENDS NEUROSCI, V19, P54, DOI 10.1016/0166-2236(96)89621-4; Lavine N, 1997, J COMP NEUROL, V380, P175, DOI 10.1002/(SICI)1096-9861(19970407)380:2<175::AID-CNE3>3.0.CO;2-0; LEWANDOWSKI MH, 1993, EXP BRAIN RES, V96, P1; Marder E, 1996, CURR BIOL, V6, P119, DOI 10.1016/S0960-9822(02)00438-4; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1986, J PHYSIOL-LONDON, V375, P169, DOI 10.1113/jphysiol.1986.sp016112; McGehee DS, 1996, CURR OPIN NEUROBIOL, V6, P342, DOI 10.1016/S0959-4388(96)80118-8; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; METHERATE R, 1992, J NEUROSCI, V12, P4701; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Ramoa AS, 1996, CEREB CORTEX, V6, P640, DOI 10.1093/cercor/6.4.640; RYE DB, 1984, NEUROSCIENCE, V13, P627, DOI 10.1016/0306-4522(84)90083-6; SAHIN M, 1992, BRAIN RES, V579, P135, DOI 10.1016/0006-8993(92)90752-U; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Steriade M, 1993, Curr Opin Neurobiol, V3, P619, DOI 10.1016/0959-4388(93)90064-6; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; TANG AC, 1994, BRAIN RES, V659, P75, DOI 10.1016/0006-8993(94)90865-6; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P19; TSODYKS M, 1996, P NATL ACAD SCI USA, V94, P719; VIDAL C, 1993, NEUROSCIENCE, V56, P23, DOI 10.1016/0306-4522(93)90558-W; WARD JM, 1990, FEBS LETT, V270, P45, DOI 10.1016/0014-5793(90)81231-C; White E.L., 1989, CORTICAL CIRCUITS SY; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	57	446	448	4	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					679	686		10.1016/S0896-6273(00)80380-3	http://dx.doi.org/10.1016/S0896-6273(00)80380-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331357	Bronze			2022-12-24	WOS:A1997XZ01600020
J	Broillet, MC; Firestein, S				Broillet, MC; Firestein, S			beta subunits of the olfactory cyclic nucleotide-gated channel form a nitric oxide activated Ca2+ channel	NEURON			English	Article							RECEPTOR NEURONS; FUNCTIONAL EXPRESSION; MOLECULAR MECHANISM; ROD PHOTORECEPTORS; ION-CHANNEL; CAMP; SENSITIVITY; SELECTIVITY; PERMEATION; CATIONS	Cyclic nucleotide-gated channels are important in visual and olfactory transduction, and possibly in other neuronal functions. These channels have a complex permeability to Ca2+ ions that may be important in their cellular functions. They are composed of two different subunits, alpha and beta, that have been cloned and expressed, but the beta subunit alone cannot be activated by cyclic nucleotides, confounding the analysis of its characteristics. However, we found that nitric oxide can activate the homomeric expressed beta subunit, and the resulting channel possesses many properties of the L-type Ca2+ channels, including high permeability to Ca2+ ions and sensitivity to Ca2+ channel blockers. Thus, the Ca2+ permeability characteristics of native channels are mostly conferred by properties of the beta subunit, and the beta subunit alone can act as a NO-sensitive Ca2+ channel. A nearly identical conductance activated by NO is present in the membrane of rat vomeronasal neurons, indicating that homomeric beta channels exist in vivo.			Broillet, MC (corresponding author), COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027, USA.			Broillet, Marie-Christine/0000-0002-0487-6638				BALASUBRAMANIAN S, 1995, J MEMBRANE BIOL, V146, P177; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Bradley J, 1997, J NEUROSCI, V17, P1993; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Bucossi G, 1997, BIOPHYS J, V72, P1165, DOI 10.1016/S0006-3495(97)78765-4; BUTLER AR, 1995, TRENDS PHARMACOL SCI, V16, P18, DOI 10.1016/S0165-6147(00)88968-3; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Kingston PA, 1996, P NATL ACAD SCI USA, V93, P10440, DOI 10.1073/pnas.93.19.10440; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Liman ER, 1996, J NEUROSCI, V16, P4625; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LYNCH JW, 1994, J GEN PHYSIOL, V103, P87, DOI 10.1085/jgp.103.1.87; NICOL GD, 1993, J PHARMACOL EXP THER, V265, P626; PARK CS, 1995, BIOCHEMISTRY-US, V34, P13328, DOI 10.1021/bi00041a008; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; ROOT MJ, 1993, NEURON, V11, P459, DOI 10.1016/0896-6273(93)90150-P; ROSKAMS AJ, 1994, NEURON, V13, P289; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SESTI F, 1995, J PHYSIOL-LONDON, V487, P17, DOI 10.1113/jphysiol.1995.sp020858; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZHAO HQ, 1994, NEUROREPORT, V6, P149, DOI 10.1097/00001756-199412300-00038; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	42	71	71	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					951	958		10.1016/S0896-6273(00)80334-7	http://dx.doi.org/10.1016/S0896-6273(00)80334-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208862	Bronze			2022-12-24	WOS:A1997XJ10200013
J	Raghavan, S; White, RAH				Raghavan, S; White, RAH			Connectin mediates adhesion in Drosophila	NEURON			English	Article							GROWTH CONE GUIDANCE; FASCICLIN-III; RECOGNITION MOLECULE; EMBRYOS; MELANOGASTER; MOTONEURONS; EXPRESSION; TARGET; SYSTEM; SUBSET	The Drosophila cell-surface molecule connectin mediates cell-cell adhesion in vitro, and its expression pattern in vivo fits well with an adhesion role in the embryonic neuromuscular system. However, connectin mutants do not show dramatic neuromuscular defects, and ectopic expression studies so far have not supported an adhesion role. Here, we demonstrate that connectin mutants do have a phenotype; the normally connectin-positive pleural muscles fail to adhere closely together. An in vivo adhesion role is supported by misexpression studies, which result in excessive adhesion of normally connectin-negative muscles. Misexpression also causes defects in axon pathfinding. While a previous study interpreted similar defects as indicating a repulsion role for connectin, we argue that the phenotypes are consistent with connectin's adhesion role.			Raghavan, S (corresponding author), UNIV CAMBRIDGE,DEPT ANAT,CAMBRIDGE CB2 3DY,ENGLAND.		White, Rob A H/G-4835-2012		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bate Michael, 1993, P1013; BRAND AH, 1993, DEVELOPMENT, V118, P401; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOULD AP, 1992, DEVELOPMENT, V116, P1163; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HALPERN ME, 1991, J NEUROSCI, V11, P3227; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; LOU L, 1994, GENE DEV, V8, P1787; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MEADOWS LA, 1994, J CELL SCI, V107, P321; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; MITCHISON TJ, 1983, DEV BIOL, V99, P261, DOI 10.1016/0012-1606(83)90275-0; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; SINK H, 1991, DEVELOPMENT, V112, P307; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5	25	30	30	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					873	880		10.1016/S0896-6273(00)80327-X	http://dx.doi.org/10.1016/S0896-6273(00)80327-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208855	Bronze			2022-12-24	WOS:A1997XJ10200006
J	Nirenberg, S; Meister, M				Nirenberg, S; Meister, M			The light response of retinal ganglion cells is truncated by a displaced amacrine circuit	NEURON			English	Article							TIGER SALAMANDER RETINA; GABA-LIKE IMMUNOREACTIVITY; GAMMA-AMINOBUTYRIC-ACID; INNER PLEXIFORM LAYER; CAT RETINA; BIPOLAR CELLS; LATERAL INTERACTIONS; VERTEBRATE RETINA; RECEPTIVE-FIELDS; FUNCTIONAL ROLES	The vertebrate retina contains ganglion cells that appear to be specialized for detecting temporal changes. The characteristic response of these cells is a transient burst of action potentials when a stationary image is presented or removed, and often a strong discharge to moving images. These transient and motion-sensitive responses are thought to result from processing in the inner retina that involves amacrine cells, but the critical interactions have been difficult to reveal. Here, we used a cell-ablation technique to remove a subpopulation of amacrine cells from the mouse retina. Their ablation changed transient ganglion cell responses into prolonged discharges. This suggests that transient responses are generated, at least in part, by a truncation of sustained excitatory input to the ganglion cells and that the ablated amacrine cells are critical for this process.			Nirenberg, S (corresponding author), HARVARD UNIV,CAMBRIDGE,MA 02138, USA.			Meister, Markus/0000-0003-2136-6506				ALLEN ND, 1988, NATURE, V333, P852, DOI 10.1038/333852a0; AMTHOR FR, 1989, J COMP NEUROL, V280, P72, DOI 10.1002/cne.902800107; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P135, DOI 10.1113/jphysiol.1982.sp014104; BALKEMA GW, 1983, SCIENCE, V219, P1085, DOI 10.1126/science.6600521; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARNES S, 1986, P NATL ACAD SCI USA, V83, P1509, DOI 10.1073/pnas.83.5.1509; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1977, J PHYSIOL-LONDON, V271, P391, DOI 10.1113/jphysiol.1977.sp012006; BELGUM JH, 1983, J PHYSIOL-LONDON, V340, P599, DOI 10.1113/jphysiol.1983.sp014782; BELGUM JH, 1982, J PHYSIOL-LONDON, V326, P91, DOI 10.1113/jphysiol.1982.sp014179; BELGUM JH, 1988, J PHYSIOL-LONDON, V396, P225, DOI 10.1113/jphysiol.1988.sp016960; BIALEK W, 1990, BIOPHYS J, V58, P1227, DOI 10.1016/S0006-3495(90)82463-2; BOLZ J, 1985, J PHYSIOL-LONDON, V362, P369, DOI 10.1113/jphysiol.1985.sp015684; BRECHA NC, 1994, J COMP NEUROL, V345, P602, DOI 10.1002/cne.903450410; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P299, DOI 10.1113/jphysiol.1978.sp012234; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; CAPOVILLA M, 1987, J PHYSIOL-LONDON, V391, P125, DOI 10.1113/jphysiol.1987.sp016730; CEPKO C, 1989, MOL NEUROBIOLOGICAL, P177; CLELAND BG, 1973, J PHYSIOL-LONDON, V228, P649, DOI 10.1113/jphysiol.1973.sp010105; DACHEUX RF, 1981, J COMP NEUROL, V198, P307, DOI 10.1002/cne.901980209; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; FISCHER B, 1975, BRAIN RES, V83, P391, DOI 10.1016/0006-8993(75)90832-X; FRUMKES TE, 1995, VISUAL NEUROSCI, V12, P651, DOI 10.1017/S0952523800008944; FRUMKES TE, 1995, VISUAL NEUROSCI, V12, P641, DOI 10.1017/S0952523800008932; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; IKEDA H, 1972, J PHYSIOL-LONDON, V227, P769, DOI 10.1113/jphysiol.1972.sp010058; JAKIELA HG, 1976, EXP BRAIN RES, V24, P335; LEVICK WR, 1975, NATURE, V254, P659, DOI 10.1038/254659a0; MAGUIRE G, 1989, J NEUROSCI, V9, P726; MARCHIAFAVA PL, 1983, VISION RES, V23, P325, DOI 10.1016/0042-6989(83)90080-9; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P121, DOI 10.1098/rspb.1984.0086; MASLAND RH, 1988, TRENDS NEUROSCI, V11, P405, DOI 10.1016/0166-2236(88)90078-1; MCREYNOLDS JS, 1989, NEUROBIOLOGY INNER R, P209; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MILLER RF, 1979, NEUROSCIENCES 4TH ST, P227; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; MOSINGER JL, 1986, EXP EYE RES, V42, P631, DOI 10.1016/0014-4835(86)90052-7; NELSON R, 1983, VISION RES, V23, P1183, DOI 10.1016/0042-6989(83)90032-9; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; NIRENBERG S, 1993, J NEUROSCI, V13, P3238, DOI 10.1523/jneurosci.13-08-03238.1993; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060; POURCHO RG, 1989, VISUAL NEUROSCI, V2, P425, DOI 10.1017/S0952523800012323; RODIECK RW, 1965, J NEUROPHYSIOL, V28, P819, DOI 10.1152/jn.1965.28.5.819; SAKAI HM, 1987, J NEUROPHYSIOL, V58, P1307, DOI 10.1152/jn.1987.58.6.1307; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; Stone J., 1983, PARALLEL PROCESSING, DOI DOI 10.1007/978-1-4684-4433-9; TACHIBANA M, 1988, VISUAL NEUROSCI, V1, P297, DOI 10.1017/S0952523800001954; VANEY DI, 1994, PROG RETIN EYE RES, V13, P301, DOI 10.1016/1350-9462(94)90014-0; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; WASSLE H, 1989, J COMP NEUROL, V279, P43, DOI 10.1002/cne.902790105; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P88, DOI 10.1085/jgp.63.1.88; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; WERBLIN FS, 1970, J NEUROPHYSIOL, V33, P342, DOI 10.1152/jn.1970.33.3.342; WERBLIN FS, 1977, J PHYSIOL-LONDON, V264, P767, DOI 10.1113/jphysiol.1977.sp011693; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; WITKOVSKY P, 1969, Z ZELLFORSCH MIK ANA, V100, P60, DOI 10.1007/BF00343821; WUNK DF, 1979, J GEN PHYSIOL, V73, P265, DOI 10.1085/jgp.73.3.265	64	101	139	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					637	650		10.1016/S0896-6273(00)80304-9	http://dx.doi.org/10.1016/S0896-6273(00)80304-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136772	Bronze			2022-12-24	WOS:A1997WW62600012
J	Sauman, I; Tsai, T; Roca, AL; Reppert, SM				Sauman, I; Tsai, T; Roca, AL; Reppert, SM			Period protein is necessary for circadian control of egg hatching behavior in the silkmoth Antheraea pernyi	NEURON			English	Article							CLOCKS	We examined the molecular basis of the circadian control of egg hatching behavior in the silkmoth Antheraea pernyi. Egg hatching is rhythmically gated, persists under constant darkness, and can be entrained by light by midembryogenesis. The time of appearance of photic entrainment by the silkmoth embryo coincides with the appearance of Period (PER) and Timeless (TIM) proteins in eight cells in embryonic brain. Although daily rhythms in PER and/or TIM immunoreactivity in embryonic brain were not detected, a robust circadian oscillation of PER immunoreactivity is present in the nuclei of midgut epithelium. per antisense oligodeoxynucleotide treatment of pharate larvae on the day before hatching consistently abolishes the circadian gate of egg hatching behavior. per antisense treatment also causes a dramatic decrease in PER immunoreactivity in newly hatched larvae. The results provide direct evidence that PER is a necessary element of a circadian system in the silkmoth.	MASSACHUSETTS GEN HOSP,SERV PEDIAT,LAB DEV CHRONOBIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School			Sauman, Ivo/H-2071-2014	Roca, Alfred/0000-0001-9217-5593	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; HALL JC, 1995, TRENDS NEUROSCI, V18, P230, DOI 10.1016/0166-2236(95)93908-G; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KAY SA, 1995, CELL, V83, P361, DOI 10.1016/0092-8674(95)90113-2; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1995, NEURON, V15, P147, DOI 10.1016/0896-6273(95)90072-1; MINIS DH, 1968, SCIENCE, V159, P534, DOI 10.1126/science.159.3814.534; MIZOGUCHI A, 1982, P NATL ACAD SCI-BIOL, V79, P2726, DOI 10.1073/pnas.79.8.2726; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; RIDDIFORD LM, 1971, P 13 INT C ENT MOSC, V1, P431; Saunder DS, 1982, INSECT CLOCKS; WILLIAMS CM, 1964, BIOL BULL, V127, P511, DOI 10.2307/1539252; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	15	54	57	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					901	909		10.1016/S0896-6273(00)80221-4	http://dx.doi.org/10.1016/S0896-6273(00)80221-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938122	Bronze			2022-12-24	WOS:A1996VV15100012
J	Gordon, JA; Cioffi, D; Silva, AJ; Stryker, MP				Gordon, JA; Cioffi, D; Silva, AJ; Stryker, MP			Deficient plasticity in the primary visual cortex of alpha-calcium/calmodulin-dependent protein kinase II mutant mice	NEURON			English	Article							LONG-TERM POTENTIATION; OCULAR DOMINANCE COLUMNS; DISTINCT PATTERNS; RAT-BRAIN; MOUSE; EXPRESSION; LOCALIZATION; EXPERIENCE; NEOCORTEX; RECEPTORS	The recent characterization of plasticity in the mouse visual cortex permits the use of mutant mice to investigate the cellular mechanisms underlying activity-dependent development. As calcium-dependent signaling pathways have been implicated in neuronal plasticity, we examined visual cortical plasticity in mice lacking the alpha-isoform of calcium/calmodulin-dependent protein kinase II (alpha CaMKII). In wild-type mice, brief occlusion of vision in one eye during a critical period reduces responses in the visual cortex. In half of the alpha CaMKII-deficient mice, visual cortical responses developed normally, but visual cortical plasticity was greatly diminished. After intensive training, spatial learning in the Morris water maze was severely impaired in a similar fraction of mutant animals. These data indicate that loss of alpha CaMKII results in a severe but variable defect in neuronal plasticity.	UNIV CALIF SAN FRANCISCO,WM KECK FDN CTR INTEGRAT NEUROSCI,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724	University of California System; University of California San Francisco; Cold Spring Harbor Laboratory	Gordon, JA (corresponding author), UNIV CALIF SAN FRANCISCO,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.		Silva, Alcino/ABD-7684-2021; Gordon, Joshua A/E-6778-2012	Silva, Alcino/0000-0002-1587-4558; Gordon, Joshua A/0000-0002-5488-8266; Silva, Alcino/0000-0001-5525-0494; Stryker, Michael/0000-0003-1546-5831				BEAR MF, 1990, J NEUROSCI, V10, P909; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BRANDT SJ, 1987, CELL, V49, P57, DOI 10.1016/0092-8674(87)90755-0; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BURGIN KE, 1990, J NEUROSCI, V10, P1788; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; FUNAUCHI M, 1992, NEUROREPORT, V3, P173, DOI 10.1097/00001756-199202000-00013; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; GORDON JA, 1996, J NEUROSCI, V126, P3274; GORDON JA, 1995, THESIS U CALIFORNIA; GORDON JA, 1996, IN PRESS GENE TARGET; HENDRY SHC, 1986, P NATL ACAD SCI USA, V83, P1536, DOI 10.1073/pnas.83.5.1536; Hensch TK, 1996, SCIENCE, V272, P554, DOI 10.1126/science.272.5261.554; HUANG FL, 1988, J NEUROSCI, V8, P4734; HUANG FL, 1987, J BIOL CHEM, V262, P15714; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYFORD M, 1995, CURR OPIN NEUROBIOL, V5, P141, DOI 10.1016/0959-4388(95)80019-0; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; Reid SNM, 1996, J PHYSIOL-LONDON, V494, P511, DOI 10.1113/jphysiol.1996.sp021509; Ruthazer ES, 1996, J PHYSIOL-LONDON, V494, P519, DOI 10.1113/jphysiol.1996.sp021510; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; STRYKER MP, 1986, J NEUROSCI, V6, P2117; TSUJINO T, 1990, J NEUROSCI, V10, P870; VIDEEN TO, 1986, BRAIN RES, V371, P1, DOI 10.1016/0006-8993(86)90803-6; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	40	86	86	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					491	499		10.1016/S0896-6273(00)80181-6	http://dx.doi.org/10.1016/S0896-6273(00)80181-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816712	Bronze			2022-12-24	WOS:A1996VJ44000015
J	Bartsch, U; Bandtlow, CE; Schnell, L; Bartsch, S; Spillmann, AA; Rubin, BP; Hillenbrand, R; Montag, D; Schwab, ME; Schachner, M				Bartsch, U; Bandtlow, CE; Schnell, L; Bartsch, S; Spillmann, AA; Rubin, BP; Hillenbrand, R; Montag, D; Schwab, ME; Schachner, M			Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS	NEURON			English	Article							NEURONAL GROWTH CONES; RAT SPINAL-CORD; NEURITE GROWTH; ADHESION; OLIGODENDROCYTE; ANTIBODIES; OUTGROWTH; COLLAPSE; TENASCIN; PROTEIN	The MAG-deficient mouse was used to test whether MAG acts as a significant inhibitor of axonal regeneration in the adult mammalian CNS, as suggested by cell culture experiments. Cell spreading, neurite elongation, or growth cone collapse of different cell types in vitro was not significantly different when myelin preparations or optic nerve cryosections from either MAG-deficient or wild-type mice were used as a substrate. More importantly, the extent of axonal regrowth in lesioned optic nerve and corticospinal tract in vivo was similarly poor in MAG-deficient and wild-type mice. However, axonal regrowth increased significantly and to a similar extent in both genotypes after application of the IN-1 antibody directed against the neurite growth inhibitors NI-35 and NI-250. These observations do not support the view that MAG is a significant inhibitor of axonal regeneration in the adult CNS.	UNIV ZURICH, BRAIN RES INST, CH-8092 ZURICH, SWITZERLAND	University of Zurich	Bartsch, U (corresponding author), ETH ZURICH, DEPT NEUROBIOL, CH-8093 ZURICH, SWITZERLAND.		Schwab, Martin E/B-6818-2016; Montag, Dirk/D-3925-2014	Montag, Dirk/0000-0002-4964-1330				Aguayo A.J., 1985, SYNAPTIC PLASTICITY, P457; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BARTSCH U, 1995, GLIA, V14, P115, DOI 10.1002/glia.440140206; BARTSCH U, 1992, EUR J NEUROSCI, V4, P338, DOI 10.1111/j.1460-9568.1992.tb00881.x; BEDI KS, 1992, EUR J NEUROSCI, V4, P193, DOI 10.1111/j.1460-9568.1992.tb00867.x; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; HALFTER W, 1987, DEV BIOL, V119, P322, DOI 10.1016/0012-1606(87)90038-8; JOHNSON D, 1986, DEV BRAIN RES, V28, P263, DOI 10.1016/0165-3806(86)90028-3; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; KEIRSTEAD HS, 1992, P NATL ACAD SCI USA, V89, P11664, DOI 10.1073/pnas.89.24.11664; Keynes Roger J., 1995, Current Opinion in Neurobiology, V5, P75, DOI 10.1016/0959-4388(95)80090-5; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RUBIN BP, 1995, IN PRESS EUR J NEURO; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SCHACHNER M, 1994, PERSPECT DEV NEUROBI, V2, P33; SCHNEIDERSCHAULIES J, 1991, NEURON, V7, P995, DOI 10.1016/0896-6273(91)90344-Y; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; SHEWAN D, 1995, J NEUROSCI, V15, P2057, DOI 10.1523/JNEUROSCI.15-03-02057.1995; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; TAYLOR J, 1993, J NEUROSCI RES, V35, P347, DOI 10.1002/jnr.490350402; UNSICKER K, 1985, DEV BRAIN RES, V17, P304, DOI 10.1016/0165-3806(85)90161-0; WEIBEL D, 1994, BRAIN RES, V642, P259, DOI 10.1016/0006-8993(94)90930-X	33	199	203	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1375	1381		10.1016/0896-6273(95)90015-2	http://dx.doi.org/10.1016/0896-6273(95)90015-2			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845160	Bronze			2022-12-24	WOS:A1995TL67800015
J	Linden, DJ				Linden, DJ			Phospholipase A(2) controls the induction of short-term versus long-term depression in the cerebellar Purkinje neuron in culture	NEURON			English	Article							PROTEIN-KINASE-C; UNSATURATED FATTY-ACIDS; ARACHIDONIC-ACID; NITRIC-OXIDE; SYNAPTIC DEPRESSION; GLUTAMATE SENSITIVITY; CLIMBING FIBER; DENTATE GYRUS; AREA CA1; CELLS	Cerebellar long-term depression (LTD) may be reliably induced in the cultured Purkinje neuron when glutamate pulses and Purkinje neuron depolarization are applied together 6 times. When the number of these conjunctive stimuli was reduced to 2, a short-term depression (STD) lasting 20-40 min was induced in 4/12 cells. The enzyme phospholipase A(2) cleaves membrane phospholipids causing liberation of free unsaturated fatty acids, which in turn synergistically activate protein kinase C when present with diacylglycerol and Ca. Application of free unsaturated fatty acids with 2 conjunctive stimuli resulted in an apparent conversion of STD cases to LTD. Application of phospholipase A(2) inhibitors during 6 conjunctions converted LTD to STD. These findings suggest a model in which liberation of unsaturated fatty acids by phospholipase A(2) contributes to a synergistic activation of protein kinase C, the full activation of which results in LTD induction, and the partial activation of which results in STD induction.			Linden, DJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, R37MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ATTWELL D, 1993, SEMIN NEUROSCI, V5, P159, DOI 10.1016/S1044-5765(05)80049-1; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; BRAMHAM CR, 1994, NEUROSCIENCE, V60, P737, DOI 10.1016/0306-4522(94)90501-0; BYRNE JH, 1993, ADV SEC MESS PHOSPH, V27, P47; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHEN SG, 1992, BIOCHEM J, V282, P33, DOI 10.1042/bj2820033; CLEMENTS MP, 1991, NEUROSCIENCE, V45, P379, DOI 10.1016/0306-4522(91)90235-G; COFFEY ET, 1994, J NEUROCHEM, V63, P1303; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; DEFREITAS JC, 1984, EXPERIENTIA, V40, P864; DUMUIS A, 1993, MOL PHARMACOL, V43, P976; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; GLASER KB, 1986, BIOCHEM PHARMACOL, V35, P449, DOI 10.1016/0006-2952(86)90218-2; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; JIN WZ, 1994, BRAIN RES, V642, P237, DOI 10.1016/0006-8993(94)90927-X; KEYSER DO, 1990, NEURON, V5, P545, DOI 10.1016/0896-6273(90)90092-T; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KOVALCHUK Y, 1994, BRAIN RES, V643, P287, DOI 10.1016/0006-8993(94)90035-3; KRUPA M, 1990, EUR J NEUROSCI, V2, P312, DOI 10.1111/j.1460-9568.1990.tb00423.x; LESTER DS, 1991, BIOCHEM BIOPH RES CO, V179, P1522, DOI 10.1016/0006-291X(91)91745-X; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LINDEN DJ, 1986, BRAIN RES, V379, P358, DOI 10.1016/0006-8993(86)90790-0; LINDEN DJ, 1987, J NEUROSCI, V7, P3783; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALLORGA P, 1980, P NATL ACAD SCI-BIOL, V77, P1341, DOI 10.1073/pnas.77.3.1341; MASSICOTTE G, 1990, BRAIN RES, V537, P49, DOI 10.1016/0006-8993(90)90338-C; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; MURAKAMI K, 1985, FEBS LETT, V192, P189, DOI 10.1016/0014-5793(85)80105-8; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; OKADA D, 1989, NEUROSCI LETT, V100, P141, DOI 10.1016/0304-3940(89)90674-5; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHAECHTER JD, 1993, J NEUROSCI, V13, P4361; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; Squire L.R, 1987, MEMORY BRAIN, P134; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; WILLIAMS JH, 1988, NEUROSCI LETT, V88, P81, DOI 10.1016/0304-3940(88)90319-9; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	66	50	51	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1393	1401		10.1016/0896-6273(95)90017-9	http://dx.doi.org/10.1016/0896-6273(95)90017-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845162	hybrid			2022-12-24	WOS:A1995TL67800017
J	Lundquist, EA; Herman, RK; Shaw, JE; Bargmann, CI				Lundquist, EA; Herman, RK; Shaw, JE; Bargmann, CI			UNC-115, a conserved protein with predicted LIM and actin-binding domains, mediates axon guidance in C-elegans	NEURON			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR CHARACTERIZATION; COLORECTAL-CANCER; NERVOUS-SYSTEM; CELL-MIGRATION; GENE; OUTGROWTH; FAMILY; RECEPTOR; ENCODES	Axon guidance receptors modulate the growth cone cytoskeleton through signaling pathways that are not well understood. Here, we describe the C. elegans unc-115 gene, which encodes a candidate cytoskeletal linker protein that acts in axon guidance, unc-115 mutants have defects in a subset of axons, particularly as the affected axons change environments during outgrowth. The unc-115 gene encodes a putative actin-binding protein that is similar to the human actin-binding protein abLIM/limatin; it has a villin headpiece domain and three LIM domains that could mediate protein interactions. unc-115 is expressed in neurons during their development and is required cell-autonomously in certain neurons for normal axon guidance. We propose that UNC-115 modulates the growth cone actin cytoskeleton in response to signals received by growth cone receptors.	Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Minnesota, Dept Genet & Cell Biol, St Paul, MN 55108 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities	Lundquist, EA (corresponding author), Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618	NICHD NIH HHS [HD22163] Funding Source: Medline; NIGMS NIH HHS [GM22387] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022387] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; BRENNER S, 1974, GENETICS, V77, P71; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; Colbert HA, 1997, J NEUROSCI, V17, P8259; Collet J, 1998, GENETICS, V148, P187; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Desai CJ, 1997, CURR OPIN NEUROBIOL, V7, P70, DOI 10.1016/S0959-4388(97)80122-5; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HERMAN RK, 1990, NATURE, V348, P169, DOI 10.1038/348169a0; HERMAN RK, 1995, CAENORHABDITIS ELEGA, P123; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kim AC, 1997, GENOMICS, V46, P291, DOI 10.1006/geno.1997.5029; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; LI W, 1992, GENETICS, V132, P675; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Macalma T, 1996, J BIOL CHEM, V271, P31470, DOI 10.1074/jbc.271.49.31470; MAHAJANMIKLOS S, 1994, CELL, V78, P291, DOI 10.1016/0092-8674(94)90298-4; MELLO C, 1995, CAENORHABDITIS ELEGA, P452; MORI I, 1988, GENETICS, V120, P397; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; OTSUKA AJ, 1995, J CELL BIOL, V129, P1081, DOI 10.1083/jcb.129.4.1081; RANA AP, 1993, P NATL ACAD SCI USA, V90, P6651, DOI 10.1073/pnas.90.14.6651; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TURNER CE, 1994, J CELL SCI, V107, P1583; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wightman B, 1997, DEVELOPMENT, V124, P2571; Wightman B, 1996, DEVELOPMENT, V122, P671; Wood W. B., 1988, NEMATODE C ELEGANS, P215; Wu RY, 1996, J BIOL CHEM, V271, P15934, DOI 10.1074/jbc.271.27.15934; YUAN JY, 1991, P NATL ACAD SCI USA, V88, P3334, DOI 10.1073/pnas.88.8.3334; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	46	77	80	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					385	392		10.1016/S0896-6273(00)80547-4	http://dx.doi.org/10.1016/S0896-6273(00)80547-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728919	Bronze			2022-12-24	WOS:000075598300015
J	Shieh, PB; Hu, SC; Bobb, K; Timmusk, T; Ghosh, A				Shieh, PB; Hu, SC; Bobb, K; Timmusk, T; Ghosh, A			Identification of a signaling pathway involved in calcium regulation of BDNF expression	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; NEUROTROPHIC FACTOR; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; SYNAPTIC TRANSMISSION; SOMATOSTATIN GENE; FACTOR FAMILY; BRAIN	A signaling pathway by which calcium influx regulates the expression of the major activity-dependent transcript of BDNF in cortical neurons has been elucidated. Deletion and mutational analysis of the promoter upstream of exon III reveals that transactivation of the BDNF gene involves two elements 5' to the mRNA start site. The first element, located between 72 and 47 bp upstream of the mRNA start site, is a novel calcium response element and is required for calcium-dependent BDNF expression in both embryonic and postnatal cortical neurons. The second element, located between 40 and 30 bp upstream of the mRNA start site, matches the consensus sequence of a CAMP response element (CRE) and is required for transactivation of the promoter in postnatal but not embryonic neurons. The ORE-dependent component of the response appears to be mediated by CREB since it is part of the complex that binds to this CRE, and since dominant negative mutants of CREB attenuate transactivation of the promoter. A constitutively active mutant of CaM kinase IV, but not of CaM kinase II, leads to activation of the promoter in the absence of extracellular stimuli, and partially occludes calcium-dependent transactivation. The effects of CaM kinase IV on the promoter require an intact ORE. These mechanisms, which implicate CaM kinase IV and CREB in the control of BDNF expression, are likely to be centrally involved in activity-dependent plasticity during development.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Uppsala, Dept Dev Neuorsci, S-75123 Uppsala, Sweden	Johns Hopkins University; Uppsala University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.		Timmusk, Tonis/H-4889-2015	Timmusk, Tonis/0000-0002-1015-3348				AKANEYA Y, 1997, J NEUROSCI, V7, P677; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; BOZZI Y, 1995, NEUROSCIENCE, V69, P1133, DOI 10.1016/0306-4522(95)00321-9; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Ghosh A, 1996, CURR BIOL, V6, P130, DOI 10.1016/S0960-9822(02)00442-6; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; Ho N, 1996, J EXP MED, V184, P101, DOI 10.1084/jem.184.1.101; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MISRA RP, 1994, J BIOL CHEM, V269, P25483; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P561; Shieh PB, 1997, CURR BIOL, V7, pR627, DOI 10.1016/S0960-9822(06)00319-8; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SUN P, 1994, GENE DEV, V8, P2526; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647	60	587	596	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					727	740		10.1016/S0896-6273(00)81011-9	http://dx.doi.org/10.1016/S0896-6273(00)81011-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581764	Bronze			2022-12-24	WOS:000073346500011
J	Qian, S; Jiang, P; Guan, XM; Singh, G; Trumbauer, ME; Yu, H; Chen, HY; Van der Ploeg, LHT; Zheng, H				Qian, S; Jiang, P; Guan, XM; Singh, G; Trumbauer, ME; Yu, H; Chen, HY; Van der Ploeg, LHT; Zheng, H			Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates A beta 1-42/43 expression	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; IN-VIVO; CAENORHABDITIS-ELEGANS; MISSENSE MUTATIONS; SENILE PLAQUES; THY-1 GENE; A-BETA; A-BETA-42(43); LOCALIZATION; TERMINUS	Mutations in presenilin I (PSI) are linked to early onset of familial Alzheimer's disease (FAD) and are shown to foster production of A beta 1-42/43 in FAD patients and transgenic mice. PSI null mice are embryonic lethal and exhibit axial skeleton malformation and CNS defects. We show that transgenic mouse lines expressing either the wild-type human PS1 protein or human PS1 with the A246E FAD mutation can rescue the PS1 knockout mouse from embryonic lethality to similar degrees, indicating that the mutation does not lead to loss of PS1 function during development. Furthermore, a 50% reduction of PS1 activity in PS1(+/-) mice does not lead to A beta 1-42/43 increase, whereas expression of human mutant PS1 on murine PSI null background is sufficient to elevate A beta 1-42/43, supporting a gain-of-function activity as the result of the PS1 mutation.	Merck Res Labs, Dept Physiol & Biochem, Rahway, NJ 07065 USA	Merck & Company	Qian, S (corresponding author), Merck Res Labs, Dept Physiol & Biochem, Rahway, NJ 07065 USA.							Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cruts M, 1996, HUM MOL GENET, V5, P1449, DOI 10.1093/hmg/5.Supplement_1.1449; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GORDON JW, 1987, CELL, V50, P445, DOI 10.1016/0092-8674(87)90498-3; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HOGAN B, 1986, MANIPULATING MOUSE E; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KIMMEL CA, 1981, STAIN TECHNOL, V56, P271, DOI 10.3109/10520298109067325; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; PerezTur J, 1995, NEUROREPORT, V7, P297; RENEKER LXW, 1995, DEVELOPMENT, V121, P1669; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE D, 1996, SCIENCE, V275, P630; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SIRINATHSINGHJI DS, 1993, MOL IMAGING NEUROSCI, P43; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; VANRIJS J, 1985, P NATL ACAD SCI USA, V82, P5832; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208	34	161	165	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1998	20	3					611	617		10.1016/S0896-6273(00)80999-X	http://dx.doi.org/10.1016/S0896-6273(00)80999-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539133	Bronze			2022-12-24	WOS:000072755600024
J	Espejo, EF; Montoro, RJ; Armengol, JA; Lopez-Barneo, J				Espejo, EF; Montoro, RJ; Armengol, JA; Lopez-Barneo, J			Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates	NEURON			English	Article							DOPAMINERGIC-NEURONS; NUCLEUS ACCUMBENS; ROTATIONAL BEHAVIOR; GRAFT-SURVIVAL; SERTOLI CELLS; ION CHANNELS; HYPOXIA; DISEASE; CHEMORECEPTORS; STRIATUM	We have tested the suitability of chromaffin-like carotid body glomus cells for dopamine cell replacement in Parkinsonian rats. Intrastriatal grafting of cell aggregates resulted in almost optimal abolishment of motor asymmetries and deficits of sensorimotor orientation. Recovery of transplanted animals was apparent 10 days after surgery and progressed throughout the 3 months of the study. The behavioral effects were correlated with the long survival of glomus cells in the host brain. In host tissue, glomus cells were organized into glomerulus-like structures and retained the ability to secrete dopamine. Several weeks after transplantation, dopaminergic fibers emerged from the graft, reinnervating the striatal gray matter. The special durability of grafted glomus cells in the conditions of brain parenchyma could be related to their sensitivity to hypoxia, which is known to induce cell growth, excitability, and dopamine synthesis. This work should stimulate research on the clinical applicability of carotid body autotransplants in Parkinson's disease.	Univ Sevilla, Fac Med, Dept Fisiol Med & Biofis, E-41009 Seville, Spain; Univ Sevilla, Fac Med, Dept Ciencias Morfol, E-41009 Seville, Spain	University of Sevilla; University of Sevilla	Lopez-Barneo, J (corresponding author), Univ Sevilla, Fac Med, Dept Fisiol Med & Biofis, E-41009 Seville, Spain.		de Mújica, José Ángel Armengol Butrón/C-8715-2017; IBIS, NEUROBIOLOGIA/O-9922-2015; Espejo, Emilio Fernández/F-9205-2015	de Mújica, José Ángel Armengol Butrón/0000-0002-9452-7828; Espejo, Emilio Fernández/0000-0003-0724-6049; Montoro Laseca, Rafael Jesus/0000-0001-8700-0828				ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ABROUS DN, 1993, NEUROSCIENCE, V54, P657, DOI 10.1016/0306-4522(93)90237-A; Baumgartl H., 1983, POLAROGRAPHIC OXYGEN, P37, DOI [10.1007/978-3-642-81863-9_4, DOI 10.1007/978-3-642-81863-9_4]; BING G, 1988, BRAIN RES BULL, V20, P399, DOI 10.1016/0361-9230(88)90069-X; BJORKLUND A, 1980, BRAIN RES, V199, P307, DOI 10.1016/0006-8993(80)90692-7; BJORKLUND A, 1987, TRENDS NEUROSCI, V10, P509, DOI 10.1016/0166-2236(87)90131-7; Bjorklund A, 1985, NEURAL GRAFTING MAMM, P3; BOHN MC, 1987, SCIENCE, V237, P913, DOI 10.1126/science.2887034; BOLAM JP, 1987, EXP BRAIN RES, V68, P131; BRUNDIN P, 1987, EXP BRAIN RES, V69, P183; BRUNDIN P, 1985, BRAIN RES, V331, P251, DOI 10.1016/0006-8993(85)91550-1; CzyzykKrzeska MF, 1996, J BIOL CHEM, V271, P3293, DOI 10.1074/jbc.271.6.3293; DOCHERTY RJ, 1978, J PHYSIOL-LONDON, V279, P425, DOI 10.1113/jphysiol.1978.sp012354; EDWARDS C, 1971, J PATHOL, V104, P1, DOI 10.1002/path.1711040102; ESPEJO EF, 1994, PSYCHOPHARMACOLOGY, V113, P500, DOI 10.1007/BF02245230; Fidone SJ., 1986, HDB PHYSL RESPIRATOR, VII, P247; FISHMAN MC, 1985, P NATL ACAD SCI USA, V82, P1448, DOI 10.1073/pnas.82.5.1448; FORNAGUERA J, 1994, BRAIN RES, V664, P178, DOI 10.1016/0006-8993(94)91968-2; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; HERMAN JP, 1988, BEHAV BRAIN RES, V29, P73, DOI 10.1016/0166-4328(88)90054-X; HERMAN JP, 1986, BRAIN RES, V372, P210, DOI 10.1016/0006-8993(86)91127-3; HONDA Y, 1992, J APPL PHYSIOL, V73, P1; Isacson O, 1997, TRENDS NEUROSCI, V20, P477, DOI 10.1016/S0166-2236(97)01081-3; JACKSON A, 1995, J NEUROBIOL, V26, P485, DOI 10.1002/neu.480260403; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; LARSON CP, 1970, NEW ENGL J MED, V283, P661; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lopez-Barneo J., 1998, OXYGEN REGULATION IO, P127; LopezBarneo J, 1996, TRENDS NEUROSCI, V19, P435; MARSHALL JF, 1977, EUR J PHARMACOL, V41, P361, DOI 10.1016/0014-2999(77)90256-4; MARSHALL JF, 1979, BRAIN RES, V177, P311, DOI 10.1016/0006-8993(79)90782-0; Montoro RJ, 1996, J GEN PHYSIOL, V107, P133, DOI 10.1085/jgp.107.1.133; PEARSE AGE, 1973, HISTOCHEMISTRY, V34, P191, DOI 10.1007/BF00303435; PICKEL VM, 1982, CYTOCHEMICAL METHODS, P229; Sanberg PR, 1996, NAT BIOTECHNOL, V14, P1692, DOI 10.1038/nbt1296-1692; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Senut MC, 1996, NAT BIOTECHNOL, V14, P1650, DOI 10.1038/nbt1296-1650; SLADEK JR, 1988, J NEUROSURG, V68, P337, DOI 10.3171/jns.1988.68.3.0337; STEA A, 1992, P NATL ACAD SCI USA, V89, P9469, DOI 10.1073/pnas.89.20.9469; STEA A, 1995, J NEUROSCI, V15, P2192, DOI 10.1523/JNEUROSCI.15-03-02192.1995; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; UNGERSTEDT U, 1970, BRAIN RES, V24, P486; URANA J, 1994, P NATL ACAD SCI USA, V91, P10208; YUREK DM, 1990, ANNU REV NEUROSCI, V13, P415, DOI 10.1146/annurev.neuro.13.1.415; ZETTERSTROM T, 1986, BRAIN RES, V376, P1, DOI 10.1016/0006-8993(86)90893-0; ZHONG H, 1995, NEUROSCI LETT, V202, P1; ZIGMOND MJ, 1990, TRENDS NEUROSCI, V13, P290, DOI 10.1016/0166-2236(90)90112-N	50	113	122	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					197	206		10.1016/S0896-6273(00)80449-3	http://dx.doi.org/10.1016/S0896-6273(00)80449-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491982	Bronze			2022-12-24	WOS:000072154700006
J	Wickman, K; Nemec, J; Gendler, SJ; Clapham, DE				Wickman, K; Nemec, J; Gendler, SJ; Clapham, DE			Abnormal heart rate regulation in GIRK4 knockout mice	NEURON			English	Article							RECTIFYING K+-CHANNEL; ACUTE MYOCARDIAL-INFARCTION; GTP-BINDING PROTEINS; BETA-GAMMA-SUBUNITS; POTASSIUM CHANNEL; INWARD RECTIFIER; RATE-VARIABILITY; TRANSGENIC MICE; SINOATRIAL NODE; ATRIAL CELLS	Acetylcholine (ACh) released from the stimulated vagus nerve decreases heart rate via modulation of several types of ion channels expressed in cardiac pacemaker cells. Although the muscarinic-gated potassium channel I-KACh has been implicated in vagally mediated heart rate regulation, questions concerning the extent of its contribution have remained unanswered. To assess the role of I-KACh in heart rate regulation in vivo, we generated a mouse line deficient in I-KACh by targeted disruption of the gene coding for GIRK4, one of the channel subunits. We analyzed heart rate and heart rate variability at rest and after pharmacological manipulation in unrestrained conscious mice using electrocardiogram (EGG) telemetry. We found that I-KACh mediated approximately half of the negative chronotropic effects of vagal stimulation and adenosine on heart rate. In addition, this study indicates that I-KACh is necessary for the fast fluctuations in heart rate responsible for beat-to-beat control of heart activity, both at rest and after vagal stimulation. Interestingly, noncholinergic systems also appear to modulate heart activity through I-KACh. Thus, I-KACh is critical for effective heart rate regulation in mice.	Harvard Univ, Childrens Hosp, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Cardiol, Boston, MA 02115 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin Scottsdale, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Wickman, Kevin/0000-0002-5179-9540				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ASHFORD MLJ, 1994, NATURE, V370, P456, DOI 10.1038/370456a0; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; BERNARDI L, 1989, J APPL PHYSIOL, V67, P1447, DOI 10.1152/jappl.1989.67.4.1447; BERTIN B, 1993, CARDIOVASC RES, V27, P1606, DOI 10.1093/cvr/27.9.1606; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; BYWATER RAR, 1990, J PHYSIOL-LONDON, V425, P1; CARRE F, 1994, EUR HEART J, V15, P58, DOI 10.1093/eurheartj/15.suppl_D.58; CLEMO HF, 1986, CIRC RES, V59, P427, DOI 10.1161/01.RES.59.4.427; CONTI A, 1993, N-S ARCH PHARMACOL, V348, P108, DOI 10.1007/BF00168545; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Davies MP, 1996, CIRC RES, V78, P15, DOI 10.1161/01.RES.78.1.15; Desai KH, 1997, AM J PHYSIOL-HEART C, V272, pH1053, DOI 10.1152/ajpheart.1997.272.2.H1053; DIFRANCESCO D, 1988, J PHYSIOL-LONDON, V405, P477, DOI 10.1113/jphysiol.1988.sp017343; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; DIFRANCESCO D, 1995, CARDIOVASC RES, V29, P449, DOI 10.1016/S0008-6363(96)88518-X; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1995, ACTA CARDIOL, V50, P414; DIMARCO JP, 1983, CIRCULATION, V68, P1254, DOI 10.1161/01.CIR.68.6.1254; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; EWING DJ, 1981, DIABETOLOGIA, V21, P18, DOI 10.1007/BF03216217; FARRELL TG, 1991, CIRCULATION, V83, P945, DOI 10.1161/01.CIR.83.3.945; FERRER J, 1995, J BIOL CHEM, V270, P26086, DOI 10.1074/jbc.270.44.26086; FREEMAN LC, 1993, CARDIOVASC DRUG THER, V7, P627, DOI 10.1007/BF00877630; GARNIER D, 1978, J PHYSIOL-LONDON, V274, P381, DOI 10.1113/jphysiol.1978.sp012154; GILES W, 1976, J PHYSIOL-LONDON, V261, P103, DOI 10.1113/jphysiol.1976.sp011550; GUO JQ, 1995, J PHYSIOL-LONDON, V483, P1; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; HARTZELL HC, 1979, J PHYSIOL-LONDON, V293, P23, DOI 10.1113/jphysiol.1979.sp012877; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HIRST GDS, 1992, TRENDS NEUROSCI, V15, P40; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; HUANG XY, 1994, P NATL ACAD SCI USA, V91, P624, DOI 10.1073/pnas.91.2.624; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Ishii K, 1996, LAB ANIM, V30, P7, DOI 10.1258/002367796780744992; Isomoto S, 1996, BIOCHEM BIOPH RES CO, V218, P286, DOI 10.1006/bbrc.1996.0050; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; IZUKA M, 1997, NEUROSCIENCE, V77, P1; Johansson C, 1997, ACTA PHYSIOL SCAND, V160, P133, DOI 10.1046/j.1365-201X.1997.00134.x; JONES LR, 1979, J BIOL CHEM, V254, P530; Karschin C, 1996, J NEUROSCI, V16, P3559; KARSCHIN C, 1994, FEBS LETT, V348, P139, DOI 10.1016/0014-5793(94)00590-7; KIM DH, 1991, PFLUG ARCH EUR J PHY, V418, P338, DOI 10.1007/BF00550871; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KOIZUMI K, 1975, BRAIN RES, V87, P247, DOI 10.1016/0006-8993(75)90422-9; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P28777, DOI 10.1074/jbc.270.48.28777; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; KURACHI Y, 1992, PROG NEUROBIOL, V39, P229, DOI 10.1016/0301-0082(92)90017-9; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LEWIS DL, 1989, PFLUG ARCH EUR J PHY, V414, P492, DOI 10.1007/BF00585062; Loewi O, 1921, PFLUG ARCH GES PHYS, V189, P239, DOI 10.1007/BF01738910; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Mansier P, 1996, AM J PHYSIOL-HEART C, V271, pH1465, DOI 10.1152/ajpheart.1996.271.4.H1465; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Murer G, 1997, NEUROSCIENCE, V80, P345, DOI 10.1016/S0306-4522(97)00001-8; Noma A, 1996, JPN HEART J, V37, P673; NOMA A, 1978, PFLUG ARCH EUR J PHY, V377, P193, DOI 10.1007/BF00584272; NOMA A, 1983, PFLUG ARCH EUR J PHY, V397, P190, DOI 10.1007/BF00584356; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; ROHRER D, 1996, P NATL ACAD SCI USA, V93, P7357; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; SAUL J, 1994, RESP SINUS ARRYTHMIA; SAUL JP, 1988, AM J CARDIOL, V61, P1292, DOI 10.1016/0002-9149(88)91172-1; SAUL JP, 1991, AM J PHYSIOL, V261, pH1231, DOI 10.1152/ajpheart.1991.261.4.H1231; SHIN K, 1995, CLIN CARDIOL, V18, P583, DOI 10.1002/clc.4960181011; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Sowell MO, 1997, P NATL ACAD SCI USA, V94, P7921, DOI 10.1073/pnas.94.15.7921; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; Wickman K, 1997, GENOMICS, V40, P395, DOI 10.1006/geno.1997.4599; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	82	298	309	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1998	20	1					103	114		10.1016/S0896-6273(00)80438-9	http://dx.doi.org/10.1016/S0896-6273(00)80438-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459446	Bronze			2022-12-24	WOS:000071719700013
J	Swain, PK; Chen, SM; Wang, QL; Affatigato, LM; Coats, CL; Brady, KD; Fishman, GA; Jacobson, SG; Swaroop, A; Stone, E; Sieving, PA; Zack, DJ				Swain, PK; Chen, SM; Wang, QL; Affatigato, LM; Coats, CL; Brady, KD; Fishman, GA; Jacobson, SG; Swaroop, A; Stone, E; Sieving, PA; Zack, DJ			Mutations in the cone-rod homeobox gene are associated with the cone-rod dystrophy photoreceptor degeneration	NEURON			English	Article							TRANSCRIPTION FACTOR NRL; CIS-ACTING ELEMENT; RAT OPSIN PROMOTER; RETINAL DYSTROPHY; CHROMOSOME 19Q; CRYSTAL-STRUCTURE; UPSTREAM REGION; PROTEIN-BINDING; DNA; EXPRESSION	Crx is a novel paired-like homeodomain protein that is expressed predominantly in retinal photoreceptors and pinealocytes. Its gene has been mapped to chromosome 19q13.3, the site of a disease locus for autosomal dominant cone-rod dystrophy (CORDII). Analysis of the proband from a family with autosomal dominant CORD revealed an Arg41Trp substitution in the third residue of the CRX homeodomain. The sequence change cosegregated with the disease phenotype and was not detected in 247 normal controls. Recombinant CRX homeodomain containing the Arg41Trp substitution showed decreased DNA binding activity. Analysis of another 169 CORD probands identified three additional CRX sequence variations (Arg41Gln, Val242Met, and a 4 bp deletion in codons 196/7) that were not found among the controls. This data suggests that mutations in the CRX gene are associated with photoreceptor degeneration and that the Crx protein is necessary for the maintenance of normal cone and rod function.	Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA; Univ Michigan, WK Kellogg Eye Ctr, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Michigan, WK Kellogg Eye Ctr, Dept Neurosci, Ann Arbor, MI 48105 USA; Univ Michigan, WK Kellogg Eye Ctr, Dept Bioengn, Ann Arbor, MI 48105 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Genet & Mol Biol, Dept Neurosci, Baltimore, MD 21287 USA; Univ Iowa, Sch Med, Dept Ophthalmol, Iowa City, IA 52242 USA; Midtown Med Ctr, Denver, CO 80205 USA; Univ Illinois, Eye & Ear Infirm, Chicago, IL 60612 USA; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University; University of Iowa; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine	Zack, DJ (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA.			Swaroop, Anand/0000-0002-1975-1141; Jacobson, Samuel/0000-0003-2122-169X; Stone, Edwin M./0000-0003-3343-4414; Zack, Don/0000-0002-7966-1973	NATIONAL EYE INSTITUTE [R01EY010539, F32EY006614, R01EY011115] Funding Source: NIH RePORTER; NEI NIH HHS [EY10539, EY06094, F32 EY006614, EY11115] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Bush RA, 1996, J OPT SOC AM A, V13, P557, DOI 10.1364/JOSAA.13.000557; BUSH RA, 1994, INVEST OPHTH VIS SCI, V35, P635; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; DESJARDIN LE, 1996, OPHTHALMOL VIS SCI, V37, P154; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; EVANS K, 1995, ARCH OPHTHALMOL-CHIC, V113, P195, DOI 10.1001/archopht.1995.01100020079033; Farjo Q, 1997, GENOMICS, V45, P395, DOI 10.1006/geno.1997.4964; FINKELSTEIN R, 1994, TRENDS GENET, V10, P310, DOI 10.1016/0168-9525(94)90033-7; Fishman GA, 1997, OPHTHALMOLOGY, V104, P299, DOI 10.1016/S0161-6420(97)30320-0; Freund C, 1996, HUM MOL GENET, V5, P1471, DOI 10.1093/hmg/5.Supplement_1.1471; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; GREGORY CY, 1994, AM J HUM GENET, V55, P1061; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; KEEN TJ, 1994, HUM MOL GENET, V3, P367, DOI 10.1093/hmg/3.2.367; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Liu Q, 1996, ONCOGENE, V12, P207; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; MORABITO MA, 1991, J BIOL CHEM, V266, P9667; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Nakazawa M, 1996, RETINA-J RET VIT DIS, V16, P405, DOI 10.1097/00006982-199616050-00007; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; WROBLEWSKI JJ, 1994, OPHTHALMOLOGY, V101, P12; YU X, 1994, J MOL NEUROSCI, V5, P259, DOI 10.1007/BF02736726; Yu X, 1996, J NEUROCHEM, V67, P2494	38	208	213	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1329	1336		10.1016/S0896-6273(00)80423-7	http://dx.doi.org/10.1016/S0896-6273(00)80423-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427255	hybrid			2022-12-24	WOS:000071236500019
J	MayerProschel, M; Kalyani, AJ; Mujtaba, T; Rao, MS				MayerProschel, M; Kalyani, AJ; Mujtaba, T; Rao, MS			Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells	NEURON			English	Article							RAT SPINAL-CORD; TYPE-2 ASTROCYTE DEVELOPMENT; PROGENITOR CELLS; CEREBRAL-CORTEX; NEURAL CREST; OLIGODENDROCYTE PRECURSORS; RECOMBINANT RETROVIRUS; CHOLINERGIC NEURONS; ADHESION MOLECULES; NERVOUS-SYSTEM	We have identified a neuronal-restricted precursor (NRP) cell that expresses E-NCAM (high polysialic-acid NCAM) and is morphologically distinct from multipotent neuroepithelial (NEP) cells (Kalyani et al., 1997) and spinal glial progenitors (Rao and Mayer-Proschel, 1997). NRP cells self renew over multiple passages in the presence of fibroblast growth factor (FGF) and neurotrophin-3 (NT-3) and differentiate in the presence of retinoic acid and the absence of FGF into postmitotic neurons. NRP cells can also be generated from multipotent E10.5 NEP cells. Clonal analysis shows that NRP cells arise from a NEP progenitor that generates other restricted CNS precursors. The NEP-derived NRPs undergo self renewal and can differentiate into multiple neuronal phenotypes. Thus, a direct lineal relationship exists between multipotential NEP cells and more restricted neuronal precursor cells present in vivo at E13.5 in the spinal cord.	UNIV UTAH,SCH MED,DEPT ANAT & NEUROBIOL,SALT LAKE CITY,UT 84132; UNIV UTAH,HUNTSMAN CANC INST,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah			Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BLASSKAMPMANN S, 1994, J NEUROSCI RES, V37, P359, DOI 10.1002/jnr.490370308; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; CHEN EW, 1992, J COMP NEUROL, V320, P291, DOI 10.1002/cne.903200303; CHUONG CM, 1984, J NEUROSCI, V4, P2354; DAVIS AA, 1994, NATURE, V362, P363; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FOKSEANG J, 1992, J NEUROSCI, V12, P2751; FOKSEANG J, 1994, J NEUROSCI RES, V37, P219, DOI 10.1002/jnr.490370208; GAO WQ, 1994, DEVELOPMENT, V120, P1059; GIRDLESTONE J, 1985, DEV BIOL, V109, P274, DOI 10.1016/0012-1606(85)90455-5; GOLDMAN SA, 1990, J NEUROSCI, V10, P2931; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HIRANO M, 1988, J NEUROSCI RES, V21, P155, DOI 10.1002/jnr.490210208; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; KILPATRICK TJ, 1993, J NEUROSCI RES, V35, P147, DOI 10.1002/jnr.490350205; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LILLIEN LE, 1990, J CELL BIOL, V111, P635, DOI 10.1083/jcb.111.2.635; LINNEMANN D, 1989, DEV NEUROSCI-BASEL, V11, P149, DOI 10.1159/000111896; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; MEHLER MF, 1995, INT J DEV NEUROSCI, V13, P213, DOI 10.1016/0736-5748(94)00060-G; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; NOLL E, 1994, DEVELOPMENT, V120, P649; NOLL E, 1993, DEVELOPMENT, V118, P563; PHELPS PE, 1990, J COMP NEUROL, V291, P9, DOI 10.1002/cne.902910103; PHELPS PE, 1988, J COMP NEUROL, V273, P459, DOI 10.1002/cne.902730403; PIXLEY SK, 1992, NEURON, V8, P1191, DOI 10.1016/0896-6273(92)90139-5; PRICE J, 1992, BRAIN PATHOL, V2, P23; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; RAY J, 1994, J NEUROSCI, V14, P3548; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SATOH J, 1995, DEV NEUROSCI-BASEL, V17, P137, DOI 10.1159/000111282; SMITHTHOMAS LC, 1990, DEVELOPMENT, V109, P925; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; Stemple DL, 1997, NEURON, V18, P1, DOI 10.1016/S0896-6273(01)80018-0; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TEMPLE S, 1994, DEVELOPMENT, V120, P999; Temple S, 1996, CURR OPIN NEUROBIOL, V6, P11, DOI 10.1016/S0959-4388(96)80003-1; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WARF BC, 1991, J NEUROSCI, V11, P2477; WENTWORTH LE, 1984, J COMP NEUROL, V222, P96, DOI 10.1002/cne.902220109; WILLIAMS BP, 1995, BIOESSAYS, V17, P391, DOI 10.1002/bies.950170506; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844; ZANGH H, 1995, MOL CELL NEUROSCI, V6, P16	61	289	327	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					773	785		10.1016/S0896-6273(00)80960-5	http://dx.doi.org/10.1016/S0896-6273(00)80960-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354325	Bronze			2022-12-24	WOS:A1997YD18900006
J	Bailey, CH; Kaang, BK; Chen, M; Martin, KC; Lim, CS; Casadio, A; Kandel, ER				Bailey, CH; Kaang, BK; Chen, M; Martin, KC; Lim, CS; Casadio, A; Kandel, ER			Mutation in the phosphorylation sites of MAP kinase blocks learning-related internalization of apCAM in Aplysia sensory neurons	NEURON			English	Article							CELL-ADHESION MOLECULES; LONG-TERM FACILITATION; IN-VITRO; SYNAPTIC PLASTICITY; PROTEIN; EXPRESSION; NCAM; OVEREXPRESSION; SENSITIZATION; POTENTIATION	The synaptic growth that accompanies 5-HT-induced long-term facilitation of the sensory to motor neuron connection in Aplysia is associated with the internalization of apCAM at the surface membrane of the sensory neuron. We have now used epitope tags to examine the fate of each of the two apCAM isoforms (membrane bound and GPI-linked) and find that only the transmembrane form is internalized. This internalization can be blocked by overexpression of transmembrane constructs with a single point mutation in the two MAPK consensus sites, as well as by injection of a specific MAPK antagonist into sensory neurons. These data suggest MAPK phosphorylation at the membrane is important for the internalization of apCAMs and, thus, may represent an early regulatory step in the growth of new synaptic connections that accompanies long-term facilitation.	COLUMBIA UNIV COLL PHYS & SURG,NEW YORK STATE PSYCHIAT INST,HOWARD HUGHES MED INST,NEW YORK,NY 10032; SEOUL NATL UNIV,MOL NEUROBIOL LAB,INST MOL BIOL & GENET,DEPT BIOL,PROGRAM COGNIT SCI,SEOUL 151742,SOUTH KOREA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Seoul National University (SNU)	Bailey, CH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,NEW YORK STATE PSYCHIAT INST,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032, USA.				NIGMS NIH HHS [GM32099] Funding Source: Medline; NIMH NIH HHS [MH37134] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH037134] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; FAZELI MS, 1994, NEUROSCI LETT, V169, P77, DOI 10.1016/0304-3940(94)90360-3; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; Harlow E., 1988, ANTIBODIES LAB MANUA; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; HU YH, 1993, NEURON, V10, P921, DOI 10.1016/0896-6273(93)90207-8; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KAANG BK, 1996, NEUROSCI LETT, V221, P1; LANDMESSER I, 1992, NEURON, V4, P655; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NELSON KK, 1993, MOL CELL BIOL, V13, P521, DOI 10.1128/MCB.13.1.521; NOEL F, 1993, MOL BRAIN RES, V19, P203, DOI 10.1016/0169-328X(93)90027-M; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; ROSE SPR, 1995, TRENDS NEUROSCI, V18, P502, DOI 10.1016/0166-2236(95)92774-K; Rutishauser U, 1993, Curr Opin Neurobiol, V3, P709, DOI 10.1016/0959-4388(93)90142-L; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SCHACHER S, 1983, J NEUROSCI, V3, P2403; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; ZHU H, 1995, J NEUROSCI, V15, P4173	38	164	166	1	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					913	924		10.1016/S0896-6273(00)80331-1	http://dx.doi.org/10.1016/S0896-6273(00)80331-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208859	Bronze			2022-12-24	WOS:A1997XJ10200010
J	Oliet, SHR; Malenka, RC; Nicoll, RA				Oliet, SHR; Malenka, RC; Nicoll, RA			Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; AREA CA1; PHARMACOLOGICAL CHARACTERIZATION; POSTSYNAPTIC INDUCTION; PROTEIN PHOSPHATASES; CA2+ CHANNELS; VISUAL-CORTEX; NITRIC-OXIDE	Two distinct forms of long-term depression (LTD), one dependent on the activation of NMDA receptors (NMDARs) and the other dependent on the activation of metabotropic glutamate receptors (mGluRs), are shown to coexist in CA1 hippocampal pyramidal cells of juvenile (11-35 day-old) rats. Both forms were pathway specific and required membrane depolarization and a rise in postsynaptic Ca2+. mGluR-LTD, but not NMDAR-LTD, required the activation of T-type Ca2+ channels, group 1 mGluRs, and protein kinase C, while NMDAR-LTD, but not mGluR-LTD, required protein phosphatase activity. NMDAR-LTD was associated with a decrease in the size of quantal excitatory postsynaptic currents, whereas for mGluR-LTD there was no change in quantal size, but a large decrease in the frequency of events. NMDAR-LTD, but not mGluR-LTD, reversed NMDAR-dependent long-term potentiation, and NMDAR-LTD was unaffected by prior saturation of mGluR-LTD. These findings indicate that NMDAR-LTD and mGluR-LTD are mechanistically distinct forms of synaptic plasticity.	UNIV CALIF SAN FRANCISCO,DEPT CELLULAR & MOL PHARMACOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Oliet, Stephane/0000-0003-0595-9029				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; AMES A, 1964, J NEUROPHYSIOL, V27, P672, DOI 10.1152/jn.1964.27.4.672; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, NEUROPHARMACOLOGY, V34, P1581, DOI 10.1016/0028-3908(95)00127-R; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; BORTOLOTTO ZA, 1993, NEUROPHARMACOLOGY, V32, P1, DOI 10.1016/0028-3908(93)90123-K; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Cavus I, 1996, J NEUROPHYSIOL, V76, P3038, DOI 10.1152/jn.1996.76.5.3038; CHRISTOFI G, 1993, J NEUROPHYSIOL, V69, P219, DOI 10.1152/jn.1993.69.1.219; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HALEY JE, 1993, NEUROSCI LETT, V160, P85, DOI 10.1016/0304-3940(93)90919-C; HEINEMANN U, 1977, EXP BRAIN RES, V27, P237; Hensch TK, 1996, SCIENCE, V272, P554, DOI 10.1126/science.272.5261.554; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Hrabetova S, 1996, J NEUROSCI, V16, P5324; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; IZUMI Y, 1993, NEUROREPORT, V4, P1131; JOLY C, 1995, J NEUROSCI, V15, P3970; KATO N, 1993, P NATL ACAD SCI USA, V90, P3650, DOI 10.1073/pnas.90.8.3650; KERR DS, 1995, P NATL ACAD SCI USA, V92, P11637, DOI 10.1073/pnas.92.25.11637; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Dell T J, 1994, Learn Mem, V1, P129; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Otani S, 1996, J PHYSIOL-LONDON, V492, P225, DOI 10.1113/jphysiol.1996.sp021303; PELLICCIARI R, 1995, J MED CHEM, V38, P3717, DOI 10.1021/jm00019a002; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SAUGSTAD JA, 1995, EUR J PHARM-MOLEC PH, V289, P395, DOI 10.1016/0922-4106(95)90120-5; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; STANTON PK, 1991, NEUROSCI LETT, V127, P61, DOI 10.1016/0304-3940(91)90895-Z; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; TAKAHASHI K, 1991, J PHARMACOL EXP THER, V256, P169; TAKAHASHI K, 1991, J NEUROPHYSIOL, V65, P148, DOI 10.1152/jn.1991.65.1.148; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; WANG JH, 1995, NEURON, V15, P443, DOI 10.1016/0896-6273(95)90048-9; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x; YANG XD, 1994, J NEUROPHYSIOL, V71, P1586, DOI 10.1152/jn.1994.71.4.1586	75	439	446	1	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					969	982		10.1016/S0896-6273(00)80336-0	http://dx.doi.org/10.1016/S0896-6273(00)80336-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208864	Bronze			2022-12-24	WOS:A1997XJ10200015
J	Apel, ED; Glass, DJ; Moscoso, LM; Yancopoulos, GD; Sanes, JR				Apel, ED; Glass, DJ; Moscoso, LM; Yancopoulos, GD; Sanes, JR			Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; TORPEDO POSTSYNAPTIC MEMBRANES; DYSTROPHIN-RELATED PROTEIN; CULTURED MUSCLE-CELLS; NEUROMUSCULAR-JUNCTION; MONOCLONAL-ANTIBODIES; SKELETAL-MUSCLE; GROWTH-FACTOR; 43K PROTEIN; EXPRESSION	Agrin-induced clustering of acetylcholine receptors (AChRs) in the postsynaptic membrane is a key step in synaptogenesis at the neuromuscular junction. The receptor tyrosine kinase MuSK is a component of the agrin receptor, while the cytoplasmic protein rapsyn is necessary for the clustering of AChRs and all other postsynaptic membrane components studied to date. We show here that MuSK remains concentrated at synaptic sites in rapsyn-deficient mutant mice, suggesting that MuSK forms a primary structural scaffold to which rapsyn attaches other synaptic components. Using nonmuscle cells, we show that rapsyn-MuSK interactions are mediated by the ectodomain of MuSK, suggesting the existence of a transmembrane intermediate. In addition to rapsyn's structural role, we demonstrate that it is required for an early step in MUSK signaling, AChR phosphorylation. This signaling requires the kinase domain of MuSK, but not its ectodomain. Thus, MuSK may interact with rapsyn in multiple ways to play both structural and signaling roles in agrin-induced differentiation.	WASHINGTON UNIV,SCH MED,DEPT MOL BIOL & PHARMACOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110; REGENERON PHARMACEUT INC,TARRYTOWN,NY 10591	Washington University (WUSTL); Washington University (WUSTL); Regeneron			Glass, David/AAI-3910-2021; Glass, David/C-4782-2012	Glass, David/0000-0001-6187-4164				APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; BARRANTES FJ, 1980, FEBS LETT, V112, P73, DOI 10.1016/0014-5793(80)80131-1; BEVAN S, 1977, J PHYSIOL-LONDON, V267, P195, DOI 10.1113/jphysiol.1977.sp011808; BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FROEHNER SC, 1981, P NATL ACAD SCI-BIOL, V78, P5230, DOI 10.1073/pnas.78.8.5230; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gillespie SKH, 1996, NEURON, V16, P953, DOI 10.1016/S0896-6273(00)80118-X; GLASS DJ, 1996, CELL, V85, P613; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; IBRAGHIMOV BO, 1992, NATURE, V355, P696; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; LAROCHELLE WJ, 1987, J BIOL CHEM, V262, P8190; MAIMONE MM, 1993, NEURON, V11, P53, DOI 10.1016/0896-6273(93)90270-2; MARTINOU JC, 1991, P NATL ACAD SCI USA, V88, P7669, DOI 10.1073/pnas.88.17.7669; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; MOSCOSO LM, 1995, MOL CELL NEUROSCI, V6, P80, DOI 10.1006/mcne.1995.1008; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1985, J CELL BIOL, V100, P1698, DOI 10.1083/jcb.100.5.1698; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; Qu ZC, 1996, MOL CELL NEUROSCI, V8, P171, DOI 10.1006/mcne.1996.0055; RIEDEL H, 1989, EMBO J, V8, P2943, DOI 10.1002/j.1460-2075.1989.tb08444.x; ROUSSELET A, 1982, EMBO J, V1, P439, DOI 10.1002/j.1460-2075.1982.tb01188.x; SANES JR, 1991, DEVELOPMENT, V113, P1181; Sanes JR, 1997, CURR OPIN NEUROBIOL, V7, P93, DOI 10.1016/S0959-4388(97)80126-2; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; TZARTOS S, 1986, J NEUROIMMUNOL, V10, P235, DOI 10.1016/0165-5728(86)90105-0; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661	53	198	202	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					623	635		10.1016/S0896-6273(00)80303-7	http://dx.doi.org/10.1016/S0896-6273(00)80303-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136771	Bronze			2022-12-24	WOS:A1997WW62600011
J	Swartz, KJ; MacKinnon, R				Swartz, KJ; MacKinnon, R			Mapping the receptor site for hanatoxin, a gating modifier of voltage-dependent K+ channels	NEURON			English	Article							DELAYED-RECTIFIER PROPERTIES; POTASSIUM-CHANNEL; CHARYBDOTOXIN BLOCK; PEPTIDE INHIBITOR; MAMMALIAN BRAIN; MUTANT CYCLES; RAT-BRAIN; PORE; DROSOPHILA; MUTATIONS	Hanatoxin (HaTx) binds to multiple sites on the surface of the drk1 voltage-gated K+ channel and modifies channel gating. We set out to identify channel residues that contribute to form these HaTx binding sites. Chimeras constructed using the drk1 and shaker K+ channels suggest that the S3-S4 linker may contain influential residues. Alanine scanning mutagenesis of the region extending from the C terminal end of S3 through S4 identified a number of residues that likely contribute to form the HaTx binding sites. The pore blocker Agitoxin(2) and the gating modifier HaTx can simultaneously bind to individual K+ channels. These results suggest that residues near the outer edges of S3 and S4 form the HaTx binding sites and are eccentrically located at least 15 Angstrom from the central pore axis on the surface of voltage-gated K+ channels.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; ROCKEFELLER UNIV,LAB MOL NEUROBIOL & BIOPHYS,NEW YORK,NY 10021	Harvard University; Harvard Medical School; Rockefeller University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43949, GM17387] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AGGARWAL SK, 1996, THESIS HARVARD U CAM; AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; DEISENHOFER J, 1989, EMBO J, V8, P2149, DOI 10.1002/j.1460-2075.1989.tb08338.x; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GRISSMER S, 1992, J BIOL CHEM, V267, P20971; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HENDERSON R, 1990, PHILOS T ROY SOC B, V326, P379, DOI 10.1098/rstb.1990.0019; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HURST RS, 1991, MOL PHARMACOL, V40, P572; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KREZEL AM, 1995, PROTEIN SCI, V4, P1478, DOI 10.1002/pro.5560040805; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; PAK MD, 1991, J NEUROSCI, V11, P869; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; REITHMEIER RAF, 1995, CURR OPIN STRUC BIOL, V5, P491, DOI 10.1016/0959-440X(95)80034-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	54	208	214	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					675	682		10.1016/S0896-6273(00)80307-4	http://dx.doi.org/10.1016/S0896-6273(00)80307-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136775	Bronze			2022-12-24	WOS:A1997WW62600015
J	Schneggenburger, R; Ascher, P				Schneggenburger, R; Ascher, P			Coupling of permeation and gating in an NMDA-channel pore mutant	NEURON			English	Article							D-ASPARTATE RECEPTOR; APLYSIA NEURONS; IONIC CHANNELS; ACETYLCHOLINE-RECEPTOR; CONDUCTANCE; CELLS; PERMEABILITY; GLUTAMATE; POTASSIUM; MEMBRANE	We report a strong coupling between permeation and gating in a mutant NMDA channel (NR1 N598Q-NR2A). The channel opens to two states that differ by their conductance and, surprisingly, by their selectivity for two permeant monovalent cations, Na+ and Cs+. The two open states are linked to the closed state via a cyclic gating reaction that proceeds preferentially in one direction under biionic conditions, indicating that the gating mechanism is not at equilibrium The direction and the magnitude of this gating asymmetry can be accounted for by assuming that ions bound to a site in the permeation pathway influence the gating of this mutant channel, and that in the closed state, the channel site is accessible to internal cations.	ECOLE NORMALE SUPER, NEUROBIOL LAB, F-75005 PARIS, FRANCE	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)								ASCHER P, 1978, J PHYSIOL-LONDON, V278, P177, DOI 10.1113/jphysiol.1978.sp012299; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CHESNOYMARCHAIS D, 1983, J PHYSIOL-LONDON, V342, P277, DOI 10.1113/jphysiol.1983.sp014851; CHESNOYMARCHAIS D, 1986, J MEMBRANE BIOL, V93, P75, DOI 10.1007/BF01871020; Colquhoun David, 1995, P397; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DIONNE VE, 1977, NATURE, V266, P263, DOI 10.1038/266263a0; FOX JA, 1987, J MEMBRANE BIOL, V97, P1, DOI 10.1007/BF01869609; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HAMILL OP, 1981, NATURE, V294, P462, DOI 10.1038/294462a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kupper J, 1996, P NATL ACAD SCI USA, V93, P8648, DOI 10.1073/pnas.93.16.8648; LAUGER P, 1985, BIOPHYS J, V47, P581, DOI 10.1016/S0006-3495(85)83954-0; LEWIS CA, 1979, MEMBRANE TRANSPORT P, P133; MARCHAIS D, 1979, J PHYSIOL-LONDON, V297, P9, DOI 10.1113/jphysiol.1979.sp013025; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; Momiyama A, 1996, J PHYSIOL-LONDON, V494, P479, DOI 10.1113/jphysiol.1996.sp021507; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; PENNEFATHER P, 1992, BIOPHYS J, V61, P448, DOI 10.1016/S0006-3495(92)81850-7; Premkumar LS, 1996, NEURON, V16, P869, DOI 10.1016/S0896-6273(00)80107-5; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; RUPPERSBERG JP, 1993, BIOCHEM PHARMACOL, V46, P1877, DOI 10.1016/0006-2952(93)90627-9; SAKURADA K, 1993, J BIOL CHEM, V268, P410; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; STERN P, 1992, P ROY SOC B-BIOL SCI, V250, P271, DOI 10.1098/rspb.1992.0159; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; TRAUTMANN A, 1982, NATURE, V298, P272, DOI 10.1038/298272a0; VANHELDEN D, 1977, NATURE, V269, P711, DOI 10.1038/269711a0; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; Wyllie DJA, 1996, P ROY SOC B-BIOL SCI, V263, P1079, DOI 10.1098/rspb.1996.0159; ZAREI MM, 1994, J GEN PHYSIOL, V103, P231, DOI 10.1085/jgp.103.2.231	38	84	86	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1997	18	1					167	177		10.1016/S0896-6273(01)80055-6	http://dx.doi.org/10.1016/S0896-6273(01)80055-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010214	Bronze			2022-12-24	WOS:A1997WE71800017
J	Shirasaki, R; Mirzayan, C; TessierLavigne, M; Murakami, F				Shirasaki, R; Mirzayan, C; TessierLavigne, M; Murakami, F			Guidance of circumferentially growing axons by netrin-dependent and -independent floor plate chemotropism in the vertebrate brain	NEURON			English	Article							COMMISSURAL GROWTH CONE; INITIAL TRACT FORMATION; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; CHICK-EMBRYO; C-ELEGANS; SEMAPHORIN-III; MOTOR AXONS; RAT-BRAIN; ZEBRAFISH	Netrin-1, a diffusible signal secreted by floor plate cells at the ventral midline of the vertebrate CNS, can attract ventrally migrating axons and repel a subset of dorsally migrating axons in the spinal cord and rostral hindbrain in vitro. Whether netrin-1 can act as a global cue to guide all circumferentially migrating axons is, however, unknown. Here, we show that netrin-1 can attract alar plate axons that cross the floor plate along its entire rostrocaudal axis. Dorsally directed axons forming the posterior commissure are, however, repelled by the floor plate by a netrin-independent mechanism. These results suggest that netrin-1 functions as a global guidance cue for attraction to the midline. Moreover, floor plate-mediated chemorepulsion may also operate generally to direct dorsal migrations, but its molecular basis may involve both netrin-dependent and -independent mechanisms.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, CELL BIOL PROGRAM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM DEV BIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shirasaki, R (corresponding author), OSAKA UNIV, FAC ENGN SCI, DEPT BIOPHYS ENGN, TOYONAKA, OSAKA 560, JAPAN.			Murakami, Fujio/0000-0002-1519-5096; Shirasaki, Ryuichi/0000-0001-8561-7023	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD07470] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTMAN J, 1981, J COMP NEUROL, V198, P677, DOI 10.1002/cne.901980409; CHEDOTAL A, 1995, EUR J NEUROSCI, V7, P198, DOI 10.1111/j.1460-9568.1995.tb01056.x; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; CHOLLEY B, 1989, DEV BRAIN RES, V45, P185, DOI 10.1016/0165-3806(89)90038-2; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EASTER SS, 1993, J NEUROSCI, V13, P285; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; EDWARDS MA, 1989, DEV BRAIN RES, V49, P185, DOI 10.1016/0165-3806(89)90021-7; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GODEMENT P, 1987, DEVELOPMENT, V101, P697; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; HATTA K, 1994, P NATL ACAD SCI USA, V91, P2061, DOI 10.1073/pnas.91.6.2061; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; LAUDER JM, 1986, NEUROSCIENCE, V19, P465, DOI 10.1016/0306-4522(86)90275-7; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Mastick GS, 1996, DEV BIOL, V173, P79, DOI 10.1006/dbio.1996.0008; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MYERS PZ, 1993, J NEUROSCI, V13, P127; MYERS PZ, 1993, J NEUROSCI, V13, P115; PATEL CK, 1994, J NEUROBIOL, V25, P345, DOI 10.1002/neu.480250402; PHELPS PE, 1993, J COMP NEUROL, V330, P1, DOI 10.1002/cne.903300102; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PRINCE JT, 1992, DEV BRAIN RES, V68, P193, DOI 10.1016/0165-3806(92)90061-Z; PUELLES L, 1977, ANAT EMBRYOL, V150, P187, DOI 10.1007/BF00316650; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; SHEPHERD IT, 1995, J COMP NEUROL, V354, P501, DOI 10.1002/cne.903540403; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; SHIRASAKI R, 1996, NEUROSCI RES       S, V20, pS113; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; TAMADA A, 1995, NEURON, V14, P1083, DOI 10.1016/0896-6273(95)90347-X; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WILSON SW, 1990, DEVELOPMENT, V108, P121; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; YAGINUMA H, 1990, DEVELOPMENT, V108, P705; YAMAMOTO M, 1986, J NEUROSCI, V6, P3576	52	114	115	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1079	1088		10.1016/S0896-6273(00)80241-X	http://dx.doi.org/10.1016/S0896-6273(00)80241-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982157	Bronze			2022-12-24	WOS:A1996WA24800007
J	Schuster, CM; Davis, GW; Fetter, RD; Goodman, CS				Schuster, CM; Davis, GW; Fetter, RD; Goodman, CS			Genetic dissection of structural and functional components of synaptic plasticity .2. Fasciclin II controls presynaptic structural plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULE; GROWTH CONE GUIDANCE; MACROMOLECULAR-SYNTHESIS; DROSOPHILA MUTANTS; CRITICAL PERIOD; MEMORY MUTANTS; DENTATE GYRUS; LATE-PHASE; APLYSIA	Increased neuronal activity (eag Shaker mutants) and cAMP concentration (dunce mutants) lead to increased synaptic structure and function at the Drosophila neuromuscular junction. Here, we show that the increase in synaptic growth is accompanied by an similar to 50% decrease in synaptic levels of the cell adhesion molecule Fasciclin II (Fas II). This decrease in Fas II is both necessary and sufficient for presynaptic sprouting; FasII mutants that decrease Fas II levels by similar to 50% lead to sprouting similar to eag Shaker and dunce, while transgenes that maintain synaptic Fas II levels suppress sprouting in eag Shaker and dunce. However, FasII mutants that cause a 50% increase in bouton number do not alter synaptic strength; rather, evoked release from single boutons has a reduced quantal content, suggesting that the wild-type amount of release machinery is distributed throughout more boutons.	UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOL & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley					NICHD NIH HHS [HD21294] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYD IA, 1956, J PHYSIOL-LONDON, V132, P74, DOI 10.1113/jphysiol.1956.sp005503; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; CORFAS G, 1990, J NEUROSCI, V10, P491; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; EVENS M, 1993, STAT DISTRIBUTIONS; FAZELI MS, 1994, NEUROSCI LETT, V169, P77, DOI 10.1016/0304-3940(94)90360-3; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; KAPLAN WD, 1969, GENETICS, V61, P399; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MURPHEY RK, 1976, SCIENCE, V191, P564, DOI 10.1126/science.1251189; Nguyen PV, 1996, J NEUROSCI, V16, P3189; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wu C F, 1992, Ion Channels, V3, P261; ZHONG Y, 1995, J NEUROSCI, V15, P6679; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644	43	262	265	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					655	667		10.1016/S0896-6273(00)80198-1	http://dx.doi.org/10.1016/S0896-6273(00)80198-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893023	Bronze			2022-12-24	WOS:A1996VP74300011
J	Trudeau, LE; Emery, DG; Haydon, PG				Trudeau, LE; Emery, DG; Haydon, PG			Direct modulation of the secretory machinery underlies PKA-dependent synaptic facilitation in hippocampal neurons	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-A; CA2+-ACTIVATED SECRETION; TRANSMITTER RELEASE; CALCIUM INFLUX; CYCLIC-AMP; IN-VITRO; PHOSPHORYLATION; TRANSMISSION; ENHANCEMENT	Activation of protein kinase A (PKA) is known to facilitate synaptic transmission. Using synapses established by hippocampal neurons in culture, we show that dialysis of PKA inhibitors in the presynaptic neuron blocks synaptic facilitation produced by the adenylyl cyclase activator forskolin, demonstrating a presynaptic locus of action. Using ruthenium red, a tool that is known to stimulate exocytosis independently of Ca2+ influx, but in a manner sensitive to tetanus toxin, we find that the secretory process is directly up-regulated under conditions where the number of functional terminals remains unchanged, as revealed by imaging of FM1-43, a vital indicator of synaptic vesicle endocytosis. Taken together with our ultrastructural analysis that suggests no enhancement of docking, our data indicate that PKA causes synaptic facilitation by directly elevating the probability of exocytosis of individual vesicles in response to an invariant Ca2+ signal.			Trudeau, LE (corresponding author), IOWA STATE UNIV,DEPT ZOOL & GENET,LAB CELLULAR SIGNALING,AMES,IA 50011, USA.		Trudeau, Louis-Eric/AAE-4782-2020	Trudeau, Louis-Eric/0000-0003-4684-1377	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026650, R01NS024233] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24233, NS26650] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Byrne JH, 1996, J NEUROSCI, V16, P425; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Dittman JS, 1996, J NEUROSCI, V16, P1623; DIXON D, 1989, J NEUROSCI, V9, P4245; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HMUANG CC, 1996, J NEUROSCI, V16, P1026; KLEIN M, 1994, NEURON, V13, P159, DOI 10.1016/0896-6273(94)90466-9; MAIGAROLI A, 1992, NATURE, V357, P134; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHELLER RH, 1995, NEURON, V14, P893; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Trudeau LE, 1996, J NEUROSCI, V16, P46; Voelker D, 1996, BIOPHYS J, V70, P818, DOI 10.1016/S0006-3495(96)79621-2; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482	39	191	194	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					789	797		10.1016/S0896-6273(00)80210-X	http://dx.doi.org/10.1016/S0896-6273(00)80210-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893035	Bronze			2022-12-24	WOS:A1996VP74300023
J	Bal, T; McCormick, DA				Bal, T; McCormick, DA			What stops synchronized thalamocortical oscillations?	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; THALAMIC RELAY NEURONS; ACTIVATED CATION CURRENT; VOLTAGE-CLAMP ANALYSIS; RETICULARIS THALAMI; IN-VITRO; ELECTROPHYSIOLOGICAL PROPERTIES; PERIGENICULATE NUCLEUS; MECHANISMS; MORPHOLOGY	Slow-wave sleep as well as generalized absence seizures are characterized by the occurrence of synchronized oscillations in thalamocortical systems that spontaneously appear and disappear. The spontaneous appearance of synchronized oscillations results from the initiation by one or a small number of cells followed by the progressive recruitment of large numbers of neighboring neurons into the synchronized network activity. Synchronized network oscillations representative of slow-wave sleep, as well as absence seizures, were demonstrated to cease spontaneously at least in part through the persistent activation of a hyperpolarization-activated cation conductance, Block of this conductance resulted in oscillations that, once generalized, occur continuously. These results indicate that the persistent activation of a hyperpolarization-activated cation conductance is a key mechanism through which synchronized oscillations in thalamocortical networks normally terminate.	YALE UNIV, SCH MED, NEUROBIOL SECT, NEW HAVEN, CT 06473 USA	Yale University			Kobelt, Liza/F-5926-2011; McCormick, David A/J-2649-2015	McCormick, David A/0000-0002-9803-8335				[Anonymous], [No title captured]; AVOLI M, 1990, GEN EPILEPSY NEUROBI, P190; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; COX CL, 1996, IN PRESS J COMP NEUR; DESCHENES M, 1984, J NEUROPHYSIOL, V51, P1196, DOI 10.1152/jn.1984.51.6.1196; DESTEXHE A, 1993, BIOPHYS J, V65, P2473, DOI 10.1016/S0006-3495(93)81297-9; DESTEXHE A, 1993, BIOPHYS J, V65, P1538, DOI 10.1016/S0006-3495(93)81190-1; DEXTEXHE A, 1996, IN PRESS J NEUROPHYS; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; HAGIWARA N, 1989, J PHYSIOL-LONDON, V409, P121, DOI 10.1113/jphysiol.1989.sp017488; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HARRIS RM, 1987, J COMP NEUROL, V258, P397, DOI 10.1002/cne.902580308; Jones EG, 1985, THALAMUS; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MULLE C, 1986, J NEUROSCI, V6, P2134; NIEDERMEYER E, 1990, EPILEPSIES DIAGNOSIS; NIEDERMEYER Ernst, 1982, ELECTROEN CLIN NEURO; NUNEZ A, 1992, NEUROSCIENCE, V48, P75, DOI 10.1016/0306-4522(92)90339-4; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SOLTESZ I, 1992, PROG BRAIN RES, V90, P151; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; SPAIN WJ, 1991, J PHYSIOL-LONDON, V434, P609, DOI 10.1113/jphysiol.1991.sp018489; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; UHLRICH DJ, 1991, J NEUROPHYSIOL, V65, P1528, DOI 10.1152/jn.1991.65.6.1528; ULRICH D, 1996, IN PRESS J PHYSL LON; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750	39	162	164	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1996	17	2					297	308		10.1016/S0896-6273(00)80161-0	http://dx.doi.org/10.1016/S0896-6273(00)80161-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780653	hybrid			2022-12-24	WOS:A1996VE84000012
J	Cases, O; Vitalis, T; Seif, I; DeMaeyer, E; Sotelo, C; Gaspar, P				Cases, O; Vitalis, T; Seif, I; DeMaeyer, E; Sotelo, C; Gaspar, P			Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: Role of a serotonin excess during the critical period	NEURON			English	Article							VISUAL CORTICAL PLASTICITY; MOUSE CEREBRAL-CORTEX; POSTNATAL-DEVELOPMENT; NEONATAL RAT; NEOCORTEX; ORGANIZATION; FIELD; INNERVATION; RECEPTORS; NEURONS	In a transgenic mouse line (Tg8) deficient for the gene encoding monoamine oxidase A (MAOA), we show that the primary somatosensory cortex (S1) lacks the characteristic barrel-like clustering of layer IV neurons, whereas normal pattern formation exists in the thalamus and the trigeminal nuclei. No barrel-like patterns were visible with tenascin or serotonin immunostaining or with labeling of thalamocortical axons. An excess of brain serotonin during the critical period of barrel formation appears to have a causal role in these cortical abnormalities, since early administration of parachlorophenylalanine, an inhibitor of serotonin synthesis, in Tg8 pups restored the formation of barrels in S1, whereas inhibition of catecholamine synthesis did not. Transient inactivation of MAOA in normal newborns reproduced a barrelless phenotype in parts of S1.	HOP LA PITIE SALPETRIERE, INSERM, U106, F-75651 PARIS, FRANCE; INST CURIE, CNRS, URA 1343, F-91405 ORSAY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie			Sotelo, Constantino/AAS-5475-2021; De Granzial, Nadine-Tania Vitalis/K-8485-2017; Gaspar, Patricia/G-8892-2011; cases, olivier/G-4882-2017	Sotelo, Constantino/0000-0001-8051-2492; De Granzial, Nadine-Tania Vitalis/0000-0002-5531-3771; Gaspar, Patricia/0000-0003-4217-5717; cases, olivier/0000-0002-5678-7362				AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BELFORD GR, 1979, J COMP NEUROL, V188, P63, DOI 10.1002/cne.901880106; BELFORD GR, 1980, J COMP NEUROL, V193, P335, DOI 10.1002/cne.901930203; BENNETTCLARKE CA, 1993, P NATL ACAD SCI USA, V90, P153, DOI 10.1073/pnas.90.1.153; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; Blue ME, 1991, CEREB CORTEX, V1, P380, DOI 10.1093/cercor/1.5.380; BOSCHERT U, 1994, NEUROSCIENCE, V58, P167, DOI 10.1016/0306-4522(94)90164-3; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CAVINESS VS, 1980, J COMP NEUROL, V194, P335, DOI 10.1002/cne.901940205; CHEN L, 1994, NEUROSCI RES, V19, P111, DOI 10.1016/0168-0102(94)90014-0; CHIAIA NL, 1989, J COMP NEUROL, V285, P325; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; CHUBAKOV AR, 1986, BRAIN RES, V369, P285, DOI 10.1016/0006-8993(86)90537-8; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; CROSSIN KL, 1989, DEV BIOL, V136, P381, DOI 10.1016/0012-1606(89)90264-9; DAMATO RJ, 1987, P NATL ACAD SCI USA, V84, P4322, DOI 10.1073/pnas.84.12.4322; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; GOLDBERG JI, 1991, J NEUROBIOL, V22, P182, DOI 10.1002/neu.480220208; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; HALLMAN H, 1984, MED BIOL, V62, P198; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; HURWITZ BE, 1990, BRAIN RES, V512, P210, DOI 10.1016/0006-8993(90)90628-O; JEANMONOD D, 1981, NEUROSCIENCE, V6, P1503, DOI 10.1016/0306-4522(81)90222-0; JENSEN KF, 1987, J NEUROSCI, V7, P3544; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; KASAMATSU T, 1979, J COMP NEUROL, V185, P163, DOI 10.1002/cne.901850110; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIDOV HGW, 1978, BRAIN RES, V153, P577, DOI 10.1016/0006-8993(78)90341-4; LINDVALL O, 1978, HDB PSYCHOPHARMACOLO, V9, P139; LOEB EP, 1987, BRAIN RES, V403, P113, DOI 10.1016/0006-8993(87)90129-6; MA PM, 1993, J COMP NEUROL, V327, P376, DOI 10.1002/cne.903270306; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OSTERHELDHAAS MC, 1994, DEV BRAIN RES, V77, P189, DOI 10.1016/0165-3806(94)90196-1; RHOADES RW, 1994, J NEUROPHYSIOL, V72, P2438, DOI 10.1152/jn.1994.72.5.2438; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; RIAD M, 1994, DEV BRAIN RES, V82, P245, DOI 10.1016/0165-3806(94)90167-8; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; Roubertoux Pierre L., 1992, V8, P423; SAMSA JM, 1979, BIOL NEONATE, V35, P249; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; STEINDLER DA, 1995, J NEUROSCI, V15, P1971, DOI 10.1523/JNEUROSCI.15-03-01971.1995; STEINDLER DA, 1990, EXP NEUROL, V109, P35, DOI 10.1016/S0014-4886(05)80007-X; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VANDERLOOS H, 1976, NEUROSCI LETT, V2, P1, DOI 10.1016/0304-3940(76)90036-7; VANDERLOOS H, 1991, NATO ADV SCI I A-LIF, V200, P229; VERNEY C, 1982, DEV BRAIN RES, V5, P41, DOI 10.1016/0165-3806(82)90111-0; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; WALLACE MN, 1987, BRAIN RES, V418, P178, DOI 10.1016/0006-8993(87)90977-2; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; WELKER E, 1986, J NEUROSCI, V6, P3355; WEYLER W, 1990, PHARMACOL THERAPEUT, V47, P391, DOI 10.1016/0163-7258(90)90064-9; WHITAKERAZMITIA PM, 1990, ANN NY ACAD SCI, V600, P315, DOI 10.1111/j.1749-6632.1990.tb16892.x; WHITAKERAZMITIA PM, 1989, BRAIN RES, V497, P80, DOI 10.1016/0006-8993(89)90972-4; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; WU HF, 1993, MOL PHARMACOL, V43, P888	64	429	437	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					297	307		10.1016/S0896-6273(00)80048-3	http://dx.doi.org/10.1016/S0896-6273(00)80048-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789945	Bronze			2022-12-24	WOS:A1996TW95700010
J	Gross, A; MacKinnon, R				Gross, A; MacKinnon, R			Agitoxin footprinting the Shaker potassium channel pore	NEURON			English	Article							CA-2+-ACTIVATED K+ CHANNEL; PEPTIDE INHIBITOR; TEA BLOCKADE; CHARYBDOTOXIN; PROTEINS; TETRAETHYLAMMONIUM; INACTIVATION; SIGNALS; BINDING; CHARGE	In voltage-dependent K+ channels, each of the four identical subunits contributes one pore loop to the central ion selectivity unit at the interface between the subunits. The pore loop is also the target for scorpion venom peptide inhibitors. These inhibitors bind at the pore entryway between the four subunits and can assume any one of four orientations. The orientations become distinguishable only if the binding site symmetry is disrupted. We have used mutagenesis and site-directed chemical modification to alter pore loop amino acids in either one or four subunits. The effects of these alterations on inhibitor affinity define the eccentricity of amino acids in the pore entryway and imply a different secondary structure for the amino and carboxyl ends of the pore loop.			Gross, A (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; AQVIST J, 1991, P NATL ACAD SCI USA, V88, P2026, DOI 10.1073/pnas.88.5.2026; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; HARPER ET, 1993, BIOCHEMISTRY-US, V32, P7605, DOI 10.1021/bi00081a001; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; LU Z, 1994, J GEN PHYSIOL, V104, P477, DOI 10.1085/jgp.104.3.477; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8087, DOI 10.1021/bi00446a019; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MRABET NT, 1992, J BIOL CHEM, V261, P5222; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	33	150	153	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					399	406		10.1016/S0896-6273(00)80057-4	http://dx.doi.org/10.1016/S0896-6273(00)80057-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789954	Bronze			2022-12-24	WOS:A1996TW95700019
J	Pusch, M; Steinmeyer, K; Koch, MC; Jentsch, TJ				Pusch, M; Steinmeyer, K; Koch, MC; Jentsch, TJ			Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel	NEURON			English	Article							MUSCLE; BECKER; EXPRESSION; CELLS	Autosomal dominant myotonia congenita (Thomsen's disease) is caused by mutations in the muscle chloride channel CIC-1. Several point mutations found in affected families (1290M, R317Q, P480L, and Q552R) dramatically shift gating to positive voltages in mutant/WT heterooligomeric channels, and, when measurable, even more so in mutant homooligomers. These channels can no longer contribute to the repolarization of action potentials, fully explaining why they cause dominant myotonia. Most replacements of the isoleucine at position 290 shift gating toward positive voltages. Mutant/WT heterooligomers can be partially activated by repetitive depolarizations, suggesting a role in shortening myotonic runs. Remarkably, a human mutation affecting an adjacent residue (E291K) is fully recessive. Large shifts in the voltage dependence of gating may be common to many mutations in dominant myotonia congenita.	UNIV MARBURG,MED CTR HUMAN GENET,W-3550 MARBURG,GERMANY	Philipps University Marburg	Pusch, M (corresponding author), UNIV HAMBURG,CTR MOLEC NEUROBIOL,MARTINISTR 52,D-20246 HAMBURG,GERMANY.			Jentsch, Thomas/0000-0002-3509-2553; Pusch, Michael/0000-0002-8644-8847				Becker PE, 1977, MYOTONIA CONGENITA S; FISHER SE, 1994, HUM MOL GENET, V3, P2053; FRANKE C, 1991, MUSCLE NERVE, V14, P762, DOI 10.1002/mus.880140811; FUJITA N, 1994, NUCLEIC ACIDS RES, V22, P1637, DOI 10.1093/nar/22.9.1637; GEORGE AL, 1994, HUM MOL GENET, V3, P2071; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; GRONEMEIER M, 1994, J BIOL CHEM, V269, P5963; HEINE R, 1994, HUM MOL GENET, V3, P1123, DOI 10.1093/hmg/3.7.1123; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482P, pS19; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; JENTSCH TJ, 1995, SOC GEN PHY, V50, P149; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; KOCH MC, 1993, J MED GENET, V30, P914, DOI 10.1136/jmg.30.11.914; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Koty P. P., 1994, American Journal of Human Genetics, V55, pA227; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LEHMANNHORN F, 1995, HUM MOL GENET, V4, P1397, DOI 10.1093/hmg/4.8.1397; LIPICKY RJ, 1971, J CLIN INVEST, V50, P2091, DOI 10.1172/JCI106703; LIPICKY RJ, 1966, J GEN PHYSIOL, V50, P89, DOI 10.1085/jgp.50.1.89; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; MEYERKLEINE C, 1994, HUM MOL GENET, V3, P1015, DOI 10.1093/hmg/3.6.1015; MEYERKLEINE C, 1995, IN PRESS AM J HUM GE; MILLER C, 1982, PHIL T R SOC LOND B, V299, P41; PUSCH M, 1994, BIOPHYS J, V66, P149, DOI 10.1016/S0006-3495(94)80753-2; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RUDEL R, 1988, MUSCLE NERVE, V11, P202, DOI 10.1002/mus.880110303; RUDEL R, 1985, PHYSIOL REV, V65, P310, DOI 10.1152/physrev.1985.65.2.310; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; STEINMEYER K, 1995, IN PRESS J BIOL CHEM; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Thomsen, 1876, ARCH PSYCHIAT NERVEN, V6, P702, DOI DOI 10.1007/BF02164912; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547	36	157	160	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1455	1463		10.1016/0896-6273(95)90023-3	http://dx.doi.org/10.1016/0896-6273(95)90023-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845168	Bronze			2022-12-24	WOS:A1995TL67800023
J	Sterling, P				Sterling, P			"Knocking out" a neural circuit	NEURON			English	Editorial Material							CAT RETINA; ROD; SIGNALS; CONES		Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Sterling, P (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.							KOLB H, 1977, J NEUROCYTOL, V6, P131, DOI 10.1007/BF01261502; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MULLER F, 1988, J NEUROPHYSIOL, V59, P1657, DOI 10.1152/jn.1988.59.6.1657; NELSON R, 1977, J COMP NEUROL, V172, P109, DOI 10.1002/cne.901720106; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SMITH RG, 1986, J NEUROSCI, V6, P3505; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; STOCKMAN A, 1995, VISUAL NEUROSCI, V12, P951, DOI 10.1017/S0952523800009500; WEST RW, 1978, VISION RES, V18, P129, DOI 10.1016/0042-6989(78)90177-3	12	2	2	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					643	644		10.1016/S0896-6273(00)80574-7	http://dx.doi.org/10.1016/S0896-6273(00)80574-7			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808444	hybrid			2022-12-24	WOS:000076697300001
J	Milone, M; Wang, HL; Ohno, K; Prince, R; Fukudome, T; Shen, XM; Brengman, JM; Griggs, RC; Sine, SM; Engel, AG				Milone, M; Wang, HL; Ohno, K; Prince, R; Fukudome, T; Shen, XM; Brengman, JM; Griggs, RC; Sine, SM; Engel, AG			Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor epsilon subunit	NEURON			English	Article							CONGENITAL MYASTHENIC SYNDROME; AGONIST BINDING-AFFINITY; CELL-LINE TE671; END-PLATE; ALPHA-SUBUNIT; CHANNEL; OLIGOMERIZATION; DEFICIENCY; CURRENTS; EVENTS	We describe the genetic and kinetic defects in a congenital myasthenic syndrome caused by heteroallelic mutations of the acetylcholine receptor (AChR) epsilon subunit gene. The mutations are an in-frame duplication of six residues in the long cytoplasmic loop (epsilon 1254ins18) and a cysteine-loop null mutation (epsilon C128S). The epsilon 1254 ins18 mutation causes mode switching in the kinetics of receptor activation in which three modes activate slowly and inactivate rapidly. The epsilon 1245ins18-AChR at the endplate shows abnormally brief activation episodes during steady state agonist application and appears electrically silent during the synaptic response to acetylcholine. The phenotypic consequences are endplate AChR deficiency, simplification of the postsynaptic region, and compensatory expression of fetal AChR that restores electrical activity at the endplate and rescues the phenotype.	Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Receptor Biol Lab, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Neurol, Muscle Res Lab, Rochester, MN 55905 USA; Univ Rochester, Dept Neurol, Rochester, NY 14641 USA	Mayo Clinic; Mayo Clinic; University of Rochester	Sine, SM (corresponding author), Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Receptor Biol Lab, Rochester, MN 55905 USA.		Ohno, Kinji/H-4020-2012	Ohno, Kinji/0000-0002-1529-2750; Griggs, Robert/0000-0001-7988-4854	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R01NS006277, R37NS031744] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31744, NS6277] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; CLAY JR, 1983, BIOPHYS J, V42, P151, DOI 10.1016/S0006-3495(83)84381-1; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Engel A.G., 1994, MYOLOGY, P1018; ENGEL AG, 1993, MUSCLE NERVE, V16, P1284, DOI 10.1002/mus.880161204; Engel AG, 1996, HUM MOL GENET, V5, P1217, DOI 10.1093/hmg/5.9.1217; ENGEL AG, 1977, NEUROLOGY, V27, P307, DOI 10.1212/WNL.27.4.307; Fu DX, 1996, J BIOL CHEM, V271, P31479, DOI 10.1074/jbc.271.49.31479; GIBB AJ, 1990, P ROY SOC B-BIOL SCI, V242, P108, DOI 10.1098/rspb.1990.0112; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Green WN, 1997, J BIOL CHEM, V272, P20945, DOI 10.1074/jbc.272.33.20945; HAMILL OP, 1981, NEURON, V15, P1231; LEE BS, 1991, J BIOL CHEM, V266, P11448; LINGLE CJ, 1992, J MEMBRANE BIOL, V126, P195; LUTHER MA, 1989, J NEUROSCI, V9, P1082; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; Milone M, 1997, J NEUROSCI, V17, P5651; MILONE M, 1994, MUSCLE NERVE, V17, P1364, DOI 10.1002/mus.880171204; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; NARANJO D, 1993, SCIENCE, V260, P1811, DOI 10.1126/science.8511590; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Ohno K, 1997, HUM MOL GENET, V6, P753, DOI 10.1093/hmg/6.5.753; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PENNEFATHER P, 1981, J GEN PHYSIOL, V78, P313, DOI 10.1085/jgp.78.3.313; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; PLOMP JJ, 1995, ANN NEUROL, V37, P627, DOI 10.1002/ana.410370513; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHOEPFER R, 1988, FEBS LETT, V226, P235, DOI 10.1016/0014-5793(88)81430-3; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Silberberg SD, 1996, BIOPHYS J, V70, P2640, DOI 10.1016/S0006-3495(96)79833-8; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; UCHITEL O, 1993, MUSCLE NERVE, V16, P1293, DOI 10.1002/mus.880161205; Wang HL, 1997, J GEN PHYSIOL, V109, P757, DOI 10.1085/jgp.109.6.757	39	69	72	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1998	20	3					575	588		10.1016/S0896-6273(00)80996-4	http://dx.doi.org/10.1016/S0896-6273(00)80996-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539130	hybrid			2022-12-24	WOS:000072755600021
J	Villarroel, A; Regalado, MP; Lerma, J				Villarroel, A; Regalado, MP; Lerma, J			Glycine-independent NMDA receptor desensitization: Localization of structural determinants	NEURON			English	Article							D-ASPARTATE RECEPTORS; CULTURED HIPPOCAMPAL-NEURONS; OUTSIDE-OUT PATCHES; GLUTAMATE RECEPTORS; ACID RECEPTORS; INSENSITIVE DESENSITIZATION; BINDING-PROTEINS; XENOPUS-OOCYTES; CHANNELS; INACTIVATION	In studying chimeras of NR2A and NR2C subunits of the NMDA receptor, we have found that glycine-independent desensitization depends on two regions of the extracellular N-terminal domain. One corresponds to a stretch of similar to 190 amino acids preceding the glutamate-binding domain S1. The other localizes at the interface between the N-terminal segment and the first transmembrane domain of NR2A subunits and involves A555 and S556. Both regions support desensitization in the absence of the other with different time courses. Desensitization did not develop with time in receptors containing the entire N-terminal region of NR2C. The introduction of A555 into the corresponding position of NR2C subunits enabled the receptors to manifest time-dependent increase in desensitization. Thus, this determinant behaves as an allosteric effector for glycine-independent desensitization.	CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Lerma, J (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.		Villarroel, Alvaro/H-5580-2015; Lerma, Juan/G-7907-2015	Lerma, Juan/0000-0001-7838-5199				BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BENVENISTE M, 1995, J PHYSIOL-LONDON, V483, P367, DOI 10.1113/jphysiol.1995.sp020591; BRORSON JR, 1995, J NEUROSCI, V15, P4515; CamposCaro A, 1997, BIOCHEMISTRY-US, V36, P2709, DOI 10.1021/bi9623486; CHOI DW, 1992, SCIENCE, V258, P241, DOI 10.1126/science.1357748; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Johnston D, 1997, SCIENCE, V278, P401, DOI 10.1126/science.278.5337.401; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kendrick SJ, 1996, J NEUROCHEM, V67, P608; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373, DOI 10.1113/jphysiol.1995.sp020736; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; LERMA J, 1990, P NATL ACAD SCI USA, V87, P2354, DOI 10.1073/pnas.87.6.2354; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; LYNCH DR, 1994, MOL PHARMACOL, V45, P540; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MAYER ML, 1995, EXCITATORY AMINO ACI, P89; MEDINA I, 1995, J PHYSIOL-LONDON, V482, P567, DOI 10.1113/jphysiol.1995.sp020540; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STEMBACH Y, 1994, NEURON, V13, P1345; Stevens CF, 1996, CELL, V87, P1147, DOI 10.1016/S0092-8674(00)81808-5; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; VILLARROEL A, 1997, TRENDS GENET, V13, P164; VYKLICKY L, 1993, J PHYSIOL-LONDON, V470, P575, DOI 10.1113/jphysiol.1993.sp019876; Wenzel A, 1997, J NEUROCHEM, V68, P469; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; ZILBERTER Y, 1991, MOL PHARMACOL, V40, P337; ZORUMSKI CF, 1990, NEURON, V5, P61, DOI 10.1016/0896-6273(90)90033-C; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	58	89	91	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					329	339		10.1016/S0896-6273(00)80460-2	http://dx.doi.org/10.1016/S0896-6273(00)80460-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491993	Bronze			2022-12-24	WOS:000072154700017
J	Keynes, R; Tannahill, D; Morgenstern, DA; Johnson, AR; Cook, GMW; Pini, A				Keynes, R; Tannahill, D; Morgenstern, DA; Johnson, AR; Cook, GMW; Pini, A			Surround repulsion of spinal sensory axons in higher vertebrate embryos	NEURON			English	Article							NEURAL CREST CELLS; DORSAL-ROOT GANGLIA; CHICK-EMBRYO; NERVOUS-SYSTEM; GUIDANCE MOLECULES; NEURITE OUTGROWTH; SEMAPHORIN-III; GROWTH CONES; MOTOR AXONS; MIGRATION	We have tested whether the orientation of axons sprouting from bipolar dorsal root ganglion neurons is influenced by diffusible cues from surrounding tissues. Surface ectoderm, dermomyotome, and notochord exert strong chemorepulsion on axons growing in collagen gels, operating at separations beyond those found in vivo and active in cocultures of chick and mouse tissues. Basal and alar plates of the neural tube are devoid of activity, as is the posterior-half-sclerotome, which repels in a contact-dependent manner. When ganglia are sandwiched between dermomyotome and notochord placed at a distance, axon growth is channeled in a bipolar trajectory. These results show that gradients of diffusible repulsion molecules flanking axon pathways can generate linear patterns of axon growth. We suggest that such ''surround repulsion'' may function generally, in concert with contact-dependent guidance mechanisms, to guide axons in the developing nervous system.	UNITED MED & DENT SCH,ST THOMAS HOSP,DEPT PHYSIOL,LONDON SE1 7EH,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Keynes, R (corresponding author), UNIV CAMBRIDGE,DEPT ANAT,DOWNING ST,CAMBRIDGE CB2 3DY,ENGLAND.		Morgenstern, Daniel A/I-4287-2019; Pini, Adrian PJ/C-5342-2009	Morgenstern, Daniel A/0000-0002-4859-1108; Tannahill, David/0000-0002-3811-6864				Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; BOLOVENTA P, 1991, DEVELOPMENT, V113, P625; BRONNERFRASER M, 1993, BIOESSAYS, V15, P221, DOI 10.1002/bies.950150402; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; FICHARD A, 1991, DEV BIOL, V148, P1, DOI 10.1016/0012-1606(91)90312-Q; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GRUNEBERG H, 1958, J EMBRYOL EXP MORPH, V6, P124; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; Keynes RJ, 1996, SEMIN NEUROSCI, V8, P339, DOI 10.1006/smns.1996.0042; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KRULL CE, 1995, DEVELOPMENT, V121, P3733; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Le Douarin N.M., 1982, NEURAL CREST; Levi-Montalcini R., 1943, ARCH BIOL, V54, P189; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; NEWGREEN DF, 1986, CELL TISSUE RES, V244, P299; NEWGREEN DF, 1990, DEV BIOL, V139, P100, DOI 10.1016/0012-1606(90)90282-N; PERRIS R, 1991, DEVELOPMENT, V111, P583; PETTWAY Z, 1990, DEV BIOL, V142, P335, DOI 10.1016/0012-1606(90)90354-L; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Ramon y Cajal S., 1909, HISTOLOGIE SYSTEME N, DOI [DOI 10.5962/BHL.TITLE.48637, 10.5962/bhl.title.48637]; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P437; Ring C, 1996, DEV BIOL, V180, P41, DOI 10.1006/dbio.1996.0283; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; STERN CD, 1991, DEVELOPMENT, V113, P207; TAN SS, 1987, P NATL ACAD SCI USA, V84, P7977, DOI 10.1073/pnas.84.22.7977; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TEILLET MA, 1983, DEV BIOL, V98, P192, DOI 10.1016/0012-1606(83)90349-4; TELLO JF, 1947, TRAB I CAJAL, V39, P1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1987, DEV BIOL, V122, P540, DOI 10.1016/0012-1606(87)90318-6; TOSNEY KW, 1990, EXP NEUROL, V109, P75, DOI 10.1016/S0014-4886(05)80010-X; VERNA JM, 1985, J EMBRYOL EXP MORPH, V86, P53; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wang LC, 1996, NEURON, V17, P849, DOI 10.1016/S0896-6273(00)80217-2; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209	49	66	66	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					889	897		10.1016/S0896-6273(00)80329-3	http://dx.doi.org/10.1016/S0896-6273(00)80329-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208857	Bronze			2022-12-24	WOS:A1997XJ10200008
J	Kane, NS; Robichon, A; Dickinson, JA; Greenspan, RJ				Kane, NS; Robichon, A; Dickinson, JA; Greenspan, RJ			Learning without performance in PKC-deficient Drosophila	NEURON			English	Article							PROTEIN-KINASE-C; GAMMA-MUTANT MICE; LONG-TERM-MEMORY; CONDITIONED COURTSHIP; SYNAPTIC FACILITATION; CONSOLIDATED MEMORY; GENE; EXPRESSION; PLASTICITY; MELANOGASTER	The performance of a task is often assumed to be a prerequisite for the learning of many tasks, including the associative conditioning of courtship in the fruit fly, Drosophila melanogaster. Transgenic flies specifically inhibited for the enzyme protein kinase C dissociate the acquisition of learning and memory from performance of the task. They fail to show immediate suppression of courtship but nonetheless develop normal memory of it.	NYU,CTR NEURAL SCI,NEW YORK,NY 10003	New York University	Kane, NS (corresponding author), NYU,DEPT BIOL,NEW YORK,NY 10003, USA.			robichon, alain/0000-0003-1075-9646				ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; ACKERMAN SL, 1986, J NEUROGENET, V3, P111, DOI 10.3109/01677068609106898; ALLWEIS C, 1991, NEURAL BEHAV PLASTIC, P370; BASSO A, 1982, NEUROPSYCHOLOGIA, V20, P263, DOI 10.1016/0028-3932(82)90101-4; BOLWIG GM, 1995, NEURON, V15, P829, DOI 10.1016/0896-6273(95)90174-4; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton SJ, 1996, J CELL BIOCHEM, V62, P484, DOI 10.1002/(SICI)1097-4644(19960915)62:4<484::AID-JCB6>3.3.CO;2-Z; BROUGHTON SJ, 1996, J CELL BIOCHEM, V60, P684; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; CHOI KW, 1991, J BIOL CHEM, V266, P15999; CLARK RE, 1993, BEHAV NEUROSCI, V107, P264, DOI 10.1037/0735-7044.107.2.264; CROW T, 1993, J NEUROPHYSIOL, V69, P636, DOI 10.1152/jn.1993.69.2.636; DAUWALDER B, 1994, J NEUROSCI, V15, P3490; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FARLEY J, 1986, NATURE, V319, P220, DOI 10.1038/319220a0; FARLEY J, 1991, P NATL ACAD SCI USA, V88, P2016, DOI 10.1073/pnas.88.5.2016; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; GAILEY DA, 1982, GENETICS, V102, P771; GAILEY DA, 1991, J COMP PHYSIOL A, V169, P685; GOLD PE, 1974, PSYCHOL REV, V81, P465, DOI 10.1037/h0036949; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; KAMIN LJ, 1957, J COMP PHYSIOL PSYCH, V50, P457, DOI 10.1037/h0044226; KAMIN LJ, 1963, J COMP PHYSIOL PSYCH, V56, P713, DOI 10.1037/h0043941; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Li W, 1996, LEARN MEMORY, V2, P320, DOI 10.1101/lm.2.6.320; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MCGAUGH JL, 1972, MEMORY CONSOLIDATION; Milner B., 1966, AMNESIA, P109; OLDS JL, 1991, NEW BIOL, V3, P27; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Sokal R. R, 1981, BIOMETRY; SUGITA S, 1992, J NEUROPHYSIOL, V68, P643, DOI 10.1152/jn.1992.68.2.643; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VANSWINDEREN B, 1995, LEARN MEMORY, V2, P49, DOI 10.1101/lm.2.2.49; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; WOODARD C, 1989, GENETICS, V123, P315; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHONG Y, 1992, J NEUROSCI, V12, P644; 1991, NEURAL BEH PLASTICIT, P370	58	74	74	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					307	314		10.1016/S0896-6273(00)80270-6	http://dx.doi.org/10.1016/S0896-6273(00)80270-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WK822	9052800	hybrid			2022-12-24	WOS:A1997WK82200013
J	Isaacson, JS; Hille, B				Isaacson, JS; Hille, B			GABA(B)-mediated presynaptic inhibition of excitatory transmission and synaptic vesicle dynamics in cultured hippocampal neurons	NEURON			English	Article							RECEPTOR-MEDIATED INHIBITION; FROG NEUROMUSCULAR-JUNCTION; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; TRANSMITTER RELEASE; NONUNIFORM PROBABILITY; CALCIUM INFLUX; AREA CA1; CURRENTS; MODULATION	Local recycling of synaptic vesicle membrane at nerve terminals is necessary to maintain a readily releasable pool of transmitter. To what extent are the dynamics of vesicle recycling subject to modulation? We examined the influence of presynaptic GABA(B) receptors on vesicle dynamics at single synapses using optical imaging of FM1-43 in cultured rat hippocampal neurons. The kinetics of FM1-43 destaining indicate that synapses from a single neuron have a unimodal distribution of release probabilities, and GABA(B)-mediated inhibition occurs uniformly at all sites. Electrical and optical recordings from single cells show that the inhibition of excitatory transmission is entirely accounted for by a rapidly reversible reduction of exocytosis. In contrast, GABA(B) receptors do not alter the rate or extent of endocytosis.			Isaacson, JS (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR017803, R37AR017803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR17803] Funding Source: Medline; NINDS NIH HHS [NS07332, NS08174] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BENNETT MR, 1980, BRIT J PHARMACOL, V69, P185, DOI 10.1111/j.1476-5381.1980.tb07889.x; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Calakos N, 1996, PHYSIOL REV, V76, P1; Capogna M, 1996, J NEUROPHYSIOL, V75, P2017, DOI 10.1152/jn.1996.75.5.2017; Dittman JS, 1996, J NEUROSCI, V16, P1623; DOZE VA, 1995, J NEUROPHYSIOL, V74, P43, DOI 10.1152/jn.1995.74.1.43; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRISON NL, 1990, J PHYSIOL-LONDON, V422, P433, DOI 10.1113/jphysiol.1990.sp017993; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Malgaroli Antonio, 1994, Seminars in Cell Biology, V5, P231, DOI 10.1006/scel.1994.1029; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MOTT DD, 1994, INT REV NEUROBIOL, V36, P97, DOI 10.1016/S0074-7742(08)60304-9; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; PENNARTZ CMA, 1994, BRAIN RES, V645, P231, DOI 10.1016/0006-8993(94)91656-X; PFRIEGER FW, 1994, NEURON, V12, P97, DOI 10.1016/0896-6273(94)90155-4; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCANZIANI M, 1995, NEUROPHARMACOLOGY, V34, P1549, DOI 10.1016/0028-3908(95)00119-Q; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHELLER RH, 1995, NEURON, V14, P893; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SHEN WX, 1996, J PHYSL, P413; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; TOTH PT, 1995, J PHYSIOL-LONDON, V485, P43, DOI 10.1113/jphysiol.1995.sp020711; UMEMIYA M, 1995, J NEUROPHYSIOL, V73, P1192, DOI 10.1152/jn.1995.73.3.1192; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	49	75	76	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					143	152		10.1016/S0896-6273(01)80053-2	http://dx.doi.org/10.1016/S0896-6273(01)80053-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010212	Bronze			2022-12-24	WOS:A1997WE71800015
J	Kearney, PC; Zhang, HY; Zhong, W; Dougherty, DA; Lester, HA				Kearney, PC; Zhang, HY; Zhong, W; Dougherty, DA; Lester, HA			Determinants of nicotinic receptor gating in natural and unnatural side chain structures at the M2 9' position	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR; DELTA-SUBUNIT; BINDING-SITE; TORPEDO-CALIFORNICA; CHANNEL DOMAIN; LIGAND-BINDING; ION-CHANNEL; ARRANGEMENT; RESIDUES; AFFINITY	A nonsense suppression method was employed to incorporate a total of four natural and six unnatural residues at the 9' position of the M2 region in the beta, gamma, and delta subunits of muscle nicotinic receptors. In 33 pairwise comparisons of functional properties as influenced by structural features including side chain length, branching, and substitution of oxygen for methylene carbons, it is concluded that increased polarity in the side chains at the 9' position consistently increases the sensitivity to acetylcholine. In addition, the stereochemistry of the side chain can have marked influences on the EC(50), primarily because of changes in the single-channel open time. For the case of isoleucine versus allo-isoleucine in the delta subunit, these changes are themselves modified by mutations at the 9' position in other subunits. The data suggest an especially strong interaction between the beta and delta subunits in the pore region, leading in turn to a suggested arrangement of subunits within the pentamer.	CALTECH, DIV PHYS MATH & ASTRON, PASADENA, CA 91125 USA; CALTECH, DIV CHEM & CHEM ENGN, PASADENA, CA 91125 USA	California Institute of Technology; California Institute of Technology	Kearney, PC (corresponding author), CALTECH, DIV BIOL, PASADENA, CA 91125 USA.				NINDS NIH HHS [NS34407, NS11756] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R01NS011756, R37NS034407] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BOULTER J, 1990, J BIOL CHEM, V265, P4472; CHARNET P, 1990, NEURON, V2, P87; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; EVANS DA, 1994, TETRAHEDRON LETT, V35, P7171, DOI 10.1016/0040-4039(94)85352-5; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; HERZ JM, 1989, J BIOL CHEM, V264, P12439; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KARLIN A, 1983, J BIOL CHEM, V258, P6678; Kearney PC, 1996, MOL PHARMACOL, V50, P1401; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; MACHOLD J, 1995, EUR J BIOCHEM, V234, P427, DOI 10.1111/j.1432-1033.1995.427_b.x; MACHOLD J, 1995, P NATL ACAD SCI USA, V92, P7282, DOI 10.1073/pnas.92.16.7282; NASS MM, 1978, BIOPHYS J, V24, P135, DOI 10.1016/S0006-3495(78)85352-1; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; OIKI S, 1995, P NATL ACAD SCI USA, V92, P2121, DOI 10.1073/pnas.92.6.2121; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Saks ME, 1996, J BIOL CHEM, V271, P23169, DOI 10.1074/jbc.271.38.23169; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SINE SM, 1991, J BIOL CHEM, V266, P19369; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; UNWIN N, 1988, J CELL BIOL, V107, P1123, DOI 10.1083/jcb.107.3.1123	30	57	58	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1221	1229		10.1016/S0896-6273(00)80252-4	http://dx.doi.org/10.1016/S0896-6273(00)80252-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982168	Bronze			2022-12-24	WOS:A1996WA24800018
J	Bouron, A; Reuter, H				Bouron, A; Reuter, H			A role of intracellular Na+ in the regulation of synaptic transmission and turnover of the vesicular pool in cultured hippocampal cells	NEURON			English	Article							SODIUM-CALCIUM EXCHANGE; LONG-TERM POTENTIATION; TRANSMITTER RELEASE; NERVE-TERMINALS; PRESYNAPTIC BOUTONS; CENTRAL NEURONS; SYNAPSES; CA2+; VERATRIDINE; CHANNELS	Propagation of action potentials in axons and dendrites increases intracellular Na+ ([Na+](i)) and Ca2+ concentrations ([Ca2+](i)). While the importance of [Ca2+](i) in synaptic transmission is well established, a possible functional role of [Na+](i) is unclear. In cultured hippocampal cells, [Na+](i) was increased by veratridine. We have then measured spontaneous excitatory postsynaptic currents (sEPSCs) and, by means of fluorescent dyes, changes in [Na+](i), in [Ca2+](i), and in the turnover of the vesicular pool of individual boutons. An elevation of [Na+](i) and a concomitant rise in [Ca2+](i) led to a large increase in sEPSC frequency and in the turnover of the presynaptic vesicular pool. Extracellular Ca2+ was essential for these effects of elevated [Na+](i) on synaptic transmission. They probably occur via Na+/Ca2+ exchange.			Bouron, A (corresponding author), UNIV BERN, DEPT PHARMACOL, CH-3010 BERN, SWITZERLAND.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Bouron, Alexandre/0000-0003-4471-7727				ANKRI N, 1994, J NEUROSCI METH, V52, P87, DOI 10.1016/0165-0270(94)90060-4; BARNES S, 1988, J GEN PHYSIOL, V91, P421, DOI 10.1085/jgp.91.3.421; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P617, DOI 10.1113/jphysiol.1975.sp010950; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; Blaustein MP, 1996, ANN NY ACAD SCI, V779, P300, DOI 10.1111/j.1749-6632.1996.tb44803.x; CARVALHO AP, 1991, ANN NY ACAD SCI, V639, P300, DOI 10.1111/j.1749-6632.1991.tb17318.x; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; FRASER DD, 1993, NEURON, V11, P633, DOI 10.1016/0896-6273(93)90075-3; FURMAN I, 1993, FEBS LETT, V319, P105, DOI 10.1016/0014-5793(93)80046-W; GLEASON E, 1994, NEURON, V13, P1109, DOI 10.1016/0896-6273(94)90049-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HILGEMANN DW, 1996, ANN NY ACAD SCI, V779; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Juhaszova M, 1996, ANN NY ACAD SCI, V779, P318, DOI 10.1111/j.1749-6632.1996.tb44804.x; KIEDROWSKI L, 1994, MOL PHARMACOL, V45, P1050; KOCH RA, 1994, J NEUROSCI, V14, P2585; Larkum ME, 1996, J NEUROPHYSIOL, V75, P154, DOI 10.1152/jn.1996.75.1.154; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MINTA A, 1989, J BIOL CHEM, V264, P19449; MULKEY RM, 1992, J NEUROSCI, V12, P4327; NAKAO M, 1989, J GEN PHYSIOL, V94, P539, DOI 10.1085/jgp.94.3.539; NORDMANN JJ, 1991, FEBS LETT, V292, P37, DOI 10.1016/0014-5793(91)80828-Q; REBER BFX, 1991, J PHYSIOL-LONDON, V435, P145, DOI 10.1113/jphysiol.1991.sp018502; REEVES JP, 1985, CURR TOP MEMBR TRANS, V25, P77; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Reuter H, 1996, CURR OPIN NEUROBIOL, V6, P331, DOI 10.1016/S0959-4388(96)80116-4; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SIGEL E, 1987, PFLUG ARCH EUR J PHY, V410, P112, DOI 10.1007/BF00581903; STEVENS CF, 1993, NEURON S, V10, P55; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	39	55	56	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1996	17	5					969	978		10.1016/S0896-6273(00)80227-5	http://dx.doi.org/10.1016/S0896-6273(00)80227-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938128	Bronze			2022-12-24	WOS:A1996VV15100018
J	Thomas, MJ; Moody, TD; Makhinson, M; ODell, TJ				Thomas, MJ; Moody, TD; Makhinson, M; ODell, TJ			Activity-dependent beta-adrenergic modulation of low frequency stimulation induced LTP in the hippocampal CA1 region	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC TRANSMISSION; RECEPTOR ACTIVATION; ADENYLYL-CYCLASE; CYCLIC-AMP; AREA CA1; NEUROMODULATORY SYSTEMS; PROTEIN PHOSPHATASES; RAT HIPPOCAMPUS; GAMMA-SUBUNITS	beta-Adrenergic receptor activation has a central role in the enhancement of memory formation that occurs during heightened states of emotional arousal. Although beta-adrenergic receptor activation may enhance memory formation by modulating long-term potentiation (LTP), a candidate synaptic mechanism involved in memory formation, the cellular basis of this modulation is not fully understood. Here, we report that, in the CA1 region of the hippocampus, beta-adrenergic receptor activation selectively enables the induction of LTP during long trains of 5 Hz synaptic stimulation. Protein phosphatase inhibitors mimic the effects of beta-adrenergic receptor activation on 5 Hz stimulation-induced LTP, suggesting that activation of noradrenergic systems during emotional arousal may enhance memory formation by inhibiting protein phosphatases that normally oppose the induction of LTP.	UNIV CALIF LOS ANGELES,SCH MED,INTERDEPT PHD PROGRAM NEUROSCI,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Thomas, MJ (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,BRAIN RES INST,LOS ANGELES,CA 90024, USA.		Thomas, Mark John/HHC-7509-2022	Thomas, Mark John/0000-0001-5721-5350	NIMH NIH HHS [MH 52876] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH052876] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDRADE R, 1993, NEURON, V10, P83, DOI 10.1016/0896-6273(93)90244-L; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; DAHL D, 1994, NEUROREPORT, V5, P657, DOI 10.1097/00001756-199401000-00032; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GEREAU RW, 1994, NEURON, V12, P1121, DOI 10.1016/0896-6273(94)90319-0; GEREAU RW, 1994, J NEUROPHYSIOL, V72, P1438, DOI 10.1152/jn.1994.72.3.1438; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HEGINBOTHAM LR, 1991, J NEUROSCI, V11, P2519; HERRON CE, 1994, J NEUROSCI, V14, P6013; HOPKINS WF, 1984, SCIENCE, V226, P350, DOI 10.1126/science.6091272; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MCGAUGH JL, 1989, ANNU REV NEUROSCI, V12, P255, DOI 10.1146/annurev.neuro.12.1.255; MCGAUGH JL, 1990, PSYCHOL SCI, V1, P15, DOI 10.1111/j.1467-9280.1990.tb00060.x; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MUSGRAVE MA, 1993, NEUROREPORT, V4, P171, DOI 10.1097/00001756-199302000-00014; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Dell T J, 1994, Learn Mem, V1, P129; PARFITT KD, 1992, HIPPOCAMPUS, V2, P59, DOI 10.1002/hipo.450020108; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; SARVEY JM, 1989, J NEUROSCI METH, V28, P109, DOI 10.1016/0165-0270(89)90016-2; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; THOMAS MJ, 1995, BRAIN RES, V695, P45, DOI 10.1016/0006-8993(95)00757-H; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482	43	243	252	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					475	482		10.1016/S0896-6273(00)80179-8	http://dx.doi.org/10.1016/S0896-6273(00)80179-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816710	Bronze			2022-12-24	WOS:A1996VJ44000013
J	Wei, J; Zhao, AZ; Chan, GCK; Baker, LP; Impey, S; Beavo, JA; Storm, DR				Wei, J; Zhao, AZ; Chan, GCK; Baker, LP; Impey, S; Beavo, JA; Storm, DR			Phosphorylation and inhibition of olfactory adenylyl cyclase by CaM kinase II in neurons: a mechanism for attenuation of olfactory signals	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; RECEPTOR NEURONS; MULTIGENE FAMILY; ODORANT RECEPTORS; GUANYLYL CYCLASE; RAPID KINETICS; IN-VIVO; TRANSDUCTION; CILIA; CELLS	Acute desensitization of olfactory signaling is a critical property of the olfactory system that allows animals to detect and respond to odorants. Correspondingly, an important feature of odorant-stimulated cAMP increases is their transient nature, a phenomenon that may be attributable to the unique regulatory properties of the olfactory adenylyl cyclase (AC3). AC3 is stimulated by receptor activation and inhibited by Ca2+ through Ca2+/calmodulin kinase II(CaMKII) phosphorylation at Ser-1076. Since odorant-stimulated cAMP increases are accompanied by elevated intracellular Ca2+, CaMKII inhibition of AC3 may contribute to termination of olfactory signaling. To test this hypothesis, we generated a polyclonal antibody specific for AC3 phosphorylated at Ser-1076. A brief exposure of mouse olfactory cilia or primary olfactory neurons to odorants stimulated phosphorylation of AC3 at Ser-1076. This phosphorylation was blocked by inhibitors of CaMKII, which also ablated cAMP decreases associated with odorant-stimulated cAMP transients. These data define a novel mechanism for termination of olfactory signaling that may be important in olfactory responses.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021723] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL44948] Funding Source: Medline; NIDDK NIH HHS [DK-21723] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHE BW, 1995, CURR OPIN NEUROBIOL, V5, P461, DOI 10.1016/0959-4388(95)80006-9; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P11983, DOI 10.1073/pnas.89.24.11983; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BORISY FF, 1992, J NEUROSCI, V12, P915; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREER H, 1994, BBA-MOL CELL RES, V1224, P277, DOI 10.1016/0167-4889(94)90201-1; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BRESSLER SL, 1980, ELECTROEN CLIN NEURO, V50, P19, DOI 10.1016/0013-4694(80)90319-3; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1992, COLD SPRING HARB SYM, V57, P505, DOI 10.1101/SQB.1992.057.01.056; DITTMAN AH, 1994, BIOCHEMISTRY-US, V33, P943, DOI 10.1021/bi00170a013; Dittman AH, 1997, NEURON, V19, P381, DOI 10.1016/S0896-6273(00)80947-2; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; JAWORSKY DE, 1995, J NEUROSCI, V15, P310; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; KRAMER RH, 1992, NEURON, V9, P897, DOI 10.1016/0896-6273(92)90242-6; Kurahashi T, 1990, Neurosci Res Suppl, V12, pS85, DOI 10.1016/0921-8696(90)90011-Q; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Restrepo D, 1996, J NEUROBIOL, V30, P37; RESTREPO D, 1993, J GEN PHYSIOL, V102, P907, DOI 10.1085/jgp.102.5.907; RONNETT GV, 1991, P NATL ACAD SCI USA, V88, P2366, DOI 10.1073/pnas.88.6.2366; RONNETT GV, 1995, NEURON, V15, P11, DOI 10.1016/0896-6273(95)90058-6; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SATO T, 1991, NEUROREPORT, V2, P229, DOI 10.1097/00001756-199105000-00003; SCHULMAN H, 1995, PROG BRAIN RES, V105, P95; SHARMA RK, 1985, P NATL ACAD SCI USA, V82, P2603, DOI 10.1073/pnas.82.9.2603; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; TAREILUS E, 1995, BBA-MOL CELL RES, V1269, P129, DOI 10.1016/0167-4889(95)00105-2; Torre V, 1995, J NEUROSCI, V15, P7757; WAYMAN GA, 1995, J BIOL CHEM, V270, P21480, DOI 10.1074/jbc.270.37.21480; WAYMAN GA, 1995, J BIOL CHEM, V270, P24108, DOI 10.1074/jbc.270.41.24108; Wei J, 1996, J BIOL CHEM, V271, P24231, DOI 10.1074/jbc.271.39.24231; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699	48	152	156	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					495	504		10.1016/S0896-6273(00)80561-9	http://dx.doi.org/10.1016/S0896-6273(00)80561-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768837	Bronze			2022-12-24	WOS:000076196400007
J	Baker, OS; Larsson, HP; Mannuzzu, LM; Isacoff, EY				Baker, OS; Larsson, HP; Mannuzzu, LM; Isacoff, EY			Three transmembrane conformations and sequence-dependent displacement of the S4 domain in shaker K+ channel gating	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; ION CHANNELS; ACTIVATION; CURRENTS; CHARGE; INACTIVATION; TRANSITIONS; MOVEMENT; SEGMENT	We have acquired structural evidence that two components evident previously in the depolarization-evoked gating currents from voltage-gated Shaker K+ channels have their origin in sequential, two-step outward movements of the S4 protein segments. A point mutation greatly destabilizes the "fully retracted" state of S4 transmembrane translocation, causing instead an intermediate state to predominate at resting potentials. This state is distinguishable topologically and fluorometrically. That a point mutation effectively excludes half the range of S4 motion from physiological voltages suggests that the diverse sensitivities among voltage-gated channels might reflect not only differences in S4 valence, but also displacement. Existence of an intermediate subunit state helps explain why modeling channel activation has required positing greater than four closed states.	Univ Calif Berkeley, Grp Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Grp Biophys, Berkeley, CA 94720 USA.		isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	NINDS NIH HHS [R01NS35549] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CREIGTON TC, 1993, PROTEINS STRUCTURES; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MCCORMACK K, 1994, NEURON, V12, P301, DOI 10.1016/0896-6273(94)90273-9; MCCORMACK K, 1994, NEURON, V12, P706; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; Stryer L., 1988, BIOCHEMISTRY-US; STUHMER W, 1991, PFLUG ARCH EUR J PHY, V418, P423, DOI 10.1007/BF00550881; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; Yang NB, 1997, BIOPHYS J, V73, P2260, DOI 10.1016/S0006-3495(97)78258-4; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	40	143	148	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1283	1294		10.1016/S0896-6273(00)80507-3	http://dx.doi.org/10.1016/S0896-6273(00)80507-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655514	Bronze			2022-12-24	WOS:000074627300022
J	Zylka, MJ; Shearman, LP; Weaver, DR; Reppert, SM				Zylka, MJ; Shearman, LP; Weaver, DR; Reppert, SM			Three period homologs in mammals: Differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain	NEURON			English	Article							EXPRESSION; RHYTHMS	We have cloned and characterized the mouse cDNA of a third mammalian homolog of the Drosophila period gene and designated it mPer3. The mPER3 protein shows similar to 37% amino acid identity with mPER1 and mPER2 proteins. The three mammalian PER proteins share several regions of sequence homology, and each contains a protein dimerization PAS domain. mPer3 RNA levels oscillate in the suprachiasmatic nuclei (SCN) and eyes. In the SCN, mPer3 RNA levels are not acutely altered by light exposure at different times during subjective night. This contrasts with the acute induction by light of mPer1 and mPer2 RNA levels during early and late subjective night. mPer3 is widely expressed in tissues outside of brain. In liver, skeletal muscle, and testis, mPer RNAs exhibit prominent, synchronous circadian oscillations. The results highlight the differential light responses among the three mammalian Per genes in the SCN and raise the possibility of circadian oscillators in mammals outside of brain and retina.	Massachusetts Gen Hosp, Lab Dev Chronobiol, Serv Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Lab Dev Chronobiol, Serv Pediat, Boston, MA 02114 USA.			Weaver, David/0000-0001-7941-6719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011547] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline; NIMH NIH HHS [MH11547] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; REEDS PJ, 1986, BIOSCIENCE REP, V6, P209, DOI 10.1007/BF01115008; Reppert SM, 1997, CELL, V89, P487, DOI 10.1016/S0092-8674(00)80229-9; Rienstein S, 1998, CHRONOBIOL INT, V15, P13, DOI 10.3109/07420529808998665; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WEAVER DR, 1993, MOL BRAIN RES, V20, P313, DOI 10.1016/0169-328X(93)90058-W; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A	24	721	741	4	37	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1103	1110		10.1016/S0896-6273(00)80492-4	http://dx.doi.org/10.1016/S0896-6273(00)80492-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655499	Bronze			2022-12-24	WOS:000074627300007
J	Fischer, M; Kaech, S; Knutti, D; Matus, A				Fischer, M; Kaech, S; Knutti, D; Matus, A			Rapid actin-based plasticity in dendritic spines	NEURON			English	Article							NEURONAL GROWTH CONE; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; SYNAPSES; DENSITY; ORGANIZATION; MICROTUBULES; INTEGRATION; CULTURES	Dendritic spines have been proposed as primary sites of synaptic plasticity in the brain. Consistent with this hypothesis, spines contain high concentrations of actin, suggesting that they might be motile. To investigate this possibility, we made video recordings from hippocampal neurons expressing actin tagged with green fluorescent protein (GFP-actin). This reagent incorporates into actin-containing structures and allows the visualization of actin dynamics in living neurons. In mature neurons, recordings of GFP fluorescence revealed large actin-dependent changes in dendritic spine shape, similar to those inferred from previous studies using fixed tissues. Visible changes occured within seconds, suggesting that anatomical plasticity at synapses can be extremely rapid. As well as providing a molecular basis for structural plasticity, the presence of motile actin in dendritic spines implicates the postsynaptic element as a primary site of this phenomenon.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Matus, A (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.			Kaech Petrie, Stefanie/0000-0002-6246-6434				BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BRAY D, 1985, J NEUROSCI, V5, P3204; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; CARLIN RK, 1983, P NATL ACAD SCI-BIOL, V80, P3517, DOI 10.1073/pnas.80.11.3517; COHEN RS, 1985, CELL MOL NEUROBIOL, V5, P271, DOI 10.1007/BF00711012; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; COSS RG, 1978, SCIENCE, V200, P363; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Dailey ME, 1996, J NEUROSCI, V16, P2983; ECCLES JC, 1979, NATURWISSENSCHAFTEN, V66, P147, DOI 10.1007/BF00368708; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; GOULD E, 1990, J NEUROSCI, V10, P1286; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HOSOKAWA T, 1992, NEUROREPORT, V3, P477, DOI 10.1097/00001756-199206000-00005; Kaech S, 1997, J NEUROSCI, V17, P9565; KOCH C, 1993, J NEUROSCI, V13, P413; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; MARCOS AR, 1969, EXP BRAIN RES, V8, P284; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; MULLER M, 1993, P NATL ACAD SCI USA, V90, P257, DOI 10.1073/pnas.90.1.257; PAPA M, 1995, J NEUROSCI, V15, P1; PARNAVELAS JG, 1977, CELL TISSUE RES, V183, P499; Peters A., 1976, FINE STRUCTURE NERVO; RAO MSS, 1995, BRAIN RES, V694, P312; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; YAMADA KM, 1970, P NATL ACAD SCI USA, V66, P1206, DOI 10.1073/pnas.66.4.1206; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	37	745	764	0	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					847	854		10.1016/S0896-6273(00)80467-5	http://dx.doi.org/10.1016/S0896-6273(00)80467-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620690	Bronze			2022-12-24	WOS:000073864700005
J	Meir, A; Dolphin, AC				Meir, A; Dolphin, AC			Known calcium channel alpha(1) subunits can form low threshold small conductance channels with similarities to native T-type channels	NEURON			English	Article							CHICK SENSORY NEURONS; LOW-VOLTAGE; FUNCTIONAL EXPRESSION; OMEGA-CONOTOXIN; BETA-SUBUNIT; SKELETAL-MUSCLE; XENOPUS OOCYTES; CURRENTS; CELLS; CA2+	Native T-type voltage-dependent calcium channels are low voltage-activated and have a small single channel conductance of 5-8 pS, which distinguishes them from any known cloned calcium channels whose conductances are 12-25 pS. Here, we show that when alpha(1B), alpha(1E) or alpha(1C) are expressed in COS7 cells, which contain no endogenous calcium channel subunits or calcium channels, they each exhibit a 4-7 pS channel as well as a large conductance channel. At low depolarizations, or when the alpha(1) subunit is expressed in the absence of auxiliary alpha(2)-delta or beta subunits, the small conductance channels are seen alone, and their biophysical properties, including voltage dependence and kinetics of activation and inactivation, are very similar to native T-type calcium channels.	UCL, Dept Pharmacol, London WC1 6BT, England	University of London; University College London	Dolphin, AC (corresponding author), UCL, Dept Pharmacol, London WC1 6BT, England.		Dolphin, Annette C/F-7416-2010	Dolphin, Annette C/0000-0003-4626-4856	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; BARISH ME, 1991, J PHYSIOL-LONDON, V444, P523, DOI 10.1113/jphysiol.1991.sp018892; BEAM KG, 1988, J GEN PHYSIOL, V91, P781, DOI 10.1085/jgp.91.6.781; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Berrow NS, 1997, EUR J NEUROSCI, V9, P739, DOI 10.1111/j.1460-9568.1997.tb01422.x; Bourinet E, 1996, J NEUROSCI, V16, P4983; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; CAMPBELL V, 1995, FEBS LETT, V370, P135, DOI 10.1016/0014-5793(95)00813-O; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P571, DOI 10.1113/jphysiol.1987.sp016552; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; CHEN CF, 1990, J GEN PHYSIOL, V96, P603, DOI 10.1085/jgp.96.3.603; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Dolphin AC, 1996, TRENDS NEUROSCI, V19, P35, DOI 10.1016/0166-2236(96)81865-0; DROOGMANS G, 1989, J PHYSIOL-LONDON, V419, P627, DOI 10.1113/jphysiol.1989.sp017890; Elmslie KS, 1997, J NEUROSCI, V17, P2658; Ertel SI, 1997, TRENDS PHARMACOL SCI, V18, P37, DOI 10.1016/S0165-6147(96)01021-8; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; Gurnett CA, 1997, J BIOL CHEM, V272, P18508, DOI 10.1074/jbc.272.29.18508; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P4290, DOI 10.1073/pnas.85.12.4290; KIM HL, 1992, P NATL ACAD SCI USA, V89, P3251, DOI 10.1073/pnas.89.8.3251; KOBRINSKY EM, 1994, NEUROSCIENCE, V58, P539, DOI 10.1016/0306-4522(94)90079-5; Lambert RC, 1997, J NEUROSCI, V17, P6621; Liu J, 1995, ANN NY ACAD SCI, V765, P119, DOI 10.1111/j.1749-6632.1995.tb16568.x; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; Neher Erwin, 1995, P147; NILLIUS B, 1985, NATURE, V316, P443; Olcese R, 1996, J PHYSIOL-LONDON, V497, P675, DOI 10.1113/jphysiol.1996.sp021799; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Page KM, 1997, J NEUROSCI, V17, P1330; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; SINGERLAHAT D, 1992, BIOCHIM BIOPHYS ACTA, V1137, P39, DOI 10.1016/0167-4889(92)90097-U; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Stephens GJ, 1997, PFLUG ARCH EUR J PHY, V433, P523, DOI 10.1007/s004240050308; Tarasenko AN, 1997, J PHYSIOL-LONDON, V499, P77, DOI 10.1113/jphysiol.1997.sp021912; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Tsien Richard W., 1995, Trends in Neurosciences, V18, P52, DOI 10.1016/0166-2236(95)93867-W; WAKAMORI M, 1994, RECEPTOR CHANNEL, V2, P303; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501	50	71	72	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1998	20	2					341	351		10.1016/S0896-6273(00)80461-4	http://dx.doi.org/10.1016/S0896-6273(00)80461-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491994	Bronze			2022-12-24	WOS:000072154700018
J	De Zeeuw, CI; Hoogenraad, CC; Goedknegt, E; Hertzberg, E; Neubauer, A; Grosveld, F; Galjart, N				De Zeeuw, CI; Hoogenraad, CC; Goedknegt, E; Hertzberg, E; Neubauer, A; Grosveld, F; Galjart, N			CLIP-115, a novel brain-specific cytoplasmic linker protein, mediates the localization of dendritic lamellar bodies	NEURON			English	Article							BINDING-PROTEIN; MICROTUBULE DISRUPTION; PURKINJE NEURONS; MOTOR PROTEINS; CA2+ STORES; DYNACTIN; DYNEIN; GENE; PHOSPHORYLATION; CALSEQUESTRIN	Intracellular localization of organelles may depend in part on specific cytoplasmic linker proteins (CLIPs) that link membranous organelles to microtubules. Here, we characterize rat cDNAs encoding a novel, brain-specific CLIP of 115 kDa. This protein contains two M-terminal microtubule-binding domains and a long coiled-coil region; it binds to microtubules and is homologous to CLIP-170, a protein mediating the binding of endosomes to microtubules. CLIP-115 is enriched in the dendritic lamellar body (DLB), a recently discovered organelle predominantly present in bulbous dendritic appendages of neurons linked by dendrodendritic gap junctions. Local microtubule depolymerization leads to a temporary reduction of DLBs. These results suggest that CLIP-115 operates in the control of brain-specific organelle translocations.	Erasmus Univ, Dept Anat, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands; Albert Einstein Coll Med, Dept Neurosci, New York, NY 10461 USA	Erasmus University Rotterdam; Erasmus University Rotterdam; Yeshiva University	De Zeeuw, CI (corresponding author), Erasmus Univ, Dept Anat, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Galjart, Niels/D-1146-2010; Hoogenraad, Casper/B-8866-2011	Galjart, Niels/0000-0003-1964-3607; Hoogenraad, Casper/0000-0002-2666-0758				Allan V, 1996, CURR BIOL, V6, P630, DOI 10.1016/S0960-9822(09)00434-5; Andreasen M, 1996, HIPPOCAMPUS, V6, P79, DOI 10.1002/(SICI)1098-1063(1996)6:1<79::AID-HIPO13>3.0.CO;2-H; AUFFRAY C, 1980, GENE, V12, P77, DOI 10.1016/0378-1119(80)90017-7; BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; BILBE G, 1992, EMBO J, V11, P2103, DOI 10.1002/j.1460-2075.1992.tb05269.x; Burkhardt JK, 1996, TRENDS CELL BIOL, V6, P127, DOI 10.1016/0962-8924(96)20002-9; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DeZeeuw CI, 1997, J NEUROPHYSIOL, V77, P1747, DOI 10.1152/jn.1997.77.4.1747; DEZEEUW CI, 1995, J NEUROSCI, V15, P1587; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fourney R.M., 1988, FOCUS, V10, P5; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Hirokawa N, 1996, CELL STRUCT FUNCT, V21, P357, DOI 10.1247/csf.21.357; HOLZBAUR EL, 1991, NATURE, V360, P579; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LI I, 1997, P NATL ACAD SCI USA, V94, P1086; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Moore JD, 1996, BIOESSAYS, V18, P207, DOI 10.1002/bies.950180308; Ogawa K, 1996, CELL STRUCT FUNCT, V21, P343, DOI 10.1247/csf.21.343; Palay S. L., 1974, CEREBELLAR CORTEX CY; PIERRE P, 1994, J CELL SCI, V107, P1909; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; Sambrook J., 2002, MOL CLONING LAB MANU; Schnapp BJ, 1997, NEURON, V18, P523, DOI 10.1016/S0896-6273(00)80293-7; SHARP DJ, 1995, J CELL BIOL, V130, P93, DOI 10.1083/jcb.130.1.93; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SWAROOP A, 1987, P NATL ACAD SCI USA, V84, P6501, DOI 10.1073/pnas.84.18.6501; TAKEI K, 1992, J NEUROSCI, V12, P489; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; TRUEHEART J, 1987, MOL CELL BIOL, V7, P2316, DOI 10.1128/MCB.7.7.2316; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; VILLA A, 1991, J CELL BIOL, V113, P779, DOI 10.1083/jcb.113.4.779; WACKER IU, 1992, J CELL BIOL, V117, P813, DOI 10.1083/jcb.117.4.813; Wade RH, 1997, CURR OPIN CELL BIOL, V9, P12, DOI 10.1016/S0955-0674(97)80146-9; Watanabe TK, 1996, CYTOGENET CELL GENET, V72, P208, DOI 10.1159/000134191; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Yamashita A, 1997, GENES CELLS, V2, P155, DOI 10.1046/j.1365-2443.1997.1100307.x; [No title captured]	51	81	83	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1187	1199		10.1016/S0896-6273(00)80411-0	http://dx.doi.org/10.1016/S0896-6273(00)80411-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427243	Green Published			2022-12-24	WOS:000071236500007
J	Hjelmstad, GO; Nicoll, RA; Malenka, RC				Hjelmstad, GO; Nicoll, RA; Malenka, RC			Synaptic refractory period provides a measure of probability of release in the hippocampus	NEURON			English	Article							LONG-TERM POTENTIATION; PAIRED-PULSE FACILITATION; EXCITATORY POSTSYNAPTIC CURRENTS; TRANSMITTER RELEASE; CA1 REGION; CENTRAL SYNAPSES; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; TRANSMISSION; GLUTAMATE	Despite extensive research, much controversy remains regarding the locus of expression of long-term potentiation (LTP) in area CA1 of the hippocampus, specifically, whether LTP is accompanied by an increase in the probability of release (p(r)) of synaptic vesicles. We have developed a novel method for assaying p(r) which utilizes the synaptic refractory period-a brief 5-6 ms period following release during which the synapse is incapable of transmission (Stevens and Wang, 1995). We show that this assay is sensitive to a battery of manipulations that affect p(r) but find no change following either NMDA receptor-dependent LTP or long-term depression (LTD).	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Malenka, RC (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.		Rammes, Gerhard/G-4357-2015					ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; ASZTELY F, 1992, EUR J NEUROSCI, V4, P681, DOI 10.1111/j.1460-9568.1992.tb00177.x; Asztely F, 1996, NEUROREPORT, V7, P1609, DOI 10.1097/00001756-199607080-00016; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Castillo PE, 1996, J NEUROSCI, V16, P5942; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KORN H, 1994, ADV SEC MESS PHOSPH, V29, P301; KORN H, 1982, J NEUROPHYSIOL, V48, P679, DOI 10.1152/jn.1982.48.3.679; KORN H, 1984, J NEUROSCI, V4, P125; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LLINAS R, 1976, BIOPHYS J, V16, P83, DOI 10.1016/S0006-3495(76)85664-0; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER D, 1989, BRAIN RES, V479, P290, DOI 10.1016/0006-8993(89)91631-4; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Raastad M, 1996, EUR J NEUROSCI, V8, P1265, DOI 10.1111/j.1460-9568.1996.tb01295.x; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schulz PE, 1997, P NATL ACAD SCI USA, V94, P5888, DOI 10.1073/pnas.94.11.5888; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STRICKER D, 1996, J PHYSL, V490, P443; TRILLER A, 1985, J NEUROCYTOL, V14, P177, DOI 10.1007/BF01258446; Voronin L L, 1994, Rev Neurosci, V5, P141; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	51	55	55	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1309	1318		10.1016/S0896-6273(00)80421-3	http://dx.doi.org/10.1016/S0896-6273(00)80421-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427253	Bronze			2022-12-24	WOS:000071236500017
J	Morin, X; Cremer, H; Hirsch, MR; Kapur, RP; Goridis, C; Brunet, JF				Morin, X; Cremer, H; Hirsch, MR; Kapur, RP; Goridis, C; Brunet, JF			Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a	NEURON			English	Article							MOTOR-NEURONS; HOMEODOMAIN PROTEIN; DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR; EXPRESSION; GDNF; HYDROXYLASE; CELLS; RAT; RET	Phox2a is a vertebrate homeodomain protein expressed in subsets of differentiating neurons. Here, we show that it is essential for proper development of the locus coeruleus, a subset of sympathetic and parasympathetic ganglia and the VIIth, IXth, and Xth cranial sensory ganglia. In the sensory ganglia, we have identified two differentiation blocks in Phox2a(-/-) mice. First, the transient expression of dopamine-beta-hydroxylase in neuroblasts is abolished, providing evidence that Phox2a controls noradrenergic traits in vivo. Second, the expression of the GDNF receptor subunit Ret is dramatically reduced, and there is a massive increase in apoptosis of ganglion cells, which are known to depend on GDNF in vivo. Therefore, Phox2a appears to regulate conventional differentiation traits and the ability of neurons to respond to essential survival factors.	UNIV MEDITERRANEE, INSERM,INST BIOL DEV MARSEILLE,CNRS, LAB GENET & PHYSIOL DEV, F-13288 MARSEILLE 9, FRANCE; CHILDRENS HOSP & MED CTR, DEPT PATHOL, SEATTLE, WA 98105 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Seattle Children's Hospital			morin, xavier/AAI-3306-2020	Morin, Xavier/0000-0001-9999-0355; Brunet, Jean-Francois/0000-0002-1985-6103; Cremer, Harold/0000-0002-8673-5176				Appel B, 1995, DEVELOPMENT, V121, P4117; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Bang AG, 1996, CURR OPIN NEUROBIOL, V6, P25, DOI 10.1016/S0959-4388(96)80005-5; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Blaugrund E, 1996, DEVELOPMENT, V122, P309; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Burglin Thomas R., 1994, P25; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Durbec PL, 1996, DEVELOPMENT, V122, P349; EASTER SS, 1993, J NEUROSCI, V13, P285; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; ERNSBERGER U, 1995, MECH DEVELOP, V52, P125, DOI 10.1016/0925-4773(95)00396-I; ESCURAT M, 1990, J NEUROSCI, V10, P764; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; GHYSEN A, 1993, BIOESSAYS, V15, P293, DOI 10.1002/bies.950150502; Goddard JM, 1996, DEVELOPMENT, V122, P3217; GROVES AK, 1995, DEVELOPMENT, V121, P887; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HIGASHIJIMA S, 1992, GENE DEV, V6, P1005, DOI 10.1101/gad.6.6.1005; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JONAKAIT GM, 1984, DEV BIOL, V101, P51, DOI 10.1016/0012-1606(84)90116-7; KAPUR RP, 1991, NEURON, V7, P717, DOI 10.1016/0896-6273(91)90275-5; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; KNITTEL T, 1995, DEVELOPMENT, V121, P1077; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARK M, 1993, DEVELOPMENT, V119, P319; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; MILLER DM, 1995, DEVELOPMENT, V121, P2877; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pinon LGP, 1996, DEVELOPMENT, V122, P3255; ROBERTSON K, 1995, MECH DEVELOP, V53, P329, DOI 10.1016/0925-4773(95)00449-1; RUBENSTEIN JLR, 1994, CURR TOP DEV BIOL, V30, P2; RUBIN E, 1985, J NEUROSCI, V5, P673; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; TISSIERSETA JP, 1993, CR ACAD SCI III-VIE, V316, P1305; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VALARCHE I, 1993, DEVELOPMENT, V119, P881; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; Zellmer E, 1995, J NEUROSCI, V15, P8109	55	269	276	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1997	18	3					411	423		10.1016/S0896-6273(00)81242-8	http://dx.doi.org/10.1016/S0896-6273(00)81242-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115735	Bronze			2022-12-24	WOS:A1997WQ07400009
J	Staley, K; Smith, R; Schaack, J; Wilcox, C; Jentsch, TJ				Staley, K; Smith, R; Schaack, J; Wilcox, C; Jentsch, TJ			Alteration of GABA(A) receptor function following gene transfer of the CLC-2 chloride channel	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; GAMMA-AMINOBUTYRIC ACID; POSTSYNAPTIC INHIBITION; EPILEPTIFORM ACTIVITY; IONIC MECHANISMS; NERVOUS-SYSTEM; SPINAL-CORD; NEURONS; BRAIN; FUROSEMIDE	The effect of GABA(A) receptor activation varies from inhibition to excitation depending on the state of the transmembrane anionic concentration gradient (del(anion)). del(anion) was genetically altered in cultured dorsal root ganglion neurons via adenoviral vector-mediated expression of ClC-2, a Cl- channel postulated to regulate the Cl- concentration in neurons in which GABA(A) receptor activation is predominantly inhibitory. ClC-2 expression was verified by the presence of the appropriate mRNA, protein, and membrane conductance. ClC-2 expression resulted in a large negative shift in the Cl- equilibrium potential (E(Cl)) that attenuated the GABA-mediated membrane depolarization and prevented GABA(A) receptor-mediated action potentials. These results establish that gene transfer of transmembrane ion channels to neurons can be used to demonstrate their physiological function, and that del(anion) can be genetically manipulated to alter the function of neuronal GABA(A) receptors in situ.	UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT B182,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MICROBIOL,DENVER,CO 80262; COLORADO STATE UNIV,DEPT MICROBIOL,FT COLLINS,CO 80523; UNIV HAMBURG,CTR MOL NEUROBIOL,ZMNH,D-20246 HAMBURG,GERMANY	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado State University; University of Hamburg	Staley, K (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT NEUROL,DENVER,CO 80262, USA.			Jentsch, Thomas/0000-0002-3509-2553				ALVAREZLEEFMANS FJ, 1988, J PHYSIOL-LONDON, V406, P225, DOI 10.1113/jphysiol.1988.sp017378; ALVAREZLEEFMANS FJ, 1990, CHLORIDE CHANNELS CA, P133; AULT B, 1994, NEUROPHARMACOLOGY, V33, P109, DOI 10.1016/0028-3908(94)90104-X; AVOLI M, 1990, J NEUROPHYSIOL, V64, P1747, DOI 10.1152/jn.1990.64.6.1747; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Cohen LB, 1977, HDB PHYSL NERVOUS SY, P137; COLLINS JJ, 1995, J PEDIATR-US, V126, P653, DOI 10.1016/S0022-3476(95)70370-5; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; ECCLES JC, 1962, J PHYSIOL-LONDON, V160, P62, DOI 10.1113/jphysiol.1962.sp006835; GALLAGHER JP, 1978, J PHYSIOL-LONDON, V275, P263, DOI 10.1113/jphysiol.1978.sp012189; Golding NL, 1996, J NEUROSCI, V16, P2208; GREGER R, 1990, METHOD ENZYMOL, V191, P793; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; HAHN JS, 1993, PEDIATR NEUROL, V9, P330, DOI 10.1016/0887-8994(93)90076-O; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; JAROLIMEK W, 1996, IN PRESS J NEUROPHYS; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482P, pS19; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LEGENDRE P, 1991, MOL PHARMACOL, V39, P267; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; MICHELSON HB, 1991, SCIENCE, V253, P1420, DOI 10.1126/science.1654594; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MOROTA N, 1995, CHILD NERV SYST, V11, P161, DOI 10.1007/BF00570257; Nicoll R A, 1979, Int Rev Neurobiol, V21, P217; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NICOLL RA, 1978, J PHYSIOL-LONDON, V283, P121, DOI 10.1113/jphysiol.1978.sp012491; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; OLSEN RW, 1994, ANNU REV NEUROSCI, V17, P569; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PUZZAN T, 1996, PHYSIOL REV, V74, P595; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rohrbough J, 1996, J NEUROSCI, V16, P82; SCHAACK J, 1995, J VIROL, V69, P3920, DOI 10.1128/JVI.69.6.3920-3923.1995; SCHER MS, 1993, PEDIATRICS, V91, P128; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH RL, 1995, J NEUROSCI, V15, P4057; SMITH RL, 1994, VIROLOGY, V201, P49; SOLTESZ I, 1994, J NEUROSCI, V14, P2365; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; THOMPSON SM, 1994, PROG NEUROBIOL, V42, P575, DOI 10.1016/0301-0082(94)90044-2; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; WHITE MM, 1990, MOL PHARMACOL, V37, P720; WONG RKS, 1982, J NEUROPHYSIOL, V48, P938, DOI 10.1152/jn.1982.48.4.938; Yancey P.H., 1994, CELLULAR MOL PHYSL C, P81	55	182	183	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					543	551		10.1016/S0896-6273(00)80186-5	http://dx.doi.org/10.1016/S0896-6273(00)80186-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816717	Bronze			2022-12-24	WOS:A1996VJ44000020
J	LucidiPhillipi, CA; Clary, DO; Reichardt, LF; Gage, FH				LucidiPhillipi, CA; Clary, DO; Reichardt, LF; Gage, FH			TrkA activation is sufficient to rescue axotomized cholinergic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; FIMBRIA-FORNIX TRANSECTION; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; BASAL FOREBRAIN; SENSORY NEURONS; GENE-EXPRESSION; KINASE-ACTIVITY; MESSENGER-RNA	To test the molecular nature of the NGF receptor responsible for the ability of NGF to rescue septal cholinergic neurons following axotomy, we infused polyclonal antibodies that act as specific agonists of trkA (RTA) into the lateral ventricle of fimbria-fornix lesioned animals. Rats receiving chronic intraventricular infusions of RTA showed significantly more low affinity NGF receptor immunoreactive (p75(NGFR-IR)) neurons on the lesioned side than did control animals 2 weeks following unilateral fimbria-fornix lesion. RTA also initiated cholinergic sprouting. Infusions of RTA in combination with an antibody that blocks p75(NGFR) (REX) did not reduce the cell savings effect observed with RTA alone. However, animals infused with RTA plus REX demonstrated significantly less sprouting. These findings suggest that antibody-induced trkA activation is sufficient to mediate NGF-promoted survival of axotomized cholinergic neurons in vivo.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; SUGEN INC,REDWOOD CITY,CA 94063	Howard Hughes Medical Institute; University of California System; University of California San Francisco	LucidiPhillipi, CA (corresponding author), SALK INST BIOL STUDIES,10010 N TORREY PINES RD,LA JOLLA,CA 92037, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006088, R01AG008514, T32AG000216, R37AG008514] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG000216, AG08514, R01 AG008514, AG06088, R37 AG008514, 5T32 AG00216] Funding Source: Medline; NIMH NIH HHS [P50 MH048200-100005] Funding Source: Medline; NINDS NIH HHS [P01 NS028121] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLSOPP TE, 1993, J CELL BIOL, V123, P1555, DOI 10.1083/jcb.123.6.1555; ARIMATSU Y, 1988, DEV BRAIN RES, V45, P297; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BARNETT J, 1990, EXP NEUROL, V110, P11, DOI 10.1016/0014-4886(90)90047-V; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; BATCHELOR PE, 1989, J COMP NEUROL, V284, P187, DOI 10.1002/cne.902840204; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GAGE FH, 1988, J COMP NEUROL, V269, P147, DOI 10.1002/cne.902690112; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; GAGE FH, 1983, BRAIN RES, V268, P27, DOI 10.1016/0006-8993(83)90387-6; GIBBS RB, 1994, J COMP NEUROL, V341, P324, DOI 10.1002/cne.903410304; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; HEFTI F, 1985, NEUROSCIENCE, V14, P55, DOI 10.1016/0306-4522(85)90163-0; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1984, BRAIN RES, V293, P305, DOI 10.1016/0006-8993(84)91237-X; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HIGGINS GA, 1989, NEURON, V3, P247, DOI 10.1016/0896-6273(89)90038-X; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LOEB DM, 1991, CELL, V66, P951; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; MONTERO CN, 1988, J NEUROSCI, V8, P2986; NAUMANN T, 1992, J COMP NEUROL, V325, P219, DOI 10.1002/cne.903250207; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PETERSON DA, 1994, J NEUROSCI, V14, P6872; PETERSON DA, 1993, J NEUROSCI METH, V46, P107, DOI 10.1016/0165-0270(93)90146-I; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RADEKE MJ, 1991, NEURON, V7, P141, DOI 10.1016/0896-6273(91)90082-B; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROVELLI G, 1993, P NATL ACAD SCI USA, V90, P8717, DOI 10.1073/pnas.90.18.8717; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; TUSZYNSKI MH, 1990, BRAIN RES, V508, P241, DOI 10.1016/0006-8993(90)90402-W; VERDI JM, 1994, P NATL ACAD SCI USA, V91, P3949, DOI 10.1073/pnas.91.9.3949; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	61	47	47	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					653	663		10.1016/S0896-6273(00)80084-7	http://dx.doi.org/10.1016/S0896-6273(00)80084-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785062	Bronze, Green Accepted			2022-12-24	WOS:A1996UC16800021
J	Wang, H; Allen, ML; Grigg, JJ; Noebels, JL; Tempel, BL				Wang, H; Allen, ML; Grigg, JJ; Noebels, JL; Tempel, BL			Hypomyelination alters K+ channel expression in mouse mutants shiverer and Trembler	NEURON			English	Article							BASIC-PROTEIN GENE; MYELINATED NERVE-FIBERS; POTASSIUM CHANNELS; SCHWANN-CELL; SODIUM-CHANNELS; MULTIPLE-SCLEROSIS; MEMBRANE CURRENTS; ION CHANNELS; SPINAL-CORD; AXONS	Voltage-gated K+ channels are localized to juxtaparanodal regions of myelinated axons. To begin to understand the role of normal compact myelin in this localization, we examined mKv1.1 and mKv1.2 expression in the dysmyelinating mouse mutants shiverer and Trembler. In neonatal wild-type and shiverer mice, the focal localization of both proteins in axon fiber tracts is similar, suggesting that cues other than mature myelin can direct initial K+ channel localization in shiverer mutants. In contrast, K+ channel localization is altered in hypomyelinated axonal fiber tracts of adult mutants, suggesting that abnormal myelination leads to channel redistribution. In shiverer adult, K+ channel expression is up-regulated in both axons and glia, as revealed by immunocytochemistry, RNase protection, and in situ hybridization studies. This up-regulation of K+ channels in hypomyelinated axon tracts may reflect a compensatory reorganization of ionic currents, allowing impulse conduction to occur in these dysmyelinating mouse mutants.	UNIV WASHINGTON, SCH MED, DEPT PHARMACOL, SEATTLE, WA 98195 USA; VET AFFAIRS MED CTR, CTR GERIATR RES EDUC & CLIN, SEATTLE, WA 98108 USA; BAYLOR COLL MED, DEPT NEUROL, NEUROPHYSIOL SECT, DEV NEUROGENET LAB, HOUSTON, TX 77030 USA	University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine	Wang, H (corresponding author), UNIV WASHINGTON, SCH MED, DEPT OTOLARYNGOL HEAD & NECK SURG, SEATTLE, WA 98195 USA.			Noebels, Jeffrey/0000-0002-2887-0839	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000018] Funding Source: NIH RePORTER; NIDCD NIH HHS [T32-DC00018] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AGARD DA, 1989, METHOD CELL BIOL, V30, P353; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; Barres B A, 1991, Curr Opin Neurobiol, V1, P354, DOI 10.1016/0959-4388(91)90052-9; BEVER CT, 1994, ANN NEUROL, V36, pS118, DOI 10.1002/ana.410360728; BIRD TD, 1978, J NEUROCHEM, V31, P387, DOI 10.1111/j.1471-4159.1978.tb12479.x; BLACK JA, 1991, BRAIN RES, V544, P59, DOI 10.1016/0006-8993(91)90885-Y; BOSMA MM, 1993, J NEUROSCI, V13, P5242, DOI 10.1523/JNEUROSCI.13-12-05242.1993; BOSTOCK H, 1981, J PHYSIOL-LONDON, V313, P301, DOI 10.1113/jphysiol.1981.sp013666; BOWE CM, 1985, PROC R SOC SER B-BIO, V224, P355, DOI 10.1098/rspb.1985.0037; BRISMAR T, 1980, J PHYSIOL-LONDON, V298, P171, DOI 10.1113/jphysiol.1980.sp013074; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; CHIU SY, 1989, J PHYSIOL-LONDON, V408, P199, DOI 10.1113/jphysiol.1989.sp017455; CHIU SY, 1979, J PHYSIOL-LONDON, V292, P149, DOI 10.1113/jphysiol.1979.sp012843; CHIU SY, 1994, GLIA, V12, P1, DOI 10.1002/glia.440120102; CHIU SY, 1991, GLIA, V4, P541, DOI 10.1002/glia.440040602; CHOI BH, 1986, J NEUROPATH EXP NEUR, V45, P513, DOI 10.1097/00005072-198609000-00003; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Hille B., 1992, IONIC CHANNELS EXCIT; HOPKINS WF, 1994, PFLUG ARCH EUR J PHY, V428, P382, DOI 10.1007/BF00724522; MI HY, 1995, J NEUROSCI, V15, P3761; MOLINEAUX SM, 1986, P NATL ACAD SCI USA, V83, P7542, DOI 10.1073/pnas.83.19.7542; MOLL C, 1991, BRAIN RES, V556, P311, DOI 10.1016/0006-8993(91)90321-L; NOEBELS JL, 1991, NATURE, V352, P431, DOI 10.1038/352431a0; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; ROSENBLUTH J, 1980, J COMP NEUROL, V194, P639, DOI 10.1002/cne.901940310; ROSENBLUTH J, 1988, INT J DEV NEUROSCI, V6, P3, DOI 10.1016/0736-5748(88)90025-1; ROSENBLUTH J, 1981, BRAIN RES, V208, P283, DOI 10.1016/0006-8993(81)90558-8; ROSENBLUTH J, 1980, J COMP NEUROL, V193, P729, DOI 10.1002/cne.901930310; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; SCHWARZ JR, 1991, NEUROSCI LETT, V122, P205, DOI 10.1016/0304-3940(91)90859-R; SHRAGER P, 1989, BRAIN RES, V483, P149, DOI 10.1016/0006-8993(89)90046-2; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; STEFOSKI D, 1987, ANN NEUROL, V21, P71, DOI 10.1002/ana.410210113; STERNBERGERLA, 1979, IMMUNOCYTOCHEMISTRY; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TARG EF, 1985, BRAIN RES, V328, P358, DOI 10.1016/0006-8993(85)91049-2; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; WAXMAN SG, 1985, SCIENCE, V228, P1502, DOI 10.1126/science.2409596; WAXMAN SG, 1984, BRAIN RES, V294, P111, DOI 10.1016/0006-8993(84)91314-3; WERKMAN TR, 1992, NEUROSCIENCE, V50, P935, DOI 10.1016/0306-4522(92)90216-O; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WILEYLIVINGSTON CA, 1980, DEV BIOL, V79, P334, DOI 10.1016/0012-1606(80)90120-7; WILSON GF, 1990, J NEUROSCI, V10, P3263	50	72	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1337	1347		10.1016/0896-6273(95)90012-8	http://dx.doi.org/10.1016/0896-6273(95)90012-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845157	Bronze			2022-12-24	WOS:A1995TL67800012
J	Yang, J; Jan, YN; Jan, LY				Yang, J; Jan, YN; Jan, LY			Determination of the subunit stoichiometry of an inwardly rectifying potassium channel	NEURON			English	Article							FUNCTIONAL EXPRESSION; CELLS; RECTIFICATION; RECEPTOR; MG-2+; BLOCK	Inwardly rectifying K+ channels are distantly related to their voltage-gated counterparts and possess a structural motif of only two putative transmembrane segments in each subunit. They are formed by the assembly of an unknown number of subunits. We have examined the subunit stoichiometry oi a strongly rectifying K+ channel, IRK1, by linking together the coding sequence of three or four subunits and distinguishing channels with different numbers of subunits carrying a double mutation that alters inward rectification and single-channel properties. We find that IRK1 channels, like voltage-gated K+ channels, are tetrameric channels. Interestingly, the high sensitivity to Mg2+ and polyamines, cations that produce inward rectification by blocking the channel pore from the cytoplasmic side, is largely retained in a channel containing only one wild-type subunit and three subunits bearing mutations that abolish high affinity Mg2+ and polyamine block.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yang, J (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GLOWATZKI, 1995, P R SOC LOND B, V261, P251; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; ISHIHARA K, 1989, J PHYSIOL-LONDON, V419, P297, DOI 10.1113/jphysiol.1989.sp017874; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MATSUDA H, 1988, J PHYSIOL-LONDON, V397, P237, DOI 10.1113/jphysiol.1988.sp016998; NICHOLS CG, 1994, J PHYSIOL-LONDON, V476, P399, DOI 10.1113/jphysiol.1994.sp020141; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Smith RM, 1974, CRITICAL STABILITY C, V1-6; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	34	196	197	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1441	1447		10.1016/0896-6273(95)90021-7	http://dx.doi.org/10.1016/0896-6273(95)90021-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845166	Bronze			2022-12-24	WOS:A1995TL67800021
J	Csicsvari, J; Hirase, H; Czurko, A; Buzsaki, G				Csicsvari, J; Hirase, H; Czurko, A; Buzsaki, G			Reliability and state dependence of pyramidal cell-interneuron synapses in the hippocampus: an ensemble approach in the behaving rat	NEURON			English	Article							LONG-TERM POTENTIATION; TRANSMITTER RELEASE; THETA-RHYTHM; INHIBITORY CELLS; NEURONS; CA3; TRANSMISSION; CONNECTIONS; OSCILLATION; RECORDINGS	Spike transmission probability between pyramidal cells and interneurons in the CA1 pyramidal layer was investigated in the behaving rat by the simultaneous recording of neuronal ensembles. Population synchrony was strongest during sharp wave (SPW) bursts. However, the increase was three times larger for pyramidal cells than for interneurons. The contribution of single pyramidal cells to the discharge of interneurons was often large (up to 0.6 probability), as assessed by the presence of significant (<3 ms) peaks in the cross-correlogram. Complex-spike bursts were more effective than single spikes. Single cell contribution was higher between SPW bursts than during SPWs or theta activity. Hence, single pyramidal cells can reliably discharge interneurons, and the probability of spike transmission is behavior dependent.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.		Czurkó, András/H-5500-2019; Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905; Buzsaki, Gyorgy/0000-0002-3100-4800; Czurko, Andras/0000-0002-1985-7296	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NCRR NIH HHS [1P41RR09754] Funding Source: Medline; NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS34994] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; AIKA Y, 1994, EXP BRAIN RES, V99, P267; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; ARANCIO O, 1994, J PHYSIOL-LONDON, V481, P395, DOI 10.1113/jphysiol.1994.sp020448; BANKMAN IN, 1993, IEEE T BIO-MED ENG, V40, P836, DOI 10.1109/10.238472; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Fortunato C, 1996, EUR J NEUROSCI, V8, P1758, DOI 10.1111/j.1460-9568.1996.tb01319.x; FOX SE, 1981, EXP BRAIN RES, V41, P399; FOX SE, 1986, EXP BRAIN RES, V62, P495; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; KUBIE JL, 1990, J NEUROSCI, V10, P1110; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McBain CJ, 1997, CAN J PHYSIOL PHARM, V75, P488, DOI 10.1139/cjpp-75-5-488; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; NADASDY Z, 1998, LARGE SCALE RECORDIN, P17; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PERLMAN G, 1980, BEHAV RES METH INSTR, V12, P554, DOI 10.3758/BF03201835; Press W. H., 1992, ART SCI COMPUTING; RAASTAD M, 1995, EUR J NEUROSCI, V7, P1882, DOI 10.1111/j.1460-9568.1995.tb00709.x; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; SIK A, 1995, J NEUROSCI, V15, P6651; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Traub RD, 1995, J COMPUT NEUROSCI, V2, P291, DOI 10.1007/BF00961441; Tsodyks MV, 1997, J NEUROSCI, V17, P4382; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YLINEN A, 1995, J NEUROSCI, V15, P30; Zador AM, 1997, NEURON, V19, P1, DOI 10.1016/S0896-6273(00)80341-4; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	63	417	421	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					179	189		10.1016/S0896-6273(00)80525-5	http://dx.doi.org/10.1016/S0896-6273(00)80525-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697862	Bronze			2022-12-24	WOS:000075061900017
J	Tandon, A; Bannykh, S; Kowalchyk, JA; Banerjee, A; Martin, TFJ; Balch, WE				Tandon, A; Bannykh, S; Kowalchyk, JA; Banerjee, A; Martin, TFJ; Balch, WE			Differential regulation of exocytosis by calcium and CAPS in semi-intact synaptosomes	NEURON			English	Article							PROTEIN-KINASE-C; SUBSTRATE B-50 GAP-43; DENSE-CORED VESICLES; SYNAPTIC VESICLES; NORADRENALINE RELEASE; CHROMAFFIN CELLS; NERVE-TERMINALS; STREPTOLYSIN-O; NEUROTOXINS; SECRETION	Using a novel approach to measure exocytosis in vitro from semi-intact synaptosomes, we establish that the Ca2+-dependent release of glutamate requires cytosolic factors for mobilization from the reserve pool. The cytosolic activity for glutamate release was not satisfied by CAPS, a soluble component required for norepinephrine (NE) release. Moreover, the CAPS-independent glutamate release from synaptic vesicles (SVs) was 200-fold less sensitive to Ca2+ than that required for dense core vesicles (DCVs). The differential regulation of exocytosis by CAPS, Ca2+, and potential novel cytosolic factor(s) suggests that the docking and fusion machinery controlling DCVs has diverged from that regulating glutamate-containing SVs.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA	Scripps Research Institute; Scripps Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.				NCI NIH HHS [CA58689] Funding Source: Medline; NIGMS NIH HHS [GM33301] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHNERTHILGER G, 1989, J NEUROCHEM, V52, P1751, DOI 10.1111/j.1471-4159.1989.tb07253.x; ANDERSSON PO, 1982, J PHYSIOL-LONDON, V322, P469, DOI 10.1113/jphysiol.1982.sp014050; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Avery Leon, 1993, Genetics, V134, P455; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; Bauerfeind R, 1993, CURR OPIN CELL BIOL, V5, P628, DOI 10.1016/0955-0674(93)90132-A; Bean AJ, 1997, NEURON, V19, P751, DOI 10.1016/S0896-6273(00)80957-5; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BHAKDI S, 1993, MED MICROBIOL IMMUN, V182, P167; BINZ T, 1994, J BIOL CHEM, V269, P1617; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; BURGOYNE RD, 1995, TRENDS NEUROSCI, V18, P191, DOI 10.1016/0166-2236(95)93900-I; Calakos N, 1996, PHYSIOL REV, V76, P1; DEKKER LV, 1991, J NEUROCHEM, V56, P1146, DOI 10.1111/j.1471-4159.1991.tb11404.x; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; FISCHER V, 1991, NATURE, V349, P79; Goodall AR, 1997, J NEUROCHEM, V68, P1542; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HENS JJH, 1993, J NEUROCHEM, V61, P602; HENS JJH, 1993, J NEUROCHEM, V60, P1264, DOI 10.1111/j.1471-4159.1993.tb03286.x; HOLZ RW, 1991, ANN NY ACAD SCI, V635, P382, DOI 10.1111/j.1749-6632.1991.tb36506.x; IP NY, 1984, NATURE, V311, P472, DOI 10.1038/311472a0; Linial M, 1997, J NEUROCHEM, V69, P1781; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; Mehta PP, 1996, P NATL ACAD SCI USA, V93, P10471, DOI 10.1073/pnas.93.19.10471; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schikorski T, 1997, J NEUROSCI, V17, P5858; STECHER B, 1989, FEBS LETT, V248, P23, DOI 10.1016/0014-5793(89)80424-7; THURESONKLEIN A, 1983, NEUROSCIENCE, V10, P245, DOI 10.1016/0306-4522(83)90132-X; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; WELDON P, 1993, NEUROSCIENCE, V55, P1045, DOI 10.1016/0306-4522(93)90318-A; Worthington C.C, 1988, WORTHINGTON ENZYME M, P199	49	104	107	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					147	154		10.1016/S0896-6273(00)80522-X	http://dx.doi.org/10.1016/S0896-6273(00)80522-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697859	Bronze			2022-12-24	WOS:000075061900014
J	Kelley, WM; Miezin, FM; McDermott, KB; Buckner, RL; Raichle, ME; Cohen, NJ; Ollinger, JM; Akbudak, E; Conturo, TE; Snyder, AZ; Petersen, SE				Kelley, WM; Miezin, FM; McDermott, KB; Buckner, RL; Raichle, ME; Cohen, NJ; Ollinger, JM; Akbudak, E; Conturo, TE; Snyder, AZ; Petersen, SE			Hemispheric specialization in human dorsal frontal cortex and medial temporal lobe for verbal and nonverbal memory encoding	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; HIPPOCAMPAL-FORMATION; PREFRONTAL CORTEX; EPISODIC MEMORY; HUMAN-BRAIN; RETRIEVAL; PET; RECOGNITION; ACTIVATION; SYSTEMS	The involvement of dorsal frontal and medial temporal regions during the encoding of words, namable line-drawn objects, and unfamiliar faces was examined using functional magnetic resonance imaging (fMRI). Robust dorsal frontal activations were observed in each instance, but lateralization was strongly dependent on the materials being encoded. Encoding of words produced left-lateralized dorsal frontal activation, whereas encoding of unfamiliar faces produced homologous right-lateralized activation. Encoding of namable objects, which are amenable to both verbal and nonverbal encoding, yielded bilateral dorsal frontal activation. A similar pattern of results was observed in the medial temporal lobe. These results indicate that regions in both hemispheres underlie human longterm memory encoding, and these regions can be engaged differentially according to the nature of the material being encoded.	Washington Univ, Sch Med, Dept Neurol & Neurol Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; Univ Illinois, Beckman Inst, Champaign, IL 61820 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kelley, WM (corresponding author), Washington Univ, Sch Med, Dept Neurol & Neurol Surg, St Louis, MO 63110 USA.		Petersen, Steve/ABF-1368-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032979] Funding Source: NIH RePORTER; NINDS NIH HHS [NS06883, NS32979] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; BUCKNER RL, 1998, IN PRESS NEUROIMAGE; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; DEMB JB, 1995, J NEUROSCI, V15, P5870; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Haxby JV, 1995, HUM BRAIN MAPP, V3, P68, DOI 10.1002/hbm.460030204; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Kapur S, 1996, COGNITIVE BRAIN RES, V4, P243, DOI 10.1016/S0926-6410(96)00058-4; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Klingberg T, 1998, CEREB CORTEX, V8, P73, DOI 10.1093/cercor/8.1.73; Martin A, 1997, HIPPOCAMPUS, V7, P587, DOI 10.1002/(SICI)1098-1063(1997)7:6<587::AID-HIPO1>3.0.CO;2-C; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; Milner B, 1972, Clin Neurosurg, V19, P421; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MILNER B, 1982, PHILOS T R SOC B, V298, P211, DOI 10.1098/rstb.1982.0083; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; PAIVIO A, 1973, COGNITIVE PSYCHOL, V5, P176, DOI 10.1016/0010-0285(73)90032-7; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimamura Arthur P., 1995, P803; Snodgrass JS, 1980, J EXP PSYCHOL HUM LE, V9, P164; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Swick D, 1996, NEUROPSYCHOLOGIA, V34, P1019, DOI 10.1016/0028-3932(96)00011-5; Talairach I., 1988, COPLANAR STEREOTACTI; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71	39	672	681	0	32	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					927	936		10.1016/S0896-6273(00)80474-2	http://dx.doi.org/10.1016/S0896-6273(00)80474-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620697	Bronze			2022-12-24	WOS:000073864700012
J	Goodman, MB; Hall, DH; Avery, L; Lockery, SR				Goodman, MB; Hall, DH; Avery, L; Lockery, SR			Active currents regulate sensitivity and dynamic range in C-elegans neurons	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; GLR-1 GLUTAMATE-RECEPTOR; TRANSMITTER RELEASE; MEMBRANE-PROPERTIES; POTASSIUM CHANNELS; CALCIUM INFLUX; HAIR-CELLS; PHOTORECEPTORS; MUTANTS	Little is known about the physiology of neurons in Caenorhabditis elegans. Using new techniques for in situ patch-clamp recording in C. elegans, we analyzed the electrical properties of an identified sensory neuron (ASER) across four developmental stages and 42 unidentified neurons at one stage. We find that ASER is nearly isopotential and fails to generate classical Na+ action potentials. Rather, ASER displays a high sensitivity to input currents coupled to a depolarization-dependent reduction in sensitivity that may endow ASER with a wide dynamic range. Voltage clamp revealed depolarization-activated K+ and Ca2+ currents that contribute to high sensitivity near the zero-current potential. The depolarization-dependent reduction in sensitivity can be attributed to activation of K+ current at voltages where it dominates the net membrane current. The voltage dependence of membrane current was similar in all neurons examined, suggesting that C. elegans neurons share a common mechanism of sensitivity and dynamic range.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Univ Texas, SW Med Ctr, Dallas, TX 75235 USA	University of Oregon; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lockery, SR (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.		Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272	NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051383, R21MH112105] Funding Source: NIH RePORTER; NCRR NIH HHS [R24 RR012596] Funding Source: Medline; NHLBI NIH HHS [R01 HL046154] Funding Source: Medline; NIMH NIH HHS [R21 MH112105, R01 MH051383] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Art JJ, 1996, ANN NY ACAD SCI, V781, P103, DOI 10.1111/j.1749-6632.1996.tb15696.x; Avery L, 1995, CAENORHABDITIS ELEGA, P251; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; CANNONE AJ, 1980, J EXP BIOL, V86, P305; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHALFIE M, 1993, J NEUROBIOL, V24, P1433, DOI 10.1002/neu.480241013; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; DAVIS RE, 1989, J NEUROSCI, V9, P403; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Elkes DA, 1997, NEURON, V19, P165, DOI 10.1016/S0896-6273(00)80356-6; FETTIPLACE R, 1987, TRENDS NEUROSCI, V10, P421, DOI 10.1016/0166-2236(87)90013-0; HALL DH, 1995, CAENORHABDITIS ELEGA, P395; HARDIE RC, 1991, J NEUROSCI, V11, P3079; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HODGKIN J, 1995, SCIENCE, V270, P410, DOI 10.1126/science.270.5235.410; HUDSPETH AJ, 1977, J PHYSIOL-LONDON, V272, P25, DOI 10.1113/jphysiol.1977.sp012032; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Johnstone DB, 1997, NEURON, V19, P151, DOI 10.1016/S0896-6273(00)80355-4; kandel, 1977, NERVOUS SYSTEM, V1; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P227; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; MAJOR G, 1994, J NEUROSCI, V14, P4613; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MAURO A, 1970, J GEN PHYSIOL, V55, P497, DOI 10.1085/jgp.55.4.497; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SERRANO EE, 1989, J NEUROSCI, V9, P4021; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; VANHATEREN JH, 1990, J COMP PHYSIOL A, V166, P437, DOI 10.1007/BF00192015; WANGBENNETT LT, 1987, J COMP PHYSIOL A, V161, P131, DOI 10.1007/BF00609461; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	50	257	264	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					763	772		10.1016/S0896-6273(00)81014-4	http://dx.doi.org/10.1016/S0896-6273(00)81014-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581767	Green Accepted, hybrid			2022-12-24	WOS:000073346500014
J	Yang, X; Kuo, YH; Devay, P; Yu, CR; Role, L				Yang, X; Kuo, YH; Devay, P; Yu, CR; Role, L			A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis	NEURON			English	Article							CHICKEN SYMPATHETIC NEURONS; NEU DIFFERENTIATION FACTORS; CILIARY GANGLION NEURONS; ACETYLCHOLINE-RECEPTORS; DEVELOPMENTAL REGULATION; NEUROMUSCULAR-JUNCTION; CARDIAC DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; SUBUNIT GENE	We report here that neuregulin (NRG) isoforms with a conserved cysteine-rich domain (CRD) in their N terminus regulate expression of nicotinic acetylcholine receptors (nAChRs) at developing interneuronal synapses and report the isolation of transmembrane NRG isoforms with this CRD within the N-terminal portion. CRD-NRG mRNA and immunoreactive protein are detected early in developing presynaptic (visceral motor) neurons. The levels of expression of CRD-NRG peak prior to the formation of synapses with their postsynaptic partners, the ganglionic sympathetic neurons. Recombinant CRD-NRG mimics the effects of presynaptic input on target neurons. Functional deletion of CRD-NRG from presynaptic neurons abolishes the upregulation of nAChR expression induced by input-derived soluble material. Thus, CRD-NRG appears to be both a necessary and a sufficient signal for the control of neuronal nAChR expression during synaptogenesis.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Role, L (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.		Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X	NINDS NIH HHS [NS29071] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029071] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anton ES, 1997, DEVELOPMENT, V124, P3501; ARENELLA LS, 1993, J NEUROSCI, V13, P4525; BENBARUCH N, 1994, P SOC EXP BIOL MED, V206, P221; BOYD RT, 1988, NEURON, V1, P495; BRUSSAARD AB, 1998, IN PRESS J PHYSL; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Busfield SJ, 1997, MOL CELL BIOL, V17, P4007, DOI 10.1128/MCB.17.7.4007; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; CORFAS G, 1993, J NEUROSCI, V13, P2118; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DEVAY P, 1994, DEV BIOL, V162, P56, DOI 10.1006/dbio.1994.1066; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; GARDETTE R, 1991, DEV BIOL, V147, P83, DOI 10.1016/S0012-1606(05)80009-0; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; GOODEARL ADJ, 1995, J CELL BIOL, V130, P1423, DOI 10.1083/jcb.130.6.1423; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; Hogg RV., 1970, INTRO MATH STAT; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; JACOB MH, 1987, J CELL BIOL, V105, P1847, DOI 10.1083/jcb.105.4.1847; JESSELL TM, 1979, P NATL ACAD SCI USA, V76, P5397, DOI 10.1073/pnas.76.10.5397; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kleiman RJ, 1996, CELL, V85, P461, DOI 10.1016/S0092-8674(00)81245-3; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Levey MS, 1996, J NEUROSCI, V16, P6878; LEVEY MS, 1995, NEURON, V14, P153, DOI 10.1016/0896-6273(95)90249-X; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; MOSS BL, 1993, J NEUROSCI, V13, P13; MOSS BL, 1989, NEURON, V3, P597, DOI 10.1016/0896-6273(89)90270-5; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; PRIGENT SA, 1992, ONCOGENE, V7, P1273; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; ROLE LW, 1988, P NATL ACAD SCI USA, V85, P2825, DOI 10.1073/pnas.85.8.2825; ROLE LW, 1984, P NATL ACAD SCI-BIOL, V81, P2924, DOI 10.1073/pnas.81.9.2924; Ruegg MA, 1996, CURR OPIN NEUROBIOL, V6, P97, DOI 10.1016/S0959-4388(96)80014-6; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	57	125	129	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					255	270		10.1016/S0896-6273(00)80454-7	http://dx.doi.org/10.1016/S0896-6273(00)80454-7			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491987	hybrid			2022-12-24	WOS:000072154700011
J	Yu, HH; Araj, HH; Ralls, SA; Kolodkin, AL				Yu, HH; Araj, HH; Ralls, SA; Kolodkin, AL			The transmembrane semaphorin Sema I is required in Drosophila for embryonic motor and CNS axon guidance	NEURON			English	Article							GROWTH CONE GUIDANCE; CENTRAL-NERVOUS-SYSTEM; GENETIC-ANALYSIS; FASCICLIN-II; TYROSINE PHOSPHATASES; EXPRESSION; PROTEIN; DEFASCICULATION; CONNECTIVITY; MELANOGASTER	The semaphorins comprise a targe family of conserved glycoproteins, several members of which have been shown to function in repulsive neuronal growth cone guidance. We show here that Drosophila Semaphorin I (Sema I), a transmembrane semaphorin expressed on embryonic motor and CNS axons, is required for correct guidance of motor axons and for the formation of CNS pathways. In mutant embryos lacking Sema I, motor axons stall and fail to defasciculate at specific choice points where normally they would project to their muscle targets. In addition, a specific CNS fascicle fails to form correctly in these embryos. Rescue and ectopic expression experiments show that Sema I is required in neurons to mediate axon guidance decisions. These studies further suggest that like secreted semaphorins, transmembrane semaphorins can function as repulsive guidance cues for specific axon guidance events during neurodevelopment.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.		Yu, Hung-Hsiang/AGP-0497-2022	Yu, Hung-Hsiang/0000-0002-2430-9251	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035165, R01NS035165] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35165] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; BATE M, 1995, NEURON, V15, P513, DOI 10.1016/0896-6273(95)90141-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CONDIC ML, 1989, J NEUROSCI, V10, P3935; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HE S, 1997, CELL, V90, P737; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Keynes R, 1996, NEURON, V17, P1031, DOI 10.1016/S0896-6273(00)80235-4; Kikuchi K, 1997, MOL BRAIN RES, V51, P229, DOI 10.1016/S0169-328X(97)00251-9; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mark MD, 1997, CELL TISSUE RES, V290, P299, DOI 10.1007/s004410050934; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wong JTW, 1997, DEVELOPMENT, V124, P3597; ZHOU L, 1997, MOL CELL NEUROSCI, V9, P25; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	44	149	149	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					207	220		10.1016/S0896-6273(00)80450-X	http://dx.doi.org/10.1016/S0896-6273(00)80450-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491983	hybrid			2022-12-24	WOS:000072154700007
J	He, W; Cowan, CW; Wensel, TG				He, W; Cowan, CW; Wensel, TG			RGS9, a GTPase accelerator for phototransduction	NEURON			English	Article							MONKEY MACACA-FASCICULARIS; PROTEIN ALPHA-SUBUNITS; ROD OUTER SEGMENTS; TRANSDUCIN GTPASE; CGMP PHOSPHODIESTERASE; ACTIVATING PROTEINS; INHIBITORY SUBUNIT; RETINAL RODS; HYDROLYSIS; CASCADE	The rod outer segment phototransduction GAP (GTPase-accelerating protein) has been identified as RGS9, a member of the RGS family of Ga GAPs. RGS9 mRNA expression is specific for photoreceptor cells, and RGS9 protein colocalizes with other phototransduction components to photoreceptor outer segment membranes. The RGS domain of RGS9 accelerates GTP hydrolysis by the visual G protein transducin (G alpha(t)), and this acceleration is enhanced by the gamma subunit of the phototransduction effector cGMP phosphodiesterase (PDEgamma). These unique properties of RGS9 match those of the rod outer segment GAP and implicate it as a key element in the recovery phase of visual transduction.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Cell & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Wensel, TG (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA.		Cowan, Christopher W/I-2497-2014	Wensel, Theodore/0000-0003-3518-9352	NATIONAL EYE INSTITUTE [R01EY007981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007696] Funding Source: NIH RePORTER; NEI NIH HHS [EY07981] Funding Source: Medline; NIDDK NIH HHS [DK07696] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albrecht U, 1997, MOL CELLULAR METHODS, P23; ANGLESON JK, 1993, NEURON, V11, P939, DOI 10.1016/0896-6273(93)90123-9; ANGLESON JK, 1994, J BIOL CHEM, V269, P16290; ANTONNY B, 1993, BIOCHEMISTRY-US, V32, P8646, DOI 10.1021/bi00084a036; ARSHAVSKY VY, 1989, FEBS LETT, V250, P353, DOI 10.1016/0014-5793(89)80754-9; ARSHAVSKY VY, 1987, FEBS LETT, V224, P19, DOI 10.1016/0014-5793(87)80414-3; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; ARSHAVSKY VY, 1994, J BIOL CHEM, V269, P19882; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; DRATZ EA, 1987, BIOCHEM BIOPH RES CO, V146, P379, DOI 10.1016/0006-291X(87)90540-7; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Faurobert E, 1997, P NATL ACAD SCI USA, V94, P2945, DOI 10.1073/pnas.94.7.2945; Gold SJ, 1997, J NEUROSCI, V17, P8024; HARLOW H, 1988, ANTIBODIES LAB MANUA; Hecht S, 1933, J GEN PHYSIOL, V17, P251, DOI 10.1085/jgp.17.2.251; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KRAFT TW, 1988, J PHYSIOL-LONDON, V404, P199, DOI 10.1113/jphysiol.1988.sp017286; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Natochin M, 1997, J BIOL CHEM, V272, P17444, DOI 10.1074/jbc.272.28.17444; NEKRASOVA ER, 1997, BIOCHEMISTRY-US, V36, P7368; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; OTTOBRUC A, 1994, BIOCHEMISTRY-US, V33, P15215, DOI 10.1021/bi00255a001; PAGES F, 1993, J BIOL CHEM, V268, P26358; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Sagoo MS, 1997, NATURE, V389, P392, DOI 10.1038/38750; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; TING TD, 1991, BIOCHEMISTRY-US, V30, P8996, DOI 10.1021/bi00101a013; VUONG TM, 1990, NATURE, V346, P71, DOI 10.1038/346071a0; VUONG TM, 1991, P NATL ACAD SCI USA, V88, P9813, DOI 10.1073/pnas.88.21.9813; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wieland T, 1997, J BIOL CHEM, V272, P8853; YAMAZAKI A, 1993, J BIOL CHEM, V268, P8899	45	289	302	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1998	20	1					95	102		10.1016/S0896-6273(00)80437-7	http://dx.doi.org/10.1016/S0896-6273(00)80437-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459445	Bronze			2022-12-24	WOS:000071719700012
J	Jin, H; Clayton, DF				Jin, H; Clayton, DF			Localized changes in immediate-early gene regulation during sensory and motor learning in zebra finches	NEURON			English	Article							SONG CONTROL-SYSTEM; VASOACTIVE INTESTINAL POLYPEPTIDE; CAT VISUAL-CORTEX; LONG-TERM-MEMORY; TAENIOPYGIA-GUTTATA; SENSITIVE PHASE; CONTROL NUCLEI; GROWTH-FACTORS; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS	A complex neural system controls birdsong learning, but its organization is not understood, nor is it known why learning only occurs during a critical period in adolescence. Here, we analyzed developmental regulation in zebra finches of zenk, an immediate-early gene (IEG) implicated in memory consolidation. Basal expression was elevated within auditory telencephalon (specifically, within the caudomedial neostriatum [NCM]) during song acquisition. Expression could be further induced by song playbacks 30 days after hatching but not at 20 days nor in juveniles reared in severe isolation. Singing itself induced zenk in song production nuclei, including Area X, even in adults. Within a compartment of the robust nucleus of the archistriatum (RA), however, this response dwindled as singing matured. These results suggest that the onset of sensory memory storage may be regulated in part at NCM, and motor plasticity may be regulated at RA.	UNIV ILLINOIS, BECKMAN INST, URBANA, IL 61801 USA; UNIV ILLINOIS, DEPT CELL & STRUCT BIOL, URBANA, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign			Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488	NIMH NIH HHS [R01 MH52086] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052086] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADRET P, 1993, ANIM BEHAV, V46, P149, DOI 10.1006/anbe.1993.1170; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ARNOLD AP, 1975, J EXP ZOOL, V191, P261, DOI 10.1002/jez.1401910212; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BALL GF, 1995, BRAIN RES, V699, P83, DOI 10.1016/0006-8993(95)00875-Q; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BOHNER J, 1990, ANIM BEHAV, V39, P369, DOI 10.1016/S0003-3472(05)80883-8; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; BOTTJER SW, 1995, BRAIN BEHAV EVOLUT, V45, P153, DOI 10.1159/000113547; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CASTO JM, 1994, J NEUROBIOL, V25, P767, DOI 10.1002/neu.480250703; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CLAYTON DF, 1988, NEURON, V1, P249, DOI 10.1016/0896-6273(88)90146-8; CLAYTON DF, 1997, IN PRESS J NEUROBIOL; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Doupe A J, 1993, Curr Opin Neurobiol, V3, P104, DOI 10.1016/0959-4388(93)90043-X; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; EALES LA, 1987, ANIM BEHAV, V35, P1356, DOI 10.1016/S0003-3472(87)80008-8; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Immelmann K., 1969, P61; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Jones AE, 1996, J COMP PSYCHOL, V110, P354; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kaminska B, 1996, J NEUROSCI, V16, P3968; Kaplan IV, 1995, DEV BRAIN RES, V90, P174, DOI 10.1016/0165-3806(96)83498-5; Kaplan IV, 1996, MOL BRAIN RES, V36, P12, DOI 10.1016/0169-328X(95)00228-K; KELLEY DB, 1979, J COMP NEUROL, V183, P455, DOI 10.1002/cne.901830302; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; KONISHI M, 1985, NATURE, V315, P145, DOI 10.1038/315145a0; KOSOFSKY BE, 1995, J COMP NEUROL, V351, P27, DOI 10.1002/cne.903510104; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; MARLER P, 1983, J NEUROSCI, V3, P517; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MOONEY R, 1994, J NEUROSCI, V14, P6532; Morgan James J., 1995, Trends in Neurosciences, V18, P66, DOI 10.1016/0166-2236(95)93874-W; MORRISON RG, 1993, J NEUROBIOL, V24, P1045, DOI 10.1002/neu.480240805; NASTIUK KL, 1994, MOL BRAIN RES, V27, P299, DOI 10.1016/0169-328X(94)90013-2; NELSON DA, 1994, P NATL ACAD SCI USA, V91, P10498, DOI 10.1073/pnas.91.22.10498; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Okuno H, 1996, EUR J NEUROSCI, V8, P2118, DOI 10.1111/j.1460-9568.1996.tb00733.x; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Siegel S., 1956, NONPARAMETRIC STAT, P116; SLATER PJB, 1993, NETH J ZOOL, V43, P80; SLATER PJB, 1991, ETHOLOGY, V88, P163; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Stripling R, 1997, J NEUROSCI, V17, P3883; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TENCATE C, 1991, ANIM BEHAV, V42, P857; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; VOLMAN SF, 1995, J COMP PSYCHOL, V109, P211, DOI 10.1037/0735-7036.109.3.211; WALLACE CS, 1995, MOL BRAIN RES, V32, P211, DOI 10.1016/0169-328X(95)00076-5; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZHANG F, 1995, EUR J NEUROSCI, V7, P1292, DOI 10.1111/j.1460-9568.1995.tb01119.x	68	128	128	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1997	19	5					1049	1059		10.1016/S0896-6273(00)80396-7	http://dx.doi.org/10.1016/S0896-6273(00)80396-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390518	Bronze			2022-12-24	WOS:A1997YH59400012
J	Rao, A; Craig, AM				Rao, A; Craig, AM			Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons	NEURON			English	Article							CEREBELLAR GRANULE CELLS; DEVELOPING NEUROMUSCULAR-JUNCTION; K+-INDUCED DEPOLARIZATION; VISUAL-CORTEX; UP-REGULATION; RAT-BRAIN; GLUTAMATE RECEPTORS; MONKEY HIPPOCAMPUS; GUANYLATE KINASES; CORTICAL-NEURONS	We describe here a novel effect of activity on the subcellular distribution of NMDA receptors in hippocampal neurons in culture. In spontaneously active neurons, NMDA receptors were clustered at a few synaptic and nonsynaptic sites. Chronic blockade of NMDA receptor activity induced a 380% increase in the number of NMDA receptor clusters and a shift to a more synaptic distribution. This effect was reversible. The distributions of the presynaptic marker synaptophysin, the AMPA-type glutamate receptor subunit GluR1, and the putative NMDA receptor clustering protein PSD-95 were not affected by blockade. Regulation of the synaptic localization of NMDA receptors by activity may define a novel mechanism by which input controls a neuron's ability to modify its synapses.	UNIV ILLINOIS,DEPT CELL & STRUCT BIOL,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign			Craig, Ann Marie/M-2054-2014		NINDS NIH HHS [NS33184] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033184] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; AOKI C, 1994, J NEUROSCI, V14, P5202; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; DEBSKI EA, 1991, J NEUROSCI, V11, P2947; DIDIER M, 1994, EUR J NEUROSCI, V6, P1536, DOI 10.1111/j.1460-9568.1994.tb00544.x; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; DURAND GM, 1993, P NATL ACAD SCI USA, V90, P6731, DOI 10.1073/pnas.90.14.6731; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Feldmeyer D, 1996, J NEUROCYTOL, V25, P857, DOI 10.1007/BF02284847; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Follesa P, 1996, J NEUROSCI, V16, P2172; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Goslin K., 1991, CULTURING NERVE CELL, P251; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HUNTLEY GW, 1994, J NEUROSCI, V14, P3603; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ISHII T, 1993, J BIOL CHEM, V268, P2836; Johnson RR, 1996, J COMP NEUROL, V368, P335, DOI 10.1002/(SICI)1096-9861(19960506)368:3<335::AID-CNE2>3.0.CO;2-6; JONES K, 1991, NEURON, V17, P103; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCDONALD JW, 1990, NEUROSCIENCE, V38, P103, DOI 10.1016/0306-4522(90)90377-G; McIlhinney RAJ, 1996, NEUROSCIENCE, V70, P989, DOI 10.1016/0306-4522(95)00419-X; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Niethammer M, 1996, J NEUROSCI, V16, P2157; OBRIETAN K, 1995, J NEUROPHYSIOL, V73, P1524, DOI 10.1152/jn.1995.73.4.1524; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PETRALIA RS, 1994, J NEUROSCI, V14, P667; RESINK A, 1995, J NEUROCHEM, V64, P558; SCHEETZ AJ, 1994, FASEB J, V8, P744; SEGAL M, 1995, J PHYSIOL-LONDON, V486, P283, DOI 10.1113/jphysiol.1995.sp020811; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SIEGEL SJ, 1995, J NEUROSCI, V15, P2707; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vallano ML, 1996, J NEUROSCI, V16, P631; WILLIAMS K, 1992, MOL PHARMACOL, V42, P147; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0	66	410	420	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					801	812		10.1016/S0896-6273(00)80962-9	http://dx.doi.org/10.1016/S0896-6273(00)80962-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354327	Bronze			2022-12-24	WOS:A1997YD18900008
J	Barth, AL; Dugas, JC; Ngai, J				Barth, AL; Dugas, JC; Ngai, J			Noncoordinate expression of odorant receptor genes tightly linked in the zebrafish genome	NEURON			English	Article							GLR-1 GLUTAMATE-RECEPTOR; IN-SITU HYBRIDIZATION; OLFACTORY EPITHELIUM; C-ELEGANS; NEURONS; FAMILY; CELLS; HUMAN-CHROMOSOME-17; ORGANIZATION; PATHWAYS	We have characterized the organization and expression of odorant receptor genes clustered within similar to 100 kb of the zebrafish genome. Physical analysis of this genomic region reveals that the receptor genes are tightly linked in tandem arrays. The expression patterns of these genes were evaluated during development as well as in the adult olfactory epithelium. Highly related genes from this array are expressed individually in different olfactory neurons, suggesting that the discriminatory capacity of the vertebrate olfactory system has been maximized by segregating the most similar receptors into distinct cellular pathways. Furthermore, genes from this cluster are activated at different times of development. Together, these results indicate that genomically linked odorant receptor genes are not coordinately regulated.	UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,DIV NEUROBIOL LIFE SCI ADDIT,BERKELEY,CA 94720	University of California System; University of California Berkeley					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002253] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC-02253] Funding Source: Medline; NIGMS NIH HHS [T32 GM07232-18] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barth AL, 1996, NEURON, V16, P23, DOI 10.1016/S0896-6273(00)80020-3; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Byrd CA, 1996, J NEUROBIOL, V29, P445, DOI 10.1002/(SICI)1097-4695(199604)29:4<445::AID-NEU3>3.0.CO;2-8; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; IsselTarver L, 1996, P NATL ACAD SCI USA, V93, P10897, DOI 10.1073/pnas.93.20.10897; Kaplan JM, 1996, CURR OPIN NEUROBIOL, V6, P494, DOI 10.1016/S0959-4388(96)80055-9; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; Leibovici M, 1996, DEV BIOL, V175, P118, DOI 10.1006/dbio.1996.0100; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; Nef S, 1996, MECH DEVELOP, V55, P65, DOI 10.1016/0925-4773(95)00491-2; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; REED RR, 1992, COLD SPRING HARB SYM, V57, P501, DOI 10.1101/SQB.1992.057.01.055; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; STROTMANN J, 1995, EUR J NEUROSCI, V7, P492, DOI 10.1111/j.1460-9568.1995.tb00345.x; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; SULLIVAN SL, 1995, NEURON, V15, P779, DOI 10.1016/0896-6273(95)90170-1; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Weth F, 1996, P NATL ACAD SCI USA, V93, P13321, DOI 10.1073/pnas.93.23.13321; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WILKINSON DG, 1987, DEVELOPMENT, V99, P493	36	54	55	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					359	369		10.1016/S0896-6273(00)80945-9	http://dx.doi.org/10.1016/S0896-6273(00)80945-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292725	Bronze			2022-12-24	WOS:A1997XU14600014
J	Iwai, Y; Usui, T; Hirano, S; Steward, R; Takeichi, M; Uemura, T				Iwai, Y; Usui, T; Hirano, S; Steward, R; Takeichi, M; Uemura, T			Axon patterning requires DN-cadherin, a novel neuronal adhesion receptor, in the Drosophila embryonic CNS	NEURON			English	Article							CELL-CELL ADHESION; GROWTH CONE GUIDANCE; N-CADHERIN; NERVOUS-SYSTEM; ALPHA-CATENIN; ARMADILLO PROTEIN; GENETIC-ANALYSIS; XENOPUS EMBRYOS; FASCICLIN-II; EXPRESSION	We identified DN-cadherin, a novel Drosophila cadherin that is expressed in axons and in the mesoderm. Although DN-cadherin has diverged from vertebrate classic cadherins in terms of its extracellular structure, it still can form a complex with catenins and induce cell aggregation, as do the vertebrate molecules. Loss-of-function mutations of the gene resulted in either embryonic lethality or uncoordinated locomotion of adults. In the central nervous system of null mutant embryos, subsets of ipsilateral axons displayed a variety of aberrant trajectories including failure of position shifts, defective bundling, and errors in directional migration of growth cones. These results suggest that processes of axon patterning critically depend on DN-cadherin-mediated axon-axon interactions.	RUTGERS STATE UNIV,WAKSMAN INST,DEPT MOL BIOL,PISCATAWAY,NJ 08855	Rutgers State University New Brunswick	Iwai, Y (corresponding author), KYOTO UNIV,FAC SCI,DEPT BIOPHYS,SAKYO KU,KYOTO 60601,JAPAN.		Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; UEMURA, Tadashi/0000-0001-7204-3606; Usui, Tadao/0000-0002-0507-1495				BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; DUSBAND JL, 1988, DEVELOPMENT, V103, P325; EDWARDS JS, 1993, J COMP NEUROL, V333, P301, DOI 10.1002/cne.903330214; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FUJIMORI T, 1990, DEVELOPMENT, V110, P97; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Goodman Corey S., 1993, P1131; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HALTER DA, 1995, DEVELOPMENT, V121, P317; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Higashijima S, 1996, DEVELOPMENT, V122, P527; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; Hoshino M, 1996, DEVELOPMENT, V122, P589; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Jan Yuh Nung, 1993, P1207; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KAWANISHI J, 1995, MOL CELL BIOL, V15, P1175; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; ODA H, 1993, J CELL BIOL, V121, P1133, DOI 10.1083/jcb.121.5.1133; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; OYAMA T, 1994, CANCER RES, V54, P6282; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEIFER M, 1993, J CELL SCI, V105, P993; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; RANSCHT B, 1994, CURR OPIN CELL BIOL, V6, P740, DOI 10.1016/0955-0674(94)90102-3; Redies C, 1996, DEV BIOL, V180, P413, DOI 10.1006/dbio.1996.0315; REDIES C, 1995, EXP CELL RES, V220, P243, DOI 10.1006/excr.1995.1313; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; STEWARD R, 1986, GENETICS, V113, P665; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THISSE C, 1992, DEVELOPMENT, P173; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	85	251	261	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					77	89		10.1016/S0896-6273(00)80349-9	http://dx.doi.org/10.1016/S0896-6273(00)80349-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247265	Bronze			2022-12-24	WOS:A1997XN39400008
J	Song, HJ; Ming, GL; Fon, E; Bellocchio, E; Edwards, RH; Poo, MM				Song, HJ; Ming, GL; Fon, E; Bellocchio, E; Edwards, RH; Poo, MM			Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging	NEURON			English	Article							NERVE-MUSCLE INTERACTIONS; XENOPUS CELL-CULTURE; CHOLINE-ACETYLTRANSFERASE; MONOAMINE TRANSPORTER; AMINE TRANSPORTER; NEUROMUSCULAR SYNAPSES; CAENORHABDITIS-ELEGANS; CHROMAFFIN GRANULES; SYNAPTIC VESICLES; GENE	A putative vesicular acetytcholine transporter (VAChT) was overexpressed in developing Xenopus spinal neurons by injection of rat VAChT cDNA or synthetic mRNA into Xenopus embryos. This resulted in a marked increase in the amplitude and frequency of miniature excitatory postsynaptic currents at neuromuscular synapses, reflecting an over 10-fold increase in the vesicular packaging of acetylcholine (ACh). The effect appeared in developing neurons even before synaptogenesis and was blocked by L-vesamicol, a specific blocker of ACh uptake into synaptic vesicles. Mutational studies showed that two highly conserved aspartate residues within putative transmembrane domains 4 and 10 are essential for the transport activity. These results provide direct evidence for the physiological function of a putative VAChT and demonstrate that quantal size can be regulated by changes in vesicular transporter activity.	UNIV CALIF SAN FRANCISCO, DEPT NEUROL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Song, HJ (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.		Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 50712] Funding Source: Medline; NINDS NIH HHS [NS 22764] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDER J, 1995, J NEUROSCI, V15, P511; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; BERRARD S, 1995, J NEUROCHEM, V65, P939; BERSE B, 1995, J BIOL CHEM, V270, P22101, DOI 10.1074/jbc.270.38.22101; BOYD IA, 1956, J PHYSIOL-LONDON, V132, P74, DOI 10.1113/jphysiol.1956.sp005503; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CERVINI R, 1995, J BIOL CHEM, V270, P24654, DOI 10.1074/jbc.270.42.24654; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DESNOS C, 1995, J BIOL CHEM, V270, P16030, DOI 10.1074/jbc.270.27.16030; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; EVERS J, 1989, J NEUROSCI, V9, P1523; Gilmor ML, 1996, J NEUROSCI, V16, P2179; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KIDOKORO Y, 1980, DEV BIOL, V78, P464, DOI 10.1016/0012-1606(80)90347-4; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; MARON R, 1983, J BIOL CHEM, V258, P1476; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; MISAWA H, 1995, NEUROREPORT, V6, P965, DOI 10.1097/00001756-199505090-00004; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; ORIDA N, 1978, NATURE, V275, P31, DOI 10.1038/275031a0; PARSONS SM, 1993, INT REV NEUROBIOL, V35, P279, DOI 10.1016/S0074-7742(08)60572-3; PRIOR C, 1992, GEN PHARMACOL, V23, P1017, DOI 10.1016/0306-3623(92)90280-W; ROGHANI A, 1994, P NATL ACAD SCI USA, V91, P10620, DOI 10.1073/pnas.91.22.10620; SCHAFER MKH, 1994, J MOL NEUROSCI, V5, P1, DOI 10.1007/BF02736691; SCHULDINER S, 1993, J BIOL CHEM, V268, P29; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SteinerMordoch S, 1996, J BIOL CHEM, V271, P13048, DOI 10.1074/jbc.271.22.13048; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Tabti N., 1991, CULTURING NERVE CELL, P137; VAROQUI H, 1994, FEBS LETT, V342, P97, DOI 10.1016/0014-5793(94)80592-X; Varoqui H, 1996, J BIOL CHEM, V271, P27229, DOI 10.1074/jbc.271.44.27229; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0	41	144	149	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1997	18	5					815	826		10.1016/S0896-6273(00)80320-7	http://dx.doi.org/10.1016/S0896-6273(00)80320-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182805	Bronze			2022-12-24	WOS:A1997XB72200014
J	Wichterle, H; GarciaVerdugo, JM; AlvarezBuylla, A				Wichterle, H; GarciaVerdugo, JM; AlvarezBuylla, A			Direct evidence for homotypic, glia-independent neuronal migration	NEURON			English	Article							CELL-ADHESION MOLECULE; DEVELOPING CEREBRAL-CORTEX; OLFACTORY-BULB; N-CAM; MONOCLONAL-ANTIBODY; SUBVENTRICULAR ZONE; SUBEPENDYMAL LAYER; POLYSIALIC ACID; NERVOUS-SYSTEM; GRANULE CELLS	Neuronal precursors born in the subventricular zone (SVZ) of the neonatal and adult rodent brain migrate 3-8 mm from the walls of the lateral ventricle into the olfactory bulb. This tangentially oriented migration occurs without the guidance of radial glia or axonal processes. The cells move closely associated, forming elongated aggregates called chains, which are ensheathed by astrocytes. We have developed a culture system in which postnatal mouse SVZ neuronal precursors assemble into chains with ultrastructural and immunocytochemical characteristics equivalent to those in vivo but without the astrocytic sheath. Time-lapse videomicrography revealed that individual cells migrate along the chains very rapidly (similar to 122 mu m/hr) in both directions. Periods of cell body translocation were interspersed with stationary periods. This saltatory behavior was similar to radial glia-guided migration but similar to 4 times faster. Neuronal precursors isolated from embryonic cortical ventricular zone or cerebellar external granule layer did not form chains under these conditions, suggesting that chain migration is characteristic of SVZ precursors. This study directly demonstrates that SVZ neuronal precursors migrate along each other without the assistance of astrocytes or other cell types. (Additional data are presented in www.cell.com).	UNIV VALENCIA,DEPT CELL BIOL,VALENCIA,SPAIN	University of Valencia	Wichterle, H (corresponding author), ROCKEFELLER UNIV,1230 YORK AVE,NEW YORK,NY 10021, USA.		García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925	NINDS NIH HHS [NS28478] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478, R01NS028478, R29NS028478] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZBUYLLA A, 1987, J COMP NEUROL, V264, P159, DOI 10.1002/cne.902640203; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; GADISSEUX JF, 1992, J COMP NEUROL, V324, P94, DOI 10.1002/cne.903240108; GREGORY WA, 1988, J NEUROSCI, V8, P1728; HEIDEMANN SR, 1994, NEUROTOXICOLOGY, V15, P95; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Jacobson M., 1991, DEV NEUROBIOLOGY; Jankovski A, 1996, J COMP NEUROL, V371, P376; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KOMURO H, 1995, J NEUROSCI, V15, P1110; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; LAMOUREUX P, 1989, Nature (London), V340, P159, DOI 10.1038/340159a0; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1994, CHEM SENSES, V19, P695, DOI 10.1093/chemse/19.6.695; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Moody SA, 1996, J COMP NEUROL, V364, P219, DOI 10.1002/(SICI)1096-9861(19960108)364:2<219::AID-CNE3>3.0.CO;2-8; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; RAKIC P, 1995, J NEUROBIOL, V26, P299, DOI 10.1002/neu.480260303; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1969, Z ANAT ENTWICKLUNGS, V129, P53, DOI 10.1007/BF00521955; ROSSELLIAUSTIN L, 1995, J DEV PHYSL, V1, P295; ROUGON G, 1986, J CELL BIOL, V103, P2429, DOI 10.1083/jcb.103.6.2429; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; RUTISHAUSER U, 1991, TRENDS NEUROSCI, V14, P528, DOI 10.1016/0166-2236(91)90006-G; SZIGETI V, 1993, GLIA, V8, P20, DOI 10.1002/glia.440080104; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; WALSH C, 1992, SCIENCE, V258, P317, DOI 10.1126/science.258.5080.317-a; WALSH FS, 1991, CELL BIOL INT REP, V15, P1151, DOI 10.1016/0309-1651(91)90061-M; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417; [No title captured]	50	344	358	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					779	791		10.1016/S0896-6273(00)80317-7	http://dx.doi.org/10.1016/S0896-6273(00)80317-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182802	Bronze			2022-12-24	WOS:A1997XB72200011
J	Kano, M; Hashimoto, K; Kurihara, H; Watanabe, M; Inoue, Y; Aiba, A; Tonegawa, S				Kano, M; Hashimoto, K; Kurihara, H; Watanabe, M; Inoue, Y; Aiba, A; Tonegawa, S			Persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking mGluR1	NEURON			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; LONG-TERM DEPRESSION; SUBUNIT MESSENGER-RNAS; STAGGERER MUTANT MOUSE; CELLULAR-LOCALIZATION; SYNAPTIC PLASTICITY; RAT CEREBELLUM; NMDA RECEPTOR; ADULT	Most of the cerebellar Purkinje cells (PCs) of an adult animal are innervated individually by a single climbing fiber (CF) that forms strong excitatory synapses with the PCs. This one-to-one relationship between a PC and a CF is a consequence of a developmentally regulated regression of the innervation of PCs by CFs. We found that, in mice deficient in the type 1 metabotropic glutamate receptor (mGluR1), the regression of supernumerary CFs ceases by the end of the second postnatal week, which is about one week earlier than in normal mice. Consequently, about one third of PCs in the mGluR1 mutant mice are innervated by multiple CFs in adulthood. We conclude that the regression of CFs normally occurs in two developmental phases and that mGluR1 plays a crucial role in the second phase.	MIT,HOWARD HUGHES MED INST,CTR LEARNING & MEMORY,CTR CANC RES,CAMBRIDGE,MA 02139; JICHI MED SCH,DEPT PHYSIOL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; RIKEN,FRONTIER RES PROGRAM,LAB NEURONAL SIGNAL TRANSDUCT,WAKO,SAITAMA 35101,JAPAN; HOKKAIDO UNIV,SCH MED,DEPT ANAT,SAPPORO,HOKKAIDO 060,JAPAN; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Jichi Medical University; RIKEN; Hokkaido University; Massachusetts Institute of Technology (MIT)			WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Hashimoto, Kouichi/0000-0002-3884-8213; Aiba, Atsu/0000-0002-8192-0778; Kano, Masanobu/0000-0002-0725-3292	NINDS NIH HHS [R01-NS32925] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032925] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1980, NATURE, V283, P483, DOI 10.1038/283483a0; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; CREPEL F, 1979, J PHYSIOL-LONDON, V290, P97, DOI 10.1113/jphysiol.1979.sp012762; CREPEL F, 1976, J NEUROBIOL, V7, P579, DOI 10.1002/neu.480070610; DESCLIN JC, 1974, BRAIN RES, V77, P365, DOI 10.1016/0006-8993(74)90628-3; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; GARCIASEGURA LM, 1984, BRAIN RES, V296, P75, DOI 10.1016/0006-8993(84)90512-2; GORCS TJ, 1993, NEUROREPORT, V4, P283; GRANDES P, 1994, NEUROREPORT, V5, P2249, DOI 10.1097/00001756-199411000-00011; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1984, CEREBELLUM NEURAL CO; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M., 1992, P54; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MARANI E, 1979, ACTA MORPHOL NEER SC, V17, P33; MARIANI J, 1980, J NEUROBIOL, V11, P41, DOI 10.1002/neu.480110106; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; OLEARY JL, 1971, J COMP NEUROL, V142, P377, DOI 10.1002/cne.901420307; Palay S. L., 1974, CEREBELLAR CORTEX CY; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; Weibel E.R, 1979, STEREOLOGICAL METHOD; WOODWARD DJ, 1974, J NEUROBIOL, V5, P283, DOI 10.1002/neu.480050402; YAMAKUNI T, 1984, NEUROSCI LETT, V45, P235, DOI 10.1016/0304-3940(84)90232-5; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	40	249	251	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					71	79		10.1016/S0896-6273(01)80047-7	http://dx.doi.org/10.1016/S0896-6273(01)80047-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010206	Bronze			2022-12-24	WOS:A1997WE71800009
J	Mennerick, S; Matthews, G				Mennerick, S; Matthews, G			Ultrafast exocytosis elicited by calcium current in synaptic terminals of retinal bipolar neurons	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; SQUID GIANT SYNAPSE; RELEASE; KINETICS	Using high resolution capacitance measurements, we have characterized an ultrafast component of transmitter release in ribbon-type synaptic terminals of retinal bipolar neurons. During depolarization, capacitance increases to a plateau of similar to 30 fF with a time constant of similar to 1.5 ms. When not limited by activation kinetics of calcium current, the small pool is depleted even faster, with a time constant of 0.5 ms. After the ultrafast pool is depleted, capacitance rises with a slower time constant of similar to 300 ms. EGTA (5 mM) depresses the slower capacitance rise but leaves the ultrafast phase intact. BAPTA (5 mM) depresses both components of exocytosis. With paired-pulse stimulation, the ultrafast pool recovers from depletion with a time constant of similar to 4 s. The ultrafast component may represent fusion of docked vesicles at the base of the synaptic ribbon, while the slower component represents more distal vesicles on the ribbon.			Mennerick, S (corresponding author), SUNY STONY BROOK,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794, USA.		Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664	NATIONAL EYE INSTITUTE [R01EY003821] Funding Source: NIH RePORTER; NEI NIH HHS [EY03821] Funding Source: Medline; NINDS NIH HHS [NS07371] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HERRINGTON J, 1993, PULSE CONTROL V3 0 I; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; Neher E., 1986, CALCIUM ELECTROGENES, V14, P80; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; USUKURA J, 1987, CELL TISSUE RES, V247, P483, DOI 10.1007/BF00215740; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONGERSDORFF H, 1996, NEURON, V16, P1211; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626	20	210	211	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1241	1249		10.1016/S0896-6273(00)80254-8	http://dx.doi.org/10.1016/S0896-6273(00)80254-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982170	Bronze			2022-12-24	WOS:A1996WA24800020
J	Lebrand, C; Cases, O; Adelbrecht, C; Doye, A; Alvarez, C; ElMestikawy, S; Seif, I; Gaspar, P				Lebrand, C; Cases, O; Adelbrecht, C; Doye, A; Alvarez, C; ElMestikawy, S; Seif, I; Gaspar, P			Transient uptake and storage of serotonin in developing thalamic neurons	NEURON			English	Article							VESICULAR MONOAMINE TRANSPORTER; VISUAL CORTICAL PLASTICITY; SOMATOSENSORY CORTEX; MESSENGER-RNA; RAT-BRAIN; CEREBRAL-CORTEX; CRANIOFACIAL MORPHOGENESIS; ULTRASTRUCTURAL ANALYSIS; TRYPTOPHAN-HYDROXYLASE; POSTNATAL-DEVELOPMENT	Serotonin (5-HT) has been shown to affect the development and patterning of the mouse barrelfield. We show that the dense transient 5-HT innervation of the somatosensory, visual, and auditory cortices originates in the thalamus rather than in the raphe: 5-HT is detected in thalamocortical fibers and most 5-HT cortical labeling disappears after thalamic lesions. Thalamic neurons do not synthesize 5-HT but take up exogenous 5-HT through 5-HT high affinity uptake sites located on thalamocortical axons and terminals. H-3-5-HT injected into the cortex is retrogradely transported to thalamic neurons. In situ hybridization shows a transient expression of the genes encoding the serotonin transporter and the vesicular monoamine transporter in thalamic sensory neurons. In these glutamatergic neurons, internalized 5-HT might thus be stored and used as a ''borrowed transmitter'' for extraneuronal signaling or could exert an intraneuronal control on thalamic maturation.	HOP LA PITIE SALPETRIERE, IFR NEUROSCI, INSERM U288, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, IFR NEUROSCI, INSERM U289, F-75651 PARIS 13, FRANCE; INST CURIE, CNRS UMR 177, F-91405 ORSAY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Lebrand, C (corresponding author), HOP LA PITIE SALPETRIERE, IFR NEUROSCI, INSERM U106, F-75651 PARIS 13, FRANCE.		Lebrand, Cecile/G-1394-2015; cases, olivier/G-4882-2017; Gaspar, Patricia/G-8892-2011	Lebrand, Cecile/0000-0002-2750-3164; cases, olivier/0000-0002-5678-7362; Gaspar, Patricia/0000-0003-4217-5717				AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BENNETTCLARKE CA, 1995, BRAIN RES, V702, P255, DOI 10.1016/0006-8993(95)00867-5; BENNETTCLARKE CA, 1991, NEUROSCIENCE, V43, P163, DOI 10.1016/0306-4522(91)90425-N; BENNETTCLARKE CA, 1993, P NATL ACAD SCI USA, V90, P153, DOI 10.1073/pnas.90.1.153; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; BENNETTCLARKE CA, 1994, J COMP NEUROL, V348, P277, DOI 10.1002/cne.903480209; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; BINA KG, 1995, J COMP NEUROL, V363, P321, DOI 10.1002/cne.903630212; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Blue ME, 1991, CEREB CORTEX, V1, P380, DOI 10.1093/cercor/1.5.380; BLUE ME, 1995, DEV BRAIN RES, V84, P11, DOI 10.1016/0165-3806(94)00147-R; BUZNIKOV GA, 1981, NEUROCHEM RES, V6, P55, DOI 10.1007/BF00963906; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; COHEN Z, 1995, NEUROSCIENCE, V66, P555, DOI 10.1016/0306-4522(94)00625-F; CONSOLAZIONE A, 1981, J HISTOCHEM CYTOCHEM, V29, P1425, DOI 10.1177/29.12.7033368; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364; DAMATO RJ, 1987, P NATL ACAD SCI USA, V84, P4322, DOI 10.1073/pnas.84.12.4322; DARMON MC, 1988, J NEUROCHEM, V51, P312, DOI 10.1111/j.1471-4159.1988.tb04871.x; DECOURCELLES DD, 1990, DEV CARDIOVASC MED, V106, P445; Dori I, 1996, EXP NEUROL, V138, P1, DOI 10.1006/exnr.1996.0041; DOUCET G, 1988, BRAIN RES, V441, P233, DOI 10.1016/0006-8993(88)91403-5; DYCK RH, 1993, J NEUROSCI, V13, P4316; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; FAURE MP, 1995, NEUROSCIENCE, V68, P519, DOI 10.1016/0306-4522(95)00145-9; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; FUJITA M, 1993, NEUROSCI LETT, V162, P59, DOI 10.1016/0304-3940(93)90559-4; FULLER RW, 1988, PHARMACOL BIOCHEM BE, V30, P715, DOI 10.1016/0091-3057(88)90089-5; GERARD A, 1978, CR ACAD SCI D NAT, V286, P891; Gerard C, 1996, SYNAPSE, V23, P164, DOI 10.1002/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2-6; GONZALEZ AM, 1994, MOL BRAIN RES, V22, P219, DOI 10.1016/0169-328X(94)90050-7; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; JENSEN KF, 1987, J NEUROSCI, V7, P3544; JOHNSON RR, 1992, EXP BRAIN RES, V89, P20; KASAMATSU T, 1979, J COMP NEUROL, V185, P163, DOI 10.1002/cne.901850110; KIMELBERG HK, 1985, SCIENCE, V228, P889, DOI 10.1126/science.3890180; KOJIMA T, 1988, J COMP NEUROL, V267, P580, DOI 10.1002/cne.902670410; KREJCI E, 1993, FEBS LETT, V335, P27, DOI 10.1016/0014-5793(93)80432-T; KRISTT DA, 1979, BRAIN RES, V178, P69, DOI 10.1016/0006-8993(79)90088-X; KRISTT DA, 1989, NEUROSCIENCE, V29, P27, DOI 10.1016/0306-4522(89)90330-8; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LESCH KP, 1993, MOL BRAIN RES, V17, P31, DOI 10.1016/0169-328X(93)90069-2; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LOMBARDO A, 1995, NEUROSCIENCE, V65, P997, DOI 10.1016/0306-4522(94)00538-G; MASANA Y, 1993, J NEUROSCI RES, V35, P468, DOI 10.1002/jnr.490350503; MOISEIWITSCH JRD, 1995, P NATL ACAD SCI USA, V92, P7182, DOI 10.1073/pnas.92.16.7182; OSTERHELDHAAS MC, 1994, DEV BRAIN RES, V77, P189, DOI 10.1016/0165-3806(94)90196-1; OsterheldHaas MC, 1996, EXP BRAIN RES, V110, P183; Ottersen OP, 1984, HDB CHEM NEUROANATOM, V3, P141; Ovalle S, 1995, NEUROREPORT, V6, P2353, DOI 10.1097/00001756-199511270-00019; PETER D, 1995, J NEUROSCI, V15, P6179; QIAN Y, 1995, J NEUROSCI, V15, P1261; RHOADES RW, 1994, J NEUROPHYSIOL, V72, P2438, DOI 10.1152/jn.1994.72.5.2438; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHROETER S, 1995, SOC NEUROSCI, P886; SHUEY DL, 1993, ANAT EMBRYOL, V187, P75; SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407; Steinbusch HWM, 1984, HDB CHEM NEUROANATOM, V3, P68; TRAMU G, 1983, CELL TISSUE RES, V228, P297; VANDERLOOS H, 1991, NATO ADV SCI I A-LIF, V200, P229; WALLACE JA, 1982, AM J ANAT, V165, P261, DOI 10.1002/aja.1001650304; WALLACE JA, 1992, HDB CHEM NEUROANATOM, V10, P619	71	271	272	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV	1996	17	5					823	835		10.1016/S0896-6273(00)80215-9	http://dx.doi.org/10.1016/S0896-6273(00)80215-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938116	Bronze			2022-12-24	WOS:A1996VV15100006
J	Rutila, JE; Zeng, HK; Le, M; Curtin, KD; Hall, JC; Rosbash, M				Rutila, JE; Zeng, HK; Le, M; Curtin, KD; Hall, JC; Rosbash, M			The tim(SL) mutant of the Drosophila rhythm gene timeless manifests allele-specific interactions with period gene mutants	NEURON			English	Article							CIRCADIAN BEHAVIORAL RHYTHMS; MESSENGER-RNA LEVELS; CLOCK MUTATION; VISUAL-SYSTEM; PROTEIN; MELANOGASTER; EXPRESSION; PRODUCT; AUTOREGULATION; OSCILLATIONS	To identify new components of the Drosophila circadian clock, we screened chemically mutagenized flies for suppressors or enhancers of the long periods characteristic of the period Goer) mutant allele per(L). We isolated a novel mutant that maps to the rhythm gene timeless (fim). This novel allele, tim(SL), alters the temporal pattern of per(L) protein nuclear localization and restores temperature compensation to per(L) flies. tim(SL) more generally manifests specific interactions with different per alleles. The identification of this first period-altering tim allele provides further evidence that TIM is a major component of the clock, and the allele-specific interactions with PER provide evidence that the PER/TIM heterodimer is a unit of circadian function. Although tim(SL) fails to restore PER-L/TIM temperature insensitivity in yeast, it alters the TIM phosphorylation pattern during the late night The effects on phosphorylation suggest that tim(SL) functions as a partial bypass suppressor of per(L) and provide evidence that the TIM phosphorylation program contributes to the circadian timekeeping mechanism.	BRANDEIS UNIV,NATL SCI FDN,SCI & TECHNOL CTR BIOL TIMING,WALTHAM,MA 02254; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254	Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; Brandeis University	Rutila, JE (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,WALTHAM,MA 02254, USA.				NIGMS NIH HHS [GM-33205] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; EWER J, 1992, J NEUROSCI, V12, P3321; EWER J, 1988, NATURE, V333, P82, DOI 10.1038/333082a0; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1994, J BIOL RHYTHM, V9, P189, DOI 10.1177/074873049400900303; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; LEE C, 1996, SCIENCE, V271, P4740; LIU X, 1992, J NEUROSCI, V12, P2735; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; ZATZ M, 1992, DISCUSS NEUROSCI, V8, P67; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; ZERR DM, 1990, J NEUROSCI, V10, P2749	31	79	80	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					921	929		10.1016/S0896-6273(00)80223-8	http://dx.doi.org/10.1016/S0896-6273(00)80223-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938124	hybrid			2022-12-24	WOS:A1996VV15100014
J	Kutsuwada, T; Sakimura, K; Manabe, T; Takayama, C; Katakura, N; Kushiya, E; Natsume, R; Watanabe, M; Inoue, Y; Yagi, T; Aizawa, S; Arakawa, M; Takahashi, T; Nakamura, Y; Mori, H; Mishina, M				Kutsuwada, T; Sakimura, K; Manabe, T; Takayama, C; Katakura, N; Kushiya, E; Natsume, R; Watanabe, M; Inoue, Y; Yagi, T; Aizawa, S; Arakawa, M; Takahashi, T; Nakamura, Y; Mori, H; Mishina, M			Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice	NEURON			English	Article							LONG-TERM POTENTIATION; SPINAL-CORD NEURONS; CYTOCHROME-OXIDASE; AREA CA1; DEVELOPMENTAL-CHANGES; PURKINJE-CELLS; NEONATAL RATS; CHANNEL; ADULT; MOUSE	Multiple epsilon subunits are major determinants of the NMDA receptor channel diversity. Based on their functional properties in vitro and distributions, we have proposed that the epsilon 1 and epsilon 2 subunits play a role in synaptic plasticity. To investigate the physiological significance of the NMDA receptor channel diversity, we generated mutant mice defective in the epsilon 2 subunit. These mice showed no suckling response and died shortly after birth but could survive by hand feeding. The mutation hindered the formation of the whisker-related neuronal barrelette structure and the clustering of primary sensory afferent terminals in the brain-stem trigeminal nucleus. In the hippocampus of the mutant mice, synaptic NMDA responses and long-term depression were abolished. These results suggest that the epsilon 2 subunit plays an essential role in both neuronal pattern formation and synaptic plasticity.	UNIV TOKYO, FAC MED, INST BRAIN RES, DEPT NEUROPHYSIOL, TOKYO 113, JAPAN; HOKKAIDO UNIV, SCH MED, DEPT ANAT, SAPPORO, HOKKAIDO 060, JAPAN; TOKYO MED & DENT UNIV, FAC DENT, DEPT PHYSIOL, TOKYO 113, JAPAN; TSUKUBA LIFE SCI CTR, INST PHYS & CHEM RES, MOLEC ONCOL LAB, IBARAKI, OSAKA 305, JAPAN; UNIV TOKYO, FAC MED, DEPT PHARMACOL, TOKYO 113, JAPAN; NIIGATA UNIV, FAC MED, DEPT INTERNAL MED 2, NIIGATA 951, JAPAN	University of Tokyo; Hokkaido University; Tokyo Medical & Dental University (TMDU); RIKEN; University of Tokyo; Niigata University	Kutsuwada, T (corresponding author), NIIGATA UNIV, BRAIN RES INST, DEPT NEUROPHARMACOL, NIIGATA 951, JAPAN.		Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Arakawa, Masao/0000-0002-2729-8666; Katakura, Nobuo/0000-0002-3495-0886				ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; ASCHER P, 1986, J PHYSIOL-LONDON, V377, pP35; ASHWELL KW, 1982, J ANAT, V135, P531; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BELFORD GR, 1979, J COMP NEUROL, V183, P305, DOI 10.1002/cne.901830207; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BROSE N, 1993, J BIOL CHEM, V268, P22663; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHIAIA NL, 1992, NEUROSCIENCE, V49, P141, DOI 10.1016/0306-4522(92)90082-D; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; ERZURUMLU RS, 1992, J NEUROSCI, V12, P3946; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; IZUMI Y, 1995, SYNAPSE, V20, P19, DOI 10.1002/syn.890200104; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MA PM, 1991, J COMP NEUROL, V309, P161, DOI 10.1002/cne.903090202; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; MISHINA M, 1993, ANN NY ACAD SCI, V707, P136, DOI 10.1111/j.1749-6632.1993.tb38049.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1989, DEV BRAIN RES, V49, P105, DOI 10.1016/0165-3806(89)90063-1; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; QUINLAN JE, 1985, NEUROSCI LETT, V60, P39, DOI 10.1016/0304-3940(85)90378-7; SAKIMURA K, 1980, J NEUROCHEM, V34, P687, DOI 10.1111/j.1471-4159.1980.tb11198.x; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SCHMECHEL D, 1978, SCIENCE, V199, P313, DOI 10.1126/science.339349; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHEN H, 1994, BRAIN RES, V635, P159, DOI 10.1016/0006-8993(94)91435-4; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; WATANABE M, 1994, NEUROSCI LETT, V165, P183, DOI 10.1016/0304-3940(94)90740-4; WESTNEAT MW, 1992, BEHAV NEUROSCI, V106, P539, DOI 10.1037/0735-7044.106.3.539; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I	59	403	408	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					333	344		10.1016/S0896-6273(00)80051-3	http://dx.doi.org/10.1016/S0896-6273(00)80051-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789948	Bronze			2022-12-24	WOS:A1996TW95700013
J	Xiao, B; Tu, JC; Petralia, RS; Yuan, JP; Doan, A; Breder, CD; Ruggiero, A; Lanahan, AA; Wenthold, RJ; Worley, PF				Xiao, B; Tu, JC; Petralia, RS; Yuan, JP; Doan, A; Breder, CD; Ruggiero, A; Lanahan, AA; Wenthold, RJ; Worley, PF			Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of Homer-related, synaptic proteins	NEURON			English	Article							ALDRICH-SYNDROME PROTEIN; TRANSGENIC MICE; GENE; SEQUENCE; CYTOSKELETON; EXPRESSION; MEMBRANE; VASP	Homer is a neuronal immediate early gene (IEG) that is enriched at excitatory synapses and binds group 1 metabotropic glutamate receptors (mGluRs). Here, we characterize a family of Homer-related proteins derived from three distinct genes. Like Homer IEG (now termed Homer 1a), all new members bind group 1 mGluRs. In contrast to Homer 1a, new members are constitutively expressed and encode a C-terminal coiled-coil (CC) domain that mediates self-multimerization. CC-Horners form natural complexes that cross-link mGluRs and are enriched at the postsynaptic density. Homer 1a does not multimerize and blocks the association of mGluRs with CC-Homer complexes. These observations support a model in which the dynamic expression of Homer 1a competes with constitutively expressed CC-Homers to modify synaptic mGluR properties.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@bs.jhmi.edu		Xiao, Bo/0000-0002-6161-9478	NIDA NIH HHS [DA10309, DA11742] Funding Source: Medline; NIMH NIH HHS [KO2 MH01152] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309, R37DA010309, R01DA011742] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; GORDON JW, 1987, CELL, V50, P445, DOI 10.1016/0092-8674(87)90498-3; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Lanahan A, 1997, J NEUROSCI, V17, P2876; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; Matsubara A, 1996, J NEUROSCI, V16, P4457; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Park HT, 1997, MOL BRAIN RES, V52, P318, DOI 10.1016/S0169-328X(97)00292-1; Petralia RS, 1997, J CHEM NEUROANAT, V13, P77, DOI 10.1016/S0891-0618(97)00023-9; Ponting CP, 1997, J MOL MED-JMM, V75, P769, DOI 10.1007/s001090050166; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STREHLER EE, 1986, J MOL BIOL, V190, P291, DOI 10.1016/0022-2836(86)90003-3; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Wang YX, 1998, J NEUROSCI, V18, P1148; WORLEY PF, 1990, MOL MECH AGING, P62; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2	27	531	554	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					707	716		10.1016/S0896-6273(00)80588-7	http://dx.doi.org/10.1016/S0896-6273(00)80588-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808458	Bronze			2022-12-24	WOS:000076697300015
J	Schopperle, WM; Holmqvist, MH; Zhou, Y; Wang, J; Wang, Z; Griffith, LC; Keselman, I; Kusinitz, F; Dagan, D; Levitan, IB				Schopperle, WM; Holmqvist, MH; Zhou, Y; Wang, J; Wang, Z; Griffith, LC; Keselman, I; Kusinitz, F; Dagan, D; Levitan, IB			Slob, a novel protein that interacts with the slowpoke calcium-dependent potassium channel	NEURON			English	Article							NMDA RECEPTOR SUBUNITS; K+ CHANNELS; ACETYLCHOLINE-RECEPTOR; GUANYLATE KINASES; BETA-SUBUNIT; SH3 DOMAIN; TYROSINE KINASE; IN-VIVO; FAMILY; SRC	Slob, a novel protein that binds to the carboxy-terminal domain of the Drosophila Slowpoke (dSlo) calcium-dependent potassium channel, was identified with a yeast two-hybrid screen. Slob and dSlo coimmunoprecipitate from Drosophila heads and heterologous host cells, suggesting that they interact in vivo. Slob also coimmunoprecipitates with the Drosophila EAG potassium channel but not with Drosophila Shaker, mouse Slowpoke, or rat K(v)1.3. Confocal fluorescence microscopy demonstrates that Slob and dSlo redistribute in cotransfected cells and are colocalized in large intracellular structures. Direct application of Slob to the cytoplasmic face of detached membrane patches containing dSlo channels leads to an increase in channel activity. Slob may represent a new class of multi-functional channel-binding proteins.	Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University; Brandeis University; Brandeis University	Levitan, IB (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA.			Wang, Zheng/0000-0001-7678-0072; Griffith, Leslie/0000-0003-3164-9876	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054408] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bowlby MR, 1996, NEUROPHARMACOLOGY, V35, P867, DOI 10.1016/0028-3908(96)00090-1; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Bridges PN, 1942, J HERED, V33, P403, DOI 10.1093/oxfordjournals.jhered.a105104; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CAI YC, 1993, J BIOL CHEM, V268, P23720; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; ENGELS WR, 1986, FOCUS, V8, P6; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474; Gillespie SKH, 1996, NEURON, V16, P953, DOI 10.1016/S0896-6273(00)80118-X; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Holmes TC, 1996, J NEUROSCI, V16, P1581; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Niethammer M, 1996, J NEUROSCI, V16, P2157; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; PARCEJ DN, 1989, BIOCHEM J, V257, P899, DOI 10.1042/bj2570899; REINHART PH, 1995, J NEUROSCI, V15, P4572; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RHODES KJ, 1995, J NEUROSCI, V15, P5360; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SWOPE SL, 1995, ANN NY ACAD SCI, V757, P197, DOI 10.1111/j.1749-6632.1995.tb17476.x; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; ZHONG Y, 1993, J NEUROSCI, V13, P4669	54	98	101	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1998	20	3					565	573		10.1016/S0896-6273(00)80995-2	http://dx.doi.org/10.1016/S0896-6273(00)80995-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539129	Bronze			2022-12-24	WOS:000072755600020
J	Hausser, M; Clark, BA				Hausser, M; Clark, BA			Tonic synaptic inhibition modulates neuronal output pattern and spatiotemporal synaptic integration	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; PASSIVE MEMBRANE-PROPERTIES; PIG HIPPOCAMPUS INVITRO; PYRAMIDAL NEURONS; GRANULE CELLS; BACKGROUND ACTIVITY; ACTION-POTENTIALS; CABLE PROPERTIES; STELLATE CELLS; RAT	Irregular firing patterns are observed in most central neurons in vivo, but their origin is controversial. Here, we shaw that two types of inhibitory neurons in the cerebellar cortex fire spontaneously and regularly in the absence of synaptic input but generate an irregular firing pattern in the presence of tonic synaptic inhibition. Paired recordings between synaptically connected neurons revealed that single action potentials in inhibitory interneurons cause highly variable delays in action potential firing in their postsynaptic cells. Activity in single and multiple inhibitory interneurons also significantly reduces postsynaptic membrane time constant and input resistance. These findings suggest that the time window for synaptic integration is a dynamic variable modulated by the level of tonic inhibition, and that rate coding and temporal coding strategies may be used in parallel in the same cell type.			Hausser, M (corresponding author), ECOLE NORMALE SUPER, NEUROBIOL LAB, 46 RUE ULM, F-75005 PARIS, FRANCE.		Hausser, Michael/AAW-6827-2020; Clark, Beverley/C-1519-2008; Oka, Yoshitaka/C-9670-2010	Hausser, Michael/0000-0002-2673-8957; Oka, Yoshitaka/0000-0002-3482-3051				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; ANDERSEN P, 1990, PROG BRAIN RES, V83, P215; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BARRETT JN, 1975, FED PROC, V34, P1398; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Bell A., 1995, INC9502; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BERNARD C, 1993, BRAIN RES, V626, P234, DOI 10.1016/0006-8993(93)90584-A; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; DURAND D, 1983, J NEUROPHYSIOL, V50, P1080, DOI 10.1152/jn.1983.50.5.1080; Eccles JC, 1967, CEREBELLUM NEURONAL; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; HOLMES WR, 1989, BRAIN RES, V505, P12, DOI 10.1016/0006-8993(89)90110-8; ITO M, 1966, EXP BRAIN RES, V2, P330; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; JACK JJB, 1983, ELECTRIC CURRENT FLO; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; JAEGER D, 1994, EXP BRAIN RES, V100, P200; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KORBO L, 1993, BRAIN RES, V609, P262, DOI 10.1016/0006-8993(93)90881-M; KUNO M, 1964, J PHYSIOL-LONDON, V175, P81, DOI 10.1113/jphysiol.1964.sp007504; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MAJOR G, 1993, BIOPHYS J, V65, P423, DOI 10.1016/S0006-3495(93)81037-3; MAJOR G, 1994, J NEUROSCI, V14, P4613; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MASON A, 1991, J NEUROSCI, V11, P72; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P355, DOI 10.1113/jphysiol.1992.sp019382; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MIYASHITA Y, 1984, J PHYSIOL-LONDON, V351, P251, DOI 10.1113/jphysiol.1984.sp015243; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Palay S. L., 1974, CEREBELLAR CORTEX CY; PERKEL DH, 1964, SCIENCE, V145, P61, DOI 10.1126/science.145.3627.61; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; RAPP M, 1992, NEURAL COMPUT, V4, P518, DOI 10.1162/neco.1992.4.4.518; Rieke F, 1997, SPIKES; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; SAYER RJ, 1990, J NEUROSCI, V10, P826; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Toth K, 1997, J PHYSIOL-LONDON, V500, P463, DOI 10.1113/jphysiol.1997.sp022033; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ueno S, 1997, J NEUROSCI, V17, P625; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	84	477	513	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1997	19	3					665	678		10.1016/S0896-6273(00)80379-7	http://dx.doi.org/10.1016/S0896-6273(00)80379-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331356	Bronze			2022-12-24	WOS:A1997XZ01600019
J	Blair, LAC; Marshall, J				Blair, LAC; Marshall, J			IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner	NEURON			English	Article							EPIDERMAL GROWTH-FACTOR; PROTEIN-KINASE-C; CEREBELLAR GRANULE NEURONS; POTASSIUM CHANNEL; FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE KINASE; ACETYLCHOLINE-RECEPTOR; SYMPATHETIC NEURONS; INSULIN-RECEPTOR	Receptor tyrosine kinases (RTKs) have long been associated with proliferation in non-neural cells, although they are also expressed in postmitotic neurons. We demonstrate that insulin-like growth factor-1 (IGF-1) induces within seconds a targe, tyrosine-kinase-dependent increase in calcium channel currents in cerebellar granule neurons. Separation of channel subtypes reveals that, while P, Q, and R channels are unaffected, N and L channel activities are strongly potentiated at specific membrane voltages: N currents triple at depolarized potentials, while L currents rapidly increase 4-fold at hyperpolarized potentials. Moreover, transient expression of dominant-negative and wild-type phosphatidylinositol 3-OH kinase (PI 3-kinase) subunits, as well as application of specific inhibitors, demonstrates that PI 3-kinase is an essential and rate-limiting messenger in this signaling pathway. Our results indicate that N and L calcium channels are downstream targets of neuronal RTKs and suggest that RTK modulation may control calcium-dependent processes, such as neurotransmitter release and IGF-l-dependent differentiation or survival.	YALE UNIV, SCH MED, DEPT PHARMACOL, NEW HAVEN, CT 06520 USA	Yale University	Blair, LAC (corresponding author), BROWN UNIV, DEPT MOL PHARMACOL PHYSIOL & BIOTECHNOL, PROVIDENCE, RI 02912 USA.				NINDS NIH HHS [R29 NS 33914-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS033914] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Bao JX, 1997, SCIENCE, V275, P969, DOI 10.1126/science.275.5302.969; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; CASTROALAMANCOS MA, 1993, P NATL ACAD SCI USA, V90, P7386, DOI 10.1073/pnas.90.15.7386; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GALLI C, 1995, J NEUROSCI, V15, P1172; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HALL KE, 1995, J NEUROSCI, V15, P6069; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HammondsOdie LP, 1996, J BIOL CHEM, V271, P18859, DOI 10.1074/jbc.271.31.18859; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; HELL JW, 1994, J BIOL CHEM, V269, P7390; HINKLE PM, 1993, ENDOCRINOLOGY, V133, P271, DOI 10.1210/en.133.1.271; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; Holmes TC, 1996, J NEUROSCI, V16, P1581; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; HOLZ GG, 1988, J NEUROSCI, V8, P463; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; JACKSON TR, 1992, J BIOL CHEM, V267, P16627; Jonas EA, 1996, J NEUROSCI, V16, P1645; KAR S, 1993, J COMP NEUROL, V333, P375, DOI 10.1002/cne.903330306; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KENNER K, 1993, DIABETES, V42, pA35; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LEMOS JR, 1989, NEURON, V2, P1419, DOI 10.1016/0896-6273(89)90187-6; LEROITH D, 1993, NEUROTROPHIC FACTORS, P391; LOVISOLO D, 1992, BIOCHIM BIOPHYS ACTA, V1104, P73, DOI 10.1016/0005-2736(92)90133-7; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; MESSER A, 1977, BRAIN RES, V130, P1, DOI 10.1016/0006-8993(77)90838-1; MISRA RP, 1994, J BIOL CHEM, V269, P25483; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NAUMOV AP, 1993, BIOCHIM BIOPHYS ACTA, V1145, P273, DOI 10.1016/0005-2736(93)90299-F; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; PARKER PJ, 1992, CELL GROWTH DIFFER, V3, P747; PEARSON HA, 1993, NEUROPHARMACOLOGY, V32, P1171, DOI 10.1016/0028-3908(93)90011-Q; PEPPELENBOSCH MP, 1991, J BIOL CHEM, V266, P19938; PEPPELENBOSCH MP, 1992, CELL, V69, P295, DOI 10.1016/0092-8674(92)90410-E; QUIRION R, 1988, SYNAPSE, V2, P212, DOI 10.1002/syn.890020307; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; SELINFREUND RH, 1994, MOL PHARMACOL, V45, P1215; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; SWOPE SL, 1995, ANN NY ACAD SCI, V757, P197, DOI 10.1111/j.1749-6632.1995.tb17476.x; TIMPE LC, 1994, J NEUROSCI, V14, P1195, DOI 10.1523/JNEUROSCI.14-03-01195.1994; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TURNER TJ, 1995, MOL PHARMACOL, V47, P348; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WILLIAMS EJ, 1994, DEVELOPMENT, V120, P1685; WILSON GF, 1993, NATURE, V366, P433, DOI 10.1038/366433a0; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B; YANO H, 1993, J BIOL CHEM, V268, P25846	65	156	159	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1997	19	2					421	429		10.1016/S0896-6273(00)80950-2	http://dx.doi.org/10.1016/S0896-6273(00)80950-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292730	hybrid			2022-12-24	WOS:A1997XU14600019
J	Crair, MC; Ruthazer, ES; Gillespie, DC; Stryker, MP				Crair, MC; Ruthazer, ES; Gillespie, DC; Stryker, MP			Relationship between the ocular dominance and orientation maps in visual cortex of monocularly deprived cats	NEURON			English	Article							MONKEY STRIATE CORTEX; CYTOCHROME-OXIDASE BLOBS; COLUMNAR PATTERNS; ORGANIZATION; SELECTIVITY; PLASTICITY; GEOMETRY; DOMAINS; LAMINAR; CLOSURE	The significance of functional maps-for cortical plasticity was investigated by imaging of intrinsic optical signals together with single-unit recording in kittens. After even a brief period of monocular deprivation during the height of the critical period, only isolated patches of visual cortex continued to respond strongly to the closed eye. These deprived-eye patches were located on the pinwheel center singularities of the orientation map and consisted of neurons that were pearly selective for stimulus orientation. Neurons in regions surrounding the deprived-eye patches responded only weakly to the deprived eye but were well tuned for the same stimulus orientation that optimally excited them when presented to the open, nondeprived eye. The coincidence of deprived-eye patches with pinwheel center singularities, and the selective toss of orientation tuning within the deprived-eye patches, indicate that the orientation and ocular dominance maps are functionally linked and provide compelling evidence that pinwheel center singularities are important far cortical plasticity.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,WM KECK FDN CTR INTEGRAT NEUROSCI,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco			Ruthazer, Edward S/P-5935-2014; Ruthazer, Edward/H-4782-2019	Ruthazer, Edward S/0000-0003-0452-3151; Ruthazer, Edward/0000-0003-0452-3151; Stryker, Michael/0000-0003-1546-5831	NATIONAL EYE INSTITUTE [R37EY002874, R01EY009760, R01EY002874] Funding Source: NIH RePORTER; NEI NIH HHS [EY09760, EY02874, R01 EY002874] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON PA, 1988, J NEUROSCI, V8, P2183; BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BLASDEL GG, 1989, SENSORY PROCESSING M, P242; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; BONHOEFFER T, 1996, BRAIN MAPPING METHOD, P75; Boyd JD, 1996, J COMP NEUROL, V365, P659; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; DYCK RH, 1993, P NATL ACAD SCI USA, V90, P9066, DOI 10.1073/pnas.90.19.9066; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; Horton JC, 1997, J NEUROSCI, V17, P3684; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1978, J COMP NEUROL, V177, P361, DOI 10.1002/cne.901770302; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1969, NATURE, V221, P747, DOI 10.1038/221747a0; KIM DS, 1994, NATURE, V372, P196, DOI 10.1038/372196a0; KIM DS, 1994, NATURE, V370, P370, DOI 10.1038/370370a0; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; LIVINGSTONE MS, 1982, P NATL ACAD SCI-BIOL, V79, P6098, DOI 10.1073/pnas.79.19.6098; LOOP MS, 1977, BRAIN RES, V128, P329, DOI 10.1016/0006-8993(77)90998-2; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MURPHY KM, 1995, J NEUROSCI, V15, P4196; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; REITER HO, 1986, EXP BRAIN RES, V65, P182; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; ROJER AS, 1990, BIOL CYBERN, V62, P381, DOI 10.1007/BF00197644; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; SPEAR PD, 1978, BRAIN RES, V155, P141, DOI 10.1016/0006-8993(78)90315-3; SPEAR PD, 1980, J NEUROPHYSIOL, V43, P559, DOI 10.1152/jn.1980.43.3.559; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	39	87	88	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					307	318		10.1016/S0896-6273(00)80941-1	http://dx.doi.org/10.1016/S0896-6273(00)80941-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292721	Bronze			2022-12-24	WOS:A1997XU14600010
J	Menegoz, M; Gaspar, P; LeBert, M; Galvez, T; Burgaya, F; Palfrey, C; Ezan, P; Amos, F; Girault, JA				Menegoz, M; Gaspar, P; LeBert, M; Galvez, T; Burgaya, F; Palfrey, C; Ezan, P; Amos, F; Girault, JA			Paranodin, a glycoprotein of neuronal paranodal membranes	NEURON			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CYTOSKELETAL-ASSOCIATED PROTEINS; GLYCOPHORIN-C; TUMOR-SUPPRESSOR; RAT STRIATUM; ADHESION; IDENTIFICATION; RECEPTOR; BINDING; BAND-4.1	Ranvier nodes are flanked by paranodal regions, at the level of which oligodendrocytes or Schwann cells interact closely with axons. Paranodes play a critical role in the physiological properties of myelinated nerve fibers. Paranodin, a prominent 180 kDa transmembrane neuronal glycoprotein, was purified and cloned from adult rat brain, and found to be highly concentrated in axonal membranes at their junction with myelinating glial cells, in paranodes of central and peripheral nerve fibers. The large extracellular domain of paranodin is related to neurexins, and its short intracellular tail binds protein 4.1, a cytoskeleton-anchoring protein. Paranodin may be a critical component of the macromolecular complex involved in the tight interactions between axons and myelinating glial cells characteristic of the paranodal region.	COLL FRANCE,INSERM,CHAIRE NEUROPHARMACOL,F-75231 PARIS,FRANCE; UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,CHICAGO,IL 60601; INSERM,U106,F-75231 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; University of Chicago; Institut National de la Sante et de la Recherche Medicale (Inserm)			Gaspar, Patricia/G-8892-2011; Girault, Jean-Antoine/F-7518-2013; Le Bert, Marc/AAR-4577-2021	Gaspar, Patricia/0000-0003-4217-5717; Girault, Jean-Antoine/0000-0002-7900-1705; Le Bert, Marc/0000-0002-5945-3800; galvez, thierry/0000-0003-2800-3732				ARPIN M, 1994, CURR OPIN CELL BIOL, V6, P136, DOI 10.1016/0955-0674(94)90127-9; BANVILLE D, 1994, J BIOL CHEM, V269, P22320; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4; CHIU SY, 1995, NEUROGLIA, P613; CLAUDIO JO, 1995, NEUROREPORT, V6, P1942, DOI 10.1097/00001756-199510020-00028; Colman D R, 1991, Curr Opin Neurobiol, V1, P377, DOI 10.1016/0959-4388(91)90056-D; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Derkinderen P, 1996, SCIENCE, V273, P1719, DOI 10.1126/science.273.5282.1719; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; FEHON RG, 1994, DEVELOPMENT, V120, P545; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GIRAULT JA, 1992, P NATL ACAD SCI USA, V89, P2769, DOI 10.1073/pnas.89.7.2769; Griffin JW, 1996, J NEUROCYTOL, V25, P33, DOI 10.1007/BF02284784; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HEMMING NJ, 1994, BIOCHEM J, V299, P191, DOI 10.1042/bj2990191; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; HUANG JP, 1993, J BIOL CHEM, V268, P3758; ICHIMURA T, 1991, J NEUROCYTOL, V20, P667, DOI 10.1007/BF01187068; JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P5677, DOI 10.1073/pnas.90.12.5677; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; LETO TL, 1984, J BIOL CHEM, V259, P4603; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Menegoz M, 1995, NEUROREPORT, V7, P125, DOI 10.1097/00001756-199512290-00030; MI HY, 1995, J NEUROSCI, V15, P3761; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Rosenbluth Jack, 1995, P613; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; SARAS J, 1994, J BIOL CHEM, V269, P24082; Scherer SS, 1995, J NEUROSCI, V15, P8281; SHENG M, 1996, CELL, V17, P575; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; WILEY CA, 1980, J CELL BIOL, V84, P261, DOI 10.1083/jcb.84.2.261; WOOD PM, 1990, J NEUROSCI, V10, P3635; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949	50	213	216	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					319	331		10.1016/S0896-6273(00)80942-3	http://dx.doi.org/10.1016/S0896-6273(00)80942-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292722	Bronze			2022-12-24	WOS:A1997XU14600011
J	Baum, PD; Garriga, G				Baum, PD; Garriga, G			Neuronal migrations and axon fasciculation are disrupted in ina-1 integrin mutants	NEURON			English	Article							CREST CELL ATTACHMENT; CAENORHABDITIS-ELEGANS; C-ELEGANS; GENE-EXPRESSION; ADHESION; OUTGROWTH; EMBRYO; MICE; FIBRONECTIN; RECEPTORS	Integrins are heterodimeric cell surface receptors implicated in cell adhesion and signaling. Our analysis of C. elegans ina-1 alpha integrin mutants provides the first genetic evidence that migrating neurons require integrins. Mosaic analysis and expression studies show that ina-1 acts autonomously in cells to promote their migrations. Although axons generally extend to their normal targets in ina-1 mutants, bundling of axons into fascicles is defective, defining a previously unrecognized role for integrins. In addition to these neuronal phenotypes, ina-1 mutants also display many morphogenetic defects. Finally, we show that the C. elegans INA-1 alpha integrin subunit associates with the PAT-3 beta subunit in vivo, suggesting that these proteins function together in cell migration, axon fasciculation, and morphogenesis.			Baum, PD (corresponding author), UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,229 STANLEY HALL,BERKELEY,CA 94720, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032057] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07127, GM07232] Funding Source: Medline; NINDS NIH HHS [NS32057] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson DC, 1995, METABOLIC MOL BASES, P3955; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHISHOLM AD, 1995, NATURE, V377, P52, DOI 10.1038/377052a0; Chuang PT, 1996, SCIENCE, V274, P1736, DOI 10.1126/science.274.5293.1736; DECURTIS I, 1993, DEVELOPMENT, V118, P377; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DUFOUR S, 1988, EMBO J, V7, P2661, DOI 10.1002/j.1460-2075.1988.tb03119.x; ELLIS RE, 1991, GENETICS, V129, P79; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FASSLER R, 1996, CURR OPIN CELL BIOL, V8, P657; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Forrester WC, 1997, DEVELOPMENT, V124, P1831; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Harlow E., 1988, ANTIBODIES LAB MANUA; HEDGECOCK EM, 1995, GENETICS, V141, P989; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HERMAN RK, 1989, J NEUROGENET, V5, P1, DOI 10.3109/01677068909167261; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; JAFFREDO T, 1988, DEVELOPMENT, V103, P431; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; LALLIER T, 1993, SCIENCE, V259, P692, DOI 10.1126/science.8430321; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller LM, 1996, GENETICS, V143, P1181; OTOOLE TE, 1989, BLOOD, V74, P14; PERRIS R, 1993, J CELL SCI, V106, P1357; RICHARDSON A, 1995, BIOESSAYS, V17, P229, DOI 10.1002/bies.950170309; Schachner M, 1993, CURR OPIN CELL BIOL, V5, P786, DOI 10.1016/0955-0674(93)90026-M; SHEPPARD AM, 1994, CELL ADHES COMMUN, V2, P27, DOI 10.3109/15419069409014200; SHIH DT, 1993, J CELL BIOL, V122, P1361, DOI 10.1083/jcb.122.6.1361; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; STEPP MA, 1994, CELL ADHES COMMUN, V2, P359, DOI 10.3109/15419069409014210; THIERY JP, 1985, ANNU REV CELL BIOL, V1, P91, DOI 10.1146/annurev.cellbio.1.1.91; TOMASELLI KJ, 1993, J NEUROSCI, V13, P4880; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; WEAVER CD, 1995, J NEUROSCI, V15, P5275; WEHRLI M, 1993, MECH DEVELOP, V43, P21, DOI 10.1016/0925-4773(93)90020-X; Wightman B, 1996, DEVELOPMENT, V122, P671; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; WILLIAMS BD, 1992, GENETICS, V131, P609; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YANG JT, 1995, DEVELOPMENT, V121, P549; YANG JT, 1993, DEVELOPMENT, V119, P1093; ZUSMAN S, 1993, DEVELOPMENT, V118, P737	61	147	150	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					51	62		10.1016/S0896-6273(00)80347-5	http://dx.doi.org/10.1016/S0896-6273(00)80347-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247263	Bronze			2022-12-24	WOS:A1997XN39400006
J	Elkes, DA; Cardozo, DL; Madison, J; Kaplan, JM				Elkes, DA; Cardozo, DL; Madison, J; Kaplan, JM			EGL-36 Shaw channels regulate C-elegans egg-laying muscle activity	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; ACTIVATED POTASSIUM CHANNELS; NERVOUS-SYSTEM; K+ CHANNELS; XENOPUS-OOCYTES; BETA-SUBUNIT; DROSOPHILA; MUTATIONS; SEROTONIN; BEHAVIOR	The C. elegans egl-36 gene encodes a Shaw-type potassium channel that regulates egg-laying behavior. Gain of function [egl-36(gf)] and dominant negative [egl-36(dn)] mutations in egl-36 cause reciprocal defects in egg laying. An egl-36::gfp reporter is expressed in the egg-laying muscles and in a few other tissues. Expression of an egl-36(gf) cDNA in the egg-laying muscles causes behavioral defects similar to those observed in egl-36(gf) mutants. Gain of function EGL-36 subunits form channels that are active at more negative potentials than wild-type channels. The egl-36(gf) alleles correspond to missense mutations in an amino terminal subunit assembly domain (E138K) and in the S6 transmembrane domain (P435S), neither of which were previously implicated in the voltage dependence of channel activation. Altogether, these results suggest that EGL-36 channels regulate the excitability of the egg-laying muscles.			Elkes, DA (corresponding author), MASSACHUSETTS GEN HOSP, DEPT MOL BIOL, BOSTON, MA 02114 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032196] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32196] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN C, 1997, IN PRESS ANN REV NEU, V21; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Davis MW, 1995, J NEUROSCI, V15, P8408; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Kaplan JM, 1996, CURR OPIN NEUROBIOL, V6, P494, DOI 10.1016/S0959-4388(96)80055-9; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; LUNEAU C, 1991, FEBS LETT, V288, P163, DOI 10.1016/0014-5793(91)81026-5; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; REINER DJ, 1995, GENETICS, V141, P961; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SHEN NV, 1993, NEURON, V11, P67; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TRENT C, 1983, GENETICS, V104, P619; Wang JW, 1996, BIOPHYS J, V71, P3167, DOI 10.1016/S0006-3495(96)79510-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WEISER M, 1995, J NEUROSCI, V15, P4298; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WU CF, 1985, J NEUROSCI, V5, P2626; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864	41	27	29	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1997	19	1					165	174		10.1016/S0896-6273(00)80356-6	http://dx.doi.org/10.1016/S0896-6273(00)80356-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247272	Bronze			2022-12-24	WOS:A1997XN39400015
J	Stoeckli, ET; Sonderegger, P; Pollerberg, GE; Landmesser, LT				Stoeckli, ET; Sonderegger, P; Pollerberg, GE; Landmesser, LT			Interference with axonin-1 and NrCAM interactions unmasks a floor-plate activity inhibitory for commissural axons	NEURON			English	Article							EMBRYO SPINAL-CORD; CHICK-EMBRYO; ADHESION MOLECULES; NERVOUS-SYSTEM; GROWTH CONES; GUIDANCE; INTERNEURONS; ORIENTATION; PROTEIN; ROLES	Axonin-1 and NrCAM were previously shown to be involved in the in vivo guidance of commissural growth cones across the floor plate of the embryonic chicken spinal cord. To further characterize their role in axon pathfinding, we developed a two-dimensional coculture system of commissural and floor-plate explants in which it was possible to study the behavior of growth cones upon floor- plate contact. Although commissural axons readily entered the floor plate under control conditions, perturbations of either axonin-1 or NrCAM interactions prevented the growth cones from entering the floor-plate explants. The presence of anti-axonin-1 resulted in the collapse of commissural growth cones upon contact with the floor plate. The perturbation of NrCAM interactions also resulted in an avoidance of the floor plate, but without inducing growth-cone collapse. Therefore, axonin-1 and NrCAM are crucial for the contact-mediated interaction between commissural growth cones and the floor plate, which in turn is required for the proper guidance of the axons across the ventral midline and their subsequent rostral turn into the longitudinal axis.	CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106; UNIV ZURICH,INST BIOCHEM,CH-8057 ZURICH,SWITZERLAND; MAX PLANCK INST DEV BIOL,D-72074 TUBINGEN,GERMANY	Case Western Reserve University; University of Zurich; Max Planck Society				Stoeckli, Esther/0000-0002-8485-0648	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019640] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 19640] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Bruemmendorf Thomas, 1993, Journal of Neurochemistry, V61, P1207; Burden-Gulley Susan M., 1995, Seminars in Developmental Biology, V6, P79, DOI 10.1016/S1044-5781(06)80017-4; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; DELAROSA EJ, 1990, J CELL BIOL, V111, P3087, DOI 10.1083/jcb.111.6.3087; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOODMAN CS, 1993, NEURON S, V10, P77; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MYERS PZ, 1993, J NEUROSCI, V13, P115; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Rathjen F. G, 1991, SEMIN NEUROSCI, V3, P297, DOI 10.1016/1044-5765(91)90047-R; Rathjen FG, 1991, CURR OPIN CELL BIOL, V3, P992, DOI 10.1016/0955-0674(91)90119-J; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHIGA T, 1990, DEV BRAIN RES, V55, P209, DOI 10.1016/0165-3806(90)90202-A; SHIGA T, 1991, J COMP NEUROL, V310, P2334; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; Stoeckli ET, 1996, DEV BIOL, V177, P15, DOI 10.1006/dbio.1996.0141; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; STOECKLI ET, 1991, J CELL BIOL, V112, P449, DOI 10.1083/jcb.112.3.449; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; YAGINUMA H, 1991, J NEUROSCI, V11, P2598; YAGINUMA H, 1990, DEVELOPMENT, V108, P705	30	146	146	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					209	221		10.1016/S0896-6273(00)80262-7	http://dx.doi.org/10.1016/S0896-6273(00)80262-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052792	Bronze, Green Accepted			2022-12-24	WOS:A1997WK82200005
J	Shao, XG; Fernandez, I; Zhang, XY; Sudhof, TC; Rizo, J				Shao, XG; Fernandez, I; Zhang, XY; Sudhof, TC; Rizo, J			Synaptotagmin-syntaxin interaction: The C-2 domain as a Ca2+-dependent electrostatic switch	NEURON			English	Article							PROTEIN-KINASE-C; NEUROTRANSMITTER RELEASE; PHOSPHOLIPID-BINDING; SOLVENT SUPPRESSION; CALCIUM-DEPENDENCE; ESCHERICHIA-COLI; NMR; EXOCYTOSIS; DROSOPHILA; P65	Synaptotagmin I is a synaptic vesicle protein that is thought to act as a Ca2+ sensor in neurotransmitter release. The first C-2 domain of synaptotagmin I (C(2)A domain) contains a bipartite Ca2+-binding motif and interacts in a Ca2+-dependent manner with syntaxin, a central component of the membrane fusion complex. Analysis by nuclear magnetic resonance spectroscopy and site-directed mutagenesis shows that this interaction is mediated by the cooperative action of basic residues surrounding the Ca2+-binding sites of the C(2)A domain and is driven by a change in the electrostatic potential of the C(2)A domain induced by Ca2+ binding. A model is proposed whereby synaptotagmin acts as an electrostatic switch in Ca2+-triggered synaptic vesicle exocytosis, promoting a structural rearrangement in the fusion machinery that is effected by its interaction with syntaxin.	UNIV TEXAS,SW MED CTR,DEPT MOL GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIMH NIH HHS [R01-MH52804-01] Funding Source: Medline; NINDS NIH HHS [R29 NS33731-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS033731] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GRONENBORN AM, 1993, J MOL BIOL, V233, P331, DOI 10.1006/jmbi.1993.1514; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; INOUE A, 1992, J BIOL CHEM, V267, P10613; Kee Y, 1996, J NEUROSCI, V16, P1975; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KELLY RB, 1993, NEURON S, V10, P43; LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; MARION D, 1989, J MAGN RESON, V84, P425, DOI 10.1016/0022-2364(89)90391-0; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	43	197	200	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1997	18	1					133	142		10.1016/S0896-6273(01)80052-0	http://dx.doi.org/10.1016/S0896-6273(01)80052-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010211	Bronze			2022-12-24	WOS:A1997WE71800014
J	Tse, FW; Tse, A; Hille, B; Horstmann, H; Almers, W				Tse, FW; Tse, A; Hille, B; Horstmann, H; Almers, W			Local Ca2+ release from internal stores controls exocytosis in pituitary gonadotrophs	NEURON			English	Article							SQUID GIANT SYNAPSE; BOVINE CHROMAFFIN CELLS; RAT GONADOTROPES; PLASMA-MEMBRANE; CALCIUM-DEPENDENCE; FLASH-PHOTOLYSIS; CYTOSOLIC CA-2+; PROTEIN-KINASE; CAGED CA2+; MAST-CELLS	Exocytosis and the cell-averaged cytosolic [Ca2+], [Ca2+](i), were tracked in single gonadotrophs. Cells released 100 granules/s at 1 mu M = [Ca2+](i) when gonadotropin-releasing hormone (GnRH) activated IP3-mediated Ca2+ release from internal stores, but only 1 granule/s when [Ca2+](i) was raised uniformly to 1 mu M by other means. Strong exocytosis was then seen only at higher [Ca2+](i) (half-maximal at 16 mu M). Parallel second messengers did not contribute to GnRH-induced exocytosis, because IP3 alone was as effective as GnRH, and because even GnRH failed to trigger rapid exocytosis when the [Ca2+](i) rise was blunted by EGTA. When [Ca2+](i) was released from stores, exocytosis depended on [Ca2+](i) rising rapidly, as if governed by Ca2+ flux into the cytosol. We suggest that IP3 releases Ca2+ selectively from subsurface cisternae, raising [Ca2+] near exocytic sites B-fold above the cell average.	UNIV ALBERTA, DEPT PHARMACOL, EDMONTON, AB T6G 2H7, CANADA; UNIV WASHINGTON, DEPT PHYSIOL & BIOPHYS, SEATTLE, WA 98195 USA; MAX PLANCK INST MED RES, ABT MOL ZELLFORSCH, D-69120 HEIDELBERG, GERMANY	University of Alberta; University of Washington; University of Washington Seattle; Max Planck Society			Tse, Amy/C-3142-2013; Oka, Yoshitaka/C-9670-2010; Tse, Frederick/C-3449-2013	Oka, Yoshitaka/0000-0002-3482-3051; Tse, Amy/0000-0002-0847-7466	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD012629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR017803, R01AR017803] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-17803] Funding Source: Medline; NICHD NIH HHS [HD12629] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P143, DOI 10.1113/jphysiol.1985.sp015818; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; DUNLOP ME, 1988, BIOCHEM J, V253, P67, DOI 10.1042/bj2530067; FOSKETT JK, 1989, P NATL ACAD SCI USA, V86, P167, DOI 10.1073/pnas.86.1.167; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GRIFFITHS G, 1984, J CELL BIOL, V98, P2133, DOI 10.1083/jcb.98.6.2133; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HILLE B, 1995, RECENT PROG HORM RES, V50, P75; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; JOBIN RM, 1995, ENDOCRINOLOGY, V136, P3398, DOI 10.1210/en.136.8.3398; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Kasai H, 1996, J PHYSIOL-LONDON, V494, P53, DOI 10.1113/jphysiol.1996.sp021475; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Lee AK, 1996, J PHYSIOL-LONDON, V495, P627, DOI 10.1113/jphysiol.1996.sp021621; LINDAU M, 1991, BIOCHIM BIOPHYS ACTA, V1071, P429, DOI 10.1016/0304-4157(91)90006-I; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; LLINAS R, 1975, P NATL ACAD SCI USA, V72, P187, DOI 10.1073/pnas.72.1.187; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LUBORSKYMOORE JL, 1978, NEUROENDOCRINOLOGY, V26, P93, DOI 10.1159/000122773; MCCRAY JA, 1992, BIOCHEMISTRY-US, V31, P8856, DOI 10.1021/bi00152a023; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; RAWLINGS SR, 1991, J BIOL CHEM, V266, P22755; REGEHR WG, 1994, J NEUROSCI, V14, P523; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V635, P221; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; ROSSIER MF, 1991, BIOCHEM J, V274, P643, DOI 10.1042/bj2740643; SCHIAVO G, 1996, IN PRESS P NATL ACAD, V93; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; STOJILKOVIC SS, 1995, J NEUROENDOCRINOL, V7, P739, DOI 10.1111/j.1365-2826.1995.tb00711.x; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TSE A, 1992, SCIENCE, V255, P462, DOI 10.1126/science.1734523; TSE A, 1993, ENDOCRINOLOGY, V132, P1475, DOI 10.1210/en.132.4.1475; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; TSE A, 1994, J PHYSIOL-LONDON, V477, P511, DOI 10.1113/jphysiol.1994.sp020212; TURGEON JL, 1986, ENDOCRINOLOGY, V118, P2053, DOI 10.1210/endo-118-5-2053; VANDERMERWE PA, 1989, BIOCHEM J, V264, P901, DOI 10.1042/bj2640901; VANDERMERWE PA, 1990, BIOCHEM J, V268, P493, DOI 10.1042/bj2680493; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; WU LG, 1994, J NEUROSCI, V14, P5613; YOO SH, 1990, J BIOL CHEM, V265, P13446	62	164	165	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1997	18	1					121	132		10.1016/S0896-6273(01)80051-9	http://dx.doi.org/10.1016/S0896-6273(01)80051-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WE718	9010210	Bronze			2022-12-24	WOS:A1997WE71800013
J	Vetter, DE; Mann, JR; Wangemann, P; Liu, JZ; McLaughlin, KJ; Lesage, F; Marcus, DC; Lazdunski, M; Heinemann, SF; Barhanin, J				Vetter, DE; Mann, JR; Wangemann, P; Liu, JZ; McLaughlin, KJ; Lesage, F; Marcus, DC; Lazdunski, M; Heinemann, SF; Barhanin, J			Inner ear defects induced by null mutation of the isk gene	NEURON			English	Article							VESTIBULAR DARK CELLS; INTRACOCHLEAR ELECTRICAL-STIMULATION; NEONATALLY DEAFENED CATS; ION-TRANSPORT MECHANISMS; EMBRYONIC STEM-CELLS; I-SK CHANNEL; POTASSIUM CHANNELS; K+ CHANNEL; GUINEA-PIG; HAIR-CELLS	The isk gene is expressed in many tissues. Pharmacological evidence from the inner ear suggests that Isk mediates potassium secretion into the endolymph. To examine the consequences of IsK null mutation on inner ear function, and to produce a system useful for examining the role(s) IsK plays elsewhere, we have produced a mouse strain that carries a disrupted isk locus. Knockout mice exhibit classic shaker/waltzer behavior. Hair cells degenerate, but those of different inner ear organs degenerate at different times. Functionally, we show that in mice lacking isk, the strial marginal cells and the vestibular dark cells of the inner ear are unable to generate an equivalent short circuit current in vitro, indicating a lack of transepithelial potassium secretion.	CITY HOPE NATL MED CTR, BECKMAN RES INST, DUARTE, CA 91010 USA; BOYS TOWN NATL RES HOSP, CELL PHYSIOL LAB, OMAHA, NE 68131 USA; CNRS, INST PHARMACOL MOL & CELLULAIRE, F-06560 VALBONNE, FRANCE; BOYS TOWN NATL RES HOSP, BIOPHYS LAB, OMAHA, NE 68131 USA	City of Hope; Beckman Research Institute of City of Hope; Boys Town National Research Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Boys Town National Research Hospital	Vetter, DE (corresponding author), SALK INST BIOL STUDIES, 10010 N TORREY PINES RD, LA JOLLA, CA 92037 USA.		Wangemann, Philine/N-2826-2013; Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011; Vetter, Douglas E./O-8150-2019; McLaughlin, Kenneth/E-3648-2011	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; 	NIDCD NIH HHS [DC 02871] Funding Source: Medline; NINDS NIH HHS [NS 28709, NS 11549] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709, R01NS011549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002871] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anniko M, 1980, Am J Otolaryngol, V1, P400, DOI 10.1016/S0196-0709(80)80021-4; ANNIKO M, 1981, ANN OTO RHINOL LARYN, V90, P25, DOI 10.1177/000348948109000107; ANNIKO M, 1980, ARCH OTO-RHINO-LARYN, V229, P281, DOI 10.1007/BF02565531; ATTALI B, 1992, J BIOL CHEM, V267, P8650; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Belal A Jr, 1980, Am J Otolaryngol, V1, P275, DOI 10.1016/S0196-0709(80)80030-5; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; BUSCH AE, 1994, BIOCHEM BIOPH RES CO, V202, P265, DOI 10.1006/bbrc.1994.1922; BUSCH AE, 1996, IN PRESS PFLUGERS AR; CORREIA MJ, 1992, ANN NY ACAD SCI, V656, P49, DOI 10.1111/j.1749-6632.1992.tb25199.x; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; CUSIMANO F, 1991, INT J PEDIATR OTORHI, V22, P49, DOI 10.1016/0165-5876(91)90096-T; Deol M S, 1968, J Med Genet, V5, P137, DOI 10.1136/jmg.5.2.137; DEOL MS, 1954, J GENET, V52, P562, DOI 10.1007/BF02985081; DEOL MS, 1963, J EMBRYOL EXP MORPH, V11, P493; DEOL MS, 1956, PROC R SOC SER B-BIO, V145, P206, DOI 10.1098/rspb.1956.0028; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Erway LC., 1978, VESTIBULAR MECHANISM, P195; FELIPE A, 1994, AM J PHYSIOL, V267, pC700, DOI 10.1152/ajpcell.1994.267.3.C700; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FRASER GR, 1964, ANN HUM GENET, V28, P133, DOI 10.1111/j.1469-1809.1964.tb00469.x; FREEMAN LC, 1993, CARDIOVASC DRUG THER, V7, P627, DOI 10.1007/BF00877630; Friedmann I, 1966, J Laryngol Otol, V80, P451, DOI 10.1017/S002221510006552X; Friedmann I, 1968, J Laryngol Otol, V82, P883; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HINOJOSA R, 1966, AM J ANAT, V118, P631, DOI 10.1002/aja.1001180218; Hogan B, 1994, MANIPULATING MOUSE E; HONORE E, 1991, EMBO J, V10, P2805, DOI 10.1002/j.1460-2075.1991.tb07829.x; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; KOROXENIDIS GT, 1966, AM J MED, V40, P149, DOI 10.1016/0002-9343(66)90196-3; LEAKE PA, 1991, HEARING RES, V54, P251, DOI 10.1016/0378-5955(91)90120-X; LEAKE PA, 1988, HEARING RES, V33, P11, DOI 10.1016/0378-5955(88)90018-4; LEAKE PA, 1992, HEARING RES, V64, P99, DOI 10.1016/0378-5955(92)90172-J; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; LESAGE F, 1992, FEBS LETT, V301, P168, DOI 10.1016/0014-5793(92)81240-M; LEWIS SM, 1958, AM HEART J, V55, P458, DOI 10.1016/0002-8703(58)90065-6; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; Liu Jianzhong, 1995, Audit Neurosci, V1, P331; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LYON MF, 1996, GENETIC VARIANTS STR; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MARCUS DC, 1994, AM J PHYSIOL, V267, pC857, DOI 10.1152/ajpcell.1994.267.3.C857; MARCUS DC, 1994, HEARING RES, V73, P101, DOI 10.1016/0378-5955(94)90287-9; MARCUS DC, 1994, BIOPHYS J, V66, P1939, DOI 10.1016/S0006-3495(94)80987-7; MARCUS NY, 1987, AM J PHYSIOL, V253, pF613, DOI 10.1152/ajprenal.1987.253.4.F613; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PONGS O, 1993, J MEMBRANE BIOL, V136, P1; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; SAKAGAMI M, 1991, HEARING RES, V56, P168, DOI 10.1016/0378-5955(91)90166-7; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SAWADA I, 1994, ACTA OTO-LARYNGOL, P20; SHEN Z, 1995, J MEMBRANE BIOL, V146, P283; SHEN Z, 1996, IN PRESS AUDIT NEURO; SHER AE, 1971, ACTA OTO-LARYNGOL, P1; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; SUGIMOTO T, 1990, J MEMBRANE BIOL, V113, P39, DOI 10.1007/BF01869604; SWANSON R, 1993, SEMIN NEUROSCI, V5, P117; SZABO P, 1994, DEVELOPMENT, V120, P1651; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Tesson F, 1996, J MOL CELL CARDIOL, V28, P2051, DOI 10.1006/jmcc.1996.0198; TOHSE N, 1990, AM J PHYSIOL, V258, pH1200, DOI 10.1152/ajpheart.1990.258.4.H1200; TSUKAHARA Y, 1995, MOL BRAIN RES, V29, P376, DOI 10.1016/0169-328X(94)00276-K; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; WANGEMANN P, 1995, HEARING RES, V90, P149, DOI 10.1016/0378-5955(95)00157-2; WANGEMANN P, 1990, PFLUG ARCH EUR J PHY, V416, P262, DOI 10.1007/BF00392062; WANGEMANN P, 1994, AM J PHYSIOL, V266, pC1046, DOI 10.1152/ajpcell.1994.266.4.C1046; WANGEMANN P, 1995, J MEMBRANE BIOL, V147, P263; WANGEMANN P, 1996, IN PRESS HEARING RES	75	303	313	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1251	1264		10.1016/S0896-6273(00)80255-X	http://dx.doi.org/10.1016/S0896-6273(00)80255-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982171	Bronze			2022-12-24	WOS:A1996WA24800021
J	Liedtke, W; Edelmann, W; Bieri, PL; Chiu, FC; Cowan, NJ; Kucherlapati, R; Raine, CS				Liedtke, W; Edelmann, W; Bieri, PL; Chiu, FC; Cowan, NJ; Kucherlapati, R; Raine, CS			GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; MESSENGER-RNA; OLIGODENDROCYTE DEVELOPMENT; INTERMEDIATE FILAMENTS; ASTROCYTIC PROCESSES; CONDITIONED MEDIUM; CELLS; BRAIN	To investigate the structural role of glial fibrillary acidic protein (GFAP) in vivo, mice carrying a null mutation in GFAP were generated. In 7/14 mutant animals older than 18 months of age, hydrocephalus associated with white matter loss was detected. Mutant mice displayed abnormal myelination including the presence of actively myelinating oligodendrocytes in adults, nonmyelinated axons in optic nerve, and reduced myelin thickness in spinal cord. White matter was poorly vascularized and the blood-brain barrier was structurally and functionally impaired. Astrocytic structure and function were abnormal, consisting of shortened astrocytic cell processes, decreased septation of white matter, and increased CNS extracellular space. Thus, GFAP expression is essential for normal white matter architecture and blood-brain barrier integrity, and its absence leads to late-onset CNS dysmyelination.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOL GENET,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROL,BRONX,NY 10461; NYU,DEPT BIOCHEM,NEW YORK,NY 10016	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University	Liedtke, W (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PATHOL,DIV NEUROPATHOL,1300 MORRIS PK AVE,BRONX,NY 10461, USA.		Kucherlapati, Raju/ABC-8807-2021; Liedtke, Wolfgang/GNH-1878-2022; Liedtke, Wolfgang B/G-4633-2011		NINDS NIH HHS [NS 08952, NS 11920, NS 07098] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098, P50NS011920, P01NS011920, R01NS008952] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNEY ER, 1983, DEV BIOL, V100, P166, DOI 10.1016/0012-1606(83)90207-5; BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BARONVANEVERCOOREN A, 1992, LAB INVEST, V66, P39; BARTLETT WP, 1988, GLIA, V1, P253, DOI 10.1002/glia.440010404; BLAKEMORE WF, 1991, TRENDS NEUROSCI, V14, P323, DOI 10.1016/0166-2236(91)90155-N; BOEGLER O, 1990, P NATL ACAD SCI USA, V87, P6368; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; BUNGE RP, 1965, ANN NY ACAD SCI, V122, P15; CHIU FC, 1989, NEURON, V2, P1435, DOI 10.1016/0896-6273(89)90189-X; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GALLO V, 1995, J NEUROSCI, V15, P394; GARD AL, 1995, DEVELOPMENT, V121, P2187; GOLDMUNTZ EA, 1986, J IMMUNOL, V137, P3444; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; HANDYSIDE AH, 1989, ROUX ARCH DEV BIOL, V198, P48, DOI 10.1007/BF00376370; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kandel ER, 1991, PRINCIPLES NEURAL SC, P22; LANDRY CF, 1990, J NEUROSCI RES, V25, P194, DOI 10.1002/jnr.490250207; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MICHAELSON MD, 1996, IN PRESS DEVELOPMENT; MOORE GRW, 1987, LAB INVEST, V57, P157; MOORE GRW, 1988, LAB INVEST, V59, P641; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Privat Alain, 1995, P3; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Raine C.S, 1991, TXB NEUROPATHOLOGY, P115; RAINE CS, 1984, J NEUROCYTOL, V13, P21, DOI 10.1007/BF01148316; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; SKOFF RP, 1976, NATURE, V264, P560, DOI 10.1038/264560a0; VAUGHN JE, 1967, AM J ANAT, V121, P131, DOI 10.1002/aja.1001210109; Virchow R., 1846, ALLG Z PSYCHIAT, V3, P242; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; WREN DR, 1989, P NATL ACAD SCI USA, V86, P9025, DOI 10.1073/pnas.86.22.9025; WU E, 1992, LAB INVEST, V67, P88; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; YU ACH, 1991, J NEUROSCI RES, V30, P72, DOI 10.1002/jnr.490300109	47	395	404	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					607	615		10.1016/S0896-6273(00)80194-4	http://dx.doi.org/10.1016/S0896-6273(00)80194-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893019	hybrid			2022-12-24	WOS:A1996VP74300007
J	Thinakaran, G; Borchelt, DR; Lee, MK; Slunt, HH; Spitzer, L; Kim, G; Ratovitsky, T; Davenport, F; Nordstedt, C; Seeger, M; Hardy, J; Levey, AI; Gandy, SE; Jenkins, NA; Copeland, NG; Price, DL; Sisodia, SS				Thinakaran, G; Borchelt, DR; Lee, MK; Slunt, HH; Spitzer, L; Kim, G; Ratovitsky, T; Davenport, F; Nordstedt, C; Seeger, M; Hardy, J; Levey, AI; Gandy, SE; Jenkins, NA; Copeland, NG; Price, DL; Sisodia, SS			Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; PRECURSOR PROTEIN GENE; MUTATION; EXPRESSION	The majority of early-onset cases of familial Alzheimer's disease (FAD) are linked to mutations in two related genes, PS1 and PS2, located on chromosome 14 and 1, respectively. Using two highly specific antibodies against nonoverlapping epitopes of the PS1-encoded polypeptide, termed presenilin 1 (PS1), we document that the preponderant PS1-related species that accumulate in cultured mammalian cells, and in the brains of rodents, primates, and humans are similar to 27-28 kDa N-terminal and similar to 16-17 kDa C-terminal derivatives. Notably, a FAD-linked PS1 variant that lacks exon 9 is not subject to endoproteolytic cleavage. In brains of transgenic mice expressing human PS1, similar to 17 kDa and similar to 27 kDa PS1 derivatives accumulate to saturable levels, and at similar to 1:1 stoichiometry, independent of transgene-derived mRNA. We conclude that PS1 is subject to endoproteolytic processing in vivo.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; KAROLINSKA INST,DEPT CLIN NEUROSCI,S-17176 STOCKHOLM,SWEDEN; CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; NCI,MAMMALIAN GENET LAB,ABL BASIC RES PROGRAM,FREDERICK CANC RES & DEV,FREDERICK,MD 21701; UNIV S FLORIDA,DEPT PSYCHIAT,SUNCOAST ALZHEIMERS DIS LABS,TAMPA,FL 33613	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Cornell University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of South Florida	Thinakaran, G (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205, USA.		Levey, Allan/F-2104-2011; Lee, Michael K/D-9491-2013; Hardy, John/C-2451-2009	Levey, Allan/0000-0002-3153-502X; Lee, Michael K/0000-0001-5865-9682; Hardy, John/0000-0002-3122-0423	NIA NIH HHS [AG05689, AG11508] Funding Source: Medline; NINDS NIH HHS [NS20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011508, R55AG011508] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boteva K, 1996, LANCET, V347, P130, DOI 10.1016/S0140-6736(96)90261-5; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; CHAPMAN J, 1995, LANCET, V346, P1040, DOI 10.1016/S0140-6736(95)91723-3; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; FISCHER M, 1996, IN PRESS EMBO J; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PerezTur J, 1995, NEUROREPORT, V7, P297; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sahara N, 1996, FEBS LETT, V381, P7, DOI 10.1016/0014-5793(96)00054-3; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1995, AMYLOID, V2, P188, DOI 10.3109/13506129509036925; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; SUZUKI T, 1996, BIOCHEM BIOPH RES CO, V219, P706; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; WASCO W, 1995, NAT MED, V1, P848, DOI 10.1038/nm0995-848a; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; 1995, NAT GENET, V11, P219	32	950	976	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					181	190		10.1016/S0896-6273(00)80291-3	http://dx.doi.org/10.1016/S0896-6273(00)80291-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755489	Bronze			2022-12-24	WOS:A1996UY98100018
J	Hedin, KE; Lim, NF; Clapham, DE				Hedin, KE; Lim, NF; Clapham, DE			Cloning of a Xenopus laevis inwardly rectifying K+ channel subunit that permits GIRK1 expression of I-KACh currents in oocytes	NEURON			English	Article							GTP-BINDING PROTEINS; ATRIAL CELLS; ACTIVATION; RECEPTOR; HEART	Xenopus oocytes injected with GIRK1 mRNA express inwardly rectifying K+ channels resembling I-KACh. Yet I-KACh, the atrial G protein-regulated ion channel, is a heteromultimer of GIRK1 and CIR. Reasoning that an oocyte protein might be substituting for CIR, we cloned XIR, a CIR homolog endogenously expressed by Xenopus oocytes. Coinjecting XIR and GIRK1 mRNAs produced large, inwardly rectifying K+ currents responsive to m2-muscarinic receptor stimulation. The m2-stimulated currents of oocytes expressing GIRK1 alone decreased 80% after injecting antisense oligonucleotides specific to the 5' untranslated region of XIR, but GIRK1/CIR currents were unaffected. Thus, GIRK1 without XIR or CIR only ineffectively produces currents in oocytes. This result suggests that GIRK1 does not form native homomultimeric channels.			Hedin, KE (corresponding author), MAYO CLIN & MAYO FDN,DEPT PHARMACOL,200 1ST ST SW,ROCHESTER,MN 55905, USA.		Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Hedin, Karen/0000-0003-1010-923X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049184] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07111-20P] Funding Source: Medline; NIDDK NIH HHS [DK49184-01P3] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Dascal N., 1992, METHODS MOL BIOL VOL, VVolume 13, P205; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; HEDIN KE, 1993, CELL SIGNAL, V5, P505, DOI 10.1016/0898-6568(93)90046-O; HILLE B, 1985, NATURE, V217, P536; KARSCHIN C, 1994, FEBS LETT, V348, P139, DOI 10.1016/0014-5793(94)00590-7; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, IN PRESS J BIOL CHEM; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; PHILIPSON LH, 1995, J BIOL CHEM, V270, P14604, DOI 10.1074/jbc.270.24.14604; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; VELIMIROVIC BM, 1996, IN PRESS FEBS LETT; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	27	161	166	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					423	429		10.1016/S0896-6273(00)80060-4	http://dx.doi.org/10.1016/S0896-6273(00)80060-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789957	Bronze			2022-12-24	WOS:A1996TW95700022
J	CameronCurry, P; LeDouarin, NM				CameronCurry, P; LeDouarin, NM			Oligodendrocyte precursors originate from both the dorsal and the ventral parts of the spinal cord	NEURON			English	Article							ALPHA-RECEPTOR EXPRESSION; CENTRAL NERVOUS-SYSTEM; CHICK CHIMERA SYSTEM; EMBRYONIC-DEVELOPMENT; BRAIN-DEVELOPMENT; PDGF RECEPTORS; GROWTH-FACTOR; GLIAL-CELLS; LINEAGE; GLIOGENESIS	Oligodendrocytes have been recently claimed to originate from bilateral columns of precursors whose extension is limited to the ventral region of the neuroepithelium. We designed an experiment in which the developmental capabilities of the different regions of the ventricular epithelium could be tested. We exchanged isotopically and isotopically defined sectors of the E2 spinal cord between quail and chick embryos and followed the production and migration of oligodendrocytes by using a quail-specific cDNA probe encoding the oligodendrocyte marker Schwann cell myelin protein. We showed that oligodendrocytes are generated in vivo from bath ventral and dorsal halves of the neural tube. Moreover, extensive ventrodorsal, as well as dorsoventral, migrations of oligodendrogenic cells take place during spinal cord differentiation.	CNRS,INST EMBRYOL CELLULAIRE & MOLEC,F-94736 NOGENT SUR MARNE,FRANCE; COLL FRANCE,F-94736 NOGENT SUR MARNE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France								BALABAN E, 1988, SCIENCE, V241, P1339, DOI 10.1126/science.3413496; CAMERONCURRY P, 1989, DEVELOPMENT, V107, P825; DULAC C, 1992, NEURON, V8, P323, DOI 10.1016/0896-6273(92)90298-R; DULAC C, 1988, NEURON, V1, P211, DOI 10.1016/0896-6273(88)90141-9; EICHMANN A, 1993, MECH DEVELOP, V42, P33, DOI 10.1016/0925-4773(93)90096-G; FUJITA S, 1965, J COMP NEUROL, V124, P51, DOI 10.1002/cne.901240105; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HART IK, 1989, DEVELOPMENT, V105, P595; HIRANO M, 1988, J NEUROSCI RES, V21, P155, DOI 10.1002/jnr.490210208; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; KINUTANI M, 1989, CELL DIFFER DEV, V26, P145, DOI 10.1016/0922-3371(89)90016-6; Le Douarin N., 1969, Bulletin Biologique de la France et de la Belgique, V103, P435; Le Douarin N.M., 1982, NEURAL CREST; LEBER SM, 1995, J NEUROSCI, V15, P1236; LEBER SM, 1990, J NEUROSCI, V10, P2451; LEDOUARIN NM, 1993, TRENDS NEUROSCI, V16, P64, DOI 10.1016/0166-2236(93)90019-I; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LEVINE SM, 1988, J NEUROSCI, V8, P3992; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; NOLL E, 1993, DEVELOPMENT, V118, P563; NORMEE HO, 1974, BRAIN RES, V73, P121; Peters A., 1976, FINE STRUCTURE NERVO; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Richardson WD, 1990, SEMIN NEUROSCI, V2, P445; SCHERER SS, 1994, NEURON, V12, P1363, DOI 10.1016/0896-6273(94)90451-0; TAN K, 1991, ANAT EMBRYOL, V183, P321; TIMSIT S, 1995, J NEUROSCI, V15, P1012; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TROUSSE F, 1995, J NEUROSCI RES, V41, P552, DOI 10.1002/jnr.490410415; WARF BC, 1991, J NEUROSCI, V11, P2477; WENGER EL, 1950, J EXP ZOOL, V114, P51, DOI 10.1002/jez.1401140103; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; ZACCHEI A M, 1961, Arch Ital Anat Embriol, V66, P36	39	75	76	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1299	1310		10.1016/0896-6273(95)90009-8	http://dx.doi.org/10.1016/0896-6273(95)90009-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845154	Bronze			2022-12-24	WOS:A1995TL67800009
J	Meyer-Franke, A; Wilkinson, GA; Kruttgen, A; Hu, M; Munro, E; Hanson, MG; Reichardt, LF; Barres, BA				Meyer-Franke, A; Wilkinson, GA; Kruttgen, A; Hu, M; Munro, E; Hanson, MG; Reichardt, LF; Barres, BA			Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; SYMPATHETIC NEURONS; PROTEIN-KINASE; PC12 CELLS; MAP KINASE; IN-VITRO; GLUCOSE-TRANSPORT; NEURITE OUTGROWTH; SURVIVAL	Here, we describe a novel mechanism for the rapid regulation of surface levels of the neurotrophin receptor TrkB. Unlike nodose ganglion neurons, both retinal ganglion cells (RGCs) and spinal motor neurons (SMNs) in culture display only low levels of surface TrkB, though high levels are present intracellularly. Within minutes of depolarization or cAMP elevation, surface TrkB levels increase by nearly 4-fold, and this increase is not blocked by cycloheximide. These findings suggest that activity and cAMP elevation rapidly recruit TrkB to the plasma membrane by translocation from intracellular stores. We propose that a fundamental difference between peripheral nervous system (PNS) and central nervous system (CNS) neurons is the activity dependence of CNS neurons for responsiveness to their peptide trophic factors and that differences in membrane compartmentalization of the receptors underlie this difference.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Physiol, Neurosci Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.		Kruttgen, Alexander P/E-9232-2010		NEI NIH HHS [R01 EY11030] Funding Source: Medline; NIGMS NIH HHS [GM 07449, T32 GM007449] Funding Source: Medline; NIMH NIH HHS [MH48200, P50 MH048200-080005] Funding Source: Medline; NATIONAL EYE INSTITUTE [U10EY011030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1989, J NEUROSCI, V9, P3169; BARTLETT PF, 1981, BRAIN RES, V204, P339, DOI 10.1016/0006-8993(81)90593-X; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Canossa M, 1996, EMBO J, V15, P3369, DOI 10.1002/j.1460-2075.1996.tb00702.x; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DECURTIS I, 1991, J CELL BIOL, V113, P405, DOI 10.1083/jcb.113.2.405; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GOSH A, 1995, SCIENCE, V268, P239; GRIMES M, 1997, J NEUROSCI, V16, P7950; HANSON MG, 1998, IN PRESS J NEUROSCI; HERMAN GA, 1994, P NATL ACAD SCI USA, V91, P12750, DOI 10.1073/pnas.91.26.12750; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; KIMURA K, 1994, J BIOL CHEM, V269, P18961; KOIKE T, 1991, P NATL ACAD SCI USA, V88, P3892, DOI 10.1073/pnas.88.9.3892; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENCER WI, 1990, J CELL BIOL, V111, P379, DOI 10.1083/jcb.111.2.379; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LEWIS SA, 1984, J MEMBRANE BIOL, V82, P123, DOI 10.1007/BF01868937; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murer H, 1996, ANNU REV PHYSIOL, V58, P607, DOI 10.1146/annurev.physiol.58.1.607; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SANCHEZMARGALET V, 1994, BIOCHEM BIOPH RES CO, V204, P446, DOI 10.1006/bbrc.1994.2480; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; SCHWARTZ GJ, 1986, ANNU REV PHYSIOL, V48, P153; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; SOMMER I, 1982, NEUROSCI LETT, V29, P183, DOI 10.1016/0304-3940(82)90351-2; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; TWISS JL, 1995, J NEUROCHEM, V64, P550; Virdee K, 1996, J NEUROCHEM, V67, P1801; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WADE JB, 1986, ANNU REV PHYSIOL, V48, P213; WAKADE AR, 1983, EXP CELL RES, V144, P377, DOI 10.1016/0014-4827(83)90417-2; WILKINSON GA, 1997, THESIS U CALIFORNIA; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Yao XB, 1996, AM J PHYSIOL-CELL PH, V271, pC61, DOI 10.1152/ajpcell.1996.271.1.C61	54	432	444	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					681	693		10.1016/S0896-6273(00)80586-3	http://dx.doi.org/10.1016/S0896-6273(00)80586-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808456	Green Accepted, Bronze			2022-12-24	WOS:000076697300013
J	Zhang, S; Ehlers, MD; Bernhardt, JP; Su, CT; Huganir, RL				Zhang, S; Ehlers, MD; Bernhardt, JP; Su, CT; Huganir, RL			Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; SPINAL-CORD NEURONS; NMDA-RECEPTOR; GLUTAMATE RECEPTORS; ALPHA-ACTININ; NR1 SUBUNIT; DESENSITIZATION; CHANNELS; TOPOLOGY; CELLS	Ca2+ influx through N-methyl-D-aspartate (NMDA) receptors activates signal transduction pathways critical for many forms of synaptic plasticity in the brain. NMDA receptor-mediated Ca2+ influx also downregulates the gating of NMDA channels through a process called Ca2+-dependent inactivation (CDI). Recent studies have demonstrated that the calcium binding protein calmodulin directly interacts with NMDA receptors, suggesting that carmodulin may play a role in CDI. We report here that the mutation of a specific calmodulin binding site in the CO region of the NR1 subunit of the NMDA receptor blocks CDI. Moreover, intracellular infusion of a calmodulin inhibitory peptide markedly reduces CDI of both recombinant and neuronal NMDA receptors. Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1. Taken together, these results demonstrate that the binding of Ca2+/ calmodulin to NR1 mediates CDI of the NMDA receptor and suggest that inactivation occurs via Ca2+/calmodulin-dependent release of the receptor complex from the neuronal cytoskeleton.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.							Allison DW, 1998, J NEUROSCI, V18, P2423; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KINCAID RL, 1982, J BIOL CHEM, V257, P638; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Kyrozis A, 1996, J PHYSIOL-LONDON, V495, P449, DOI 10.1113/jphysiol.1996.sp021606; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MAYER ML, 1987, J NEUROSCI, V7, P3230; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Medina I, 1996, J PHYSIOL-LONDON, V495, P411, DOI 10.1113/jphysiol.1996.sp021603; MEDINA I, 1995, J PHYSIOL-LONDON, V482, P567, DOI 10.1113/jphysiol.1995.sp020540; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Paoletti P, 1997, J NEUROSCI, V17, P5711; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; VINCENZI FF, 1980, CALCIUM CELL FUNCTIO, P127; VYKLICKY L, 1993, J PHYSIOL-LONDON, V470, P575, DOI 10.1113/jphysiol.1993.sp019876; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; ZORUMSKI CF, 1989, CELL MOL NEUROBIOL, V9, P95, DOI 10.1007/BF00711446	48	237	245	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1998	21	2					443	453		10.1016/S0896-6273(00)80553-X	http://dx.doi.org/10.1016/S0896-6273(00)80553-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728925	hybrid			2022-12-24	WOS:000075598300021
J	Liu, DT; Tibbs, GR; Paoletti, P; Siegelbaum, SA				Liu, DT; Tibbs, GR; Paoletti, P; Siegelbaum, SA			Constraining ligand-binding site stoichiometry suggests that a cyclic nucleotide-gated channel is composed of two functional dimers	NEURON			English	Article							SUBUNIT STOICHIOMETRY; POTASSIUM CHANNEL; ION-CHANNEL; ACETYLCHOLINE-RECEPTOR; MOLECULAR MECHANISM; ROD PHOTORECEPTORS; ACTIVATED CHANNELS; SINGLE-CHANNEL; RETINAL RODS; CONDUCTANCE	Cyclic nucleotide-gated ion channels are composed of four pore-forming subunits. Binding of cyclic nucleotide to a site in the intracellular carboxyl terminus of each subunit leads to channel activation. Since there are four subunits, four binding events are possible. In this study, we investigate the effects of individual binding events on activation by studying channels containing one, two, three, or four functional binding sites. The binding of a single ligand significantly increases opening, although four ligands are required for full activation. The data are inconsistent with models in which the four subunits activate in a single concerted step (Monod-Wyman-Changeux model) or in four independent steps (Hodgkin-Huxley model). Instead, the four subunits may associate and activate as two independent dimers.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Siegelbaum, SA (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				ALTENHOFEN W, 1991, P NATL ACAD SCI USA, V88, P9868, DOI 10.1073/pnas.88.21.9868; Bucossi G, 1997, BIOPHYS J, V72, P1165, DOI 10.1016/S0006-3495(97)78765-4; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; ILDEFONSE M, 1991, J MEMBRANE BIOL, V123, P133, DOI 10.1007/BF01998084; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1994, NEURON, V12, P301, DOI 10.1016/0896-6273(94)90273-9; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Molokanova E, 1997, J NEUROSCI, V17, P9068; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PERUTZ MF, 1987, ACCOUNTS CHEM RES, V20, P309, DOI 10.1021/ar00141a001; PICONES A, 1995, J PHYSIOL-LONDON, V485, P699, DOI 10.1113/jphysiol.1995.sp020763; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; ROYER WE, 1995, J MOL BIOL, V253, P168, DOI 10.1006/jmbi.1995.0543; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SHABB JB, 1992, J BIOL CHEM, V267, P5723; STRYER L, 1987, CHEM SCRIPTA, V27B, P161; TAYLOR WR, 1995, J PHYSIOL-LONDON, V483, P567, DOI 10.1113/jphysiol.1995.sp020607; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	40	118	118	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					235	248		10.1016/S0896-6273(00)80530-9	http://dx.doi.org/10.1016/S0896-6273(00)80530-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697867	hybrid			2022-12-24	WOS:000075061900022
J	Yang, ZH; Emerson, M; Su, HS; Sehgal, A				Yang, ZH; Emerson, M; Su, HS; Sehgal, A			Response of the timeless protein to light correlates with behavioral entrainment and suggests a nonvisual pathway for circadian photoreception	NEURON			English	Article							DROSOPHILA-MELANOGASTER; CLOCK; CALCIUM; MUTANTS; RHYTHMS; TRP	The period (per) and timeless (tim) genes are required for circadian behavioral rhythms in Drosophila. The current model for how these rhythms entrain to light is based upon the right induced decrease in timeless protein (TIM) levels. We show here that the TIM response to light correlates with the effect of light on the behavioral rhythm. To identify components of the entrainment pathway, we also assayed the TIM response in flies with mutant visual systems. Flies that lacked eyes displayed a normal response in lateral neurons. The TIM response to a light pulse was attenuated in flies that were mutant for the transient receptor potential (trp) and trp-like (trpl) genes, which are required for calcium conductance in the visual transduction cascade. The reduced TIM response was accompanied by a reduced phase shift in the behavioral rhythm, but neither response was completely eliminated, and the trpl;trp flies entrain to light-dark cycles, suggesting that these genes perturb some aspect of circadian entrainment when mutated but are not essential for it. The TIM response was also unaffected in ninaE flies that lack the rhodopsin protein (rh1). These results support the hypothesis that circadian entrainment does not rely on the visual system and likely involves a dedicated pathway for photoreception.	Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA.							AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; ASCHOFF J, 1965, CIRCADIAN CLOCKS, P94; Batschelet E, 1981, CIRCULAR STAT BIOL; Cheng YZ, 1998, J NEUROSCI, V18, P741; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; DUNLAP JC, 1995, CIBA F SYMP, V183, P3; DUSHAY MS, 1989, J BIOL RHYTHM, V4, P1, DOI 10.1177/074873048900400101; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; FRANK KD, 1969, SCIENCE, V163, P688, DOI 10.1126/science.163.3868.688; GEUSZ ME, 1994, NEUROSCI BIOBEHAV R, V18, P555, DOI 10.1016/0149-7634(94)90011-6; Giebultowicz JM, 1997, NATURE, V386, P664, DOI 10.1038/386664a0; Gillette MU, 1996, PROG BRAIN RES, V111, P121, DOI 10.1016/S0079-6123(08)60404-5; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; HELFRICH C, 1986, J NEUROGENET, V3, P321, DOI 10.3109/01677068609106857; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Ousley A, 1998, GENETICS, V148, P815; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SEHGAL A, 1992, P NATL ACAD SCI USA, V89, P1423, DOI 10.1073/pnas.89.4.1423; Sehgal A, 1996, MOL CELL NEUROSCI, V7, P165, DOI 10.1006/mcne.1996.0013; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; ZATZ M, 1995, J NEUROCHEM, V65, P1332; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	42	110	110	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					215	223		10.1016/S0896-6273(00)80528-0	http://dx.doi.org/10.1016/S0896-6273(00)80528-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697865	hybrid			2022-12-24	WOS:000075061900020
J	Stefanacci, L; Reber, P; Costanza, J; Wong, E; Buxton, R; Zola, S; Squire, L; Albright, T				Stefanacci, L; Reber, P; Costanza, J; Wong, E; Buxton, R; Zola, S; Squire, L; Albright, T			fMRI of monkey visual cortex	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; MACAQUE; NEURONS; AREAS	While functional magnetic resonance imaging (fMRI) is now used widely for demonstrating neural activity-related signals associated with perceptual, motor, and cognitive processes in humans, to date this technique has not been developed for use with nonhuman primates, fMRI in monkeys offers a potentially valuable experimental approach for investigating brain function, which will complement and aid existing techniques such as electrophysiology and the behavioral analysis of the effects of brain lesions. There are, however, a number of significant technical challenges involved in using fMRI with monkeys. Here, we describe the procedures by which we have overcome these challenges to carry out successful fMRI experiments in an alert monkey, and we present the first evidence of activity-related fMRI signals from monkey cerebral cortex.	Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; Vet Adm Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Stefanacci, L (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.				NIMH NIH HHS [5 T32 MH18399] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018399] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; BARASH PG, 1997, CLIN ANESTH, P705; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; COURTNEY M, 1997, CURR OPIN NEUROBIOL, V7, P554; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; MACKO KA, 1982, SCIENCE, V218, P394, DOI 10.1126/science.7123241; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Reppas JB, 1997, NATURE, V388, P175, DOI 10.1038/40633; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VANESSEN DC, 1983, TRENDS NEUROSCI, V6, P370, DOI 10.1016/0166-2236(83)90167-4	18	88	90	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1051	1057		10.1016/S0896-6273(00)80485-7	http://dx.doi.org/10.1016/S0896-6273(00)80485-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655492	Green Published, Bronze			2022-12-24	WOS:000074627300001
J	MacNeil, MA; Masland, RH				MacNeil, MA; Masland, RH			Extreme diversity among amacrine cells: Implications for function	NEURON			English	Article							RETINAL GANGLION-CELLS; LOCAL CIRCUIT NEURONS; MONKEY STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; RABBIT RETINA; CAT RETINA; MAMMALIAN RETINA; BIPOLAR CELLS; ACCUMULATING NEURONS; DIHYDRORHODAMINE 123	We report a quantitative survey of the population of amacrine cells present in the retina of the rabbit. The cells' dendritic shape and level of stratification were visualized by a photochemical method in which a fluorescent product was created within an individual cell by focal irradiation of that cell's nucleus. A systematically random sample of 261 amacrine cells was examined. Four previously known amacrine cells were revealed at their correct frequencies. Our central finding is that the heterogeneous collection of other amacrine cells is broadly distributed among at least 22 types: only one type of amacrine cell makes up more than 5% of the total amacrine cell population. With these results, the program of identification and classification of retinal neurons begun by Cajal is nearing completion. The complexity encountered has implications both for the retina and for the many regions of the central nervous system where less is known.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Masland, RH (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.							AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; BOYCOTT BB, 1969, PHILOS T ROY SOC B, V255, P109, DOI 10.1098/rstb.1969.0004; CARRINGTON WA, 1990, NONINVASIVE TECHNIQU, P53; CASINI G, 1995, J COMP NEUROL, V356, P132, DOI 10.1002/cne.903560109; CASINI G, 1991, J COMP NEUROL, V305, P313, DOI 10.1002/cne.903050212; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; DACEY DM, 1990, J COMP NEUROL, V301, P461, DOI 10.1002/cne.903010310; DALVA MB, 1994, J NEUROSCI, V14, P3588; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; Dowling J. E., 1987, RETINA APPROACHABLE; EINSTEIN G, 1987, J COMP NEUROL, V260, P76, DOI 10.1002/cne.902600107; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P406, DOI 10.1002/cne.903160403; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; HAMOS JE, 1983, J COMP NEUROL, V217, P449, DOI 10.1002/cne.902170409; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; HENDERSON LM, 1993, EUR J BIOCHEM, V217, P973, DOI 10.1111/j.1432-1033.1993.tb18328.x; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; KOLB H, 1981, VISION RES, V21, P1625, DOI 10.1016/0042-6989(81)90046-8; KOLB H, 1981, VISION RES, V21, P1081, DOI 10.1016/0042-6989(81)90013-4; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; Lund JS, 1997, J COMP NEUROL, V384, P109, DOI 10.1002/(SICI)1096-9861(19970721)384:1<109::AID-CNE7>3.0.CO;2-5; LUND JS, 1991, J COMP NEUROL, V311, P234, DOI 10.1002/cne.903110206; LUND JS, 1988, J COMP NEUROL, V276, P1, DOI 10.1002/cne.902760102; LUND JS, 1987, J COMP NEUROL, V257, P60, DOI 10.1002/cne.902570106; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; Marc RE, 1989, PROGR RETINAL RES, P67; MARIANI AP, 1990, J COMP NEUROL, V301, P382, DOI 10.1002/cne.903010305; MARTIN PR, 1992, J COMP NEUROL, V323, P269, DOI 10.1002/cne.903230210; MASLAND RH, 1988, TRENDS NEUROSCI, V11, P405, DOI 10.1016/0166-2236(88)90078-1; MASLAND RH, 1986, TRENDS NEUROSCI, V9, P218, DOI 10.1016/0166-2236(86)90062-7; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; NIRENBERG S, 1993, J NEUROSCI, V13, P3238, DOI 10.1523/jneurosci.13-08-03238.1993; NIRENBERG SA, 1995, NEURON, V18, P637; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060; PERRY VH, 1979, PROC R SOC SER B-BIO, V204, P363, DOI 10.1098/rspb.1979.0033; Polyak S. L., 1941, RETINA-J RET VIT DIS; RODIECK RW, 1992, J COMP NEUROL, V321, P46, DOI 10.1002/cne.903210106; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SANDELL JH, 1989, J COMP NEUROL, V283, P303, DOI 10.1002/cne.902830210; SANDELL JH, 1986, J NEUROSCI, V6, P3331; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; SOLNICK B, 1984, P NATL ACAD SCI-BIOL, V81, P3898, DOI 10.1073/pnas.81.12.3898; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1995, J NEUROSCI, V15, P875; Strettoi E, 1996, P NATL ACAD SCI USA, V93, P14906, DOI 10.1073/pnas.93.25.14906; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; TAUCHI M, 1990, J COMP NEUROL, V293, P178, DOI 10.1002/cne.902930203; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1994, PROG RETIN EYE RES, V13, P301, DOI 10.1016/1350-9462(94)90014-0; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; VANEY DI, 1986, SCIENCE, V233, P444, DOI 10.1126/science.3726538; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P157, DOI 10.1098/rspb.1981.0032; WASSLE H, 1989, EUR J NEUROSCI, V1, P421, DOI 10.1111/j.1460-9568.1989.tb00350.x; WASSLE H, 1978, PROC R SOC SER B-BIO, V203, P269, DOI 10.1098/rspb.1978.0105; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Wright LL, 1997, VISUAL NEUROSCI, V14, P473, DOI 10.1017/S0952523800012141; YANG G, 1994, J NEUROSCI, V14, P5267; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	70	373	374	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1998	20	5					971	982		10.1016/S0896-6273(00)80478-X	http://dx.doi.org/10.1016/S0896-6273(00)80478-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620701	Bronze			2022-12-24	WOS:000073864700016
J	Rossi, DJ; Hamann, M				Rossi, DJ; Hamann, M			Spillover-mediated transmission at inhibitory synapses promoted by high affinity alpha(6) subunit GABA(A) receptors and glomerular geometry	NEURON			English	Article							CEREBELLAR GRANULE CELLS; GAMMA-AMINOBUTYRIC-ACID; ADRENAL CHROMAFFIN CELLS; RAT CEREBELLUM; A RECEPTOR; SYNAPTIC CURRENTS; HIPPOCAMPAL-NEURONS; PURKINJE-CELLS; NIPECOTIC ACID; MESSENGER-RNA	Divergence and convergence of synaptic connections make a crucial contribution to the information processing capacity of the brain. Until recently, it was thought that transmitter released at a synapse affected only a specific postsynaptic cell. We show here that spillover of inhibitory transmitter at the Golgi to granule cell synapse produces significant cross-talk to non-postsynaptic cells, which is promoted both by the anatomical specialization of this glomerular synapse and by the presence of the high affinity alpha(6) subunit-containing GABA, receptor in granule cells. Cross-talk is manifested as a novel slow rising and decaying small amplitude inhibitory postsynaptic current (IPSC) that can also contribute a long-lasting component to more typical IPSCs, which is prolonged by inhibition of the neuronal GABA transporter GAT-1. Because of the long duration of IPSCs generated by spillover, the total charge carried is three times that of IPSCs generated by directly connected terminals. GABA spillover within the mossy fiber glomerulus may play an important role in regulating the number of granule cells active in the cerebellar cortex, a regulation that is suggested by theoretical models to optimize cerebellar information processing.	Univ London Univ Coll, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Rossi, DJ (corresponding author), Univ London Univ Coll, Dept Physiol, London WC1E 6BT, England.			HAMANN, Martine/0000-0002-9142-6773	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Crank J., 1975, MATH DIFFUSION; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DUCIC I, 1995, J PHARMACOL EXP THER, V272, P438; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; HAMANN M, J PHYSL, V501, pP1397; HAMORI J, 1966, EXP BRAIN RES, V2, P35; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Itouji A, 1996, MOL BRAIN RES, V37, P309; JAKAB R L, 1989, Acta Morphologica Hungarica, V37, P11; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; KORPI ER, 1995, MOL PHARMACOL, V47, P283; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; LARSSON OM, 1988, J NEUROCHEM, V50, P818, DOI 10.1111/j.1471-4159.1988.tb02986.x; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P764, DOI 10.1152/jn.1978.41.3.764; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, J NEUROSCI, V16, P103; NUSSER Z, 1995, J NEUROSCI, V15, P2948; OTIS TS, 1992, NEUROSCIENCE, V49, P13, DOI 10.1016/0306-4522(92)90073-B; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PERSOHN E, 1992, J COMP NEUROL, V326, P193, DOI 10.1002/cne.903260204; PUIA G, 1994, NEURON, V12, P117, DOI 10.1016/0896-6273(94)90157-0; QUIRK K, 1994, J BIOL CHEM, V269, P16020; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; SALLIN PA, 1996, J NEUROPHYSIOL, V75, P1573; Saxena NC, 1996, MOL PHARMACOL, V49, P567; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SOLIS JM, 1992, NEUROSCI LETT, V147, P16, DOI 10.1016/0304-3940(92)90764-X; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Takahashi M, 1997, J EXP BIOL, V200, P401; THOMPSON SM, 1992, J NEUROPHYSIOL, V67, P1698, DOI 10.1152/jn.1992.67.6.1698; Tia S, 1996, J NEUROSCI, V16, P3630; Tia S, 1996, NEUROPHARMACOLOGY, V35, P1375, DOI 10.1016/S0028-3908(96)00018-4; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; VARECKA L, 1994, J COMP NEUROL, V339, P341, DOI 10.1002/cne.903390304; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WALL MJ, 1996, J PHYSL, V494, pP83; Wisden W, 1996, NEUROPHARMACOLOGY, V35, P1139, DOI 10.1016/S0028-3908(96)00076-7; ZHENG T, 1993, DEV BRAIN RES, V75, P91, DOI 10.1016/0165-3806(93)90068-L; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zhu WJ, 1996, J NEUROSCI, V16, P6648	64	277	281	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					783	795		10.1016/S0896-6273(00)81016-8	http://dx.doi.org/10.1016/S0896-6273(00)81016-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581769	Bronze			2022-12-24	WOS:000073346500016
J	Brivanlou, IH; Warland, DK; Meister, M				Brivanlou, IH; Warland, DK; Meister, M			Mechanisms of concerted firing among retinal ganglion cells	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; TIGER SALAMANDER RETINA; CATFISH INNER RETINA; ROD OUTER SEGMENTS; HORIZONTAL CELLS; GAP-JUNCTIONS; CAT RETINA; ACTION-POTENTIALS; MAMMALIAN RETINA; AMACRINE CELLS	Nearby retinal ganglion cells often fire action potentials in near synchrony. We have investigated the circuit mechanisms that underlie these correlations by recording simultaneously from many ganglion cells in the salamander retina. During spontaneous activity in darkness, three types of correlations were distinguished: broad (firing synchrony within 40-100 ms), medium (10-50 ms), and narrow (<1 ms). When chemical synaptic transmission was blocked, the broad correlations disappeared, but the medium and narrow correlations persisted. Further analysis of the strength and time course of synchronous firing suggests that nearby ganglion cells share inputs from photoreceptors conveyed through interneurons via chemical synapses (broad correlations), share excitation from amacrine cells via electrical junctions (medium), and excite each other via electrical junctions (narrow). It appears that the firing patterns in the optic nerve are strongly shaped by electrical coupling in the inner retina.	Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Meister, M (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.			Meister, Markus/0000-0003-2136-6506				ABELES M, 1994, PROG BRAIN RES, V102, P395; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AHO AC, 1988, NATURE, V334, P348, DOI 10.1038/334348a0; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ARNETT D, 1981, J PHYSIOL-LONDON, V317, P29, DOI 10.1113/jphysiol.1981.sp013812; ARNETT DW, 1978, EXP BRAIN RES, V32, P49; Barlow H B, 1971, Vision Res, VSuppl 3, P87; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BERRY MJ, 1998, IN PRESS J NEUROSCI; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; COOK JE, 1995, MICROSC RES TECHNIQ, V31, P408, DOI 10.1002/jemt.1070310510; COOK PB, 1994, J NEUROSCI, V14, P3852; DACEY DM, 1993, VISUAL NEUROSCI, V10, P1081, DOI 10.1017/S0952523800010191; DACEY DM, 1992, VISUAL NEUROSCI, V9, P279, DOI 10.1017/S0952523800010695; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; DEVRIES SH, 1996, INVEST OPHTHALM VI S, V37, P688; Dowling J. E., 1987, RETINA APPROACHABLE; FERSTER D, 1995, SCIENCE, V270, P756, DOI 10.1126/science.270.5237.756; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Jacoby R, 1996, J NEUROSCI, V16, P8041; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JOHNSEN JA, 1983, J PHYSIOL-LONDON, V345, P439, DOI 10.1113/jphysiol.1983.sp014987; KRUGER J, 1991, SPRINGER SERIES SYNE; LASATER EM, 1985, P NATL ACAD SCI USA, V82, P3025, DOI 10.1073/pnas.82.9.3025; Lu CB, 1996, VISUAL NEUROSCI, V13, P1049, DOI 10.1017/S0952523800007707; LUKASIEWICZ PD, 1990, J NEUROSCI, V10, P210; MAPLE BR, 1994, VISION RES, V34, P2357, DOI 10.1016/0042-6989(94)90281-X; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MCMAHON DG, 1989, P NATL ACAD SCI USA, V86, P7639, DOI 10.1073/pnas.86.19.7639; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; MITTMAN S, 1990, J PHYSIOL-LONDON, V428, P175, DOI 10.1113/jphysiol.1990.sp018206; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; PEICHL L, 1983, J PHYSIOL-LONDON, V341, P309, DOI 10.1113/jphysiol.1983.sp014807; PEPPERBERG DR, 1994, VISUAL NEUROSCI, V11, P53, DOI 10.1017/S095252380001110X; QIAN HH, 1993, VISUAL NEUROSCI, V10, P287, DOI 10.1017/S0952523800003680; SAKAI HM, 1988, J NEUROPHYSIOL, V60, P1549, DOI 10.1152/jn.1988.60.5.1549; SAKAI HM, 1990, J NEUROPHYSIOL, V63, P105, DOI 10.1152/jn.1990.63.1.105; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sterling P., 1990, SYNAPTIC ORG BRAIN, P170; Stone J., 1983, PARALLEL PROCESSING, DOI DOI 10.1007/978-1-4684-4433-9; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Taylor WR, 1996, VISUAL NEUROSCI, V13, P979, DOI 10.1017/S0952523800009202; VANEY DI, 1994, PROG RETIN EYE RES, V13, P301, DOI 10.1016/1350-9462(94)90014-0; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VANEY DI, 1994, J NEUROSCI, V14, P6301; VANEY DI, 1990, PROGR RETINAL RES, V9, P1; VENANCE L, 1995, NATURE, V376, P590, DOI 10.1038/376590a0; WANG XJ, 1993, NEUROSCIENCE, V53, P899, DOI 10.1016/0306-4522(93)90474-T; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Xin DY, 1997, J COMP NEUROL, V383, P512, DOI 10.1002/(SICI)1096-9861(19970714)383:4<512::AID-CNE8>3.0.CO;2-5; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	61	184	190	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1998	20	3					527	539		10.1016/S0896-6273(00)80992-7	http://dx.doi.org/10.1016/S0896-6273(00)80992-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539126	Bronze			2022-12-24	WOS:000072755600017
J	Nusser, Z; CullCandy, S; Farrant, M				Nusser, Z; CullCandy, S; Farrant, M			Differences in synaptic GABA(A) receptor number underlie variation in GABA mini amplitude	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; HIPPOCAMPAL PYRAMIDAL CELLS; INHIBITORY POSTSYNAPTIC CURRENTS; CENTRAL SYNAPSES; GABAERGIC INHIBITION; GLYCINE RECEPTORS; QUANTAL ANALYSIS; RAT HIPPOCAMPUS; DENTATE GYRUS; GRANULE CELLS	In many neurons, responses to individual quanta of transmitter exhibit large variations in amplitude. The origin of this variability, although central to our understanding of synaptic transmission and plasticity, remains controversial. To examine the relationship between quantal amplitude and postsynaptic receptor number, we adopted a novel approach, combining patch-clamp recording of synaptic currents with quantitative immunogold localization of synaptic receptors. Here, we report that in cerebellar stellate cells, where variability in GABA miniature synaptic currents is particularly marked, the distribution of quantal amplitudes parallels that of synaptic GABA(A) receptor number. We also show that postsynaptic GABA(A) receptor density is uniform, allowing synaptic area to be used as a measure of relative receptor content. Flurazepam, which increases GABA(A) receptor affinity, prolongs the decay of all miniature currents but selectively increases the amplitude of large events. From this differential effect, we show that a quantum of GABA saturates postsynaptic receptors when <80 receptors are present but results in incomplete occupancy at larger synapses.	UNIV OXFORD,MRC,ANAT NEUROPHARMACOL UNIT,OXFORD OX1 3TH,ENGLAND	University of Oxford	Nusser, Z (corresponding author), UNIV LONDON UNIV COLL,DEPT PHARMACOL,GOWER ST,LONDON WC1E 6BT,ENGLAND.		Nusser, Zoltan/K-8587-2014	Farrant, Mark/0000-0002-9918-0376; Nusser, Zoltan/0000-0001-7004-4111; Cull-Candy, Stuart G/0000-0002-0831-8326	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Bier M, 1996, J NEUROPHYSIOL, V75, P1008, DOI 10.1152/jn.1996.75.3.1008; BORST JGG, 1994, J NEUROPHYSIOL, V71, P639, DOI 10.1152/jn.1994.71.2.639; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Chang YC, 1996, J NEUROSCI, V16, P5415; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; Frerking M, 1996, BIOPHYS J, V70, P2078, DOI 10.1016/S0006-3495(96)79774-6; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; GRAY EG, 1959, J ANAT, V93, P420; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HARING P, 1985, P NATL ACAD SCI USA, V82, P4837, DOI 10.1073/pnas.82.14.4837; Hestrin S, 1996, J NEUROSCI, V16, P5290; HODGSON AJ, 1985, J HISTOCHEM CYTOCHEM, V33, P229, DOI 10.1177/33.3.3973378; JACK JJB, 1994, ADV SEC MESS PHOSPH, V29, P275; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KORN H, 1987, P NATL ACAD SCI USA, V84, P5981, DOI 10.1073/pnas.84.16.5981; Koulen P, 1996, J NEUROSCI, V16, P2127; Lavoie AM, 1996, NEUROPHARMACOLOGY, V35, P1383, DOI 10.1016/S0028-3908(96)00077-9; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Matsubara A, 1996, J NEUROSCI, V16, P4457; NEWLAND CF, 1991, J PHYSIOL-LONDON, V432, P203, DOI 10.1113/jphysiol.1991.sp018382; NUSSER Z, 1995, J NEUROSCI, V15, P2948; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; NUSSER Z, 1995, EUR J NEUROSCI, V7, P630, DOI 10.1111/j.1460-9568.1995.tb00667.x; OTIS TS, 1992, NEUROSCIENCE, V49, P13, DOI 10.1016/0306-4522(92)90073-B; Palay S. L., 1974, CEREBELLAR CORTEX CY; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PERSOHN E, 1992, J COMP NEUROL, V326, P193, DOI 10.1002/cne.903260204; PIERCE JP, 1993, J NEUROSCI, V13, P4748; PITLER TA, 1994, NEURON, V13, P1447; Poncer JC, 1996, NEUROPHARMACOLOGY, V35, P1169, DOI 10.1016/S0028-3908(96)00055-X; Popratiloff A, 1996, J NEUROSCI, V16, P3363; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; SASSOEPOGNETTO M, 1995, J COMP NEUROL, V356, P1; Sheng M, 1997, NATURE, V386, P221, DOI 10.1038/386221a0; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; SOLTESZ I, 1994, J NEUROSCI, V14, P2365; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; SOMOGYI P, 1985, J HISTOCHEM CYTOCHEM, V33, P249, DOI 10.1177/33.3.2579124; SUR C, 1995, J COMP NEUROL, V351, P247, DOI 10.1002/cne.903510205; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Tretter V, 1997, J NEUROSCI, V17, P2728; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; VICINI S, 1986, P NATL ACAD SCI USA, V83, P9269, DOI 10.1073/pnas.83.23.9269; WALMSLEY B, 1995, P ROY SOC B-BIOL SCI, V261, P245, DOI 10.1098/rspb.1995.0144; ZEZULA J, 1991, BRAIN RES, V563, P325, DOI 10.1016/0006-8993(91)91556-G; ZHANG L, 1993, J PHARMACOL EXP THER, V266, P1227	69	359	363	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					697	709		10.1016/S0896-6273(00)80382-7	http://dx.doi.org/10.1016/S0896-6273(00)80382-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331359	Bronze			2022-12-24	WOS:A1997XZ01600022
J	Broadie, K; Rushton, E; Skoulakis, EMC; Davis, RL				Broadie, K; Rushton, E; Skoulakis, EMC; Davis, RL			Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; LONG-TERM POTENTIATION; SYNAPTIC TRANSMISSION; CYCLIC-AMP; KINASE-C; NEUROMUSCULAR SYNAPSE; IN-VITRO; 14-3-3-PROTEINS; MUTANTS; PLASTICITY	The leonardo gene encodes a conserved member of the 14-3-3 protein family, which plays a role in Drosophila teaming. Immunological localization of the protein shows that it is expressed at synaptic connections and enriched in presynaptic boutons of the neuromuscular junction (NMJ). Null leonardo mutants die as mature embryos. Electrophysiological assays of the mutant NMJ demonstrate that basal synaptic transmission is reduced by 30% and that transmission amplitude, fidelity, and fatigue resistance properties are reduced at elevated stimulation frequencies and in low external [Ca2+]. Moreover, transmission augmentation and post-tetanic potentiation (PTP) are disrupted in the mutant. These results suggest that Leonardo plays a role in the regulation of synaptic vesicle dynamics, a function which may underlie synaptic modulation properties enabling learning.	BAYLOR COLL MED, DEPT CELL BIOL & NEUROL, HOUSTON, TX 77030 USA	Baylor College of Medicine	Broadie, K (corresponding author), UNIV UTAH, DEPT BIOL, SALT LAKE CITY, UT 84112 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIGMS NIH HHS [GM15406] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015406] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITKEN A, 1995, MOL CELL BIOCHEM, V149, P41, DOI 10.1007/BF01076562; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROADIE KS, 1994, J PHYSIOLOGY-PARIS, V88, P123, DOI 10.1016/0928-4257(94)90023-X; Broadie KS, 1996, BIOCHEM SOC T, V24, P639, DOI 10.1042/bst0240639; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Byrne JH, 1996, J NEUROSCI, V16, P425; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; ICHIMURA T, 1995, J BIOL CHEM, V270, P28515, DOI 10.1074/jbc.270.48.28515; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; JOHANSEN J, 1989, J NEUROSCI, V9, P710; JONES DH, 1995, FEBS LETT, V368, P55, DOI 10.1016/0014-5793(95)00598-4; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; MARAIS R, 1995, STRUCTURE, V3, P751, DOI 10.1016/S0969-2126(01)00209-X; MARTIN H, 1994, J NEUROCHEM, V63, P2259; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; PATEL Y, 1994, BBA-MOL CELL RES, V1222, P405, DOI 10.1016/0167-4889(94)90048-5; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; ROTH D, 1995, FEBS LETT, V374, P77, DOI 10.1016/0014-5793(95)01080-X; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0; ZHONG Y, 1993, J NEUROGENET, V9, P15, DOI 10.3109/01677069309167273; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZUPAN LA, 1992, J BIOL CHEM, V267, P8707	50	136	138	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1997	19	2					391	402		10.1016/S0896-6273(00)80948-4	http://dx.doi.org/10.1016/S0896-6273(00)80948-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292728	Bronze			2022-12-24	WOS:A1997XU14600017
J	Schwartz, PM; Borghesani, PR; Levy, RL; Pomeroy, SL; Segal, RA				Schwartz, PM; Borghesani, PR; Levy, RL; Pomeroy, SL; Segal, RA			Abnormal cerebellar development and foliation in BDNF-/- mice reveals a role for neurotrophins in CNS patterning	NEURON			English	Article							NERVE GROWTH-FACTOR; PURKINJE-CELLS; GRANULE NEURONS; RECEPTOR GENE; DIFFERENTIAL EXPRESSION; POSTNATAL-DEVELOPMENT; TARGETED DISRUPTION; DNA FRAGMENTATION; VISUAL-SYSTEM; BRAIN	While target-derived neurotrophins are required for the survival of developing neurons in the PNS, the functions of neurotrophins in the CNS are unclear. Mice with a targeted gene deletion of brain-derived neurotrophic factor (BDNF) exhibit a wide-based gait. Consistent with this behavioral evidence of cerebellar dysfunction, there is increased death of granule cells, stunted growth of Purkinje cell dendrites, impaired formation of horizontal layers, and defects in the rostral-caudal foliation pattern. These abnormalities are accompanied by decreased Trk activation in granule and Purkinje cells of mutant animals, indicating that both cell types are direct targets for BDNF. These data suggest that BDNF acts as an anterograde or an autocrine-paracrine factor to regulate survival and morphologic differentiation of developing CNS neurons, and thereby affects neural patterning.	HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA; CHILDRENS HOSP, DEPT NEUROL, DIV NEUROSCI, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Schwartz, PM (corresponding author), BETH ISRAEL MED CTR, DEPT NEUROL, BOSTON, MA 02115 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035148] Funding Source: NIH RePORTER; NICHD NIH HHS [HD18655-MR] Funding Source: Medline; NINDS NIH HHS [NS35148-RAS] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; ALLEN C, 1981, J COMP NEUROL, V203, P771, DOI 10.1002/cne.902030413; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1971, EXP NEUROL, V30, P492, DOI 10.1016/0014-4886(71)90150-6; ALTMAN J, 1997, DEV  CEREBELLAR SYST; ALVAREZDOLADO M, 1994, MOL BRAIN RES, V27, P249, DOI 10.1016/0169-328X(94)90007-8; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; Bianchi LM, 1996, DEVELOPMENT, V122, P1965; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; BUCKLEY KM, 1994, J MEMBRANE BIOL, V139, P75; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; CHRISTAKOS S, 1987, METHOD ENZYMOL, V139, P534; COHENCORY S, 1991, J NEUROSCI, V11, P462; Conner JM, 1997, J NEUROSCI, V17, P2295; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; GAO WQ, 1995, J NEUROSCI, V15, P2656; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; HERRUP K, 1987, J NEUROSCI, V7, P829; Herrup K, 1996, DEV BRAIN RES, V96, P28, DOI 10.1016/0165-3806(96)00069-7; INOUYE M, 1980, J COMP NEUROL, V190, P357, DOI 10.1002/cne.901900209; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kawamoto Y, 1996, NEUROSCIENCE, V74, P1209, DOI 10.1016/S0306-4522(96)00245-X; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, DEVELOPMENT, V109, P845; KRUEGER BK, 1995, J NEUROSCI, V15, P3366; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Larkfors L, 1996, J NEUROCHEM, V66, P1362; LARSELL O, 1952, J COMP NEUROL, V97, P281, DOI 10.1002/cne.900970204; LAUDER JM, 1974, BRAIN RES, V76, P33, DOI 10.1016/0006-8993(74)90511-3; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Neveu I, 1996, J CELL BIOL, V133, P631, DOI 10.1083/jcb.133.3.631; PEHLEMANN FW, 1985, DEV BIOL, V110, P136, DOI 10.1016/0012-1606(85)90071-5; PRIVAT A, 1976, J COMP NEUROL, V166, P201, DOI 10.1002/cne.901660207; PURVES D, 1986, TRENDS NEUROSCI, V9, P486, DOI 10.1016/0166-2236(86)90155-4; RAFFIONI S, 1993, ANNU REV BIOCHEM, V62, P823; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SEGAL RA, 1995, J NEUROSCI, V15, P4970; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SNIDER WD, 1989, ANN NEUROL, V26, P489, DOI 10.1002/ana.410260402; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SNIDER WD, 1988, J NEUROSCI, V8, P2628; SOTELO C, 1976, BRAIN RES, V111, P389, DOI 10.1016/0006-8993(76)90782-4; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; WAHLSTEN D, 1991, BRAIN RES, V557, P184, DOI 10.1016/0006-8993(91)90133-G; WANG J, 1995, J BIOL CHEM, V270, P12774, DOI 10.1074/jbc.270.21.12774; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2	73	350	357	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1997	19	2					269	281		10.1016/S0896-6273(00)80938-1	http://dx.doi.org/10.1016/S0896-6273(00)80938-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292718	Bronze			2022-12-24	WOS:A1997XU14600007
J	Garbern, JY; Cambi, F; Tang, XM; Sima, AAF; Vallat, JM; Bosch, EP; Lewis, R; Shy, M; Sohi, J; Kraft, G; Chen, KL; Joshi, I; Leonard, DGB; Johnson, W; Raskind, W; Dlouhy, SR; Pratt, V; Hodes, ME; Bird, T; Kamholz, J				Garbern, JY; Cambi, F; Tang, XM; Sima, AAF; Vallat, JM; Bosch, EP; Lewis, R; Shy, M; Sohi, J; Kraft, G; Chen, KL; Joshi, I; Leonard, DGB; Johnson, W; Raskind, W; Dlouhy, SR; Pratt, V; Hodes, ME; Bird, T; Kamholz, J			Proteolipid protein is necessary in peripheral as well as central myelin	NEURON			English	Article							PELIZAEUS-MERZBACHER DISEASE; LINKED SPASTIC PARAPLEGIA; MARIE-TOOTH DISEASE; NERVOUS-SYSTEM; GENE-EXPRESSION; MESSENGER-RNAS; SCHWANN-CELLS; MUTATION; DM-20; PLP	Alternative products of the proteolipid protein gene (PLP), proteolipid protein (PLP) and DM20, are major components of compact myelin in the central nervous system, but quantitatively minor constituents of Schwann cells, A family with a null allele of PLP has a less severe CNS phenotype than those with other types of PLP mutations. Moreover, individuals with PLP null mutations have a demyelinating peripheral neuropathy, not seen with other PLP mutations of humans or animals. Direct analysis of normal peripheral nerve demonstrates that PLP is localized to compact myelin. This and the clinical and pathologic observations of the PLP null phenotype indicate that PLP/DM20 is necessary for proper myelin function both in the central and peripheral nervous systems.	WAYNE STATE UNIV,SCH MED,CTR MOL MED & GENET,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,DEPT PATHOL,DETROIT,MI 48201; THOMAS JEFFERSON UNIV,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19107; UNIV HOSP,DEPT NEUROL,F-87042 LIMOGES,FRANCE; MAYO CLIN & MAYO FDN,DEPT NEUROL,SCOTTSDALE,AZ 85259; UNIV WASHINGTON,SCH MED,DEPT PHYS MED & REHABIL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT NEUROL,SEATTLE,WA 98195; UNIV PENN,DEPT PATHOL,MOL DIAGNOST LAB,PHILADELPHIA,PA 19104; ROBERT WOOD JOHNSON MED SCH,DEPT NEUROL,PISCATAWAY,NJ 08854; INDIANA UNIV,SCH MED,DEPT MED & MOL GENET,INDIANAPOLIS,IN 46202	Wayne State University; Wayne State University; Jefferson University; CHU Limoges; Mayo Clinic; Mayo Clinic Phoenix; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Garbern, JY (corresponding author), WAYNE STATE UNIV,SCH MED,DEPT NEUROL,DETROIT,MI 48201, USA.			Shy, Michael/0000-0001-8460-6971				AGRAWAL HC, 1991, NEUROCHEM RES, V16, P855, DOI 10.1007/BF00965533; ANDRE M, 1990, J NEURORADIOLOGY, V17, P216; ASOTRA K, 1993, J NEUROSCI RES, V34, P571, DOI 10.1002/jnr.490340509; BAER ROBERT D., 1965, ARCH PHYS MED REHABIL, V46, P698; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BIZZOZERO OA, 1989, ANAL BIOCHEM, V180, P59, DOI 10.1016/0003-2697(89)90087-0; BOISON D, 1995, J NEUROSCI, V15, P5502; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cambi F, 1996, NEUROLOGY, V46, P1112, DOI 10.1212/WNL.46.4.1112; CARO PA, 1990, MAGN RESON IMAGING, V8, P791, DOI 10.1016/0730-725X(90)90015-T; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Chen, 1996, Mol Diagn, V1, P65, DOI 10.1016/S1084-8592(96)70023-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; DIEHL HJ, 1991, P NATL ACAD SCI USA, V88, P617; DUCHALA CS, 1995, DEV NEUROSCI-BASEL, V17, P70, DOI 10.1159/000111276; GAMSTORP I, 1963, ACTA PAEDIATR SC   S, V146, P68; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; GRIFFITHS IR, 1995, BRAIN PATHOL, V5, P275, DOI 10.1111/j.1750-3639.1995.tb00604.x; GUPTA SK, 1991, J NEUROCHEM, V56, P1754, DOI 10.1111/j.1471-4159.1991.tb02077.x; HARDING B, 1995, NEUROPATH APPL NEURO, V21, P111, DOI 10.1111/j.1365-2990.1995.tb01036.x; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; HELYNCK G, 1983, EUR J BIOCHEM, V1333, P689; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; IYODA K, 1988, PEDIATR NEUROL, V4, P252, DOI 10.1016/0887-8994(88)90041-0; JASEK F, 1990, ARCH FR PEDIATR, V47, P265; JOURNEL H, 1987, NEURORADIOLOGY, V29, P403, DOI 10.1007/BF00348925; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KAMHOLZ J, 1992, J NEUROSCI RES, V31, P231, DOI 10.1002/jnr.490310204; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; KIMURA J, 1974, NEUROLOGY, V24, P539, DOI 10.1212/WNL.24.6.539; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; KOEPPEN AH, 1987, ANN NEUROL, V21, P159, DOI 10.1002/ana.410210208; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lees Marjorie B., 1992, P237; Lemke G., 1992, INTRO MOL NEUROBIOLO, P281; MARKAND ON, 1982, ELECTROEN CLIN NEURO, V54, P39, DOI 10.1016/0013-4694(82)90229-2; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1995, J NEUROSCI, V15, P4488; MORELL P, 1975, ANAL BIOCHEM, V68, P148, DOI 10.1016/0003-2697(75)90688-0; NADON NL, 1995, J NEUROSCI RES, V41, P96, DOI 10.1002/jnr.490410111; NADON NL, 1994, J NEUROCHEM, V63, P822; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OSAKA H, 1995, BIOCHEM BIOPH RES CO, V215, P835, DOI 10.1006/bbrc.1995.2539; Panayiotopoulos CP, 1996, ELECTROMYOGR MOTOR C, V101, P365, DOI 10.1016/S0921-884X(96)95635-0; PHAMDINH D, 1991, NEUROREPORT, V2, P89, DOI 10.1097/00001756-199102000-00006; PRATT VM, 1993, AM J HUM GENET, V52, P1053; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; Sambrook J.E.F., 1989, MOL CLONING LAB MANU, P1659; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SCHINDLER P, 1990, J NEUROCHEM, V55, P2079, DOI 10.1111/j.1471-4159.1990.tb05798.x; SCHNEIDER A, 1995, P NATL ACAD SCI USA, V92, P4447, DOI 10.1073/pnas.92.10.4447; SEITELBERGER F, 1995, BRAIN PATHOL, V5, P267, DOI 10.1111/j.1750-3639.1995.tb00603.x; SEITELBERGER F, 1984, NEUROPEDIATRICS, V15, P53, DOI 10.1055/s-2008-1052382; SEITELBERGER F, 1970, HDB CLIN NEUROLOGY L, P150; SIMA AAF, 1997, IN PRESS NEUROPATHOL; SINOWAY MP, 1994, J NEUROSCI RES, V37, P551, DOI 10.1002/jnr.490370502; Sistermans EA, 1996, HUM GENET, V97, P337, DOI 10.1007/s004390050046; SKOFF RP, 1995, BRAIN PATHOL, V5, P283, DOI 10.1111/j.1750-3639.1995.tb00605.x; SUGIYAMA N, 1996, AM J HUM GENET, V59, pA276; SUNDERLAND S, 1968, NERVE NERVE INJURIES, P277; TIMSIT S, 1995, J NEUROSCI, V15, P101; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; Vallat JM, 1996, ANN NEUROL, V39, P813, DOI 10.1002/ana.410390621; WANG PJ, 1995, PEDIATR NEUROL, V12, P47, DOI 10.1016/0887-8994(94)00124-K; WIGGINS RC, 1975, BRAIN RES, V89, P99, DOI 10.1016/0006-8993(75)90137-7; WILKUS RJ, 1976, NEUROLOGY, V26, P1042, DOI 10.1212/WNL.26.11.1042; Yoshida M, 1996, NEURON, V16, P1115, DOI 10.1016/S0896-6273(00)80138-5; YOUNG RR, 1978, MUSCLE NERVE, V1, P248, DOI 10.1002/mus.880010312; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; ZEMAN W, 1964, J NEUROPATH EXP NEUR, V23, P334, DOI 10.1097/00005072-196404000-00008	81	105	106	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					205	218		10.1016/S0896-6273(00)80360-8	http://dx.doi.org/10.1016/S0896-6273(00)80360-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247276	hybrid			2022-12-24	WOS:A1997XN39400019
J	Hynes, M; Stone, DM; Dowd, M; PittsMeek, S; Goddard, A; Gurney, A; Rosenthal, A				Hynes, M; Stone, DM; Dowd, M; PittsMeek, S; Goddard, A; Gurney, A; Rosenthal, A			Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1	NEURON			English	Article							GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; TERMINAL CLEAVAGE PRODUCT; GENE CUBITUS-INTERRUPTUS; CENTRAL-NERVOUS-SYSTEM; SONIC-HEDGEHOG; FLOOR PLATE; POLARIZING ACTIVITY; ADENOVIRUS E1A; HOMEO BOX; EXPRESSION	Sonic hedgehog (Shh) is a putative morphogen secreted by the floor plate and notochord, which specifies the fate of multiple cell types in the ventral aspect of the vertebrate nervous system. Since in Drosophila the actions of Hh have been shown to be transduced by Cubitus interruptus (Ci), a zinc finger transcription factor, we examined whether a vertebrate homolog of this protein can mediate the functions of Shh in the vertebrate nervous system. Here, we demonstrate that expression of Gli-1, one of three vertebrate homologs of Ci, can be induced by Shh in the neural tube. Further, ectopic expression of Gli-1 in the dorsal midbrain and hindbrain of transgenic mice mimics the effects of ectopically expressed Shh-N, leading to the activation of ventral neural tube markers such as Ptc, HNF-3 beta, and Shh; to the suppression of dorsal markers such as Pax-3 and AL-1; and to the formation of ectopic dorsal clusters of dopaminergic and serotonergic neurons. These findings demonstrate that GLI-1 can reproduce the cell patterning actions of Shh in the developing nervous system and provide support for the hypothesis that it is a mediator of the Shh signal in vertebrates.	GENENTECH INC, DEPT NEUROSCI, San Francisco, CA 94080 USA; GENENTECH INC, DEPT BIOL MOL, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech				Hynes, Mary/0000-0001-6623-6727				Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Concordet JP, 1996, DEVELOPMENT, V122, P2835; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE TC, 1994, ONCOGENE, V9, P1047; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; MARCHAND R, 1983, NEUROSCIENCE, V9, P373, DOI 10.1016/0306-4522(83)90300-7; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Marigo V, 1996, DEVELOPMENT, V122, P1225; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; PARR BA, 1993, DEVELOPMENT, V119, P247; PLACZEK M, 1991, DEVELOPMENT, P105; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROBERTS WM, 1989, CANCER RES, V49, P5407; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Sasaki H, 1997, DEVELOPMENT, V124, P1313; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; SASAKI H, 1993, DEVELOPMENT, V118, P47; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Tremblay P, 1996, DEVELOPMENT, V122, P2555; VORTKAMP A, 1992, MAMM GENOME, V3, P461, DOI 10.1007/BF00356157; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; [No title captured]	70	236	253	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1997	19	1					15	26		10.1016/S0896-6273(00)80344-X	http://dx.doi.org/10.1016/S0896-6273(00)80344-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247260	Bronze			2022-12-24	WOS:A1997XN39400003
J	Dobrunz, LE; Stevens, CF				Dobrunz, LE; Stevens, CF			Heterogeneity of release probability, facilitation, and depletion at central synapses	NEURON			English	Article							PAIRED-PULSE FACILITATION; LONG-TERM POTENTIATION; TRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; HIPPOCAMPAL SLICES; PRESYNAPTIC CALCIUM; QUANTAL ANALYSIS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; TRANS-ACPD	Previous studies of short-term plasticity in central nervous systems synapses have largely focused on average synaptic properties. In this study, we use recordings from putative single synaptic release sites in hippocampal slices to show that significant heterogeneity exists in facilitation and depletion among synapses. In particular, the amount of paired-pulse facilitation is inversely related to the initial release probability of the synapse. We also examined depletion at individual synapses using high frequency stimulation, and estimated the size of the readily releasable vesicle pool, which averaged 5.0 +/- 3.0 quanta (n = 13 synapses). In addition, these experiments demonstrate that the release probability at a synapse is directly correlated with the size of its readily releasable vesicle pool.			Dobrunz, LE (corresponding author), SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,MOL NEUROBIOL LAB,LA JOLLA,CA 92037, USA.			Dobrunz, Lynn E./0000-0002-3317-554X				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; Bennett M V, 1976, Cold Spring Harb Symp Quant Biol, V40, P25; BERTOLINO M, 1993, RECEPTOR CHANNEL, V1, P267; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Choi S, 1996, J NEUROSCI, V16, P36; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; EATON SA, 1993, EUR J PHARM-MOLEC PH, V244, P195, DOI 10.1016/0922-4106(93)90028-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MURPHY TH, 1995, NEURON, V15, P159, DOI 10.1016/0896-6273(95)90073-X; MURTHY VN, 1997, NEURON, V18, P559; PALMER E, 1989, EUR J PHARMACOL, V166, P585, DOI 10.1016/0014-2999(89)90383-X; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAASTAD M, 1995, EUR J NEUROSCI, V7, P1882, DOI 10.1111/j.1460-9568.1995.tb00709.x; REGEHR WG, 1994, J NEUROSCI, V14, P523; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; SCHIKORSKI T, 1997, IN PRESS J NEUROSCI; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; WU LG, 1994, J NEUROSCI, V14, P645; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	43	909	915	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					995	1008		10.1016/S0896-6273(00)80338-4	http://dx.doi.org/10.1016/S0896-6273(00)80338-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208866	Bronze			2022-12-24	WOS:A1997XJ10200017
J	Krasnoperov, VG; Bittner, MA; Beavis, R; Kuang, YN; Salnikow, KV; Chepurny, OG; Little, AR; Plotnikov, AN; Wu, DQ; Holz, RW; Petrenko, AG				Krasnoperov, VG; Bittner, MA; Beavis, R; Kuang, YN; Salnikow, KV; Chepurny, OG; Little, AR; Plotnikov, AN; Wu, DQ; Holz, RW; Petrenko, AG			alpha-latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor	NEURON			English	Article							WIDOW SPIDER VENOM; ADRENAL CHROMAFFIN CELLS; FROG NEUROMUSCULAR-JUNCTION; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; BRAIN SYNAPTOSOMES; SYNAPTIC VESICLES; MOLECULAR-CLONING; DIVALENT-CATIONS; PLASMA-MEMBRANE	alpha-Latrotoxin is a potent stimulator of neurosecretion. Its action requires extracellular binding to high affinity presynaptic receptors. Neurexin I alpha was previously described as a high affinity alpha-latrotoxin receptor that binds the toxin only in the presence of calcium ions. Therefore, the interaction of alpha-latrotoxin with neurexin I alpha cannot explain how alpha-latrotoxin stimulates neurotransmitter release in the absence of calcium. We describe molecular cloning and functional expression of the calcium-independent receptor of alpha-latrotoxin (GIRL), which is a second high affinity alpha-latrotoxin receptor that may be the major mediator of alpha-latrotoxin's effects. GIRL appears to be a novel orphan G-protein-coupled receptor, a member of the secretin receptor family. In contrast with other known serpentine receptors, GIRL has two subunits of the 120 and 85 kDa that are the result of endogenous proteolytic cleavage of a precursor polypeptide. GIRL is found in brain where it is enriched in the striatum and cortex. Expression of GIRL in chromaffin cells increases the sensitivity of the cells to the effects of alpha-latrotoxin, demonstrating that this protein is functional in coupling to secretion. Syntaxin, a component of the fusion complex, copurifies with GIRL on an alpha-latrotoxin affinity column and forms stable complexes with this receptor in vitro. Interaction of GIRL with a specific presynaptic neurotoxin and with a component of the docking-fusion machinery suggests its role in regulation of neurosecretion.	NYU,MED CTR,DEPT ENVIRONM MED,NEW YORK,NY 10016; NYU,MED CTR,DEPT PHYSIOL & NEUROSCI,SKIRBALL INST BIOMED RES,NEW YORK,NY 10016; UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48109; UNIV ROCHESTER,SCH MED,DEPT PHARMACOL PHYSIOL & ONCOL,ROCHESTER,NY 14620	New York University; New York University; University of Michigan System; University of Michigan; University of Rochester			Little, A/O-6191-2014	Little, A/0000-0001-6831-0177; Petrenko, Alexander/0000-0002-6689-6546	NIEHS NIH HHS [ES00260] Funding Source: Medline; NINDS NIH HHS [R01NS34937, R01NS35098] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035098, R01NS034937] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnett DW, 1996, PFLUG ARCH EUR J PHY, V432, P1039, DOI 10.1007/s004240050232; BAUD V, 1995, GENOMICS, V26, P334, DOI 10.1016/0888-7543(95)80218-B; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bittner MA, 1996, J BIOL CHEM, V271, P11214, DOI 10.1074/jbc.271.19.11214; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Capogna M, 1996, J NEUROPHYSIOL, V75, P2017, DOI 10.1152/jn.1996.75.5.2017; Capogna M, 1996, J NEUROPHYSIOL, V76, P3149, DOI 10.1152/jn.1996.76.5.3149; CECCARELLI B, 1979, J CELL BIOL, V81, P163, DOI 10.1083/jcb.81.1.163; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; CLARK AW, 1970, NATURE, V225, P703, DOI 10.1038/225703a0; DANIELSON PE, 1994, J NEUROSCI RES, V38, P468, DOI 10.1002/jnr.490380413; DAVLETOV BA, 1995, J BIOL CHEM, V270, P23903, DOI 10.1074/jbc.270.41.23903; Davletov BA, 1996, J BIOL CHEM, V271, P23239, DOI 10.1074/jbc.271.38.23239; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DUCHEN LW, 1981, J PHYSIOL-LONDON, V316, P279, DOI 10.1113/jphysiol.1981.sp013787; DUNN LA, 1983, J BIOL CHEM, V258, P4989; FINKELSTEIN A, 1976, SCIENCE, V193, P1009, DOI 10.1126/science.948756; FRONTALI N, 1976, J CELL BIOL, V68, P462, DOI 10.1083/jcb.68.3.462; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GORIO A, 1978, J NEUROCYTOL, V7, P193, DOI 10.1007/BF01217918; GRASSO A, 1980, NATURE, V283, P774, DOI 10.1038/283774a0; GRASSO A, 1978, FEBS LETT, V85, P241, DOI 10.1016/0014-5793(78)80464-5; GRASSO A, 1993, NEUROSCIENCE, V54, P595, DOI 10.1016/0306-4522(93)90231-4; GUM JR, 1994, J BIOL CHEM, V269, P2440; HAMANN J, 1995, J IMMUNOL, V155, P1942; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; HURLBUT WP, 1994, J MEMBRANE BIOL, V138, P91, DOI 10.1007/BF00211072; Krasnoperov VG, 1996, BIOCHEM BIOPH RES CO, V227, P868, DOI 10.1006/bbrc.1996.1598; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LINIAL M, 1995, EUR J NEUROSCI, V7, P742, DOI 10.1111/j.1460-9568.1995.tb00678.x; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; MA WJ, 1992, J BIOL CHEM, V267, P22728; MALGAROLI A, 1989, NEUROSCIENCE, V32, P393, DOI 10.1016/0306-4522(89)90088-2; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; MELDOLESI J, 1983, NEUROSCIENCE, V10, P997, DOI 10.1016/0306-4522(83)90238-5; MELDOLESI J, 1982, J NEUROCHEM, V38, P1559, DOI 10.1111/j.1471-4159.1982.tb06633.x; MELDOLESI J, 1984, P NATL ACAD SCI-BIOL, V81, P620, DOI 10.1073/pnas.81.2.620; MISLER S, 1979, P NATL ACAD SCI USA, V76, P991, DOI 10.1073/pnas.76.2.991; NICHOLLS DG, 1982, P NATL ACAD SCI-BIOL, V79, P7924, DOI 10.1073/pnas.79.24.7924; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; OKAMOTO M, 1971, SCIENCE, V172, P733, DOI 10.1126/science.172.3984.733; OZEKI Y, 1991, BIOCHEMISTRY-US, V30, P2391, DOI 10.1021/bi00223a014; Petrenko AG, 1996, J NEUROSCI, V16, P4360; PETRENKO AG, 1990, EMBO J, V9, P2023, DOI 10.1002/j.1460-2075.1990.tb08331.x; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; PETRENKO AG, 1993, FEBS LETT, V325, P81, DOI 10.1016/0014-5793(93)81418-Y; ROBBINS N, 1990, INT J DEV NEUROSCI, V8, P667, DOI 10.1016/0736-5748(90)90061-6; ROBELLO M, 1987, J MEMBRANE BIOL, V95, P55, DOI 10.1007/BF01869630; ROSENTHAL L, 1990, MOL PHARMACOL, V38, P917; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; RUBIN LL, 1978, BRAIN RES, V143, P107, DOI 10.1016/0006-8993(78)90755-2; SCHEER H, 1984, J PHYSIOLOGY PARIS, V79, P216; SCHEER H, 1985, EMBO J, V4, P323, DOI 10.1002/j.1460-2075.1985.tb03632.x; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SHOJIKASAI Y, 1994, FEBS LETT, V353, P315, DOI 10.1016/0014-5793(94)01069-2; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; SURKOVA I, 1994, ANN NY ACAD SCI, V710, P48, DOI 10.1111/j.1749-6632.1994.tb26613.x; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; TZENG MC, 1979, J NEUROCHEM, V33, P263, DOI 10.1111/j.1471-4159.1979.tb11728.x; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; VALTORTA F, 1984, J CELL BIOL, V99, P124, DOI 10.1083/jcb.99.1.124; VICENTINI LM, 1984, BIOCHEM BIOPH RES CO, V121, P538, DOI 10.1016/0006-291X(84)90215-8; WANKE E, 1986, BIOCHEM BIOPH RES CO, V134, P320, DOI 10.1016/0006-291X(86)90565-6; WICK PF, 1993, J BIOL CHEM, V268, P10983; WILSON SP, 1996, ANAL BIOCHEM, V226, P212; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1993, J BIOL CHEM, V268, P3704; WU DQ, 1992, J BIOL CHEM, V267, P25798; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655	77	274	286	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					925	937		10.1016/S0896-6273(00)80332-3	http://dx.doi.org/10.1016/S0896-6273(00)80332-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208860	hybrid			2022-12-24	WOS:A1997XJ10200011
J	Lang, T; Wacker, I; Steyer, J; Kaether, C; Wunderlich, I; Soldati, T; Gerdes, HH; Almers, W				Lang, T; Wacker, I; Steyer, J; Kaether, C; Wunderlich, I; Soldati, T; Gerdes, HH; Almers, W			Ca2+-triggered peptide secretion neurotechnique in single cells imaged with green fluorescent protein and evanescent-wave microscopy	NEURON			English	Article							PC12 CELLS; SYNAPTOTAGMIN; RELEASE	Green fluorescent protein fused to human chromogranin B or neuropeptide Y was expressed in PC12 cells and caused bright, punctate fluorescence. The fluorescent points colocalized with the endogenous secretory granule marker dopamine beta-hydroxylase. Stimulation of live PC12 cells with elevated [K+], or of permeabilized PC12 cells with Ca2+, led to Ca2+-dependent loss of fluorescence from neurites. Ca2+ stimulated secretion of both fusion proteins equally well. In living cells, single fluorescent granules were imaged by evanescent-wave fluorescence microscopy. Granules were seen to migrate; to stop, as if trapped by plasmalemmal docking sites; and then to disappear abruptly, as if through exocytosis. Evidently, GFP fused to secreted peptides is a fluorescent marker for dense-core secretory granules and may be used for time-resolved microscopy of single granules.	MAX PLANCK INST MED RES,D-69120 HEIDELBERG,GERMANY; INST NEUROBIOL,INF 364,D-69120 HEIDELBERG,GERMANY	Max Planck Society			SOLDATI, Thierry/U-6494-2019; SOLDATI, Thierry/A-2902-2009	SOLDATI, Thierry/0000-0002-2056-7931; SOLDATI, Thierry/0000-0002-2056-7931				BANERJEE A, 1993, NEUROSCI LETT, V164, P93, DOI 10.1016/0304-3940(93)90865-I; BAUERFEIND R, 1995, FEBS LETT, V364, P328, DOI 10.1016/0014-5793(95)00419-A; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Gerdes HH, 1996, FEBS LETT, V389, P44, DOI 10.1016/0014-5793(96)00586-8; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; HALBAN PA, 1994, BIOCHEM J, V299, P1; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HEUMANN R, 1983, EXP CELL RES, V145, P179, DOI 10.1016/S0014-4827(83)80019-6; KAETHER C, 1995, FEBS LETT, V369, P267, DOI 10.1016/0014-5793(95)00765-2; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; MCINNES C, 1990, FEBS LETT, V261, P323, DOI 10.1016/0014-5793(90)80582-4; Milgram SL, 1996, MOL ENDOCRINOL, V10, P837, DOI 10.1210/me.10.7.837; MOORE HPH, 1983, CELL, V35, P531, DOI 10.1016/0092-8674(83)90187-3; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; STOUT AL, 1989, APPL OPTICS, V28, P5237, DOI 10.1364/AO.28.005237; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; WACKER I, 1997, IN PRESS J CELL SCI; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1	24	192	196	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					857	863		10.1016/S0896-6273(00)80325-6	http://dx.doi.org/10.1016/S0896-6273(00)80325-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208853	Bronze, Green Published			2022-12-24	WOS:A1997XJ10200004
J	Hsueh, YP; Kim, E; Sheng, M				Hsueh, YP; Kim, E; Sheng, M			Disulfide-linked head-to-head multimerization in the mechanism of ion channel clustering by PSD-95	NEURON			English	Article							TUMOR-SUPPRESSOR PROTEIN; GUANYLATE KINASES; K+ CHANNELS; SYNAPSES; HOMOLOG; SAP90	The PSD-95/SAP90 family of PDZ-containing proteins is directly involved in the clustering of specific ion channels at synapses. We report that channel clustering depends on a conserved N-terminal domain of PSD-95 that mediates multimerization and disulfide linkage of PSD-95 protomers. This N-terminal multimerization domain confers channel clustering activity on a single PDZ domain. Thus, channel clustering depends on aggregation of PDZ domains achieved by head-to-head multimerization of PSD-95, rather than by concatenation of PDZ domains in PSD-95 monomers. This mechanism predicts that PSD-95 can organize heterogeneous membrane protein clusters via differential binding specificities of its three PDZ domains. PSD-95 and its relative chapsyn-110 exist as disulfide-linked complexes in rat brain, consistent with head-to-head multimerization of these proteins in vivo.	MASSACHUSETTS GEN HOSP,DEPT NEUROBIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hsueh, YP (corresponding author), MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02114, USA.		Kim, Eunjoon/C-1566-2011; Hsueh, Yi-Ping/ABH-5052-2020	Hsueh, Yi-Ping/0000-0002-0866-6275; Sheng, Morgan/0000-0002-8703-5366				Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Brenman JE, 1996, J NEUROSCI, V16, P7407; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CRAIG WS, 1982, BIOCHEMISTRY-US, V21, P5707, DOI 10.1021/bi00265a049; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Hunt CA, 1996, J NEUROSCI, V16, P1380; KELLY PT, 1977, J BIOL CHEM, V252, P786; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lu KH, 1996, MOL BIOL CELL, V7, P679, DOI 10.1091/mbc.7.5.679; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Niethammer M, 1996, J NEUROSCI, V16, P2157; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Sheng M, 1996, CURR OPIN NEUROBIOL, V6, P602, DOI 10.1016/S0959-4388(96)80091-2; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Wang XT, 1996, NATURE, V383, P434, DOI 10.1038/383434a0; ZICK SK, 1982, J BIOL CHEM, V257, P2287	29	177	179	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					803	814		10.1016/S0896-6273(00)80319-0	http://dx.doi.org/10.1016/S0896-6273(00)80319-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182804	Bronze			2022-12-24	WOS:A1997XB72200013
J	Smart, SL; Lopantsev, V; Zhang, CL; Robbins, CA; Wang, H; Chiu, SY; Schwartzkroin, PA; Messing, A; Tempel, BL				Smart, SL; Lopantsev, V; Zhang, CL; Robbins, CA; Wang, H; Chiu, SY; Schwartzkroin, PA; Messing, A; Tempel, BL			Deletion of the K(v)1.1 potassium channel causes epilepsy in mice	NEURON			English	Article							HETEROMULTIMERIC K+ CHANNELS; DENTATE GRANULE CELLS; EMBRYONIC STEM-CELLS; CA3 PYRAMIDAL CELLS; RAT-BRAIN; EXTRACELLULAR POTASSIUM; HIPPOCAMPAL SLICE; BETA-SUBUNIT; SHAKER LOCUS; MOUSE-BRAIN	Mice lacking the voltage-gated potassium channel a subunit, K(v)1.1, display frequent spontaneous seizures throughout adult life. In hippocampal slices from homozygous K(v)1.1 null animals, intrinsic passive properties of CA3 pyramidal cells are normal. However, antidromic action potentials are recruited at lower thresholds in K(v)1.1 null slices. Furthermore, in a subset of slices, mossy fiber stimulation triggers synaptically mediated long-latency epileptiform burst discharges. These data indicate that loss of K(v)1.1 from its normal localization in axons and terminals of the CA3 region results in increased excitability in the CA3 recurrent axon collateral system, perhaps contributing to the limbic and tonic-clonic components of the observed epileptic phenotype. Axonal action potential conduction was altered as well in the sciatic nerve-a deficit potentially related to the pathophysiology of episodic ataxia/myokymia, a disease associated with missense mutations of the human K(v)1.1 gene.	Univ Washington, Sch Med, VM Bloedel Hearig Res Ctr, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Physiol Biophys, Seattle, WA 98195 USA; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; Univ Wisconsin, Dept Neurophysiol, Madison, WI 53706 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tempel, BL (corresponding author), Univ Washington, Sch Med, VM Bloedel Hearig Res Ctr, Seattle, WA 98195 USA.							Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; BAGETTA G, 1992, NEUROSCI LETT, V139, P34, DOI 10.1016/0304-3940(92)90851-W; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BOSMA MM, 1993, J NEUROSCI, V13, P5242, DOI 10.1523/JNEUROSCI.13-12-05242.1993; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BUCKMASTER PS, 1993, J NEUROPHYSIOL, V70, P1281, DOI 10.1152/jn.1993.70.4.1281; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; CRONIN J, 1992, BRAIN RES, V573, P305, DOI 10.1016/0006-8993(92)90777-7; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; ELMSLIE F, 1995, CURR OPIN NEUROL, V8, P126, DOI 10.1097/00019052-199504000-00007; FISHER RS, 1976, ARCH NEUROL-CHICAGO, V33, P76, DOI 10.1001/archneur.1976.00500020004002; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FRANCK JE, 1995, EPILEPSIA, V36, P543, DOI 10.1111/j.1528-1157.1995.tb02566.x; Gutman G.A., 1993, SEMIN NEUROSCI, P101; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; Hille B., 1992, IONIC CHANNELS EXCIT; Ho CS, 1997, P NATL ACAD SCI USA, V94, P1533, DOI 10.1073/pnas.94.4.1533; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; JENSEN FE, 1991, ANN NEUROL, V29, P629, DOI 10.1002/ana.410290610; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KIMURA J, 1981, DEMYELINATING DIS BA, V31, P239; KOCSIS JD, 1983, J NEUROPHYSIOL, V50, P449, DOI 10.1152/jn.1983.50.2.449; LOCK LF, 1994, GENOMICS, V20, P354, DOI 10.1006/geno.1994.1188; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; MI HY, 1995, J NEUROSCI, V15, P3761; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; Noebels JL, 1996, NEURON, V16, P241, DOI 10.1016/S0896-6273(00)80042-2; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PRICHARD JW, 1969, J PHARMACOL EXP THER, V166, P170; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RHODES KJ, 1995, J NEUROSCI, V15, P5360; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; RUTECKI PA, 1990, J NEUROPHYSIOL, V64, P1077, DOI 10.1152/jn.1990.64.4.1077; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; Scharfman HE, 1996, NEUROSCIENCE, V72, P655, DOI 10.1016/0306-4522(95)00569-2; SCHWARTZKROIN PA, 1994, EPILEPSY RES, V17, P185, DOI 10.1016/0920-1211(94)90049-3; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Street VA, 1997, J NEUROSCI, V17, P635; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TRAUB RD, 1987, J NEUROPHYSIOL, V58, P752, DOI 10.1152/jn.1987.58.4.752; TRAUB RD, 1983, J NEUROPHYSIOL, V49, P459, DOI 10.1152/jn.1983.49.2.459; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442	66	449	459	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					809	819		10.1016/S0896-6273(00)81018-1	http://dx.doi.org/10.1016/S0896-6273(00)81018-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581771	Bronze			2022-12-24	WOS:000073346500018
J	Oh, S; Ri, Y; Bennett, MVL; Trexler, EB; Verselis, VK; Bargiello, TA				Oh, S; Ri, Y; Bennett, MVL; Trexler, EB; Verselis, VK; Bargiello, TA			Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease	NEURON			English	Article							GAP JUNCTION CHANNELS; PERIPHERAL NERVOUS-SYSTEM; HEREDITARY MOTOR; POINT MUTATIONS; SCHWANN-CELLS; CYCLIC-AMP; GENE; NEUROPATHY; MYELIN; EXPRESSION	The relationship between the loss of connexin 32 function and clinical manifestations of X-linked Charcot-Marie-Tooth (CMTX) disease is unknown. Here, we report that eight of nine CMTX mutations investigated form channels with measurable electrical conductance. Single-channel studies of two mutations demonstrate reduced junctional permeability caused by a decrease in either pore size (S26L) or open channel probability (M34T) that favors residency in a low-conductance substate. Permeation of second messengers such as cAMP through reflexive gap junctions between adjacent cytoplasmic loops of myelinating Schwann cells is likely to be reduced or absent in these channels. We propose that CMTX mutations impair the transduction of signals arising from normal glial-neuronal interactions and thereby cause demyelination and axonal degeneration.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine					NIGMS NIH HHS [GM 46889] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; BENNETT MVL, 1994, NATURE, V368, P18, DOI 10.1038/368018a0; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BEVANS CG, 1997, IN PRESS J BIOL CHEM; BEZRUKOV SM, 1993, BIOPHYS J, V64, P16, DOI 10.1016/S0006-3495(93)81336-5; BONE LJ, 1995, NEUROLOGY, V45, P1863, DOI 10.1212/WNL.45.10.1863; BRUZZONE R, 1994, J CELL SCI, V107, P955; BRUZZONE R, 1994, NEURON, V13, P1253, DOI 10.1016/0896-6273(94)90063-9; BUKAUSKAS FF, 1994, BIOPHYS J, V67, P613, DOI 10.1016/S0006-3495(94)80521-1; Chang M, 1996, DEV BIOL, V175, P50, DOI 10.1006/dbio.1996.0094; Doyle JP, 1993, CURR OPIN CELL BIOL, V5, P779, DOI 10.1016/0955-0674(93)90025-L; FAIRWEATHER N, 1994, HUM MOL GENET, V3, P29, DOI 10.1093/hmg/3.1.29; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; HARRIS AL, 1992, MOL BRAIN RES, V15, P269, DOI 10.1016/0169-328X(92)90118-U; Hille B, 1975, Membranes, V3, P255; Ionasescu V, 1996, AM J MED GENET, V63, P486, DOI 10.1002/(SICI)1096-8628(19960614)63:3<486::AID-AJMG14>3.0.CO;2-I; IONASESCU V, 1994, HUM MOL GENET, V3, P355, DOI 10.1093/hmg/3.2.355; IONASESCU V, 1995, NEUROMUSCULAR DISORD, V5, P297, DOI 10.1016/0960-8966(94)00077-M; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KRASILNIKOV OV, 1995, BRAZ J MED BIOL RES, V28, P693; KUMAR NM, 1986, J CELL BIOL, V103, P767, DOI 10.1083/jcb.103.3.767; LEBLANC AC, 1992, MOL BRAIN RES, V12, P31, DOI 10.1016/0169-328X(92)90065-J; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMKE G, 1990, SEMIN NEUROSCI, V2, P437; MILLER T, 1988, BIOSCIENCE REP, V8, P455, DOI 10.1007/BF01121644; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; Mirsky R, 1996, CURR OPIN NEUROBIOL, V6, P89, DOI 10.1016/S0959-4388(96)80013-4; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; NICHOLSON G, 1993, NEUROLOGY, V43, P2558, DOI 10.1212/WNL.43.12.2558; OHNISHI A, 1995, CLIN NEUROL, V35, P843; Omori Y, 1996, MOL BIOL CELL, V7, P907, DOI 10.1091/mbc.7.6.907; ORTH U, 1994, HUM MOL GENET, V3, P1699, DOI 10.1093/hmg/3.9.1699; PODUSLO JF, 1995, J NEUROCHEM, V65, P149; RABADANDIEHL C, 1994, FEBS LETT, V351, P90, DOI 10.1016/0014-5793(94)00819-1; RENKIN EM, 1954, J GEN PHYSIOL, V38, P225; ROZEAR MP, 1987, NEUROLOGY, V37, P1460, DOI 10.1212/WNL.37.9.1460; RUBIN JB, 1992, BIOPHYS J, V62, P183, DOI 10.1016/S0006-3495(92)81804-0; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SALZER JL, 1980, J CELL BIOL, V84, P753, DOI 10.1083/jcb.84.3.753; SANKARARAMAKRISHNAN R, 1992, INT J PEPT PROT RES, V39, P356; Scherer SS, 1997, NEURON, V18, P13, DOI 10.1016/S0896-6273(01)80042-8; Scherer SS, 1995, J NEUROSCI, V15, P8281; SOLOMON AK, 1986, J MEMBRANE BIOL, V94, P227, DOI 10.1007/BF01869718; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Unger VM, 1997, NAT STRUCT BIOL, V4, P39, DOI 10.1038/nsb0197-39; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; VODYANOY I, 1992, BIOPHYS J, V62, P10, DOI 10.1016/S0006-3495(92)81762-9; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4; Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1	54	206	217	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					927	938		10.1016/S0896-6273(00)80973-3	http://dx.doi.org/10.1016/S0896-6273(00)80973-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354338	Bronze			2022-12-24	WOS:A1997YD18900019
J	Deiner, MS; Kennedy, TE; Fazeli, A; Serafini, T; TessierLavigne, M; Sretavan, DW				Deiner, MS; Kennedy, TE; Fazeli, A; Serafini, T; TessierLavigne, M; Sretavan, DW			Netrin-1 and DCC mediate axon guidance locally at the optic disc: Loss of function leads to optic nerve hypoplasia	NEURON			English	Article							DEVELOPMENTAL EXPRESSION; CELL-DIFFERENTIATION; ADHESION MOLECULES; EMBRYONIC CHICK; AVIAN RETINA; TIME-LAPSE; MOUSE; GROWTH; PAX2; MICE	Embryonic retinal ganglion cell (RGC) axons must extend toward and grow through the optic disc to exit the eye into the optic nerve. in the embryonic mouse eye, we found that immunoreactivity for the axon guidance molecule netrin-1 was specifically on neuroepithelial cells at the disk surrounding exiting RGC axons, and RGC axons express the netrin receptor, DCC (deleted in colorectal cancer). In vitro, anti-DCC antibodies reduced RGC neurite outgrowth responses to netrin-1. In netrin-1- and DCC-deficient embryos, RGC axon pathfinding to the disc was unaffected; however, axons failed to exit into the optic nerve, resulting in optic nerve hypoplasia. Thus, netrin-1 through DCC appears to guide RGC axons locally at the optic disc rather than at long range, apparently reflecting the localization of netrin-1 protein to the vicinity of netrin-1-producing cells at the optic disc.	UNIV CALIF SAN FRANCISCO,DEPT OPHTHALMOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,PROGRAM BIOMED SCI,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT ANAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)								Bancroft J.D., 1996, THEORY PRACTICE HIST, VVolume 6; BARISHAK YR, 1992, EMBRYOLOGY EYE ITS A; BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P413, DOI 10.1006/mcne.1995.1031; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Brodsky MC., 1996, PEDIAT NEUROOPHTHALM; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CHUNG WW, 1991, J COMP NEUROL, V314, P290, DOI 10.1002/cne.903140207; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; GOLDBERG S, 1972, J COMP NEUROL, V146, P507, DOI 10.1002/cne.901460406; Halfter W, 1996, DEV BIOL, V177, P160, DOI 10.1006/dbio.1996.0153; HALFTER W, 1986, DEV BIOL, V114, P296, DOI 10.1016/0012-1606(86)90194-6; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; HALFTER W, 1984, DEV BIOL, V102, P344, DOI 10.1016/0012-1606(84)90199-4; Harris WA, 1997, P NATL ACAD SCI USA, V94, P2098, DOI 10.1073/pnas.94.6.2098; HOLT CE, 1989, J NEUROSCI, V9, P3123; JAN JE, 1977, DEV MED CHILD NEUROL, V19, P353; Kaufman M.H., 1992, ATLAS MOUSE DEV; KEINO MK, 1996, CELL, V87, P175; KELLER SA, 1994, GENOMICS, V23, P309, DOI 10.1006/geno.1994.1506; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Keynes R, 1996, NEURON, V17, P1031, DOI 10.1016/S0896-6273(00)80235-4; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; KRAYANEK S, 1981, DEV BIOL, V84, P41, DOI 10.1016/0012-1606(81)90368-7; LAMBERT SR, 1987, SURV OPHTHALMOL, V32, P1, DOI 10.1016/0039-6257(87)90069-5; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; NORNES HO, 1990, DEVELOPMENT, V109, P797; PUSCHEL AW, 1992, MECH DEVELOP, V38, P197, DOI 10.1016/0925-4773(92)90053-M; Ramon y Cajal S, 1972, STRUCTURE RETINA; REDIES C, 1993, GLIA, V8, P161, DOI 10.1002/glia.440080304; REICHARDT LF, 1992, COLD SPRING HARB SYM, V57, P419, DOI 10.1101/SQB.1992.057.01.047; ROBB M, 1978, INVEST OPHTH VIS SCI, V17, P468; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; SILVER J, 1979, DEV BIOL, V68, P175, DOI 10.1016/0012-1606(79)90252-5; SILVER J, 1980, J COMP NEUROL, V189, P101, DOI 10.1002/cne.901890106; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SILVER J, 1981, J COMP NEUROL, V202, P521, DOI 10.1002/cne.902020406; Skamers W.C., 1995, P NATL ACAD SCI USA, V92, P6592; SKARF B, 1984, ARCH OPHTHALMOL-CHIC, V102, P62, DOI 10.1001/archopht.1984.01040030046032; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; Torres MA, 1996, DEVELOPMENT, V122, P3381; Wang LC, 1996, NEURON, V17, P849, DOI 10.1016/S0896-6273(00)80217-2	51	343	348	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					575	589		10.1016/S0896-6273(00)80373-6	http://dx.doi.org/10.1016/S0896-6273(00)80373-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331350	Bronze			2022-12-24	WOS:A1997XZ01600013
J	Li, YH; Maher, P; Schubert, D				Li, YH; Maher, P; Schubert, D			A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion	NEURON			English	Article							ARACHIDONIC-ACID METABOLISM; EMBRYONIC CORTICAL-NEURONS; AMYLOID-BETA PROTEIN; GLUTAMATE TOXICITY; OXIDATIVE STRESS; PARKINSONS-DISEASE; LEUKOTRIENE BIOSYNTHESIS; SELECTIVE INHIBITOR; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE	An early and highly specific decrease in glutathione (GSH) in the substantia nigra is associated with Parkinson's disease, and low levels of GSH lead to the degeneration of cultured dopaminergic neurons. Using immature cortical neurons and a clonal nerve cell line, it is shown that a decrease in GSH triggers the activation of neuronal 12-lipoxygenase (12-LOX), which leads to the production of peroxides, the influx of Ca2+, and ultimately to cell death. The supporting evidence includes: 1) inhibitors of arachidonate metabolism and 12-LOX block cell death induced by GSH depletion; 2) there is an increase in 12-LOX activity and a membrane translocation in HT22 cells, and an induction of the enzyme in primary cortical neurons following the reduction of GSH; 3) 12-LOX is directly inhibited by GSH; and 4) exogenous arachidonic acid potentiates cell death. These data show that the LOX pathway is a critical intermediate in at least some forms of neuronal degeneration.	Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute	Li, YH (corresponding author), SALK INST BIOL STUDIES, CELLULAR NEUROBIOL LAB, 10010 N TORREY PINES RD, LA JOLLA, CA 92037 USA.			Li, Yonghong/0000-0001-7326-0717	NIA NIH HHS [1 F32 AG 05769-01] Funding Source: Medline; NINDS NIH HHS [R01 NS09658, 5PO1-NS28121] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028121, R01NS009658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005769] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABE K, 1990, JPN J PHARMACOL, V53, P221, DOI 10.1254/jjp.53.221; BABA A, 1989, J BIOL CHEM, V264, P15790; BEHL C, 1993, BIOCHEM BIOPH RES CO, V197, P949, DOI 10.1006/bbrc.1993.2571; BENDANI MK, 1995, NEUROSCI LETT, V189, P159, DOI 10.1016/0304-3940(95)11482-C; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; DEXTER DT, 1994, ANN NEUROL, V35, P38, DOI 10.1002/ana.410350107; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; DUMUIS A, 1993, MOL PHARMACOL, V43, P976; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGMANN W, 1993, PROSTAGLANDINS, V46, P471, DOI 10.1016/0090-6980(93)90066-G; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; HALLIWELL B, 1989, FREE RADICAL BIO MED, P93; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; JUNE CH, 1991, CURR PROT IMMUNOL; Kinzig A, 1997, FEBS LETT, V402, P162, DOI 10.1016/S0014-5793(96)01517-7; Korystov YN, 1996, FEBS LETT, V388, P238, DOI 10.1016/0014-5793(96)00538-8; KOSHIHARA Y, 1984, BIOCHIM BIOPHYS ACTA, V792, P92; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maher P, 1996, J NEUROSCI, V16, P6394; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; McConkey David J., 1994, Trends in Cell Biology, V4, P370, DOI 10.1016/0962-8924(94)90087-6; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURPHY T, 1989, ANN NY ACAD SCI, V559, P474; MURPHY TH, 1990, DEV BRAIN RES, V57, P146, DOI 10.1016/0165-3806(90)90195-5; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; NATARAJAN R, 1993, P NATL ACAD SCI USA, V90, P4947, DOI 10.1073/pnas.90.11.4947; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; PILEBLAD E, 1989, J NEUROCHEM, V52, P978, DOI 10.1111/j.1471-4159.1989.tb02550.x; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; RAO GN, 1993, NUCLEIC ACIDS RES, V21, P1259, DOI 10.1093/nar/21.5.1259; RATAN RR, 1994, J NEUROCHEM, V62, P376; RATAN RR, 1994, J NEUROSCI, V14, P4385; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SAUTEBIN L, 1978, PROSTAGLANDINS, V16, P985, DOI 10.1016/0090-6980(78)90115-6; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; SCHUBERT D, 1992, P NATL ACAD SCI USA, V89, P8264, DOI 10.1073/pnas.89.17.8264; SEKIYA K, 1982, BIOCHEM BIOPH RES CO, V105, P1090, DOI 10.1016/0006-291X(82)91081-6; SHIMIZU T, 1987, J NEUROCHEM, V48, P1541, DOI 10.1111/j.1471-4159.1987.tb05698.x; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; SHORNICK LP, 1993, J BIOL CHEM, V268, P371; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; SNIDER RM, 1984, P NATL ACAD SCI-BIOL, V81, P3905, DOI 10.1073/pnas.81.12.3905; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; SOK DE, 1982, BIOCHEM BIOPH RES CO, V107, P101, DOI 10.1016/0006-291X(82)91675-8; STERN N, 1993, ENDOCRINOLOGY, V133, P843, DOI 10.1210/en.133.2.843; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Tang DG, 1996, P NATL ACAD SCI USA, V93, P5241, DOI 10.1073/pnas.93.11.5241; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; VOGT M, 1963, P NATL ACAD SCI USA, V49, P171, DOI 10.1073/pnas.49.2.171; WATANABE T, 1993, EUR J BIOCHEM, V212, P605, DOI 10.1111/j.1432-1033.1993.tb17699.x; Wullner U, 1996, NEUROREPORT, V7, P921; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470	62	399	417	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1997	19	2					453	463		10.1016/S0896-6273(00)80953-8	http://dx.doi.org/10.1016/S0896-6273(00)80953-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292733	Bronze			2022-12-24	WOS:A1997XU14600022
J	Juusola, M; French, AS				Juusola, M; French, AS			The efficiency of sensory information coding by mechanoreceptor neurons	NEURON			English	Article							RECEPTOR CURRENT; DYNAMICS; CATFISH; CELLS	Most sensory systems encode external signals into action potentials for transmission to the central nervous system, but little is known about the cost or efficiency of this encoding. We measured the information capacity at three stages of encoding in the neurons of a spider slit-sense mechanoreceptor organ. For the receptor current under voltage clamp, the capacity was similar to 1400 bits/s, but when the neuron was allowed to generate a receptor potential, nonlinear membrane processes improved the capacity to >2000 bits/s. Finally, when action potentials were produced, the capacity dropped to similar to 200 bits/s, or similar to 14% of the receptor current capacity. These measurements provide a quantitative estimation of the cost of encoding analog signals into action potentials.	DALHOUSIE UNIV,DEPT PHYSIOL & BIOPHYS,HALIFAX,NS B3H 4H7,CANADA	Dalhousie University			Juusola, Mikko/E-6948-2011	French, Andrew/0000-0001-8190-4084; Juusola, Mikko/0000-0002-4428-5330				BARTH FG, 1970, Z MORPHOL TIERE, V68, P343, DOI 10.1007/BF00376006; BARTH FG, 1985, NEUROBIOLOGY ARACHNI, P163; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; BOHNENBERGER J, 1981, J COMP PHYSIOL, V142, P391, DOI 10.1007/BF00605451; Chubbuck JG, 1966, APL TECH DIGEST, V5, P18; FRENCH AS, 1972, KYBERNETIK, V11, P15, DOI 10.1007/BF00267761; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; FRENCH AS, 1971, KYBERNETIK, V8, P165, DOI 10.1007/BF00291117; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; JUUSOLA M, 1994, J NEUROPHYSIOL, V72, P3026, DOI 10.1152/jn.1994.72.6.3026; Juusola M, 1995, J NEUROPHYSIOL, V74, P2513, DOI 10.1152/jn.1995.74.6.2513; JUUSOLA M, 1994, J NEUROSCI METH, V53, P1, DOI 10.1016/0165-0270(94)90137-6; JUUSOLA M, 1995, PFLUG ARCH EUR J PHY, V431, P125, DOI 10.1007/BF00374385; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; JUUSOLA M, 1997, IN PRESS J NEUROSCI; KOUVALAINEN E, 1994, VISUAL NEUROSCI, V95, P1221; LAUGHLIN SB, 1987, TRENDS NEUROSCI, V10, P478, DOI 10.1016/0166-2236(87)90104-4; MAIER L, 1987, J COMP PHYSIOL B, V157, P285, DOI 10.1007/BF00693355; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Marmarelis P.Z., 1978, ANAL PHYSL SYSTEMS; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Roddey JC, 1996, J NEUROPHYSIOL, V75, P1365, DOI 10.1152/jn.1996.75.4.1365; SACHS F, 1986, MEMBRANE BIOCHEM, V6, P173, DOI 10.3109/09687688609065448; SAKAI HM, 1995, J GEN PHYSIOL, V105, P795, DOI 10.1085/jgp.105.6.795; SAKURANAGA M, 1987, J GEN PHYSIOL, V90, P229, DOI 10.1085/jgp.90.2.229; SCHWARTZ LS, 1963, PRINCIPLES CODING FI; SEYFARTH EA, 1994, J NEUROPHYSIOL, V71, P1422, DOI 10.1152/jn.1994.71.4.1422; Shannon C., 1964, MATH THEORY COMMUNIC; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Stemmler M, 1996, NETWORK-COMP NEURAL, V7, P687, DOI 10.1088/0954-898X/7/4/005; VANHATEREN JH, 1992, BIOL CYBERN, V68, P23, DOI 10.1007/BF00203134; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; Wessel R, 1996, J NEUROPHYSIOL, V75, P2280, DOI 10.1152/jn.1996.75.6.2280	39	70	71	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1997	18	6					959	968		10.1016/S0896-6273(00)80335-9	http://dx.doi.org/10.1016/S0896-6273(00)80335-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XJ102	9208863	Bronze			2022-12-24	WOS:A1997XJ10200014
J	Kavalali, ET; Zhuo, M; Bito, H; Tsien, RW				Kavalali, ET; Zhuo, M; Bito, H; Tsien, RW			Dendritic Ca2+ channels characterized by recordings from isolated hippocampal dendritic segments	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; ACTIVATED CALCIUM CHANNELS; SUBCELLULAR-DISTRIBUTION; SYNAPTIC TRANSMISSION; SENSORY NEURONS; PURKINJE-CELLS; N-TYPE; BIOCHEMICAL-PROPERTIES; PERIPHERAL NEURONS; ACTION-POTENTIALS	Dendritic arbors are critical for the information processing capability of central neurons, but quantitative analysis of their membrane properties has been hampered by their geometrical complexity. Here, we have focused on an important source of Ca2+ entry in dendrites, the voltage-gated Ca2+ channels, by applying the whole-cell voltage-clamp technique to isolated dendritic segments (''dendrosomes'') from rat hippocampal neurons. We found that low voltage-activated T-type Ca2+ channels provide a significantly larger fraction of the Ca2+ influx in dendrites than their counterparts in cell bodies. Surprisingly, 60%-70% of the high voltage-activated Ca2+ current in dendrosomes was N and P/Q type, and these channels were susceptible to neurotransmitter inhibition, suggesting a novel physiological role for G protein-regulated Ca2+ channel modulation in controlling dendritic excitability and Ca2+ signaling.	STANFORD UNIV,SCH MED,BECKMAN CTR,STANFORD,CA 94305	Stanford University	Kavalali, ET (corresponding author), STANFORD UNIV,SCH MED,DEPT MOL & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		Bito, Haruhiko/A-8635-2008; Zhuo, Min/A-2072-2008	Zhuo, Min/0000-0001-9062-3241; Bito, Haruhiko/0000-0001-6315-9594	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Avery RB, 1996, J NEUROSCI, V16, P5567; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BENARDO LS, 1982, J NEUROSCI, V2, P1614; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Brody DL, 1997, J PHYSIOL-LONDON, V499, P637, DOI 10.1113/jphysiol.1997.sp021956; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Day NC, 1996, NEUROSCIENCE, V71, P1013, DOI 10.1016/0306-4522(95)00514-5; Dittman JS, 1996, J NEUROSCI, V16, P1623; DROOGMANS G, 1989, J PHYSIOL-LONDON, V419, P627, DOI 10.1113/jphysiol.1989.sp017890; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HUGUENARD JR, 1989, P NATL ACAD SCI USA, V86, P2473, DOI 10.1073/pnas.86.7.2473; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kavalali ET, 1996, J NEUROSCI, V16, P1072; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KOSIK KS, 1987, J NEUROSCI, V7, P3142; KRIEGSTEIN AR, 1983, J NEUROSCI, V3, P1634; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2520, DOI 10.1073/pnas.73.7.2520; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1996, J NEUROPHYSIOL, V76, P3460, DOI 10.1152/jn.1996.76.5.3460; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MASUKAWA LM, 1984, J NEUROSCI, V4, P217; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MCCOBB DP, 1991, NEURON, V7, P119, DOI 10.1016/0896-6273(91)90080-J; McDonough SI, 1996, J NEUROSCI, V16, P2612; MILLS LR, 1994, J NEUROSCI, V14, P6815; MINTZ IM, 1992, NATURE, V292, P251; Mouginot D, 1997, J NEUROSCI, V17, P160, DOI 10.1523/JNEUROSCI.17-01-00160.1997; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANDALL A, 1995, J NEUROSCI, V15, P2995; RANDALL A, 1997, IN PRESS T TYPE CALC; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; THOMPSON SM, 1991, J PHYSIOL-LONDON, V439, P671, DOI 10.1113/jphysiol.1991.sp018687; Tottene A, 1996, J NEUROSCI, V16, P6353; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; YOKOYAMA CT, 1995, J NEUROSCI, V15, P6419; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	63	121	123	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1997	18	4					651	663		10.1016/S0896-6273(00)80305-0	http://dx.doi.org/10.1016/S0896-6273(00)80305-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136773	Bronze			2022-12-24	WOS:A1997WW62600013
J	Harris, R; Sabatelli, LM; Seeger, MA				Harris, R; Sabatelli, LM; Seeger, MA			Guidance cues at the Drosophila CNS midline: Identification and characterization of two Drosophila Netrin/UNC-6 homologs	NEURON			English	Article							PIONEER AXON MIGRATIONS; CENTRAL-NERVOUS-SYSTEM; GROWTH CONE GUIDANCE; C-ELEGANS; COMMISSURAL AXONS; FLOOR PLATE; GUIDES CELL; EXPRESSION; MELANOGASTER; CHEMOATTRACTANT	Netrins are chemotropic guidance signals that play important roles in circumferential axon guidance in C. elegans and in the developing vertebrate spinal cord. We have identified two Drosophila homologs of this protein family (Netrin-A and Netrin-B). Both Netrins are dynamically expressed throughout embryogenesis, including CNS midline expression at the time of commissure formation. Both Netrin genes map close to each other on the X chromosome, and embryos deficient for this region exhibit defects in commissure formation. This CNS phenotype can be rescued by expression of either Netrin at the CNS midline, confirming an important role for Drosophila Netrins in commissural growth cone guidance. A localized source of Netrin protein at the midline is apparently important for function, since ectopic expression of either Netrin throughout the CNS results in phenotypic defects similar to the loss-of-function phenotype.			Harris, R (corresponding author), OKLAHOMA MED RES FDN,PROGRAM MOL & CELL BIOL,825 NE 13TH ST,OKLAHOMA CITY,OK 73104, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032839, R29NS032839] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32839] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bate Michael, 1993, P1013; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Cohen Stephen M., 1993, P747; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; DRYSDALE R, 1991, GENETICS, V127, P497; Goodman Corey S., 1993, P1131; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HARLOW E, 1988, ANTIBODIES LAB MNAUA; HEDGECOCK EM, 1990, NEURON, V2, P61; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Manning Gerards, 1993, P609; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MITCHELL KJ, 1996, IN PRESS NEURON, V17; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PLACZEK M, 1990, COLD SPRING HARB SYM, V55, P279; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J., 2002, MOL CLONING LAB MANU; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SMOLLER DA, 1991, CHROMOSOMA, V100, P487, DOI 10.1007/BF00352199; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; YAGINUMA H, 1991, J NEUROSCI, V11, P2598; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	44	268	272	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					217	228		10.1016/S0896-6273(00)80154-3	http://dx.doi.org/10.1016/S0896-6273(00)80154-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780646	Bronze			2022-12-24	WOS:A1996VE84000005
J	Ashery, U; Penner, R; Spira, ME				Ashery, U; Penner, R; Spira, ME			Acceleration of membrane recycling by axotomy of cultured Aplysia neurons	NEURON			English	Article							FROG NEUROMUSCULAR JUNCTION; PATCH-CLAMP TECHNIQUES; GROWTH CONES; CAPACITANCE MEASUREMENTS; INTRACELLULAR CALCIUM; NERVE REGENERATION; SYNAPTIC VESICLES; MOTOR NEURONS; CELLS; ENDOCYTOSIS	The rapid transition of a stationary axon into a motile growth cone requires the recruitment of membrane and its strategic insertion into the neurolemma. The source of membrane to support the initial rapid growth postaxotomy is not known. Using membrane capacitance measurements, we examined quantitative aspects of membrane dynamics following axotomy of cultured Aplysia neurons. Axotomy activates two processes in parallel: membrane retrieval and exocytosis. Unexpectedly, membrane retrieval is the dominant process in the majority of the experiments. Thus, while a growth cone is vigorously extending, the total neuronal surface area decreases. We suggest that the initial rapid extension phase of the newly formed growth cone postaxotomy is supported by a pool of intracellular membrane that is rapidly retrieved from the neurolemma.	MAX PLANCK INST BIOPHYS CHEM,GOTTINGEN,GERMANY	Max Planck Society	Ashery, U (corresponding author), HEBREW UNIV JERUSALEM,INTRUNIV INST MARINE SCI,INST LIFE SCI,DEPT NEUROBIOL,ELAT,ISRAEL.		Spira, Micha/B-6470-2012	Penner, Reinhold/0000-0002-5366-1537; Ashery, Uri/0000-0001-6338-7888				BAAS PW, 1986, J CELL BIOL, V103, P917, DOI 10.1083/jcb.103.3.917; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BAILEY CH, 1994, SEMIN NEUROSCI, V6, P35; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BENBASSAT D, 1994, EUR J NEUROSCI, V6, P1605, DOI 10.1111/j.1460-9568.1994.tb00551.x; BENBASSAT D, 1993, EXP NEUROL, V122, P295, DOI 10.1006/exnr.1993.1129; BRAY D, 1973, NATURE, V244, P93, DOI 10.1038/244093a0; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; BRAY D, 1992, NERVE GROWTH CONE, P7; BUNGE MB, 1977, J NEUROCYTOL, V6, P407, DOI 10.1007/BF01178226; BURGOYNE RD, 1995, TRENDS NEUROSCI, V18, P191, DOI 10.1016/0166-2236(95)93900-I; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHENG TPO, 1987, J NEUROSCI, V7, P1752; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FELDMAN EL, 1981, J NEUROBIOL, V12, P591, DOI 10.1002/neu.480120607; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FISHMAN HM, 1990, BIOCHIM BIOPHYS ACTA, V1023, P421, DOI 10.1016/0005-2736(90)90135-B; GRIFFIN JW, 1981, J CELL BIOL, V88, P205, DOI 10.1083/jcb.88.1.205; GUNSTREAM JD, 1995, J NEUROSCI, V15, P439; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYDON PG, 1987, J NEUROBIOL, V18, P197, DOI 10.1002/neu.480180206; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HOCHNER B, 1987, J NEUROSCI, V7, P261; HU YH, 1993, NEURON, V10, P921, DOI 10.1016/0896-6273(93)90207-8; Johnston R N, 1980, Curr Top Dev Biol, V16, P165; Kandel ER., 1976, CELLULAR BASIS BEHAV; KATER SB, 1991, J NEUROSCI, V11, P891; Keynes R J, 1992, Curr Opin Neurobiol, V2, P55, DOI 10.1016/0959-4388(92)90162-E; KRAUSE TL, 1994, J NEUROSCI, V1, P6638; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; MARSH M, 1980, J MOL BIOL, V142, P439, DOI 10.1016/0022-2836(80)90281-8; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PENNER R, 1989, TRENDS NEUROSCI, V12, P159, DOI 10.1016/0166-2236(89)90059-3; PFENNINGER KH, 1993, DEV BRAIN RES, V71, P181, DOI 10.1016/0165-3806(93)90170-F; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SHAW G, 1977, EXP CELL RES, V104, P55, DOI 10.1016/0014-4827(77)90068-4; SHELTON DP, 1985, NEUROSCIENCE, V14, P111, DOI 10.1016/0306-4522(85)90168-X; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; WATSON AHD, 1981, CELL TISSUE RES, V215, P325; WESSELLS NK, 1978, EXP CELL RES, V117, P335, DOI 10.1016/0014-4827(78)90147-7; WESSELLS NK, 1974, TISSUE CELL, V6, P757, DOI 10.1016/0040-8166(74)90014-7; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625, DOI 10.1152/jn.1995.74.6.2625	52	26	27	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					641	651		10.1016/S0896-6273(00)80083-5	http://dx.doi.org/10.1016/S0896-6273(00)80083-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785061	Bronze			2022-12-24	WOS:A1996UC16800020
J	Garcia, EP; Mehta, S; Blair, LAC; Wells, DG; Shang, J; Fukushima, T; Fallon, JR; Garner, CC; Marshall, J				Garcia, EP; Mehta, S; Blair, LAC; Wells, DG; Shang, J; Fukushima, T; Fallon, JR; Garner, CC; Marshall, J			SAP90 binds and clusters kainate receptors causing incomplete desensitization	NEURON			English	Article							POSTSYNAPTIC DENSITY PROTEIN; TUMOR-SUPPRESSOR GENE; RAT HIPPOCAMPAL-NEURONS; SINGLE AMINO-ACID; GLUTAMATE RECEPTORS; NMDA RECEPTOR; SYNAPTIC TRANSMISSION; SH3 DOMAIN; GUANYLATE KINASES; PSD-95 FAMILY	The mechanism of kainate receptor targeting and clustering is still unresolved. Here, we demonstrate that members of the SAP90/PSD-95 family colocalize and associate with kainate receptors. SAP90 and SAP102 coimmunoprecipitate with both KA2 and GluR6, but only SAP97 coimmunoprecipitates with GluR6. Similar to NMDA receptors, GluR6 clustering is mediated by the interaction of its C-terminal amino acid sequence, ETMA, with the PDZ1 domain of SAP90. in contrast, the KA2 C-terminal region binds to, and is clustered by, the SH3 and GK domains of SAP90. Finally, we show that SAP90 coexpressed with GluR6 or GluR6/KA2 receptors alters receptor function by reducing desensitization. These studies suggest that the organization and electrophysiological properties of synaptic kainate receptors are modified by association with members of the SAP90/PSD-95 family.	Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Univ Alabama, Neurobiol Res Ctr, Birmingham, AL 35213 USA	Brown University; Brown University; University of Alabama System; University of Alabama Birmingham	Marshall, J (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	john_marshall@brown.edu		Garner, Craig/0000-0003-1970-5417	NICHD NIH HHS [R01 HD023924, R01 HD052083] Funding Source: Medline; NINDS NIH HHS [R29 NS 33914-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052083, R01HD023924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS033914] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BUNNEL SC, 1997, J BIOL CHEM, V271, P25646; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Goslin K., 1991, CULTURING NERVE CELL, P251; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Hunt CA, 1996, J NEUROSCI, V16, P1380; HUNTLEY GW, 1993, J NEUROSCI, V13, P2965; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KUHLENDAHL S, 1998, IN PRESS EUR J BIOCH; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; Matoskova B, 1996, ONCOGENE, V12, P2679; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; Otis T, 1996, J NEUROSCI, V16, P7496; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PAWSON T, 1997, SCIENCE, V278, P2975; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rao A, 1998, J NEUROSCI, V18, P1217; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; SASTRY L, 1995, ONCOGENE, V11, P1107; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; WENTHOLD RJ, 1994, J BIOL CHEM, V269, P1332; Wilding TJ, 1997, J NEUROSCI, V17, P2713; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Zorumski CF, 1996, J PHYSIOL-LONDON, V494, P465, DOI 10.1113/jphysiol.1996.sp021506	70	215	222	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					727	739		10.1016/S0896-6273(00)80590-5	http://dx.doi.org/10.1016/S0896-6273(00)80590-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808460	Bronze			2022-12-24	WOS:000076697300017
J	Tu, JC; Xiao, B; Yuan, JP; Lanahan, AA; Leoffert, K; Li, M; Linden, DJ; Worley, PF				Tu, JC; Xiao, B; Yuan, JP; Lanahan, AA; Leoffert, K; Li, M; Linden, DJ; Worley, PF			Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors	NEURON			English	Article							LONG-TERM POTENTIATION; ALDRICH-SYNDROME PROTEIN; CEREBELLAR PURKINJE-CELLS; PDZ-DOMAIN PROTEIN; MOLECULAR CHARACTERIZATION; SYNAPTIC TRANSMISSION; ENDOPLASMIC-RETICULUM; SIGNAL TRANSDUCTION; DENDRITIC SPINES; SPLICE VARIANTS	Group 1 metabotropic glutamate receptors (mGluRs) activate PI turnover and thereby trigger intracellular calcium release. Previously, we demonstrated that mGluRs form natural complexes with members of a family of Homer-related synaptic proteins. Here, we present evidence that Homer proteins form a physical tether linking mGluRs with the inositol trisphosphate receptors (IP3R). A novel proline-rich "Homer ligand" (PPXXFr) is identified in group 1 mGluRs and IP3R, and these receptors coimmunoprecipitate as a complex with Homer from brain. Expression of the IEG form of Homer, which lacks the ability to cross-link, modulates mGluR-induced intracellular calcium release. These studies identify a novel mechanism in calcium signaling and provide evidence that an IEG, whose expression is driven by synaptic activity, can directly modify a specific synaptic function.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@bs.jhmi.edu		Xiao, Bo/0000-0002-6161-9478	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011742, R01DA010309, R37DA010309] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 10309, DA 11742] Funding Source: Medline; NIMH NIH HHS [KO2 MH01152] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABE T, 1992, J BIOL CHEM, V267, P13361; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Bordi F, 1996, EUR J PHARMACOL, V301, pR15, DOI 10.1016/0014-2999(96)00138-0; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CHEN JK, 1993, J AM CHEM SOC, V115, P12591, DOI 10.1021/ja00079a051; CHINESTRA P, 1994, NEUROSCI LETT, V182, P177, DOI 10.1016/0304-3940(94)90791-9; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Cook T, 1996, J NEUROCHEM, V67, P927; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Flor PJ, 1996, J NEUROCHEM, V67, P58; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GRANDES P, 1994, NEUROREPORT, V5, P2249, DOI 10.1097/00001756-199411000-00011; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; HARRIS KM, 1988, J NEUROSCI, V8, P4455; HSIA AY, 1995, NEUROPHARMACOLOGY, V34, P1567, DOI 10.1016/0028-3908(95)00115-M; Ingi T, 1998, J NEUROSCI, V18, P7178; JOLY C, 1995, J NEUROSCI, V15, P3970; JONES DG, 1995, REV NEUROSCIENCE, V6, P177; Kaczmarek L, 1997, PHYSIOL REV, V77, P217, DOI 10.1152/physrev.1997.77.1.217; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kawabata S, 1998, J BIOL CHEM, V273, P17381, DOI 10.1074/jbc.273.28.17381; Lester LB, 1997, RECENT PROG HORM RES, V52, P409; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Lu YM, 1997, J NEUROSCI, V17, P5196; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; MANZONI OJ, 1994, EUR J NEUROSCI, V6, P1050, DOI 10.1111/j.1460-9568.1994.tb00599.x; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; NAKATA T, 1993, J CELL SCI, V105, P1; NARASIMHAN K, 1998, IN PRESS J NEUROPHYS; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Petralia RS, 1997, J CHEM NEUROANAT, V13, P77, DOI 10.1016/S0891-0618(97)00023-9; Philipp S, 1997, FEBS LETT, V413, P243, DOI 10.1016/S0014-5793(97)00877-6; Ponting CP, 1997, J MOL MED-JMM, V75, P769, DOI 10.1007/s001090050166; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; Saugstad JA, 1998, J NEUROSCI, V18, P905; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; TAKEI K, 1992, J NEUROSCI, V12, P489; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; ZHENG F, 1992, NEURON, V9, P163, DOI 10.1016/0896-6273(92)90231-2	66	712	742	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					717	726		10.1016/S0896-6273(00)80589-9	http://dx.doi.org/10.1016/S0896-6273(00)80589-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808459	Bronze			2022-12-24	WOS:000076697300016
J	Berwin, B; Floor, E; Martin, TFJ				Berwin, B; Floor, E; Martin, TFJ			CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis	NEURON			English	Article							SYNAPTIC VESICLES; NEUROENDOCRINE CELLS; TRANSMITTER RELEASE; PEPTIDE SECRETION; NERVE-TERMINALS; IN-VITRO; FUSION; BRAIN; CALCIUM; SYNAPTOSOMES	CAPS is a neural/endocrine-specific protein discovered as a cytosolic factor required for Ca2+-activated dense-core vesicle (DCV) exocytosis in permeable neuroendocrine cells. We report that CAPS is also a membrane-associated, peripherally bound protein in brain homogenates that localizes selectively to plasma membranes and to DCVs but not to small clear synaptic vesicles (SVs). CAPS exhibits high affinity and saturable binding to DCVs by interaction with bilayer phospholipids. Specific CAPS antibodies inhibit Ca2+-activated norepinephrine release from lysed synaptosomes that contain membrane-associated CAPS, indicating that membrane-bound CAPS is essential for neural DCV exocytosis. CAPS is a functional component of the exocytotic machinery that localizes selectively to DCVs, and it may confer distinct regulatory features on neuropeptide and biogenic amine transmitter secretion.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Kansas, Dept Physiol & Cell Biol, Lawrence, KS 66045 USA	University of Wisconsin System; University of Wisconsin Madison; University of Kansas	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Berwin, Brent/0000-0001-9196-3256				Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Avery Leon, 1993, Genetics, V134, P455; BEAN AJ, 1994, FASEB J, V8, P630, DOI 10.1096/fasebj.8.9.8005390; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DECAMILLI P, 1991, TRENDS PHARMACOL SCI, V12, P446, DOI 10.1016/0165-6147(91)90631-2; DEKKER LV, 1991, J NEUROCHEM, V56, P1146, DOI 10.1111/j.1471-4159.1991.tb11404.x; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; FLOOR E, 1988, J NEUROCHEM, V50, P1588, DOI 10.1111/j.1471-4159.1988.tb03048.x; FLOOR E, 1995, J NEUROCHEM, V64, P689; FLOOR E, 1982, NEUROSCIENCE, V7, P1647, DOI 10.1016/0306-4522(82)90023-9; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KLEIN RL, 1984, HDB NEUROCHEMISTRY, V7, P71; Livingstone D., 1991, THESIS CAMBRIDGE U C; LOYET KM, 1998, IN PRESS J BIOL CHEM, V273; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THURESONKLEIN A, 1983, NEUROSCIENCE, V10, P245, DOI 10.1016/0306-4522(83)90132-X; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Whittaker VP, 1969, HDB NEUROCHEMISTRY, VII, P327, DOI DOI 10.1007/978-1-4899-7321-4_14	38	112	115	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					137	145		10.1016/S0896-6273(00)80521-8	http://dx.doi.org/10.1016/S0896-6273(00)80521-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697858	Bronze			2022-12-24	WOS:000075061900013
J	Tang, LX; Hung, CP; Schuman, EM				Tang, LX; Hung, CP; Schuman, EM			A role for the cadherin family of cell adhesion molecules in hippocampal long term potentiation	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; N-CADHERIN; TRANSMITTER RELEASE; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; CATENIN COMPLEX; A-CAM; EXPRESSION; CALCIUM; LOCALIZATION	The cadherins are a family of cell-cell adhesion molecules that mediate Ca2+-dependent homophilic interactions between cells and transduce signals by interacting with cytoplasmic proteins. In the hippocampus, immunostaining combined with confocal microscopy revealed that both neural- (N-) and epithelial- (E-) cadherin are present at synaptic sites, implying a role in synaptic function. Pretreatment of hippocampal slices with antibodies (Abs) raised against the extracellular domain of either N-cad or E-cad had no effect on basal synaptic properties but significantly reduced long-term potentiation (LTP). Infusion of antagonistic peptides containing the His-Ala-Val (HAV) consensus sequence for cadherin dimerization also attenuated LTP induction without affecting previously established LTP. Because the intense synaptic stimulation associated with LTP induction might transiently deplete extracellular Ca2+ and hence potentially destabilize cadherin-cadherin interactions, we examined whether slices could be protected from inhibition by N-cad Abs or HAV peptides by raising the extracellular Ca2+ concentration. Indeed, we found that high extracellular Ca2+ prevented the block of LTP by these agents. Taken together, these results indicate that cadherins are involved in synaptic plasticity, and the stability of cadherin-cadherin bonds may be regulated by synaptic stimulation.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA.		Schuman, Erin M/D-6204-2011					ABERLE H, 1994, J CELL SCI, V107, P3655; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Bahr BA, 1997, J NEUROSCI, V17, P1320; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BEESLEY PW, 1995, J NEUROCHEM, V64, P2288; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buxton R S, 1992, Semin Cell Biol, V3, P157; CHEN BM, 1995, SCIENCE, V269, P1578, DOI 10.1126/science.7667637; CHUAH MI, 1991, DEV BRAIN RES, V60, P123, DOI 10.1016/0165-3806(91)90040-P; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HISAJIMA H, 1992, J NEUROSCI RES, V31, P549, DOI 10.1002/jnr.490310319; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; HYAFIL F, 1981, CELL, V26, P447, DOI 10.1016/0092-8674(81)90214-2; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Jones LS, 1996, TRENDS NEUROSCI, V19, P68; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KARTHIKEYAN L, 1994, J CELL SCI, V107, P3213; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; KRNJEVIC K, 1982, CAN J PHYSIOL PHARM, V60, P1643, DOI 10.1139/y82-243; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; LITWACK ED, 1994, J NEUROSCI, V14, P3713; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MBALAVIELE G, 1995, J CLIN INVEST, V95, P2757, DOI 10.1172/JCI117979; MEGE RM, 1992, J CELL SCI, V103, P897; MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Serafini T, 1997, TRENDS NEUROSCI, V20, P322; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; STAUBLI U, 1990, BEHAV NEURAL BIOL, V53, P1, DOI 10.1016/0163-1047(90)90712-F; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Vaughn DE, 1996, NEURON, V16, P261, DOI 10.1016/S0896-6273(00)80045-8; VOLK T, 1990, DEV BIOL, V139, P314, DOI 10.1016/0012-1606(90)90301-X; WILLEMS J, 1995, FEBS LETT, V363, P289, DOI 10.1016/0014-5793(95)00334-6; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; XIAO P, 1991, NEUROREPORT, V2, P547; YAMAGATA M, 1995, J NEUROSCI, V15, P4556	52	285	288	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1998	20	6					1165	1175		10.1016/S0896-6273(00)80497-3	http://dx.doi.org/10.1016/S0896-6273(00)80497-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655504	Bronze			2022-12-24	WOS:000074627300012
J	Fode, C; Gradwohl, G; Morin, X; Dierich, A; LeMeur, M; Goridis, C; Guillemot, F				Fode, C; Gradwohl, G; Morin, X; Dierich, A; LeMeur, M; Goridis, C; Guillemot, F			The bHLH protein NEUROGENIN 2 is a determination factor for epibranchial placode-derived sensory neurons	NEURON			English	Article							LOOP-HELIX PROTEIN; MOUSE EMBRYOGENESIS; RESTRICTED EXPRESSION; NERVOUS-SYSTEM; GENE; DROSOPHILA; CELLS; ACHAETE; MICE; PROTOONCOGENE	neurogenin2 encodes a neural-specific basic helix-loop-helix (bHLH) transcription factor related to the Drosophila proneural factor atonal. We show here that the murine ngn2 gene is essential for development of the epibranchial placode-derived cranial sensory ganglia. An ngn2 null mutation blocks the delamination of neuronal precursors from the placodes, the first morphological sign of differentiation in these lineages. Mutant placodal cells fail to express downstream bHLH differentiation factors and the Notch ligand Delta-like 1. These data suggest that ngn2 functions like the Drosophila proneural genes in the determination of neuronal fate in distal cranial ganglia. Interestingly, the homeobox gene Phox2a is activated independently of ngn2 in epibranchial placodes, suggesting that neuronal fate and neuronal subtype identity may be specified independently in cranial sensory ganglia.	Univ Strasbourg 1, IGBMC, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France; Univ Mediterranee, CNRS, INSERM, IBDM, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Guillemot, F (corresponding author), Univ Strasbourg 1, IGBMC, CNRS, INSERM, CU Strasbourg, F-67404 Illkirch Graffenstaden, France.		Guillemot, Francois/AAV-1482-2021; Gradwohl, Gérard/H-8543-2014; Gradwohl, Gérard/AFM-9024-2022; morin, xavier/AAI-3306-2020	Gradwohl, Gérard/0000-0002-6730-2615; Gradwohl, Gérard/0000-0002-6730-2615; Schuurmans, Carol/0000-0003-3567-0058; Morin, Xavier/0000-0001-9999-0355				AYERLELIEVRE CS, 1982, DEV BIOL, V94, P291, DOI 10.1016/0012-1606(82)90349-9; BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Blader P, 1997, DEVELOPMENT, V124, P4557; BRAND M, 1993, DEVELOPMENT, V119, P1; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; Cau E, 1997, DEVELOPMENT, V124, P1611; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Filosa S, 1997, DEVELOPMENT, V124, P2843; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HARRISON TA, 1995, CELL TISSUE RES, V281, P379, DOI 10.1007/BF00583407; Hay ED, 1993, CURR OPIN CELL BIOL, V5, P1029, DOI 10.1016/0955-0674(93)90088-8; Henrique D, 1997, GENE DEV, V11, P603, DOI 10.1101/gad.11.5.603; Jan Yuh Nung, 1994, Current Opinion in Neurobiology, V4, P8, DOI 10.1016/0959-4388(94)90025-6; Kim P, 1997, DEV BIOL, V187, P1, DOI 10.1006/dbio.1997.8572; KUNISCH M, 1994, P NATL ACAD SCI USA, V91, P10139, DOI 10.1073/pnas.91.21.10139; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; LEWIS J, 1991, CIBA F SYMP, V160, P25, DOI 10.4171/RMI/104; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; MARK M, 1993, DEVELOPMENT, V119, P319; MARTINEZ C, 1991, SCIENCE, V251, P1485, DOI 10.1126/science.1900954; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Roztocil T, 1997, DEVELOPMENT, V124, P3263; SHOUKIMAS GM, 1978, J COMP NEUROL, V179, P795, DOI 10.1002/cne.901790407; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STONER CM, 1989, CANCER RES, V49, P1497; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Tiveron MC, 1996, J NEUROSCI, V16, P7649; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M	46	370	380	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1998	20	3					483	494		10.1016/S0896-6273(00)80989-7	http://dx.doi.org/10.1016/S0896-6273(00)80989-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539123	Bronze			2022-12-24	WOS:000072755600014
J	Schwartz, TH; Rabinowitz, D; Unni, V; Kumar, VS; Smetters, DK; Tsiola, A; Yuste, R				Schwartz, TH; Rabinowitz, D; Unni, V; Kumar, VS; Smetters, DK; Tsiola, A; Yuste, R			Networks of coactive neurons in developing layer 1	NEURON			English	Article							CAJAL-RETZIUS NEURONS; RAT VISUAL-CORTEX; DEVELOPING NEOCORTEX; CORTICAL-NEURONS; I NEURONS; REELER; CELLS; GABA; GENE; CAT	Spontaneous neuronal activity plays an important role in the development of cortical circuitry, yet its spatiotemporal dynamics are poorly understood. Cajal-Retzius (CR) neurons in developing layer 1 are necessary for correct cortical lamination and are strategically located to coordinate early circuit activity. To characterize the spontaneous activity of CR and other layer 1 neurons during cortical development, we imaged calcium transients in populations of layer 1 neurons in hemispheres and slices from postnatal rat somatosensory neocortex. The spontaneous activity in layer 1 had complex spatio-temporal patterns. Groups of non-CR cells showed synchronous activations and formed networks of correlated neurons superimposed in the same territory. Correlated activity among non-CR cells was mediated by a depolarizing effect of GABA and was modulated by glutamate, probably released by CR cells. Our findings demonstrate that developing layer 1 can sustain complex patterns of correlated activity and reveal a circuit mechanism that dan mediate this patterned activity.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Stat, New York, NY 10027 USA	Columbia University; Columbia University	Schwartz, TH (corresponding author), Columbia Presbyterian Med Ctr, Inst Neurol, Dept Neurol Surg, NI-102,710 W 168th St, New York, NY 10032 USA.		Schwartz, Theodore/AAK-3320-2020					BEAR MF, 1985, J COMP NEUROL, V234, P411, DOI 10.1002/cne.902340402; BECKER CM, 1993, BRAIN RES, V606, P220, DOI 10.1016/0006-8993(93)90988-Y; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Christie MJ, 1997, SEMIN CELL DEV BIOL, V8, P29, DOI 10.1006/scdb.1996.0118; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P323; Hanse E, 1997, SEMIN CELL DEV BIOL, V8, P35, DOI 10.1006/scdb.1996.0119; Herkenham M., 1986, CEREB CORTEX, V5, P403; Hestrin S, 1996, J NEUROSCI, V16, P5290; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HUNTLEY GW, 1990, J NEUROCYTOL, V19, P200, DOI 10.1007/BF01217298; Jacobs JM, 1997, J NEUROSCI, V17, P4129; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LEVITT P, 1979, BRAIN RES, V162, P243, DOI 10.1016/0006-8993(79)90287-7; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MARINPADILLA M, 1982, ANAT EMBRYOL, V164, P161, DOI 10.1007/BF00318504; MARINPADILLA M, 1972, Z ANAT ENTWICKLUNGS, V136, P125, DOI 10.1007/BF00519174; MARINPADILLA M, 1984, CEREB CORTEX, V1, P1; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MUELLER AL, 1983, NEUROSCI LETT, V39, P193, DOI 10.1016/0304-3940(83)90076-9; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; ODonovan MJ, 1997, SEMIN CELL DEV BIOL, V8, P21, DOI 10.1006/scdb.1996.0117; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PARNAVELAS JG, 1983, J NEUROCYTOL, V12, P863, DOI 10.1007/BF01258156; Rohrbough J, 1996, J NEUROSCI, V16, P82; ROSSNER S, 1994, DEV BRAIN RES, V77, P55; Soriano E, 1997, NEURON, V18, P563, DOI 10.1016/S0896-6273(00)80298-6; Spitzer NC, 1997, SEMIN CELL DEV BIOL, V8, P13, DOI 10.1006/scdb.1996.0116; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Wong ROL, 1997, SEMIN CELL DEV BIOL, V8, P5, DOI 10.1006/scdb.1996.0115; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Yuste R, 1997, SEMIN CELL DEV BIOL, V8, P1, DOI 10.1006/scdb.1996.0114; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zhou FM, 1996, J NEUROSCI, V16, P1131; Zhou FM, 1996, J COMP NEUROL, V376, P198, DOI 10.1002/(SICI)1096-9861(19961209)376:2<198::AID-CNE3>3.0.CO;2-Z	46	111	117	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1998	20	3					541	552		10.1016/S0896-6273(00)80993-9	http://dx.doi.org/10.1016/S0896-6273(00)80993-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZE079	9539127	hybrid			2022-12-24	WOS:000072755600018
J	Gereau, RW; Heinemann, SF				Gereau, RW; Heinemann, SF			Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5	NEURON			English	Article							PHARMACOLOGICAL CHARACTERIZATION; CELL-LINE; ACTIVATION; HIPPOCAMPUS; TRANSPORTER; INHIBITION; 1-ALPHA; RELEASE; SIGNAL; NMDA	Metabotropic glutamate receptors (mGluRs) coupled to phosphoinositide hydrolysis desensitize in response to prolonged or repeated agonist exposure, and evidence suggests that this involves activation of protein kinase C (PKC). The present studies were undertaken to determine if cloned mGluR5 undergoes similar PKC-mediated desensitization and to investigate the molecular mechanism underlying PKC-induced desensitization. In Xenopus oocytes, both mGluR5a and mGluR5b showed pronounced desensitization in response to a brief activation by glutamate. Pharmacological studies clearly suggest that this desensitization requires PKC-mediated phosphorylation. Analysis of PKC consensus phosphorylation site mutants suggests that PKC phosphorylates mGluR5 at multiple sites to induce a relatively rapid form of desensitization. Because mGluRs play important roles in synaptic plasticity and in excitotoxicity, this desensitization may be involved in the dynamic regulation of these processes.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Gereau, RW (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							ABE T, 1992, J BIOL CHEM, V267, P13361; ALALUF S, 1995, FEBS LETT, V367, P301, DOI 10.1016/0014-5793(95)00575-T; ANIKSZTEJN L, 1991, EUR J PHARMACOL, V205, P327, DOI 10.1016/0014-2999(91)90921-C; ARONICA E, 1993, MOL PHARMACOL, V44, P981; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CATANIA MV, 1991, J NEUROCHEM, V56, P1329, DOI 10.1111/j.1471-4159.1991.tb11429.x; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DESAI MA, 1991, J NEUROPHYSIOL, V66, P40, DOI 10.1152/jn.1991.66.1.40; DESAI MA, 1995, MOL PHARMACOL, V48, P648; Desai MA, 1996, BRIT J PHARMACOL, V118, P1558, DOI 10.1111/j.1476-5381.1996.tb15574.x; GEREAU RW, 1995, J NEUROSCI, V15, P6879; GEREAU RW, 1995, J NEUROPHYSIOL, V74, P122, DOI 10.1152/jn.1995.74.1.122; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; GODFREY PP, 1990, NEUROCHEM INT, V16, P65, DOI 10.1016/0197-0186(90)90124-C; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Guerineau NC, 1997, J PHYSIOL-LONDON, V500, P487, DOI 10.1113/jphysiol.1997.sp022035; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HERRERO I, 1994, EUR J NEUROSCI, V6, P115, DOI 10.1111/j.1460-9568.1994.tb00253.x; HU GY, 1992, BRAIN RES, V568, P339; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; Lu YM, 1997, J NEUROSCI, V17, P5196; MINAKAMI R, 1994, BIOCHEM BIOPH RES CO, V199, P1136, DOI 10.1006/bbrc.1994.1349; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; SCHOEPP DD, 1988, BIOCHEM PHARMACOL, V37, P4299, DOI 10.1016/0006-2952(88)90610-7; THOMSEN C, 1993, BRAIN RES, V619, P22, DOI 10.1016/0006-8993(93)91592-G; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z	27	167	171	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1998	20	1					143	151		10.1016/S0896-6273(00)80442-0	http://dx.doi.org/10.1016/S0896-6273(00)80442-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459450	Bronze			2022-12-24	WOS:000071719700017
J	Lin, RC; Scheller, RH				Lin, RC; Scheller, RH			Structural organization of the synaptic exocytosis core complex	NEURON			English	Article							ENERGY-TRANSFER; FUSION COMPLEX; COILED COILS; SYNTAXIN; DOMAINS; HEMAGGLUTININ; SYNAPTOTAGMIN; DOCKING	Syntaxin, vesicle-associated membrane protein (VAMP), and synaptosome-associated protein of 25 kDa (SNAP-25) form a ternary ''core complex'' central to the process of synaptic vesicle docking and fusion. Several lines of evidence support the hypothesis that the proteins assemble in a coiled-coil structure, but the alignment of alpha helices in this coil and the overall conformation of the coil are unknown. We employ the technique of fluorescence resonance energy transfer (FRET) to investigate the alignment between syntaxin and VAMP. With the acceptor probe coupled to the aminoterminal end of the VAMP coiled-coil domain, the donor probe fluorescence is quenched to a greater extent when it is on the amino-terminal end of the syntaxin H3 domain than when it is on the carboxy-terminal end. The data indicate that syntaxin and VAMP bind primarily in a parallel arrangement and suggest a coiled-coil structure that is bent rather than fully extended. We propose a model in which binding of SNAP receptor (SNARE) protein coiled-coil domains helps drive vesicle fusion.	STANFORD UNIV,SCH MED,DEPT MOL & CELLULAR PHYSIOL,HOWARD HUGHES MED INST,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University					NIGMS NIH HHS [5T32 GM07365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; Fairclough R H, 1978, Methods Enzymol, V48, P347; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Gerst JE, 1997, J BIOL CHEM, V272, P16591, DOI 10.1074/jbc.272.26.16591; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hao JC, 1997, J NEUROSCI, V17, P1596; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Kee Y, 1996, J NEUROSCI, V16, P1975; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; SCHELLER RH, 1995, NEURON, V14, P893; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TALOR DL, 1981, J CELL BIOL, V89, P362; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Zhong PY, 1997, BIOCHEMISTRY-US, V36, P4317, DOI 10.1021/bi9625408	23	268	275	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1087	1094		10.1016/S0896-6273(00)80399-2	http://dx.doi.org/10.1016/S0896-6273(00)80399-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390521	Bronze			2022-12-24	WOS:A1997YH59400015
J	Olsson, M; Campbell, K; Turnbull, DH				Olsson, M; Campbell, K; Turnbull, DH			Specification of mouse telencephalic and mid-hindbrain progenitors following heterotopic ultrasound-guided embryonic transplantation	NEURON			English	Article							LATERAL GANGLIONIC EMINENCE; BACKSCATTER MICROSCOPE; VENTRAL FOREBRAIN; CEREBRAL GRAFTS; NEURAL-TUBE; NEURONS; DIFFERENTIATION; BRAIN; CELLS; CONNECTIONS	We have demonstrated the utility of ultrasound backscatter microscopy for targeted intraparenchymal injections into embryonic day (E) 13.5 mouse embryos. This system has been used to test the degree of commitment present in neural progenitors from the embryonic ventral telencephalon and mid-hindbrain region. Many E13.5 ventral telencephalic progenitors were observed to integrate and adopt local phenotypes following heterotopic transplantation into telencephalic or mid-hindbrain targets, whereas mid-hindbrain cells of the same stage were unable to integrate and change fate in the telencephalon. In contrast, many mid-hindbrain cells from an earlier developmental stage (E10.5) were capable,of integrating and adopting a forebrain phenotype after grafting into the telencephalon, suggesting that mouse mid-hindbrain progenitors become restricted in their developmental potential between E10.5 and E13.5.	NYU,MED CTR,SKIRBALL INST BIOMOL MED,NEW YORK,NY 10016; LUND UNIV,DEPT PHYSIOL & BIOPHYS,WALLENBERG NEUROSCI CTR,S-22362 LUND,SWEDEN	New York University; Lund University			Campbell, Kenneth/ABC-3570-2021	Turnbull, Daniel/0000-0003-0889-5155				Altman J. B. S., 1995, ATLAS PRENATAL RAT B; ALVARADOMALLART RM, 1993, J NEUROBIOL, V24, P1341, DOI 10.1002/neu.480241007; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BARBE MF, 1995, J NEUROSCI, V15, P1819, DOI 10.1523/JNEUROSCI.15-03-01819.1995; BARBE MF, 1992, P NATL ACAD SCI USA, V89, P3706, DOI 10.1073/pnas.89.9.3706; BARBE MF, 1991, J NEUROSCI, V11, P519; Barbe MF, 1996, NEURON, V16, P1, DOI 10.1016/S0896-6273(00)80015-X; Bayer Shirley A., 1995, P1041; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; CROSSLEY PH, 1996, NATURE, V380, P86; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1991, DEVELOPMENT, V111, P287; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; FISHELL G, 1995, DEVELOPMENT, V121, P803; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; LEE SMK, 1997, DEVELOPMENT, V124, P971; Levitt P, 1993, Perspect Dev Neurobiol, V1, P65; MATISE MP, 1997, IN PRESS J NEUROSCI, V17; Nakagawa Y, 1996, DEVELOPMENT, V122, P2449; Olsson M, 1997, NEUROSCIENCE, V79, P57, DOI 10.1016/S0306-4522(96)00606-9; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; OLSSON M, 1997, IN PRESS EUR J NEURO; OLSSON M, 1997, IN PRESS NEUROSCIENC; PAKZABAN P, 1993, EXP BRAIN RES, V97, P13; Pierce E T, 1973, Prog Brain Res, V40, P53; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; Shimamura K, 1995, DEVELOPMENT, V121, P3923; SMART IHM, 1979, NEOSTRIATUM, P127; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; TURNBULL DH, 1995, ULTRASOUND MED BIOL, V21, P79, DOI 10.1016/0301-5629(94)00083-2; TURNBULL DH, 1995, P NATL ACAD SCI USA, V92, P2239, DOI 10.1073/pnas.92.6.2239; VICARIOABEJON C, 1995, J NEUROSCI, V15, P6351; WURST W, 1994, DEVELOPMENT, V120, P2065	41	116	118	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					761	772		10.1016/S0896-6273(00)80959-9	http://dx.doi.org/10.1016/S0896-6273(00)80959-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354324	hybrid			2022-12-24	WOS:A1997YD18900005
J	Ryba, NJP; Tirindelli, R				Ryba, NJP; Tirindelli, R			A new multigene family of putative pheromone receptors	NEURON			English	Article							ACCESSORY OLFACTORY-BULB; VOMERONASAL SYSTEM; MOLECULAR-CLONING; G-PROTEINS; DIFFERENTIAL LOCALIZATION; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; GENE-EXPRESSION; BINDING PROTEIN; NEURONS	The vomeronasal organ (VNO) mediates detection of pheromones related to social and reproductive behavior in most terrestrial vertebrates. We have identified a new multigene family of G protein-linked receptors (V2Rs) that are specifically expressed in the VNO. V2Rs have no significant homology to other putative pheromone receptors (V1Rs) or to olfactory receptors but are related to the Ca2+-sensing receptor and metabotropic glutamate receptors. V2Rs are expressed at high levels in small subpopulations of VNO neurons. V2Rs are primarily expressed in a different layer of VNO neurons from V1Rs, thus both gene families are likely to encode mammalian pheromone receptors.	UNIV PARMA,IST FISIOL UMANA,I-43100 PARMA,ITALY	University of Parma	Ryba, NJP (corresponding author), NIDR,TASTE & SMELL UNIT,ORAL INFECT & IMMUNOL BRANCH,NIH,BETHESDA,MD 20892, USA.			Ryba, Nicholas/0000-0002-2060-8393				AXEL R, 1995, SCI AM, V273, P219; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BARBER PC, 1974, BRAIN RES, V81, P21, DOI 10.1016/0006-8993(74)90476-4; BARBER PC, 1978, BRAIN RES, V147, P297, DOI 10.1016/0006-8993(78)90841-7; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Berghard A, 1996, J NEUROSCI, V16, P909; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CLANCY AN, 1984, J NEUROSCI, V4, P2222; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; JOHNS MA, 1978, NATURE, V272, P446, DOI 10.1038/272446a0; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; LOMAS DE, 1982, J REPROD FERTIL, V66, P101, DOI 10.1530/jrf.0.0660101; MEREDITH M, 1986, PHYSIOL BEHAV, V36, P737, DOI 10.1016/0031-9384(86)90362-8; MEREDITH M, 1994, PSYCHONEUROENDOCRINO, V19, P657, DOI 10.1016/0306-4530(94)90048-5; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; REYNOLDS J, 1979, J REPROD FERTIL, V57, P31; ROGERS KE, 1987, P NATL ACAD SCI USA, V84, P1704, DOI 10.1073/pnas.84.6.1704; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SHINOHARA H, 1992, J NEUROSCI, V12, P1275; TROEMEL ER, 1995, CELL, V83, P201; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; WALTON KM, 1993, NEURON, V11, P387, DOI 10.1016/0896-6273(93)90193-U; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wu YM, 1996, BIOCHEM BIOPH RES CO, V220, P900, DOI 10.1006/bbrc.1996.0503; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1980, SCIENCE, V207, P781, DOI 10.1126/science.7352288; WYSOCKI CJ, 1989, NEURAL CONTROL REPRO, P545	48	477	498	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					371	379		10.1016/S0896-6273(00)80946-0	http://dx.doi.org/10.1016/S0896-6273(00)80946-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292726	Bronze			2022-12-24	WOS:A1997XU14600015
J	Bosse, R; Fumagalli, F; Jaber, M; Giros, B; Gainetdinov, RR; Wetsel, WC; Missale, C; Caron, MG				Bosse, R; Fumagalli, F; Jaber, M; Giros, B; Gainetdinov, RR; Wetsel, WC; Missale, C; Caron, MG			Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter	NEURON			English	Article							HORMONE-RELEASING-FACTOR; TRANSFORMING GROWTH-FACTOR; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MESSENGER-RNA; RAT HYPOTHALAMUS; FACTOR GRF; PROLACTIN; RECEPTOR; PIT-1	Deletion of the dopamine transporter (DAT) results in increased dopaminergic tone, anterior pituitary hypoplasia, dwarfism, and an inability to lactate. DAT elimination alters the spatial distribution and dramatically reduces the numbers of lactotrophs and somatotrophs in the pituitary. Despite having normal circulating levels of growth hormone and prolactin in blood, hypoplastic glands from DAT(-/-) mice fail to respond to secretagog stimulation. The effects of DAT deletion on pituitary function result from elevated DA levels that down-regulate the lactotroph D-2 DA receptors and depress hypothalamic growth hormone-releasing hormone content. These results reveal an unexpected and important role or DA in the control of developmental events in the pituitary gland and assign a critical role for hypothalamic DA reuptake in regulating these events.	DUKE UNIV,MED CTR,DEPT CELL BIOL,HOWARD HUGHES MED INST LABS,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,HOWARD HUGHES MED INST LABS,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT PSYCHIAT & BEHAV SCI,HOWARD HUGHES MED INST LABS,DURHAM,NC 27710	Duke University; Duke University; Duke University			Fumagalli, Fabio/E-8992-2012; Missale, Mariacristina/E-6600-2010; GIROS, Bruno/ABD-5790-2021; Gainetdinov, Raul R/G-5875-2011	GIROS, Bruno/0000-0001-5876-9822; Gainetdinov, Raul R/0000-0003-2951-6038; Fumagalli, Fabio/0000-0002-8814-7706; Jaber, Mohamed/0000-0003-2536-1913				AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BARINAGA M, 1983, NATURE, V306, P84, DOI 10.1038/306084a0; BENDOTTI C, 1990, MOL BRAIN RES, V8, P343, DOI 10.1016/0169-328X(90)90048-I; BENJONATHAN N, 1985, ENDOCR REV, V6, P564, DOI 10.1210/edrv-6-4-564; BILLESTRUP N, 1986, P NATL ACAD SCI USA, V83, P6854, DOI 10.1073/pnas.83.18.6854; BJORKLUND A, 1973, BRAIN RES, V51, P171, DOI 10.1016/0006-8993(73)90371-5; BODNER M, 1987, CELL, V50, P267, DOI 10.1016/0092-8674(87)90222-4; BORGUNDVAAG B, 1992, ENDOCRINOLOGY, V130, P3453, DOI 10.1210/en.130.6.3453; BORRELLI E, 1992, P NATL ACAD SCI USA, V89, P2764, DOI 10.1073/pnas.89.7.2764; CARON MG, 1978, J BIOL CHEM, V253, P2244; CASTRILLO JL, 1991, SCIENCE, V253, P197, DOI 10.1126/science.1677216; CASTRILLO JL, 1989, SCIENCE, V243, P814, DOI 10.1126/science.2563596; CHOMCZYNSKI P, 1988, MOL ENDOCRINOL, V2, P236, DOI 10.1210/mend-2-3-236; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COTE TE, 1982, NEUROENDOCRINOLOGY, V35, P217, DOI 10.1159/000123384; CUNNAH D, 1991, CLIN ENDOCRINOL, V34, P231, DOI 10.1111/j.1365-2265.1991.tb00299.x; DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V; ELSHOLTZ HP, 1991, J BIOL CHEM, V266, P22919; ENJALBERT A, 1983, MOL PHARMACOL, V23, P576; FODOR M, 1994, J CHEM NEUROANAT, V8, P61, DOI 10.1016/0891-0618(94)90036-1; FRACKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849; FROHMAN LA, 1992, FRONT NEUROENDOCRIN, V13, P344; FULROTH R, 1989, AM J DIS CHILD, V143, P905, DOI 10.1001/archpedi.1989.02150200057018; Fumagalli F, 1996, BRAIN RES, V719, P225, DOI 10.1016/0006-8993(96)00119-9; GARRIS PA, 1991, BRAIN RES, V556, P123, DOI 10.1016/0006-8993(91)90555-A; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; GLUCKMAN PD, 1981, ENDOCR REV, V2, P363, DOI 10.1210/edrv-2-4-363; GUILLEMIN R, 1982, SCIENCE, V218, P585, DOI 10.1126/science.6812220; HALL H, 1991, PSYCHOPHARMACOLOGY, V103, P6, DOI 10.1007/BF02244067; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; KOBRIN MS, 1987, ENDOCRINOLOGY, V121, P1412, DOI 10.1210/endo-121-4-1412; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; MCANDREW J, 1995, ENDOCRINOLOGY, V136, P4479, DOI 10.1210/en.136.10.4479; MEISTER B, 1993, NEUROENDOCRINOLOGY, V58, P388, DOI 10.1159/000126568; MISSALE C, 1995, ENDOCRINOLOGY, V136, P1205, DOI 10.1210/en.136.3.1205; Missale C, 1996, P NATL ACAD SCI USA, V93, P4240, DOI 10.1073/pnas.93.9.4240; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; MULLER EE, 1987, PHYSIOL REV, V67, P962, DOI 10.1152/physrev.1987.67.3.962; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; OSAMURA RY, 1985, INT REV CYTOL, V95, P103, DOI 10.1016/S0074-7696(08)60580-X; PATTERSON JC, 1994, ENDOCRINOLOGY, V135, P1689, DOI 10.1210/en.135.4.1689; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; RATTRAY M, 1994, EUR J PHARM-MOLEC PH, V268, P439, DOI 10.1016/0922-4106(94)90070-1; RIVIER J, 1982, NATURE, V300, P276, DOI 10.1038/300276a0; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; SARKAR DK, 1982, SCIENCE, V218, P684, DOI 10.1126/science.7134966; SAWCHENKO PE, 1985, J COMP NEUROL, V237, P100, DOI 10.1002/cne.902370108; Smith RG, 1996, RECENT PROG HORM RES, V51, P261; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; STACK J, 1991, J PHYSIOL-LONDON, V439, P37, DOI 10.1113/jphysiol.1991.sp018655; SUHR ST, 1989, MOL ENDOCRINOL, V3, P1693, DOI 10.1210/mend-3-11-1693; VOSS JW, 1992, CELL, V70, P527, DOI 10.1016/0092-8674(92)90422-9; WASS JAH, 1983, CLIN ENDOCRINOL META, V12, P695, DOI 10.1016/S0300-595X(83)80061-9; YAMAUCHI N, 1991, REGUL PEPTIDES, V33, P71, DOI 10.1016/0167-0115(91)90016-A	58	152	154	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					127	138		10.1016/S0896-6273(00)80353-0	http://dx.doi.org/10.1016/S0896-6273(00)80353-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247269	Bronze			2022-12-24	WOS:A1997XN39400012
J	Gao, TY; Yatani, A; DellAcqua, ML; Sako, H; Green, SA; Dascal, N; Scott, JD; Hosey, MM				Gao, TY; Yatani, A; DellAcqua, ML; Sako, H; Green, SA; Dascal, N; Scott, JD; Hosey, MM			CAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits	NEURON			English	Article							PROTEIN-KINASE-A; CALCIUM CHANNELS; ANCHORING PROTEIN; ALPHA(1) SUBUNIT; BETA-SUBUNITS; MUSCLE CELLS; ASSOCIATION; EXPRESSION; RECEPTORS; SKELETAL	The cardiac L-type Ca2+ channel is a textbook example of an ion channel regulated by protein phosphorylation; however, the molecular events that underlie its regulation remain unknown. Here, we report that in transiently transfected HEK293 cells expressing L-type channels, elevations in cAMP resulted in phosphorylation of the alpha(1C) and beta(2a) channel subunits and increases in channel activity. Channel phosphorylation and regulation were facilitated by submembrane targeting of protein kinase A (PKA), through association with an A-kinase anchoring protein called AKAP79. In transfected cells expressing a mutant AKAP79 that is unable to bind PKA, phosphorylation of the alpha(1C) subunit and regulation of channel activity were not observed. Furthermore, we have demonstrated that the association of an AKAP with PKA was required for beta-adrenergic receptor-mediated regulation of L-type channels in native cardiac myocytes, illustrating that the events observed in the heterologous expression system reflect those occurring in the native system. Mutation of Ser1928 to alanine in the C-terminus of the alpha(1C) subunit resulted in a complete loss of cAMP-mediated phosphorylation and a loss of channel regulation. Thus, the PKA-mediated regulation of L-type Ca2+ channels is critically dependent on a functional AKAP and phosphorylation of the alpha(1C) subunit at Ser1928.	UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267; HOWARD HUGHES MED INST,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201; UNIV CINCINNATI,COLL MED,DEPT PULM MED,CINCINNATI,OH 45267; TEL AVIV UNIV,SACKLER SCH MED,DEPT PHYSIOL & PHARMACOL,IL-69978 RAMAT AVIV,ISRAEL	University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; Oregon Health & Science University; University System of Ohio; University of Cincinnati; Tel Aviv University; Sackler Faculty of Medicine	Gao, TY (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT BIOL CHEM & MOL PHARMACOL,CHICAGO,IL 60611, USA.		Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146; Dell'Acqua, Mark/0000-0003-3798-3461	NHLBI NIH HHS [HL23306] Funding Source: Medline; NIGMS NIH HHS [GM48231] Funding Source: Medline; NINDS NIH HHS [R21 NS094453] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL023306, R01HL023306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048231, R01GM048231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094453] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CARR DW, 1992, J BIOL CHEM, V267, P13376; CHANG FC, 1988, J BIOL CHEM, V263, P18929; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; COGHLAN VM, 1995, BIOCHEM SOC T, V23, P592, DOI 10.1042/bst0230592; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; De Waard M, 1996, Ion Channels, V4, P41; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; GAO T, 1997, IN PRESS J BIOL CHEM; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; Hosey MM, 1996, TRENDS CARDIOVAS MED, V6, P265, DOI 10.1016/S1050-1738(96)00109-0; Johnson BD, 1997, J NEUROSCI, V17, P1243; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Masaki H, 1997, AM J PHYSIOL-HEART C, V272, pH606, DOI 10.1152/ajpheart.1997.272.2.H606; MCCARTNEY S, 1995, J BIOL CHEM, V270, P9327, DOI 10.1074/jbc.270.16.9327; MCCARTNEY S, 1995, BIOCHEM SOC T, V23, pS268, DOI 10.1042/bst023268s; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Mitterdorfer J, 1996, BIOCHEMISTRY-US, V35, P9400, DOI 10.1021/bi960683o; NDUBUKA C, 1993, J BIOL CHEM, V268, P7621; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004, DOI 10.1074/jbc.270.48.29004; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; PEREZGARCIA MT, 1995, J GEN PHYSIOL, V105, P289, DOI 10.1085/jgp.105.2.289; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PEREZREYES E, 1994, FEBS LETT, V342, P119, DOI 10.1016/0014-5793(94)80484-2; PURI TS, 1997, IN PRESS BIOCHEMISTR; RICHARDSON RM, 1992, J BIOL CHEM, V267, P22249; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SINGERLAHAT D, 1994, RECEPTOR CHANNEL, V2, P215; WEI XY, 1994, J BIOL CHEM, V269, P1635; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Yamamoto S, 1996, J PHYSIOL-LONDON, V495, P733, DOI 10.1113/jphysiol.1996.sp021629; YATANI A, 1994, CIRC RES, V75, P315, DOI 10.1161/01.RES.75.2.315; YATANI A, 1995, CIRC RES, V76, P335, DOI 10.1161/01.RES.76.3.335; YOSHIDA A, 1992, FEBS LETT, V309, P343, DOI 10.1016/0014-5793(92)80804-P; ZONG XG, 1995, PFLUG ARCH EUR J PHY, V430, P340, DOI 10.1007/BF00373908	39	409	423	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					185	196		10.1016/S0896-6273(00)80358-X	http://dx.doi.org/10.1016/S0896-6273(00)80358-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247274	Bronze			2022-12-24	WOS:A1997XN39400017
J	Kikuchi, Y; Segawa, H; Tokumoto, M; Tsubokawa, T; Hotta, Y; Uyemura, K; Okamoto, H				Kikuchi, Y; Segawa, H; Tokumoto, M; Tsubokawa, T; Hotta, Y; Uyemura, K; Okamoto, H			Ocular and cerebellar defects in zebrafish induced by overexpression of the LIM domains of the islet-3 LIM/homeodomain protein	NEURON			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; MESSENGER-RNA EXPRESSION; HOMEOBOX-CONTAINING GENE; DNA-BINDING SPECIFICITY; EMBRYONIC ZEBRAFISH; COOPERATIVE INTERACTIONS; INT-1 PROTOONCOGENE; ENGRAILED GENES; XENOPUS-LAEVIS; CELL LINEAGE	Islet-3 is an LIM/homeodomain protein that is expressed specifically in the eyes and the presumptive tectum in the central nervous system of zebrafish (Danio rerio) embryos. Overexpression of the protein (LIM(Isl-3))consisting only of the Islet-3 LIM domains in embryos specifically prevented formation of the optic vesicles; caused abnormal termination of the expression of wnt1, engrailed2, and pax2 in the mesencephalic and metencephalic region between 14 hr and 20 hr postfertilization; and severely impaired morphogenetic movement in this region between 20 hr and 26 hr, which should normally lead to formation of the cerebellar primordium. Such defects were all rescued by simultaneous overexpression of Islet-3, suggesting that LIM(Isl-3) acted as a specific dominant-negative variant of Islet-3. These data, combined with the results of mosaic analyses, suggest that Islet-3 is activated by putative LIM-binding cofactors and functions to promote evagination of the optic vesicles and to maintain reciprocal interaction between the mesencephalon and the mesencephalic-metencephalic boundary essential for normal development of this region.	KEIO UNIV,SCH MED,DEPT REHABIL MED,SHINJUKU KU,TOKYO 160,JAPAN; NATL INST BASIC BIOL,DEPT CELL BIOL,DIV CELLULAR COMMUN,OKAZAKI,AICHI 444,JAPAN; UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN	Keio University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Tokyo	Kikuchi, Y (corresponding author), KEIO UNIV,SCH MED,DEPT PHYSIOL,SHINJUKU KU,TOKYO 160,JAPAN.		Okamoto, Hitoshi/P-9767-2015	Okamoto, Hitoshi/0000-0002-7512-8549; Kikuchi, Yutaka/0000-0001-5688-7358				Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; ALTABA ARI, 1992, DEVELOPMENT, V115, P67; ANG SL, 1993, DEVELOPMENT, V118, P139; Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; BALLYCUIF L, 1994, DEVELOPMENT, V120, P3379; BALLYCUIF L, 1995, MECH DEVELOP, V53, P23, DOI 10.1016/0925-4773(95)00421-1; BALLYCUIF L, 1995, CURR OPIN GENET DEV, V5, P450, DOI 10.1016/0959-437X(95)90048-L; Bang AG, 1996, CURR OPIN NEUROBIOL, V6, P25, DOI 10.1016/S0959-4388(96)80005-5; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; Copeland JWR, 1996, NATURE, V379, P162, DOI 10.1038/379162a0; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Daston MM, 1996, NEURON, V17, P5, DOI 10.1016/S0896-6273(00)80275-5; DAWLD IB, 1995, CR HEBD ACAD SCI, V318, P295; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; DONIACH T, 1992, SCIENCE, V257, P542, DOI 10.1126/science.1636091; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; EKKER M, 1992, DEVELOPMENT, V116, P1001; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; FJOSE A, 1992, MECH DEVELOP, V39, P51, DOI 10.1016/0925-4773(92)90025-F; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; GRAINGER RM, 1992, TRENDS GENET, V8, P349, DOI 10.1016/0168-9525(92)90280-H; HATTA K, 1991, DEVELOPMENT, V112, P821; HEMMATIBRIVANLOU A, 1990, SCIENCE, V250, P800, DOI 10.1126/science.1978411; HENRY JJ, 1990, DEV BIOL, V141, P149, DOI 10.1016/0012-1606(90)90110-5; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; JACOBSON AG, 1988, DEVELOPMENT, V104, P341; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KELLY GM, 1995, DEV GENET, V17, P129, DOI 10.1002/dvg.1020170205; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KORZH V, 1993, DEVELOPMENT, V118, P417; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; KRAUSS S, 1992, NATURE, V360, P87, DOI 10.1038/360087a0; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; MARIN F, 1994, DEV BIOL, V163, P19, DOI 10.1006/dbio.1994.1120; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MIKKOLA I, 1992, J NEUROBIOL, V23, P933, DOI 10.1002/neu.480230802; Miyagawa T, 1996, GENES CELLS, V1, P369, DOI 10.1046/j.1365-2443.1996.d01-246.x; MOLVEN A, 1991, EMBO J, V10, P799, DOI 10.1002/j.1460-2075.1991.tb08012.x; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Oliver G, 1995, DEVELOPMENT, V121, P4045; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PUSCHEL AW, 1992, DEVELOPMENT, V114, P643; PUSCHEL AW, 1992, MECH DEVELOP, V38, P197, DOI 10.1016/0925-4773(92)90053-M; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SANCHEZGARCIA I, 1993, EMBO J, V12, P4243, DOI 10.1002/j.1460-2075.1993.tb06108.x; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SAWADA K, 1990, JPN J OPHTHALMOL, V37, P355; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; TAIRA M, 1993, DEV BIOL, V159, P245, DOI 10.1006/dbio.1993.1237; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; TOKUMOTO M, 1995, DEV BIOL, V171, P578, DOI 10.1006/dbio.1995.1306; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WILSON SW, 1990, DEVELOPMENT, V108, P121; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239	75	55	56	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					369	382		10.1016/S0896-6273(00)81239-8	http://dx.doi.org/10.1016/S0896-6273(00)81239-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115732	Bronze			2022-12-24	WOS:A1997WQ07400006
J	Sontag, E; NunbhakdiCraig, V; Lee, G; Bloom, GS; Mumby, MC				Sontag, E; NunbhakdiCraig, V; Lee, G; Bloom, GS; Mumby, MC			Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A	NEURON			English	Article							PAIRED HELICAL FILAMENTS; CENTRAL NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MONOCLONAL-ANTIBODY; DEPHOSPHORYLATION; SUBUNIT; KINASE; BRAIN; IDENTIFICATION; SITES	Recently, we reported that a pool of protein phosphatase 2A (PP2A) is associated with microtubules. Here, we demonstrate that specific isoforms of PP2A bind and dephosphorylate the neuronal microtubule-associated protein tau. Coexpression of tau and SV40 small t, a specific inhibitor of PP2A, in CV-1, NIH 3T3, or NT2 cells induced the phosphorylation of tau at multiple sites, including Ser-199, Ser-202, Thr-205, Ser-396, and Ser-404. Immunofluorescent and biochemical analyses revealed that hyperphosphorylation correlated with dissociation of tau from microtubules and a loss of tau-induced microtubule stabilization. Taken together, these results support the hypothesis that PP2A controls the phosphorylation state of tau in vivo.	UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT NEUROSCI & CELL BIOL,DALLAS,TX 75235; HARVARD UNIV,SCH MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Sontag, E (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PATHOL,DALLAS,TX 75235, USA.		SONTAG, ESTELLE/AAE-9805-2020	Lee, Gloria/0000-0002-8633-1534	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030485] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL31107] Funding Source: Medline; NINDS NIH HHS [NS30485] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1993, J BIOL CHEM, V268, P3414; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GOEDERT M, 1995, NEUROBIOL AGING, V16, P325, DOI 10.1016/0197-4580(95)00017-9; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1994, FEBS LETT, V341, P94, DOI 10.1016/0014-5793(94)80247-5; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; KAMIBAYASHI C, 1991, J BIOL CHEM, V266, P13251; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; LEE G, 1992, J CELL SCI, V102, P227; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MorishimaKawashima M, 1996, MOL BIOL CELL, V7, P893, DOI 10.1091/mbc.7.6.893; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; MUMBY MC, 1985, J BIOL CHEM, V260, P3763; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; SAITO T, 1995, FEBS LETT, V376, P238, DOI 10.1016/0014-5793(95)01292-0; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; VALLEE RB, 1983, P NATL ACAD SCI-BIOL, V80, P6259, DOI 10.1073/pnas.80.20.6259; YAMAMOTO H, 1995, J BIOCHEM-TOKYO, V118, P1224, DOI 10.1093/oxfordjournals.jbchem.a125011; YANG SI, 1991, MOL CELL BIOL, V64, P1988	35	335	340	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1201	1207		10.1016/S0896-6273(00)80250-0	http://dx.doi.org/10.1016/S0896-6273(00)80250-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982166	Bronze			2022-12-24	WOS:A1996WA24800016
J	GrayKeller, MP; Detwiler, PB				GrayKeller, MP; Detwiler, PB			Ca2+ dependence of dark- and light-adapted flash responses in rod photoreceptors	NEURON			English	Article							CYTOPLASMIC CALCIUM-CONCENTRATION; CYCLIC-GMP PHOSPHODIESTERASE; OUTER SEGMENTS; RETINAL RODS; GUANYLATE-CYCLASE; ACTIVATION STEPS; SALAMANDER RODS; VERTEBRATE ROD; GATED CHANNEL; ADAPTATION	Light adaptation is thought to be orchestrated by a Ca2+ feedback signal that desensitizes the response by speeding recovery. To evaluate the role of Ca2+ in adaptation, we compared the effect of lowered Ca2+ on response properties in darkness and during adaptation. Internal Ca2+ was reduced from its normal resting dark level (535 nM) by either background illumination or exposure to Ringer's solution containing low Ca2+ and/or cyclic GMP-gated channel blockers in darkness. Ca2+ reductions in light decreased the activation gain of the transduction process and speeded recovery kinetics, while equivalent Ca2+ reductions in darkness caused similar gain reduction without accelerating recovery. This indicates that adaptational changes in the response are not due purely to feedback effects on recovery.			GrayKeller, MP (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.			Detwiler, Peter/0000-0003-3910-2023	NATIONAL EYE INSTITUTE [R01EY002048] Funding Source: NIH RePORTER; NEI NIH HHS [EY02048] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; FAIN GL, 1990, TRENDS NEUROSCI, V13, P378, DOI 10.1016/0166-2236(90)90023-4; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; JONES GJ, 1995, J PHYSIOL-LONDON, V487, P441, DOI 10.1113/jphysiol.1995.sp020891; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KORENBROT JI, 1989, VISION RES, V29, P939, DOI 10.1016/0042-6989(89)90108-9; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; LAGNADO L, 1994, NATURE, V367, P273, DOI 10.1038/367273a0; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; Matthews HR, 1996, J PHYSIOL-LONDON, V490, P1; MATTHEWS HR, 1995, J PHYSIOL-LONDON, V484, P267, DOI 10.1113/jphysiol.1995.sp020664; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MCCARTHY ST, 1994, BIOPHYS J, V67, P2076, DOI 10.1016/S0006-3495(94)80691-5; MCNAUGHTON PA, 1986, NATURE, V322, P261, DOI 10.1038/322261a0; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NICOL GD, 1989, J GEN PHYSIOL, V94, P233, DOI 10.1085/jgp.94.2.233; PANNBACKER RG, 1973, SCIENCE, V182, P1138, DOI 10.1126/science.182.4117.1138; PEPE IM, 1986, FEBS LETT, V203, P73, DOI 10.1016/0014-5793(86)81439-9; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PEPPERBERG DR, 1994, VISUAL NEUROSCI, V11, P53, DOI 10.1017/S095252380001110X; PUGH E, 1988, NATURE, V334, P16, DOI 10.1038/334016a0; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; QUANDT FN, 1991, NEUROSCIENCE, V42, P629, DOI 10.1016/0306-4522(91)90032-J; RATTO GM, 1988, J NEUROSCI, V8, P3240; RISPOLI G, 1993, J PHYSIOL-LONDON, V465, P513, DOI 10.1113/jphysiol.1993.sp019691; RISPOLI G, 1992, SIGNAL TRANSDUCTION, P217; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SATHER WA, 1988, THESIS U WASHINGTON; TAMURA T, 1991, J GEN PHYSIOL, V98, P95, DOI 10.1085/jgp.98.1.95; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	39	56	57	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					323	331		10.1016/S0896-6273(00)80163-4	http://dx.doi.org/10.1016/S0896-6273(00)80163-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780655	Bronze			2022-12-24	WOS:A1996VE84000014
J	Komuro, H; Rakic, P				Komuro, H; Rakic, P			Intracellular Ca2+ fluctuations modulate the rate of neuronal migration	NEURON			English	Article							CEREBELLAR GRANULE NEURONS; CELL-MIGRATION; ADHESION MOLECULE; HUMAN-NEUTROPHILS; CALCIUM CHANNELS; FURA-RED; INVITRO; GLIA; DIFFERENTIATION; MOTILITY	Transient elevations of intracellular Ca2+ levels play critical roles in neuronal development, but such elevations have not been demonstrated in migrating neurons. Here, we show that the amplitude and frequency components of Ca2+ fluctuations are correlated positively with the rate of granule cell movement in cerebellar microexplant cultures. Moreover, depression of the amplitude and frequency components of Ca2+ fluctuations by blockade of Ca2+ influx across the plasma membrane results in a reversible retardation of cell movement. These results indicate that the combination of amplitude and frequency components of intracellular Ca2+ fluctuations may provide an intracellular signal controlling the rate of neuronal cell migration.			Komuro, H (corresponding author), YALE UNIV, SCH MED, NEUROBIOL SECT, NEW HAVEN, CT 06510 USA.							Anton ES, 1996, J NEUROSCI, V16, P2283; ANTON ES, 1995, J NEUROSCI, V15, P584; ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; BRUNDAGE RA, 1993, AM J PHYSIOL, V265, pC1527, DOI 10.1152/ajpcell.1993.265.6.C1527; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; CAMERON RS, 1994, J NEUROSCI, V14, P3139; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; EDELMAN GM, 1984, ANNU REV NEUROSCI, V7, P339; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; FISHELL G, 1991, DEVELOPMENT, V113, P755; FLOTO RA, 1995, CELL CALCIUM, V18, P377, DOI 10.1016/0143-4160(95)90053-5; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOMEZ TM, 1995, NEURON, V14, P1233, DOI 10.1016/0896-6273(95)90270-8; GREGORY WA, 1988, J NEUROSCI, V8, P1728; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; HATTEN ME, 1984, J NEUROSCI, V4, P1163; HATTEN ME, 1986, J NEUROSCI, V6, P2676; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IVINS JK, 1991, J NEUROSCI, V11, P1597; JACONI MEE, 1991, J CELL BIOL, V112, P1249, DOI 10.1083/jcb.112.6.1249; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KATER SB, 1991, J NEUROSCI, V11, P891; KOMURO H, 1995, J NEUROSCI, V15, P1110; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; LANKFORD KL, 1989, J CELL BIOL, V109, P1229, DOI 10.1083/jcb.109.3.1229; LANKFORD KL, 1995, DEV BRAIN RES, V84, P151, DOI 10.1016/0165-3806(94)00159-W; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; LIPP P, 1993, BIOPHYS J, V65, P2272, DOI 10.1016/S0006-3495(93)81316-X; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; MINTA A, 1989, J BIOL CHEM, V264, P8171; MORAN D, 1991, AM J ANAT, V192, P14, DOI 10.1002/aja.1001920103; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; NELSON EJ, 1994, BIOCHEM J, V302, P147, DOI 10.1042/bj3020147; NEWGREEN DF, 1985, CELL TISSUE RES, V239, P329; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; RAKIC P, 1995, J NEUROBIOL, V26, P299, DOI 10.1002/neu.480260303; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; RAKIC P, 1975, COLD SPRING HARB SYM, V40, P333, DOI 10.1101/SQB.1976.040.01.033; Rakic P, 1985, CELL CONTACT ADHESIO, P67; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; RIVAS RJ, 1995, J NEUROSCI, V15, P981; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; SAWYER DW, 1985, SCIENCE, V230, P663, DOI 10.1126/science.4048951; SCHILD D, 1994, CELL CALCIUM, V15, P341, DOI 10.1016/0143-4160(94)90009-4; SHMIGOL A, 1995, NEUROSCIENCE, V65, P1109, DOI 10.1016/0306-4522(94)00553-H; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; SLATER NT, 1996, EXCITATORY AMINO ACI, P215; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1	64	347	353	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1996	17	2					275	285		10.1016/S0896-6273(00)80159-2	http://dx.doi.org/10.1016/S0896-6273(00)80159-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780651	hybrid			2022-12-24	WOS:A1996VE84000010
J	Shibuki, K; Gomi, H; Chen, L; Bao, SW; Kim, JSK; Wakatsuki, H; Fujisaki, T; Fujimoto, J; Katoh, A; Ikeda, T; Chen, C; Thompson, RF; Itohara, S				Shibuki, K; Gomi, H; Chen, L; Bao, SW; Kim, JSK; Wakatsuki, H; Fujisaki, T; Fujimoto, J; Katoh, A; Ikeda, T; Chen, C; Thompson, RF; Itohara, S			Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice	NEURON			English	Article							NICTITATING-MEMBRANE RESPONSE; PURKINJE-CELLS; MEMORY TRACE; RAT-BRAIN; SYNAPTIC DEPRESSION; GLUTAMATE RECEPTORS; MOUSE CEREBELLUM; CLIMBING FIBER; MESSENGER-RNA; LESIONS	Mice devoid of glial fibrillary acidic protein (GFAP), an intermediate filament protein specifically expressed in astrocytes, develop normally and do not show any detectable abnormalities in the anatomy of the brain. In the cerebellum, excitatory synaptic transmission from parallel fibers (PFs) or climbing fibers (CFs) to Purkinje cells is unaltered, and these synapses display normal short-term synaptic plasticity to paired stimuli in GFAP mutant mice. In contrast, long-term depression (LTD) at PF-Purkinje cell synapses is clearly deficient. Furthermore, GFAP mutant mice exhibited a significant impairment of eyeblink conditioning without any detectable deficits in motor coordination tasks. These results suggest that GFAP is required for communications between Bergmann glia and Purkinje cells during LTD induction and maintenance. The data support the notion that cerebellar LTD is a cellular mechanism closely associated with eyeblink conditioning, but is not essential for motor coordination tasks tested.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROPHYSIOL,NIIGATA 951,JAPAN; UNIV SO CALIF,PROGRAM NEURAL INFORMAT & BEHAV SCI,LOS ANGELES,CA 90089; KYOTO UNIV,FAC MED,DEPT ANAT,SAKYO KU,KYOTO 60601,JAPAN; MIT,CTR LEARNING & MEMORY,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139	Niigata University; University of Southern California; Kyoto University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Shibuki, K (corresponding author), KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 60601,JAPAN.		Itohara, Shigeyoshi/I-8769-2012; Katoh, Akira/B-2683-2010	Itohara, Shigeyoshi/0000-0002-2410-9989; Katoh, Akira/0000-0001-7867-2964; Kim, Jeansok/0000-0001-7964-106X; Chen, Lu/0000-0002-8097-2699				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ATTWELL D, 1994, NATURE, V369, P707, DOI 10.1038/369707a0; BAUDE A, 1994, J NEUROSCI, V14, P2830; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CHEN C, 1995, LEARN MEMORY, V185, P185; CLARK RE, 1992, BEHAV NEUROSCI, V106, P879, DOI 10.1037/0735-7044.106.6.879; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; CUENOD M, 1990, TRENDS PHARMACOL SCI, V11, P477; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Goldowitz Dan, 1992, V8, P271; GOMI H, 1995, NEURON, V14, P39; GRANDES P, 1991, EUR J NEUROSCI, V3, P1370, DOI 10.1111/j.1460-9568.1991.tb00070.x; IACOPINO AM, 1990, MOL BRAIN RES, V8, P283, DOI 10.1016/0169-328X(90)90041-B; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 1984, CEREBELLUM NEURAL CO; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; KRUPA DJ, 1993, THESIS U SO CALIFORN; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LAVOND DG, 1989, BEHAV BRAIN RES, V33, P113, DOI 10.1016/S0166-4328(89)80047-6; LAVOND DG, 1987, EXP BRAIN RES, V67, P569; LINCOLN JS, 1982, BRAIN RES, V242, P190, DOI 10.1016/0006-8993(82)90510-8; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LISBERGER SG, 1995, CURR BIOL, V5, P221, DOI 10.1016/S0960-9822(95)00043-1; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MALENKA RC, 1994, NATURE, V372, P218, DOI 10.1038/372218a0; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; MURPHY TH, 1993, J NEUROSCI, V13, P2672, DOI 10.1523/JNEUROSCI.13-06-02672.1993; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Peters A., 1991, FINE STRUCTURE NERVO; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P185, DOI 10.1016/0165-3806(84)90096-8; Polak M., 1982, HISTOL HISTOPATHOL, P363; RACINE RJ, 1986, EXP BRAIN RES, V63, P158; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SKELTON RW, 1988, BEHAV NEUROSCI, V102, P586, DOI 10.1037/0735-7044.102.4.586; STEINMETZ JE, 1992, J NEUROSCI, V12, P4403; TEICHBERG VI, 1991, FASEB J, V5, P3086, DOI 10.1096/fasebj.5.15.1660422; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; THOMPSON RF, 1993, SYNAPTIC PLASTICITY; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; WEISS C, 1991, NEUROBIOL AGING, V12, P249, DOI 10.1016/0197-4580(91)90105-S; WELSH JP, 1989, J NEUROSCI, V9, P299; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	72	281	286	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					587	599		10.1016/S0896-6273(00)80078-1	http://dx.doi.org/10.1016/S0896-6273(00)80078-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785056	Bronze			2022-12-24	WOS:A1996UC16800015
J	Denk, W; Holt, JR; Shepherd, GMG; Corey, DP				Denk, W; Holt, JR; Shepherd, GMG; Corey, DP			Calcium imaging of single stereocilia in hair cells: Localization of transduction channels at both ends of tip links	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; FLUORESCENCE MICROSCOPY; MECHANICAL STIMULATION; BUNDLE; ADAPTATION; CHICK; SENSITIVITY; DEPENDENCE; CURRENTS; COCHLEA	Mechanically gated ''transduction'' channels in inner ear hair cells are thought to be connected to tip links stretched between adjacent stereocilia. To locate active channels, calcium-green fluorescence in single stereocilia was measured with two-photon laser scanning microscopy. Bundle deflection increased fluorescence in many but not all stereocilia; the increase was blocked by depolarization. The number of stereocilia responding was proportional to the transduction current, consistent with Ca2+ influx through transduction channels. Fluorescence rose first in the tips of stereocilia and then in the bases, in agreement with channel localization at the tips. Some of the shortest stereocilia in a bundle showed a fluorescence increase, as did some of the tallest, indicating that transduction channels can be at either or both ends of tip links.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,NEUROL SERV,PROGRAM NEUROSCI,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,HOWARD HUGHES MED INST,NEUROL SERV,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Denk, W (corresponding author), AT&T BELL LABS,BIOL COMPUTAT RES DEPT,600 MT AVE,MURRAY HILL,NJ 07974, USA.		Shepherd, Gordon/F-2679-2010; denk, winfried/I-6627-2012		NIDCD NIH HHS [DC00304] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; COREY DP, 1980, J NEUROSCI METH, V3, P183, DOI 10.1016/0165-0270(80)90025-4; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DENK W, 1989, PHYS REV LETT, V63, P207, DOI 10.1103/PhysRevLett.63.207; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; Denk W., 1995, 2 PHOTON MOL EXCITAT, P445; EBERHARD M, 1991, BIOCHEM BIOPH RES CO, V180, P209, DOI 10.1016/S0006-291X(05)81278-1; FUCHS PA, 1992, J NEUROSCI, V12, P800; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; HACKNEY CM, 1992, P ROY SOC B-BIOL SCI, V248, P215, DOI 10.1098/rspb.1992.0064; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HIRAOKA Y, 1990, BIOPHYS J, V57, P325, DOI 10.1016/S0006-3495(90)82534-0; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; METCALF AB, 1994, P NATL ACAD SCI USA, V91, P11821, DOI 10.1073/pnas.91.25.11821; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; OHMORI H, 1988, J PHYSIOL-LONDON, V399, P115; OSBORNE MP, 1988, HEARING RES, V35, P99, DOI 10.1016/0378-5955(88)90044-5; PICKLES JO, 1992, TRENDS NEUROSCI, V15, P254, DOI 10.1016/0166-2236(92)90066-H; PICKLES JO, 1993, HEARING RES, V68, P159, DOI 10.1016/0378-5955(93)90120-P; PICKLES JO, 1991, HEARING RES, V54, P153, DOI 10.1016/0378-5955(91)90116-Q; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; RUSCH A, IN PRESS ANN NY ACAD, V781; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SHEPHERD GMG, 1991, J GEN PHYSIOL, V95, pA25; SHEPPARD CJR, 1990, OPTIK, V86, P104; Solc CK, 1994, AUDIT NEUROSCI, V1, P63; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Wilson T., 1984, THEORY PRACTICE SCAN; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	46	208	214	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1311	1321		10.1016/0896-6273(95)90010-1	http://dx.doi.org/10.1016/0896-6273(95)90010-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845155	Bronze			2022-12-24	WOS:A1995TL67800010
J	Tominaga, M; Caterina, MJ; Malmberg, AB; Rosen, TA; Gilbert, H; Skinner, K; Raumann, BE; Basbaum, AI; Julius, D				Tominaga, M; Caterina, MJ; Malmberg, AB; Rosen, TA; Gilbert, H; Skinner, K; Raumann, BE; Basbaum, AI; Julius, D			The cloned capsaicin receptor integrates multiple pain-producing stimuli	NEURON			English	Article							PRIMARY SENSORY NEURONS; ROOT GANGLION NEURONS; GENE-RELATED PEPTIDE; SPINAL-CORD; DORSAL HORN; RESINIFERATOXIN BINDING; H-3 RESINIFERATOXIN; ACTIVATED CURRENT; ACID-PHOSPHATASE; URINARY-BLADDER	Capsaicin, the main pungent ingredient in "hot" chili peppers, elicits burning pain by activating specific (vanilloid) receptors on sensory nerve endings. The cloned vanilloid receptor (VR1) is a cation channel that is also activated by noxious heat. Here, analysis of heat-evoked single channel currents in excised membrane patches suggests that heat gates VR1 directly. We also show that protons decrease the temperature threshold for VR1 activation such that even moderately acidic conditions (pH less than or equal to 5.9) activate VR1 at room temperature. VR1 can therefore be viewed as a molecular integrator of chemical and physical stimuli that elicit pain. Immunocytochemical analysis indicates that the receptor is located in a neurochemically heterogeneous population of small diameter primary afferent fibers. A role for VR1 in injury-induced hypersensitivity at the level of the sensory neuron is presented.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, W M Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.							ACS G, 1994, LIFE SCI, V55, P1017, DOI 10.1016/0024-3205(94)00636-9; Acs G, 1996, LIFE SCI, V59, P1899, DOI 10.1016/S0024-3205(96)00537-1; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BEVAN S, 1994, TRENDS NEUROSCI, V17, P509, DOI 10.1016/0166-2236(94)90149-X; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bevan S., 1993, CAPSAICIN STUDY PAIN, P27; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; DEVOR M, 1980, BRAIN RES, V190, P17, DOI 10.1016/0006-8993(80)91156-7; Dubner R, 1994, TXB PAIN, P225; Fields H. L., 1987, PAIN; FOX AJ, 1995, NEUROSCIENCE, V67, P741, DOI 10.1016/0306-4522(95)00115-Y; GEPPETTI P, 1990, NEUROSCI LETT, V114, P101, DOI 10.1016/0304-3940(90)90435-C; HAMMOND DL, 1991, J COMP NEUROL, V312, P436, DOI 10.1002/cne.903120310; Harlow E., 1988, ANTIBODIES LAB MANUA; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Kirschstein T, 1997, NEUROSCI LETT, V231, P33, DOI 10.1016/S0304-3940(97)00533-8; KONNERTH A, 1987, J PHYSIOL-LONDON, V386, P603, DOI 10.1113/jphysiol.1987.sp016553; Kress M, 1996, NEUROSCI LETT, V211, P5, DOI 10.1016/0304-3940(96)12691-4; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Levine J.D., 1994, TXB PAIN, P45; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; Liu L, 1997, NEUROSCI LETT, V228, P29, DOI 10.1016/S0304-3940(97)00358-3; LIU L, 1994, P NATL ACAD SCI USA, V91, P738, DOI 10.1073/pnas.91.2.738; LLEWELLYNSMITH IJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1741, DOI 10.1177/40.11.1431060; MAGGI CA, 1992, LIFE SCI, V51, P1777, DOI 10.1016/0024-3205(92)90047-S; MARFURT CF, 1981, J COMP NEUROL, V203, P785, DOI 10.1002/cne.902030414; MARTIN HA, 1987, NEUROSCIENCE, V22, P651, DOI 10.1016/0306-4522(87)90360-5; MEYER RA, 1981, SCIENCE, V213, P1527, DOI 10.1126/science.7280675; MEYER RA, 1994, TXB PAIN, P13; MOLANDER C, 1985, J COMP NEUROL, V237, P476, DOI 10.1002/cne.902370405; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MORGAN C, 1981, J COMP NEUROL, V201, P415, DOI 10.1002/cne.902010308; NAGY JI, 1983, J NEUROSCI, V3, P399; PETERSEN M, 1993, PAIN, V54, P37, DOI 10.1016/0304-3959(93)90097-9; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; RITTER S, 1992, J COMP NEUROL, V318, P103, DOI 10.1002/cne.903180108; SANTICIOLI P, 1993, BRIT J PHARMACOL, V110, P609, DOI 10.1111/j.1476-5381.1993.tb13854.x; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; STEEN KH, 1993, NEUROSCI LETT, V154, P113, DOI 10.1016/0304-3940(93)90184-M; STEEN KH, 1992, J NEUROSCI, V12, P86; STEVENS CR, 1991, ANN RHEUM DIS, V50, P124, DOI 10.1136/ard.50.2.124; Stoop R, 1997, J NEUROPHYSIOL, V78, P1837, DOI 10.1152/jn.1997.78.4.1837; STRICHARTZ G, 1987, ANNU REV NEUROSCI, V10, P237; Szallasi A, 1995, BRAIN RES, V703, P175, DOI 10.1016/0006-8993(95)01094-7; SZALLASI A, 1994, GEN PHARMACOL-VASC S, V25, P223, DOI 10.1016/0306-3623(94)90049-3; SZOLCSANYI J, 1988, BRAIN RES, V446, P262, DOI 10.1016/0006-8993(88)90885-2; Szolcsanyi J., 1993, CAPSAICIN STUDY PAIN, P1; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WINTER J, 1993, NEUROSCIENCE, V57, P747, DOI 10.1016/0306-4522(93)90021-7	57	2386	2491	13	164	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					531	543		10.1016/S0896-6273(00)80564-4	http://dx.doi.org/10.1016/S0896-6273(00)80564-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768840	Bronze			2022-12-24	WOS:000076196400010
J	Smith, GW; Aubry, JM; Dellu, F; Contarino, A; Bilezikjian, LM; Gold, LH; Chen, RP; Marchuk, Y; Hauser, C; Bentley, CA; Sawchenko, PE; Koob, GF; Vale, W; Lee, KF				Smith, GW; Aubry, JM; Dellu, F; Contarino, A; Bilezikjian, LM; Gold, LH; Chen, RP; Marchuk, Y; Hauser, C; Bentley, CA; Sawchenko, PE; Koob, GF; Vale, W; Lee, KF			Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development	NEURON			English	Article							MESSENGER-RIBONUCLEIC-ACID; PARVOCELLULAR NEUROSECRETORY NEURONS; RAT-BRAIN; VASOPRESSIN IMMUNOREACTIVITY; HORMONE-RECEPTOR; RNA EXPRESSION; CRF RECEPTOR; PLUS-MAZE; PITUITARY; BEHAVIOR	Corticotropin releasing factor (CRF) is a major integrator of adaptive responses to stress. Two biochemically and pharmacologically distinct CRF receptor subtypes (CRFR1 and CRFR2) have been described. We have generated mice null for the CRFR1 gene to elucidate the specific developmental and physiological roles of CRF receptor mediated pathways. Behavioral analyses revealed that mice lacking CRFR1 displayed markedly reduced anxiety. Mutant mice also failed to exhibit the characteristic hormonal response to stress due to a disruption of the hypothalamic-pituitary-adrenal (HPA) axis. Homozygous mutant mice derived from crossing heterozygotes displayed low plasma corticosterone concentrations resulting from a marked agenesis of the zona fasciculata region of the adrenal gland. The offspring from homozygote crosses died within 48 hr after birth due to a pronounced lung dysplasia. The adrenal agenesis in mutant animals was attributed to insufficient adrenocorticotropic hormone (ACTH) production during the neonatal period and was rescued by ACTH replacement. These results suggest that CRFR1 plays an important role both in the development of a functional HPA axis and in mediating behavioral changes associated with anxiety.	Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Salk Inst, Lab Neuronal Struct & Funct, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Lee, KF (corresponding author), Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		LE MOINE, Catherine/E-2671-2014; Contarino, Angelo/C-9429-2014	Contarino, Angelo/0000-0002-7286-6941	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009551, P01DK026741] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK09551, DK-26741] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1994, SEMIN NEUROSCI; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; AvishaiEliner S, 1996, DEV BRAIN RES, V91, P159, DOI 10.1016/0165-3806(95)00158-1; BALLARD PL, 1989, ENDOCR REV, V10, P165, DOI 10.1210/edrv-10-2-165; BRITTON KT, 1986, LIFE SCI, V39, P1281, DOI 10.1016/0024-3205(86)90189-X; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHAN RKW, 1993, J NEUROSCI, V13, P5126, DOI 10.1523/JNEUROSCI.13-12-05126.1993; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; DAIKOKU S, 1976, CELL TISSUE RES, V168, P549, DOI 10.1007/BF00216002; DENENBERG VH, 1967, BIOL BEHAVIOR NEUROP, P161; GERTZ BJ, 1987, ENDOCRINOLOGY, V120, P381, DOI 10.1210/endo-120-1-381; Grigoriadis DE, 1996, ANN NY ACAD SCI, V780, P60, DOI 10.1111/j.1749-6632.1996.tb15112.x; Heinrichs SC, 1997, REGUL PEPTIDES, V71, P15, DOI 10.1016/S0167-0115(97)01005-7; Idelman S, 1970, Int Rev Cytol, V27, P181, DOI 10.1016/S0074-7696(08)61248-6; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Mansi JA, 1996, ENDOCRINOLOGY, V137, P4619, DOI 10.1210/en.137.11.4619; Martinez V, 1997, J PHARMACOL EXP THER, V280, P754; MISSLIN R, 1989, BEHAV PROCESS, V18, P119, DOI 10.1016/S0376-6357(89)80010-5; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; ORTH DN, 1992, ENDOCR REV, V13, P164, DOI 10.1210/er.13.2.164; OWENS MJ, 1991, PHARMACOL REV, V43, P425; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; POTTER E, 1994, P NATL ACAD SCI USA, V91, P8777, DOI 10.1073/pnas.91.19.8777; Pozzoli G, 1996, ENDOCRINOLOGY, V137, P65, DOI 10.1210/en.137.1.65; RabadanDiehl C, 1996, ENDOCRINOLOGY, V137, P3808, DOI 10.1210/en.137.9.3808; RIVEST S, 1995, J NEUROSCI, V15, P2680; SAWCHENKO PE, 1984, P NATL ACAD SCI-BIOL, V81, P1883, DOI 10.1073/pnas.81.6.1883; SAWCHENKO PE, 1987, J NEUROSCI, V7, P1093; Schulz DW, 1996, P NATL ACAD SCI USA, V93, P10477, DOI 10.1073/pnas.93.19.10477; SKUTELLA T, 1994, NEUROREPORT, V5, P2181, DOI 10.1097/00001756-199410270-00048; STENZEL P, 1995, MOL ENDOCRINOL, V9, P637, DOI 10.1210/me.9.5.637; SWIERGIEL AH, 1993, BRAIN RES, V623, P229, DOI 10.1016/0006-8993(93)91432-R; TAKAHASHI LK, 1989, BEHAV NEUROSCI, V103, P648, DOI 10.1037/0735-7044.103.3.648; Vale W, 1997, ENDOCRINOLOGIST, V7, pS3, DOI 10.1097/00019616-199707011-00002; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VALE W, 1983, METHODS ENZYMOLOGY N, P585; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; WOOD P, 1984, ADV NEUROCHEM, V5, P1; WYLLIE AH, 1973, J PATHOL, V111, P85, DOI 10.1002/path.1711110203; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	46	698	716	1	44	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1093	1102		10.1016/S0896-6273(00)80491-2	http://dx.doi.org/10.1016/S0896-6273(00)80491-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655498	Bronze			2022-12-24	WOS:000074627300006
J	Calver, AR; Hall, AC; Yu, WP; Walsh, FS; Heath, JK; Betsholtz, C; Richardson, WD				Calver, AR; Hall, AC; Yu, WP; Walsh, FS; Heath, JK; Betsholtz, C; Richardson, WD			Oligodendrocyte population dynamics and the role of PDGF in vivo	NEURON			English	Article							RAT OPTIC-NERVE; GLIAL PROGENITOR-CELL; GROWTH-FACTOR; DEVELOPMENTAL CLOCK; TYPE-2 ASTROCYTE; NG2 PROTEOGLYCAN; PRECURSOR CELLS; SPINAL-CORD; PROLIFERATION; LINEAGE	Oligodendrocyte progenitors originate near the floor plate of the spinal cord, then proliferate and migrate throughout the cord before giving rise to oligodendrocytes. Progenitor cell proliferation stops before birth because the cell cycle slows down, linked to an increase in differentiation and death. Experiments with transgenic mice show that platelet-derived growth factor (PDGF) drives progenitor cell division and suggest that slowing of and exit from the cycle reflects a decline in PDGF signaling. Overexpressing PDGF induces hyperproliferation of progenitor cells and excessive, ectopic production of oligodendrocytes. However, the superfluous oligodendrocytes die at an immature stage of differentiation, leaving a normal complement of myelin-forming cells. Therefore, cell survival controls override proliferation controls for determining the final number and distribution of mature oligodendrocytes.	Univ London Univ Coll, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; Univ London Univ Coll, Dept Biol, London WC1E 6BT, England; Gothenburg Univ, Dept Med Biochem, S-41390 Gothenburg, Sweden; Univ Birmingham, Sch Biochem, Birmingham B15 2TT, W Midlands, England; SmithKline Beecham Pharmaceut, Dept Neurosci Res, Harlow CM19 5AW, Essex, England	University of London; University College London; University of London; University College London; University of Gothenburg; University of Birmingham; GlaxoSmithKline	Calver, AR (corresponding author), Univ London Univ Coll, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.		Richardson, William/C-1762-2008; Messier, Claude/A-2322-2008	Richardson, William/0000-0001-7261-2485; Messier, Claude/0000-0002-4791-1763				BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; BROOKS RF, 1988, J CELL SCI, V90, P601; Burne JF, 1996, J NEUROSCI, V16, P2064; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; ELLISON JA, 1994, J NEUROSCI RES, V37, P116, DOI 10.1002/jnr.490370116; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; FULTON BP, 1991, ANN NY ACAD SCI, V633, P27; Gao FB, 1997, CURR BIOL, V7, P152, DOI 10.1016/S0960-9822(06)00060-1; Gao FB, 1997, J CELL BIOL, V138, P1367, DOI 10.1083/jcb.138.6.1367; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; Hall A, 1996, DEVELOPMENT, V122, P4085; Hardy RJ, 1996, DEVELOPMENT, V122, P2059; HART IK, 1989, DEVELOPMENT, V105, P595; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; Ibarrola N, 1996, DEV BIOL, V180, P1, DOI 10.1006/dbio.1996.0280; JORDAN C, 1989, J NEUROSCI, V9, P248; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MAGAUD JP, 1989, J HISTOCHEM CYTOCHEM, V37, P1517, DOI 10.1177/37.10.2476478; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Pollock RA, 1992, GROWTH FACTORS, V7, P267, DOI 10.3109/08977199209046409; PRINGLE N, 1989, EMBO J, V8, P1049, DOI 10.1002/j.1460-2075.1989.tb03472.x; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; RAFF MC, 1985, CELL, V42, P61, DOI 10.1016/S0092-8674(85)80101-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; RICHARDSON WD, 1997, DEV NEUROSCI, V19, P54; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHIELDS R, 1977, J CELL PHYSIOL, V91, P345, DOI 10.1002/jcp.1040910304; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; TAKAHASHI T, 1994, P NATL ACAD SCI USA, V91, P375, DOI 10.1073/pnas.91.1.375; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; ZHANG H, 1995, MOL CELL NEUROSCI, V6, P16, DOI 10.1006/mcne.1995.1003	57	383	391	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					869	882		10.1016/S0896-6273(00)80469-9	http://dx.doi.org/10.1016/S0896-6273(00)80469-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620692	Bronze			2022-12-24	WOS:000073864700007
J	Jareb, M; Banker, G				Jareb, M; Banker, G			The polarized sorting of membrane proteins expressed in cultured hippocampal neurons using viral vectors	NEURON			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; CANINE KIDNEY-CELLS; INFLUENZA-VIRUS HEMAGGLUTININ; HUMAN TRANSFERRIN RECEPTOR; GPI-ANCHORED PROTEINS; EPITHELIAL-CELLS; MDCK CELLS; PLASMA-MEMBRANE; CYTOPLASMIC DOMAIN	One model of neuronal polarity (Dotti and Simons, 1990) proposes that neurons and polarized epithelia use similar mechanisms to sort membrane proteins. To explore this hypothesis, we used viral vectors to express proteins in cultured neurons and assessed their distribution using quantitative immunofluorescence microscopy. Basolateral epithelial proteins were polarized to dendrites; more significantly, mutations of sequences required for their basolateral targeting in epithelia also disrupted dendritic targeting. Unexpectedly, apical proteins were not polarized to axons but were expressed at roughly equal amounts in dendrites and axons. These data provide strong evidence that targeting of basolateral and dendritic proteins depends on common mechanisms. In contrast, the sorting of proteins to the axon requires signals that are not present in apical proteins.	Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia	Banker, G (corresponding author), Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, L606,3181 SW Sam Jackson Pk Rd, Portland, OR 97210 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017112] Funding Source: NIH RePORTER; NICHD NIH HHS [HD07323] Funding Source: Medline; NINDS NIH HHS [NS17112] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn J, 1996, J BIOL CHEM, V271, P6917, DOI 10.1074/jbc.271.12.6917; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BINDER LI, 1984, P NATL ACAD SCI-BIOL, V81, P5613, DOI 10.1073/pnas.81.17.5613; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; DANIELSEN EM, 1995, BIOCHEMISTRY-US, V34, P1596, DOI 10.1021/bi00005a016; DEHOOP M, 1995, J CELL BIOL, V130, P1447, DOI 10.1083/jcb.130.6.1447; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1993, BRAIN RES, V610, P141, DOI 10.1016/0006-8993(93)91227-J; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; FAIVRESARRAILH C, 1992, J NEUROSCI, V12, P257; FAIVRESARRAILH C, 1993, MOL NEUROBIOL, V7, P49, DOI 10.1007/BF02780608; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; GOSLIN K, 1997, CULTURING NERVE CELL, P252; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; HANNAN LA, 1993, J CELL BIOL, V120, P353, DOI 10.1083/jcb.120.2.353; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HO DY, 1995, J NEUROSCI METH, V57, P205, DOI 10.1016/0165-0270(94)00150-F; HO DY, 1994, METHOD CELL BIOL, V43, P191; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; KEMBLE GW, 1992, J VIROL, V66, P4940, DOI 10.1128/JVI.66.8.4940-4950.1992; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KUNDU A, 1994, J VIROL, V68, P1812, DOI 10.1128/JVI.68.3.1812-1818.1994; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LEGALL AH, 1995, SEMIN NEPHROL, V15, P272; LEMMON V, 1986, J NEUROSCI, V6, P2987; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1990, J MEMBRANE BIOL, V113, P155, DOI 10.1007/BF01872889; LOWENSTEIN PR, 1994, NEUROSCIENCE, V60, P1059, DOI 10.1016/0306-4522(94)90283-6; Mandell JW, 1996, J NEUROSCI, V16, P5727; MATLIN KS, 1984, J CELL BIOL, V99, P2131, DOI 10.1083/jcb.99.6.2131; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; MIGLIACCIO G, 1990, EUR J CELL BIOL, V52, P291; Mirre C, 1996, AM J PHYSIOL-CELL PH, V271, pC887, DOI 10.1152/ajpcell.1996.271.3.C887; MISEK DE, 1984, CELL, V39, P537, DOI 10.1016/0092-8674(84)90460-4; MORRIS RJ, 1985, J NEUROCYTOL, V14, P427, DOI 10.1007/BF01217754; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; MOSTOV KE, 1995, BIOESSAYS, V17, P129, DOI 10.1002/bies.950170208; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Musch A, 1996, J CELL BIOL, V133, P543, DOI 10.1083/jcb.133.3.543; NEWMAN LS, 1995, CELL, V82, P773, DOI 10.1016/0092-8674(95)90474-3; Odorizzi G, 1997, J CELL BIOL, V137, P1255, DOI 10.1083/jcb.137.6.1255; Odorizzi G, 1996, J CELL BIOL, V135, P139, DOI 10.1083/jcb.135.1.139; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OMARY MB, 1981, J BIOL CHEM, V256, P4715; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; PEREZVELAZQUEZ JL, 1993, NATURE, V361, P457, DOI 10.1038/361457a0; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071; ROMAN LM, 1986, J CELL BIOL, V103, P2607, DOI 10.1083/jcb.103.6.2607; SIMONS M, 1995, J NEUROSCI RES, V41, P121, DOI 10.1002/jnr.490410114; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; SKIBBENS JE, 1989, J CELL BIOL, V108, P821, DOI 10.1083/jcb.108.3.821; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; VAN MEER G, 1988, J CELL BIOCHEM, V36, P51, DOI 10.1002/jcb.240360106; VANDENPOL AN, 1993, J COMP NEUROL, V332, P237, DOI 10.1002/cne.903320208; Vogt L, 1996, CURR BIOL, V6, P1153, DOI 10.1016/S0960-9822(02)70682-9; WARD CW, 1981, BIOCHEM J, V193, P953, DOI 10.1042/bj1930953; West AE, 1997, J NEUROSCI, V17, P6038; XUE GP, 1990, DEVELOPMENT, V109, P851; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; Yoon SO, 1996, P NATL ACAD SCI USA, V93, P11974, DOI 10.1073/pnas.93.21.11974; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247	78	151	152	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					855	867		10.1016/S0896-6273(00)80468-7	http://dx.doi.org/10.1016/S0896-6273(00)80468-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620691	hybrid			2022-12-24	WOS:000073864700006
J	Forsythe, ID; Tsujimoto, T; Barnes-Davies, M; Cuttle, MF; Takahashi, T				Forsythe, ID; Tsujimoto, T; Barnes-Davies, M; Cuttle, MF; Takahashi, T			Inactivation of presynaptic calcium current contributes to synaptic depression at a fast central synapse	NEURON			English	Article							AUDITORY BRAIN-STEM; SQUID GIANT SYNAPSE; MEDIAL NUCLEUS; TRAPEZOID BODY; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; COCHLEAR NUCLEUS; AMPA RECEPTORS; CHANNEL TYPES; N-TYPE	Voltage-gated calcium channels are well characterized at neuronal somata but less thoroughly understood at the presynaptic terminal where they trigger transmitter release. In order to elucidate how the intrinsic properties of presynaptic calcium channels influence synaptic function, we have made direct recordings of the presynaptic calcium current (I-pCa) in a brainstem giant synapse called the calyx of Held. The current was pharmacologically classified as P-type and exhibited marked inactivation. The inactivation was largely dependent upon the inward calcium current magnitude rather than the membrane potential, displayed little selectivity between divalent charge carriers (Ca2+, Ba2+ and Sr2+), and exhibited slow recovery. Simultaneous pre-and postsynaptic whole-cell recording revealed that I-pCa inactivation predominantly contributes to posttetanic depression of EPSCs. Thus, because of its slow recovery, I-pCa inactivation underlies this short-term synaptic plasticity.	Univ Leicester, Dept Cell Physiol & Pharmacol, Ion Channel Grp, Leicester LE1 9HN, Leics, England; Univ Tokyo, Fac Med, Dept Neurophysiol, Tokyo 113, Japan	University of Leicester; University of Tokyo	Forsythe, ID (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Ion Channel Grp, Leicester LE1 9HN, Leics, England.		Takahashi, Tomoyuki/G-5951-2015	Takahashi, Tomoyuki/0000-0002-8771-7666; Forsythe, Ian/0000-0001-8216-0419	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALMERS W, 1981, J PHYSIOL-LONDON, V312, P177, DOI 10.1113/jphysiol.1981.sp013623; ASHCROFT FM, 1981, SCIENCE, V213, P224, DOI 10.1126/science.213.4504.224; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Branchaw JL, 1997, J NEUROSCI, V17, P5772; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; COX DH, 1994, J GEN PHYSIOL, V104, P311, DOI 10.1085/jgp.104.2.311; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Eccles, 2013, PHYSL SYNAPSES; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Ferreira G, 1997, J GEN PHYSIOL, V109, P449, DOI 10.1085/jgp.109.4.449; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; FORSYTHE ID, 1995, EXCITATORY AMINO ACI, P133; FRIAUF E, 1988, EXP BRAIN RES, V73, P263; Hille B., 1992, ION CHANNELS EXCITAB; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; KATZ B, 1971, J PHYSIOL-LONDON, V216, P503, DOI 10.1113/jphysiol.1971.sp009537; Katz B., 1969, RELEASE NEURAL TRANS; KATZ E, 1997, J PHYSIOL-LONDON, V97, P687; KONNERTH A, 1987, J PHYSIOL-LONDON, V386, P603, DOI 10.1113/jphysiol.1987.sp016553; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LEMOS JR, 1989, NEURON, V2, P1419, DOI 10.1016/0896-6273(89)90187-6; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Ludwig A, 1997, J NEUROSCI, V17, P1339; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; Oertel D, 1997, NEURON, V19, P959, DOI 10.1016/S0896-6273(00)80388-8; OERTEL D, 1985, J ACOUST SOC AM, V78, P328, DOI 10.1121/1.392494; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Otis T, 1996, J NEUROSCI, V16, P7496; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SIVARAMAKRISHNAN S, 1995, J NEUROSCI, V15, P6576; STANLEY EF, 1991, J NEUROSCI, V11, P985; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; vonGersdorff H, 1996, J NEUROSCI, V16, P115; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; WU SH, 1993, HEARING RES, V68, P189, DOI 10.1016/0378-5955(93)90123-I; YAWO H, 1993, J PHYSIOL-LONDON, V460, P153, DOI 10.1113/jphysiol.1993.sp019464; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301	59	284	287	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					797	807		10.1016/S0896-6273(00)81017-X	http://dx.doi.org/10.1016/S0896-6273(00)81017-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581770	Bronze			2022-12-24	WOS:000073346500017
J	Nicolson, T; Rusch, A; Friedrich, RW; Granato, M; Ruppersberg, JP; Nusslein-Volhard, C				Nicolson, T; Rusch, A; Friedrich, RW; Granato, M; Ruppersberg, JP; Nusslein-Volhard, C			Genetic analysis of vertebrate sensory hair cell mechanosensation: the zebrafish circler mutants	NEURON			English	Article							TRANSDUCTION CHANNELS; INNER-EAR; MECHANOELECTRICAL TRANSDUCTION; CAENORHABDITIS-ELEGANS; STEREOCILIA; DEAFNESS; INTEGRITY; BUNDLE; LINKS	The molecular basis of sensory hair cell mechanotransduction is largely unknown. In order to identify genes that are essential for mechanosensory hair cell function, we characterized a group of recently isolated zebrafish motility mutants. These mutants are defective in balance and swim in circles but have no obvious morphological defects. We examined the mutants using calcium imaging of acoustic-vibrational and tactile escape responses, high resolution microscopy of sensory neuroepithelia in live larvae, and recordings of extracellular hair cell potentials (microphonics). Based on the analyses, we have identified several classes of genes. Mutations in sputnik and mariner affect hair bundle integrity. Mutant astronaut and cosmonaut hair cells have relatively normal microphonics and thus appear to affect events downstream of mechanotransduction. Mutant orbiter, mercury, and gemini larvae have normal hair cell morphology and yet do not respond to acoustic-vibrational stimuli. The microphonics of lateral line hair cells of orbiter, mercury, and gemini larvae are absent or strongly reduced. Therefore, these genes may encode components of the transduction apparatus.	Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany; Max Planck Inst Entwicklungsbiol, Phys Biol Abt, D-72076 Tubingen, Germany; Max Planck Inst Entwicklungsbiol, Inst Physiol, D-72076 Tubingen, Germany; Univ Tubingen, Hals Nasen Ohren Klin, Sekt Sensor Biophys, D-72076 Tubingen, Germany; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Max Planck Society; Max Planck Society; Max Planck Society; Eberhard Karls University of Tubingen; University of Pennsylvania	Nicolson, T (corresponding author), Max Planck Inst Entwicklungsbiol, Genet Abt, Spemannstr 35, D-72076 Tubingen, Germany.			Friedrich, Rainer/0000-0001-9107-0482				[Anonymous], PUBL ZOOL STAT NAPOL; ASHMORE JF, 1991, ANNU REV PHYSIOL, V53, P465, DOI 10.1146/annurev.physiol.53.1.465; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; BAGGERSJOBACK D, 1973, J NEUROCYTOL, V2, P329, DOI 10.1007/BF01104034; BROWN SDM, 1994, HUM MOL GENET, V3, P1453, DOI 10.1093/hmg/3.suppl_1.1453; COREY DP, 1983, J NEUROSCI, V3, P962; CORWIN JT, 1991, ANNU REV NEUROSCI, V14, P301, DOI 10.1146/annurev.neuro.14.1.301; Cox KJA, 1996, J NEUROSCI METH, V68, P185; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; FLOCK A, 1962, J CELL BIOL, V15, P19, DOI 10.1083/jcb.15.1.19; FLOCK A, 1965, COLD SPRING HARB SYM, V30, P133, DOI 10.1101/SQB.1965.030.01.016; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILLESPIE P, 1995, CURR BIOL, V4, P449; Granato M, 1996, DEVELOPMENT, V123, P399; HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1, DOI 10.1152/ajpcell.1995.268.1.C1; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Haffter P, 1996, DEVELOPMENT, V123, P1; Hamill OP, 1996, TRENDS NEUROSCI, V19, P258, DOI 10.1016/S0166-2236(96)30009-X; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; JORGENSEN F, 1988, J PHYSIOL-LONDON, V403, P577, DOI 10.1113/jphysiol.1988.sp017265; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; Korn H, 1996, CURR OPIN NEUROBIOL, V6, P826, DOI 10.1016/S0959-4388(96)80034-1; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; LITTLE KF, 1985, CELL TISSUE RES, V242, P427; Malicki J, 1996, DEVELOPMENT, V123, P275; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; OSBORNE MP, 1984, CELL TISSUE RES, V237, P43; PFEIFFER WOLFGANG, 1964, INT REV GEN EXP ZOOL, V1, P77; PICKLES JO, 1993, HEARING RES, V68, P159, DOI 10.1016/0378-5955(93)90120-P; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; PLATT C, 1993, HEARING RES, V65, P133, DOI 10.1016/0378-5955(93)90208-I; POPPER AN, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P49; Popper Arthur N., 1993, P99; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; THURM U, 1981, BIOPHYS STRUCT MECH, V7, P245, DOI 10.1007/BF02425378; VONBAUMGARTEN RJ, 1975, AVIAT SPACE ENVIR MD, V46, P902; VONHOLST E, 1950, Z VERGL PHYSIOL, V32, P60; Whitfield TT, 1996, DEVELOPMENT, V123, P241	48	225	228	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					271	283		10.1016/S0896-6273(00)80455-9	http://dx.doi.org/10.1016/S0896-6273(00)80455-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491988	hybrid			2022-12-24	WOS:000072154700012
J	Gabso, M; Neher, E; Spira, ME				Gabso, M; Neher, E; Spira, ME			Low mobility of the Ca2+ buffers in axons of cultured Aplysia neurons	NEURON			English	Article							CALCIUM-BINDING PROTEINS; HIPPOCAMPAL-NEURONS; MOLLUSCAN NEURONS; CHROMAFFIN CELLS; DIFFUSION; INFLUX; CA-2+; MODULATION; GRADIENTS; DENDRITES	Cellular Ca2+ buffers determine amplitude and diffusional spread of neuronal Ca2+ signals. Fixed Ca2+ buffers tend to retard the signal and to lower the apparent diffusion coefficient (D-app) of Ca2+, whereas mobile buffers contribute to Ca2+ redistribution. To estimate the impact of the expression of specific Ca2+-binding proteins or the errors in Ca2+ measurement introduced by indicator dyes, the diffusion coefficient D-e and the Ca2+-binding ratio kappa(e) of endogenous Ca2+ buffers must be known. In this study, we obtain upper bounds to these quantities (D-e < 16 mu m(2)/s; kappa(e) < 60) for axoplasm of metacerebral cells of Aplysia california. Due to these very low values, even minute concentrations of indicator dyes will interfere with the spatiotemporal pattern of Ca2+ signals and will conceal changes in the expression of specific Ca2+-binding proteins, which in the native neuron are expected to have significant effects on Ca2+ signals.	MAX PLANCK INST BIOPHYS CHEM,D-37033 GOTTINGEN,GERMANY	Max Planck Society	Gabso, M (corresponding author), HEBREW UNIV JERUSALEM,INST LIFE SCI,DEPT NEUROBIOL,INTERUNIV INST MARINE SCI EILAT ISRAEL,IL-91904 JERUSALEM,ISRAEL.		Spira, Micha/B-6470-2012; Neher, Erwin/A-2109-2013					AHMED Z, 1988, CELL CALCIUM, V9, P57, DOI 10.1016/0143-4160(88)90025-5; ALBALDAWI NF, 1995, CELL CALCIUM, V17, P409, DOI 10.1016/0143-4160(95)90087-X; ALBALDAWI NF, 1995, CELL CALCIUM, V17, P422, DOI 10.1016/0143-4160(95)90088-8; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BENZONANA G, 1972, BIOCHIM BIOPHYS ACTA, V278, P110, DOI 10.1016/0005-2795(72)90111-0; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; FIELDS RD, 1994, J NEUROBIOL, V25, P281, DOI 10.1002/neu.480250308; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heizmann C. W., 1995, CALCIUM REGULATION C; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HERMANN A, 1991, CELL MOL NEUROBIOL, V11, P371, DOI 10.1007/BF00711419; HODGKIN AL, 1957, J PHYSIOL-LONDON, V138, P253, DOI 10.1113/jphysiol.1957.sp005850; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; KASAI H, 1993, NEUROSCI RES, V16, P1, DOI 10.1016/0168-0102(93)90002-8; KONOSU S, 1965, BIOCHEM J, V96, P98, DOI 10.1042/bj0960098; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; LOWENSTEIN DH, 1991, NEURON, V6, P627, DOI 10.1016/0896-6273(91)90065-8; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; NASI E, 1985, BIOPHYS J, V47, P735, DOI 10.1016/S0006-3495(85)83972-2; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SMITH SJ, 1980, J PHYSIOL-LONDON, V300, P167, DOI 10.1113/jphysiol.1980.sp013157; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; TIMMERMAN MP, 1986, FEBS LETT, V209, P1, DOI 10.1016/0014-5793(86)81073-0; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; YAO Y, 1994, J PHYSIOL-LONDON, V476, P17; ZADOR A, 1994, J NEUROSCI, V14, P4705; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625, DOI 10.1152/jn.1995.74.6.2625	41	106	107	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					473	481		10.1016/S0896-6273(00)81247-7	http://dx.doi.org/10.1016/S0896-6273(00)81247-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115740	Bronze, Green Published			2022-12-24	WOS:A1997WQ07400014
J	Wang, HU; Anderson, DJ				Wang, HU; Anderson, DJ			Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth	NEURON			English	Article							RECEPTOR TYROSINE KINASES; CELL-MIGRATION; CHICK-EMBRYO; AVIAN EMBRYO; NEURITE GROWTH; BINDING; PROTEIN; TISSUES; INHIBITORS; EXPRESSION	In vertebrate embryos, neural crest cell migration and motor axon outgrowth are restricted to rostral somite halves by repulsive factors located in the caudal somite compartment. We show that two Eph family transmembrane ligands, Lerk2 and HtkL, are expressed in caudal somite halves, and that crest cells and motor axons express receptors for these ligands. In several independent in vitro assays, preclustered ligand-Fc fusion proteins can repulsively guide both crest migration and motor axon outgrowth. These repulsive activities depend on a graded or discontinuous presentation of the ligands when tested in the context of permissive substrates, such as laminin or fibronectin. These results identify Lerk2 and HtkL as potential determinants of segmental pattern in the peripheral nervous system.			Wang, HU (corresponding author), CALTECH,HOWARD HUGHES MED INST,DIV BIOL 21676,PASADENA,CA 91125, USA.							ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BECKER N, 1994, MECH DEVELOP, V47, P3, DOI 10.1016/0925-4773(94)90091-4; BENNETT BD, 1995, P NATL ACAD SCI USA, V92, P1866, DOI 10.1073/pnas.92.6.1866; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Brambilla R, 1995, MOL CELL NEUROSCI, V6, P487, DOI 10.1006/mcne.1995.0001; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; BRONNERFRASER M, 1991, DEV BIOL, V143, P213, DOI 10.1016/0012-1606(91)90071-A; BRONNERFRASER M, 1992, J NEUROBIOL, V24, P233; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DAVIES JA, 1990, NEURON, V2, P11; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; ERICKSON CA, 1992, DEV BIOL, V151, P251, DOI 10.1016/0012-1606(92)90231-5; FLETCHER FA, 1994, ONCOGENE, V9, P3241; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; Friedman GC, 1996, CURR OPIN NEUROBIOL, V6, P127, DOI 10.1016/S0959-4388(96)80018-3; Gale NW, 1996, ONCOGENE, V13, P1343; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hotary KB, 1996, DEV BIOL, V176, P22, DOI 10.1006/dbio.1996.9997; Irving C, 1996, DEV BIOL, V173, P26, DOI 10.1006/dbio.1996.0004; KEYNES RJ, 1984, NATURE, V310, P413; KRULL CE, 1995, DEVELOPMENT, V121, P3733; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOISEIWITSCH JR, 1995, P NATL ACAD SCI USA, V921, P7182; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; OAKLEY RA, 1994, DEVELOPMENT, V120, P103; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; Ohta K, 1996, MECH DEVELOP, V54, P59, DOI 10.1016/0925-4773(95)00461-0; Orike N, 1996, CURR BIOL, V6, P108, DOI 10.1016/S0960-9822(02)00435-9; PANDEY A, 1995, CURR BIOL, V5, P986, DOI 10.1016/S0960-9822(95)00195-3; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; PERRIS R, 1987, J CELL BIOL, V105, P2511, DOI 10.1083/jcb.105.6.2511; RANSCHT B, 1991, DEVELOPMENT, V111, P15; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P437; Ring C, 1996, DEV BIOL, V180, P41, DOI 10.1006/dbio.1996.0283; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STERN CD, 1987, DEVELOPMENT, V99, P261; TEILLET MA, 1987, DEV BIOL, V120, P329, DOI 10.1016/0012-1606(87)90236-3; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TOSNEY KW, 1991, BIOESSAYS, V13, P17; TUCKER GC, 1988, DEVELOPMENT, V103, P82; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xu QL, 1995, DEVELOPMENT, V121, P4005	57	412	421	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					383	396		10.1016/S0896-6273(00)81240-4	http://dx.doi.org/10.1016/S0896-6273(00)81240-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115733	Bronze			2022-12-24	WOS:A1997WQ07400007
J	Fruttiger, M; Calver, AR; Kruger, WH; Mudhar, HS; Michalovich, D; Takakura, N; Nishikawa, SI; Richardson, WD				Fruttiger, M; Calver, AR; Kruger, WH; Mudhar, HS; Michalovich, D; Takakura, N; Nishikawa, SI; Richardson, WD			PDGF mediates a neuron-astrocyte interaction in the developing retina	NEURON			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; FACTOR-A-CHAIN; VASCULAR-PERMEABILITY FACTOR; TRANSGENIC MICE; FACTOR RECEPTOR; OPTIC-NERVE; MONOCLONAL-ANTIBODIES; DIABETIC-RETINOPATHY; PRERETINAL MEMBRANES	Astrocytes invade the developing retina from the optic nerve head, over the axons of retinal ganglion cells (RGCs). RGCs express the platelet-derived growth factor A-chain (PDGF-A) and retinal astrocytes the PDGF alpha-receptor (PDGFR alpha), suggesting that PDGF mediates a paracrine interaction between these cells. To test this, we inhibited PDGF signaling in the eye with a neutralizing anti-PDGFR alpha antibody or a soluble extracellular fragment of PDGFR alpha. These treatments inhibited development of the astrocyte network. We also generated transgenic mice that overexpress PDGF-A in RGCs. This resulted in hyperproliferation of astrocytes, which in turn induced excessive vasculogenesis. Thus, PDGF appears to be a link in the chain of cell-cell interactions responsible for matching numbers of neurons, astrocytes, and blood vessels during retinal development.	UCL, DEPT BIOL, LONDON WC1E 6BT, ENGLAND; UNIV CONNECTICUT, SCH MED, DEPT MICROBIOL, FARMINGTON, CT 06030 USA; UNIV CONNECTICUT, SCH MED, PROGRAM NEUROL SCI, FARMINGTON, CT 06030 USA; KYOTO UNIV, FAC MED, DEPT MOL GENET, SAKYO KU, KYOTO 60601, JAPAN; UNITED MED & DENT SCH, DEPT EXPT PATHOL, LONDON SE1 9RT, ENGLAND	University of London; University College London; University of Connecticut; University of Connecticut; Kyoto University; University of London; King's College London	Fruttiger, M (corresponding author), UCL, MRC, MOL CELL BIOL LAB, MORTIMER ST, LONDON WC1E 6BT, ENGLAND.		Richardson, William/C-1762-2008; Fruttiger, Marcus/C-1899-2008	Richardson, William/0000-0001-7261-2485; Michalovich, David/0000-0003-4452-5776; Fruttiger, Marcus/0000-0002-6962-5485	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABEDI H, 1995, J BIOL CHEM, V270, P11367, DOI 10.1074/jbc.270.19.11367; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; BARINAGA M, 1995, SCIENCE, V267, P452, DOI 10.1126/science.7824943; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; BREITMAN ML, 1989, DEVELOPMENT, V106, P457; CHANLING TL, 1994, PROG RETIN EYE RES, V13, P357, DOI 10.1016/1350-9462(94)90015-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEZARDIN P, 1985, J CHROMATOGR, V319, P67, DOI 10.1016/S0021-9673(01)90540-0; COATS SR, 1994, BIOCHEM J, V297, P379, DOI 10.1042/bj2970379; CONNOLLY DT, 1991, J CELL BIOCHEM, V47, P219, DOI 10.1002/jcb.240470306; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; DAMORE PA, 1993, GROWTH FACTORS, V8, P61, DOI 10.3109/08977199309029135; ENGERMAN RL, 1965, AM J OPHTHALMOL, V60, P628, DOI 10.1016/0002-9394(65)92251-8; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Ferns GAA, 1990, GROWTH FACTORS, V3, P315, DOI 10.3109/08977199009003674; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1989, TRENDS GENET, V5, P108, DOI 10.1016/0168-9525(89)90040-1; HERKEN R, 1990, J ANAT, V169, P189; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOSODA Y, 1993, OPHTHALMIC RES, V25, P289, DOI 10.1159/000267327; IGUCHI I, 1995, CORNEA, V14, P365, DOI 10.1097/00003226-199507000-00004; JERDAN JA, 1986, ARCH OPHTHALMOL-CHIC, V104, P286, DOI 10.1001/archopht.1986.01050140144038; KAUR S, 1989, DEVELOPMENT, V105, P613; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P1660; KLAGSBRUN M, 1993, CURR BIOL, V3, P699, DOI 10.1016/0960-9822(93)90073-W; KOYAMA N, 1994, J CELL PHYSIOL, V158, P1, DOI 10.1002/jcp.1041580102; KOYAMA N, 1994, CIRC RES, V75, P682, DOI 10.1161/01.RES.75.4.682; KOYAMA N, 1992, J BIOL CHEM, V267, P22806; LANDEL CP, 1988, GENE DEV, V2, P1168, DOI 10.1101/gad.2.9.1168; LAROCHELLE WJ, 1991, GENE DEV, V5, P1191, DOI 10.1101/gad.5.7.1191; LATERRA J, 1990, J CELL PHYSIOL, V144, P204, DOI 10.1002/jcp.1041440205; LEE KH, 1990, MOL CELL BIOL, V10, P2237, DOI 10.1128/MCB.10.5.2237; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LING TL, 1989, J COMP NEUROL, V286, P345, DOI 10.1002/cne.902860305; LING TL, 1988, DEV BRAIN RES, V44, P73, DOI 10.1016/0165-3806(88)90119-8; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; OHIRA A, 1990, OPHTHALMOLOGICA, V201, P187, DOI 10.1159/000310150; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; PEER J, 1995, LAB INVEST, V72, P638; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Pollock RA, 1992, GROWTH FACTORS, V7, P267, DOI 10.3109/08977199209046409; PRUSS R, 1979, NATURE, V303, P396; RAINES EW, 1992, J CELL BIOL, V116, P533, DOI 10.1083/jcb.116.2.533; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; SEILER MJ, 1995, EXP BRAIN RES, V105, P59; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SIEGBAHN A, 1990, J CLIN INVEST, V85, P916, DOI 10.1172/JCI114519; Smits A, 1989, GROWTH FACTORS, V2, P1, DOI 10.3109/08977198909069076; SRAMEK SJ, 1989, OPHTHALMOLOGY, V96, P835; STAVRI GT, 1995, FEBS LETT, V358, P311, DOI 10.1016/0014-5793(94)01458-D; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; UCHIHORI Y, 1991, INVEST OPHTH VIS SCI, V32, P2689; UREN A, 1994, BIOCHEM BIOPH RES CO, V204, P628, DOI 10.1006/bbrc.1994.2505; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; YU JC, 1994, J BIOL CHEM, V269, P10668	75	184	188	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1117	1131		10.1016/S0896-6273(00)80244-5	http://dx.doi.org/10.1016/S0896-6273(00)80244-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982160	Bronze			2022-12-24	WOS:A1996WA24800010
J	Fannon, AM; Colman, DR				Fannon, AM; Colman, DR			A model for central synaptic junctional complex formation based on the differential adhesive specificities of the cadherins	NEURON			English	Article							CELL-CELL-ADHESION; INTERCELLULAR ADHERENS JUNCTIONS; A-CAM; MOLECULE UVOMORULIN; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; EPITHELIAL-CELLS; 135-KD RECEPTOR; R-CADHERIN; N-CADHERIN	Cadherins control critical developmental events through well-documented hemophilic interactions. In epithelia, they are hallmark constituents of junctions that mediate intercellular adhesion. Brain tissue expresses several cadherins, and we now show that two of these, neural (N)- and epithelial (E)-cadherin, are localized to synaptic complexes in mutually exclusive distributions. In cerebellum, N-cadherin is frequently found associated with synapses, some of which are perforated, and in hippocampus, N- and E-cadherin-containing synapses are found aligned along dendritic shafts within the stratum lucidum of CA3. We propose that the cadherins function as primary adhesive moieties between pre- and postsynaptic membranes in the synaptic complex. According to this model, once neurites have been guided to the vicinity of their cognate targets, it is the differential distribution of cadherins along the axonal and dendritic plasma membranes, and ultimately cadherin self-association, that "locks in" nascent synaptic connections.			Fannon, AM (corresponding author), CUNY MT SINAI SCH MED, BROOKDALE CTR MOL BIOL, NEW YORK, NY 10029 USA.				NINDS NIH HHS [NS20147] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; CHANPALAY V, 1971, Z ANAT ENTWICKLUNGS, V133, P274, DOI 10.1007/BF00519303; COHEN RS, 1978, J CELL BIOL, V78, P36, DOI 10.1083/jcb.78.1.36; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; DOTTI CG, 1991, J CELL SCI, P75; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Einheber S, 1996, J COMP NEUROL, V370, P105; Elferink LA, 1995, PROG BRAIN RES, V105, P79; ELLISMAN MH, 1987, ENCY NEUROSCIENCE, V2, P1232; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gaze RM, 1970, FORMATION NERVE CONN; GEIGER B, 1992, ANNU REV CELL BIOL, V8, P307, DOI 10.1146/annurev.cb.08.110192.001515; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GOODWIN L, 1990, BIOCHEM BIOPH RES CO, V173, P1224, DOI 10.1016/S0006-291X(05)80917-9; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; Grunwald GB, 1993, CURR OPIN CELL BIOL, V5, P797, DOI 10.1016/0955-0674(93)90028-O; GUMBINER BM, 1993, NEURON, V11, P551, DOI 10.1016/0896-6273(93)90068-3; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; GURD JW, 1982, J NEUROCHEM, V39, P1117, DOI 10.1111/j.1471-4159.1982.tb11504.x; ICHIMURA T, 1988, J NEUROCYTOL, V17, P3, DOI 10.1007/BF01735373; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; ITARAT W, 1993, J NEUROCYTOL, V22, P753, DOI 10.1007/BF01181321; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; LAGUNOWICH LA, 1992, J NEUROSCI RES, V32, P202, DOI 10.1002/jnr.490320209; Magee AI, 1991, CURR OPIN CELL BIOL, V3, P854, DOI 10.1016/0955-0674(91)90060-C; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Peters A., 1991, FINE STRUCTURE NERVO; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; PHEND KD, 1992, J HISTOCHEM CYTOCHEM, V40, P1011, DOI 10.1177/40.7.1376741; REDIES C, 1993, J COMP NEUROL, V333, P398, DOI 10.1002/cne.903330307; RUTISHAUSER U, 1992, DEVELOPMENT, P99; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Sperry RW, 1943, J COMP NEUROL, V79, P33, DOI 10.1002/cne.900790104; SPERRY RW, 1945, J NEUROPHYSIOL, V8, P15, DOI 10.1152/jn.1945.8.1.15; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sperry RW, 1944, J NEUROPHYSIOL, V7, P57, DOI 10.1152/jn.1944.7.1.57; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUZUKI S, 1991, CELL REGUL, V2, P261, DOI 10.1091/mbc.2.4.261; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TSUKITA S, 1991, J CELL BIOL, V113, P867, DOI 10.1083/jcb.113.4.867; Vaughn DE, 1996, NEURON, V16, P261, DOI 10.1016/S0896-6273(00)80045-8; VOLK T, 1987, CELL, V50, P987, DOI 10.1016/0092-8674(87)90525-3; VOLK T, 1986, J CELL BIOL, V103, P1451, DOI 10.1083/jcb.103.4.1451; VOLK T, 1986, J CELL BIOL, V103, P1441, DOI 10.1083/jcb.103.4.1441; WAGNER G, 1995, SCIENCE, V267, P342, DOI 10.1126/science.7824932; YAMAGATA M, 1995, J NEUROSCI, V15, P4556	65	363	367	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					423	434		10.1016/S0896-6273(00)80175-0	http://dx.doi.org/10.1016/S0896-6273(00)80175-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816706	Bronze			2022-12-24	WOS:A1996VJ44000009
J	Muller, U				Muller, U			Inhibition of nitric oxide synthase impairs a distinct form of long-term memory in the honeybee, Apis mellifera	NEURON			English	Article							INTERCELLULAR MESSENGER; GUANYLATE-CYCLASE; POTENTIATION; BRAIN; HIPPOCAMPUS; GLUTAMATE; ENHANCEMENT; CEREBELLUM; ACTIVATION; DEPRESSION	Nitric oxide has been shown to be implicated in neural plasticity that underlies processes of learning and memory. In the honeybee, studies on the role of nitric oxide in associative olfactory learning reveal its specific function in memory formation. Inhibition of nitric oxide synthase during olfactory conditioning impairs a distinct long-term memory that is formed as a consequence of multiple learning trials. Acquisition or retrieval of memory or memory formation induced by a single learning trial is not affected by blocking of nitric oxide synthase. This finding provides a first step toward dissection of molecular mechanisms involved in memory formation, in general, and the special function of nitric oxide synthase, in particular.			Muller, U (corresponding author), FREE UNIV BERLIN,INST NEUROBIOL,KONIGIN LUISE STR 28-30,D-14195 BERLIN,GERMANY.							ALLWEIS C, 1991, NEURAL BEHAV PLASTIC, P351; ALTFELDER K, 1991, INSECT BIOCHEM, V21, P487, DOI 10.1016/0020-1790(91)90102-K; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; BANNERMAN DM, 1994, J NEUROSCI, V14, P7415; BANNERMAN DM, 1994, J NEUROSCI, V14, P7404; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOHME GA, 1993, P NATL ACAD SCI USA, V90, P9191, DOI 10.1073/pnas.90.19.9191; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; CHAPMAN PF, 1992, NEUROREPORT, V3, P567, DOI 10.1097/00001756-199207000-00005; CHETKOVICH DM, 1993, NEUROREPORT, V4, P919, DOI 10.1097/00001756-199307000-00020; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; ELPHICK MR, 1993, BRAIN RES, V619, P344, DOI 10.1016/0006-8993(93)91632-3; ELPHICK MR, 1995, J EXP BIOL, V198, P821; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; ERBER J, 1976, J COMP PHYSIOL PSYCH, V90, P41, DOI 10.1037/h0077258; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GOADSBY PJ, 1992, BRAIN RES, V595, P167, DOI 10.1016/0006-8993(92)91470-Y; GOY MF, 1991, TRENDS NEUROSCI, V14, P293, DOI 10.1016/0166-2236(91)90140-P; GRIBKOFF VK, 1992, J NEUROPHYSIOL, V68, P639, DOI 10.1152/jn.1992.68.2.639; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HALEY JE, 1993, NEUROSCI LETT, V160, P85, DOI 10.1016/0304-3940(93)90919-C; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; HAMMER M, 1994, BEHAV NEURAL BIOL, V62, P210, DOI 10.1016/S0163-1047(05)80019-6; Heisenberg M., 1989, Progress in Zoology, V37, P3; HILDEEBRANDT H, 1994, P 22 GOTT NEUR C, P653; HOLSCHER C, 1992, NEUROSCI LETT, V145, P165, DOI 10.1016/0304-3940(92)90012-V; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Menzel R., 1974, P195; MENZEL R, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P323; Menzel R, 1985, EXPT BEHAV ECOLOGY, P55; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; MULLER U, 1994, J NEUROSCI, V14, P7521; MULLER U, 1995, EUR J NEUROSCI, V7, P2240, DOI 10.1111/j.1460-9568.1995.tb00645.x; MULLER U, 1994, EUR J NEUROSCI, V6, P1382; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Squire L. R., 1987, MEMORY BRAIN; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; WILLIAMS JH, 1993, NEURON, V11, P877, DOI 10.1016/0896-6273(93)90117-A; WITTSTOCK S, 1993, J NEUROSCI, V13, P1379; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368; ZHUO M, 1994, NEUROREPORT, V5, P1033, DOI 10.1097/00001756-199405000-00004	58	172	175	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					541	549		10.1016/S0896-6273(00)80073-2	http://dx.doi.org/10.1016/S0896-6273(00)80073-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785051	Bronze			2022-12-24	WOS:A1996UC16800010
J	Srivastava, S; Osten, P; Vilim, FS; Khatri, L; Inman, G; States, B; Daly, C; DeSouza, S; Abagyan, R; Valtschanoff, JG; Weinberg, RJ; Ziff, EB				Srivastava, S; Osten, P; Vilim, FS; Khatri, L; Inman, G; States, B; Daly, C; DeSouza, S; Abagyan, R; Valtschanoff, JG; Weinberg, RJ; Ziff, EB			Novel anchorage of GruR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP	NEURON			English	Article							SILENT SYNAPSES; GLUTAMATE RECEPTORS; GUANYLATE KINASES; PSD-95 FAMILY; EXPRESSION; DOMAIN; PDZ; LTP; RECOGNITION; INTERACTS	We report the cloning of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor-binding protein (ABP), a postsynaptic density (PSD) protein related to glutamate receptor-interacting protein (GRIP) with two sets of three PDZ domains, which binds the GruR2/3 AMPA receptor subunits. ABP exhibits widespread CNS expression and is found at the postsynaptic membrane. We show that the protein interactions of the ABP/GRIP family differ from the PSD-95 family, which binds N-methyl-D-aspartate (NMDA) receptors. ABP binds to the GruR2/3 C-terminal VKI-COOH motif via class II hydrophobic PDZ interactions, distinct from the class I PSD-95-NMDA receptor interaction. ABP and GRIP also form homo- and heteromultimers through PDZ-PDZ interactions but do not bind PSD-95. We suggest that the ABP/GRIP and PSD-95 families form distinct scaffolds that anchor, respectively, AMPA and NMDA receptors.	NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA; NYU, Med Ctr, Skirball Inst, Dept Biochem, New York, NY 10016 USA; NYU, Courant Inst Math, New York, NY 10012 USA; Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; University of North Carolina; University of North Carolina Chapel Hill	Ziff, EB (corresponding author), NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA.		Weinberg, Richard/AAC-1898-2020	Inman, Gareth/0000-0002-6264-4253; Daly, Christopher/0000-0003-3800-8174; Ziff, Edward/0000-0001-7389-8649	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013620, R01AG013620] Funding Source: NIH RePORTER; NIA NIH HHS [AG13620] Funding Source: Medline; NINDS NIH HHS [NS29879] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; HAMPSON DR, 1992, NEUROSCIENCE, V50, P11, DOI 10.1016/0306-4522(92)90378-F; Hayashi Y, 1997, MOL BRAIN RES, V46, P338, DOI 10.1016/S0169-328X(97)00073-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kharazia VN, 1997, NEUROSCI LETT, V238, P41, DOI 10.1016/S0304-3940(97)00846-X; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4850; KOMAU HC, 1995, SCIENCE, V269, P1737; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Niethammer M, 1996, J NEUROSCI, V16, P2157; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Rao A, 1998, J NEUROSCI, V18, P1217; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; SOMOGYI P, 1998, BRAIN RES REV, V26; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	40	311	337	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					581	591		10.1016/S0896-6273(00)80568-1	http://dx.doi.org/10.1016/S0896-6273(00)80568-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768844	hybrid			2022-12-24	WOS:000076196400014
J	Ringstedt, T; Linnarsson, S; Wagner, J; Lendahl, U; Kokaia, Z; Arenas, E; Ernfors, P; Ibanez, CF				Ringstedt, T; Linnarsson, S; Wagner, J; Lendahl, U; Kokaia, Z; Arenas, E; Ernfors, P; Ibanez, CF			BDNF regulates Reelin expression and Cajal-Retzius cell development in the cerebral cortex	NEURON			English	Article							FOREBRAIN CHOLINERGIC NEURONS; NEUROTROPHIC FACTOR PROMOTES; MESSENGER-RNA EXPRESSION; NERVOUS-SYSTEM; DENTATE GYRUS; RAT-BRAIN; MICE; MOUSE; GENE; HIPPOCAMPAL	Cajar-Retzius (CR) cells of the cerebral cortex express receptors for the neurotrophin brain-derived neurotrophic factor (BDNF) and downregulate expression of the extracellular matrix protein Reelin during early postnatal development, coincident with the onset of cortical BDNF expression. During this period, mice lacking BDNF have elevated levels of Reelin in CR cells. Acute BDNF stimulation of cortical neuron cultures and overexpression of BDNF in the developing brain of transgenic mice prior to the onset of endogenous production causes a profound, dose-dependent reduction of Reelin expression in CR cells. In addition, overexpression of BDNF produces gaps and heterotopias in the marginal zone and disorganization and aggregation of cortical CR cells and induces several other malformations, including aberrant cortical lamination, similar to the phenotype of reeler mutant mice, which lack Reelin. These results demonstrate a role for BDNF on cortical CR cells and identify Reelin as a direct effector of this neurotrophin during brain development.	Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Univ Lund Hosp, Wallenberg Neurosci Ctr, Sect Restorat Neurol, S-22185 Lund, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Lund University; Skane University Hospital	Ringstedt, T (corresponding author), Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden.		Arenas, Ernest/AAO-5231-2020; Kokaia, Zaal/AAL-6009-2020; Linnarsson, Sten/HCH-3909-2022	Arenas, Ernest/0000-0003-0197-6577; Kokaia, Zaal/0000-0003-2296-2449; Ernfors, Patrik/0000-0002-1140-3986; Lendahl, Urban/0000-0001-9543-8141				Alcantara S, 1997, J NEUROSCI, V17, P3623; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; CAVINESS VS, 1973, J COMP NEUROL, V147, P235, DOI 10.1002/cne.901470206; CAVINESS VS, 1988, DEV MATURATION CEREB, P59; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DelRio JA, 1996, J NEUROSCI, V16, P6896; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; EMFORS P, 1994, NATURE, V368, P147; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Fagan AM, 1997, J NEUROSCI, V17, P7644; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; Gilmore EC, 1997, CURR BIOL, V7, pR231, DOI 10.1016/S0960-9822(06)00108-4; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; GOFFINET AM, 1984, DEV BRAIN RES, V16, P263, DOI 10.1016/0165-3806(84)90031-2; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liu Y, 1996, EXP BRAIN RES, V108, P389; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; Marty S, 1996, J NEUROSCI, V16, P675; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PAMAVELAS JG, 1983, J NEUROCYTOL, V12, P863; Pappas IS, 1997, EXP NEUROL, V144, P302, DOI 10.1006/exnr.1997.6411; Pearlman A L, 1996, Prog Brain Res, V108, P117; Ringstedt T, 1997, DEVELOPMENT, V124, P2603; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Soriano E, 1997, NEURON, V18, P563, DOI 10.1016/S0896-6273(00)80298-6; STANFIELD BB, 1979, J COMP NEUROL, V185, P423, DOI 10.1002/cne.901850303; TIMMUSK T, 1994, NEUROSCIENCE, V60, P287, DOI 10.1016/0306-4522(94)90242-9; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	44	129	136	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1998	21	2					305	315		10.1016/S0896-6273(00)80540-1	http://dx.doi.org/10.1016/S0896-6273(00)80540-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728912	Bronze			2022-12-24	WOS:000075598300008
J	Patil, PG; Brody, DL; Yue, DT				Patil, PG; Brody, DL; Yue, DT			Preferential closed-state inactivation of neuronal calcium channels	NEURON			English	Article							BULLFROG SYMPATHETIC NEURONS; SQUID GIANT SYNAPSE; CHICK SENSORY NEURONS; N-TYPE; CA2+ CHANNELS; POTASSIUM CHANNELS; SODIUM-CHANNEL; DEPENDENT INACTIVATION; FUNCTIONAL EXPRESSION; VOLTAGE-DEPENDENCE	We have investigated the inactivation mechanism of neuronal N-, P/Q-, and R-type calcium channels. Although channels inactivate slowly during square-pulse depolarization, as observed previously, we now find that they inactivate profoundly during a train of action potential (AP) waveforms. The apparent paradox arises from a voltage-dependent mechanism in which channels inactivate preferentially from intermediate closed states along the activation pathway. Inactivation can therefore extend beyond the brief duration of AP waveforms to continue between spikes, as the channel undergoes repetitive cycles of activation and deactivation. The extent of inactivation during a train is strongly affected by the subunit composition of channels. Preferential closed-state inactivation of neuronal calcium channels could produce widely variable depression of Ca2+ entry during a train of APs.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Program Mol & Cellular Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Program Mol & Cellular Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Program Mol & Cellular Physiol, Baltimore, MD 21205 USA.		Patil, Parag G/D-1618-2016					Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALDRICH RW, 1981, BIOPHYS J, V36, P519, DOI 10.1016/S0006-3495(81)84750-9; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; BEAN BP, 1981, BIOPHYS J, V35, P595, DOI 10.1016/S0006-3495(81)84815-1; BECHEM M, 1985, PFLUG ARCH EUR J PHY, V404, P10, DOI 10.1007/BF00581485; BLACKMORE PF, 1985, J BIOL CHEM, V260, P4477; BOLAND LM, 1993, J NEUROSCI, V13, P516; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Brody DL, 1997, J PHYSIOL-LONDON, V499, P637, DOI 10.1113/jphysiol.1997.sp021956; Carabelli V, 1996, BIOPHYS J, V70, P2144, DOI 10.1016/S0006-3495(96)79780-1; Cens T, 1996, FEBS LETT, V391, P232, DOI 10.1016/0014-5793(96)00704-1; CHANDLER WK, 1970, J PHYSIOL-LONDON, V211, P653, DOI 10.1113/jphysiol.1970.sp009298; CHANDLER WK, 1970, J PHYSIOL-LONDON, V211, P623, DOI 10.1113/jphysiol.1970.sp009297; CHARLTON MP, 1990, BRAIN RES, V525, P133, DOI 10.1016/0006-8993(90)91328-E; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CLARK RB, 1988, J PHYSIOL-LONDON, V405, P147, DOI 10.1113/jphysiol.1988.sp017326; COX DH, 1994, J GEN PHYSIOL, V104, P311, DOI 10.1085/jgp.104.2.311; DECOURSEY TE, 1990, J GEN PHYSIOL, V95, P617, DOI 10.1085/jgp.95.4.617; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Elmslie KS, 1997, J NEUROSCI, V17, P2658; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; GINGRICH KJ, 1985, J NEUROPHYSIOL, V53, P652, DOI 10.1152/jn.1985.53.3.652; GRISSMER S, 1989, J GEN PHYSIOL, V93, P609, DOI 10.1085/jgp.93.4.609; HADLEY RW, 1995, AM J PHYSIOL-HEART C, V269, pH1784, DOI 10.1152/ajpheart.1995.269.5.H1784; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JOHNSTON D, 1995, FDN CELLULAR NEUROPH, P344; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; KASAI H, 1988, PFLUG ARCH EUR J PHY, V411, P695, DOI 10.1007/BF00580869; KLEIN M, 1980, J EXP BIOL, V89, P117; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; KUO CC, 1994, NEURON, V12, P819, DOI 10.1016/0896-6273(94)90335-2; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; Ma JY, 1997, NEURON, V19, P443, DOI 10.1016/S0896-6273(00)80952-6; MORAD M, 1988, SCIENCE, V241, P842, DOI 10.1126/science.2457253; NEHER E, 1971, PFLUG ARCH EUR J PHY, V322, P35, DOI 10.1007/BF00586662; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; PEREZREYES E, 1994, DRUG DEVELOP RES, V33, P295, DOI 10.1002/ddr.430330311; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SHIROKOV R, 1993, J GEN PHYSIOL, V102, P1005, DOI 10.1085/jgp.102.6.1005; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; WEI XY, 1991, J BIOL CHEM, V266, P21943; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	58	165	167	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					1027	1038		10.1016/S0896-6273(00)80483-3	http://dx.doi.org/10.1016/S0896-6273(00)80483-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620706	hybrid			2022-12-24	WOS:000073864700021
J	Frisen, J; Yates, PA; McLaughlin, T; Friedman, GC; O'Leary, DDM; Barbacid, M				Frisen, J; Yates, PA; McLaughlin, T; Friedman, GC; O'Leary, DDM; Barbacid, M			Ephrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and topographic mapping in the mammalian visual system	NEURON			English	Article							RECEPTOR TYROSINE KINASES; RETINOCOLLICULAR PROJECTION; RETINOTECTAL PROJECTION; COMMISSURAL AXONS; OPTIC TECTUM; IN-VITRO; EPH; EXPRESSION; LIGANDS; INVITRO	Ephrin-A5 (AL-1/RAGS), a ligand for Eph receptor tyrosine kinases, repels retinal axons in vitro and has a graded expression in the superior colliculus (SC), the major midbrain target of retinal ganglion cells. These properties implicate ephrin-A5 in the formation of topographic maps, a fundamental organizational feature of the nervous system. To test this hypothesis, we generated mice lacking ephrin-A5. The majority of ephrin-A5(-/-) mice develop to adulthood, are morphologically intact, and have normal anterior-posterior patterning of the midbrain. However, within the SC, retinal axons establish and maintain dense arborizations at topographically incorrect sites that correlate with locations of low expression of the related ligand ephrin-A2. In addition, retinal axons transiently over-shoot the SC and extend aberrantly into the inferior colliculus (IC). This defect is consistent with the high lever of ephrin-A5 expression in the IC and the finding that retinal axon growth on membranes from wild-type IC is inhibited relative to that on membranes from ephrin-A5(-/-) IC. These findings show that ephrin-A5 is required for the proper guidance and mapping of retinal axons in the mammalian midbrain.	Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Mol Oncol, Princeton, NJ 08543 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Bristol-Myers Squibb; Salk Institute	O'Leary, DDM (corresponding author), Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Mol Oncol, Princeton, NJ 08543 USA.				NEI NIH HHS [EY 07025] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; Brambilla R, 1995, MOL CELL NEUROSCI, V6, P487, DOI 10.1006/mcne.1995.0001; Brennan C, 1997, DEVELOPMENT, V124, P655; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Donoghue MJ, 1996, MOL CELL NEUROSCI, V8, P185, DOI 10.1006/mcne.1996.0056; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Flanagan JG, 1997, CELL, V90, P403; Friedman GC, 1996, J NEUROSCI, V16, P5498; Friedman GC, 1996, CURR OPIN NEUROBIOL, V6, P127, DOI 10.1016/S0959-4388(96)80018-3; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GODEMENT P, 1989, DEVELOPMENT, V106, P313; GOULDING M, 1994, DEVELOPMENT, V120, P957; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; ITASAKI N, 1992, NEURON, V8, P787, DOI 10.1016/0896-6273(92)90099-Y; Itasaki N, 1996, NEURON, V16, P55, DOI 10.1016/S0896-6273(00)80023-9; JOYNER AL, 1993, PRACTICAL APPROACH S; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; PANDEY A, 1995, CURR BIOL, V5, P986, DOI 10.1016/S0960-9822(95)00195-3; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; Shigetani Y, 1997, NEUROSCI RES, V27, P211, DOI 10.1016/S0168-0102(96)01151-0; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1994, DEV BIOL, V162, P384, DOI 10.1006/dbio.1994.1095; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TUZI NL, 1994, BRIT J CANCER, V69, P417, DOI 10.1038/bjc.1994.77; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WALTER J, 1987, DEVELOPMENT, V101, P685; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Xu QL, 1995, DEVELOPMENT, V121, P4005; Zhang JH, 1996, J NEUROSCI, V16, P7182	44	349	357	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					235	243		10.1016/S0896-6273(00)80452-3	http://dx.doi.org/10.1016/S0896-6273(00)80452-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491985	Bronze			2022-12-24	WOS:000072154700009
J	Dittman, AH; Quinn, TP; Nevitt, GA; Hacker, B; Storm, DR				Dittman, AH; Quinn, TP; Nevitt, GA; Hacker, B; Storm, DR			Sensitization of olfactory guanylyl cyclase to a specific imprinted odorant in coho salmon	NEURON			English	Article							SENSITIVE ADENYLATE-CYCLASE; 2ND MESSENGER FORMATION; ONCORHYNCHUS-KISUTCH; ATLANTIC SALMON; RECEPTOR-CELLS; BINDING-SITES; CYCLIC-GMP; CILIA; STIMULATION; CHANNEL	The role of cGMP in olfactory signaling is not fully understood, but it is believed to play a modulatory role in intracellular signaling in vertebrate olfactory receptor neurons (ORNs). Here, we present evidence that cGMP in ORNs may play an important role in recognition of biologically relevant odors and olfactory learning. Specifically, we investigated the cellular mechanisms underlying olfactory imprinting in salmon. Salmon learn odors associated with their natal site as juveniles and later use these odors to guide their homing migration. This imprinting is believed to involve sensitization of the peripheral olfactory system to specific homestream odorants. We imprinted juvenile salmon to the odorant beta-phenylethyl alcohol (PEA) and examined the sensitivity of olfactory adenylyl and guanylyl cyclases to PEA during development. Stimulation of guanylyl cyclase activity by PEA was significantly greater in olfactory cilia isolated from PEA-imprinted salmon compared with PEA-naive fish only at the time of the homing migration, 2 years after PEA exposure. These results suggest that sensitization of olfactory guanylyl cyclase may play an important role in olfactory imprinting by salmon.	UNIV WASHINGTON,SCH FISHERIES,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT ZOOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dittman, AH (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,BOX 357280,SEATTLE,WA 98195, USA.				NIEHS NIH HHS [ES07032] Funding Source: Medline; NIGMS NIH HHS [GM07108-14] Funding Source: Medline; NINDS NIH HHS [NS 20498] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANHOLT RRH, 1990, BIOCHEMISTRY-US, V29, P4049, DOI 10.1021/bi00469a004; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; BREER H, 1992, NEUROREPORT, V3, P1030, DOI 10.1097/00001756-199211000-00022; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Broillet MC, 1996, J NEUROBIOL, V30, P49, DOI 10.1002/(SICI)1097-4695(199605)30:1<49::AID-NEU5>3.0.CO;2-G; BROSTROM CO, 1975, P NATL ACAD SCI USA, V72, P64, DOI 10.1073/pnas.72.1.64; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CARDWELL JR, 1995, J COMP PHYSIOL A, V176, P55; CERRA MC, 1994, CARDIOSCIENCE, V5, P215; CHEN Z, 1986, J NEUROSCI, V6, P2146; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; COOPER JC, 1976, J FISH RES BOARD CAN, V33, P703, DOI 10.1139/f76-087; Dittman AH, 1996, CAN J FISH AQUAT SCI, V53, P434, DOI 10.1139/cjfas-53-2-434; FITZPATRICK MS, 1986, GEN COMP ENDOCR, V62, P437, DOI 10.1016/0016-6480(86)90054-7; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HARA TJ, 1982, CHEMORECEPTION FISHE, P135; HARA TJ, 1992, FISH CHEMORECEPTION, P150; Hasler A.D., 1983, OLFACTORY IMPRINTING; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; HUQUE T, 1986, BIOCHEM BIOPH RES CO, V137, P36, DOI 10.1016/0006-291X(86)91172-1; INGE T, 1995, J NEUROSCI, V15, P8214; JULIFS DM, 1997, P NATL ACAD SCI USA, V94, P3388; LeindersZufall T, 1996, P ROY SOC B-BIOL SCI, V263, P803, DOI 10.1098/rspb.1996.0120; LO YH, 1991, COMP BIOCHEM PHYS B, V98, P121, DOI 10.1016/0305-0491(91)90317-7; LO YH, 1993, BIOCHEMISTRY-US, V32, P12358, DOI 10.1021/bi00097a012; MOORE A, 1991, PHILOS T ROY SOC B, V332, P241, DOI 10.1098/rstb.1991.0052; MORIN PP, 1992, CAN J FISH AQUAT SCI, V49, P1704, DOI 10.1139/f92-189; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NESBITT JA, 1976, J BIOL CHEM, V251, P2344; NEVITT GA, 1992, J EXP BIOL, V166, P1; NEVITT GA, 1994, P NATL ACAD SCI USA, V91, P4288, DOI 10.1073/pnas.91.10.4288; REHNBERG BG, 1986, J COMP PHYSIOL A, V159, P61, DOI 10.1007/BF00612496; RESTREPO D, 1993, AM J PHYSIOL, V264, pC906, DOI 10.1152/ajpcell.1993.264.4.C906; RHEIN LD, 1983, J NEUROCHEM, V41, P569, DOI 10.1111/j.1471-4159.1983.tb04777.x; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; SEMKE E, 1995, NATURWISSENSCHAFTEN, V82, P148; Shimizu M, 1995, J FISH BIOL, V47, P1044, DOI 10.1111/j.1095-8649.1995.tb06028.x; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; STEINLEN S, 1990, BIOCHIM BIOPHYS ACTA, V1054, P69, DOI 10.1016/0167-4889(90)90206-S; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; WEITKAMP LA, 1995, 24 NOAA NMFSNWFSC, P258; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	47	39	40	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					381	389		10.1016/S0896-6273(00)80947-2	http://dx.doi.org/10.1016/S0896-6273(00)80947-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292727	Bronze			2022-12-24	WOS:A1997XU14600016
J	Bruijn, LI; Becher, MW; Lee, MK; Anderson, KL; Jenkins, NA; Copeland, NG; Sisodia, SS; Rothstein, JD; Borchelt, DR; Price, DL; Cleveland, DW				Bruijn, LI; Becher, MW; Lee, MK; Anderson, KL; Jenkins, NA; Copeland, NG; Sisodia, SS; Rothstein, JD; Borchelt, DR; Price, DL; Cleveland, DW			ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE ACTIVITY; GLUTAMATE TRANSPORTER; NEUROTROPHIC FACTOR; TRANSGENIC MICE; ANIMAL-MODEL; RAT-BRAIN; WILD-TYPE; MUTATIONS; NEURONS	High levels of familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 mutants G93A and G37R were previously shown to mediate disease in mice through an acquired toxic property. We report here that even low levels of another mutant, G85R, cause motor neuron disease characterized by an extremely rapid clinical progression, without changes in SOD1 activity. Initial indicators of disease are astrocytic inclusions that stain intensely with SOD1 antibodies and ubiquitin and SOD1-containing aggregates in motor neurons, features common with some cases of SOD1 mutant-mediated ALS. Astrocytic inclusions escalate markedly as disease progresses, concomitant with a decrease in the glial glutamate transporter (GLT-1). Thus, the G85R SOD1 mutant mediates direct damage to astrocytes, which may promote the nearly synchronous degeneration of motor neurons.	UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROPATHOL,BALTIMORE,MD 21205; NCI,MAMMALIAN GENET LAB,ADV BIOSCI LABS RES PROGRAM,FREDERICK,MD 21701	University of California System; University of California San Diego; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bruijn, LI (corresponding author), UNIV CALIF SAN DIEGO,LUDWIG INST CANC RES,LA JOLLA,CA 92093, USA.		Cleveland, Don/AAN-9783-2021; rothstein, jeffrey d/C-9470-2013; Lee, Michael K/D-9491-2013	Lee, Michael K/0000-0001-5865-9682; Cleveland, Don/0000-0002-1934-3682	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027036, R37NS027036] Funding Source: NIH RePORTER; NIA NIH HHS [AG 05146] Funding Source: Medline; NINDS NIH HHS [NS 27036, NS 10580] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANKER BQ, 1986, MYOLOGY 2, P2031; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; DELISLE MB, 1984, J NEUROL SCI, V63, P241, DOI 10.1016/0022-510X(84)90199-0; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; FUJII J, 1995, J NEUROCHEM, V64, P1456; GALLOWAY P, 1996, AM J PATHOL, V140, P809; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Kato S, 1996, J NEUROPATH EXP NEUR, V55, P1089, DOI 10.1097/00005072-199655100-00009; LABBE M, 1990, METHOD ENZYMOL, V38, P232; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; POGUN S, 1994, SYNAPSE, V18, P21, DOI 10.1002/syn.890180104; REUME AG, 1996, NAT GENET, V13, P43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROBBERECHT W, 1994, J NEUROCHEM, V62, P384; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; ROTHSTEIN JD, 1994, P NATL ACAD SCI USA, V91, P4155, DOI 10.1073/pnas.91.10.4155; ROTHSTEIN JD, 1996, NEURON, V16, P674; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; XY Z, 1993, J CELL SCI S, V17, P101; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	39	1026	1054	0	58	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					327	338		10.1016/S0896-6273(00)80272-X	http://dx.doi.org/10.1016/S0896-6273(00)80272-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052802	hybrid			2022-12-24	WOS:A1997WK82200015
J	Paresce, DM; Ghosh, RN; Maxfield, FR				Paresce, DM; Ghosh, RN; Maxfield, FR			Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor	NEURON			English	Article							HAMSTER OVARY CELLS; LOW-DENSITY-LIPOPROTEIN; PRECURSOR PROTEIN; IMMUNOHISTOCHEMICAL LOCALIZATION; NEUROLOGICAL DISEASE; BINDING-PROPERTIES; AMEBOID MICROGLIA; APOLIPOPROTEIN-E; BRAIN-TISSUE; A-BETA	Microglia are immune system cells associated with Alzheimer's disease plaques containing beta-amyloid (A beta). Murine microglia internalize microaggregates of fluorescently labeled or radioiodinated A beta peptide 1-42. Uptake was confirmed using aggregates of unlabeled A beta detected by immunofluorescence. Uptake of A beta was reduced by coincubation with excess acetyl-low density lipoprotein (Ac-LDL) or other scavenger receptor (SR) ligands, and Dil-labeled Ac-LDL uptake by microglia was blocked by excess A beta. CHO cells transfected with class A or B SRs showed significantly enhanced uptake of A beta. These results show that microglia express SRs that may play a significant role in the clearance of A beta plaques. Binding to SRs could activate inflammation responses that contribute to the pathology of Alzheimer's disease.	COLUMBIA UNIV, DEPT BIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV, ALZHEIMERS DIS RES CTR, NEW YORK, NY 10032 USA; COLUMBIA UNIV, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA; CORNELL UNIV, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA	Columbia University; Columbia University; Columbia University; Cornell University	Paresce, DM (corresponding author), COLUMBIA UNIV, DEPT PATHOL, NEW YORK, NY 10032 USA.		Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027083, R37DK027083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034761] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK27083] Funding Source: Medline; NINDS NIH HHS [NS34761] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; ARAUJO DM, 1992, BRAIN RES, V569, P141, DOI 10.1016/0006-8993(92)90380-R; ASHKENAS J, 1993, J LIPID RES, V34, P983; BELL MD, 1994, J NEUROCYTOL, V23, P605, DOI 10.1007/BF01191555; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; Christie RH, 1996, AM J PATHOL, V148, P399; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; COTMAN CW, 1992, NEUROBIOL AGING, V13, P587, DOI 10.1016/0197-4580(92)90060-B; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Elkabes S, 1996, J NEUROSCI, V16, P2508; FRACKOWIAK J, 1992, ACTA NEUROPATHOL, V84, P225; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1993, ANN NY ACAD SCI, V695, P103, DOI 10.1111/j.1749-6632.1993.tb23036.x; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GOREVIC PD, 1987, BIOCHEM BIOPH RES CO, V147, P854, DOI 10.1016/0006-291X(87)91008-4; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1991, J NEUROSCI, V11, P3783; HERZ J, 1991, J BIOL CHEM, V266, P21232; JOHNSON WJ, 1982, SCIENCE, V218, P574, DOI 10.1126/science.6289443; JOHNSTON PA, 1987, J IMMUNOL, V138, P1551; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KRIEGER M, 1992, TRENDS BIOCHEM SCI, V17, P141, DOI 10.1016/0968-0004(92)90322-Z; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MAXFIELD FR, 1989, METHOD CELL BIOL, V29, P13; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; MCGEER PL, 1992, J NEUROSCI RES, V31, P428, DOI 10.1002/jnr.490310305; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; NAKAJIMA K, 1989, BIOMED RES-TOKYO, V10, P411; PALKAMA T, 1991, IMMUNOLOGY, V74, P432; PENMAN M, 1991, J BIOL CHEM, V266, P23985; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; QUERFURTH HW, 1995, MOL BRAIN RES, V28, P319, DOI 10.1016/0169-328X(94)00224-3; REBECK GW, 1993, NEURON, V11, P575; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J NEUROCHEM, V61, P1916, DOI 10.1111/j.1471-4159.1993.tb09834.x; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; SALZMAN NH, 1988, J CELL BIOL, V106, P1083, DOI 10.1083/jcb.106.4.1083; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHACKELFORD RE, 1995, J BIOL CHEM, V270, P3475, DOI 10.1074/jbc.270.8.3475; SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; WEGIEL J, 1990, ACTA NEUROPATHOL, V81, P116, DOI 10.1007/BF00334499; WISNIEWSKI HM, 1990, AM J MED GENET, P287, DOI 10.1002/ajmg.1320370757; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8	66	550	577	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					553	565		10.1016/S0896-6273(00)80187-7	http://dx.doi.org/10.1016/S0896-6273(00)80187-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816718	hybrid			2022-12-24	WOS:A1996VJ44000021
J	Deshmukh, M; Johnson, EM				Deshmukh, M; Johnson, EM			Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome c	NEURON			English	Article							NERVE GROWTH-FACTOR; PROGRAMMED CELL-DEATH; RAT SYMPATHETIC NEURONS; ICE FAMILY PROTEASES; FACTOR DEPRIVATION; NEURODEGENERATIVE DISORDERS; FACTOR WITHDRAWAL; ION-CHANNEL; APOPTOSIS; BCL-2	Sympathetic neurons undergoing programmed cell death after nerve growth factor (NGF) deprivation are shown to exhibit a protein synthesis-dependent, BAX-dependent loss of cytochrome c from the mitochondria. However, cytoplasmic microinjection of cytochrome c was insufficient to induce cell death in NGF-maintained sympathetic neurons. In contrast, microinjection of cytochrome c rapidly induced a caspase-dependent death in NGF-deprived, Bax-deficient or NGF-deprived, cycloheximide-treated neurons. Cells needed to be deprived of NGF for 15-20 hr before they acquired competence to die with injection of cytochrome c. These data suggest that NGF deprivation induced the translocation of cytochrome c and another event, which we term as competence-to-die, that was independent of macromolecular synthesis and BAX function. Both these processes were required for neurons to undergo apoptosis.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Johnson, EM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.				NIA NIH HHS [AG 12947] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG012947] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du YS, 1997, J NEUROCHEM, V69, P1382; Duckett CS, 1998, MOL CELL BIOL, V18, P608, DOI 10.1128/MCB.18.1.608; Easton RM, 1997, J NEUROSCI, V17, P9656; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; Ellerby HM, 1997, J NEUROSCI, V17, P6165; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; JOHNSON MI, 1983, METHOD ENZYMOL, V103, P334; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kharbanda S, 1997, P NATL ACAD SCI USA, V94, P6939, DOI 10.1073/pnas.94.13.6939; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Linnik MD, 1996, RESTOR NEUROL NEUROS, V9, P219, DOI 10.3233/RNN-1996-9404; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; McCarthy MJ, 1997, J CELL SCI, V110, P2165; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Reed J C, 1997, Adv Pharmacol, V41, P501, DOI 10.1016/S1054-3589(08)61070-4; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; RUIT KG, 1990, J NEUROSCI, V10, P2412; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Scarlett JL, 1997, FEBS LETT, V418, P282, DOI 10.1016/S0014-5793(97)01391-4; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Stefanis L, 1997, CURR OPIN NEUROL, V10, P299, DOI 10.1097/00019052-199708000-00004; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang JC, 1998, FREE RADICAL BIO MED, V24, P624, DOI 10.1016/S0891-5849(97)00367-5	50	247	249	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					695	705		10.1016/S0896-6273(00)80587-5	http://dx.doi.org/10.1016/S0896-6273(00)80587-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808457	Bronze			2022-12-24	WOS:000076697300014
J	Rogers, SW				Rogers, SW			Exploring dinosaur neuropaleobiology: Viewpoint computed tomography scanning and analysis of an Allosaurus fragilis endocast	NEURON			English	Editorial Material							THEROPOD	The unique opportunity to examine an exceptionally well-preserved natural endocranial cast (endocast) from a carnivorous dinosaur of the late Jurassic period, Allosaurus fragilis, was afforded this neurobiologist. The endocast exhibits numerous surface features including the complete vestibular apparatus. Spiral computed tomography scanning revealed multiple internal features including putative blood vessels, connective tissue-like arrays, and a prominent symmetrical density consistent with the putative brain or its cast. The evidence suggests that this organism's neurobiology resembled closely that of modern crocodylian species and should be included for consideration when examining ideas of Allosaurus evolution, behavior, and eventual extinction.	Salt Lake City Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Salt Lake City, UT 84112 USA; Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Anat & Neurobiol, Salt Lake City, UT 84112 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Salt Lake City Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Salt Lake City, UT 84112 USA.	scott.rogers@hci.utah.edu						Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; BURDA DJ, 1969, J COMP NEUROL, V135, P369, DOI 10.1002/cne.901350402; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; Carroll R. L, 1988, VERTEBRATE PALEONTOL, P331; Case EC, 1928, J COMP NEUROL, V45, P161, DOI 10.1002/cne.900450105; Case EC, 1921, J COMP NEUROL, V33, P133; Chatterjee S., 1997, THE RISE OF BIRDS; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Craigie EH, 1930, J COMP NEUROL, V49, P223, DOI 10.1002/cne.900490202; Crosby EC, 1917, J COMP NEUROL, V27, P325, DOI 10.1002/cne.900270304; Dall Sasso C, 1998, NATURE, V392, P383; Dickman JD, 1996, EXP BRAIN RES, V111, P8; EDINGER TILLY, 1926, ANN & MAG NAT HIST, V18, P151; FISHMAN EK, 1995, SPIRAL CT PRINCIPLES; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GURLEY LR, 1991, J PROTEIN CHEM, V10, P75, DOI 10.1007/BF01024658; HENN V, 1988, ANN NY ACAD SCI, V545, P1; HIRSCH KF, 1989, SCIENCE, V243, P1711, DOI 10.1126/science.243.4899.1711; Hopson J.A., 1979, P39; Jerison HJ., 1973, EVOLUTION BRAIN INTE; JONES GM, 1974, VESTIBULAR SYSTEM, V1, P171; Karten H J, 1989, J Cogn Neurosci, V1, P291, DOI 10.1162/jocn.1989.1.4.291; Kellner AWA, 1996, NATURE, V379, P32, DOI 10.1038/379032a0; KRUGER L, 1960, J COMP NEUROL, V115, P125, DOI 10.1002/cne.901150203; LOWENSTEIN OE, 1974, VESTIBULAR SYSTEM, V1, P1; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; MUYZER G, 1992, GEOLOGY, V20, P871, DOI 10.1130/0091-7613(1992)020<0871:POTBPO>2.3.CO;2; NORTHCUTT RG, 1981, ANNU REV NEUROSCI, V4, P301, DOI 10.1146/annurev.ne.04.030181.001505; Parrish JM, 1997, ENCY DINOSAURS, P20; Reid R.E.H., 1997, P449; Ruben JA, 1997, SCIENCE, V278, P1267, DOI 10.1126/science.278.5341.1267; RUSSELL DA, 1997, ENCY DINOSAURS, P370; STOKES WL, 1985, CLEVELAND LLOYD QUAR; WERSALL J, 1974, VESTIBULAR SYSTEM, V1, P124; WEVER EG, 1978, REPTILE EAR	35	46	48	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					673	679		10.1016/S0896-6273(00)80585-1	http://dx.doi.org/10.1016/S0896-6273(00)80585-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808455	Bronze			2022-12-24	WOS:000076697300012
J	Rutherford, LC; Nelson, SB; Turrigiano, GG				Rutherford, LC; Nelson, SB; Turrigiano, GG			BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses	NEURON			English	Article							NERVE GROWTH-FACTOR; RAT VISUAL-CORTEX; CORTICAL DENDRITIC GROWTH; NEUROTROPHIC FACTOR; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; MESSENGER-RNA; MONOCULAR DEPRIVATION; CEREBRAL-CORTEX; BRAIN	Recently, we have identified a novel form of synaptic plasticity that acts to stabilize neocortical firing rates by scaling the quantal amplitude of AMPA-mediated synaptic inputs up or down as a function of neuronal activity. Here, we show that the effects of activity blockade on quantal amplitude are mediated through the neurotrophin brain-derived neurotrophic factor (BDNF). Exogenous BDNF prevented, and a TrkB-IgG fusion protein reproduced, the effects of activity blockade on pyramidal quantal amplitude. BDNF had opposite effects on pyramidal neuron and interneuron quantal amplitudes and modified the ratio of pyramidal neuron to interneuron firing rates. These data demonstrate a novel role for BDNF in the homeostatic regulation of excitatory synaptic strengths and in the maintenance of the balance of cortical excitation and inhibition.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.			Nelson, Sacha/0000-0002-0108-8599	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853, K02NS001893] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS36853, K02 NS01893] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaneya Y, 1996, J NEUROPHYSIOL, V76, P4198, DOI 10.1152/jn.1996.76.6.4198; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BOZZI Y, 1995, NEUROSCIENCE, V69, P1133, DOI 10.1016/0306-4522(95)00321-9; Cabelli RJ, 1996, J NEUROSCI, V16, P7965; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Carmignoto G, 1997, J PHYSIOL-LONDON, V498, P153, DOI 10.1113/jphysiol.1997.sp021848; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Cellerino A, 1996, EUR J NEUROSCI, V8, P1190, DOI 10.1111/j.1460-9568.1996.tb01287.x; Cohen RI, 1996, J NEUROSCI, V16, P6433; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Kirkwood Alfredo, 1995, Biological Research, V28, P73; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; Liou JC, 1997, J NEUROSCI, V17, P2459; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; Marty S, 1996, J NEUROSCI, V16, P675; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; Pinon LGP, 1995, EUR J NEUROSCI, V7, P2397, DOI 10.1111/j.1460-9568.1995.tb01037.x; RAMAKERS GJA, 1990, EXP BRAIN RES, V79, P157; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Rutherford LC, 1997, J NEUROSCI, V17, P4527; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; STOOP R, 1996, J NEUROSCI, V16, P3258; Takei N, 1997, J NEUROCHEM, V68, P370; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; von der Malsburg C, 1973, Kybernetik, V14, P85; WANG T, 1995, J NEUROSCI, V15, P4796; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; WIDMER HR, 1994, DEV BRAIN RES, V80, P279, DOI 10.1016/0165-3806(94)90114-7; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	54	368	375	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					521	530		10.1016/S0896-6273(00)80563-2	http://dx.doi.org/10.1016/S0896-6273(00)80563-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768839	Bronze			2022-12-24	WOS:000076196400009
J	Feldman, DE; Nicoll, RA; Malenka, RC; Isaac, JTR				Feldman, DE; Nicoll, RA; Malenka, RC; Isaac, JTR			Long-term depression at thalamocortical synapses in developing rat somatosensory cortex	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; VISUAL-CORTEX; CRITICAL PERIOD; BARREL CORTEX; SILENT SYNAPSES; MONOCULAR DEPRIVATION; DEVELOPMENTAL-CHANGES; VOLTAGE-DEPENDENCE; PYRAMIDAL CELLS; SENSORY CORTEX	Sensory experience during an early critical period guides the development of thalamocortical circuits in many cortical areas. This process has been hypothesized to involve long-term potentiation (LTP) end longterm depression (LTD) at thalamocortical synapses. Here, we show that thalamocortical synapses in rat barrel cortex can express LTD, and that LTD is most readily induced during a developmental period that is similar to the critical period for thalamocortical plasticity in vivo. Thalamocortical LTD is homosynaptic and dependent on activation of N-methyl-D-aspartate (NMDA) receptors. The age-related decline of LTD is not due to changes in inhibition nor to changes in NMDA receptor voltage dependence. Minimal stimulation experiments indicate that, unlike thalamocortical LTP, thalamocortical LTD is not associated with a significant change in failure rate. The existence of LTD and its developmental time course suggest that LTD, like LTP, may contribute to the refinement of thalamocortical inputs in vivo.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Bristol, Dept Anat, Bristol BS8 1TD, Avon, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Bristol	Malenka, RC (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BENARI Y, 1988, NEUROSCI LETT, V94, P88, DOI 10.1016/0304-3940(88)90275-3; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BURGARD EC, 1994, DEV BRAIN RES, V80, P275, DOI 10.1016/0165-3806(94)90113-9; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dudek SM, 1996, NEURON, V16, P1097, DOI 10.1016/S0896-6273(00)80136-1; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FOX K, 1992, J NEUROSCI, V12, P1826; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; FREGNAC Y, 1994, J NEUROPHYSIOL, V71, P1403, DOI 10.1152/jn.1994.71.4.1403; Gil Z, 1996, J NEUROPHYSIOL, V76, P2547, DOI 10.1152/jn.1996.76.4.2547; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hebb Donald O., 1949, ORG BEHAV; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KATO N, 1993, P NATL ACAD SCI USA, V90, P7114, DOI 10.1073/pnas.90.15.7114; KATO N, 1993, P NATL ACAD SCI USA, V90, P3650, DOI 10.1073/pnas.90.8.3650; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LUHMANN HJ, 1990, DEV BRAIN RES, V54, P287, DOI 10.1016/0165-3806(90)90152-O; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SEGEV I, 1995, J COMPUT NEUROSCI, V2, P117, DOI 10.1007/BF00961883; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Stricker C, 1996, J PHYSIOL-LONDON, V490, P443, DOI 10.1113/jphysiol.1996.sp021156; TSUMOTO T, 1992, PROG NEUROBIOL, V39, P209, DOI 10.1016/0301-0082(92)90011-3; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WOOLSEY TA, 1976, J COMP NEUROL, V170, P53, DOI 10.1002/cne.901700105; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	73	147	147	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					347	357		10.1016/S0896-6273(00)80544-9	http://dx.doi.org/10.1016/S0896-6273(00)80544-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728916	Bronze			2022-12-24	WOS:000075598300012
J	Chen, HJ; Rojas-Soto, M; Oguni, A; Kennedy, MB				Chen, HJ; Rojas-Soto, M; Oguni, A; Kennedy, MB			A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II	NEURON			English	Article							LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY FRACTION; D-ASPARTATE RECEPTOR; HIPPOCAMPAL-NEURONS; MUTANT MICE; BRAIN; SUBUNIT; PHOSPHORYLATION; IDENTIFICATION; PURIFICATION	Ca2+ influx through N-methyl-D-aspartate-(NMDA-) type glutamate receptors plays a critical role in synaptic plasticity in the brain. One of the proteins activated by the increase in Ca2+ is CaM kinase II (CaMKII). Here, we report a novel synaptic Ras-GTPase activating protein (p135 SynGAP) that is a major component of the postsynaptic density, a complex of proteins associated with synaptic NMDA receptors. p135 SynGAP is almost exclusively localized at synapses in hippocampal neurons where it binds to and closely colocalizes with the scaffold protein PSD-95 and colocalizes with NMDA receptors. The Ras-GTPase activating activity of p135 SynGAP is inhibited by phosphorylation by CaMKII located in the PSD protein complex. Inhibition of p135 SynGAP by CaMKII will stop inactivation of GTP-bound Ras and thus could result in activation of the mitogen-activated protein (MAP) kinase pathway in hippocampal neurons upon activation of NMDA receptors.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Kennedy, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.			Kennedy, Mary/0000-0003-1369-0525	NINDS NIH HHS [NS-17660, NS-28710] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017660, R01NS028710] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Apperson ML, 1996, J NEUROSCI, V16, P6839; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CAMPBELLBURK SL, 1995, METHOD ENZYMOL, V255, P3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Nakamura T, 1998, J BIOL CHEM, V273, P6960, DOI 10.1074/jbc.273.12.6960; Niethammer M, 1996, J NEUROSCI, V16, P2157; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; OU SKH, 1993, J IMMUNOL METHODS, V165, P75, DOI 10.1016/0022-1759(93)90108-J; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Prakash N, 1996, NATURE, V381, P702, DOI 10.1038/381702a0; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH DB, 1995, CURRENT PROTOCOLS MO, P1671; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WIGLER MH, 1990, NATURE, V346, P696, DOI 10.1038/346696a0; XIA X, 1996, J NEUROSCI, V16, P5425	58	452	467	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					895	904		10.1016/S0896-6273(00)80471-7	http://dx.doi.org/10.1016/S0896-6273(00)80471-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620694	Bronze			2022-12-24	WOS:000073864700009
J	Kuromi, H; Kidokoro, Y				Kuromi, H; Kidokoro, Y			Two distinct pools of synaptic vesicles in single presynaptic boutons in a temperature-sensitive Drosophila mutant, shibire	NEURON			English	Article							MOTOR-NERVE TERMINALS; NEUROMUSCULAR-JUNCTIONS; NEUROTRANSMITTER RELEASE; CELLS; MELANOGASTER; ACTIN; ULTRASTRUCTURE; CYTOCHALASIN; COMPARTMENTS; SEPARATION	In a temperature-sensitive Drosophila mutant, shibire, synaptic vesicles are completely depleted in nerve terminals after stimulation at 34 degrees C, but upon returning to 22 degrees C, endocytosis resumes. In this study, synaptic vesicles in the boutons of nerve terminals at the mutant neuromuscular junction were loaded with a fluorescent dye, FM1-43, during vesicle reformation at 22 degrees C after complete depletion at 34 degrees C. We found two distinct pools of synaptic vesicles, namely an exo/endo cycling pool, located in the periphery of the bouton, and a reserve pool, located in its center. Cytochalasin D treatment eliminated the reserve pool and reduced synaptic transmission evoked by high frequency stimulation. Thus, the reserve pool may play a crucial role for sustaining high frequency synaptic transmission.	Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Gunma University	Kuromi, H (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.							AGOSTON DV, 1985, J NEUROCHEM, V44, P299, DOI 10.1111/j.1471-4159.1985.tb07144.x; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; AUNIS D, 1988, J EXP BIOL, V139, P253; Bauerfeind R, 1993, CURR OPIN CELL BIOL, V5, P628, DOI 10.1016/0955-0674(93)90132-A; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; BETZ WJ, 1994, J CELL BIOL, V124, P843, DOI 10.1083/jcb.124.5.843; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; Calakos N, 1996, PHYSIOL REV, V76, P1; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; EWING AG, 1983, SCIENCE, V221, P169, DOI 10.1126/science.6857277; GIOMPRES PE, 1981, NEUROSCIENCE, V6, P765, DOI 10.1016/0306-4522(81)90160-3; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KRISTENSEN HK, 1994, J NEUROSCI METH, V51, P183, DOI 10.1016/0165-0270(94)90009-4; Kuromi H, 1997, NEUROSCI RES, V27, P101, DOI 10.1016/S0168-0102(96)01132-7; KUROMI H, 1997, NEUROSCI RES       S, V21, pS56; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; NUAE O, 1988, J CELL BIOL, V107, P2117; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; PRADO MAM, 1992, J NEUROCHEM, V59, P544, DOI 10.1111/j.1471-4159.1992.tb09404.x; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; ZIMMERMANN H, 1977, NATURE, V267, P633, DOI 10.1038/267633a0; ZIMMERMANN H, 1977, NEUROSCIENCE, V2, P715, DOI 10.1016/0306-4522(77)90025-2	38	219	222	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					917	925		10.1016/S0896-6273(00)80473-0	http://dx.doi.org/10.1016/S0896-6273(00)80473-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620696	Bronze			2022-12-24	WOS:000073864700011
J	Parra, P; Gulyas, AI; Miles, R				Parra, P; Gulyas, AI; Miles, R			How many subtypes of inhibitory cells in the hippocampus?	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT FRONTAL-CORTEX; MORPHOLOGICAL-CHARACTERISTICS; GABAERGIC INTERNEURONS; SYNAPTIC INHIBITION; CEREBRAL-CORTEX; IN-VITRO; CA1; NEURONS; MODULATION	Hippocampal inhibitory cells are diverse. It is supposed that they fall into functionally distinct subsets defined by a similar morphology and physiology. Switching between functions could be accomplished by activating receptors for modulating transmitters expressed selectively by different subsets of interneurons. We tested this hypothesis by comparing morphology, physiology, and neurotransmitter receptor expression for CA1 hippocampal interneurons. We distinguished 16 distinct morphological phenotypes and 3 different modes of discharge. Subsets of inhibitory cells were excited or inhibited by agonists at receptors for noradrenaline, muscarine, serotonin, and mGluRs. Most cells responded to 2 or 3 agonists, and 25 different response combinations were detected. Subsets defined by morphology, physiology, and receptor expression did not coincide, suggesting that hippocampal interneurons cannot easily be segregated into a few well-defined groups.	Inst Pasteur, Lab Neurobiol Cellulaire, F-75724 Paris, France; Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Miles, R (corresponding author), Inst Pasteur, Lab Neurobiol Cellulaire, 25 Rue Dr Roux, F-75724 Paris, France.			Gulyas, Attila/0000-0003-4961-636X; Miles, Richard/0000-0001-7303-0233	NIMH NIH HHS [MH54671] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alcantara S, 1996, EUR J NEUROSCI, V8, P1329, DOI 10.1111/j.1460-9568.1996.tb01595.x; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BEHRENDS JC, 1993, J NEUROPHYSIOL, V69, P626, DOI 10.1152/jn.1993.69.2.626; Bergles DE, 1996, J NEUROSCI, V16, P572; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Cauli B, 1997, J NEUROSCI, V17, P3894; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Eccles J.C., 1969, INHIBITORY PATHWAYS; FRASER DD, 1991, J NEUROSCI, V11, P2812; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; FREUND TF, 1996, HIPPOCAMPUS, V6, P345; Guerineau NC, 1997, J PHYSIOL-LONDON, V500, P487, DOI 10.1113/jphysiol.1997.sp022035; Gulyas AI, 1996, J NEUROSCI, V16, P3397; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; KAWA K, 1994, J NEUROPHYSIOL, V71, P1935, DOI 10.1152/jn.1994.71.5.1935; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MANZONI OJ, 1994, SCIENCE, V265, P2096; Marty S, 1997, NEUROSCIENCE, V80, P79, DOI 10.1016/S0306-4522(97)00134-6; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MIONE MC, 1994, J NEUROSCI, V14, P107; MOTT DD, 1997, J NEUROSCI, V17, P3390; NICOLL RA, 1994, NATURE, V368, P808, DOI 10.1038/368808a0; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Rocamora N, 1996, J NEUROSCI, V16, P3991; ROPERT N, 1991, J PHYSIOL-LONDON, V441, P121, DOI 10.1113/jphysiol.1991.sp018742; SCHMITZ D, 1995, J NEUROSCI, V15, P7217; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998	47	278	281	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					983	993		10.1016/S0896-6273(00)80479-1	http://dx.doi.org/10.1016/S0896-6273(00)80479-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620702	Bronze			2022-12-24	WOS:000073864700017
J	Isaacson, JS; Strowbridge, BW				Isaacson, JS; Strowbridge, BW			Olfactory reciprocal synapses: Dendritic signaling in the CNS	NEURON			English	Article							EXCITATORY SYNAPTIC TRANSMISSION; GRANULE CELLS; DENDRODENDRITIC INHIBITION; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; CA2+ CHANNELS; CALCIUM CHELATORS; N-TYPE; BULB; SPINES	Synaptic transmission between dendrites in the olfactory bulb is thought to play a major role in the processing of olfactory information. Glutamate released from mitral cell dendrites excites the dendrites of granule cells, which in turn mediate GABAergic dendrodendritic inhibition back onto mitral dendrites. We examined the mechanisms governing reciprocal dendritic transmission in rat olfactory bulb slices. We find that NMDA receptors play a critical role in this dendrodendritic inhibition. As with axenic synapses, the dendritic release of fast neurotransmitters relies on N- and P/Q-type calcium channels. The magnitude of dendrodendritic transmission is directly proportional to dendritic calcium influx. Furthermore, recordings from pairs of mitral cells show that dendrodendritic synapses can mediate lateral inhibition independently of axonal action potentials.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Isaacson, JS (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS033590, R01NS033590] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33590] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; Avery RB, 1996, J NEUROSCI, V16, P5567; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BORST JG, 1996, NATURE, V383, P43; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P263, DOI 10.1016/0166-2236(87)90170-6; DOWLING JE, 1968, PROC R SOC SER B-BIO, V170, P205, DOI 10.1098/rspb.1968.0034; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Galarreta M, 1997, J NEUROSCI, V17, P7220; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; ISAACSON JS, 1995, J NEUROPHYSIOL, V73, P964, DOI 10.1152/jn.1995.73.3.964; JAHR CE, 1982, NATURE, V297, P227, DOI 10.1038/297227a0; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; KOCH C, 1993, J NEUROSCI, V13, P413; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; NICOLL RA, 1969, BRAIN RES, V14, P157, DOI 10.1016/0006-8993(69)90037-7; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; PHILLIPS CG, 1963, J PHYSIOL-LONDON, V168, P65, DOI 10.1113/jphysiol.1963.sp007178; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; PRICE JL, 1970, J CELL SCI, V7, P125; PRICE JL, 1970, J CELL SCI, V7, P91; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Shepherd G. M., 1990, SYNAPTIC ORG BRAIN, P133; SIMMONS ML, 1995, NEURON, V14, P1265, DOI 10.1016/0896-6273(95)90273-2; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TROMBLEY PQ, 1990, J NEUROPHYSIOL, V64, P598, DOI 10.1152/jn.1990.64.2.598; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WELLIS DP, 1994, J PHYSIOL-LONDON, V475, P419, DOI 10.1113/jphysiol.1994.sp020082; WELLIS DP, 1993, J PHYSIOL-LONDON, V469, P315, DOI 10.1113/jphysiol.1993.sp019816; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WINSLOW JL, 1994, J NEUROPHYSIOL, V72, P1769, DOI 10.1152/jn.1994.72.4.1769; WOOLF TB, 1991, J NEUROSCI, V11, P1837; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	50	390	394	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					749	761		10.1016/S0896-6273(00)81013-2	http://dx.doi.org/10.1016/S0896-6273(00)81013-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581766	Bronze			2022-12-24	WOS:000073346500013
J	Milbrandt, J; de Sauvage, FJ; Fahrner, TJ; Baloh, RH; Leitner, ML; Tansey, MG; Lampe, PA; Heuckeroth, RO; Kotzbauer, PT; Simburger, KS; Golden, JP; Davies, JA; Vejsada, R; Kato, AC; Hynes, M; Sherman, D; Nishimura, M; Wang, LC; Vandlen, R; Moffat, B; Klein, RD; Poulsen, K; Gray, C; Garces, A; Henderson, CE; Phillips, HS; Johnson, EM				Milbrandt, J; de Sauvage, FJ; Fahrner, TJ; Baloh, RH; Leitner, ML; Tansey, MG; Lampe, PA; Heuckeroth, RO; Kotzbauer, PT; Simburger, KS; Golden, JP; Davies, JA; Vejsada, R; Kato, AC; Hynes, M; Sherman, D; Nishimura, M; Wang, LC; Vandlen, R; Moffat, B; Klein, RD; Poulsen, K; Gray, C; Garces, A; Henderson, CE; Phillips, HS; Johnson, EM			Persephin, a novel neurotrophic factor related to GDNF and neurturin	NEURON			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; MICE LACKING GDNF; SURVIVAL FACTOR; IN-VIVO; KIDNEY DEVELOPMENT; TYROSINE KINASE; MOTOR-NEURONS; CELL-DEATH; RECEPTOR; MOTONEURONS	A novel neurotrophic factor named Persephin that is similar to 40% identical to glial eel line-derived neurotrophic factor (GDNF) and neurturin (NTN) has been identified using degenerate PCR. Persephin, like GDNF and NTN, promotes the survival of ventral midbrain dopaminergic neurons in culture and prevents their degeneration after 6-hydroxydopamine treatment in vivo. Persephin also supports the survival of motor neurons in culture and in vivo after sciatic nerve axotomy and, like GDNF, promotes ureteric bud branching. However, in contrast to GDNF and NTN, persephin does not support any of the peripheral neurons that were examined. Fibroblasts transfected with Ret and one of the core-ceptors GFR alpha-1 or GFR alpha-2 do not respond to persephin, suggesting that persephin utilizes additional, or different, receptor components than GDNF and NTN.	Washington Univ, Sch Med, St Louis, MO 63110 USA; Genentech Inc, S San Francisco, CA 94080 USA; Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Geneva, Sch Med, CH-1211 Geneva 4, Switzerland; Univ Mediterranee, CNRS, INSERM, U382, Marseille 09, France	Washington University (WUSTL); Roche Holding; Genentech; University of Edinburgh; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Milbrandt, J (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.		Lampe, Patricia/AAH-9545-2020; de Sauvage, Frederic/ABE-8400-2020; Davies, Jamie/AAE-7111-2019	de Sauvage, Frederic/0000-0002-5275-2584; Davies, Jamie/0000-0001-6660-4032; Golden, Judith/0000-0002-5168-8525; Hynes, Mary/0000-0001-6623-6727; Heuckeroth, Robert/0000-0002-3282-1765; Garces, Alain/0000-0001-6252-9995; Milbrandt, Jeffrey/0000-0002-5477-7689; Henderson, Christopher/0000-0002-9936-3279	NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG13729, R01 AG13730] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; DAVIES J, 1995, DEVELOPMENT, V121, P1507; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; FARLEY JR, 1978, ARCH BIOCHEM BIOPHYS, V185, P376, DOI 10.1016/0003-9861(78)90180-7; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HYNES MA, 1994, J NEUROSCI RES, V37, P144, DOI 10.1002/jnr.490370118; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; RAPRAEGER AC, 1991, SCIENCE, V252, P371; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Suvanto P, 1997, HUM MOL GENET, V6, P1267, DOI 10.1093/hmg/6.8.1267; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; WIDENFALK J, 1997, J NEUROSCI, V17, P8505; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0	39	412	445	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					245	253		10.1016/S0896-6273(00)80453-5	http://dx.doi.org/10.1016/S0896-6273(00)80453-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491986	Bronze			2022-12-24	WOS:000072154700010
J	Kidd, T; Russell, C; Goodman, CS; Tear, G				Kidd, T; Russell, C; Goodman, CS; Tear, G			Dosage-sensitive and complementary functions of roundabout and commissureless control axon crossing of the CNS midline	NEURON			English	Article							GROWTH CONE GUIDANCE; CELL-ADHESION MOLECULE; GENETIC-ANALYSIS; DROSOPHILA; CONNECTIN; SYSTEM	commissureless and roundabout lead to complementary mutant phenotypes in which either too few or too many axons cross the midline. The robo;comm double-mutant phenotype is identical to robe alone, suggesting that in the absence of robe, comm is no longer required. Comm is expressed on midline cells; Robe is expressed in a dynamic fashion on growth cones and appears to function as an axon guidance receptor. robe function is dosage-sensitive. Overexpression of comm is also dosage-sensitive and leads to a phenotype identical to robe loss-of-function. Comm controls Robe expression; increasing Comm leads to a reduction of Robe protein. The levels of Comm and Robe appear to be tightly regulated to assure that only certain growth cones cross the midline and that those growth cones that do cross never do so again.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AZ, England	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Imperial College London	Kidd, T (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.		Kidd, Thomas/AAT-9993-2020; Tear, Guy/C-5444-2009; Russell, Claire/A-4879-2012	Russell, Claire/0000-0002-6748-9301; Kidd, Thomas/0000-0001-7190-4208	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18366] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRAND AH, 1993, DEVELOPMENT, V118, P401; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; MEADOWS LA, 1994, J CELL SCI, V107, P321; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PATEL NH, 1994, METHOD CELL BIOL, V44, P7; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5	13	253	258	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1998	20	1					25	33		10.1016/S0896-6273(00)80431-6	http://dx.doi.org/10.1016/S0896-6273(00)80431-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459439	Bronze			2022-12-24	WOS:000071719700006
J	Topinka, JR; Bredt, DS				Topinka, JR; Bredt, DS			N-terminal palmitoylation of PSD-95 regulates association with cell membranes and interaction with K+ channel K(v)1.4	NEURON			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-SUPPRESSOR GENE; DENSITY PROTEIN PSD-95; CLUSTERING ACTIVITY; GUANYLATE KINASES; RECEPTOR; CAVEOLAE; DEPALMITOYLATION; HOMOLOG; ANKYRIN	Ion channels and associated signal transduction cascades are clustered at excitatory synapses by PSD-95 and related PDZ-containing proteins. Mechanisms that target PSD-95 to synaptic membranes, however, are unknown. Here, PSD-95 is shown to partition as an integral membrane protein in brain homogenates. Metabolic labeling of brain slices or cultured cells demonstrates that PSD-95 is modified by thioester-linked palmitate, a long chain fatty acid that targets proteins to cell membranes. In fact, PSD-95 is a major palmitoylated protein in intact cells, and palmitoylated PSD-95 partitions exclusively with cell membranes. Mutagenesis indicates that palmitoylation of PSD-95 occurs on conserved N-terminal cysteines 3 and 5. Palmitoylation-deficient mutants of PSD-95 do not partition as integral membrane proteins and do not participate in PDZ-ion channel interactions in vivo. This work identifies palmitoylation as a critical regulatory mechanism for receptor interactions with PSD-95.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.							ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; BOUVIER M, 1995, BIOCHEM SOC T, V23, P577, DOI 10.1042/bst0230577; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Das AK, 1997, J BIOL CHEM, V272, P11021; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HALL ZW, 1993, NEURON S, V10, P99; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; LISANTI MP, 1995, MOL MEMBR BIOL, V12, P121, DOI 10.3109/09687689509038506; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; LIU JW, 1995, BIOCHEMISTRY-US, V34, P12333, DOI 10.1021/bi00038a029; MILLIGAN G, 1995, BIOCHEM SOC T, V23, P583, DOI 10.1042/bst0230583; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; ROBINSON LJ, 1995, J BIOL CHEM, V270, P995, DOI 10.1074/jbc.270.3.995; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	51	236	239	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1998	20	1					125	134		10.1016/S0896-6273(00)80440-7	http://dx.doi.org/10.1016/S0896-6273(00)80440-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459448	Bronze			2022-12-24	WOS:000071719700015
J	McNabb, SL; Baker, JD; Agapite, J; Steller, H; Riddiford, LM; Truman, JW				McNabb, SL; Baker, JD; Agapite, J; Steller, H; Riddiford, LM; Truman, JW			Disruption of a behavioral sequence by targeted death of peptidergic neurons in Drosophila	NEURON			English	Article							PROGRAMMED CELL-DEATH; FMRFAMIDE NEUROPEPTIDE GENE; ECLOSION HORMONE; MANDUCA-SEXTA; NEUROENDOCRINE CONTROL; TOBACCO HORNWORM; MELANOGASTER; EXPRESSION; ECDYSIS; IDENTIFICATION	The neuropeptide eclosion hormone (EH) is a key regulator of insect ecdysis. We tested the role of the two EH-producing neurons in Drosophila by using an EH cell-specific enhancer to activate cell death genes reaper and head involution defective to ablate the EH cells. In the EH cell knockout flies, larval and adult ecdyses were disrupted, yet a third of the knockouts emerged as adults, demonstrating that EH has a significant but nonessential role in ecdysis. The EH cell knockouts had discrete behavioral deficits, including slow, uncoordinated eclosion and an insensitivity to ecdysis-triggering hormone. The knockouts lacked the lights-on eclosion response despite having a normal circadian eclosion rhythm. This study represents a novel approach to the dissection of neuropeptide regulation of a complex behavioral program.	MIT,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	McNabb, SL (corresponding author), UNIV WASHINGTON,DEPT ZOOL,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013079] Funding Source: NIH RePORTER; NINDS NIH HHS [2R01 NS13079-20] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELLEN HJ, 1992, DEVELOPMENT, V114, P787; BRAND A, 1995, TRENDS GENET, V11, P324, DOI 10.1016/S0168-9525(00)89091-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; COPENHAVER PF, 1986, J NEUROSCI, V6, P1738; DICKINSON PS, 1990, NATURE, V344, P155, DOI 10.1038/344155a0; ENGELMANN W, 1966, NATURWISSENSCHAFTEN, V53, P588, DOI 10.1007/BF00600545; Ephrussi B, 1936, AM NAT, V70, P218, DOI 10.1086/280658; EWER J, 1994, J NEUROSCI, V14, P7704; Ewer J, 1996, J COMP NEUROL, V370, P330; Ewer J, 1997, J EXP BIOL, V200, P869; FERNANDES J, 1991, DEVELOPMENT, V113, P67; Gammie SC, 1997, J COMP PHYSIOL A, V180, P329, DOI 10.1007/s003590050052; Gammie SC, 1997, J NEUROSCI, V17, P4389; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hahm SH, 1996, J NEUROCHEM, V67, P1872; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HEWES RS, 1991, J COMP PHYSIOL A, V168, P697; Horodyski FM, 1996, J INSECT PHYSIOL, V42, P917, DOI 10.1016/0022-1910(96)00035-2; HORODYSKI FM, 1993, EUR J BIOCHEM, V215, P221, DOI 10.1111/j.1432-1033.1993.tb18026.x; JOHNSON SA, 1987, TISSUE CELL, V19, P505, DOI 10.1016/0040-8166(87)90044-9; KALB JM, 1993, P NATL ACAD SCI USA, V90, P8093, DOI 10.1073/pnas.90.17.8093; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KATAOKA H, 1987, BIOCHEM BIOPH RES CO, V146, P746, DOI 10.1016/0006-291X(87)90592-4; KIMURA K, 1990, J NEUROSCI, V10, P403; KUNES S, 1991, GENE DEV, V5, P970, DOI 10.1101/gad.5.6.970; MARTI T, 1987, FEBS LETT, V219, P415, DOI 10.1016/0014-5793(87)80263-6; Mayeri E., 1985, P285; MINTH CD, 1986, J BIOL CHEM, V261, P1974; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; Nordstrom W, 1996, DEV BIOL, V180, P213, DOI 10.1006/dbio.1996.0296; OBRIEN MA, 1994, GENETICS, V137, P121; Pittendrigh CS, 1965, CIRCADIAN CLOCKS, P277; RIDDIFORD LM, 1994, J NEUROBIOL, V25, P819, DOI 10.1002/neu.480250707; ROBINOW S, 1993, DEVELOPMENT, V119, P1251; SCHNEIDER LE, 1993, NEURON, V10, P279, DOI 10.1016/0896-6273(93)90318-L; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Thummel CS, 1992, DROS INF SERV, V71, P150; TRUMAN JW, 1992, PROG BRAIN RES, V92, P361, DOI 10.1016/S0079-6123(08)61189-9; TRUMAN JW, 1981, NATURE, V291, P70, DOI 10.1038/291070a0; TRUMAN JW, 1989, J EXP BIOL, V147, P457; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; Truman JW, 1971, P INT S CIRCADIAN RH, P111; WATSON AHD, 1981, CELL TISSUE RES, V215, P325; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131; ZIPURSKY SL, 1985, P NATL ACAD SCI USA, V82, P1855, DOI 10.1073/pnas.82.6.1855; Zitnan D, 1996, SCIENCE, V271, P88, DOI 10.1126/science.271.5245.88	49	166	168	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1997	19	4					813	823		10.1016/S0896-6273(00)80963-0	http://dx.doi.org/10.1016/S0896-6273(00)80963-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD189	9354328	Bronze			2022-12-24	WOS:A1997YD18900009
J	Kang, HJ; Welcher, AA; Shelton, D; Schuman, EM				Kang, HJ; Welcher, AA; Shelton, D; Schuman, EM			Neurotrophins and time: Different roles for TrkB signaling in hippocampal long-term potentiation	NEURON			English	Article							NERVE GROWTH-FACTOR; MESSENGER-RNA EXPRESSION; NITRIC-OXIDE SYNTHASE; SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; PROTEIN-KINASE; FACTOR BDNF; BRAIN; NEURONS; LTP	We examined the role of TrkB ligands in hippocampal long-term potentiation (LTP) using function-blocking TrkB antiserum (Ab) and Trk-IgG fusion proteins. Incubation of hippocampal slices with TrkB Ab had no effect on basal synaptic transmission, short-term plasticity, or LTP induced by several trains of tetanic stimulation. The TrkB Ab-treated slices, however, showed significant deficits in LTP induced by either theta-burst stimulation (TBS) or ''pairing.'' Slices exposed to the same number of inducing stimuli, delivered either as TBS or as a single 100 Hz epoch, only exhibited TrkB-sensitive LTP when TBS was used, indicating that the temporal pattern of stimulation determines the neurotrophin dependence. The late phase of LTP (2-3 hr) was also significantly impaired in slices pretreated with TrkB Ab or a TrkB-IgG. The application of a TrkB-IgG 30 min after LTP induction caused previously potentiated synaptic transmission to return to baseline levels, indicating that TrkB ligands are required to maintain LTP for up to 1 hr after induction. Taken together, these results indicate that both the temporal patterns of synaptic activity and the different temporal phases of synaptic enhancement are important in determining the neurotrophin dependence of plasticity in the hippocampus.	CALTECH,HOWARD HUGHES MED INST,DIV BIO 21676,PASADENA,CA 91125; AMGEN INC,AMGEN CTR 51E,DEPT IMMUNOL,THOUSAND OAKS,CA 91320; GENENTECH INC,DEPT NEUROSCI,S SAN FRANCISCO,CA 94080	California Institute of Technology; Howard Hughes Medical Institute; Amgen; Roche Holding; Genentech			Schuman, Erin M/D-6204-2011					BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; Barnea A, 1996, BRAIN RES, V732, P52, DOI 10.1016/0006-8993(96)00486-6; BEMINGER B, 1993, NEUROREPORT, V4, P1303; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CARMIGNOTO G, 1997, IN PRESS J PHYSL; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; DELANEY KR, 1989, J NEUROSCI, V9, P3358; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GALLIN WJ, 1995, CURR OPIN NEUROBIOL, V5, P367, DOI 10.1016/0959-4388(95)80050-6; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GOODMAN LJ, 1996, MOL CELL NEUROSCI, V7, P223; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; GWAG BJ, 1993, NEUROREPORT, V5, P125, DOI 10.1097/00001756-199311180-00007; HALEY JE, 1993, NEUROSCI LETT, V160, P85, DOI 10.1016/0304-3940(93)90919-C; IMPREY S, 1996, NEURON, V16, P973; IP NY, 1993, J NEUROSCI, V13, P3394; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kang HJ, 1996, LEARN MEMORY, V3, P188, DOI 10.1101/lm.3.2-3.188; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNIPPER M, 1994, EUR J NEUROSCI, V6, P668, DOI 10.1111/j.1460-9568.1994.tb00312.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LeSauteur L, 1996, J NEUROSCI, V16, P1308; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; NAWA H, 1994, J NEUROSCI, V14, P3751; NAZIF FA, 1991, BRAIN RES, V539, P324, DOI 10.1016/0006-8993(91)91638-H; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; PHILO J, 1994, J BIOL CHEM, V269, P27840; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Stoop R, 1996, J NEUROSCI, V16, P3256; TAPLEY P, 1992, ONCOGENE, V7, P371; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; WILLIAMS JH, 1993, NEURON, V11, P877, DOI 10.1016/0896-6273(93)90117-A; Yan Q, 1997, J COMP NEUROL, V378, P135; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	62	382	386	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					653	664		10.1016/S0896-6273(00)80378-5	http://dx.doi.org/10.1016/S0896-6273(00)80378-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331355	Bronze			2022-12-24	WOS:A1997XZ01600018
J	Threadgill, R; Bobb, K; Ghosh, A				Threadgill, R; Bobb, K; Ghosh, A			Regulation of dendritic growth and remodeling by Rho, Rac, and Cdc42	NEURON			English	Article							ACTIN STRESS FIBERS; VISUAL-CORTEX; PROJECTION NEURONS; SIGNALING PATHWAY; SMALL GTPASES; PC12 CELLS; DIFFERENTIATION; MORPHOLOGY; NUCLEUS; PATTERN	The acquisition of cell type-specific morphologies is a central feature of neuronal differentiation and has important consequences for nervous system function. To begin to identify the underlying molecular mechanisms, we have explored the role of Rho-related GTPases in the dendritic development of cortical neurons. Expression of dominant negative mutants of Rac or Cdc42, the Rho-inhibitory molecule C3 transferase, or the GTPase-activating protein RhoGAP p190 causes a marked reduction in the number of primary dendrites in nonpyramidal (multipolar) neurons and in the number of basal dendrites in neurons with pyramidal morphologies. Conversely, the expression of constitutively active mutants of Rho, Rac, or Cdc42 leads to an increase in the number of primary and basal dendrites. In cortical cultures, as in vivo, dendritic remodeling leads to an apparent transformation from pyramidal to nonpyramidal morphologies over time. Strikingly, this shift in favor of nonpyramidal morphologies is also inhibited by the expression of dominant negative mutants of Cdc42 and Rac and by RhoGAP p190. These observations indicate that Rho, Rac, and Cdc42 play a central role in dendritic development and suggest that differential activation of Rho-related GTPases may contribute to the generation of morphological diversity in the developing cortex.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University								BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; BRAY D, 1985, J NEUROSCI, V5, P3204; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DALVA MB, 1994, J NEUROSCI, V14, P3588; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GREENOUGH WT, 1988, DEV BRAIN RES, V43, P148, DOI 10.1016/0165-3806(88)90160-5; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HALLMAN LE, 1988, J COMP NEUROL, V272, P149, DOI 10.1002/cne.902720111; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; HUBENER M, 1990, J COMP NEUROL, V301, P655, DOI 10.1002/cne.903010412; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; KOESTER SE, 1992, J NEUROSCI, V12, P1382; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MACKAY DJG, 1995, TRENDS NEUROSCI, V18, P496, DOI 10.1016/0166-2236(95)92773-J; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Rall W., 1964, THEORETICAL SIGNIFIC; RAMOA AS, 1988, J NEUROSCI, V8, P4239; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RIDLEY AJ, 1993, EMBO J, V7, P5150; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; WISE SP, 1979, NEUROSCIENCE, V4, P1275, DOI 10.1016/0306-4522(79)90157-X	33	419	423	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					625	634		10.1016/S0896-6273(00)80376-1	http://dx.doi.org/10.1016/S0896-6273(00)80376-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331353	hybrid			2022-12-24	WOS:A1997XZ01600016
J	Paulson, HL; Perez, MK; Trottier, Y; Trojanowski, JQ; Subramony, SH; Das, SS; Vig, P; Mandel, JL; Fischbeck, KH; Pittman, RN				Paulson, HL; Perez, MK; Trottier, Y; Trojanowski, JQ; Subramony, SH; Das, SS; Vig, P; Mandel, JL; Fischbeck, KH; Pittman, RN			Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3	NEURON			English	Article							MACHADO-JOSEPH DISEASE; CAG REPEAT; HUNTINGTONS-DISEASE; NEURODEGENERATIVE DISEASES; GLUTAMINE REPEATS; SUBCELLULAR-LOCALIZATION; TRINUCLEOTIDE REPEAT; TRANSGENIC MICE; JAPANESE FAMILY; PRION DISEASES	The mechanism of neurodegeneration in CAG/polyglutamine repeat expansion diseases is unknown but is thought to occur at the protein level. Here, in studies of spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/MJD), we show that the disease protein ataxin-3 accumulates in ubiquitinated intranuclear inclusions selectively in neurons of affected brain regions. We further provide evidence in vitro for a model of disease in which an expanded polyglutamine-containing fragment recruits full-length protein into insoluble aggregates. Together with recent findings from transgenic models, our results suggest that intranuclear aggregation of the expanded protein is a unifying feature of CAG/polyglutamine diseases and may be initiated or catalyzed by a glutamine-containing fragment of the disease protein.	UNIV PENN,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19104; INST GENET & BIOL MOL & CELLULAIRE,F-67404 ILLKIRCH GRAFFENS,FRANCE; UNIV MISSISSIPPI,DEPT NEUROL,JACKSON,MS 38677	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Mississippi			Trottier, Yvon/H-8852-2016	Trottier, Yvon/0000-0001-7230-4810				[Anonymous], ADV NEUROL; Bao J, 1996, P NATL ACAD SCI USA, V93, P5037, DOI 10.1073/pnas.93.10.5037; Bates G, 1996, BIOESSAYS, V18, P175, DOI 10.1002/bies.950180303; Blumen SC, 1996, NEUROLOGY, V46, P1324, DOI 10.1212/WNL.46.5.1324; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DEARMOND SJ, 1995, AM J PATHOL, V146, P785; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; DICKSON DW, 1990, LAB INVEST, V63, P87; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; GALVIN JE, 1997, IN PRESS ADV NEUROL; GAREN PD, 1996, ACTA NEUROPATHOL, V70, P327; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; *HUNT DIS COLL RES, 1993, CELL, V72, P971; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; IMBERT G, 1994, GENOMICS, V21, P667, DOI 10.1006/geno.1994.1335; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOSINSKI CM, 1997, IN PRESS EXP NEUROL; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; LOWE J, 1993, BRAIN PATHOL, V3, P55, DOI 10.1111/j.1750-3639.1993.tb00726.x; MacDonald ME, 1996, CURR OPIN NEUROBIOL, V6, P638, DOI 10.1016/S0959-4388(96)80097-3; MACIEL P, 1995, AM J HUM GENET, V57, P54; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MATILLA T, 1995, ANN NEUROL, V38, P68, DOI 10.1002/ana.410380113; Mengual E, 1996, J NEUROSCI, V16, P6331; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PALO J, 1984, ANN NEUROL, V15, P322, DOI 10.1002/ana.410150404; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Perutz MF, 1996, CURR OPIN STRUC BIOL, V6, P848, DOI 10.1016/S0959-440X(96)80016-9; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1995, AM J HUM GENET, V57, P603; ROSENBERG RN, 1992, MOVEMENT DISORD, V7, P193, DOI 10.1002/mds.870070302; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; SACHDEV HS, 1982, NEUROLOGY, V32, P192, DOI 10.1212/WNL.32.2.192; Sambrook J., 2002, MOL CLONING LAB MANU; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; WEIDENHEIM KM, 1995, CLIN NEUROPATHOL, V14, P93; YUASA T, 1986, ANN NEUROL, V19, P152, DOI 10.1002/ana.410190207; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zoghbi HY, 1996, NAT GENET, V14, P237, DOI 10.1038/ng1196-237	66	681	692	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					333	344		10.1016/S0896-6273(00)80943-5	http://dx.doi.org/10.1016/S0896-6273(00)80943-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292723	hybrid			2022-12-24	WOS:A1997XU14600012
J	Kelly, MA; Rubinstein, M; Asa, SL; Zhang, G; Saez, C; Bunzow, JR; Allen, RG; Hnasko, R; BenJonathan, N; Grandy, DK; Low, MJ				Kelly, MA; Rubinstein, M; Asa, SL; Zhang, G; Saez, C; Bunzow, JR; Allen, RG; Hnasko, R; BenJonathan, N; Grandy, DK; Low, MJ			Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice	NEURON			English	Article							HORMONE-RELEASING HORMONE; RAT PITUITARY; INTERMEDIATE LOBE; INSITU HYBRIDIZATION; ANTERIOR-PITUITARY; PROLACTIN CELLS; GROWTH-FACTOR; TUMOR CELLS; EXPRESSION; PROOPIOMELANOCORTIN	Dopamine secreted from hypophysial hypothalamic neurons is a principal inhibitory regulator of pituitary hormone secretion. Mice with a disrupted D2 dopamine receptor gene had chronic hyperprolactinemia and developed anterior robe lactotroph hyperplasia without evidence of adenomatous transformation. Unexpectedly, the mutant mice had no hyperplasia of the intermediate robe melanotrophs. Aged female D2 receptor -/- mice developed uterine adenomyosis in response to prolonged prolactin exposure. These data reveal a critical role of hypothalamic dopamine in controlling pituitary growth and support a multistep mechanism for the induction and perpetuation of lactotroph hyperplasia, involving the lack of dopamine signaling, a low androgen/estrogen ratio, and a final autocrine or paracrine ''feed-forward'' stimulation of mitogenesis, probably by prolactin itself.	MT SINAI HOSP,DEPT PATHOL,TORONTO,ON M5G 1X5,CANADA; OREGON HLTH SCI UNIV,CTR RES OCCUPAT & ENVIRONM TOXICOL,PORTLAND,OR 97201; UNIV CINCINNATI,SCH MED,DEPT CELL BIOL,CINCINNATI,OH 45267; UNIV CINCINNATI,SCH MED,DEPT ANAT,CINCINNATI,OH 45267	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Oregon Health & Science University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Kelly, MA (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.		IBIS, TUMORIGENESIS/P-3506-2015; Sáez, Carmen/B-9468-2015	Sáez, Carmen/0000-0002-8600-0508; Low, Malcolm/0000-0002-9900-3708; Kelly, Michele/0000-0003-1799-055X; Asa, Sylvia/0000-0001-8418-5054	NIDA NIH HHS [DA09620] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA009620] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ASA SL, 1982, ARCH PATHOL LAB MED, V106, P360; ASA SL, 1990, P SOC EXP BIOL MED, V193, P232; ASA SL, 1992, ENDOCRINOLOGY, V131, P2083, DOI 10.1210/en.131.5.2083; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BORRELLI E, 1992, P NATL ACAD SCI USA, V89, P2764, DOI 10.1073/pnas.89.7.2764; BUNZOW JR, 1995, J NEUROCHEM, V64, P14; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; CACCAVELLI L, 1992, HORM RES, V38, P78, DOI 10.1159/000182494; CHRONWALL BM, 1988, ENDOCRINOLOGY, V123, P1992, DOI 10.1210/endo-123-4-1992; CHRONWALL BM, 1987, ENDOCRINOLOGY, V120, P1201, DOI 10.1210/endo-120-3-1201; CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281; COTE TE, 1982, NEUROENDOCRINOLOGY, V35, P217, DOI 10.1159/000123384; DASILVA L, 1994, J BIOL CHEM, V269, P18267; DAVIS MD, 1984, NEUROENDOCRINOLOGY, V39, P1; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; DOPPLER W, 1994, REV PHYSIOL BIOCH P, V124, P93, DOI 10.1007/BFb0031032; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FLORIO T, 1992, J BIOL CHEM, V267, P24169; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; HOLIT V, 1982, ENDOCRINOLOGY, V110, P1885; HORVATH E, 1988, PATHOL RES PRACT, V183, P623, DOI 10.1016/S0344-0338(88)80026-8; HU NP, 1994, ONCOGENE, V9, P1021; HUSBY RA, 1985, ENDOCRINOLOGY, V116, P1440; HUSBY RA, 1982, AM J OBSTET GYNECOL, V144, P939; JAY V, 1991, ACTA NEUROPATHOL, V82, P147, DOI 10.1007/BF00293958; JUNG Y, 1972, Archives of Pathology, V94, P265; KIINO DR, 1981, ENDOCRINOLOGY, V109, P1264, DOI 10.1210/endo-109-4-1264; KOVACS K, 1986, ARCH PATHOL LAB MED, V110, P607; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LLOYD HM, 1975, NATURE, V255, P497, DOI 10.1038/255497a0; LOW MJ, 1993, J BIOL CHEM, V268, P24967; MCANDREW J, 1995, ENDOCRINOLOGY, V136, P4479, DOI 10.1210/en.136.10.4479; MEADORWOODRUFF JH, 1990, NEUROENDOCRINOLOGY, V51, P294, DOI 10.1159/000125353; MELLER E, 1991, J PHARMACOL EXP THER, V257, P668; MELMED S, 1986, BRAIN RES, V369, P83, DOI 10.1016/0006-8993(86)90515-9; MOLITCH ME, 1995, PITUITARY, P146; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Orth DN, 1992, WILLIAMS TXB ENDOCRI, P489; PEILLON F, 1991, J CLIN ENDOCR METAB, V73, P1008, DOI 10.1210/jcem-73-5-1008; PHELPS C, 1983, NEUROENDOCRINOLOGY, V37, P23, DOI 10.1159/000123511; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; SCHEITHAUER BW, 1989, MAYO CLIN PROC, V64, P1077, DOI 10.1016/S0025-6196(12)64976-3; SCHEITHAUER BW, 1990, MAYO CLIN PROC, V65, P461, DOI 10.1016/S0025-6196(12)60946-X; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; SIBLEY DR, 1993, INT REV NEUROBIOL, V35, P391, DOI 10.1016/S0074-7742(08)60573-5; SIBLEY DR, 1983, MOL PHARMACOL, V23, P585; SINGTRIPOP T, 1991, LIFE SCI, V49, P201, DOI 10.1016/0024-3205(91)90004-U; Steinmetz R, 1997, ENDOCRINOLOGY, V138, P1780, DOI 10.1210/en.138.5.1780; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; WASS JAH, 1982, BRIT MED J, V284, P1908, DOI 10.1136/bmj.284.6333.1908; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Zhang GE, 1996, J PHARMACOL EXP THER, V277, P551	54	343	347	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1997	19	1					103	113		10.1016/S0896-6273(00)80351-7	http://dx.doi.org/10.1016/S0896-6273(00)80351-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN394	9247267	Bronze			2022-12-24	WOS:A1997XN39400010
J	McMahon, LL; Kauer, JA				McMahon, LL; Kauer, JA			Hippocampal interneurons express a novel form of synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; GUINEA-PIG HIPPOCAMPUS; LACUNOSUM-MOLECULARE INTERNEURONS; EPSP SPIKE DISSOCIATION; RAT HIPPOCAMPUS; LASTING POTENTIATION; PYRAMIDAL CELLS; PERFORANT PATH; DENTATE GYRUS; INTRADENDRITIC RECORDINGS	Individual GABAergic interneurons in hippocampus can powerfully inhibit more than a thousand excitatory pyramidal neurons. Therefore, control of interneuron excitability provides control over hippocampal networks. We have identified a novel mechanism in hippocampus that weakens excitatory synapses onto GABAergic interneurons. Following stimulation that elicits long-term potentiation at neighboring synapses onto excitatory cells, excitatory synapses onto inhibitory interneurons undergo a long-term synaptic depression (interneuron LTD; iLTD). Unlike most other forms of hippocampal synaptic plasticity, iLTD is not synapse specific: stimulation of an afferent pathway triggers depression not only of activated synapses but also of inactive excitatory synapses onto the same interneuron. These results suggest that high frequency afferent activity increases hippocampal excitability through a dual mechanism, simultaneously potentiating synapses onto excitatory neurons and depressing synapses onto inhibitory neurons.			McMahon, LL (corresponding author), DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710, USA.		McMahon, Lori/C-2922-2009	Kauer, Julie/0000-0002-3362-1642	NINDS NIH HHS [NS09734, NS30500] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030500, R29NS030500, F32NS009734] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; ABRAHAM WC, 1985, J PHYSIOL-LONDON, V363, P335, DOI 10.1113/jphysiol.1985.sp015714; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; ALGER BE, 1976, BRAIN RES, V110, P463, DOI 10.1016/0006-8993(76)90858-1; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; ANDERSEN P, 1973, Acta Physiologica Scandinavica Supplementum, V396, P34; ASHWOOD TJ, 1984, BRAIN RES, V293, P279, DOI 10.1016/0006-8993(84)91235-6; ASZETELY F, 1994, HIPPOCAMPUS, V4, P148; BABB TL, 1988, J COMP NEUROL, V278, P121, DOI 10.1002/cne.902780108; BARR DS, 1995, J NEUROSCI, V15, P5402; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bruton C., 1988, NEUROPATHOLOGY TEMPO; BUHL EH, 1994, J NEUROPHYSIOL, V71, P1289, DOI 10.1152/jn.1994.71.4.1289; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1982, J NEUROPHYSIOL, V48, P597, DOI 10.1152/jn.1982.48.3.597; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHRISTIE BR, 1994, HIPPOCAMPUS, V4, P127, DOI 10.1002/hipo.450040203; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DUDEK SM, 1992, P ANTL ACAD SCI US, V89, P4367; FOX SE, 1981, EXP BRAIN RES, V41, P399; FRANCK JE, 1988, J NEUROSCI, V8, P1991; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; FROTSCHER M, 1984, NEUROSCI LETT, V46, P137, DOI 10.1016/0304-3940(84)90431-2; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KAWAGUCHI Y, 1988, EXP BRAIN RES, V72, P494; KAWAGUCHI Y, 1987, BRAIN RES, V411, P190, DOI 10.1016/0006-8993(87)90700-1; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; KNOWLES WD, 1981, J NEUROSCI, V1, P317; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LACAILLE JC, 1989, HIPPOCAMPUS, P287; LI XG, 1992, EXP BRAIN RES, V90, P519; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Maccaferri G, 1996, J NEUROSCI, V16, P5334; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nakajima S, 1991, Hippocampus, V1, P67, DOI 10.1002/hipo.450010107; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; SAH P, 1990, J PHYSIOL-LONDON, V430, P605, DOI 10.1113/jphysiol.1990.sp018310; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SCHARFMAN HE, 1990, NEUROSCIENCE, V35, P491, DOI 10.1016/0306-4522(90)90324-W; SCHWARTZKROIN PA, 1978, BRAIN RES, V157, P1, DOI 10.1016/0006-8993(78)90991-5; SCHWARTZKROIN PA, 1985, J COMP NEUROL, V232, P205, DOI 10.1002/cne.902320206; SIK A, 1995, J NEUROSCI, V15, P6651; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; SLOVITER RS, 1987, J COMP NEUROL, V256, P42, DOI 10.1002/cne.902560105; SLOVITER RS, 1992, NEUROSCI LETT, V137, P91, DOI 10.1016/0304-3940(92)90306-R; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; STELZER A, 1994, P NATL ACAD SCI USA, V91, P3058, DOI 10.1073/pnas.91.8.3058; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; TAUBE JS, 1987, BRAIN RES, V419, P32, DOI 10.1016/0006-8993(87)90565-8; TAUBE JS, 1988, J NEUROSCI, V8, P1632; TOMASULO RA, 1991, BRAIN RES, V561, P27, DOI 10.1016/0006-8993(91)90745-H; TOTH K, 1992, NEUROSCIENCE, V49, P793, DOI 10.1016/0306-4522(92)90357-8; WILSON R C, 1981, Journal of Neurophysiology (Bethesda), V46, P339; WILSON RC, 1981, J NEUROPHYSIOL, V46, P324, DOI 10.1152/jn.1981.46.2.324; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442; WONG RKS, 1979, SCIENCE, V204, P1228, DOI 10.1126/science.451569; ZHAO DC, 1991, BRAIN RES, V564, P220, DOI 10.1016/0006-8993(91)91457-C	72	147	147	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					295	305		10.1016/S0896-6273(00)80269-X	http://dx.doi.org/10.1016/S0896-6273(00)80269-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052799	Bronze			2022-12-24	WOS:A1997WK82200012
J	Kaech, S; Ludin, B; Matus, A				Kaech, S; Ludin, B; Matus, A			Cytoskeletal plasticity in cells expressing neuronal microtubule-associated proteins	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; REAL-TIME OBSERVATIONS; DYNAMIC INSTABILITY; LIVING CELLS; TAU-PROTEIN; POSTTRANSLATIONAL MODIFICATION; NONNEURONAL CELLS; CORTICAL-NEURONS; BINDING MOTIF; GROWTH CONES	MAP2 and tau are the two most prominent neuron-specific microtubule-associated proteins. They have been implicated in the stabilization of microtubules and consequently of neurite morphology. To investigate their influence on microtubule dynamics, we have tagged both proteins with green fluorescent protein and expressed them in non-neuronal cells. Time-lapse recordings of living cells showed that MAP2 and tau did not significantly affect the rates of microtubule growth and shrinkage. Longer recordings revealed the growth and disappearance of MAP-induced microtubule bundles coinciding with changes in cell shape. This supports the idea that microtubule dynamics are influenced by the cortical cytoskeleton. The dynamics-preserving stabilization of microtubules by MAP2 and tau thus provides a molecular basis for the morphological plasticity reported to exist in established neurites.			Kaech, S (corresponding author), FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND.			Kaech Petrie, Stefanie/0000-0002-6246-6434				AHMAD FJ, 1993, J NEUROSCI, V13, P856; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; BURTON PR, 1987, BRAIN RES, V409, P71, DOI 10.1016/0006-8993(87)90742-6; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CUMMING R, 1984, J CELL BIOL, V98, P347, DOI 10.1083/jcb.98.1.347; Dailey ME, 1996, J NEUROSCI, V16, P2983; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOLL T, 1993, J CELL SCI, V106, P633; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; DYE RB, 1993, J BIOL CHEM, V268, P6847; EDSON K, 1993, DEVELOPMENT, V117, P689; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; HARRISON RG, 1910, J EXP ZOOL, V17, P521; HEIDEMANN SR, 1990, CELL MOTIL CYTOSKEL, V17, P6, DOI 10.1002/cm.970170103; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HILL TL, 1982, INT REV CYTOL, V78, P1, DOI 10.1016/S0074-7696(08)60105-9; ITOH TJ, 1994, CELL STRUCT FUNCT, V19, P279, DOI 10.1247/csf.19.279; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KURACHI M, 1995, CELL MOTIL CYTOSKEL, V30, P221, DOI 10.1002/cm.970300306; LEE G, 1992, J CELL SCI, V102, P227; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; LUBYPHELPS K, 1988, CELL MOTIL CYTOSKEL, V10, P28, DOI 10.1002/cm.970100107; Ludin B, 1996, GENE, V173, P107, DOI 10.1016/0378-1119(95)00899-3; Ludin B, 1996, J CELL SCI, V109, P91; MANSFIELD SG, 1991, J NEUROCYTOL, V20, P654, DOI 10.1007/BF01187067; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; PRYER NK, 1992, J CELL SCI, V103, P965; Ramon y Cajal S, 1960, STUDIES VERTEBRATE N; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; SAMMAK PJ, 1988, CELL MOTIL CYTOSKEL, V10, P237, DOI 10.1002/cm.970100128; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; SHARMA N, 1994, CELL MOTIL CYTOSKEL, V27, P234, DOI 10.1002/cm.970270305; Sharp DJ, 1996, J NEUROSCI, V16, P4370; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; TAKEMURA R, 1992, J CELL SCI, V103, P953; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; WEEKS PRG, 1991, BIOESSAYS, V13, P235; WEEKS PRG, 1989, DEV BRAIN RES, V49, P305; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WEISSHAAR B, 1992, DEVELOPMENT, V116, P1151; Wordeman Linda, 1994, V13, P287	66	134	141	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1189	1199		10.1016/S0896-6273(00)80249-4	http://dx.doi.org/10.1016/S0896-6273(00)80249-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982165	Bronze			2022-12-24	WOS:A1996WA24800015
J	Borchelt, DR; Thinakaran, G; Eckman, CB; Lee, MK; Davenport, F; Ratovitsky, T; Prada, CM; Kim, G; Seekins, S; Yager, D; Slunt, HH; Wang, R; Seeger, M; Levey, AI; Gandy, SE; Copeland, NG; Jenkins, NA; Price, DL; Younkin, SG				Borchelt, DR; Thinakaran, G; Eckman, CB; Lee, MK; Davenport, F; Ratovitsky, T; Prada, CM; Kim, G; Seekins, S; Yager, D; Slunt, HH; Wang, R; Seeger, M; Levey, AI; Gandy, SE; Copeland, NG; Jenkins, NA; Price, DL; Younkin, SG			Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-PROTEIN; A-BETA; MISSENSE MUTATIONS; SENILE PLAQUES; DOWN-SYNDROME; GENE; A-BETA-42(43); CHROMOSOME-1; PEPTIDE	Mutations in the presenilin 1 (PS1) and presenilin 2 genes cosegregate with the majority of early-onset familial Alzheimer's disease (FAD) pedigrees. We now document that the A beta 1-42(43)/A beta 1-40 ratio in the conditioned media of independent N2a cell lines expressing three FAD-linked PS1 variants is uniformly elevated relative to cells expressing similar levels of wild-type PS1. Similarly, the A beta 1-42(43)/A beta 1-40 ratio is elevated in the brains of young transgenic animals coexpressing a chimeric amyloid precursor protein (APP) and an FAD-linked PS1 variant compared with brains of transgenic mice expressing APP alone or transgenic mice coexpressing wild-type human PS1 and APP. These studies provide compelling support for the view that one mechanism by which these mutant PS1 cause AD is by increasing the extracellular concentration of A beta peptides terminating at 42(43), species that foster A beta deposition.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106; MAYO CLIN JACKSONVILLE,JACKSONVILLE,FL 32224; ROCKEFELLER UNIV,MASS SPECTROMETRY LAB,NEW YORK,NY 10021; CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Case Western Reserve University; Mayo Clinic; Rockefeller University; Cornell University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Borchelt, DR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205, USA.		Levey, Allan/F-2104-2011; Lee, Michael K/D-9491-2013; Wang, Rong/A-8721-2009	Levey, Allan/0000-0002-3153-502X; Lee, Michael K/0000-0001-5865-9682; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NIA NIH HHS [AG05689, AG05146] Funding Source: Medline; NINDS NIH HHS [NS 20471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*ALZH DIS COLL GRO, 1995, NAT GENET, V11, P219; Boteva K, 1996, LANCET, V347, P130, DOI 10.1016/S0140-6736(96)90261-5; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; CHAPMAN J, 1995, LANCET, V346, P1040, DOI 10.1016/S0140-6736(95)91723-3; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; HYMAN BT, 1995, P NATL ACAD SCI USA, V92, P3586, DOI 10.1073/pnas.92.8.3586; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LO ACY, 1994, J BIOL CHEM, V269, P30966; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PerezTur J, 1995, NEUROREPORT, V7, P297; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROHER AE, 1993, J BIOL CHEM, V268, P3072; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SLUNT HH, 1995, AMYLOID, V2, P188, DOI 10.3109/13506129509036925; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; VANNOSTRAND WE, 1989, NATURE, V341, P546; WASCO W, 1995, NAT MED, V1, P848, DOI 10.1038/nm0995-848a	41	1269	1348	2	74	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					1005	1013		10.1016/S0896-6273(00)80230-5	http://dx.doi.org/10.1016/S0896-6273(00)80230-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938131	hybrid			2022-12-24	WOS:A1996VV15100021
J	Lagnado, L; Gomis, A; Job, C				Lagnado, L; Gomis, A; Job, C			Continuous vesicle cycling in the synaptic terminal of retinal bipolar cells	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; BOVINE CHROMAFFIN CELLS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; GOLDFISH RETINA; CALCIUM CURRENT; HAIR-CELLS; ENDOCYTOSIS; EXOCYTOSIS; SECRETION	Endocytosis and exocytosis were investigated in the synaptic terminal of retinal bipolar cells by monitoring the uptake and loss of the fluorescent dye FM1-43. Depolarization in the presence of Ca2+ stimulated a continuous cycle of exocytosis and endocytosis that was approximately balanced at rates up to 3800 vesicles per s. Vesicles became available for exocytosis within 1 min of endocytosis, and about 700,000 releasable vesicles were specifically localized to a region within 2 mu m of the plasma membrane. Release of caged Ca2+ using NP-EGTA while simultaneously monitoring cytosolic Ca2+ with Fura-2 indicated that continuous exocytosis was stimulated by sub-micromolar levels of Ca2+. It has been suggested that the ribbon synapse of bipolar cells only supports transient exocytosis, but our results demonstrate that this synapse is specialized for the continuous secretion of neurotransmitter.			Lagnado, L (corresponding author), MRC,MOL BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.		Gomis, Ana/S-1854-2017	Gomis, Ana/0000-0003-4651-7673				ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, NEURON, V9, P805, DOI 10.1016/0896-6273(92)90235-6; BETZ WJ, 1995, CURR BIOL, V5, P1095; COPENHAGEN DR, 1989, NATURE, V341, P356; DEBELLO WM, 1993, CELL, V74, P947, DOI 10.1016/0092-8674(93)90716-4; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Dowling J. E., 1987, RETINA APPROACHABLE; DOWLING JE, 1973, NATURE, V242, P101, DOI 10.1038/242101a0; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1995, J NEUROSCI, V15, P8246; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; Katz B., 1966, NERVE MUSCLE SYNAPSE; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS RR, 1982, SCI AM, V247, P56, DOI 10.1038/scientificamerican1082-56; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1994, NATURE, V372, P316, DOI 10.1038/372316a0; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PENNER R, 1989, TRENDS NEUROSCI, V12, P159, DOI 10.1016/0166-2236(89)90059-3; RIEKE F, 1996, J PHYSL, P1; RIEKE F, 1994, NEURON, V13, P865; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SAITO T, 1978, VISION RES, V18, P591, DOI 10.1016/0042-6989(78)90208-0; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	50	164	164	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					957	967		10.1016/S0896-6273(00)80226-3	http://dx.doi.org/10.1016/S0896-6273(00)80226-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938127	Bronze			2022-12-24	WOS:A1996VV15100017
J	Gross, RE; Mehler, MF; Mabie, PC; Zang, ZY; Santschi, L; Kessler, JA				Gross, RE; Mehler, MF; Mabie, PC; Zang, ZY; Santschi, L; Kessler, JA			Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; OLIGODENDROCYTES IN-VITRO; FIBRILLARY ACIDIC PROTEIN; RAT CEREBRAL-CORTEX; GROWTH-FACTOR; PRECURSOR CELLS; NEURAL CREST; STEM-CELLS; NEURONAL DIFFERENTIATION; ASTROCYTE DEVELOPMENT	The epigenetic signals that regulate lineage development in the embryonic mammalian brain are poorly understood. Here we demonstrate that a specific subclass of the transforming growth factor beta superfamily, the bone morphogenetic proteins (BMPs), cause the selective, dose-dependent elaboration of the astroglial lineage from murine embryonic subventricular zone (SVZ) multipotent progenitor cells. The astroglial inductive effect is characterized by enhanced morphological complexity and expression of glial fibrillary acidic protein, with concurrent suppression of neuronal and oligodendroglial cell fates. SVZ progenitor cells express transcripts for the appropriate BMP-specific type I and II receptor subunits and selective BMP ligands, suggesting the presence of paracrine or autocrine developmental signaling pathways (or both). These observations suggest that the BMPs have a selective role in determining the cell fate of SVZ multipotent progenitor cells or their more developmentally restricted progeny.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSURG,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,ROSE F KENNEDY CTR RES MENTAL RETARDAT & HUMAN DE,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine					NINDS NIH HHS [NS-20013, NS-34758, NS-20778] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034758, R01NS020013, R01NS020778] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED S, 1995, J NEUROSCI, V15, P5765; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; Anderson DJ, 1995, NEURON, V15, P1219, DOI 10.1016/0896-6273(95)90001-2; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; CAMMER W, 1992, J COMP NEUROL, V321, P33, DOI 10.1002/cne.903210104; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Craig CG, 1996, J NEUROSCI, V16, P2649; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P45, DOI 10.3109/08977199409015050; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FANN MJ, 1994, J NEUROCHEM, V63, P2074; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; GODSAVE SF, 1991, DEVELOPMENT, V111, P523; GREEN JBA, 1994, CELL, V77, P317, DOI 10.1016/0092-8674(94)90145-7; GRUNZ H, 1989, CELL DIFFER DEV, V28, P211, DOI 10.1016/0922-3371(89)90006-3; Heitzler P, 1996, DEVELOPMENT, V122, P161; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; JONES CM, 1991, DEVELOPMENT, V111, P531; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LIU F, 1995, MOL CELL BIOL, V15, P3479; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MAYER M, 1994, DEVELOPMENT, V120, P143; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MEHLER MF, 1995, INT J DEV NEUROSCI, V13, P213, DOI 10.1016/0736-5748(94)00060-G; MEHLER MF, 1994, DEV NEUROSCI-BASEL, V16, P180, DOI 10.1159/000112105; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; NAKAFUKU M, 1995, J NEUROSCI RES, V41, P153, DOI 10.1002/jnr.490410203; PATTERSON PH, 1993, CELL, V72, P123, DOI 10.1016/S0092-8674(05)80032-7; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; PERIDES G, 1992, P NATL ACAD SCI USA, V89, P10326, DOI 10.1073/pnas.89.21.10326; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Pourquie O, 1996, CELL, V84, P461, DOI 10.1016/S0092-8674(00)81291-X; PRIVAT A, 1972, J COMP NEUROL, V146, P277, DOI 10.1002/cne.901460302; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SAKAI Y, 1990, P NATL ACAD SCI USA, V87, P8378, DOI 10.1073/pnas.87.21.8378; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SIMPSON P, 1995, NEURON, V15, P739, DOI 10.1016/0896-6273(95)90163-9; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TOMIZAWA K, 1995, MOL BRAIN RES, V28, P122, DOI 10.1016/0169-328X(94)00199-O; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; WALL NA, 1994, CURR OPIN GENET DEV, V4, P517, DOI 10.1016/0959-437X(94)90066-C; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; YOSHIDA T, 1993, DEV BRAIN RES, V76, P147, DOI 10.1016/0165-3806(93)90132-T; YOSHIDA T, 1993, J NEUROSCI RES, V35, P129, DOI 10.1002/jnr.490350203	83	553	575	4	30	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					595	606		10.1016/S0896-6273(00)80193-2	http://dx.doi.org/10.1016/S0896-6273(00)80193-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893018	Bronze			2022-12-24	WOS:A1996VP74300006
J	Yamoah, EN; Gillespie, PG				Yamoah, EN; Gillespie, PG			Phosphate analogs block adaptation in hair cells by inhibiting adaptation-motor force production	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; BERYLLIUM FLUORIDE; MYOSIN SUBFRAGMENT-1; INORGANIC-PHOSPHATE; BULLFROGS SACCULUS; ALUMINUM FLUORIDE; MUSCLE-FIBERS; VANADATE; EAR; COMPLEXES	To ensure optimal sensitivity for mechanoelectrical transduction, hair cells adapt to prolonged stimuli using active motors. Adaptation motors are thought to employ myosin molecules as their force-producing components. We find that beryllium fluoride, vanadate, and sulfate, phosphate analogs that inhibit the ATPase activity of myosin, inhibit adaptation by abolishing motor force production. Phosphate analogs interact with a 120-kDa bundle protein, most likely myosin I beta, in a manner that coincides with their effects on adaptation. Features of transduction following inhibition of motor force production suggest that the gating and extent springs of the hair cell orient in parallel at rest and that the negative limit of adaptation arises when force in the stretched extent spring matches the force output of the adaptation motor.	JOHNS HOPKINS UNIV, DEPT NEUROSCI, BALTIMORE, MD 21205 USA	Johns Hopkins University	Yamoah, EN (corresponding author), JOHNS HOPKINS UNIV, DEPT PHYSIOL, BALTIMORE, MD 21205 USA.			Barr-Gillespie, Peter/0000-0002-9787-5860	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002368, P60DC000979] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC02368, P60 DC00979] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1992, J NEUROSCI, V12, P3291; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; CHASE PB, 1994, J MUSCLE RES CELL M, V15, P119, DOI 10.1007/BF00130423; CHASE PB, 1993, J PHYSIOL-LONDON, V460, P231, DOI 10.1113/jphysiol.1993.sp019469; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; COREY DP, 1983, J NEUROSCI, V3, P942; DANTZIG JA, 1985, J GEN PHYSIOL, V86, P305, DOI 10.1085/jgp.86.3.305; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FORD LE, 1981, J PHYSIOL-LONDON, V311, P219, DOI 10.1113/jphysiol.1981.sp013582; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; GILLESPIE PG, 1995, CURR OPIN NEUROBIOL, V5, P449, DOI 10.1016/0959-4388(95)80004-2; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; HIROKAWA N, 1982, J CELL BIOL, V95, P249, DOI 10.1083/jcb.95.1.249; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; KOYAMA H, 1982, BRAIN RES, V250, P168, DOI 10.1016/0006-8993(82)90964-7; LEIBLER S, 1993, J CELL BIOL, V121, P1357, DOI 10.1083/jcb.121.6.1357; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; MACARA IG, 1980, TRENDS BIOCHEM SCI, V5, P92, DOI 10.1016/0968-0004(80)90256-X; MARUTA S, 1993, J BIOL CHEM, V268, P7093; METCALF AB, 1994, P NATL ACAD SCI USA, V91, P11821, DOI 10.1073/pnas.91.25.11821; Ostap EM, 1996, J CELL BIOL, V132, P1053, DOI 10.1083/jcb.132.6.1053; PHAN BC, 1993, BIOCHEMISTRY-US, V32, P7712, DOI 10.1021/bi00081a016; PYBUS J, 1975, J PHYSIOL-LONDON, V247, P71, DOI 10.1113/jphysiol.1975.sp010921; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SOLO CF, 1994, AUDIT NEUROSCI, V1, P63; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; TESI C, 1988, FEBS LETT, V236, P256, DOI 10.1016/0014-5793(88)80326-0; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; WILSON GJ, 1995, BIOPHYS J, V68, P216, DOI 10.1016/S0006-3495(95)80177-3	43	48	50	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					523	533		10.1016/S0896-6273(00)80184-1	http://dx.doi.org/10.1016/S0896-6273(00)80184-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816715	hybrid			2022-12-24	WOS:A1996VJ44000018
J	Mitchell, KJ; Doyle, JL; Serafini, T; Kennedy, TE; TessierLavigne, M; Goodman, CS; Dickson, BJ				Mitchell, KJ; Doyle, JL; Serafini, T; Kennedy, TE; TessierLavigne, M; Goodman, CS; Dickson, BJ			Genetic analysis of Netrin genes in Drosophila: Netrins guide CNS commissural axons and peripheral motor axons	NEURON			English	Article							GROWTH CONE GUIDANCE; CENTRAL-NERVOUS-SYSTEM; ABL TYROSINE KINASE; C-ELEGANS; CELL; MIDLINE; EXPRESSION; MUTATIONS; UNC-6; CHEMOATTRACTANT	Two tandem Netrin genes in Drosophila are expressed at the midline of the developing CNS and in different subsets of neurons, muscles, and epidermal patches. In embryos carrying a small deficiency that deletes both genes, CNS axon commissures are partially missing or thinner. This phenotype is rescued by expressing either Netrin gene at the midline. Pan-neural expression of either gene causes disruption of commissural and longitudinal tracts, indicating that the pattern of Netrin expression is crucial and that Netrins function as instructive cues. The double mutant also shows defects in motor axon projections. Expression of either Netrin gene in all muscles also results in aberrant motor projections. Thus, Drosophila Netrins are required for the guidance of commissural axons at the midline, and of motor axons to their target muscles.	UNIV CALIF SAN FRANCISCO,DEPT ANAT,HOWARD HUGHES MED INST,CELL BIOL PROGRAM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT ANAT,HOWARD HUGHES MED INST,PROGRAM DEV BIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT ANAT,HOWARD HUGHES MED INST,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Mitchell, KJ (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT CELL & MOL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.		Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Mitchell, Kevin/0000-0002-3433-4530	NINDS NIH HHS [NS18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOSSING T, 1994, DEVELOPMENT, V120, P1895; BRAND AH, 1993, DEVELOPMENT, V118, P401; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HILL KK, 1995, GENETICS, V141, P595; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MADUENO E, 1995, GENETICS, V139, P1631; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; PLACZEK M, 1990, DEVELOPMENT, V110, P19; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHARP PM, 1993, ATLAS DROSOPHILA GEN, P378; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6	35	374	379	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					203	215		10.1016/S0896-6273(00)80153-1	http://dx.doi.org/10.1016/S0896-6273(00)80153-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780645	Bronze			2022-12-24	WOS:A1996VE84000004
J	Slesinger, PA; Patil, N; Liao, YJ; Jan, YN; Jan, LY; Cox, DR				Slesinger, PA; Patil, N; Liao, YJ; Jan, YN; Jan, LY; Cox, DR			Functional effects of the mouse weaver mutation on g protein-gated inwardly rectifying K+ channels	NEURON			English	Article							MUTANT MOUSE; GRANULE CELL; CEREBELLAR CORTEX; NEURONAL DIFFERENTIATION; FIBER VULNERABILITY; MESOSTRIATAL SYSTEM; TEA BLOCKADE; GENE-ACTION; MICE; DOPAMINE	The weaver mutation corresponds to a substitution of glycine to serine in the H5 region of a G protein-gated inwardly rectifying K+ channel gene (GIRK2). By studying mutant GIRK2 weaver homomultimeric channels and heteromultimeric channels comprised of GIRK2 weaver and GIRK1 in Xenopus oocytes, we found that GIRK2 weaver homomultimeric channels lose their selectivity for KC ions, giving rise to inappropriate receptor-activated and basally active Na+ currents, whereas heteromultimers of GIRK2 weaver and GIRK1 appeared to have reduced current. Immunohistochemical localization indicates that GIRK2 and GIRK1 proteins are expressed in the cerebellar neurons of mice at postnatal day 4, at a time when these neurons normally undergo differentiation. Thus, the aberrant behavior of mutant GIRK2 weaver channels could affect the development of weaver mice in at least two distinct ways.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT BIOCHEM,SAN FRANCISCO,CA 94143; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Stanford University	Slesinger, PA (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT PHYSIOL,BOX 0444,SAN FRANCISCO,CA 94143, USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024610] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24610] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHFORD MLJ, 1994, NATURE, V370, P456, DOI 10.1038/370456a0; BOND CT, 1995, FEBS LETT, V367, P61, DOI 10.1016/0014-5793(95)00497-W; BRADLEY P, 1978, BRAIN RES, V142, P135, DOI 10.1016/0006-8993(78)90182-8; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; DEPAOLI AM, 1994, MOL CELL NEUROSCI, V5, P515, DOI 10.1006/mcne.1994.1063; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; GALLI C, 1995, J NEUROSCI, V15, P1172; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GASPAR P, 1994, NEUROSCIENCE, V61, P293, DOI 10.1016/0306-4522(94)90232-1; GHETTI B, 1992, NEUROCHEM INT, V20, pS305; GOLDOWITZ D, 1989, NEURON, V2, P1565, DOI 10.1016/0896-6273(89)90045-7; GOLDOWITZ D, 1982, J NEUROSCI, V2, P1474; GRAYBIEL AM, 1990, J NEUROSCI, V10, P720; GUPTA M, 1987, BRAIN RES, V402, P379, DOI 10.1016/0006-8993(87)90050-3; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HATTEN ME, 1984, J NEUROSCI, V4, P1163; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HERRUP K, 1987, NEUROSCIENCE, V23, P871, DOI 10.1016/0306-4522(87)90164-3; Hille B., 1992, IONIC CHANNELS EXCIT; KARSCHIN C, 1994, FEBS LETT, V348, P139, DOI 10.1016/0014-5793(94)00590-7; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAPIVINSKY G, 1995, NATURE, V374, P125; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MIGHELI A, 1995, NEUROSCI LETT, V199, P53, DOI 10.1016/0304-3940(95)12015-V; MURTOMAKI S, 1995, DEV BIOL, V168, P635, DOI 10.1006/dbio.1995.1108; ORRENIUS S, 1994, J NEURAL TRANSM-SUPP, V43, P1; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; REZAI Z, 1972, DEV BIOL, V29, P17, DOI 10.1016/0012-1606(72)90039-5; RICHTER JA, 1992, NEUROCHEM RES, V17, P437, DOI 10.1007/BF00969889; ROFFLERTARLOV S, 1990, J NEUROSCI, V10, P734; ROFFLERTARLOV S, 1984, NATURE, V307, P62, DOI 10.1038/307062a0; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SCHMIDT MJ, 1982, J NEUROSCI, V2, P376; Sidman RL., 1965, CATALOG NEUROLOGICAL, DOI [10.4159/harvard.9780674424326, DOI 10.4159/HARVARD.9780674424326]; SIMON JR, 1994, J NEUROCHEM, V62, P543; SMEYNE RJ, 1989, J NEUROSCI, V9, P1608; SMEYNE RJ, 1990, DEV BRAIN RES, V52, P211, DOI 10.1016/0165-3806(90)90237-S; TAKANO K, 1995, NEURON, V14, P999, DOI 10.1016/0896-6273(95)90338-0; TRIARHOU LC, 1988, EXP BRAIN RES, V70, P256; TSAUR ML, 1995, DIABETES, V44, P592, DOI 10.2337/diabetes.44.5.592; WONG ROL, 1995, P NATL ACAD SCI USA, V92, P1797, DOI 10.1073/pnas.92.6.1797; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; YAMAGUCHI K, 1990, J PHYSIOL-LONDON, V426, P499, DOI 10.1113/jphysiol.1990.sp018151; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	59	234	238	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					321	331		10.1016/S0896-6273(00)80050-1	http://dx.doi.org/10.1016/S0896-6273(00)80050-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789947	Bronze			2022-12-24	WOS:A1996TW95700012
J	Sommer, L; Shah, N; Rao, M; Anderson, DJ				Sommer, L; Shah, N; Rao, M; Anderson, DJ			The cellular function of MASH1 in autonomic neurogenesis	NEURON			English	Article							NEURAL CREST CELLS; PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE HOMOLOG-1; INVITRO CLONAL ANALYSIS; NEURONAL DIFFERENTIATION; SYMPATHETIC-GANGLIA; PROGENITOR CELLS; SCHWANN-CELLS; DORSAL-ROOT; GENE FAMILY	Using primary cultures and immortalized multipotential stem cell lines derived from wild-type and MASH1 mutant neural crest cells, we have analyzed the cellular function of MASH1 in autonomic neurogenesis. We present evidence for the existence of a precursor expressing MASH1 and neuronal markers such as neurofilament, neuron-specific tubulin, and tetanus toxin receptor. This cell has a nonneuronal morphology. Differentiation of this precursor to neurons that express markers such as SCG10, peripherin, and neuron-specific enolase is dependent upon MASH1 function. These data imply that the differentiation of autonomic neurons from uncommitted neural crest cells occurs in several sequential steps. Moreover, they suggest that MASH1 does not commit multipotent cells to a neural fate, like its Drosophila achaete-scute counterparts, but rather promotes the differentiation of a committed neuronal precursor.	CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125	California Institute of Technology; Howard Hughes Medical Institute	Sommer, L (corresponding author), CALTECH,DIV BIOL 21676,PASADENA,CA 91125, USA.			Sommer, Lukas/0000-0002-1143-7908				ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BLAUGRUND E, 1996, IN PRESS DEVELOPMENT, V122; BOISSEAU S, 1989, DEVELOPMENT, V106, P665; BRAND M, 1993, DEVELOPMENT, V119, P1; CARNAHAN JF, 1991, J NEUROSCI, V11, P3520; COCHARD P, 1984, J NEUROSCI, V4, P2080; COHEN AM, 1975, DEV BIOL, V46, P262, DOI 10.1016/0012-1606(75)90104-9; CONDRON BG, 1994, J NEUROSCI, V14, P5766; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DUFF RS, 1991, DEV BIOL, V147, P451, DOI 10.1016/0012-1606(91)90303-K; FERREIRO B, 1992, MECH DEVELOP, V40, P25; FRIEDMAN B, 1990, J COMP NEUROL, V295, P43, DOI 10.1002/cne.902950105; GELSERT EE, 1989, NEUROSCI LETT, V102, P137; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GHYSEN A, 1989, DEVELOPMENT, V105, P35; GROVES AK, 1995, DEVELOPMENT, V121, P887; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; ITO K, 1993, DEV BIOL, V157, P517, DOI 10.1006/dbio.1993.1154; JAMEN AP, 1993, DEVELOPMENT, V119, P19; JAN YN, 1994, ANNU REV GENET, V28, P373, DOI 10.1146/annurev.ge.28.120194.002105; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JESSEN KR, 1990, DEVELOPMENT, V109, P91; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; JULIEN JP, 1986, MOL BRAIN RES, V1, P243, DOI 10.1016/0169-328X(86)90030-6; KALCHEIM C, 1986, DEV BIOL, V116, P451, DOI 10.1016/0012-1606(86)90146-6; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN N, 1991, GLIA, V4, P175; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; LO LC, 1994, PERSPECT DEV NEUROBI, V2, P191; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marusich MF, 1991, CURR OPIN GENET DEV, V1, P221, DOI 10.1016/S0959-437X(05)80074-7; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; MICHELSOHN AM, 1992, NEURON, V8, P589, DOI 10.1016/0896-6273(92)90285-L; MORRISONGRAHAM K, 1990, DEV BIOL, V139, P299, DOI 10.1016/0012-1606(90)90299-X; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; RAJU TR, 1982, BRAIN RES, V248, P196, DOI 10.1016/0006-8993(82)91165-9; RAY J, 1994, J NEUROSCI, V14, P3548; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Sieber-Blum M., 1990, Comments on Developmental Neurobiology, V1, P225; SMITHTHOMAS LC, 1989, DEVELOPMENT, V105, P251; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Sternberg Paul W., 1992, P1; TEMPLE S, 1994, DEVELOPMENT, V120, P999; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; UDOLPH G, 1993, DEVELOPMENT, V118, P765; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221	63	217	221	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1245	1258		10.1016/0896-6273(95)90005-5	http://dx.doi.org/10.1016/0896-6273(95)90005-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845150	Bronze			2022-12-24	WOS:A1995TL67800005
J	Luscher, C; Malenka, RC; Nicoll, RA				Luscher, C; Malenka, RC; Nicoll, RA			Monitoring glutamate release during LTP with glial transporter currents	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPUS; EXPRESSION	Although much has been learned about the mechanisms underlying NMDA receptor-dependent longterm potentiation (LTP), considerable debate remains as to whether LTP is expressed as an increase in the synaptic release of glutamate or as an increase in the sensitivity of the postsynaptic glutamate receptors. We have directly measured changes in the synaptic release of glutamate by recording synaptically evoked glial glutamate transporter currents with whole-cell recording. Glial cell responses were very sensitive to manipulations known to change the release of glutamate yet remained constant during LTP. These results argue strongly for a postsynaptic expression mechanism for LTP.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596				ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brundege J M, 1997, Adv Pharmacol, V39, P353, DOI 10.1016/S1054-3589(08)60076-9; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; POGUN S, 1994, ANN NY ACAD SCI, V738, P305; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SARANTIS M, 1993, J PHYSIOL-LONDON, V459, pP246; SCANZIANI M, 1998, IN PRESS P NATL ACAD; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	22	112	113	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1998	21	2					435	441		10.1016/S0896-6273(00)80552-8	http://dx.doi.org/10.1016/S0896-6273(00)80552-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114FK	9728924	Bronze			2022-12-24	WOS:000075598300020
J	Cacalano, G; Farinas, I; Wang, LC; Hagler, K; Forgie, A; Moore, M; Armanini, M; Phillips, H; Ryan, AM; Reichardt, LF; Hynes, M; Davies, A; Rosenthal, A				Cacalano, G; Farinas, I; Wang, LC; Hagler, K; Forgie, A; Moore, M; Armanini, M; Phillips, H; Ryan, AM; Reichardt, LF; Hynes, M; Davies, A; Rosenthal, A			GFR alpha 1 is an essential receptor component for GDNF in the developing nervous system and kidney	NEURON			English	Article							MICE LACKING GDNF; MIDBRAIN DOPAMINERGIC-NEURONS; TYROSINE KINASE RECEPTOR; NEUROTROPHIC FACTOR; SURVIVAL FACTOR; IN-VIVO; BRAIN; TRKB; RET; DEGENERATION	Glial cell line-derived neurotrophic factor (GDNF) is a distant member of the TGF beta protein family that is essential for neuronal survival and renal morphogenesis. We show that mice who are deficient in the glycosyl-phosphatidyl inositol (GPI)-linked protein GFR alpha 1 (GDNFR alpha) display deficits in the kidneys, the enteric nervous system, and spinal motor and sensory neurons that are strikingly similar to those of the GDNF- and Ret-deficient mice. GFR alpha 1-deficient dopaminergic and nodose sensory ganglia neurons no longer respond to GDNF or to the structurally related protein neurturin (NTN) but can be rescued when exposed to GDNF or neurturin in the presence of soluble GFR alpha 1. in contrast, GFR alpha 1-deficient submandibular parasympathetic neurons retain normal response to these two factors. Taken together with the available genetic and biochemical data, these findings support the idea that GFR alpha 1 and the transmembrane tyrosine kinase net are both necessary receptor components for GDNF in the developing kidney and nervous system, and that GDNF and neurturin can mediate some of their activities through a second receptor.	Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, S San Francisco, CA 94080 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ St Andrews, St Andrews, Fife, Scotland; Deltagen Inc, San Carlos, CA 94070 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of St Andrews	Rosenthal, A (corresponding author), Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA.		Davies, Alun M/A-4334-2010; Farinas, Isabel/L-7118-2014	Davies, Alun M/0000-0001-5841-8176; Hynes, Mary/0000-0001-6623-6727; Farinas, Isabel/0000-0003-2903-4960	NINDS NIH HHS [P01 NS016033-180014, P01 NS016033-260014, P01 NS016033] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; BALOH RH, 1997, RET NEURON, V18, P793; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Durbec PL, 1996, DEVELOPMENT, V122, P349; Eng C, 1998, ONCOGENE, V16, P597, DOI 10.1038/sj.onc.1201573; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LICHING L, 1995, NEURON, V15, P527; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Masure S, 1998, EUR J BIOCHEM, V251, P622, DOI 10.1046/j.1432-1327.1998.2510622.x; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 1993, GENE TARGETING PRACT; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Nosrat CA, 1997, EXP BRAIN RES, V115, P410, DOI 10.1007/PL00005711; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Saxen L., 1987, ORGANOGENESIS KIDNEY; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Thompson J, 1998, MOL CELL NEUROSCI, V11, P117, DOI 10.1006/mcne.1998.0682; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502; YAN Q, 1995, NATURE, V373, P41	41	437	445	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					53	62		10.1016/S0896-6273(00)80514-0	http://dx.doi.org/10.1016/S0896-6273(00)80514-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697851	Green Accepted, Bronze			2022-12-24	WOS:000075061900006
J	Krizaj, D; Copenhagen, DR				Krizaj, D; Copenhagen, DR			Compartmentalization of calcium extrusion mechanisms in the outer and inner segments of photoreceptors	NEURON			English	Article							PLASMA-MEMBRANE; RETINAL RODS; CONE PHOTORECEPTORS; TIGER SALAMANDER; BOVINE RETINA; HAIR-CELLS; NEURONS; LIGHT; PUMP; CA2+	Differential localization of calcium channel subtypes in divergent regions of individual neurons strongly suggests that calcium signaling and regulation could be compartmentalized. Region-specific expression of calcium extrusion transporters would serve also to partition calcium regulation within single cells. Little is known about selective localization of the calcium extrusion transporters, nor has compartmentalized calcium regulation within single neurons been studied in detail. Sensory neurons provide an experimentally tractable preparation to investigate this functional compartmentalization. We studied calcium regulation in the outer segment (OS) and inner segment/synaptic terminal (IS/ST) regions of rods and cones. We report these areas can function as separate compartments. Moreover, ionic, pharmacological, and immunolocalization results show that a Ca-ATPase, but not the Na+/K+, Ca2+ exchanger found in the OSs, extrudes calcium from the IS/ST region. The compartmentalization of calcium regulation in the photoreceptor outer and inner segments implies that transduction and synaptic signaling can be independently controlled. Similar separation of calcium-dependent functions is likely to apply in many types of neuron.	Univ Calif San Francisco, Sch Med, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Krizaj, D (corresponding author), Univ Calif San Francisco, Sch Med, Program Neurosci, San Francisco, CA 94143 USA.		Krrr, Daa/ABG-2688-2020	Krrr, Daa/0000-0003-4468-3029	NEI NIH HHS [R01 EY013870, R01 EY013870-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013870] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMO HP, 1992, J BIOL CHEM, V267, P14244; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; BLAUSTEI.MP, 1969, J PHYSIOL-LONDON, V200, P497, DOI 10.1113/jphysiol.1969.sp008704; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CHAMBERS JP, 1990, EXP EYE RES, V50, P127, DOI 10.1016/0014-4835(90)90222-G; COPENHAGEN DR, 1990, J GEN PHYSIOL, V95, P717, DOI 10.1085/jgp.95.4.717; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DIXON DB, 1993, NEURON, V11, P267, DOI 10.1016/0896-6273(93)90183-R; FAIN GL, 1990, J NEUROSCI, V10, P2238; FAIN GL, 1977, NATURE, V265, P181, DOI 10.1038/265181a0; GIETZEN K, 1981, BIOCHEM BIOPH RES CO, V101, P418, DOI 10.1016/0006-291X(81)91276-6; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; HAASE W, 1990, J NEUROSCI, V10, P1486; HAGINS WA, 1970, BIOPHYS J, V10, P380, DOI 10.1016/S0006-3495(70)86308-1; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Herscher CJ, 1996, BIOCHEMISTRY-US, V35, P14917, DOI 10.1021/bi961879r; IUVONE PM, 1990, J NEUROCHEM, V55, P673, DOI 10.1111/j.1471-4159.1990.tb04186.x; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; KOCH KW, 1994, EMBO J, V13, P3312, DOI 10.1002/j.1460-2075.1994.tb06633.x; KORENBROT JI, 1995, CELL CALCIUM, V18, P285, DOI 10.1016/0143-4160(95)90025-X; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; LAGNADO L, 1992, J PHYSIOL-LONDON, V455, P111, DOI 10.1113/jphysiol.1992.sp019293; Lenzi David, 1994, Current Opinion in Neurobiology, V4, P496, DOI 10.1016/0959-4388(94)90049-3; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; MARICQ AV, 1988, NEURON, V1, P503, DOI 10.1016/0896-6273(88)90181-X; McCarthy ST, 1996, J NEUROPHYSIOL, V76, P1991, DOI 10.1152/jn.1996.76.3.1991; MCNAUGHTON PA, 1990, PHYSIOL REV, V70, P847, DOI 10.1152/physrev.1990.70.3.847; MILANICK MA, 1990, AM J PHYSIOL, V258, pC552, DOI 10.1152/ajpcell.1990.258.3.C552; MILLER DL, 1987, J GEN PHYSIOL, V90, P397, DOI 10.1085/jgp.90.3.397; MURESAN Z, 1993, J COMP NEUROL, V331, P149, DOI 10.1002/cne.903310202; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NIGGLI V, 1982, J BIOL CHEM, V257, P2350; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Saarikoski J, 1997, J PHYSIOL-LONDON, V498, P61, DOI 10.1113/jphysiol.1997.sp021841; SCHNAPF JL, 1982, NATURE, V296, P862, DOI 10.1038/296862a0; SCHNETKAMP PPM, 1995, J BIOL CHEM, V270, P13231, DOI 10.1074/jbc.270.22.13231; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Trapp S, 1996, NEUROREPORT, V7, P2000, DOI 10.1097/00001756-199608120-00029; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	46	106	107	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					249	256		10.1016/S0896-6273(00)80531-0	http://dx.doi.org/10.1016/S0896-6273(00)80531-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697868	Bronze, Green Accepted			2022-12-24	WOS:000075061900023
J	Kohmura, N; Senzaki, K; Hamada, S; Kai, N; Yasuda, R; Watanabe, M; Ishii, H; Yasuda, M; Mishina, M; Yagi, T				Kohmura, N; Senzaki, K; Hamada, S; Kai, N; Yasuda, R; Watanabe, M; Ishii, H; Yasuda, M; Mishina, M; Yagi, T			Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex	NEURON			English	Article							FYN TYROSINE KINASE; POSTSYNAPTIC DENSITY FRACTION; CELL-ADHESION MOLECULES; LONG-TERM POTENTIATION; DEFICIENT MICE; INCREASED FEARFULNESS; CYTOPLASMIC DOMAIN; MUTANT MICE; RAT-BRAIN; PROTEIN	In mammals, neurons are highly differentiated and play distinctive functions even in the same brain region. We found a novel cadherin-related neuronal receptor (Cnr) gene family by studying Fyn-binding activity in mouse brain. CNR1 protein is located in the synaptic junction and forms a complex with Fyn. Sequence analysis of eight Cnr products of similar to 20 genes indicates that these comprise a novel cadherin family of the cadherin superfamily. The expression patterns of each member of this novel family were grossly similar to each other but restricted to subpopulations of neurons of the same type. The diversity of the Cnr family genes suggests that there are molecular mechanisms that govern highly differentiated neural networks in the mammalian CNS.	Natl Inst Physiol Sci, Lab Neurobiol & Behav Genet, Okazaki, Aichi 444, Japan; Univ Tsukuba, Sch Med, Dept Anat, Tsukuba, Ibaraki 305, Japan; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Tsukuba; Hokkaido University	Yagi, T (corresponding author), Natl Inst Physiol Sci, Lab Neurobiol & Behav Genet, Okazaki, Aichi 444, Japan.		Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138				Atkinson EA, 1996, J BIOL CHEM, V271, P5968, DOI 10.1074/jbc.271.11.5968; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BARE DJ, 1993, ONCOGENE, V8, P1429; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; BIXBY JL, 1993, J NEUROSCI, V13, P3421; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P417, DOI 10.1002/hipo.450030404; GENNARINI G, 1986, J NEUROSCI, V6, P1983; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hess US, 1995, J NEUROSCI, V15, P7796; Kai N, 1997, J NEUROSCI RES, V48, P407, DOI 10.1002/(SICI)1097-4547(19970601)48:5<407::AID-JNR3>3.3.CO;2-F; Kitazawa H, 1998, J NEUROPHYSIOL, V79, P137, DOI 10.1152/jn.1998.79.1.137; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Miyakawa T, 1996, MOL BRAIN RES, V37, P145; MIYAKAWA T, 1994, MOL BRAIN RES, V27, P179, DOI 10.1016/0169-328X(94)90201-1; MIYAKAWA T, 1995, MOL BRAIN RES, V28, P349, DOI 10.1016/0169-328X(94)00251-9; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Rabinowich H, 1996, J IMMUNOL, V157, P1485; REDIES C, 1995, EXP CELL RES, V220, P243, DOI 10.1006/excr.1995.1313; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SUEMORI H, 1990, CELL DIFFER DEV, V29, P181, DOI 10.1016/0922-3371(90)90120-L; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; SWOPE SL, 1994, J BIOL CHEM, V269, P29817; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE S, 1995, BIOCHEM BIOPH RES CO, V213, P130, DOI 10.1006/bbrc.1995.2107; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; YAGI T, 1994, DEV GROWTH DIFFER, V36, P543; YAGI T, 1993, ONCOGENE, V8, P3343; Yasunaga M, 1996, J CELL BIOL, V132, P91, DOI 10.1083/jcb.132.1.91; ZAMBONI L, 1967, J CELL BIOL, V35, pA148	57	380	386	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1137	1151		10.1016/S0896-6273(00)80495-X	http://dx.doi.org/10.1016/S0896-6273(00)80495-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655502	Bronze			2022-12-24	WOS:000074627300010
J	Li, Z; Chapleau, MW; Bates, JN; Bielefeld, K; Lee, HC; Abboud, FM				Li, Z; Chapleau, MW; Bates, JN; Bielefeld, K; Lee, HC; Abboud, FM			Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons	NEURON			English	Article							RAT AORTIC BARORECEPTORS; CULTURED CILIARY GANGLIA; SENSORY NEURONS; POTASSIUM CHANNELS; S-NITROSOCYSTEINE; CAROTID-BODY; POSTGANGLIONIC NEURONS; AFFERENT-FIBERS; SKELETAL-MUSCLE; NODOSE NEURONS	Arterial baroreceptors are mechanosensitive nerve endings in the aortic arch and carotid sinus that play a critical role in acute regulation of arterial blood pressure. A previous study has shown that nitric oxide (NO) or NO-related species suppress action potential discharge of baroreceptors. In the present study, we investigated the effects of NO on Na+ currents of isolated baroreceptor neurons in culture. Exogenous NO donors inhibited both tetrodotoxin (TTX) -sensitive and -insensitive Na+ currents. The inhibition was not mediated by cGMP but by NO interaction with channel thiols. Acute inhibition of NO synthase increased the Na+ currents. NO scavengers (hemoglobin and ferrous diethyldithiocarbamate) increased Na+ currents before but not after inhibition of NO synthase. Furthermore, NO production in the neuronal cultures was detected by chemiluminescence and immunoreactivity to the neuronal isoform of NO synthase was identified in fluorescently identified baroreceptor neurons. These results indicate that NO/NO-related species function as autocrine regulators of Na+ currents in baroreceptor neurons. Modulation of Na+ channels may represent a novel response to NO.	Univ Iowa, Coll Med, Ctr Cardiovasc, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Ctr Cardiovasc, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Ctr Cardiovasc, Dept Anesthesia, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Abboud, FM (corresponding author), Univ Iowa, Coll Med, Ctr Cardiovasc, Dept Physiol & Biophys, Iowa City, IA 52242 USA.			Chapleau, Mark/0000-0001-6961-931X; Bates, James/0000-0002-6898-9527; Abboud, Francois/0000-0002-7284-9148	NHLBI NIH HHS [HL14388] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AIMI Y, 1991, J COMP NEUROL, V306, P382, DOI 10.1002/cne.903060303; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; ANDRESEN MC, 1994, J PHYSIOL-LONDON, V477, P309, DOI 10.1113/jphysiol.1994.sp020192; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; BACCAGLINI PI, 1982, J PHYSIOL-LONDON, V324, P429, DOI 10.1113/jphysiol.1982.sp014122; BELMONTE C, 1983, J PHYSIOL-LONDON, V342, P603, DOI 10.1113/jphysiol.1983.sp014871; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Borovikov D.V., 1997, PRIMARY SENSORY NEUR, V2, P65, DOI 10.1163/; BOSSU JL, 1984, NEUROSCI LETT, V51, P241, DOI 10.1016/0304-3940(84)90558-5; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; BROWN AM, 1980, CIRC RES, V46, P1, DOI 10.1161/01.RES.46.1.1; BROWN AM, 1981, J PHYSIOL-LONDON, V318, P479; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CETINER M, 1993, BRIT J PHARMACOL, V110, P995, DOI 10.1111/j.1476-5381.1993.tb13912.x; CHAPLEAU MW, 1991, NEWS PHYSIOL SCI, V6, P206; CHEN C, 1995, J PHYSIOL-LONDON, V482, P521, DOI 10.1113/jphysiol.1995.sp020537; CHEN HI, 1990, CIRC RES, V67, P1394, DOI 10.1161/01.RES.67.6.1394; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; CUNNINGHAM JT, 1995, J NEUROPHYSIOL, V73, P2094, DOI 10.1152/jn.1995.73.5.2094; DUN NJ, 1995, NEUROSCIENCE, V65, P231, DOI 10.1016/0306-4522(94)00455-E; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; Fagni L, 1996, J CHEM NEUROANAT, V10, P231, DOI 10.1016/0891-0618(95)00140-9; GARLAND CJ, 1992, BRIT J PHARMACOL, V105, P429, DOI 10.1111/j.1476-5381.1992.tb14270.x; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARPER AA, 1991, EXP PHYSIOL, V76, P369, DOI 10.1113/expphysiol.1991.sp003504; HIGASHI H, 1986, PROG BRAIN RES, V67, P149; HOHLER B, 1994, CELL TISSUE RES, V276, P559; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030; IKEDA SR, 1986, J NEUROPHYSIOL, V55, P527, DOI 10.1152/jn.1986.55.3.527; IKEDA SR, 1987, J PHYSIOL-LONDON, V389, P255, DOI 10.1113/jphysiol.1987.sp016656; JEFTINIJA S, 1994, BRAIN RES, V639, P125, DOI 10.1016/0006-8993(94)91772-8; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KHURANA G, 1993, BRIT J PHARMACOL, V109, P480, DOI 10.1111/j.1476-5381.1993.tb13594.x; KIRCHHEIM HR, 1976, PHYSIOL REV, V56, P100, DOI 10.1152/physrev.1976.56.1.100; KITAMURA K, 1993, BRIT J PHARMACOL, V109, P415, DOI 10.1111/j.1476-5381.1993.tb13585.x; Koh SD, 1995, J PHYSIOL-LONDON, V489, P735, DOI 10.1113/jphysiol.1995.sp021087; KOSTYUK PG, 1981, NEUROSCIENCE, V6, P2423, DOI 10.1016/0306-4522(81)90088-9; KRAUHS JM, 1979, J NEUROCYTOL, V8, P401, DOI 10.1007/BF01214800; KRYLOV BV, 1995, PRIMARY SENSORY NEUR, V1, P3; KURENNY DE, 1994, NEURON, V13, P315, DOI 10.1016/0896-6273(94)90349-2; LEALCARDOSO H, 1993, J AUTONOM NERV SYST, V45, P29, DOI 10.1016/0165-1838(93)90359-3; Li Z, 1997, J PHYSIOL-LONDON, V501, P275, DOI 10.1111/j.1469-7793.1997.275bn.x; MATSUDA T, 1995, CIRC RES, V76, P426, DOI 10.1161/01.RES.76.3.426; MATSUMURA K, 1995, NEUROSCIENCE, V65, P493, DOI 10.1016/0306-4522(94)00505-Y; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; MOY JA, 1991, J BIOL CHEM, V266, P8092; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; SAPRU HN, 1981, BRAIN RES BULL, V6, P393, DOI 10.1016/S0361-9230(81)80009-3; SCHALLER KL, 1995, J NEUROSCI, V15, P3231; SCHILD JH, 1994, J NEUROPHYSIOL, V71, P2338, DOI 10.1152/jn.1994.71.6.2338; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STEA A, 1992, NEUROSCIENCE, V47, P727, DOI 10.1016/0306-4522(92)90180-A; TANAKA K, 1994, MICROSC RES TECHNIQ, V29, P90, DOI 10.1002/jemt.1070290205; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; VEDERNIKOV YP, 1992, EUR J PHARMACOL, V212, P125, DOI 10.1016/0014-2999(92)90085-I; WAHLER GM, 1995, AM J PHYSIOL-CELL PH, V268, pC45, DOI 10.1152/ajpcell.1995.268.1.C45; WANG ZZ, 1993, J COMP NEUROL, V336, P419, DOI 10.1002/cne.903360308; YOSHIDA S, 1994, CELL MOL NEUROBIOL, V14, P227, DOI 10.1007/BF02088322	69	113	125	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					1039	1049		10.1016/S0896-6273(00)80484-5	http://dx.doi.org/10.1016/S0896-6273(00)80484-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620707	Bronze			2022-12-24	WOS:000073864700022
J	Pringle, NP; Guthrie, S; Lumsden, A; Richardson, WD				Pringle, NP; Guthrie, S; Lumsden, A; Richardson, WD			Dorsal spinal cord neuroepithelium generates astrocytes but not oligodendrocytes	NEURON			English	Article							MONOCLONAL-ANTIBODIES O1; PDGF ALPHA-RECEPTOR; NEURAL-TUBE; PRECURSORS ORIGINATE; PROGENITOR CELLS; VENTRICULAR ZONE; EXPRESSION; LINEAGE; DIFFERENTIATION; DIVERSITY	There is evidence that oligodendrocytes in the spinal cord are derived from a restricted part of the ventricular zone near the floor plate. An alternative view is that oligodendrocytes are generated from all parts of the ventricular zone. We reinvestigated glial origins by constructing chick-quail chimeras in which dorsal or ventral segments of the embryonic chick neural tube were replaced with equivalent segments of quail neural tube. Ventral grafts gave rise to both oligodendrocytes and astrocytes. In contrast, dorsal grafts produced astrocytes but not oligodendrocytes, In mixed cultures of ventral and dorsal cells, only ventral cells generated oligodendrocytes, whereas both ventral and dorsal cells generated astrocytes. Therefore, oligodendrocytes are derived specifically from ventral neuroepithelium, and astrocytes from both dorsal and ventral.	Univ London Univ Coll, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; Univ London Univ Coll, Dept Biol, London WC1E 6BT, England; United Med & Dent Sch Guys & St Thomas, Div Anat & Dev Biol, London SE1 9RT, England	University of London; University College London; University of London; University College London; University of London; King's College London	Richardson, WD (corresponding author), Univ London Univ Coll, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.		Lumsden, Andrew/C-5146-2009; Guthrie, Sarah C/C-5727-2009; Richardson, William/C-1762-2008	Richardson, William/0000-0001-7261-2485	NICHD NIH HHS [N01-HD-2-3144] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD023144] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; BOHME G, 1988, J ANAT, V159, P37; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; DULAC C, 1992, NEURON, V8, P323, DOI 10.1016/0896-6273(92)90298-R; DULAC C, 1988, NEURON, V1, P211, DOI 10.1016/0896-6273(88)90141-9; Hall A, 1996, DEVELOPMENT, V122, P4085; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; ISOMURA G, 1986, ANAT ANZEIGER, V161, P285; LEBER SM, 1995, J NEUROSCI, V15, P1236; LEBER SM, 1990, J NEUROSCI, V10, P2451; LEDOUARIN NM, 1993, TRENDS NEUROSCI, V16, P64, DOI 10.1016/0166-2236(93)90019-I; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Miller RH, 1997, J NEUROSCI RES, V50, P157; MILLER RH, 1991, DEVELOPMENT, V113, P353; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; NOLL E, 1993, DEVELOPMENT, V118, P563; ONO K, 1995, DEVELOPMENT, V121, P1743; Ono K, 1997, NEURON, V19, P283, DOI 10.1016/S0896-6273(00)80939-3; Orentas DM, 1996, DEV BIOL, V177, P43, DOI 10.1006/dbio.1996.0143; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; REYNOLDS R, 1988, DEVELOPMENT, V102, P406; RICHARDSON WD, 1997, DEV NEUROSCI, V19, P54; SHARMA K, 1995, NEURON, V14, P143, DOI 10.1016/0896-6273(95)90248-1; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TIMSIT S, 1995, J NEUROSCI, V15, P1012; TROUSSE F, 1995, J NEUROSCI RES, V41, P552, DOI 10.1002/jnr.490410415; WALDEYER W, 1876, VIRCHOWS ARCH PATHOL, V68, P20; WARF BC, 1991, J NEUROSCI, V11, P2477; WECHSLER W, 1966, Z ZELLFORSCH MIK ANA, V74, P423, DOI 10.1007/BF00401265; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; ZACCHEI A M, 1961, Arch Ital Anat Embriol, V66, P36	39	81	82	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					883	893		10.1016/S0896-6273(00)80470-5	http://dx.doi.org/10.1016/S0896-6273(00)80470-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620693	Bronze			2022-12-24	WOS:000073864700008
J	Niethammer, M; Valtschanoff, JG; Kapoor, TM; Allison, DW; Weinberg, RJ; Craig, AM; Sheng, M				Niethammer, M; Valtschanoff, JG; Kapoor, TM; Allison, DW; Weinberg, RJ; Craig, AM; Sheng, M			CRIPT, a novel postsynaptic protein that binds to the third PDZ domain of PSD-95/SAP90	NEURON			English	Article							TUMOR-SUPPRESSOR PROTEIN; CLUSTERING ACTIVITY; POTASSIUM CHANNEL; GUANYLATE KINASES; HUMAN HOMOLOG; DROSOPHILA; IDENTIFICATION; TUBULIN; SUBUNIT; FAMILY	The synaptic protein PSD-95/SAP90 binds to and clusters a variety of membrane proteins via its two N-terminal PDZ domains. We report a novel protein, CRIPT, which is highly conserved from mammals to plants and binds selectively to the third PDZ domain (PDZ3) of PSD-95 via its C terminus. While conforming to the consensus PDZ-binding C-terminal sequence (X-S/TX-V-COOH), residues at the -1 position and upstream of the last four amino acids of CRIPT determine its specificity for PDZ3. In heterologous cells, CRIPT causes a redistribution of PSD-95 to microtubules. In brain, CRIPT colocalizes with PSD-95 in the postsynaptic density and can be coimmunoprecipitated with PSD-95 and tubulin. These findings suggest that CRIPT may regulate PSD-95 interaction with a tubulin-based cytoskeleton in excitatory synapses.	Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; University of Illinois System; University of Illinois Urbana-Champaign	Sheng, M (corresponding author), Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA.		Craig, Ann Marie/M-2054-2014; Weinberg, Richard/AAC-1898-2020	Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [NS29879, NS35050, NS33184] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033184, R01NS035050, R01NS029879] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLISON DW, 1998, IN PRESS J NEUROSCI; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Banker G., 1991, CULTURING NERVE CELL; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARTEL PL, 1993, USING 2 HYBRID SYSTE; BERG JM, 1990, ANNU REV BIOPHYS BIO, V19, P405; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; CARLIN RK, 1982, J NEUROCHEM, V38, P94, DOI 10.1111/j.1471-4159.1982.tb10858.x; CHANG YC, 1997, SOC NEUROSCI, V23; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; De Zeeuw CI, 1997, NEURON, V19, P1187, DOI 10.1016/S0896-6273(00)80411-0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Gee SH, 1998, J NEUROSCI, V18, P128; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Horio Y, 1997, J BIOL CHEM, V272, P12885, DOI 10.1074/jbc.272.20.12885; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1997, CURR OPIN NEUROBIOL, V7, P368; KOMAU HC, 1995, SCIENCE, V269, P1737; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Marfatia SM, 1996, J CELL BIOL, V135, P753, DOI 10.1083/jcb.135.3.753; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Niethammer M, 1996, J NEUROSCI, V16, P2157; NIETHAMMER M, 1998, IN PRESS METHODS ENZ; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Rao A, 1998, J NEUROSCI, V18, P1217; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Sheng M, 1996, CURR OPIN NEUROBIOL, V6, P602, DOI 10.1016/S0959-4388(96)80091-2; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; WALTERS BB, 1975, NATURE, V257, P496, DOI 10.1038/257496a0; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	65	245	256	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					693	707		10.1016/S0896-6273(00)81009-0	http://dx.doi.org/10.1016/S0896-6273(00)81009-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581762	Green Published, Bronze			2022-12-24	WOS:000073346500009
J	Cha, A; Bezanilla, F				Cha, A; Bezanilla, F			Characterizing voltage-dependent conformational changes in the Shaker K+ channel with fluorescence	NEURON			English	Article							POTASSIUM CHANNEL; GATING CURRENTS; ELECTROPHORUS-ELECTRICUS; SODIUM-CHANNEL; XANTHENE DYES; TEA BLOCKADE; S4 SEGMENT; PORE; MUTATIONS; REGION	We examined voltage-dependent conformational changes in three specific regions of the Shaker potassium channel with site-directed fluorescent labeling: the fourth transmembrane segment (S4), the second transmembrane segment (S2), and the putative pore region. The fluorescence changes displayed distinctive properties that correlate with gating, activation, and slow inactivation of the channel. The fluorescence signals measured near the S2 and S4 segments suggest that the S2 segment may undergo voltage-sensitive conformational changes that precede those in the S4 segment. In contrast, fluorescence changes in the pore correlated with the voltage dependence and time course of ionic activation and slow inactivation. Spectroscopy indicated that the mechanism of fluorescence change involves voltage-dependent quenching of the probe in an aqueous environment by other parts of the protein.	UNIV CALIF LOS ANGELES, SCH MED, DEPT PHYSIOL, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT ANESTHESIOL, LOS ANGELES, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA			Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051	NIGMS NIH HHS [GM08042, GM30376] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AJTAI K, 1992, BIOCHEMISTRY-US, V31, P12431, DOI 10.1021/bi00164a019; Ajtai K, 1995, BIOCHEMISTRY-US, V34, P15943, DOI 10.1021/bi00049a009; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Burghardt TP, 1996, BIOPHYS CHEM, V59, P119, DOI 10.1016/0301-4622(95)00118-2; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; KOSOWER EM, 1985, FEBS LETT, V182, P234, DOI 10.1016/0014-5793(85)80306-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LIN TI, 1982, BIOPHYS CHEM, V15, P289, DOI 10.1016/0301-4622(82)80012-4; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACDONALD RI, 1990, J BIOL CHEM, V265, P13533; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MOORE D, 1994, CURRENT PROTOCOLS MO; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; ROHATGI KK, 1966, J PHYS CHEM-US, V70, P1695, DOI 10.1021/j100878a002; ROHATGI KK, 1963, J PHYS CHEM-US, V67, P2844, DOI 10.1021/j100806a504; SELWYN JE, 1972, J PHYS CHEM-US, V76, P762, DOI 10.1021/j100649a026; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHAO XM, 1993, NEURON, V11, P343, DOI 10.1016/0896-6273(93)90189-X; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	40	284	295	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1997	19	5					1127	1140		10.1016/S0896-6273(00)80403-1	http://dx.doi.org/10.1016/S0896-6273(00)80403-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390525	Bronze			2022-12-24	WOS:A1997YH59400019
J	Feller, MB; Butts, DA; Aaron, HL; Rokhsar, DS; Shatz, CJ				Feller, MB; Butts, DA; Aaron, HL; Rokhsar, DS; Shatz, CJ			Dynamic processes shape spatiotemporal properties of retinal waves	NEURON			English	Article							CHOLINERGIC AMACRINE CELLS; DEVELOPING MAMMALIAN RETINA; RABBIT RETINA; GANGLION-CELLS; SYNAPTIC ORGANIZATION; OLFACTORY NETWORK; BURSTING ACTIVITY; NEURONS; CAT; ACETYLCHOLINE	In the developing mammalian retina, spontaneous waves of action potentials are present in the ganglion cell layer weeks before vision. These waves are known to be generated by a synaptically connected network of amacrine cells and retinal ganglion cells, and exhibit complex spatiotemporal patterns, characterized by shifting domains of coactivation. Here, we present a novel dynamical model consisting of two coupled populations of cells that quantitatively reproduces the experimentally observed domain sizes, interwave intervals, and wavefront velocity profiles. Model and experiment together show that the highly correlated activity generated by retinal waves can be explained by a combination of random spontaneous activation of cells and the past history of local retinal activity.	UNIV CALIF BERKELEY, DEPT MOL & CELL BIOL, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, LAWRENCE BERKELEY LAB, DIV LIFE SCI, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, DEPT PHYS, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Feller, MB (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, BERKELEY, CA 94720 USA.		Butts, Daniel A/B-8346-2008	Butts, Daniel A/0000-0002-0158-5317; Rokhsar, Daniel/0000-0002-8704-2224	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 48108] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baldridge WH, 1996, J NEUROSCI, V16, P5060; BLAZYNSKI C, 1992, J NEUROCHEM, V58, P761, DOI 10.1111/j.1471-4159.1992.tb09783.x; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; BURGI PY, 1994, J NEUROSCI, V14, P7426; Charles AC, 1996, MOL CELL NEUROSCI, V7, P337, DOI 10.1006/mcne.1996.0025; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; DANN JF, 1989, J COMP NEUROL, V289, P143, DOI 10.1002/cne.902890112; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; GARRAGHTY PE, 1993, PHYSIOL REV, V73, P529, DOI 10.1152/physrev.1993.73.3.529; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HAMASSAKIBRITTO DE, 1994, J COMP NEUROL, V347, P161, DOI 10.1002/cne.903470202; HARE WA, 1995, VISUAL NEUROSCI, V12, P443, DOI 10.1017/S0952523800008348; HUTCHINS JB, 1995, EXP EYE RES, V60, P113, DOI 10.1016/S0014-4835(95)80001-8; JOHNSON SM, 1994, J NEUROPHYSIOL, V72, P2598, DOI 10.1152/jn.1994.72.6.2598; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; KLEINFELD D, 1994, J NEUROPHYSIOL, V72, P1402, DOI 10.1152/jn.1994.72.3.1402; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MARIANI AP, 1988, J COMP NEUROL, V267, P269, DOI 10.1002/cne.902670209; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; MASLAND RH, 1986, TRENDS NEUROSCI, V9, P218, DOI 10.1016/0166-2236(86)90062-7; MASLIM J, 1986, BRAIN RES, V373, P35, DOI 10.1016/0006-8993(86)90313-6; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLAR TJ, 1987, NEUROSCI LETT, V74, P281, DOI 10.1016/0304-3940(87)90310-7; MITROFANIS J, 1989, J COMP NEUROL, V289, P228, DOI 10.1002/cne.902890205; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; NISHIMURA Y, 1987, NEUROSCI RES, pS253, DOI 10.1016/0921-8696(87)90021-1; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; PENN AA, 1994, J NEUROSCI, V14, P3805; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; RAMOA AS, 1988, J NEUROSCI, V8, P4239; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VELTE TJ, 1995, VISUAL NEUROSCI, V12, P165, DOI 10.1017/S0952523800007392; Wingate RJT, 1996, MOL NEUROBIOL, V12, P133, DOI 10.1007/BF02740650; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; WONG ROL, 1989, J COMP NEUROL, V287, P164, DOI 10.1002/cne.902870203; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334; Zhou ZJ, 1996, P NATL ACAD SCI USA, V93, P8057, DOI 10.1073/pnas.93.15.8057	57	129	132	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1997	19	2					293	306		10.1016/S0896-6273(00)80940-X	http://dx.doi.org/10.1016/S0896-6273(00)80940-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292720	Bronze			2022-12-24	WOS:A1997XU14600009
J	Baloh, RH; Tansey, MG; Golden, JP; Creedon, DJ; Heuckeroth, RO; Keck, CL; Zimonjic, DB; Popescu, NC; Johnson, EM; Milbrandt, J				Baloh, RH; Tansey, MG; Golden, JP; Creedon, DJ; Heuckeroth, RO; Keck, CL; Zimonjic, DB; Popescu, NC; Johnson, EM; Milbrandt, J			TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret	NEURON			English	Article							NERVE GROWTH-FACTOR; PROGRAMMED CELL-DEATH; NEUROTROPHIC FACTOR; IN-VIVO; SYMPATHETIC NEURONS; NONNEURONAL CELLS; GENE-EXPRESSION; SURVIVAL FACTOR; MOTOR-NEURONS; MESSENGER-RNA	Glial cell line-derived neurotrophic factor (GDNF) and neurturin (NTN) comprise a family of TGF-P-related neurotrophic factors (TRNs), which have trophic influences on a variety of neuronal populations. A receptor complex comprised of TrnR1 (GDNFR alpha) and Ret was recently identified and found to be capable of mediating both GDNF and NTN signaling. We have identified a novel receptor based on homology to TrnR1, called TrnR2, that is 48% identical to TrnR1, and is located on the short arm of chromosome 8. TrnR2 is attached to the cell surface via a GPI-linkage, and can mediate both NTN and GDNF signaling through Ret in vitro. Fibroblasts expressing TrnR2 and Ret are similar to 30-fold more sensitive to NTN than to GDNF treatment, whereas those expressing TrnR1 and Ret respond equivalently to both factors, suggesting the TrnR2-Ret complex acts preferentially as a receptor for NTN. TrnR2 and Ret are expressed in neurons of the superior cervical and dorsal root ganglia, and in the adult brain. Comparative analysis of TrnR1, TrnR2, and Ret expression indicates that multiple receptor complexes, capable of mediating GDNF and NTN signaling, exist in vivo.	WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOL BIOL & PHARMACOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110; NCI,EXPT CARCINOGENESIS LAB,BETHESDA,MD 20892	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Baloh, RH (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110, USA.		Zimonjic, Drazen/AAX-7513-2020	Milbrandt, Jeffrey/0000-0002-5477-7689; Golden, Judith/0000-0002-5168-8525; Heuckeroth, Robert/0000-0002-3282-1765	NIA NIH HHS [R01 AG13730, R01 AG13729] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARY DO, 1994, P NATL ACAD SCI USA, V91, P11133, DOI 10.1073/pnas.91.23.11133; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; CREEDON DJ, 1997, IN PRESS P NATL ACAD; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; Imbert A, 1996, GENOMICS, V32, P29, DOI 10.1006/geno.1996.0073; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDSAY RM, 1995, NATURE, V373, P289, DOI 10.1038/373289a0; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SPRINGER JE, 1995, EXP NEUROL, V131, P47, DOI 10.1016/0014-4886(95)90006-3; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; Svaren J, 1996, MOL CELL BIOL, V16, P3545; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZHAN X, 1987, ONCOGENE, V1, P369; ZIMONJIC DB, 1995, CANCER GENET CYTOGEN, V80, P100, DOI 10.1016/0165-4608(94)00161-4	47	292	319	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					793	802		10.1016/S0896-6273(00)80318-9	http://dx.doi.org/10.1016/S0896-6273(00)80318-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182803	Bronze			2022-12-24	WOS:A1997XB72200012
J	Fried, I; MacDonald, KA; Wilson, CL				Fried, I; MacDonald, KA; Wilson, CL			Single neuron activity in human hippocampus and amygdala during recognition of faces and objects	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; SHORT-TERM-MEMORY; HUMAN EXTRASTRIATE CORTEX; FREELY-BEHAVING RATS; UNIT-ACTIVITY; CORTICAL AFFERENTS; INFEROTEMPORAL CORTEX; SELECTIVE RESPONSES; FACIAL EXPRESSIONS; PREFRONTAL CORTEX	The hippocampus and its associated structures play a key role in human memory, yet the underlying neuronal mechanisms remain unknown. Here, we report that during encoding and recognition, single neurons in the medial temporal lobe discriminated faces from inanimate objects. Some units responded selectively to specific emotional expressions or to conjunctions of facial expression and gender. Such units were especially prevalent during recognition, and the responses depended on stimulus novelty or familiarity. Traces of exposure to faces or objects were found a few seconds after stimulus removal as well as 10 hr later. Some neurons maintained a record of previous stimulus presentation that was more accurate than the person's conscious recollection. We propose that the human medial temporal lobe constructs a ''cognitive map'' of stimulus attributes comparable to the map of the spatial environment described in the rodent hippocampus.	UNIV CALIF LOS ANGELES, SCH MED, DEPT PSYCHIAT & BIOBEHAV SCI, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fried, I (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DIV NEUROSURG, LOS ANGELES, CA 90095 USA.				NINDS NIH HHS [NS02808, NS33221] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS002808, R01NS033221] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; BARNES CA, 1990, PROG BRAIN RES, V83, P287; BAYLIS GC, 1987, J NEUROSCI, V7, P330; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BORDI F, 1993, BEHAV NEUROSCI, V107, P757, DOI 10.1037/0735-7044.107.5.757; BORDI F, 1992, J NEUROSCI, V12, P2493; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; BROWN MW, 1977, BRAIN RES, V123, P241, DOI 10.1016/0006-8993(77)90477-2; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BUCKNER RL, 1995, J NEUROSCI, V15, P12; CAHUSAC PMB, 1989, BEHAV BRAIN RES, V33, P229, DOI 10.1016/S0166-4328(89)80118-4; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; COLOMBO M, 1994, BEHAV NEUROSCI, V108, P443, DOI 10.1037/0735-7044.108.3.443; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; EIFUKU S, 1995, J NEUROSCI, V15, P4952; Ekman P., 1976, PICTURES FACIAL AFFE; FAHY FL, 1993, EXP BRAIN RES, V96, P457; FRIED I, 1982, BRAIN, V105, P349, DOI 10.1093/brain/105.2.349; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; GEORGE MS, 1993, J NEUROPSYCH CLIN N, V5, P384; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; GRASBY PM, 1993, NEUROSCI LETT, V163, P185, DOI 10.1016/0304-3940(93)90378-X; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HAGLUND MM, 1994, J NEUROSCI, V14, P1507, DOI 10.1523/JNEUROSCI.14-03-01507.1994; Hamann SB, 1996, NATURE, V379, P497, DOI 10.1038/379497a0; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; KUBOTA K, 1971, J NEUROPHYSIOL, V34, P337, DOI 10.1152/jn.1971.34.3.337; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; McNaughton BL, 1990, NEUROSCIENCE CONNECT, P1; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Miller EK, 1996, J NEUROSCI, V16, P5154; MISHKIN M, 1994, CURR OPIN NEUROBIOL, V4, P200, DOI 10.1016/0959-4388(94)90073-6; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; NAKAMURA K, 1992, J NEUROPHYSIOL, V67, P1447, DOI 10.1152/jn.1992.67.6.1447; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OJEMANN JG, 1992, BRAIN, V115, P1, DOI 10.1093/brain/115.1.1; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; ONO T, 1991, NEUROSCI LETT, V121, P194, DOI 10.1016/0304-3940(91)90683-K; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROLLS ET, 1993, EXP BRAIN RES, V93, P299; ROLLS ET, 1989, J NEUROSCI, V9, P1835; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; ROLLS ET, 1986, EXP BRAIN RES, V65, P38; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; ROLLS ET, 1992, PHILOS T R SOC B, V335, P11, DOI 10.1098/rstb.1992.0002; ROLLS ET, 1981, AMYGDALOID COMPLEX, P383; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; SALTZMAN E, 1993, BEHAV BRAIN RES, V53, P133; Schacter D. L., 1994, MEMORY SYSTEMS 1994; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sergent J., 1994, VIS COGN, V1, P349, DOI [10.1080/13506289408402305, DOI 10.1080/13506289408402305]; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; VANHOESEN GW, 1972, SCIENCE, V175, P1471, DOI 10.1126/science.175.4029.1471; WATANABE T, 1985, BRAIN RES, V325, P241, DOI 10.1016/0006-8993(85)90320-8; WIBLE CG, 1986, BRAIN RES, V399, P97, DOI 10.1016/0006-8993(86)90604-9; WICKELGREN WA, 1979, PSYCHOL REV, V86, P44, DOI 10.1037/0033-295X.86.1.44; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; WILSON FAW, 1993, EXP BRAIN RES, V93, P367; YOUNG A W, 1991, European Journal of Cognitive Psychology, V3, P5, DOI 10.1080/09541449108406218; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	95	383	386	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1997	18	5					753	765		10.1016/S0896-6273(00)80315-3	http://dx.doi.org/10.1016/S0896-6273(00)80315-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182800	Bronze			2022-12-24	WOS:A1997XB72200009
J	Soriano, E; AlvaradoMallart, RM; Dumesnil, N; DelRio, JA; Sotelo, C				Soriano, E; AlvaradoMallart, RM; Dumesnil, N; DelRio, JA; Sotelo, C			Cajal-Retzius cells regulate the radial glia phenotype in the adult and developing cerebellum and alter granule cell migration	NEURON			English	Article							DEVELOPING CEREBRAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; GUIDED NEURONAL MIGRATION; BINDING PROTEIN; SUBPLATE NEURONS; GROWTH-FACTOR; GENE ENCODES; MUTANT MOUSE; SPINAL-CORD; REELER	Studies on the reeler mutation have shown that pioneer Cajal-Retzius (CR) cells are involved in neuronal migration in the developing cortex. Here, we use grafting and coculture experiments to investigate the mechanisms by which CR cells govern migration. We show that transplantation of embryonic CR cells, but not other cortical neurons, into adult cerebella induces a transient rejuvenation of host Bergmann glia into a radial glia phenotype. Similarly, CR cells sustain the phenotype of developing radial glia in postnatal cerebellar slices and induce the organization of a glial scaffold inside the CR cell explants. Studies with semipermeable inserts show that these effects are mediated by diffusible signals. We also show that CR cells adjacent to the surface of cerebellar slices reverse the direction of the migration of granule cells. Finally, CR cells from reeler mutant embryos elicited similar effects. These observations imply a role for CR cells in the regulation of the radial glia phenotype, a key step for neuronal migration, and suggest that these pioneer neurons may also exert a chemoattractive influence on migrating neurons.	UNIV BARCELONA, FAC BIOL, DEPT ANIM & PLANT CELL BIOL, BARCELONA 08028, SPAIN	University of Barcelona	Soriano, E (corresponding author), U106 INSERM, 47 BLVD HOP, F-75651 PARIS 13, FRANCE.		Sotelo, Constantino/AAS-5475-2021; Del Rio Fernandez, Jose A/AAD-1121-2020	Sotelo, Constantino/0000-0001-8051-2492; Del Rio, Jose Antonio/0000-0002-5214-4909				ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Altman J., 1982, CEREBELLUM NEW VISTA, V47, P8; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anton ES, 1996, J NEUROSCI, V16, P2283; Bayer S.A., 1991, NEOCORTICAL DEV; BEHAR TN, 1994, J NEUROSCI, V14, P29; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; CAMERON RS, 1994, J NEUROSCI, V14, P3139; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; COBAS A, 1991, NEUROSCIENCE, V40, P375, DOI 10.1016/0306-4522(91)90127-A; COHENTANNOUDJI M, 1992, MOL REPROD DEV, V33, P149, DOI 10.1002/mrd.1080330206; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DelRio JA, 1996, J NEUROSCI, V16, P6896; DELRIO JA, 1992, J COMP NEUROL, V326, P501, DOI 10.1002/cne.903260403; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; DERER P, 1979, NEUROSCI LETT, V13, P195, DOI 10.1016/0304-3940(79)90041-7; Derer P, 1992, DEV CENTRAL NERVOUS, P113; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMUNDS SM, 1982, J NEUROCYTOL, V11, P427, DOI 10.1007/BF01257987; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FENG L, 1995, DEVELOPMENT, V121, P1719; FISHELL G, 1991, DEVELOPMENT, V113, P755; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GADISSEUX JF, 1992, J COMP NEUROL, V322, P246, DOI 10.1002/cne.903220210; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GARD AL, 1995, DEVELOPMENT, V121, P2187; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GOFFINET AM, 1995, NATURE, V374, P675, DOI 10.1038/374675a0; GUENET JL, 1981, MOUSE NEWS LETT, V41; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; HUNTER KE, 1995, SOC NEUROSCI, V21; Jankovski A, 1996, EUR J NEUROSCI, V8, P2308, DOI 10.1111/j.1460-9568.1996.tb01194.x; KOMURO H, 1995, J NEUROSCI, V15, P1110; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; Marin-Padilla M., 1984, CEREB CORTEX, V1, P447; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; MARINPADILLA M, 1988, CEREB CORTEX, V7, P1; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MISSON JP, 1991, THESIS U LIEGE BELGI, P1; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Ramon y Cajal S., 1955, HISTOLOGIE SYSTEME N; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; RIVAS RJ, 1995, J NEUROSCI, V15, P981; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SORIANO E, 1994, J COMP NEUROL, V342, P571, DOI 10.1002/cne.903420406; SORIANO E, 1995, P NATL ACAD SCI USA, V92, P11676, DOI 10.1073/pnas.92.25.11676; SOTELO C, 1988, PROG BRAIN RES, V78, P141; SOTELO C, 1994, J NEUROSCI, V14, P124; SPENCER R, 1976, EUR J BIOCHEM, V71, P399, DOI 10.1111/j.1432-1033.1976.tb11127.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	88	112	113	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1997	18	4					563	577		10.1016/S0896-6273(00)80298-6	http://dx.doi.org/10.1016/S0896-6273(00)80298-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW626	9136766	Bronze			2022-12-24	WOS:A1997WW62600006
J	Thor, S; Thomas, JB				Thor, S; Thomas, JB			The Drosophila islet gene governs axon pathfinding and neurotransmitter identity	NEURON			English	Article							MONOAMINE NEURON SYSTEMS; DOPA DECARBOXYLASE GENE; POU-DOMAIN PROTEIN; MOTOR-NEURONS; TYROSINE-HYDROXYLASE; EMBRYONIC-DEVELOPMENT; TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN; ENDOCRINE-CELLS; RAT-BRAIN	We have isolated the Drosophila homolog of the vertebrate islet-1 and islet-2 genes, two members of the LIM homeodomain family implicated in the transcriptional control of motor neuronal differentiation. Similar to vertebrates, Drosophila islet is expressed in a discrete subset of embryonic motor neurons and interneurons that includes the dopaminergic and serotonergic cells of the ventral nerve cord. In contrast to mouse where mutation of islet-l leads to loss of neurons due to programmed cell death, Drosophila islet is not required for neuron survival. Instead, loss of islet function causes defects in axon pathfinding and targeting plus loss of dopamine and serotonin synthesis. Ectopic expression of islet induces both specific alterations in pathfinding and changes in neurotransmitter identity. These findings indicate that islet coordinately controls two distinct aspects of neuronal identity.			Thor, S (corresponding author), SALK INST,MOL NEUROBIOL LAB,POB 85800,SAN DIEGO,CA 92186, USA.		Thor, Stefan/Y-5804-2019	Thor, Stefan/0000-0001-5095-541X				ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123; Appel B, 1995, DEVELOPMENT, V121, P4117; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bang AG, 1996, CURR OPIN NEUROBIOL, V6, P25, DOI 10.1016/S0959-4388(96)80005-5; Basson M, 1996, GENE DEV, V10, P1953, DOI 10.1101/gad.10.15.1953; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Burger C, 1996, J NEUROSCI, V16, P1412; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Callahan CA, 1996, DEVELOPMENT, V122, P2761; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CASINI G, 1992, J COMP NEUROL, V326, P302, DOI 10.1002/cne.903260211; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Chang TN, 1996, J NEUROSCI, V16, P5715; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; DOE CQ, 1993, DEV DROSOPHILA MELAN, P1131; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; GARCIAARRARAS JE, 1990, CELL TISSUE RES, V262, P363, DOI 10.1007/BF00309891; GOODMAN CS, 1979, NATURE, V280, P208, DOI 10.1038/280208a0; GORCZYCA MG, 1994, DEVELOPMENT, V120, P2143; GROVES AK, 1995, DEVELOPMENT, V121, P887; HIRSH J, 1981, MOL CELL BIOL, V1, P475, DOI 10.1128/MCB.1.6.475; HOKFELT T, 1977, MED BIOL, V55, P21; HOKFELT T, 1976, MED BIOL, V54, P427; Iversen L L, 1970, Adv Biochem Psychopharmacol, V2, P109; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; KORZH V, 1993, DEVELOPMENT, V118, P417; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LIN DM, 1995, NEURON, V14, P707, DOI 10.1016/0896-6273(95)90215-5; Lundell MJ, 1996, MOL CELL NEUROSCI, V7, P46, DOI 10.1006/mcne.1996.0004; LUNDELL MJ, 1992, DEV BIOL, V154, P84, DOI 10.1016/0012-1606(92)90050-Q; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; NECKAMEYER WS, 1989, NEURON, V4, P1167; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PHELPS PE, 1991, J COMP NEUROL, V307, P77, DOI 10.1002/cne.903070108; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schussler N, 1995, J NEUROSCI RES, V42, P846, DOI 10.1002/jnr.490420613; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; TAGHERT PH, 1984, J NEUROSCI, V4, P989; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TEITELMAN G, 1990, DEV BIOL, V142, P368, DOI 10.1016/0012-1606(90)90357-O; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; TOKUMOTO M, 1995, DEV BIOL, V171, P578, DOI 10.1006/dbio.1995.1306; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VANVACTOR D, 1993, CELL, V73, P1155; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WRIGHT TRF, 1976, GENETICS, V84, P287; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	72	228	229	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					397	409		10.1016/S0896-6273(00)81241-6	http://dx.doi.org/10.1016/S0896-6273(00)81241-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115734	Bronze			2022-12-24	WOS:A1997WQ07400008
J	Kimpo, RR; Doupe, AJ				Kimpo, RR; Doupe, AJ			FOS is induced by singing in distinct neuronal populations in a motor network	NEURON			English	Article							ZEBRA FINCH SONG; WHITE-CROWNED SPARROW; NERVE GROWTH-FACTOR; C-FOS; GENE-EXPRESSION; CONTROL-SYSTEM; AVIAN SONG; FOREBRAIN NUCLEUS; MESSENGER-RNA; VOCAL CENTER	Mechanisms underlying the learned vocal behavior of songbirds were studied by examining expression of the protein product of the immediate early gene c-fos (Fos) in zebra finches. Auditory stimuli including the bird's own song did not induce Fos in the song system. In contrast, the motor act of singing induced Fos in two song sensorimotor nuclei, HVc and RA. This induction was independent of auditory feedback, since it occurred in deafened birds that sang. Double-labeling studies demonstrated that only one of the two sets of projection neurons in HVc expressed singing-related Fos. The motor-driven induction of Fos identifies functionally distinct cell populations in a network for singing and may point to sites of cellular plasticity necessary for song maintenance.	UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kimpo, RR (corresponding author), UNIV CALIF SAN FRANCISCO,KECK CTR INTEGRAT NEUROSCI,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.							ALVAREZBUYLLA A, 1992, J NEUROBIOL, V23, P396, DOI 10.1002/neu.480230406; ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; ANOKHIN KV, 1991, BRAIN RES, V544, P101, DOI 10.1016/0006-8993(91)90890-8; BISCHOF HJ, 1986, BEHAV BRAIN RES, V21, P215, DOI 10.1016/0166-4328(86)90239-1; BISCHOF HJ, 1988, BEHAV NEURAL BIOL, V49, P386, DOI 10.1016/S0163-1047(88)90402-5; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Chergui K, 1996, NEUROSCIENCE, V72, P141, DOI 10.1016/0306-4522(95)00513-7; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1997, J NEUROSCI, V17, P1147; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; HOUGH GE, 1996, SOC NEUROSCI, V22, P963; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Jarvis E. D., 1996, Society for Neuroscience Abstracts, V22, P692; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Jurgens U, 1996, EUR J NEUROSCI, V8, P2, DOI 10.1111/j.1460-9568.1996.tb01162.x; KELLEY DB, 1979, J COMP NEUROL, V183, P455, DOI 10.1002/cne.901830302; Kleim JA, 1996, J NEUROSCI, V16, P4529; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; KORNHAUSER JM, 1992, SCIENCE, V255, P1581, DOI 10.1126/science.1549784; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LABINER DM, 1993, J NEUROSCI, V13, P744; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; MCCASLAND JS, 1981, P NATL ACAD SCI USA, V78, P8715; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MOONEY R, 1991, P NATL ACAD SCI USA, V88, P4075, DOI 10.1073/pnas.88.10.4075; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORRIS D, 1970, PATTERNS REPRODUCTIV, P399; MORRISON RG, 1993, J NEUROBIOL, V24, P1045, DOI 10.1002/neu.480240805; NASTIUK KL, 1994, MOL BRAIN RES, V27, P299, DOI 10.1016/0169-328X(94)90013-2; NORDEEN KW, 1987, J NEUROBIOL, V18, P569, DOI 10.1002/neu.480180607; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; PERKEL DJ, 1995, SOC NEUR ABSTR, V20, P165; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SHARP FR, 1993, CRIT REV NEUROBIOL, V7, P205; SHARP PJ, 1995, CELL TISSUE RES, V282, P351, DOI 10.1007/BF00319125; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; SOHRABJI F, 1989, BRAIN RES, V488, P253, DOI 10.1016/0006-8993(89)90715-4; VICARIO DS, 1993, J NEUROBIOL, V24, P488, DOI 10.1002/neu.480240407; Volman SF, 1996, J COMP PHYSIOL A, V178, P849; VOLMAN SF, 1993, J NEUROSCI, V13, P4737; Vu E. T., 1994, Society for Neuroscience Abstracts, V20, P166; VU ET, 1994, J NEUROSCI, V14, P6924; WAN XST, 1992, NEUROSCIENCE, V49, P749, DOI 10.1016/0306-4522(92)90353-4; WILLIAMS H, 1993, J NEUROBIOL, V24, P903, DOI 10.1002/neu.480240704; WILLIAMS H, 1992, BEHAV NEURAL BIOL, V57, P67, DOI 10.1016/0163-1047(92)90768-Y; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZUSCHRATTER W, 1995, EUR J NEUROSCI, V7, P1614, DOI 10.1111/j.1460-9568.1995.tb01157.x; [No title captured]	69	121	123	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					315	325		10.1016/S0896-6273(00)80271-8	http://dx.doi.org/10.1016/S0896-6273(00)80271-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052801	Bronze			2022-12-24	WOS:A1997WK82200014
J	Doan, A; Thinakaran, G; Borchelt, DR; Slunt, HH; Ratovitsky, T; Podlisny, M; Selkoe, DJ; Seeger, M; Gandy, SE; Price, DL; Sisodia, SS				Doan, A; Thinakaran, G; Borchelt, DR; Slunt, HH; Ratovitsky, T; Podlisny, M; Selkoe, DJ; Seeger, M; Gandy, SE; Price, DL; Sisodia, SS			Protein topology of presenilin 1	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; MISSENSE MUTATIONS; N-GLYCOSYLATION; GENE; CHROMOSOME-1; CELLS; LOCUS	Mutations in a gene encoding a multitransmembrane protein, termed presenilin 1 (PS1), are causative in the majority of early-onset cases of AD. To determine the topology of PS1, we utilized two strategies: first, we tested whether putative transmembranes are sufficient to export a protease-sensitive substrate across a lipid bilayer; and second, we examined the binding of antibodies to specific PS1 epitopes in cultured cells selectively permeabilized with the pore-forming toxin, streptolysin-O. We document that the ''loop,'' N-terminal, and C-terminal domains of PS1 are oriented toward the cytoplasm.	JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115; CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021	Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Cornell University	Doan, A (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NIA NIH HHS [AG05146, AG11508] Funding Source: Medline; NINDS NIH HHS [NS 20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R55AG011508, R01AG011508] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BHAKDI S, 1993, MED MICROBIOL IMMUN, V182, P167; BORCHELT BR, 1996, IN PRESS NEURON, V17; Busfield Frances, 1995, P59, DOI 10.1016/B978-012286965-5/50006-6; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUOVILA AP, 1992, J CELL BIOL, V188, P1305; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; LEE MK, 1996, IN PRESS J NEUROSCI; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LI X, 1996, IN PRESS NEURON, V17; LO ACY, 1994, J BIOL CHEM, V269, P30966; MCGOVERN K, 1991, EMBO J, V10, P2773, DOI 10.1002/j.1460-2075.1991.tb07826.x; PerezTur J, 1995, NEUROREPORT, V7, P297; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1995, AMYLOID, V2, P188, DOI 10.3109/13506129509036925; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Van Broeckhoven C, 1995, NAT GENET, V11, P230; VANNOSTRAND WE, 1989, NATURE, V341, P546; Wisniewski HM., 1973, PROGR NEUROPATHOLOGY, P1; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154	30	358	368	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					1023	1030		10.1016/S0896-6273(00)80232-9	http://dx.doi.org/10.1016/S0896-6273(00)80232-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938133	hybrid			2022-12-24	WOS:A1996VV15100023
J	MorenoLopez, B; Escudero, M; DelgadoGarcia, JM; Estrada, C				MorenoLopez, B; Escudero, M; DelgadoGarcia, JM; Estrada, C			Nitric oxide production by brain stem neurons is required for normal performance of eye movements in alert animals	NEURON			English	Article							LONG-TERM POTENTIATION; RELAXING FACTOR; INTERCELLULAR MESSENGER; NADPH DIAPHORASE; ABDUCENS NUCLEUS; PREPOSITUS; CAT; SYNTHASE; RELEASE; LOCALIZATION	Although nitric oxide (NO) is produced by discrete groups of neurons in the brain, participation of NO in premotor structures directly involved in reflexively evoked, sensory-motor functions has not been demonstrated so far. We now show that NO is a physiological mediator in the generation of a specific motor response in alert behaving animals. In the oculomotor system, numerous neurons expressing nitric oxide synthase (NOS) are located in the prepositus hypoglossi, a nucleus involved in the control of horizontal eye movements. Unilateral inhibition of NOS within this nucleus results in severe ocular nystagmus with slow phases directed to the contralateral side. Accordingly, local increases of NO or cyclic GMP produced a nystagmus in the opposite direction. It is concluded that a balanced production of NO by prepositus hypoglossi neurons is a necessary condition for the normal performance of eye movements in alert animals.	UNIV AUTONOMA MADRID,FAC MED,DEPT FISIOL,E-28029 MADRID,SPAIN	Autonomous University of Madrid	MorenoLopez, B (corresponding author), UNIV SEVILLA,LAB NEUROCIENCIA,DEPT FISIOL & BIOL ANIM,FAC BIOL,E-41012 SEVILLE,SPAIN.		Delgado-Garcia, Jose M./V-1567-2019; Moreno-López, Bernardo/S-5148-2019; Escudero, Miguel/E-6335-2010	Moreno-López, Bernardo/0000-0003-2897-6227; Escudero, Miguel/0000-0002-0075-8802				BAKER R, 1975, BRAIN RES, V86, P121, DOI 10.1016/0006-8993(75)90643-5; BAKER RG, 1969, BRAIN RES, V15, P577, DOI 10.1016/0006-8993(69)90189-9; Berman A.L., 1968, BRAIN STEM CAT CYTOA; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Buttner-Ennever J. A., 1988, REV OCULOMOTOR RES, V2; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1382; CHERON G, 1986, J PHYSIOL-LONDON, V372, P95, DOI 10.1113/jphysiol.1986.sp015999; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DELGADOGARCIA JM, 1986, NEUROSCIENCE, V17, P929, DOI 10.1016/0306-4522(86)90072-2; DELGADOGARCIA JM, 1989, NEUROSCIENCE, V29, P291, DOI 10.1016/0306-4522(89)90058-4; ESCUDERO M, 1988, EXP BRAIN RES, V71, P218; ESCUDERO M, 1992, J PHYSIOL-LONDON, V458, P539, DOI 10.1113/jphysiol.1992.sp019433; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; MCCREA RA, 1985, J COMP NEUROL, V237, P377, DOI 10.1002/cne.902370308; NAGAO S, 1991, NEUROREPORT, V2, P193, DOI 10.1097/00001756-199104000-00008; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RAPHAN T, 1985, ADAPTIVE PROCESSES V, P285; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; Robinson DA, 1975, BASIC MECH OCULAR MO, P337; RODRIGO J, 1994, PHILOS T R SOC B, V345, P175, DOI 10.1098/rstb.1994.0096; ROSKAMS AJ, 1994, NEURON, V13, P289; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; YOKOTA JI, 1993, CONT OCULAR MOTOR VE, P453	33	44	44	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					739	745		10.1016/S0896-6273(00)80205-6	http://dx.doi.org/10.1016/S0896-6273(00)80205-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893030	Bronze			2022-12-24	WOS:A1996VP74300018
J	Grunewald, M; Bendahan, A; Kanner, BI				Grunewald, M; Bendahan, A; Kanner, BI			Biotinylation of single cysteine mutants of the glutamate transporter GLT-1 from rat brain reveals its unusual topology	NEURON			English	Article							AMINO-ACID TRANSPORTER; MEMBRANE TOPOLOGY; HIGH-AFFINITY; FUNCTIONAL-CHARACTERIZATION; ASPARTATE TRANSPORTER; ESCHERICHIA-COLI; K+ CHANNEL; EXPRESSION; CLONING; GLAST-1	In the central nervous system, (Na+ + K+)-coupled glutamate transporters restrict the neurotoxicity of this transmitter and limit the duration of synaptic excitation at some synapses. The Various isotransporters exhibit a particularly high homology in an extended hydrophobic domain of ill-defined topology that contains several determinants involved in ion and transmitter binding. Here, we describe the determination of the membrane topology of the cloned astroglial glutamate transporter GLT-1. A series of functional transporters containing single cysteines was engineered. Their topological disposition was determined by using a biotinylated sulfhydryl reagent. The glutamate transporter has eight transmembrane domains long enough to span the membrane as cu helices. Strikingly, between the seventh and eighth domains, a structure reminiscent of a pore loop and an outward-facing hydrophobic linker are positioned.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel.							ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CONRADT M, 1995, J BIOL CHEM, V270, P25207, DOI 10.1074/jbc.270.42.25207; CONRADT M, 1995, EUR J BIOCHEM, V229, P682, DOI 10.1111/j.1432-1033.1995.tb20514.x; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; Diamond JS, 1997, J NEUROSCI, V17, P4672; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Kekuda R, 1996, J BIOL CHEM, V271, P18657, DOI 10.1074/jbc.271.31.18657; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KRISHNASASTRY M, 1994, FEBS LETT, V356, P66, DOI 10.1016/0014-5793(94)01240-7; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TOLNER B, 1995, J BACTERIOL, V177, P2863, DOI 10.1128/jb.177.10.2863-2869.1995; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wahle S, 1996, J CELL BIOL, V135, P1867, DOI 10.1083/jcb.135.6.1867; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	48	136	138	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					623	632		10.1016/S0896-6273(00)80572-3	http://dx.doi.org/10.1016/S0896-6273(00)80572-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768848	Bronze			2022-12-24	WOS:000076196400018
J	Shen, K; Teruel, MN; Subramanian, K; Meyer, T				Shen, K; Teruel, MN; Subramanian, K; Meyer, T			CaMKII beta functions as an F-actin targeting module that localizes CaMKII alpha/beta heterooligomers to dendritic spines	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; II MUTANT MICE; POSTSYNAPTIC DENSITY; DEVELOPMENTAL-CHANGES; HIPPOCAMPAL SYNAPSES; GLUTAMATE RECEPTORS; RAT-BRAIN; CALMODULIN; AUTOPHOSPHORYLATION	Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a serine/threonine protein kinase that regulates long-term potentiation and other forms of neuronal plasticity. Functional differences between the neuronal CaMKII alpha and CaMKII beta isoforms are not yet known. Here, we use green fluorescent protein-tagged (GFP-tagged) CaMKII isoforms and show that CaMKII beta is bound to F-actin in dendritic spines and cell cortex while CaMKII alpha is largely a cytosolic enzyme. When expressed together, the two isoforms form large heterooligomers, and a small fraction of CaMKII beta is sufficient to dock the predominant CaMKII alpha to the actin cytoskeleton. Thus, CaMKII beta functions as a targeting module that localizes a much larger number of CaMKII alpha isozymes to synaptic and cytoskeletal sites of action.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Meyer, T (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.			Meyer, Tobias/0000-0003-4339-3804; Teruel, Mary/0000-0002-2854-3598	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM048113, R01GM048113] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-48113, GM-51457] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 1996, MOL CELL BIOL, V16, P29; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BROCKE L, 1995, J NEUROSCI, V15, P6797; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; EGELHOFF TT, 1991, J CELL BIOL, V112, P677, DOI 10.1083/jcb.112.4.677; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; GuptaRoy B, 1996, J NEUROCHEM, V66, P1282; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; KELLY PT, 1985, DEV BRAIN RES, V18, P211, DOI 10.1016/0165-3806(85)90265-2; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nomura T, 1997, BRAIN RES, V766, P129, DOI 10.1016/S0006-8993(97)00535-0; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Shen K, 1998, J NEUROCHEM, V70, P96; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SODERLING TR, 1993, MOL CELL BIOCHEM, V128, P93, DOI 10.1007/BF01076760; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Sugai R, 1996, J BIOCHEM, V120, P773; Teruel MN, 1997, BIOPHYS J, V73, P1785, DOI 10.1016/S0006-3495(97)78209-2; VALLANO ML, 1986, ANN NY ACAD SCI, V466, P357, DOI 10.1111/j.1749-6632.1986.tb38406.x; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; YAMAUCHI T, 1989, J BIOL CHEM, V264, P19108; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	56	269	276	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1998	21	3					593	606		10.1016/S0896-6273(00)80569-3	http://dx.doi.org/10.1016/S0896-6273(00)80569-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768845	Bronze			2022-12-24	WOS:000076196400015
J	Rodriguez-Moreno, A; Lerma, J				Rodriguez-Moreno, A; Lerma, J			Kainate receptor modulation of GABA release involves a metabotropic function	NEURON			English	Article							PROTEIN-KINASE-C; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; CA2+ CHANNELS; BRAIN; EXPRESSION; INHIBITION; CURRENTS	The mechanism through which kainate receptors downregulate the release of GABA in the hippocampus is not known. We have found that the action of kainate on the hippocampal inhibitory postsynaptic current (IPSC) is mediated by a metabotropic process that is sensitive to Pertussis toxin (PTx) and independent of ion channel current. The downregulation of GABA IPSCs by kainate was also prevented in a dose-dependent manner by calphostin C, a specific inhibitor of PKC, and the inhibition of phospholipase C (PL.C) drastically reduced the action of kainate. The effect of kainate was completely occluded by phorbol esters and by increasing extracellular Ca2+ but remained unaltered after inhibition or activation of protein kinase A (PKA). These results demonstrate that the activation of kainate receptors triggers a second messenger cascade, which results in the stimulation of PKC, and therefore document a metabotropic action of kainate receptors, which results in the inhibition of GABA release.	CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Lerma, J (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.		Lerma, Juan/G-7907-2015; Rodriguez-Moreno, Antonio/I-5225-2015	Lerma, Juan/0000-0001-7838-5199; Rodriguez-Moreno, Antonio/0000-0002-8078-6175				Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; BAHN S, 1994, J NEUROSCI, V14, P5525; Bischoff S, 1997, J COMP NEUROL, V379, P541, DOI 10.1002/(SICI)1096-9861(19970324)379:4<541::AID-CNE6>3.0.CO;2-2; BOLAND LM, 1993, J NEUROSCI, V13, P516; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; CATILLO PE, 1997, NATURE, V388, P182; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DOLPHIN AC, 1986, J PHYSIOL-LONDON, V373, P47, DOI 10.1113/jphysiol.1986.sp016034; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Lena C, 1997, J NEUROSCI, V17, P576; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; McGehee DS, 1996, CURR OPIN NEUROBIOL, V6, P342, DOI 10.1016/S0959-4388(96)80118-8; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PATERNAIN AV, 1998, IN PRESS NEUROPHARMA; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Rettig J, 1997, J NEUROSCI, V17, P6647; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Sahara Y, 1997, J NEUROSCI, V17, P6611; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; SCHOEPP DD, 1994, J NEUROCHEM, V63, P769; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; TSUNODA S, 1997, NATURE, V388, P241; VAELLO ML, 1994, J BIOL CHEM, V269, P2002; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; Wilding TJ, 1997, J NEUROSCI, V17, P2713; WILLARD JM, 1992, J BIOL CHEM, V267, P19112; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; ZIEGRA CJ, 1992, P NATL ACAD SCI USA, V89, P4134, DOI 10.1073/pnas.89.9.4134	41	263	267	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1211	1218		10.1016/S0896-6273(00)80501-2	http://dx.doi.org/10.1016/S0896-6273(00)80501-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655508	Bronze			2022-12-24	WOS:000074627300016
J	Smith, C; Moser, T; Xu, T; Neher, E				Smith, C; Moser, T; Xu, T; Neher, E			Cytosolic Ca2+ acts by two separate pathways to modulate the supply of release-competent vesicles in chromaffin cells	NEURON			English	Article							PROTEIN-KINASE-C; POSTTETANIC POTENTIATION; TRANSMITTER RELEASE; CALCIUM; EXOCYTOSIS; SECRETION; DEPRESSION; KINETICS; SYNAPSE; SIZE	Recovery from depletion of the readily releasable pool of vesicles (RRP) in adrenal chromaffin cells was studied at differing basal [Ca2+](i) or following protein kinase C (PKC) activation by phorbol esters. Following depletion, the pool size was estimated at varied times from cell capacitance jumps in response to paired depolarizations. The experimentally observed RRP recovery time course and steady-state size could be predicted from the measured [Ca2+](i) signal assuming a Michaelis-Menten-type regulation of the vesicle supply by Ca2+. An elevated recruitment activity was observed at increased [Ca2+](i) even when protein kinase C was blocked, but maximum effects could be obtained only after stimulation of PKC by phorbol esters or by prolonged elevations in [Ca2+](i). We suggest that, in chromaffin cells, elevated cytosolic Ca2+ modulates exocytotic plasticity via PKC-dependent and -independent pathways.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Univ Gottingen, Sch Med, ENT Unit, D-37074 Gottingen, Germany	Max Planck Society; University of Gottingen	Smith, C (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.		Moser, Tobias/L-5068-2014; Neher, Erwin/A-2109-2013	Moser, Tobias/0000-0001-7145-0533; 				AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; Bennett MK, 1997, CURR OPIN NEUROBIOL, V7, P316, DOI 10.1016/S0959-4388(97)80058-X; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Byrne JH, 1996, J NEUROSCI, V16, P425; Chow Robert H., 1995, P245; Deeney JT, 1996, J BIOL CHEM, V271, P18154, DOI 10.1074/jbc.271.30.18154; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Gerke V, 1997, BBA-MOL CELL RES, V1357, P129, DOI 10.1016/S0167-4889(97)00038-4; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GILLIS KD, 1985, SINGLE CHANNEL RECOR, P155; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; KNIGHT DE, 1983, FEBS LETT, V160, P98, DOI 10.1016/0014-5793(83)80944-2; KRETZ R, 1982, P NATL ACAD SCI-BIOL, V79, P5430, DOI 10.1073/pnas.79.17.5430; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Moser T, 1997, J NEUROSCI, V17, P2314; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NEHER E, 1994, ADV SEC MESS PHOSPH, V29, P353; NEHER E, 1989, NEUROMUSCULAR JUNCTI, P65; NISHIZAKI T, 1992, J BIOL CHEM, V267, P23972; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; Seward EP, 1996, J NEUROSCI, V16, P553; SEWARD EP, 1995, J NEUROSCI, V15, P3390; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; TERBUSH DR, 1988, J BIOL CHEM, V263, P18873; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; ZUCKER RS, 1991, ANN NY ACAD SCI, V635, P191, DOI 10.1111/j.1749-6632.1991.tb36492.x; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	52	191	194	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1998	20	6					1243	1253		10.1016/S0896-6273(00)80504-8	http://dx.doi.org/10.1016/S0896-6273(00)80504-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655511	Bronze, Green Published			2022-12-24	WOS:000074627300019
J	Buracas, GT; Zador, AM; DeWeese, MR; Albright, TD				Buracas, GT; Zador, AM; DeWeese, MR; Albright, TD			Efficient discrimination of temporal patterns by motion-sensitive neurons in primate visual cortex	NEURON			English	Article							AREA MT; INFORMATION; MACAQUE; NOISE; CELLS; ORIENTATION; SELECTIVITY; DIRECTION; RESPONSES; CODE	Although motion-sensitive neurons in macaque middle temporal (MT) area are conventionally characterized using stimuli whose velocity remains constant for 1-3 s, many ecologically relevant stimuli change on a shorter time scale (30-300 ms). We compared neuronal responses to conventional (constant-velocity) and time-varying stimuli in alert primates. The responses to both stimulus ensembles were well described as rate-modulated Poisson processes but with very high precision (similar to 3 ms) modulation functions underlying the time-varying responses. Information-theoretic analysis revealed that the responses encoded only similar to 1 bit/s about constant-velocity stimuli but up to 29 bits/s about the time-varying stimuli. Analysis of local field potentials revealed that part of the residual response variability arose from "noise" sources extrinsic to the neuron. Our results demonstrate that extrastriate neurons in alert primates can encode the fine temporal structure of visual stimuli.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Buracas, GT (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Buracas, Giedrius/A-4904-2011	Zador, Anthony/0000-0002-8431-9136				ADRIAN ED, 1926, BASIS SENSATION ACTI; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bair W, 1997, ADV NEUR IN, V9, P34; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Cover T.M., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; DeWeese M, 1996, ADV NEUR IN, V8, P281; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; FERSTER D, 1995, SCIENCE, V270, P756, DOI 10.1126/science.270.5237.756; FITZHUGH R, 1957, J GEN PHYSIOL, V40, P925, DOI 10.1085/jgp.40.6.925; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Green DM, 1966, SIGNAL DETECTION THE; Gur M, 1997, J NEUROSCI, V17, P2914; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; RIEKE F, 1997, SPIKES BRADFORD BOOK; Shadlen M N, 1995, Curr Opin Neurobiol, V5, P248, DOI 10.1016/0959-4388(95)80033-6; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1996, ADV NEUR IN, V8, P75; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; TEICH MC, 1990, HEARING RES, V46, P41, DOI 10.1016/0378-5955(90)90138-F; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; ZADOR A, 1998, J NEUROPHYSIOL, V19, P1230; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	38	289	290	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1998	20	5					959	969		10.1016/S0896-6273(00)80477-8	http://dx.doi.org/10.1016/S0896-6273(00)80477-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZQ464	9620700	Bronze			2022-12-24	WOS:000073864700015
J	LaBar, KS; Gatenby, JC; Gore, JC; LeDoux, JE; Phelps, EA				LaBar, KS; Gatenby, JC; Gore, JC; LeDoux, JE; Phelps, EA			Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study	NEURON			English	Article							UNILATERAL TEMPORAL LOBECTOMY; POTENTIATED STARTLE; CENTRAL NUCLEUS; FACIAL EXPRESSIONS; RETROGRADE-AMNESIA; EMOTION; HIPPOCAMPUS; STIMULI; NEURONS; LESIONS	Echoplanar functional magnetic resonance imaging (fMRI) was used in normal human subjects to investigate the role of the amygdala in conditioned fear acquisition and extinction. A simple discrimination procedure was employed in which activation to a visual cue predicting shock (CS+) was compared with activation to another cue presented alone (CS-). CS+ and CS-trial types were intermixed in a pseudorandom order. Functional images were acquired with an asymmetric spin echo pulse sequence from three coronal slices centered on the amygdala. Activation of the amygdala/periamygdaloid cortex was observed during conditioned fear acquisition and extinction. The extent of activation during acquisition was significantly correlated with autonomic indices of conditioning in individual subjects. Consistent with a recent electrophysiological recording study in the rat (Quirk et at., 1997), the profile of the amygdala response was temporally graded, although this dynamic was only statistically reliable during extinction. These results provide further evidence for the conservation of amygdala function across species and implicate an amygdalar contribution to both acquisition and extinction processes during associative emotional learning tasks.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Yale University; Yale University; New York University	Phelps, EA (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.		anand, amit/A-7222-2009		NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033332] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50812] Funding Source: Medline; NINDS NIH HHS [NS33332] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; AMARAL D G, 1992, P1; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BJORKSTRAND PA, 1990, BIOL PSYCHOL, V30, P35, DOI 10.1016/0301-0511(90)90089-F; BORDI F, 1992, J NEUROSCI, V12, P2493; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; BRONEN RA, 1991, MAGN RESON IMAGING, V9, P449, DOI 10.1016/0730-725X(91)90434-N; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Damasio A.R., 1994, DESCARTES ERROR EMOT; DAVIS M, 1994, INT REV NEUROBIOL, V36, P225, DOI 10.1016/S0074-7742(08)60305-0; FALLS WA, 1992, J NEUROSCI, V12, P854; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Fredrikson M, 1995, NEUROREPORT, V7, P97, DOI 10.1097/00001756-199512000-00023; FURMARK T, 1997, NEUROREPORT, V8, P3657; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GENTILE CG, 1986, BEHAV BRAIN RES, V20, P263, DOI 10.1016/0166-4328(86)90226-3; HUGDAHL K, 1995, NEUROREPORT, V6, P1723, DOI 10.1097/00001756-199509000-00005; KAPP B S, 1992, P229; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KIM M, 1993, BEHAV NEUROSCI, V107, P580, DOI 10.1037/0735-7044.107.4.580; KIM M, 1993, BEHAV NEUROSCI, V107, P1088; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1996, BEHAV NEUROSCI, V110, P991, DOI 10.1037/0735-7044.110.5.991; LABAR KS, 1997, BEHAV NEUROLOGY NEUR, P675; LeDoux J. E., 1996, EMOTIONAL BRAIN; LeDoux J. E., 1990, LEARNING COMPUTATION, P3; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Levey A. B., 1981, MODEL PERSONALITY, P123, DOI [DOI 10.1007/978-3-642-67783-0_5, 10. 1007/978-3-642-67783-0_5]; LOCKHART RA, 1966, PSYCHOPHYSIOLOGY, V3, P108; MAREN S, 1991, BRAIN RES, V549, P311, DOI 10.1016/0006-8993(91)90473-9; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; MCGAUGH J L, 1992, P431; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1997, P ROY SOC B-BIOL SCI, V264, P769, DOI 10.1098/rspb.1997.0109; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; PARENT MB, 1992, BEHAV NEUROSCI, V106, P789, DOI 10.1037/0735-7044.106.5.789; PASCOE JP, 1985, BEHAV BRAIN RES, V16, P117, DOI 10.1016/0166-4328(85)90087-7; Pavlov I.P., 1927, CONDITIONED REFLEXES; Phelps EA, 1997, CURR BIOL, V7, pR311, DOI 10.1016/S0960-9822(06)00146-1; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Poremba A, 1997, J NEUROSCI, V17, P5237; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; SCHELL AM, 1991, PSYCHOPHYSIOLOGY, V28, P140, DOI 10.1111/j.1469-8986.1991.tb00403.x; SHALEV AY, 1992, BIOL PSYCHIAT, V31, P863, DOI 10.1016/0006-3223(92)90113-E; Talairach J., 1988, COPLANAR STEREOTAXIC; Whalen PJ, 1998, J NEUROSCI, V18, P411; WOLPE J, 1988, BEHAV RES THER, V26, P441, DOI 10.1016/0005-7967(88)90138-6; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279; [No title captured]	57	1026	1033	0	108	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1998	20	5					937	945		10.1016/S0896-6273(00)80475-4	http://dx.doi.org/10.1016/S0896-6273(00)80475-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ZQ464	9620698	hybrid			2022-12-24	WOS:000073864700013
J	Giniger, E				Giniger, E			A role for abl in notch signaling	NEURON			English	Article							ABELSON TYROSINE KINASE; DROSOPHILA-ABL; NUCLEOTIDE-SEQUENCE; AXONAL OUTGROWTH; FACTOR-RECEPTOR; CELL FATES; C-SRC; PROTEIN; GENE; DIFFERENTIATION	Abl is an axonal tyrosine kinase that has yet to be clearly linked to a receptor; Notch is a receptor for which the signaling pathway remains incompletely understood. We show here that Notch and abl mutations interact synergistically to produce synthetic lethality and defects in axon extension. Surprisingly, we cannot account for these axonal aberrations on the basis of changes in cell identity. We show, moreover, that Notch is present in the growth cones of extending axons, and that the Abl accessory protein Disabled binds to a signaling domain of Notch in vitro. We therefore speculate that Disabled and Abl may play a role in Notch signaling in Drosophila axons, perhaps by binding to the Notch intracellular domain.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Giniger, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.		Giniger, Edward/C-1764-2015	Giniger, Edward/0000-0002-8340-6158				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BATE M, 1993, DEVELOPMENT, P149; BENNETT RL, 1992, DEVELOPMENT, V116, P953; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Bruno KS, 1996, P NATL ACAD SCI USA, V93, P4775, DOI 10.1073/pnas.93.10.4775; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; FORTINI ME, 1993, CELL, V75, P1245, DOI 10.1016/0092-8674(93)90611-S; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; GINIGER E, 1993, DEVELOPMENT, V117, P431; GINIGER E, 1993, ROUX ARCH DEV BIOL, V202, P112, DOI 10.1007/BF00636536; GINIGER E, 1994, DEVELOPMENT, V120, P1385; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Goodman Corey S., 1993, P1131; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HIRATA T, 1993, DEVELOPMENT, V119, P49; HOFFMANN FM, 1991, TRENDS GENET, V7, P351, DOI 10.1016/0168-9525(91)90254-F; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; Larkin MK, 1996, DEVELOPMENT, V122, P3639; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Shawber C, 1996, DEVELOPMENT, V122, P3765; SHELLENBARGER DL, 1978, DEV BIOL, V62, P432, DOI 10.1016/0012-1606(78)90226-9; SIMON MA, 1985, CELL, V42, P831, DOI 10.1016/0092-8674(85)90279-X; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Takahashi F, 1996, GENE DEV, V10, P1645, DOI 10.1101/gad.10.13.1645; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; WANG JYJ, 1993, CURR OPIN GENET DEV, V3, P35, DOI 10.1016/S0959-437X(05)80338-7; Wang SW, 1997, DEVELOPMENT, V124, P4435; Wettstein DA, 1997, DEVELOPMENT, V124, P693; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	62	145	148	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1998	20	4					667	681		10.1016/S0896-6273(00)81007-7	http://dx.doi.org/10.1016/S0896-6273(00)81007-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581760	Bronze			2022-12-24	WOS:000073346500007
J	Frade, JM; Barde, YA				Frade, JM; Barde, YA			Microglia-derived nerve growth factor causes cell death in the developing retina	NEURON			English	Article							BRAIN MACROPHAGES; CHICK-EMBRYO; NEURONAL SURVIVAL; MOUSE; RECEPTOR; RELEASE; INVITRO; SYSTEM; NGF; DIFFERENTIATION	While nerve growth factor (NGF) is best known for its trophic functions, recent experiments indicate that it can also cause cell death during development by activating the neurotrophin receptor p75. We now identify microglial cells as the source of NGF as a killing agent in the developing eye. When the retina is separated from the surrounding tissue before colonization by microglial cells, no NGF can be detected, and cell death is dramatically reduced. It is restored by the addition of microglial cells, an effect that is blocked by NGF antibodies. NGF adsorbed at the surface of beads, but not soluble NGF, mimics the killing action of microglial cells. These results indicate an active role for macrophages in neuronal death.	Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Planegg Martinsried, Germany	Max Planck Society	Frade, JM (corresponding author), Max Planck Inst Neurobiol, Dept Neurobiochem, Klopferspitz 18A, D-82152 Planegg Martinsried, Germany.		Barde, Yves/F-6019-2011; Frade, Jose M/E-7913-2013	Frade, Jose M/0000-0001-7067-2505; Barde, Yves/0000-0002-7627-461X				Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; CUADROS MA, 1991, J ANAT, V177, P145; CUADROS MA, 1992, DEVELOPMENT, V115, P157; CUADROS MA, 1988, ANAT EMBRYOL, V178, P543, DOI 10.1007/BF00305042; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; EBENDAL T, 1986, EMBO J, V5, P1483, DOI 10.1002/j.1460-2075.1986.tb04386.x; Elkabes S, 1996, J NEUROSCI, V16, P2508; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Frade JM, 1997, DEVELOPMENT, V124, P3313; Frade JM, 1996, NATURE, V383, P166; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; GIULIAN D, 1993, J NEUROSCI, V13, P29; GOTZ R, 1992, EUR J BIOCHEM, V204, P745, DOI 10.1111/j.1432-1033.1992.tb16689.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Heese K, 1997, NEUROSCI LETT, V231, P83, DOI 10.1016/S0304-3940(97)00545-4; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; KORSCHING S, 1987, METHOD ENZYMOL, V147, P167; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; Majdan M, 1997, J NEUROSCI, V17, P6988; MALLAT M, 1989, DEV BIOL, V133, P309, DOI 10.1016/0012-1606(89)90322-9; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; MARTINPARTIDO G, 1988, ANAT REC, V222, P272, DOI 10.1002/ar.1092220308; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Moore S, 1996, PROG NEUROBIOL, V48, P441, DOI 10.1016/0301-0082(95)00051-8; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAMBA M, 1983, STAIN TECHNOL, V58, P207, DOI 10.3109/10520298309066786; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; SUDA K, 1978, P NATL ACAD SCI USA, V75, P4042, DOI 10.1073/pnas.75.8.4042; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; THANOS S, 1993, J NEUROSCI, V13, P455; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; THOMAS WE, 1992, BRAIN RES REV, V17, P61; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; Yaginuma H, 1996, J NEUROSCI, V16, P3685; Yeo TT, 1997, J NEUROSCI, V17, P7594	47	269	278	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1998	20	1					35	41		10.1016/S0896-6273(00)80432-8	http://dx.doi.org/10.1016/S0896-6273(00)80432-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459440	Bronze			2022-12-24	WOS:000071719700007
J	Roayaie, K; Crump, JG; Sagasti, A; Bargmann, CI				Roayaie, K; Crump, JG; Sagasti, A; Bargmann, CI			The G alpha protein ODR-3 mediates olfactory and nociceptive function and controls cilium morphogenesis in C-elegans olfactory neurons	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; SIGNAL-TRANSDUCTION; RECEPTORS; GENE; MUTATIONS; DROSOPHILA; MUTANT; MICROSCOPY; ALIGNMENT	The G(i)/G(o)-like G alpha protein ODR-3 is strongly and selectively implicated in the function of C. elegans olfactory and nociceptive neurons. Either loss of odr-3 function or overexpression of odr-3 causes severe olfactory defects, and odr-3 function is essential in the ASH neurons that sense noxious chemical and mechanical stimuli. In the nociceptive neurons, ODR-3 may interact with OSM-9, a channel similar to the mammalian capsaicin receptor implicated in pain sensation; in AWC olfactory neurons, ODR-3 may interact with another signal transduction pathway. ODR-3 exhibits an unexpected ability to regulate morphogenesis of the olfactory cilia. In odr-3 null mutants, the fan-like AWC cilia take on a filamentous morphology like normal AWA cilia, whereas ODR-3 overexpression in AWA transforms its filamentous cilia into a fan-like morphology.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, Genet Program, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, Program Dev Biol, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618; Crump, Gage/0000-0002-3209-0026				AGARD DA, 1989, METHOD CELL BIOL, V30, P353; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barber VC, 1974, CILIA FLAGELLA, P403; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berghard A, 1996, J NEUROSCI, V16, P909; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; CULOTTI JG, 1978, GENETICS, V90, P243; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hiraoka Y, 1991, Semin Cell Biol, V2, P153; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KLOTZ KN, 1994, BIOESSAYS, V16, P193, DOI 10.1002/bies.950160310; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Korswagen HC, 1997, GENE DEV, V11, P1493, DOI 10.1101/gad.11.12.1493; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; RENSDOMIANO S, 1995, FASEB J, V9, P1059, DOI 10.1096/fasebj.9.11.7649405; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; STARICH TA, 1995, GENETICS, V139, P171; Sullivan LS, 1996, MOL MED TODAY, V2, P380, DOI 10.1016/S1357-4310(96)10037-X; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TALLURI S, 1995, P NATL ACAD SCI USA, V92, P11475, DOI 10.1073/pnas.92.25.11475; TAMAR H, 1992, PRINCIPLES SENSORY P; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; TUCK S, 1995, GENE DEV, V9, P341, DOI 10.1101/gad.9.3.341; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; WOODARD C, 1992, J NEUROGENET, V8, P17, DOI 10.3109/01677069209167269; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zwaal RR, 1997, GENETICS, V145, P715; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	64	233	244	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1998	20	1					55	67		10.1016/S0896-6273(00)80434-1	http://dx.doi.org/10.1016/S0896-6273(00)80434-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459442	Bronze			2022-12-24	WOS:000071719700009
J	Koppel, AM; Feiner, L; Kobayashi, H; Raper, JA				Koppel, AM; Feiner, L; Kobayashi, H; Raper, JA			A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members	NEURON			English	Article							BINDING-SITE; GROWTH; DIFFERENTIATION; IDENTIFICATION; MOLECULES; COLLAPSIN; CD100; BETA; NGF	The semaphorin family contains secreted and transmembrane signaling proteins that function in the nervous, immune, and cardiovascular systems. Chick collapsin-1 is a repellent for specific growth cones. Two other secreted members of the semaphorin family, collapsin-2 and -3, are structurally similar to collapsin-1 but have different biological activities. Semaphorins contain a 500 amino acid family signature semaphorin domain. We show in this study that (1) the semaphorin domain of collapsin-1 is both necessary and sufficient for biological activity, (2) the semaphorin domain contains a 70 amino acid region that specifies the biological activity of the three family members, and (3) the positively charged carboxy terminus potentiates activity without affecting specificity. We propose that semaphorins interact with their receptors through two independent binding sites: one that mediates the biological response and one that potentiates it.	UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104	University of Pennsylvania								Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; HEROLD C, 1995, INT IMMUNOL, V7, P1, DOI 10.1093/intimm/7.1.1; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; KOBAYASHI H, 1997, IN PRESS J NEUROSCI, V17; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LEV S, 1993, MOL CELL BIOL, V13, P2224, DOI 10.1128/MCB.13.4.2224; LUO Y, 1995, NEURON, V15, P5; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MIYAZAKI J, 1989, GENE, V79, P269; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; QIAN SW, 1992, P NATL ACAD SCI USA, V89, P6290, DOI 10.1073/pnas.89.14.6290; Shepherd IT, 1997, DEVELOPMENT, V124, P1377	19	131	137	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					531	537		10.1016/S0896-6273(00)80369-4	http://dx.doi.org/10.1016/S0896-6273(00)80369-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331346	hybrid			2022-12-24	WOS:A1997XZ01600009
J	Pettit, DL; Wang, SSH; Gee, KR; Augustine, GJ				Pettit, DL; Wang, SSH; Gee, KR; Augustine, GJ			Chemical two-photon uncaging: a novel approach to mapping glutamate receptors	NEURON			English	Article							PHOTOLABILE PRECURSORS; CAGED COMPOUNDS; MICROSCOPY; ACTIVATION; RELEASE	Functional mapping of neurotransmitter receptors requires rapid and localized application of transmitter. The usefulness of caged glutamate for this purpose has been limited, because photolysis by unfocused light above and below the target cell limits depth resolution. This problem is eliminated by using a double-caged glutamate that requires absorption of two photons for conversion to active glutamate, resulting in a substantial improvement in spatial resolution over conventional caged glutamate. This method was used to map the distribution of glutamate receptors on hippocampal pyramidal neurons. A higher density of AMPA receptors was found on distal apical dendrites than on basal or primary apical dendrites, suggesting that synaptic efficacy is locally heterogeneous. Such ''chemical two-photon uncaging'' offers a simple, general, and economical strategy for spatially localized photolysis of caged compounds.	MOL PROBES INC,EUGENE,OR 97402		Pettit, DL (corresponding author), DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710, USA.		Augustine, George James/J-9228-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034045, P01NS017771] Funding Source: NIH RePORTER; NIMH NIH HHS [MH15177] Funding Source: Medline; NINDS NIH HHS [NS34045, NS17771] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Crank J., 1975, MATH DIFFUSION; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk Winfried, 1995, P445; Dingledine R., 1984, BRAIN SLICES; Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; HESS GP, 1995, ANN NY ACAD SCI, V757, P23, DOI 10.1111/j.1749-6632.1995.tb17462.x; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Inoue S, 1986, VIDEO MICROSCOPY; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; ONEILL SC, 1990, AM J PHYSIOL, V258, pC1165, DOI 10.1152/ajpcell.1990.258.6.C1165; PARKER I, 1991, P ROY SOC B-BIOL SCI, V246, P269, DOI 10.1098/rspb.1991.0154; Siegman A. E., 1971, INTRO LASERS MASERS; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; WALKER JW, 1989, BIOCHEMISTRY-US, V28, P3272, DOI 10.1021/bi00434a023; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; WIEBOLDT R, 1994, P NATL ACAD SCI USA, V91, P8752, DOI 10.1073/pnas.91.19.8752	24	143	148	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1997	19	3					465	471		10.1016/S0896-6273(00)80361-X	http://dx.doi.org/10.1016/S0896-6273(00)80361-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ016	9331338	Bronze			2022-12-24	WOS:A1997XZ01600001
J	Ware, ML; Fox, JW; Gonzalez, JL; Davis, NM; deRouvroit, CL; Russo, CJ; Chua, SC; Goffinet, AM; Walsh, CA				Ware, ML; Fox, JW; Gonzalez, JL; Davis, NM; deRouvroit, CL; Russo, CJ; Chua, SC; Goffinet, AM; Walsh, CA			Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse	NEURON			English	Article							PCR IRS-PCR; GENETIC-MAP; MUTANT MICE; NEURITE OUTGROWTH; BRAIN-DEVELOPMENT; TYROSINE KINASES; REELER MICE; SRC; SEQUENCE; NEURONS	Although accurate long-distance neuronal migration is a cardinal feature of cerebral cortical development, little is known about control of this migration. The scrambler(scm) mouse shows abnormal cortical lamination that is indistinguishable from reeler. Genetic and physical mapping of scm identified yeast artificial chromosomes containing an exon of mdab1, a homolog of Drosophila disabled, which encodes a phosphoprotein that binds nonreceptor tyrosine kinases. mdab1 transcripts showed abnormal splicing in scm homozygotes, with 1.5 kb of intracisternal A particle retrotransposon sequence inserted into the mdab1 coding region in antisense orientation, producing a mutated and truncated predicted protein. Therefore, mdab1 is most likely the scm gene, thus implicating nonreceptor tyrosine kinases in neuronal migration and lamination in developing cerebral cortex.	HARVARD UNIV, SCH MED,BETH ISRAEL MED CTR,DIV NEUROGENET, HARVARD INST MED,DEPT NEUROL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, PROGRAM BIOL & BIOMED SCI, BOSTON, MA 02115 USA; FAC UNIV NOTRE DAME PAIX, SCH MED, DEPT PHYSIOL, B-5000 NAMUR, BELGIUM; ROCKEFELLER UNIV, HUMAN BEHAV & METAB LAB, NEW YORK, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Namur; Rockefeller University			Ware, Marcus/E-4981-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001520, R01NS032457] Funding Source: NIH RePORTER; NINDS NIH HHS [KO8-NS01520, NS32457] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albertsen HM, 1996, GENOMICS, V33, P207, DOI 10.1006/geno.1996.0185; AMARIGLIO N, 1993, ENVIRON MOL MUTAGEN, V21, P212, DOI 10.1002/em.2850210303; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BAR I, 1995, GENOMICS, V26, P543, DOI 10.1016/0888-7543(95)80173-J; BECKERS MC, 1994, GENOMICS, V23, P685, DOI 10.1006/geno.1994.1557; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; COX ME, 1992, SEMIN CELL BIOL, V3, P117; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; GOFFINET AM, 1992, INT J DEV BIOL, V36, P101; GOLDOWITZ D, 1997, IN PRESS J NEUROSCI; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Hunter KW, 1996, GENOME RES, V6, P290, DOI 10.1101/gr.6.4.290; HUNTER KW, 1994, MAMM GENOME, V5, P597, DOI 10.1007/BF00411453; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; LUEDERS KK, 1987, P NATL ACAD SCI USA, V77, P3571; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; MIKOSHIBA K, 1985, DEV GROWTH DIFFER, V27, P737; *MOUS GEN INF LAB, 1997, MOUS GEN DAT; OGILVIE DJ, 1996, METHOD MOL BIOL, P131; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Royaux I, 1997, GENOMICS, V42, P479, DOI 10.1006/geno.1997.4772; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Sweet HO, 1996, MAMM GENOME, V7, P798, DOI 10.1007/s003359900240; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; *WHIT I MIT CTR GE, 1996, GEN MAP MOUS DAT REL; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	50	219	226	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1997	19	2					239	249		10.1016/S0896-6273(00)80936-8	http://dx.doi.org/10.1016/S0896-6273(00)80936-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292716	Bronze			2022-12-24	WOS:A1997XU14600005
J	Asztely, F; Erdemli, G; Kullmann, DM				Asztely, F; Erdemli, G; Kullmann, DM			Extrasynaptic glutamate spillover in the hippocampus: Dependence on temperature and the role of active glutamate uptake	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC TRANSMISSION; PAIRED-PULSE FACILITATION; METHYL-D-ASPARTATE; NEUROTRANSMITTER RELEASE; PRESYNAPTIC MECHANISM; NMDA RECEPTORS; CELLS; SYNAPSES; NEURONS	At excitatory synapses on CA1 pyramidal cells of the hippocampus, a larger quantal content is sensed by N-methyl-D-aspartic acid receptors (MMDARs) than by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs). A novel explanation for this discrepancy is that glutamate released from terminals presynaptic to one cell can diffuse to and activate NMDARs, but not AMPARs, on a neighboring cell. If this occurs in the living brain, it could invalidate the view that glutamatergic synapses function as private communication channels between neurons. Here, we show that the discrepancy in quantal content mediated by the two receptors is greatly decreased at physiological temperature, compared with conventional recording conditions. This effect of temperature is not due to changes in release probability or uncovering of latent AMPARs. It is, however, partially reversed by the glutamate uptake inhibitor dihydrokainate. The results suggest that glutamate transporters play a critical role in limiting the extrasynaptic diffusion of glutamate, thereby minimizing cross-talk between neighboring excitatory synapses.			Asztely, F (corresponding author), INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND.		Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; CASADO M, 1993, J BIOL CHEM, V268, P27313; CHUNG SH, 1995, NEUROSCI LETT, V187, P181, DOI 10.1016/0304-3940(95)11369-8; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; FELDMEYER D, 1993, J PHYSIOL-LONDON, V459, pP284; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1989, J NEUROSCI METH, V30, P231, DOI 10.1016/0165-0270(89)90134-9; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MAKI R, 1994, J NEUROSCI, V14, P6754; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; ROBINSON MB, 1993, J NEUROCHEM, V60, P167, DOI 10.1111/j.1471-4159.1993.tb05835.x; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SCHULZ PE, 1995, J PHYSIOLOGY-PARIS, V89, P3, DOI 10.1016/0928-4257(96)80546-8; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Takahashi M, 1996, J PHYSIOL-LONDON, V497, P523, DOI 10.1113/jphysiol.1996.sp021785; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wang JH, 1996, J NEUROPHYSIOL, V76, P276, DOI 10.1152/jn.1996.76.1.276	47	349	353	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					281	293		10.1016/S0896-6273(00)80268-8	http://dx.doi.org/10.1016/S0896-6273(00)80268-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052798	Bronze			2022-12-24	WOS:A1997WK82200011
J	Isaac, JTR; Crair, MC; Nicoll, RA; Malenka, RC				Isaac, JTR; Crair, MC; Nicoll, RA; Malenka, RC			Silent synapses during development of thalamocortical inputs	NEURON			English	Article							LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; SOMATOSENSORY CORTEX; CRITICAL PERIOD; NMDA RECEPTORS; PLASTICITY; TRANSMISSION; DEPRESSION; RESPONSES; BLOCKADE	During development, activity-dependent mechanisms are thought to contribute to the refinement of topographical projections from the thalamus to the cortex. Because activity-dependent increases in synaptic strength may contribute to the stabilization of synaptic connections, we have explored the mechanisms of long-term potentiation (LTP) at thalamocortical synapses in rat somatosensory (barrel) cortex. During early postnatal development (postnatal days 2-5), we find that a significant proportion of thalamocortical synapses are functionally silent and that these are converted to functional synapses during LTP. Silent synapses disappear by postnatal day 8-9, the exact time at which the susceptibility of these synapses to LTP is lost. These findings suggest that the activity-dependent conversion of silent to functional synapses due to correlated pre- and postsynaptic activity may contribute to the early development and refinement of thalamocortical inputs to cortex.	UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MOL & CELLULAR PHARMACOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco								AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1992, J NEUROPHYSIOL, V67, P1; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CATALANO SM, 1996, J COMP NEUROL, V366, P36; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P217, DOI 10.1113/jphysiol.1985.sp015821; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FOX K, 1993, TRENDS NEUROSCI, V16, P116, DOI 10.1016/0166-2236(93)90136-A; GOODMAN CS, 1993, CELL S, V10, P77; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONES EG, 1969, PROC R SOC SER B-BIO, V172, P173, DOI 10.1098/rspb.1969.0018; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIMURA F, 1989, J PHYSIOL-LONDON, V414, P125, DOI 10.1113/jphysiol.1989.sp017680; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124, DOI 10.1152/jn.1988.59.1.124; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; PATENEAU DK, 1990, J NEUROSCI, V10, P2385; PERKINS AT, 1988, BRAIN RES, V439, P222; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; TSUMOTO T, 1992, PROG NEUROBIOL, V39, P209, DOI 10.1016/0301-0082(92)90011-3; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	41	401	411	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					269	280		10.1016/S0896-6273(00)80267-6	http://dx.doi.org/10.1016/S0896-6273(00)80267-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052797	Bronze			2022-12-24	WOS:A1997WK82200010
J	VarelaEchavarria, A; Tucker, A; Puschel, AW; Guthrie, S				VarelaEchavarria, A; Tucker, A; Puschel, AW; Guthrie, S			Motor axon subpopulations respond differentially to the chemorepellents netrin-1 and semaphorin D	NEURON			English	Article							CHICK-EMBRYO HINDBRAIN; GROWTH CONE GUIDANCE; FLOOR PLATE; COMMISSURAL AXONS; NEURON INDUCTION; SONIC HEDGEHOG; SPINAL-CORD; C-ELEGANS; EXPRESSION; FAMILY	During development, growing motor axons are excluded from the ventral midline of the neural tube by diffusible chemorepellents emanating from this region. Molecular candidates for this chemorepellent activity include semaphorin D and netrin-1; the latter is known to repel trochlear motor axons. Qualitatively or quantitatively different responses to these molecules might underlie the initial deflection from the midline and subsequent segregation of motor axon trajectories. To test this idea, we have cocultured cell aggregates secreting netrin-1 or semaphorin D at a distance from tissue explants containing different motor neuron subpopulations, in collagen gels. Cranial motor axons that project dorsally in vivo such as those of the trigeminal, facial, and glossopharyngeal nuclei were repelled by both netrin-1 and semaphorin D. By contrast, ventrally projecting spinal motor axons and abducens axons were not affected by netrin-1. Spinal and abducens motor neurons also responded to semaphorin D. The ventrally projecting axons of oculomotor neurons were not repelled by netrin-1 or semaphorin D. Differential responsiveness to netrin-1 and semaphorin D could thus contribute to the generation of dorsal and ventral motor axon pathways during development.	MAX PLANCK INST HIRNFORSCH,NEUROCHEM ABT,D-60528 FRANKFURT,GERMANY	Max Planck Society	VarelaEchavarria, A (corresponding author), UNITED MED & DENT SCH,GUYS HOSP,DEPT DEV NEUROBIOL,LONDON SE1 9RT,ENGLAND.		Guthrie, Sarah C/C-5727-2009		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Friedman GC, 1996, CURR OPIN NEUROBIOL, V6, P127, DOI 10.1016/S0959-4388(96)80018-3; GILLAND E, 1993, ACTA ANAT, V148, P110; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; GUTHRIE S, 1992, DEVELOPMENT, V114, P663; GUTHRIE S, 1994, NEUROPROTOCOLS, V4, P116; HEDGECOCK EM, 1990, NEURON, V2, P61; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hinck L., 1996, Society for Neuroscience Abstracts, V22, P1470; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LITWACK ED, 1996, SOC NEUROSCI, V2, P1022; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUO Y, 1993, CELL, V75, P1389; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; PRINCE JT, 1992, DEV BRAIN RES, V68, P193, DOI 10.1016/0165-3806(92)90061-Z; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Sambrook J., 2002, MOL CLONING LAB MANU; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; SIMON H, 1994, J NEUROBIOL, V25, P1129, DOI 10.1002/neu.480250908; TAMADA A, 1995, NEURON, V14, P1165; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tucker A, 1996, EUR J NEUROSCI, V8, P906, DOI 10.1111/j.1460-9568.1996.tb01577.x; VARELAECHAVARRI.A, 1996, IN PRESS MOL CELL NE	50	211	212	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					193	207		10.1016/S0896-6273(00)80261-5	http://dx.doi.org/10.1016/S0896-6273(00)80261-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052791	Bronze			2022-12-24	WOS:A1997WK82200004
J	Warner, LE; Hilz, MJ; Appel, SH; Killian, JM; Kolodny, EH; Karpati, G; Carpenter, S; Watters, GV; Wheeler, C; Witt, D; Bodell, A; Nelis, E; Van Broeckhoven, C; Lupski, JR				Warner, LE; Hilz, MJ; Appel, SH; Killian, JM; Kolodny, EH; Karpati, G; Carpenter, S; Watters, GV; Wheeler, C; Witt, D; Bodell, A; Nelis, E; Van Broeckhoven, C; Lupski, JR			Clinical phenotypes of different MPZ (P-0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination	NEURON			English	Article							MYELIN PO GENE; PERIPHERAL-NERVE MYELIN; DISEASE TYPE 1B; POINT MUTATION; BASIC-PROTEIN; PMP22 GENE; NEUROPATHY TYPE-1B; ADHESION MOLECULE; GLYCOPROTEIN; DUPLICATION	Hereditary demyelinating peripheral neuropathies consist of a heterogeneous group of genetic disorders that includes hereditary neuropathy with liability to pressure palsies (HNPP), Charcot-Marie-Tooth disease (CMT), Dejerine-Sottas syndrome (DSS), and congenital hypomyelination (CH). The clinical classification of these neuropathies into discrete categories can sometimes be difficult because there can be both clinical and pathologic variation and overlap between these disorders. We have identified five novel mutations in the myelin protein zero (MPZ) gene, encoding the major structural protein (P-0) of peripheral nerve myelin, in patients with either CMT1B, DSS, or CH. This finding suggests that these disorders may not be distinct pathophysiologic entities, but rather represent a spectrum of related ''myelinopathies'' due to an underlying defect in myelination. Furthermore, we hypothesize the differences in clinical severity seen with mutations in MPZ are related to the type of mutation and its subsequent effect on protein function (i.e., loss of function versus dominant negative).	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, CTR HUMAN GENOME, HOUSTON, TX 77030 USA; UNIV ERLANGEN NURNBERG, DEPT NEUROL, D-91054 ERLANGEN, GERMANY; NYU, SCH MED, DEPT NEUROL, NEW YORK, NY 10016 USA; MONTREAL NEUROL HOSP & INST, MONTREAL, PQ H3A 2B4, CANADA; TORONTO HOSP, WESTERN DIV, DEPT NEUROPATHOL, TORONTO, ON M5T 2S8, CANADA; MONTREAL CHILDRENS HOSP, DEPT NEUROL, MONTREAL, PQ H3H 1P3, CANADA; KAISER PERMANENTE CARE PROGRAM NO CALIF, DEPT NEUROL FREMONT, SAN JOSE, CA 95119 USA; KAISER PERMANENTE CARE PROGRAM NO CALIF, DEPT GENET SAN JOSE, SAN JOSE, CA 95119 USA; UNIV ANTWERP VIB, BORN BUNGE FDN, DEPT BIOCHEM,LAB NEUROGENET, B-2610 ANTWERP, BELGIUM	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Erlangen Nuremberg; New York University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McGill University; Kaiser Permanente; Kaiser Permanente; Flanders Institute for Biotechnology (VIB); University of Antwerp	Warner, LE (corresponding author), BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA.		Van Broeckhoven, Christine/M-7853-2019	Van Broeckhoven, Christine/0000-0003-0183-7665	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32-GM08307] Funding Source: Medline; NINDS NIH HHS [R01-NS27042] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALESTRINI MR, 1991, NEUROPEDIATRICS, V22, P65, DOI 10.1055/s-2008-1071419; Bellone E, 1996, HUM MUTAT, V7, P377, DOI 10.1002/humu.1380070403; BIRD TD, 1982, AM J HUM GENET, V34, P388; BLANQUETGROSSAR.F, 1996, IN PRESS HUM MUT; BlanquetGrossard F, 1995, CLIN GENET, V48, P281; BOYLAN KB, 1992, ANN NEUROL, V31, P337, DOI 10.1002/ana.410310318; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; CHARNAS L, 1988, NEUROLOGY, V38, P966, DOI 10.1212/WNL.38.6.966; CHEIFETZ S, 1985, BIOCHEMISTRY-US, V24, P5170, DOI 10.1021/bi00340a032; CHEIFETZ S, 1985, BIOCHEMISTRY-US, V24, P1909, DOI 10.1021/bi00329a016; DING YG, 1994, J BIOL CHEM, V269, P10764; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; Dyck P.J, 1993, PNP, P1094; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GABREELSFESTEN AAW, 1996, IN PRESS NEUROLOGY; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HARATI Y, 1985, J NEUROL NEUROSUR PS, V48, P1269, DOI 10.1136/jnnp.48.12.1269; HAYASAKA K, 1993, GENOMICS, V17, P755, DOI 10.1006/geno.1993.1400; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; HAYASAKA K, 1993, HUM MOL GENET, V2, P1369, DOI 10.1093/hmg/2.9.1369; HIMORO M, 1993, BIOCHEM MOL BIOL INT, V31, P169; Ikegami T, 1996, BIOCHEM BIOPH RES CO, V222, P107, DOI 10.1006/bbrc.1996.0705; IONASESCU VV, 1995, NEUROLOGY, V45, P1766, DOI 10.1212/WNL.45.9.1766; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KENNEDY WR, 1977, ARCH NEUROL-CHICAGO, V34, P337, DOI 10.1001/archneur.1977.00500180031007; KILLIAN JM, 1979, ANN NEUROL, V5, P515, DOI 10.1002/ana.410050604; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LATOUR P, 1995, HUM MUTAT, V6, P50, DOI 10.1002/humu.1380060110; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LYON G, 1969, ACTA NEUROPATHOL, V13, P131, DOI 10.1007/BF00687025; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1995, J NEUROSCI, V15, P4488; NELIS E, 1994, J MED GENET, V31, P811, DOI 10.1136/jmg.31.10.811; NELIS E, 1994, HUM GENET, V94, P653, DOI 10.1007/BF00206959; NELIS E, 1996, IN PRESS EUR J HUM G; ONO J, 1982, EUR J PEDIATR, V138, P265, DOI 10.1007/BF00441215; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; RAUTENSTRAUSS B, 1994, HUM MOL GENET, V3, P1701, DOI 10.1093/hmg/3.9.1701; Roa BB, 1996, HUM MUTAT, V7, P36, DOI 10.1002/(SICI)1098-1004(1996)7:1<36::AID-HUMU5>3.0.CO;2-N; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; SUZUKI M, 1990, J NEUROCHEM, V55, P1966, DOI 10.1111/j.1471-4159.1990.tb05783.x; Tachi N, 1996, NEUROSCI LETT, V204, P173, DOI 10.1016/0304-3940(96)12347-8; THEIN SL, 1990, P NATL ACAD SCI USA, V87, P3924, DOI 10.1073/pnas.87.10.3924; VALENTIJN LJ, 1995, HUM MUTAT, V5, P76, DOI 10.1002/humu.1380050110; WISE CA, 1993, AM J HUM GENET, V53, P853	53	309	312	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					451	460		10.1016/S0896-6273(00)80177-4	http://dx.doi.org/10.1016/S0896-6273(00)80177-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816708	hybrid			2022-12-24	WOS:A1996VJ44000011
J	Canoll, PD; Musacchio, JM; Hardy, R; Reynolds, R; Marchionni, MA; Salzer, JL				Canoll, PD; Musacchio, JM; Hardy, R; Reynolds, R; Marchionni, MA; Salzer, JL			GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; RAT OPTIC-NERVE; PROTEIN GENE-EXPRESSION; SCHWANN-CELLS; IN-VITRO; MATURE OLIGODENDROCYTES; MESSENGER-RNA; BRAIN; ASTROCYTES	We show that GGF/neuregulin is a mitogen for pro-oligodendrocytes (O4+/O1- cells), oligodendrocytes (O4+/O1+ cells), and type-2 astrocytes. Heregulin beta 1, another neuregulin isoform, is also mitogenic. The proliferative effect of glial growth factor (GGF) does not require, but is greatly potentiated by, serum factors. GGF also promotes the survival of pro-oligodendrocytes under serum-free conditions. High levels of GGF reversibly inhibit the differentiation and lineage commitment of oligodendrocyte progenitors and, in differentiated cultures, result in loss of O1 and myelin basic protein expression. All three erbB receptors are expressed by progenitors and are activated by GGF; the relative abundance of these receptors changes during differentiation. Finally, cortical neurons release a soluble mitogen for pro-oligodendrocytes that is specifically blocked by antibodies to GGF. These results implicate the neuregulins in the neuronal regulation of oligodendrocyte progenitor proliferation, survival, and differentiation.	NYU,SCH MED,DEPT CELL BIOL,NEW YORK,NY 10016; NYU,SCH MED,DEPT NEUROL,NEW YORK,NY 10016; NYU,SCH MED,KAPLAN CANC CTR,NEW YORK,NY 10016; CHARING CROSS & WESTMINSTER COLL,DEPT ANAT,LONDON W6 8RF,ENGLAND; CAMBRIDGE NEUROSCI INC,CAMBRIDGE,MA 02139	New York University; New York University; New York University; Imperial College London	Canoll, PD (corresponding author), NYU,SCH MED,DEPT PHARMACOL,NEW YORK,NY 10016, USA.			Salzer, James/0000-0001-9126-7197	NIGMS NIH HHS [2T32 GM07308] Funding Source: Medline; NINDS NIH HHS [NS26001] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026001] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BOTTENSTEIN J S, 1990, P56; BROCKES JP, 1980, J BIOL CHEM, V255, P8374; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; CHEN SJ, 1989, J NEUROCHEM, V52, P325, DOI 10.1111/j.1471-4159.1989.tb10936.x; Cheng LL, 1996, NEURON, V16, P309, DOI 10.1016/S0896-6273(00)80049-5; COLLARINI EJ, 1992, DEVELOPMENT, V116, P193; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DAVID S, 1984, J NEUROCYTOL, V13, P961, DOI 10.1007/BF01148596; DELOSMONTEROS AE, 1993, P NATL ACAD SCI USA, V90, P50, DOI 10.1073/pnas.90.1.50; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; DUTLY F, 1991, GLIA, V4, P559, DOI 10.1002/glia.440040603; ECCLESTON PA, 1984, BRAIN RES, V210, P315; EDGAR AD, 1985, DEV NEUROSCI-BASEL, V7, P206, DOI 10.1159/000112289; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; FRESSINAUD C, 1995, J NEUROSCI RES, V40, P285, DOI 10.1002/jnr.490400302; FULORAND J, 1977, J COMP NEUROL, V176, P189; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; GOLDMAN JE, 1992, TRENDS NEUROSCI, V15, P359, DOI 10.1016/0166-2236(92)90179-C; GUENARD V, 1995, J NEUROSCI, V15, P419; HARDY R, 1993, J NEUROSCI RES, V36, P121, DOI 10.1002/jnr.490360202; HARDY R, 1993, J NEUROSCI RES, V34, P589, DOI 10.1002/jnr.490340510; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HUNTER SF, 1991, J NEUROSCI RES, V28, P574, DOI 10.1002/jnr.490280415; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; JIN JJ, 1993, CELL GROWTH DIFFER, V4, P227; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; KIDD GJ, 1990, J NEUROSCI RES, V26, P409, DOI 10.1002/jnr.490260403; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; LEVI ADO, 1995, J NEUROSCI, V15, P1329; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LOGAN A, 1986, NEUROSCI LETT, V69, P162, DOI 10.1016/0304-3940(86)90596-3; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MAYER M, 1993, GLIA, V8, P12, DOI 10.1002/glia.440080103; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MCPHILEMY K, 1990, J NEUROCYTOL, V19, P494, DOI 10.1007/BF01257239; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MORGAN L, 1994, DEVELOPMENT, V120, P1399; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Muir DA, 1996, J NEUROSCI RES, V44, P1; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NORDLUND M, 1992, GLIA, V5, P182, DOI 10.1002/glia.440050304; ORRURTREGER A, 1993, P NATL ACAD SCI USA, V90, P1867, DOI 10.1073/pnas.90.5.1867; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; RIVA MA, 1991, DEV BRAIN RES, V62, P45, DOI 10.1016/0165-3806(91)90188-O; ROSENBAUM C, 1996, T AM SOC NEUROCHEM; SANETO RP, 1985, P NATL ACAD SCI USA, V82, P3509, DOI 10.1073/pnas.82.10.3509; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shaw CE, 1996, J NEUROSCI, V16, P1163; SOMMER J, 1980, DEV BIOL, V83, P311; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; WOOD PM, 1986, NATURE, V320, P756, DOI 10.1038/320756a0; WOOD PM, 1991, GLIA, V4, P225, DOI 10.1002/glia.440040214; YASUDA T, 1995, J NEUROSCI RES, V40, P306, DOI 10.1002/jnr.490400304; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; ZAJICEK J, 1994, BRAIN, V117, P1333, DOI 10.1093/brain/117.6.1333	78	316	332	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					229	243		10.1016/S0896-6273(00)80155-5	http://dx.doi.org/10.1016/S0896-6273(00)80155-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780647	hybrid			2022-12-24	WOS:A1996VE84000006
J	Nusser, Z; Lujan, R; Laube, G; Roberts, JDB; Molnar, E; Somogyi, P				Nusser, Z; Lujan, R; Laube, G; Roberts, JDB; Molnar, E; Somogyi, P			Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus	NEURON			English	Article							LONG-TERM POTENTIATION; GLUTAMATE-RECEPTOR; RAT-BRAIN; SILENT SYNAPSES; PYRAMIDAL CELLS; MESSENGER-RNAS; SUBUNIT GLUR1; IMMUNOGOLD LOCALIZATION; RELEASE PROBABILITY; EXCITATORY SYNAPSES	It has been suggested that some glutamatergic synapses lack functional AMPA receptors. We used quantitative immunogold localization to determine the number and variability of synaptic AMPA receptors in the rat hippocampus. Three classes of synapses show distinct patterns of AMPA receptor content. Mossy fiber synapses on CA3 pyramidal spines and synapses on GABAergic interneurons are all immunopositive, have less variability, and contain 4 times as many AMPA receptors as synapses made by Schaffer collaterals on CA1 pyramidal spines and by commissural/associational (C/A) terminals on CA3 pyramidal spines. Up to 17% of synapses in the tatter two connections are immunonegative. After calibrating the immunosignal (1 gold = 2.3 functional receptors) at mossy synapses of a 17-day-old rat, we estimate that the AMPA receptor content of CIA synapses on CA3 pyramidal spines ranges from <3 to 140. A similar range is found in adult Schaffer collateral and C/A synapses.	Univ Oxford, MRC, Anat Neuropharmacol Unit, Dept Pharmacol, Oxford OX1 3TH, England	University of Oxford	Nusser, Z (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.		Lujan, Rafael/G-2555-2015; Nusser, Zoltan/K-8587-2014; Molnár, Elek/D-1427-2019	Molnár, Elek/0000-0002-3525-4671; Lujan Miras, Rafael/0000-0003-2001-9545; Nusser, Zoltan/0000-0001-7004-4111				ANDERSEN P, 1966, EXP BRAIN RES, V1, P236; BAUDE A, 1994, J NEUROSCI, V14, P2830; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Fritschy JM, 1998, J COMP NEUROL, V390, P194; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JACK JJB, 1994, ADV SEC MESS PHOSPH, V29, P275; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kharazia VN, 1996, J COMP NEUROL, V368, P399, DOI 10.1002/(SICI)1096-9861(19960506)368:3<399::AID-CNE6>3.0.CO;2-0; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Maccaferri G, 1996, J NEUROSCI, V16, P5334; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; Matsubara A, 1996, J NEUROSCI, V16, P4457; McIlhinney RAJ, 1996, BIOCHEM J, V315, P217; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Popratiloff A, 1996, J NEUROSCI, V16, P3363; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Racca C, 1997, J NEUROSCI, V17, P1691; Rao A, 1998, J NEUROSCI, V18, P1217; Richmond SA, 1996, NEUROSCIENCE, V75, P69, DOI 10.1016/0306-4522(96)00217-5; ROGERS SW, 1991, J NEUROSCI, V11, P2713; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; SATO K, 1993, NEUROSCIENCE, V52, P515, DOI 10.1016/0306-4522(93)90403-3; Schikorski T, 1997, J NEUROSCI, V17, P5858; Sheng M, 1997, NATURE, V386, P221, DOI 10.1038/386221a0; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Sorra KE, 1998, J NEUROSCI, V18, P658; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Steward Oswald, 1995, Current Opinion in Neurobiology, V5, P55, DOI 10.1016/0959-4388(95)80087-5; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	68	612	623	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP	1998	21	3					545	559		10.1016/S0896-6273(00)80565-6	http://dx.doi.org/10.1016/S0896-6273(00)80565-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124RV	9768841	Bronze			2022-12-24	WOS:000076196400011
J	Mizuseki, K; Kishi, M; Shiota, K; Nakanishi, S; Sasai, Y				Mizuseki, K; Kishi, M; Shiota, K; Nakanishi, S; Sasai, Y			SoxD: an essential mediator of induction of anterior neural tissues in Xenopus embryos	NEURON			English	Article							GENES; SIGNALS; CHORDIN; NOGGIN; CREST; BMP-4; ACTIVATION; INHIBITION; EXPRESSION; MESODERM	Vertebrate neurogenesis is initiated by the organizer factors that inhibit antineuralizing activities of bone morphogenetic proteins (BMPs) in the ectoderm. Here, we report a candidate mediator of neuralization, SoxD. Expression of SoxD starts at late blastula stages widely in the prospective ectoderm and becomes restricted to the dorsal ectoderm by mid-gastrula stages. SoxD expression is enhanced by the neural inducer Chordin and is suppressed by BMP4 and its downstream genes. Microinjection of SoxD mRNA causes ectopic formation of neural tissues in vivo and induces neural and neuronal markers in the isolated animal cap. Injection of a dominant-negative form of SoxD mRNA can block neuralization of ectoderm caused by attenuation of BMP signals and can strongly suppress formation of anterior neural tissues in vivo. These data show that SoxD functions as an essential mediator of downstream signaling of neural induction.	Kyoto Univ, Fac Med,Inst Frontier Med Sci, Dept Med Embryol & Neurobiol, Sakyo Ku, Kyoto 6068397, Japan; Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 6068397, Japan; Kyoto Univ, Fac Med, Dept Anat & Dev Biol, Sakyo Ku, Kyoto 6068397, Japan	Kyoto University; Kyoto University; Kyoto University	Sasai, Y (corresponding author), Kyoto Univ, Fac Med,Inst Frontier Med Sci, Dept Med Embryol & Neurobiol, Sakyo Ku, Kyoto 6068397, Japan.		Mizuseki, Kenji/A-9214-2011; Kishi, Masashi/GLU-0437-2022	Mizuseki, Kenji/0000-0002-1456-2149; 				BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Collignon J, 1996, DEVELOPMENT, V122, P509; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Gomez-Skarmeta JL, 1998, EMBO J, V17, P181, DOI 10.1093/emboj/17.1.181; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; HAMBURGER V, 1988, HERITAGE EXPT EMBRYO, P137; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; KAMACHI Y, 1995, EMBO J, V14, P3510, DOI 10.1002/j.1460-2075.1995.tb07357.x; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mancilla A, 1996, DEV BIOL, V177, P580, DOI 10.1006/dbio.1996.0187; MAYOR R, 1995, DEVELOPMENT, V121, P767; Mizuseki K, 1998, DEVELOPMENT, V125, P579; NIETO MA, 1991, DEVELOPMENT, P59; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; SCHEUCHER M, 1995, ROUX ARCH DEV BIOL, V204, P203, DOI 10.1007/BF00241274; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Spemann H, 1918, W ROUX ARCH ENTWMECH, V43, P448, DOI [10.1007/BF02267308, DOI 10.1007/BF02267308]; Suzuki A, 1997, DEVELOPMENT, V124, P3037; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Waddington CH, 1933, J EXP BIOL, V10, P38; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Xu RH, 1997, MOL CELL BIOL, V17, P436, DOI 10.1128/MCB.17.1.436; ZHANG CH, 1994, J BIOL CHEM, V269, P478; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	42	108	109	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					77	85		10.1016/S0896-6273(00)80516-4	http://dx.doi.org/10.1016/S0896-6273(00)80516-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697853	Bronze			2022-12-24	WOS:000075061900008
J	Osten, P; Srivastava, S; Inman, GJ; Vilim, FS; Khatri, L; Lee, LM; States, BA; Einheber, S; Milner, TA; Hanson, PI; Ziff, EB				Osten, P; Srivastava, S; Inman, GJ; Vilim, FS; Khatri, L; Lee, LM; States, BA; Einheber, S; Milner, TA; Hanson, PI; Ziff, EB			The AMPA receptor GluR2 C terminus can mediate a reversible, ATP-dependent interaction with NSF and alpha- and beta-SNAPs	NEURON			English	Article							RAT-BRAIN; HIPPOCAMPAL-NEURONS; IN-VITRO; PROTEIN; SUBUNIT; FUSION; CHANNELS; LOCALIZATION; MECHANISM; SUGGESTS	In this study, we demonstrate specific interaction of the GluR2 alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor subunit c-terminal peptide with an ATPase N-ethylmaleimide-sensitive fusion protein (NSF) and alpha- and beta-soluble NSF attachment proteins (SNAPs), as well as dendritic colocalization of these proteins. The assembly of the GluR2-NSF-SNAP complex is ATP hydrolysis reversible and resembles the binding of NSF and SNAP with the SNAP receptor (SNARE) membrane fusion apparatus. We provide evidence that the molar ratio of NSF to SNAP in the GluR2-NSF-SNAP complex is similar to that of the t-SNARE syntaxin-NSF-SNAP complex. NSF is known to disassemble the SNARE protein complex in a chaperone-like interaction driven by ATP hydrolysis. We propose a model in which NSF functions as a chaperone in the molecular processing of the AMPA receptor.	NYU Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; NYU Med Ctr, Dept Biochem, New York, NY 10016 USA; NYU Med Ctr, Dept Cell Biol, New York, NY 10016 USA; Cornell Univ, Med Ctr, Coll Med, Dept Neurol & Neurosci,Div Neurosci, New York, NY 10021 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; Cornell University; Washington University (WUSTL)	Ziff, EB (corresponding author), NYU Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA.		Hanson, Phyllis/E-9420-2012	Inman, Gareth/0000-0002-6264-4253; Ziff, Edward/0000-0001-7389-8649	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013620, R37AG013620] Funding Source: NIH RePORTER; NIA NIH HHS [AG13620] Funding Source: Medline; NIMH NIH HHS [MH42834] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHAN J, 1990, J NEUROSCI METH, V33, P113, DOI 10.1016/0165-0270(90)90015-8; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Einheber S, 1996, J COMP NEUROL, V370, P105; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Richmond SA, 1996, NEUROSCIENCE, V75, P69, DOI 10.1016/0306-4522(96)00217-5; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Seeburg PH, 1996, J NEUROCHEM, V66, P1; SESACK SR, 1995, NEUROSCIENCE, V67, P993, DOI 10.1016/0306-4522(95)00087-Y; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; SIMPSON IA, 1982, ANAL BIOCHEM, V119, P424, DOI 10.1016/0003-2697(82)90608-X; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Vissavajjhala P, 1996, EXP NEUROL, V142, P296, DOI 10.1006/exnr.1996.0199; WALSH MJ, 1992, J NEUROCHEM, V59, P667, DOI 10.1111/j.1471-4159.1992.tb09421.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	43	304	314	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1998	21	1					99	110		10.1016/S0896-6273(00)80518-8	http://dx.doi.org/10.1016/S0896-6273(00)80518-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697855	hybrid			2022-12-24	WOS:000075061900010
J	Wang, C; Zucker, RS				Wang, C; Zucker, RS			Regulation of synaptic vesicle recycling by calcium and serotonin	NEURON			English	Article							CRAYFISH NEUROMUSCULAR-JUNCTION; MOTOR-NERVE TERMINALS; SPONTANEOUS TRANSMITTER RELEASE; APLYSIA SENSORIMOTOR SYNAPSES; SENSORY NEURONS; PRESYNAPTIC INHIBITION; SHORT-TERM; CHROMAFFIN CELLS; HIPPOCAMPAL SYNAPSES; INDUCED FACILITATION	Serotonin, a neuromodulator at the crayfish neuromuscular junction, regulates neurotransmission without changing intracellular calcium levels. However, the mechanism of this regulation remains unclear. By analysis of synaptic depression using a depletion model and measurement of vesicle recycling using the styryl dye FM1-43, we show that serotonin increases the number of vesicles available for transmitter release (total synaptic vesicle pool size). This regulation is due either to an increase in the number of vesicles at each release site or to an activation of previously nonsecreting or silent synapses. We also observed that low calcium medium rendered part of the vesicle pool unavailable for release. These results suggest a new mechanism for regulating synaptic transmission.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zucker, RS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343	NINDS NIH HHS [NS 15114] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWOOD HL, 1986, INT REV NEUROBIOL, V28, P275, DOI 10.1016/S0074-7742(08)60111-7; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BAXTER DA, 1989, J NEUROPHYSIOL, V62, P665, DOI 10.1152/jn.1989.62.3.665; BELARDETTI F, 1987, NATURE, V325, P153, DOI 10.1038/325153a0; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BETZ WJ, 1992, NEURON, V9, P805, DOI 10.1016/0896-6273(92)90235-6; BITTNER GD, 1970, J CELL BIOL, V47, P585, DOI 10.1083/jcb.47.3.585; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Capogna M, 1996, J NEUROPHYSIOL, V75, P2017, DOI 10.1152/jn.1996.75.5.2017; CHRISTENSEN BN, 1970, J PHYSIOL-LONDON, V210, P933, DOI 10.1113/jphysiol.1970.sp009250; COOPER RL, 1995, J NEUROSCI, V15, P4209; CRITZ SD, 1991, J NEUROPHYSIOL, V66, P1912, DOI 10.1152/jn.1991.66.6.1912; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DELANEY K, 1991, J NEUROSCI, V11, P2631; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Dittman JS, 1996, J NEUROSCI, V16, P1623; DIXON D, 1989, J NEUROPHYSIOL, V62, P239, DOI 10.1152/jn.1989.62.1.239; DIXON D, 1989, J NEUROSCI, V9, P4246; DIXON D, 1989, J NEUROPHYSIOL, V62, P1251, DOI 10.1152/jn.1989.62.6.1251; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; EDMONDS B, 1990, SCIENCE, V250, P1142, DOI 10.1126/science.2174573; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; FOSSIER P, 1994, P NATL ACAD SCI USA, V91, P4771, DOI 10.1073/pnas.91.11.4771; Fu WM, 1995, J PHYSIOL-LONDON, V489, P813, DOI 10.1113/jphysiol.1995.sp021094; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GLUSMAN S, 1982, J PHYSIOL-LONDON, V325, P223, DOI 10.1113/jphysiol.1982.sp014147; GOLDSMITH BA, 1992, P NATL ACAD SCI USA, V89, P11481, DOI 10.1073/pnas.89.23.11481; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; HEIDELBERGER R, 1991, P NATL ACAD SCI USA, V88, P7135, DOI 10.1073/pnas.88.16.7135; Henkel AW, 1995, J NEUROSCI, V15, P8246; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8794, DOI 10.1073/pnas.83.22.8794; HOLZ GG, 1989, J NEUROSCI, V9, P657; Hori Y, 1996, J PHYSIOL-LONDON, V492, P867, DOI 10.1113/jphysiol.1996.sp021352; Huang CC, 1996, J NEUROSCI, V16, P1026; HUSTON E, 1995, NEUROSCIENCE, V68, P465, DOI 10.1016/0306-4522(95)00172-F; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATO M, 1992, BRAIN RES, V574, P138, DOI 10.1016/0006-8993(92)90810-V; KLEIN M, 1982, P NATL ACAD SCI-BIOL, V79, P5713, DOI 10.1073/pnas.79.18.5713; KLEIN M, 1993, J NEUROSCI, V13, P3793; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MUDGE AW, 1979, P NATL ACAD SCI USA, V76, P526, DOI 10.1073/pnas.76.1.526; MULKEY RM, 1991, NATURE, V350, P153, DOI 10.1038/350153a0; MULKEY RM, 1993, J PHYSIOL-LONDON, V462, P243, DOI 10.1113/jphysiol.1993.sp019553; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Qian SM, 1997, BRAIN RES, V771, P259, DOI 10.1016/S0006-8993(97)00812-3; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V435, P373, DOI 10.1113/jphysiol.1991.sp018515; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SHAPIRO E, 1980, P NATL ACAD SCI-BIOL, V77, P1185, DOI 10.1073/pnas.77.2.1185; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; Singer JH, 1996, J NEUROPHYSIOL, V76, P799, DOI 10.1152/jn.1996.76.2.799; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; TAKEUCHI A, 1966, J PHYSIOL-LONDON, V183, P433, DOI 10.1113/jphysiol.1966.sp007875; TARASKEVICH PS, 1971, BIOCHIM BIOPHYS ACTA, V241, P700, DOI 10.1016/0005-2736(71)90071-X; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; THOMPSON CS, 1984, J NEUROCYTOL, V13, P267, DOI 10.1007/BF01148119; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; UMEMIYA M, 1994, NEURON, V13, P1439, DOI 10.1016/0896-6273(94)90429-4; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; YAWO H, 1993, NATURE, V365, P256, DOI 10.1038/365256a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; ZUCKER RS, 1983, J GEN PHYSIOL, V81, P355, DOI 10.1085/jgp.81.3.355; ZUCKER RS, 1974, J PHYSIOL-LONDON, V241, P91, DOI 10.1113/jphysiol.1974.sp010642; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	81	79	81	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1998	21	1					155	167		10.1016/S0896-6273(00)80523-1	http://dx.doi.org/10.1016/S0896-6273(00)80523-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	105FK	9697860	Bronze			2022-12-24	WOS:000075061900015
J	Chung, S; Ferster, D				Chung, S; Ferster, D			Strength and orientation tuning of the thalamic input to simple cells revealed by electrically evoked cortical suppression	NEURON			English	Article							CAT VISUAL-CORTEX; RECEPTIVE-FIELD PROPERTIES; CROSS-CORRELATION ANALYSIS; STRIATE CORTEX; GENICULOCORTICAL AFFERENTS; POSTSYNAPTIC POTENTIALS; INTRACELLULAR ANALYSIS; SYNAPTIC POTENTIALS; SINGLE CELLS; AREA 17	Is thalamic input to the visual cortex strong and well tuned for orientation, as predicted by Hubel and Wiesel's (1962) model of orientation selectivity in simple cells? We directly measured the size of the thalamic input to single simple cells intracellularly by combining electrical stimulation of the cortex with a briefly flashed visual stimulus. In nearby cells, the electrical stimulation evoked a long-lasting inhibition that prevented them from firing in response to the visual stimulus. The visually evoked excitatory postsynaptic potentials (EPSPs) recorded during the period of cortical suppression, therefore, reflected largely the thalamic input. In 16 neurons that received monosynaptic input from the thalamus, cortical suppression left 46% of normal visual response on average (12%-86% in range). In those cells tested, this remaining visual response was as well tuned for orientation as the normal response to the visual stimulus alone. We conclude that the thalamic input to cortical simple cells with monosynaptic input from the thalamus is strong and well tuned in orientation, and that the intracortical input does not appear to sharpen orientation tuning in these cells.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Chung, S (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.				NATIONAL EYE INSTITUTE [R01EY004726] Funding Source: NIH RePORTER; NEI NIH HHS [EY04726] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; ALBUS K, 1975, EXP BRAIN RES, V24, P181, DOI 10.1007/BF00234062; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; AVOLI M, 1986, BRAIN RES, V370, P165, DOI 10.1016/0006-8993(86)91118-2; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; BorgGraham L, 1996, J PHYSIOLOGY-PARIS, V90, P185, DOI 10.1016/S0928-4257(97)81421-0; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V198, P237, DOI 10.1113/jphysiol.1968.sp008604; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; CREUTZFELDT OD, 1974, EXP BRAIN RES, V21, P251; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P1, DOI 10.1016/0013-4694(66)90136-2; DANIELS JD, 1975, BRAIN RES, V93, P41, DOI 10.1016/0006-8993(75)90285-1; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; DOUGLAS RJ, 1988, NATURE, V332, P642, DOI 10.1038/332642a0; DREIFUSS JJ, 1969, EXP BRAIN RES, V9, P137, DOI 10.1007/BF00238327; EYSEL UT, 1990, EXP BRAIN RES, V80, P626; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P217, DOI 10.1113/jphysiol.1985.sp015821; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FERSTER D, 1992, J NEUROSCI, V12, P1262; GAREY LJ, 1971, PROC R SOC SER B-BIO, V179, P41, DOI 10.1098/rspb.1971.0080; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; HAMMOND P, 1978, EXP BRAIN RES, V31, P341; HATA Y, 1988, NATURE, V335, P815, DOI 10.1038/335815a0; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; HENRY GH, 1974, VISION RES, V14, P767, DOI 10.1016/0042-6989(74)90141-2; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; KRNJEVIC K, 1966, J PHYSIOL-LONDON, V184, P16, DOI 10.1113/jphysiol.1966.sp007902; LEVAY S, 1986, J NEUROSCI, V6, P3564; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; LI CL, 1960, J NEUROPHYSIOL, V23, P592, DOI 10.1152/jn.1960.23.6.592; Maex R, 1996, J NEUROPHYSIOL, V75, P1515, DOI 10.1152/jn.1996.75.4.1515; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; PEI X, 1994, J NEUROSCI, V14, P7130; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; RAMOA AS, 1986, NATURE, V321, P237, DOI 10.1038/321237a0; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; ROSE D, 1974, EXP BRAIN RES, V20, P1; ROSE D, 1977, J PHYSIOL-LONDON, V271, P1; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TROYER TW, 1998, IN PRESS J NEUROSCI, V18; TSO DY, 1986, J NEUROSCI, V6, P1160; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351; WATANABE S, 1966, EXP BRAIN RES, V1, P272; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; WINFIELD DA, 1983, BRAIN RES, V277, P223, DOI 10.1016/0006-8993(83)90929-0; WORGOTTER F, 1990, EUR J NEUROSCI, V2, P928, DOI 10.1111/j.1460-9568.1990.tb00005.x	69	200	202	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1998	20	6					1177	1189		10.1016/S0896-6273(00)80498-5	http://dx.doi.org/10.1016/S0896-6273(00)80498-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZY493	9655505	Bronze			2022-12-24	WOS:000074627300013
J	Kim, JH; Liao, DZ; Lau, LF; Huganir, RL				Kim, JH; Liao, DZ; Lau, LF; Huganir, RL			SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family	NEURON			English	Article							POSTSYNAPTIC DENSITY PROTEIN; LONG-TERM POTENTIATION; TUMOR-SUPPRESSOR PROTEIN; MESSENGER-RNA EXPRESSION; NEUROTROPHIC FACTOR; KINASE-C; GLUTAMATE RECEPTORS; BINDING-PROTEIN; RAT-BRAIN; BDNF	The PSD-95/SAP90 family of proteins has recently been implicated in the organization of synaptic structure. Here, we describe the isolation of a novel Ras-GTPase activating protein, SynGAP, that interacts with the PDZ domains of PSD-95 and SAP102 in vitro and in vivo. SynGAP is selectively expressed in brain and is highly enriched at excitatory synapses, where it is present in a large macromolecular complex with PSD-95 and the NMDA receptor. SynGAP stimulates the GTPase activity of Ras, suggesting that it negatively regulates Ras activity at excitatory synapses. Ras signaling at the postsynaptic membrane may be involved in the modulation of excitatory synaptic transmission by NMDA receptors and neurotrophins. These results indicate that SynGAP may play an important role in the modulation of synaptic plasticity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.				NINDS NIH HHS [T32NS07368] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007368] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banker G., 1991, CULTURING NERVE CELL; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; CARLIN RK, 1983, J CELL BIOL, V96, P443, DOI 10.1083/jcb.96.2.443; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; GWAG BJ, 1993, NEUROREPORT, V5, P125, DOI 10.1097/00001756-199311180-00007; Hunt CA, 1996, J NEUROSCI, V16, P1380; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1995, SCIENCE, V269, P1737; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; LUO JH, 1993, J BIOL CHEM, V268, P23580; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; PERIN MS, 1991, J BIOL CHEM, V266, P623; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	69	471	495	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					683	691		10.1016/S0896-6273(00)81008-9	http://dx.doi.org/10.1016/S0896-6273(00)81008-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581761	hybrid			2022-12-24	WOS:000073346500008
J	Tao, X; Finkbeiner, S; Arnold, DB; Shaywitz, AJ; Greenberg, ME				Tao, X; Finkbeiner, S; Arnold, DB; Shaywitz, AJ; Greenberg, ME			Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism	NEURON			English	Article							LONG-TERM-MEMORY; NEUROTROPHIC FACTOR GENE; CAMP-RESPONSIVE ELEMENT; CENTRAL-NERVOUS-SYSTEM; FACTOR MESSENGER-RNA; C-FOS TRANSCRIPTION; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; MEMBRANE DEPOLARIZATION; BINDING-PROTEIN	CREB is a transcription factor implicated in the control of adaptive neuronal responses. Although one function of CREB in neurons is believed to be the regulation of genes whose products control synaptic function, the targets of CREB that mediate synaptic function have not yet been identified. This report describes experiments demonstrating that CREB or a closely related protein mediates Ca2+-dependent regulation of BDNF, a neurotrophin that modulates synaptic activity. In cortical neurons, Ca2+ influx triggers phosphorylation of CREB, which by binding to a critical Ca2+ response element (CRE) within the BDNF gene activates BDNF transcription. Mutation of the BDNF CRE or an adjacent novel regulatory element as well as a blockade of CREB function resulted in a dramatic loss of BDNF transcription. These findings suggest that a CREB family member acts cooperatively with an additional transcription factor(s) to regulate BDNF transcription. We conclude that the BDNF gene is a CREB family target whose protein product functions at synapses to control adaptive neuronal responses.	Harvard Univ, Sch Med, Div Neurosci, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Cardiol, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Div Neurosci, Childrens Hosp, Boston, MA 02115 USA.				NICHD NIH HHS [P30-HD 18655] Funding Source: Medline; NINDS NIH HHS [NS288829, K08 NS01817] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001817] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; CASTREN E, 1993, NEUROREPORT, V4, P895, DOI 10.1097/00001756-199307000-00014; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CohenCory S, 1996, DEV BIOL, V179, P102, DOI 10.1006/dbio.1996.0244; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DRAGUNOW M, 1993, NEUROSCI LETT, V160, P232, DOI 10.1016/0304-3940(93)90420-P; ERNFORS P, 1990, NEURON, V5, P51; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; LORIAUX MM, 1993, P NATL ACAD SCI USA, V90, P9046, DOI 10.1073/pnas.90.19.9046; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORI Y, 1993, J BIOL CHEM, V268, P26482; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; NAKAYAMA M, 1994, MOL BRAIN RES, V21, P206, DOI 10.1016/0169-328X(94)90251-8; OHARA O, 1992, GENE, V121, P383, DOI 10.1016/0378-1119(92)90148-I; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHINTANI A, 1992, BIOCHEM BIOPH RES CO, V182, P325, DOI 10.1016/S0006-291X(05)80148-2; SUN PQ, 1995, J BIOL CHEM, V270, P7041, DOI 10.1074/jbc.270.13.7041; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	80	1228	1254	3	60	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1998	20	4					709	726		10.1016/S0896-6273(00)81010-7	http://dx.doi.org/10.1016/S0896-6273(00)81010-7			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZK649	9581763	Bronze			2022-12-24	WOS:000073346500010
J	McNeil, GP; Zhang, XL; Genova, G; Jackson, FR				McNeil, GP; Zhang, XL; Genova, G; Jackson, FR			A molecular rhythm mediating circadian clock output in Drosophila	NEURON			English	Article							PERIOD GENE; PROTEIN DBP; MELANOGASTER; EXPRESSION; TIMELESS; MUTANTS; LIGHT; AUTOREGULATION; TRANSCRIPTION; DEGRADATION	Analysis of the Drosophila lark gene indicates that it encodes an RNA-binding protein that functions as a regulatory element of the circadian clock output pathway controlling adult eclosion. We now demonstrate that the lark RNA-binding protein oscillates in abundance during the circadian cycle; importantly, the phasing of the lark rhythm is consistent with gene-dosage studies, which indicate that the protein behaves as a repressor molecule. The lark protein rhythm persists in constant conditions (continuous darkness and constant temperature) and is eliminated by period gene null mutations, confirming that it is under clock control and suggesting that it acts as an output mechanism that mediates the temporal regulation of adult eclosion. We also show that lark protein oscillates in abundance within a defined group of neuropeptide (CCAP) -containing neurons of the ventral nervous system (VNS), which in other insects are thought to comprise cellular elements of the clock output pathway regulating eclosion.	Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University	Jackson, FR (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059873] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59873] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON SL, 1994, PLANT J, V6, P457, DOI 10.1046/j.1365-313X.1994.6040457.x; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BELLPEDERSEN D, 1992, GENE DEV, V6, P2382, DOI 10.1101/gad.6.12a.2382; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; Ewer J, 1997, J EXP BIOL, V200, P869; Gammie SC, 1997, J NEUROSCI, V17, P4389; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; HUNT T, 1992, J CELL BIOL, V116, P707, DOI 10.1083/jcb.116.3.707; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Kreps JA, 1997, PLANT CELL, V9, P297, DOI 10.1105/tpc.9.3.297; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mittag M, 1996, P NATL ACAD SCI USA, V93, P14401, DOI 10.1073/pnas.93.25.14401; MORSE DS, 1990, TRENDS BIOCHEM SCI, V15, P262, DOI 10.1016/0968-0004(90)90050-L; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Newby LM, 1996, J NEUROBIOL, V31, P117, DOI 10.1002/(SICI)1097-4695(199609)31:1<117::AID-NEU10>3.0.CO;2-I; NEWBY LM, 1993, GENETICS, V135, P1077; NEWBY LM, 1991, GENETICS, V128, P571; NEWBY LM, 1991, J NEUROGENET, V7, P85, DOI 10.3109/01677069109066213; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Rosbash M, 1996, COLD SPRING HARB SYM, V61, P265; Rouyer F, 1997, EMBO J, V16, P3944, DOI 10.1093/emboj/16.13.3944; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; TEI H, 1997, NATURE, V389, P612; VanGelder RN, 1996, EMBO J, V15, P1625, DOI 10.1002/j.1460-2075.1996.tb00507.x; Worden, 1974, NEUROSCIENCES 3RD ST, P437; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Young MW, 1996, COLD SPRING HARB SYM, V61, P279; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	43	96	101	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					297	303		10.1016/S0896-6273(00)80457-2	http://dx.doi.org/10.1016/S0896-6273(00)80457-2			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491990	Bronze			2022-12-24	WOS:000072154700014
J	Speicher, S; Garcia-Alonso, L; Carmena, A; Martin-Bermudo, MD; de la Escalera, S; Jimenez, F				Speicher, S; Garcia-Alonso, L; Carmena, A; Martin-Bermudo, MD; de la Escalera, S; Jimenez, F			Neurotactin functions in concert with other identified CAMs in growth cone guidance in Drosophila	NEURON			English	Article							CELL-ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; PROTEIN-TYROSINE PHOSPHATASES; GENETIC-ANALYSIS; IMMUNOGLOBULIN SUPERFAMILY; TRANSMEMBRANE PROTEIN; SERINE ESTERASES; FASCICLIN-II; EXPRESSION; CNS	We have isolated and characterized mutations in Drosophila neurotactin, a gene that encodes a cell adhesion protein widely expressed during neural development. Analysis of both loss and gain of gene function conditions during embryonic and postembryonic development revealed specific requirements for neurotactin during axon outgrowth, fasciculation, and guidance. Furthermore, embryos of some double mutant combinations of neurotactin and other genes encoding adhesion/signaling molecules, including neuroglian, derailed, and kekkon1, displayed phenotypic synergy. This result provides evidence for functional cooperativity in vivo between the adhesion and signaling pathways controlled by neorotactin and the other three genes.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Jimenez, F (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Martin Bermudo, M Dolores/L-2306-2014; Carmena, Ana/H-3506-2015; Garcia-Alonso, Luis A/A-3403-2008	Martin Bermudo, M Dolores/0000-0002-8060-1695; Carmena, Ana/0000-0003-1855-7934; Garcia-Alonso, Luis A/0000-0001-5866-3542				AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; BARTHALAY Y, 1990, EMBO J, V9, P3603, DOI 10.1002/j.1460-2075.1990.tb07571.x; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BOSSING T, 1994, DEVELOPMENT, V120, P1895; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Butler SJ, 1997, DEVELOPMENT, V124, P781; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; Darboux I, 1996, EMBO J, V15, P4835, DOI 10.1002/j.1460-2075.1996.tb00864.x; DELAESCALERA S, 1990, EMBO J, V9, P3593, DOI 10.1002/j.1460-2075.1990.tb07570.x; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Fashena SJ, 1995, CURR BIOL, V5, P1367, DOI 10.1016/S0960-9822(95)00272-7; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GarciaAlonso L, 1996, DEVELOPMENT, V122, P2611; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GREENINGLOH G, 1991, CELL, V67, P45; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; Hall SG, 1997, J NEUROBIOL, V32, P325, DOI 10.1002/(SICI)1097-4695(199703)32:3<325::AID-NEU6>3.3.CO;2-N; HALTER DA, 1995, DEVELOPMENT, V121, P317; HAMILTON BA, 1995, ROUX ARCH DEV BIOL, V204, P187, DOI 10.1007/BF00241271; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; HORTSCH M, 1990, DEVELOPMENT, V110, P1327; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; JACOBS JR, 1989, NEURON, V2, P1625; JACOBS JR, 1989, J NEUROSCI, V9, P2402; KANIA A, 1995, ROUX ARCH DEV BIOL, V204, P259, DOI 10.1007/BF00208493; KEINES R, 1995, CELL, V83, P161; KELLER EB, 1985, NUCLEIC ACIDS RES, V13, P4971, DOI 10.1093/nar/13.13.4971; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; Muller Ulrich, 1995, Current Opinion in Neurobiology, V5, P36, DOI 10.1016/0959-4388(95)80084-0; Musacchio M, 1996, DEV BIOL, V178, P63, DOI 10.1006/dbio.1996.0198; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; OLSON PF, 1990, EMBO J, V9, P1219, DOI 10.1002/j.1460-2075.1990.tb08229.x; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; ROBERTSON HM, 1988, GENETICS, V118, P461; ROMANI S, 1987, EMBO J, V6, P2085, DOI 10.1002/j.1460-2075.1987.tb02474.x; Rutishauser U, 1993, Curr Opin Neurobiol, V3, P709, DOI 10.1016/0959-4388(93)90142-L; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; Zhang SD, 1996, GENE DEV, V10, P1108, DOI 10.1101/gad.10.9.1108; ZHONG Y, 1995, J NEUROSCI, V15, P6679	67	54	56	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1998	20	2					221	233		10.1016/S0896-6273(00)80451-1	http://dx.doi.org/10.1016/S0896-6273(00)80451-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YY510	9491984	Bronze			2022-12-24	WOS:000072154700008
J	Flint, AC; Liu, XL; Kriegstein, AR				Flint, AC; Liu, XL; Kriegstein, AR			Nonsynaptic glycine receptor activation during early neocortical development	NEURON			English	Article							CEREBRAL CORTICAL-NEURONS; DEVELOPING RAT-BRAIN; SYNAPTIC LOCALIZATION; REGIONAL DISTRIBUTION; NEURITE OUTGROWTH; TAURINE RELEASE; PRIMARY CULTURE; DEVELOPING MICE; VISUAL-CORTEX; AMINO-ACIDS	Glycine receptors (GlyRs) contribute to fast inhibitory synaptic transmission in the brain stem and spinal cord. GlyR subunits are expressed in the developing neocortex, but a neurotransmitter system involving cortical GlyRs has yet to be demonstrated. Here, we show that GlyRs in immature neocortex are excitatory and activated by a nonsynaptically released endogenous ligand. Of the potential ligands for cortical GlyRs, taurine is by far the most abundant in the developing neocortex. We found that taurine is stored in immature cortical neurons and that manipulations known to elevate extracellular taurine cause GlyR activation. These data indicate that nonsynaptically released taurine activates GlyRs during neocortical development. As fetal taurine deprivation can cause cortical dysgenesis, it is possible that taurine influences neocortical development by activating GlyRs.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Columbia University; Columbia University	Flint, AC (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.			Flint, Alexander/0000-0002-3721-2694	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21223] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGRAWAL HC, 1971, BIOCHEM J, V122, P759, DOI 10.1042/bj1220759; APRISON MH, 1969, COMP BIOCHEM PHYSIOL, V28, P1345, DOI 10.1016/0010-406X(69)90571-4; BECKER CM, 1993, BRAIN RES, V606, P220, DOI 10.1016/0006-8993(93)90988-Y; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; BETZ H, 1994, J PHYSIOLOGY-PARIS, V88, P243, DOI 10.1016/0928-4257(94)90087-6; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; BURGARD EC, 1993, J NEUROPHYSIOL, V69, P230, DOI 10.1152/jn.1993.69.1.230; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chen DZ, 1996, NEUROCHEM INT, V28, P601, DOI 10.1016/0197-0186(95)00110-7; CLARK RM, 1976, J PHYSIOL-LONDON, V262, P383, DOI 10.1113/jphysiol.1976.sp011600; CLEMENTS JR, 1990, J ELECTRON MICR TECH, V15, P49, DOI 10.1002/jemt.1060150106; COLLINS GCS, 1974, BRIT J PHARMACOL, V50, pP451; Conejero C, 1997, AM J PHYSIOL-CELL PH, V272, pC1457; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; DEBELLEROCHE JS, 1973, J NEUROCHEM, V21, P441, DOI 10.1111/j.1471-4159.1973.tb04264.x; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; Flint AC, 1997, J NEUROSCI, V17, P2469; FROSTHOLM A, 1985, BRAIN RES BULL, V15, P473, DOI 10.1016/0361-9230(85)90038-3; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; Hussy N, 1997, J PHYSIOL-LONDON, V502, P609, DOI 10.1111/j.1469-7793.1997.609bj.x; HUXTABLE RJ, 1980, FED PROC, V39, P2685; ITO S, 1991, J PHYSIOL-LONDON, V440, P67, DOI 10.1113/jphysiol.1991.sp018696; Jones Edward G., 1995, P111; KIM HG, 1995, CEREB CORTEX, V5, P148, DOI 10.1093/cercor/5.2.148; KISHI M, 1988, BIOCHIM BIOPHYS ACTA, V939, P615, DOI 10.1016/0005-2736(88)90109-5; KOCSIS JD, 1994, J NEUROBIOL, V25, P252, DOI 10.1002/neu.480250306; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KRIEGSTEIN AR, 1987, DEV BRAIN RES, V34, P161, DOI 10.1016/0165-3806(87)90206-9; KRNJEVIC K, 1981, HDB PHYSL, P107; KUBO T, 1992, J PHARMACOBIO-DYNAM, V15, P519, DOI 10.1248/bpb1978.15.519; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KWON HM, 1995, CURR OPIN CELL BIOL, V7, P465, DOI 10.1016/0955-0674(95)80002-6; LEHMANN A, 1984, J NEUROCHEM, V42, P1286, DOI 10.1111/j.1471-4159.1984.tb02785.x; LOMBARDINI JB, 1978, TAURINE NEUROLOGICAL, P119; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; LU PM, 1991, INT J DEV NEUROSCI, V9, P621, DOI 10.1016/0736-5748(91)90024-G; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MATZENBACH B, 1994, J BIOL CHEM, V269, P2607; NEAL MJ, 1971, J PHYSIOL-LONDON, V215, P103, DOI 10.1113/jphysiol.1971.sp009460; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Ohkuma S, 1996, ADV EXP MED BIOL, V403, P417; OHKUMA S, 1986, INT J DEV NEUROSCI, V4, P383, DOI 10.1016/0736-5748(86)90056-0; Oja SS, 1996, NEUROCHEM RES, V21, P161, DOI 10.1007/BF02529133; OJA SS, 1992, J NEUROSCI RES, V32, P551, DOI 10.1002/jnr.490320410; OLEA RS, 1991, J MEMBRANE BIOL, V121, P1, DOI 10.1007/BF01870646; Owens DF, 1996, J NEUROSCI, V16, P6414; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; SANCHEZOLEA R, 1995, AM J PHYSIOL-CELL PH, V269, pC1280, DOI 10.1152/ajpcell.1995.269.5.C1280; SATO K, 1992, BRAIN RES, V590, P95, DOI 10.1016/0006-8993(92)91085-S; Schell MJ, 1997, J NEUROSCI, V17, P1604; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SMITH JE, 1975, ANAL BIOCHEM, V64, P149, DOI 10.1016/0003-2697(75)90417-0; SMITH KE, 1992, MOL PHARMACOL, V42, P563; SOLEM M, 1995, J NEUROSCI, V15, P5966; STURMAN JA, 1977, PEDIATR RES, V11, P28, DOI 10.1203/00006450-197711010-00008; STURMAN JA, 1986, ANN NY ACAD SCI, V477, P196, DOI 10.1111/j.1749-6632.1986.tb40337.x; STURMAN JA, 1978, TAURINE NEUROLOGICAL, P49; Stutzin A, 1997, AM J PHYSIOL-CELL PH, V273, pC999, DOI 10.1152/ajpcell.1997.273.3.C999; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; VANDENPOL AN, 1988, J NEUROSCI, V8, P472; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x	66	265	275	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1998	20	1					43	53		10.1016/S0896-6273(00)80433-X	http://dx.doi.org/10.1016/S0896-6273(00)80433-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YU459	9459441	hybrid			2022-12-24	WOS:000071719700008
J	Fon, EA; Pothos, EN; Sun, BC; Killeen, N; Sulzer, D; Edwards, RH				Fon, EA; Pothos, EN; Sun, BC; Killeen, N; Sulzer, D; Edwards, RH			Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action	NEURON			English	Article							MOUSE FETAL DEVELOPMENT; TYROSINE-HYDROXYLASE; SYNAPTIC VESICLES; NEUROTRANSMITTER TRANSPORTERS; ACETYLCHOLINE TRANSPORTER; SUBSTRATE RECOGNITION; CHROMAFFIN GRANULES; AMINE TRANSPORTER; REVERSE TRANSPORT; HUMAN BRAIN	To assess the role of exocytotic release in signaling by monoamines, we have disrupted the neuronal vesicular monoamine transporter 2 (VMAT2) gene. VMAT2(-/-) mice move little, feed poorly, and die within a few days after birth. Monoamine cell groups and their projections are indistinguishable from those of wild-type littermates, but the brains of mutant mice show a drastic reduction in monoamines. Using midbrain cultures from the mutant animals, amphetamine but not depolarization induces dopamine release. In vivo, amphetamine increases movement, promotes feeding, and prolongs the survival of VMAT2(-/-) animals, indicating that precise, temporally regulated exocytotic release of monoamine is not required for certain complex behaviors. In addition, the brains of VMAT2 heterozygotes contain substantially lower monoamine levels than those of wild-type littermates, and depolarization induces less dopamine release from heterozygous than from wild-type cultures, suggesting that VMAT2 expression regulates monoamine storage and release.	Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, Grad Program Cell Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Cell Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, Grad Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Immunol & Microbiol, San Francisco, CA 94143 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Columbia University	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Neurosci, San Francisco, CA 94143 USA.			Pothos, Emmanuel/0000-0001-8825-7852				ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; BOADLEBIBER MC, 1993, PROG BIOPHYS MOL BIO, V60, P1, DOI 10.1016/0079-6107(93)90009-9; Brannan T, 1996, J NEURAL TRANSM, V103, P1287, DOI 10.1007/BF01271189; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CHEN K, 1990, CATECHOLAMINES BRIDG, P292; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Finn JP, 1997, J BIOL CHEM, V272, P16301, DOI 10.1074/jbc.272.26.16301; FISHELL G, 1987, J NEUROSCI, V7, P1969; FLORIN SM, 1995, J PHARMACOL EXP THER, V274, P231; Frize E.D., 1954, NEW ENGL J MED, V251, P1006; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gilmor ML, 1996, J NEUROSCI, V16, P2179; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GRAYBIEL AM, 1981, P NATL ACAD SCI-BIOL, V78, P5871, DOI 10.1073/pnas.78.9.5871; JOHNSON MP, 1988, J SCHOOL HEALTH, V58, P232, DOI 10.1111/j.1746-1561.1988.tb05871.x; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Krantz DE, 1997, J BIOL CHEM, V272, P6752, DOI 10.1074/jbc.272.10.6752; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; MARON R, 1983, J BIOL CHEM, V258, P1476; MELEGA WP, 1995, J PHARMACOL EXP THER, V274, P90; Mena MA, 1997, J NEUROCHEM, V69, P21; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Napolitano A, 1995, J NEURAL TRANSM-SUPP, P35; PERLMAN RL, 1982, BIOCHIM BIOPHYS ACTA, V719, P334, DOI 10.1016/0304-4165(82)90107-6; PETER D, 1994, J BIOL CHEM, V269, P7231; PETER D, 1995, J NEUROSCI, V15, P6179; PIERCE RC, 1995, J PHARMACOL EXP THER, V275, P1019; Pothos E, 1996, J NEUROCHEM, V66, P629; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Robinson TE, 1991, TANIGUCHI S BRAIN SC, P185; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SAURA J, 1992, J NEUROSCI, V12, P1977; SCHELLER RH, 1995, NEURON, V14, P893; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; SPECTOR S, 1967, MOL PHARMACOL, V3, P549; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; Sulzer D, 1996, MOL PHARMACOL, V49, P338; SULZER D, 1995, J NEUROSCI, V15, P4102; SULZER D, 1990, NEURON, V5, P797, DOI 10.1016/0896-6273(90)90339-H; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730; WESTLUND KN, 1988, NEUROSCIENCE, V25, P439, DOI 10.1016/0306-4522(88)90250-3; WISE RA, 1990, PSYCHOTROPIC DRUGS A, P23; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	62	254	259	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1997	19	6					1271	1283		10.1016/S0896-6273(00)80418-3	http://dx.doi.org/10.1016/S0896-6273(00)80418-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427250	hybrid			2022-12-24	WOS:000071236500014
J	Shearman, LP; Zylka, MJ; Weaver, DR; Kolakowski, LF; Reppert, SM				Shearman, LP; Zylka, MJ; Weaver, DR; Kolakowski, LF; Reppert, SM			Two period homologs: Circadian expression and photic regulation in the suprachiasmatic nuclei	NEURON			English	Article							SILKMOTH ANTHERAEA-PERNYI; MULTIPLE SEQUENCE ALIGNMENTS; CLOCK GENE; TIMELESS; RHYTHMS; PROTEIN; LIGHT; MECHANISMS; BEHAVIOR; NEURONS	We have characterized a mammalian homolog of the Drosophila period gene and designated it Per?. The PERS protein shows >40% amino acid identity to the protein of another mammalian per homolog (designated Per1) that was recently cloned and characterized. Both PER1 and PER2 proteins share several regions of homology with the Drosophila PER protein, including the protein dimerization PAS domain. Phylogenetic analysis supports the existence of a family of mammalian per genes. In the mouse, Per1 and Per2 RNA levels exhibit circadian rhythms in the SCN and eyes, sites of circadian clocks. Both Per1 and Per2 RNAs in the SCN are increased by light exposure during subjective night but not during subjective day. The results advance our knowledge of candidate clock elements in mammals.	Massachusetts Gen Hosp, Lab Dev Chronobiol Pediat Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health San Antonio	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Lab Dev Chronobiol Pediat Serv, Boston, MA 02114 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Weaver, David/0000-0001-7941-6719	NICHD NIH HHS [R37 HD14427] Funding Source: Medline; NIMH NIH HHS [MH11547] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011547] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; EWER J, 1992, J NEUROSCI, V12, P3321; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; HALL JC, 1995, TRENDS NEUROSCI, V18, P230, DOI 10.1016/0166-2236(95)93908-G; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; REPPERT SM, 1995, CIBA F SYMP, V183, P198; Reppert SM, 1997, CELL, V89, P487, DOI 10.1016/S0092-8674(00)80229-9; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; Sauman I, 1996, NEURON, V17, P901, DOI 10.1016/S0896-6273(00)80221-4; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; SWOFFORD DL, 1991, PAUP PHYLOGENETIC AN; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Weaver DR, 1996, DEV BRAIN RES, V94, P205, DOI 10.1016/0165-3806(96)00049-1; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; ZATZ M, 1992, DISCUSS NEUROSCI, V8, P67; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	34	620	639	1	38	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1997	19	6					1261	1269		10.1016/S0896-6273(00)80417-1	http://dx.doi.org/10.1016/S0896-6273(00)80417-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP053	9427249	Bronze			2022-12-24	WOS:000071236500013
J	Zito, K; Fetter, RD; Goodman, CS; Isacoff, EY				Zito, K; Fetter, RD; Goodman, CS; Isacoff, EY			Synaptic clustering of Fasciclin II and Shaker: Essential targeting sequences and role of Dlg	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; FUNCTIONAL COMPONENTS; POTASSIUM-CHANNEL; DROSOPHILA; PROTEIN; PLASTICITY; JUNCTION; PSD-95; FAMILY; RECOGNITION	Previous studies have shown that both the Fasciclin II (Fas II) cell adhesion molecule and the Shaker potassium channel are localized at the Drosophila neuromuscular junction, where they function in the growth and plasticity of the synapse. Here, we use the GAL4-UAS system to drive expression of the chimeric proteins CD8-Fas II and CD8-Shaker and show that the C-terminal sequences of both Fas II and Shaker are necessary and sufficient to drive the synaptic localization of a heterologous protein. Moreover, we show that the PDZ-containing protein Discs-Large (Dlg) controls the localization of these proteins, most likely through a direct interaction with their C-terminal amino acids. Finally, transient expression studies show that the pathway these proteins take to the synapse involves either an active clustering or a selective stabilization in the synaptic membrane.	UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	Zito, K (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DIV NEUROBIOL,BERKELEY,CA 94720, USA.		isacoff, ehud/AAP-1459-2020	Zito, Karen/0000-0002-0799-0460; Isacoff, Ehud Y./0000-0003-4775-9359	NICHD NIH HHS [HD21294] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Sheng M, 1997, NATURE, V386, P221, DOI 10.1038/386221a0; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; ZHONG Y, 1992, J NEUROSCI, V12, P644	34	180	184	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1997	19	5					1007	1016		10.1016/S0896-6273(00)80393-1	http://dx.doi.org/10.1016/S0896-6273(00)80393-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH594	9390515	Bronze			2022-12-24	WOS:A1997YH59400009
J	Burrows, RC; Wancio, D; Levitt, P; Lillien, L				Burrows, RC; Wancio, D; Levitt, P; Lillien, L			Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex	NEURON			English	Article							EPIDERMAL GROWTH-FACTOR; CEREBRAL CORTICAL PROGENITORS; EMBRYONIC VENTRAL ECTODERM; POSTNATAL RAT FOREBRAIN; SUBVENTRICULAR ZONE; NEURONAL DIFFERENTIATION; FACTOR RECEPTOR; MOUSE-BRAIN; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM	Early cortical progenitor cells of the ventricular zone (VZ) differ from later progenitor cells of the subventricular zone (SVZ) in cell-type generation and their level of epidermal growth factor receptors (EGFRs). To determine whether differences in their behavior are causally related to EGFR number/density, we introduced extra EGFRs into VZ cells with a retrovirus in vivo and in vitro. This results in premature expression of traits characteristic of late SVZ progenitor cells, including migration patterns, differentiation into astrocytes, and proliferation of multipotential cells to form spheres. The choice between proliferation and differentiation depends on ligand concentration and progenitor cell age and may reflect different thresholds of stimulation. The level of EGFRs expressed by progenitor cells in the cortex may therefore contribute to the timing of their maturation and choice of response to pleiotropic environmental signals.	UNIV PITTSBURGH,DEPT NEUROBIOL,PITTSBURGH,PA 15261; ALLEGHENY UNIV HLTH SCI,DEPT ANAT & NEUROBIOL,PHILADELPHIA,PA 19129; UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT NEUROSCI & CELL BIOL,PISCATAWAY,NJ 08854	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Drexel University; Rutgers State University New Brunswick; Rutgers State University Medical Center					NIMH NIH HHS [MH45507] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH045507, R01MH045507] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; AHMED S, 1995, J NEUROSCI, V15, P5765; ANGULO Y, 1992, ANAT REC, V52, P117; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; AUSUBLE F, 1995, SHORT PROTOCOLS MOL; BARRES BA, 1993, DEVELOPMENT, V118, P283; Bayer S.A., 1991, NEOCORTICAL DEV; BAYER SA, 1990, EXP NEUROL, V107, P48, DOI 10.1016/0014-4886(90)90062-W; BERRY M, 1964, J ANAT, V98, P291; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; *BOULD COMM, 1970, ANAT REC, V166, P257; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Craig CG, 1996, J NEUROSCI, V16, P2649; CRANDALL JE, 1989, J NEUROCHEM, V53, P1910, DOI 10.1111/j.1471-4159.1989.tb09261.x; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; Eagleson KL, 1997, DEVELOPMENT, V124, P1623; Eagleson KL, 1996, CEREB CORTEX, V6, P540, DOI 10.1093/cercor/6.3.540; Ferri RT, 1996, DEV BIOL, V175, P184, DOI 10.1006/dbio.1996.0106; FERRI RT, 1995, DEVELOPMENT, V121, P1151; FERRI RT, 1993, CEREB CORTEX, V3, P187, DOI 10.1093/cercor/3.3.187; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gabay L, 1996, DEVELOPMENT, V122, P3355; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Golembo M, 1996, DEVELOPMENT, V122, P3363; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; Hussain R. J., 1996, Society for Neuroscience Abstracts, V22, P1961; IGNACIO MPD, 1995, ANAT EMBRYOL, V191, P89; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; KONIG N, 1977, NEUROSCI LETT, V4, P21, DOI 10.1016/0304-3940(77)90118-5; Kornblum HI, 1997, J COMP NEUROL, V380, P243, DOI 10.1002/(SICI)1096-9861(19970407)380:2<243::AID-CNE7>3.0.CO;2-3; KORSCHING S, 1993, J NEUROSCI, V13, P2739; Kostovic I., 1975, RAD JAZU, V371, P155; LAZAR LM, 1992, J NEUROSCI, V12, P1688; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LILLIEN L, 1992, DEVELOPMENT, V115, P253; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; LILLIEN LE, 1985, NATURE, V317, P632, DOI 10.1038/317632a0; LONG J. A., 1938, UNIV CALIFORNIA PUBL ZOOL, V43, P143; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; MAGAUD JJ, 1988, J HISTOCHEM CYTOCHEM, V37, P1517; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; PINKASKRAMARSKI R, 1996, EMBO J, V15, P2542; PRIGENT S A, 1992, Progress in Growth Factor Research, V4, P1, DOI 10.1016/0955-2235(92)90002-Y; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAZ E, 1993, GENE DEV, V7, P1937, DOI 10.1101/gad.7.10.1937; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; SEROOGY KB, 1995, BRAIN RES, V670, P157, DOI 10.1016/0006-8993(94)01300-7; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; SMART IHM, 1982, J ANAT, V134, P273; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; VALVERDE F, 1995, CEREB CORTEX, V5, P483, DOI 10.1093/cercor/5.6.483; VELU TJ, 1989, J CELL BIOCHEM, V39, P153, DOI 10.1002/jcb.240390207; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WEICKERT CS, 1995, DEV BRAIN RES, V86, P206; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; YAMADA M, 1995, EUR J NEUROSCI, V7, P2130, DOI 10.1111/j.1460-9568.1995.tb00635.x; ZERLIN M, 1995, J NEUROSCI, V15, P7238; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; ZHOU JW, 1994, DEV BRAIN RES, V81, P318, DOI 10.1016/0165-3806(94)90318-2	89	263	266	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1997	19	2					251	267		10.1016/S0896-6273(00)80937-X	http://dx.doi.org/10.1016/S0896-6273(00)80937-X			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU146	9292717	Bronze			2022-12-24	WOS:A1997XU14600006
J	Hamilton, BA; Smith, DJ; Mueller, KL; Kerrebrock, AW; Bronson, RT; vanBerkel, V; Daly, MJ; Kruglyak, L; Reeve, MP; Nemhauser, JL; Hawkins, TL; Rubin, EM; Lander, ES				Hamilton, BA; Smith, DJ; Mueller, KL; Kerrebrock, AW; Bronson, RT; vanBerkel, V; Daly, MJ; Kruglyak, L; Reeve, MP; Nemhauser, JL; Hawkins, TL; Rubin, EM; Lander, ES			The vibrator mutation causes neurodegeneration via reduced expression of PITP alpha: Positional complementation cloning and extragenic suppression	NEURON			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; NEUROTROPHIC FACTOR PREVENTS; YEAST SECRETORY PATHWAY; RETINAL-DEGENERATION; GOLGI-COMPLEX; MOTOR NEURONS; GENE ENCODES; DROSOPHILA; TRANSPORT; MUTANT	The mouse vibrator mutation causes an early-onset progressive action tremor, degeneration of brain stem and spinal cord neurons, and juvenile death. We cloned the vibrator mutation using an in vivo positional complementation approach and complete resequencing of the resulting 76 kb critical region from vibrator and its parental chromosome. The mutation is an intracisternal A particle retroposon insertion in intron 4 of the phosphatidylinositol transfer protein alpha gene, causing a 5-fold reduction in RNA and protein levels. Expression of neurofilament light chain is also reduced in vibrator, suggesting one signaling pathway that may underlie vibrator pathology. The vibrator phenotype is suppressed in one intercross. We performed a complete genome scan and mapped a major suppressor locus (Mvb-1) to proximal chromosome 19.	WHITEHEAD INST BIOMED RES,CAMBRIDGE CTR 9,CAMBRIDGE,MA 02142; UNIV CALIF BERKELEY,CTR HUMAN GENOME,BERKELEY,CA 94720; TUFTS UNIV,SCH MED,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,BOSTON,MA 02111; JACKSON LAB,BAR HARBOR,ME 04609; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley; Tufts University; Tufts University; Jackson Laboratory; Massachusetts Institute of Technology (MIT)			Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Hamilton, Bruce/0000-0001-5599-9139				ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AQUA MS, 1991, GENE, V104, P211, DOI 10.1016/0378-1119(91)90252-7; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; COOK SA, 1995, MAMM GENOME, V6, P187, DOI 10.1007/BF00293010; Cossee M, 1997, NAT GENET, V15, P337, DOI 10.1038/ng0497-337; CUNNINGHAM E, 1995, CURR BIOL, V5, P775, DOI 10.1016/S0960-9822(95)00154-0; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; HAGG T, 1992, NEURON, V8, P145, DOI 10.1016/0896-6273(92)90116-U; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HAWLEY RG, 1982, P NATL ACAD SCI-BIOL, V79, P7425, DOI 10.1073/pnas.79.23.7425; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; KAUFFMANNZEH A, 1995, SCIENCE, V268, P1188, DOI 10.1126/science.7761838; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; LEMARCHE J, 1982, CAN J NEUROL SCI, V9, P137; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; OHASHI M, 1995, NATURE, V377, P544, DOI 10.1038/377544a0; OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817; Perou CM, 1996, P NATL ACAD SCI USA, V93, P5905, DOI 10.1073/pnas.93.12.5905; SAHLY I, 1992, P NATL ACAD SCI USA, V89, P435, DOI 10.1073/pnas.89.1.435; Sambrook J., 2002, MOL CLONING LAB MANU; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SMITH DJ, 1995, GENOMICS, V27, P425, DOI 10.1006/geno.1995.1073; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; STRATHMANN M, 1991, P NATL ACAD SCI USA, V88, P1247, DOI 10.1073/pnas.88.4.1247; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; VIHTELIC TS, 1991, GENETICS, V127, P761; WEIMAR WR, 1982, BRAIN RES, V251, P357, DOI 10.1016/0006-8993(82)90754-5; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0	49	155	161	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1997	18	5					711	722		10.1016/S0896-6273(00)80312-8	http://dx.doi.org/10.1016/S0896-6273(00)80312-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB722	9182797	Bronze			2022-12-24	WOS:A1997XB72200006
J	Hanlon, DW; Yang, ZH; Goldstein, LSB				Hanlon, DW; Yang, ZH; Goldstein, LSB			Characterization of KIFC2, a neuronal kinesin superfamily member in mouse	NEURON			English	Article							END-DIRECTED MOTOR; MEMBRANOUS ORGANELLES INVIVO; AXONAL-TRANSPORT; MITOTIC SPINDLE; DROSOPHILA KINESIN; MICROTUBULE MOTOR; SYNAPTIC VESICLES; MONOMERIC MOTOR; HEAVY-CHAIN; C-ELEGANS	Members of the kinesin superfamily of microtubule-associated proteins are involved in a variety of intracellular processes including cell division and organelle transport. In the case of axonal transport, all kinesin superfamily members reported thus far appear to play a role in anterograde transport, while a different type of microtubule motor, dynein, appears to function in retrograde transport. To better understand the role of kinesins in axonal transport, we cloned and characterized KIFC2, a novel kinesin superfamily member from mouse brain. KIFC2 encodes a 792 amino acid protein, which contains the conserved motor domain at the C-terminal end of the protein and is most similar to members of the KAR3 family involved in cell division. However, expression analysis localized KIFC2 mRNA to nonproliferative neuronal cells in the central nervous system, and immunolocalization studies demonstrated that KIFC2 is present in axons and dendrites of neurons in the central and peripheral nervous systems. Immunolocalization and biochemical fractionation studies suggest that KIFC2 localizes with some, but not all, axonally transported organelles. Finally, ligation of mouse peripheral nerves showed that KlFC2 accumulates at the proximal and distal sides of an axonal ligature. Taken together, the data suggest that, unlike other C-terminal motor proteins that appear to be involved in cell division, KIFC2 may play a role in retrograde axonal transport.			Hanlon, DW (corresponding author), UNIV CALIF SAN DIEGO,DEPT PHARMACOL,HOWARD HUGHES MED INST,DIV CELLULAR & MOL MED,LA JOLLA,CA 92093, USA.							BARTON NR, 1995, MOL BIOL CELL, V6, P1563, DOI 10.1091/mbc.6.11.1563; BRADY ST, 1995, TRENDS CELL BIOL, V5, P159, DOI 10.1016/S0962-8924(00)88980-1; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1601; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLE DG, 1994, J BIOL CHEM, V269, P22913; DAHLSTROM AB, 1991, ACTA PHYSIOL SCAND, V141, P469, DOI 10.1111/j.1748-1716.1991.tb09107.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dillman JF, 1996, P NATL ACAD SCI USA, V93, P141, DOI 10.1073/pnas.93.1.141; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; GOLDSTEIN LSB, 1993, ANNU REV GENET, V27, P319; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; KURIYAMA R, 1995, J CELL BIOL, V129, P1049, DOI 10.1083/jcb.129.4.1049; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; MITSUI H, 1993, MOL GEN GENET, V238, P362, DOI 10.1007/BF00291995; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; NEIGHBORS BW, 1988, J CELL BIOL, V106, P1193, DOI 10.1083/jcb.106.4.1193; OCONNELL MJ, 1993, J CELL BIOL, V120, P153, DOI 10.1083/jcb.120.1.153; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; PESAVENTO PA, 1994, J CELL BIOL, V127, P1041, DOI 10.1083/jcb.127.4.1041; PORTER ME, 1987, J BIOL CHEM, V262, P2794; Sambrook J., 2002, MOL CLONING LAB MANU; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; SAXTON WM, 1988, P NATL ACAD SCI USA, V85, P1109, DOI 10.1073/pnas.85.4.1109; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; SCHOLEY JM, 1985, NATURE, V318, P483, DOI 10.1038/318483a0; SCHROER TA, 1989, CELL, V56, P937, DOI 10.1016/0092-8674(89)90627-2; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SMITH RS, 1980, J NEUROCYTOL, V9, P39, DOI 10.1007/BF01205226; STEWART RJ, 1991, P NATL ACAD SCI USA, V88, P8470, DOI 10.1073/pnas.88.19.8470; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; YANG JT, 1988, P NATL ACAD SCI USA, V85, P1864, DOI 10.1073/pnas.85.6.1864	50	81	85	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1997	18	3					439	451		10.1016/S0896-6273(00)81244-1	http://dx.doi.org/10.1016/S0896-6273(00)81244-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WQ074	9115737	Bronze			2022-12-24	WOS:A1997WQ07400011
J	Burne, JF; Raff, MC				Burne, JF; Raff, MC			Retinal ganglion cell axons drive the proliferation of astrocytes in the developing rodent optic nerve	NEURON			English	Article							OLIGODENDROCYTE SURVIVAL; RAT; NEURONS; GROWTH; DIFFERENTIATION; MIGRATION; ANTIGEN; INVITRO; CULTURE; DEATH	We show that the proliferation of astrocytes in the developing rodent optic nerve absolutely depends on axons and that this axonal influence depends on axonal transport but not on axonal electrical activity. We also show that purified retinal ganglion cells stimulate DNA synthesis in optic nerve astrocytes in culture and that the effect can be mimicked by fibroblast growth factor but not by neuregulins or several other growth factors. Taken together with previous findings, our present results indicate that axons promote glial cell proliferation and survival in the developing optic nerve by at least three distinct mechanisms.	UNIV LONDON UNIV COLL,DEPT BIOL,LONDON WC1E 6BT,ENGLAND	University of London; University College London	Burne, JF (corresponding author), UNIV LONDON UNIV COLL,MRC,DEV NEUROBIOL PROGRAMME,MOL CELL BIOL LAB,TORRINGTON PL,LONDON WC1E 6BT,ENGLAND.							AUSUBEL I, 1991, CURRENT PROTOCOLS MO; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BROCKES JP, 1980, J BIOL CHEM, V255, P8374; Burne JF, 1996, J NEUROSCI, V16, P2064; De longh R., 1992, GROWTH FACTORS, V6, P159; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GASSER UE, 1990, J NEUROSCI, V10, P1276; JENSEN A, 1997, IN PRESS DEVELOPMENT; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MATTHEWS MA, 1982, NEUROSCIENCE, V7, P385, DOI 10.1016/0306-4522(82)90274-3; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; PRUSS R, 1979, NATURE, V303, P390; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; SILVER J, 1979, DEV BIOL, V68, P175, DOI 10.1016/0012-1606(79)90252-5; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0	33	31	32	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1997	18	2					223	230		10.1016/S0896-6273(00)80263-9	http://dx.doi.org/10.1016/S0896-6273(00)80263-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK822	9052793	Bronze			2022-12-24	WOS:A1997WK82200006
J	Crino, PB; Eberwine, J				Crino, PB; Eberwine, J			Molecular characterization of the dendritic growth cone: Regulated mRNA transport and local protein synthesis	NEURON			English	Article							DEVELOPING RAT-BRAIN; INTERMEDIATE FILAMENT PROTEIN; HIPPOCAMPAL-NEURONS; MESSENGER-RNAS; ALPHA-INTERNEXIN; NERVOUS-SYSTEM; EXPRESSION; CULTURE; CALCIUM; GENE	The molecular mechanisms that regulate growth cone guidance of dendrite outgrowth remain to be elucidated. We hypothesized that mRNA localization in dendritic growth cones and their local protein synthesis may be important for growth cone functioning. The appearance of 23 of 31 growth cone mRNAs was developmentally regulated. Also, alteration of growth cone morphology affected the relative levels of three mRNAs. Finally, using single dendrite transfection, it was shown that local protein synthesis occurs in dendrites and growth cones. A heterogeneous population of mRNAs exists in dendritic growth cones of cultured hippocampal neurons whose relative abundances are developmentally regulated and can vary with changes in growth cone physiology. The demonstration of protein synthesis in growth cones suggests that translation of the localized mRNAs may contribute to regulation of growth cone motility and dendrite outgrowth.	UNIV PENN,SCH MED,DEPT PSYCHIAT,PHILADELPHIA,PA 19104	University of Pennsylvania	Crino, PB (corresponding author), UNIV PENN,SCH MED,DEPT PHARMACOL,36TH & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.		Eberwine, James/B-2247-2010		NIA NIH HHS [AG9900] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009900, R37AG009900] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAAS PW, 1989, J CELL BIOL, V109, P3085, DOI 10.1083/jcb.109.6.3085; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; BUCHHALTER JR, 1991, BRAIN RES BULL, V26, P333, DOI 10.1016/0361-9230(91)90003-3; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; EBERWINE J, 1995, NEUROSCIENTIST, V54, P155; FLIEGNER KH, 1994, J COMP NEUROL, V342, P161, DOI 10.1002/cne.903420202; GARNER C, 1988, NATURE, V336, P374; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; KATER SB, 1990, COLD SH Q B, V55, P359; KATER SB, 1991, J NEUROSCI, V11, P891; KUHN TB, 1995, NEURON, V14, P275, DOI 10.1016/0896-6273(95)90285-6; Lankford K, 1990, CURR OPIN CELL BIOL, V2, P80, DOI 10.1016/S0955-0674(05)80035-3; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LENDAHL U, 1990, CELL, V60, P685; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; LOCKERBIE RO, 1990, BRAIN RES REV, V15, P145, DOI 10.1016/0165-0173(90)90016-H; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MOHR E, 1991, EMBO J, V10, P2419, DOI 10.1002/j.1460-2075.1991.tb07781.x; NEELY MD, 1994, J NEUROSCI, V14, P7511; PALDINO AM, 1979, EXP NEUROL, V64, P620, DOI 10.1016/0014-4886(79)90236-X; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; POULTER M, 1993, J NEUROSCI, V12, P2888; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STEWARD O, 1986, J NEUROSCI, V6, P412; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TAYLOR J, 1989, J NEUROCHEM, V53, P834, DOI 10.1111/j.1471-4159.1989.tb11780.x; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; WEILER IJ, 1994, PROG BRAIN RES, V100, P189; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168	46	217	226	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1173	1187		10.1016/S0896-6273(00)80248-2	http://dx.doi.org/10.1016/S0896-6273(00)80248-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982164	hybrid			2022-12-24	WOS:A1996WA24800014
J	Schackwitz, WS; Inoue, T; Thomas, JH				Schackwitz, WS; Inoue, T; Thomas, JH			Chemosensory neurons function in parallel to mediate a pheromone response in C-elegans	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CONTROLLING DAUER FORMATION; GREEN FLUORESCENT PROTEIN; LARVAL DEVELOPMENT; INTERACTING GENES; ENCODES; TEMPERATURE; EXPRESSION; MUTATIONS; MUTANTS	Formation of the C. elegans dauer larva is repressed by the chemosensory neurons ADF, ASI, and ASG. Mutant analysis has defined two parallel genetic pathways that control dauer formation. By killing neurons in these mutants, we show that mutations in one of these genetic pathways disrupt dauer repression by ADF, ASI, and ASG. One gene in this pathway is daf-7, which encodes a TGF beta-related protein. We find that daf-7::GFP fusions are expressed specifically in ASI and that expression is regulated by dauer-inducing sensory stimuli. We also show that a different chemosensory neuron, ASJ, functions in parallel to these neurons to induce dauer formation. Mutations in the second genetic pathway activate dauer formation in an ASJ-dependent manner. Thus, the genetic redundancy in this process is reflected at the neuronal level.			Schackwitz, WS (corresponding author), UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195, USA.		Schackwitz, Wendy/GXH-9536-2022	Schackwitz, Wendy/0000-0002-3013-9180	NIGMS NIH HHS [T32GM07735, R10GM48700] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007735] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHE BW, 1991, SMELL TASTE HLTH DIS, P3; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; LIM CS, 1993, THESIS U MISSOURI CO; MALONE EA, 1994, GENETICS, V136, P879; Malone EA, 1996, GENETICS, V143, P1193; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; SCHILLER PH, 1982, NTURE, V297, P581; SHAKIR MA, 1993, NEUROREPORT, V4, P1151; SOLOMON JM, 1995, GENE DEV, V9, P547, DOI 10.1101/gad.9.5.547; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; TESSIERLAVIGNE M, 1991, PRINCIPLES NEURAL SC; THOMAS JH, 1993, BIOESSAYS, V15, P791, DOI 10.1002/bies.950151204; THOMAS JH, 1993, GENETICS, V134, P1105; VOWELS JJ, 1994, GENETICS, V138, P303; VOWELS JJ, 1992, GENETICS, V130, P105; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	36	229	237	1	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					719	728		10.1016/S0896-6273(00)80203-2	http://dx.doi.org/10.1016/S0896-6273(00)80203-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893028	Bronze			2022-12-24	WOS:A1996VP74300016
